<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38865168</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>21</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1533-4406</ISSN><JournalIssue CitedMedium="Internet"><Volume>391</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>22</Day></PubDate></JournalIssue><Title>The New England journal of medicine</Title><ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal><ArticleTitle>A Randomized Trial of Intravenous Amino Acids for Kidney Protection.</ArticleTitle><Pagination><StartPage>687</StartPage><EndPage>698</EndPage><MedlinePgn>687-698</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1056/NEJMoa2403769</ELocationID><Abstract><AbstractText Label="BACKGROUND">Acute kidney injury (AKI) is a serious and common complication of cardiac surgery, for which reduced kidney perfusion is a key contributing factor. Intravenous amino acids increase kidney perfusion and recruit renal functional reserve. However, the efficacy of amino acids in reducing the occurrence of AKI after cardiac surgery is uncertain.</AbstractText><AbstractText Label="METHODS">In a multinational, double-blind trial, we randomly assigned adult patients who were scheduled to undergo cardiac surgery with cardiopulmonary bypass to receive an intravenous infusion of either a balanced mixture of amino acids, at a dose of 2 g per kilogram of ideal body weight per day, or placebo (Ringer's solution) for up to 3 days. The primary outcome was the occurrence of AKI, defined according to the Kidney Disease: Improving Global Outcomes creatinine criteria. Secondary outcomes included the severity of AKI, the use and duration of kidney-replacement therapy, and all-cause 30-day mortality.</AbstractText><AbstractText Label="RESULTS">We recruited 3511 patients at 22 centers in three countries and assigned 1759 patients to the amino acid group and 1752 to the placebo group. AKI occurred in 474 patients (26.9%) in the amino acid group and in 555 (31.7%) in the placebo group (relative risk, 0.85; 95% confidence interval [CI], 0.77 to 0.94; P&#x2009;=&#x2009;0.002). Stage 3 AKI occurred in 29 patients (1.6%) and 52 patients (3.0%), respectively (relative risk, 0.56; 95% CI, 0.35 to 0.87). Kidney-replacement therapy was used in 24 patients (1.4%) in the amino acid group and in 33 patients (1.9%) in the placebo group. There were no substantial differences between the two groups in other secondary outcomes or in adverse events.</AbstractText><AbstractText Label="CONCLUSIONS">Among adult patients undergoing cardiac surgery, infusion of amino acids reduced the occurrence of AKI. (Funded by the Italian Ministry of Health; PROTECTION ClinicalTrials.gov number, NCT03709264.).</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Massachusetts Medical Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monaco</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ti</LastName><ForeName>Lian Kah</ForeName><Initials>LK</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baiardo Redaelli</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bradic</LastName><ForeName>Nikola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Comis</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotani</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-9532-2859</Identifier><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brambillasca</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garofalo</LastName><ForeName>Eugenio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scandroglio</LastName><ForeName>Anna Mara</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viscido</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paternoster</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franco</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porta</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrod</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calabr&#xf2;</LastName><ForeName>Maria Grazia</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pisano</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vendramin</LastName><ForeName>Igor</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barucco</LastName><ForeName>Gaia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Federici</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Severi</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belletti</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cortegiani</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruni</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galbiati</LastName><ForeName>Carola</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Covino</LastName><ForeName>Angelo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baryshnikova</LastName><ForeName>Ekaterina</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giardina</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Venditto</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kroeller</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakhnoukh</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mantovani</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silvetti</LastName><ForeName>Simona</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Licheri</LastName><ForeName>Margherita</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guarracino</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lobreglio</LastName><ForeName>Rosetta</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Prima</LastName><ForeName>Ambra Licia</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fresilli</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Labanca</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mucchetti</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lembo</LastName><ForeName>Rosalba</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Losiggio</LastName><ForeName>Rosario</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bove</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranucci</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fominskiy</LastName><ForeName>Evgeny</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Longhini</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zangrillo</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute (G.L., F.M., M.B.R., A.M.S., A.F., M.G.C., G.B., A. Belletti, C.G., G.G., C.N., M.L., A.L.D.P., S.F., R. Labanca, M.M., R. Lembo, R. Losiggio, E.F., A.Z.), Vita-Salute San Raffaele University (G.L., A.Z.), and Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino (C.B.), Milan, S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Turin (M.C., C.V., S.P., F. Ferrod), the Department of Medical and Surgical Sciences, University Hospital "R. Dulbecco," Magna Graecia University, Catanzaro (E.G., A. Bruni, F.L.), Cardiovascular Anesthesia and ICU San Carlo Hospital, Potenza (G.P., A. Covino), Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples (A.P., M.V.), the Department of Medicine, University of Udine (I.V., T.B.), the Division of Cardiac Surgery, Azienda Sanitaria Universitaria Friuli Centrale (I.V.), and the Department of Anesthesia and Intensive Care Medicine, ASUFC University-Hospital of Central Friuli (T.B.), Udine, UOC Anestesia e Rianimazione, Azienda Ospedaliero Universitaria Sant'Andrea (F. Federici), and UO Complessa Anestesia e Rianimazione, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliera San Camillo Forlanini (L.S.), Rome, the Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, and the Department of Anesthesia Analgesia Intensive Care and Emergency, University Hospital Policlinico Paolo Giaccone, Palermo (A. Cortegiani), the Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, San Donato Milanese (E.B., M.R.), IRCCS Humanitas Research Hospital, Anestesia e Terapia Intensiva Cardiochirurgica, Rozzano (D.K.), the Department of Anesthesia and ICU Maria Cecilia Hospital GVM Care and Research, Cotignola (L.M.), the Department of Cardiac Anesthesia and Intensive Care, Ospedale Policlinico San Martino IRCCS-IRCCS Cardiovascular Network, Genoa (S.S.), the Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa (F.G.), and the Department of Anesthesia, Intensive Care and Emergency, 'Citta della Salute e della Scienza' University Hospital, Turin (R. Lobreglio) - all in Italy; the Department of Anaesthesia, National University Hospital, Singapore (L.K.T.); the Clinic of Anesthesiology, Resuscitation, and Intensive Medicine, University Hospital Dubrava, Zagreb, and University North, Department of Nursing, Varazdin - both in Croatia (N.B.); the Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan (Y.K.); and the Department of Critical Care, University of Melbourne, the Australian and New Zealand Intensive Care Research Centre, Monash University, and the Department of Intensive Care, Austin Hospital - all in Melbourne, VIC, Australia (R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>PROTECTION Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03709264</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>RF-2016-02363260</GrantID><Agency>Ministero della Salute</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>N Engl J Med</MedlineTA><NlmUniqueID>0255562</NlmUniqueID><ISSNLinking>0028-4793</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000596">Amino Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>N Engl J Med. 2024 Nov 21;391(20):1963-1964. doi: 10.1056/NEJMc2412012.</RefSource><PMID Version="1">39565998</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>N Engl J Med. 2024 Nov 21;391(20):1964. doi: 10.1056/NEJMc2412012.</RefSource><PMID Version="1">39565999</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>N Engl J Med. 2024 Nov 21;391(20):1964-1965. doi: 10.1056/NEJMc2412012.</RefSource><PMID Version="1">39566000</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>N Engl J Med. 2024 Nov 21;391(20):1965. doi: 10.1056/NEJMc2412012.</RefSource><PMID Version="1">39566001</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>N Engl J Med. 2024 Nov 21;391(20):1965-1966. doi: 10.1056/NEJMc2412012.</RefSource><PMID Version="1">39566002</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000596" MajorTopicYN="Y">Amino Acids</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="Y">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007262" MajorTopicYN="N">Infusions, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="N">Renal Replacement Therapy</DescriptorName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Monaco</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ti</LastName><ForeName>Lian Kah</ForeName><Initials>LK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baiardo Redaelli</LastName><ForeName>Martina</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bradic</LastName><ForeName>Nikola</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Comis</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kotani</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brambillasca</LastName><ForeName>Claudio</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garofalo</LastName><ForeName>Eugenio</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scandroglio</LastName><ForeName>Anna Mara</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Viscido</LastName><ForeName>Cristina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Paternoster</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Franco</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Porta</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ferrod</LastName><ForeName>Federica</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Calabr&#xf2;</LastName><ForeName>Maria Grazia</ForeName><Initials>MG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pisano</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vendramin</LastName><ForeName>Igor</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barucco</LastName><ForeName>Gaia</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Federici</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Severi</LastName><ForeName>Luca</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Belletti</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cortegiani</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bruni</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Galbiati</LastName><ForeName>Carola</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Covino</LastName><ForeName>Angelo</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baryshnikova</LastName><ForeName>Ekaterina</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giardina</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Venditto</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kroeller</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nakhnoukh</LastName><ForeName>Cristina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mantovani</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Silvetti</LastName><ForeName>Simona</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Licheri</LastName><ForeName>Margherita</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guarracino</LastName><ForeName>Fabio</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lobreglio</LastName><ForeName>Rosetta</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Di Prima</LastName><ForeName>Ambra Licia</ForeName><Initials>AL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fresilli</LastName><ForeName>Stefano</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Labanca</LastName><ForeName>Rosa</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mucchetti</LastName><ForeName>Marta</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lembo</LastName><ForeName>Rosalba</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Losiggio</LastName><ForeName>Rosario</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bove</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ranucci</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fominskiy</LastName><ForeName>Evgeny</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Longhini</LastName><ForeName>Federico</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zangrillo</LastName><ForeName>Alberto</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bonaccorso</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Campugiani</LastName><ForeName>Aurora</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Crivellari</LastName><ForeName>Martina</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>D'Amico</LastName><ForeName>Filippo</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>D'Andria Ursoleo</LastName><ForeName>Jacopo</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Frau</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fustini</LastName><ForeName>Carolina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lazzari</LastName><ForeName>Stefano</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lombardi</LastName><ForeName>Gaetano</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maimeri</LastName><ForeName>Nicol&#xf2;</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Manazza</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marchetti</LastName><ForeName>Cristiano</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marmiere</LastName><ForeName>Marilena</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marzaroli</LastName><ForeName>Matteo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mongardini</LastName><ForeName>Edoardo</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Monti</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nisi</LastName><ForeName>Francesco Giuseppe</ForeName><Initials>FG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oliva</LastName><ForeName>Federico Mattia</ForeName><Initials>FM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Piazza</LastName><ForeName>Enrica</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Piersanti</LastName><ForeName>Gioia</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pontillo</LastName><ForeName>Domenico</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pruna</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ronca</LastName><ForeName>Erica</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scquizzato</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Turi</LastName><ForeName>Stefano</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Veneziano</LastName><ForeName>Marta</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vietri</LastName><ForeName>Simone</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zaraca</LastName><ForeName>Luisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Corea</LastName><ForeName>Angela</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lentini</LastName><ForeName>Lucia</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neri</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ferrante</LastName><ForeName>Palma</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rurali</LastName><ForeName>Erica</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arangino</LastName><ForeName>Cristina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salvi</LastName><ForeName>Luca</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Anguissola</LastName><ForeName>Martina</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mazzotta</LastName><ForeName>Vittoria</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tucciariello</LastName><ForeName>Maria Teresa</ForeName><Initials>MT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gallicchio</LastName><ForeName>Francesca</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Verniero</LastName><ForeName>Luigi</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>di Fraja</LastName><ForeName>Diana</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Castro</LastName><ForeName>Fabio</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scapol</LastName><ForeName>Sara</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meroi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rocco</LastName><ForeName>Monica</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mastrangelo</LastName><ForeName>Lucia</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Re</LastName><ForeName>Maria Rosaria</ForeName><Initials>MR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Palmeri Di Villalba</LastName><ForeName>Cesira</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Crescenzi</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rago</LastName><ForeName>Antonello</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tenti</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rapetti</LastName><ForeName>Francesca</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brizzi</LastName><ForeName>Giulia</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ramanathan</LastName><ForeName>Kollengode</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jinghui</LastName><ForeName>Yang</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Costamagna</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haxhiademi</LastName><ForeName>Dorela</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tripodi</LastName><ForeName>Vincenzo Francesco</ForeName><Initials>VF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Persec</LastName><ForeName>Jasminka</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pov&#x161;i&#x107;-&#x10c;evra</LastName><ForeName>Zdenko</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bukamal</LastName><ForeName>Nazar</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chong</LastName><ForeName>Lei</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Biondi-Zoccai</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>D'Ascenzo</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Romagnoli</LastName><ForeName>Enrico</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Belletti</LastName><ForeName>Evgeny Alessandro</ForeName><Initials>EA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bradi&#x107;</LastName><ForeName>Nikola</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Biondi-Zoccai</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>D'Ascenzo</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Romagnoli</LastName><ForeName>Enrico</ForeName><Initials>E</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>21</Day><Hour>18</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>12</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>12</Day><Hour>11</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38865168</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa2403769</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30236233</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>22</Day></DateCompleted><DateRevised><Year>2019</Year><Month>01</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>121</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>Oct</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Intraoperative hypotension and the risk of postoperative adverse outcomes: a systematic review.</ArticleTitle><Pagination><StartPage>706</StartPage><EndPage>721</EndPage><MedlinePgn>706-721</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2018.04.036</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(18)30376-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Intraoperative hypotension is a common side effect of general anaesthesia and might lead to inadequate organ perfusion. It is unclear to what extent hypotension during noncardiac surgery is associated with unfavourable outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a systematic search in PubMed, Embase, Web of Science, and CINAHL, and classified the quality of retrieved articles according to predefined adapted STROBE and CONSORT criteria. Reported strengths of associations from high-quality studies were classified into end-organ specific injury risks, such as acute kidney injury, myocardial injury, and stroke, and overall organ injury risks for various arterial blood pressure thresholds.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We present an overview of 42 articles on reported associations between various absolute and relative intraoperative hypotension definitions and their associations with postoperative adverse outcomes after noncardiac surgery. Elevated risks of end-organ injury were reported for prolonged exposure (&#x2265;10&#xa0;min) to mean arterial pressures &lt;80&#xa0;mm Hg and for shorter durations &lt;70&#xa0;mm Hg. Reported risks increase with increased durations for mean arterial pressures &lt;65-60&#xa0;mm Hg or for any exposure &lt;55-50&#xa0;mm Hg.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The reported associations suggest that organ injury might occur when mean arterial pressure decreases &lt;80&#xa0;mm Hg for &#x2265;10&#xa0;min, and that this risk increases with blood pressures becoming progressively lower. Given the retrospective observational design of the studies reviewed, reflected by large variability in patient characteristics, hypotension definitions and outcomes, solid conclusions on which blood pressures under which circumstances are truly too low cannot be drawn. We provide recommendations for the design of future studies. CLINICAL REGISTRATION NUMBER: (PROSPERO ID). CRD42013005171.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wesselink</LastName><ForeName>E M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Utrecht, The Netherlands. Electronic address: e.m.wesselink-5@umcutrecht.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kappen</LastName><ForeName>T H</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torn</LastName><ForeName>H M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slooter</LastName><ForeName>A J C</ForeName><Initials>AJC</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Klei</LastName><ForeName>W A</ForeName><Initials>WA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>06</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Br J Anaesth. 2019 Dec;123(6):e528-e529. doi: 10.1016/j.bja.2019.09.002.</RefSource><PMID Version="1">31587834</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">hypotension</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">myocardial ischemia</Keyword><Keyword MajorTopicYN="N">stroke</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30236233</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2018.04.036</ArticleId><ArticleId IdType="pii">S0007-0912(18)30376-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40503713</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>31</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1533-4406</ISSN><JournalIssue CitedMedium="Internet"><Volume>393</Volume><Issue>5</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>31</Day></PubDate></JournalIssue><Title>The New England journal of medicine</Title><ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal><ArticleTitle>A Randomized Trial of Acute Normovolemic Hemodilution in Cardiac Surgery.</ArticleTitle><Pagination><StartPage>450</StartPage><EndPage>460</EndPage><MedlinePgn>450-460</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1056/NEJMoa2504948</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients undergoing cardiac surgery often receive red-cell transfusions, along with the associated risks and costs. Early intraoperative normovolemic hemodilution (i.e., acute normovolemic hemodilution [ANH]) is a blood-conservation technique that entails autologous blood collection before initiation of cardiopulmonary bypass and reinfusion of the collected blood after bypass weaning. More data are needed on whether ANH reduces the number of patients receiving allogeneic red-cell transfusion.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In a multinational, single-blind trial, we randomly assigned adults from 32 centers and 11 countries who were undergoing cardiac surgery with cardiopulmonary bypass to receive ANH (withdrawal of &#x2265;650 ml of whole blood with crystalloids replacement if needed) or usual care. The primary outcome was the transfusion of at least one unit of allogeneic red cells during the hospital stay. Secondary outcomes were death from any cause within 30 days after surgery or during the hospitalization for surgery, bleeding complications, ischemic complications, and acute kidney injury.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 2010 patients underwent randomization; 1010 were assigned to ANH and 1000 to usual care. Among patients with available data, 274 of 1005 (27.3%) in the ANH group and 291 of 997 (29.2%) in the usual-care group received at least one allogeneic red-cell transfusion (relative risk, 0.93; 95% confidence interval, 0.81 to 1.07; P&#x2009;=&#x2009;0.34). Surgery for postoperative bleeding was performed in 38 of 1004 patients (3.8%) in the ANH group and 26 of 995 patients (2.6%) in the usual-care group. Death within 30 days or during hospitalization occurred in 14 of 1008 patients (1.4%) in the ANH group and 16 of 997 patients (1.6%) in the usual-care group. Safety outcomes were similar in the two groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Among adults undergoing cardiac surgery, ANH did not reduce the number of patients receiving allogeneic red-cell transfusion. (Funded by the Italian Ministry of Health; ANH ClinicalTrials.gov number, NCT03913481.).</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Massachusetts Medical Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Monaco</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Chong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Anesthesia Clinical Research Center, Xijing Hospital, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonizzoni</LastName><ForeName>Matteo Aldo</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Efremov</LastName><ForeName>Sergey</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Saint-Petersburg State University Hospital, St. Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morselli</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guarracino</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic and Vascular Anesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giardina</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arangino</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Anesthesia and Intensive Care, IRCCS Centro Cardiologico Monzino, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pontillo</LastName><ForeName>Domenico</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vitiello</LastName><ForeName>Michelangelo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiovascular Anesthesia and Intensive Care, San Carlo Hospital, Potenza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belletti</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3131-0565</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ajello</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Cardiac Anesthesia, Tor Vergata University Hospital, Rome.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Licheri</LastName><ForeName>Margherita</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nigro Neto</LastName><ForeName>Caetano</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Dante Pazzanese Institute of Cardiology, S&#xe3;o Paulo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barucco</LastName><ForeName>Gaia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bukamal</LastName><ForeName>Nazar A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Mohammed Bin Khalifa Specialist Cardiac Center, Awali, Bahrain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faustini</LastName><ForeName>Carolina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mantovani</LastName><ForeName>Lorenzo Filippo</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Maria Cecilia Hospital, GVM International, Cotignola, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oriani</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santonocito</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care Medicine III, Centro di Alte Specialit&#xe0; e Trapianti, Azienda Ospedaliero Universitaria Policlinico G. Rodolico-San Marco, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mucchetti</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Federici</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Unit&#xe0; Operativa Complessa Anestesia e Rianimazione, Azienda Ospedaliero-Universitaria Sant'Andrea, Rome.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerli</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porta</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>S.C. Anestesia e Rianimazione Cardiovascolare, Azienda Ospedaliera Ordine Mauriziano Umberto I di Torino, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scandroglio</LastName><ForeName>Anna Mara</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Xijing Hospital, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pieri</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Vita-Salute San Raffaele University, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osinsky</LastName><ForeName>Roman</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center, Novosibirsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lazzari</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leonova</LastName><ForeName>Elizaveta</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Saint-Petersburg State University Hospital, St. Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calabr&#xf2;</LastName><ForeName>Maria Grazia</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amitrano</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic and Vascular Anesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turi</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prati</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiac Anesthesia, Tor Vergata University Hospital, Rome.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fresilli</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Amico</LastName><ForeName>Filippo</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Andria Ursoleo</LastName><ForeName>Jacopo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Labanca</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marmiere</LastName><ForeName>Marilena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pruna</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scquizzato</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#x131;rali</LastName><ForeName>Kaan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Kosuyolu High Specialization Education and Research Hospital, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monti</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Vita-Salute San Raffaele University, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carmona</LastName><ForeName>Maria Jos&#xe9; Carvalho</ForeName><Initials>MJC</Initials><AffiliationInfo><Affiliation>Instituto do Cora&#xe7;&#xe3;o, InCor, Hospital das Cl&#xed;nicas da Faculdade de Medicina da Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Kenichi</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-5051-1365</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Oklahoma Health, Oklahoma City.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Likhvantsev</LastName><ForeName>Valery</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Federal Clinical and Research Center of Intensive Care and Rehabilitation, Moscow.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Loginov Moscow Clinical Scientifi&#x441; Center, Moscow.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ti</LastName><ForeName>Lian Kah</ForeName><Initials>LK</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, National University Hospital, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bove</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Emergency, University Hospital of Udine, Azienda Sanitaria Universitaria Friuli Centrale Santa Maria della Misericordia, Udine, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Udine, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paternoster</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Health Science, Anesthesia and Intensive Care, School of Medicine, University of Basilicata San Carlo Hospital, Potenza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University of Virginia Health, Charlottesville.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;rc&#xfc;</LastName><ForeName>Mustafa Emre</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Kosuyolu High Specialization Education and Research Hospital, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lomivorotov</LastName><ForeName>Vladimir</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center, Novosibirsk, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Penn State Milton S. Hershey Medical Center, Hershey, PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Vita-Salute San Raffaele University, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Critical Care, University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zangrillo</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Vita-Salute San Raffaele University, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>ANH Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03913481</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>RF-2018-12366749</GrantID><Agency>Ministero della Salute</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>N Engl J Med</MedlineTA><NlmUniqueID>0255562</NlmUniqueID><ISSNLinking>0028-4793</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="N">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017707" MajorTopicYN="Y">Erythrocyte Transfusion</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006438" MajorTopicYN="Y">Hemodilution</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007430" MajorTopicYN="N">Intraoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019106" MajorTopicYN="N">Postoperative Hemorrhage</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Monaco</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lei</LastName><ForeName>Chong</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bonizzoni</LastName><ForeName>Matteo Aldo</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Efremov</LastName><ForeName>Sergey</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morselli</LastName><ForeName>Federica</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guarracino</LastName><ForeName>Fabio</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giardina</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arangino</LastName><ForeName>Cristina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pontillo</LastName><ForeName>Domenico</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vitiello</LastName><ForeName>Michelangelo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Belletti</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ajello</LastName><ForeName>Valentina</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Licheri</LastName><ForeName>Margherita</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nigro Neto</LastName><ForeName>Caetano</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barucco</LastName><ForeName>Gaia</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bukamal</LastName><ForeName>Nazar A</ForeName><Initials>NA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Faustini</LastName><ForeName>Carolina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mantovani</LastName><ForeName>Lorenzo Filippo</ForeName><Initials>LF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oriani</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Santonocito</LastName><ForeName>Cristina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mucchetti</LastName><ForeName>Marta</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Federici</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gerli</LastName><ForeName>Chiara</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Porta</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scandroglio</LastName><ForeName>Anna Mara</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hui</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pieri</LastName><ForeName>Marina</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Osinsky</LastName><ForeName>Roman</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lazzari</LastName><ForeName>Stefano</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leonova</LastName><ForeName>Elizaveta</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Calabr&#xf2;</LastName><ForeName>Maria Grazia</ForeName><Initials>MG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Amitrano</LastName><ForeName>Daniele</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Turi</LastName><ForeName>Stefano</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Prati</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fresilli</LastName><ForeName>Stefano</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>D'Amico</LastName><ForeName>Filippo</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>D'Andria Ursoleo</LastName><ForeName>Jacopo</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Labanca</LastName><ForeName>Rosa</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marmiere</LastName><ForeName>Marilena</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pruna</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scquizzato</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kirali</LastName><ForeName>Kaan</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Monti</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carvalho Carmona</LastName><ForeName>Maria Jos&#xe9;</ForeName><Initials>MJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Kenichi</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Likhvantsev</LastName><ForeName>Valery</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ti</LastName><ForeName>Lian Kah</ForeName><Initials>LK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bove</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Paternoster</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Singh</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>G&#xfc;rc&#xfc;</LastName><ForeName>Mustafa Emre</ForeName><Initials>ME</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lomivorotov</LastName><ForeName>Vladimir</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zangrillo</LastName><ForeName>Alberto</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Agosta</LastName><ForeName>Viviana Teresa</ForeName><Initials>VT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bottussi</LastName><ForeName>Alice</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chiodi</LastName><ForeName>Benedetta</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Piccoli</LastName><ForeName>Noemi</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Delrio</LastName><ForeName>Silvia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Di Prima</LastName><ForeName>Ambra Licia</ForeName><Initials>AL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fominskiy</LastName><ForeName>Evgeny</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fiorito</LastName><ForeName>Sara</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Franco</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Frau</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lembo</LastName><ForeName>Rosalba</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Losiggio</LastName><ForeName>Rosario</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nakhnoukh</LastName><ForeName>Cristina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nardelli</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Notarianni</LastName><ForeName>Lisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nutta</LastName><ForeName>Anita</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oliva</LastName><ForeName>Federico Mattia</ForeName><Initials>FM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ortalda</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ronca</LastName><ForeName>Erica</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zaraca</LastName><ForeName>Luisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Asiller</LastName><ForeName>&#xd6;zg&#xfc;n &#xd6;mer</ForeName><Initials>&#xd6;&#xd6;</Initials></Investigator><Investigator ValidYN="Y"><LastName>Veneziano</LastName><ForeName>Marta</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Veltri</LastName><ForeName>Deborah</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ferrod</LastName><ForeName>Federica</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Viscida</LastName><ForeName>Cristina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Angelone</LastName><ForeName>Manuela</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Caruso</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mazzamuto</LastName><ForeName>Massimo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pasyuga</LastName><ForeName>Vadim</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carollo</LastName><ForeName>Cristiana</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Isirdi</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Trunfio</LastName><ForeName>Danila</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Villano</LastName><ForeName>Michela</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giorni</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rocco</LastName><ForeName>Monica</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wongsopa</LastName><ForeName>Chananya</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lobreglio</LastName><ForeName>Rosetta</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Costamagna</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fiorentino</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lesanovis</LastName><ForeName>Jelena</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cherniavsky</LastName><ForeName>Alexandr</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lomivorotova</LastName><ForeName>Liudmila</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vorontsov</LastName><ForeName>Mikhail</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barbosa Gomes Galas</LastName><ForeName>Filomena Regina</ForeName><Initials>FR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Strunin</LastName><ForeName>Oleg</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yavorovskiy</LastName><ForeName>Andrey</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ballotta</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grieco</LastName><ForeName>Simone</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Angeletti</LastName><ForeName>Paolo Matteo</ForeName><Initials>PM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Crescenzi</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Angiussola</LastName><ForeName>Martina</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baryshnikova</LastName><ForeName>Ekaterina</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kotani</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alzahrani</LastName><ForeName>Haitham</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Erdem</LastName><ForeName>Esin</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Erkilin&#xe7;</LastName><ForeName>Atakan</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karaca Baysal</LastName><ForeName>Pinar</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Subbotin</LastName><ForeName>Valery</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vachev</LastName><ForeName>Sergey</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tenti</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>PharKok Tong</ForeName><Initials>PT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shirshov&#x430;</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Turina</LastName><ForeName>Polina</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guarini</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Palo</LastName><ForeName>Carmine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Felice</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Franceschini</LastName><ForeName>Giulia</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>D'Amora</LastName><ForeName>Mauro</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Auci</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vendramin</LastName><ForeName>Igor</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baiardo Redaelli</LastName><ForeName>Martina</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vandyck</LastName><ForeName>Kofi</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Teman</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mazzeffi</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>McNeil</LastName><ForeName>John S</ForeName><Initials>JS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gao</LastName><ForeName>Baobao</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gao</LastName><ForeName>Jiao</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hou</LastName><ForeName>Lihong</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pasin</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Putzu</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Romero Garcia</LastName><ForeName>Carolina Soledad</ForeName><Initials>CS</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>31</Day><Hour>12</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>12</Day><Hour>12</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>12</Day><Hour>7</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40503713</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa2504948</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26231194</PMID><DateCompleted><Year>2016</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1555-905X</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>9</Issue><PubDate><Year>2015</Year><Month>Sep</Month><Day>04</Day></PubDate></JournalIssue><Title>Clinical journal of the American Society of Nephrology : CJASN</Title><ISOAbbreviation>Clin J Am Soc Nephrol</ISOAbbreviation></Journal><ArticleTitle>Epidemiology and Clinical Correlates of AKI in Chinese Hospitalized Adults.</ArticleTitle><Pagination><StartPage>1510</StartPage><EndPage>1518</EndPage><MedlinePgn>1510-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2215/CJN.02140215</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES" NlmCategory="OBJECTIVE">Comprehensive epidemiologic data on AKI are particularly lacking in Asian countries. This study sought to assess the epidemiology and clinical correlates of AKI among hospitalized adults in China.</AbstractText><AbstractText Label="DESIGN, SETTING, PARTICIPANTS, &amp; MEASUREMENTS" NlmCategory="METHODS">This was a multicenter retrospective cohort study of 659,945 hospitalized adults from a wide range of clinical settings in nine regional central hospitals across China in 2013. AKI was defined and staged according to Kidney Disease Improving Global Outcomes criteria. The incidence of AKI in the cohort was estimated using a novel two-step approach with adjustment for the frequency of serum creatinine tests and other potential confounders. Risk factor profiles for hospital-acquired (HA) and community-acquired (CA) AKI were examined. The in-hospital outcomes of AKI, including mortality, renal recovery, length of stay, and daily cost, were assessed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The incidence of CA-AKI and HA-AKI was 2.5% and 9.1%, respectively, giving rise to an overall incidence of 11.6%. Although the risk profiles for CA-AKI and HA-AKI differed, preexisting CKD was a major risk factor for both, contributing to 20% of risk in CA-AKI and 12% of risk in HA-AKI. About 40% of AKI cases were possibly drug-related and 16% may have been induced by Chinese traditional medicines or remedies. The in-hospital mortality of AKI was 8.8%. The risk of in-hospital death was higher among patients with more severe AKI. Preexisting CKD and need for intensive care unit admission were associated with higher death risk in patients at any stage of AKI. Transiency of AKI did not modify the risk of in-hospital death. AKI was associated with longer length of stay and higher daily costs, even after adjustment for confounders.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">AKI is common in hospitalized adults in China and is associated with significantly higher in-hospital mortality and resource utilization.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015 by the American Society of Nephrology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nie</LastName><ForeName>Sheng</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhangsuo</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chunbo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Guangdong General Hospital, Guangzhou, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Gang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zha</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Guizhou Provincial People's Hospital, Guiyang Medical University, Guiyang, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Guizhou Provincial People's Hospital, Guiyang Medical University, Guiyang, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Bicheng</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Zhongda Hospital, Southeast University, Nanjing, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Shuai</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The Second Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, China; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Anping</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Xing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Fan Fan</ForeName><Initials>FF</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, China; ffhouguangzhou@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>07</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin J Am Soc Nephrol</MedlineTA><NlmUniqueID>101271570</NlmUniqueID><ISSNLinking>1555-9041</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004365">Drugs, Chinese Herbal</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064420" MajorTopicYN="N">Drug-Related Side Effects and Adverse Reactions</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004365" MajorTopicYN="N">Drugs, Chinese Herbal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007049" MajorTopicYN="N">Iatrogenic Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007297" MajorTopicYN="N">Inpatients</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020127" MajorTopicYN="N">Recovery of Function</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="N">Renal Insufficiency, Chronic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute renal failure</Keyword><Keyword MajorTopicYN="N">epidemiology and outcomes</Keyword><Keyword MajorTopicYN="N">hospitalization</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>9</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26231194</ArticleId><ArticleId IdType="pmc">PMC4559507</ArticleId><ArticleId IdType="doi">10.2215/CJN.02140215</ArticleId><ArticleId IdType="pii">CJN.02140215</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bellomo R, Kellum JA, Ronco C: Acute kidney injury. Lancet 380: 756&#x2013;766, 2012</Citation><ArticleIdList><ArticleId IdType="pubmed">22617274</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali T, Khan I, Simpson W, Prescott G, Townend J, Smith W, Macleod A: Incidence and outcomes in acute kidney injury: A comprehensive population-based study. J Am Soc Nephrol 18: 1292&#x2013;1298, 2007</Citation><ArticleIdList><ArticleId IdType="pubmed">17314324</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo LJ, Go AS, Chertow GM, McCulloch CE, Fan D, Ordo&#xf1;ez JD, Hsu CY: Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int 76: 893&#x2013;899, 2009</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2771754</ArticleId><ArticleId IdType="pubmed">19641480</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafrance JP, Miller DR: Defining acute kidney injury in database studies: The effects of varying the baseline kidney function assessment period and considering CKD status. Am J Kidney Dis 56: 651&#x2013;660, 2010</Citation><ArticleIdList><ArticleId IdType="pubmed">20673605</ArticleId></ArticleIdList></Reference><Reference><Citation>Wald R, Quinn RR, Adhikari NK, Burns KE, Friedrich JO, Garg AX, Harel Z, Hladunewich MA, Luo J, Mamdani M, Perl J, Ray JG, University of Toronto Acute Kidney Injury Research Group : Risk of chronic dialysis and death following acute kidney injury. Am J Med 125: 585&#x2013;593, 2012</Citation><ArticleIdList><ArticleId IdType="pubmed">22516564</ArticleId></ArticleIdList></Reference><Reference><Citation>James MT, Hemmelgarn BR, Wiebe N, Pannu N, Manns BJ, Klarenbach SW, Tonelli M, Alberta Kidney Disease Network : Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: A cohort study. Lancet 376: 2096&#x2013;2103, 2010</Citation><ArticleIdList><ArticleId IdType="pubmed">21094997</ArticleId></ArticleIdList></Reference><Reference><Citation>Han SS, Kim S, Ahn SY, Lee J, Kim DK, Chin HJ, Chae DW, Na KY: Duration of acute kidney injury and mortality in critically ill patients: A retrospective observational study. BMC Nephrol 14: 133&#x2013;139, 2013</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3697999</ArticleId><ArticleId IdType="pubmed">23802916</ArticleId></ArticleIdList></Reference><Reference><Citation>Bihorac A, Brennan M, Ozrazgat-Baslanti T, Bozorgmehri S, Efron PA, Moore FA, Segal MS, Hobson CE: National surgical quality improvement program underestimates the risk associated with mild and moderate postoperative acute kidney injury. Crit Care Med 41: 2570&#x2013;2583, 2013</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3812338</ArticleId><ArticleId IdType="pubmed">23928835</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C, Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators : Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294: 813&#x2013;818, 2005</Citation><ArticleIdList><ArticleId IdType="pubmed">16106006</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang JW, Jeng MJ, Yang LY, Chen TJ, Chiang SC, Soong WJ, Wu KG, Lee YS, Wang HH, Yang CF, Tsai HL. The epidemiology and prognostic factors of mortality in critically ill children with acute kidney injury in Taiwan. Kidney Int 87: 632&#x2013;639, 2014</Citation><ArticleIdList><ArticleId IdType="pubmed">25252027</ArticleId></ArticleIdList></Reference><Reference><Citation>Li PK, Burdmann EA, Mehta RL, World Kidney Day Steering Committee 2013 : Acute kidney injury: global health alert. Kidney Int 83: 372&#x2013;376, 2013</Citation><ArticleIdList><ArticleId IdType="pubmed">23302721</ArticleId></ArticleIdList></Reference><Reference><Citation>Susantitaphong P, Cruz DN, Cerda J, Abulfaraj M, Alqahtani F, Koulouridis I, Jaber BL, Acute Kidney Injury Advisory Group of the American Society of Nephrology : World incidence of AKI: A meta-analysis. Clin J Am Soc Nephrol 8: 1482&#x2013;1493, 2013</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3805065</ArticleId><ArticleId IdType="pubmed">23744003</ArticleId></ArticleIdList></Reference><Reference><Citation>KDIGO AKI Work Group : KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2: 1&#x2013;138, 2012</Citation></Reference><Reference><Citation>Lewington A, Kanagasundaram S: Renal Association clinical practice guidelines on acute kidney injury. Nephron Clin Pract 118[Suppl 1]: c349&#x2013;c390, 2011</Citation><ArticleIdList><ArticleId IdType="pubmed">21555903</ArticleId></ArticleIdList></Reference><Reference><Citation>Palevsky PM, Liu KD, Brophy PD, Chawla LS, Parikh CR, Thakar CV, Tolwani AJ, Waikar SS, Weisbord SD: KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis 61: 649&#x2013;672, 2013</Citation><ArticleIdList><ArticleId IdType="pubmed">23499048</ArticleId></ArticleIdList></Reference><Reference><Citation>Fliser D, Laville M, Covic A, Fouque D, Vanholder R, Juillard L, Van Biesen W, Ad-hoc working group of ERBP : A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: Part 1: Definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant 27: 4263&#x2013;4272, 2012</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3520085</ArticleId><ArticleId IdType="pubmed">23045432</ArticleId></ArticleIdList></Reference><Reference><Citation>James M, Bouchard J, Ho J, Klarenbach S, LaFrance JP, Rigatto C, Wald R, Zappitelli M, Pannu N: Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis 61: 673&#x2013;685, 2013</Citation><ArticleIdList><ArticleId IdType="pubmed">23518195</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchino S, Bellomo R, Bagshaw SM, Goldsmith D: Transient azotaemia is associated with a high risk of death in hospitalized patients. Nephrol Dial Transplant 25: 1833&#x2013;1839, 2010</Citation><ArticleIdList><ArticleId IdType="pubmed">20054022</ArticleId></ArticleIdList></Reference><Reference><Citation>The National Collaborating Centre for Chronic Conditions (UK): Chronic kidney disease: National clinical guideline for early identification and management in adults in primary and secondary care. 2008. Available at: http://www.nice.org.uk/CG73 Accessed September 2008.</Citation><ArticleIdList><ArticleId IdType="pubmed">21413194</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier P, Bonfils RM, Vogt B, Burnand B, Burnier M: Referral patterns and outcomes in noncritically ill patients with hospital-acquired acute kidney injury. Clin J Am Soc Nephrol 6: 2215&#x2013;2225, 2011</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3359001</ArticleId><ArticleId IdType="pubmed">21817132</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW: Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16: 3365&#x2013;3370, 2005</Citation><ArticleIdList><ArticleId IdType="pubmed">16177006</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HE, Muntner P, Chertow GM, Warnock DG: Acute kidney injury and mortality in hospitalized patients. Am J Nephrol 35: 349&#x2013;355, 2012</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3362180</ArticleId><ArticleId IdType="pubmed">22473149</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R, Muci&#xf1;o-Bermejo MJ, Armignacco P, Fang Y, Cai H, Zhang M, Dai H, Zhang W, Ni Z, Qian J, Yan Y, Ronco C: Survey of acute kidney injury and related risk factors of mortality in hospitalized patients in a third-level urban hospital of Shanghai. Blood Purif 38: 140&#x2013;148, 2014</Citation><ArticleIdList><ArticleId IdType="pubmed">25471326</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Y, Ding X, Zhong Y, Zou J, Teng J, Tang Y, Lin J, Lin P: Acute kidney injury in a Chinese hospitalized population. Blood Purif 30: 120&#x2013;126, 2010</Citation><ArticleIdList><ArticleId IdType="pubmed">20714143</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JH, Wang NS, Wang F, Xiang HY, Wu HL, Wu QM: Acute renal failure in hospitalized patients in China: A prospective study. Ren Fail 31: 431&#x2013;437, 2009</Citation><ArticleIdList><ArticleId IdType="pubmed">19839819</ArticleId></ArticleIdList></Reference><Reference><Citation>Aitken E, Carruthers C, Gall L, Kerr L, Geddes C, Kingsmore D: Acute kidney injury: outcomes and quality of care. QJM 106: 323&#x2013;332, 2013</Citation><ArticleIdList><ArticleId IdType="pubmed">23345468</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafrance JP, Miller DR: Acute kidney injury associates with increased long-term mortality. J Am Soc Nephrol 21: 345&#x2013;352, 2010</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2834549</ArticleId><ArticleId IdType="pubmed">20019168</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng X, McMahon GM, Brunelli SM, Bates DW, Waikar SS: Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals. Clin J Am Soc Nephrol 9: 12&#x2013;20, 2014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3878695</ArticleId><ArticleId IdType="pubmed">24178971</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HE, Jain G, Glassock RJ, Warnock DG: Comparison of absolute serum creatinine changes versus Kidney Disease: Improving Global Outcomes consensus definitions for characterizing stages of acute kidney injury. Nephrol Dial Transplant 28: 1447&#x2013;1454, 2013</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3685303</ArticleId><ArticleId IdType="pubmed">23355628</ArticleId></ArticleIdList></Reference><Reference><Citation>Pannu N, James M, Hemmelgarn BR, Dong J, Tonelli M, Klarenbach S, Alberta Kidney Disease Network : Modification of outcomes after acute kidney injury by the presence of CKD. Am J Kidney Dis 58: 206&#x2013;213, 2011</Citation><ArticleIdList><ArticleId IdType="pubmed">21496979</ArticleId></ArticleIdList></Reference><Reference><Citation>Lia&#xf1;o F, Pascual J, Madrid Acute Renal Failure Study Group : Epidemiology of acute renal failure: A prospective, multicenter, community-based study. Kidney Int 50: 811&#x2013;818, 1996</Citation><ArticleIdList><ArticleId IdType="pubmed">8872955</ArticleId></ArticleIdList></Reference><Reference><Citation>Obialo CI, Okonofua EC, Tayade AS, Riley LJ: Epidemiology of de novo acute renal failure in hospitalized African Americans: Comparing community-acquired vs hospital-acquired disease. Arch Intern Med 160: 1309&#x2013;1313, 2000</Citation><ArticleIdList><ArticleId IdType="pubmed">10809034</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Cui Z, Fan M: Hospital-acquired and community-acquired acute renal failure in hospitalized Chinese: A ten-year review. Ren Fail 29: 163&#x2013;168, 2007</Citation><ArticleIdList><ArticleId IdType="pubmed">17365931</ArticleId></ArticleIdList></Reference><Reference><Citation>Luyckx VA, Naicker S: Acute kidney injury associated with the use of traditional medicines. Nat Clin Pract Nephrol 4: 664&#x2013;671, 2008</Citation><ArticleIdList><ArticleId IdType="pubmed">18838981</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchino S, Bellomo R, Goldsmith D, Bates S, Ronco C: An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med 34: 1913&#x2013;1917, 2006</Citation><ArticleIdList><ArticleId IdType="pubmed">16715038</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricci Z, Cruz D, Ronco C: The RIFLE criteria and mortality in acute kidney injury: A systematic review. Kidney Int 73: 538&#x2013;546, 2008</Citation><ArticleIdList><ArticleId IdType="pubmed">18160961</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagshaw SM, George C, Bellomo R, ANZICS Database Management Committe : A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients. Nephrol Dial Transplant 23: 1569&#x2013;1574, 2008</Citation><ArticleIdList><ArticleId IdType="pubmed">18281319</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh A, Shaw A: The economics of renal failure and kidney disease in critically ill patients. Crit Care Clin 28: 99&#x2013;111, vii, 2012</Citation><ArticleIdList><ArticleId IdType="pubmed">22123102</ArticleId></ArticleIdList></Reference><Reference><Citation>Lahoti A, Nates JL, Wakefield CD, Price KJ, Salahudeen AK: Costs and outcomes of acute kidney injury in critically ill patients with cancer. J Support Oncol 9: 149&#x2013;155, 2011</Citation><ArticleIdList><ArticleId IdType="pubmed">21809520</ArticleId></ArticleIdList></Reference><Reference><Citation>Doi K, Yuen PS, Eisner C, Hu X, Leelahavanichkul A, Schnermann J, Star RA: Reduced production of creatinine limits its use as marker of kidney injury in sepsis. J Am Soc Nephrol 20: 1217&#x2013;1221, 2009</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2689892</ArticleId><ArticleId IdType="pubmed">19389851</ArticleId></ArticleIdList></Reference><Reference><Citation>Macedo E, Bouchard J, Soroko SH, Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL, Program to Improve Care in Acute Renal Disease Study : Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients. Crit Care 14: R82, 2010</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2911707</ArticleId><ArticleId IdType="pubmed">20459609</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu KD, Thompson BT, Ancukiewicz M, Steingrub JS, Douglas IS, Matthay MA, Wright P, Peterson MW, Rock P, Hyzy RC, Anzueto A, Truwit JD, National Institutes of Health National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Network : Acute kidney injury in patients with acute lung injury: Impact of fluid accumulation on classification of acute kidney injury and associated outcomes. Crit Care Med 39: 2665&#x2013;2671, 2011</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3220741</ArticleId><ArticleId IdType="pubmed">21785346</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J, Barrantes F, Amoateng-Adjepong Y, Manthous CA: Rapid reversal of acute kidney injury and hospital outcomes: A retrospective cohort study. Am J Kidney Dis 53: 974&#x2013;981, 2009</Citation><ArticleIdList><ArticleId IdType="pubmed">19362401</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JR, Kramer RS, Coca SG, Parikh CR: Duration of acute kidney injury impacts long-term survival after cardiac surgery. Ann Thorac Surg 90: 1142&#x2013;1148, 2010</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3819730</ArticleId><ArticleId IdType="pubmed">20868804</ArticleId></ArticleIdList></Reference><Reference><Citation>Coca SG, King JT, Jr, Rosenthal RA, Perkal MF, Parikh CR: The duration of postoperative acute kidney injury is an additional parameter predicting long-term survival in diabetic veterans. Kidney Int 78: 926&#x2013;933, 2010</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3082138</ArticleId><ArticleId IdType="pubmed">20686452</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28577069</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1238</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>6</Issue><PubDate><Year>2017</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Intensive care medicine</Title><ISOAbbreviation>Intensive Care Med</ISOAbbreviation></Journal><ArticleTitle>Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017 : Expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine.</ArticleTitle><Pagination><StartPage>730</StartPage><EndPage>749</EndPage><MedlinePgn>730-749</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00134-017-4832-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute kidney injury (AKI) in the intensive care unit is associated with significant mortality and morbidity.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To determine and update previous recommendations for the prevention of AKI, specifically the role of fluids, diuretics, inotropes, vasopressors/vasodilators, hormonal and nutritional interventions, sedatives, statins, remote ischaemic preconditioning and care bundles.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">A systematic search of the literature was performed for studies published between 1966 and March 2017 using these potential protective strategies in adult patients at risk of AKI. The following clinical conditions were considered: major surgery, critical illness, sepsis, shock, exposure to potentially nephrotoxic drugs and radiocontrast. Clinical endpoints included incidence or grade of AKI, the need for renal replacement therapy and mortality. Studies were graded according to the international GRADE system.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We formulated 12 recommendations, 13 suggestions and seven best practice statements. The few strong recommendations with high-level evidence are mostly against the intervention in question (starches, low-dose dopamine, statins in cardiac surgery). Strong recommendations with lower-level evidence include controlled fluid resuscitation with crystalloids, avoiding fluid overload, titration of norepinephrine to a target MAP of 65-70&#xa0;mmHg (unless chronic hypertension) and not using diuretics or levosimendan for kidney protection solely.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The results of recent randomised controlled trials have allowed the formulation of new recommendations and/or increase the strength of previous recommendations. On the other hand, in many domains the available evidence remains insufficient, resulting from the limited quality of the clinical trials and the poor reporting of kidney outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Joannidis</LastName><ForeName>M</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6996-0881</Identifier><AffiliationInfo><Affiliation>Division of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University Innsbruck, Anichstasse 35, 6020, Innsbruck, Austria. michael.joannidis@i-med.ac.at.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Druml</LastName><ForeName>W</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine III, University Hospital Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forni</LastName><ForeName>L G</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>Department of Clinical and Experimental Medicine, Faculty of Health and Medical Sciences, University of Surrey and Surrey Perioperative Anaesthesia and Critical Care Collaborative Research Group (SPACeR), Intensive Care Unit, Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford, GU2 7XX, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Groeneveld</LastName><ForeName>A B J</ForeName><Initials>ABJ</Initials></Author><Author ValidYN="Y"><LastName>Honore</LastName><ForeName>P M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoste</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Ghent University Hospital, Ghent University, De Pintelaan 185, 9000, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostermann</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Critical Care and Nephrology, Guy's and St Thomas' Hospital, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oudemans-van Straaten</LastName><ForeName>H M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Adult Intensive Care, VU University Medical Centre, De Boelelaan 1118, 1081 HZ, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schetz</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Department and Laboratory of Intensive Care Medicine, Division of Cellular and Molecular Medicine, KU Leuven University, Leuven, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Intensive Care Med</MedlineTA><NlmUniqueID>7704851</NlmUniqueID><ISSNLinking>0342-4642</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N">Europe</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="Y">Practice Guidelines as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Prevention</Keyword><Keyword MajorTopicYN="N">Recommendations</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword><Keyword MajorTopicYN="N">Vasopressors</Keyword><Keyword MajorTopicYN="N">Volume expansion</Keyword></KeywordList><CoiStatement>MJ has received honoraria or research support from Baxter Healthcare Corp, AM-Pharma, CLS Behring, Fresenius and Astute Medical. WD declares no conflicts of interest. LF has received honoraria and research support from Astute Medical, Fresenius, Baxter Gambro Renal and Orthoclinical Diagnostics. PH had received research grants from Baxter, AM Pharma, Bellco, and Pfizer EH received speaker&#x2019;s fees from Alexion and Astute Medical, and a research grant from Bellco. MO has received honoraria and research funding from Fresenius Medical Care and Baxter Gambro. HO has financial congress support from Dirinco (Netherlands) and speaker&#x2019;s honoraria from Fresenius and Gambro/Baxter. MS declares no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>6</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28577069</ArticleId><ArticleId IdType="pmc">PMC5487598</ArticleId><ArticleId IdType="doi">10.1007/s00134-017-4832-y</ArticleId><ArticleId IdType="pii">10.1007/s00134-017-4832-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chertow GM, Burdick E, Honour M. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16:3365&#x2013;3370. doi: 10.1681/ASN.2004090740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2004090740</ArticleId><ArticleId IdType="pubmed">16177006</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1&#x2013;138. doi: 10.1038/kisup.2012.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/kisup.2012.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Kane-Gill SL, Sileanu FE, Murugan R, Trietley GS, Handler SM, Kellum JA. Risk factors for acute kidney injury in older adults with critical illness: a retrospective cohort study. Am J Kidney Dis. 2015;65:860&#x2013;869. doi: 10.1053/j.ajkd.2014.10.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2014.10.018</ArticleId><ArticleId IdType="pmc">PMC4442750</ArticleId><ArticleId IdType="pubmed">25488106</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirwan CJ, Blunden MJ, Dobbie H, James A, Nedungadi A, Prowle JR. Critically ill patients requiring acute renal replacement therapy are at an increased risk of long-term renal dysfunction, but rarely receive specialist nephrology follow-up. Nephron. 2015;129:164&#x2013;170. doi: 10.1159/000371448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000371448</ArticleId><ArticleId IdType="pubmed">25765730</ArticleId></ArticleIdList></Reference><Reference><Citation>Joannidis M, Metnitz B, Bauer P, Schusterschitz N, Moreno R, Druml W, Metnitz PG. Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med. 2009;35:1692&#x2013;1702. doi: 10.1007/s00134-009-1530-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-009-1530-4</ArticleId><ArticleId IdType="pubmed">19547955</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D, Honore PM, Joannes-Boyau O, Joannidis M, Korhonen AM, Lavrentieva A, Mehta RL, Palevsky P, Roessler E, Ronco C, Uchino S, Vazquez JA, Vidal Andrade E, Webb S, Kellum JA. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41:1411&#x2013;1423. doi: 10.1007/s00134-015-3934-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3934-7</ArticleId><ArticleId IdType="pubmed">26162677</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccinni P, Cruz DN, Gramaticopolo S, Garzotto F, Dal Santo M, Aneloni G, Rocco M, Alessandri E, Giunta F, Michetti V, Iannuzzi M, Belluomo Anello C, Brienza N, Carlini M, Pelaia P, Gabbanelli V, Ronco C, Investigators N. Prospective multicenter study on epidemiology of acute kidney injury in the ICU: a critical care nephrology Italian collaborative effort (NEFROINT) Minerva Anestesiol. 2011;77:1072&#x2013;1083.</Citation><ArticleIdList><ArticleId IdType="pubmed">21597441</ArticleId></ArticleIdList></Reference><Reference><Citation>Srisawat N, Sileanu FE, Murugan R, Bellomod R, Calzavacca P, Cartin-Ceba R, Cruz D, Finn J, Hoste EE, Kashani K, Ronco C, Webb S, Kellum JA, Acute Kidney Injury-6 Study Group Variation in risk and mortality of acute kidney injury in critically ill patients: a multicenter study. Am J Nephrol. 2015;41:81&#x2013;88. doi: 10.1159/000371748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000371748</ArticleId><ArticleId IdType="pubmed">25677982</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell S, Dekker FW, Vadiveloo T, Marwick C, Deshmukh H, Donnan PT, Van Diepen M. Risk of postoperative acute kidney injury in patients undergoing orthopaedic surgery&#x2013;development and validation of a risk score and effect of acute kidney injury on survival: observational cohort study. BMJ. 2015;351:h5639. doi: 10.1136/bmj.h5639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h5639</ArticleId><ArticleId IdType="pmc">PMC4641433</ArticleId><ArticleId IdType="pubmed">26561522</ArticleId></ArticleIdList></Reference><Reference><Citation>Joannidis M, Druml W, Forni LG, Groeneveld AB, Honore P, Oudemans-van Straaten HM, Ronco C, Schetz MR, Woittiez AJ, Critical Care Nephrology Working Group of the European Society of Intensive Care Medicine Prevention of acute kidney injury and protection of renal function in the intensive care unit. Expert opinion of the Working Group for Nephrology, ESICM. Intensive Care Med. 2010;36:392&#x2013;411. doi: 10.1007/s00134-009-1678-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-009-1678-y</ArticleId><ArticleId IdType="pubmed">19921152</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichai C, Vinsonneau C, Souweine B, Armando F, Canet E, Clec&#x2019;h C, Constantin JM, Darmon M, Duranteau J, Gaillot T, Garnier A, Jacob L, Joannes-Boyau O, Juillard L, Journois D, Lautrette A, Muller L, Legrand M, Lerolle N, Rimmele T, Rondeau E, Tamion F, Walrave Y, Velly L, Soci&#xe9;t&#xe9; fran&#xe7;aise d&#x2019;anesth&#xe9;sie et de r&#xe9;animation (Sfar) Soci&#xe9;t&#xe9; de r&#xe9;animation de langue fran&#xe7;aise (SRLF) Groupe francophone de r&#xe9;animation et urgences p&#xe9;diatriques (GFRUP) Soci&#xe9;t&#xe9; fran&#xe7;aise de n&#xe9;phrologie (SFN) Acute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies) Ann Intensive Care. 2016;6:48. doi: 10.1186/s13613-016-0145-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-016-0145-5</ArticleId><ArticleId IdType="pmc">PMC4882312</ArticleId><ArticleId IdType="pubmed">27230984</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schunemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924&#x2013;926. doi: 10.1136/bmj.39489.470347.AD.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, Alderson P, Glasziou P, Falck-Ytter Y, Schunemann HJ. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol. 2011;64:395&#x2013;400. doi: 10.1016/j.jclinepi.2010.09.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2010.09.012</ArticleId><ArticleId IdType="pubmed">21194891</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Schunemann HJ, Djulbegovic B, Akl EA. Guideline panels should not GRADE good practice statements. J Clin Epidemiol. 2015;68:597&#x2013;600. doi: 10.1016/j.jclinepi.2014.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2014.12.011</ArticleId><ArticleId IdType="pubmed">25660962</ArticleId></ArticleIdList></Reference><Reference><Citation>de Mendonca A, Vincent JL, Suter PM, Moreno R, Dearden NM, Antonelli M, Takala J, Sprung C, Cantraine F. Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med. 2000;26:915&#x2013;921. doi: 10.1007/s001340051281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001340051281</ArticleId><ArticleId IdType="pubmed">10990106</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerin C, Girard R, Selli JM, Perdrix JP, Ayzac L. Initial versus delayed acute renal failure in the intensive care unit. A multicenter prospective epidemiological study. Rhone-Alpes Area Study Group on Acute Renal Failure. Am J Respir Crit Care Med. 2000;161:872&#x2013;879. doi: 10.1164/ajrccm.161.3.9809066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.161.3.9809066</ArticleId><ArticleId IdType="pubmed">10712336</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwilk B, Wiedeck H, Stein B, Reinelt H, Treiber H, Bothner U. Epidemiology of acute renal failure and outcome of haemodiafiltration in intensive care. Intensive Care Med. 1997;23:1204&#x2013;1211. doi: 10.1007/s001340050487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001340050487</ArticleId><ArticleId IdType="pubmed">9470074</ArticleId></ArticleIdList></Reference><Reference><Citation>Himmelfarb J, Joannidis M, Molitoris B, Schietz M, Okusa MD, Warnock D, Laghi F, Goldstein SL, Prielipp R, Parikh CR, Pannu N, Lobo SM, Shah S, D&#x2019;Intini V, Kellum JA. Evaluation and initial management of acute kidney injury. Clin J Am Soc Nephrol. 2008;3:962&#x2013;967. doi: 10.2215/CJN.04971107.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.04971107</ArticleId><ArticleId IdType="pmc">PMC2440262</ArticleId><ArticleId IdType="pubmed">18354074</ArticleId></ArticleIdList></Reference><Reference><Citation>Joannidis M. Drug-induced renal failure in the ICU. Int J Artif Organs. 2004;27:1034&#x2013;1042.</Citation><ArticleIdList><ArticleId IdType="pubmed">15645613</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43:304&#x2013;377. doi: 10.1007/s00134-017-4683-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-4683-6</ArticleId><ArticleId IdType="pubmed">28101605</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Kirwan CJ, Bellomo R. Fluid management for the prevention and attenuation of acute kidney injury. Nat Rev Nephrol. 2014;10:37&#x2013;47. doi: 10.1038/nrneph.2013.232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2013.232</ArticleId><ArticleId IdType="pubmed">24217464</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostermann M, Straaten HM, Forni LG. Fluid overload and acute kidney injury: cause or consequence? Crit Care. 2015;19:443. doi: 10.1186/s13054-015-1163-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-1163-7</ArticleId><ArticleId IdType="pmc">PMC4699346</ArticleId><ArticleId IdType="pubmed">26707872</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Chawla LS, Keener C, Singbartl K, Palevsky PM, Pike FL, Yealy DM, Huang DT, Angus DC, ProCESS and ProGReSS-AKI Investigators The effects of alternative resuscitation strategies on acute kidney injury in patients with septic shock. Am J Respir Crit Care Med. 2016;193:281&#x2013;287. doi: 10.1164/rccm.201505-0995OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201505-0995OC</ArticleId><ArticleId IdType="pmc">PMC4803059</ArticleId><ArticleId IdType="pubmed">26398704</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and Plasma-lyte&#xae; 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg. 2012;256:18&#x2013;24. doi: 10.1097/SLA.0b013e318256be72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e318256be72</ArticleId><ArticleId IdType="pubmed">22580944</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkes NJ, Woolf R, Mutch M, Mallett SV, Peachey T, Stephens R, Mythen MG. The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg. 2001;93:811&#x2013;816. doi: 10.1097/00000539-200110000-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000539-200110000-00003</ArticleId><ArticleId IdType="pubmed">11574338</ArticleId></ArticleIdList></Reference><Reference><Citation>Alphonsus CS, Rodseth RN. The endothelial glycocalyx: a review of the vascular barrier. Anaesthesia. 2014;69:777&#x2013;784. doi: 10.1111/anae.12661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.12661</ArticleId><ArticleId IdType="pubmed">24773303</ArticleId></ArticleIdList></Reference><Reference><Citation>Chappell D, Jacob M. Role of the glycocalyx in fluid management: small things matter. Best Pract Res Clin Anaesthesiol. 2014;28:227&#x2013;234. doi: 10.1016/j.bpa.2014.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpa.2014.06.003</ArticleId><ArticleId IdType="pubmed">25208958</ArticleId></ArticleIdList></Reference><Reference><Citation>Perner A, Prowle JR, Joannidis M, Young P, Hjortrup PB, Pettil&#xe4; V (2017) Fluid management in acute kidney injury. Intensive Care Med. doi:10.1007/s00134-017-4817-x</Citation><ArticleIdList><ArticleId IdType="pubmed">28470347</ArticleId></ArticleIdList></Reference><Reference><Citation>Horgan KJ, Ottaviano YL, Watson AJ. Acute renal-failure due to mannitol intoxication. Am J Nephrol. 1989;9:106&#x2013;109. doi: 10.1159/000167946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000167946</ArticleId><ArticleId IdType="pubmed">2500855</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozich JD, Paul RV. Acute renal failure precipitated by elevated colloid osmotic pressure. Am J Med. 1989;87:359&#x2013;360. doi: 10.1016/S0002-9343(89)80171-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(89)80171-8</ArticleId><ArticleId IdType="pubmed">2773975</ArticleId></ArticleIdList></Reference><Reference><Citation>Legendre C, Thervet E, Page B, Percheron A, Noel LH, Kreis H. Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet. 1993;342:248&#x2013;249. doi: 10.1016/0140-6736(93)92345-T.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0140-6736(93)92345-T</ArticleId><ArticleId IdType="pubmed">7686994</ArticleId></ArticleIdList></Reference><Reference><Citation>Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet. 1996;348:1620&#x2013;1622. doi: 10.1016/S0140-6736(96)07588-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(96)07588-5</ArticleId><ArticleId IdType="pubmed">8961992</ArticleId></ArticleIdList></Reference><Reference><Citation>Skinsnes OK. Gelatin nephrosis; renal tissue changes in man resulting from the intravenous administration of gelatin. Surg Gynecol Obstetri. 1947;85:563&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pubmed">20266769</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyer R, Harmening U, Rittmeyer O, Zielmann S, Mielck F, Kazmaier S, Kettler D. Use of modified fluid gelatin and hydroxyethyl starch for colloidal volume replacement in major orthopaedic surgery. Brit J Anaesth. 1997;78:44&#x2013;50. doi: 10.1093/bja/78.1.44.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/78.1.44</ArticleId><ArticleId IdType="pubmed">9059203</ArticleId></ArticleIdList></Reference><Reference><Citation>Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet. 2001;357:911&#x2013;916. doi: 10.1016/S0140-6736(00)04211-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(00)04211-2</ArticleId><ArticleId IdType="pubmed">11289347</ArticleId></ArticleIdList></Reference><Reference><Citation>Mardel SN, Saunders FM, Allen H, Menezes G, Edwards CM, Ollerenshaw L, Baddeley D, Kennedy A, Ibbotson RM. Reduced quality of clot formation with gelatin-based plasma substitutes. Br J Anaesth. 1998;80:204&#x2013;207. doi: 10.1093/bja/80.2.204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/80.2.204</ArticleId><ArticleId IdType="pubmed">9602586</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabuchi N, deHaan J, Huet RCGG, Boonstra PW, vanOeveren W. Gelatin use impairs platelet adhesion during cardiac surgery. Thromb Haemostasis. 1995;74:1447&#x2013;1451.</Citation><ArticleIdList><ArticleId IdType="pubmed">8772218</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurnik BR, Singer F, Groh WC. Case report: dextran-induced acute anuric renal failure. Am J Med Sci. 1991;302:28&#x2013;30. doi: 10.1097/00000441-199107000-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000441-199107000-00007</ArticleId><ArticleId IdType="pubmed">1712152</ArticleId></ArticleIdList></Reference><Reference><Citation>Laxenaire MC, Charpentier C, Feldman L. Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study. Ann Fr Anesth Reanim. 1994;13:301&#x2013;310. doi: 10.1016/S0750-7658(94)80038-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0750-7658(94)80038-3</ArticleId><ArticleId IdType="pubmed">7992937</ArticleId></ArticleIdList></Reference><Reference><Citation>Mailloux L, Swartz CD, Capizzi R, Kim KE, Onesti G, Ramirez O, Brest AN. Acute renal failure after administration of low-molecular weight dextran. N Engl J Med. 1967;277:1113&#x2013;1118. doi: 10.1056/NEJM196711232772103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM196711232772103</ArticleId><ArticleId IdType="pubmed">6054998</ArticleId></ArticleIdList></Reference><Reference><Citation>Messmer KFW. The use of plasma substitutes with special attention to their side-effects. World J Surg. 1987;11:69&#x2013;74. doi: 10.1007/BF01658463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01658463</ArticleId><ArticleId IdType="pubmed">3544523</ArticleId></ArticleIdList></Reference><Reference><Citation>Fliser D, Zurbruggen I, Mutschler E, Bischoff I, Nussberger J, Franek E, Ritz E. Coadministration of albumin and furosemide in patients with the nephrotic syndrome. Kidney Int. 1999;55:629&#x2013;634. doi: 10.1046/j.1523-1755.1999.00298.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1523-1755.1999.00298.x</ArticleId><ArticleId IdType="pubmed">9987087</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue M, Okajima K, Itoh K, Ando Y, Watanabe N, Yasaka T, Nagase S, Morino Y. Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients. Kidney Int. 1987;32(2):198&#x2013;203. doi: 10.1038/ki.1987.192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.1987.192</ArticleId><ArticleId IdType="pubmed">3656933</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedermann CJ, Dunzendorfer S, Gaioni LU, Zaraca F, Joannidis M. Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trials. Crit Care. 2010;14:R191. doi: 10.1186/cc9308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc9308</ArticleId><ArticleId IdType="pmc">PMC3219298</ArticleId><ArticleId IdType="pubmed">21029460</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedermann CJ, Joannidis M. Nephroprotective potential of human albumin infusion: a narrative review. Gastroenterol Res Pract. 2015;2015:912839. doi: 10.1155/2015/912839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/912839</ArticleId><ArticleId IdType="pmc">PMC4475554</ArticleId><ArticleId IdType="pubmed">26136776</ArticleId></ArticleIdList></Reference><Reference><Citation>Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R, SAFE Study Investigators A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350:2247&#x2013;2256. doi: 10.1056/NEJMoa040232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa040232</ArticleId><ArticleId IdType="pubmed">15163774</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, Early Goal-Directed Therapy Collaborative Group Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368&#x2013;1377. doi: 10.1056/NEJMoa010307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa010307</ArticleId><ArticleId IdType="pubmed">11794169</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano AB, Candela-Toha AM, Zamora J, Vera J, Muriel A, Del Rey JM, Liano F. Preoperative hydration with 0.9% normal saline to prevent acute kidney injury after major elective open abdominal surgery: a randomised controlled trial. Eur J Anaesthesiol. 2016;33:436&#x2013;443. doi: 10.1097/EJA.0000000000000421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000421</ArticleId><ArticleId IdType="pubmed">26825017</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjortrup PB, Haase N, Bundgaard H, Thomsen SL, Winding R, Pettila V, Aaen A, Lodahl D, Berthelsen RE, Christensen H, Madsen MB, Winkel P, Wetterslev J, Perner A, CLASSIC Trial Group. Scandinavian Critical Care Trials Group Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial. Intensive Care Med. 2016;42:1695&#x2013;1705. doi: 10.1007/s00134-016-4500-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4500-7</ArticleId><ArticleId IdType="pubmed">27686349</ArticleId></ArticleIdList></Reference><Reference><Citation>Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012;308:1566&#x2013;1572. doi: 10.1001/jama.2012.13356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2012.13356</ArticleId><ArticleId IdType="pubmed">23073953</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw AD, Raghunathan K, Peyerl FW, Munson SH, Paluszkiewicz SM, Schermer CR. Association between intravenous chloride load during resuscitation and in-hospital mortality among patients with SIRS. Intensive Care Med. 2014;40:1897&#x2013;1905. doi: 10.1007/s00134-014-3505-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-014-3505-3</ArticleId><ArticleId IdType="pmc">PMC4239799</ArticleId><ArticleId IdType="pubmed">25293535</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Lameire N, KDIGO AKI Guideline Work Group Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1) Crit Care. 2013;17:204. doi: 10.1186/cc11454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11454</ArticleId><ArticleId IdType="pmc">PMC4057151</ArticleId><ArticleId IdType="pubmed">23394211</ArticleId></ArticleIdList></Reference><Reference><Citation>Young P, Bailey M, Beasley R, Henderson S, Mackle D, McArthur C, McGuinness S, Mehrtens J, Myburgh J, Psirides A, Reddy S, Bellomo R. Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: the SPLIT randomized clinical trial. JAMA. 2015;314:1701&#x2013;1710. doi: 10.1001/jama.2015.12334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.12334</ArticleId><ArticleId IdType="pubmed">26444692</ArticleId></ArticleIdList></Reference><Reference><Citation>Joannidis M, Forni LG. Acute kidney injury: buffered crystalloids or saline in the ICU&#x2014;a SPLIT decision. Nat Rev Nephrol. 2016;12:6&#x2013;8. doi: 10.1038/nrneph.2015.190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2015.190</ArticleId><ArticleId IdType="pubmed">26592191</ArticleId></ArticleIdList></Reference><Reference><Citation>Semler MW, Wanderer JP, Ehrenfeld JM, Stollings JL, Self WH, Siew ED, Wang L, Byrne DW, Shaw AD, Bernard GR, Rice TW, SALT Investigators and the Pragmatic Critical Care Research Group (2017) Balanced crystalloids versus saline in the intensive care unit: the SALT randomized trial. Am J Respir Crit Care Med. doi: 10.1164/rccm.201607-1345OC</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5443900</ArticleId><ArticleId IdType="pubmed">27749094</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase M, Haase-Fielitz A, Bellomo R, Devarajan P, Story D, Matalanis G, Reade MC, Bagshaw SM, Seevanayagam N, Seevanayagam S, Doolan L, Buxton B, Dragun D. Sodium bicarbonate to prevent increases in serum creatinine after cardiac surgery: a pilot double-blind, randomized controlled trial. Crit Care Med. 2009;37:39&#x2013;47. doi: 10.1097/CCM.0b013e318193216f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318193216f</ArticleId><ArticleId IdType="pubmed">19112278</ArticleId></ArticleIdList></Reference><Reference><Citation>McGuinness SP, Parke RL, Bellomo R, Van Haren FM, Bailey M. Sodium bicarbonate infusion to reduce cardiac surgery-associated acute kidney injury: a phase II multicenter double-blind randomized controlled trial. Crit Care Med. 2013;41:1599&#x2013;1607. doi: 10.1097/CCM.0b013e31828a3f99.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31828a3f99</ArticleId><ArticleId IdType="pubmed">23685640</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristeller JL, Zavorsky GS, Prior JE, Keating DA, Brady MA, Romaldini TA, Hickman TL, Stahl RF. Lack of effectiveness of sodium bicarbonate in preventing kidney injury in patients undergoing cardiac surgery: a randomized controlled trial. Pharmacotherapy. 2013;33:710&#x2013;717. doi: 10.1002/phar.1262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/phar.1262</ArticleId><ArticleId IdType="pubmed">23553549</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase M, Haase-Fielitz A, Plass M, Kuppe H, Hetzer R, Hannon C, Murray PT, Bailey MJ, Bellomo R, Bagshaw SM. Prophylactic perioperative sodium bicarbonate to prevent acute kidney injury following open heart surgery: a multicenter double-blinded randomized controlled trial. PLoS Med. 2013;10:e1001426. doi: 10.1371/journal.pmed.1001426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001426</ArticleId><ArticleId IdType="pmc">PMC3627643</ArticleId><ArticleId IdType="pubmed">23610561</ArticleId></ArticleIdList></Reference><Reference><Citation>Tie HT, Luo MZ, Luo MJ, Zhang M, Wu QC, Wan JY. Sodium bicarbonate in the prevention of cardiac surgery-associated acute kidney injury: a systematic review and meta-analysis. Crit Care. 2014;18:517. doi: 10.1186/s13054-014-0517-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-014-0517-x</ArticleId><ArticleId IdType="pmc">PMC4177432</ArticleId><ArticleId IdType="pubmed">25212718</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian ML, Hu Y, Yuan J, Zha Y. Efficacy and safety of perioperative sodium bicarbonate therapy for cardiac surgery-associated acute kidney injury: a meta-analysis. J Cardiovasc Pharmacol. 2015;65:130&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pubmed">25264756</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JH, Kim HJ, Kim JY, Ahn H, Ahn IM, Choe WJ, Lim CH. Meta-analysis of sodium bicarbonate therapy for prevention of cardiac surgery-associated acute kidney injury. J Cardiothorac Vasc Anesth. 2015;29:1248&#x2013;1256. doi: 10.1053/j.jvca.2015.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2015.03.007</ArticleId><ArticleId IdType="pubmed">26119410</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey M, McGuinness S, Haase M, Haase-Fielitz A, Parke R, Hodgson CL, Forbes A, Bagshaw SM, Bellomo R. Sodium bicarbonate and renal function after cardiac surgery: a prospectively planned individual patient meta-analysis. Anesthesiology. 2015;122:294&#x2013;306. doi: 10.1097/ALN.0000000000000547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000547</ArticleId><ArticleId IdType="pubmed">25501691</ArticleId></ArticleIdList></Reference><Reference><Citation>Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArthur C, McGuinness S, Rajbhandari D, Taylor CB, Webb SA, CHEST Investigators. Australian and New Zealand Intensive Care Society Clinical Trials Group Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367:1901&#x2013;1911. doi: 10.1056/NEJMoa1209759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1209759</ArticleId><ArticleId IdType="pubmed">23075127</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K, German Competence Network Sepsis (SepNet) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125&#x2013;139. doi: 10.1056/NEJMoa070716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa070716</ArticleId><ArticleId IdType="pubmed">18184958</ArticleId></ArticleIdList></Reference><Reference><Citation>Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Aneman A, Madsen KR, Moller MH, Elkjaer JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Soe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjaeldgaard AL, Fabritius ML, Mondrup F, Pott FC, Moller TP, Winkel P, Wetterslev J, 6S Trial Group. Scandinavian Critical Care Trials Group Hydroxyethyl starch 130/0.42 versus Ringer&#x2019;s acetate in severe sepsis. N Engl J Med. 2012;367:124&#x2013;134. doi: 10.1056/NEJMoa1204242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1204242</ArticleId><ArticleId IdType="pubmed">22738085</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattas DJ, Dan A, Myburgh J, Billot L, Lo S, Finfer S, CHEST Management Committee Fluid resuscitation with 6% hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy. Intensive Care Med. 2013;39:558&#x2013;568. doi: 10.1007/s00134-013-2840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-013-2840-0</ArticleId><ArticleId IdType="pubmed">23407978</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarychanski R, Abou-Setta AM, Turgeon AF, Houston BL, McIntyre L, Marshall JC, Fergusson DA. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA. 2013;309:678&#x2013;688. doi: 10.1001/jama.2013.430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.430</ArticleId><ArticleId IdType="pubmed">23423413</ArticleId></ArticleIdList></Reference><Reference><Citation>Rochwerg B, Alhazzani W, Gibson A, Ribic CM, Sindi A, Heels-Ansdell D, Thabane L, Fox-Robichaud A, Mbuagbaw L, Szczeklik W, Alshamsi F, Altayyar S, Ip W, Li G, Wang M, Wludarczyk A, Zhou Q, Annane D, Cook DJ, Jaeschke R, Guyatt GH. Fluid type and the use of renal replacement therapy in sepsis: a systematic review and network meta-analysis. Intensive Care Med. 2015;41:1561&#x2013;1571. doi: 10.1007/s00134-015-3794-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3794-1</ArticleId><ArticleId IdType="pubmed">25904181</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase N, Perner A, Hennings LI, Siegemund M, Lauridsen B, Wetterslev M, Wetterslev J. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ. 2013;346:f839. doi: 10.1136/bmj.f839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.f839</ArticleId><ArticleId IdType="pmc">PMC3573769</ArticleId><ArticleId IdType="pubmed">23418281</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutter TC, Ruth CA, Dart AB (2013) Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev 7:CD007594. doi:10.1002/14651858.CD007594.pub3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11561698</ArticleId><ArticleId IdType="pubmed">23881659</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhart K, Perner A, Sprung CL, Jaeschke R, Schortgen F, Johan Groeneveld AB, Beale R, Hartog CS, European Society of Intensive Care Medicine Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med. 2012;38:368&#x2013;383. doi: 10.1007/s00134-012-2472-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-012-2472-9</ArticleId><ArticleId IdType="pubmed">22323076</ArticleId></ArticleIdList></Reference><Reference><Citation>Moeller C, Fleischmann C, Thomas-Rueddel D, Vlasakov V, Rochwerg B, Theurer P, Gattinoni L, Reinhart K, Hartog CS. How safe is gelatin? A systematic review and meta-analysis of gelatin-containing plasma expanders vs crystalloids and albumin. J Crit Care. 2016;35:75&#x2013;83. doi: 10.1016/j.jcrc.2016.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2016.04.011</ArticleId><ArticleId IdType="pubmed">27481739</ArticleId></ArticleIdList></Reference><Reference><Citation>Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M, Fanizza C, Caspani L, Faenza S, Grasselli G, Iapichino G, Antonelli M, Parrini V, Fiore G, Latini R, Gattinoni L, ALBIOS Study Investigators Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370:1412&#x2013;1421. doi: 10.1056/NEJMoa1305727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1305727</ArticleId><ArticleId IdType="pubmed">24635772</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois MJ, Orellana-Jimenez C, Melot C, De Backer D, Berre J, Leeman M, Brimioulle S, Appoloni O, Creteur J, Vincent JL. Albumin administration improves organ function in critically ill hypoalbuminemic patients: a prospective, randomized, controlled, pilot study. Crit Care Med. 2006;34:2536&#x2013;2540. doi: 10.1097/01.CCM.0000239119.57544.0C.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000239119.57544.0C</ArticleId><ArticleId IdType="pubmed">16915107</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedermann CJ, Joannidis M. Albumin replacement in severe sepsis or septic shock. N Engl J Med. 2014;371:83. doi: 10.1056/NEJMc1405675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1405675</ArticleId><ArticleId IdType="pubmed">24988572</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A, Laffan MA, Waheed U, Brett SJ. Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality. BMJ. 2014;349:g4561. doi: 10.1136/bmj.g4561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.g4561</ArticleId><ArticleId IdType="pmc">PMC4106199</ArticleId><ArticleId IdType="pubmed">25099709</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EH, Kim WJ, Kim JY, Chin JH, Choi DK, Sim JY, Choo SJ, Chung CH, Lee JW, Choi IC. Effect of exogenous albumin on the incidence of postoperative acute kidney injury in patients undergoing off-pump coronary artery bypass surgery with a preoperative albumin level of less than 4.0&#xa0;g/dl. Anesthesiology. 2016;124:1001&#x2013;1011. doi: 10.1097/ALN.0000000000001051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001051</ArticleId><ArticleId IdType="pubmed">26891150</ArticleId></ArticleIdList></Reference><Reference><Citation>Pannu N, Nadim MK. An overview of drug-induced acute kidney injury. Crit Care Med. 2008;36:S216&#x2013;223. doi: 10.1097/CCM.0b013e318168e375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318168e375</ArticleId><ArticleId IdType="pubmed">18382197</ArticleId></ArticleIdList></Reference><Reference><Citation>Perazella MA, Luciano RL. Review of select causes of drug-induced AKI. Expert Rev Clin Pharmacol. 2015;8(4):367&#x2013;371. doi: 10.1586/17512433.2015.1045489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/17512433.2015.1045489</ArticleId><ArticleId IdType="pubmed">26109096</ArticleId></ArticleIdList></Reference><Reference><Citation>Branch RA. Prevention of amphotericin-B induced renal impairment. A review on the use of sodium supplementation. Arch Intern Med. 1988;148:2389&#x2013;2394. doi: 10.1001/archinte.1988.00380110049010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.1988.00380110049010</ArticleId><ArticleId IdType="pubmed">3056312</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung TW, Jayaweera DT, Pearce D, Benson P, Nahass R, Olson C, Wool GM. Safety of oral versus intravenous hydration during induction therapy with intravenous foscarnet in AIDS patients with cytomegalovirus infections. Int J STD AIDS. 2000;11:640&#x2013;647. doi: 10.1258/0956462001914995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1258/0956462001914995</ArticleId><ArticleId IdType="pubmed">11057934</ArticleId></ArticleIdList></Reference><Reference><Citation>Safrin S, Cherrington J, Jaffe HS. Cidofovir. Review of current and potential clinical uses. Adv Exp Med Biol. 1999;458:111&#x2013;120. doi: 10.1007/978-1-4615-4743-3_10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4615-4743-3_10</ArticleId><ArticleId IdType="pubmed">10549383</ArticleId></ArticleIdList></Reference><Reference><Citation>Perazella MA. Crystal-induced acute renal failure. Am J Med. 1999;106:459&#x2013;465. doi: 10.1016/S0002-9343(99)00041-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(99)00041-8</ArticleId><ArticleId IdType="pubmed">10225250</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon R, Werner C, Mann D, D&#x2019;Elia J, Silva P. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med. 1994;331:1416&#x2013;1420. doi: 10.1056/NEJM199411243312104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199411243312104</ArticleId><ArticleId IdType="pubmed">7969280</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, Marsch S, Roskamm H. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med. 2002;162:329&#x2013;336. doi: 10.1001/archinte.162.3.329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.162.3.329</ArticleId><ArticleId IdType="pubmed">11822926</ArticleId></ArticleIdList></Reference><Reference><Citation>Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, Bersin RM, Van Moore A, Simonton CA, 3rd, Rittase RA, Norton HJ, Kennedy TP. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA. 2004;291:2328&#x2013;2334. doi: 10.1001/jama.291.19.2328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.291.19.2328</ArticleId><ArticleId IdType="pubmed">15150204</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozcan EE, Guneri S, Akdeniz B, Akyildiz IZ, Senaslan O, Baris N, Aslan O, Badak O. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial. Am Heart J. 2007;154:539&#x2013;544. doi: 10.1016/j.ahj.2007.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2007.05.012</ArticleId><ArticleId IdType="pubmed">17719303</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuda M, Yamada T, Mine T, Morita T, Tamaki S, Tsukamoto Y, Okuda K, Iwasaki Y, Hori M, Fukunami M. Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure. Am J Cardiol. 2007;100:781&#x2013;786. doi: 10.1016/j.amjcard.2007.03.098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2007.03.098</ArticleId><ArticleId IdType="pubmed">17719320</ArticleId></ArticleIdList></Reference><Reference><Citation>Briguori C, Airoldi F, D&#x2019;Andrea D, Bonizzoni E, Morici N, Focaccio A, Michev I, Montorfano M, Carlino M, Cosgrave J, Ricciardelli B, Colombo A. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation. 2007;115:1211&#x2013;1217.</Citation><ArticleIdList><ArticleId IdType="pubmed">17309916</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen EC, Rennenberg RJ, Nelemans PJ, Essers BA, Janssen MM, Vermeeren MA, Ommen VV, Wildberger JE. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet. 2017;389:1312&#x2013;1322. doi: 10.1016/S0140-6736(17)30057-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)30057-0</ArticleId><ArticleId IdType="pubmed">28233565</ArticleId></ArticleIdList></Reference><Reference><Citation>Newhouse JH, Kho D, Rao QA, Starren J. Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. AJR Am J Roentgenol. 2008;191:376&#x2013;382. doi: 10.2214/AJR.07.3280.</Citation><ArticleIdList><ArticleId IdType="doi">10.2214/AJR.07.3280</ArticleId><ArticleId IdType="pubmed">18647905</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilhelm-Leen E, Montez-Rath ME, Chertow G. Estimating the risk of radiocontrast-associated nephropathy. J Am Soc Nephrol. 2017;28:653&#x2013;659. doi: 10.1681/ASN.2016010021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2016010021</ArticleId><ArticleId IdType="pmc">PMC5280012</ArticleId><ArticleId IdType="pubmed">27688297</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste EA, Doom S, De Waele J, Delrue LJ, Defreyne L, Benoit DD, Decruyenaere J. Epidemiology of contrast-associated acute kidney injury in ICU patients: a retrospective cohort analysis. Intensive Care Med. 2011;37:1921&#x2013;1931. doi: 10.1007/s00134-011-2389-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-011-2389-8</ArticleId><ArticleId IdType="pubmed">22048719</ArticleId></ArticleIdList></Reference><Reference><Citation>Cely CM, Schein RM, Quartin AA. Risk of contrast induced nephropathy in the critically ill: a prospective, case matched study. Crit Care. 2012;16:R67. doi: 10.1186/cc11317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11317</ArticleId><ArticleId IdType="pmc">PMC3681396</ArticleId><ArticleId IdType="pubmed">22534554</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrmann S, Badin J, Savath L, Pajot O, Garot D, Pham T, Capdevila X, Perrotin D, Lakhal K. Acute kidney injury in the critically ill: is iodinated contrast medium really harmful? Crit Care Med. 2013;41:1017&#x2013;1026. doi: 10.1097/CCM.0b013e318275871a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318275871a</ArticleId><ArticleId IdType="pubmed">23324952</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald JS, McDonald RJ, Williamson EE, Kallmes DF, Kashani K (2017) Post-contrast acute kidney injury in intensive care unit patients: a propensity score-adjusted study. Intensive Care Med. doi:10.1007/s00134-017-4699-y</Citation><ArticleIdList><ArticleId IdType="pubmed">28213620</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinson JS, Ehmann MR, Fine DM, Fishman EK, Toerper MF, Rothman RE, Klein EY (2017) Risk of acute kidney injury after intravenous contrast media administration. Ann Emerg Med 69:577&#x2013;586.e4</Citation><ArticleIdList><ArticleId IdType="pubmed">28131489</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrmann S, Quartin A, Hobbs BP, Robert-Edan V, Cely C, Bell C, Lyons G, Pham T, Schein R, Geng Y, Lakhal K, Ng CS (2017) Contrast-associated acute kidney injury in the critically ill: systematic review and Bayesian meta-analysis. Intensive Care Med. doi:10.1007/s00134-017-4700-9</Citation><ArticleIdList><ArticleId IdType="pubmed">28197679</ArticleId></ArticleIdList></Reference><Reference><Citation>Valette X, Desmeulles I, Savary B, Masson R, Seguin A, Sauneuf B, Brunet J, Verrier P, Pottier V, Orabona M, Samba D, Viquesnel G, Lermuzeaux M, Hazera P, Dutheil JJ, Hanouz JL, Parienti JJ, du Cheyron D. Sodium bicarbonate versus sodium chloride for preventing contrast-associated acute kidney injury in critically ill patients: a randomized controlled trial. Crit Care Med. 2017;45:637&#x2013;644. doi: 10.1097/CCM.0000000000002267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000002267</ArticleId><ArticleId IdType="pubmed">28181941</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Li H, Chen S, Chen J, Tan N, Zhou Y, Liu Y, Ye P, Ran P, Duan C, Chen P (2016) Excessively high hydration volume may not be associated with decreased risk of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with renal insufficiency. J Am Heart Assoc. doi:10.1161/JAHA.115.003171</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4937263</ArticleId><ArticleId IdType="pubmed">27233298</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagshaw SM, Delaney A, Jones D, Ronco C, Bellomo R. Diuretics in the management of acute kidney injury: a multinational survey. Contrib Nephrol. 2007;156:236&#x2013;249. doi: 10.1159/000102089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000102089</ArticleId><ArticleId IdType="pubmed">17464133</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayati A, Nygren K, Kallskog O, Wolgast M. The effect of loop diuretics on the long-term outcome of post-ischaemic acute renal failure in the rat. Acta Physiol Scand. 1990;139:271&#x2013;279. doi: 10.1111/j.1748-1716.1990.tb08924.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1748-1716.1990.tb08924.x</ArticleId><ArticleId IdType="pubmed">2368616</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyman SN, Rosen S, Epstein FH, Spokes K, Brezis ML. Loop diuretics reduce hypoxic damage to proximal tubules of the isolated perfused rat kidney. Kidney Int. 1994;45:981&#x2013;985. doi: 10.1038/ki.1994.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.1994.132</ArticleId><ArticleId IdType="pubmed">8007601</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer HJ, Schuurmann J, Wassermann C, Dusing R. Prostaglandin-independent protection by furosemide from oliguric ischemic renal failure in conscious rats. Kidney Int. 1980;17:455&#x2013;464. doi: 10.1038/ki.1980.53.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.1980.53</ArticleId><ArticleId IdType="pubmed">7392420</ArticleId></ArticleIdList></Reference><Reference><Citation>Legrand M, Dupuis C, Simon C, Gayat E, Mateo J, Lukaszewicz AC, Payen D. Association between systemic hemodynamics and septic acute kidney injury in critically ill patients: a retrospective observational study. Crit Care. 2013;17:R278. doi: 10.1186/cc13133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc13133</ArticleId><ArticleId IdType="pmc">PMC4056656</ArticleId><ArticleId IdType="pubmed">24289206</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen KP, Cavender S, Lee J, Feng M, Mark RG, Celi LA, Mukamal KJ, Danziger J. Peripheral edema, central venous pressure, and risk of AKI in critical illness. Clinic J Am Soc Nephrol. 2016;11:602&#x2013;608. doi: 10.2215/CJN.08080715.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.08080715</ArticleId><ArticleId IdType="pmc">PMC4822669</ArticleId><ArticleId IdType="pubmed">26787777</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu YF, Zheng YP, Zhang N, Liu H, Zheng QX, Yang FT, Wu YF. Study on the correlation between the changes in intra-abdominal pressure and renal functional in the patients with abdominal compartment syndrome. Eur Rev Med Pharmacol Sci. 2015;19:3682&#x2013;3687.</Citation><ArticleIdList><ArticleId IdType="pubmed">26502858</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordemans C, De Laet I, Van Regenmortel N, Schoonheydt K, Dits H, Huber W, Malbrain ML. Fluid management in critically ill patients: the role of extravascular lung water, abdominal hypertension, capillary leak, and fluid balance. Ann Intensive Care. 2012;2:S1. doi: 10.1186/2110-5820-2-S1-S1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2110-5820-2-S1-S1</ArticleId><ArticleId IdType="pmc">PMC3390304</ArticleId><ArticleId IdType="pubmed">22873410</ArticleId></ArticleIdList></Reference><Reference><Citation>Chawla LS, Davison DL, Brasha-Mitchell E, Koyner JL, Arthur JM, Shaw AD, Tumlin JA, Trevino SA, Kimmel PL, Seneff MG. Development and standardization of a furosemide stress test to predict the severity of acute kidney injury. Crit Care. 2013;17:R207. doi: 10.1186/cc13015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc13015</ArticleId><ArticleId IdType="pmc">PMC4057505</ArticleId><ArticleId IdType="pubmed">24053972</ArticleId></ArticleIdList></Reference><Reference><Citation>National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF, Jr, Hite RD, Harabin AL. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354:2564&#x2013;2575. doi: 10.1056/NEJMoa062200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa062200</ArticleId><ArticleId IdType="pubmed">16714767</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol. 2000;11:97&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">10616845</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown CB, Ogg CS, Cameron JS. High dose frusemide in acute renal failure: a controlled trial. Clin Nephrol. 1981;15:90&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">7011622</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho KM, Power BM. Benefits and risks of furosemide in acute kidney injury. Anaesthesia. 2010;65:283&#x2013;293. doi: 10.1111/j.1365-2044.2009.06228.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2009.06228.x</ArticleId><ArticleId IdType="pubmed">20085566</ArticleId></ArticleIdList></Reference><Reference><Citation>Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, LeWinter MM, Deswal A, Rouleau JL, Ofili EO, Anstrom KJ, Hernandez AF, McNulty SE, Velazquez EJ, Kfoury AG, Chen HH, Givertz MM, Semigran MJ, Bart BA, Mascette AM, Braunwald E, O&#x2019;Connor CM, NHLBI Heart Failure Clinical Research Network Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011;364:797&#x2013;805. doi: 10.1056/NEJMoa1005419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1005419</ArticleId><ArticleId IdType="pmc">PMC3412356</ArticleId><ArticleId IdType="pubmed">21366472</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotter G, Weissgarten J, Metzkor E, Moshkovitz Y, Litinski I, Tavori U, Perry C, Zaidenstein R, Golik A. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure. Clin Pharmacol Ther. 1997;62:187&#x2013;193. doi: 10.1016/S0009-9236(97)90067-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0009-9236(97)90067-9</ArticleId><ArticleId IdType="pubmed">9284855</ArticleId></ArticleIdList></Reference><Reference><Citation>Hager B, Betschart M, Krapf R. Effect of postoperative intravenous loop diuretic on renal function after major surgery. Schweiz Med Wochenschr. 1996;126:666&#x2013;673.</Citation><ArticleIdList><ArticleId IdType="pubmed">8658094</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Voort PHJ, Boerma EC, Koopmans M, Zandberg M, de Ruiter J, Gerritsen RT, Egbers PH, Kingma WP, Kuiper MA. Furosemide does not improve renal recovery after hemofiltration for acute renal failure in critically ill patients: a double blind randomized controlled trial. Crit Care Med. 2009;37:533&#x2013;538. doi: 10.1097/CCM.0b013e318195424d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318195424d</ArticleId><ArticleId IdType="pubmed">19114909</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahsan N, Palmer BF, Wheeler D, Greenlee RG, Jr, Toto RD. Intravenous immunoglobulin-induced osmotic nephrosis. Arch Intern Med. 1994;154:1985&#x2013;1987. doi: 10.1001/archinte.154.17.1985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.154.17.1985</ArticleId><ArticleId IdType="pubmed">8074604</ArticleId></ArticleIdList></Reference><Reference><Citation>Shilliday IR, Quinn KJ, Allison ME. Loop diuretics in the management of acute renal failure: a prospective, double-blind, placebo-controlled, randomized study. Nephrol Dial Transplant. 1997;12:2592&#x2013;2596. doi: 10.1093/ndt/12.12.2592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/12.12.2592</ArticleId><ArticleId IdType="pubmed">9430857</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirivella S, Gielchinsky I, Parsonnet V. Mannitol, furosemide, and dopamine infusion in postoperative renal failure complicating cardiac surgery. Ann Thorac Surg. 2000;69:501&#x2013;506. doi: 10.1016/S0003-4975(99)01298-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-4975(99)01298-9</ArticleId><ArticleId IdType="pubmed">10735688</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho KM, Sheridan DJ. Meta-analysis of frusemide to prevent or treat acute renal failure. BMJ. 2006;333:420. doi: 10.1136/bmj.38902.605347.7C.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38902.605347.7C</ArticleId><ArticleId IdType="pmc">PMC1553510</ArticleId><ArticleId IdType="pubmed">16861256</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagshaw SM, Delaney A, Haase M, Ghali WA, Bellomo R. Loop diuretics in the management of acute renal failure: a systematic review and meta-analysis. Crit Care Resusc. 2007;9:60&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">17352669</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampath S, Moran JL, Graham PL, Rockliff S, Bersten AD, Abrams KR. The efficacy of loop diuretics in acute renal failure: assessment using Bayesian evidence synthesis techniques. Crit Care Med. 2007;35:2516&#x2013;2524. doi: 10.1097/01.CCM.0000284503.88148.6F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000284503.88148.6F</ArticleId><ArticleId IdType="pubmed">18084840</ArticleId></ArticleIdList></Reference><Reference><Citation>Asfar P, Meziani F, Hamel JF, Grelon F, Megarbane B, Anguel N, Mira JP, Dequin PF, Gergaud S, Weiss N, Legay F, Le Tulzo Y, Conrad M, Robert R, Gonzalez F, Guitton C, Tamion F, Tonnelier JM, Guezennec P, Van Der Linden T, Vieillard-Baron A, Mariotte E, Pradel G, Lesieur O, Ricard JD, Herve F, du Cheyron D, Guerin C, Mercat A, Teboul JL, Radermacher P, Investigators S. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014;370:1583&#x2013;1593. doi: 10.1056/NEJMoa1312173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1312173</ArticleId><ArticleId IdType="pubmed">24635770</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi AI, Palesch YY, Suarez JI. Intensive blood-pressure lowering in cerebral hemorrhage. N Eng J Med. 2016;375:e48. doi: 10.1056/NEJMoa1603460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1603460</ArticleId><ArticleId IdType="pubmed">27959682</ArticleId></ArticleIdList></Reference><Reference><Citation>De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent JL, SOAP II Investigators Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362:779&#x2013;789. doi: 10.1056/NEJMoa0907118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0907118</ArticleId><ArticleId IdType="pubmed">20200382</ArticleId></ArticleIdList></Reference><Reference><Citation>Serpa Neto A, Nassar AP, Cardoso SO, Manetta JA, Pereira VG, Esposito DC, Damasceno MC, Russell JA. Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials. Crit Care. 2012;16:R154. doi: 10.1186/cc11469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11469</ArticleId><ArticleId IdType="pmc">PMC3580743</ArticleId><ArticleId IdType="pubmed">22889256</ArticleId></ArticleIdList></Reference><Reference><Citation>Bragadottir G, Redfors B, Nygren A, Sellgren J, Ricksten SE. Low-dose vasopressin increases glomerular filtration rate, but impairs renal oxygenation in post-cardiac surgery patients. Acta Anaesthesiol Scand. 2009;53:1052&#x2013;1059. doi: 10.1111/j.1399-6576.2009.02037.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.2009.02037.x</ArticleId><ArticleId IdType="pubmed">19572935</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell JA, Walley KR, Singer J, Gordon AC, Hebert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D, VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877&#x2013;887. doi: 10.1056/NEJMoa067373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa067373</ArticleId><ArticleId IdType="pubmed">18305265</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon AC, Russell JA, Walley KR, Singer J, Ayers D, Storms MM, Holmes CL, Hebert PC, Cooper DJ, Mehta S, Granton JT, Cook DJ, Presneill JJ. The effects of vasopressin on acute kidney injury in septic shock. Intensive Care Med. 2010;36:83&#x2013;91. doi: 10.1007/s00134-009-1687-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-009-1687-x</ArticleId><ArticleId IdType="pubmed">19841897</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, Pogson DG, Aya HD, Anjum A, Frazier GJ, Santhakumaran S, Ashby D, Brett SJ, VANISH Investigators Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA. 2016;316:509&#x2013;518. doi: 10.1001/jama.2016.10485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.10485</ArticleId><ArticleId IdType="pubmed">27483065</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajjar LA, Vincent JL, Barbosa Gomes Galas FR, Rhodes A, Landoni G, Osawa EA, Melo RR, Sundin MR, Grande SM, Gaiotto FA, Pomerantzeff PM, Dallan LO, Franco RA, Nakamura RE, Lisboa LA, de Almeida JP, Gerent AM, Souza DH, Gaiane MA, Fukushima JT, Park CL, Zambolim C, Rocha Ferreira GS, Strabelli TM, Fernandes FL, Camara L, Zeferino S, Santos VG, Piccioni MA, Jatene FB, Costa Auler JO, Jr, Filho RK. Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery: the VANCS randomized controlled trial. Anesthesiology. 2017;126:85&#x2013;93. doi: 10.1097/ALN.0000000000001434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001434</ArticleId><ArticleId IdType="pubmed">27841822</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramaswamy D, Corrigan G, Polhemus C, Boothroyd D, Scandling J, Sommer FG, Alfrey E, Higgins J, Deen WM, Olshen R, Myers BD. Maintenance and recovery stages of postischemic acute renal failure in humans. Am J Physiol Renal Physiol. 2002;282:F271&#x2013;F280. doi: 10.1152/ajprenal.0068.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.0068.2001</ArticleId><ArticleId IdType="pubmed">11788441</ArticleId></ArticleIdList></Reference><Reference><Citation>Conger J, Robinette J, Villar A, Raij L, Shultz P. Increased nitric oxide synthase activity despite lack of response to endothelium-dependent vasodilators in postischemic acute renal failure in rats. J Clin Invest. 1995;96:631&#x2013;638. doi: 10.1172/JCI118078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI118078</ArticleId><ArticleId IdType="pmc">PMC185238</ArticleId><ArticleId IdType="pubmed">7542287</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan L, Bagshaw SM, Langenberg C, Saotome T, May C, Bellomo R. Pathophysiology of septic acute kidney injury: what do we really know? Crit Care Med. 2008;36:S198&#x2013;S203. doi: 10.1097/CCM.0b013e318168ccd5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318168ccd5</ArticleId><ArticleId IdType="pubmed">18382194</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa K, May CN, Gobe G, Langenberg C, Bellomo R. Pathophysiology of septic acute kidney injury: a different view of tubular injury. Contrib Nephrol. 2010;165:18&#x2013;27. doi: 10.1159/000313740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000313740</ArticleId><ArticleId IdType="pubmed">20427951</ArticleId></ArticleIdList></Reference><Reference><Citation>Legrand M, Bezemer R, Kandil A, Demirci C, Payen D, Ince C. The role of renal hypoperfusion in development of renal microcirculatory dysfunction in endotoxemic rats. Intensive Care Med. 2011;37:1534&#x2013;1542. doi: 10.1007/s00134-011-2267-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-011-2267-4</ArticleId><ArticleId IdType="pmc">PMC3155675</ArticleId><ArticleId IdType="pubmed">21695476</ArticleId></ArticleIdList></Reference><Reference><Citation>Molitoris BA, Sutton TA. Endothelial injury and dysfunction: role in the extension phase of acute renal failure. Kidney Int. 2004;66:496&#x2013;499. doi: 10.1111/j.1523-1755.2004.761_5.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1523-1755.2004.761_5.x</ArticleId><ArticleId IdType="pubmed">15253696</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauschke A, Teichgraber UKM, Frei U, Eckardt KU. &#x2018;Low-dose&#x2019; dopamine worsens renal perfusion in patients with acute renal failure. Kidney Int. 2006;69:1669&#x2013;1674. doi: 10.1038/sj.ki.5000310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ki.5000310</ArticleId><ArticleId IdType="pubmed">16572117</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedrich JO, Adhikari N, Herridge MS, Beyene J. Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med. 2005;142:510&#x2013;524. doi: 10.7326/0003-4819-142-7-200504050-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-142-7-200504050-00010</ArticleId><ArticleId IdType="pubmed">15809463</ArticleId></ArticleIdList></Reference><Reference><Citation>Karthik S, Lisbon A. Low-dose dopamine in the intensive care unit. Semin Dial. 2006;19:465&#x2013;471. doi: 10.1111/j.1525-139X.2006.00208.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1525-139X.2006.00208.x</ArticleId><ArticleId IdType="pubmed">17150046</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes CL, Walley KR. Bad medicine: low-dose dopamine in the ICU. Chest. 2003;123:1266&#x2013;1275. doi: 10.1378/chest.123.4.1266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.123.4.1266</ArticleId><ArticleId IdType="pubmed">12684320</ArticleId></ArticleIdList></Reference><Reference><Citation>Landoni G, Biondi-Zoccai GG, Tumlin JA, Bove T, De Luca M, Calabro MG, Ranucci M, Zangrillo A. Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials. Am J Kidney Dis. 2007;49:56&#x2013;68. doi: 10.1053/j.ajkd.2006.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2006.10.013</ArticleId><ArticleId IdType="pubmed">17185146</ArticleId></ArticleIdList></Reference><Reference><Citation>Zangrillo A, Biondi-Zoccai GG, Frati E, Covello RD, Cabrini L, Guarracino F, Ruggeri L, Bove T, Bignami E, Landoni G. Fenoldopam and acute renal failure in cardiac surgery: a meta-analysis of randomized placebo-controlled trials. J Cardiothorac Vasc Anesth. 2012;26:407&#x2013;413. doi: 10.1053/j.jvca.2012.01.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2012.01.038</ArticleId><ArticleId IdType="pubmed">22459931</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillies MA, Kakar V, Parker RJ, Honore PM, Ostermann M. Fenoldopam to prevent acute kidney injury after major surgery-a systematic review and meta-analysis. Crit Care. 2015;19:449. doi: 10.1186/s13054-015-1166-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-1166-4</ArticleId><ArticleId IdType="pmc">PMC4699343</ArticleId><ArticleId IdType="pubmed">26703329</ArticleId></ArticleIdList></Reference><Reference><Citation>Bove T, Zangrillo A, Guarracino F, Alvaro G, Persi B, Maglioni E, Galdieri N, Comis M, Caramelli F, Pasero DC, Pala G, Renzini M, Conte M, Paternoster G, Martinez B, Pinelli F, Frontini M, Zucchetti MC, Pappalardo F, Amantea B, Camata A, Pisano A, Verdecchia C, Dal CE, Cariello C, Faita L, Baldassarri R, Scandroglio AM, Saleh O, Lembo R, Calabro MG, Bellomo R, Landoni G. Effect of fenoldopam on use of renal replacement therapy among patients with acute kidney injury after cardiac surgery: a randomized clinical trial. JAMA. 2014;312:2244&#x2013;2253. doi: 10.1001/jama.2014.13573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.13573</ArticleId><ArticleId IdType="pubmed">25265449</ArticleId></ArticleIdList></Reference><Reference><Citation>Sward K, Valson F, Ricksten SE. Long-term infusion of atrial natriuretic peptide (ANP) improves renal blood flow and glomerular filtration rate in clinical acute renal failure. Acta Anaesthesiol Scand. 2001;45:536&#x2013;542. doi: 10.1034/j.1399-6576.2001.045005536.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1399-6576.2001.045005536.x</ArticleId><ArticleId IdType="pubmed">11309000</ArticleId></ArticleIdList></Reference><Reference><Citation>Sward K, Valsson F, Sellgren J, Ricksten SE. Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans. Intensive Care Med. 2005;31:79&#x2013;85. doi: 10.1007/s00134-004-2490-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-004-2490-3</ArticleId><ArticleId IdType="pubmed">15565364</ArticleId></ArticleIdList></Reference><Reference><Citation>Houben AJ, van der Zander K, de Leeuw PW. Vascular and renal actions of brain natriuretic peptide in man: physiology and pharmacology. Fundam Clin Pharmacol. 2005;19:411&#x2013;419. doi: 10.1111/j.1472-8206.2005.00336.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1472-8206.2005.00336.x</ArticleId><ArticleId IdType="pubmed">16011727</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn M. Endothelial actions of atrial and B-type natriuretic peptides. Br J Pharmacol. 2012;166:522&#x2013;531. doi: 10.1111/j.1476-5381.2012.01827.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1476-5381.2012.01827.x</ArticleId><ArticleId IdType="pmc">PMC3417485</ArticleId><ArticleId IdType="pubmed">22220582</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitaka C, Kudo T, Haraguchi G, Tomita M. Cardiovascular and renal effects of carperitide and nesiritide in cardiovascular surgery patients: a systematic review and meta-analysis. Crit Care. 2011;15:R258. doi: 10.1186/cc10519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10519</ArticleId><ArticleId IdType="pmc">PMC3334809</ArticleId><ArticleId IdType="pubmed">22032777</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel NN, Rogers CA, Angelini GD, Murphy GJ. Pharmacological therapies for the prevention of acute kidney injury following cardiac surgery: a systematic review. Heart Fail Rev. 2011;16:553&#x2013;567. doi: 10.1007/s10741-011-9235-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10741-011-9235-5</ArticleId><ArticleId IdType="pubmed">21400231</ArticleId></ArticleIdList></Reference><Reference><Citation>Nigwekar SU, Navaneethan SD, Parikh CR, Hix JK (2009) Atrial natriuretic peptide for preventing and treating acute kidney injury. Cochrane Database Syst Rev CD006028. doi:10.1002/14651858.CD006028.pub2</Citation><ArticleIdList><ArticleId IdType="pubmed">19821351</ArticleId></ArticleIdList></Reference><Reference><Citation>Sezai A, Nakata K, Iida M, Yoshitake I, Wakui S, Hata H, Shiono M. Results of low-dose carperitide infusion in high-risk patients undergoing coronary artery bypass grafting. Ann Thorac Surg. 2013;96:119&#x2013;126. doi: 10.1016/j.athoracsur.2013.03.090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2013.03.090</ArticleId><ArticleId IdType="pubmed">23702231</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori Y, Kamada T, Ochiai R. Reduction in the incidence of acute kidney injury after aortic arch surgery with low-dose atrial natriuretic peptide: a randomised controlled trial. Eur J Anaesthesiol. 2014;31:381&#x2013;387. doi: 10.1097/EJA.0000000000000035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000035</ArticleId><ArticleId IdType="pubmed">24384584</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong B, Wang C, Yao Y, Huang Y, Tan J, Cao Y, Zou Y, Huang J. The dose-dependent effect of nesiritide on renal function in patients with acute decompensated heart failure: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2015;10:e0131326. doi: 10.1371/journal.pone.0131326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0131326</ArticleId><ArticleId IdType="pmc">PMC4479574</ArticleId><ArticleId IdType="pubmed">26107522</ArticleId></ArticleIdList></Reference><Reference><Citation>Papp Z, Edes I, Fruhwald S, De Hert SG, Salmenpera M, Leppikangas H, Mebazaa A, Landoni G, Grossini E, Caimmi P, Morelli A, Guarracino F, Schwinger RH, Meyer S, Algotsson L, Wikstrom BG, Jorgensen K, Filippatos G, Parissis JT, Gonzalez MJ, Parkhomenko A, Yilmaz MB, Kivikko M, Pollesello P, Follath F. Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan. Int J Cardiol. 2012;159:82&#x2013;87. doi: 10.1016/j.ijcard.2011.07.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2011.07.022</ArticleId><ArticleId IdType="pubmed">21784540</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasslacher J, Bijuklic K, Bertocchi C, Kountchev J, Bellmann R, Dunzendorfer S, Joannidis M. Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: a prospective observational study. Crit Care. 2011;15:R166. doi: 10.1186/cc10307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10307</ArticleId><ArticleId IdType="pmc">PMC3387603</ArticleId><ArticleId IdType="pubmed">21749676</ArticleId></ArticleIdList></Reference><Reference><Citation>Bove T, Matteazzi A, Belletti A, Paternoster G, Saleh O, Taddeo D, Dossi R, Greco T, Bradic N, Husedzinovic I, Nigro Neto C, Lomivorotov VV, Calabro MG. Beneficial impact of levosimendan in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials. Heart Lung Vessel. 2015;7:35&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4381821</ArticleId><ArticleId IdType="pubmed">25861589</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou C, Gong J, Chen D, Wang W, Liu M, Liu B. Levosimendan for prevention of acute kidney injury after cardiac surgery: a meta-analysis of randomized controlled trials. Am J Kidney Dis. 2016;67:408&#x2013;416. doi: 10.1053/j.ajkd.2015.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2015.09.015</ArticleId><ArticleId IdType="pubmed">26518388</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon AC, Perkins GD, Singer M, McAuley DF, Orme RM, Santhakumaran S, Mason AJ, Cross M, Al-Beidh F, Best-Lane J, Brealey D, Nutt CL, McNamee JJ, Reschreiter H, Breen A, Liu KD, Ashby D. Levosimendan for the prevention of acute organ dysfunction in sepsis. N Engl J Med. 2016;375:1638&#x2013;1648. doi: 10.1056/NEJMoa1609409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1609409</ArticleId><ArticleId IdType="pubmed">27705084</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RH, Leimberger JD, van Diepen S, Meza J, Wang A, Jankowich R, Harrison RW, Hay D, Fremes S, Duncan A, Soltesz EG, Luber J, Park S, Argenziano M, Murphy E, Marcel R, Kalavrouziotis D, Nagpal D, Bozinovski J, Toller W, Heringlake M, Goodman SG, Levy JH, Harrington RA, Anstrom KJ, Alexander JH, LEVO-CTS Investigators (2017) Levosimendan in patients with left ventricular dysfunction undergoing cardiac surgery. N Engl J Med. doi:10.1056/NEJMoa1616218</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Landoni G, Lomivorotov VV, Alvaro G, Lobreglio R, Pisano A, Guarracino F, Calabro MG, Grigoryev EV, Likhvantsev VV, Salgado-Filho MF, Bianchi A, Pasyuga VV, Baiocchi M, Pappalardo F, Monaco F, Boboshko VA, Abubakirov MN, Amantea B, Lembo R, Brazzi L, Verniero L, Bertini P, Scandroglio AM, Bove T, Belletti A, Michienzi MG, Shukevich DL, Zabelina TS, Bellomo R, Zangrillo A, CHEETAH Study Group (2017) Levosimendan for hemodynamic support after cardiac surgery. N Engl J Med. doi:10.1056/NEJMoa1616325</Citation><ArticleIdList><ArticleId IdType="pubmed">28320259</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo C, Yuan D, Li X, Yao W, Luo G, Chi X, Li H, Irwin MG, Xia Z, Hei Z. Propofol attenuated acute kidney injury after orthotopic liver transplantation via inhibiting gap junction composed of connexin 32. Anesthesiology. 2015;122:72&#x2013;86. doi: 10.1097/ALN.0000000000000448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000448</ArticleId><ArticleId IdType="pubmed">25254904</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsing CH, Chou W, Wang JJ, Chen HW, Yeh CH. Propofol increases bone morphogenetic protein-7 and decreases oxidative stress in sepsis-induced acute kidney injury. Nephrol Dial Transplant. 2011;26:1162&#x2013;1172. doi: 10.1093/ndt/gfq572.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfq572</ArticleId><ArticleId IdType="pubmed">20864551</ArticleId></ArticleIdList></Reference><Reference><Citation>Villela NR, Nascimento Junior P, Carvalho LR, Teixeira A. Effects of dexmedetomidine on renal system and on vasopressin plasma levels. Experimental study in dogs. Rev Bras Anestesiol. 2005;55:429&#x2013;440. doi: 10.1590/S0034-70942005000400007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0034-70942005000400007</ArticleId><ArticleId IdType="pubmed">19468631</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FT, Chen SW, Kim M, Park SW, Song JH, Wang S, Herman J, D&#x2019;Agati V, Lee HT. alpha2-Adrenergic agonists protect against radiocontrast-induced nephropathy in mice. Am J Physiol Renal Physiol. 2008;295:F741&#x2013;748. doi: 10.1152/ajprenal.90244.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.90244.2008</ArticleId><ArticleId IdType="pubmed">18579700</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsing CH, Lin CF, So E, Sun DP, Chen TC, Li CF, Yeh CH. alpha2-Adrenoceptor agonist dexmedetomidine protects septic acute kidney injury through increasing BMP-7 and inhibiting HDAC2 and HDAC5. Am J Physiol Renal Physiol. 2012;303:F1443&#x2013;F1453. doi: 10.1152/ajprenal.00143.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.00143.2012</ArticleId><ArticleId IdType="pubmed">22933299</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan F, Chen Y, Yuan D, Gong C, Li X, Zhou S. Dexmedetomidine protects against acute kidney injury through downregulating inflammatory reactions in endotoxemia rats. Biomed Rep. 2015;3:365&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4467244</ArticleId><ArticleId IdType="pubmed">26137237</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao H, Chi X, Jin Y, Wang Y, Huang P, Wu S, Xia Z, Cai J. Dexmedetomidine inhibits TLR4/NF-kappaB activation and reduces acute kidney injury after orthotopic autologous liver transplantation in rats. Sci Rep. 2015;5:16849. doi: 10.1038/srep16849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep16849</ArticleId><ArticleId IdType="pmc">PMC4653646</ArticleId><ArticleId IdType="pubmed">26585410</ArticleId></ArticleIdList></Reference><Reference><Citation>Reade MC, Finfer S. Sedation and delirium in the intensive care unit. N Engl J Med. 2014;370:444&#x2013;454. doi: 10.1056/NEJMra1208705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1208705</ArticleId><ArticleId IdType="pubmed">24476433</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirrakhimov AE, Voore P, Halytskyy O, Khan M, Ali AM. Propofol infusion syndrome in adults: a clinical update. Crit Care Res Pract. 2015;2015:260385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4410753</ArticleId><ArticleId IdType="pubmed">25954513</ArticleId></ArticleIdList></Reference><Reference><Citation>Krajcova A, Waldauf P, Andel M, Duska F. Propofol infusion syndrome: a structured review of experimental studies and 153 published case reports. Crit Care. 2015;19:398. doi: 10.1186/s13054-015-1112-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-1112-5</ArticleId><ArticleId IdType="pmc">PMC4642662</ArticleId><ArticleId IdType="pubmed">26558513</ArticleId></ArticleIdList></Reference><Reference><Citation>Cremer OL, Moons KG, Bouman EA, Kruijswijk JE, de Smet AM, Kalkman CJ. Long-term propofol infusion and cardiac failure in adult head-injured patients. Lancet. 2001;357:117&#x2013;118. doi: 10.1016/S0140-6736(00)03547-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(00)03547-9</ArticleId><ArticleId IdType="pubmed">11197401</ArticleId></ArticleIdList></Reference><Reference><Citation>Leite TT, Macedo E, Martins Ida S, Neves FM, Liborio AB. Renal outcomes in critically ill patients receiving propofol or midazolam. Clin J Am Soc Nephrol. 2015;10:1937&#x2013;1945. doi: 10.2215/CJN.02330315.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.02330315</ArticleId><ArticleId IdType="pmc">PMC4633782</ArticleId><ArticleId IdType="pubmed">26342046</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo YC, Shim JK, Song Y, Yang SY, Kwak YL. Anesthetics influence the incidence of acute kidney injury following valvular heart surgery. Kidney Int. 2014;86:414&#x2013;422. doi: 10.1038/ki.2013.532.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2013.532</ArticleId><ArticleId IdType="pubmed">24429400</ArticleId></ArticleIdList></Reference><Reference><Citation>Menting TP, Wever KE, Ozdemir-van Brunschot DM, Van der Vliet DJ, Rovers MM, Warle MC. Ischaemic preconditioning for the reduction of renal ischaemia reperfusion injury. Cochrane Database Syst Rev. 2017;3:Cd010777.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6464274</ArticleId><ArticleId IdType="pubmed">28258686</ArticleId></ArticleIdList></Reference><Reference><Citation>Pichot C, Longrois D, Ghignone M, Quintin L. Dexmedetomidine and clonidine: a review of their pharmacodynamy to define their role for sedation in intensive care patients. Ann Fr Anesth Reanim. 2012;31:876&#x2013;896. doi: 10.1016/j.annfar.2012.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annfar.2012.07.018</ArticleId><ArticleId IdType="pubmed">23089375</ArticleId></ArticleIdList></Reference><Reference><Citation>Leino K, Hynynen M, Jalonen J, Salmenpera M, Scheinin H, Aantaa R, Dexmedetomidine in Cardiac Surgery Study Group Renal effects of dexmedetomidine during coronary artery bypass surgery: a randomized placebo-controlled study. BMC Anesthesiol. 2011;11:9. doi: 10.1186/1471-2253-11-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2253-11-9</ArticleId><ArticleId IdType="pmc">PMC3123640</ArticleId><ArticleId IdType="pubmed">21605394</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji F, Li Z, Young JN, Yeranossian A, Liu H. Post-bypass dexmedetomidine use and postoperative acute kidney injury in patients undergoing cardiac surgery with cardiopulmonary bypass. PLoS One. 2013;8:e77446. doi: 10.1371/journal.pone.0077446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0077446</ArticleId><ArticleId IdType="pmc">PMC3795046</ArticleId><ArticleId IdType="pubmed">24130886</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon T, Tsai JY, Vachhani S, Peng SP, Feng L, Vaporciyan AA, Cata JP. The use of intraoperative dexmedetomidine is not associated with a reduction in acute kidney injury after lung cancer surgery. J Cardiothorac Vasc Anesth. 2016;30:51&#x2013;55. doi: 10.1053/j.jvca.2015.03.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2015.03.025</ArticleId><ArticleId IdType="pubmed">26260907</ArticleId></ArticleIdList></Reference><Reference><Citation>Balkanay OO, Goksedef D, Omeroglu SN, Ipek G. The dose-related effects of dexmedetomidine on renal functions and serum neutrophil gelatinase-associated lipocalin values after coronary artery bypass grafting: a randomized, triple-blind, placebo-controlled study. Interact Cardiovasc Thorac Surg. 2015;20:209&#x2013;214. doi: 10.1093/icvts/ivu367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivu367</ArticleId><ArticleId IdType="pubmed">25392341</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho JS, Shim JK, Soh S, Kim MK, Kwak YL. Perioperative dexmedetomidine reduces the incidence and severity of acute kidney injury following valvular heart surgery. Kidney Int. 2016;89:693&#x2013;700. doi: 10.1038/ki.2015.306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2015.306</ArticleId><ArticleId IdType="pubmed">26444030</ArticleId></ArticleIdList></Reference><Reference><Citation>Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978&#x2013;982. doi: 10.1210/jcem.87.3.8341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jcem.87.3.8341</ArticleId><ArticleId IdType="pubmed">11889147</ArticleId></ArticleIdList></Reference><Reference><Citation>Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003;78:1471&#x2013;1478. doi: 10.4065/78.12.1471.</Citation><ArticleIdList><ArticleId IdType="doi">10.4065/78.12.1471</ArticleId><ArticleId IdType="pubmed">14661676</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359&#x2013;1367. doi: 10.1056/NEJMoa011300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa011300</ArticleId><ArticleId IdType="pubmed">11794168</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449&#x2013;461. doi: 10.1056/NEJMoa052521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa052521</ArticleId><ArticleId IdType="pubmed">16452557</ArticleId></ArticleIdList></Reference><Reference><Citation>Schetz M, Vanhorebeek I, Wouters PJ, Wilmer A, van den Berghe G (2008) Tight blood glucose control is renoprotective in critically ill patients. J Am Soc Nephrol 19: 571&#x2013;578</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2391044</ArticleId><ArticleId IdType="pubmed">18235100</ArticleId></ArticleIdList></Reference><Reference><Citation>Arabi YM, Dabbagh OC, Tamim HM, Al-Shimemeri AA, Memish ZA, Haddad SH, Syed SJ, Giridhar HR, Rishu AH, Al-Daker MO, Kahoul SH, Britts RJ, Sakkijha MH. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med. 2008;36:3190&#x2013;3197. doi: 10.1097/CCM.0b013e31818f21aa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31818f21aa</ArticleId><ArticleId IdType="pubmed">18936702</ArticleId></ArticleIdList></Reference><Reference><Citation>Investigators N-SS, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hebert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283&#x2013;1297. doi: 10.1056/NEJMoa0810625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0810625</ArticleId><ArticleId IdType="pubmed">19318384</ArticleId></ArticleIdList></Reference><Reference><Citation>Preiser JC, Devos P, Ruiz-Santana S, Melot C, Annane D, Groeneveld J, Iapichino G, Leverve X, Nitenberg G, Singer P, Wernerman J, Joannidis M, Stecher A, Chiolero R. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009;35:1738&#x2013;1748. doi: 10.1007/s00134-009-1585-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-009-1585-2</ArticleId><ArticleId IdType="pubmed">19636533</ArticleId></ArticleIdList></Reference><Reference><Citation>Arabi YM, Tamim HM, Dhar GS, Al-Dawood A, Al-Sultan M, Sakkijha MH, Kahoul SH, Brits R. Permissive underfeeding and intensive insulin therapy in critically ill patients: a randomized controlled trial. Am J Clin Nutr. 2011;93:569&#x2013;577. doi: 10.3945/ajcn.110.005074.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.110.005074</ArticleId><ArticleId IdType="pubmed">21270385</ArticleId></ArticleIdList></Reference><Reference><Citation>De La Rosa GC, Donado JH, Restrepo AH, Quintero AM, Gonzalez LG, Saldarriaga NE, Bedoya M, Toro JM, Velasquez JB, Valencia JC, Arango CM, Aleman PH, Vasquez EM, Chavarriaga JC, Yepes A, Pulido W, Cadavid CA. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit Care. 2008;12:R120. doi: 10.1186/cc7017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc7017</ArticleId><ArticleId IdType="pmc">PMC2592751</ArticleId><ArticleId IdType="pubmed">18799004</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Berghe G, Schetz M, Vlasselaers D, Hermans G, Wilmer A, Bouillon R, Mesotten D. Clinical review: intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target? J Clin Endocrinol Metab. 2009;94:3163&#x2013;3170. doi: 10.1210/jc.2009-0663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2009-0663</ArticleId><ArticleId IdType="pubmed">19531590</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling Y, Li X, Gao X. Intensive versus conventional glucose control in critically ill patients: a meta-analysis of randomized controlled trials. Eur J Intern Med. 2012;23:564&#x2013;574. doi: 10.1016/j.ejim.2012.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2012.02.013</ArticleId><ArticleId IdType="pubmed">22863436</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickerson RN, Hamilton LA, Connor KA, Maish GO, 3rd, Croce MA, Minard G, Brown RO. Increased hypoglycemia associated with renal failure during continuous intravenous insulin infusion and specialized nutritional support. Nutrition. 2011;27:766&#x2013;772. doi: 10.1016/j.nut.2010.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2010.08.009</ArticleId><ArticleId IdType="pubmed">20971617</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosiborod M, Inzucchi SE, Goyal A, Krumholz HM, Masoudi FA, Xiao L, Spertus JA. Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. JAMA. 2009;301:1556&#x2013;1564. doi: 10.1001/jama.2009.496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2009.496</ArticleId><ArticleId IdType="pubmed">19366775</ArticleId></ArticleIdList></Reference><Reference><Citation>Mowery NT, Guillamondegui OD, Gunter OL, Diaz JJ, Jr, Collier BR, Dossett LA, Dortch MJ, May AK. Severe hypoglycemia while on intensive insulin therapy is not an independent predictor of death after trauma. J Trauma. 2010;68:342&#x2013;347. doi: 10.1097/TA.0b013e3181c825f2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e3181c825f2</ArticleId><ArticleId IdType="pubmed">20154546</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE-SUGAR Study Investigators. Finfer S, Liu B, Chittock DR, Norton R, Myburgh JA, McArthur C, Mitchell I, Foster D, Dhingra V, Henderson WR, Ronco JJ, Bellomo R, Cook D, McDonald E, Dodek P, Hebert PC, Heyland DK, Robinson BG. Hypoglycemia and risk of death in critically ill patients. N Engl J Med. 2012;367:1108&#x2013;1118. doi: 10.1056/NEJMoa1204942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1204942</ArticleId><ArticleId IdType="pubmed">22992074</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. EndocrPract. 2009;15:353&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pubmed">19454396</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Berghe G (2013) What&#x2019;s new in glucose control in the ICU? Intensive Care Med 39:823&#x2013;825</Citation><ArticleIdList><ArticleId IdType="pubmed">23460140</ArticleId></ArticleIdList></Reference><Reference><Citation>Dieleman JM, Nierich AP, Rosseel PM, van der Maaten JM, Hofland J, Diephuis JC, Schepp RM, Boer C, Moons KG, van Herwerden LA, Tijssen JG, Numan SC, Kalkman CJ, van Dijk D, Dexamethasone for Cardiac Surgery Study Group Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial. JAMA. 2012;308:1761&#x2013;1767. doi: 10.1001/jama.2012.14144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2012.14144</ArticleId><ArticleId IdType="pubmed">23117776</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob KA, Leaf DE, Dieleman JM, van Dijk D, Nierich AP, Rosseel PM, van der Maaten JM, Hofland J, Diephuis JC, de Lange F, Boer C, Kluin J, Waikar SS, Dexamethasone for Cardiac Surgery Study Group Intraoperative high-dose dexamethasone and severe AKI after cardiac surgery. J Am Soc Nephrol. 2015;26:2947&#x2013;2951. doi: 10.1681/ASN.2014080840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2014080840</ArticleId><ArticleId IdType="pmc">PMC4657835</ArticleId><ArticleId IdType="pubmed">25952257</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitlock RP, Devereaux PJ, Teoh KH, Lamy A, Vincent J, Pogue J, Paparella D, Sessler DI, Karthikeyan G, Villar JC, Zuo Y, Avezum A, Quantz M, Tagarakis GI, Shah PJ, Abbasi SH, Zheng H, Pettit S, Chrolavicius S, Yusuf S. Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial. Lancet. 2015;386:1243&#x2013;1253. doi: 10.1016/S0140-6736(15)00273-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)00273-1</ArticleId><ArticleId IdType="pubmed">26460660</ArticleId></ArticleIdList></Reference><Reference><Citation>Song YR, Lee T, You SJ, Chin HJ, Chae DW, Lim C, Park KH, Han S, Kim JH, Na KY. Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: a pilot study. Am J Nephrol. 2009;30:253&#x2013;260. doi: 10.1159/000223229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000223229</ArticleId><ArticleId IdType="pubmed">19494484</ArticleId></ArticleIdList></Reference><Reference><Citation>de Seigneux S, Ponte B, Weiss L, Pugin J, Romand JA, Martin PY, Saudan P. Epoetin administrated after cardiac surgery: effects on renal function and inflammation in a randomized controlled study. BMC Nephrol. 2012;13:132. doi: 10.1186/1471-2369-13-132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2369-13-132</ArticleId><ArticleId IdType="pmc">PMC3506492</ArticleId><ArticleId IdType="pubmed">23033926</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo YC, Shim JK, Kim JC, Jo YY, Lee JH, Kwak YL. Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. Anesthesiology. 2011;115:929&#x2013;937. doi: 10.1097/ALN.0b013e318232004b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318232004b</ArticleId><ArticleId IdType="pubmed">22027622</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JH, Shim JK, Song JW, Song Y, Kim HB, Kwak YL. Effect of erythropoietin on the incidence of acute kidney injury following complex valvular heart surgery: a double blind, randomized clinical trial of efficacy and safety. Crit Care. 2013;17:R254. doi: 10.1186/cc13081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc13081</ArticleId><ArticleId IdType="pmc">PMC4056185</ArticleId><ArticleId IdType="pubmed">24156702</ArticleId></ArticleIdList></Reference><Reference><Citation>Tasanarong A, Duangchana S, Sumransurp S, Homvises B, Satdhabudha O. Prophylaxis with erythropoietin versus placebo reduces acute kidney injury and neutrophil gelatinase-associated lipocalin in patients undergoing cardiac surgery: a randomized, double-blind controlled trial. BMC Nephrol. 2013;14:136. doi: 10.1186/1471-2369-14-136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2369-14-136</ArticleId><ArticleId IdType="pmc">PMC3704968</ArticleId><ArticleId IdType="pubmed">23829828</ArticleId></ArticleIdList></Reference><Reference><Citation>Tie HT, Luo MZ, Lin D, Zhang M, Wan JY, Wu QC. Erythropoietin administration for prevention of cardiac surgery-associated acute kidney injury: a meta-analysis of randomized controlled trials. Eur J Cardiothorac Surg. 2015;48:32&#x2013;39. doi: 10.1093/ejcts/ezu378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezu378</ArticleId><ArticleId IdType="pubmed">25312524</ArticleId></ArticleIdList></Reference><Reference><Citation>Penny-Dimri JC, Cochrane AD, Perry LA, Smith JA. Characterising the role of perioperative erythropoietin for preventing acute kidney injury after cardiac surgery: systematic review and meta-analysis. Heart Lung Circ. 2016;25:1067&#x2013;1076. doi: 10.1016/j.hlc.2016.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2016.04.016</ArticleId><ArticleId IdType="pubmed">27523464</ArticleId></ArticleIdList></Reference><Reference><Citation>Dardashti A, Ederoth P, Algotsson L, Bronden B, Grins E, Larsson M, Nozohoor S, Zinko G, Bjursten H. Erythropoietin and protection of renal function in cardiac surgery (the EPRICS Trial) Anesthesiology. 2014;121:582&#x2013;590. doi: 10.1097/ALN.0000000000000321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000321</ArticleId><ArticleId IdType="pubmed">25225746</ArticleId></ArticleIdList></Reference><Reference><Citation>Endre ZH, Walker RJ, Pickering JW, Shaw GM, Frampton CM, Henderson SJ, Hutchison R, Mehrtens JE, Robinson JM, Schollum JB, Westhuyzen J, Celi LA, McGinley RJ, Campbell IJ, George PM. Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial) Kidney Int. 2010;77:1020&#x2013;1030. doi: 10.1038/ki.2010.25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2010.25</ArticleId><ArticleId IdType="pubmed">20164823</ArticleId></ArticleIdList></Reference><Reference><Citation>Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Shapiro MJ, Corwin MJ, Colton T, EPO Critical Care Trials Group Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA. 2002;288:2827&#x2013;2835. doi: 10.1001/jama.288.22.2827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.288.22.2827</ArticleId><ArticleId IdType="pubmed">12472324</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C, Lin Z, Luo Q, Xia X, Yu X, Huang F. Efficacy and safety of erythropoietin to prevent acute kidney injury in patients with critical illness or perioperative care: a systematic review and meta-analysis of randomized controlled trials. J Cardiovasc Pharmacol. 2015;65:593&#x2013;600. doi: 10.1097/FJC.0000000000000229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FJC.0000000000000229</ArticleId><ArticleId IdType="pmc">PMC4461384</ArticleId><ArticleId IdType="pubmed">26065644</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JE, Song SW, Kim JY, Lee HJ, Chung KH, Shim YH. Effect of a single bolus of erythropoietin on renoprotection in patients undergoing thoracic aortic surgery with moderate hypothermic circulatory arrest. Ann Thorac Surg. 2016;101:690&#x2013;696. doi: 10.1016/j.athoracsur.2015.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2015.08.007</ArticleId><ArticleId IdType="pubmed">26576750</ArticleId></ArticleIdList></Reference><Reference><Citation>Shema-Didi L, Kristal B, Eizenberg S, Marzuq N, Sussan M, Feldman-Idov Y, Ofir P, Atar S. Prevention of contrast-induced nephropathy with single bolus erythropoietin in patients with diabetic kidney disease: a randomized controlled trial. Nephrology (Carlton) 2016;21:295&#x2013;300. doi: 10.1111/nep.12609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nep.12609</ArticleId><ArticleId IdType="pubmed">26370061</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons M, Plante I, LeBrun M, Gourde P, Simard M, Grenier L, Thibault L, Labrecque G, Beauchamp D. Protein-rich diet attenuates cyclosporin a-induced renal tubular damage in rats. J Ren Nutr. 2003;13:84&#x2013;92. doi: 10.1053/jren.2003.50027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/jren.2003.50027</ArticleId><ArticleId IdType="pubmed">12671830</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts PR, Black KW, Zaloga GP. Enteral feeding improves outcome and protects against glycerol-induced acute renal failure in the rat. Am J Respir Crit Care Med. 1997;156:1265&#x2013;1269. doi: 10.1164/ajrccm.156.4.9607003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.156.4.9607003</ArticleId><ArticleId IdType="pubmed">9351632</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouser JF, Hak EB, Kuhl DA, Dickerson RN, Gaber LW, Hak LJ. Recovery from ischemic acute renal failure is improved with enteral compared with parenteral nutrition. Crit Care Med. 1997;25:1748&#x2013;1754. doi: 10.1097/00003246-199710000-00028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199710000-00028</ArticleId><ArticleId IdType="pubmed">9377893</ArticleId></ArticleIdList></Reference><Reference><Citation>Zager RA. Amino acid hyperalimentation in acute renal failure: a potential therapeutic paradox. Kidney Int Suppl. 1987;22:S72&#x2013;S75.</Citation><ArticleIdList><ArticleId IdType="pubmed">3123764</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyland DK, Elke G, Cook D, Berger MM, Wischmeyer PE, Albert M, Muscedere J, Jones G, Day AG. Glutamine and antioxidants in the critically ill patient: a post hoc analysis of a large-scale randomized trial. JPEN J Parenter Enteral Nutr. 2015;39:401&#x2013;409. doi: 10.1177/0148607114529994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0148607114529994</ArticleId><ArticleId IdType="pmc">PMC6800175</ArticleId><ArticleId IdType="pubmed">24803474</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell JR, Verweij M, Brand K, van de Ven M, Goemaere N, van den Engel S, Chu T, Forrer F, Muller C, de Jong M, van IJcken W, IJzermans JN, Hoeijmakers JH, de Bruin RW (2010) Short-term dietary restriction and fasting precondition against ischemia reperfusion injury in mice. Aging Cell 9:40&#x2013;53</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3412229</ArticleId><ArticleId IdType="pubmed">19878145</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel RM, Beck CH, Jr, Abbott WM, Ryan JA, Jr, Barnett GO, Fischer JE. Improved survival from acute renal failure after treatment with intravenous essential l-amino acids and glucose. Results of a prospective, double-blind study. N Engl J Med. 1973;288:695&#x2013;699. doi: 10.1056/NEJM197304052881401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM197304052881401</ArticleId><ArticleId IdType="pubmed">4631743</ArticleId></ArticleIdList></Reference><Reference><Citation>Doig GS, Simpson F, Bellomo R, Heighes PT, Sweetman EA, Chesher D, Pollock C, Davies A, Botha J, Harrigan P, Reade MC. Intravenous amino acid therapy for kidney function in critically ill patients: a randomized controlled trial. Intensive Care Med. 2015;41:1197&#x2013;1208. doi: 10.1007/s00134-015-3827-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3827-9</ArticleId><ArticleId IdType="pubmed">25925203</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunst J, Vanhorebeek I, Casaer MP, Hermans G, Wouters PJ, Dubois J, Claes K, Schetz M, Van den Berghe G. Impact of early parenteral nutrition on metabolism and kidney injury. J Am Soc Nephrol. 2013;24:995&#x2013;1005. doi: 10.1681/ASN.2012070732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2012070732</ArticleId><ArticleId IdType="pmc">PMC3665391</ArticleId><ArticleId IdType="pubmed">23539756</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Dorzi HM, Albarrak A, Ferwana M, Murad MH, Arabi YM. Lower versus higher dose of enteral caloric intake in adult critically ill patients: a systematic review and meta-analysis. Crit Care. 2016;20:358. doi: 10.1186/s13054-016-1539-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1539-3</ArticleId><ArticleId IdType="pmc">PMC5097427</ArticleId><ArticleId IdType="pubmed">27814776</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzales DA, Norsworthy KJ, Kern SJ, Banks S, Sieving PC, Star RA, Natanson C, Danner RL. A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity. BMC Med. 2007;5:32. doi: 10.1186/1741-7015-5-32.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1741-7015-5-32</ArticleId><ArticleId IdType="pmc">PMC2200657</ArticleId><ArticleId IdType="pubmed">18001477</ArticleId></ArticleIdList></Reference><Reference><Citation>Zagler A, Azadpour M, Mercado C, Hennekens CH. N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials. Am Heart J. 2006;151:140&#x2013;145. doi: 10.1016/j.ahj.2005.01.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2005.01.055</ArticleId><ArticleId IdType="pubmed">16368307</ArticleId></ArticleIdList></Reference><Reference><Citation>Duong MH, MacKenzie TA, Malenka DJ. N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: comprehensive meta-analysis. Catheter Cardiovasc Interv. 2005;64:471&#x2013;479. doi: 10.1002/ccd.20342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.20342</ArticleId><ArticleId IdType="pubmed">15789388</ArticleId></ArticleIdList></Reference><Reference><Citation>Pannu N, Manns B, Lee H, Tonelli M. Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int. 2004;65:1366&#x2013;1374. doi: 10.1111/j.1523-1755.2004.00516.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1523-1755.2004.00516.x</ArticleId><ArticleId IdType="pubmed">15086476</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso A, Lau J, Jaber BL, Weintraub A, Sarnak MJ. Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials. Am J Kidney Dis. 2004;43:1&#x2013;9. doi: 10.1053/j.ajkd.2003.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2003.09.009</ArticleId><ArticleId IdType="pubmed">14712421</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med. 2008;148:284&#x2013;294. doi: 10.7326/0003-4819-148-4-200802190-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-148-4-200802190-00007</ArticleId><ArticleId IdType="pubmed">18283206</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao SJ, Zhong ZS, Qi GX, Tian W. The efficacy of N-acetylcysteine plus sodium bicarbonate in the prevention of contrast-induced nephropathy after cardiac catheterization and percutaneous coronary intervention: a meta-analysis of randomized controlled trials. Int J Cardiol. 2016;221:251&#x2013;259. doi: 10.1016/j.ijcard.2016.07.086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2016.07.086</ArticleId><ArticleId IdType="pubmed">27404685</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang N, Qian P, Kumar S, Yan TD, Phan K. The effect of N-acetylcysteine on the incidence of contrast-induced kidney injury: a systematic review and trial sequential analysis. Int J Cardiol. 2016;209:319&#x2013;327. doi: 10.1016/j.ijcard.2016.02.083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2016.02.083</ArticleId><ArticleId IdType="pubmed">26922293</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang X, Hu DY, Li CB, Ai ZS, Peng A. N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with pre-existing renal insufficiency or diabetes: a systematic review and meta-analysis. Ren Fail. 2015;37(10):297&#x2013;303. doi: 10.3109/0886022X.2015.1012985.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/0886022X.2015.1012985</ArticleId><ArticleId IdType="pubmed">26458505</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z, Fu Q, Cao L, Jin W, Cheng L, Li Z (2013) Intravenous N-acetylcysteine for prevention of contrast-induced nephropathy: a meta-analysis of randomized, controlled trials. PLoS One 8:e55124</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3559541</ArticleId><ArticleId IdType="pubmed">23383076</ArticleId></ArticleIdList></Reference><Reference><Citation>ACT Investigators Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT) Circulation. 2011;124:1250&#x2013;1259. doi: 10.1161/CIRCULATIONAHA.111.038943.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.111.038943</ArticleId><ArticleId IdType="pubmed">21859972</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns KE, Chu MW, Novick RJ, Fox SA, Gallo K, Martin CM, Stitt LW, Heidenheim AP, Myers ML, Moist L. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing CABG surgery: a randomized controlled trial. JAMA. 2005;294:342&#x2013;350. doi: 10.1001/jama.294.3.342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.294.3.342</ArticleId><ArticleId IdType="pubmed">16030279</ArticleId></ArticleIdList></Reference><Reference><Citation>Macedo E, Abdulkader R, Castro I, Sobrinho AC, Yu L, Vieira JM., Jr Lack of protection of N-acetylcysteine (NAC) in acute renal failure related to elective aortic aneurysm repair-a randomized controlled trial. Nephrol Dial Transplant. 2006;21:1863&#x2013;1869. doi: 10.1093/ndt/gfl079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfl079</ArticleId><ArticleId IdType="pubmed">16522657</ArticleId></ArticleIdList></Reference><Reference><Citation>Komisarof JA, Gilkey GM, Peters DM, Koudelka CW, Meyer MM, Smith SM. N-acetylcysteine for patients with prolonged hypotension as prophylaxis for acute renal failure (NEPHRON) Crit Care Med. 2007;35:435&#x2013;441. doi: 10.1097/01.CCM.0000253816.83011.DB.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000253816.83011.DB</ArticleId><ArticleId IdType="pubmed">17205018</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisillo E, Ceriani R, Bortone F, Juliano G, Salvi L, Veglia F, Fiorentini C, Marenzi G. N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial. Crit Care Med. 2008;36:81&#x2013;86. doi: 10.1097/01.CCM.0000295305.22281.1D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000295305.22281.1D</ArticleId><ArticleId IdType="pubmed">18090169</ArticleId></ArticleIdList></Reference><Reference><Citation>Adabag AS, Ishani A, Koneswaran S, Johnson DJ, Kelly RF, Ward HB, McFalls EO, Bloomfield HE, Chandrashekhar Y. Utility of N-acetylcysteine to prevent acute kidney injury after cardiac surgery: a randomized controlled trial. Am Heart J. 2008;155:1143&#x2013;1149. doi: 10.1016/j.ahj.2008.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2008.01.013</ArticleId><ArticleId IdType="pubmed">18513531</ArticleId></ArticleIdList></Reference><Reference><Citation>Song JW, Shim JK, Soh S, Jang J, Kwak YL. Double-blinded, randomized controlled trial of N-acetylcysteine for prevention of acute kidney injury in high risk patients undergoing off-pump coronary artery bypass. Nephrology (Carlton) 2015;20:96&#x2013;102. doi: 10.1111/nep.12361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nep.12361</ArticleId><ArticleId IdType="pubmed">25384603</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeysundera DN, Beattie WS, Rao V, Granton JT, Chan CT. N-acetylcysteine for preventing acute kidney injury in cardiac surgery patients with pre-existing moderate renal insufficiency. Can J Anaesth. 2007;54:872&#x2013;881. doi: 10.1007/BF03026790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03026790</ArticleId><ArticleId IdType="pubmed">17975231</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandilands EA, Bateman DN. Adverse reactions associated with acetylcysteine. Clin Toxicol (Phila) 2009;47:81&#x2013;88. doi: 10.1080/15563650802665587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15563650802665587</ArticleId><ArticleId IdType="pubmed">19280424</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnar Z, Shearer E, Lowe D. N-Acetylcysteine treatment to prevent the progression of multisystem organ failure: a prospective, randomized, placebo-controlled study. Crit Care Med. 1999;27:1100&#x2013;1104. doi: 10.1097/00003246-199906000-00028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199906000-00028</ArticleId><ArticleId IdType="pubmed">10397212</ArticleId></ArticleIdList></Reference><Reference><Citation>Peake SL, Moran JL, Leppard PI. N-acetyl-l-cysteine depresses cardiac performance in patients with septic shock. Crit Care Med. 1996;24:1302&#x2013;1310. doi: 10.1097/00003246-199608000-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199608000-00006</ArticleId><ArticleId IdType="pubmed">8706483</ArticleId></ArticleIdList></Reference><Reference><Citation>Angstwurm MW, Schottdorf J, Schopohl J, Gaertner R. Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. Crit Care Med. 1999;27:1807&#x2013;1813. doi: 10.1097/00003246-199909000-00017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199909000-00017</ArticleId><ArticleId IdType="pubmed">10507602</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra V, Baines M, Perry SE, McLaughlin PJ, Carson J, Wenstone R, Shenkin A. Effect of selenium supplementation on biochemical markers and outcome in critically ill patients. Clin Nutr. 2007;26:41&#x2013;50. doi: 10.1016/j.clnu.2006.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2006.10.003</ArticleId><ArticleId IdType="pubmed">17174015</ArticleId></ArticleIdList></Reference><Reference><Citation>Angstwurm MW, Engelmann L, Zimmermann T, Lehmann C, Spes CH, Abel P, Strauss R, Meier-Hellmann A, Insel R, Radke J, Schuttler J, Gartner R. Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med. 2007;35:118&#x2013;126. doi: 10.1097/01.CCM.0000251124.83436.0E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000251124.83436.0E</ArticleId><ArticleId IdType="pubmed">17095947</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloos F, Trips E, Nierhaus A, Briegel J, Heyland DK, Jaschinski U, Moerer O, Weyland A, Marx G, Grundling M, Kluge S, Kaufmann I, Ott K, Quintel M, Jelschen F, Meybohm P, Rademacher S, Meier-Hellmann A, Utzolino S, Kaisers UX, Putensen C, Elke G, Ragaller M, Gerlach H, Ludewig K, Kiehntopf M, Bogatsch H, Engel C, Brunkhorst FM, Loeffler M, Reinhart K, for SepNet Critical Care Trials G (2016) Effect of sodium selenite administration and procalcitonin-guided therapy on mortality in patients with severe sepsis or septic shock: a randomized clinical trial. JAMA intern med 176: 1266-1276</Citation><ArticleIdList><ArticleId IdType="pubmed">27428731</ArticleId></ArticleIdList></Reference><Reference><Citation>Kavalipati N, Shah J, Ramakrishan A, Vasnawala H. Pleiotropic effects of statins. Indian J Endocrinol Metab. 2015;19:554&#x2013;562. doi: 10.4103/2230-8210.163106.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2230-8210.163106</ArticleId><ArticleId IdType="pmc">PMC4566334</ArticleId><ArticleId IdType="pubmed">26425463</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y, Zhu G, Han L, Hou F, Huang W, Liu H, Gan J, Jiang T, Li X, Wang W, Ding S, Jia S, Shen W, Wang D, Sun L, Qiu J, Wang X, Li Y, Deng J, Li J, Xu K, Xu B, Mehran R, Huo Y. Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease. J Am Coll Cardiol. 2014;63:62&#x2013;70. doi: 10.1016/j.jacc.2013.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2013.09.017</ArticleId><ArticleId IdType="pubmed">24076297</ArticleId></ArticleIdList></Reference><Reference><Citation>Leoncini M, Toso A, Maioli M, Tropeano F, Villani S, Bellandi F. Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: results from the PRATO-ACS Study (Protective EFFECT of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome) J Am Coll Cardiol. 2014;63:71&#x2013;79. doi: 10.1016/j.jacc.2013.04.105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2013.04.105</ArticleId><ArticleId IdType="pubmed">24076283</ArticleId></ArticleIdList></Reference><Reference><Citation>Quintavalle C, Fiore D, De Micco F, Visconti G, Focaccio A, Golia B, Ricciardelli B, Donnarumma E, Bianco A, Zabatta MA, Troncone G, Colombo A, Briguori C, Condorelli G. Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury. Circulation. 2012;126:3008&#x2013;3016. doi: 10.1161/CIRCULATIONAHA.112.103317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.112.103317</ArticleId><ArticleId IdType="pubmed">23147173</ArticleId></ArticleIdList></Reference><Reference><Citation>Shehata M, Hamza M. Impact of high loading dose of atorvastatin in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention: a randomized controlled trial. Cardiovasc Ther. 2015;33:35&#x2013;41. doi: 10.1111/1755-5922.12108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1755-5922.12108</ArticleId><ArticleId IdType="pubmed">25677920</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Li Y, Xu B, Jia G, Guo T, Wang D, Xu K, Deng J, Han Y. Short-term rosuvastatin therapy prevents contrast-induced acute kidney injury in female patients with diabetes and chronic kidney disease: a subgroup analysis of the TRACK-D study. J Thorac Dis. 2016;8:1000&#x2013;1006. doi: 10.21037/jtd.2016.03.26.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2016.03.26</ArticleId><ArticleId IdType="pmc">PMC4842819</ArticleId><ArticleId IdType="pubmed">27162677</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbieri L, Verdoia M, Schaffer A, Nardin M, Marino P, De Luca G. The role of statins in the prevention of contrast induced nephropathy: a meta-analysis of 8 randomized trials. J Thromb Thrombolysis. 2014;38:493&#x2013;502. doi: 10.1007/s11239-014-1076-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-014-1076-3</ArticleId><ArticleId IdType="pubmed">24705677</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JM, Park J, Jeon KH, Jung JH, Lee SE, Han JK, Kim HL, Yang HM, Park KW, Kang HJ, Koo BK, Jo SH, Kim HS. Efficacy of short-term high-dose statin pretreatment in prevention of contrast-induced acute kidney injury: updated study-level meta-analysis of 13 randomized controlled trials. PLoS One. 2014;9:e111397. doi: 10.1371/journal.pone.0111397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0111397</ArticleId><ArticleId IdType="pmc">PMC4219719</ArticleId><ArticleId IdType="pubmed">25369120</ArticleId></ArticleIdList></Reference><Reference><Citation>Ukaigwe A, Karmacharya P, Mahmood M, Pathak R, Aryal MR, Jalota L, Donato AA. Meta-analysis on efficacy of statins for prevention of contrast-induced acute kidney injury in patients undergoing coronary angiography. Am J Cardiol. 2014;114:1295&#x2013;1302. doi: 10.1016/j.amjcard.2014.07.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2014.07.059</ArticleId><ArticleId IdType="pubmed">25239829</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh N, Lee JZ, Huang JJ, Low SW, Howe C, Pandit A, Suryanarayana P, Lee KS. Benefit of statin pretreatment in prevention of contrast-induced nephropathy in different adult patient population: systematic review and meta-analysis. Open Heart. 2014;1:e000127. doi: 10.1136/openhrt-2014-000127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/openhrt-2014-000127</ArticleId><ArticleId IdType="pmc">PMC4189228</ArticleId><ArticleId IdType="pubmed">25332824</ArticleId></ArticleIdList></Reference><Reference><Citation>Marenzi G, Cosentino N, Werba JP, Tedesco CC, Veglia F, Bartorelli AL. A meta-analysis of randomized controlled trials on statins for the prevention of contrast-induced acute kidney injury in patients with and without acute coronary syndromes. Int J Cardiol. 2015;183:47&#x2013;53. doi: 10.1016/j.ijcard.2015.01.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2015.01.046</ArticleId><ArticleId IdType="pubmed">25662053</ArticleId></ArticleIdList></Reference><Reference><Citation>Liakopoulos OJ, Choi YH, Haldenwang PL, Strauch J, Wittwer T, Dorge H, Stamm C, Wassmer G, Wahlers T. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30,000 patients. Eur Heart J. 2008;29:1548&#x2013;1559. doi: 10.1093/eurheartj/ehn198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehn198</ArticleId><ArticleId IdType="pubmed">18506053</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Gu C, Gao M, Yu W, Yu Y. Preoperative statin therapy and renal outcomes after cardiac surgery: a meta-analysis and meta-regression of 59,771 patients. Can J Cardiol. 2015;31:1051&#x2013;1060. doi: 10.1016/j.cjca.2015.02.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2015.02.034</ArticleId><ArticleId IdType="pubmed">26081692</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewicki M, Ng I, Schneider AG. HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass. Cochrane Database Syst Rev. 2015;3:CD010480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10788137</ArticleId><ArticleId IdType="pubmed">25758322</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FT, Hendricks PA, Schildcrout JS, Shi Y, Petracek MR, Byrne JG, Brown NJ. High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial. JAMA. 2016;315:877&#x2013;888. doi: 10.1001/jama.2016.0548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0548</ArticleId><ArticleId IdType="pmc">PMC4843765</ArticleId><ArticleId IdType="pubmed">26906014</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JH, Shim JK, Song JW, Soh S, Kwak YL. Effect of atorvastatin on the incidence of acute kidney injury following valvular heart surgery: a randomized, placebo-controlled trial. Intensive Care Med. 2016;42:1398&#x2013;1407. doi: 10.1007/s00134-016-4358-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4358-8</ArticleId><ArticleId IdType="pubmed">27120082</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z, Jayaram R, Jiang L, Emberson J, Zhao Y, Li Q, Du J, Guarguagli S, Hill M, Chen Z, Collins R, Casadei B. Perioperative rosuvastatin in cardiac surgery. N Engl J Med. 2016;374:1744&#x2013;1753. doi: 10.1056/NEJMoa1507750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1507750</ArticleId><ArticleId IdType="pubmed">27144849</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, Schmidt C, Van Aken H, Wempe C, Martens S, Zahn PK, Wolf B, Goebel U, Schwer CI, Rosenberger P, Haeberle H, Gorlich D, Kellum JA, Meersch M, Renal RI. Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA. 2015;313:2133&#x2013;2141. doi: 10.1001/jama.2015.4189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.4189</ArticleId><ArticleId IdType="pubmed">26024502</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmerman RF, Ezeanuna PU, Kane JC, Cleland CD, Kempananjappa TJ, Lucas FL, Kramer RS. Ischemic preconditioning at a remote site prevents acute kidney injury in patients following cardiac surgery. Kidney Int. 2011;80:861&#x2013;867. doi: 10.1038/ki.2011.156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2011.156</ArticleId><ArticleId IdType="pubmed">21677633</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim TK, Min JJ, Cho YJ, Hausenloy DJ, Ahn H, Kim KH, Hwang HY, Hong DM, Jeon Y. Effects of delayed remote ischemic preconditioning on peri-operative myocardial injury in patients undergoing cardiac surgery&#x2014;a randomized controlled trial. Int J Cardiol. 2017;227:511&#x2013;515. doi: 10.1016/j.ijcard.2016.10.111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2016.10.111</ArticleId><ArticleId IdType="pubmed">27839807</ArticleId></ArticleIdList></Reference><Reference><Citation>Meybohm P, Bein B, Brosteanu O, Cremer J, Gruenewald M, Stoppe C, Coburn M, Schaelte G, Boning A, Niemann B, Roesner J, Kletzin F, Strouhal U, Reyher C, Laufenberg-Feldmann R, Ferner M, Brandes IF, Bauer M, Stehr SN, Kortgen A, Wittmann M, Baumgarten G, Meyer-Treschan T, Kienbaum P, Heringlake M, Schon J, Sander M, Treskatsch S, Smul T, Wolwender E, Schilling T, Fuernau G, Hasenclever D, Zacharowski K. A multicenter trial of remote ischemic preconditioning for heart surgery. N Engl J Med. 2015;373:1397&#x2013;1407. doi: 10.1056/NEJMoa1413579.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1413579</ArticleId><ArticleId IdType="pubmed">26436208</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong DM, Lee EH, Kim HJ, Min JJ, Chin JH, Choi DK, Bahk JH, Sim JY, Choi IC, Jeon Y. Does remote ischaemic preconditioning with postconditioning improve clinical outcomes of patients undergoing cardiac surgery? Remote Ischaemic Preconditioning with Postconditioning Outcome Trial. Eur Heart J. 2014;35:176&#x2013;183. doi: 10.1093/eurheartj/eht346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/eht346</ArticleId><ArticleId IdType="pubmed">24014392</ArticleId></ArticleIdList></Reference><Reference><Citation>Hausenloy DJ, Candilio L, Evans R, Ariti C, Jenkins DP, Kolvekar S, Knight R, Kunst G, Laing C, Nicholas J, Pepper J, Robertson S, Xenou M, Clayton T, Yellon DM, ERICCA Trial Investigators Remote ischemic preconditioning and outcomes of cardiac surgery. N Engl J Med. 2015;373:1408&#x2013;1417. doi: 10.1056/NEJMoa1413534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1413534</ArticleId><ArticleId IdType="pubmed">26436207</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh M, Whitlock R, Garg AX, Legare JF, Duncan AE, Zimmerman R, Miller S, Fremes S, Kieser T, Karthikeyan G, Chan M, Ho A, Nasr V, Vincent J, Ali I, Lavi R, Sessler DI, Kramer R, Gardner J, Syed S, VanHelder T, Guyatt G, Rao-Melacini P, Thabane L, Devereaux PJ, Remote IMPACT Investigators Effects of remote ischemic preconditioning in high-risk patients undergoing cardiac surgery (Remote IMPACT): a randomized controlled trial. CMAJ. 2016;188:329&#x2013;336. doi: 10.1503/cmaj.150632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.150632</ArticleId><ArticleId IdType="pmc">PMC4786386</ArticleId><ArticleId IdType="pubmed">26668200</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Diao Y, Chen G, Tanaka A, Eastwood GM, Bellomo R. Remote ischemic conditioning for kidney protection: a meta-analysis. J Crit Care. 2016;33:224&#x2013;232. doi: 10.1016/j.jcrc.2016.01.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2016.01.026</ArticleId><ArticleId IdType="pubmed">26936039</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou C, Jeon Y, Meybohm P, Zarbock A, Young PJ, Li L, Hausenloy DJ. Renoprotection by remote ischemic conditioning during elective coronary revascularization: a systematic review and meta-analysis of randomized controlled trials. Int J Cardiol. 2016;222:295&#x2013;302. doi: 10.1016/j.ijcard.2016.07.176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2016.07.176</ArticleId><ArticleId IdType="pubmed">27498373</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Lang XB, Zhang P, Lv R, Wang YF, Chen JH. Remote ischemic preconditioning for prevention of acute kidney injury: a meta-analysis of randomized controlled trials. Am J Kidney Dis. 2014;64:574&#x2013;583. doi: 10.1053/j.ajkd.2014.04.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2014.04.029</ArticleId><ArticleId IdType="pubmed">24954246</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, Lang X, Cao L, Wang Y, Lu Y, Feng S, Yang Y, Chen J, Jiang H. Effect of remote ischemic preconditioning on postoperative acute kidney injury among patients undergoing cardiac and vascular interventions: a meta-analysis. J Nephrol. 2017;30:19&#x2013;33. doi: 10.1007/s40620-016-0301-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40620-016-0301-x</ArticleId><ArticleId IdType="pmc">PMC5316401</ArticleId><ArticleId IdType="pubmed">27091767</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J, Liu S, Jia P, Xu X, Song N, Zhang T, Chen R, Ding X. Protection of remote ischemic preconditioning against acute kidney injury: a systematic review and meta-analysis. Crit Care. 2016;20:111. doi: 10.1186/s13054-016-1272-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1272-y</ArticleId><ArticleId IdType="pmc">PMC4837562</ArticleId><ArticleId IdType="pubmed">27095379</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce B, Bole I, Patel V, Brown DL (2017) Clinical outcomes of remote ischemic preconditioning prior to cardiac surgery: a meta-analysis of randomized controlled trials. J Am Heart Assoc. doi:10.1161/JAHA.116.004666</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5523764</ArticleId><ArticleId IdType="pubmed">28219918</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi B, Chen X, Shi H, Lin T, Lin H, Xu Y, Rong J (2017) Remote ischaemic preconditioning reduces acute kidney injury in adult patients undergoing cardiac surgery with cardiopulmonary bypass: a meta-analysis. Eur J Cardiothorac Surg 51:616&#x2013;623</Citation><ArticleIdList><ArticleId IdType="pubmed">28329336</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou C, Bulluck H, Fang N, Li L, Hausenloy DJ. Age and surgical complexity impact on renoprotection by remote ischemic preconditioning during adult cardiac surgery: a meta analysis. Sci Rep. 2017;7:215. doi: 10.1038/s41598-017-00308-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-00308-3</ArticleId><ArticleId IdType="pmc">PMC5428278</ArticleId><ArticleId IdType="pubmed">28303021</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Zhang X, Chi D, Wang S, Wei H, Yu H, Li Q, Liu B. Remote ischemic preconditioning for prevention of acute kidney injury in patients undergoing on-pump cardiac surgery: a systematic review and meta-analysis. Medicine. 2016;95:e3465. doi: 10.1097/MD.0000000000003465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000003465</ArticleId><ArticleId IdType="pmc">PMC5402542</ArticleId><ArticleId IdType="pubmed">27631199</ArticleId></ArticleIdList></Reference><Reference><Citation>Pei H, Wu Y, Wei Y, Yang Y, Teng S, Zhang H. Remote ischemic preconditioning reduces perioperative cardiac and renal events in patients undergoing elective coronary intervention: a meta-analysis of 11 randomized trials. PLoS One. 2014;9:e115500. doi: 10.1371/journal.pone.0115500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0115500</ArticleId><ArticleId IdType="pmc">PMC4281209</ArticleId><ArticleId IdType="pubmed">25551671</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Li G, Yu C, Li Y. The role of remote ischemic preconditioning on postoperative kidney injury in patients undergoing cardiac and vascular interventions: a meta-analysis. J Cardiothorac Surg. 2013;8:43. doi: 10.1186/1749-8090-8-43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-8090-8-43</ArticleId><ArticleId IdType="pmc">PMC3639828</ArticleId><ArticleId IdType="pubmed">23497625</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukkar L, Hong D, Wong MG, Badve SV, Rogers K, Perkovic V, Walsh M, Yu X, Hillis GS, Gallagher M, Jardine M. Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: systematic review and meta-analysis. BMJ. 2016;355:i5599. doi: 10.1136/bmj.i5599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i5599</ArticleId><ArticleId IdType="pmc">PMC5098417</ArticleId><ArticleId IdType="pubmed">27821641</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou CC, Ge YZ, Yao WT, Wu R, Xin H, Lu TZ, Li MH, Song KW, Wang M, Zhu YP, Zhu M, Geng LG, Gao XF, Zhou LH, Zhang SL, Zhu JG, Jia RP. Limited clinical utility of remote ischemic conditioning in renal transplantation: a meta-analysis of randomized controlled trials. PLoS One. 2017;12:e0170729. doi: 10.1371/journal.pone.0170729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0170729</ArticleId><ArticleId IdType="pmc">PMC5271340</ArticleId><ArticleId IdType="pubmed">28129389</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolhe NV, Reilly T, Leung J, Fluck RJ, Swinscoe KE, Selby NM, Taal MW. A simple care bundle for use in acute kidney injury: a propensity score-matched cohort study. Nephrol Dial Transplant. 2016;31:1846&#x2013;1854. doi: 10.1093/ndt/gfw087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfw087</ArticleId><ArticleId IdType="pubmed">27190331</ArticleId></ArticleIdList></Reference><Reference><Citation>Joslin J, Wilson H, Zubli D, Gauge N, Kinirons M, Hopper A, Pile T, Ostermann M. Recognition and management of acute kidney injury in hospitalised patients can be partially improved with the use of a care bundle. Clinic Med (Lond) 2015;15:431&#x2013;436. doi: 10.7861/clinmedicine.15-5-431.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmedicine.15-5-431</ArticleId><ArticleId IdType="pmc">PMC4953226</ArticleId><ArticleId IdType="pubmed">26430180</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhagwanani A, Carpenter R, Yusuf A (2014) Improving the management of acute kidney injury in a district general hospital: introduction of the DONUT bundle. BMJ Qual Improv Rep. doi:10.1136/bmjquality.u202650.w1235</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4663825</ArticleId><ArticleId IdType="pubmed">26734238</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersch M, Schmidt C, Hoffmeier A, Van Aken H, Wempe C, Gerss J, Zarbock A (2017) Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med. doi:10.1007/s00134-016-4670-3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5633630</ArticleId><ArticleId IdType="pubmed">28110412</ArticleId></ArticleIdList></Reference><Reference><Citation>Angus DC, Barnato AE, Bell D, Bellomo R, Chong CR, Coats TJ, Davies A, Delaney A, Harrison DA, Holdgate A, Howe B, Huang DT, Iwashyna T, Kellum JA, Peake SL, Pike F, Reade MC, Rowan KM, Singer M, Webb SA, Weissfeld LA, Yealy DM, Young JD. A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe investigators. Intensive Care Med. 2015;41:1549&#x2013;1560. doi: 10.1007/s00134-015-3822-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3822-1</ArticleId><ArticleId IdType="pubmed">25952825</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative workgroup Acute renal failure&#x2014;definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204&#x2013;R212. doi: 10.1186/cc2872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc2872</ArticleId><ArticleId IdType="pmc">PMC522841</ArticleId><ArticleId IdType="pubmed">15312219</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A. Acute Kidney Injury Network (AKIN): report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31. doi: 10.1186/cc5713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc5713</ArticleId><ArticleId IdType="pmc">PMC2206446</ArticleId><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38954672</PMID><DateCompleted><Year>2025</Year><Month>03</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-9159</ISSN><JournalIssue CitedMedium="Internet"><Volume>111</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of surgery (London, England)</Title><ISOAbbreviation>Int J Surg</ISOAbbreviation></Journal><ArticleTitle>Association between frailty and acute kidney injury after cardiac surgery: unraveling the moderation effect of body fat through an international, retrospective, multicohort study.</ArticleTitle><Pagination><StartPage>761</StartPage><EndPage>770</EndPage><MedlinePgn>761-770</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/JS9.0000000000001861</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute kidney injury (AKI) is a common and serious complication after cardiac surgery that significantly affects patient outcomes. Given the limited treatment options available, identifying modifiable risk factors is critical. Frailty and obesity, two heterogeneous physiological states, have significant implications for identifying and preventing AKI. Our study investigated the interplay among frailty, body composition, and AKI risk after cardiac surgery to inform patient management strategies.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">This retrospective cohort study included three international cohorts. Primary analysis was conducted on adult patients who underwent cardiac surgery between 2014 and 2019 at Wuhan Union Hospital, China. We tested the generalizability of our findings with data from two independent international cohorts, the Medical Information Mart for Intensive Care IV (MIMIC-IV) and the eICU Collaborative Research Database. Frailty was assessed using a clinical lab-based frailty index (FI-LAB), while total body fat percentage (BF%) was calculated based on a formula accounting for BMI, sex, and age. Logistic regression models were used to analyze the associations between frailty, body fat, and AKI, adjusting for pertinent covariates.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 8785 patients across three international cohorts were included in the study. In the primary analysis of 3569 patients from Wuhan Union Hospital, moderate and severe frailty were associated with an increased AKI risk after cardiac surgery. Moreover, a nonlinear relationship was observed between BF% and AKI risk. When stratified by the degree of frailty, lower body fat correlated with a decreased incidence of AKI. Extended analyses using the MIMIC-IV and eICU cohorts ( n =3951 and n =1265, respectively) validated these findings and demonstrated that a lower total BF% was associated with decreased AKI incidence. Moderation analysis revealed that the effect of frailty on AKI risk was moderated by the BF%. Sensitivity analyses demonstrated results consistent with the main analyses.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Higher degrees of frailty were associated with an elevated risk of AKI following cardiac surgery, and total BF% moderated this relationship. This research underscores the significance of integrating frailty and body fat assessments into routine cardiovascular care to identify high-risk patients for AKI and implement personalized interventions to improve patient outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Yun-Xiao</ForeName><Initials>YX</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Anesthesiology and Resuscitation (Huazhong University of Science and Technology), Ministry of Education, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zi-Hao</ForeName><Initials>ZH</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Anesthesiology and Resuscitation (Huazhong University of Science and Technology), Ministry of Education, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Anesthesiology and Resuscitation (Huazhong University of Science and Technology), Ministry of Education, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Zhen-Zhen</ForeName><Initials>ZZ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Anesthesiology and Resuscitation (Huazhong University of Science and Technology), Ministry of Education, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Yi-Qi</ForeName><Initials>YQ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Anesthesiology and Resuscitation (Huazhong University of Science and Technology), Ministry of Education, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Guo-Yang</ForeName><Initials>GY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Anesthesiology and Resuscitation (Huazhong University of Science and Technology), Ministry of Education, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Ping</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yan-Ting</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Anesthesiology and Resuscitation (Huazhong University of Science and Technology), Ministry of Education, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Nian-Guo</ForeName><Initials>NG</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Qing-Ping</ForeName><Initials>QP</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Anesthesiology and Resuscitation (Huazhong University of Science and Technology), Ministry of Education, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>01</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Surg</MedlineTA><NlmUniqueID>101228232</NlmUniqueID><ISSNLinking>1743-9159</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073496" MajorTopicYN="Y">Frailty</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000273" MajorTopicYN="Y">Adipose Tissue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The author(s) have no potential conflicts of interest to disclose. Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>3</Month><Day>7</Day><Hour>18</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>2</Day><Hour>21</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>2</Day><Hour>14</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>1</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38954672</ArticleId><ArticleId IdType="pmc">PMC11745703</ArticleId><ArticleId IdType="doi">10.1097/JS9.0000000000001861</ArticleId><ArticleId IdType="pii">01279778-990000000-01754</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wang Y, Bellomo R. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol 2017;13:697&#x2013;711.</Citation><ArticleIdList><ArticleId IdType="pubmed">28869251</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Gao Y, Tian Y, et al. . Prediction of acute kidney injury after cardiac surgery from preoperative N-terminal pro-B-type natriuretic peptide. Br J Anaesth 2021;127:862&#x2013;870.</Citation><ArticleIdList><ArticleId IdType="pubmed">34561052</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernardi MH, Schmidlin D, Ristl R, et al. . Serum creatinine back-estimation in cardiac surgery patients: misclassification of AKI using existing formulae and a data-driven model. Clin J Am Soc Nephrol 2016;11:395&#x2013;404.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4791819</ArticleId><ArticleId IdType="pubmed">26801479</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao H, Katz N, Ariyanon W, et al. . Cardiac surgery-associated acute kidney injury. Cardiorenal Med 2013;3:178&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3884176</ArticleId><ArticleId IdType="pubmed">24454314</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson CE, Yavas S, Segal MS, et al. . Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation 2009;119:2444&#x2013;2453.</Citation><ArticleIdList><ArticleId IdType="pubmed">19398670</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste EAJ, Bagshaw SM, Bellomo R, et al. . Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intens Care Med 2015;41:1411&#x2013;1423.</Citation><ArticleIdList><ArticleId IdType="pubmed">26162677</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow GM, Levy EM, Hammermeister KE, et al. . Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 1998;104:343&#x2013;348.</Citation><ArticleIdList><ArticleId IdType="pubmed">9576407</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco C, Bellomo R, Kellum JA. Acute kidney injury. Lancet 2019;394:1949&#x2013;1964.</Citation><ArticleIdList><ArticleId IdType="pubmed">31777389</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickkers P, Darmon M, Hoste E, et al. . Acute kidney injury in the critically ill: an updated review on pathophysiology and management. Intens Care Med 2021;47:835&#x2013;850.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8249842</ArticleId><ArticleId IdType="pubmed">34213593</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoogendijk EO, Afilalo J, Ensrud KE, et al. . Frailty: implications for clinical practice and public health. Lancet 2019;394:1365&#x2013;1375.</Citation><ArticleIdList><ArticleId IdType="pubmed">31609228</ArticleId></ArticleIdList></Reference><Reference><Citation>Dent E, Martin FC, Bergman H, et al. . Management of frailty: opportunities, challenges, and future directions. Lancet 2019;394:1376&#x2013;1386.</Citation><ArticleIdList><ArticleId IdType="pubmed">31609229</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Lup&#xf3;n J, Vid&#xe1;n MT, et al. . Impact of frailty on mortality and hospitalization in chronic heart failure: a systematic review and meta-analysis. J Am Heart Assoc 2018;7:e008251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6405567</ArticleId><ArticleId IdType="pubmed">30571603</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeiren S, Vella-Azzopardi R, Beckw&#xe9;e D, et al. . Frailty and the prediction of negative health outcomes: a meta-analysis. J Am Med Dir Assoc 2016;17:1163.e1&#x2013;1163.e17.</Citation><ArticleIdList><ArticleId IdType="pubmed">27886869</ArticleId></ArticleIdList></Reference><Reference><Citation>Clegg A, Young J, Iliffe S, et al. . Frailty in elderly people. Lancet 2013;381:752&#x2013;762.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4098658</ArticleId><ArticleId IdType="pubmed">23395245</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace LMK, Theou O, Godin J, et al. . Investigation of frailty as a moderator of the relationship between neuropathology and dementia in Alzheimer&#x2019;s disease: a cross-sectional analysis of data from the Rush Memory and Aging Project. Lancet Neurol 2019;18:177&#x2013;184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11062500</ArticleId><ArticleId IdType="pubmed">30663607</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanlon P, Nicholl BI, Jani BD, et al. . Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493&#x2008;737 UK Biobank participants. Lancet Public Health 2018;3:e323&#x2013;e332.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6028743</ArticleId><ArticleId IdType="pubmed">29908859</ArticleId></ArticleIdList></Reference><Reference><Citation>Tutor AW, Lavie CJ, Kachur S, et al. . Updates on obesity and the obesity paradox in cardiovascular diseases. Prog Cardiovasc Dis 2023;78:2&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">36481212</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianchettin RG, Lavie CJ, Lopez-Jimenez F. Challenges in cardiovascular evaluation and management of obese patients: JACC state-of-the-art review. J Am Coll Cardiol 2023;81:490&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pubmed">36725178</ArticleId></ArticleIdList></Reference><Reference><Citation>Despr&#xe9;s JP, Carpentier AC, Tchernof A, et al. . Management of obesity in cardiovascular practice: JACC focus seminar. J Am Coll Cardiol 2021;78:513&#x2013;531.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8609918</ArticleId><ArticleId IdType="pubmed">34325840</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew G, Agha R, Albrecht J, et al. . STROCSS 2021: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery. Int J Surg 2021;96:106165.</Citation><ArticleIdList><ArticleId IdType="pubmed">34774726</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson AEW, Bulgarelli L, Shen L, et al. . MIMIC-IV, a freely accessible electronic health record dataset. Sci Data 2023;10:1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9810617</ArticleId><ArticleId IdType="pubmed">36596836</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollard TJ, Johnson AEW, Raffa JD, et al. . The eICU Collaborative Research Database, a freely available multi-center database for critical care research. Sci Data 2018;5:180178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6132188</ArticleId><ArticleId IdType="pubmed">30204154</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012;120:c179&#x2013;c184.</Citation><ArticleIdList><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Howlett SE, Rockwood MR, Mitnitski A, et al. . Standard laboratory tests to identify older adults at increased risk of death. BMC Med 2014;12:171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4190374</ArticleId><ArticleId IdType="pubmed">25288274</ArticleId></ArticleIdList></Reference><Reference><Citation>Blodgett JM, Theou O, Howlett SE, et al. . A frailty index from common clinical and laboratory tests predicts increased risk of death across the life course. Geroscience 2017;39:447&#x2013;455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5636769</ArticleId><ArticleId IdType="pubmed">28866737</ArticleId></ArticleIdList></Reference><Reference><Citation>Deurenberg P, Weststrate JA, Seidell JC. Body mass index as a measure of body fatness: age- and sex-specific prediction formulas. Br J Nutr 1991;65:105&#x2013;114.</Citation><ArticleIdList><ArticleId IdType="pubmed">2043597</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaskirbayeva D, West R, Jaafari H, et al. . Progression of frailty as measured by a cumulative deficit index: a systematic review. Ageing Res Rev 2023;84:101789.</Citation><ArticleIdList><ArticleId IdType="pubmed">36396032</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng S, Chen X, Bai K, et al. . Association of the cl&#xed;nica universidad de navarra-body adiposity estimator with type 2 diabetes: a retrospective cohort study. Int J Public Health 2023;68:1606063.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10551821</ArticleId><ArticleId IdType="pubmed">37810434</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiesisibieke ZL, Tung TH, Xu QY, et al. . Association of acute kidney injury with frailty in elderly population: a systematic review and meta-analysis. Ren Fail 2019;41:1021&#x2013;1027.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6913666</ArticleId><ArticleId IdType="pubmed">31809623</ArticleId></ArticleIdList></Reference><Reference><Citation>Aykut A, Salman N. Poor nutritional status and frailty associated with acute kidney injury after cardiac surgery: A retrospective observational study. J Card Surg 2022;37:4755&#x2013;4761.</Citation><ArticleIdList><ArticleId IdType="pubmed">36352787</ArticleId></ArticleIdList></Reference><Reference><Citation>Tirupakuzhi Vijayaraghavan BK, Rashan A, Ranganathan L, et al. . Prevalence of frailty and association with patient centered outcomes: a prospective registry-embedded cohort study from India. J Crit Care 2024;80:154509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10830405</ArticleId><ArticleId IdType="pubmed">38134715</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol 2018;15:505&#x2013;522.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6146930</ArticleId><ArticleId IdType="pubmed">30065258</ArticleId></ArticleIdList></Reference><Reference><Citation>Vives M, Hernandez A, Parramon F, et al. . Acute kidney injury after cardiac surgery: prevalence, impact and management challenges. Int J Nephrol Renovasc Dis 2019;12:153&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6612286</ArticleId><ArticleId IdType="pubmed">31303781</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu CY, McCulloch CE, Iribarren C, et al. . Body mass index and risk for end-stage renal disease. Ann Intern Med 2006;144:21&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">16389251</ArticleId></ArticleIdList></Reference><Reference><Citation>Berthoux F, Mariat C, Maillard N. Overweight/obesity revisited as a predictive risk factor in primary IgA nephropathy. Nephrol Dial Transplant 2013;28(suppl 4):iv160&#x2013;iv166.</Citation><ArticleIdList><ArticleId IdType="pubmed">24026246</ArticleId></ArticleIdList></Reference><Reference><Citation>Curran SP, Famure O, Li Y, et al. . Increased recipient body mass index is associated with acute rejection and other adverse outcomes after kidney transplantation. Transplantation 2014;97:64&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">24056619</ArticleId></ArticleIdList></Reference><Reference><Citation>Gross ML, Amann K, Ritz E. Nephron number and renal risk in hypertension and diabetes. J Am Soc Nephrol 2005;16(Suppl 1):S27&#x2013;S29.</Citation><ArticleIdList><ArticleId IdType="pubmed">15938029</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">7678183</ArticleId></ArticleIdList></Reference><Reference><Citation>Clemente-Su&#xe1;rez VJ, Redondo-Fl&#xf3;rez L, Beltr&#xe1;n-Velasco AI, et al. . The Role of Adipokines in Health and Disease. Biomedicines 2023;11:1290.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10216288</ArticleId><ArticleId IdType="pubmed">37238961</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser M, Bouter LM, McQuillan GM, et al. . Elevated C-reactive protein levels in overweight and obese adults. Jama 1999;282:2131&#x2013;2135.</Citation><ArticleIdList><ArticleId IdType="pubmed">10591334</ArticleId></ArticleIdList></Reference><Reference><Citation>Basile DP, Anderson MD, Sutton TA. Pathophysiology of acute kidney injury. Compr Physiol 2012;2:1303&#x2013;1353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3919808</ArticleId><ArticleId IdType="pubmed">23798302</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinsey GR, McHowat J, Patrick KS, et al. . Role of Ca2+-independent phospholipase A2gamma in Ca2+-induced mitochondrial permeability transition. J Pharmacol Exp Ther 2007;321:707&#x2013;715.</Citation><ArticleIdList><ArticleId IdType="pubmed">17312185</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldkamp T, Park JS, Pasupulati R, et al. . Regulation of the mitochondrial permeability transition in kidney proximal tubules and its alteration during hypoxia-reoxygenation. Am J Physiol Renal Physiol 2009;297:F1632&#x2013;F1646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2801335</ArticleId><ArticleId IdType="pubmed">19741014</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh SW, Ahn SY, Jianwei X, et al. . Relationship between changes in body fat and a decline of renal function in the elderly. PLoS One 2014;9:e84052.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3894176</ArticleId><ArticleId IdType="pubmed">24454716</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma C, Avenell A, Bolland M, et al. . Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis. Bmj 2017;359:j4849.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5682593</ArticleId><ArticleId IdType="pubmed">29138133</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin M, Wu S, Deng X, et al. . Visceral fat and its dynamic change are associated with renal damage: Evidence from two cohorts. Clin Exp Hypertens 2023;45:2271187.</Citation><ArticleIdList><ArticleId IdType="pubmed">37871163</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Gindan YY, Hankey CR, Govan L, et al. . Derivation and validation of simple anthropometric equations to predict adipose tissue mass and total fat mass with MRI as the reference method. Br J Nutr 2015;114:1852&#x2013;1867.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5276707</ArticleId><ArticleId IdType="pubmed">26435103</ArticleId></ArticleIdList></Reference><Reference><Citation>Vel&#xe1;zquez-Alva MC, Irigoyen-Camacho ME, Zepeda-Zepeda MA, et al. . Comparison of body fat percentage assessments by bioelectrical impedance analysis, anthropometrical prediction equations, and dual-energy X-ray absorptiometry in older women. Front Nutr 2022;9:978971.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9812576</ArticleId><ArticleId IdType="pubmed">36618693</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38527923</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>133</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Preoperative risk prediction models for acute kidney injury after noncardiac surgery: an independent external validation cohort study.</ArticleTitle><Pagination><StartPage>508</StartPage><EndPage>518</EndPage><MedlinePgn>508-518</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2024.02.018</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(24)00097-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Numerous models have been developed to predict acute kidney injury (AKI) after noncardiac surgery, yet there is a lack of independent validation and comparison among them.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a systematic literature search to review published risk prediction models for AKI after noncardiac surgery. An independent external validation was performed using a retrospective surgical cohort at a large Chinese hospital from January 2019 to October 2022. The cohort included patients undergoing a wide range of noncardiac surgeries with perioperative creatinine measurements. Postoperative AKI was defined according to the Kidney Disease Improving Global Outcomes creatinine criteria. Model performance was assessed in terms of discrimination (area under the receiver operating characteristic curve, AUROC), calibration (calibration plot), and clinical utility (net benefit), before and after model recalibration through intercept and slope updates. A sensitivity analysis was conducted by including patients without postoperative creatinine measurements in the validation cohort and categorising them as non-AKI cases.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Nine prediction models were evaluated, each with varying clinical and methodological characteristics, including the types of surgical cohorts used for model development, AKI definitions, and predictors. In the validation cohort involving 13,186 patients, 650 (4.9%) developed AKI. Three models demonstrated fair discrimination (AUROC between 0.71 and 0.75); other models had poor or failed discrimination. All models exhibited some miscalibration; five of the nine models were well-calibrated after intercept and slope updates. Decision curve analysis indicated that the three models with fair discrimination consistently provided a positive net benefit after recalibration. The results were confirmed in the sensitivity analysis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We identified three models with fair discrimination and potential clinical utility after recalibration for assessing the risk of acute kidney injury after noncardiac surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhuo</LastName><ForeName>Xiao-Yu</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, China; Guangdong Provincial Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Shao-Hui</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, China; Guangdong Provincial Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection, Guangzhou, China; College of Anaesthesiology, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Lan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, China; Department of Biostatistics, Lejiu Healthcare Technology Co., Ltd, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Ya-Wen</ForeName><Initials>YW</Initials><AffiliationInfo><Affiliation>College of Anaesthesiology, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jiao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>College of Anaesthesiology, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Yong-Jia</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>College of Anaesthesiology, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ke-Xuan</ForeName><Initials>KX</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, China; Guangdong Provincial Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection, Guangzhou, China; College of Anaesthesiology, Southern Medical University, Guangzhou, China; Outcomes Research Consortium, Cleveland, OH, USA. Electronic address: liukexuan705@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Wei-Feng</ForeName><Initials>WF</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, China; Guangdong Provincial Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection, Guangzhou, China; College of Anaesthesiology, Southern Medical University, Guangzhou, China. Electronic address: sglwfeng01@21cn.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Bing-Cheng</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, China; Guangdong Provincial Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection, Guangzhou, China; College of Anaesthesiology, Southern Medical University, Guangzhou, China; Outcomes Research Consortium, Cleveland, OH, USA. Electronic address: zhaobch@mail2.sysu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">clinical prediction model</Keyword><Keyword MajorTopicYN="N">noncardiac surgery</Keyword><Keyword MajorTopicYN="N">perioperative care</Keyword><Keyword MajorTopicYN="N">validation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>11</Day><Hour>4</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>26</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>25</Day><Hour>22</Hour><Minute>56</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38527923</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2024.02.018</ArticleId><ArticleId IdType="pii">S0007-0912(24)00097-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39319450</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1524-4539</ISSN><JournalIssue CitedMedium="Internet"><Volume>150</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>22</Day></PubDate></JournalIssue><Title>Circulation</Title><ISOAbbreviation>Circulation</ISOAbbreviation></Journal><ArticleTitle>Effect of Delayed Remote Ischemic Preconditioning on Acute Kidney Injury and Outcomes in Patients Undergoing Cardiac Surgery: A Randomized Clinical Trial.</ArticleTitle><Pagination><StartPage>1366</StartPage><EndPage>1376</EndPage><MedlinePgn>1366-1376</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1161/CIRCULATIONAHA.124.071408</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Remote ischemic preconditioning (RIPC) has 2 time windows for organ protection: acute and delayed. Previous studies have mainly focused on the organoprotective effects of acute RIPC. We aimed to determine whether delayed RIPC can reduce the occurrence of acute kidney injury (AKI) and postoperative complications in patients undergoing cardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This prospective, single-center, double-blind, randomized controlled trial involved 509 patients at high risk for AKI who were scheduled for elective cardiac surgery requiring cardiopulmonary bypass. Patients were randomized to receive RIPC (4 cycles of 5-minute inflation and 5-minute deflation on 1 upper arm with a blood pressure cuff) 24 hours before surgery or a sham condition (control group) that was induced by 4 cycles of 5-minute inflation to a pressure of 20 mm&#x2009;Hg followed by 5-minute cuff deflation. The primary end point was the incidence of AKI within the prior 7 days after cardiac surgery. The secondary end points included renal replacement therapy during hospitalization, change in urinary biomarkers of AKI and markers of myocardial injury, duration of intensive care unit stay and mechanical ventilation, and occurrence of nonfatal myocardial infarction, stroke, and all-cause mortality by day 90.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 509 patients (mean age, 65.2&#xb1;8.2 years; 348 men [68.4%]) were randomly assigned to the RIPC group (n=254) or control group (n=255). AKI was significantly reduced in the RIPC group compared with the control group (69/254 [27.2%] versus 90/255 [35.3%]; odds ratio, 0.68 [95% CI, 0.47-1.00]; <i>P</i>=0.048). There were no significant between-group differences in the secondary end points of perioperative myocardial injury (assessed by the concentrations of cardiac troponin T, creatine kinase myocardial isoenzyme, and NT-proBNP [N-terminal pro-brain natriuretic peptide]), duration of stay in the intensive care unit and hospital, and occurrence of nonfatal myocardial infarction, stroke, and all-cause mortality by day 90.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Among high-risk patients undergoing cardiac surgery, delayed RIPC significantly reduced the occurrence of AKI.</AbstractText><AbstractText Label="REGISTRATION" NlmCategory="UNASSIGNED">URL: https://www.chictr.org.cn; Unique identifier: ChiCTR2000035568.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Jia</LastName><ForeName>Ping</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-0608-161X</Identifier><AffiliationInfo><Affiliation>Department of Nephrology, Zhongshan Hospital, Fudan University, and Shanghai Medical Center of Kidney, and Shanghai Key Laboratory of Kidney and Blood Purification, China (P.J., Z.Z., Q.Z., T.R., W.C., Z.Y., D.S., Y.L., F.P., B.S., J.X., X.D.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ji</LastName><ForeName>Qiang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery (Q.J., C.W.), Zhongshan Hospital, Fudan University, Shanghai.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Zhouping</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0001-5835-3405</Identifier><AffiliationInfo><Affiliation>Department of Nephrology, Zhongshan Hospital, Fudan University, and Shanghai Medical Center of Kidney, and Shanghai Key Laboratory of Kidney and Blood Purification, China (P.J., Z.Z., Q.Z., T.R., W.C., Z.Y., D.S., Y.L., F.P., B.S., J.X., X.D.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Zhongshan Hospital, Fudan University, and Shanghai Medical Center of Kidney, and Shanghai Key Laboratory of Kidney and Blood Purification, China (P.J., Z.Z., Q.Z., T.R., W.C., Z.Y., D.S., Y.L., F.P., B.S., J.X., X.D.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Ting</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-2191-0711</Identifier><AffiliationInfo><Affiliation>Department of Nephrology, Zhongshan Hospital, Fudan University, and Shanghai Medical Center of Kidney, and Shanghai Key Laboratory of Kidney and Blood Purification, China (P.J., Z.Z., Q.Z., T.R., W.C., Z.Y., D.S., Y.L., F.P., B.S., J.X., X.D.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Weize</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-7198-2027</Identifier><AffiliationInfo><Affiliation>Department of Nephrology, Zhongshan Hospital, Fudan University, and Shanghai Medical Center of Kidney, and Shanghai Key Laboratory of Kidney and Blood Purification, China (P.J., Z.Z., Q.Z., T.R., W.C., Z.Y., D.S., Y.L., F.P., B.S., J.X., X.D.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Zhixin</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Zhongshan Hospital, Fudan University, and Shanghai Medical Center of Kidney, and Shanghai Key Laboratory of Kidney and Blood Purification, China (P.J., Z.Z., Q.Z., T.R., W.C., Z.Y., D.S., Y.L., F.P., B.S., J.X., X.D.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Daoqi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Zhongshan Hospital, Fudan University, and Shanghai Medical Center of Kidney, and Shanghai Key Laboratory of Kidney and Blood Purification, China (P.J., Z.Z., Q.Z., T.R., W.C., Z.Y., D.S., Y.L., F.P., B.S., J.X., X.D.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Zhongshan Hospital, Fudan University, and Shanghai Medical Center of Kidney, and Shanghai Key Laboratory of Kidney and Blood Purification, China (P.J., Z.Z., Q.Z., T.R., W.C., Z.Y., D.S., Y.L., F.P., B.S., J.X., X.D.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Fangyuan</ForeName><Initials>F</Initials><Identifier Source="ORCID">0009-0000-2619-0293</Identifier><AffiliationInfo><Affiliation>Department of Nephrology, Zhongshan Hospital, Fudan University, and Shanghai Medical Center of Kidney, and Shanghai Key Laboratory of Kidney and Blood Purification, China (P.J., Z.Z., Q.Z., T.R., W.C., Z.Y., D.S., Y.L., F.P., B.S., J.X., X.D.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-8355-4903</Identifier><AffiliationInfo><Affiliation>Cardiac Intensive Care Center (Y.S., Z.L.), Zhongshan Hospital, Fudan University, Shanghai.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jiarui</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4925-2770</Identifier><AffiliationInfo><Affiliation>Department of Nephrology, Zhongshan Hospital, Fudan University, and Shanghai Medical Center of Kidney, and Shanghai Key Laboratory of Kidney and Blood Purification, China (P.J., Z.Z., Q.Z., T.R., W.C., Z.Y., D.S., Y.L., F.P., B.S., J.X., X.D.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Zhongshan Hospital, Fudan University, and Shanghai Medical Center of Kidney, and Shanghai Key Laboratory of Kidney and Blood Purification, China (P.J., Z.Z., Q.Z., T.R., W.C., Z.Y., D.S., Y.L., F.P., B.S., J.X., X.D.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Zhe</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Cardiac Intensive Care Center (Y.S., Z.L.), Zhongshan Hospital, Fudan University, Shanghai.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chunsheng</ForeName><Initials>C</Initials><Identifier Source="ORCID">0009-0008-4582-5897</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery (Q.J., C.W.), Zhongshan Hospital, Fudan University, Shanghai.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Xiaoqiang</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0003-4954-8539</Identifier><AffiliationInfo><Affiliation>Department of Nephrology, Zhongshan Hospital, Fudan University, and Shanghai Medical Center of Kidney, and Shanghai Key Laboratory of Kidney and Blood Purification, China (P.J., Z.Z., Q.Z., T.R., W.C., Z.Y., D.S., Y.L., F.P., B.S., J.X., X.D.).</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ChiCTR</DataBankName><AccessionNumberList><AccessionNumber>ChiCTR2000035568</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Circulation</MedlineTA><NlmUniqueID>0147763</NlmUniqueID><ISSNLinking>0009-7322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019194" MajorTopicYN="Y">Ischemic Preconditioning</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="N">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">cardiac surgical procedures</Keyword><Keyword MajorTopicYN="N">ischemic preconditioning</Keyword></KeywordList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>4</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>7</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>5</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39319450</ArticleId><ArticleId IdType="pmc">PMC11495536</ArticleId><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.124.071408</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hobson CE, Yavas S, Segal MS, Schold JD, Tribble CG, Layon AJ, Bihorac A. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation. 2009;119:2444&#x2013;2453. doi: 10.1161/CIRCULATIONAHA.108.800011</Citation><ArticleIdList><ArticleId IdType="pubmed">19398670</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J, Chen R, Liu S, Yu X, Zou J, Ding X. Global incidence and outcomes of adult patients with acute kidney injury after cardiac surgery: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth. 2016;30:82&#x2013;89. doi: 10.1053/j.jvca.2015.06.017</Citation><ArticleIdList><ArticleId IdType="pubmed">26482484</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Bellomo R. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol. 2017;13:697&#x2013;711. doi: 10.1038/nrneph.2017.119</Citation><ArticleIdList><ArticleId IdType="pubmed">28869251</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao H, Katz N, Ariyanon W, Blanca-Martos L, Ad&#xfd;belli Z, Giuliani A, Danesi TH, Kim JC, Nayak A, Neri M, et al. . Cardiac surgery-associated acute kidney injury. Cardiorenal Med. 2013;3:178&#x2013;199. doi: 10.1159/000353134</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3884176</ArticleId><ArticleId IdType="pubmed">24454314</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega-Loubon C, Fern&#xe1;ndez-Molina M, Carrascal-Hinojal Y, Fulquet-Carreras E. Cardiac surgery-associated acute kidney injury. Ann Card Anaesth. 2016;19:687&#x2013;698. doi: 10.4103/0971-9784.191578</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070330</ArticleId><ArticleId IdType="pubmed">27716701</ArticleId></ArticleIdList></Reference><Reference><Citation>Milne B, Gilbey T, Kunst G. Perioperative management of the patient at high-risk for cardiac surgery-associated acute kidney injury. J Cardiothorac Vasc Anesth. 2022;36:4460&#x2013;4482. doi: 10.1053/j.jvca.2022.08.016</Citation><ArticleIdList><ArticleId IdType="pubmed">36241503</ArticleId></ArticleIdList></Reference><Reference><Citation>Pet&#xe4;j&#xe4; L, Vaara S, Liuhanen S, Suojaranta-Ylinen R, Mildh L, Nisula S, Korhonen AM, Kaukonen KM, Salmenper&#xe4; M, Pettil&#xe4; V. Acute kidney injury after cardiac surgery by complete KDIGO criteria predicts increased mortality. J Cardiothorac Vasc Anesth. 2017;31:827&#x2013;836. doi: 10.1053/j.jvca.2016.08.026</Citation><ArticleIdList><ArticleId IdType="pubmed">27856153</ArticleId></ArticleIdList></Reference><Reference><Citation>Howitt SH, Grant SW, Caiado C, Carlson E, Kwon D, Dimarakis I, Malagon I, McCollum C. The KDIGO acute kidney injury guidelines for cardiac surgery patients in critical care: a validation study. BMC Nephrol. 2018;19:149. doi: 10.1186/s12882-018-0946-x</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6020229</ArticleId><ArticleId IdType="pubmed">29940876</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiele RH, Isbell JM, Rosner MH. AKI associated with cardiac surgery. Clin J Am Soc Nephrol. 2015;10:500&#x2013;514. doi: 10.2215/CJN.07830814</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4348689</ArticleId><ArticleId IdType="pubmed">25376763</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Neal JB, Shaw AD, Billings FT. Acute kidney injury following cardiac surgery: current understanding and future directions. Crit Care. 2016;20:187. doi: 10.1186/s13054-016-1352-z</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4931708</ArticleId><ArticleId IdType="pubmed">27373799</ArticleId></ArticleIdList></Reference><Reference><Citation>Vives M, Hernandez A, Parramon F, Estanyol N, Pardina B, Mu&#xf1;oz A, Alvarez P, Hernandez C. Acute kidney injury after cardiac surgery: prevalence, impact and management challenges. Int J Nephrol Renovasc Dis. 2019;12:153&#x2013;166. doi: 10.2147/IJNRD.S167477</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6612286</ArticleId><ArticleId IdType="pubmed">31303781</ArticleId></ArticleIdList></Reference><Reference><Citation>Choe SH, Cho H, Bae J, Ji SH, Yoon HK, Lee HJ, Lee JH, Kim JT, Kim WH. Severity and duration of acute kidney injury and chronic kidney disease after cardiac surgery. J Clin Med. 2021;10:1556. doi: 10.3390/jcm10081556</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8067973</ArticleId><ArticleId IdType="pubmed">33917221</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoole SP, Heck PM, Sharples L, Khan SN, Duehmke R, Densem CG, Clarke SC, Shapiro LM, Schofield PM, O&#x2019;Sullivan M, et al. . Cardiac remote ischemic preconditioning in coronary stenting (CRISP Stent) study: a prospective, randomized control trial. Circulation. 2009;119:820&#x2013;827. doi: 10.1161/CIRCULATIONAHA.108.809723</Citation><ArticleIdList><ArticleId IdType="pubmed">19188504</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, Schmidt C, Van Aken H, Wempe C, Martens S, Zahn PK, Wolf B, Goebel U, Schwer CI, Rosenberger P, et al. ; RenalRIPC Investigators. Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA. 2015;313:2133&#x2013;2141. doi: 10.1001/jama.2015.4189</Citation><ArticleIdList><ArticleId IdType="pubmed">26024502</ArticleId></ArticleIdList></Reference><Reference><Citation>Meybohm P, Bein B, Brosteanu O, Cremer J, Gruenewald M, Stoppe C, Coburn M, Schaelte G, B&#xf6;ning A, Niemann B, et al. ; RIPHeart Study Collaborators. A multicenter trial of remote ischemic preconditioning for heart surgery. N Engl J Med. 2015;373:1397&#x2013;1407. doi: 10.1056/NEJMoa1413579</Citation><ArticleIdList><ArticleId IdType="pubmed">26436208</ArticleId></ArticleIdList></Reference><Reference><Citation>Hausenloy DJ, Candilio L, Evans R, Ariti C, Jenkins DP, Kolvekar S, Knight R, Kunst G, Laing C, Nicholas J, et al. ; ERICCA Trial Investigators. Remote ischemic preconditioning and outcomes of cardiac surgery. N Engl J Med. 2015;373:1408&#x2013;1417. doi: 10.1056/NEJMoa1413534</Citation><ArticleIdList><ArticleId IdType="pubmed">26436207</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J, Liu S, Jia P, Xu X, Song N, Zhang T, Chen R, Ding X. Protection of remote ischemic preconditioning against acute kidney injury: a systematic review and meta-analysis. Crit Care. 2016;20:111. doi: 10.1186/s13054-016-1272-y</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4837562</ArticleId><ArticleId IdType="pubmed">27095379</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolli R. Preconditioning: a paradigm shift in the biology of myocardial ischemia. Am J Physiol Heart Circ Physiol. 2007;292:H19&#x2013;H27. doi: 10.1152/ajpheart.00712.2006</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3242363</ArticleId><ArticleId IdType="pubmed">16963615</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolli R. The late phase of preconditioning. Circ Res. 2000;87:972&#x2013;983. doi: 10.1161/01.res.87.11.972</Citation><ArticleIdList><ArticleId IdType="pubmed">11090541</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim TK, Min JJ, Cho YJ, Hausenloy DJ, Ahn H, Kim KH, Hwang HY, Hong DM, Jeon Y. Effects of delayed remote ischemic preconditioning on peri-operative myocardial injury in patients undergoing cardiac surgery: a randomized controlled trial. Int J Cardiol. 2017;227:511&#x2013;515. doi: 10.1016/j.ijcard.2016.10.111</Citation><ArticleIdList><ArticleId IdType="pubmed">27839807</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang W, Teng J, Xu J, Shen B, Wang Y, Fang Y, Zou Z, Jin J, Zhuang Y, Liu L, et al. . Dynamic predictive scores for cardiac surgery-associated acute kidney injury. J Am Heart Assoc. 2016;5:e003754. doi: 10.1161/JAHA.116.003754</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5015294</ArticleId><ArticleId IdType="pubmed">27491837</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo H, Qi X, Shi H, Zhao H, Liu C, Chen H, Peng R, Yu Z, Hu K, Wang C, et al. . Single-dose del Nido cardioplegia used in adult minimally invasive valve surgery. J Thorac Dis. 2019;11:2373&#x2013;2382. doi: 10.21037/jtd.2019.05.78</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6626819</ArticleId><ArticleId IdType="pubmed">31372274</ArticleId></ArticleIdList></Reference><Reference><Citation>KDIGO AKI Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1&#x2013;138.</Citation></Reference><Reference><Citation>Hariri G, Collet L, Duarte L, Martin GL, Resche-Rigon M, Lebreton G, Bougl&#xe9; A, Dechartres A. Prevention of cardiac surgery-associated acute kidney injury: a systematic review and meta-analysis of non-pharmacological interventions. Crit Care. 2023;27:354. doi: 10.1186/s13054-023-04640-1</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10498585</ArticleId><ArticleId IdType="pubmed">37700297</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou C, Bulluck H, Fang N, Li L, Hausenloy DJ. Age and surgical complexity impact on renoprotection by remote ischemic preconditioning during adult cardiac surgery: a meta analysis. Sci Rep. 2017;7:215. doi: 10.1038/s41598-017-00308-3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5428278</ArticleId><ArticleId IdType="pubmed">28303021</ArticleId></ArticleIdList></Reference><Reference><Citation>Haji Mohd Yasin NA, Herbison P, Saxena P, Praporski S, Konstantinov IE. The role of remote ischemic preconditioning in organ protection after cardiac surgery: a meta-analysis. J Surg Res. 2014;186:207&#x2013;216. doi: 10.1016/j.jss.2013.09.006</Citation><ArticleIdList><ArticleId IdType="pubmed">24135377</ArticleId></ArticleIdList></Reference><Reference><Citation>Hausenloy DJ, Yellon DM. The second window of preconditioning (SWOP) where are we now? Cardiovasc Drugs Ther. 2010;24:235&#x2013;254. doi: 10.1007/s10557-010-6237-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20496105</ArticleId></ArticleIdList></Reference><Reference><Citation>Pei H, Zhou C. Cardiac or renal protection by delayed remote ischemic preconditioning in the clinical practice: potential additive effect from concurrent medications with pharmacological mimicking conditioning. Int J Cardiol. 2017;234:105&#x2013;106. doi: 10.1016/j.ijcard.2016.12.157</Citation><ArticleIdList><ArticleId IdType="pubmed">28043663</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Guo Y, Zhang SX, Wu WJ, Wang J, Bao W, Bolli R. Ischemic preconditioning upregulates inducible nitric oxide synthase in cardiac myocyte. J Mol Cell Cardiol. 2002;34:5&#x2013;15. doi: 10.1006/jmcc.2001.1482</Citation><ArticleIdList><ArticleId IdType="pubmed">11812160</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang JA, Kim J. Remote ischaemic preconditioning: translating cardiovascular benefits to humans. J Physiol. 2022;600:3053&#x2013;3067. doi: 10.1113/JP282568</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9327506</ArticleId><ArticleId IdType="pubmed">35596644</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner R, Piler P, Bedanova H, Adamek P, Grodecka L, Freiberger T. Myocardial injury is decreased by late remote ischaemic preconditioning and aggravated by tramadol in patients undergoing cardiac surgery: a randomised controlled trial. Interact Cardiovasc Thorac Surg. 2010;11:758&#x2013;762. doi: 10.1510/icvts.2010.243600</Citation><ArticleIdList><ArticleId IdType="pubmed">20847065</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerra GG, Joffe AR, Seal R, Phillipos E, Wong M, Moez EK, Dinu IA, Duff JP, Ross D, Rebeyka I, et al. . Pilot randomized controlled trial on early and late remote ischemic preconditioning prior to complex cardiac surgery in young infants. Paediatr Anaesth. 2017;27:433&#x2013;441. doi: 10.1111/pan.13125</Citation><ArticleIdList><ArticleId IdType="pubmed">28300357</ArticleId></ArticleIdList></Reference><Reference><Citation>Wever KE, Menting TP, Rovers M, van der Vliet JA, Rongen GA, Masereeuw R, Ritskes-Hoitinga M, Hooijmans CR, Warl&#xe9; M. Ischemic preconditioning in the animal kidney, a systematic review and meta-analysis. PLoS One. 2012;7:e32296. doi: 10.1371/journal.pone.0032296</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3289650</ArticleId><ArticleId IdType="pubmed">22389693</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan T, Jia P, Chen N, Fang Y, Liang Y, Guo M, Ding X. Delayed remote ischemic preconditioning confers renoprotection against septic acute kidney injury via exosomal miR-21. Theranostics. 2019;9:405&#x2013;423. doi: 10.7150/thno.29832</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6376188</ArticleId><ArticleId IdType="pubmed">30809283</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Chawla LS. Cell-cycle arrest and acute kidney injury: the light and the dark sides. Nephrol Dial Transplant. 2016;31:16&#x2013;22. doi: 10.1093/ndt/gfv130</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4703048</ArticleId><ArticleId IdType="pubmed">26044835</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Zou Z, Jin J, Teng J, Xu J, Shen B, Jiang W, Zhuang Y, Liu L, Luo Z, et al. . Urinary TIMP-2 and IGFBP7 for the prediction of acute kidney injury following cardiac surgery. BMC Nephrol. 2017;18:177. doi: 10.1186/s12882-017-0592-8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5450378</ArticleId><ArticleId IdType="pubmed">28558754</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Shen B, Cao X, Lu Z, Zhang Y, Zhu B, Zhang W, Shi Y, Wang J, Fang Y, et al. . Serum IGFBP7 deriving from spleen and lung could be used for early recognition of cardiac surgery-associated acute kidney injury. Cardiorenal Med. 2023;13:221&#x2013;231. doi: 10.1159/000531489</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10664329</ArticleId><ArticleId IdType="pubmed">37311433</ArticleId></ArticleIdList></Reference><Reference><Citation>Wetz AJ, Richardt EM, Wand S, Kunze N, Schotola H, Quintel M, Br&#xe4;uer A, Moerer O. Quantification of urinary TIMP-2 and IGFBP-7: an adequate diagnostic test to predict acute kidney injury after cardiac surgery? Crit Care. 2015;19:3. doi: 10.1186/s13054-014-0717-4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4310039</ArticleId><ArticleId IdType="pubmed">25560277</ArticleId></ArticleIdList></Reference><Reference><Citation>Irqsusi M, Beckers J, Wiesmann T, Talipov I, Ramzan R, Rastan AJ, Vogt S. Urinary TIMP-2 and IGFBP-7 protein levels as early predictors of acute kidney injury after cardiac surgery. J Card Surg. 2022;37:717&#x2013;724. doi: 10.1111/jocs.16200</Citation><ArticleIdList><ArticleId IdType="pubmed">35001430</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayan A, Faubel S, Askenazi DJ, Cerda J, Fissell WH, Heung M, Humphreys BD, Koyner JL, Liu KD, Mour G, et al. ; American Society of Nephrology Acute Kidney Injury Advisory Group. Clinical use of the urine biomarker [TIMP-2] &#xd7; [IGFBP7] for acute kidney injury risk assessment. Am J Kidney Dis. 2016;68:19&#x2013;28. doi: 10.1053/j.ajkd.2015.12.033</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4921267</ArticleId><ArticleId IdType="pubmed">26948834</ArticleId></ArticleIdList></Reference><Reference><Citation>Honore PM, Jacobs R, Spapen HD. Remote ischemic preconditioning to prevent cardiac surgery-related acute kidney injury: how far away from a breakthrough? Ann Transl Med. 2016;4:314. doi: 10.21037/atm.2016.08.10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5009019</ArticleId><ArticleId IdType="pubmed">27668234</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiber A, Ravid T. Chaperoning proteins for destruction: diverse roles of Hsp70 chaperones and their co-chaperones in targeting misfolded proteins to the proteasome. Biomolecules. 2014;4:704&#x2013;724. doi: 10.3390/biom4030704</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4192669</ArticleId><ArticleId IdType="pubmed">25036888</ArticleId></ArticleIdList></Reference><Reference><Citation>Stankiewicz AR, Lachapelle G, Foo CP, Radicioni SM, Mosser DD. Hsp70 inhibits heat-induced apoptosis upstream of mitochondria by preventing Bax translocation. J Biol Chem. 2005;280:38729&#x2013;38739. doi: 10.1074/jbc.M509497200</Citation><ArticleIdList><ArticleId IdType="pubmed">16172114</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong Z, Dong H, Wu Y, Zhou S, Li H, Huang P, Tian H, Li X, Xiao H, Yang T, et al. . Remote ischemic preconditioning enhances aerobic performance by accelerating regional oxygenation and improving cardiac function during acute hypobaric hypoxia exposure. Front Physiol. 2022;13:950086. doi: 10.3389/fphys.2022.950086</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9500473</ArticleId><ArticleId IdType="pubmed">36160840</ArticleId></ArticleIdList></Reference><Reference><Citation>Thielmann M, Kottenberg E, Kleinbongard P, Wendt D, Gedik N, Pasa S, Price V, Tsagakis K, Neuh&#xe4;user M, Peters J, et al. . Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial. Lancet. 2013;382:597&#x2013;604. doi: 10.1016/S0140-6736(13)61450-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23953384</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaugg M, Lucchinetti E. Remote ischemic preconditioning in cardiac surgery: ineffective and risky? N Engl J Med. 2015;373:1470&#x2013;1472. doi: 10.1056/NEJMe1510338</Citation><ArticleIdList><ArticleId IdType="pubmed">26436209</ArticleId></ArticleIdList></Reference><Reference><Citation>Kottenberg E, Musiolik J, Thielmann M, Jakob H, Peters J, Heusch G. Interference of propofol with signal transducer and activator of transcription 5 activation and cardioprotection by remote ischemic preconditioning during coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2014;147:376&#x2013;382. doi: 10.1016/j.jtcvs.2013.01.005</Citation><ArticleIdList><ArticleId IdType="pubmed">23465551</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaugg M, Lucchinetti E, Clanachan A, Finegan B. Remote ischemic preconditioning is redundant in patients undergoing coronary artery bypass graft surgery who are already protected by volatile anesthetics. Circ Res. 2012;110:e42&#x2013;e43. doi: 10.1161/CIRCRESAHA.112.265116</Citation><ArticleIdList><ArticleId IdType="pubmed">22383713</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucchinetti E, Bestmann L, Feng J, Freidank H, Clanachan AS, Finegan BA, Zaugg M. Remote ischemic preconditioning applied during isoflurane inhalation provides no benefit to the myocardium of patients undergoing on-pump coronary artery bypass graft surgery: lack of synergy or evidence of antagonism in cardioprotection? Anesthesiology. 2012;116:296&#x2013;310. doi: 10.1097/ALN.0b013e318242349a</Citation><ArticleIdList><ArticleId IdType="pubmed">22222469</ArticleId></ArticleIdList></Reference><Reference><Citation>Kehl F, Pagel PS, Krolikowski JG, Gu W, Toller W, Wartltier DC, Kersten JR. Isoflurane does not produce a second window of preconditioning against myocardial infarction in vivo. Anest Analg. 2002;95:1162&#x2013;1168.</Citation><ArticleIdList><ArticleId IdType="pubmed">12401584</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30685166</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-685X</ISSN><JournalIssue CitedMedium="Internet"><Volume>157</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The Journal of thoracic and cardiovascular surgery</Title><ISOAbbreviation>J Thorac Cardiovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Intravenous amino acid therapy for kidney protection in cardiac surgery patients: A pilot randomized controlled trial.</ArticleTitle><Pagination><StartPage>2356</StartPage><EndPage>2366</EndPage><MedlinePgn>2356-2366</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jtcvs.2018.11.097</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-5223(18)33243-4</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To determine whether a continuous intravenous infusion of standard amino acids could preserve kidney function after on-pump cardiac surgery.</AbstractText><AbstractText Label="METHODS">Adult patients scheduled to receive cardiac surgery lasting longer than 1&#xa0;hour on-pump were randomized to standard care (n&#xa0;=&#xa0;36) or an infusion of amino acids initiated immediately after induction of anesthesia (n&#xa0;=&#xa0;33). The study's primary outcome measurements assessed renal function. These assessments included duration of renal dysfunction, duration and severity of acute kidney injury (AKI), estimated glomerular filtration rate (eGFR) over time, urine output, and use of renal-replacement therapy. Complications and other measures of morbidity were also assessed.</AbstractText><AbstractText Label="RESULTS">Sixty-nine patients (mean age 71.5 [standard deviation 9.2] years; 19 of 69 women) were enrolled and randomized. Patients received coronary artery bypass graft surgery (37/69), valve surgery (24/69), coronary artery bypass graft and valve surgery (6/69), or other procedures (2/69). Mean on-pump time was 268 [standard deviation 136] minutes. Duration of renal dysfunction did not differ between the groups (relative risk, 0.86; 95% confidence interval [CI], 0.19-3.79, P&#xa0;=&#xa0;.84). However, patients who received the amino acid infusion had a reduced duration of AKI (relative risk, 0.02; 95% CI, 0.005-0.11, P&#xa0;&lt;&#xa0;.0001) and greater eGFR (+10.8%; 95% CI, 1.0%-20.8%, P&#xa0;=&#xa0;.033). Daily mean urine output was also significantly greater in patients who received the amino acid infusion (1.4&#xa0;&#xb1;&#xa0;0.5 vs 1.7&#xa0;&#xb1;&#xa0;0.9&#xa0;L/d; P&#xa0;=&#xa0;.046).</AbstractText><AbstractText Label="CONCLUSIONS">Commencing an infusion of standard amino acids immediately after the induction of anesthesia did not alter duration of renal dysfunction; however, other key measures of renal function (duration of AKI, eGFR and urine output) were significantly improved. These results warrant replication in multicenter clinical trials.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 The American Association for Thoracic Surgery. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pu</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Northern Clinical School Intensive Care Research Unit, Sydney Medical School, University of Sydney, Sydney, Australia; Department of Critical Care Medicine, Sichuan Academy of Medical Sciences &amp; Sichuan Provincial People's Hospital, Chengdu, Peoples Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doig</LastName><ForeName>Gordon S</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Northern Clinical School Intensive Care Research Unit, Sydney Medical School, University of Sydney, Sydney, Australia. Electronic address: gdoig@med.usyd.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heighes</LastName><ForeName>Philippa T</ForeName><Initials>PT</Initials><AffiliationInfo><Affiliation>Northern Clinical School Intensive Care Research Unit, Sydney Medical School, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allingstrup</LastName><ForeName>Matilde J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Northern Clinical School Intensive Care Research Unit, Sydney Medical School, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Andy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Northern Clinical School, Sydney Medical School, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brereton</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Northern Clinical School, Sydney Medical School, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pollock</LastName><ForeName>Carol</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Northern Clinical School, Sydney Medical School, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chesher</LastName><ForeName>Douglas</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>New South Wales Health, Pathology, St. Leonards, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia; School of Medicine, University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Thorac Cardiovasc Surg</MedlineTA><NlmUniqueID>0376343</NlmUniqueID><ISSNLinking>0022-5223</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000596">Amino Acids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Thorac Cardiovasc Surg. 2019 Jun;157(6):2367-2368. doi: 10.1016/j.jtcvs.2018.11.122.</RefSource><PMID Version="1">30685168</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000596" MajorTopicYN="N">Amino Acids</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005919" MajorTopicYN="N">Glomerular Filtration Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007262" MajorTopicYN="N">Infusions, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="N">Renal Replacement Therapy</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">amino acids</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">pilot</Keyword><Keyword MajorTopicYN="N">randomized controlled trial</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>5</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>11</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30685166</ArticleId><ArticleId IdType="doi">10.1016/j.jtcvs.2018.11.097</ArticleId><ArticleId IdType="pii">S0022-5223(18)33243-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39110454</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>09</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2168-6262</ISSN><JournalIssue CitedMedium="Internet"><Volume>159</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA surgery</Title><ISOAbbreviation>JAMA Surg</ISOAbbreviation></Journal><ArticleTitle>Intraoperative Oxygen Treatment, Oxidative Stress, and Organ Injury Following Cardiac Surgery: A Randomized Clinical Trial.</ArticleTitle><Pagination><StartPage>1106</StartPage><EndPage>1116</EndPage><MedlinePgn>1106-1116</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamasurg.2024.2906</ELocationID><Abstract><AbstractText Label="IMPORTANCE" NlmCategory="UNASSIGNED">Liberal oxygen (hyperoxia) is commonly administered to patients during surgery, and oxygenation is known to impact mechanisms of perioperative organ injury.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To evaluate the effect of intraoperative hyperoxia compared to maintaining normoxia on oxidative stress, kidney injury, and other organ dysfunctions after cardiac surgery.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS" NlmCategory="UNASSIGNED">This was a participant- and assessor-blinded, randomized clinical trial conducted from April 2016 to October 2020 with 1 year of follow-up at a single tertiary care medical center. Adult patients (&gt;18 years) presenting for elective open cardiac surgery without preoperative oxygen requirement, acute coronary syndrome, carotid stenosis, or dialysis were included. Of 3919 patients assessed, 2501 were considered eligible and 213 provided consent. Of these, 12 were excluded prior to randomization and 1 following randomization whose surgery was cancelled, leaving 100 participants in each group.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="UNASSIGNED">Participants were randomly assigned to hyperoxia (1.00 fraction of inspired oxygen [FiO2]) or normoxia (minimum FiO2 to maintain oxygen saturation 95%-97%) throughout surgery.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES" NlmCategory="UNASSIGNED">Participants were assessed for oxidative stress by measuring F2-isoprostanes and isofurans, for acute kidney injury (AKI), and for delirium, myocardial injury, atrial fibrillation, and additional secondary outcomes. Participants were monitored for 1 year following surgery.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Two hundred participants were studied (median [IQR] age, 66 [59-72] years; 140 male and 60 female; 82 [41.0%] with diabetes). F2-isoprostanes and isofurans (primary mechanistic end point) increased on average throughout surgery, from a median (IQR) of 73.3 (53.1-101.1) pg/mL at baseline to a peak of 85.5 (64.0-109.8) pg/mL at admission to the intensive care unit and were 9.2 pg/mL (95% CI, 1.0-17.4; P&#x2009;=&#x2009;.03) higher during surgery in patients assigned to hyperoxia. Median (IQR) change in serum creatinine (primary clinical end point) from baseline to postoperative day 2 was 0.01 mg/dL (-0.12 to 0.19) in participants assigned hyperoxia and -0.01 mg/dL (-0.16 to 0.19) in those assigned normoxia (median difference, 0.03; 95% CI, -0.04 to 0.10; P&#x2009;=&#x2009;.45). AKI occurred in 21 participants (21%) in each group. Intraoperative oxygen treatment did not affect additional acute organ injuries, safety events, or kidney, neuropsychological, and functional outcomes at 1 year.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Among adults receiving cardiac surgery, intraoperative hyperoxia increased intraoperative oxidative stress compared to normoxia but did not affect kidney injury or additional measurements of organ injury including delirium, myocardial injury, and atrial fibrillation.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="UNASSIGNED">ClinicalTrials.gov Identifier: NCT02361944.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lopez</LastName><ForeName>Marcos G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center and Vanderbilt University School of Medicine, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shotwell</LastName><ForeName>Matthew S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Vanderbilt University Medical Center and Vanderbilt University School of Medicine, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hennessy</LastName><ForeName>Cassandra</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Vanderbilt University Medical Center and Vanderbilt University School of Medicine, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pretorius</LastName><ForeName>Mias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center and Vanderbilt University School of Medicine, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McIlroy</LastName><ForeName>David R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center and Vanderbilt University School of Medicine, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kimlinger</LastName><ForeName>Melissa J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Vanderbilt University Medical Center and Vanderbilt University School of Medicine, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mace</LastName><ForeName>Eric H</ForeName><Initials>EH</Initials><AffiliationInfo><Affiliation>Department of Surgery, Vanderbilt University Medical Center and Vanderbilt University School of Medicine, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Absi</LastName><ForeName>Tarek</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Vanderbilt University Medical Center and Vanderbilt University School of Medicine, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Ashish S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Vanderbilt University Medical Center and Vanderbilt University School of Medicine, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Nancy J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, Vanderbilt University Medical Center and Vanderbilt University School of Medicine, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Billings</LastName><ForeName>Frederic T</ForeName><Initials>FT</Initials><Suffix>4th</Suffix><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center and Vanderbilt University School of Medicine, Nashville, Tennessee.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Vanderbilt University Medical Center and Vanderbilt University School of Medicine, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>ROCS trial investigators</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02361944</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR000445</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM145375</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 GM129662</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM112871</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM108554</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Surg</MedlineTA><NlmUniqueID>101589553</NlmUniqueID><ISSNLinking>2168-6254</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>JAMA Surg. 2024 Oct 1;159(10):1116. doi: 10.1001/jamasurg.2024.2921.</RefSource><PMID Version="1">39110430</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="Y">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018496" MajorTopicYN="Y">Hyperoxia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010102" MajorTopicYN="N">Oxygen Inhalation Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007430" MajorTopicYN="N">Intraoperative Care</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Brown reported serving as science advisory board member for Alnylam Pharmaceuticals and eStar Biotech outside the submitted work. Dr Billings reported grants from the National Institutes of Health outside the submitted work. No other disclosures were reported.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Deegan</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eagle</LastName><ForeName>Susan S</ForeName><Initials>SS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hernandez</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gelfand</LastName><ForeName>Brian J</ForeName><Initials>BJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kertai</LastName><ForeName>Miklos D</ForeName><Initials>MD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kingeter</LastName><ForeName>Meredith</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>LeFevre</LastName><ForeName>Ryan</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lombard</LastName><ForeName>Frederic W</ForeName><Initials>FW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mantinan</LastName><ForeName>Michael F</ForeName><Initials>MF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mishra</LastName><ForeName>Kelly K</ForeName><Initials>KK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shaw</LastName><ForeName>Andrew D</ForeName><Initials>AD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Siegrist</LastName><ForeName>Kara K</ForeName><Initials>KK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sileshi</LastName><ForeName>Ban</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Freundlich</LastName><ForeName>Robert E</ForeName><Initials>RE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wanderer</LastName><ForeName>Jonathan P</ForeName><Initials>JP</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>7</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>7</Day><Hour>11</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39110454</ArticleId><ArticleId IdType="pmc">PMC11307166</ArticleId><ArticleId IdType="doi">10.1001/jamasurg.2024.2906</ArticleId><ArticleId IdType="pii">2821958</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hu J, Chen R, Liu S, Yu X, Zou J, Ding X. Global incidence and outcomes of adult patients with acute kidney injury after cardiac surgery: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth. 2016;30(1):82-89. doi: 10.1053/j.jvca.2015.06.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2015.06.017</ArticleId><ArticleId IdType="pubmed">26482484</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown CH IV, Probert J, Healy R, et al. Cognitive decline after delirium in patients undergoing cardiac surgery. Anesthesiology. 2018;129(3):406-416. doi: 10.1097/ALN.0000000000002253</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000002253</ArticleId><ArticleId IdType="pmc">PMC6513020</ArticleId><ArticleId IdType="pubmed">29771710</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadava M, Hughey AB, Crawford TC. Postoperative atrial fibrillation: incidence, mechanisms, and clinical correlates. Heart Fail Clin. 2016;12(2):299-308. doi: 10.1016/j.hfc.2015.08.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hfc.2015.08.023</ArticleId><ArticleId IdType="pubmed">26968672</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandharipande PP, Girard TD, Jackson JC, et al. ; BRAIN-ICU Study Investigators . Long-term cognitive impairment after critical illness. N Engl J Med. 2013;369(14):1306-1316. doi: 10.1056/NEJMoa1301372</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1301372</ArticleId><ArticleId IdType="pmc">PMC3922401</ArticleId><ArticleId IdType="pubmed">24088092</ArticleId></ArticleIdList></Reference><Reference><Citation>LaPar DJ, Speir AM, Crosby IK, et al. ; Investigators for the Virginia Cardiac Surgery Quality Initiative . Postoperative atrial fibrillation significantly increases mortality, hospital readmission, and hospital costs. Ann Thorac Surg. 2014;98(2):527-533. doi: 10.1016/j.athoracsur.2014.03.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2014.03.039</ArticleId><ArticleId IdType="pubmed">25087786</ArticleId></ArticleIdList></Reference><Reference><Citation>Loef BG, Epema AH, Smilde TD, et al. Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J Am Soc Nephrol. 2005;16(1):195-200. https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=15563558. doi: 10.1681/ASN.2003100875
</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2003100875</ArticleId><ArticleId IdType="pubmed">15563558</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FT IV, Pretorius M, Schildcrout JS, et al. Obesity and oxidative stress predict AKI after cardiac surgery. J Am Soc Nephrol. 2012;23(7):1221-1228. doi: 10.1681/ASN.2011090940</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2011090940</ArticleId><ArticleId IdType="pmc">PMC3380645</ArticleId><ArticleId IdType="pubmed">22626819</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez MG, Pandharipande P, Morse J, et al. Intraoperative cerebral oxygenation, oxidative injury, and delirium following cardiac surgery. Free Radic Biol Med. 2017;103:192-198. doi: 10.1016/j.freeradbiomed.2016.12.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2016.12.039</ArticleId><ArticleId IdType="pmc">PMC5258679</ArticleId><ArticleId IdType="pubmed">28039082</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez MG, Hughes CG, DeMatteo A, et al. Intraoperative oxidative damage and delirium after cardiac surgery. Anesthesiology. 2020;132(3):551-561. doi: 10.1097/ALN.0000000000003016</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003016</ArticleId><ArticleId IdType="pmc">PMC7015795</ArticleId><ArticleId IdType="pubmed">31770146</ArticleId></ArticleIdList></Reference><Reference><Citation>Eltzschig HK, Eckle T. Ischemia and reperfusion&#x2013;from mechanism to translation. Nat Med. 2011;17(11):1391-1401. doi: 10.1038/nm.2507</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2507</ArticleId><ArticleId IdType="pmc">PMC3886192</ArticleId><ArticleId IdType="pubmed">22064429</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh M, Devereaux PJ, Garg AX, et al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology. 2013;119(3):507-515. doi: 10.1097/ALN.0b013e3182a10e26</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3182a10e26</ArticleId><ArticleId IdType="pubmed">23835589</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenthal G, Hemphill JC III, Sorani M, et al. Brain tissue oxygen tension is more indicative of oxygen diffusion than oxygen delivery and metabolism in patients with traumatic brain injury. Crit Care Med. 2008;36(6):1917-1924. doi: 10.1097/CCM.0b013e3181743d77</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181743d77</ArticleId><ArticleId IdType="pubmed">18496376</ArticleId></ArticleIdList></Reference><Reference><Citation>Nortje J, Coles JP, Timofeev I, et al. Effect of hyperoxia on regional oxygenation and metabolism after severe traumatic brain injury: preliminary findings. Crit Care Med. 2008;36(1):273-281. doi: 10.1097/01.CCM.0000292014.60835.15</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000292014.60835.15</ArticleId><ArticleId IdType="pubmed">18090356</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattishent K, Thavarajah M, Sinha A, et al. Safety of 80% vs 30-35% fraction of inspired oxygen in patients undergoing surgery: a systematic review and meta-analysis. Br J Anaesth. 2019;122(3):311-324. doi: 10.1016/j.bja.2018.11.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2018.11.026</ArticleId><ArticleId IdType="pubmed">30770049</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman DL, Brookes PS. Oxygen sensitivity of mitochondrial reactive oxygen species generation depends on metabolic conditions. J Biol Chem. 2009;284(24):16236-16245. doi: 10.1074/jbc.M809512200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M809512200</ArticleId><ArticleId IdType="pmc">PMC2713566</ArticleId><ArticleId IdType="pubmed">19366681</ArticleId></ArticleIdList></Reference><Reference><Citation>Mace EH, Kimlinger MJ, No TJ, et al. Soluble guanylyl cyclase activation rescues hyperoxia-induced dysfunction of vascular relaxation. Shock. 2022;58(4):280-286. doi: 10.1097/SHK.0000000000001982</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0000000000001982</ArticleId><ArticleId IdType="pmc">PMC9588649</ArticleId><ArticleId IdType="pubmed">36018251</ArticleId></ArticleIdList></Reference><Reference><Citation>Reilly MP, Delanty N, Roy L, et al. Increased formation of the isoprostanes IPF2alpha-I and 8-epi-prostaglandin F2alpha in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans. Circulation. 1997;96(10):3314-3320. doi: 10.1161/01.CIR.96.10.3314</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.96.10.3314</ArticleId><ArticleId IdType="pubmed">9396422</ArticleId></ArticleIdList></Reference><Reference><Citation>Chouchani ET, Pell VR, Gaude E, et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 2014;515(7527):431-435. doi: 10.1038/nature13909</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13909</ArticleId><ArticleId IdType="pmc">PMC4255242</ArticleId><ArticleId IdType="pubmed">25383517</ArticleId></ArticleIdList></Reference><Reference><Citation>McIlroy DR, Shotwell MS, Lopez MG, et al. ; Multicenter Perioperative Outcomes Group . Oxygen administration during surgery and postoperative organ injury: observational cohort study. BMJ. 2022;379:e070941. doi: 10.1136/bmj-2022-070941</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-070941</ArticleId><ArticleId IdType="pmc">PMC9710248</ArticleId><ArticleId IdType="pubmed">36450405</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez MG, Pretorius M, Shotwell MS, et al. The Risk of Oxygen During Cardiac Surgery (ROCS) trial: study protocol for a randomized clinical trial. Trials. 2017;18(1):295. doi: 10.1186/s13063-017-2021-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-017-2021-5</ArticleId><ArticleId IdType="pmc">PMC5485572</ArticleId><ArticleId IdType="pubmed">28651648</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadiiska MB, Gladen BC, Baird DD, et al. Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?
Free Radic Biol Med. 2005;38(6):698-710. https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=15721980. doi: 10.1016/j.freeradbiomed.2004.09.017
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2004.09.017</ArticleId><ArticleId IdType="pubmed">15721980</ArticleId></ArticleIdList></Reference><Reference><Citation>Milne GL, Sanchez SC, Musiek ES, Morrow JD. Quantification of F2-isoprostanes as a biomarker of oxidative stress. Nat Protoc. 2007;2(1):221-226. https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17401357. doi: 10.1038/nprot.2006.375
</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2006.375</ArticleId><ArticleId IdType="pubmed">17401357</ArticleId></ArticleIdList></Reference><Reference><Citation>KDIGO AKI Work Group . KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1-138.</Citation></Reference><Reference><Citation>Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365(9466):1231-1238. doi: 10.1016/S0140-6736(05)74811-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(05)74811-X</ArticleId><ArticleId IdType="pubmed">15811456</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings JJ, Shaw AD, Shi J, Lopez MG, O&#x2019;Neal JB, Billings FT IV. Intraoperative prediction of cardiac surgery-associated acute kidney injury using urinary biomarkers of cell cycle arrest. J Thorac Cardiovasc Surg. 2019;157(4):1545-1553.e5. doi: 10.1016/j.jtcvs.2018.08.090</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2018.08.090</ArticleId><ArticleId IdType="pmc">PMC6431272</ArticleId><ArticleId IdType="pubmed">30389130</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashani K, Al-Khafaji A, Ardiles T, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013;17(1):R25. doi: 10.1186/cc12503</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc12503</ArticleId><ArticleId IdType="pmc">PMC4057242</ArticleId><ArticleId IdType="pubmed">23388612</ArticleId></ArticleIdList></Reference><Reference><Citation>Ely EW, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA. 2001;286(21):2703-2710. doi: 10.1001/jama.286.21.2703</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.286.21.2703</ArticleId><ArticleId IdType="pubmed">11730446</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindroth H, Khan BA, Carpenter JS, et al. Delirium severity trajectories and outcomes in ICU patients. defining a dynamic symptom phenotype. Ann Am Thorac Soc. 2020;17(9):1094-1103. doi: 10.1513/AnnalsATS.201910-764OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.201910-764OC</ArticleId><ArticleId IdType="pmc">PMC7462321</ArticleId><ArticleId IdType="pubmed">32383964</ArticleId></ArticleIdList></Reference><Reference><Citation>Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H. Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. Am J Psychiatry. 1983;140(6):734-739. doi: 10.1176/ajp.140.6.734</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/ajp.140.6.734</ArticleId><ArticleId IdType="pubmed">6846631</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FT IV, Hendricks PA, Schildcrout JS, et al. High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial. JAMA. 2016;315(9):877-888. doi: 10.1001/jama.2016.0548</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0548</ArticleId><ArticleId IdType="pmc">PMC4843765</ArticleId><ArticleId IdType="pubmed">26906014</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer DF. Constructing confidence sets using rank statistics. J Am Stat Assoc. 1972;67(339):687-690. doi: 10.1080/01621459.1972.10481279</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01621459.1972.10481279</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagerland MW, Lydersen S, Laake P. Recommended confidence intervals for two independent binomial proportions. Stat Methods Med Res. 2015;24(2):224-254. doi: 10.1177/0962280211415469</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280211415469</ArticleId><ArticleId IdType="pubmed">21996567</ArticleId></ArticleIdList></Reference><Reference><Citation>Althouse AD. Adjust for multiple comparisons? it&#x2019;s not that simple. Ann Thorac Surg. 2016;101(5):1644-1645. doi: 10.1016/j.athoracsur.2015.11.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2015.11.024</ArticleId><ArticleId IdType="pubmed">27106412</ArticleId></ArticleIdList></Reference><Reference><Citation>Feise RJ. Do multiple outcome measures require <i>P</i> value adjustment?
BMC Med Res Methodol. 2002;2:8. doi: 10.1186/1471-2288-2-8
</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-2-8</ArticleId><ArticleId IdType="pmc">PMC117123</ArticleId><ArticleId IdType="pubmed">12069695</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006;1(1):19-32. https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17699187. doi: 10.2215/CJN.00240605
</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.00240605</ArticleId><ArticleId IdType="pubmed">17699187</ArticleId></ArticleIdList></Reference><Reference><Citation>McGuinness SP, Parke RL, Drummond K, et al. ; SO-COOL investigators . A multicenter, randomized, controlled phase IIB trial of avoidance of hyperoxemia during cardiopulmonary bypass. Anesthesiology. 2016;125(3):465-473. doi: 10.1097/ALN.0000000000001226</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001226</ArticleId><ArticleId IdType="pubmed">27404222</ArticleId></ArticleIdList></Reference><Reference><Citation>Nam K, Nam JS, Kim HB, et al. ; Cardiac Surgery and Oxygen Therapy (CARROT) Investigators . Effects of intraoperative inspired oxygen fraction (FiO<sub>2</sub> 0.3 vs 0.8) on patients undergoing off-pump coronary artery bypass grafting: the CARROT multicenter, cluster-randomized trial. Crit Care. 2023;27(1):286. doi: 10.1186/s13054-023-04558-8
</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-023-04558-8</ArticleId><ArticleId IdType="pmc">PMC10339585</ArticleId><ArticleId IdType="pubmed">37443130</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaefi S, Shankar P, Mueller AL, et al. Intraoperative oxygen concentration and neurocognition after cardiac surgery. Anesthesiology. 2021;134(2):189-201. doi: 10.1097/ALN.0000000000003650</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003650</ArticleId><ArticleId IdType="pmc">PMC7855826</ArticleId><ArticleId IdType="pubmed">33331902</ArticleId></ArticleIdList></Reference><Reference><Citation>Holse C, Aasvang EK, Vester-Andersen M, et al. ; VIXIE Trial Group . Hyperoxia and antioxidants for myocardial injury in noncardiac surgery: a 2&#x2009;&#xd7;&#x2009;2 factorial, blinded, randomized clinical trial. Anesthesiology. 2022;136(3):408-419. doi: 10.1097/ALN.0000000000004117</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000004117</ArticleId><ArticleId IdType="pubmed">35120193</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36925330</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>130</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Norepinephrine versus phenylephrine for treating hypotension during general anaesthesia in adult patients undergoing major noncardiac surgery: a multicentre, open-label, cluster-randomised, crossover, feasibility, and pilot trial.</ArticleTitle><Pagination><StartPage>519</StartPage><EndPage>527</EndPage><MedlinePgn>519-527</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2023.02.004</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(23)00062-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">Intraoperative hypotension is associated with postoperative complications. The use of vasopressors is often required to correct hypotension but the best vasopressor is unknown.</AbstractText><AbstractText Label="METHODS">A multicentre, cluster-randomised, crossover, feasibility and pilot trial was conducted across five hospitals in California. Phenylephrine (PE) vs norepinephrine (NE) infusion as the first-line vasopressor in patients under general anaesthesia alternated monthly at each hospital for 6 months. The primary endpoint was first-line vasopressor administration compliance of 80% or higher. Secondary endpoints were acute kidney injury (AKI), 30-day mortality, myocardial injury after noncardiac surgery (MINS), hospital length of stay, and rehospitalisation within 30 days.</AbstractText><AbstractText Label="RESULTS">A total of 3626 patients were enrolled over 6 months; 1809 patients were randomised in the NE group, 1817 in the PE group. Overall, 88.2% received the assigned first-line vasopressor. No drug infiltrations requiring treatment were reported in either group. Patients were median 63 yr old, 50% female, and 58% white. Randomisation in the NE group vs PE group did not reduce readmission within 30 days (adjusted odds ratio=0.92; 95% confidence interval, 0.6-1.39), 30-day mortality (1.01; 0.48-2.09), AKI (1.1; 0.92-1.31), or MINS (1.63; 0.84-3.16).</AbstractText><AbstractText Label="CONCLUSIONS">A large and diverse population undergoing major surgery under general anaesthesia was successfully enrolled and randomised to receive NE or PE infusion. This pilot and feasibility trial was not powered for adverse postoperative outcomes and a follow-up multicentre effectiveness trial is planned.</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION">NCT04789330 (ClinicalTrials.gov).</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Legrand</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA; INI-CRCT Network, Nancy, France. Electronic address: Matthieu.Legrand@ucsf.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kothari</LastName><ForeName>Rishi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA; Department of Anesthesiology and Perioperative Medicine, Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fong</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA; School of Medicine, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palaniappa</LastName><ForeName>Nandini</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boldt</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, Los Angeles, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Lee-Lynn</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurien</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gabel</LastName><ForeName>Eilon</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, Los Angeles, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sturgess-DaPrato</LastName><ForeName>Jillene</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harhay</LastName><ForeName>Michael O</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pirracchio</LastName><ForeName>Romain</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bokoch</LastName><ForeName>Michael P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>VEGA-1 trial investigators</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04789330</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>1WS297W6MV</RegistryNumber><NameOfSubstance UI="D010656">Phenylephrine</NameOfSubstance></Chemical><Chemical><RegistryNumber>X4W3ENH1CV</RegistryNumber><NameOfSubstance UI="D009638">Norepinephrine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010656" MajorTopicYN="N">Phenylephrine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009638" MajorTopicYN="N">Norepinephrine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="N">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">cluster-randomised crossover trial</Keyword><Keyword MajorTopicYN="N">intraoperative hypotension</Keyword><Keyword MajorTopicYN="N">noncardiac surgery</Keyword><Keyword MajorTopicYN="N">norepinephrine</Keyword><Keyword MajorTopicYN="N">phenylephrine</Keyword><Keyword MajorTopicYN="N">postoperative outcomes</Keyword><Keyword MajorTopicYN="N">vasopressor</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>16</Day><Hour>23</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36925330</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2023.02.004</ArticleId><ArticleId IdType="pii">S0007-0912(23)00062-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38445452</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-9159</ISSN><JournalIssue CitedMedium="Internet"><Volume>110</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of surgery (London, England)</Title><ISOAbbreviation>Int J Surg</ISOAbbreviation></Journal><ArticleTitle>Development of interpretable machine learning models for prediction of acute kidney injury after noncardiac surgery: a retrospective cohort study.</ArticleTitle><Pagination><StartPage>2950</StartPage><EndPage>2962</EndPage><MedlinePgn>2950-2962</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/JS9.0000000000001237</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Early identification of patients at high-risk of postoperative acute kidney injury (AKI) can facilitate the development of preventive approaches. This study aimed to develop prediction models for postoperative AKI in noncardiac surgery using machine learning algorithms. The authors also evaluated the predictive performance of models that included only preoperative variables or only important predictors.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Adult patients undergoing noncardiac surgery were retrospectively included in the study (76&#xa0;457 patients in the discovery cohort and 11&#xa0;910 patients in the validation cohort). AKI was determined using the KDIGO criteria. The prediction model was developed using 87 variables (56 preoperative variables and 31 intraoperative variables). A variety of machine learning algorithms were employed to develop the model, including logistic regression, random forest, extreme gradient boosting, and gradient boosting decision trees. The performance of different models was compared using the area under the receiver operating characteristic curve (AUROC). Shapley Additive Explanations (SHAP) analysis was employed for model interpretation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The patients in the discovery cohort had a median age of 52 years (IQR: 42-61 years), and 1179 patients (1.5%) developed AKI after surgery. The gradient boosting decision trees algorithm showed the best predictive performance using all available variables, or only preoperative variables. The AUROCs were 0.849 (95% CI: 0.835-0.863) and 0.828 (95% CI: 0.813-0.843), respectively. The SHAP analysis showed that age, surgical duration, preoperative serum creatinine, and gamma-glutamyltransferase, as well as American Society of Anesthesiologists physical status III were the most important five features. When gradually reducing the features, the AUROCs decreased from 0.852 (including the top 40 features) to 0.839 (including the top 10 features). In the validation cohort, the authors observed a similar pattern regarding the models' predictive performance.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The machine learning models the authors developed had satisfactory predictive performance for identifying high-risk postoperative AKI patients. Furthermore, the authors found that model performance was only slightly affected when only preoperative variables or only the most important predictive features were included.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Rao</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shiyong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Yuna</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Yidu Cloud Technology Inc, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Liu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Health Management Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Qiaoqiao</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhan</LastName><ForeName>Gaofeng</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Xu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Yuqin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Yidu Cloud Technology Inc, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xinhua</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Ailin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Zhiqiang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT06146829</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Surg</MedlineTA><NlmUniqueID>101228232</NlmUniqueID><ISSNLinking>1743-9159</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>15</Day><Hour>23</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>6</Day><Hour>4</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38445452</ArticleId><ArticleId IdType="pmc">PMC11093510</ArticleId><ArticleId IdType="doi">10.1097/JS9.0000000000001237</ArticleId><ArticleId IdType="pii">01279778-202405000-00050</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pang Z, Liang S, Xing M, et al. . The correlation of intraoperative oliguria with acute kidney injury after noncardiac surgery: a systematic review and meta-analysis. Int J Surg 2023;109:449&#x2013;457.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10389605</ArticleId><ArticleId IdType="pubmed">36912515</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun R, Zhou Z, Li X, et al. . Prognostic significance of preoperative nutritional status for postoperative acute kidney injury in older patients undergoing major abdominal surgery: a retrospective cohort study. Int J Surg 2024;110:873&#x2013;883.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10871641</ArticleId><ArticleId IdType="pubmed">37921644</ArticleId></ArticleIdList></Reference><Reference><Citation>French WB, Shah PR, Fatani YI, et al. . Mortality and costs associated with acute kidney injury following major elective, non-cardiac surgery. J Clin Anesth 2022;82:110933.</Citation><ArticleIdList><ArticleId IdType="pubmed">35933842</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok V, Nixon J, Hu J, et al. . The impact of perioperative acute kidney injury/failure on short and long surgical outcomes. Anesthesiol Perioperat Sci 2023;1:9.</Citation></Reference><Reference><Citation>Hoste EA, Bagshaw SM, Bellomo R, et al. . Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 2015;41:1411&#x2013;1423.</Citation><ArticleIdList><ArticleId IdType="pubmed">26162677</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamout F, Zhu T, Clifton DA. Machine learning for clinical outcome prediction. IEEE Rev Biomed Eng 2021;14:116&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pubmed">32746368</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngiam KY, Khor IW. Big data and machine learning algorithms for health-care delivery. Lancet Oncol 2019;20:e262&#x2013;e273.</Citation><ArticleIdList><ArticleId IdType="pubmed">31044724</ArticleId></ArticleIdList></Reference><Reference><Citation>Nohara Y, Matsumoto K, Soejima H, et al. . Explanation of machine learning models using shapley additive explanation and application for real data in hospital. Comput Methods Programs Biomed 2022;214:106584.</Citation><ArticleIdList><ArticleId IdType="pubmed">34942412</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Y, Loftus TJ, Datta S, et al. . Performance of a machine learning algorithm using electronic health record data to predict postoperative complications and report on a mobile platform. JAMA Netw Open 2022;5:e2211973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9112066</ArticleId><ArticleId IdType="pubmed">35576007</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue B, Li D, Lu C, et al. . Use of machine learning to develop and evaluate models using preoperative and intraoperative data to identify risks of postoperative complications. JAMA Netw Open 2021;4:e212240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010590</ArticleId><ArticleId IdType="pubmed">33783520</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofer IS, Lee C, Gabel E, et al. . Development and validation of a deep neural network model to predict postoperative mortality, acute kidney injury, and reintubation using a single feature set. NPJ Digit Med 2020;3:58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7170922</ArticleId><ArticleId IdType="pubmed">32352036</ArticleId></ArticleIdList></Reference><Reference><Citation>Satapathy P, Pradhan KB, Rustagi S, et al. . Application of machine learning in surgery research: current uses and future directions - editorial. Int J Surg 2023, 109:1550&#x2013;1551.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10389442</ArticleId><ArticleId IdType="pubmed">37094825</ArticleId></ArticleIdList></Reference><Reference><Citation>Fransvea P, Fransvea G, Liuzzi P, et al. . Study and validation of an explainable machine learning-based mortality prediction following emergency surgery in the elderly: a prospective observational study. Int J Surg 2022;107:106954.</Citation><ArticleIdList><ArticleId IdType="pubmed">36229017</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei VJ, Luong T, Shan E, et al. . Risk stratification for postoperative acute kidney injury in major noncardiac surgery using preoperative and intraoperative data. JAMA Netw Open 2019;2:e1916921.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6902769</ArticleId><ArticleId IdType="pubmed">31808922</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng PY, Chen YT, Wang CH, et al. . Prediction of the development of acute kidney injury following cardiac surgery by machine learning. Crit Care 2020;24:478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7395374</ArticleId><ArticleId IdType="pubmed">32736589</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Chen L, Yao G, et al. . Novel blood cytokine-based model for predicting severe acute kidney injury and poor outcomes after cardiac surgery. J Am Heart Assoc 2020;9:e018004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7763725</ArticleId><ArticleId IdType="pubmed">33131359</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HC, Yoon HK, Nam K, et al. . Derivation and validation of machine learning approaches to predict acute kidney injury after cardiac surgery. J Clin Med 2018;7:322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6210196</ArticleId><ArticleId IdType="pubmed">30282956</ArticleId></ArticleIdList></Reference><Reference><Citation>Thongprayoon C, Pattharanitima P, Kattah AG, et al. . Explainable preoperative automated machine learning prediction model for cardiac surgery-associated acute kidney injury. J Clin Med 2022;11:6264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9656700</ArticleId><ArticleId IdType="pubmed">36362493</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikkinen O, Kolehmainen T, Aaltonen T, et al. . Developing a supervised machine learning model for predicting perioperative acute kidney injury in arthroplasty patients. Comput Biol Med 2022;144:105351.</Citation><ArticleIdList><ArticleId IdType="pubmed">35286890</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HC, Yoon S, Yang SM, et al. . Prediction of acute kidney injury after liver transplantation: machine learning approaches vs. logistic regression model. J Clin Med 2018;7:428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6262324</ArticleId><ArticleId IdType="pubmed">30413107</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu M, Jiang X, Du K, et al. . Ensemble machine learning algorithm for predicting acute kidney injury in patients admitted to the neurointensive care unit following brain surgery. Sci Rep 2023;13:6705.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10130041</ArticleId><ArticleId IdType="pubmed">37185782</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew G, Agha R, Albrecht J, et al. . STROCSS 2021: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery. Int J Surg 2021;96:106165.</Citation><ArticleIdList><ArticleId IdType="pubmed">34774726</ArticleId></ArticleIdList></Reference><Reference><Citation>Lameire NH, Levin A, Kellum JA, et al. . Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int 2021;100:516&#x2013;526.</Citation><ArticleIdList><ArticleId IdType="pubmed">34252450</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkharusi H. Categorical variables in regression analysis: a comparison of dummy and effect coding. Int J Educat 2012;4:202&#x2013;210.</Citation></Reference><Reference><Citation>Bihorac A, Ozrazgat-Baslanti T, Ebadi A, et al. . MySurgeryRisk: development and validation of a machine-learning risk algorithm for major complications and death after surgery. Ann Surg 2019;269:652&#x2013;662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6110979</ArticleId><ArticleId IdType="pubmed">29489489</ArticleId></ArticleIdList></Reference><Reference><Citation>McKinlay J, Tyson E, Forni LG. Renal complications of anaesthesia. Anaesthesia 2018;73(suppl 1):85&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">29313905</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Forni LG, Bell M, et al. . Postoperative acute kidney injury in adult non-cardiac surgery: joint consensus report of the Acute Disease Quality Initiative and PeriOperative Quality Initiative. Nat Rev Nephrol 2021;17:605&#x2013;618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8367817</ArticleId><ArticleId IdType="pubmed">33976395</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaara ST, Bellomo R. Postoperative renal dysfunction after noncardiac surgery. Curr Opin Crit Care 2017;23:440&#x2013;446.</Citation><ArticleIdList><ArticleId IdType="pubmed">28820797</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyigun M, Aykut G, Tosun M, et al. . Perioperative risk factors of acute kidney injury after non-cardiac surgery: a multicenter, prospective, observational study in patients with low grade American Society of Anesthesiologists physical status. Am J Surg 2019;218:457&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pubmed">30739741</ArticleId></ArticleIdList></Reference><Reference><Citation>Grams ME, Sang Y, Coresh J, et al. . Acute kidney injury after major surgery: a retrospective analysis of veterans health administration data. Am J Kidney Dis 2016;67:872&#x2013;880.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4775458</ArticleId><ArticleId IdType="pubmed">26337133</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun K, Li F, Lin D, et al. . Serum gamma - glutamyltransferase is associated with albuminuria: a population-based study. PLoS One 2014;9:e114970.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4263709</ArticleId><ArticleId IdType="pubmed">25500578</ArticleId></ArticleIdList></Reference><Reference><Citation>Yilmaz MI, Turgut F, Kanbay M, et al. . Serum gamma-glutamyltransferase levels are inversely related to endothelial function in chronic kidney disease. Int Urol Nephrol 2013;45:1071&#x2013;1078.</Citation><ArticleIdList><ArticleId IdType="pubmed">23242503</ArticleId></ArticleIdList></Reference><Reference><Citation>Javid M, Mirdamadi A, Javid M, et al. . Gamma glutamyl transferase as a biomarker to predict contrast-induced nephropathy among patients with acute coronary syndrome undergoing coronary interventions: a meta-analysis. Ann Med Surg (Lond) 2023;85:4033&#x2013;4040.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10406001</ArticleId><ArticleId IdType="pubmed">37554858</ArticleId></ArticleIdList></Reference><Reference><Citation>Limaye K, Yang JD, Hinduja A. Role of admission serum albumin levels in patients with intracerebral hemorrhage. Acta Neurol Belg 2016;116:27&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">26133948</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N, Qiao H, Guo JF, et al. . Preoperative hypoalbuminemia was associated with acute kidney injury in high-risk patients following non-cardiac surgery: a retrospective cohort study. BMC Anesthesiol 2019;19:171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6719349</ArticleId><ArticleId IdType="pubmed">31477030</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EH, Baek SH, Chin JH, et al. . Preoperative hypoalbuminemia is a major risk factor for acute kidney injury following off-pump coronary artery bypass surgery. Intensive Care Med 2012;38:1478&#x2013;1486.</Citation><ArticleIdList><ArticleId IdType="pubmed">22618092</ArticleId></ArticleIdList></Reference><Reference><Citation>Kertai MD, Zhou S, Karhausen JA, et al. . Platelet counts, acute kidney injury, and mortality after coronary artery bypass grafting surgery. Anesthesiology 2016;124:339&#x2013;352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5040517</ArticleId><ArticleId IdType="pubmed">26599400</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghdaii N, Ferasatkish R, Mohammadzadeh Jouryabi A, et al. . Significance of preoperative total lymphocyte count as a prognostic criterion in adult cardiac surgery. Anesth Pain Med 2014;4:e20331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4183084</ArticleId><ArticleId IdType="pubmed">25289377</ArticleId></ArticleIdList></Reference><Reference><Citation>Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 2006;17:17&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">16291837</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Chen J, Luo C, et al. . Predicting the risk of postoperative acute kidney injury: development and assessment of a novel predictive nomogram. J Int Med Res 2021;49:3000605211032838.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8366143</ArticleId><ArticleId IdType="pubmed">34382465</ArticleId></ArticleIdList></Reference><Reference><Citation>De Rosa S, Greco M, Rauseo M, et al. . The good, the bad, and the serum creatinine: exploring the effect of muscle mass and nutrition. Blood Purif 2023;52:775&#x2013;785.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10623400</ArticleId><ArticleId IdType="pubmed">37742621</ArticleId></ArticleIdList></Reference><Reference><Citation>Bang JY, Jun IG, Lee JB, et al. . Impact of sarcopenia on acute kidney injury after infrarenal abdominal aortic aneurysm surgery: a propensity matching analysis. Nutrients 2021;13:2212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8308481</ArticleId><ArticleId IdType="pubmed">34199110</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR Croal B Abbott TEF et al. . investigators Ms . Cystatin C or creatinine for pre-operative assessment of kidney function and risk of post-operative acute kidney injury: a secondary analysis of the METS cohort study. Clin Kidney J 2024;17:sfae004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10807905</ArticleId><ArticleId IdType="pubmed">38269033</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanda E, Muneyuki T, Kanno Y, et al. . Uric acid level has a U-shaped association with loss of kidney function in healthy people: a prospective cohort study. PLoS One 2015;10:e0118031.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4320097</ArticleId><ArticleId IdType="pubmed">25658588</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JH, Jo YI, Lee JH. Renal effects of uric acid: hyperuricemia and hypouricemia. Korean J Intern Med 2020;35:1291&#x2013;1304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7652664</ArticleId><ArticleId IdType="pubmed">32872730</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez CE, Der Mesropian PJ, Mathew RO, et al. . Hyperglycemia and acute kidney injury during the perioperative period. Curr Diab Rep 2016;16:10.</Citation><ArticleIdList><ArticleId IdType="pubmed">26792142</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang J, Li S, Zhao Y, et al. . Intensive glucose control during the perioperative period for diabetic patients undergoing surgery: an updated systematic review and meta-analysis. J Clin Anesth 2021;75:110504.</Citation><ArticleIdList><ArticleId IdType="pubmed">34509960</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YL, Chen BK, Lin KD, et al. . The impact of severe hypoglycemia on renal impairment in type 2 diabetes. Diabetes Res Clin Pract 2015;108:448&#x2013;455.</Citation><ArticleIdList><ArticleId IdType="pubmed">25779866</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun JS, Park YM, Han K, et al. . Severe hypoglycemia and the risk of end stage renal disease in type 2 diabetes. Sci Rep 2021;11:4305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7900096</ArticleId><ArticleId IdType="pubmed">33619302</ArticleId></ArticleIdList></Reference><Reference><Citation>Boon AC, Bulmer AC, Coombes JS, et al. . Circulating bilirubin and defense against kidney disease and cardiovascular mortality: mechanisms contributing to protection in clinical investigations. Am J Physiol Renal Physiol 2014;307:F123&#x2013;F136.</Citation><ArticleIdList><ArticleId IdType="pubmed">24761005</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Pant P, Basu S, et al. . Oxidative stress in neonatal hyperbilirubinemia. J Trop Pediatr 2007;53:69&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">17158814</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu YH, Wu CY, Cheng CY, et al. . Severe hyperbilirubinemia is associated with higher risk of contrast-related acute kidney injury following contrast-enhanced computed tomography. PLoS One 2020;15:e0231264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159198</ArticleId><ArticleId IdType="pubmed">32294106</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, Weiss R, Albert F, et al. . Epidemiology of surgery associated acute kidney injury (EPIS-AKI): a prospective international observational multi-center clinical study. Intensive Care Med 2023;49:1441&#x2013;1455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10709241</ArticleId><ArticleId IdType="pubmed">37505258</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu C, Fong N, Lazzareschi D, et al. . Fluids, vasopressors, and acute kidney injury after major abdominal surgery between 2015 and 2019: a multicentre retrospective analysis. Br J Anaesth 2022;129:317&#x2013;326.</Citation><ArticleIdList><ArticleId IdType="pubmed">35688657</ArticleId></ArticleIdList></Reference><Reference><Citation>Karkouti K, Grocott HP, Hall R, et al. . Interrelationship of preoperative anemia, intraoperative anemia, and red blood cell transfusion as potentially modifiable risk factors for acute kidney injury in cardiac surgery: a historical multicentre cohort study. Can J Anaesth 2015;62:377&#x2013;384.</Citation><ArticleIdList><ArticleId IdType="pubmed">25537735</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu S, Lu P, Liu Z, et al. . Longitudinal hemoglobin trajectories and acute kidney injury in patients undergoing cardiac surgery: a retrospective cohort study. Front Cardiovasc Med 2023;10:1181617.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10229827</ArticleId><ArticleId IdType="pubmed">37265564</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Liu S. Threshold heterogeneity of perioperative hemoglobin drop for acute kidney injury after noncardiac surgery: a propensity score weighting analysis. BMC Nephrol 2022;23:206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9188693</ArticleId><ArticleId IdType="pubmed">35690725</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40498523</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2168-6262</ISSN><JournalIssue CitedMedium="Internet"><Volume>160</Volume><Issue>8</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA surgery</Title><ISOAbbreviation>JAMA Surg</ISOAbbreviation></Journal><ArticleTitle>Postoperative 20% Albumin Infusion and Acute Kidney Injury in High-Risk Cardiac Surgery Patients: The ALBICS AKI Randomized Clinical Trial.</ArticleTitle><Pagination><StartPage>835</StartPage><EndPage>844</EndPage><MedlinePgn>835-844</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamasurg.2025.1683</ELocationID><Abstract><AbstractText Label="IMPORTANCE" NlmCategory="UNASSIGNED">Acute kidney injury (AKI) after cardiac surgery is a common and serious complication. Protein loading appears nephroprotective; thus, continuous hyperoncotic albumin infusion may impact AKI following high-risk cardiac surgery.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To evaluate the effect of postoperative 20% albumin infusion compared with usual care on the occurrence of AKI in high-risk cardiac surgery patients.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS" NlmCategory="UNASSIGNED">This was an investigator-initiated randomized multicenter open-label pragmatic clinical trial. Participants were stratified by site and estimated glomerular filtration rate (eGFR) above and below 60 mL/min/1.73 m2. The study was conducted at 7 cardiac centers in Australia and Italy between July 2019 and August 2024. Patients undergoing on-pump cardiac surgery with a preoperative eGFR of greater than 15 mL/min/1.73 m2 and less than 60 mL/min/1.73 m2 or undergoing a combined cardiac surgical procedure or major aortic surgery were included, excluding those who were in intensive care for longer than 6 hours following the index surgery, had a serum albumin level less than 20 g/L, were dialysis dependent, had a previous kidney transplant, were receiving extracorporeal life support or ventricular assist device, or had an objection to receiving albumin or blood products.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="UNASSIGNED">Participants were randomized 1:1 within 6 hours after surgery to receive a 300-mL infusion of 20% albumin over 15 hours or usual care, as per clinician discretion. All patients received volume resuscitation and hemodynamic treatment according to participating centers' protocols.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES" NlmCategory="UNASSIGNED">The primary outcome was stage 1-3 AKI according to the creatinine-based Kidney Disease Improving Global Outcomes definition. The main secondary outcomes included major adverse kidney events and mortality at hospital discharge or day 28 following randomization.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The primary analysis included 307 patients randomized to the 20% albumin group and 304 to usual care. The mean (SD) age was 69 (10.8) years, and 281 patients (45.8%) had an eGFR less than 60 mL/min/1.73 m2. The median (IQR) European System for Cardiac Operative Risk Evaluation score-II was 3.23 (1.91-5.30). AKI occurred in 150 of 307 patients in the albumin group (48.9%) vs 132 of 304 in usual care (43.4%) (unadjusted relative risk, 1.13; 95% CI, 0.95-1.34; P&#x2009;=&#x2009;.18; strata-adjusted relative risk, 1.12; 95% CI, 1.04-1.21; P&#x2009;=&#x2009;.003). This effect was more pronounced in patients with an eGFR of &lt;60 mL/min/1.73 m2 (adjusted relative risk, 1.14; 95% CI; 1.07-1.22; P&#x2009;&lt;&#x2009;.001). There were more blood transfusions given in the albumin group (116 [37.8%] vs 91 [29.9%]; P&#x2009;=&#x2009;.04) but no other significant differences in secondary outcomes.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE" NlmCategory="UNASSIGNED">In this study of cardiac surgery patients at high risk of AKI, an infusion of 20% albumin increased the risk of AKI. These findings do not support the routine use of hyperoncotic albumin infusion in patients undergoing high-risk cardiac surgery.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="UNASSIGNED">Anzctr.org.au Identifier: ACTRN12619001355167.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shehabi</LastName><ForeName>Yahya</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Monash Health School of Clinical Sciences, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Victorian Heart Hospital, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical School of Medicine, University of New South Wales, Prince of Wales Hospital Randwick, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balachandran</LastName><ForeName>Mayurathan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Victorian Heart Hospital, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, Monash Health, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Bassam</LastName><ForeName>Wisam</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Monash Health School of Clinical Sciences, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Victorian Heart Hospital, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, Monash Health, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bailey</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Critical Care, The University of Melbourne, Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, Austin Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bihari</LastName><ForeName>Shailesh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of ICU, Flinders Medical Centre, Bedford Park, South Australia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Alana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Monash Health School of Clinical Sciences, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Victorian Heart Hospital, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Alastair</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Critical Care, University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collins</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Prince of Wales and Prince of Wales Private Hospital, Randwick, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Darlison</LastName><ForeName>Phoebe R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Department of Critical Care, University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Mozhu Alice</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Monash Health School of Clinical Sciences, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Victorian Heart Hospital, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mandarano</LastName><ForeName>Raffaele</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarode</LastName><ForeName>Vineet</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Cabrini Health, Malvern, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pakavakis</LastName><ForeName>Adrian</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Monash Health School of Clinical Sciences, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Victorian Heart Hospital, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, Monash Health, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>ALBICS AKI Study Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D065007">Pragmatic Clinical Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Surg</MedlineTA><NlmUniqueID>101589553</NlmUniqueID><ISSNLinking>2168-6254</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000418">Albumins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005919" MajorTopicYN="N">Glomerular Filtration Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000418" MajorTopicYN="Y">Albumins</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011182" MajorTopicYN="Y">Postoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> None reported.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Glassford</LastName><ForeName>Neil</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grant</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harington</LastName><ForeName>Claire</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raymond</LastName><ForeName>Lewis</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dougherty</LastName><ForeName>Lisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maeda</LastName><ForeName>Akinori</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chaba</LastName><ForeName>Anis</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Phongphithakchai</LastName><ForeName>Atthaphong</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eastwood</LastName><ForeName>Glenn</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Spano</LastName><ForeName>Sofia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Young</LastName><ForeName>Helen</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peck</LastName><ForeName>Leah</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bleetman</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Holmes</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>King</LastName><ForeName>Melissa</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ordering</LastName><ForeName>Adelle</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Luk</LastName><ForeName>Viean</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>McIntyre</LastName><ForeName>Joanne</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bottari</LastName><ForeName>Vanessa</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Olivo</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Galeotti</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Albano</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Paul</LastName><ForeName>Eldo</ForeName><Initials>E</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2026</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>31</Day><Hour>20</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>11</Day><Hour>12</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>11</Day><Hour>11</Hour><Minute>34</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40498523</ArticleId><ArticleId IdType="pmc">PMC12159861</ArticleId><ArticleId IdType="doi">10.1001/jamasurg.2025.1683</ArticleId><ArticleId IdType="pii">2835041</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>O&#x2019;Neal JB, Shaw AD, Billings FT IV. Acute kidney injury following cardiac surgery: current understanding and future directions. Crit Care. 2016;20(1):187. doi: 10.1186/s13054-016-1352-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1352-z</ArticleId><ArticleId IdType="pmc">PMC4931708</ArticleId><ArticleId IdType="pubmed">27373799</ArticleId></ArticleIdList></Reference><Reference><Citation>Palomba H, Castro I, Yu L, Burdmann EA. The duration of acute kidney injury after cardiac surgery increases the risk of long-term chronic kidney disease. J Nephrol. 2017;30(4):567-572. doi: 10.1007/s40620-016-0351-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40620-016-0351-0</ArticleId><ArticleId IdType="pubmed">27704389</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassnigg A, Schmidlin D, Mouhieddine M, et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004;15(6):1597-1605. doi: 10.1097/01.ASN.0000130340.93930.DD</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ASN.0000130340.93930.DD</ArticleId><ArticleId IdType="pubmed">15153571</ArticleId></ArticleIdList></Reference><Reference><Citation>Priyanka P, Zarbock A, Izawa J, Gleason TG, Renfurm RW, Kellum JA. The impact of acute kidney injury by serum creatinine or urine output criteria on major adverse kidney events in cardiac surgery patients. J Thorac Cardiovasc Surg. 2021;162(1):143-151.e7. doi: 10.1016/j.jtcvs.2019.11.137</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2019.11.137</ArticleId><ArticleId IdType="pubmed">32033818</ArticleId></ArticleIdList></Reference><Reference><Citation>Kork F, Balzer F, Spies CD, et al. Minor postoperative increases of creatinine are associated with higher mortality and longer hospital length of stay in surgical patients. Anesthesiology. 2015;123(6):1301-1311. doi: 10.1097/ALN.0000000000000891</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000891</ArticleId><ArticleId IdType="pmc">PMC4679549</ArticleId><ArticleId IdType="pubmed">26492475</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JR, Kramer RS, Coca SG, Parikh CR. Duration of acute kidney injury impacts long-term survival after cardiac surgery. Ann Thorac Surg. 2010;90(4):1142-1148. doi: 10.1016/j.athoracsur.2010.04.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2010.04.039</ArticleId><ArticleId IdType="pmc">PMC3819730</ArticleId><ArticleId IdType="pubmed">20868804</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyer N, Eldridge J, Prowle JR, Forni LG. Postoperative acute kidney injury. Clin J Am Soc Nephrol. 2022;17(10):1535-1545. doi: 10.2215/CJN.16541221</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.16541221</ArticleId><ArticleId IdType="pmc">PMC9528271</ArticleId><ArticleId IdType="pubmed">35710717</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Auriemma S, Fabbri A, et al. The pathophysiology of cardiac surgery-associated acute kidney injury (CSA-AKI). Int J Artif Organs. 2008;31(2):166-178. doi: 10.1177/039139880803100210</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/039139880803100210</ArticleId><ArticleId IdType="pubmed">18311733</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Li C, Zhu S, et al. Diagnosis, pathophysiology and preventive strategies for cardiac surgery-associated acute kidney injury: a narrative review. Eur J Med Res. 2023;28(1):45. doi: 10.1186/s40001-023-00990-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40001-023-00990-2</ArticleId><ArticleId IdType="pmc">PMC9872411</ArticleId><ArticleId IdType="pubmed">36694233</ArticleId></ArticleIdList></Reference><Reference><Citation>Sladen RN. Perioperative acute renal injury: revisiting pathophysiology. Anesthesiology. 2024;141(1):151-158. doi: 10.1097/ALN.0000000000004993</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000004993</ArticleId><ArticleId IdType="pubmed">38728065</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans TW. Review article: albumin as a drug&#x2013;biological effects of albumin unrelated to oncotic pressure. Aliment Pharmacol Ther. 2002;16(suppl 5):6-11. doi: 10.1046/j.1365-2036.16.s5.2.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2036.16.s5.2.x</ArticleId><ArticleId IdType="pubmed">12423448</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabelink TJ, de Zeeuw D. The glycocalyx&#x2013;linking albuminuria with renal and cardiovascular disease. Nat Rev Nephrol. 2015;11(11):667-676. doi: 10.1038/nrneph.2015.162</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2015.162</ArticleId><ArticleId IdType="pubmed">26460356</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. The antioxidant properties of serum albumin. FEBS Lett. 2008;582(13):1783-1787. doi: 10.1016/j.febslet.2008.04.057</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2008.04.057</ArticleId><ArticleId IdType="pubmed">18474236</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingeter AJ, Raghunathan K, Munson SH, et al. Association between albumin administration and survival in cardiac surgery: a retrospective cohort study. Can J Anaesth. 2018;65(11):1218-1227. doi: 10.1007/s12630-018-1181-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-018-1181-4</ArticleId><ArticleId IdType="pubmed">30006911</ArticleId></ArticleIdList></Reference><Reference><Citation>Berbel-Franco D, Lopez-Delgado JC, Putzu A, et al. The influence of postoperative albumin levels on the outcome of cardiac surgery. J Cardiothorac Surg. 2020;15(1):78. doi: 10.1186/s13019-020-01133-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13019-020-01133-y</ArticleId><ArticleId IdType="pmc">PMC7216430</ArticleId><ArticleId IdType="pubmed">32393356</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Dorzi HM, Arabi YM. Early administration of high protein for critically ill patients with acute kidney injury? Crit Care. 2023;27(1):484. doi: 10.1186/s13054-023-04764-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-023-04764-4</ArticleId><ArticleId IdType="pmc">PMC10704753</ArticleId><ArticleId IdType="pubmed">38062515</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EH, Kim WJ, Kim JY, et al. Effect of exogenous albumin on the incidence of postoperative acute kidney injury in patients undergoing off-pump coronary artery bypass surgery with a preoperative albumin level of less than 4.0 g/dl. Anesthesiology. 2016;124(5):1001-1011. doi: 10.1097/ALN.0000000000001051</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001051</ArticleId><ArticleId IdType="pubmed">26891150</ArticleId></ArticleIdList></Reference><Reference><Citation>Callum J, Skubas NJ, Bathla A, et al. ; International Collaboration for Transfusion Medicine Guidelines Intravenous Albumin Guideline Group . Use of intravenous albumin: a guideline from the international collaboration for transfusion medicine guidelines. Chest. 2024;166(2):321-338. doi: 10.1016/j.chest.2024.02.049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2024.02.049</ArticleId><ArticleId IdType="pmc">PMC11317816</ArticleId><ArticleId IdType="pubmed">38447639</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe5;rtensson J, Bihari S, Bannard-Smith J, et al. Small volume resuscitation with 20% albumin in intensive care: physiological effects: the SWIPE randomised clinical trial. Intensive Care Med. 2018;44(11):1797-1806. doi: 10.1007/s00134-018-5253-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-018-5253-2</ArticleId><ArticleId IdType="pubmed">30343313</ArticleId></ArticleIdList></Reference><Reference><Citation>Wigmore GJ, Anstey JR, St John A, et al. 20% human albumin solution fluid bolus administration therapy in patients after cardiac surgery (the HAS FLAIR study). J Cardiothorac Vasc Anesth. 2019;33(11):2920-2927. doi: 10.1053/j.jvca.2019.03.049</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2019.03.049</ArticleId><ArticleId IdType="pubmed">31097338</ArticleId></ArticleIdList></Reference><Reference><Citation>Wigmore GJ, Deane AM, Presneill JJ, et al. ; HAS FLAIR-II investigators . Twenty percent human albumin solution fluid bolus administration therapy in patients after cardiac surgery-II: a multicentre randomised controlled trial. Intensive Care Med. 2024;50(7):1075-1085. doi: 10.1007/s00134-024-07488-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-024-07488-3</ArticleId><ArticleId IdType="pmc">PMC11245445</ArticleId><ArticleId IdType="pubmed">38953926</ArticleId></ArticleIdList></Reference><Reference><Citation>Caironi P, Tognoni G, Masson S, et al. ; ALBIOS Study Investigators . Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370(15):1412-1421. doi: 10.1056/NEJMoa1305727</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1305727</ArticleId><ArticleId IdType="pubmed">24635772</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawidson IJ, Sandor ZF, Coorpender L, et al. Intraoperative albumin administration affects the outcome of cadaver renal transplantation. Transplantation. 1992;53(4):774-782. doi: 10.1097/00007890-199204000-00014</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007890-199204000-00014</ArticleId><ArticleId IdType="pubmed">1566343</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Kirwan CJ, Bellomo R. Fluid management for the prevention and attenuation of acute kidney injury. Nat Rev Nephrol. 2014;10(1):37-47. doi: 10.1038/nrneph.2013.232</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2013.232</ArticleId><ArticleId IdType="pubmed">24217464</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanase F, Tosif SH, Churilov L, et al. A randomized, multicenter, open-label, blinded end point, phase 2, feasibility, efficacy, and safety trial of preoperative microvascular protection in patients undergoing major abdominal surgery. Anesth Analg. 2021;133(4):1036-1047. doi: 10.1213/ANE.0000000000005667</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005667</ArticleId><ArticleId IdType="pubmed">34269720</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu R, Allingstrup MJ, Perner A, Doig GS; Nephro-Protective Trial Investigators Group . The effect of IV amino acid supplementation on mortality in ICU patients may be dependent on kidney function: post hoc subgroup analyses of a multicenter randomized trial. Crit Care Med. 2018;46(8):1293-1301. doi: 10.1097/CCM.0000000000003221</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000003221</ArticleId><ArticleId IdType="pubmed">29771700</ArticleId></ArticleIdList></Reference><Reference><Citation>Husain-Syed F, Emlet DR, Wilhelm J, et al. ; IRRIV-AKI Study Group . Effects of preoperative high-oral protein loading on short- and long-term renal outcomes following cardiac surgery: a cohort study. J Transl Med. 2022;20(1):204. doi: 10.1186/s12967-022-03410-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03410-x</ArticleId><ArticleId IdType="pmc">PMC9092825</ArticleId><ArticleId IdType="pubmed">35538495</ArticleId></ArticleIdList></Reference><Reference><Citation>Landoni G, Monaco F, Ti LK, et al. ; PROTECTION Study Group . A randomized trial of intravenous amino acids for kidney protection. N Engl J Med. 2024;391(8):687-698. doi: 10.1056/NEJMoa2403769</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2403769</ArticleId><ArticleId IdType="pubmed">38865168</ArticleId></ArticleIdList></Reference><Reference><Citation>Bihari S, Bannard-Smith J, Bellomo R. Albumin as a drug: its biological effects beyond volume expansion. Crit Care Resusc. 2020;22(3):257-265. doi: 10.1016/S1441-2772(23)00394-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1441-2772(23)00394-0</ArticleId><ArticleId IdType="pmc">PMC10692529</ArticleId><ArticleId IdType="pubmed">32900333</ArticleId></ArticleIdList></Reference><Reference><Citation>Balachandran M, Banneheke P, Pakavakis A, et al. Postoperative 20% albumin vs standard care and acute kidney injury after high-risk cardiac surgery (ALBICS): study protocol for a randomised trial. Trials. 2021;22(1):558. doi: 10.1186/s13063-021-05519-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-021-05519-8</ArticleId><ArticleId IdType="pmc">PMC8380013</ArticleId><ArticleId IdType="pubmed">34419128</ArticleId></ArticleIdList></Reference><Reference><Citation>Balachandran M, Pakavakis A, Al-Bassam W, et al. Postoperative 20% albumin and cardiac surgery associated kidney injury, statistical analysis plan and updated protocol. medRxiv. Preprint posted online September 17, 2024. doi: 10.1101/2024.09.17.24313807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.09.17.24313807</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)&#x2014;a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381. doi: 10.1016/j.jbi.2008.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2008.08.010</ArticleId><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Minor BL, et al. ; REDCap Consortium . The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208. doi: 10.1016/j.jbi.2019.103208</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103208</ArticleId><ArticleId IdType="pmc">PMC7254481</ArticleId><ArticleId IdType="pubmed">31078660</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Lameire N, Aspelin P, et al. Kidney disease improving global outcomes (KDIGO) acute kidney injury work group . KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1-138. doi: 10.1038/kisup.2012.1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/kisup.2012.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeda A, Inokuchi R, Bellomo R, Doi K. Heterogeneity in the definition of major adverse kidney events: a scoping review. Intensive Care Med. 2024;50(7):1049-1063. doi: 10.1007/s00134-024-07480-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-024-07480-x</ArticleId><ArticleId IdType="pmc">PMC11245451</ArticleId><ArticleId IdType="pubmed">38801518</ArticleId></ArticleIdList></Reference><Reference><Citation>Robert AM, Kramer RS, Dacey LJ, et al. ; Northern New England Cardiovascular Disease Study Group . Cardiac surgery-associated acute kidney injury: a comparison of two consensus criteria. Ann Thorac Surg. 2010;90(6):1939-1943. doi: 10.1016/j.athoracsur.2010.08.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2010.08.018</ArticleId><ArticleId IdType="pubmed">21095340</ArticleId></ArticleIdList></Reference><Reference><Citation>Nashef SA, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41(4):734-744. doi: 10.1093/ejcts/ezs043</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezs043</ArticleId><ArticleId IdType="pubmed">22378855</ArticleId></ArticleIdList></Reference><Reference><Citation>Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system. risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991;100(6):1619-1636. doi: 10.1378/chest.100.6.1619</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.100.6.1619</ArticleId><ArticleId IdType="pubmed">1959406</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanley C, Callum J, Karkouti K, Bartoszko J. Albumin in adult cardiac surgery: a narrative review. Can J Anaesth. 2021;68(8):1197-1213. doi: 10.1007/s12630-021-01991-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-021-01991-7</ArticleId><ArticleId IdType="pubmed">33884561</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesonen E, Vlasov H, Suojaranta R, et al. Effect of 4% albumin solution vs ringer acetate on major adverse events in patients undergoing cardiac surgery with cardiopulmonary bypass: a randomized clinical trial. JAMA. 2022;328(3):251-258. doi: 10.1001/jama.2022.10461</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.10461</ArticleId><ArticleId IdType="pmc">PMC9297113</ArticleId><ArticleId IdType="pubmed">35852528</ArticleId></ArticleIdList></Reference><Reference><Citation>Bag&#xe1;n JM, Quiles LP, Iglesias PP, et al. The potential role of albumin in reducing cardiac surgery-associated acute kidney injury: a randomized controlled trial. J Cardiothorac Vasc Anesth. 2025;39(2):453-460. doi: 10.1053/j.jvca.2024.10.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2024.10.012</ArticleId><ArticleId IdType="pubmed">39922683</ArticleId></ArticleIdList></Reference><Reference><Citation>Skubas NJ, Callum J, Bathla A, et al. Intravenous albumin in cardiac and vascular surgery: a systematic review and meta-analysis. Br J Anaesth. 2023;132(2):237-250. doi: 10.1016/j.bja.2023.11.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2023.11.009</ArticleId><ArticleId IdType="pubmed">38101966</ArticleId></ArticleIdList></Reference><Reference><Citation>Matebele MP, Ramanan M, Thompson K, Cornmell G, Naidoo RV, Shekar K. Albumin use after cardiac surgery. Crit Care Explor. 2020;2(7):e0164. doi: 10.1097/CCE.0000000000000164</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCE.0000000000000164</ArticleId><ArticleId IdType="pmc">PMC7365709</ArticleId><ArticleId IdType="pubmed">32766560</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Gonz&#xe1;lez G, Rodr&#xed;guez-Chitiva N, Ca&#xf1;ameras C, et al. Albuminuria, forgotten no more: underlining the emerging role in cardiorenal crosstalk. J Clin Med. 2024;13(3):777. doi: 10.3390/jcm13030777</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm13030777</ArticleId><ArticleId IdType="pmc">PMC10856688</ArticleId><ArticleId IdType="pubmed">38337471</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Sileanu FE, Murugan R, Lucko N, Shaw AD, Clermont G. Classifying AKI by urine output versus serum creatinine level. J Am Soc Nephrol. 2015;26(9):2231-2238. doi: 10.1681/ASN.2014070724</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2014070724</ArticleId><ArticleId IdType="pmc">PMC4552117</ArticleId><ArticleId IdType="pubmed">25568178</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39019743</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Early Acute Kidney Injury Recovery in Elderly Patients Undergoing Valve Replacement Surgery.</ArticleTitle><Pagination><StartPage>2261</StartPage><EndPage>2268</EndPage><MedlinePgn>2261-2268</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2024.06.027</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(24)00397-5</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This study was designed to determine the incidence, contributing factors, and prognostic implications of acute kidney injury (AKI) recovery patterns in patients who experienced AKI after valve replacement surgery (VRS).</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A retrospective cohort study was conducted.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">The work took place in a postoperative care center in a single large-volume cardiovascular center.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Patients undergoing VRS between January 2010 and December 2019 were enrolled.</AbstractText><AbstractText Label="INTERVENTION" NlmCategory="METHODS">Patients were categorized into three groups based on their postoperative AKI status: non-AKI, AKI with early recovery (less than 48 hours), and persistent AKI.</AbstractText><AbstractText Label="MEASUREMENT AND MAIN RESULTS" NlmCategory="RESULTS">The primary outcome was in-hospital major adverse clinical events. The secondary outcomes included in-hospital and 1-year mortality. A total of 4,161 patients who developed AKI following VRS were included. Of these, 1,513 (36.4%) did not develop postoperative AKI, 1,875 (45.1%) experienced AKI with early recovery, and 773 (18.6%) had persistent AKI. Advanced age, diabetes, New York Heart Association III-IV heart failure, moderate-to-severe renal dysfunction, anemia, and AKI stages 2 and 3 were identified as independent risk factors for persistent AKI. In-hospital major adverse clinical events occurred in 59 (3.9%) patients without AKI, 88 (4.7%) with early AKI recovery, and 159 (20.6%) with persistent AKI (p &lt; 0.001). Persistent AKI was independently associated with an increased risk of in-hospital adverse events and 1-year mortality. In contrast, AKI with early recovery did not pose additional risk compared with non-AKI patients.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In patients who develop AKI following VRS, early AKI recovery does not pose additional risk compared with non-AKI. However, AKI lasting more than 48 hours is associated with an increased risk of in-hospital and long-term adverse outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Ying-Wen</ForeName><Initials>YW</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Pei-Shan</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Department of Geriatric Intensive Medicine, Guangdong Provincial Geriatrics Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Mei</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiao-Hua</ForeName><Initials>XH</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shou-Hong</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Geriatric Intensive Medicine, Guangdong Provincial Geriatrics Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Xiaolong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Geriatric Intensive Medicine, Guangdong Provincial Geriatrics Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Qing-Chun</ForeName><Initials>QC</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Dan-Qing</ForeName><Initials>DQ</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Xue-Biao</ForeName><Initials>XB</Initials><AffiliationInfo><Affiliation>Department of Geriatric Intensive Medicine, Guangdong Provincial Geriatrics Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, 510080, China. Electronic address: weixuebiao@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019918" MajorTopicYN="Y">Heart Valve Prosthesis Implantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020127" MajorTopicYN="N">Recovery of Function</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">early recovery</Keyword><Keyword MajorTopicYN="N">postoperative care</Keyword><Keyword MajorTopicYN="N">valve replacement surgery</Keyword></KeywordList><CoiStatement>Declaration of competing interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>15</Day><Hour>14</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>18</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>17</Day><Hour>22</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39019743</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2024.06.027</ArticleId><ArticleId IdType="pii">S1053-0770(24)00397-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38728933</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Intraoperative hypotension during liver transplantation and postoperative outcomes: Retrospective cohort study.</ArticleTitle><Pagination><StartPage>111486</StartPage><MedlinePgn>111486</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2024.111486</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(24)00115-6</ELocationID><Abstract><AbstractText Label="STUDY OBJECTIVES">Evaluation of the association between intraoperative hypotension (IOH) and important postoperative outcomes after liver transplant such as incidence and severity of acute kidney injury (AKI), MACE and early allograft dysfunction (EAD).</AbstractText><AbstractText Label="DESIGN">Retrospective, single institution study.</AbstractText><AbstractText Label="SETTINGS">Operating room.</AbstractText><AbstractText Label="PATIENTS">1576 patients who underwent liver transplant in our institution between January 2005 and February 2022.</AbstractText><AbstractText Label="MEASUREMENTS">IOH was measured as the time, area under the threshold (AUT), or time-weighted average (TWA) of mean arterial pressure (MAP) less than certain thresholds (55,60 and 65&#xa0;mmHg). Associations between IOH exposures and AKI severity were assessed via proportional odds models. The odds ratio from the proportional odds model estimated the relative odds of having higher stage of AKI for higher exposure to IOH. Associations between exposures and MACE and EAD were assessed through logistic regression models. Potential confounding variables including patient baseline and surgical characteristics were adjusted for all models.</AbstractText><AbstractText Label="MAIN RESULTS">The primary analysis included 1576 surgeries that met the inclusion and exclusion criteria. Of those, 1160 patients (74%) experienced AKI after liver transplant surgery, with 780 (49%), 248(16%), and 132 (8.4%) experiencing mild, moderate, and severe injury, respectively. No significant association between hypotension exposure and postoperative AKI (yes or no) nor severity of AKI was observed. The odds ratios (95% CI) of having more severe AKI were 1.02 (0.997, 1.04) for a 50-mmHg&#xb7;min increase in AUT of MAP &lt;55&#xa0;mmHg (P&#xa0;=&#xa0;0.092); 1.03 (0.98, 1.07) for a 15-min increase in time spent under MAP &lt;55&#xa0;mmHg (P&#xa0;=&#xa0;0.27); and 1.24 (0.98, 1.57) for a 1&#xa0;mmHg increase in TWA of MAP &lt;55&#xa0;mmHg (P&#xa0;=&#xa0;0.068). The associations between IOH and the incidence of MACE or EAD were not significant.</AbstractText><AbstractText Label="CONCLUSION">Our results did not show the association between IOH and investigated outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cywinski</LastName><ForeName>Jacek B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, USA; Department of General Anesthesiology, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, USA. Electronic address: cywinsj@ccf.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yufei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of General Anesthesiology, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, USA; Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiaodan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khanna</LastName><ForeName>Sandeep</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General Anesthesiology, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, USA; Department of Cardiothoracic Anesthesiology, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Irefin</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General Anesthesiology, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mousa</LastName><ForeName>Ahmad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of General Anesthesiology, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maheshwari</LastName><ForeName>Kamal</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016031" MajorTopicYN="Y">Liver Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="Y">Intraoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062186" MajorTopicYN="N">Arterial Pressure</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Intraoperative hypotension</Keyword><Keyword MajorTopicYN="N">Liver transplantation</Keyword><Keyword MajorTopicYN="N">Major cardiovascular events</Keyword><Keyword MajorTopicYN="N">Primary graft dysfunction</Keyword></KeywordList><CoiStatement>Declaration of competing interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>15</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>11</Day><Hour>8</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>10</Day><Hour>18</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38728933</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2024.111486</ArticleId><ArticleId IdType="pii">S0952-8180(24)00115-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32785846</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1436-2813</ISSN><JournalIssue CitedMedium="Internet"><Volume>51</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Surgery today</Title><ISOAbbreviation>Surg Today</ISOAbbreviation></Journal><ArticleTitle>Risk factors for acute kidney injury in an enhanced recovery pathway for colorectal surgery.</ArticleTitle><Pagination><StartPage>537</StartPage><EndPage>544</EndPage><MedlinePgn>537-544</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00595-020-02107-2</ELocationID><Abstract><AbstractText Label="PURPOSES" NlmCategory="OBJECTIVE">Enhanced recovery pathways (ERPs) have been disseminated worldwide to improve the perioperative patient outcomes while lowering direct healthcare costs. Recent evidence has revealed a potential association between ERPs for colorectal surgery and acute kidney injury (AKI). We, therefore, sought to identify the risk factors associated with postoperative AKI among patients in an ERP for colorectal surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We analyzed the data resulting from a large multicenter, prospective cohort study of patients in an ERP for colorectal surgery. A multivariable analysis was performed to identify factors independently associated with postoperative AKI. The receiver operating characteristic (ROC) curves and contour representations were plotted for the diagnostic prediction analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among those patients included in the analysis (n&#x2009;=&#x2009;1652), the overall incidence of postoperative AKI was 7.7% (95% CI 6.5-9.1%). After adjustment, the independent risk factors for AKI included age&#x2009;&gt;&#x2009;60 (OR 1.03, 95% CI 1.01-1.05), male gender (OR 2.33, 95% CI 1.36-4.02), ASA III-IV (OR 2.43, 95% CI 1.39-4.26), CKD (OR 2.45, 95% CI 1.42-4.23), open surgical approach (OR 2.62, 95% CI 1.63-4.21) and serum albumin&#x2009;&lt;&#x2009;3.5&#xa0;g/dL (OR 1.68, 95% CI 1.02-2.79). An ROC analysis revealed that the composite of albumin, creatinine and age was a strong predictor of postoperative AKI [area under the curve (AUC) 0.756; 95% CI 0.705-0.808].</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Postoperative AKI is common in the setting of ERPs for colorectal surgery and it is associated with a poor clinical outcome. Of those characteristics associated with postoperative AKI, one modifiable factor is a low preoperative albumin level. Screening for malnourished patients or optimizing the nutritional status may be a useful preoperative intervention to prevent postoperative AKI and associated complications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zorrilla-Vaca</LastName><ForeName>Andr&#xe9;s</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8140-8486</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, University of Texas, MD Anderson Cancer Center, Houston, TX, USA. azorrilla@mdanderson.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mena</LastName><ForeName>Gabriel E</ForeName><Initials>GE</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, University of Texas, MD Anderson Cancer Center, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ripolles-Melchor</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care, Infanta Leonor University Hospital, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorente</LastName><ForeName>Juan Victor</ForeName><Initials>JV</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Hospital Juan Ramon Jimenez, Huelva, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramirez-Rodriguez</LastName><ForeName>Juan Jos&#xe9; M</ForeName><Initials>JJM</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Lozano Blesa University Hospital Zaragoza Spain, Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grant</LastName><ForeName>Michael C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Surg Today</MedlineTA><NlmUniqueID>9204360</NlmUniqueID><ISSNLinking>0941-1291</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012709">Serum Albumin</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003106" MajorTopicYN="N">Colon</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013505" MajorTopicYN="N">Digestive System Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000080482" MajorTopicYN="Y">Enhanced Recovery After Surgery</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044342" MajorTopicYN="N">Malnutrition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009752" MajorTopicYN="N">Nutritional Status</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012007" MajorTopicYN="N">Rectum</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012709" MajorTopicYN="N">Serum Albumin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Albumin</Keyword><Keyword MajorTopicYN="N">Colorectal surgery</Keyword><Keyword MajorTopicYN="N">Enhanced recovery pathways</Keyword><Keyword MajorTopicYN="N">Perioperative medicine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32785846</ArticleId><ArticleId IdType="doi">10.1007/s00595-020-02107-2</ArticleId><ArticleId IdType="pii">10.1007/s00595-020-02107-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Feldheiser A, Aziz O, Baldini G, Cox BP, Fearon KC, Feldman LS, et al. Enhanced recovery after surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for anaesthesia practice. Acta Anaesthesiol Scand. 2016;60:289&#x2013;334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.12651</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott MJ, Baldini G, Fearon KC, Feldheiser A, Feldman LS, Gan TJ, et al. Enhanced recovery after surgery (ERAS) for gastrointestinal surgery, part 1: pathophysiological considerations. Acta Anaesthesiol Scand. 2015;59:1212&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.12601</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafsson UO, Scott MJ, Hubner M, Nygren J, Demartines N, Francis N, et al. Guidelines for perioperative care in elective colorectal surgery: enhanced recovery after surgery (ERAS<sup>&#xae;</sup>) society recommendations: 2018. World J Surg. 2019;43:659&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-018-4844-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiele RH, Raghunathan K, Brudney CS, Lobo DN, Martin D, Senagore A, et al. American society for enhanced recovery (ASER) and perioperative quality initiative (POQI) joint consensus statement on perioperative fluid management within an enhanced recovery pathway for colorectal surgery. Perioper Med (Lond). 2016;5:24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13741-016-0049-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant MC, Hanna A, Benson A, Hobson D, Wu CL, Yuan CT, et al. Dedicated operating room teams and clinical outcomes in an enhanced recovery after surgery pathway for colorectal surgery. J Am Coll Surg. 2018;226:267&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2017.12.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant MC, Isada T, Ruzankin P, Whitman G, Lawton JS, Dodd OJ, et al. Results from an enhanced recovery program for cardiac surgery. J Thorac Cardiovasc Surg. 2020;159(1393&#x2013;1402):e1397.</Citation></Reference><Reference><Citation>Grant MC, Pio Roda CM, Canner JK, Sommer P, Galante D, Hobson D, et al. The impact of anesthesia-influenced process measure compliance on length of stay: results from an enhanced recovery after surgery for colorectal surgery cohort. Anesth Analg. 2019;128:68&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000003458</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollis RH, Kennedy GD. Postoperative complications after colorectal surgery: where are we in the era of enhanced recovery? Curr Gastroenterol Rep. 2020;22:26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11894-020-00763-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Koerner CP, Lopez-Aguiar AG, Zaidi M, Speegle S, Balch G, Shaffer VO, et al. Caution: increased acute kidney injury in enhanced recovery after surgery (ERAS) protocols. Am Surg. 2019;85:156&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000313481908500221</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcotte JH, Patel K, Desai R, Gaughan JP, Rattigan D, Cahill KW, et al. Acute kidney injury following implementation of an enhanced recovery after surgery (ERAS) protocol in colorectal surgery. Int J Colorectal Dis. 2018;33:1259&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00384-018-3084-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiener JGD, Goss L, Wahl TS, Terry MA, Burge KG, Chu DI, et al. The association of enhanced recovery pathway and acute kidney injury in patients undergoing colorectal surgery. Dis Colon Rectum. 2020;63:233&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/DCR.0000000000001528</ArticleId></ArticleIdList></Reference><Reference><Citation>Slagelse C, Gammelager H, Iversen LH, Sorensen HT, Christiansen CF. Acute kidney injury and 1-year mortality after colorectal cancer surgery: a population-based cohort study. BMJ Open. 2019;9:e024817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2018-024817</ArticleId></ArticleIdList></Reference><Reference><Citation>Turan A, Cohen B, Adegboye J, Makarova N, Liu L, Mascha EJ, et al. Mild acute kidney injury after noncardiac surgery is associated with long-term renal dysfunction: a retrospective cohort study. Anesthesiology. 2020;132:1053&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003109</ArticleId></ArticleIdList></Reference><Reference><Citation>Ripolles-Melchor J, Ramirez-Rodriguez JM, Casans-Frances R, Aldecoa C, Abad-Motos A, Logrono-Egea M, et al. Association between use of enhanced recovery after surgery protocol and postoperative complications in colorectal surgery: the postoperative outcomes within enhanced recovery after surgery protocol (POWER) study. JAMA Surg. 2019;154(8):725&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2019.0995</ArticleId></ArticleIdList></Reference><Reference><Citation>Ripoll&#xe9;s-Melchor J, Fuenmayor Varela M, Camargo S, Jerez Fern&#xe1;ndez P, Contreras del Barrio A, Mart&#xed;nez-Hurtado E, et al. Enhanced recovery after surgery protocol versus conventional perioperative care in colorectal surgery. A single center cohort study. Rev Bras Anestesiol. 2018;68:358&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjan.2018.01.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from kidney disease: Improving global outcomes (KDIGO). Kidney Int. 2005;67:2089&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1523-1755.2005.00365.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Masoomi H, Carmichael JC, Dolich M, Mills S, Ketana N, Pigazzi A, et al. Predictive factors of acute renal failure in colon and rectal surgery. Am Surg. 2012;78:1019&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000313481207801001</ArticleId></ArticleIdList></Reference><Reference><Citation>Grass F, Lovely JK, Crippa J, Mathis KL, Hubner M, Larson DW. Early acute kidney injury within an established enhanced recovery pathway: uncommon and transitory. World J Surg. 2019;43:1207&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-019-04923-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Frenette AJ, Bouchard J, Bernier P, Charbonneau A, Nguyen LT, Rioux JP, et al. Albumin administration is associated with acute kidney injury in cardiac surgery: a propensity score analysis. Crit Care. 2014;18:602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-014-0602-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksoy R, Adademir T, Yilmaz E, Cevirme D, Sengor M, Koksal C, et al. Is hypoalbuminemia a predictor for acute kidney injury after coronary bypass grafting in diabetes mellitus patients? Braz J Cardiovasc Surg. 2019;34:565&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">31165612</ArticleId><ArticleId IdType="pmc">6852450</ArticleId></ArticleIdList></Reference><Reference><Citation>Bang JY, Kim SO, Kim SG, Song JG, Kang J, Kim JW, et al. Impact of the serum albumin level on acute kidney injury after cerebral artery aneurysm clipping. PLoS ONE. 2018;13:e0206731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0206731</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K, Bang JY, Kim SO, Kim S, Kim JU, Song JG. Association of preoperative hypoalbuminemia with postoperative acute kidney injury in patients undergoing brain tumor surgery: a retrospective study. J Neurosurg. 2018;128:1115&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2016.11.JNS162237</ArticleId></ArticleIdList></Reference><Reference><Citation>Kee YK, Kim H, Jhee JH, Han SH, Yoo TH, Kang SW, et al. Incidence of and risk factors for delayed acute kidney injury in patients undergoing colorectal surgery. Am J Surg. 2019;218:907&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2019.03.027</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung SE, Hilkewich L, Gillis C, Heine JA, Fenton TR. Protein intakes are associated with reduced length of stay: a comparison between enhanced recovery after surgery (ERAS) and conventional care after elective colorectal surgery. Am J Clin Nutr. 2017;106:44&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">28468890</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EH, Kim WJ, Kim JY, Chin JH, Choi DK, Sim JY, et al. Effect of exogenous albumin on the incidence of postoperative acute kidney injury in patients undergoing off-pump coronary artery bypass surgery with a preoperative albumin level of less than 4.0 g/dl. Anesthesiology. 2016;124:1001&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001051</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26495853</PMID><DateCompleted><Year>2016</Year><Month>09</Month><Day>02</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1421-9670</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>4</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>American journal of nephrology</Title><ISOAbbreviation>Am J Nephrol</ISOAbbreviation></Journal><ArticleTitle>Intervention Associated Acute Kidney Injury and Long-Term Cardiovascular Outcomes.</ArticleTitle><Pagination><StartPage>285</StartPage><EndPage>294</EndPage><MedlinePgn>285-94</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1159/000440986</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute kidney injury (AKI) has been associated with all-cause short- and long-term mortality. However, its association with cardiovascular (CV) events remains unclear. We sought to investigate this in patients undergoing open (OAR) or endovascular (EVAR) abdominal aortic aneurysm repair, as they are likely to develop both AKI and CV morbidity. A meta-analysis was subsequently performed to confirm this in other CV-interventions.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">AKI-incidence was assessed in a multicentre-cohort of 1,068 patients undergoing EVAR (947 individuals) or OAR electively using the 'Acute Kidney Injury Network' criteria. A composite-endpoint was used, consisting of non-fatal myocardial infarction (MI), stroke, vascular event, hospitalisation due to heart failure and CV death. A systematic literature review identified studies reporting AKI-incidence and CV events. Risk ratios (RRs) at 1 and 5 years were combined using meta-analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">During a median follow-up of 62 months (range 11-121), AKI was associated with CV events on adjusted (for CV risk-factors) analyses (Incidence 36% of EVAR, 32% of OAR patients; hazard ratio 1.73, 95% CI 1.06-3.39, p=0.03) for the overall population. In the meta-analysis, 7 studies reported incidence of MI on 23,936 patients 1-year after coronary intervention (PCI) with a pooled RR of 1.76 (95% CI 1.45-2.83, p&lt;0.001); at 2 years, 3 studies reported MI incidence on 17,773 patients after PCI with a pooled RR of 1.34 (95% CI 1.10-1.63, p=0.003). MI-incidence was reported 5 years after cardiac surgery by 3 studies (33,701 patients) with a pooled RR of 1.60 (95% CI 1.43-1.81).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">AKI is associated with long-term CV events after surgery or endovascular intervention.</AbstractText><CopyrightInformation>&#xa9; 2015 S. Karger AG, Basel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Saratzis</LastName><ForeName>Athanasios</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences and NIHR Leicester Cardiovascular Biomedical Research Unit, University of Leicester, Leicester Royal Infirmary, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harrison</LastName><ForeName>Seamus</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Barratt</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Sayers</LastName><ForeName>Robert D</ForeName><Initials>RD</Initials></Author><Author ValidYN="Y"><LastName>Sarafidis</LastName><ForeName>Pantelis A</ForeName><Initials>PA</Initials></Author><Author ValidYN="Y"><LastName>Bown</LastName><ForeName>Matthew J</ForeName><Initials>MJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>10</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Am J Nephrol</MedlineTA><NlmUniqueID>8109361</NlmUniqueID><ISSNLinking>0250-8095</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Am J Nephrol. 2015;42(4):282-4. doi: 10.1159/000440686.</RefSource><PMID Version="1">26496654</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017544" MajorTopicYN="N">Aortic Aneurysm, Abdominal</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="Y">Endovascular Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062645" MajorTopicYN="N">Percutaneous Coronary Intervention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014656" MajorTopicYN="N">Vascular Surgical Procedures</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>7</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26495853</ArticleId><ArticleId IdType="doi">10.1159/000440986</ArticleId><ArticleId IdType="pii">000440986</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31623901</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>26</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0267</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>12</Issue><PubDate><Year>2019</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Injury</Title><ISOAbbreviation>Injury</ISOAbbreviation></Journal><ArticleTitle>Acute kidney injury following hip fracture.</ArticleTitle><Pagination><StartPage>2268</StartPage><EndPage>2271</EndPage><MedlinePgn>2268-2271</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.injury.2019.10.008</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0020-1383(19)30589-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hip fracture causes disability and excess mortality in the aging population. Acute kidney injury (AKI), is known to diminish survival of critically ill and trauma patients. AKI is also a common perioperative complication among surgical patients. We examined the effect of AKI on the survival of hip fracture patients in a Finnish hip fracture population and the risk factors for AKI in a prospective study.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study cohort constituted of 486 consecutive low-energy trauma hip fracture patients referred to Satakunta Central Hospital (Pori, Finland) and Turku University Hospital (Turku, Finland). The patients underwent standard diagnostics and treatment in the emergency department (ER) and were operated according to the local treatment protocol. Serum creatinine (sCr) was analyzed daily pre- and post-operatively during the hospital stay. Patients were divided into groups; AKI and non-AKI based on Kidney Disease: Improving Global Outcomes (KDIGO) criteria.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The incidence of AKI in the study cohort was 8.4% (40/475). Eleven patients were excluded due to missing sCr data. The baseline characteristics of AKI and non-AKI groups differed significantly concerning baseline sCr but were otherwise similar. At 90-day follow-up, the overall mortality was 14.4%. Patients with AKI had a significantly higher mortality (35.0%) than those with no AKI (12.7%) (p&#xa0;&lt;&#xa0;0.001). Dementia, preoperative sCr and any stage of AKI were independent predictors for mortality. Dementia and preoperative sCr were independently associated with post-operative AKI.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In this study AKI was a significant factor associated with a 3 -fold mortality during the first three months after surgery for low-energy trauma hip fracture.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rantalaiho</LastName><ForeName>Ida</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics and Traumatology, Turku University Hospital and University of Turku, P.O. Box 28, FIN-20701, Turku, Finland. Electronic address: ida.rantalaiho@tyks.fi.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gunn</LastName><ForeName>Jarmo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Heart Center, Turku University Hospital, Turku, Finland; Department of Surgery, University of Turku, Turku, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kukkonen</LastName><ForeName>Juha</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Orthopaedic and Trauma Surgery, Satakunta Central Hospital, Pori, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaipia</LastName><ForeName>Antti</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Urology, Tampere University Hospital and University of Tampere, Tampere, Finland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Injury</MedlineTA><NlmUniqueID>0226040</NlmUniqueID><ISSNLinking>0020-1383</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Injury. 2020 Jun;51(6):1406-1407. doi: 10.1016/j.injury.2020.03.060.</RefSource><PMID Version="1">32327230</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005387" MajorTopicYN="N" Type="Geographic">Finland</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="Y">Hip Fractures</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007677" MajorTopicYN="N">Kidney Function Tests</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010043" MajorTopicYN="N">Outcome and Process Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AKI</Keyword><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Hip fracture</Keyword><Keyword MajorTopicYN="N">Incidence</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31623901</ArticleId><ArticleId IdType="doi">10.1016/j.injury.2019.10.008</ArticleId><ArticleId IdType="pii">S0020-1383(19)30589-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35384076</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-0012</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Clinical transplantation</Title><ISOAbbreviation>Clin Transplant</ISOAbbreviation></Journal><ArticleTitle>Acute kidney injury after hip fracture in organ transplant recipients.</ArticleTitle><Pagination><StartPage>e14664</StartPage><MedlinePgn>e14664</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ctr.14664</ELocationID><Abstract><AbstractText Label="BACKGROUND">This study aimed to investigate the incidence and risk factors of acute kidney injury (AKI) after hip fracture in organ transplant recipients.</AbstractText><AbstractText Label="METHODS">In this single-center retrospective cohort study, 795 elderly patients who underwent hip fracture surgery were enrolled. AKI was defined according to Acute Kidney Injury Network criteria. Among the 795 patients, 23 underwent kidney transplantation (KT) and 20 underwent liver transplantation (LT). The incidence of AKI, dialysis requirement, and renal recovery rate were investigated.</AbstractText><AbstractText Label="RESULTS">AKI occurred in 83 patients (10.5%), of whom 9 (39.1%), 3 (15%), and 71 (9.5%) were in the KT, LT, and nontransplantation groups, respectively. The incidence rates of AKI and severe AKI (17.4%&#xa0;vs. 1.4%) were significantly higher in the KT group than in the nontransplantation group (P&#xa0;=&#xa0;.001 for both). The renal recovery rate was significantly lower in the KT group than in the nontransplantation group (P&#xa0;=&#xa0;.033). The multivariate analysis revealed that male; body mass index; CKD; alkaline phosphatase; intraoperative hypotension; and history of KT were independent predictors of AKI development.</AbstractText><AbstractText Label="CONCLUSIONS">AKI and severe AKI after hip fracture occurred more frequently in the KT recipients with lower renal recovery rates. Transplanted kidneys are more vulnerable to AKI after hip fracture.</AbstractText><CopyrightInformation>&#xa9; 2022 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moon</LastName><ForeName>Jun-Ki</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Chung-Ang University Gwang Myeong Hospital, Gwang Myeong, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hyosang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Jae Suk</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Asan Medical Center, Ulsan University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moon</LastName><ForeName>Sung Ho</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Asan Medical Center, Ulsan University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ji Wan</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Asan Medical Center, Ulsan University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Clin Transplant</MedlineTA><NlmUniqueID>8710240</NlmUniqueID><ISSNLinking>0902-0063</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016030" MajorTopicYN="Y">Kidney Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016031" MajorTopicYN="Y">Liver Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066027" MajorTopicYN="N">Transplant Recipients</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">hip fracture</Keyword><Keyword MajorTopicYN="N">kidney</Keyword><Keyword MajorTopicYN="N">liver</Keyword><Keyword MajorTopicYN="N">transplant</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>6</Day><Hour>9</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35384076</ArticleId><ArticleId IdType="doi">10.1111/ctr.14664</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Ju DG, Rajaee SS, Mirocha J, Lin CA, Moon CN. Nationwide analysis of femoral neck fractures in elderly patients: a receding tide. J Bone Joint Surg Am. 2017;99(22):1932-1940.</Citation></Reference><Reference><Citation>Griffin XL, Parsons N, Achten J, Fernandez M, Costa ML. Recovery of health-related quality of life in a United Kingdom hip fracture population. The Warwick Hip Trauma Evaluation-a prospective cohort study. Bone Joint J. 2015;97-B(3):372-382.</Citation></Reference><Reference><Citation>Panula J, Pihlajam&#xe4;ki H, Mattila VM, et&#xa0;al. Mortality and cause of death in hip fracture patients aged 65 or older: a population-based study. BMC Musculoskelet Disord. 2011;12:105.</Citation></Reference><Reference><Citation>Gundel O, Thygesen LC, G&#xf6;genur I, Ekeloef S. Postoperative mortality after a hip fracture over a 15-year period in Denmark: a national register study. Acta Orthop. 2020;91(1):58-62.</Citation></Reference><Reference><Citation>Biteker M, Dayan A, Tekke&#x15f;in AI, et&#xa0;al. Incidence, risk factors, and outcomes of perioperative acute kidney injury in noncardiac and nonvascular surgery. Am J Surg. 2014;207(1):53-59.</Citation></Reference><Reference><Citation>Pedersen AB, Christiansen CF, Gammelager H, Kahlert J, S&#xf8;rensen HT. Risk of acute renal failure and mortality after surgery for a fracture of the hip: a population-based cohort study. Bone Joint J. 2016;98-B(8):1112-1118.</Citation></Reference><Reference><Citation>Porter CJ, Moppett IK, Juurlink I, Nightingale J, Moran CG, Devonald MAJ. Acute and chronic kidney disease in elderly patients with hip fracture: prevalence, risk factors and outcome with development and validation of a risk prediction model for acute kidney injury. BMC Nephrol. 2017;18(1):20.</Citation></Reference><Reference><Citation>Ramsey-Goldman R, Dunn JE, Dunlop DD, et&#xa0;al. Increased risk of fracture in patients receiving solid organ transplants. J Bone Miner Res. 1999;14(3):456-463.</Citation></Reference><Reference><Citation>Sukumaran Nair S, Lenihan CR, Montez-Rath ME, Lowenberg DW, Chertow GM, Winkelmayer WC. Temporal trends in the incidence, treatment and outcomes of hip fracture after first kidney transplantation in the United States. Am J Transplant. 2014;14(4):943-951.</Citation></Reference><Reference><Citation>Mehrotra A, Rose C, Pannu N, Gill J, Tonelli M, Gill JS. Incidence and consequences of acute kidney injury in kidney transplant recipients. Am J Kidney Dis. 2012;59(4):558-565.</Citation></Reference><Reference><Citation>Thongprayoon C, Kaewput W, Thamcharoen N, et&#xa0;al. Incidence and impact of acute kidney injury after liver transplantation: a meta-analysis. J Clin Med. 2019;8(3):372.</Citation></Reference><Reference><Citation>Zongyi Y, Baifeng Li, Funian Z, Hao Li, Xin W. Risk factors of acute kidney injury after orthotopic liver transplantation in China. Sci Rep. 2017;7:41555.</Citation></Reference><Reference><Citation>Cooper JE, Wiseman AC. Acute kidney injury in kidney transplantation. Curr Opin Nephrol Hypertens. 2013;22(6):698-703.</Citation></Reference><Reference><Citation>Dudreuilh C, Aguiar R, Ostermann M. Acute kidney injury in kidney transplant patients. Acute Med. 2018;17(1):31-35.</Citation></Reference><Reference><Citation>Hilmi IA, Damian D, Al-Khafaji A, et&#xa0;al. Acute kidney injury following orthotopic liver transplantation: incidence, risk factors, and effects on patient and graft outcomes. Br J Anaesth. 2015;114(6):919-926.</Citation></Reference><Reference><Citation>Angeli P, Bezinover D, Biancofiore G, et&#xa0;al. Acute kidney injury in liver transplant candidates: a position paper on behalf of the Liver Intensive Care Group of Europe. Minerva Anestesiol. 2017;83(1):88-101.</Citation></Reference><Reference><Citation>Levey AS, Stevens LA, Schmid CH, et&#xa0;al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-612.</Citation></Reference><Reference><Citation>Levey AS, Eckardt K-U, Tsukamoto Y, et&#xa0;al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67(6):2089-2100.</Citation></Reference><Reference><Citation>Bijker JB, Van Klei WA, Kappen TH, Van Wolfswinkel L, Moons KGM, Kalkman CJ. Incidence of intraoperative hypotension as a function of the chosen definition: literature definitions applied to a retrospective cohort using automated data collection. Anesthesiology. 2007;107(2):213-220.</Citation></Reference><Reference><Citation>Mehta RL, Kellum JA, Shah SV, et&#xa0;al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31.</Citation></Reference><Reference><Citation>Waikar SS, Liu KD, Chertow GM. Diagnosis, epidemiology and outcomes of acute kidney injury. Clin J Am Soc Nephrol. 2008;3(3):844-861.</Citation></Reference><Reference><Citation>Chawla LS, Bellomo R, Bihorac A, et&#xa0;al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol. 2017;13(4):241-257.</Citation></Reference><Reference><Citation>Heung M, Steffick DE, Zivin K, et&#xa0;al. Acute kidney injury recovery pattern and subsequent risk of CKD: an analysis of veterans health administration data. Am J Kidney Dis. 2016;67(5):742-752.</Citation></Reference><Reference><Citation>Forni LG, Darmon M, Ostermann M, et&#xa0;al. Renal recovery after acute kidney injury. Intensive Care Med. 2017;43(6):855-866.</Citation></Reference><Reference><Citation>Ulucay C, Eren Z, Kaspar EC, et&#xa0;al. Risk factors for acute kidney injury after hip fracture surgery in the elderly individuals. Geriatr Orthop Surg Rehabil. 2012;3(4):150-156.</Citation></Reference><Reference><Citation>Shin K-Ho, Han S-B. Early postoperative hypoalbuminemia is a risk factor for postoperative acute kidney injury following hip fracture surgery. Injury. 2018;49(8):1572-1576.</Citation></Reference><Reference><Citation>Hong SE, Kim T-Y, Yoo Je-H, et&#xa0;al. Acute kidney injury can predict in-hospital and long-term mortality in elderly patients undergoing hip fracture surgery. PLoS One. 2017;12(4):e0176259.</Citation></Reference><Reference><Citation>Grams ME, Sang Y, Coresh J, et&#xa0;al. Acute kidney injury after major surgery: a retrospective analysis of veterans health administration data. Am J Kidney Dis. 2016;67(6):872-880.</Citation></Reference><Reference><Citation>Luo X, Jiang Li, Du B, Wen Y, Wang M, Xi X. A comparison of different diagnostic criteria of acute kidney injury in critically ill patients. Crit Care. 2014;18(4):R144.</Citation></Reference><Reference><Citation>Palamuthusingam D, Kunarajah K, Pascoe EM, Johnson DW, Hawley CM, Fahim M. Postoperative outcomes of kidney transplant recipients undergoing non-transplant-related elective surgery: a systematic review and meta-analysis. BMC Nephrol. 2020;21(1):365.</Citation></Reference><Reference><Citation>Choi Y-J, Lee E-H, Hahm K-D, Kwon K, Ro YJ. Transplantation is a risk factor for acute kidney injury in patients undergoing total hip replacement arthroplasty for avascular necrosis: an observational study. Transplant Proc. 2013;45(6):2220-2225.</Citation></Reference><Reference><Citation>Charette RS, Sloan M, Lee G-C. Not all hip arthroplasties are created equal: increased complications and re-admissions after total hip arthroplasty for femoral neck fractures compared with osteoarthritis. Bone Joint J. 2019;101-B(6_Supple_B):84-90.</Citation></Reference><Reference><Citation>Le Manach Y, Collins G, Bhandari M, et&#xa0;al. Outcomes after hip fracture surgery compared with elective total hip replacement. JAMA. 2015;314(11):1159-1166.</Citation></Reference><Reference><Citation>De Mattos AM, Olyaei AJ, Bennett WM. Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. Am J Kidney Dis. 2000;35(2):333-346.</Citation></Reference><Reference><Citation>Naesens M, Kuypers DRJ, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol. 2009;4(2):481-508.</Citation></Reference><Reference><Citation>Peters DH, Fitton A, Plosker GL, Faulds D. Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation. Drugs. 1993;46(4):746-794.</Citation></Reference><Reference><Citation>Barri YM, Sanchez EQ, Jennings LW, et&#xa0;al. Acute kidney injury following liver transplantation: definition and outcome. Liver Transpl. 2009;15(5):475-483.</Citation></Reference><Reference><Citation>Chen J, Singhapricha T, Hu Ke-Q, et&#xa0;al. Postliver transplant acute renal injury and failure by the RIFLE criteria in patients with normal pretransplant serum creatinine concentrations: a matched study. Transplantation. 2011;91(3):348-353.</Citation></Reference><Reference><Citation>Croome KP, Lee DD, Croome S, et&#xa0;al. The impact of postreperfusion syndrome during liver transplantation using livers with significant macrosteatosis. Am J Transplant. 2019;19(9):2550-2559.</Citation></Reference><Reference><Citation>De Haan JE, Hoorn EJ, De Geus HRH. Acute kidney injury after liver transplantation: recent insights and future perspectives. Best Pract Res Clin Gastroenterol. 2017;31(2):161-169.</Citation></Reference><Reference><Citation>Leithead JA, Armstrong MJ, Corbett C, et&#xa0;al. Hepatic ischemia reperfusion injury is associated with acute kidney injury following donation after brain death liver transplantation. Transpl Int. 2013;26(11):1116-1125.</Citation></Reference><Reference><Citation>Azpiazu D, Gonzalo S, Villa-Bellosta R. Tissue non-specific alkaline phosphatase and vascular calcification: a potential therapeutic target. Curr Cardiol Rev. 2019;15(2):91-95.</Citation></Reference><Reference><Citation>Sheen CR, Kuss P, Narisawa S, et&#xa0;al. Pathophysiological role of vascular smooth muscle alkaline phosphatase in medial artery calcification. J Bone Miner Res. 2015;30(5):824-836.</Citation></Reference><Reference><Citation>Taliercio JJ, Schold JD, Simon JF, et&#xa0;al. Prognostic importance of serum alkaline phosphatase in CKD stages 3-4 in a clinical population. Am J Kidney Dis. 2013;62(4):703-710.</Citation></Reference><Reference><Citation>Regidor DL, Kovesdy CP, Mehrotra R, et&#xa0;al. Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol. 2008;19(11):2193-2203.</Citation></Reference><Reference><Citation>Silva BC, Bilezikian JP. Parathyroid hormone: anabolic and catabolic actions on the skeleton. Curr Opin Pharmacol. 2015;22:41-50.</Citation></Reference><Reference><Citation>Sandid MS, Assi MA, Hall S. Intraoperative hypotension and prolonged operative time as risk factors for slow graft function in kidney transplant recipients. Clin Transplant. 2006;20(6):762-768.</Citation></Reference><Reference><Citation>Joosten A, Lucidi V, Ickx B, et&#xa0;al. Intraoperative hypotension during liver transplant surgery is associated with postoperative acute kidney injury: a historical cohort study. BMC Anesthesiol. 2021;21(1):12.</Citation></Reference><Reference><Citation>Jang WY, Jung J-K, Lee DKi, Han S-B. Intraoperative hypotension is a risk factor for postoperative acute kidney injury after femoral neck fracture surgery: a retrospective study. BMC Musculoskelet Disord. 2019;20(1):131.</Citation></Reference><Reference><Citation>Dolla C, Mella A, Vigilante G, et&#xa0;al. Recipient pre-existing chronic hypotension is associated with delayed graft function and inferior graft survival in kidney transplantation from elderly donors. PLoS One. 2021;16(4):e0249552.</Citation></Reference><Reference><Citation>Filiponi TC, Requi&#xe3;o-Moura LR, Tonato EJ, Carvalho De Matos AC, E Silva-Filho AP, De Souza Dur&#xe3;o Junior M. Hospital admission following acute kidney injury in kidney transplant recipients is associated with a negative impact on graft function after 1-year. PLoS One. 2015;10(9):e0138944.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25445101</PMID><DateCompleted><Year>2015</Year><Month>03</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1523-6838</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>2</Issue><PubDate><Year>2015</Year><Month>Feb</Month></PubDate></JournalIssue><Title>American journal of kidney diseases : the official journal of the National Kidney Foundation</Title><ISOAbbreviation>Am J Kidney Dis</ISOAbbreviation></Journal><ArticleTitle>Acute kidney injury and prognosis after cardiopulmonary bypass: a meta-analysis of cohort studies.</ArticleTitle><Pagination><StartPage>283</StartPage><EndPage>293</EndPage><MedlinePgn>283-93</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.ajkd.2014.09.008</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0272-6386(14)01252-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Robust estimates and sources of variation in risks of clinical outcomes for cardiopulmonary bypass (CPB)-associated acute kidney injury (AKI) are needed to inform clinical practice and policy. We aimed to assess whether the methods for defining acute kidney disease modify the estimated association of AKI with CPB.</AbstractText><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Systematic review and meta-analysis.</AbstractText><AbstractText Label="SETTING &amp; POPULATION" NlmCategory="METHODS">Adults undergoing CPB.</AbstractText><AbstractText Label="SELECTION CRITERIA FOR STUDIES" NlmCategory="METHODS">Cohort studies reporting adjusted associations between CPB-associated AKI and early mortality, later mortality, stroke, myocardial infarction, congestive heart failure, all-cause hospitalization, chronic kidney disease, end-stage kidney disease, bleeding complications, or perioperative infection.</AbstractText><AbstractText Label="PREDICTORS" NlmCategory="METHODS">CPB-associated AKI and renal replacement therapy.</AbstractText><AbstractText Label="OUTCOMES" NlmCategory="RESULTS">The primary outcome was early mortality (in-hospital or within 90 days of surgery) in studies reporting adjusted associations and secondary outcomes including total and cardiovascular mortality, major adverse cardiovascular events, rehospitalization, end-stage kidney disease, bleeding, and perioperative infection.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">46 studies with 47 unique cohorts comprising 242,388 participants were included. The pooled rate of CPB-associated AKI was 18.2%, and of renal replacement therapy, 2.1%. CPB-associated AKI was associated with early mortality (risk ratio [RR], 4.0; 95% CI, 3.1-5.2; crude mortality with CPB-associated AKI, 4.6%; without CPB-AKI, 1.5%) with considerable heterogeneity between studies (I(2)=87%). The AKI definition did not modify prognostic estimates (P for subgroup analysis&#xa0;= 0.9). When heterogeneity was fully accounted for using credibility ceilings, risks of early mortality were attenuated (RR, 2.2; 95% CI, 1.8-2.8) but remained high. Renal replacement therapy also was associated with early mortality (RR, 5.3; 95% CI, 3.4-8.1). CPB-associated AKI also was associated with long-term mortality (RR, 2.0; 95% CI, 1.7-2.3) and stroke (RR, 2.2; 95% CI, 1.1-4.5). No other outcomes were reported in more than 3 studies.</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">Unclear attrition from follow-up in most studies and variable adjustment for confounders across studies.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">CPB-associated AKI is associated with a more than 2-fold increase in early mortality regardless of AKI definition.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pickering</LastName><ForeName>John W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand. Electronic address: john.pickering@otago.ac.nz.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>James</LastName><ForeName>Matthew T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palmer</LastName><ForeName>Suetonia C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>11</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Kidney Dis</MedlineTA><NlmUniqueID>8110075</NlmUniqueID><ISSNLinking>0272-6386</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="N">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiopulmonary bypass (CBP)</Keyword><Keyword MajorTopicYN="N">acute kidney injury (AKI)</Keyword><Keyword MajorTopicYN="N">acute renal failure (ARF)</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">coronary artery bypass graft</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">stroke</Keyword><Keyword MajorTopicYN="N">valve surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25445101</ArticleId><ArticleId IdType="doi">10.1053/j.ajkd.2014.09.008</ArticleId><ArticleId IdType="pii">S0272-6386(14)01252-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">20517593</PMID><DateCompleted><Year>2011</Year><Month>02</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1238</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>10</Issue><PubDate><Year>2010</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Intensive care medicine</Title><ISOAbbreviation>Intensive Care Med</ISOAbbreviation></Journal><ArticleTitle>Hypoalbuminemia and acute kidney injury: a meta-analysis of observational clinical studies.</ArticleTitle><Pagination><StartPage>1657</StartPage><EndPage>1665</EndPage><MedlinePgn>1657-1665</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00134-010-1928-z</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To test the hypothesis that hypoalbuminemia is independently associated with increased risk of acute kidney injury (AKI).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A meta-analysis was performed of observational clinical studies evaluating the relationship between serum albumin level and the occurrence of AKI by multivariate methods. Additionally, the impact was assessed of lower serum albumin on mortality in patients who developed AKI. Eligible studies were sought by multiple methods, and adjusted odds ratios (OR) were quantitatively combined using a random effects model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Seventeen clinical studies with 3,917 total patients were included: 11 studies (6 in surgical or intensive care unit patients and 5 in other hospital settings) evaluating the influence of serum albumin on AKI incidence and 6 studies describing the relationship between serum albumin and mortality among patients who had developed AKI. Lower serum albumin was an independent predictor both of AKI and of death after AKI development. With each 10&#xa0;g&#xa0;L(-1) serum albumin decrement, the odds of AKI increased by 134%. The pooled OR for AKI was 2.34 with a 95% confidence interval (CI) of 1.74-3.14. Among patients who had developed AKI, the odds of death rose 147% (pooled OR 2.47, 95% CI 1.51-4.05) with each 10&#xa0;g&#xa0;L(-1) serum albumin decrement.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This meta-analysis provides evidence that hypoalbuminemia is a significant independent predictor both of AKI and of death following AKI development. Serum albumin determinations may be of utility in identifying patients at increased risk for AKI or for death after AKI. Controlled studies are warranted to assess interventions aimed at correcting hypoalbuminemia.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wiedermann</LastName><ForeName>Christian J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Division of Internal Medicine, Central Hospital of Bolzano, Lorenz B&#xf6;hler Street 5, 39100, Bolzano, Italy. christian.wiedermann@asbz.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiedermann</LastName><ForeName>Wolfgang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Division of Applied Psychology and Research Methodology, Institute of Psychology, University of Klagenfurt, Klagenfurt, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joannidis</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>06</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Intensive Care Med</MedlineTA><NlmUniqueID>7704851</NlmUniqueID><ISSNLinking>0342-4642</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Intensive Care Med. 2021 Feb;47(2):262. doi: 10.1007/s00134-020-06268-z.</RefSource><PMID Version="1">33052419</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034141" MajorTopicYN="N">Hypoalbuminemia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2009</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2010</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2010</Year><Month>6</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20517593</ArticleId><ArticleId IdType="pmc">PMC7728653</ArticleId><ArticleId IdType="doi">10.1007/s00134-010-1928-z</ArticleId><ArticleId IdType="pii">10.1007/s00134-010-1928-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Metnitz PG, Krenn CG, Steltzer H, Lang T, Ploder J, Lenz K, Le Gall JR, Druml W. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med. 2002;30:2051&#x2013;2058. doi: 10.1097/00003246-200209000-00016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200209000-00016</ArticleId><ArticleId IdType="pubmed">12352040</ArticleId></ArticleIdList></Reference><Reference><Citation>Joannidis M, Metnitz B, Bauer P, Schusterschitz N, Moreno R, Druml W, Metnitz PG. Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med. 2009;35:1692&#x2013;1702. doi: 10.1007/s00134-009-1530-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-009-1530-4</ArticleId><ArticleId IdType="pubmed">19547955</ArticleId></ArticleIdList></Reference><Reference><Citation>de Mendon&#xe7;a A, Vincent JL, Suter PM, Moreno R, Dearden NM, Antonelli M, Takala J, Sprung C, Cantraine F. Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med. 2000;26:915&#x2013;921. doi: 10.1007/s001340051281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001340051281</ArticleId><ArticleId IdType="pubmed">10990106</ArticleId></ArticleIdList></Reference><Reference><Citation>Joannidis M, Metnitz PG. Epidemiology and natural history of acute renal failure in the ICU. Crit Care Clin. 2005;21:239&#x2013;249. doi: 10.1016/j.ccc.2004.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2004.12.005</ArticleId><ArticleId IdType="pubmed">15781160</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg. 2003;237:319&#x2013;334. doi: 10.1097/00000658-200303000-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-200303000-00005</ArticleId><ArticleId IdType="pmc">PMC1514323</ArticleId><ArticleId IdType="pubmed">12616115</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev. 1987;9:1&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">3678409</ArticleId></ArticleIdList></Reference><Reference><Citation>Rich MW, Keller AJ, Schechtman KB, Marshall WG, Jr, Kouchoukos NT. Increased complications and prolonged hospital stay in elderly cardiac surgical patients with low serum albumin. Am J Cardiol. 1989;63:714&#x2013;718. doi: 10.1016/0002-9149(89)90257-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9149(89)90257-9</ArticleId><ArticleId IdType="pubmed">2923060</ArticleId></ArticleIdList></Reference><Reference><Citation>Rich MW, Crecelius CA. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70&#xa0;years of age or older. A prospective study. Arch Intern Med. 1990;150:1237&#x2013;1242. doi: 10.1001/archinte.150.6.1237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.150.6.1237</ArticleId><ArticleId IdType="pubmed">2353856</ArticleId></ArticleIdList></Reference><Reference><Citation>Contreras AM, Ram&#xed;rez M, Cueva L, Alvarez S, de Loza R, Gamba G. Low serum albumin and the increased risk of amikacin nephrotoxicity. Rev Invest Clin. 1994;46:37&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">8079062</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow GM, Lazarus JM, Paganini EP, Allgren RL, Lafayette RA, Sayegh MH. Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis. The Auriculin Anaritide Acute Renal Failure Study Group. J Am Soc Nephrol. 1998;9:692&#x2013;698.</Citation><ArticleIdList><ArticleId IdType="pubmed">9555672</ArticleId></ArticleIdList></Reference><Reference><Citation>Obialo CI, Okonofua EC, Nzerue MC, Tayade AS, Riley LJ. Role of hypoalbuminemia and hypocholesterolemia as copredictors of mortality in acute renal failure. Kidney Int. 1999;56:1058&#x2013;1063. doi: 10.1046/j.1523-1755.1999.00622.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1523-1755.1999.00622.x</ArticleId><ArticleId IdType="pubmed">10469374</ArticleId></ArticleIdList></Reference><Reference><Citation>Lins RL, Elseviers M, Daelemans R, Zachee P, Gheuens E, Lens S, De Broe ME. Prognostic value of a new scoring system for hospital mortality in acute renal failure. Clin Nephrol. 2000;53:10&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">10661477</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xe9;tourneau I, Dorval M, B&#xe9;langer R, L&#xe9;gar&#xe9; M, Fortier L, Leblanc M. Acute renal failure in bone marrow transplant patients admitted to the intensive care unit. Nephron. 2002;90:408&#x2013;412. doi: 10.1159/000054728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000054728</ArticleId><ArticleId IdType="pubmed">11961399</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim GH, Oh KH, Yoon JW, Koo JW, Kim HJ, Chae DW, Noh JW, Kim JH, Park YK. Impact of burn size and initial serum albumin level on acute renal failure occurring in major burn. Am J Nephrol. 2003;23:55&#x2013;60. doi: 10.1159/000066299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000066299</ArticleId><ArticleId IdType="pubmed">12373081</ArticleId></ArticleIdList></Reference><Reference><Citation>Chawla LS, Abell L, Mazhari R, Egan M, Kadambi N, Burke HB, Junker C, Seneff MG, Kimmel PL. Identifying critically ill patients at high risk for developing acute renal failure: a pilot study. Kidney Int. 2005;68:2274&#x2013;2280. doi: 10.1111/j.1523-1755.2005.00686.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1523-1755.2005.00686.x</ArticleId><ArticleId IdType="pubmed">16221229</ArticleId></ArticleIdList></Reference><Reference><Citation>Dharan KS, John GT, Antonisamy B, Kirubakaran MG, Jacob CK. Prediction of mortality in acute renal failure in the tropics. Ren Fail. 2005;27:289&#x2013;296.</Citation><ArticleIdList><ArticleId IdType="pubmed">15957545</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyle JM, Moualla S, Arrigain S, Worley S, Bakri MH, Starling RC, Heyka R, Thakar CV. Risks and outcomes of acute kidney injury requiring dialysis after cardiac transplantation. Am J Kidney Dis. 2006;48:787&#x2013;796. doi: 10.1053/j.ajkd.2006.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2006.08.002</ArticleId><ArticleId IdType="pubmed">17059998</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabezuelo JB, Ram&#xed;rez P, R&#xed;os A, Acosta F, Torres D, Sansano T, Pons JA, Bru M, Montoya M, Bueno FS, Robles R, Parrilla P. Risk factors of acute renal failure after liver transplantation. Kidney Int. 2006;69:1073&#x2013;1080. doi: 10.1038/sj.ki.5000216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ki.5000216</ArticleId><ArticleId IdType="pubmed">16528257</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahajan S, Tiwari S, Bharani R, Bhowmik D, Ravi S, Agarwal SK, Tiwari SC. Spectrum of acute renal failure and factors predicting its outcome in an intensive care unit in India. Ren Fail. 2006;28:119&#x2013;124. doi: 10.1080/08860220500530395.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08860220500530395</ArticleId><ArticleId IdType="pubmed">16538968</ArticleId></ArticleIdList></Reference><Reference><Citation>Sezer MT, Demir M, Gungor G, Senol A. Predictors of mortality in patients with acute renal failure. Acta Medica (Hradec Kralove) 2006;49:183&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">17117607</ArticleId></ArticleIdList></Reference><Reference><Citation>Drawz PE, Miller RT, Sehgal AR. Predicting hospital-acquired acute kidney injury&#x2014;a case-controlled study. Ren Fail. 2008;30:848&#x2013;855. doi: 10.1080/08860220802356515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08860220802356515</ArticleId><ArticleId IdType="pubmed">18925522</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J, Chung HC, Lee JS, Lee BM, Kim DM, Hwang JC, Jo MW, Noh M, Shin JW. Acute kidney injury after transarterial chemoembolization for hepatocellular carcinoma: a retrospective analysis. Blood Purif. 2008;26:454&#x2013;459. doi: 10.1159/000157322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000157322</ArticleId><ArticleId IdType="pubmed">18810227</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung CC, Liu WC, Kuo MC, Lee CH, Hwang SJ, Chen HC. Acute renal failure and its risk factors in Stevens-Johnson syndrome and toxic epidermal necrolysis. Am J Nephrol. 2009;29:633&#x2013;638. doi: 10.1159/000195632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000195632</ArticleId><ArticleId IdType="pubmed">19155617</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure&#x2013;definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204&#x2013;R212. doi: 10.1186/cc2872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc2872</ArticleId><ArticleId IdType="pmc">PMC522841</ArticleId><ArticleId IdType="pubmed">15312219</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31. doi: 10.1186/cc5713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc5713</ArticleId><ArticleId IdType="pmc">PMC2206446</ArticleId><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawidson IJ, Sandor ZF, Coorpender L, Palmer B, Peters P, Lu C, Sagalowsky A, Risser R, Willms C. Intraoperative albumin administration affects the outcome of cadaver renal transplantation. Transplantation. 1992;53:774&#x2013;782. doi: 10.1097/00007890-199204000-00014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007890-199204000-00014</ArticleId><ArticleId IdType="pubmed">1566343</ArticleId></ArticleIdList></Reference><Reference><Citation>Pockaj BA, Yang JC, Lotze MT, Lange JR, Spencer WF, Steinberg SM, Topalian SL, Schwartzentruber DJ, White DE, Rosenberg SA. A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin-2 therapy. J Immunother. 1994;15:22&#x2013;28. doi: 10.1097/00002371-199401000-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002371-199401000-00003</ArticleId><ArticleId IdType="pubmed">8110727</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461&#x2013;470.</Citation><ArticleIdList><ArticleId IdType="pubmed">10075613</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine JS, Koh JS, Triaca V, Lieberthal W. Lysophosphatidic acid: a novel growth and survival factor for renal proximal tubular cells. Am J Physiol. 1997;273:F575&#x2013;F585.</Citation><ArticleIdList><ArticleId IdType="pubmed">9362335</ArticleId></ArticleIdList></Reference><Reference><Citation>Iglesias J, Abernethy VE, Wang Z, Lieberthal W, Koh JS, Levine JS. Albumin is a major serum survival factor for renal tubular cells and macrophages through scavenging of ROS. Am J Physiol. 1999;277:F711&#x2013;F722.</Citation><ArticleIdList><ArticleId IdType="pubmed">10564234</ArticleId></ArticleIdList></Reference><Reference><Citation>Burleson RL, Jones DB, Yenikomshian AM, Cornwall C, DeVoe C, DeRito J. Clinical renal preservation by cryoperfusion with an albumin perfusate: renal perfusion with albumin. Arch Surg. 1978;113:688&#x2013;692.</Citation><ArticleIdList><ArticleId IdType="pubmed">350192</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufmann MA, Castelli I, Pargger H, Drop LJ. Nitric oxide dose-response study in the isolated perfused rat kidney after inhibition of endothelium-derived relaxing factor synthesis: the role of serum albumin. J Pharmacol Exp Ther. 1995;273:855&#x2013;862.</Citation><ArticleIdList><ArticleId IdType="pubmed">7752090</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerkens JF. Reproducible vasodilatation by platelet-activating factor in blood- and Krebs-perfused rat kidneys is albumin-dependent. Eur J Pharmacol. 1990;177:119&#x2013;126. doi: 10.1016/0014-2999(90)90261-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-2999(90)90261-4</ArticleId><ArticleId IdType="pubmed">2311673</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamlauski-Tucker M, Cohen JJ. Effect of substrate-free albumin on perfused rat kidney function. Ren Physiol. 1988;10:352&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pubmed">3231893</ArticleId></ArticleIdList></Reference><Reference><Citation>MacPhee PJ, Michel CC. Fluid uptake from the renal medulla into the ascending vasa recta in anaesthetized rats. J Physiol. 1995;487:169&#x2013;183.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1156607</ArticleId><ArticleId IdType="pubmed">7473246</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon R, Brunskill NJ. Activation of mitogenic pathways by albumin in kidney proximal tubule epithelial cells: implications for the pathophysiology of proteinuric states. J Am Soc Nephrol. 1999;10:1487&#x2013;1497.</Citation><ArticleIdList><ArticleId IdType="pubmed">10405204</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YJ, Han HJ. Albumin-stimulated DNA synthesis is mediated by Ca2+/PKC as well as EGF receptor-dependent p44/42 MAPK and NF-&#x3ba;B signal pathways in renal proximal tubule cells. Am J Physiol Renal Physiol. 2008;294:F534&#x2013;F541. doi: 10.1152/ajprenal.00408.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.00408.2007</ArticleId><ArticleId IdType="pubmed">18160626</ArticleId></ArticleIdList></Reference><Reference><Citation>Joannidis M, Druml W, Forni LG, Groeneveld AB, Honore P, Oudemans-van Straaten HM, Ronco C, Schetz MR, Woittiez AJ. Prevention of acute kidney injury and protection of renal function in the intensive care unit Expert opinion of the Working Group for Nephrology, ESICM. Intensive Care Med. 2010;36:392&#x2013;411. doi: 10.1007/s00134-009-1678-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-009-1678-y</ArticleId><ArticleId IdType="pubmed">19921152</ArticleId></ArticleIdList></Reference><Reference><Citation>Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350:2247&#x2013;2256. doi: 10.1056/NEJMoa040232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa040232</ArticleId><ArticleId IdType="pubmed">15163774</ArticleId></ArticleIdList></Reference><Reference><Citation>Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, Castells L, Vargas V, Soriano G, Guevara M, Gin&#xe8;s P, Rod&#xe9;s J. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999;341:403&#x2013;409. doi: 10.1056/NEJM199908053410603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199908053410603</ArticleId><ArticleId IdType="pubmed">10432325</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T-A, Tsao Y-C, Chen A, Lo G-H, Lin C-K, Yu H-C, Cheng L-C, Hsu P-I, Tsai W-L. Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis. Scand J Gastroenterol. 2009;44:619&#x2013;625. doi: 10.1080/00365520902719273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00365520902719273</ArticleId><ArticleId IdType="pubmed">19191184</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez J, Monteagudo J, Bargallo X, Jim&#xe9;nez W, Bosch J, Arroyo V, Navasa M. A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis. Hepatology. 2005;42:627&#x2013;634. doi: 10.1002/hep.20829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.20829</ArticleId><ArticleId IdType="pubmed">16108036</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega R, Gin&#xe8;s P, Uriz J, C&#xe1;rdenas A, Calahorra B, De Las Heras D, Guevara M, Bataller R, Jim&#xe9;nez W, Arroyo V, Rod&#xe9;s J. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology. 2002;36:941&#x2013;948.</Citation><ArticleIdList><ArticleId IdType="pubmed">12297842</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitzner SR, Stange J, Klammt S, Risler T, Erley CM, Bader BD, Berger ED, Lauchart W, Peszynski P, Freytag J, Hickstein H, Loock J, L&#xf6;hr J-M, Liebe S, Emmrich J, Korten G, Schmidt R. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl. 2000;6:277&#x2013;286. doi: 10.1053/lv.2000.6355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/lv.2000.6355</ArticleId><ArticleId IdType="pubmed">10827226</ArticleId></ArticleIdList></Reference><Reference><Citation>Elias MM, Comin EJ, Grosman ME, Galeazzi SA, Rodriguez Garay EA. Inhibitory effect of unconjugated bilirubin on p-aminohippurate transport in rat kidney cortex slices. Biochim Biophys Acta. 1982;693:265&#x2013;272. doi: 10.1016/0005-2736(82)90431-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0005-2736(82)90431-X</ArticleId><ArticleId IdType="pubmed">7159579</ArticleId></ArticleIdList></Reference><Reference><Citation>Elias MM, Comin EJ, Grosman ME, Galeazzi SA, Rodriguez Garay EA. Possible mechanism of unconjugated bilirubin toxicity on renal tissue. Comp Biochem Physiol A Comp Physiol. 1987;87:1003&#x2013;1007. doi: 10.1016/0300-9629(87)90027-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0300-9629(87)90027-2</ArticleId><ArticleId IdType="pubmed">2887366</ArticleId></ArticleIdList></Reference><Reference><Citation>Fliser D, Zurbr&#xfc;ggen I, Mutschler E, Bischoff I, Nussberger J, Franek E, Ritz E. Coadministration of albumin and furosemide in patients with the nephrotic syndrome. Kidney Int. 1999;55:629&#x2013;634. doi: 10.1046/j.1523-1755.1999.00298.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1523-1755.1999.00298.x</ArticleId><ArticleId IdType="pubmed">9987087</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38599161</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Processed electroencephalography-guided general anesthesia and norepinephrine requirements: A randomized trial in patients having vascular surgery.</ArticleTitle><Pagination><StartPage>111459</StartPage><MedlinePgn>111459</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2024.111459</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(24)00088-6</ELocationID><Abstract><AbstractText Label="STUDY OBJECTIVE">Processed electroencephalography (pEEG) may help clinicians optimize depth of general anesthesia. Avoiding excessive depth of anesthesia may reduce intraoperative hypotension and the need for vasopressors. We tested the hypothesis that pEEG-guided - compared to non-pEEG-guided - general anesthesia reduces the amount of norepinephrine needed to keep intraoperative mean arterial pressure above 65&#xa0;mmHg in patients having vascular surgery.</AbstractText><AbstractText Label="DESIGN">Randomized controlled clinical trial.</AbstractText><AbstractText Label="SETTING">University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</AbstractText><AbstractText Label="PATIENTS">110 patients having vascular surgery.</AbstractText><AbstractText Label="INTERVENTIONS">pEEG-guided general anesthesia.</AbstractText><AbstractText Label="MEASUREMENTS">Our primary endpoint was the average norepinephrine infusion rate from the beginning of induction of anesthesia until the end of surgery.</AbstractText><AbstractText Label="MAIN RESULT">96 patients were analyzed. The mean&#xa0;&#xb1;&#xa0;standard deviation average norepinephrine infusion rate was 0.08&#xa0;&#xb1;&#xa0;0.04&#xa0;&#x3bc;g&#xa0;kg<sup>-1</sup>&#xa0;min<sup>-1</sup> in patients assigned to pEEG-guided and 0.12&#xa0;&#xb1;&#xa0;0.09&#xa0;&#x3bc;g&#xa0;kg<sup>-1</sup>&#xa0;min<sup>-1</sup> in patients assigned to non-pEEG-guided general anesthesia (mean difference 0.04&#xa0;&#x3bc;g&#xa0;kg<sup>-1</sup>&#xa0;min<sup>-1</sup>, 95% confidence interval 0.01 to 0.07&#xa0;&#x3bc;g&#xa0;kg<sup>-1</sup>&#xa0;min<sup>-1</sup>, p&#xa0;=&#xa0;0.004). Patients assigned to pEEG-guided versus non-pEEG-guided general anesthesia, had a median time-weighted minimum alveolar concentration of 0.7 (0.6, 0.8) versus 0.8 (0.7, 0.8) (p&#xa0;=&#xa0;0.006) and a median percentage of time Patient State Index was &lt;25 of 12 (1, 41) % versus 23 (3, 49) % (p&#xa0;=&#xa0;0.279).</AbstractText><AbstractText Label="CONCLUSION">pEEG-guided - compared to non-pEEG-guided - general anesthesia reduced the amount of norepinephrine needed to keep mean arterial pressure above 65&#xa0;mmHg by about a third in patients having vascular surgery. Whether reduced intraoperative norepinephrine requirements resulting from pEEG-guided general anesthesia translate into improved patient-centered outcomes remains to be determined in larger trials.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thomsen</LastName><ForeName>Kristen K</ForeName><Initials>KK</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: science.thomsen@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sessler</LastName><ForeName>Daniel I</ForeName><Initials>DI</Initials><AffiliationInfo><Affiliation>OutcomesResearch Consortium, Department of Anesthesiology, Cleveland Clinic, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krause</LastName><ForeName>Linda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoppe</LastName><ForeName>Phillip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Opitz</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kessler</LastName><ForeName>Till</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chindris</LastName><ForeName>Viorel</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bergholz</LastName><ForeName>Alina</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flick</LastName><ForeName>Moritz</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kouz</LastName><ForeName>Karim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; OutcomesResearch Consortium, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Z&#xf6;llner</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulte-Uentrop</LastName><ForeName>Leonie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saugel</LastName><ForeName>Bernd</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; OutcomesResearch Consortium, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05293288</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>X4W3ENH1CV</RegistryNumber><NameOfSubstance UI="D009638">Norepinephrine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009638" MajorTopicYN="Y">Norepinephrine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004569" MajorTopicYN="Y">Electroencephalography</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014656" MajorTopicYN="Y">Vascular Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="Y">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062186" MajorTopicYN="N">Arterial Pressure</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="N">Monitoring, Intraoperative</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Anesthesia</Keyword><Keyword MajorTopicYN="N">Blood pressure</Keyword><Keyword MajorTopicYN="N">Electroencephalography</Keyword><Keyword MajorTopicYN="N">Hemodynamic monitoring</Keyword><Keyword MajorTopicYN="N">Hypotension</Keyword><Keyword MajorTopicYN="N">Patient state index</Keyword><Keyword MajorTopicYN="N">Vasopressor</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: KKT has no conflicts of interest to declare. DIS has received research funding from Edwards Lifesciences; he also is an advisor and has equity interest in Perceptive Medical (Newport Beach, CA, USA). LK has no conflicts of interest to declare. PH has no conflicts of interest to declare. BO has no conflicts of interest to declare. TK has no conflicts of interest to declare. VC has no conflicts of interest to declare. AB has no conflicts of interest to declare. MF is a consultant for Edwards Lifesciences (Irvine, CA, USA) and has received honoraria for consulting and giving lectures from CNSystems Medizintechnik (Graz, Austria). KK is a consultant for and has received honoraria for giving lectures from Edwards Lifesciences (Irvine, CA, USA). KK is a consultand for Vygon (Aachen, Germany). CZ has no conflict of interest to declare. LS-U has no conflicts of interest to declare. BS has received honoraria for giving lectures from Masimo (Neuch&#xe2;tel, Switzerland). BS is a consultant for and has received institutional restricted research grants and honoraria for giving lectures from Edwards Lifesciences (Irvine, CA, USA). BS is a consultant for Philips North America (Cambridge, MA, USA) and has received honoraria for giving lectures from Philips Medizin Systeme B&#xf6;blingen (B&#xf6;blingen, Germany). BS has received institutional restricted research grants and honoraria for giving lectures from Baxter (Deerfield, IL, USA). BS is a consultant for and has received institutional restricted research grants and honoraria for giving lectures from GE Healthcare (Chicago, IL, USA). BS has received institutional restricted research grants and honoraria for giving lectures from CNSystems Medizintechnik (Graz, Austria). BS is a consultant for Maquet Critical Care (Solna, Sweden). BS has received honoraria for giving lectures from Getinge (Gothenburg, Sweden). BS is a consultant for and has received institutional restricted research grants and honoraria for giving lectures from Pulsion Medical Systems (Feldkirchen, Germany). BS is a consultant for and has received institutional restricted research grants and honoraria for giving lectures from Vygon (Aachen, Germany). BS is a consultant for and has received institutional restricted research grants from Retia Medical (Valhalla, NY, USA). BS is a consultant for Dynocardia (Cambridge, MA, USA). BS has received institutional restricted research grants from Osypka Medical (Berlin, Germany). BS was a consultant for and has received institutional restricted research grants from Tensys Medical (San Diego, CA, USA). BS is an Editor of the British Journal of Anesthesia.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>28</Day><Hour>7</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>11</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>10</Day><Hour>18</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38599161</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2024.111459</ArticleId><ArticleId IdType="pii">S0952-8180(24)00088-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29203473</PMID><DateCompleted><Year>2019</Year><Month>07</Month><Day>08</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1533-3450</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of the American Society of Nephrology : JASN</Title><ISOAbbreviation>J Am Soc Nephrol</ISOAbbreviation></Journal><ArticleTitle>Perioperative THR-184 and AKI after Cardiac Surgery.</ArticleTitle><Pagination><StartPage>670</StartPage><EndPage>679</EndPage><MedlinePgn>670-679</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1681/ASN.2017020217</ELocationID><Abstract><AbstractText>AKI after cardiac surgery is associated with mortality, prolonged hospital length of stay, use of dialysis, and subsequent CKD. We evaluated the effects of THR-184, a bone morphogenetic protein-7 agonist, in patients at high risk for AKI after cardiac surgery. We conducted a randomized, double-blind, placebo-controlled, multidose comparison of the safety and efficacy of perioperative THR-184 using a two-stage seamless adaptive design in 452 patients between 18 and 85 years of age who were scheduled for nonemergent cardiac surgery requiring cardiopulmonary bypass and had recognized risk factors for AKI. The primary efficacy end point was the proportion of patients who developed AKI according to Kidney Disease Improving Global Outcomes (KDIGO) criteria. The proportion of patients who developed AKI within 7 days of surgery was similar in THR-184 treatment groups and placebo groups (range, 74%-79%; <i>P</i>=0.43). Prespecified secondary end point analysis did not show significant differences in the severity of AKI stage (<i>P</i>=0.53) or the total duration of AKI (<i>P</i>=0.44). A composite of death, dialysis, or sustained impaired renal function by day 30 after surgery did not differ between groups (range, 11%-20%; <i>P</i>=0.46). Safety-related outcomes were similar across all treatment groups. In conclusion, compared with placebo, administration of perioperative THR-184 through a range of dose exposures failed to reduce the incidence, severity, or duration of AKI after cardiac surgery in high-risk patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 by the American Society of Nephrology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Himmelfarb</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine, Kidney Research Institute, University of Washington, Seattle, Washington; Jhimmelfarb@nephrology.washington.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chertow</LastName><ForeName>Glenn M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>School of Medicine, Stanford University, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCullough</LastName><ForeName>Peter A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Baylor University Medical Center, Dallas, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mesana</LastName><ForeName>Thierry</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University of Ottawa Heart Institute, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Andrew D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sundt</LastName><ForeName>Thoralf M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Craig</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, New Brunswick Heart Centre, Saint John, New Brunswick, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cortville</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Cardiac and Vascular Research Center, McLaren Northern Michigan, Petoskey, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dagenais</LastName><ForeName>Fran&#xe7;ois</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Institut Universitaire de Cardiologie et de Pneumologie, Quebec City, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Varennes</LastName><ForeName>Benoit</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Surgery, McGill University Health Centre, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fontes</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Yale University School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossert</LastName><ForeName>Jerome</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Thrasos Therapeutics, Inc., Boston, Massachusetts; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tardif</LastName><ForeName>Jean-Claude</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Medicine, Montreal Heart Institute, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR001863</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000076362">Adaptive Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Soc Nephrol</MedlineTA><NlmUniqueID>9013836</NlmUniqueID><ISSNLinking>1046-6673</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C525819">BMP7 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D055419">Bone Morphogenetic Protein 7</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009842">Oligopeptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000632227">THR-184</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055419" MajorTopicYN="N">Bone Morphogenetic Protein 7</DescriptorName><QualifierName UI="Q000819" MajorTopicYN="Y">agonists</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009842" MajorTopicYN="N">Oligopeptides</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059035" MajorTopicYN="N">Perioperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017211" MajorTopicYN="N">Treatment Failure</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute renal failure</Keyword><Keyword MajorTopicYN="N">bone morphogenetic protein</Keyword><Keyword MajorTopicYN="N">randomized controlled trials</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29203473</ArticleId><ArticleId IdType="pmc">PMC5791058</ArticleId><ArticleId IdType="doi">10.1681/ASN.2017020217</ArticleId><ArticleId IdType="pii">ASN.2017020217</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bellomo R, Kellum JA, Ronco C: Acute kidney injury. Lancet 380: 756&#x2013;766, 2012</Citation><ArticleIdList><ArticleId IdType="pubmed">22617274</ArticleId></ArticleIdList></Reference><Reference><Citation>Chawla LS, Eggers PW, Star RA, Kimmel PL: Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med 371: 58&#x2013;66, 2014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9720902</ArticleId><ArticleId IdType="pubmed">24988558</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu CY, McCulloch CE, Fan D, Ordo&#xf1;ez JD, Chertow GM, Go AS: Community-based incidence of acute renal failure. Kidney Int 72: 208&#x2013;212, 2007</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2673495</ArticleId><ArticleId IdType="pubmed">17507907</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiele RH, Isbell JM, Rosner MH: AKI associated with cardiac surgery. Clin J Am Soc Nephrol 10: 500&#x2013;514, 2015</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4348689</ArticleId><ArticleId IdType="pubmed">25376763</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators : Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA 294: 813&#x2013;818, 2005</Citation><ArticleIdList><ArticleId IdType="pubmed">16106006</ArticleId></ArticleIdList></Reference><Reference><Citation>McCullough PA, Bennett-Guerrero E, Chawla LS, Beaver T, Mehta RL, Molitoris BA, Eldred A, Ball G, Lee HJ, Houser MT, Khan S: ABT-719 for the prevention of acute kidney injury in patients undergoing high-risk cardiac surgery: A randomized phase 2b clinical trial. J Am Heart Assoc 5: e003549, 2016</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5015281</ArticleId><ArticleId IdType="pubmed">27543797</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase M, Bellomo R, Matalanis G, Calzavacca P, Dragun D, Haase-Fielitz A: A comparison of the RIFLE and Acute Kidney Injury Network classifications for cardiac surgery-associated acute kidney injury: A prospective cohort study. J Thorac Cardiovasc Surg 138: 1370&#x2013;1376, 2009</Citation><ArticleIdList><ArticleId IdType="pubmed">19733864</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuitunen A, Vento A, Suojaranta-Ylinen R, Pettil&#xe4; V: Acute renal failure after cardiac surgery: Evaluation of the RIFLE classification. Ann Thorac Surg 81: 542&#x2013;546, 2006</Citation><ArticleIdList><ArticleId IdType="pubmed">16427848</ArticleId></ArticleIdList></Reference><Reference><Citation>Robert AM, Kramer RS, Dacey LJ, Charlesworth DC, Leavitt BJ, Helm RE, Hernandez F, Sardella GL, Frumiento C, Likosky DS, Brown JR; Northern New England Cardiovascular Disease Study Group : Cardiac surgery-associated acute kidney injury: A comparison of two consensus criteria. Ann Thorac Surg 90: 1939&#x2013;1943, 2010</Citation><ArticleIdList><ArticleId IdType="pubmed">21095340</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanardo G, Michielon P, Paccagnella A, Rosi P, Cal&#xf3; M, Salandin V, Da Ros A, Michieletto F, Simini G: Acute renal failure in the patient undergoing cardiac operation. Prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg 107: 1489&#x2013;1495, 1994</Citation><ArticleIdList><ArticleId IdType="pubmed">8196394</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryd&#xe9;n L, Sartipy U, Evans M, Holzmann MJ: Acute kidney injury after coronary artery bypass grafting and long-term risk of end-stage renal disease. Circulation 130: 2005&#x2013;2011, 2014</Citation><ArticleIdList><ArticleId IdType="pubmed">25239439</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng XM, Chung AC, Lan HY: Role of the TGF-&#x3b2;/BMP-7/Smad pathways in renal diseases. Clin Sci (Lond) 124: 243&#x2013;254, 2013</Citation><ArticleIdList><ArticleId IdType="pubmed">23126427</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D, Zhao M, Mundy GR: Bone morphogenetic proteins. Growth Factors 22: 233&#x2013;241, 2004</Citation><ArticleIdList><ArticleId IdType="pubmed">15621726</ArticleId></ArticleIdList></Reference><Reference><Citation>Vukicevic S, Basic V, Rogic D, Basic N, Shih MS, Shepard A, Jin D, Dattatreyamurty B, Jones W, Dorai H, Ryan S, Griffiths D, Maliakal J, Jelic M, Pastorcic M, Stavljenic A, Sampath TK: Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat. J Clin Invest 102: 202&#x2013;214, 1998</Citation><ArticleIdList><ArticleId IdType="pmc">PMC509082</ArticleId><ArticleId IdType="pubmed">9649574</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould SE, Day M, Jones SS, Dorai H: BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells. Kidney Int 61: 51&#x2013;60, 2002</Citation><ArticleIdList><ArticleId IdType="pubmed">11786084</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffith DL, Keck PC, Sampath TK, Rueger DC, Carlson WD: Three-dimensional structure of recombinant human osteogenic protein 1: Structural paradigm for the transforming growth factor beta superfamily. Proc Natl Acad Sci U S A 93: 878&#x2013;883, 1996</Citation><ArticleIdList><ArticleId IdType="pmc">PMC40151</ArticleId><ArticleId IdType="pubmed">8570652</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugimoto H, LeBleu VS, Bosukonda D, Keck P, Taduri G, Bechtel W, Okada H, Carlson W Jr, Bey P, Rusckowski M, Tampe B, Tampe D, Kanasaki K, Zeisberg M, Kalluri R: Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis. Nat Med 18: 396&#x2013;404, 2012</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3998727</ArticleId><ArticleId IdType="pubmed">22306733</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeisberg M, Bottiglio C, Kumar N, Maeshima Y, Strutz F, M&#xfc;ller GA, Kalluri R: Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am J Physiol Renal Physiol 285: F1060&#x2013;F1067, 2003</Citation><ArticleIdList><ArticleId IdType="pubmed">12915382</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R: BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9: 964&#x2013;968, 2003</Citation><ArticleIdList><ArticleId IdType="pubmed">12808448</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob KA, Leaf DE, Dieleman JM, van Dijk D, Nierich AP, Rosseel PM, van der Maaten JM, Hofland J, Diephuis JC, de Lange F, Boer C, Kluin J, Waikar SS; Dexamethasone for Cardiac Surgery (DECS) Study Group : Intraoperative high-dose dexamethasone and severe AKI after cardiac surgery. J Am Soc Nephrol 26: 2947&#x2013;2951, 2015</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4657835</ArticleId><ArticleId IdType="pubmed">25952257</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FT IV, Hendricks PA, Schildcrout JS, Shi Y, Petracek MR, Byrne JG, Brown NJ: High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery: A randomized clinical trial. JAMA 315: 877&#x2013;888, 2016</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4843765</ArticleId><ArticleId IdType="pubmed">26906014</ArticleId></ArticleIdList></Reference><Reference><Citation>ClinicalTrials.gov: A Study to Evaluate the Safety and Efficacy of AC607 for the Treatment of Kidney Injury in Cardiac Surgery Subjects (ACT-AKI). NCT01602328. 2012, 2016. Available at: http://clinicaltrials.gov/ct2/show/NCT01602328. Accessed August 8, 2016</Citation></Reference><Reference><Citation>Choi YS, Shim JK, Kim JC, Kang KS, Seo YH, Ahn KR, Kwak YL: Effect of remote ischemic preconditioning on renal dysfunction after complex valvular heart surgery: A randomized controlled trial. J Thorac Cardiovasc Surg 142: 148&#x2013;154, 2011</Citation><ArticleIdList><ArticleId IdType="pubmed">21272897</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallagher SM, Jones DA, Kapur A, Wragg A, Harwood SM, Mathur R, Archbold RA, Uppal R, Yaqoob MM: Remote ischemic preconditioning has a neutral effect on the incidence of kidney injury after coronary artery bypass graft surgery. Kidney Int 87: 473&#x2013;481, 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">25075773</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmerman RF, Ezeanuna PU, Kane JC, Cleland CD, Kempananjappa TJ, Lucas FL, Kramer RS: Ischemic preconditioning at a remote site prevents acute kidney injury in patients following cardiac surgery. Kidney Int 80: 861&#x2013;867, 2011</Citation><ArticleIdList><ArticleId IdType="pubmed">21677633</ArticleId></ArticleIdList></Reference><Reference><Citation>Meybohm P, Bein B, Brosteanu O, Cremer J, Gruenewald M, Stoppe C, Coburn M, Schaelte G, B&#xf6;ning A, Niemann B, Roesner J, Kletzin F, Strouhal U, Reyher C, Laufenberg-Feldmann R, Ferner M, Brandes IF, Bauer M, Stehr SN, Kortgen A, Wittmann M, Baumgarten G, Meyer-Treschan T, Kienbaum P, Heringlake M, Sch&#xf6;n J, Sander M, Treskatsch S, Smul T, Wolwender E, Schilling T, Fuernau G, Hasenclever D, Zacharowski K; RIPHeart Study Collaborators : A multicenter trial of remote ischemic preconditioning for heart surgery. N Engl J Med 373: 1397&#x2013;1407, 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">26436208</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, O&#x2019;Brien PC, Johnson MG, Williams AR, Cutshall SM, Mundy LM, Rizza RA, McMahon MM: Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: A randomized trial. Ann Intern Med 146: 233&#x2013;243, 2007</Citation><ArticleIdList><ArticleId IdType="pubmed">17310047</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajjar LA, Vincent JL, Galas FR, Nakamura RE, Silva CM, Santos MH, Fukushima J, Kalil Filho R, Sierra DB, Lopes NH, Mauad T, Roquim AC, Sundin MR, Le&#xe3;o WC, Almeida JP, Pomerantzeff PM, Dallan LO, Jatene FB, Stolf NA, Auler JO Jr.: Transfusion requirements after cardiac surgery: The TRACS randomized controlled trial. JAMA 304: 1559&#x2013;1567, 2010</Citation><ArticleIdList><ArticleId IdType="pubmed">20940381</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow SC, Corey R: Benefits, challenges and obstacles of adaptive clinical trial designs. Orphanet J Rare Dis 6: 79, 2011</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3248853</ArticleId><ArticleId IdType="pubmed">22129361</ArticleId></ArticleIdList></Reference><Reference><Citation>Coffey CS, Levin B, Clark C, Timmerman C, Wittes J, Gilbert P, Harris S: Overview, hurdles, and future work in adaptive designs: Perspectives from a National Institutes of Health-funded workshop. Clin Trials 9: 671&#x2013;680, 2012</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5570450</ArticleId><ArticleId IdType="pubmed">23250942</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt DL, Mehta C: Adaptive designs for clinical trials. N Engl J Med 375: 65&#x2013;74, 2016</Citation><ArticleIdList><ArticleId IdType="pubmed">27406349</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group : KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2: 1&#x2013;138, 2012</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36512724</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1175</ISSN><JournalIssue CitedMedium="Internet"><Volume>138</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Postoperative Acute Kidney Injury by Age and Sex: A Retrospective Cohort Association Study.</ArticleTitle><Pagination><StartPage>184</StartPage><EndPage>194</EndPage><MedlinePgn>184-194</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ALN.0000000000004436</ELocationID><Abstract><AbstractText Label="BACKGROUND">Acute kidney injury (AKI) after noncardiac surgery is common and has substantial health impact. Preclinical and clinical studies examining the influence of sex on AKI have yielded conflicting results, although they typically do not account for age-related changes. The objective of the study was to determine the association of age and sex groups on postoperative AKI. The authors hypothesized that younger females would display lower risk of postoperative AKI than males of similar age, and the protection would be lost in older females.</AbstractText><AbstractText Label="METHODS">This was a multicenter retrospective cohort study across 46 institutions between 2013 and 2019. Participants included adult inpatients without pre-existing end-stage kidney disease undergoing index major noncardiac, nonkidney/urologic surgeries. The authors' primary exposure was age and sex groups defined as females 50 yr or younger, females older than 50 yr, males 50 yr or younger, and males older than 50 yr. The authors' primary outcome was development of AKI by Kidney Disease-Improving Global Outcomes serum creatinine criteria. Exploratory analyses included associations of ascending age groups and hormone replacement therapy home medications with postoperative AKI.</AbstractText><AbstractText Label="RESULTS">Among 390,382 patients, 25,809 (6.6%) developed postoperative AKI (females 50 yr or younger: 2,190 of 58,585 [3.7%]; females older than 50 yr: 9,320 of 14,4047 [6.5%]; males 50 yr or younger: 3,289 of 55,503 [5.9%]; males older than 50 yr: 11,010 of 132,447 [8.3%]). When adjusted for AKI risk factors, compared to females younger than 50 yr (odds ratio, 1), the odds of AKI were higher in females older than 50 yr (odds ratio, 1.51; 95% CI, 1.43 to 1.59), males younger than 50 yr (odds ratio, 1.90; 95% CI, 1.79 to 2.01), and males older than 50 yr (odds ratio, 2.06; 95% CI, 1.96 to 2.17).</AbstractText><AbstractText Label="CONCLUSIONS">Younger females display a lower odds of postoperative AKI that gradually increases with age. These results suggest that age-related changes in women should be further studied as modifiers of postoperative AKI risk after noncardiac surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022, the American Society of Anesthesiologists. All Rights Reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Privratsky</LastName><ForeName>Jamie R</ForeName><Initials>JR</Initials><Identifier Source="ORCID">0000-0003-3598-4911</Identifier><AffiliationInfo><Affiliation>Critical Care and Perioperative Population Health Research Unit, Department of Anesthesiology, and Center for Perioperative Organ Protection, Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuller</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Population Health Research Unit, Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raghunathan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Population Health Research Unit, Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina; and Durham Veterans Administration Medical Center, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohnuma</LastName><ForeName>Tetsu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Population Health Research Unit, Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartz</LastName><ForeName>Raquel R</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Population Health Research Unit, Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schroeder</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Population Health Research Unit, Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina; and Durham Veterans Administration Medical Center, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Price</LastName><ForeName>Thomas M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Population Health Research Unit, Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sigurdsson</LastName><ForeName>Martin I</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Division of Anesthesia and Intensive Care Medicine, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland; and University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathis</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Michigan, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naik</LastName><ForeName>Bhiken</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Virginia, Charlottesville, Virginia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krishnamoorthy</LastName><ForeName>Vijay</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Population Health Research Unit, Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K01 HL141701</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K08 GM132689</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK131065</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK133226</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007676" MajorTopicYN="Y">Kidney Failure, Chronic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Conflicts of Interest: The authors declare no competing interests. The authors report the following not related to the present manuscript: K08-GM132689 from NIH-NIGMS and R01-DK131065 from NIH-NIDDK (JRP); past financial relationship with American Board of Obstetrics (TMP); and K01-HL141701 from NIH-NHLBI and R01-DK133226 award from NIH-NIDDK (MRM).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>13</Day><Hour>15</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36512724</ArticleId><ArticleId IdType="mid">NIHMS1922848</ArticleId><ArticleId IdType="pmc">PMC10439699</ArticleId><ArticleId IdType="doi">10.1097/ALN.0000000000004436</ArticleId><ArticleId IdType="pii">137235</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kork F, Balzer F, Spies CD, Wernecke KD, Ginde AA, Jankowski J, Eltzschig HK: Minor Postoperative Increases of Creatinine Are Associated with Higher Mortality and Longer Hospital Length of Stay in Surgical Patients. Anesthesiology 2015; 123: 1301&#x2013;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4679549</ArticleId><ArticleId IdType="pubmed">26492475</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor ME, Hewson RW, Kirwan CJ, Ackland GL, Pearse RM, Prowle JR: Acute kidney injury and mortality 1 year after major non-cardiac surgery. Br J Surg 2017; 104: 868&#x2013;876</Citation><ArticleIdList><ArticleId IdType="pubmed">28218392</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, Koyner JL, Hoste EAJ, Kellum JA: Update on Perioperative Acute Kidney Injury. Anesth Analg 2018; 127: 1236&#x2013;1245</Citation><ArticleIdList><ArticleId IdType="pubmed">30138176</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris DG, McCrone MP, Koo G, Weltz AS, Chiu WC, Scalea TM, Diaz JJ, Lissauer ME: Epidemiology and outcomes of acute kidney injury in critically ill surgical patients. J Crit Care 2015; 30: 102&#x2013;6</Citation><ArticleIdList><ArticleId IdType="pubmed">25171816</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P, Hiesmayr M: Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 2004; 15: 1597&#x2013;605</Citation><ArticleIdList><ArticleId IdType="pubmed">15153571</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson CE, Yavas S, Segal MS, Schold JD, Tribble CG, Layon AJ, Bihorac A: Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation 2009; 119: 2444&#x2013;53</Citation><ArticleIdList><ArticleId IdType="pubmed">19398670</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishani A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA, Collins AJ: Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 2009; 20: 223&#x2013;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2615732</ArticleId><ArticleId IdType="pubmed">19020007</ArticleId></ArticleIdList></Reference><Reference><Citation>Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C-yY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296&#x2013;1305</Citation><ArticleIdList><ArticleId IdType="pubmed">15385656</ArticleId></ArticleIdList></Reference><Reference><Citation>Doi K, Rabb H: Impact of acute kidney injury on distant organ function: recent findings and potential therapeutic targets. Kidney Int 2016; 89: 555&#x2013;564</Citation><ArticleIdList><ArticleId IdType="pubmed">26880452</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D, Honor&#xe9; PM, Joannes-Boyau O, Joannidis M, Korhonen A-MM, Lavrentieva A, Mehta RL, Palevsky P, Roessler E, Ronco C, Uchino S, Vazquez JA, Vidal Andrade E, Webb S, Kellum JA: Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 2015; 41: 1411&#x2013;1423</Citation><ArticleIdList><ArticleId IdType="pubmed">26162677</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson C, Lysak N, Huber M, Scali S, Bihorac A: Epidemiology, outcomes, and management of acute kidney injury in the vascular surgery patient. Journal of vascular surgery 2018; 68: 916&#x2013;928</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6236681</ArticleId><ArticleId IdType="pubmed">30146038</ArticleId></ArticleIdList></Reference><Reference><Citation>Loftus TJ, Bihorac A, Ozrazgat-Baslanti T, Jordan JR, Croft CA, Smith RS, Efron PA, Moore FA, Mohr AM, Brakenridge SC: Acute Kidney Injury Following Exploratory Laparotomy and Temporary Abdominal Closure. Shock (Augusta, Ga.) 2017; 48: 5&#x2013;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5468485</ArticleId><ArticleId IdType="pubmed">28009772</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaught AJ, Ozrazgat-Baslanti T, Javed A, Morgan L, Hobson CE, Bihorac A: Acute kidney injury in major gynaecological surgery: an observational study. BJOG : an international journal of obstetrics and gynaecology 2015; 122: 1340&#x2013;1348</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4334755</ArticleId><ArticleId IdType="pubmed">25134440</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis MR, Naik BI, Freundlich RE, Shanks AM, Heung M, Kim M, Burns ML, Colquhoun DA, Rangrass G, Janda A, Engoren MC, Saager L, Tremper KK, Kheterpal S, Aziz MF, Coffman T, Durieux ME, Levy WJ, Schonberger RB, Soto R, Wilczak J, Berman MF, Berris J, Biggs DA, Coles P, Craft RM, Cummings KC, Ellis TA 2nd, Fleishut PM, Helsten DL, Jameson LC, van Klei WA, Kooij F, LaGorio J, Lins S, Miller SA, Molina, Nair B, Paganelli WC, Peterson W, Tom S, Wanderer JP, Wedeven C, Multicenter Perioperative Outcomes Group I: Preoperative Risk and the Association between Hypotension and Postoperative Acute Kidney Injury. Anesthesiology 2020; 132: 461&#x2013;475</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7015776</ArticleId><ArticleId IdType="pubmed">31794513</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutchens MP, Fujiyoshi T, Komers R, Herson PS, Anderson S: Estrogen protects renal endothelial barrier function from ischemia-reperfusion in vitro and in vivo. Am J Physiol Renal Physiol 2012; 303: F377&#x2013;85</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3774263</ArticleId><ArticleId IdType="pubmed">22622457</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang KP, Lee JE, Lee AS, Jung YJ, Kim D, Lee S, Hwang HP, Kim W, Park SK: Effect of gender differences on the regulation of renal ischemia-reperfusion-induced inflammation in mice. Mol Med Rep 2014; 9: 2061&#x2013;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4055478</ArticleId><ArticleId IdType="pubmed">24682292</ArticleId></ArticleIdList></Reference><Reference><Citation>Satake A, Takaoka M, Nishikawa M, Yuba M, Shibata Y, Okumura K, Kitano K, Tsutsui H, Fujii K, Kobuchi S, Ohkita M, Matsumura Y: Protective effect of 17beta-estradiol on ischemic acute renal failure through the PI3K/Akt/eNOS pathway. Kidney Int 2008; 73: 308&#x2013;17</Citation><ArticleIdList><ArticleId IdType="pubmed">18004295</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka R, Tsutsui H, Kobuchi S, Sugiura T, Yamagata M, Ohkita M, Takaoka M, Yukimura T, Matsumura Y: Protective effect of 17beta-estradiol on ischemic acute kidney injury through the renal sympathetic nervous system. Eur J Pharmacol 2012; 683: 270&#x2013;5</Citation><ArticleIdList><ArticleId IdType="pubmed">22426161</ArticleId></ArticleIdList></Reference><Reference><Citation>Kher A, Meldrum KK, Wang M, Tsai BM, Pitcher JM, Meldrum DR: Cellular and molecular mechanisms of sex differences in renal ischemia-reperfusion injury. Cardiovasc Res 2005; 67: 594&#x2013;603</Citation><ArticleIdList><ArticleId IdType="pubmed">15950202</ArticleId></ArticleIdList></Reference><Reference><Citation>Park KM, Kim JI, Ahn Y, Bonventre AJ, Bonventre JV: Testosterone is responsible for enhanced susceptibility of males to ischemic renal injury. J Biol Chem 2004; 279: 52282&#x2013;92</Citation><ArticleIdList><ArticleId IdType="pubmed">15358759</ArticleId></ArticleIdList></Reference><Reference><Citation>Palevsky PM, Liu KD, Brophy PD, Chawla LS, Parikh CR, Thakar CV, Tolwani AJ, Waikar SS, Weisbord SD: KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. American journal of kidney diseases : the official journal of the National Kidney Foundation 2013; 61: 649&#x2013;672</Citation><ArticleIdList><ArticleId IdType="pubmed">23499048</ArticleId></ArticleIdList></Reference><Reference><Citation>Neugarten J, Golestaneh L: Female sex reduces the risk of hospital-associated acute kidney injury: a meta-analysis. BMC Nephrol 2018; 19: 314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6225636</ArticleId><ArticleId IdType="pubmed">30409132</ArticleId></ArticleIdList></Reference><Reference><Citation>Colquhoun DA, Shanks AM, Kapeles SR, Shah N, Saager L, Vaughn MT, Buehler K, Burns ML, Tremper KK, Freundlich RE, Aziz M, Kheterpal S, Mathis MR: Considerations for Integration of Perioperative Electronic Health Records Across Institutions for Research and Quality Improvement: The Approach Taken by the Multicenter Perioperative Outcomes Group. Anesth Analg 2020; 130: 1133&#x2013;1146</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7663856</ArticleId><ArticleId IdType="pubmed">32287121</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Vaughn MT, Dubovoy TZ, Shah NJ, Bash LD, Colquhoun DA, Shanks AM, Mathis MR, Soto RG, Bardia A, Bartels K, McCormick PJ, Schonberger RB, Saager L: Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): A Multicenter Matched Cohort Analysis. Anesthesiology 2020; 132: 1371&#x2013;1381</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7864000</ArticleId><ArticleId IdType="pubmed">32282427</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun E, Mello MM, Rishel CA, Vaughn MT, Kheterpal S, Saager L, Fleisher LA, Damrose EJ, Kadry B, Jena AB, Multicenter Perioperative Outcomes G: Association of Overlapping Surgery With Perioperative Outcomes. JAMA 2019; 321: 762&#x2013;772</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6439866</ArticleId><ArticleId IdType="pubmed">30806696</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G: A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004; 44: 1393&#x2013;9</Citation><ArticleIdList><ArticleId IdType="pubmed">15464318</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore RD, Smith CR, Lipsky JJ, Mellits ED, Lietman PS: Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Intern Med 1984; 100: 352&#x2013;7</Citation><ArticleIdList><ArticleId IdType="pubmed">6364908</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahon GM, Zeng X, Waikar SS: A risk prediction score for kidney failure or mortality in rhabdomyolysis. JAMA Intern Med 2013; 173: 1821&#x2013;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5152583</ArticleId><ArticleId IdType="pubmed">24000014</ArticleId></ArticleIdList></Reference><Reference><Citation>Neugarten J, Sandilya S, Singh B, Golestaneh L: Sex and the Risk of AKI Following Cardio-thoracic Surgery: A Meta-Analysis. Clin J Am Soc Nephrol 2016; 11: 2113&#x2013;2122</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5142065</ArticleId><ArticleId IdType="pubmed">27797892</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris DG, Koo G, McCrone MP, Weltz AS, Chiu WC, Sarkar R, Scalea TM, Diaz JJ, Lissauer ME, Crawford RS: Acute Kidney Injury in Critically Ill Vascular Surgery Patients is Common and Associated with Increased Mortality. Frontiers in surgery 2014; 2: 8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4353172</ArticleId><ArticleId IdType="pubmed">25806372</ArticleId></ArticleIdList></Reference><Reference><Citation>Neugarten J, Golestaneh L, Kolhe NV: Sex differences in acute kidney injury requiring dialysis. BMC Nephrol 2018; 19: 131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5994053</ArticleId><ArticleId IdType="pubmed">29884141</ArticleId></ArticleIdList></Reference><Reference><Citation>George RL, McGwin G Jr., Windham ST, Melton SM, Metzger J, Chaudry IH, Rue LW 3rd: Age-related gender differential in outcome after blunt or penetrating trauma. Shock 2003; 19: 28&#x2013;32</Citation><ArticleIdList><ArticleId IdType="pubmed">12558140</ArticleId></ArticleIdList></Reference><Reference><Citation>Zangrillo A, Morselli F, Biagioni E, Stella RD, Coloretti I, Moizo E, Plumari VP, Monti G, Borghi G, Salonia A, Almirante G, Maraggia D, Zambon M, Langiano N, Roasio A, Pasin L, Mucci M, Beccaria PF, Pasculli N, Redaelli MB, Pallanch O, Gallo G, Real G, Nava M, Venturelli S, Tosi M, Munari E, Visconti MG, Perno S, Girardis M, Landoni G: Sex-related mortality differences in young adult septic shock patients. Signa Vitae 2022; doi:10.22514/sv.2022.017</Citation><ArticleIdList><ArticleId IdType="doi">10.22514/sv.2022.017</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckenrode HE, Gutierrez OM, Osis G, Agarwal A, Curtis LM: Kidney Disease Prevalence in Transgender Individuals. Clin J Am Soc Nephrol 2021</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8823938</ArticleId><ArticleId IdType="pubmed">34872973</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer KE, Riddle NC : Sex Differences in Aging: Genomic Instability. J Gerontol A Biol Sci Med Sci 2018; 73: 166&#x2013;174</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5861920</ArticleId><ArticleId IdType="pubmed">28575157</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagg S, Jylhava J: Sex differences in biological aging with a focus on human studies. Elife 2021; 10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8118651</ArticleId><ArticleId IdType="pubmed">33982659</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampathkumar NK, Bravo JI, Chen Y, Danthi PS, Donahue EK, Lai RW, Lu R, Randall LT, Vinson N, Benayoun BA: Widespread sex dimorphism in aging and age-related diseases. Hum Genet 2020; 139: 333&#x2013;356</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7031050</ArticleId><ArticleId IdType="pubmed">31677133</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33079777</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1473-5687</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>12</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>European journal of gastroenterology &amp; hepatology</Title><ISOAbbreviation>Eur J Gastroenterol Hepatol</ISOAbbreviation></Journal><ArticleTitle>Intraoperative systemic biomarkers predict post-liver transplantation acute kidney injury.</ArticleTitle><Pagination><StartPage>1556</StartPage><EndPage>1563</EndPage><MedlinePgn>1556-1563</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/MEG.0000000000001892</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Liver transplant (LT) is a definitive therapeutic option for patients with chronic liver disease. However, acute kidney injury after LT (post-LT AKI) is a frequent complication that may lead to graft dysfunction and decrease life expectancy. Delay in AKI detection by traditional biomarkers boosted research with new biomarkers for post-LT AKI as neutrophil gelatinase-associated lipocalin (NGAL) and syndecan-1. We aim to evaluate associations of intraoperative systemic NGAL and syndecan-1 levels with post-LT AKI.</AbstractText><AbstractText Label="METHODS">This is a prospective study conducted in 46 patients selected for LT. Patients were evaluated preoperatively and blood samples were collected intraoperatively: T1 (after induction of anesthesia), T2 (anhepatic phase) and T3 (2 h after reperfusion of the graft).</AbstractText><AbstractText Label="RESULTS">The mean age was 54 &#xb1; 12 years and 60% were male. Post-LT AKI was observed in 24 (52%) patients of which 12% needed dialysis. Serum NGAL and syndecan-1 increased along surgical phases. Mostly, increment values of serum NGAL of T2 to T3 and syndecan-1 at T3 were importantly associated with post-LT AKI. Into a multivariate model with model for end-stage liver disease score, age, gender, warm ischemia, cold ischemia and surgery time, syndecan-1 levels at T3 remains capable to predict post-LT AKI. Serum NGAL had significance only with increment values calculated by the ratio of 'T3/T2'. Finally, serum syndecan-1 at T3 had a better diagnostic performance in receiver operating characteristic curve analysis.</AbstractText><AbstractText Label="CONCLUSION">Serum syndecan-1 levels in 2 h after reperfusion were most useful in early post-LT AKI diagnosis and may be used to construct new risk groups in this context.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cezar</LastName><ForeName>Lia Cavalcante</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Medical Surgery Science Post-Graduate Program, Department of Surgery.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meneses</LastName><ForeName>Gdayllon Cavalcante</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>Medical Sciences Post-Graduate Program, School of Medicine, Federal University of Cear&#xe1;, Universidade de Fortaleza- UNIFOR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silva Junior</LastName><ForeName>Geraldo Bezerra</ForeName><Initials>GB</Initials><AffiliationInfo><Affiliation>School of Medicine, Health Sciences Center, University of Fortaleza.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bezerra</LastName><ForeName>Gabriela Freire</ForeName><Initials>GF</Initials><AffiliationInfo><Affiliation>Department of Physiology and Pharmacology, School of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>Alice Maria Costa</ForeName><Initials>AMC</Initials><AffiliationInfo><Affiliation>Clinical and Toxicological Analysis Department, School of Pharmacy, Federal University of Cear&#xe1;, Cear&#xe1;, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lib&#xf3;rio</LastName><ForeName>Alexandre Braga</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Medical Sciences Post-Graduate Program, School of Medicine, Federal University of Cear&#xe1;, Universidade de Fortaleza- UNIFOR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daher</LastName><ForeName>Elizabeth De Francesco</ForeName><Initials>EF</Initials><AffiliationInfo><Affiliation>Medical Sciences Post-Graduate Program, School of Medicine, Federal University of Cear&#xe1;, Universidade de Fortaleza- UNIFOR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia</LastName><ForeName>Jos&#xe9; Huygens Parente</ForeName><Initials>JHP</Initials><AffiliationInfo><Affiliation>Medical Surgery Science Post-Graduate Program, Department of Surgery.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Gastroenterol Hepatol</MedlineTA><NlmUniqueID>9000874</NlmUniqueID><ISSNLinking>0954-691X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000209">Acute-Phase Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054834">Lipocalins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011518">Proto-Oncogene Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000209" MajorTopicYN="N">Acute-Phase Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058625" MajorTopicYN="Y">End Stage Liver Disease</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054834" MajorTopicYN="N">Lipocalins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016031" MajorTopicYN="Y">Liver Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011518" MajorTopicYN="N">Proto-Oncogene Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>20</Day><Hour>17</Hour><Minute>9</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33079777</ArticleId><ArticleId IdType="doi">10.1097/MEG.0000000000001892</ArticleId><ArticleId IdType="pii">00042737-202112000-00015</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gallegos-Orozco JF, Vargas HE. Liver transplantation: from Child to MELD. Med Clin North Am 2009; 93:931&#x2013;50, ix.</Citation></Reference><Reference><Citation>Carrion AF, Aye L, Martin P. Patient selection for liver transplantation. Expert Rev Gastroenterol Hepatol 2013; 7:571&#x2013;9.</Citation></Reference><Reference><Citation>Alqahtani SA. Update in liver transplantation. Curr Opin Gastroenterol 2012; 28:230&#x2013;238.</Citation></Reference><Reference><Citation>Magalh&#xe3;es CBA, Lima JMC, Viana CFG, Pereira EDB. Risk factors for acute kidney injury and 30-day mortality after liver transplantation. Ann Hepatol 2015; 14:688&#x2013;694.</Citation></Reference><Reference><Citation>Thongprayoon C, Kaewput W, Thamcharoen N, Bathini T, Watthanasuntorn K, Lertjitbanjong P, et al. Incidence and impact of acute kidney injury after liver transplantation: a meta-analysis. J Clin Med 2019; 8:372.</Citation></Reference><Reference><Citation>Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet 2005; 365:417&#x2013;430.</Citation></Reference><Reference><Citation>Kellum JA, Lameire N; KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care 2013; 17:204</Citation></Reference><Reference><Citation>Parikh CR, Mansour SG. Perspective on clinical application of biomarkers in AKI. J Am Soc Nephrol 2017; 28:1677&#x2013;1685.</Citation></Reference><Reference><Citation>Yeung ACY, Morozov A, Robertson FP, Fuller BJ, Davidson BR. Neutrophil Gelatinase-Associated Lipocalin (NGAL) in predicting acute kidney injury following orthotopic liver transplantation: a systematic review. Int J Surg 2018; 59:48&#x2013;54.</Citation></Reference><Reference><Citation>Kohan DE, Inscho EW, Wesson D, Pollock DM. Physiology of endothelin and the kidney. Compr Physiol 2011; 1:883&#x2013;919.</Citation></Reference><Reference><Citation>Dane MJ, Khairoun M, Lee DH, van den Berg BM, Eskens BJ, Boels MG, et al. Association of kidney function with changes in the endothelial surface layer. Clin J Am Soc Nephrol 2014; 9:698&#x2013;704.</Citation></Reference><Reference><Citation>Vlahu CA, Lemkes BA, Struijk DG, Koopman MG, Krediet RT, Vink H. Damage of the endothelial glycocalyx in dialysis patients. J Am Soc Nephrol 2012; 23:1900&#x2013;1908.</Citation></Reference><Reference><Citation>Padberg JS, Wiesinger A, di Marco GS, Reuter S, Grabner A, Kentrup D, et al. Damage of the endothelial glycocalyx in chronic kidney disease. Atherosclerosis 2014; 234:335&#x2013;343.</Citation></Reference><Reference><Citation>Thiago F, Salmito S, Macedo F, Neves DO, Cavalcante G. Glycocalyx injury in adults with nephrotic syndrome: association with endothelial function. Clin Chim Acta 2015; 447:55&#x2013;58.</Citation></Reference><Reference><Citation>Neves FM, Meneses GC, Sousa NE, Menezes RR, Parahyba MC, Martins AM, Lib&#xf3;rio AB. Syndecan-1 in acute decompensated heart failure&#x2013;association with renal function and mortality. Circ J 2015; 79:1511&#x2013;1519.</Citation></Reference><Reference><Citation>de Melo Bezerra Cavalcante CT, Castelo Branco KM, Pinto J&#xfa;nior VC, Meneses GC, de Oliveira Neves FM, de Souza NM, et al. Syndecan-1 improves severe acute kidney injury prediction after pediatric cardiac surgery. J Thorac Cardiovasc Surg 2016; 152:178&#x2013;186.e2.</Citation></Reference><Reference><Citation>Shenoda B, Boselli J. Vascular syndromes in liver cirrhosis. Clin J Gastroenterol 2019; 12:387&#x2013;397.</Citation></Reference><Reference><Citation>Schiefer J, Lebherz-Eichinger D, Erdoes G, Berlakovich G, Bacher A, Krenn CG, Faybik P. Alterations of endothelial glycocalyx during orthotopic liver transplantation in patients with end-stage liver disease. Transplantation 2015; 99:2118&#x2013;2123.</Citation></Reference><Reference><Citation>Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 2014; 63:713&#x2013;735.</Citation></Reference><Reference><Citation>Hosein Shokouh-Amiri M, Osama Gaber A, Bagous WA, Grewal HP, Hathaway DK, Vera SR, et al. Choice of surgical technique influences perioperative outcomes in liver transplantation. Ann Surg 2000; 231:814&#x2013;823.</Citation></Reference><Reference><Citation>Hoo ZH, Candlish J, Teare D. What is an ROC curve? Emerg Med J 2017; 34:357&#x2013;359.</Citation></Reference><Reference><Citation>Zongyi Y, Baifeng L, Funian Z, Hao L, Xin W. Risk factors of acute kidney injury after orthotopic liver transplantation in China. Sci Rep 2017; 7:41555.</Citation></Reference><Reference><Citation>Durand F, Francoz C, Asrani SK, Khemichian S, Pham TA, Sung RS, et al. Acute kidney injury after liver transplantation. Transplantation 2018; 102:1636&#x2013;1649.</Citation></Reference><Reference><Citation>Sanchez EQ, Gonwa TA, Levy MF, Goldstein RM, Mai ML, Hays SR, et al. Preoperative and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantation. Transplantation 2004; 78:1048&#x2013;1054.</Citation></Reference><Reference><Citation>Schiefer J, Lebherz-Eichinger D, Erdoes G, Berlakovich G, Bacher A, Krenn CG, Faybik P. Alterations of endothelial glycocalyx during orthotopic liver transplantation in patients with end-stage liver disease. Transplantation 2015; 99:2118&#x2013;2123.</Citation></Reference><Reference><Citation>Robertson FP, Yeung AC, Male V, Rahman S, Mallett S, Fuller BJ, Davidson BR. Urinary neutrophil gelatinase associated lipocalins (NGALs) predict acute kidney injury post liver transplant. HPB (Oxford) 2019; 21:473&#x2013;481.</Citation></Reference><Reference><Citation>Buonafine M, Martinez-Martinez E, Jaisser F. More than a simple biomarker: the role of NGAL in cardiovascular and renal diseases. Clin Sci (Lond) 2018; 132:909&#x2013;923.</Citation></Reference><Reference><Citation>Kuwabara T, Mori K, Mukoyama M, Kasahara M, Yokoi H, Saito Y, et al. Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons. Kidney Int 2009; 75:285&#x2013;294.</Citation></Reference><Reference><Citation>Hryniewiecka E, Gala K, Krawczyk M, P&#x105;czek L. Is neutrophil gelatinase-associated lipocalin an optimal marker of renal function and injury in liver transplant recipients? Transplant Proc 2014; 46:2782&#x2013;2785.</Citation></Reference><Reference><Citation>Aljumah AA, Tamim H, Saeed M, Tamimi W, Alfawaz H, Al Qurashi S, et al. The role of urinary neutrophil gelatinase-associated lipocalin in predicting acute kidney dysfunction in patients with liver cirrhosis. J Clin Med Res 2018; 10:419&#x2013;428.</Citation></Reference><Reference><Citation>Jeong TD, Kim S, Lee W, Song GW, Kim YK, Chun S, et al. Neutrophil gelatinase-associated lipocalin as an early biomarker of acute kidney injury in liver transplantation. Clin Transplant 2012; 26:775&#x2013;781.</Citation></Reference><Reference><Citation>Ijtsma AJ, van der Hilst CS, de Boer MT, de Jong KP, Peeters PM, Porte RJ, Slooff MJ. The clinical relevance of the anhepatic phase during liver transplantation. Liver Transpl 2009; 15:1050&#x2013;1055.</Citation></Reference><Reference><Citation>Iwakiri Y, Shah V, Rockey DC. Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions. J Hepatol 2014; 61:912&#x2013;924.</Citation></Reference><Reference><Citation>Gupta TK, Toruner M, Chung MK, Groszmann RJ. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats. Hepatology 1998; 28:926&#x2013;931.</Citation></Reference><Reference><Citation>Ikeda M, Matsumoto H, Ogura H, Hirose T, Shimizu K, Yamamoto K, et al. Circulating syndecan-1 predicts the development of disseminated intravascular coagulation in patients with sepsis. J Crit Care 2018; 43:48&#x2013;53.</Citation></Reference><Reference><Citation>Post EH, Kellum JA, Bellomo R, Vincent JL. Renal perfusion in sepsis: from macro- to microcirculation. Kidney Int 2017; 91:45&#x2013;60.</Citation></Reference><Reference><Citation>Rehm M, Bruegger D, Christ F, Conzen P, Thiel M, Jacob M, et al. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 2007; 116:1896&#x2013;1906.</Citation></Reference><Reference><Citation>Svennevig K, Hoel T, Thiara A, Kolset S, Castelheim A, Mollnes T, et al. Syndecan-1 plasma levels during coronary artery bypass surgery with and without cardiopulmonary bypass. Perfusion 2008; 23:165&#x2013;171.</Citation></Reference><Reference><Citation>Meneses GC, Cavalcante MG, da Silva Junior GB, Martins AMC, Neto RDJP, Lib&#xf3;rio AB, De Francesco Daher E. Endothelial glycocalyx damage and renal dysfunction in HIV patients receiving combined antiretroviral therapy. AIDS Res Hum Retroviruses 2017; 33:703&#x2013;710.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38471194</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Postoperative haemoglobin and anaemia-associated ischaemic events after major noncardiac surgery: A sex-stratified cohort study.</ArticleTitle><Pagination><StartPage>111439</StartPage><MedlinePgn>111439</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2024.111439</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(24)00068-0</ELocationID><Abstract><AbstractText Label="STUDY OBJECTIVE">To determine the sex-specific associations between postoperative haemoglobin and mortality or complications reflecting ischaemia or inadequate oxygen supply after major noncardiac surgery.</AbstractText><AbstractText Label="DESIGN">A retrospective cohort study with prospective validation.</AbstractText><AbstractText Label="SETTING">A large university hospital health system in China.</AbstractText><AbstractText Label="PATIENTS">Men and women undergoing elective major noncardiac surgery.</AbstractText><AbstractText Label="INTERVENTIONS AND MEASUREMENTS">The primary exposure was nadir haemoglobin within 48&#xa0;h after surgery. The outcome of interest was a composite of postoperative mortality or ischaemic events including myocardial injury, acute kidney injury and stroke within hospitalisation.</AbstractText><AbstractText Label="MAIN RESULTS">The study included 26,049 patients (15,757 men and 10,292 women). Low postoperative haemoglobin was a strong predictor of the composite outcome in both sexes, with the risk progressively increasing as the nadir haemoglobin concentration dropped below 130&#xa0;g&#xa0;l<sup>-1</sup> in men and 120&#xa0;g&#xa0;l<sup>-1</sup> in women (adjusted odds ratio [OR] 1.43, 95% CI 1.37-1.50 in men, and OR 1.45, 95% CI 1.35-1.55 in women, per 10&#xa0;g&#xa0;l<sup>-1</sup> decrease in postoperative nadir haemoglobin). Above these sex-specific thresholds, the change of nadir haemoglobin was no longer associated with odds of the composite outcome in either men or women. There was no significant interaction between patient sex and the association between postoperative haemoglobin and the composite outcome (Pinteraction&#xa0;=&#xa0;0.673). Validation in an external prospective cohort (n&#xa0;=&#xa0;2120) with systematic postoperative troponin and creatinine measurement confirmed our findings.</AbstractText><AbstractText Label="CONCLUSIONS">Postoperative haemoglobin levels following major noncardiac surgery were nonlinearly associated with ischaemic complications or mortality, without any clinically important interaction with patient sex.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Bing-Cheng</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Yi-Shan</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Wen-Chi</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Shao-Hui</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jia-Ming</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Ye-Hong</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Wei-Feng</ForeName><Initials>WF</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China. Electronic address: sglwfeng01@21cn.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ke-Xuan</ForeName><Initials>KX</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China. Electronic address: liukexuan705@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006454">Hemoglobins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006454" MajorTopicYN="Y">Hemoglobins</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000740" MajorTopicYN="Y">Anemia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007511" MajorTopicYN="N">Ischemia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anaemia</Keyword><Keyword MajorTopicYN="N">Haemoglobin</Keyword><Keyword MajorTopicYN="N">Noncardiac surgery</Keyword><Keyword MajorTopicYN="N">Patient blood management</Keyword><Keyword MajorTopicYN="N">Sex</Keyword></KeywordList><CoiStatement>Declaration of competing interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>28</Day><Hour>7</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>13</Day><Hour>0</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>12</Day><Hour>19</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38471194</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2024.111439</ArticleId><ArticleId IdType="pii">S0952-8180(24)00068-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38567745</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1478-596X</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>The international journal of medical robotics + computer assisted surgery : MRCAS</Title><ISOAbbreviation>Int J Med Robot</ISOAbbreviation></Journal><ArticleTitle>Acute kidney injury after robot-assisted laparoscopic prostatectomy: A meta-analysis.</ArticleTitle><Pagination><StartPage>e2630</StartPage><MedlinePgn>e2630</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/rcs.2630</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">We investigated the rates of acute kidney injury (AKI) post robot-assisted laparoscopic prostatectomy (RALP).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A comprehensive search was conducted to identify studies that reported the rates of AKI post-RALP. A random effects model was used, and the pooled rates of AKI were calculated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 10 studies with 60,937 patients to be included. The mean age was 65.1&#xa0;years. The mean anaesthesia time was 234.3&#xa0;min (95% CI: 177.8-290.9). The mean operation time was 212.2&#xa0;min (95% CI: 188.7-235.6). The mean estimated blood loss was 314.1&#xa0;mL (95% CI: 153-475.3). The mean intraoperative IV fluids administered were 1985&#xa0;mL (95% CI: 1516.3-2453.7). The pooled rate of AKI post RALP was 7.2% (95% CI 19-23.9).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The rates of AKI after RALP are significant. Further studies are needed to detect the risk factors for AKI and to determine the rates of chronic kidney disease post-RALP.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors. The International Journal of Medical Robotics and Computer Assisted Surgery published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chandramohan</LastName><ForeName>Deepak</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine/Nephrology, University of Alabama at Birmingham, Birmingham, Alabama, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konda</LastName><ForeName>Raghunandan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine/Nephrology, University of Alabama at Birmingham, Birmingham, Alabama, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pujari</LastName><ForeName>Ashwini</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine/Nephrology, University of Alabama at Birmingham, Birmingham, Alabama, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avula</LastName><ForeName>Sreekant</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3909-2531</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine/Endocrinology, University of Minnesota Twin Cities, Minneapolis, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palleti</LastName><ForeName>Sujith Kumar</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine/Nephrology, Louisiana State University, Shreveport, Louisiana, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jena</LastName><ForeName>Nihar</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine/Cardiovascular Medicine, Trinity Health Oakland/Wayne State University, Pontiac, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naik</LastName><ForeName>Roopa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medicine, Geisinger Health, Wilkes-Barre, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bali</LastName><ForeName>Atul</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Geisinger Health, Wilkes-Barre, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Med Robot</MedlineTA><NlmUniqueID>101250764</NlmUniqueID><ISSNLinking>1478-5951</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011468" MajorTopicYN="Y">Prostatectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065287" MajorTopicYN="Y">Robotic Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="Y">Laparoscopy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011471" MajorTopicYN="N">Prostatic Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">pneumoperitoneum</Keyword><Keyword MajorTopicYN="N">prostate cancer</Keyword><Keyword MajorTopicYN="N">robot assisted laparoscopic radical prostatectomy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>3</Day><Hour>12</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38567745</ArticleId><ArticleId IdType="doi">10.1002/rcs.2630</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019;10(2):63&#x2010;89. https://doi.org/10.14740/wjon1191</Citation></Reference><Reference><Citation>Huang X, Wang L, Zheng X, Wang X. Comparison of perioperative, functional, and oncologic outcomes between standard laparoscopic and robotic&#x2010;assisted radical prostatectomy: a systemic review and meta&#x2010;analysis. Surg Endosc. 2017;31(3):1045&#x2010;1060. https://doi.org/10.1007/s00464&#x2010;016&#x2010;5125&#x2010;1</Citation></Reference><Reference><Citation>De Carlo F, Celestino F, Verri C, Masedu F, Liberati E, Di Stasi SM. Retropubic, laparoscopic, and robot&#x2010;assisted radical prostatectomy: surgical, oncological, and functional outcomes: a systematic review. Urol Int. 2014;93(4):373&#x2010;383. https://doi.org/10.1159/000366008</Citation></Reference><Reference><Citation>Costalonga EC, Costa ESVT, Caires R, Hung J, Yu L, Burdmann EA. Prostatic surgery associated acute kidney injury. World J Nephrol. 2014;3(4):198&#x2010;209.</Citation></Reference><Reference><Citation>Singh A, Dass B, Ejaz A, Bali A. Post&#x2010;obstructive diuresis: a cautionary tale. Cureus. 2019;11(12):e6328. https://doi.org/10.7759/cureus.6328</Citation></Reference><Reference><Citation>Chandramohan D, Garc&#xed;a JJC, Kata M, Naik R, Bali A, Shaik BF. Acute kidney injury. Annal of Clin Med &amp; Med Res. 2023;1(1):1&#x2010;17. https://doi.org/10.5281/zenodo</Citation></Reference><Reference><Citation>El&#x2010;Taji O, Howell&#x2010;Etienne J, Taktak S, Hanchanale V. Lower vs standard pressure pneumoperitoneum in robotic&#x2010;assisted radical prostatectomy: a systematic review and meta&#x2010;analysis. J Robot Surg. 2023;17(2):303&#x2010;312. https://doi.org/10.1007/s11701&#x2010;022&#x2010;01445&#x2010;2</Citation></Reference><Reference><Citation>Palleti SK, Avula S, Naik R. Chronic kidney disease. Int Clinc Med Case Rep Jour. 2023;2(11):1&#x2010;15.</Citation></Reference><Reference><Citation>Caddeo G, Williams ST, McIntyre CW, Selby NM. Acute kidney injury in urology patients: incidence, causes and outcomes. Nephro&#x2010;Urol Mon. 2013;5(5):955&#x2010;961. https://doi.org/10.5812/numonthly.12721</Citation></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et&#xa0;al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906. https://doi.org/10.1016/j.ijsu.2021.105906</Citation></Reference><Reference><Citation>Barker TH, Migliavaca CB, Stein C, et&#xa0;al. Conducting proportional meta&#x2010;analysis in different types of systematic reviews: a guide for synthesisers of evidence. BMC Med Res Methodol. 2021;21(1):1&#x2010;9. https://doi.org/10.1186/s12874&#x2010;021&#x2010;01381&#x2010;z</Citation></Reference><Reference><Citation>DerSimonian R, Laird N. Meta&#x2010;analysis in clinical trials. Contr Clin Trials. 1986;7(3):177&#x2010;188. https://doi.org/10.1016/0197&#x2010;2456(86)90046&#x2010;2</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta&#x2010;analyses. BMJ. 2003;327(7414):557&#x2010;560. https://doi.org/10.1136/bmj.327.7414.557</Citation></Reference><Reference><Citation>Wells GA, Shea B, O&#x2019;Connell D, et&#xa0;al. The Newcastle&#x2010;Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta&#x2010;Analyses; 2000.</Citation></Reference><Reference><Citation>Zhang Y, Huang L, Wang D, Ren P, Hong Q, Kang D. The ROBINS&#x2010;I and the NOS had similar reliability but differed in applicability: a random sampling observational studies of systematic reviews/meta&#x2010;analysis. J Evid Base Med. 2021;14(2):112&#x2010;122. https://doi.org/10.1111/jebm.12427</Citation></Reference><Reference><Citation>Ahn JH, Lim CH, Chung HI, Choi SU, Youn SZ, Lim HJ. Postoperative renal function in patients is unaltered after robotic&#x2010;assisted radical prostatectomy. Korean J Anesthesiol. 2011;60(3):192&#x2010;197. https://doi.org/10.4097/kjae.2011.60.3.192</Citation></Reference><Reference><Citation>Ergin G, Doluoglu OG, K&#x131;ra&#xe7; M, et&#xa0;al. Comparison of renal function after robot &#x2010; assisted laparoscopic radical prostatectomy versus retropubic radical prostatectomy. Int Braz J Urol. 2019;45(1):83&#x2010;88. https://doi.org/10.1590/s1677&#x2010;5538.ibju.2018.0103</Citation></Reference><Reference><Citation>Erkoc SK, Guclu CY, Ergin GY, Safak B, Meco BC, Yilmaz AA. Anesthesia management and patient outcomes in robotic assisted laparoscopic surgery: a single center experience. Medicine. 2022;11(4):1482&#x2010;1486. https://doi.org/10.5455/medscience.2022.08.192</Citation></Reference><Reference><Citation>Joo EY, Moon YJ, Yoon SH, Chin JH, Hwang JH, Kim YK. Comparison of acute kidney injury after robot&#x2010;assisted laparoscopic radical prostatectomy versus retropubic radical prostatectomy: a propensity score matching analysis. Medicine (Baltim). 2016;95(5):e2650. https://doi.org/10.1097/md.0000000000002650</Citation></Reference><Reference><Citation>Kim TL, Kim N, Shin HJ, Cho MR, Park HR, Kim SY. Intraoperative mean arterial pressure and acute kidney injury after robot&#x2010;assisted laparoscopic prostatectomy: a retrospective study. Sci Rep. 2023;13(1):3318. https://doi.org/10.1038/s41598&#x2010;023&#x2010;30506&#x2010;1</Citation></Reference><Reference><Citation>Kong YG, Park JH, Park JY, et&#xa0;al. Effect of intraoperative mannitol administration on acute kidney injury after robot&#x2010;assisted laparoscopic radical prostatectomy: a propensity score matching analysis. Medicine (Baltim). 2018;97(26):e11338. https://doi.org/10.1097/md.0000000000011338</Citation></Reference><Reference><Citation>Naito A, Taguchi S, Suzuki M, et&#xa0;al. Transient acute kidney injury observed immediately after robot&#x2010;assisted radical prostatectomy but not after open radical prostatectomy. Mol Clin Oncol. 2020;13(3):18. https://doi.org/10.3892/mco.2020.2087</Citation></Reference><Reference><Citation>Ning C, Hu X, Liu F, et&#xa0;al. Post&#x2010;surgical outcomes of patients with chronic kidney disease and end stage renal disease undergoing radical prostatectomy: 10&#x2010;year results from the US National Inpatient Sample. BMC Nephrol. 2019;20(1):278. https://doi.org/10.1186/s12882&#x2010;019&#x2010;1455&#x2010;2</Citation></Reference><Reference><Citation>Sato H, Narita S, Saito M, et&#xa0;al. Acute kidney injury and its impact on renal prognosis after robot&#x2010;assisted laparoscopic radical prostatectomy. Int J Med Robot. 2020;16(5):1&#x2010;7. https://doi.org/10.1016/s2666&#x2010;1683(20)34022&#x2010;2</Citation></Reference><Reference><Citation>Cho JE, Shim JK, Chang JH, et&#xa0;al. Effect of nicardipine on renal function after robot&#x2010;assisted laparoscopic radical prostatectomy. Urology. 2009;73(5):1056&#x2010;1060. https://doi.org/10.1016/j.urology.2008.08.490</Citation></Reference><Reference><Citation>Atkinson TM, Giraud GD, Togioka BM, Jones DB, Cigarroa JE. Cardiovascular and ventilatory consequences of laparoscopic surgery. Circulation. 2017;135(7):700&#x2010;710. https://doi.org/10.1161/circulationaha.116.023262</Citation></Reference><Reference><Citation>Maerz DA, Beck LN, Sim AJ, Gainsburg DM. Complications of robotic&#x2010;assisted laparoscopic surgery distant from the surgical site. Br J Anaesth. 2017;118(4):492&#x2010;503. https://doi.org/10.1093/bja/aex003</Citation></Reference><Reference><Citation>Vasdev N, Poon ASK, Gowrie&#x2010;Mohan S, et&#xa0;al. The physiologic and anesthetic considerations in elderly patients undergoing robotic renal surgery. Rev Urol. 2014;16(1):1.</Citation></Reference><Reference><Citation>Gumbert SD, Kork F, Jackson ML, et&#xa0;al. Perioperative acute kidney injury. Anesthesiology. 2020;132(1):180&#x2010;204. https://doi.org/10.1097/aln.0000000000002968</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36450405</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1756-1833</ISSN><JournalIssue CitedMedium="Internet"><Volume>379</Volume><PubDate><Year>2022</Year><Month>Nov</Month><Day>30</Day></PubDate></JournalIssue><Title>BMJ (Clinical research ed.)</Title><ISOAbbreviation>BMJ</ISOAbbreviation></Journal><ArticleTitle>Oxygen administration during surgery and postoperative organ injury: observational cohort study.</ArticleTitle><Pagination><StartPage>e070941</StartPage><MedlinePgn>e070941</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e070941</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmj-2022-070941</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To examine whether supraphysiological oxygen administration during surgery is associated with lower or higher postoperative kidney, heart, and lung injury.</AbstractText><AbstractText Label="DESIGN">Observational cohort study.</AbstractText><AbstractText Label="SETTING">42 medical centers across the United States participating in the Multicenter Perioperative Outcomes Group data registry.</AbstractText><AbstractText Label="PARTICIPANTS">Adult patients undergoing surgical procedures &#x2265;120 minutes' duration with general anesthesia and endotracheal intubation who were admitted to hospital after surgery between January 2016 and November 2018.</AbstractText><AbstractText Label="INTERVENTION">Supraphysiological oxygen administration, defined as the area under the curve of the fraction of inspired oxygen above air (21%) during minutes when the hemoglobin oxygen saturation was greater than 92%.</AbstractText><AbstractText Label="MAIN OUTCOMES">Primary endpoints were acute kidney injury defined using Kidney Disease Improving Global Outcomes criteria, myocardial injury defined as serum troponin &gt;0.04 ng/mL within 72 hours of surgery, and lung injury defined using international classification of diseases hospital discharge diagnosis codes.</AbstractText><AbstractText Label="RESULTS">The cohort comprised 350&#x2009;647 patients with median age 59 years (interquartile range 46-69 years), 180&#x2009;546 women (51.5%), and median duration of surgery 205 minutes (interquartile range 158-279 minutes). Acute kidney injury was diagnosed in 19&#x2009;207 of 297&#x2009;554 patients (6.5%), myocardial injury in 8972 of 320&#x2009;527 (2.8%), and lung injury in 13&#x2009;789 of 312&#x2009;161 (4.4%). The median fraction of inspired oxygen was 54.0% (interquartile range 47.5%-60.0%), and the area under the curve of supraphysiological inspired oxygen was 7951% min (5870-11&#x2009;107% min), equivalent to an 80% fraction of inspired oxygen throughout a 135 minute procedure, for example. After accounting for baseline covariates and other potential confounding variables, increased oxygen exposure was associated with a higher risk of acute kidney injury, myocardial injury, and lung injury. Patients at the 75th centile for the area under the curve of the fraction of inspired oxygen had 26% greater odds of acute kidney injury (95% confidence interval 22% to 30%), 12% greater odds of myocardial injury (7% to 17%), and 14% greater odds of lung injury (12% to 16%) compared with patients at the 25th centile. Sensitivity analyses evaluating alternative definitions of the exposure, restricting the cohort, and conducting an instrumental variable analysis confirmed these observations.</AbstractText><AbstractText Label="CONCLUSIONS">Increased supraphysiological oxygen administration during surgery was associated with a higher incidence of kidney, myocardial, and lung injury. Residual confounding of these associations cannot be excluded.</AbstractText><AbstractText Label="TRIAL REGISTRATION">Open Science Framework osf.io/cfd2m.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McIlroy</LastName><ForeName>David R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shotwell</LastName><ForeName>Matthew S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez</LastName><ForeName>Marcos G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaughn</LastName><ForeName>Michelle T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Michigan, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olsen</LastName><ForeName>Joanna S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Oregon Health and Science University, Portland, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hennessy</LastName><ForeName>Cassandra</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wanderer</LastName><ForeName>Jonathan P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Semler</LastName><ForeName>Matthew S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rice</LastName><ForeName>Todd W</ForeName><Initials>TW</Initials><AffiliationInfo><Affiliation>Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kheterpal</LastName><ForeName>Sachin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Michigan, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Billings</LastName><ForeName>Frederic T</ForeName><Initials>FT</Initials><Suffix>4th</Suffix><Identifier Source="ORCID">0000-0001-7135-7785</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA frederic.t.billings@vumc.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Multicenter Perioperative Outcomes Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 GM129662</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM112871</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM145375</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ</MedlineTA><NlmUniqueID>8900488</NlmUniqueID><ISSNLinking>0959-8138</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055370" MajorTopicYN="Y">Lung Injury</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006335" MajorTopicYN="Y">Heart Injuries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/disclosure-of-interest/ and declare: support from United States NIH, Association of University Anesthesiologists, departmental and institutional resources at each contributing medical center, Blue Cross Blue Shield of Michigan/Blue Care Network for the submitted work; DRM is chair of the data safety and monitoring board for the HOT-ROX trial (ACTRN12619000115134), an investigator initiated, multicenter international, randomized controlled trial of restrictive FIO2, liberal FIO2, and usual FIO2 in surgical patients; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Cuff</LastName><ForeName>Germaine</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Freundlich</LastName><ForeName>Robert E</ForeName><Initials>RE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kurz</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Naik</LastName><ForeName>Bhiken I</ForeName><Initials>BI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mathis</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schonberger</LastName><ForeName>Robert B</ForeName><Initials>RB</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>30</Day><Hour>20</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36450405</ArticleId><ArticleId IdType="pmc">PMC9710248</ArticleId><ArticleId IdType="doi">10.1136/bmj-2022-070941</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Greif R, Ak&#xe7;a O, Horn EP, Kurz A, Sessler DI, Outcomes Research Group . Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. N Engl J Med 2000;342:161-7. 10.1056/NEJM200001203420303&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200001203420303</ArticleId><ArticleId IdType="pubmed">10639541</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Botello SA, Garc&#xed;a-Granero E, Lillo R, L&#xf3;pez-Mozos F, Mill&#xe1;n M, Lled&#xf3; S. Randomized clinical trial to evaluate the effects of perioperative supplemental oxygen administration on the colorectal anastomosis. Br J Surg 2006;93:698-706. 10.1002/bjs.5370&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.5370</ArticleId><ArticleId IdType="pubmed">16703624</ArticleId></ArticleIdList></Reference><Reference><Citation>Allegranzi B, Zayed B, Bischoff P, et al. WHO Guidelines Development Group . New WHO recommendations on intraoperative and postoperative measures for surgical site infection prevention: an evidence-based global perspective. Lancet Infect Dis 2016;16:e288-303. 10.1016/S1473-3099(16)30402-9&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(16)30402-9</ArticleId><ArticleId IdType="pubmed">27816414</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenk M, Van Aken H, Zarbock A. The new World Health Organization recommendations on perioperative administration of oxygen to prevent surgical site infections: a dangerous reductionist approach? Anesth Analg 2017;125:682-7. 10.1213/ANE.0000000000002256&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000002256</ArticleId><ArticleId IdType="pubmed">28682957</ArticleId></ArticleIdList></Reference><Reference><Citation>Helmerhorst HJF, Schultz MJ, van der Voort PHJ, de Jonge E, van Westerloo DJ. Bench-to-bedside review: the effects of hyperoxia during critical illness. Crit Care 2015;19:284. 10.1186/s13054-015-0996-4&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-0996-4</ArticleId><ArticleId IdType="pmc">PMC4538738</ArticleId><ArticleId IdType="pubmed">26278383</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhilyaev SY, Moskvin AN, Platonova TF, Gutsaeva DR, Churilina IV, Demchenko IT. Hyperoxic vasoconstriction in the brain is mediated by inactivation of nitric oxide by superoxide anions. Neurosci Behav Physiol 2003;33:783-7. 10.1023/A:1025145331149&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1025145331149</ArticleId><ArticleId IdType="pubmed">14635993</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouren S, Souktani R, Beaussier M, et al. . Mechanisms of coronary vasoconstriction induced by high arterial oxygen tension. Am J Physiol 1997;272:H67-75.</Citation><ArticleIdList><ArticleId IdType="pubmed">9038923</ArticleId></ArticleIdList></Reference><Reference><Citation>Eltzschig HK, Bratton DL, Colgan SP. Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases. Nat Rev Drug Discov 2014;13:852-69. 10.1038/nrd4422&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd4422</ArticleId><ArticleId IdType="pmc">PMC4259899</ArticleId><ArticleId IdType="pubmed">25359381</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FT, 4th, Pretorius M, Schildcrout JS, et al. . Obesity and oxidative stress predict AKI after cardiac surgery. J Am Soc Nephrol 2012;23:1221-8. 10.1681/ASN.2011090940&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2011090940</ArticleId><ArticleId IdType="pmc">PMC3380645</ArticleId><ArticleId IdType="pubmed">22626819</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez MG, Pandharipande P, Morse J, et al. . Intraoperative cerebral oxygenation, oxidative injury, and delirium following cardiac surgery. Free Radic Biol Med 2017;103:192-8. 10.1016/j.freeradbiomed.2016.12.039&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2016.12.039</ArticleId><ArticleId IdType="pmc">PMC5258679</ArticleId><ArticleId IdType="pubmed">28039082</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez MG, Hughes CG, DeMatteo A, et al. . Intraoperative oxidative damage and delirium after cardiac surgery. Anesthesiology 2020;132:551-61. 10.1097/ALN.0000000000003016&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003016</ArticleId><ArticleId IdType="pmc">PMC7015795</ArticleId><ArticleId IdType="pubmed">31770146</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki S, Mihara Y, Hikasa Y, et al. Okayama Research Investigation Organizing Network (ORION) investigators . Current ventilator and oxygen management during general anesthesia: a multicenter, cross-sectional observational study. Anesthesiology 2018;129:67-76. 10.1097/ALN.0000000000002181&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000002181</ArticleId><ArticleId IdType="pubmed">29553985</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarte LA, Schober P, Loer SA. Benefits and harms of increased inspiratory oxygen concentrations. Curr Opin Anaesthesiol 2019;32:783-91. 10.1097/ACO.0000000000000791&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0000000000000791</ArticleId><ArticleId IdType="pubmed">31464698</ArticleId></ArticleIdList></Reference><Reference><Citation>Torbati D, Tan GH, Smith S, et al. . Multiple-organ effect of normobaric hyperoxia in neonatal rats. J Crit Care 2006;21:85-93, discussion 93-4. 10.1016/j.jcrc.2005.09.057&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2005.09.057</ArticleId><ArticleId IdType="pubmed">16616630</ArticleId></ArticleIdList></Reference><Reference><Citation>Colquhoun DA, Shanks AM, Kapeles SR, et al. . Considerations for integration of perioperative electronic health records across institutions for research and quality improvement: the approach taken by the Multicenter Perioperative Outcomes Group. Anesth Analg 2020;130:1133-46. 10.1213/ANE.0000000000004489&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000004489</ArticleId><ArticleId IdType="pmc">PMC7663856</ArticleId><ArticleId IdType="pubmed">32287121</ArticleId></ArticleIdList></Reference><Reference><Citation>Beasley R, Chien J, Douglas J, et al. . Thoracic Society of Australia and New Zealand oxygen guidelines for acute oxygen use in adults: &#x2018;Swimming between the flags&#x2019;. Respirology 2015;20:1182-91. 10.1111/resp.12620&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/resp.12620</ArticleId><ArticleId IdType="pmc">PMC4654337</ArticleId><ArticleId IdType="pubmed">26486092</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Driscoll BR, Howard LS, Earis J, Mak V, British Thoracic Society Emergency Oxygen Guideline Group. BTS Emergency Oxygen Guideline Development Group . BTS guideline for oxygen use in adults in healthcare and emergency settings. Thorax 2017;72(Suppl 1):ii1-90. 10.1136/thoraxjnl-2016-209729&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2016-209729</ArticleId><ArticleId IdType="pubmed">28507176</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012;120:c179-84. 10.1159/000339789&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000339789</ArticleId><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller T, Zeller T, Peetz D, et al. . Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:868-77. 10.1056/NEJMoa0903515&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0903515</ArticleId><ArticleId IdType="pubmed">19710485</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbott TEF, Fowler AJ, Pelosi P, et al. StEP-COMPAC Group . A systematic review and consensus definitions for standardised end-points in perioperative medicine: pulmonary complications. Br J Anaesth 2018;120:1066-79. 10.1016/j.bja.2018.02.007&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2018.02.007</ArticleId><ArticleId IdType="pubmed">29661384</ArticleId></ArticleIdList></Reference><Reference><Citation>Jammer I, Wickboldt N, Sander M, et al. European Society of Anaesthesiology (ESA) and the European Society of Intensive Care Medicine (ESICM) European Society of Anaesthesiology. European Society of Intensive Care Medicine . Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine: European Perioperative Clinical Outcome (EPCO) definitions: a statement from the ESA-ESICM joint taskforce on perioperative outcome measures. Eur J Anaesthesiol 2015;32:88-105. 10.1097/EJA.0000000000000118&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000118</ArticleId><ArticleId IdType="pubmed">25058504</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladha K, Vidal Melo MF, McLean DJ, et al. . Intraoperative protective mechanical ventilation and risk of postoperative respiratory complications: hospital based registry study. BMJ 2015;351:h3646. 10.1136/bmj.h3646&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h3646</ArticleId><ArticleId IdType="pmc">PMC4501577</ArticleId><ArticleId IdType="pubmed">26174419</ArticleId></ArticleIdList></Reference><Reference><Citation>Saager L, Hesler BD, You J, et al. . Intraoperative transitions of anesthesia care and postoperative adverse outcomes. Anesthesiology 2014;121:695-706. 10.1097/ALN.0000000000000401&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000401</ArticleId><ArticleId IdType="pubmed">25102312</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Vaughn MT, Dubovoy TZ, et al. . Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): a multicenter matched cohort analysis. Anesthesiology 2020;132:1371-81. 10.1097/ALN.0000000000003256&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003256</ArticleId><ArticleId IdType="pmc">PMC7864000</ArticleId><ArticleId IdType="pubmed">32282427</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan H, Sundararajan V, Halfon P, et al. . Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130-9. 10.1097/01.mlr.0000182534.19832.83&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mlr.0000182534.19832.83</ArticleId><ArticleId IdType="pubmed">16224307</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore BJ, White S, Washington R, Coenen N, Elixhauser A. Identifying increased risk of readmission and in-hospital mortality using hospital administrative data: the AHRQ Elixhauser Comorbidity Index. Med Care 2017;55:698-705. 10.1097/MLR.0000000000000735&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0000000000000735</ArticleId><ArticleId IdType="pubmed">28498196</ArticleId></ArticleIdList></Reference><Reference><Citation>
van Buuren S, Groothuis-Oudshoorn K. mice: Multivariate Imputation by Chained Equations in R
. J Stat Softw
2011;45:1-67. https://www.jstatsoft.org/v45/i03/
10.18637/jss.v045.i03.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v045.i03</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin DB, Schenker N. Multiple imputation in health-care databases: an overview and some applications. Stat Med 1991;10:585-98. 10.1002/sim.4780100410&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.4780100410</ArticleId><ArticleId IdType="pubmed">2057657</ArticleId></ArticleIdList></Reference><Reference><Citation>Angrist JD, Imbens GW, Rubin DB. Identification of causal effects using instrumental variables. J Am Stat Assoc 1996;91:444-55 10.1080/01621459.1996.10476902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01621459.1996.10476902</ArticleId></ArticleIdList></Reference><Reference><Citation>Robins JM, Hern&#xe1;n MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology 2000;11:550-60. 10.1097/00001648-200009000-00011&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001648-200009000-00011</ArticleId><ArticleId IdType="pubmed">10955408</ArticleId></ArticleIdList></Reference><Reference><Citation>Greifer N. WeightIt: Weighting for Covariate Balance in Observational Studies. R package version 0.13.1. 2022. Available from: https://CRAN.R-project.org/package=WeightIt
</Citation></Reference><Reference><Citation>McGuinness SP, Parke RL, Drummond K, et al. SO-COOL investigators . A multicenter, randomized, controlled phase IIb trial of avoidance of hyperoxemia during cardiopulmonary bypass. Anesthesiology 2016;125:465-73. 10.1097/ALN.0000000000001226&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001226</ArticleId><ArticleId IdType="pubmed">27404222</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaefi S, Shankar P, Mueller AL, et al. . Intraoperative oxygen concentration and neurocognition after cardiac surgery. Anesthesiology 2021;134:189-201. 10.1097/ALN.0000000000003650&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003650</ArticleId><ArticleId IdType="pmc">PMC7855826</ArticleId><ArticleId IdType="pubmed">33331902</ArticleId></ArticleIdList></Reference><Reference><Citation>Holse C, Aasvang EK, Vester-Andersen M, et al. VIXIE Trial Group . Hyperoxia and antioxidants for myocardial injury in noncardiac surgery: a 2 &#xd7; 2 factorial, blinded, randomized clinical trial. Anesthesiology 2022;136:408-19. 10.1097/ALN.0000000000004117&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000004117</ArticleId><ArticleId IdType="pubmed">35120193</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruetzler K, Cohen B, Leung S, et al. . Supplemental intraoperative oxygen does not promote acute kidney injury or cardiovascular complications after noncardiac surgery: subanalysis of an alternating intervention trial. Anesth Analg 2020;130:933-40. 10.1213/ANE.0000000000004359&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000004359</ArticleId><ArticleId IdType="pubmed">31490254</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurz A, Kopyeva T, Suliman I, et al. . Supplemental oxygen and surgical-site infections: an alternating intervention controlled trial. Br J Anaesth 2018;120:117-26. 10.1016/j.bja.2017.11.003&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2017.11.003</ArticleId><ArticleId IdType="pubmed">29397118</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyhoff CS, Jorgensen LN, Wetterslev J, Christensen KB, Rasmussen LS, PROXI Trial Group . Increased long-term mortality after a high perioperative inspiratory oxygen fraction during abdominal surgery: follow-up of a randomized clinical trial. Anesth Analg 2012;115:849-54. 10.1213/ANE.0b013e3182652a51&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e3182652a51</ArticleId><ArticleId IdType="pubmed">22798533</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrando C, Aldecoa C, Unzueta C, et al. iPROVE-O2 Network . Effects of oxygen on post-surgical infections during an individualised perioperative open-lung ventilatory strategy: a randomised controlled trial. Br J Anaesth 2020;124:110-20. 10.1016/j.bja.2019.10.009&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2019.10.009</ArticleId><ArticleId IdType="pubmed">31767144</ArticleId></ArticleIdList></Reference><Reference><Citation>Staehr-Rye AK, Meyhoff CS, Scheffenbichler FT, et al. . High intraoperative inspiratory oxygen fraction and risk of major respiratory complications. Br J Anaesth 2017;119:140-9. 10.1093/bja/aex128&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aex128</ArticleId><ArticleId IdType="pubmed">28974067</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae J, Kim J, Lee S, et al. . Association between intraoperative hyperoxia and acute kidney injury after cardiac surgery: a retrospective observational study. J Cardiothorac Vasc Anesth 2021;35:2405-14. 10.1053/j.jvca.2020.11.054&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2020.11.054</ArticleId><ArticleId IdType="pubmed">33342731</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen SS, Holse C, Mathar CE, et al. . Intraoperative inspiratory oxygen fraction and myocardial injury after noncardiac surgery: results from an international observational study in relation to recent controlled trials. Anesth Analg 2022;135:1021-30. 10.1213/ANE.0000000000006042&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000006042</ArticleId><ArticleId IdType="pubmed">35417425</ArticleId></ArticleIdList></Reference><Reference><Citation>Leisman DE. The Goldilocks effect in the ICU-when the data speak, but not the truth. Crit Care Med 2020;48:1887-9. 10.1097/CCM.0000000000004669&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004669</ArticleId><ArticleId IdType="pubmed">33255103</ArticleId></ArticleIdList></Reference><Reference><Citation>Labrecque J, Swanson SA. Understanding the assumptions underlying instrumental variable analyses: a brief review of falsification strategies and related tools. Curr Epidemiol Rep 2018;5:214-20. 10.1007/s40471-018-0152-1&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40471-018-0152-1</ArticleId><ArticleId IdType="pmc">PMC6096851</ArticleId><ArticleId IdType="pubmed">30148040</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiser TG, Regenbogen SE, Thompson KD, et al. . An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 2008;372:139-44. 10.1016/S0140-6736(08)60878-8&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(08)60878-8</ArticleId><ArticleId IdType="pubmed">18582931</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31888922</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1555-905X</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month><Day>07</Day></PubDate></JournalIssue><Title>Clinical journal of the American Society of Nephrology : CJASN</Title><ISOAbbreviation>Clin J Am Soc Nephrol</ISOAbbreviation></Journal><ArticleTitle>Intraoperative Arterial Pressure Variability and Postoperative Acute Kidney Injury.</ArticleTitle><Pagination><StartPage>35</StartPage><EndPage>46</EndPage><MedlinePgn>35-46</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2215/CJN.06620619</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES">High BP variability may cause AKI because of inappropriate kidney perfusion. This study aimed to investigate the association between intraoperative BP variability and postoperative AKI in patients who underwent noncardiac surgery.</AbstractText><AbstractText Label="DESIGN, SETTING, PARTICIPANTS, &amp; MEASUREMENTS">We performed a cohort study of adults undergoing noncardiac surgery in hospitals in South Korea. We studied three cohorts using the following recording windows for intraoperative BP: discovery cohort, 1-minute intervals; first validation cohort, 5-minute intervals; and second validation cohort, 2-second intervals. We calculated four variability parameters (SD, coefficient of variation, variation independent of mean, and average real variability) based on the measured mean arterial pressure values. The primary outcomes were postoperative AKI (defined by the Kidney Disease Improving Global Outcomes serum creatinine cutoffs) and critical AKI (consisting of stage 2 or higher AKI and post-AKI death or dialysis within 90 days).</AbstractText><AbstractText Label="RESULTS">In the three cohorts, 45,520, 29,704, and 7435 patients were analyzed, each with 2230 (443 critical), 1552 (444 critical), and 300 (91 critical) postoperative AKI events, respectively. In the discovery cohort, all variability parameters were significantly associated with risk of AKI, even after adjusting for intraoperative hypotension. For example, average real variability was associated with higher risks of postoperative AKI (adjusted odds ratio, 1.13 per 1 SD increment; 95% CI, 1.07 to 1.19) and critical AKI (adjusted odds ratio, 1.13 per 1 SD increment; 95% CI, 1.02 to 1.26). Associations were evident predominantly among patients who also experienced intraoperative hypotension. In the validation analysis with 5-minute-interval BP records, all four variability parameters were associated with the risk of postoperative AKI or critical AKI. In the validation cohort with 2-second-interval BP records, average real variability was the only significant variability parameter.</AbstractText><AbstractText Label="CONCLUSIONS">Higher intraoperative BP variability is associated with higher risks of postoperative AKI after noncardiac surgery, independent of hypotension and other clinical characteristics.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 by the American Society of Nephrology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sehoon</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4221-2453</Identifier><AffiliationInfo><Affiliation>Departments of Biomedical Sciences.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Armed Forces Capital Hospital, Gyeonggi-do, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Hyung-Chul</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>Chul-Woo</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Yunhee</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Medical Research Collaborating Center.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoon</LastName><ForeName>Hyung Jin</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Biomedical Engineering, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sejoong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Internal Medicine, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University Bundang Hospital, Gyeonggi-do, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chin</LastName><ForeName>Ho Jun</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Internal Medicine, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University Bundang Hospital, Gyeonggi-do, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Myoungsuk</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Biomedical Research Institute, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Yong Chul</ForeName><Initials>YC</Initials><Identifier Source="ORCID">0000-0003-3215-8681</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Dong Ki</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Internal Medicine, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kidney Research Institute, Seoul National University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joo</LastName><ForeName>Kwon Wook</ForeName><Initials>KW</Initials><AffiliationInfo><Affiliation>Internal Medicine, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kidney Research Institute, Seoul National University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Yon Su</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Departments of Biomedical Sciences.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Internal Medicine, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kidney Research Institute, Seoul National University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Hajeong</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-1873-1587</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea; and.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin J Am Soc Nephrol</MedlineTA><NlmUniqueID>101271570</NlmUniqueID><ISSNLinking>1555-9041</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062186" MajorTopicYN="Y">Arterial Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001795" MajorTopicYN="N">Blood Pressure Determination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007432" MajorTopicYN="N">Intraoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">blood pressure</Keyword><Keyword MajorTopicYN="N">variability</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>1</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31888922</ArticleId><ArticleId IdType="pmc">PMC6946069</ArticleId><ArticleId IdType="doi">10.2215/CJN.06620619</ArticleId><ArticleId IdType="pii">01277230-202001000-00009</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abelha FJ, Botelho M, Fernandes V, Barros H: Determinants of postoperative acute kidney injury. Crit Care 13: R79, 2009</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2717442</ArticleId><ArticleId IdType="pubmed">19463152</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson C, Ozrazgat-Baslanti T, Kuxhausen A, Thottakkara P, Efron PA, Moore FA, Moldawer LL, Segal MS, Bihorac A: Cost and mortality associated with postoperative acute kidney injury. Ann Surg 261: 1207&#x2013;1214, 2015</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4247993</ArticleId><ArticleId IdType="pubmed">24887982</ArticleId></ArticleIdList></Reference><Reference><Citation>Biteker M, Dayan A, Tekke&#x15f;in AI, Can MM, Tayc&#x131; &#x130;, &#x130;lhan E, &#x15e;ahin G: Incidence, risk factors, and outcomes of perioperative acute kidney injury in noncardiac and nonvascular surgery. Am J Surg 207: 53&#x2013;59, 2014</Citation><ArticleIdList><ArticleId IdType="pubmed">24050540</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Kellum JA, Ronco C: Acute kidney injury. Lancet 380: 756&#x2013;766, 2012</Citation><ArticleIdList><ArticleId IdType="pubmed">22617274</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S, Cho H, Park S, Lee S, Kim K, Yoon HJ, Park J, Choi Y, Lee S, Kim JH, Kim S, Chin HJ, Kim DK, Joo KW, Kim YS, Lee H: Simple postoperative AKI risk (SPARK) classification before noncardiac surgery: A prediction index development study with external validation. J Am Soc Nephrol 30: 170&#x2013;181, 2019</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6317608</ArticleId><ArticleId IdType="pubmed">30563915</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Tremper KK, Heung M, Rosenberg AL, Englesbe M, Shanks AM, Campbell DA Jr.: Development and validation of an acute kidney injury risk index for patients undergoing general surgery: Results from a national data set. Anesthesiology 110: 505&#x2013;515, 2009</Citation><ArticleIdList><ArticleId IdType="pubmed">19212261</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S, Lee H: Acute kidney injury prediction models: Current concepts and future strategies. Curr Opin Nephrol Hypertens 28: 552&#x2013;559, 2019</Citation><ArticleIdList><ArticleId IdType="pubmed">31356235</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares DM, Pessanha JF, Sharma A, Brocca A, Ronco C: Delayed Nephrology consultation and high mortality on acute kidney injury: A meta-analysis. Blood Purif 43: 57&#x2013;67, 2017</Citation><ArticleIdList><ArticleId IdType="pubmed">27915348</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S, Baek SH, Ahn S, Lee KH, Hwang H, Ryu J, Ahn SY, Chin HJ, Na KY, Chae DW, Kim S: Impact of electronic Acute Kidney Injury (AKI) alerts with automated nephrologist consultation on detection and Severity of AKI: A quality improvement study. Am J Kidney Dis 71: 9&#x2013;19, 2018</Citation><ArticleIdList><ArticleId IdType="pubmed">28754457</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;cze I, Jauch D, G&#xf6;tz M, Kennedy P, Jung B, Zeman F, Gnewuch C, Graf BM, Gnann W, Banas B, Bein T, Schlitt HJ, Bergler T: Biomarker-guided intervention to prevent acute kidney injury after major surgery: The prospective randomized BigpAK study. Ann Surg 267: 1013&#x2013;1020, 2018</Citation><ArticleIdList><ArticleId IdType="pubmed">28857811</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersch M, Schmidt C, Hoffmeier A, Van Aken H, Wempe C, Gerss J, Zarbock A: Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: The PrevAKI randomized controlled trial. Intensive Care Med 43: 1551&#x2013;1561, 2017</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5633630</ArticleId><ArticleId IdType="pubmed">28110412</ArticleId></ArticleIdList></Reference><Reference><Citation>Munshi R, Hsu C, Himmelfarb J: Advances in understanding ischemic acute kidney injury. BMC Med 9: 11, 2011</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3038966</ArticleId><ArticleId IdType="pubmed">21288330</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh M, Devereaux PJ, Garg AX, Kurz A, Turan A, Rodseth RN, Cywinski J, Thabane L, Sessler DI: Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: Toward an empirical definition of hypotension. Anesthesiology 119: 507&#x2013;515, 2013</Citation><ArticleIdList><ArticleId IdType="pubmed">23835589</ArticleId></ArticleIdList></Reference><Reference><Citation>KDIGO Work Group : KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2: 6, 2012</Citation></Reference><Reference><Citation>Salmasi V, Maheshwari K, Yang D, Mascha EJ, Singh A, Sessler DI, Kurz A: Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery: A retrospective cohort analysis. Anesthesiology 126: 47&#x2013;65, 2017</Citation><ArticleIdList><ArticleId IdType="pubmed">27792044</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesselink EM, Kappen TH, Torn HM, Slooter AJC, van Klei WA: Intraoperative hypotension and the risk of postoperative adverse outcomes: A systematic review. Br J Anaesth 121: 706&#x2013;721, 2018</Citation><ArticleIdList><ArticleId IdType="pubmed">30236233</ArticleId></ArticleIdList></Reference><Reference><Citation>Collange O, Jazaerli L, Lejay A, Biermann C, Caillard S, Moulin B, Chakfe N, Severac F, Schaeffer M, Mertes PM, Steib A: Intraoperative pleth variability index is linked to delayed graft function after kidney transplantation. Transplant Proc 48: 2615&#x2013;2621, 2016</Citation><ArticleIdList><ArticleId IdType="pubmed">27788791</ArticleId></ArticleIdList></Reference><Reference><Citation>Mascha EJ, Yang D, Weiss S, Sessler DI: Intraoperative mean arterial pressure variability and 30-day mortality in patients having noncardiac surgery. Anesthesiology 123: 79&#x2013;91, 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">25929547</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Z, Liao X, Yin W, Kang Y, Guo J, Lu M: Relationship between short-term blood pressure variability and incidence of acute kidney injury in critically ill patients. Kidney Blood Press Res 42: 1238&#x2013;1246, 2017</Citation><ArticleIdList><ArticleId IdType="pubmed">29248933</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HC, Jung CW: Vital Recorder-a free research tool for automatic recording of high-resolution time-synchronised physiological data from multiple anaesthesia devices. Sci Rep 8: 1527, 2018</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5784161</ArticleId><ArticleId IdType="pubmed">29367620</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HC, Ryu HG, Chung EJ, Jung CW: Prediction of bispectral index during target-controlled infusion of propofol and remifentanil: A deep learning approach. Anesthesiology 128: 492&#x2013;501, 2018</Citation><ArticleIdList><ArticleId IdType="pubmed">28953500</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikuya M, Ohkubo T, Metoki H, Asayama K, Hara A, Obara T, Inoue R, Hoshi H, Hashimoto J, Totsune K, Satoh H, Imai Y: Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: The Ohasama study. Hypertension 52: 1045&#x2013;1050, 2008</Citation><ArticleIdList><ArticleId IdType="pubmed">18981332</ArticleId></ArticleIdList></Reference><Reference><Citation>Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, Gheeraert PJ, Missault LH, Braun JJ, Six RO, Van Der Niepen P, O&#x2019;Brien E; Office versus Ambulatory Pressure Study Investigators : Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 348: 2407&#x2013;2415, 2003</Citation><ArticleIdList><ArticleId IdType="pubmed">12802026</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothwell PM, Howard SC, Dolan E, O&#x2019;Brien E, Dobson JE, Dahl&#xf6;f B, Sever PS, Poulter NR: Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 375: 895&#x2013;905, 2010</Citation><ArticleIdList><ArticleId IdType="pubmed">20226988</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierdomenico SD, Di Nicola M, Esposito AL, Di Mascio R, Ballone E, Lapenna D, Cuccurullo F: Prognostic value of different indices of blood pressure variability in hypertensive patients. Am J Hypertens 22: 842&#x2013;847, 2009</Citation><ArticleIdList><ArticleId IdType="pubmed">19498342</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin DC, Yun SR, Lee SW, Han SW, Kim W, Park J, Kim YK: Current characteristics of dialysis therapy in Korea: 2016 registry data focusing on diabetic patients. Kidney Res Clin Pract 37: 20&#x2013;29, 2018</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5875573</ArticleId><ArticleId IdType="pubmed">29629274</ArticleId></ArticleIdList></Reference><Reference><Citation>Bijker JB, van Klei WA, Kappen TH, van Wolfswinkel L, Moons KG, Kalkman CJ: Incidence of intraoperative hypotension as a function of the chosen definition: Literature definitions applied to a retrospective cohort using automated data collection. Anesthesiology 107: 213&#x2013;220, 2007</Citation><ArticleIdList><ArticleId IdType="pubmed">17667564</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg AX, Devereaux PJ, Yusuf S, Cuerden MS, Parikh CR, Coca SG, Walsh M, Novick R, Cook RJ, Jain AR, Pan X, Noiseux N, Vik K, Stolf NA, Ritchie A, Favaloro RR, Parvathaneni S, Whitlock RP, Ou Y, Lawrence M, Lamy A; CORONARY Investigators : Kidney function after off-pump or on-pump coronary artery bypass graft surgery: A randomized clinical trial [Published correction appears in JAMA 312: 97, 2014]. JAMA 311: 2191&#x2013;2198, 2014</Citation><ArticleIdList><ArticleId IdType="pubmed">24886787</ArticleId></ArticleIdList></Reference><Reference><Citation>Shroyer AL, Grover FL, Hattler B, Collins JF, McDonald GO, Kozora E, Lucke JC, Baltz JH, Novitzky D; Veterans Affairs Randomized On/Off Bypass (ROOBY) Study Group : On-pump versus off-pump coronary-artery bypass surgery. N Engl J Med 361: 1827&#x2013;1837, 2009</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonventre JV, Weinberg JM: Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 14: 2199&#x2013;2210, 2003</Citation><ArticleIdList><ArticleId IdType="pubmed">12874476</ArticleId></ArticleIdList></Reference><Reference><Citation>Guazzi MD, Barbier P, Loaldi A, Montorsi P, Polese A, Tosi E, Fiorentini C: Intrarenal beta-receptor and renal baroreceptor interaction in the control of the renin response to transient reduction of the renal perfusion pressure in man. J Hypertens 3: 39&#x2013;45, 1985</Citation><ArticleIdList><ArticleId IdType="pubmed">2987340</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou TL, Kroon AA, Reesink KD, Schram MT, Koster A, Schaper NC, Dagnelie PC, van der Kallen CJH, Sep SJS, Stehouwer CDA, Henry RMA: Blood pressure variability in individuals with and without (pre)diabetes: The Maastricht Study. J Hypertens 36: 259&#x2013;267, 2018</Citation><ArticleIdList><ArticleId IdType="pubmed">28885385</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarafidis PA, Ruilope LM, Loutradis C, Gorostidi M, de la Sierra A, de la Cruz JJ, Vinyoles E, Divis&#xf3;n-Garrote JA, Segura J, Banegas JR: Blood pressure variability increases with advancing chronic kidney disease stage: A cross-sectional analysis of 16&#x200a;546 hypertensive patients. J Hypertens 36: 1076&#x2013;1085, 2018</Citation><ArticleIdList><ArticleId IdType="pubmed">29465710</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40490616</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1496-8975</ISSN><JournalIssue CitedMedium="Internet"><Volume>72</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Canadian journal of anaesthesia = Journal canadien d'anesthesie</Title><ISOAbbreviation>Can J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Dexmedetomidine and acute kidney injury in patients with sepsis: a retrospective cohort study.</ArticleTitle><Pagination><StartPage>966</StartPage><EndPage>974</EndPage><MedlinePgn>966-974</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12630-025-02977-5</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Acute kidney injury (AKI) is a common complication of sepsis. AKI is associated with increased morbidity and mortality. Studies show that dexmedetomidine has a protective effect against AKI. We sought to evaluate the association between dexmedetomidine administration and AKI in patients with sepsis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a retrospective cohort study of 331 adult patients with sepsis. We divided patients into two groups: patients who received an infusion of dexmedetomidine of&#x2009;&#x2265;&#x2009;0.2&#xa0;&#xb5;g&#xb7;kg<sup>-1</sup>&#xb7;hr<sup>-1</sup> for&#x2009;&gt;&#x2009;6&#xa0;hr within 72&#xa0;hr of sepsis diagnosis (the dexmedetomidine group; N&#x2009;=&#x2009;73) and patients who did not receive a dexmedetomidine infusion (the nondexmedetomidine group; N&#x2009;=&#x2009;258). The primary outcome was the incidence of AKI within seven days, defined by the Kidney Disease Improving Global Outcomes (KDIGO) criteria. We analyzed our results using multivariable logistic regression models including 1) the entire cohort (331 patients) or 2) a 1:1 propensity-score-matched cohort (73 patients per group).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Acute kidney injury was diagnosed in 190/331 (57.4%) patients. The incidence of AKI was not different between the dexmedetomidine group and the nondexmedetomidine group in both the entire cohort (54.8% vs 58.1%; P&#x2009;=&#x2009;0.61) and the propensity-matched cohort (54.7% vs 63.0%; P&#x2009;=&#x2009;0.31). Additionally, there were no significant differences between groups in the incidence of renal replacement therapy (10.9% vs 13.6%; P&#x2009;=&#x2009;0.61) and 30-day mortality (32.8% vs 24.6%; P&#x2009;=&#x2009;0.27). We observed a statistically significant interaction between patient age&#x2009;&gt;&#x2009;65&#xa0;yr and reduced odds of developing AKI in patients who received dexmedetomidine (adjusted odds ratio, 0.25; 95% confidence interval, 0.07 to 0.90; P&#x2009;=&#x2009;0.03).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">While there was no association between dexmedetomidine administration and AKI in our overall cohort of patients with sepsis, we observed reduced odds of developing AKI in older patients (aged&#x2009;&gt;&#x2009;65&#xa0;yr) who received dexmedetomidine. Further research is needed to confirm that dexmedetomidine has a protective effect against AKI in this patient population.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chaengsuthiworawat</LastName><ForeName>Papawadee</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Chonburi Hospital, Chonburi, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thampongsa</LastName><ForeName>Tharin</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Surgery, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thamjamrassri</LastName><ForeName>Thanyalak</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Rama VI Road, Bangkok, 10400, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pisitsak</LastName><ForeName>Chawika</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0487-7673</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Rama VI Road, Bangkok, 10400, Thailand. chawika_p@hotmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Dexm&#xe9;d&#xe9;tomidine et insuffisance r&#xe9;nale aigu&#xeb; chez les personnes atteintes de septic&#xe9;mie : une &#xe9;tude de cohorte r&#xe9;trospective.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Can J Anaesth</MedlineTA><NlmUniqueID>8701709</NlmUniqueID><ISSNLinking>0832-610X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>67VB76HONO</RegistryNumber><NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006993">Hypnotics and Sedatives</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020927" MajorTopicYN="Y">Dexmedetomidine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006993" MajorTopicYN="Y">Hypnotics and Sedatives</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="fre"><AbstractText>R&#xe9;SUM&#xe9;: OBJECTIF: L&#x2019;insuffisance r&#xe9;nale aigu&#xeb; (IRA) est une complication fr&#xe9;quente de la septic&#xe9;mie. L&#x2019;IRA est associ&#xe9;e &#xe0; une augmentation de la morbidit&#xe9; et de la mortalit&#xe9;. Des &#xe9;tudes montrent que la dexm&#xe9;d&#xe9;tomidine a un effet protecteur contre l&#x2019;IRA. Nous avons cherch&#xe9; &#xe0; &#xe9;valuer l&#x2019;association entre l&#x2019;administration de dexm&#xe9;d&#xe9;tomidine et l&#x2019;IRA chez la patient&#xe8;le atteinte de septic&#xe9;mie. M&#xe9;THODE: Nous avons men&#xe9; une &#xe9;tude de cohorte r&#xe9;trospective de 331 adultes atteints de septic&#xe9;mie. Nous avons divis&#xe9; les patientes et patients en deux groupes : les personnes ayant re&#xe7;u une perfusion de dexm&#xe9;d&#xe9;tomidine de&#x2009;&#x2265;&#x2009;0,2&#xa0;&#x3bc;g&#xb7;kg<sup>&#x2212;1</sup>&#xb7;h<sup>&#x2212;1</sup> pour&#x2009;&gt;&#x2009;6 heures dans les 72&#xa0;heures suivant le diagnostic de septic&#xe9;mie (groupe dexm&#xe9;d&#xe9;tomidine; N&#x2009;=&#x2009;73) et les personnes n&#x2019;ayant pas re&#xe7;u de perfusion de dexm&#xe9;d&#xe9;tomidine (groupe non-dexm&#xe9;d&#xe9;tomidine; N&#x2009;=&#x2009;258). Le crit&#xe8;re d&#x2019;&#xe9;valuation principal &#xe9;tait l&#x2019;incidence d&#x2019;IRA dans les sept jours, d&#xe9;finie selon les crit&#xe8;res KDIGO (Kidney Disease Improving Global Outcomes). Nous avons analys&#xe9; nos r&#xe9;sultats &#xe0; l&#x2019;aide de mod&#xe8;les de r&#xe9;gression logistique multivari&#xe9;s incluant 1) la cohorte enti&#xe8;re (331 personnes) ou 2) une cohorte appari&#xe9;e par score de propension 1:1 (73 personnes par groupe). R&#xe9;SULTATS: Une insuffisance r&#xe9;nale aigu&#xeb; a &#xe9;t&#xe9; diagnostiqu&#xe9;e chez 190/331 (57,4&#xa0;%) personnes. L&#x2019;incidence d&#x2019;IRA n&#x2019;&#xe9;tait pas diff&#xe9;rente entre le groupe dexm&#xe9;d&#xe9;tomidine et le groupe non dexm&#xe9;d&#xe9;tomidine dans l&#x2019;ensemble de la cohorte (54,8&#xa0;% vs 58,1&#xa0;%; P&#x2009;=&#x2009;0,61) et la cohorte appari&#xe9;e selon la propension (54,7&#xa0;%) vs 63,0&#xa0;%; P&#x2009;=&#x2009;0,31). De plus, il n&#x2019;y avait pas de diff&#xe9;rences significatives entre les groupes dans l&#x2019;incidence du traitement substitutif de l&#x2019;insuffisance r&#xe9;nale (10,9&#xa0;% vs 13,6&#xa0;%; P&#x2009;=&#x2009;0,61) et la mortalit&#xe9; &#xe0; 30 jours (32,8&#xa0;% vs 24,6&#xa0;%; P&#x2009;=&#x2009;0,27). Nous avons observ&#xe9; une interaction statistiquement significative entre la patient&#xe8;le &#xe2;g&#xe9;e&#x2009;&gt;&#x2009;65&#xa0;ans et une r&#xe9;duction des risques de d&#xe9;velopper une IRA chez les personnes ayant re&#xe7;u de la dexm&#xe9;d&#xe9;tomidine (rapport de cotes ajust&#xe9;, 0,25; intervalle de confiance &#xe0; 95&#xa0;%, 0,07 &#xe0; 0,90; P&#x2009;=&#x2009;0,03). CONCLUSION: Bien qu&#x2019;il n&#x2019;y ait pas eu d&#x2019;association entre l&#x2019;administration de dexm&#xe9;d&#xe9;tomidine et l&#x2019;IRA dans notre cohorte globale de personnes atteintes de septic&#xe9;mie, nous avons observ&#xe9; une r&#xe9;duction des risques de d&#xe9;velopper une IRA chez la patient&#xe8;le &#xe2;g&#xe9;e (&#xe2;ge&#x2009;&gt;&#x2009;65&#xa0;ans) ayant re&#xe7;u de la dexm&#xe9;d&#xe9;tomidine. D&#x2019;autres recherches sont n&#xe9;cessaires pour confirmer que la dexm&#xe9;d&#xe9;tomidine a un effet protecteur contre l&#x2019;IRA dans cette population.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">dexmedetomidine</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword></KeywordList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>5</Day><Hour>20</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>10</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>9</Day><Hour>23</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40490616</ArticleId><ArticleId IdType="pmc">PMC12228650</ArticleId><ArticleId IdType="doi">10.1007/s12630-025-02977-5</ArticleId><ArticleId IdType="pii">10.1007/s12630-025-02977-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation><i>Peerapornratana S, Fiorentino M, Priyanka P, Murugan R, Kellum JA</i>. Recovery after AKI: effects on outcomes over 15 years. J Crit Care 2023; 76: 154280. 10.1016/j.jcrc.2023.154280
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10238673</ArticleId><ArticleId IdType="pubmed">36848723</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Liu J, Xie H, Ye Z, Li F, Wang L</i>. Rates, predictors, and mortality of sepsis-associated acute kidney injury: a systematic review and meta-analysis. BMC Nephrol 2020; 21: 318. 10.1186/s12882-020-01974-8
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7393862</ArticleId><ArticleId IdType="pubmed">32736541</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Nakashima T, Miyamoto K, Shima N, et al</i>. Dexmedetomidine improved renal function in patients with severe sepsis: an exploratory analysis of a randomized controlled trial. J Intensive Care 2020; 8: 1. 10.1186/s40560-019-0415-z
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6939335</ArticleId><ArticleId IdType="pubmed">31908779</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Hu H, An S, Sha T, et al</i>. Association between dexmedetomidine administration and outcomes in critically ill patients with sepsis-associated acute kidney injury. J Clin Anesth 2022; 83: 110960. 10.1016/j.jclinane.2022.110960
</Citation><ArticleIdList><ArticleId IdType="pubmed">36272399</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Gao Y, Kang K, Liu YS, et al</i>. Mechanisms of renal-splenic axis involvement in acute kidney injury mediated by the &#x3b1;7nAChR-NF-&#x3ba;B signaling pathway. Inflammation 2021; 44: 746&#x2013;57. 10.1007/s10753-020-01374-y
</Citation><ArticleIdList><ArticleId IdType="pubmed">33141376</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Liu J, Shi K, Hong J, et al</i>. Dexmedetomidine protects against acute kidney injury in patients with septic shock. Ann Palliat Med 2020; 9: 224&#x2013;30. 10.21037/apm.2020.02.08
</Citation><ArticleIdList><ArticleId IdType="pubmed">32156136</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Feng X, Guan W, Zhao Y, et al</i>. Dexmedetomidine ameliorates lipopolysaccharide-induced acute kidney injury in rats by inhibiting inflammation and oxidative stress via the GSK-3&#x3b2;/Nrf2 signaling pathway. J Cell Physiol 2019; 234: 18994&#x2013;9009. 10.1002/jcp.28539
</Citation><ArticleIdList><ArticleId IdType="pubmed">30919976</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Lankadeva YR, Ma S, Iguchi N, et al</i>. Dexmedetomidine reduces norepinephrine requirements and preserves renal oxygenation and function in ovine septic acute kidney injury. Kidney Int 2019; 96: 1150&#x2013;61. 10.1016/j.kint.2019.06.013
</Citation><ArticleIdList><ArticleId IdType="pubmed">31530477</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Rouch AJ, Kudo LH, H&#xe9;bert C</i>. Dexmedetomidine inhibits osmotic water permeability in the rat cortical collecting duct. J Pharmacol Exp Ther 1997; 281.</Citation><ArticleIdList><ArticleId IdType="pubmed">9103481</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Shehabi Y, Howe BD, Bellomo R, et al</i>. Early sedation with dexmedetomidine in critically ill patients. N Engl J Med 2019; 380: 2506&#x2013;17. 10.1056/nejmoa1904710
</Citation><ArticleIdList><ArticleId IdType="pubmed">31112380</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Kawazoe Y, Miyamoto K, Morimoto T, et al</i>. Effect of dexmedetomidine on mortality and ventilator-free days in patients requiring mechanical ventilation with sepsis: a randomized clinical trial. JAMA 2017; 317: 1321&#x2013;8.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5469298</ArticleId><ArticleId IdType="pubmed">28322414</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Evans L, Rhodes A, Alhazzani W, et al</i>. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med 2021; 49: e1063&#x2013;143. 10.1097/ccm.0000000000005337
</Citation><ArticleIdList><ArticleId IdType="pubmed">34605781</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Khwaja A</i>. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012; 120: c179&#x2013;84. 10.1159/000339789
</Citation><ArticleIdList><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D</i>. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461&#x2013;70. 10.7326/0003-4819-130-6-199903160-00002
</Citation><ArticleIdList><ArticleId IdType="pubmed">10075613</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Zhang J, Wang Z, Wang Y, Zhou G, Li H</i>. The effect of dexmedetomidine on inflammatory response of septic rats. BMC Anesthesiol 2015; 15: 68. 10.1186/s12871-015-0042-8
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4422264</ArticleId><ArticleId IdType="pubmed">25929655</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Wang K, Wu M, Xu J, et al</i>. Effects of dexmedetomidine on perioperative stress, inflammation, and immune function: systematic review and meta-analysis. Br J Anaesth 2019; 123: 777&#x2013;94. 10.1016/j.bja.2019.07.027
</Citation><ArticleIdList><ArticleId IdType="pubmed">31668347</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Soh S, Shim JK, Song JW, Bae JC, Kwak YL</i>. Effect of dexmedetomidine on acute kidney injury after aortic surgery: a single-centre, placebo-controlled, randomised controlled trial. Br J Anaesth 2020; 124: 386&#x2013;94. 10.1016/j.bja.2019.12.036
</Citation><ArticleIdList><ArticleId IdType="pubmed">32007239</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Liu X, Hu Q, Chen Q, Jia J, Liao YH, Feng J</i>. Effect of dexmedetomidine for prevention of acute kidney injury after cardiac surgery: an updated systematic review and meta-analysis. Ren Fail 2022; 44: 1150&#x2013;9. 10.1080/0886022x.2022.2097923
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9291681</ArticleId><ArticleId IdType="pubmed">35834360</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Zhu H, Ren A, Zhou K, Chen Q, Zhang M, Liu J</i>. Impact of dexmedetomidine infusion on postoperative acute kidney injury in elderly patients undergoing major joint replacement: a retrospective cohort study. Drug Des Devel Ther 2020; 14: 4695&#x2013;701. 10.2147/dddt.s278342
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7646437</ArticleId><ArticleId IdType="pubmed">33173279</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Ng KT, Shubash CJ, Chong JS</i>. The effect of dexmedetomidine on delirium and agitation in patients in intensive care: systematic review and meta-analysis with trial sequential analysis. Anaesthesia 2019; 74: 380&#x2013;92. 10.1111/anae.14472
</Citation><ArticleIdList><ArticleId IdType="pubmed">30367689</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Su X, Meng ZT, Wu XH, et al.</i> Dexmedetomidine for prevention of delirium in elderly patients after non-cardiac surgery: a randomised, double-blind, placebo-controlled trial. Lancet 2016; 388: 1893&#x2013;902. 10.1016/s0140-6736(16)30580-3
</Citation><ArticleIdList><ArticleId IdType="pubmed">27542303</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35652892</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>03</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8191</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of cardiac surgery</Title><ISOAbbreviation>J Card Surg</ISOAbbreviation></Journal><ArticleTitle>Mortality and morbidity of surgical and transcatheter mitral valve repair in octogenarians: A systematic review.</ArticleTitle><Pagination><StartPage>2752</StartPage><EndPage>2760</EndPage><MedlinePgn>2752-2760</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jocs.16653</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Valvular heart disease (VHD) is a prominent problem in healthcare today with mitral regurgitation (MR) being the leading cause of VHD in the elderly population. While mitral valve repair (MVr) surgery is&#xa0;one of the only options for the end-stage disease, octogenarians are often denied MVr due to concerns with operative mortality and postoperative morbidity. To provide information on this underrepresented group of surgical patients, a systematic approach was taken to review the mortality and morbidity rates of octogenarians who received MVr.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Pubmed and Medline were searched for articles containing outcomes of octogenarians receiving surgical mitral valve repair (SMVr) or transcatheter mitral valve repair (TMVr) published after 2000. Ten articles met the inclusion criteria for a total of 7968 patients included in the analysis using Microsoft Excel, Version 2105.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Short-term mortality rates for SMVr and TMVr were 2.6% and 1.4% for in-hospital, and 7.8% and 3.3% for 30 days, respectively. The average incidence of stroke, acute kidney injury, infection, and major bleeding for SMVr were 3.2%, 11.2%, 7.7%, and 24%, respectively, and 0.3%, 6.7%, 2.7%, and 7.9% for TMVr, respectively.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Octogenarians receiving SMVr or TMVr experienced similar rates of short-term mortality and morbidity as younger populations, and when considering life expectancy, midterm mortality was also similar. With these results, denying octogenarians MVr operations based on age alone should be reconsidered. Depending on risk factors and comorbidities, either SMVr or TMVr is a viable and relatively safe option for octogenarians with severe MR.</AbstractText><CopyrightInformation>&#xa9; 2022 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Watkins</LastName><ForeName>Abeline R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fialka</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Andari</LastName><ForeName>Ryaan</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7146-4337</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Jimmy J H</ForeName><Initials>JJH</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Department of Surgery, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bozso</LastName><ForeName>Sabin J</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0001-7067-3102</Identifier><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Department of Surgery, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moon</LastName><ForeName>Michael C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Department of Surgery, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagendran</LastName><ForeName>Jayan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Department of Surgery, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagendran</LastName><ForeName>Jeevan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2050-6717</Identifier><AffiliationInfo><Affiliation>Division of Cardiac Surgery, Department of Surgery, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Card Surg</MedlineTA><NlmUniqueID>8908809</NlmUniqueID><ISSNLinking>0886-0440</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006328" MajorTopicYN="N">Cardiac Catheterization</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006349" MajorTopicYN="Y">Heart Valve Diseases</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019918" MajorTopicYN="Y">Heart Valve Prosthesis Implantation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008943" MajorTopicYN="N">Mitral Valve</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008944" MajorTopicYN="Y">Mitral Valve Insufficiency</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009017" MajorTopicYN="N">Morbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000087742" MajorTopicYN="N">Octogenarians</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">TMVR</Keyword><Keyword MajorTopicYN="N">elderly</Keyword><Keyword MajorTopicYN="N">mitral regurgitation</Keyword><Keyword MajorTopicYN="N">mitral valve repair</Keyword><Keyword MajorTopicYN="N">octogenarians</Keyword><Keyword MajorTopicYN="N">review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>2</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35652892</ArticleId><ArticleId IdType="doi">10.1111/jocs.16653</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Etzioni D, Starnes V. The Epidemiology and Economics of Cardiothoracic Surgery in the Elderly. Vol 5. Springer; 2011.</Citation></Reference><Reference><Citation>Botly LCP, Lindsay MP, Mulvagh SL, et al. Recent trends in hospitalizations for cardiovascular disease, stroke, and vascular cognitive impairment in Canada. Can J Cardiol. 2020;36:1081-1090. doi:10.1016/j.cjca.2020.03.007</Citation></Reference><Reference><Citation>Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139:e56-e528. doi:10.1161/CIR.0000000000000659</Citation></Reference><Reference><Citation>Rostagno C. Heart valve disease in elderly. World J Cardiol. 2019;11:71-83. doi:10.4330/wjc.v11.i2.71</Citation></Reference><Reference><Citation>Mirabel M, Iung B, Baron G, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J. 2007;28:1358-1365. doi:10.1093/eurheartj/ehm001</Citation></Reference><Reference><Citation>Taramasso M, Maisano F, Denti P, et al. Percutaneous edge-to-edge repair in high-risk and elderly patients with degenerative mitral regurgitation: midterm outcomes in a single-center experience. J Thorac Cardiovasc Surg. 2014;148:2743-2750. doi:10.1016/j.jtcvs.2014.03.036</Citation></Reference><Reference><Citation>Freeman WK, Schaff HV, O'Brien PC, Orszulak TA, Naessens JM, Jamil Tajik A. Cardiac surgery in the octogenarian: perioperative outcome and clinical follow-up. J Am Coll Cardiol. 1991;18:29-35. doi:10.1016/S0735-1097(10)80212-8</Citation></Reference><Reference><Citation>Roques F, Nashef SAM, Michel P, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardio-Thoracic Surg. 1999;15:816-823. doi:10.1016/S1010-7940(99)00106-2</Citation></Reference><Reference><Citation>Ambler G, Omar RZ, Royston P, Kinsman R, Keogh BE, Taylor KM. Generic, simple risk stratification model for heart valve surgery. Circulation. 2005;112:224-231. doi:10.1161/CIRCULATIONAHA.104.515049</Citation></Reference><Reference><Citation>Mkalaluh S, Szczechowicz M, Dib B, Szabo G, Karck M, Weymann A. Outcomes and predictors of mortality after mitral valve surgery in high-risk elderly patients: the Heidelberg experience. Med Sci Monit. 2017;23:6193-6200. doi:10.12659/MSM.906003</Citation></Reference><Reference><Citation>Chivasso P, Bruno VD, Farid S, et al. Predictors of survival in octogenarians after mitral valve surgery for degenerative disease: the mitral surgery in octogenarians study. J Thorac Cardiovasc Surg. 2018;155:1474-1482. doi:10.1016/j.jtcvs.2017.11.027</Citation></Reference><Reference><Citation>Collart F, Feier H, Kerbaul F, et al. Valvular surgery in octogenarians: operative risks factors, evaluation of Euroscore and long term results. Eur J Cardio-Thoracic Surg. 2005;27:276-280. doi:10.1016/j.ejcts.2004.10.041</Citation></Reference><Reference><Citation>Bonnet V, Boisselier C, Saplacan V, et al. The role of age and comorbidities in postoperative outcome of mitral valve repair. Medicine. 2016;95:e3938. doi:10.1097/MD.0000000000003938</Citation></Reference><Reference><Citation>Nagendran J, Norris C, Maitland A, Koshal A, Ross DB. Is mitral valve surgery safe in octogenarians? Eur J Cardio-Thoracic Surg. 2005;28:83-87. doi:10.1016/j.ejcts.2004.12.067</Citation></Reference><Reference><Citation>Nloga J, H&#xe9;naine R, Vergnat M, et al. Mitral valve surgery in octogenarians: should we fight for repair? A survival and quality-of-life assessment. Eur J Cardio-Thoracic Surg. 2011;39:875-880. doi:10.1016/j.ejcts.2010.11.019</Citation></Reference><Reference><Citation>Shang X, Lu R, Liu M, Xiao S, Dong N. Mitral valve repair versus replacement in elderly patients: a systematic review and meta-analysis. J Thorac Dis. 2017;9:3045-3051. doi:10.21037/jtd.2017.08.43</Citation></Reference><Reference><Citation>Farid S, Ladwiniec A, Hern&#xe1;ndez-S&#xe1;nchez J, et al. Early outcomes after mitral valve repair versus replacement in the elderly: a propensity matched analysis. Hear Lung Circ. 2019;28:314-319. doi:10.1016/j.hlc.2017.10.027</Citation></Reference><Reference><Citation>Geis N, Raake P, Mereles D, et al. Percutaneous repair of severe mitral valve regurgitation secondary to chordae rupture in octogenarians using MitraClip. J Interv Cardiol. 2018;31:76-82. doi:10.1111/joic.12455</Citation></Reference><Reference><Citation>Alozie A, Paranskaya L, Westphal B, et al. Clinical outcomes of conventional surgery versus MitraClip&#xae; therapy for moderate to severe symptomatic mitral valve regurgitation in the elderly population: an institutional experience. BMC Cardiovasc Disord. 2017;17:85. doi:10.1186/s12872-017-0523-4</Citation></Reference><Reference><Citation>Nazir S, Ahuja KR, Virk HUH, et al. Comparison of outcomes of transcatheter mitral valve repair (MitraClip) in patients &lt;80 years versus &#x2265;80 years. Am J Cardiol. 2020;131:91-98. doi:10.1016/j.amjcard.2020.06.050</Citation></Reference><Reference><Citation>Malik AH, Zaid S, Yandrapalli S, et al. Trends and outcomes with transcatheter versus surgical mitral valve repair in patients &#x2265;80 years of age. Am J Cardiol. 2020;125:1083-1087. doi:10.1016/j.amjcard.2019.12.050</Citation></Reference><Reference><Citation>Buzzatti N, Maisano F, Latib A, et al. Comparison of outcomes of percutaneous MitraClip versus surgical repair or replacement for degenerative mitral regurgitation in octogenarians. Am J Cardiol. 2015;115:487-492. doi:10.1016/j.amjcard.2014.11.031</Citation></Reference><Reference><Citation>Kang JJH, Bozso SJ, El-Andari R, Adams C, Nagendran J. Transcatheter mitral valve repair and replacement: the next frontier of transcatheter valve intervention. Curr Opin Cardiol. 2020;36:163-171. doi:10.1097/HCO.0000000000000803</Citation></Reference><Reference><Citation>Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. doi:10.1136/bmj.n160</Citation></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71</Citation></Reference><Reference><Citation>Chikwe J, Goldstone AB, Passage J, et al. A propensity score-adjusted retrospective comparison of early and mid-term results of mitral valve repair versus replacement in octogenarians. Eur Heart J. 2011;32:618-626. doi:10.1093/eurheartj/ehq331</Citation></Reference><Reference><Citation>DiGregorio V, Zehr KJ, Orszulak TA, et al. Results of mitral surgery in octogenarians with isolated nonrheumatic mitral regurgitation. Ann Thorac Surg. 2004;78:807-813. doi:10.1016/j.athoracsur.2004.03.041</Citation></Reference><Reference><Citation>Takagi H, Ando T, Umemoto T. A review of comparative studies of MitraClip versus surgical repair for mitral regurgitation. Int J Cardiol. 2017;228:289-294. doi:10.1016/j.ijcard.2016.11.153</Citation></Reference><Reference><Citation>Parikh AG, Pinney SP. Transcatheter mitral valve repair in functional mitral regurgitation: who will benefit? Ann Cardiothorac Surg. 2021;10:161. doi:10.21037/ACS-2020-MV-14</Citation></Reference><Reference><Citation>Ch&#xe2;teauneuf G, Nazif TM, Beaupr&#xe9; F, Kodali S, Rod&#xe9;s-Cabau J, Paradis JM. Cerebrovascular events after transcatheter mitral valve interventions: a systematic review and meta-analysis. Heart. 2020;106:1759-1768. doi:10.1136/heartjnl-2019-316331</Citation></Reference><Reference><Citation>Armijo G, Estevez-Loureiro R, Carrasco-Chinchilla F, et al. Acute kidney injury after percutaneous edge-to-edge mitral repair. J Am Coll Cardiol. 2020;76:2463-2473. doi:10.1016/j.jacc.2020.09.582</Citation></Reference><Reference><Citation>Tripathi B, Sawant AC, Sharma P, et al. Short term outcomes after transcatheter mitral valve repair. Int J Cardiol. 2021;327:163-169. doi:10.1016/j.ijcard.2020.11.050</Citation></Reference><Reference><Citation>David TE, David CM, Tsang W, Lafreniere-Roula M, Manlhiot C. Long-term results of mitral valve repair for regurgitation due to leaflet prolapse. J Am Coll Cardiol. 2019;74:1044-1053. doi:10.1016/j.jacc.2019.06.052</Citation></Reference><Reference><Citation>Machaalany J, S&#xe9;n&#xe9;chal M, O'connor K, et al. Early and late mortality after repair or replacement in mitral valve prolapse and functional ischemic mitral regurgitation: a systematic review and meta-analysis of observational studies. Int J Cardiol. 2014;173:499-505. doi:10.1016/j.ijcard.2014.02.029</Citation></Reference><Reference><Citation>Marmagkiolis K, Hakeem A, Ebersole DG, Iliescu C, Ates I, Cilingiroglu M. Clinical outcomes of percutaneous mitral valve repair with MitraClip for the management of functional mitral regurgitation. Catheter Cardiovasc Interv. 2019;94:820-826. doi:10.1002/ccd.28203</Citation></Reference><Reference><Citation>Detaint D, Sundt TM, Nkomo VT, et al. Surgical correction of mitral regurgitation in the elderly: outcomes and recent improvements. Circulation. 2006;114:265-272. doi:10.1161/CIRCULATIONAHA.106.619239</Citation></Reference><Reference><Citation>Dziadzko V, Clavel MA, Dziadzko M, et al. Outcome and undertreatment of mitral regurgitation: a community cohort study. Lancet. 2018;391:960-969. doi:10.1016/S0140-6736(18)30473-2</Citation></Reference><Reference><Citation>Lee CW, Sung SH, Huang WM, et al. Can elderly patients with severe mitral regurgitation benefit from trans-catheter mitral valve repair? Korean Circ J. 2019;49:532-541. doi:10.4070/kcj.2018.0417</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24103711</PMID><DateCompleted><Year>2014</Year><Month>07</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>6</Issue><PubDate><Year>2013</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Reducing mortality in acute kidney injury patients: systematic review and international web-based survey.</ArticleTitle><Pagination><StartPage>1384</StartPage><EndPage>1398</EndPage><MedlinePgn>1384-98</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2013.06.028</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(13)00390-X</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To identify all interventions that increase or reduce mortality in patients with acute kidney injury (AKI) and to establish the agreement between stated beliefs and actual practice in this setting.</AbstractText><AbstractText Label="DESIGN AND SETTING" NlmCategory="METHODS">Systematic literature review and international web-based survey.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">More than 300 physicians from 62 countries.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Several databases, including MEDLINE/PubMed, were searched with no time limits (updated February 14, 2012) to identify all the drugs/techniques/strategies that fulfilled all the following criteria: (a) published in a peer-reviewed journal, (b) dealing with critically ill adult patients with or at risk for acute kidney injury, and (c) reporting a statistically significant reduction or increase in mortality.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">Of the 18 identified interventions, 15 reduced mortality and 3 increased mortality. Perioperative hemodynamic optimization, albumin in cirrhotic patients, terlipressin for hepatorenal syndrome type 1, human immunoglobulin, peri-angiography hemofiltration, fenoldopam, plasma exchange in multiple-myeloma-associated AKI, increased intensity of renal replacement therapy (RRT), CVVH in severely burned patients, vasopressin in septic shock, furosemide by continuous infusion, citrate in continuous RRT, N-acetylcysteine, continuous and early RRT might reduce mortality in critically ill patients with or at risk for AKI; positive fluid balance, hydroxyethyl starch and loop diuretics might increase mortality in critically ill patients with or at risk for AKI. Web-based opinion differed from consensus opinion for 30% of interventions and self-reported practice for 3 interventions.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The authors identified all interventions with at least 1 study suggesting a significant effect on mortality in patients with or at risk of AKI and found that there is discordance between participant stated beliefs and actual practice regarding these topics.</AbstractText><CopyrightInformation>Copyright &#xa9; 2013 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, San Raffaele Scientific Institute, Milan, Italy. Electronic address: landoni.giovanni@hsr.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bove</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Sz&#xe9;kely</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Comis</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Rodseth</LastName><ForeName>Reitze N</ForeName><Initials>RN</Initials></Author><Author ValidYN="Y"><LastName>Pasero</LastName><ForeName>Daniela</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Ponschab</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Mucchetti</LastName><ForeName>Marta</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Bove</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Azzolini</LastName><ForeName>Maria L</ForeName><Initials>ML</Initials></Author><Author ValidYN="Y"><LastName>Caramelli</LastName><ForeName>Fabio</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Paternoster</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Pala</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Cabrini</LastName><ForeName>Luca</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Amitrano</LastName><ForeName>Daniele</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Borghi</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Capasso</LastName><ForeName>Antonella</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Cariello</LastName><ForeName>Claudia</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Carpanese</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Feltracco</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Gottin</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Lobreglio</LastName><ForeName>Rosetta</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Mattioli</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Monaco</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Morgese</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Musu</LastName><ForeName>Mario</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Pasin</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Pisano</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Roasio</LastName><ForeName>Agostino</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Russo</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Slaviero</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Villari</LastName><ForeName>Nicola</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Vittorio</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Zucchetti</LastName><ForeName>Mariachiara</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Guarracino</LastName><ForeName>Fabio</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Morelli</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>De Santis</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Del Sarto</LastName><ForeName>Paolo A</ForeName><Initials>PA</Initials></Author><Author ValidYN="Y"><LastName>Corcione</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Ranieri</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Finco</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Zangrillo</LastName><ForeName>Alberto</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>10</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019538" MajorTopicYN="N">Health Care Surveys</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="N">Monitoring, Intraoperative</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney failure</Keyword><Keyword MajorTopicYN="N">acute renal injury</Keyword><Keyword MajorTopicYN="N">anesthesia</Keyword><Keyword MajorTopicYN="N">consensus</Keyword><Keyword MajorTopicYN="N">consensus conference</Keyword><Keyword MajorTopicYN="N">critical care</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">renal failure</Keyword><Keyword MajorTopicYN="N">survival</Keyword><Keyword MajorTopicYN="N">web vote</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24103711</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2013.06.028</ArticleId><ArticleId IdType="pii">S1053-0770(13)00390-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38749845</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0828</ISSN><JournalIssue CitedMedium="Internet"><Volume>127</Volume><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>European journal of internal medicine</Title><ISOAbbreviation>Eur J Intern Med</ISOAbbreviation></Journal><ArticleTitle>Acute kidney injury predicts mortality in very elderly critically-ill patients.</ArticleTitle><Pagination><StartPage>119</StartPage><EndPage>125</EndPage><MedlinePgn>119-125</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejim.2024.05.007</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0953-6205(24)00193-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The increasing admissions of very elderly patients to intensive care units (ICUs) over recent decades highlight a growing need for understanding acute kidney injury (AKI) in this population. Although these individuals are potentially at high risk for AKI and adverse outcomes, data on AKI in this population is scarce. This study investigates the AKI incidence and outcomes of critically-ill patients aging at least 90 years.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective cohort study conducted at the Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Germany (2008-2020), investigates AKI incidence and outcomes between 2008 and 2020 in critically-ill patients aged &#x2265; 90 years. AKI was defined according to Kidney Disease: Improving Global Outcomes (KDIGO) criteria using creatinine dynamics and/or urine output. Primary endpoint was overall mortality after 1 year. Secondary endpoints were in-hospital mortality, length of ICU and hospital stay.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">During the study period 92,958 critically-ill patients were treated and 1108 were &#x2265; 90 years. Of these, 1054 patients had available creatinine values and were included in the present study. AKI occurred in 24.4%, mostly classified as mild (17.5%). AKI was independently associated with a significant increase in overall mortality (HR 1.21, 95 %-CI: 1.01-1.46), in-hospital mortality (OR 2, 1.41-2.85), length of ICU (+2.8 days, 2.3-3.3) and hospital stay (+2.3 days, 0.9-3.7). Severity escalated these effects, but even mild AKI showed significance. Introducing urine-based criteria increased incidence but compromised mortality prediction.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">AKI is a frequent complication in very elderly critically-ill patients. Occurrence of AKI at any stage was associated with increased mortality. Predictive ability applied to AKI defined by creatinine but not urine output. Careful attention of creatinine dynamics is essential in very elderly ICU-patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Authors. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alba Schmidt</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Hamburg Center for Kidney Health (HCKH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Rosa</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Medical Sciences - CISMed, University of Trento, Via S. Maria Maddalena 1, 38122 Trento, Italy; Anesthesia and Intensive Care, Santa Chiara Regional Hospital, APSS Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;ller</LastName><ForeName>Jakob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; Department of Anaesthesia, Tabea Hospital, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H&#xfc;sing</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daniels</LastName><ForeName>Rikus</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Theile</LastName><ForeName>Pauline</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schweingruber</LastName><ForeName>Nils</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kluge</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huber</LastName><ForeName>Tobias B</ForeName><Initials>TB</Initials><AffiliationInfo><Affiliation>III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Hamburg Center for Kidney Health (HCKH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roedl</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidt-Lauber</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Hamburg Center for Kidney Health (HCKH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: c.schmidt-lauber@uke.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Eur J Intern Med</MedlineTA><NlmUniqueID>9003220</NlmUniqueID><ISSNLinking>0953-6205</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="Y">Critical Illness</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="Y">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="Y">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Critically-ill</Keyword><Keyword MajorTopicYN="N">Elderly</Keyword><Keyword MajorTopicYN="N">Intensive care unit</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Nonagenarians</Keyword><Keyword MajorTopicYN="N">Outcome</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>4</Day><Hour>1</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>16</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>15</Day><Hour>22</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38749845</ArticleId><ArticleId IdType="doi">10.1016/j.ejim.2024.05.007</ArticleId><ArticleId IdType="pii">S0953-6205(24)00193-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39581988</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>24</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Epidemiology of sepsis-associated acute kidney injury in critically ill patients: a multicenter, prospective, observational cohort study in South Korea.</ArticleTitle><Pagination><StartPage>383</StartPage><MedlinePgn>383</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">383</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-024-05167-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">Despite the clinical importance of sepsis-associated acute kidney injury (SA-AKI), little is known about its epidemiology. We aimed to investigate the incidence and outcomes of SA-AKI, as well as the risk factors for mortality among patients with severe SA-AKI in critically ill patients.</AbstractText><AbstractText Label="METHODS">This secondary multicenter, observational, prospective cohort analysis of sepsis in South Korea evaluated patients aged&#x2009;&#x2265;&#x2009;19&#xa0;years admitted to intensive care units with a diagnosis of sepsis. The primary outcome was the incidence of SA-AKI, defined using the new consensus definition of the Acute Disease Quality Initiative 28 Workgroup. Secondary outcomes were in-hospital mortality and risk factors for in-hospital mortality.</AbstractText><AbstractText Label="RESULTS">Between September 2019 and December 2022, 5100 patients were admitted to intensive care units with a diagnosis of sepsis, and 3177 (62.3%) developed SA-AKI. A total of 613 (19.3%), 721 (22.7%), and 1843 (58.0%) patients had stage 1, 2, and 3 SA-AKI, respectively. Severe SA-AKI (stages 2 and 3 combined) was associated with an increased risk of in-hospital mortality. Adherence to the fluid resuscitation component of the one-hour sepsis bundle was associated with a decreased risk of in-hospital mortality in severe SA-AKI (adjusted odds ratio, 0.62; 95% confidence interval, 0.48-0.79; P&#x2009;&lt;&#x2009;0.001).</AbstractText><AbstractText Label="CONCLUSIONS">Of the patients admitted to the intensive care unit for sepsis, 62.3% developed SA-AKI. Severe SA-AKI was associated with an increased risk of mortality. Adherence to the fluid resuscitation component of the one-hour sepsis bundle can potentially improve outcomes in these patients.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Song</LastName><ForeName>Myung Jin</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, 82 Gumi-ro, Bundang-gu, Seongnam-si , 13620, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Jang</LastName><ForeName>Yeonhoon</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Office of Hospital Information, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Legrand</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, Division of Critical Care Medicine, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sunghoon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pulmonary, Allergy and Critical Care Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>RyoungEun</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suh</LastName><ForeName>Gee Young</ForeName><Initials>GY</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Dong Kyu</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Su Yeon</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Mi Hyeon</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Chae-Man</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>Se Young</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Office of Hospital Information, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea. syjung@snubh.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Family Medicine, College of Medicine, Seoul National University, Seoul, Republic of Korea. syjung@snubh.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Sung Yoon</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, 82 Gumi-ro, Bundang-gu, Seongnam-si , 13620, Republic of Korea. nucleon727@snu.ac.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Korean Sepsis Alliance (KSA) investigator</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM151494</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>06-2022-0139</GrantID><Agency>Seoul National University Bundang Hospital</Agency><Country/></Grant><Grant><GrantID>R01-GM151494-01</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="Y">Critical Illness</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Intensive care unit</Keyword><Keyword MajorTopicYN="N">Kidney</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList><CoiStatement>Declarations. Availability of data and materials: No datasets were generated or analysed during the current study. The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request. Ethics approval and consent to participate: This study was approved by the institutional review boards of each participating hospital, including the Seoul National University Bundang Hospital (IRB number: B-1810-500-402). The requirement for informed consent was waived because of the noninterventional, observational nature of the study. Consent for publication: Not applicable. Competing interests: The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>25</Day><Hour>1</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>25</Day><Hour>1</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>24</Day><Hour>23</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39581988</ArticleId><ArticleId IdType="pmc">PMC11587587</ArticleId><ArticleId IdType="doi">10.1186/s13054-024-05167-9</ArticleId><ArticleId IdType="pii">10.1186/s13054-024-05167-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, Colombara DV, Ikuta KS, Kissoon N, Finfer S, Fleischmann-Struzek C, Machado FR, Reinhart KK, Rowan K, Seymour CW, Watson RS, West TE, Marinho F, Hay SI, Lozano R, Lopez AD, Angus DC, Murray CJL, Naghavi M. Global, regional, and national sepsis incidence and mortality, 1990&#x2013;2017: analysis for the global burden of disease study. Lancet. 2020;395:200&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6970225</ArticleId><ArticleId IdType="pubmed">31954465</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294:813&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16106006</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D, Honor&#xe9; PM, Joannes-Boyau O, Joannidis M, Korhonen AM, Lavrentieva A, Mehta RL, Palevsky P, Roessler E, Ronco C, Uchino S, Vazquez JA, Vidal Andrade E, Webb S, Kellum JA. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41:1411&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">26162677</ArticleId></ArticleIdList></Reference><Reference><Citation>Peerapornratana S, Manrique-Caballero CL, G&#xf3;mez H, Kellum JA. Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney Int. 2019;96:1083&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6920048</ArticleId><ArticleId IdType="pubmed">31443997</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia HM, Jiang YJ, Zheng X, Li W, Wang MP, Xi XM, Li WX. The attributable mortality of sepsis for acute kidney injury: a propensity-matched analysis based on multicenter prospective cohort study. Ren Fail. 2023;45:2162415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9848315</ArticleId><ArticleId IdType="pubmed">36637012</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuwabara S, Goggins E, Okusa MD. The pathophysiology of sepsis-associated AKI. Clin J Am Soc Nephrol. 2022;17:1050&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9269625</ArticleId><ArticleId IdType="pubmed">35764395</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, Nadim MK, Pickkers P, Gomez H, Bell S, Joannidis M, Kashani K, Koyner JL, Pannu N, Meersch M, Reis T, Rimmel&#xe9; T, Bagshaw SM, Bellomo R, Cantaluppi V, Deep A, De Rosa S, Perez-Fernandez X, Husain-Syed F, Kane-Gill SL, Kelly Y, Mehta RL, Murray PT, Ostermann M, Prowle J, Ricci Z, See EJ, Schneider A, Soranno DE, Tolwani A, Villa G, Ronco C, Forni LG. Sepsis-associated acute kidney injury: consensus report of the 28th acute disease quality initiative workgroup. Nat Rev Nephrol. 2023;19:401&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">36823168</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL, Bouchard J, Soroko SB, Ikizler TA, Paganini EP, Chertow GM, Himmelfarb J. Sepsis as a cause and consequence of acute kidney injury: program to improve care in acute renal disease. Intensive Care Med. 2011;37:241&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3028102</ArticleId><ArticleId IdType="pubmed">21152901</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Xie H, Ye Z, Li F, Wang L. Rates, predictors, and mortality of sepsis-associated acute kidney injury: a systematic review and meta-analysis. BMC Nephrol. 2020;21:318.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7393862</ArticleId><ArticleId IdType="pubmed">32736541</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120:c179&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko RE, Kang D, Cho J, Na SJ, Chung CR, Lim SY, Lee YJ, Park S, Oh DK, Lee SY, Park MH, Lee H, Lim CM, Suh GY. Influence of gender on age-associated in-hospital mortality in patients with sepsis and septic shock: a prospective nationwide multicenter cohort study. Crit Care. 2023;27:229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10257805</ArticleId><ArticleId IdType="pubmed">37303037</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP. Strengthening the reporting of observational studies in epidemiology (strobe) statement: guidelines for reporting observational studies. BMJ. 2007;335:806&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2034723</ArticleId><ArticleId IdType="pubmed">17947786</ArticleId></ArticleIdList></Reference><Reference><Citation>Z&#xe1;vada J, Hoste E, Cartin-Ceba R, Calzavacca P, Gajic O, Clermont G, Bellomo R, Kellum JA. A comparison of three methods to estimate baseline creatinine for RIFLE classification. Nephrol Dial Transplant. 2010;25:3911&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">20100732</ArticleId></ArticleIdList></Reference><Reference><Citation>Merlo J, Chaix B, Ohlsson H, Beckman A, Johnell K, Hjerpe P, R&#xe5;stam L, Larsen K. A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena. J Epidemiol Community Health. 2006;60:290&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2566165</ArticleId><ArticleId IdType="pubmed">16537344</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibshirani R. Regression shrinkage and selection via the lasso. J R Stat Soc. 1996. 10.1111/j.2517-6161.1996.tb02080.x.</Citation></Reference><Reference><Citation>White KC, Serpa-Neto A, Hurford R, Clement P, Laupland KB, See E, McCullough J, White H, Shekar K, Tabah A, Ramanan M, Garrett P, Attokaran AG, Luke S, Senthuran S, McIlroy P, Bellomo R. Sepsis-associated acute kidney injury in the intensive care unit: incidence, patient characteristics, timing, trajectory, treatment, and associated outcomes. A multicenter, observational study. Intensive Care Med. 2023. 10.1007/s00134-023-07138-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10499944</ArticleId><ArticleId IdType="pubmed">37432520</ArticleId></ArticleIdList></Reference><Reference><Citation>Federspiel CK, Itenov TS, Mehta K, Hsu RK, Bestle MH, Liu KD. Duration of acute kidney injury in critically ill patients. Ann Intensive Care. 2018;8:30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5823799</ArticleId><ArticleId IdType="pubmed">29473104</ArticleId></ArticleIdList></Reference><Reference><Citation>Khader A, Zelnick LR, Sathe NA, Kestenbaum BR, Himmelfarb J, Johnson NJ, Shapiro NI, Douglas IS, Hough CL, Bhatraju PK. The interaction of acute kidney injury with resuscitation strategy in sepsis: a secondary analysis of a multicenter, phase 3, randomized clinical trial (CLOVERS). Am J Respir Crit Care Med. 2023;208:1335&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10765399</ArticleId><ArticleId IdType="pubmed">37870416</ArticleId></ArticleIdList></Reference><Reference><Citation>Legrand M, Payen D. Understanding urine output in critically ill patients. Ann Intensive Care. 2011;1:13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3224471</ArticleId><ArticleId IdType="pubmed">21906341</ArticleId></ArticleIdList></Reference><Reference><Citation>Tallarico RT, McCoy IE, D&#xe9;pret F, Legrand M. Meaning and management of perioperative oliguria. Anesthesiology. 2024;140:304&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10843636</ArticleId><ArticleId IdType="pubmed">37812766</ArticleId></ArticleIdList></Reference><Reference><Citation>Priyanka P, Zarbock A, Izawa J, Gleason TG, Renfurm RW, Kellum JA. The impact of acute kidney injury by serum creatinine or urine output criteria on major adverse kidney events in cardiac surgery patients. J Thorac Cardiovasc Surg. 2021;162:143&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">32033818</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Sileanu FE, Murugan R, Lucko N, Shaw AD, Clermont G. Classifying AKI by urine output versus serum creatinine level. J Am Soc Nephrol. 2015;26:2231&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4552117</ArticleId><ArticleId IdType="pubmed">25568178</ArticleId></ArticleIdList></Reference><Reference><Citation>Leedahl DD, Frazee EN, Schramm GE, Dierkhising RA, Bergstralh EJ, Chawla LS, Kashani KB. Derivation of urine output thresholds that identify a very high risk of AKI in patients with septic shock. Clin J Am Soc Nephrol. 2014;9:1168&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078959</ArticleId><ArticleId IdType="pubmed">24789551</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Chawla LS, Keener C, Singbartl K, Palevsky PM, Pike FL, Yealy DM, Huang DT, Angus DC. The effects of alternative resuscitation strategies on acute kidney injury in patients with septic shock. Am J Respir Crit Care Med. 2016;193:281&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4803059</ArticleId><ArticleId IdType="pubmed">26398704</ArticleId></ArticleIdList></Reference><Reference><Citation>Sood MM, Shafer LA, Ho J, Reslerova M, Martinka G, Keenan S, Dial S, Wood G, Rigatto C, Kumar A. Early reversible acute kidney injury is associated with improved survival in septic shock. J Crit Care. 2014;29:711&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">24927984</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhel F, Peters-Sengers H, Falahi F, Scicluna BP, van Vught LA, Bonten MJ, Cremer OL, Schultz MJ, van der Poll T. Mortality and host response aberrations associated with transient and persistent acute kidney injury in critically ill patients with sepsis: a prospective cohort study. Intensive Care Med. 2020;46:1576&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7381452</ArticleId><ArticleId IdType="pubmed">32514599</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez ML, Ferrer R, Torrents E, Guillamat-Prats R, Gom&#xe0; G, Su&#xe1;rez D, &#xc1;lvarez-Rocha L, Pozo Laderas JC, Mart&#xed;n-Loeches I, Levy MM, Artigas A. Impact of source control in patients with severe sepsis and septic shock. Crit Care Med. 2017;45:11&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">27611975</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe T, Ogura H, Kushimoto S, Shiraishi A, Sugiyama T, Deshpande GA, Uchida M, Nagata I, Saitoh D, Fujishima S, Mayumi T, Hifumi T, Shiino Y, Nakada TA, Tarui T, Otomo Y, Okamoto K, Umemura Y, Kotani J, Sakamoto Y, Sasaki J, Shiraishi SI, Takuma K, Tsuruta R, Hagiwara A, Yamakawa K, Masuno T, Takeyama N, Yamashita N, Ikeda H, Ueyama M, Fujimi S, Gando S. Variations in infection sites and mortality rates among patients in intensive care units with severe sepsis and septic shock in Japan. J Intensive Care. 2019;7:28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6500015</ArticleId><ArticleId IdType="pubmed">31073407</ArticleId></ArticleIdList></Reference><Reference><Citation>Leligdowicz A, Dodek PM, Norena M, Wong H, Kumar A, Kumar A. Association between source of infection and hospital mortality in patients who have septic shock. Am J Respir Crit Care Med. 2014;189:1204&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">24635548</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med. 2004;351:159&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">15247356</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyhoff TS, Hjortrup PB, Wetterslev J, Sivapalan P, Laake JH, Cronhjort M, Jakob SM, Cecconi M, Nalos M, Ostermann M, Malbrain M, Pettil&#xe4; V, M&#xf8;ller MH, Kj&#xe6;r MN, Lange T, Overgaard-Steensen C, Brand BA, Winther-Olesen M, White JO, Quist L, Westergaard B, Jonsson AB, Hjorts&#xf8; CJS, Meier N, Jensen TS, Engstr&#xf8;m J, Nebrich L, Andersen-Ranberg NC, Jensen JV, Joseph NA, Poulsen LM, Herl&#xf8;v LS, S&#xf8;lling CG, Pedersen SK, Knudsen KK, Straarup TS, Vang ML, Bundgaard H, Rasmussen BS, Aagaard SR, Hildebrandt T, Russell L, Bestle MH, Sch&#xf8;nemann-Lund M, Br&#xf8;chner AC, Elvander CF, Hoffmann SKL, Rasmussen ML, Martin YK, Friberg FF, Seter H, Aslam TN, &#xc5;dn&#xf8;y S, Seidel P, Strand K, Johnstad B, Joelsson-Alm E, Christensen J, Ahlstedt C, Pfortmueller CA, Siegemund M, Greco M, Rad&#x11b;j J, K&#x159;&#xed;&#x17e; M, Gould DW, Rowan KM, Mouncey PR, Perner A. Restriction of intravenous fluid in ICU patients with septic shock. N Engl J Med. 2022;386:2459&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">35709019</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro NI, Douglas IS, Brower RG, Brown SM, Exline MC, Ginde AA, Gong MN, Grissom CK, Hayden D, Hough CL, Huang W, Iwashyna TJ, Jones AE, Khan A, Lai P, Liu KD, Miller CD, Oldmixon K, Park PK, Rice TW, Ringwood N, Semler MW, Steingrub JS, Talmor D, Thompson BT, Yealy DM, Self WH. Early restrictive or liberal fluid management for sepsis-induced hypotension. N Engl J Med. 2023;388:499&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10685906</ArticleId><ArticleId IdType="pubmed">36688507</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39592204</PMID><DateCompleted><Year>2025</Year><Month>02</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2044</ISSN><JournalIssue CitedMedium="Internet"><Volume>80</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Anaesthesia</Title><ISOAbbreviation>Anaesthesia</ISOAbbreviation></Journal><ArticleTitle>Influence of the type of anaesthesia on acute kidney injury after nephrectomy: a randomised controlled trial.</ArticleTitle><Pagination><StartPage>278</StartPage><EndPage>287</EndPage><MedlinePgn>278-287</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/anae.16490</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Acute kidney injury develops frequently after nephrectomy, causing increased hospital duration of stay and mortality. Both propofol and volatile anaesthetic agents are thought to have renoprotective effects. We investigated whether the type of maintenance anaesthetic (propofol or desflurane) affected the incidence of acute kidney injury after nephrectomy.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This single-centre, randomised controlled trial enrolled adult patients with renal cell carcinoma undergoing nephrectomy. In patients allocated to the propofol group, anaesthesia was induced and maintained using a target-controlled infusion of propofol. In patients allocated to the desflurane group, anaesthesia was induced with a bolus of thiopental and maintained with desflurane. Both groups received a target-controlled infusion of remifentanil during surgery. The primary outcome was the incidence of acute kidney injury within 7 postoperative days based on the serum creatinine component of the Kidney Disease: Improving Global Outcomes criteria.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We analysed 317 patients (median (IQR [range]) age 62 (52-70 [26-85] y); 221 (70%) men). Postoperative AKI developed in 79 (25%) patients: 43 (27%) in the propofol group and 36 (23%) in the desflurane group (absolute risk difference (95%CI) 4.6 (-4.9-14.0%), p&#x2009;=&#x2009;0.347). The severity of kidney injury was stage 1 in 76 patients, stage 2 in two patients and stage 3 in one patient.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">The type of anaesthetic maintenance drug (propofol vs. desflurane) did not affect the incidence of acute kidney injury after nephrectomy. Future research might be better directed towards investigating other potentially modifiable risk factors for postoperative acute kidney injury in this patient population.</AbstractText><CopyrightInformation>&#xa9; 2024 Association of Anaesthetists.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yoon</LastName><ForeName>Soo-Hyuk</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Yoon Jung</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seo</LastName><ForeName>Jeong-Hwa</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Hanbyeol</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Ho-Jin</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwak</LastName><ForeName>Cheol</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Urology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Won Ho</ForeName><Initials>WH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoon</LastName><ForeName>Hyun-Kyu</ForeName><Initials>HK</Initials><Identifier Source="ORCID">0000-0001-5424-3559</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Anaesthesia</MedlineTA><NlmUniqueID>0370524</NlmUniqueID><ISSNLinking>0003-2409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>YI7VU623SF</RegistryNumber><NameOfSubstance UI="D015742">Propofol</NameOfSubstance></Chemical><Chemical><RegistryNumber>CRS35BZ94Q</RegistryNumber><NameOfSubstance UI="D000077335">Desflurane</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018686">Anesthetics, Intravenous</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018685">Anesthetics, Inhalation</NameOfSubstance></Chemical><Chemical><RegistryNumber>CYS9AKD70P</RegistryNumber><NameOfSubstance UI="D007530">Isoflurane</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015742" MajorTopicYN="Y">Propofol</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009392" MajorTopicYN="Y">Nephrectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077335" MajorTopicYN="N">Desflurane</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018686" MajorTopicYN="Y">Anesthetics, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018685" MajorTopicYN="N">Anesthetics, Inhalation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007530" MajorTopicYN="N">Isoflurane</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007680" MajorTopicYN="N">Kidney Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002292" MajorTopicYN="N">Carcinoma, Renal Cell</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">desflurane</Keyword><Keyword MajorTopicYN="N">nephrectomy</Keyword><Keyword MajorTopicYN="N">postoperative complications</Keyword><Keyword MajorTopicYN="N">propofol</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>14</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>27</Day><Hour>0</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>26</Day><Hour>21</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39592204</ArticleId><ArticleId IdType="doi">10.1111/anae.16490</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Prowle JR, Forni LG, Bell M, et&#xa0;al. Postoperative acute kidney injury in adult non&#x2010;cardiac surgery: joint consensus report of the Acute Disease Quality Initiative and PeriOperative Quality Initiative. Nat Rev Neurol 2021; 17: 605&#x2013;618. https://doi.org/10.1038/s41581&#x2010;021&#x2010;00418&#x2010;2.</Citation></Reference><Reference><Citation>Ljungberg B, Albiges L, Abu&#x2010;Ghanem Y, et&#xa0;al. European Association of Urology guidelines on renal cell carcinoma: the 2019 update. Eur Urol 2019; 75: 799&#x2013;810. https://doi.org/10.1016/j.eururo.2019.02.011.</Citation></Reference><Reference><Citation>Mir MC, Ercole C, Takagi T, et&#xa0;al. Decline in renal function after partial nephrectomy: etiology and prevention. J Urol 2015; 193: 1889&#x2013;1898. https://doi.org/10.1016/j.juro.2015.01.093.</Citation></Reference><Reference><Citation>Garofalo C, Liberti ME, Russo D, et&#xa0;al. Effect of post&#x2010;nephrectomy acute kidney injury on renal outcome: a retrospective long&#x2010;term study. World J Urol 2018; 36: 59&#x2013;63. https://doi.org/10.1007/s00345&#x2010;017&#x2010;2104&#x2010;7.</Citation></Reference><Reference><Citation>Schmid M, Krishna N, Ravi P, et&#xa0;al. Trends of acute kidney injury after radical or partial nephrectomy for renal cell carcinoma. Urol Oncol 2016; 34: e1&#x2013;e10. https://doi.org/10.1016/j.urolonc.2016.02.018.</Citation></Reference><Reference><Citation>Nie S, Tang L, Zhang W, Feng Z, Chen X. Are there modifiable risk factors to improve AKI? Biomed Res Int 2017; 2017: 1&#x2013;9. https://doi.org/10.1155/2017/5605634.</Citation></Reference><Reference><Citation>Cai J, Xu R, Yu X, Fang Y, Ding X. Volatile anesthetics in preventing acute kidney injury after cardiac surgery: a systematic review and meta&#x2010;analysis. J Thorac Cardiovasc Surg 2014; 148: 3127&#x2013;3136. https://doi.org/10.1016/j.jtcvs.2014.07.085.</Citation></Reference><Reference><Citation>Franz&#xe9;n S, Frithiof R, Hultstr&#xf6;m M. Postoperative acute kidney injury after volatile or intravenous anesthesia: a meta&#x2010;analysis. Am J Physiol Renal Physiol 2023; 324: F329&#x2013;F334. https://doi.org/10.1152/ajprenal.00316.2022.</Citation></Reference><Reference><Citation>Lee HJ, Bae J, Kwon Y, et&#xa0;al. General anesthetic agents and renal function after nephrectomy. J Clin Med 2019; 8: 1530. https://doi.org/10.3390/jcm8101530.</Citation></Reference><Reference><Citation>Moher D, Hopewell S, Schulz KF, et&#xa0;al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340: c869. https://doi.org/10.1136/bmj.c869.</Citation></Reference><Reference><Citation>Kutikov A, Uzzo RG. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 2009; 182: 844&#x2013;853. https://doi.org/10.1016/j.juro.2009.05.035.</Citation></Reference><Reference><Citation>Moch H, Artibani W, Delahunt B, et&#xa0;al. Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma. Eur Urol 2009; 56: 636&#x2013;643. https://doi.org/10.1016/j.eururo.2009.06.036.</Citation></Reference><Reference><Citation>Kellum JA, Lameire N, et&#xa0;al. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (part 1). Crit Care 2013; 17: 204. https://doi.org/10.1186/cc11454.</Citation></Reference><Reference><Citation>Franzen S, Semenas E, Taavo M, Martensson J, Larsson A, Frithiof R. Renal function during sevoflurane or total intravenous propofol anaesthesia: a single&#x2010;centre parallel randomised controlled study. Br J Anaesth 2022; 128: 838&#x2013;848. https://doi.org/10.1016/j.bja.2022.02.030.</Citation></Reference><Reference><Citation>Bonanni A, Signori A, Alicino C, Mannucci I, Grasso MA, Martinelli L, Deferrari G. Volatile anesthetics versus propofol for cardiac surgery with cardiopulmonary bypass: meta&#x2010;analysis of randomized trials. Anesthesiology 2020; 132: 1429&#x2013;1446. https://doi.org/10.1097/ALN.0000000000003236.</Citation></Reference><Reference><Citation>Jiao X&#x2010;F, Lin X&#x2010;M, Ni X&#x2010;F, et&#xa0;al. Volatile anesthetics versus total intravenous anesthesia in patients undergoing coronary artery bypass grafting: an updated meta&#x2010;analysis and trial sequential analysis of randomized controlled trials. PLoS One 2019; 14: e0224562. https://doi.org/10.1371/journal.pone.0224562.</Citation></Reference><Reference><Citation>Scosyrev E, Messing EM, Sylvester R, Campbell S, Van Poppel H. Renal function after nephron&#x2010;sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904. Eur Urol 2014; 65: 372&#x2013;377. https://doi.org/10.1016/j.eururo.2013.06.044.</Citation></Reference><Reference><Citation>Chapman D, Moore R, Klarenbach S, Braam B. Residual renal function after partial or radical nephrectomy for renal cell carcinoma. Can Urol Assoc J 2013; 4: 337&#x2013;343. https://doi.org/10.5489/cuaj.909.</Citation></Reference><Reference><Citation>Kim M, Brady JE, Li G. Variations in the risk of acute kidney injury across intraabdominal surgery procedures. Anesth Analg 2014; 119: 1121&#x2013;1132. https://doi.org/10.1213/ANE.0000000000000425.</Citation></Reference><Reference><Citation>Sun LY, Wijeysundera DN, Tait GA, Beattie WS. Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery. Anesthesiology 2015; 123: 515&#x2013;523. https://doi.org/10.1097/aln.0000000000000765.</Citation></Reference><Reference><Citation>Mano R, Tin AL, Silagy AW, et&#xa0;al. The association between modifiable perioperative parameters and renal function after nephrectomy. BJU Int 2022; 129: 380&#x2013;386. https://doi.org/10.1111/bju.15531.</Citation></Reference><Reference><Citation>Zeng B, Liu Y, Xu J, et&#xa0;al. Future directions in optimizing anesthesia to reduce perioperative acute kidney injury. Am J Nephrol 2023; 54: 434&#x2013;450. https://doi.org/10.1159/000533534.</Citation></Reference><Reference><Citation>Zheng G, Qu H, Li F, Ma W, Yang H. Propofol attenuates sepsis&#x2010;induced acute kidney injury by regulating miR&#x2010;290&#x2010;5p/CCL&#x2010;2 signaling pathway. Braz J Med Biol Res 2018; 51: e7655. https://doi.org/10.1590/1414&#x2010;431X20187655.</Citation></Reference><Reference><Citation>Lee HT, Ota&#x2010;Setlik A, Fu Y, Nasr SH, Emala CW. Differential protective effects of volatile anesthetics against renal ischemia&#x2013;reperfusion injury in vivo. Anesthesiology 2004; 101: 1313&#x2013;1324. https://doi.org/10.1097/00000542&#x2010;200412000&#x2010;00011.</Citation></Reference><Reference><Citation>Obal D, Rascher K, Favoccia C, Dettwiler S, Schlack W. Post&#x2010;conditioning by a short administration of desflurane reduced renal reperfusion injury after differing of ischaemia times in rats. Br J Anaesth 2006; 97: 783&#x2013;791. https://doi.org/10.1093/bja/ael245.</Citation></Reference><Reference><Citation>Hashiguchi H, Morooka H, Miyoshi H, Matsumoto M, Koji T, Sumikawa K. Isoflurane protects renal function against ischemia and reperfusion through inhibition of protein kinases, JNK and ERK. Anesth Analg 2005; 101: 1584&#x2013;1589. https://doi.org/10.1213/01.ANE.0000184044.51749.B8.</Citation></Reference><Reference><Citation>Fukazawa K, Lee HT. Volatile anesthetics and AKI: risks, mechanisms, and a potential therapeutic window. J Am Soc Nephrol 2014; 25: 884&#x2013;892. https://doi.org/10.1681/asn.2013111215.</Citation></Reference><Reference><Citation>Sun G, Zhou Y, Li H, et&#xa0;al. Over&#x2010;expression of microRNA&#x2010;494 up&#x2010;regulates hypoxia&#x2010;inducible factor&#x2010;1 alpha expression via PI3K/Akt pathway and protects against hypoxia&#x2010;induced apoptosis. J Biomed Sci 2013; 20: 1&#x2013;9. https://doi.org/10.1186/1423&#x2010;0127&#x2010;20&#x2010;100.</Citation></Reference><Reference><Citation>Iguchi N, Kosaka J, Iguchi Y, Evans RG, Bellomo R, May CN, Lankadeva YR. Systemic haemodynamic, renal perfusion and renal oxygenation responses to changes in inspired oxygen fraction during total intravenous or volatile anaesthesia. Br J Anaesth 2020; 125: 192&#x2013;200. https://doi.org/10.1016/j.bja.2020.03.033.</Citation></Reference><Reference><Citation>Zhang Z, Zhao J, Dong W, et&#xa0;al. Acute kidney injury after partial nephrectomy: role of parenchymal mass reduction and ischemia and impact on subsequent functional recovery. Eur Urol 2016; 69: 745&#x2013;752. https://doi.org/10.1016/j.eururo.2015.10.023.</Citation></Reference><Reference><Citation>Volpe A, Blute ML, Ficarra V, et&#xa0;al. Renal ischemia and function after partial nephrectomy: a collaborative review of the literature. Eur Urol 2015; 68: 61&#x2013;74. https://doi.org/10.1016/j.eururo.2015.01.025.</Citation></Reference><Reference><Citation>Munshi R, Johnson A, Siew ED, et&#xa0;al. MCP&#x2010;1 gene activation marks acute kidney injury. J Am Soc Nephrol 2011; 22: 165&#x2013;175. https://doi.org/10.1681/ASN.2010060641.</Citation></Reference><Reference><Citation>Yoo YC, Shim JK, Song Y, Yang SY, Kwak YL. Anesthetics influence the incidence of acute kidney injury following valvular heart surgery. Kidney Int 2014; 86: 414&#x2013;422. https://doi.org/10.1038/ki.2013.532.</Citation></Reference><Reference><Citation>Wildes TS, Mickle AM, Ben Abdallah A, et&#xa0;al. Effect of electroencephalography&#x2010;guided anesthetic administration on postoperative delirium among older adults undergoing major surgery. JAMA 2019; 321: 473&#x2013;483. https://doi.org/10.1001/jama.2018.22005.</Citation></Reference><Reference><Citation>Alameddine M, Koru&#x2010;Sengul T, Moore KJ, et&#xa0;al. Trends in utilization of robotic and open partial nephrectomy for management of cT1 renal masses. Eur Urol Focus 2019; 5: 482&#x2013;487. https://doi.org/10.1016/j.euf.2017.12.006.</Citation></Reference><Reference><Citation>Ryan SM, Nielsen CJ. Global warming potential of inhaled anesthetics: application to clinical use. Anesth Analg 2010; 111: 92&#x2013;98. https://doi.org/10.1213/ANE.0b013e3181e058d7.</Citation></Reference><Reference><Citation>Golembiewski J. Economic considerations in the use of inhaled anesthetic agents. Am J Health Syst Pharm 2010; 67: S9&#x2013;S12. https://doi.org/10.2146/ajhp100093.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34665309</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-2323</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>World journal of surgery</Title><ISOAbbreviation>World J Surg</ISOAbbreviation></Journal><ArticleTitle>Acute Kidney Injury within an Enhanced Recovery after Surgery (ERAS) Program for Colorectal Surgery.</ArticleTitle><Pagination><StartPage>19</StartPage><EndPage>33</EndPage><MedlinePgn>19-33</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00268-021-06343-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">We aimed to determine the prevalence, risk factors, and outcomes of acute kidney injury (AKI) within an ERAS program for colorectal surgery (CRS).</AbstractText><AbstractText Label="METHODS">This is a retrospective case-control study conducted from March 2016 to September 2018 at a single tertiary hospital in Singapore. All adult patients requiring CRS within our ERAS program were considered eligible. Exclusions were stage 5 chronic kidney disease or patients requiring a synchronous liver resection. The primary outcome was AKI as defined by the Kidney Disease Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. Secondary outcomes included mortality, major complications, and hospital length of stay. Patient, surgical, and anaesthesia-related data were analysed to determine factors associated with AKI.</AbstractText><AbstractText Label="RESULTS">A total of 575 patients were eligible for the study. Twenty patients were excluded from the study leaving 555 patients for analysis. Mean age was 67.8 (SD 11.4) years. Seventy-four patients met the criteria for AKI (13.4%: stage 1-11.2%, stage 2-2.0%, stage 3-0.2%). One patient required renal replacement therapy (RRT). Patients with AKI had a longer length of stay (median [IQR], 11.0 [5.0-17.0] days vs 6.0 [4.0-8.0] days; P&#x2009;&lt;&#x2009;.001), more major complications (OR, 6.55; 95% CI, 3.00-14.35, P&#x2009;&lt;&#x2009;.001), and a trend towards higher mortality at one year (OR, 1.44; 95% CI 0.48-4.30; p&#x2009;=&#x2009;0.511. After multivariable regression analysis, factors associated with AKI were preoperative creatinine (OR, 1.01 per 10&#xa0;&#xb5;mol/l; 95% CI, 1.03-1.22; P&#x2009;=&#x2009;0.01), robotic surgery vs open surgery (OR, 0.15; 95% CI, 0.06-0.39; P&#x2009;&lt;&#x2009;0.001), anaesthesia duration (OR, 1.38 per hour; 95% CI, 1.22-1.55; P&#x2009;&lt;&#x2009;0.001), and major complications (OR, 5.55; 95% CI, 2.63-11.70; P&#x2009;&lt;&#x2009;0.001).</AbstractText><AbstractText Label="CONCLUSIONS">Within the present cohort, the implementation of an ERAS program for CRS was associated with a low prevalence of moderate to severe AKI despite a balanced intravenous fluid regimen. Patients having open surgery, longer procedures, and major complications are at increased risk of AKI.</AbstractText><CopyrightInformation>&#xa9; 2021. Soci&#xe9;t&#xe9; Internationale de Chirurgie.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Drakeford</LastName><ForeName>Paul Andrew</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Intensive Care and Pain Medicine, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Novena, 308433, Singapore. paul.drakeford@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tham</LastName><ForeName>Shu Qi</ForeName><Initials>SQ</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Intensive Care and Pain Medicine, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Novena, 308433, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwek</LastName><ForeName>Jia Li</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Intensive Care and Pain Medicine, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Novena, 308433, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Vera</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Intensive Care and Pain Medicine, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Novena, 308433, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Chien Joo</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Clinical Research &amp; Innovation Office, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Novena, 308433, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>How</LastName><ForeName>Kwang Yeong</ForeName><Initials>KY</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Novena, 308433, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ljungqvist</LastName><ForeName>Olle</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Health, School of Health and Medical Sciences, Department of Surgery, &#xd6;rebro University, &#xd6;rebro, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World J Surg</MedlineTA><NlmUniqueID>7704052</NlmUniqueID><ISSNLinking>0364-2313</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003107" MajorTopicYN="Y">Colorectal Surgery</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000080482" MajorTopicYN="Y">Enhanced Recovery After Surgery</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>19</Day><Hour>12</Hour><Minute>27</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34665309</ArticleId><ArticleId IdType="doi">10.1007/s00268-021-06343-6</ArticleId><ArticleId IdType="pii">10.1007/s00268-021-06343-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gameiro J, Fonseca JA, Neves M et al (2018) Acute kidney injury in major abdominal surgery: incidence, risk factors, pathogenesis and outcomes. Ann Intensive Care 8:22&#x2013;24</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-018-0369-7</ArticleId></ArticleIdList></Reference><Reference><Citation>KDIGO Clinical Practice Guideline for Acute Kidney Injury, Kidney International Supplements (2012) Kidney Disease: Improving Global Outcomes (KDIGO) Working Group. Kidney Int Suppl 2:8&#x2013;12</Citation></Reference><Reference><Citation>Marcotte JH, Patel K, Desai R et al (2018) Acute kidney injury following implementation of an enhanced recovery after surgery (ERAS) protocol in colorectal surgery. Int J Colorectal Dis 33:1259&#x2013;1267</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00384-018-3084-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Koerner CP, Lopez-Aguiar AG, Zaidi M, Speegle S, Balch G (2019) Caution: increased acute kidney injury in enhanced recovery after surgery (ERAS) protocols. Am Surg 85:156&#x2013;161</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000313481908500221</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim JW, Kim KR, Jung Y et al (2020) Role of intraoperative oliguria in risk stratification for postoperative acute kidney injury in patients undergoing colorectal surgery with an enhanced recovery protocol: a propensity score matching analysis. PLoS ONE 15:e0231447</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0231447</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiener JGD, Goss L, Wahl TS et al (2020) The association of enhanced recovery pathway and acute kidney injury in patients undergoing colorectal surgery. Dis Colon Rectum 63:233&#x2013;241</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/DCR.0000000000001528</ArticleId></ArticleIdList></Reference><Reference><Citation>Grass F, Lovely JK, Crippa J et al (2019) Early acute kidney injury within an established enhanced recovery pathway: uncommon and transitory. World J Surg 43:1207&#x2013;1215</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-019-04923-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassinger TE, Turrentine FE, Thiele RH et al (2018) Acute kidney injury in the age of enhanced recovery protocols. Dis Colon Rectum 61:946&#x2013;954</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/DCR.0000000000001059</ArticleId></ArticleIdList></Reference><Reference><Citation>Long TE, Helgason D, Helgadottir S et al (2016) Acute kidney injury after abdominal surgery: incidence, risk factors, and outcome. Anesth Analg 122:1912&#x2013;1920</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000001323</ArticleId></ArticleIdList></Reference><Reference><Citation>Myles PS, Bellomo R, Corcoran T et al (2018) Restrictive versus liberal fluid therapy for major abdominal surgery. N Engl J Med 378:2263&#x2013;2274</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1801601</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldheiser A, Aziz O, Baldini G et al (2016) Enhanced recovery after surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for anaesthesia practice. Acta Anaesthesiol Scand 60:289&#x2013;334</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.12651</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafsson UO, Scott MJ, Hubner M et al (2019) Guidelines for perioperative care in elective colorectal surgery: enhanced recovery after surgery (ERAS((R))) society recommendations: 2018. World J Surg 43:659&#x2013;695</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-018-4844-y</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M et al (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology 18:800&#x2013;804</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0b013e3181577654</ArticleId></ArticleIdList></Reference><Reference><Citation>Encare ERAS Interactive Audit System, https://www.encare.net/healthcare-professionals/products-and-services/eras-interactive-audit-system-eias , 2019.</Citation></Reference><Reference><Citation>MDRD for Adults (Conventional Units), National Institute for Diabetes and Digestive and Kidney Diseases Online Calculator: https://www.niddk.nih.gov/health-information/professionals/clinical-tools-patient-management/kidney-disease/laboratory-evaluation/glomerular-filtration-rate-calculators/mdrd-adults-si-units . Accessed 15 Dec 2018</Citation></Reference><Reference><Citation>Shiba A, Uchino S, Fujii T et al (2018) Association between intraoperative oliguria and acute kidney injury after major noncardiac surgery. Anesth Analg 127:1229&#x2013;1235</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000003576</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor ME, Kirwan CJ, Pearse RM et al (2016) Incidence and associations of acute kidney injury after major abdominal surgery. Intensive Care Med 42:521&#x2013;530</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-4157-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Horres CR, Adam MA, Sun Z et al (2017) Enhanced recovery protocols for colorectal surgery and postoperative renal function: a retrospective review. Perioper Med (Lond) 6:13</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13741-017-0069-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Kork F, Balzer F, Spies CD et al (2015) Minor postoperative increases of creatinine are associated with higher mortality and longer hospital length of stay in surgical patients. Anesthesiology 123:1301&#x2013;1311</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000891</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortrie G, de Geus HRH, Betjes MGH (2019) The aftermath of acute kidney injury: a narrative review of long-term mortality and renal function. Crit Care 23:24</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2314-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Lilot M, Ehrenfeld JM, Lee C et al (2015) Variability in practice and factors predictive of total crystalloid administration during abdominal surgery: retrospective two-centre analysis. Br J Anaesth 114:767&#x2013;776</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aeu452</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson C, Ruchi R, Bihorac A (2017) Perioperative acute kidney injury: risk factors and predictive strategies. Crit Care Clin 33:379&#x2013;396</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2016.12.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Elias KM, Stone AB, McGinigle K et al (2019) The reporting on eras compliance, outcomes, and elements research (RECOvER) checklist: a joint statement by the ERAS((R)) and ERAS((R)) USA societies. World J Surg 43:1&#x2013;8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-018-4753-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesselink EM, Kappen TH, Torn HM et al (2018) Intraoperative hypotension and the risk of postoperative adverse outcomes: a systematic review. Br J Anaesth 121:706&#x2013;721</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2018.04.036</ArticleId></ArticleIdList></Reference><Reference><Citation>Goren O, Matot I (2015) Perioperative acute kidney injury. Br J Anaesth 115(Suppl 2):ii3-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aev380</ArticleId></ArticleIdList></Reference><Reference><Citation>Giglio M, Dalfino L, Puntillo F et al (2019) Hemodynamic goal-directed therapy and postoperative kidney injury: an updated meta-analysis with trial sequential analysis. Crit Care 23:232</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2516-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Lefrant JY, Guinot PG et al (2017) Effect of individualized vs standard blood pressure management strategies on postoperative organ dysfunction among high-risk patients undergoing major surgery: a randomized clinical trial. JAMA 318:1346&#x2013;1357</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.14172</ArticleId></ArticleIdList></Reference><Reference><Citation>Vittinghoff E, McCulloch CE (2007) Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 165:710&#x2013;718</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwk052</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32151389</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>22</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2623</ISSN><JournalIssue CitedMedium="Internet"><Volume>52</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Transplantation proceedings</Title><ISOAbbreviation>Transplant Proc</ISOAbbreviation></Journal><ArticleTitle>Acute Kidney Injury After Lung Transplantation: Perioperative Risk Factors and Outcome.</ArticleTitle><Pagination><StartPage>967</StartPage><EndPage>976</EndPage><MedlinePgn>967-976</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.transproceed.2020.01.018</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0041-1345(19)31242-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute kidney injury (AKI) is associated with increased short-term and long-term mortality and morbidity after lung transplantation (LT). The primary objective of this study was to analyze the perioperative factors associated with AKI according to Kidney Disease: Improving Global Outcome (KDIGO) criteria during hospitalization in an intensive care unit (ICU) after LT.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a single-center, observational, prospective study. AKI was defined according to KDIGO criteria. Results are expressed as median, interquartile range, absolute numbers, and percentages. Statistical analyses were performed using &#x3c7;<sup>2</sup> test, Fisher exact test, and Mann-Whitney U test. P&#xa0;&lt; .05 was considered to be significant. Multivariate analysis was performed to identify independent risk factors.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Between January 2016 and April 2018, 94 patients underwent LT (70% bilateral LT). AKI occurred during ICU stay in 46 patients (49%). KDIGO 1 AKI was observed in 16 patients (17%), KDIGO 2 in 14 patients (15%), and KDIGO 3 in 16 patients (17%), including 12 patients (75%) who required renal replacement therapy. AKI occurred before the fifth day after surgery for 38 patients (82% of the AKI patients). On multivariate analysis, independent factors associated with AKI were bilateral LT and mechanical ventilation &gt;3 days (odds ratio [OR] 4.26, 95% confidence interval [CI] [1.49; 13.63] P&#xa0;= .010 and OR 5.56 [1.25; 11.47] P&#xa0;= .018, respectively). AKI and the need for renal replacement therapy were significantly associated with ICU mortality, 28-day mortality, and 1-year mortality.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">AKI is common during ICU stay after LT, especially after bilateral LT, and is associated with prolonged mechanical ventilation and increased short-term and long-term mortality.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Atchade</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Assistance Publique-H&#xf4;pitaux de Paris, Centre Hospitalier Universitaire Bichat-Claude Bernard, D&#xe9;partement d'Anesth&#xe9;sie R&#xe9;animation, Paris, France. Electronic address: enora.atchade@aphp.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barour</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Assistance Publique-H&#xf4;pitaux de Paris, Centre Hospitalier Universitaire Bichat-Claude Bernard, D&#xe9;partement d'Anesth&#xe9;sie R&#xe9;animation, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tran-Dinh</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Assistance Publique-H&#xf4;pitaux de Paris, Centre Hospitalier Universitaire Bichat-Claude Bernard, D&#xe9;partement d'Anesth&#xe9;sie R&#xe9;animation, Paris, France; Laboratory for Vascular Translational Science, Inserm U1148, Centre Hospitalier Universitaire Bichat-Claude Bernard, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jean-Baptiste</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Assistance Publique-H&#xf4;pitaux de Paris, Centre Hospitalier Universitaire Bichat-Claude Bernard, D&#xe9;partement d'Anesth&#xe9;sie R&#xe9;animation, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Assistance Publique-H&#xf4;pitaux de Paris, Centre Hospitalier Universitaire Bichat-Claude Bernard, D&#xe9;partement d'Anesth&#xe9;sie R&#xe9;animation, Paris, France; Universit&#xe9; de la R&#xe9;union, Inserm Unit&#xe9; Mixte de Recherche 1188 Diab&#xe8;te Ath&#xe9;rothrombose, R&#xe9;union Ocean Indien, Saint Denis de la R&#xe9;union, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tashk</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Assistance Publique-H&#xf4;pitaux de Paris, Centre Hospitalier Universitaire Bichat-Claude Bernard, D&#xe9;partement d'Anesth&#xe9;sie R&#xe9;animation, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Snauwaert</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Assistance Publique-H&#xf4;pitaux de Paris, Centre Hospitalier Universitaire Bichat-Claude Bernard, D&#xe9;partement d'Anesth&#xe9;sie R&#xe9;animation, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lortat-Jacob</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Assistance Publique-H&#xf4;pitaux de Paris, Centre Hospitalier Universitaire Bichat-Claude Bernard, D&#xe9;partement d'Anesth&#xe9;sie R&#xe9;animation, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mourin</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Assistance Publique-H&#xf4;pitaux de Paris, Centre Hospitalier Universitaire Bichat-Claude Bernard, Service de Pneumologie B et Transplantation Pulmonaire, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mordant</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Assistance Publique-H&#xf4;pitaux de Paris, Centre Hospitalier Universitaire Bichat-Claude Bernard, Service de Chirurgie Vasculaire, Thoracique et Transplantation, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castier</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Assistance Publique-H&#xf4;pitaux de Paris, Centre Hospitalier Universitaire Bichat-Claude Bernard, Service de Chirurgie Vasculaire, Thoracique et Transplantation, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mal</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Assistance Publique-H&#xf4;pitaux de Paris, Centre Hospitalier Universitaire Bichat-Claude Bernard, Service de Pneumologie B et Transplantation Pulmonaire, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Tymowski</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Assistance Publique-H&#xf4;pitaux de Paris, Centre Hospitalier Universitaire Bichat-Claude Bernard, D&#xe9;partement d'Anesth&#xe9;sie R&#xe9;animation, Paris, France; Inserm U1149 Immunorecepteur et Immunopathologie r&#xe9;nale, Centre Hospitalier Universitaire Bichat-Claude Bernard, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montravers</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Assistance Publique-H&#xf4;pitaux de Paris, Centre Hospitalier Universitaire Bichat-Claude Bernard, D&#xe9;partement d'Anesth&#xe9;sie R&#xe9;animation, Paris, France; Inserm, Unit&#xe9; Mixte de Recherche 1152, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Transplant Proc</MedlineTA><NlmUniqueID>0243532</NlmUniqueID><ISSNLinking>0041-1345</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016040" MajorTopicYN="N">Lung Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059035" MajorTopicYN="N">Perioperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="N">Renal Replacement Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32151389</ArticleId><ArticleId IdType="doi">10.1016/j.transproceed.2020.01.018</ArticleId><ArticleId IdType="pii">S0041-1345(19)31242-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29136086</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>17</Day></DateCompleted><DateRevised><Year>2019</Year><Month>04</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>119</Volume><Issue>6</Issue><PubDate><Year>2017</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Intraoperative oliguria predicts acute kidney injury after major abdominal surgery.</ArticleTitle><Pagination><StartPage>1127</StartPage><EndPage>1134</EndPage><MedlinePgn>1127-1134</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/bja/aex255</ELocationID><Abstract><AbstractText Label="BACKGROUND">The threshold of intraoperative urine output below which the risk of acute kidney injury (AKI) increases is unclear. The aim of this retrospective cohort study was to investigate the relationship between intraoperative urine output during major abdominal surgery and the development of postoperative AKI and to identify an optimal threshold for predicting the differential risk of AKI.</AbstractText><AbstractText Label="METHODS">Perioperative data were collected retrospectively on 3560 patients undergoing major abdominal surgery (liver, colorectal, gastric, pancreatic, or oesophageal resection) at Kyoto University Hospital. We evaluated the relationship between intraoperative urine output and the development of postoperative AKI as defined by recent guidelines. Logistic regression analysis was performed to adjust for patient and operative variables, and the minimum P -value approach was used to determine the threshold of intraoperative urine output that independently altered the risk of AKI.</AbstractText><AbstractText Label="RESULTS">The overall incidence of AKI in the study population was 6.3%. Using the minimum P -value approach, a threshold of 0.3&#x2009;ml kg -1 h -1 was identified, below which there was an increased risk of AKI (adjusted odds ratio, 2.65; 95% confidence interval, 1.77-3.97; P &lt;0.001). The addition of oliguria &lt;0.3&#x2009;ml kg -1 h -1 to a model with conventional risk factors significantly improved risk stratification for AKI (net reclassification improvement, 0.159; 95% confidence interval, 0.049-0.270; P =0.005).</AbstractText><AbstractText Label="CONCLUSIONS">Among patients undergoing major abdominal surgery, intraoperative oliguria &lt;0.3&#x2009;ml kg -1 h -1 was significantly associated with increased risk of postoperative AKI.</AbstractText><CopyrightInformation>&#xa9; The Author 2017. Published by Oxford University Press on behalf of the British Journal of Anaesthesia. All rights reserved. For Permissions, please email: journals.permissions@oup.com</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mizota</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Kyoto University Hospital, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Healthcare Epidemiology, School of Public Health in the Graduate School of Medicine, Kyoto University, Yoshida Konoemachi, Sakyo-ku, Kyoto 606-8501, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamada</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Kyoto University Hospital, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsukawa</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Kyoto University Hospital, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimizu</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Kyoto University Hospital, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kai</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Kyoto University Hospital, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="N">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="Y">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009846" MajorTopicYN="N">Oliguria</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="Y">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">general surgery</Keyword><Keyword MajorTopicYN="N">intraoperative</Keyword><Keyword MajorTopicYN="N">monitoring</Keyword><Keyword MajorTopicYN="N">oliguria</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29136086</ArticleId><ArticleId IdType="doi">10.1093/bja/aex255</ArticleId><ArticleId IdType="pii">S0007-0912(17)54140-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28060555</PMID><DateCompleted><Year>2018</Year><Month>08</Month><Day>08</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1521-0553</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of investigative surgery : the official journal of the Academy of Surgical Research</Title><ISOAbbreviation>J Invest Surg</ISOAbbreviation></Journal><ArticleTitle>Efficacy of N-Acetylcysteine in Preventing Acute Kidney Injury After Cardiac Surgery: A Meta-Analysis Study.</ArticleTitle><Pagination><StartPage>14</StartPage><EndPage>23</EndPage><MedlinePgn>14-23</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/08941939.2016.1269853</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To evaluate whether perioperative N-acetylcysteine (NAC) administration reduces the risk of cardiac surgery associated acute kidney injury (CSA-AKI).</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">A systematic literature review (Medline, PubMed, Cochrane, Biomedical central, Google Scholar) identified 10 studies (1391 patients; 695 NAC and 696 placebo) that compared the efficacy and adverse effects of perioperative NAC administration for CSA-AKI prevention in adults undergoing elective cardiac surgery. Meta-analysis was performed using Comprehensive Meta-Analysis statistical software.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Patients in the NAC-treated and placebo groups had similar rate of CSA-AKI occurrence, change in creatinine levels, as well as the in-hospital mortality rate (RR = 0.841, 95% CI = 0.691 to 1.023, p = 0.083; pooled difference in means = -0.328, 95% CI = -0.712 to 0.056, p = 0.094; RR = 0.741, 95% CI = 0.388 to 1.418, p = 0.366, respectively).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our study does not support perioperative NAC administration as a mean to reduce the risk of CSA-AKI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mei</LastName><ForeName>Mei</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>a Department of Kidney , Southwest Hospital, Third Military Medical University , Chongqing 400038 , P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Hong-Wen</ForeName><Initials>HW</Initials><AffiliationInfo><Affiliation>a Department of Kidney , Southwest Hospital, Third Military Medical University , Chongqing 400038 , P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Qian-Guang</ForeName><Initials>QG</Initials><AffiliationInfo><Affiliation>a Department of Kidney , Southwest Hospital, Third Military Medical University , Chongqing 400038 , P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pu</LastName><ForeName>You-Min</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>a Department of Kidney , Southwest Hospital, Third Military Medical University , Chongqing 400038 , P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Mao-Zhi</ForeName><Initials>MZ</Initials><AffiliationInfo><Affiliation>a Department of Kidney , Southwest Hospital, Third Military Medical University , Chongqing 400038 , P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Bing-Bing</ForeName><Initials>BB</Initials><AffiliationInfo><Affiliation>a Department of Kidney , Southwest Hospital, Third Military Medical University , Chongqing 400038 , P.R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>01</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Invest Surg</MedlineTA><NlmUniqueID>8809255</NlmUniqueID><ISSNLinking>0894-1939</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016166">Free Radical Scavengers</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical><Chemical><RegistryNumber>WYQ7N0BPYC</RegistryNumber><NameOfSubstance UI="D000111">Acetylcysteine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000111" MajorTopicYN="N">Acetylcysteine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016166" MajorTopicYN="N">Free Radical Scavengers</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">N-acetylcysteine</Keyword><Keyword MajorTopicYN="N">acute kidney injury/kidney injury</Keyword><Keyword MajorTopicYN="N">cardiac surgery/heart surgery</Keyword><Keyword MajorTopicYN="N">coronary artery bypass</Keyword><Keyword MajorTopicYN="N">creatinine</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28060555</ArticleId><ArticleId IdType="doi">10.1080/08941939.2016.1269853</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25134440</PMID><DateCompleted><Year>2015</Year><Month>11</Month><Day>16</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-0528</ISSN><JournalIssue CitedMedium="Internet"><Volume>122</Volume><Issue>10</Issue><PubDate><Year>2015</Year><Month>Sep</Month></PubDate></JournalIssue><Title>BJOG : an international journal of obstetrics and gynaecology</Title><ISOAbbreviation>BJOG</ISOAbbreviation></Journal><ArticleTitle>Acute kidney injury in major gynaecological surgery: an observational study.</ArticleTitle><Pagination><StartPage>1340</StartPage><EndPage>1348</EndPage><MedlinePgn>1340-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/1471-0528.13026</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess the prevalence, outcomes and cost associated with acute kidney injury (AKI) defined by consensus risk, injury, failure, loss, and end-stage kidney (RIFLE) criteria after gynaecologic surgery.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective single-centre cohort study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Academic medical centre.</AbstractText><AbstractText Label="SAMPLE" NlmCategory="METHODS">Two thousand three hundred and forty-one adult women undergoing major inpatient gynaecologic surgery between January 2000 and November 2010.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">AKI was defined by RIFLE criteria as an increase in serum creatinine greater than or equal to 50% from the reference creatinine. We used multivariable regression analyses to determine the association between perioperative factors, AKI, mortality and cost.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">AKI, combined major adverse events (hospital mortality, sepsis or mechanical ventilation), 90-day mortality and hospital cost.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall prevalence of AKI was 13%. The prevalence of AKI was associated with the primary diagnosis. Of women with benign tumour surgeries, 5% (43/801) experienced AKI compared with 18% (211/1159) of women with malignant disease (P &lt; 0.001). Only 1.3% of the whole cohort had evidence of urologic mechanical injury. In a multivariable logistic regression analysis, AKI patients had nine times the odds of a major adverse event compared to patients without AKI (adjusted odds ratio 8.95, 95% confidence interval 5.27-15.22). We have identified several readily available perioperative factors that can be used to identify patients at high risk for AKI after in-hospital gynaecologic surgery.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">AKI is a common complication after major inpatient gynaecologic surgery associated with an increase in resource utilisation and hospital cost, morbidity and mortality.</AbstractText><CopyrightInformation>&#xa9; 2014 Royal College of Obstetricians and Gynaecologists.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vaught</LastName><ForeName>A J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ozrazgat-Baslanti</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Javed</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morgan</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Gynecology, University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hobson</LastName><ForeName>C E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Department of Health Services Research, Management and Policy, University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Malcom Randall Veterans Affairs Medical Center, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bihorac</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 GM087709</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23GM087709</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>08</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BJOG</MedlineTA><NlmUniqueID>100935741</NlmUniqueID><ISSNLinking>1470-0328</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>BJOG. 2016 Jun;123(7):1234-5. doi: 10.1111/1471-0528.13932.</RefSource><PMID Version="1">27206043</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005431" MajorTopicYN="N" Type="Geographic">Florida</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013509" MajorTopicYN="Y">Gynecologic Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017721" MajorTopicYN="N">Hospital Costs</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">gynecologic procedure</Keyword><Keyword MajorTopicYN="N">outcomes</Keyword></KeywordList><CoiStatement><b>Disclosure of Interests</b>. The authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>11</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25134440</ArticleId><ArticleId IdType="mid">NIHMS612512</ArticleId><ArticleId IdType="pmc">PMC4334755</ArticleId><ArticleId IdType="doi">10.1111/1471-0528.13026</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hoste EA, Schurgers M. Epidemiology of acute kidney injury: How big is the problem? Crit Care Med. 2008 Apr;36(4):S146&#x2013;S151.</Citation><ArticleIdList><ArticleId IdType="pubmed">18382186</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricci Z, Cruz DN, Ronco C. Classification and staging of acute kidney injury: beyond the RIFLE and AKIN criteria. Nat Rev Nephrol. 2011 Apr;7(4):201&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pubmed">21364520</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204&#x2013;R212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC522841</ArticleId><ArticleId IdType="pubmed">15312219</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. Clinical Practice Guideline for Acute Kidney Injury. Kidney inter, Suppl. 2012;2(1):1&#x2013;138.</Citation></Reference><Reference><Citation>Bihorac A, Brennan M, Ozrazgat Baslanti T, Bozorgmehri S, Efron PA, Moore FA, et al. National Surgical Quality Improvement Program Underestimates the Risk Associated with Mild and Moderate Postoperative Acute Kidney Injury. Crit Care Med. 2013;41(11):2570&#x2013;2583.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3812338</ArticleId><ArticleId IdType="pubmed">23928835</ArticleId></ArticleIdList></Reference><Reference><Citation>Bihorac A, Delano MJ, Schold JD, Lopez MC, Nathens AB, Maier RV, et al. Incidence, clinical predictors, genomics, and outcome of acute kidney injury among trauma patients. Ann Surg. 2010 Jul;252(1):158&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3357629</ArticleId><ArticleId IdType="pubmed">20562612</ArticleId></ArticleIdList></Reference><Reference><Citation>Bihorac A, Yavas S, Subbiah S, Hobson CE, Schold JD, Gabrielli A, et al. Long-term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg. 2009 May;249(5):851&#x2013;858.</Citation><ArticleIdList><ArticleId IdType="pubmed">19387314</ArticleId></ArticleIdList></Reference><Reference><Citation>Borthwick E, Ferguson A. Perioperative acute kidney injury: risk factors, recognition, management, and outcomes. BMJ. 2010;341:c3365.</Citation><ArticleIdList><ArticleId IdType="pubmed">20603317</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JR, Cochran RP, Dacey LJ, Ross CS, Kunzelman KS, Dunton RF, et al. Perioperative increases in serum creatinine are predictive of increased 90-day mortality after coronary artery bypass graft surgery. Circulation. 2006 Jul 4;114(1 Suppl):I409&#x2013;I413.</Citation><ArticleIdList><ArticleId IdType="pubmed">16820609</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson CE, Yavas S, Segal MS, Schold JD, Tribble CG, Layon AJ, et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation. 2009 May 12;119(18):2444&#x2013;2453.</Citation><ArticleIdList><ArticleId IdType="pubmed">19398670</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliphant SS, Jones KA, Wang L, Bunker CH, Lowder JL. Trends over time with commonly performed obstetric and gynecologic inpatient procedures. Obstet Gynecol. 2010 Oct;116(4):926&#x2013;931.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3253706</ArticleId><ArticleId IdType="pubmed">20859157</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteman M, Hills S, Jamieson D, Morrow B, Podgomik M, Brett K, et al. Inpatient hysterectomy surveillance in the United States, 2000&#x2013;2004. Am J Obstet Gynecol. 2008;198(1):7.</Citation><ArticleIdList><ArticleId IdType="pubmed">17981254</ArticleId></ArticleIdList></Reference><Reference><Citation>Wald R, Waikar SS, Liangos O, Pereira BJG, Chertow GM, Jaber BL. Acute renal failure after endovascular vs open repair of abdominal aortic aneurysm. J Vasc Surg. 2006;43(3):460&#x2013;466.</Citation><ArticleIdList><ArticleId IdType="pubmed">16520155</ArticleId></ArticleIdList></Reference><Reference><Citation>American College of Surgeons National Surgical Quality Improvement Program. User Guide for the 2010 Participant Use Data File. Chicago, IL: American College of Surgeons; 2010. pp. 60611&#x2013;63211.</Citation></Reference><Reference><Citation>Siew ED, Ikizler T, Matheny ME, Shi Y, Schildcrout JS, Dancui I. Estimating baseline kidney function in hospitalized patients with impaired kidney function. J Am Soc Nephrol. 2012;7(5):8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3338282</ArticleId><ArticleId IdType="pubmed">22422536</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel TR, Dombrovskiy VY, Carson JL, Graham AM, Lowry SF. Postoperative sepsis in the United States. Ann Surg. 2010 Dec;252(6):1065&#x2013;1071.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2951484</ArticleId><ArticleId IdType="pubmed">20571363</ArticleId></ArticleIdList></Reference><Reference><Citation>Agency for Healthcare Research and Quality.  [cited 2012 April 9];Patient safety indicators: technical specifications. 2010  Ver. 4.2. Available from:  http://www.qualityindicators.ahrq.gov.</Citation></Reference><Reference><Citation>Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project (HCUP) 2003 &#x2013; 2008. Rockville, MD: Agency for Healthcare Research and Quality; 2008. Healthcare Cost and Utilization Project 2008 National Statistics.</Citation><ArticleIdList><ArticleId IdType="pubmed">21413206</ArticleId></ArticleIdList></Reference><Reference><Citation>LaPar DJ, Bhamidipati CM, Mery CM, Stukenborg GJ, Jones DR, Schirmer BD, et al. Primary payer status affects mortality for major surgical operations. Ann Surg. 2010 Sep;252(3):544&#x2013;550. discussion 50-1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3071622</ArticleId><ArticleId IdType="pubmed">20647910</ArticleId></ArticleIdList></Reference><Reference><Citation>Guller U, Hervey S, Purves H, Muhlbaier LH, Peterson ED, Eubanks S, et al. Laparoscopic versus open appendectomy: outcomes comparison based on a large administrative database. Ann Surg. 2004 Jan;239(1):43&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1356191</ArticleId><ArticleId IdType="pubmed">14685099</ArticleId></ArticleIdList></Reference><Reference><Citation>Frankman EA, Wang L, Bunker CH, Lowder JL. Lower urinary tract injury in women in the United States, 1979&#x2013;2006. Am J Obstet Gynecol. 2010 May;202(205):495, e1&#x2013;e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3086842</ArticleId><ArticleId IdType="pubmed">20223442</ArticleId></ArticleIdList></Reference><Reference><Citation>Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity Measures for Use with Administrative Data. Med Care. 1998;36(1):8&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">9431328</ArticleId></ArticleIdList></Reference><Reference><Citation>Juillard C, Lashoher A, Sewell CA, Uddin S, Griffith JG, Chang DC. A national analysis of the relationship between hospital volume, academic center status, and surgical outcomes for abdominal hysterectomy done for leiomyoma. J Am Coll Surg. 2009 Apr;208(4):599&#x2013;606.</Citation><ArticleIdList><ArticleId IdType="pubmed">19476796</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>United States Census Bureau.  [cited 04/02/2011];American FactFinder. 2010  Available from:  http://www2.census.gov/</Citation></Reference><Reference><Citation>Pebesma EJ, Bivand RS. Classes and methods for spatial data in R. R News. 2005</Citation></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007 Oct 16;147(8):573&#x2013;577.</Citation><ArticleIdList><ArticleId IdType="pubmed">17938396</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasta DJ. Estimating Standard Errors for CLASS Variables in Generalized Linear Models Using PROC IML. SAS Users Group International Proceedings. 2003;28:364&#x2013;328.</Citation></Reference><Reference><Citation>Duan N. Smearing Estimate: A Nonparametric Retransformation Method. J Am Stat Assoc. 1983;78(383):605&#x2013;610.</Citation></Reference><Reference><Citation>Aitken E, Carruthers C, Gall L, Kerr L, Geddes C, Kingsmore D. Acute kidney injury: outcomes and quality of care. QJM. 2013 Apr;106(4):323&#x2013;332.</Citation><ArticleIdList><ArticleId IdType="pubmed">23345468</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Eeden SK, Glasser M, Mathias SD, Colwell HH, Pasta DJ, Kunz K. Quality of life, health care utilization, and costs among women undergoing hysterectomy in a managed-care setting. Am J Obstet Gynecol. 1998 Jan;178(1 Pt 1):91&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">9465810</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorsey JH, Holtz PM, Griffiths RI, McGrath MM, Steinberg EP. Costs and charges associated with three alternative techniques of hysterectomy. N Engl J Med. 1996 Aug 15;335(7):476&#x2013;482.</Citation><ArticleIdList><ArticleId IdType="pubmed">8672153</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Tremper KK, Heung M, Rosenberg AL, Englesbe M, Shanks AM, et al. Development and validation of an acute kidney injury risk index for patients undergoing general surgery: results from a national data set. Anesthesiology. 2009 Mar;110(3):505&#x2013;515.</Citation><ArticleIdList><ArticleId IdType="pubmed">19212261</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs SA, Thakar CV. Perioperative risk assessment, prevention, and treatment of acute kidney injury. Int Anesthesiol Clin. 2009 Fall;47(4):89&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">19820480</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimick JB, Chen SL, Taheri PA, Henderson WG, Khuri SF, Campbell DA., Jr. Hospital costs associated with surgical complications: a report from the private-sector National Surgical Quality Improvement Program. J Am Coll Surg. 2004 Oct;199(4):531&#x2013;537.</Citation><ArticleIdList><ArticleId IdType="pubmed">15454134</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff BG, Viscusi ER, Delaney CP, Du W, Techner L. Patterns of gastrointestinal recovery after bowel resection and total abdominal hysterectomy: pooled results from the placebo arms of alvimopan phase III North American clinical trials. J Am Coll Surg. 2007 Jul;205(1):43&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">17617331</ArticleId></ArticleIdList></Reference><Reference><Citation>Wechter ME, Pearlman MD, Hartmann KE. Reclosure of the disrupted laparotomy wound: a systematic review. Obstet Gynecol. 2005 Aug;106(2):376&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pubmed">16055590</ArticleId></ArticleIdList></Reference><Reference><Citation>Hur HC, Guido RS, Mansuria SM, Hacker MR, Sanfilippo JS, Lee TT. Incidence and patient characteristics of vaginal cuff dehiscence after different modes of hysterectomies. J Minim Invasive Gynecol. 2007 May-Jun;14(3):311&#x2013;317.</Citation><ArticleIdList><ArticleId IdType="pubmed">17478361</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai SW, Huh EH, Jung da J, Park JH, Rha KH, Kim SK, et al. Urinary tract injuries during pelvic surgery: incidence rates and predisposing factors. Int Urogynecol J Pelvic Floor Dysfunct. 2006 Jun;17(4):360&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pubmed">16195819</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibeanu OA, Chesson RR, Echols KT, Nieves M, Busangu F, Nolan TE. Urinary tract injury during hysterectomy based on universal cystoscopy. Obstet Gynecol. 2009 Jan;113(1):6&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">19104353</ArticleId></ArticleIdList></Reference><Reference><Citation>Schilder JM, Hurteau JA, Look KY, Moore DH, Raff G, Stehman FB, et al. A prospective controlled trial of early postoperative oral intake following major abdominal gynecologic surgery. Gynecol Oncol. 1997 Dec;67(3):235&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pubmed">9441769</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmichael P, Carmichael AR. Acute renal failure in the surgical setting. ANZ J Surg. 2003 Mar;73(3):144&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pubmed">12608979</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornelison TL, Reed E. Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin. Gynecol Oncol. 1993 Aug;50(2):147&#x2013;158.</Citation><ArticleIdList><ArticleId IdType="pubmed">8375728</ArticleId></ArticleIdList></Reference><Reference><Citation>Ljungman S, Laragh JH, Cody RJ. Role of the Kidney in Congestive Heart-Failure - Relationship of Cardiac Index to Kidney-Function. Drugs. 1990;39:10&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">2354670</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28218392</PMID><DateCompleted><Year>2017</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2168</ISSN><JournalIssue CitedMedium="Internet"><Volume>104</Volume><Issue>7</Issue><PubDate><Year>2017</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The British journal of surgery</Title><ISOAbbreviation>Br J Surg</ISOAbbreviation></Journal><ArticleTitle>Acute kidney injury and mortality 1 year after major non-cardiac surgery.</ArticleTitle><Pagination><StartPage>868</StartPage><EndPage>876</EndPage><MedlinePgn>868-876</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/bjs.10498</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Even mild and transient acute kidney injury (AKI), defined by increases in serum creatinine level, has been associated with adverse outcomes after major surgery. However, characteristic decreases in creatinine concentration during major illness could confound accurate assessment of postoperative AKI.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In a single-hospital, retrospective cohort study of non-cardiac surgery, the association between postoperative AKI, defined using the Kidney Disease: Improving Global Outcomes criteria, and 1-year survival was modelled using a multivariable Cox proportional hazards analysis. Factors associated with development of AKI were examined by means of multivariable logistic regression. Temporal changes in serum creatinine during and after the surgical admission in patients with and without AKI were compared.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Some 1869 patients were included in the study, of whom 128 (6&#xb7;8 per cent) sustained AKI (101 stage 1, 27 stage 2-3). Seventeen of the 128 patients with AKI (13&#xb7;3 per cent) died in hospital compared with 16 of 1741 (0&#xb7;9 per cent) without AKI (P &lt; 0&#xb7;001). By 1 year, 34 patients with AKI (26&#xb7;6 per cent) had died compared with 106 (6&#xb7;1 per cent) without AKI (P &lt; 0&#xb7;001). Over the 8-365 days after surgery, AKI was associated with an adjusted hazard ratio for death of 2&#xb7;96 (95 per cent c.i. 1&#xb7;86 to 4&#xb7;71; P &lt; 0&#xb7;001). Among hospital survivors without AKI, the creatinine level fell consistently (median difference at discharge versus baseline -7 (i.q.r. -15 to 0) &#xb5;mol/l), but not in those with AKI (0 (-16 to 26) &#xb5;mol/l) (P &lt; 0&#xb7;001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Although the majority of postoperative AKI was mild, there was a strong association with risk of death in the year after surgery. Underlying decreases in serum creatinine concentration after major surgery could lead to underestimation of AKI severity and overestimation of recovery.</AbstractText><CopyrightInformation>&#xa9; 2017 BJS Society Ltd Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>O'Connor</LastName><ForeName>M E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Medicine Research Group, William Harvey Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Adult Critical Care Unit, Royal London Hospital, Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hewson</LastName><ForeName>R W</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Medicine Research Group, William Harvey Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Adult Critical Care Unit, Royal London Hospital, Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia, Royal London Hospital, Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirwan</LastName><ForeName>C J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Medicine Research Group, William Harvey Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Adult Critical Care Unit, Royal London Hospital, Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Renal and Transplant Medicine, Royal London Hospital, Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ackland</LastName><ForeName>G L</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Medicine Research Group, William Harvey Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia, Royal London Hospital, Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pearse</LastName><ForeName>R M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Medicine Research Group, William Harvey Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Adult Critical Care Unit, Royal London Hospital, Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia, Royal London Hospital, Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prowle</LastName><ForeName>J R</ForeName><Initials>JR</Initials><Identifier Source="ORCID">0000-0002-5002-2721</Identifier><AffiliationInfo><Affiliation>Critical Care and Perioperative Medicine Research Group, William Harvey Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Adult Critical Care Unit, Royal London Hospital, Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Renal and Transplant Medicine, Royal London Hospital, Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RP_2014-04-022</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>02</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Surg</MedlineTA><NlmUniqueID>0372553</NlmUniqueID><ISSNLinking>0007-1323</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009026" MajorTopicYN="Y">Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28218392</ArticleId><ArticleId IdType="doi">10.1002/bjs.10498</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">24612945</PMID><DateCompleted><Year>2015</Year><Month>06</Month><Day>18</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1741-7015</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2014</Year><Month>Mar</Month><Day>10</Day></PubDate></JournalIssue><Title>BMC medicine</Title><ISOAbbreviation>BMC Med</ISOAbbreviation></Journal><ArticleTitle>Local versus general anesthesia for transcatheter aortic valve implantation (TAVR)--systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>41</StartPage><MedlinePgn>41</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/1741-7015-12-41</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The hypothesis of this study was that local anesthesia with monitored anesthesia care (MAC) is not harmful in comparison to general anesthesia (GA) for patients undergoing Transcatheter Aortic Valve Implantation (TAVR).TAVR is a rapidly spreading treatment option for severe aortic valve stenosis. Traditionally, in most centers, this procedure is done under GA, but more recently procedures with MAC have been reported.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a systematic review and meta-analysis comparing MAC versus GA in patients undergoing transfemoral TAVR. Trials were identified through a literature search covering publications from 1 January 2005 through 31 January 2013. The main outcomes of interest of this literature meta-analysis were 30-day overall mortality, cardiac-/procedure-related mortality, stroke, myocardial infarction, sepsis, acute kidney injury, procedure time and duration of hospital stay. A random effects model was used to calculate the pooled relative risks (RR) with 95% confidence intervals.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Seven observational studies and a total of 1,542 patients were included in this analysis. None of the studies were randomized. Compared to GA, MAC was associated with a shorter hospital stay (-3.0 days (-5.0 to -1.0); P = 0.004) and a shorter procedure time (MD -36.3 minutes (-58.0 to -15.0 minutes); P &lt;0.001). Overall 30-day mortality was not significantly different between MAC and GA (RR 0.77 (0.38 to 1.56); P = 0.460), also cardiac- and procedure-related mortality was similar between both groups (RR 0.90 (0.34 to 2.39); P = 0.830).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These data did not show a significant difference in short-term outcomes for MAC or GA in TAVR. MAC may be associated with reduced procedural time and shorter hospital stay. Now randomized trials are needed for further evaluation of MAC in the setting of TAVR.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fr&#xf6;hlich</LastName><ForeName>Georg M</ForeName><Initials>GM</Initials></Author><Author ValidYN="Y"><LastName>Lansky</LastName><ForeName>Alexandra J</ForeName><Initials>AJ</Initials></Author><Author ValidYN="Y"><LastName>Webb</LastName><ForeName>John</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Roffi</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Toggweiler</LastName><ForeName>Stefan</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Reinthaler</LastName><ForeName>Markus</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Duolao</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Hutchinson</LastName><ForeName>Nevil</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Wendler</LastName><ForeName>Olaf</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Hildick-Smith</LastName><ForeName>David</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Meier</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>The Heart Hospital, University College London Hospitals, London, UK. pascalmeier74@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>03</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med</MedlineTA><NlmUniqueID>101190723</NlmUniqueID><ISSNLinking>1741-7015</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000772" MajorTopicYN="Y">Anesthesia, Local</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="N">Aortic Valve Stenosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065467" MajorTopicYN="N">Transcatheter Aortic Valve Replacement</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>3</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24612945</ArticleId><ArticleId IdType="pmc">PMC4022332</ArticleId><ArticleId IdType="doi">10.1186/1741-7015-12-41</ArticleId><ArticleId IdType="pii">1741-7015-12-41</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S. PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597&#x2013;1607. doi: 10.1056/NEJMoa1008232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1008232</ArticleId><ArticleId IdType="pubmed">20961243</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancellotti P, Rosenhek R, Pibarot P, Iung B, Otto CM, Tornos P, Donal E, Prendergast B, Magne J, La Canna G, Pi&#xe9;rard LA, Maurer G. ESC Working Group on Valvular Heart Disease Position Paper - heart valve clinics: organization, structure, and experiences. Eur Heart J. 2013;34:1597&#x2013;1606. doi: 10.1093/eurheartj/ehs443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehs443</ArticleId><ArticleId IdType="pubmed">23293304</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Lefevre T, Himbert D, Tchetche D, Carri&#xe9; D, Albat B, Cribier A, Rioufol G, Sudre A, Blanchard D, Collet F, Dos Santos P, Meneveau N, Tirouvanziam A, Caussin C, Guyon P, Boschat J, Le Breton H, Collart F, Houel R. et al.Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012;366:1705&#x2013;1715. doi: 10.1056/NEJMoa1114705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1114705</ArticleId><ArticleId IdType="pubmed">22551129</ArticleId></ArticleIdList></Reference><Reference><Citation>Stiles S.  TAVR in-Hospital Death, Stroke Rates Stay Low Even as Use Climbs: GARY. Munich: European Society of Cardiology ESC 2012; 2012.   http://www.medscape.com/viewarticle/769866.</Citation></Reference><Reference><Citation>Linke A, Bosmans J, Gerckens U, Wenaweser P, Tamburino C, Brecker S, Bauernschmitt R. Local vs. General Anaesthesia: Impact on the outcomes of transcatheter aortic valve implantation: insights from the multicentre ADVANCE study. Munich: European Society of Cardiology ESC; 2012.</Citation></Reference><Reference><Citation>Motloch LJ, Rottlaender D, Reda S, Larbig R, Bruns M, M&#xfc;ller-Ehmsen J, Strauch J, Madershahian N, Erdmann E, Wahlers T, Hoppe UC. Local versus general anesthesia for transfemoral aortic valve implantation. Clin Res Cardiol. 2012;101:45&#x2013;53. doi: 10.1007/s00392-011-0362-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-011-0362-8</ArticleId><ArticleId IdType="pubmed">21931964</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto M, Meguro K, Mouillet G, Bergoend E, Monin JL, Lim P, Dubois-Rande JL, Teiger E. Effect of local anesthetic management with conscious sedation in patients undergoing transcatheter aortic valve implantation. Am J Cardiol. 2013;111:94&#x2013;99. doi: 10.1016/j.amjcard.2012.08.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2012.08.053</ArticleId><ArticleId IdType="pubmed">23068861</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruppert V, Leurs LJ, Rieger J, Steckmeier B, Buth J, Umscheid T. EUROSTAR Collaborators. Risk-adapted outcome after endovascular aortic aneurysm repair: analysis of anesthesia types based on EUROSTAR data. J Endovasc Ther. 2007;14:12&#x2013;22. doi: 10.1583/06-1957.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1583/06-1957.1</ArticleId><ArticleId IdType="pubmed">17291150</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilpatrick B, Slinger P. Lung protective strategies in anaesthesia. Br J Anaesth. 2010;105:i108&#x2013;i116. doi: 10.1093/bja/aeq299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aeq299</ArticleId><ArticleId IdType="pmc">PMC9149602</ArticleId><ArticleId IdType="pubmed">21148650</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim T, Kim HJ, Lee JM, Kim JH, Hong DM, Jeon Y, Roh YJ, Lim YJ, Bahk JH. The head-down tilt position decreases vasopressor requirement during hypotension following induction of anaesthesia in patients undergoing elective coronary artery bypass graft and valvular heart surgeries. Eur J Anaesthesiol. 2011;28:45&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">21088595</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K. EPIC II Group of Investigators. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302:2323&#x2013;2329. doi: 10.1001/jama.2009.1754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2009.1754</ArticleId><ArticleId IdType="pubmed">19952319</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. doi: 10.1136/bmj.b2535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2535</ArticleId><ArticleId IdType="pmc">PMC2714657</ArticleId><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference><Reference><Citation>Tricco AC, Straus SE, Moher D. How can we improve the interpretation of systematic reviews? BMC Med. 2011;9:31. doi: 10.1186/1741-7015-9-31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1741-7015-9-31</ArticleId><ArticleId IdType="pmc">PMC3072347</ArticleId><ArticleId IdType="pubmed">21450084</ArticleId></ArticleIdList></Reference><Reference><Citation>tctmd. The Source for Interventional Cardiovascular News and Education.   http://www.tctmd.com.</Citation></Reference><Reference><Citation>The Heart Org. Medscape Cardiology.   http://www.theheart.org.</Citation></Reference><Reference><Citation>EuroPCR:   http://www.europcronline.com.</Citation></Reference><Reference><Citation>American College of Cardiology. CardioSource.   http://www.cardiosource.com.</Citation></Reference><Reference><Citation>CRTonline.   http://www.crtonline.org.</Citation></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177&#x2013;188. doi: 10.1016/0197-2456(86)90046-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(86)90046-2</ArticleId><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc. 2009;172:137&#x2013;159. doi: 10.1111/j.1467-985X.2008.00552.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1467-985X.2008.00552.x</ArticleId><ArticleId IdType="pmc">PMC2667312</ArticleId><ArticleId IdType="pubmed">19381330</ArticleId></ArticleIdList></Reference><Reference><Citation>Sankey SS, Weissfeld LA, Fine MJ, Kapoor W. An assessment of the use of the continuity correction for sparse data in meta-analysis. Commun Stat. 1996;25:1031&#x2013;1056.</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539&#x2013;1558. doi: 10.1002/sim.1186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller JJ. The inverse of the Freeman-Tukey double arcsine transformation. Am Stat. 1978;32:138.</Citation></Reference><Reference><Citation>Behan M, Haworth P, Hutchinson N, Trivedi U, Laborde JC, Hildick-Smith D. Percutaneous aortic valve implants under sedation: our initial experience. Catheter Cardiovasc Interv. 2008;72:1012&#x2013;1015. doi: 10.1002/ccd.21777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.21777</ArticleId><ArticleId IdType="pubmed">19021273</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Dor I, Looser PM, Maluenda G, Weddington TC, Kambouris NG, Barbash IM, Hauville C, Okubagzi P, Corso PJ, Satler LF, Pichard AD, Waksman R. Transcatheter aortic valve replacement under monitored anesthesia care versus general anesthesia with intubation. Cardiovasc Revasc Med. 2012;13:207&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">22818531</ArticleId></ArticleIdList></Reference><Reference><Citation>Covello RD, Ruggeri L, Landoni G, Guarracino F, Bignami E, Gonfalini M, Virzo I, Michev I, Colombo A, Zangrillo A. Transcatheter implantation of an aortic valve: anesthesiological management. Minerva Anestesiol. 2010;76:100&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pubmed">20150850</ArticleId></ArticleIdList></Reference><Reference><Citation>Deh&#xe9;din B, Guinot PG, Ibrahim H, Allou N, Provench&#xe8;re S, Dilly MP, Vahanian A, Himbert D, Brochet E, Radu C, Nataf P, Montravers P, Longrois D, Depoix JP. Anesthesia and perioperative management of patients who undergo transfemoral transcatheter aortic valve implantation: an observational study of general versus local/regional anesthesia in 125 consecutive patients. J Cardiothorac Vasc Anesth. 2011;25:1036&#x2013;1043. doi: 10.1053/j.jvca.2011.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2011.05.008</ArticleId><ArticleId IdType="pubmed">21803602</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulur P, Nishimori M, Ballantyne JC. Regional anaesthesia versus general anaesthesia, morbidity and mortality. Best Pract Res Clin Anaesthesiol. 2006;20:249&#x2013;263. doi: 10.1016/j.bpa.2005.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpa.2005.10.002</ArticleId><ArticleId IdType="pubmed">16850776</ArticleId></ArticleIdList></Reference><Reference><Citation>Bainbridge D, Martin J, Arango M, Cheng D. for the Evidence-based Peri-operative Clinical Outcomes Research (EpiCOR) Group. Evidence-based peri-operative clinical outcomes research, perioperative and anaesthetic-related mortality in developed and developing countries: a systematic review and meta-analysis. Lancet. 2012;380:1075&#x2013;1081. doi: 10.1016/S0140-6736(12)60990-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)60990-8</ArticleId><ArticleId IdType="pubmed">22998717</ArticleId></ArticleIdList></Reference><Reference><Citation>Cioni M, Taramasso M, Giacomini A, Montorfano M, Latib A, Colombo A, Alfieri O, Maisano F. Transaxillary approach: short- and mid-term results in a single-center experience. Innovations (Phila) 2011;6:361&#x2013;365. doi: 10.1097/IMI.0b013e318248e9ed.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/IMI.0b013e318248e9ed</ArticleId><ArticleId IdType="pubmed">22436770</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips D. Aortic stenosis: a review. AANA J. 2006;74:309&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pubmed">16918123</ArticleId></ArticleIdList></Reference><Reference><Citation>Gripari P, Ewe SH, Fusini L, Muratori M, Ng AC, Cefal&#xf9; C, Delgado V, Schalij MJ, Bax JJ, Marsan NA, Tamborini G, Pepi M. Intraoperative 2D and 3D transoesophageal echocardiographic predictors of aortic regurgitation after transcatheter aortic valve implantation. Heart. 2012;98:1229&#x2013;1236. doi: 10.1136/heartjnl-2012-301998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2012-301998</ArticleId><ArticleId IdType="pubmed">22826560</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold M, Achenbach S, Pfeiffer I, Ensminger S, Marwan M, Einhaus F, Pflederer T, Ropers D, Schuhbaeck A, Anders K, Lell M, Uder M, Ludwig J, Weyand M, Daniel WG, Feyrer R. A method to determine suitable fluoroscopic projections for transcatheter aortic valve implantation by computed tomography. J Cardiovasc Comput Tomogr. 2012;6:422&#x2013;428. doi: 10.1016/j.jcct.2012.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcct.2012.10.008</ArticleId><ArticleId IdType="pubmed">23217463</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Ling LH, Halloran K, Morton JB, Spence SJ, Joseph S, Kistler PM, Sparks PB, Kalman JM. Esophageal hematoma after atrial fibrillation ablation: incidence, clinical features, and sequelae of esophageal injury of a different sort. Circ Arrhythm Electrophysiol. 2012;5:701&#x2013;705. doi: 10.1161/CIRCEP.112.970624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.112.970624</ArticleId><ArticleId IdType="pubmed">22544279</ArticleId></ArticleIdList></Reference><Reference><Citation>Association of Anaesthetists of Great Britain and Ireland. Day case and short stay surgery: 2. Anaesthesia. 2011;66:417&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pubmed">21418041</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzel RP, Edmond MB. The impact of hospital-acquired bloodstream infections. Emerg Infect Dis. 2001;7:174&#x2013;177. doi: 10.3201/eid0702.010203.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid0702.010203</ArticleId><ArticleId IdType="pmc">PMC2631709</ArticleId><ArticleId IdType="pubmed">11294700</ArticleId></ArticleIdList></Reference><Reference><Citation>Duggan M, Kavanagh BP. Perioperative modifications of respiratory function. Best Pract Res Clin Anaesthesiol. 2010;24:145&#x2013;155. doi: 10.1016/j.bpa.2009.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpa.2009.12.001</ArticleId><ArticleId IdType="pubmed">20608553</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Guerrero ML, Verdejo C, Azofra J, de G&#xf3;rgolas M. Hospital-acquired infectious endocarditis not associated with cardiac surgery: an emerging problem. Clin Infect Dis. 1995;20:16&#x2013;23. doi: 10.1093/clinids/20.1.16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/20.1.16</ArticleId><ArticleId IdType="pubmed">7727642</ArticleId></ArticleIdList></Reference><Reference><Citation>Neyt M, Van Brabandt H, Devriese S, Van De Sande S. A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population. BMJ Open. 2012;2:e001032.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3358616</ArticleId><ArticleId IdType="pubmed">22561354</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasta JF, McLaughlin TP, Mody SH, Piech CT. Daily cost of an intensive care unit day: the contribution of mechanical ventilation. Crit Care Med. 2005;33:1266&#x2013;1271. doi: 10.1097/01.CCM.0000164543.14619.00.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000164543.14619.00</ArticleId><ArticleId IdType="pubmed">15942342</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarantini G, Gasparetto V, Napodano M, Fraccaro C, Gerosa G, Isabella G. Valvular leak after transcatheter aortic valve implantation: a clinician update on epidemiology, pathophysiology and clinical implications. Am J Cardiovasc Dis. 2011;1:312&#x2013;320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3253519</ArticleId><ArticleId IdType="pubmed">22254207</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36008696</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2584</ISSN><JournalIssue CitedMedium="Internet"><Volume>55</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>International urology and nephrology</Title><ISOAbbreviation>Int Urol Nephrol</ISOAbbreviation></Journal><ArticleTitle>Risk factors of perioperative acute kidney injury in elderly patients: a single-center retrospective study.</ArticleTitle><Pagination><StartPage>459</StartPage><EndPage>467</EndPage><MedlinePgn>459-467</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11255-022-03345-8</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The elderly are vulnerable to perioperative acute kidney injury. The aim of this study was to determine the risk factors that associated with acute kidney injury among elderly patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Clinical data of elderly patients (&gt;&#x2009;65&#xa0;years) who underwent noncardiac, nonrenal surgery between Dec 1 2009 and July 1 2016 were collected for this single-centered historical cohort study. Univariate and multivariate analyses were conducted to explore the risk factors that contribute to acute kidney injury, which was defined as a serum creatinine increase &gt;0.3&#xa0;mg/dL within 48&#xa0;h or 1.5 times increase in serum creatinine within 7 days after surgery.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">7775 patients were eligible for the final analysis, among which 511 (6.57%) patients developed acute kidney injury. We observed 21 risk factors being associated with perioperative acute kidney injury, with the most important disposing factors being history of kidney disease (adjusted OR&#x2009;=&#x2009;2.94, 95% CI 2.25-3.84), operation time&#x2009;&gt;&#x2009;180&#xa0;min (aOR&#x2009;=&#x2009;2.93, 95% CI 2.04-4.24), preoperative eGFR [15, 30) (aOR&#x2009;=&#x2009;2.43, 95% CI 1.29-4.45), and protective factor being intraoperative use of sufentanil (aOR&#x2009;=&#x2009;0.35, 95% CI 0.23-0.54).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study determined risk factors for perioperative acute kidney injury among the elderly in the Second Xiangya Hospital and visualized the risk factors using nomogram and Excel calculator, which may provide some clues to further investigations. Overall, the prevalence of AKI among this large cohort is 6.57%.</AbstractText><AbstractText Label="CLINICAL TRIALS REGISTRATION" NlmCategory="BACKGROUND">http://www.chictr.org.cn ; ChiCTR1900027007; October 28, 2019.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Nature B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Sun</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Province Center for Clinical Anesthesia and Anesthesiology, Research Institute of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhao</LastName><ForeName>Yujing</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Province Center for Clinical Anesthesia and Anesthesiology, Research Institute of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Binyi</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Province Center for Clinical Anesthesia and Anesthesiology, Research Institute of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mo</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Le9 Healthcare Technology Co., Ltd., Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Junmei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China. xujunmei001@csu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Province Center for Clinical Anesthesia and Anesthesiology, Research Institute of Central South University, Changsha, China. xujunmei001@csu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Yulong</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-2677-654X</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China. cuiyulong@csu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Province Center for Clinical Anesthesia and Anesthesiology, Research Institute of Central South University, Changsha, China. cuiyulong@csu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Grant No. 2018YFC2001902</GrantID><Agency>National Key Research and Development Program of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int Urol Nephrol</MedlineTA><NlmUniqueID>0262521</NlmUniqueID><ISSNLinking>0301-1623</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Elderly patients</Keyword><Keyword MajorTopicYN="N">Risk factors</Keyword><Keyword MajorTopicYN="N">Surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>25</Day><Hour>23</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36008696</ArticleId><ArticleId IdType="doi">10.1007/s11255-022-03345-8</ArticleId><ArticleId IdType="pii">10.1007/s11255-022-03345-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Doyle JF, Forni LG (2016) Acute kidney injury: short-term and long-term effects. Crit Care 20(1):188</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1353-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Rewa O, Bagshaw SM (2014) Acute kidney injury-epidemiology, outcomes and economics. Nat Rev Nephrol 10(4):193&#x2013;207</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2013.282</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu JR, Zhu JM, Jiang J, Ding XQ, Fang Y, Shen B et al (2015) Risk factors for long-term mortality and progressive chronic kidney disease associated with acute kidney injury after cardiac surgery. Medicine (Baltimore) 94(45):e2025</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000002025</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Y, Ding X, Zhong Y, Zou J, Teng J, Tang Y et al (2010) Acute kidney injury in a chinese hospitalized population. Blood Purif 30(2):120&#x2013;126</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000319972</ArticleId></ArticleIdList></Reference><Reference><Citation>Koza Y (2016) Acute kidney injury: current concepts and new insights. J Inj Violence Res 8(1):58&#x2013;62</Citation></Reference><Reference><Citation>Hoste EA, Clermont G, Kersten A, Venkataraman R, Angus DC, De Bacquer D et al (2006) RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 10(3):R73</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc4915</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Murugan R (2016) Effects of non-severe acute kidney injury on clinical outcomes in critically ill patients. Crit Care 20(1):159</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1295-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutherland SM, Goldstein SL, Bagshaw SM (2018) Acute kidney injury and big data. Contrib Nephrol 193:55&#x2013;67</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000484963</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosner MH, La Manna G, Ronco C (2018) Acute kidney injury in the geriatric population. Contrib nephrol. Contributions to nephrology. S. Karger AG, Berlin, pp 149&#x2013;160</Citation></Reference><Reference><Citation>Chronopoulos A, Rosner MH, Cruz DN, Ronco C (2010) Acute kidney injury in elderly intensive care patients: a review. Intensive Care Med 36(9):1454&#x2013;1464</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-010-1957-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A (2012) KDIGO clinical practice guidelines for acute kidney injury. Nature Publ. Group, New York, p 138</Citation></Reference><Reference><Citation>Gumbert SD, Kork F, Jackson ML, Vanga N, Ghebremichael SJ, Wang CY et al (2020) Perioperative acute kidney injury. Anesthesiology 132(1):180&#x2013;204</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000002968</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Ye Y, Mi Q, Huang W, He T, Huang P et al (2016) A predictive model for assessing surgery-related acute kidney injury risk in hypertensive patients: a retrospective cohort study. PLoS ONE 11(11):e0165280</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0165280</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung S, Brovman EY, Aglio LS, Beutler SS, Urman RD (2020) Risk factors and associated complications of acute kidney injury in adult patients undergoing a craniotomy. Clin Neurol Neurosurg 190:105642</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2019.105642</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob KA, Leaf DE (2019) Prevention of cardiac surgery-associated acute kidney injury: a review of current strategies. Anesthesiol Clin 37(4):729&#x2013;749</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anclin.2019.08.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickering JW, James MT, Palmer SC (2015) Acute kidney injury and prognosis after cardiopulmonary bypass: a meta-analysis of cohort studies. Am J Kidney Dis 65(2):283&#x2013;293</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2014.09.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosla N, Soroko SB, Chertow GM, Himmelfarb J, Ikizler TA, Paganini E et al (2009) Preexisting chronic kidney disease: a potential for improved outcomes from acute kidney injury. Clin J Am Soc Nephrol 4(12):1914&#x2013;1919</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.01690309</ArticleId></ArticleIdList></Reference><Reference><Citation>Dean M (2004) Opioids in renal failure and dialysis patients. J Pain Symptom Manag 28(5):497&#x2013;504</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpainsymman.2004.02.021</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob KA, Leaf DE, Dieleman JM, van Dijk D, Nierich AP, Rosseel PM et al (2015) Intraoperative high-dose dexamethasone and severe AKI after cardiac surgery. J Am Soc Nephrol 26(12):2947&#x2013;2951</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2014080840</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitlock RP, Devereaux PJ, Teoh KH, Lamy A, Vincent J, Pogue J et al (2015) Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial. Lancet 386(10000):1243&#x2013;1253</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)00273-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun LY, Wijeysundera DN, Tait GA, Beattie WS (2015) Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery. Anesthesiology 123(3):515&#x2013;523</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000765</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh M, Devereaux PJ, Garg AX, Kurz A, Turan A, Rodseth RN et al (2013) Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology 119(3):507&#x2013;515</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3182a10e26</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngu JMC, Jabagi H, Chung AM, Boodhwani M, Ruel M, Bourke M et al (2020) Defining an intraoperative hypotension threshold in association with de novo renal replacement therapy after cardiac surgery. Anesthesiology 132(6):1447&#x2013;1457</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003254</ArticleId></ArticleIdList></Reference><Reference><Citation>Bijker JB, van Klei WA, Vergouwe Y, Eleveld DJ, van Wolfswinkel L, Moons KG et al (2009) Intraoperative hypotension and 1-year mortality after noncardiac surgery. Anesthesiology 111(6):1217&#x2013;1226</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3181c14930</ArticleId></ArticleIdList></Reference><Reference><Citation>Bijker JB, van Klei WA, Kappen TH, van Wolfswinkel L, Moons KGM, Kalkman CJ (2007) Incidence of intraoperative hypotension as a function of the chosen definition-literature definitions applied to a retrospective cohort using automated data collection. Anesthesiology 107(2):213&#x2013;220</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.anes.0000270724.40897.8e</ArticleId></ArticleIdList></Reference><Reference><Citation>Singbartl K, Joannidis M (2015) Short-term effects of acute kidney injury. Crit Care Clin 31(4):751&#x2013;762</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2015.06.010</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40042458</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>11</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2060</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Annals of medicine</Title><ISOAbbreviation>Ann Med</ISOAbbreviation></Journal><ArticleTitle>Intraoperative hemodynamics in prediction of postoperative kidney injury after type a aortic dissection surgery: a retrospective cohort study.</ArticleTitle><Pagination><StartPage>2474859</StartPage><MedlinePgn>2474859</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2474859</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/07853890.2025.2474859</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Type A aortic dissection (TAAD) is a severe cardiovascular condition associated with high risks for postoperative complications, particularly renal dysfunction. This study investigated whether intraoperative hypotension and venous congestion are important predictors of postoperative kidney injury and major adverse events.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We retrospectively analyzed 543 adults undergoing TAAD surgery (2016-2023). Primary outcomes were acute kidney injury (AKI) and acute kidney disease (AKD). Secondary outcomes included death, stroke and composite outcome. Patients were divided into four groups: AKI only, AKD only, AKI and AKD, Non-AKI or AKD. We used restricted cubic spline and multivariate logistic regression models to adjust for confounding factors.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">AKI or AKD was significantly associated with each 10-minute epoch of central venous pressure (CVP) &#x2265;10, 12, 16, 20&#x2009;mmHg (all <i>p</i>&#x2009;&lt;&#x2009;0.001), with each 60-minute epoch of CVP &#x2265;10, 12, 16, 20&#x2009;mmHg area under the curve (AUC) (all p&#x2009;&lt;&#x2009;0.001). Regarding death, a 6% to 13% increase rate for each 10-minute epoch of CVP &#x2265;10, 12, 16, 20&#x2009;mmHg (all <i>p</i>&#x2009;&#x2264;&#x2009;0.003), a 5% to 21% increase for each 60-minute epoch of CVP &#x2265;10, 12, 16, 20&#x2009;mmHg AUC (all <i>p</i>&#x2009;&lt;&#x2009;0.001). In terms of stroke risk, a 5% increase rate for every 10-minute increase in the CVP AUC above 16&#x2009;mmHg, and an 11% increased risk for CVP AUC above 20&#x2009;mmHg (<i>p</i>&#x2009;=&#x2009;0.039 and <i>p</i>&#x2009;=&#x2009;0.031, respectively).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Elevated CVP and lower MAP levels were linked to postoperative AKI and AKD risk. CVP showed stronger associations with mortality and stroke. Optimizing perioperative hemodynamic management may improve individualized interventions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Lihai</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of International Business, China Pharmaceutical University, Nanjing, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bu</LastName><ForeName>Xinyi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Zhongda Hospital, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xuesheng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, First Affiliated Hospital of Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Siyu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of International Business, China Pharmaceutical University, Nanjing, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Yali</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-8417-1672</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Hongwei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Jifang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of International Business, China Pharmaceutical University, Nanjing, Jiangsu, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Med</MedlineTA><NlmUniqueID>8906388</NlmUniqueID><ISSNLinking>0785-3890</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000784" MajorTopicYN="Y">Aortic Dissection</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="Y">Hemodynamics</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002496" MajorTopicYN="N">Central Venous Pressure</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="plain-language-summary" Language="eng"><AbstractText>Acute kidney injury and acute kidney disease are common and serious complications after Type A aortic dissection surgery.This observational cohort study showed that both intraoperative venous congestion and hypotension are associated with acute kidney injury and acute kidney disease. In addition intraoperative venous congestion displayed a direct correlation with postoperative outcomes such as death and stroke.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">acute kidney disease</Keyword><Keyword MajorTopicYN="N">intraoperative hypotension</Keyword><Keyword MajorTopicYN="N">type A aortic dissection</Keyword><Keyword MajorTopicYN="N">venous congestion</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>3</Month><Day>5</Day><Hour>12</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>5</Day><Hour>12</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>5</Day><Hour>10</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>3</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40042458</ArticleId><ArticleId IdType="pmc">PMC11884094</ArticleId><ArticleId IdType="doi">10.1080/07853890.2025.2474859</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mussa FF, Horton JD, Moridzadeh R, et al. . Acute aortic dissection and intramural hematoma: a systematic review. JAMA. 2016;316(7):754&#x2013;763. doi: 10.1001/jama.2016.10026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.10026</ArticleId><ArticleId IdType="pubmed">27533160</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Zhong G, Lv X, et al. . Risk factors for acute kidney injury after Stanford type A aortic dissection repair surgery: a systematic review and meta-analysis. Ren Fail. 2022;44(1):1462&#x2013;1476. doi: 10.1080/0886022X.2022.2113795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/0886022X.2022.2113795</ArticleId><ArticleId IdType="pmc">PMC9427034</ArticleId><ArticleId IdType="pubmed">36036431</ArticleId></ArticleIdList></Reference><Reference><Citation>Helgadottir S, Sigurdsson MI, Palsson R, et al. . Renal recovery and long-term survival following acute kidney injury after coronary artery surgery: a nationwide study. Acta Anaesthesiol Scand. 2016;60(9):1230&#x2013;1240. doi: 10.1111/aas.12758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.12758</ArticleId><ArticleId IdType="pubmed">27378715</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryd&#xe9;n LC, Sartipy U, Holzmann MJ.. Acute kidney injury after surgical AVR and long-term risk of death and end-stage renal disease. J Am Coll Cardiol. 2015;66(20):2263&#x2013;2264. doi: 10.1016/j.jacc.2015.08.883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2015.08.883</ArticleId><ArticleId IdType="pubmed">26553408</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Sileanu FE, Bihora A, et al. . Recovery after acute kidney injury. Am J Respir Crit Care Med. 2017;195(6):784&#x2013;791. doi: 10.1164/rccm.201604-0799OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201604-0799OC</ArticleId><ArticleId IdType="pmc">PMC5363967</ArticleId><ArticleId IdType="pubmed">27635668</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryo M, Masao I, Hidekazu M, et al. . The clinical course of acute kidney disease after cardiac surgery: a retrospective observational study. Sci Rep. 2020;10(1):6490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7162986</ArticleId><ArticleId IdType="pubmed">32300140</ArticleId></ArticleIdList></Reference><Reference><Citation>Chawla LS, Bellomo R, Bihorac A, et al. . Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol. 2017;13(4):241&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="pubmed">28239173</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitra KN, Lui GF, Azra B, et al. . Cardiac and vascular surgery-associated acute kidney injury: the 20th International Consensus Conference of the ADQI (Acute Disease Quality Initiative) Group. J Am Heart Assoc. 2018;7(11):e008834.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6015369</ArticleId><ArticleId IdType="pubmed">29858368</ArticleId></ArticleIdList></Reference><Reference><Citation>Anran D, Zhou Z, Fan J, et al. . Incorporating intraoperative blood pressure time-series variables to assist in prediction of acute kidney injury after type A acute aortic dissection repair: an interpretable machine learning model. Ann Med. 2023;55(2):2266458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10563625</ArticleId><ArticleId IdType="pubmed">37813109</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Hong L, Ma A, et al. . Intraoperative venous congestion rather than hypotension is associated with acute adverse kidney events after cardiac surgery: a retrospective cohort study. Br J Anaesth. 2022;128(5):785&#x2013;795. doi: 10.1016/j.bja.2022.01.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2022.01.032</ArticleId><ArticleId IdType="pubmed">35249707</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko T, Higashitani M, Sato A, et al. . Impact of acute kidney injury on early to long-term outcomes in patients who underwent surgery for type A acute aortic dissection. Am J Cardiol. 2015;116(3):463&#x2013;468. doi: 10.1016/j.amjcard.2015.04.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2015.04.043</ArticleId><ArticleId IdType="pubmed">26026862</ArticleId></ArticleIdList></Reference><Reference><Citation>Razminia M, Trivedi A, Molnar J, et al. . Validation of a new formula for mean arterial pressure calculation: the new formula is superior to the standard formula. Catheter Cardiovasc Interv. 2004;63(4):419&#x2013;425. doi: 10.1002/ccd.20217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.20217</ArticleId><ArticleId IdType="pubmed">15558774</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C-H, Chen S-W, Chen J-J, et al. . Incidence and transition of acute kidney injury, acute kidney disease to chronic kidney disease after acute type A aortic dissection surgery. J Clin Med. 2021;10(20):4769. doi: 10.3390/jcm10204769.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10204769</ArticleId><ArticleId IdType="pmc">PMC8540632</ArticleId><ArticleId IdType="pubmed">34682894</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng K, McIlroy DR, Bollen BA, et al. . Society of cardiovascular anesthesiologists clinical practice update for management of acute kidney injury associated with cardiac surgery. Anesth Analg. 2022;135(4):744&#x2013;756. doi: 10.1213/ANE.0000000000006068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000006068</ArticleId><ArticleId IdType="pubmed">35544772</ArticleId></ArticleIdList></Reference><Reference><Citation>Makhija N, Magoon R, Das D, et al. . Haemodynamic predisposition to acute kidney injury: shadow and light!. J Anaesthesiol Clin Pharmacol. 2022;38(3):353&#x2013;359. doi: 10.4103/joacp.JOACP_547_20.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/joacp.JOACP_547_20</ArticleId><ArticleId IdType="pmc">PMC9728413</ArticleId><ArticleId IdType="pubmed">36505192</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopitk&#xf3; C, Gondos T, F&#xfc;l&#xf6;p T, et al. . Reinterpreting renal hemodynamics: the importance of venous congestion and effective organ perfusion in acute kidney injury. Am J Med Sci. 2020;359(4):193&#x2013;205. doi: 10.1016/j.amjms.2020.01.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2020.01.012</ArticleId><ArticleId IdType="pubmed">32089228</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang PT, Lopez BE, Togashi K.. A decrease in effective renal perfusion pressure is associated with increased acute kidney injury in patients undergoing cardiac surgery. Cureus. 2023;15(9):e45036. doi: 10.7759/cureus.45036.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.45036</ArticleId><ArticleId IdType="pmc">PMC10566397</ArticleId><ArticleId IdType="pubmed">37829983</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniel DB, Rocio R, Jacques D.. Hemodynamic management of acute kidney injury. Curr Opin Crit Care. 2024;30(6):542&#x2013;547.</Citation><ArticleIdList><ArticleId IdType="pubmed">39503203</ArticleId></ArticleIdList></Reference><Reference><Citation>Isselbacher EM, Bonaca MP, Di Eusanio M, et al. . Recurrent aortic dissection: observations from the International Registry of Aortic Dissection. Circulation. 2016;134(14):1013&#x2013;1024. doi: 10.1161/CIRCULATIONAHA.115.019359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.115.019359</ArticleId><ArticleId IdType="pubmed">27587434</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyul-Toth A, Fulop GA, Tarantini S, et al. . Cerebral venous congestion exacerbates cerebral microhemorrhages in mice. Geroscience. 2022;44(2):805&#x2013;816. doi: 10.1007/s11357-021-00504-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-021-00504-0</ArticleId><ArticleId IdType="pmc">PMC9135950</ArticleId><ArticleId IdType="pubmed">34989944</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40314957</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>5</Issue><PubDate><Year>2025</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Hospital and Clinician Practice Variation in Cardiac Surgery and Postoperative Acute Kidney Injury.</ArticleTitle><Pagination><StartPage>e258342</StartPage><MedlinePgn>e258342</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e258342</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2025.8342</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Approximately 30% of US patients develop acute kidney injury (AKI) after cardiac surgery, which is associated with increased morbidity, mortality, and health care costs. The variation in potentially modifiable hospital- and clinician-level operating room practices and their implications for AKI have not been rigorously evaluated.</AbstractText><AbstractText Label="OBJECTIVE">To quantify variation in clinician- and hospital-level hemodynamic and resuscitative practices during cardiac surgery and identify their associations with AKI.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This cohort study analyzed integrated hospital, clinician, and patient data extracted from the Multicenter Perioperative Outcomes Group dataset and the Society of Thoracic Surgeons Adult Cardiac Surgical Database. Participants were adult patients (aged &#x2265;18 years) who underwent cardiac surgical procedures between January 1, 2014, and February 1, 2022, at 8 geographically diverse US hospitals. Patients were followed up through March 2, 2022. Statistical analyses were performed from October 2024 to February 2025.</AbstractText><AbstractText Label="EXPOSURES">Hospital- and clinician-level variations in operating room hemodynamic practices (inotrope infusion &gt;60 minutes and vasopressor infusion &gt;60 minutes) and resuscitative practices (homologous red blood cell [RBC] transfusion and total fluid volume administration).</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">The primary outcome was consensus guideline-defined AKI (any stage) within 7 days after cardiac surgery. Hospital- and clinician-level variations were quantified using intraclass correlation coefficients (ICCs). Associations of hospital- and clinician-level practices with AKI were analyzed using multilevel mixed-effects models, adjusting for patient-level characteristics.</AbstractText><AbstractText Label="RESULTS">Among 23&#x202f;389 patients (mean [SD] age, 63 [13] years; 16&#x202f;122 males [68.9%]), 4779 (20.4%) developed AKI after cardiac surgery. AKI rates varied across hospitals (median [IQR], 21.7% [15.5%-27.2%]) and clinicians (18.1% [10.1%-23.7%]). Significant clinician- and hospital-level variation existed for inotrope infusion (ICC, 6.2% [95% CI, 4.2%-8.0%] vs 17.9% [95% CI, 3.3%-31.9%]), vasopressor infusion (ICC, 11.7% [95% CI, 8.3%-14.9%] vs 44.5% [95% CI, 11.7%-63.5%]), RBC transfusion (ICC, 1.7% [95% CI, 0.9%-2.6%] vs 4.5% [95% CI, 1.2%-9.4%]), and fluid volume administration (ICC, 2.1% [95% CI, 1.3%-2.7%] vs 23.8% [95% CI, 2.7%-39.9%]). In multilevel risk-adjusted models, the AKI rate was higher for patients at hospitals with higher inotrope infusion rates (adjusted odds ratio [AOR], 1.98; 95% CI, 1.18-3.33; P&#x2009;=&#x2009;.01) and lower among clinicians with higher RBC transfusion rates (AOR, 0.89; 95% CI, 0.79-0.99; P&#x2009;=&#x2009;.03). Other practice variations were not associated with AKI.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">This cohort study of adult patients found that hospital- and clinician-level variation in operating room practices was associated with AKI after cardiac surgery, suggesting possible targets for intervention.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mathis</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Michigan Medical School, Ann Arbor.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computational Bioinformatics, University of Michigan Medical School, Ann Arbor.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mentz</LastName><ForeName>Graciela B</ForeName><Initials>GB</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Michigan Medical School, Ann Arbor.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Joan and Irwin Jacobs Center for Health Innovation, University of California San Diego.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balczewski</LastName><ForeName>Emily A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Department of Computational Bioinformatics, University of Michigan Medical School, Ann Arbor.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Janda</LastName><ForeName>Allison M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Michigan Medical School, Ann Arbor.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Likosky</LastName><ForeName>Donald S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, University of Michigan Medical School, Ann Arbor.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schonberger</LastName><ForeName>Robert B</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Yale School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hawkins</LastName><ForeName>Robert B</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, University of Michigan Medical School, Ann Arbor.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heung</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Nephrology Division, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ailawadi</LastName><ForeName>Gorav</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, University of Michigan Medical School, Ann Arbor.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ladhania</LastName><ForeName>Rahul</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Health Management and Policy, University of Michigan, Ann Arbor.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of Michigan, Ann Arbor.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sjoding</LastName><ForeName>Michael W</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Pulmonary and Critical Care Medicine, University of Michigan Medical School, Ann Arbor.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kheterpal</LastName><ForeName>Sachin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Michigan Medical School, Ann Arbor.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Karandeep</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Joan and Irwin Jacobs Center for Health Innovation, University of California San Diego.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Biomedical Informatics, Department of Medicine, University of California, San Diego.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>MPOG Collaborators</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 HL166685</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK133226</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM007863</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL167790</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM086287</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM103730</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010818" MajorTopicYN="Y">Practice Patterns, Physicians'</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="Y">Hospitals</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Mathis reported receiving grants from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) during the conduct of the study and Chiesi industry-sponsored research funding outside the submitted work. Dr Janda reported receiving grants from the National Institute of General Medical Sciences (NIGMS) and the NHLBI during the conduct of the study and grants paid to the University of Michigan from Haisco-USA Pharmaceuticals Inc and Bio IntelliSense Inc outside the submitted work. Prof Likosky reported receiving grants from the NIH during the conduct of the study and grants from the NIH and the Agency for Healthcare Research and Quality, personal fees from AmSECT, and salary support paid to institution from Blue Cross Blue Shield of Michigan (BCBSM) outside the submitted work. Dr Schonberger reported receiving personal fees from Johnson &amp; Johnson and holding stock and grants from Merck Inc outside the submitted work. Dr Hawkins reported receiving personal fees from Medtronic outside the submitted work. Dr Ladhania reported receiving grants from the NIH during the conduct of the study. Dr Sjoding reported receiving grants from NIH outside the submitted work. Dr Kheterpal reported holding patent 11288445 (issued, The Regents of the University of Michigan, &#x201c;Automated system and method for assigning billing codes to medical procedures&#x201d;) outside the submitted work. Dr Singh reported receiving grants from the NIDDK during the conduct of the study. No other disclosures were reported.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Sundt</LastName><ForeName>Thoralf M</ForeName><Initials>TM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fitzsimons</LastName><ForeName>Michael G</ForeName><Initials>MG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shann</LastName><ForeName>Kenneth G</ForeName><Initials>KG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kumar</LastName><ForeName>Vikram</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yarboro</LastName><ForeName>Leora T</ForeName><Initials>LT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Naik</LastName><ForeName>Bhiken I</ForeName><Initials>BI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tibayan</LastName><ForeName>Frederick A</ForeName><Initials>FA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aziz</LastName><ForeName>Michael F</ForeName><Initials>MF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mulligan</LastName><ForeName>Michael S</ForeName><Initials>MS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jelacic</LastName><ForeName>Srdjan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kaneko</LastName><ForeName>Tsuyoshi</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Graetz</LastName><ForeName>Thomas J</ForeName><Initials>TJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Assi</LastName><ForeName>Roland</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mallidi</LastName><ForeName>Hari R</ForeName><Initials>HR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Querejeta-Roca</LastName><ForeName>Gabriela</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shook</LastName><ForeName>Douglas C</ForeName><Initials>DC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tsai</LastName><ForeName>Chu-An</ForeName><Initials>CA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jewell</LastName><ForeName>Elizabeth S</ForeName><Initials>ES</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wanderer</LastName><ForeName>Jonathan P</ForeName><Initials>JP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Freundlich</LastName><ForeName>Robert E</ForeName><Initials>RE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rock</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Douville</LastName><ForeName>Nicholas J</ForeName><Initials>NJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fisher</LastName><ForeName>Clark A</ForeName><Initials>CA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pace</LastName><ForeName>Nathan L</ForeName><Initials>NL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Domino</LastName><ForeName>Karen B</ForeName><Initials>KB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wagener</LastName><ForeName>Gebhard</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>King</LastName><ForeName>Christopher R</ForeName><Initials>CR</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Reilly-Shah</LastName><ForeName>Vikas</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bardia</LastName><ForeName>Amit</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clark</LastName><ForeName>David J</ForeName><Initials>DJ</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>2</Day><Hour>12</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>2</Day><Hour>12</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>2</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40314957</ArticleId><ArticleId IdType="pmc">PMC12048843</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2025.8342</ArticleId><ArticleId IdType="pii">2833439</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vives M, Hernandez A, Parramon F, et al. . Acute kidney injury after cardiac surgery: prevalence, impact and management challenges. Int J Nephrol Renovasc Dis. 2019;12:153-166. doi:10.2147/IJNRD.S167477</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJNRD.S167477</ArticleId><ArticleId IdType="pmc">PMC6612286</ArticleId><ArticleId IdType="pubmed">31303781</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Agostino RS, Jacobs JP, Badhwar V, et al. . The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2018 update on outcomes and quality. Ann Thorac Surg. 2018;105(1):15-23. doi:10.1016/j.athoracsur.2017.10.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2017.10.035</ArticleId><ArticleId IdType="pubmed">29233331</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT; The Multicenter Study of Perioperative Ischemia Research Group . Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. Ann Intern Med. 1998;128(3):194-203. doi:10.7326/0003-4819-128-3-199802010-00005</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-128-3-199802010-00005</ArticleId><ArticleId IdType="pubmed">9454527</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson C, Ozrazgat-Baslanti T, Kuxhausen A, et al. . Cost and mortality associated with postoperative acute kidney injury. Ann Surg. 2015;261(6):1207-1214. doi:10.1097/SLA.0000000000000732</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000000732</ArticleId><ArticleId IdType="pmc">PMC4247993</ArticleId><ArticleId IdType="pubmed">24887982</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998;104(4):343-348. doi:10.1016/S0002-9343(98)00058-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(98)00058-8</ArticleId><ArticleId IdType="pubmed">9576407</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasta JF, Kane-Gill SL, Durtschi AJ, Pathak DS, Kellum JA. Costs and outcomes of acute kidney injury (AKI) following cardiac surgery. Nephrol Dial Transplant. 2008;23(6):1970-1974. doi:10.1093/ndt/gfm908</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfm908</ArticleId><ArticleId IdType="pubmed">18178605</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado MN, Nakazone MA, Maia LN. Prognostic value of acute kidney injury after cardiac surgery according to kidney disease: improving global outcomes definition and staging (KDIGO) criteria. PLoS One. 2014;9(5):e98028. doi:10.1371/journal.pone.0098028</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0098028</ArticleId><ArticleId IdType="pmc">PMC4020924</ArticleId><ArticleId IdType="pubmed">24826910</ArticleId></ArticleIdList></Reference><Reference><Citation>Schurle A, Koyner JL. CSA-AKI: incidence, epidemiology, clinical outcomes, and economic impact. J Clin Med. 2021;10(24):5746. doi:10.3390/jcm10245746</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10245746</ArticleId><ArticleId IdType="pmc">PMC8706363</ArticleId><ArticleId IdType="pubmed">34945041</ArticleId></ArticleIdList></Reference><Reference><Citation>Chawla LS, Bellomo R, Bihorac A, et al. ; Acute Disease Quality Initiative Workgroup 16. . Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 workgroup. Nat Rev Nephrol. 2017;13(4):241-257. doi:10.1038/nrneph.2017.2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2017.2</ArticleId><ArticleId IdType="pubmed">28239173</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng K, McIlroy DR, Bollen BA, et al. . Society of Cardiovascular Anesthesiologists clinical practice update for management of acute kidney injury associated with cardiac surgery. Anesth Analg. 2022;135(4):744-756. doi:10.1213/ANE.0000000000006068</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000006068</ArticleId><ArticleId IdType="pubmed">35544772</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco RA, de Almeida JP, Landoni G, et al. . Dobutamine-sparing versus dobutamine-to-all strategy in cardiac surgery: a randomized noninferiority trial. Ann Intensive Care. 2021;11(1):15. doi:10.1186/s13613-021-00808-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-021-00808-6</ArticleId><ArticleId IdType="pmc">PMC7838231</ArticleId><ArticleId IdType="pubmed">33496877</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazer CD, Whitlock RP, Fergusson DA, et al. ; TRICS Investigators and Perioperative Anesthesia Clinical Trials Group . Restrictive or liberal red-cell transfusion for cardiac surgery. N Engl J Med. 2017;377(22):2133-2144. doi:10.1056/NEJMoa1711818</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1711818</ArticleId><ArticleId IdType="pubmed">29130845</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, K&#xfc;llmar M, Ostermann M, et al. . Prevention of cardiac surgery-associated acute kidney injury by implementing the KDIGO guidelines in high-risk patients identified by biomarkers: the PrevAKI-multicenter randomized controlled trial. Anesth Analg. 2021;133(2):292-302. doi:10.1213/ANE.0000000000005458</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005458</ArticleId><ArticleId IdType="pubmed">33684086</ArticleId></ArticleIdList></Reference><Reference><Citation>Magruder JT, Crawford TC, Harness HL, et al. . A pilot goal-directed perfusion initiative is associated with less acute kidney injury after cardiac surgery. J Thorac Cardiovasc Surg. 2017;153(1):118-125.e1. doi:10.1016/j.jtcvs.2016.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2016.09.016</ArticleId><ArticleId IdType="pmc">PMC5517016</ArticleId><ArticleId IdType="pubmed">27832832</ArticleId></ArticleIdList></Reference><Reference><Citation>Shander A, Kim TY, Goodnough LT. Thresholds, triggers or requirements: time to look beyond the transfusion trials. J Thorac Dis. 2018;10(3):1152-1157. doi:10.21037/jtd.2018.02.15</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2018.02.15</ArticleId><ArticleId IdType="pmc">PMC5906285</ArticleId><ArticleId IdType="pubmed">29708142</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen WC, Lin MH, Chen CL, et al. . Comprehensive comparisons among inotropic agents on mortality and risk of renal dysfunction in patients who underwent cardiac surgery: a network meta-analysis of randomized controlled trials. J Clin Med. 2021;10(5):1032. doi:10.3390/jcm10051032</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10051032</ArticleId><ArticleId IdType="pmc">PMC7959132</ArticleId><ArticleId IdType="pubmed">33802296</ArticleId></ArticleIdList></Reference><Reference><Citation>Huette P, Moussa MD, Beyls C, et al. . Association between acute kidney injury and norepinephrine use following cardiac surgery: a retrospective propensity score-weighted analysis. Ann Intensive Care. 2022;12(1):61. doi:10.1186/s13613-022-01037-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-022-01037-1</ArticleId><ArticleId IdType="pmc">PMC9250911</ArticleId><ArticleId IdType="pubmed">35781575</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett-Guerrero E, Zhao Y, O&#x2019;Brien SM, et al. . Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA. 2010;304(14):1568-1575. doi:10.1001/jama.2010.1406</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2010.1406</ArticleId><ArticleId IdType="pubmed">20940382</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Bellomo R. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol. 2017;13(11):697-711. doi:10.1038/nrneph.2017.119</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2017.119</ArticleId><ArticleId IdType="pubmed">28869251</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis MR. Multicenter variation in intraoperative anesthesia practices for cardiac surgery and associations with acute kidney injury. Open Science Framework. December 29, 2023. Accessed December 29, 2023. https://osf.io/cq2fj/</Citation></Reference><Reference><Citation>Benchimol EI, Smeeth L, Guttmann A, et al. ; RECORD Working Committee . The Reporting of Studies Conducted Using Observational Routinely-collected Health Data (RECORD) statement. PLoS Med. 2015;12(10):e1001885. doi:10.1371/journal.pmed.1001885</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001885</ArticleId><ArticleId IdType="pmc">PMC4595218</ArticleId><ArticleId IdType="pubmed">26440803</ArticleId></ArticleIdList></Reference><Reference><Citation>Colquhoun DA, Shanks AM, Kapeles SR, et al. . Considerations for integration of perioperative electronic health records across institutions for research and quality improvement: the approach taken by the Multicenter Perioperative Outcomes Group. Anesth Analg. 2020;130(5):1133-1146. doi:10.1213/ANE.0000000000004489</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000004489</ArticleId><ArticleId IdType="pmc">PMC7663856</ArticleId><ArticleId IdType="pubmed">32287121</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis MR, Dubovoy TZ, Caldwell MD, Engoren MC. Making sense of big data to improve perioperative care: learning health systems and the Multicenter Perioperative Outcomes Group. J Cardiothorac Vasc Anesth. 2020;34(3):582-585. doi:10.1053/j.jvca.2019.11.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2019.11.012</ArticleId><ArticleId IdType="pmc">PMC8640957</ArticleId><ArticleId IdType="pubmed">31813832</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkley Shroyer AL, Bakaeen F, Shahian DM, et al. . The Society of Thoracic Surgeons Adult Cardiac Surgery Database: the driving force for improvement in cardiac surgery. Semin Thorac Cardiovasc Surg. 2015;27(2):144-151. doi:10.1053/j.semtcvs.2015.07.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semtcvs.2015.07.007</ArticleId><ArticleId IdType="pubmed">26686440</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179-c184. doi:10.1159/000339789</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000339789</ArticleId><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Apostolidou E, Kolte D, Kennedy KF, et al. . Institutional red blood cell transfusion rates are correlated following endovascular and surgical cardiovascular procedures: evidence that local culture influences transfusion decisions. J Am Heart Assoc. 2020;9(22):e016232. doi:10.1161/JAHA.119.016232</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.119.016232</ArticleId><ArticleId IdType="pmc">PMC7763716</ArticleId><ArticleId IdType="pubmed">33140685</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis MR, Janda AM, Kheterpal S, et al. ; Multicenter Perioperative Outcomes Group . Patient-, clinician-, and institution-level variation in inotrope use for cardiac surgery: a multicenter observational analysis. Anesthesiology. 2023;139(2):122-141. doi:10.1097/ALN.0000000000004593</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000004593</ArticleId><ArticleId IdType="pmc">PMC10524016</ArticleId><ArticleId IdType="pubmed">37094103</ArticleId></ArticleIdList></Reference><Reference><Citation>Orbegozo Cort&#xe9;s D, Gamarano Barros T, Njimi H, Vincent JL. Crystalloids versus colloids: exploring differences in fluid requirements by systematic review and meta-regression. Anesth Analg. 2015;120(2):389-402. doi:10.1213/ANE.0000000000000564</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000000564</ArticleId><ArticleId IdType="pubmed">25565318</ArticleId></ArticleIdList></Reference><Reference><Citation>Multicenter Perioperative Outcomes Group. Phenotypes. Accessed April 21, 2020. https://phenotypes.mpog.org/</Citation></Reference><Reference><Citation>The Society of Thoracic Surgeons. Adult Cardiac Surgery Database. Data collection forms. December 19, 2023. Accessed December 30, 2023. https://www.sts.org/data-collection-forms</Citation></Reference><Reference><Citation>Merlo J, Chaix B, Ohlsson H, et al. . A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena. J Epidemiol Community Health. 2006;60(4):290-297. doi:10.1136/jech.2004.029454</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jech.2004.029454</ArticleId><ArticleId IdType="pmc">PMC2566165</ArticleId><ArticleId IdType="pubmed">16537344</ArticleId></ArticleIdList></Reference><Reference><Citation>Heung M, Dickinson T, Wu X, et al. ; PERForm Registry and the Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative . The role of race on acute kidney injury after cardiac surgery. Ann Thorac Surg. 2022;114(6):2188-2194. doi:10.1016/j.athoracsur.2021.10.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2021.10.031</ArticleId><ArticleId IdType="pubmed">34838514</ArticleId></ArticleIdList></Reference><Reference><Citation>Demirjian S, Bashour CA, Shaw A, et al. . Predictive accuracy of a perioperative laboratory test-based prediction model for moderate to severe acute kidney injury after cardiac surgery. JAMA. 2022;327(10):956-964. doi:10.1001/jama.2022.1751</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.1751</ArticleId><ArticleId IdType="pmc">PMC8905398</ArticleId><ArticleId IdType="pubmed">35258532</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy GJ, Pike K, Rogers CA, et al. ; TITRe2 Investigators . Liberal or restrictive transfusion after cardiac surgery. N Engl J Med. 2015;372(11):997-1008. doi:10.1056/NEJMoa1403612</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1403612</ArticleId><ArticleId IdType="pubmed">25760354</ArticleId></ArticleIdList></Reference><Reference><Citation>Oshita T, Hiraoka A, Nakajima K, et al. . A better predictor of acute kidney injury after cardiac surgery: the largest area under the curve below the oxygen delivery threshold during cardiopulmonary bypass. J Am Heart Assoc. 2020;9(15):e015566. doi:10.1161/JAHA.119.015566</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.119.015566</ArticleId><ArticleId IdType="pmc">PMC7792239</ArticleId><ArticleId IdType="pubmed">32720572</ArticleId></ArticleIdList></Reference><Reference><Citation>Carson JL, Brooks MM, H&#xe9;bert PC, et al. ; MINT Investigators . Restrictive or liberal transfusion strategy in myocardial infarction and anemia. N Engl J Med. 2023;389(26):2446-2456. doi:10.1056/NEJMoa2307983</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2307983</ArticleId><ArticleId IdType="pmc">PMC10837004</ArticleId><ArticleId IdType="pubmed">37952133</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayek SS, Leaf DE, Samman Tahhan A, et al. . Soluble urokinase receptor and acute kidney injury. N Engl J Med. 2020;382(5):416-426. doi:10.1056/NEJMoa1911481</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1911481</ArticleId><ArticleId IdType="pmc">PMC7065830</ArticleId><ArticleId IdType="pubmed">31995687</ArticleId></ArticleIdList></Reference><Reference><Citation>Likosky DS, Goldberg JB, DiScipio AW, et al. ; Northern New England Cardiovascular Disease Study Group . Variability in surgeons&#x2019; perioperative practices may influence the incidence of low-output failure after coronary artery bypass grafting surgery. Circ Cardiovasc Qual Outcomes. 2012;5(5):638-644. doi:10.1161/CIRCOUTCOMES.112.967091</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.112.967091</ArticleId><ArticleId IdType="pubmed">22828825</ArticleId></ArticleIdList></Reference><Reference><Citation>Perneger TV. What&#x2019;s wrong with Bonferroni adjustments. BMJ. 1998;316(7139):1236-1238. doi:10.1136/bmj.316.7139.1236</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.316.7139.1236</ArticleId><ArticleId IdType="pmc">PMC1112991</ArticleId><ArticleId IdType="pubmed">9553006</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34908546</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>134</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Postoperative Acute Kidney Injury Is Associated With Progression of Chronic Kidney Disease Independent of Severity.</ArticleTitle><Pagination><StartPage>49</StartPage><EndPage>58</EndPage><MedlinePgn>49-58</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000005702</ELocationID><Abstract><AbstractText Label="BACKGROUND">Both postoperative acute kidney injury (AKI) and preoperative chronic kidney disease (CKD) are associated with significantly worse outcomes following surgery. The relationship of both of these conditions with each other and with CKD progression after surgery remains poorly studied. Our objective was to assess if there was an interaction between preoperative kidney function estimated by preoperative estimated glomerular filtration rate (eGFR)/CKD stage, postoperative AKI, and eGFR/CKD progression within 1 year of surgery. Our hypothesis was that AKI severity would be associated with a faster time to eGFR/CKD stage progression within 1 year of surgery in a graded-fashion, which would be exacerbated by preoperative kidney dysfunction.</AbstractText><AbstractText Label="METHODS">This was a retrospective cohort study at Landspitali University Hospital in Iceland, which serves about 75% of the population. Participants included adults receiving their first major anesthetic between 2005 and 2018. Patients with CKD stage 5, undergoing major urologic procedures, or having missing creatinine values for follow-up of eGFR stage were excluded from analysis. The primary exposure was postoperative AKI stage within 7 days after surgery classified by the kidney disease improving global outcome (KDIGO) criteria. The primary outcome was time to progression of CKD by at least 1 eGFR/CKD stage within 1-year following surgery. Multivariable Cox proportional hazards models were used to estimate hazard of eGFR/CKD stage progression, including an interaction between AKI and preoperative CKD on eGFR/CKD stage progression.</AbstractText><AbstractText Label="RESULTS">A total of 5548 patients were studied. In the multivariable model adjusting for baseline eGFR/CKD stage, when compared to patients without AKI, postoperative AKI stage 1 (hazard ratio [HR], 5.91; 95% confidence interval [CI], 4.34-8.05), stage 2 (HR, 3.86; 95% CI, 1.82-8.16), and stage 3 (HR, 3.61; 95% CI, 1.49-8.74) were all independently associated with faster time to eGFR/CKD stage progression within 1 year following surgery, though increasing AKI severity did not confer additional risk. The only significant interaction between the degree of AKI and the preexisting renal function was for stage 1 AKI, where the odds of 1-year eGFR/CKD stage progression actually decreased in patients with preoperative CKD categories 3a, 3b, and 4.</AbstractText><AbstractText Label="CONCLUSIONS">KDIGO-AKI was independently associated with eGFR/CKD stage progression within the year following surgery after adjustment for baseline eGFR/CKD stage and without an interaction between worse preoperative kidney function and higher stage AKI. Our observations suggest that further studies are warranted to test whether CKD progression could be prevented by the adoption of perioperative kidney protective practices.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 International Anesthesia Research Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Privratsky</LastName><ForeName>Jamie R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>From the Critical Care and Perioperative Population Health Research (CAPER) Unit.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Perioperative Organ Protection (CPOP), Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krishnamoorthy</LastName><ForeName>Vijay</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>From the Critical Care and Perioperative Population Health Research (CAPER) Unit.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raghunathan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>From the Critical Care and Perioperative Population Health Research (CAPER) Unit.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology Service Division, Durham Veterans Affairs Medical Center, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohnuma</LastName><ForeName>Tetsu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>From the Critical Care and Perioperative Population Health Research (CAPER) Unit.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasouli</LastName><ForeName>Mohammad R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Stanford University, Palo Alto, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Thorir E</ForeName><Initials>TE</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sigurdsson</LastName><ForeName>Martin I</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Division of Anesthesia and Intensive Care Medicine, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="Y">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005919" MajorTopicYN="N">Glomerular Filtration Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007055" MajorTopicYN="N" Type="Geographic">Iceland</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="N">Renal Insufficiency, Chronic</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>12</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34908546</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000005702</ArticleId><ArticleId IdType="pii">00000539-202201000-00011</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kork F, Balzer F, Spies CD, et al. Minor postoperative increases of creatinine are associated with higher mortality and longer hospital length of stay in surgical patients. Anesthesiology. 2015;123:1301&#x2013;1311.</Citation></Reference><Reference><Citation>O&#x2019;Connor ME, Hewson RW, Kirwan CJ, Ackland GL, Pearse RM, Prowle JR. Acute kidney injury and mortality 1 year after major non-cardiac surgery. Br J Surg. 2017;104:868&#x2013;876.</Citation></Reference><Reference><Citation>Mathis MR, Naik BI, Freundlich RE, et al.; Multicenter Perioperative Outcomes Group Investigators. Preoperative risk and the association between hypotension and postoperative acute kidney injury. Anesthesiology. 2020;132:461&#x2013;475.</Citation></Reference><Reference><Citation>Hu J, Chen R, Liu S, Yu X, Zou J, Ding X. Global incidence and outcomes of adult patients with acute kidney injury after cardiac surgery: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth. 2016;30:82&#x2013;89.</Citation></Reference><Reference><Citation>Hoste EA, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41:1411&#x2013;1423.</Citation></Reference><Reference><Citation>Lassnigg A, Schmidlin D, Mouhieddine M, et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004;15:1597&#x2013;1605.</Citation></Reference><Reference><Citation>Hobson CE, Yavas S, Segal MS, et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation. 2009;119:2444&#x2013;2453.</Citation></Reference><Reference><Citation>Ishani A, Xue JL, Himmelfarb J, et al. Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol. 2009;20:223&#x2013;228.</Citation></Reference><Reference><Citation>Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296&#x2013;1305.</Citation></Reference><Reference><Citation>Turan A, Cohen B, Adegboye J, et al. Mild acute kidney injury after noncardiac surgery is associated with long-term renal dysfunction: a retrospective cohort study. Anesthesiology. 2020;132:1053&#x2013;1061.</Citation></Reference><Reference><Citation>Ackland GL, Moran N, Cone S, Grocott MP, Mythen MG. Chronic kidney disease and postoperative morbidity after elective orthopedic surgery. Anesth Analg. 2011;112:1375&#x2013;1381.</Citation></Reference><Reference><Citation>Bahrainwala JZ, Gelfand SL, Shah A, Abramovitz B, Hoffman B, Leonberg-Yoo AK. Preoperative risk assessment and management in adults receiving maintenance dialysis and those with earlier stages of CKD. Am J Kidney Dis. 2020;75:245&#x2013;255.</Citation></Reference><Reference><Citation>Gaber AO, Moore LW, Aloia TA, et al. Cross-sectional and case-control analyses of the association of kidney function staging with adverse postoperative outcomes in general and vascular surgery. Ann Surg. 2013;258:169&#x2013;177.</Citation></Reference><Reference><Citation>Mathew A, Devereaux PJ, O&#x2019;Hare A, et al. Chronic kidney disease and postoperative mortality: a systematic review and meta-analysis. Kidney Int. 2008;73:1069&#x2013;1081.</Citation></Reference><Reference><Citation>Gumbert SD, Kork F, Jackson ML, et al. Perioperative acute kidney injury. Anesthesiology. 2020;132:180&#x2013;204.</Citation></Reference><Reference><Citation>Sigurdsson MI, Helgadottir S, Long TE, et al. Association between preoperative opioid and benzodiazepine prescription patterns and mortality after noncardiac surgery. JAMA Surg. 2019;154:e191652.</Citation></Reference><Reference><Citation>Palevsky PM, Liu KD, Brophy PD, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis. 2013;61:649&#x2013;672.</Citation></Reference><Reference><Citation>Foundation NK. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 suppl 1):S1&#x2013;S266.</Citation></Reference><Reference><Citation>Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515&#x2013;526.</Citation></Reference><Reference><Citation>Ishani A, Nelson D, Clothier B, et al. The magnitude of acute serum creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease, and death. Arch Intern Med. 2011;171:226&#x2013;233.</Citation></Reference><Reference><Citation>Cho JS, Shim JK, Lee S, et al. Chronic progression of cardiac surgery associated acute kidney injury: intermediary role of acute kidney disease. J Thorac Cardiovasc Surg. 2021;161:681&#x2013;688.e3.</Citation></Reference><Reference><Citation>Sharma A, Mucino MJ, Ronco C. Renal functional reserve and renal recovery after acute kidney injury. Nephron Clin Pract. 2014;127:94&#x2013;100.</Citation></Reference><Reference><Citation>Long TE, Helgason D, Helgadottir S, et al. Acute kidney injury after abdominal surgery: incidence, risk factors, and outcome. Anesth Analg. 2016;122:1912&#x2013;1920.</Citation></Reference><Reference><Citation>Brown JR, Kramer RS, Coca SG, Parikh CR. Duration of acute kidney injury impacts long-term survival after cardiac surgery. Ann Thorac Surg. 2010;90:1142&#x2013;1148.</Citation></Reference><Reference><Citation>Coca SG, King JT Jr, Rosenthal RA, Perkal MF, Parikh CR. The duration of postoperative acute kidney injury is an additional parameter predicting long-term survival in diabetic veterans. Kidney Int. 2010;78:926&#x2013;933.</Citation></Reference><Reference><Citation>Nickolas TL, O&#x2019;Rourke MJ, Yang J, et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med. 2008;148:810&#x2013;819.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27706879</PMID><DateCompleted><Year>2018</Year><Month>08</Month><Day>27</Day></DateCompleted><DateRevised><Year>2018</Year><Month>08</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1440-1797</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Nephrology (Carlton, Vic.)</Title><ISOAbbreviation>Nephrology (Carlton)</ISOAbbreviation></Journal><ArticleTitle>Acute kidney injury post-major orthopaedic surgery: A single-Centre case-control study.</ArticleTitle><Pagination><StartPage>126</StartPage><EndPage>132</EndPage><MedlinePgn>126-132</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/nep.12942</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To identify risk factors for acute kidney injury following major orthopaedic surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We included all patients undergoing major orthopaedic surgery at University Hospital Geelong between 2008 and 2014 in the study. Out of 2188 surgeries audited, we identified cases of acute kidney injury using the RIFLE criteria and matched those to controls 2:1 for age, sex, procedure and chronic kidney disease stage. We reviewed their records for risk factors of postoperative acute kidney injury, including medications such as gentamicin, diuretics, non-steroidal anti-inflammatory drugs and angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use. We reviewed the patients' history of cardiovascular disease, chronic liver disease, hypertension and diabetes mellitus along with presence of sepsis and obesity. Associations of hypothetical risk factors were estimated using conditional logistic regression.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 164 cases of AKI in an elderly cohort (median age&#xa0;=&#xa0;73&#xa0;years). Controlling for baseline comorbidities, both diuretic and angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use were found to be associated with a twofold risk of acute kidney injury (diuretic - OR 2.06 95% CI:1.30-3.26, P&#xa0;&lt;&#xa0;0.005, angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use OR 2.09 95% CI:1.31-3.32, P&#xa0;&lt;&#xa0;0.005). A dose-effect model accounting for perioperative nonsteroidal anti-inflammatory drug administration demonstrated a linear relationship between the number of times these drugs were given and postoperative acute kidney injury risk (OR 1.35 95% CI:1.05-1.73, P&#xa0;=&#xa0;0.02).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We identified perioperative diuretics, non-steroidal anti-inflammatory drugs and angiotensin-converting enzyme inhibitor or angiotensin receptor blocker to be significantly associated with postoperative AKI. Further prospective studies are required to confirm this.</AbstractText><CopyrightInformation>&#xa9; 2016 Asian Pacific Society of Nephrology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ying</LastName><ForeName>Tracey</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Renal Medicine, University Hospital Geelong, Geelong, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Level 6 Renal Department, Royal Prince Alfred Hospital, Missenden Road, Camperdown 2050, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Samantha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Renal Medicine, University Hospital Geelong, Geelong, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lane</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Barwon Health Biostatistics Unit, University Hospital Geelong, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Somerville</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Renal Medicine, University Hospital Geelong, Geelong, Victoria, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Nephrology (Carlton)</MedlineTA><NlmUniqueID>9615568</NlmUniqueID><ISSNLinking>1320-5358</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057911">Angiotensin Receptor Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000806">Angiotensin-Converting Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000894">Anti-Inflammatory Agents, Non-Steroidal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004232">Diuretics</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057911" MajorTopicYN="N">Angiotensin Receptor Antagonists</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000806" MajorTopicYN="N">Angiotensin-Converting Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000894" MajorTopicYN="N">Anti-Inflammatory Agents, Non-Steroidal</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004232" MajorTopicYN="N">Diuretics</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016014" MajorTopicYN="N">Linear Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019637" MajorTopicYN="N">Orthopedic Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="N">Renal Insufficiency, Chronic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014739" MajorTopicYN="N">Victoria</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">case-control study</Keyword><Keyword MajorTopicYN="N">chronic kidney disease (CKD)</Keyword><Keyword MajorTopicYN="N">elderly</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27706879</ArticleId><ArticleId IdType="doi">10.1111/nep.12942</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29094339</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>20</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-6576</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Acta anaesthesiologica Scandinavica</Title><ISOAbbreviation>Acta Anaesthesiol Scand</ISOAbbreviation></Journal><ArticleTitle>Prospective study on long-term outcome after abdominal surgery.</ArticleTitle><Pagination><StartPage>147</StartPage><EndPage>158</EndPage><MedlinePgn>147-158</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/aas.13025</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Complications following major abdominal surgery are common and an important cause of morbidity and mortality. The aim of this study was to describe 1-year mortality and identify factors that influence adverse outcomes after abdominal surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This prospective observational cohort study was performed in Landspitali University Hospital and included all adult patients undergoing abdominal surgery requiring &gt;&#xa0;24-h hospital admission over 13&#xa0;months. The follow-up period was 60&#xa0;days for complications and 24&#xa0;months for mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Data were available for 1113 (99.5%) of the 1119 patients who fulfilled inclusion criteria. A total of 23% of patients had at least one underlying co-morbidity. Non-elective surgeries were 48% and 13% of the patients were admitted to ICU post-operatively. A total of 20% of patients developed complications. Mortality at 30&#xa0;days, 1 and 2&#xa0;years was 1.8%, 5.6%, and 8.3% respectively. One-year mortality for those admitted to ICU was 18%. The long-term survival of the individuals surviving 30&#xa0;days was significantly worse than for an age- and gender-matched population control group. Independent predictors for 1-year mortality were age, pre-operative acute kidney injury and intermediate- or major surgery.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Post-operative complication rates and mortality following abdominal surgery in Iceland were comparable or in the lower range of previously published outcomes, validating the utility of offering a full host of abdominal surgical services in geographically isolated region with a relatively small referral base.</AbstractText><CopyrightInformation>&#xa9; 2017 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brynjarsdottir</LastName><ForeName>E D</ForeName><Initials>ED</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sigurdsson</LastName><ForeName>M I</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Duke University School of Medicine, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sigmundsdottir</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care Medicine, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xf6;ller</LastName><ForeName>P H</ForeName><Initials>PH</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sigurdsson</LastName><ForeName>G H</ForeName><Initials>GH</Initials><Identifier Source="ORCID">0000-0003-4171-9153</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care Medicine, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>11</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Anaesthesiol Scand</MedlineTA><NlmUniqueID>0370270</NlmUniqueID><ISSNLinking>0001-5172</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="N">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007055" MajorTopicYN="N" Type="Geographic">Iceland</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29094339</ArticleId><ArticleId IdType="doi">10.1111/aas.13025</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39048691</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>24</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Biomarker-guided acute kidney injury risk assessment under liberal versus restrictive fluid therapy - the prospective-randomized MAYDAY-trial.</ArticleTitle><Pagination><StartPage>17094</StartPage><MedlinePgn>17094</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">17094</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-68079-2</ELocationID><Abstract><AbstractText>Acute kidney injury (AKI) prevalence in surgical patients is high, emphasizing the need for preventative measures. This study addresses the insufficient evidence on nephroprotective intraoperative fluid resuscitation and highlights the drawbacks of relying solely on serum creatinine/urine output to monitor kidney function. This study assessed the impact of intraoperative fluid management on AKI in female breast cancer patients undergoing autologous breast reconstruction, utilizing novel urinary biomarkers (TIMP-2 and IGFBP-7). In a monocentric prospective randomized controlled trial involving 40 patients, liberal (LFA) and restrictive (FRV) fluid management strategies were compared. TIMP-2 and IGFBP-7 biomarker levels were assessed using the NephroCheck (bioMerieux, France) test kit at preoperative, immediate postoperative, and 24-h postoperative stages. FRV showed significantly higher immediate postoperative biomarker levels, indicating renal tubular stress. FRV patients had 21% (4/19) experiencing AKI compared to 13% (2/15) in the LFA group according to KDIGO criteria (p&#x2009;=&#x2009;0.385). Restrictive fluid resuscitation increases the risk of AKI in surgical patients significantly, emphasizing the necessity for individualized hemodynamic management. The findings underscore the importance of urinary biomarkers in early AKI detection.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Anker</LastName><ForeName>Alexandra M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Plastic, Reconstructive, Aesthetic, and Hand Surgery, University Hospital Regensburg, University of Regensburg, Franz-Josef-Strau&#xdf;-Allee 11, 93053, Regensburg, Germany. alexandra.anker@ukr.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruewe</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Plastic, Reconstructive, Aesthetic, and Hand Surgery, University Hospital Regensburg, University of Regensburg, Franz-Josef-Strau&#xdf;-Allee 11, 93053, Regensburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prantl</LastName><ForeName>Lukas</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Plastic, Reconstructive, Aesthetic, and Hand Surgery, University Hospital Regensburg, University of Regensburg, Franz-Josef-Strau&#xdf;-Allee 11, 93053, Regensburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baringer</LastName><ForeName>Magnus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Plastic, Reconstructive, Aesthetic, and Hand Surgery, University Hospital Regensburg, University of Regensburg, Franz-Josef-Strau&#xdf;-Allee 11, 93053, Regensburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pawlik</LastName><ForeName>Michael T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Caritas Hospital St. Josef, Landshuter Str. 65, 93053, Regensburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeman</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Center for Clinical Studies, University Hospital Regensburg, University of Regensburg, Franz-Josef-Strau&#xdf;-Allee 11, 93053, Regensburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goecze</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Surgery and Operative Intensive Care, University Hospital Regensburg, University of Regensburg, Franz-Josef-Strau&#xdf;-Allee 11, 93053, Regensburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klein</LastName><ForeName>Silvan M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Plastic, Reconstructive, Aesthetic, and Hand Surgery, University Hospital Regensburg, University of Regensburg, Franz-Josef-Strau&#xdf;-Allee 11, 93053, Regensburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C102529">insulin-like growth factor binding protein-related protein 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018969">Insulin-Like Growth Factor Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>127497-59-0</RegistryNumber><NameOfSubstance UI="D019716">Tissue Inhibitor of Metalloproteinase-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C560823">TIMP2 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="Y">Biomarkers</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="Y">Fluid Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018969" MajorTopicYN="Y">Insulin-Like Growth Factor Binding Proteins</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019716" MajorTopicYN="Y">Tissue Inhibitor of Metalloproteinase-2</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Breast neoplasms/surgery</Keyword><Keyword MajorTopicYN="N">Breast reconstruction</Keyword><Keyword MajorTopicYN="N">Fluid therapy</Keyword><Keyword MajorTopicYN="N">Intraoperative fluid management</Keyword><Keyword MajorTopicYN="N">Urinary biomarkers</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>26</Day><Hour>12</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>26</Day><Hour>12</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>24</Day><Hour>23</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39048691</ArticleId><ArticleId IdType="pmc">PMC11269689</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-68079-2</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-68079-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lewington, A. J., Cerda, J. &amp; Mehta, R. L. Raising awareness of acute kidney injury: A global perspective of a silent killer. Kidney Int.84, 457&#x2013;467 (2013). 10.1038/ki.2013.153</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2013.153</ArticleId><ArticleId IdType="pmc">PMC3758780</ArticleId><ArticleId IdType="pubmed">23636171</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo, R., Kellum, J. A. &amp; Ronco, C. Acute kidney injury. Lancet380, 756&#x2013;766 (2012). 10.1016/S0140-6736(11)61454-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)61454-2</ArticleId><ArticleId IdType="pubmed">22617274</ArticleId></ArticleIdList></Reference><Reference><Citation>Raphael Weiss, M. M., Pavenst&#xe4;dt, H.-J. &amp; Zarbock, A. Acute kidney injury&#x2014;A frequently underestimated problem in perioperative medicine. Dtsch. Arztebl. Int.1, 833&#x2013;842 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6962766</ArticleId><ArticleId IdType="pubmed">31888797</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor, M. E., Kirwan, C. J., Pearse, R. M. &amp; Prowle, J. R. Incidence and associations of acute kidney injury after major abdominal surgery. Intens. Care Med.42, 521&#x2013;530 (2016).10.1007/s00134-015-4157-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-4157-7</ArticleId><ArticleId IdType="pubmed">26602784</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock, A. et al. Epidemiology of surgery associated acute kidney injury (EPIS-AKI): A prospective international observational multi-center clinical study. Intens. Care Med.10.1007/s00134-023-07169-7 (2023).10.1007/s00134-023-07169-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-023-07169-7</ArticleId><ArticleId IdType="pmc">PMC10709241</ArticleId><ArticleId IdType="pubmed">37505258</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung, H. M. et al. Association between postoperative acute kidney injury and mortality after plastic and reconstructive surgery. Sci. Rep.12, 20050 (2022). 10.1038/s41598-022-24564-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-24564-0</ArticleId><ArticleId IdType="pmc">PMC9681753</ArticleId><ArticleId IdType="pubmed">36414767</ArticleId></ArticleIdList></Reference><Reference><Citation>Myles, P. S. et al. Restrictive versus liberal fluid therapy for major abdominal surgery. N. Engl. J. Med.378, 2263&#x2013;2274 (2018). 10.1056/NEJMoa1801601</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1801601</ArticleId><ArticleId IdType="pubmed">29742967</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmid, S. et al. Algorithm-guided goal-directed haemodynamic therapy does not improve renal function after major abdominal surgery compared to good standard clinical care: A prospective randomised trial. Crit Care20, 50 (2016). 10.1186/s13054-016-1237-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1237-1</ArticleId><ArticleId IdType="pmc">PMC4782303</ArticleId><ArticleId IdType="pubmed">26951105</ArticleId></ArticleIdList></Reference><Reference><Citation>Gocze, I. et al. Biomarker-guided intervention to prevent acute kidney injury after major surgery: The prospective randomized BigpAK study. Ann. Surg.267, 1013&#x2013;1020 (2018). 10.1097/SLA.0000000000002485</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000002485</ArticleId><ArticleId IdType="pubmed">28857811</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, L. Y., Wijeysundera, D. N., Tait, G. A. &amp; Beattie, W. S. Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery. Anesthesiology123, 515&#x2013;523 (2015). 10.1097/ALN.0000000000000765</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000765</ArticleId><ArticleId IdType="pubmed">26181335</ArticleId></ArticleIdList></Reference><Reference><Citation>Karamanos, E., Walker, R., Wang, H. T. &amp; Shah, A. R. Perioperative fluid resuscitation in free flap breast reconstruction: When is enough enough? Plast. Reconstr. Surg. Glob. Open8, e2662 (2020). 10.1097/GOX.0000000000002662</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/GOX.0000000000002662</ArticleId><ArticleId IdType="pmc">PMC7253255</ArticleId><ArticleId IdType="pubmed">32537330</ArticleId></ArticleIdList></Reference><Reference><Citation>Motakef, S., Mountziaris, P. M., Ismail, I. K., Agag, R. L. &amp; Patel, A. Emerging paradigms in perioperative management for microsurgical free tissue transfer: Review of the literature and evidence-based guidelines. Plast. Reconstr. Surg.135, 290&#x2013;299 (2015). 10.1097/PRS.0000000000000839</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PRS.0000000000000839</ArticleId><ArticleId IdType="pubmed">25539313</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrone, R. D., Madias, N. E. &amp; Levey, A. S. Serum creatinine as an index of renal function: New insights into old concepts. Clin. Chem.38, 1933&#x2013;1953 (1992). 10.1093/clinchem/38.10.1933</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinchem/38.10.1933</ArticleId><ArticleId IdType="pubmed">1394976</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe5;rtensson, J., Martling, C.-R. &amp; Bell, M. Novel biomarkers of acute kidney injury and failure: Clinical applicability. Br. J. Anaesth.109, 843&#x2013;850 (2012). 10.1093/bja/aes357</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aes357</ArticleId><ArticleId IdType="pubmed">23048068</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostermann, M. et al. Recommendations on acute kidney injury biomarkers from the acute disease quality initiative consensus conference: A consensus statement. JAMA Netw. Open3, e2019209 (2020). 10.1001/jamanetworkopen.2020.19209</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.19209</ArticleId><ArticleId IdType="pubmed">33021646</ArticleId></ArticleIdList></Reference><Reference><Citation>Joannidis, M. et al. Use of cell cycle arrest biomarkers in conjunction with classical markers of acute kidney injury. Crit. Care Med.47, e820&#x2013;e826 (2019). 10.1097/CCM.0000000000003907</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000003907</ArticleId><ArticleId IdType="pmc">PMC6750148</ArticleId><ArticleId IdType="pubmed">31343478</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostermann, M. et al. Kinetics of urinary cell cycle arrest markers for acute kidney injury following exposure to potential renal insults. Crit. Care Med.46, 375&#x2013;383 (2018). 10.1097/CCM.0000000000002847</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000002847</ArticleId><ArticleId IdType="pmc">PMC5821475</ArticleId><ArticleId IdType="pubmed">29189343</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Z., Tie, H., Shi, R., Rossaint, J. &amp; Zarbock, A. Urinary [TIMP-2]&#xb7;[IGFBP7]-guided implementation of the KDIGO bundle to prevent acute kidney injury: A meta-analysis. Br. J. Anaesth.128, e24&#x2013;e26 (2022). 10.1016/j.bja.2021.10.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2021.10.015</ArticleId><ArticleId IdType="pubmed">34794767</ArticleId></ArticleIdList></Reference><Reference><Citation>Obata, Y., Kamijo-Ikemori, A., Shimmi, S. &amp; Inoue, S. Clinical usefulness of urinary biomarkers for early prediction of acute kidney injury in patients undergoing transaortic valve implantation. Sci. Rep.13, 18569 (2023). 10.1038/s41598-023-46015-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-46015-0</ArticleId><ArticleId IdType="pmc">PMC10616062</ArticleId><ArticleId IdType="pubmed">37903844</ArticleId></ArticleIdList></Reference><Reference><Citation>Anker, A. M. et al. Assessment of DIEP flap perfusion with intraoperative indocyanine green fluorescence imaging in vasopressor-dominated hemodynamic support versus liberal fluid administration: A randomized controlled trial with breast cancer patients. Ann. Surg. Oncol.27, 399&#x2013;406 (2020). 10.1245/s10434-019-07758-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-019-07758-1</ArticleId><ArticleId IdType="pubmed">31468214</ArticleId></ArticleIdList></Reference><Reference><Citation>Anker, A. M. et al. Clinical impact of DIEP flap perforator characteristics&#x2014;A prospective indocyanine green fluorescence imaging study. J. Plast. Reconstr. Aesthetic Surg.73, 1526&#x2013;1533 (2020).10.1016/j.bjps.2020.01.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjps.2020.01.019</ArticleId><ArticleId IdType="pubmed">32507580</ArticleId></ArticleIdList></Reference><Reference><Citation>Anker, A. M. et al. Vasopressor support vs liberal fluid administration in deep inferior epigastric perforator (DIEP) free flap breast reconstruction&#x2014;A randomized controlled trial. Clin. Hemorheol. Microcirc.69, 37&#x2013;44 (2018). 10.3233/CH-189129</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CH-189129</ArticleId><ArticleId IdType="pubmed">29660924</ArticleId></ArticleIdList></Reference><Reference><Citation>Pajenda, S. et al. NephroCheck data compared to serum creatinine in various clinical settings. BMC Nephrol.16, 206 (2015). 10.1186/s12882-015-0203-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12882-015-0203-5</ArticleId><ArticleId IdType="pmc">PMC4674950</ArticleId><ArticleId IdType="pubmed">26651477</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja, A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin. Pract.120, c179&#x2013;c184 (2012). 10.1159/000339789</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000339789</ArticleId><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciolino, J. D., Kaizer, A. M. &amp; Bonner, L. B. Guidance on interim analysis methods in clinical trials. J. Clin. Transl. Sci.7, e124 (2023). 10.1017/cts.2023.552</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cts.2023.552</ArticleId><ArticleId IdType="pmc">PMC10260346</ArticleId><ArticleId IdType="pubmed">37313374</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu, F. et al. Efficacy and safety of platinum-based chemotherapy as first-line therapy for metastatic triple-negative breast cancer: A meta-analysis of randomized controlled trials. Technol. Cancer Res. Treat.20, 15330338211016368 (2021). 10.1177/15330338211016369</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/15330338211016369</ArticleId><ArticleId IdType="pmc">PMC8120541</ArticleId><ArticleId IdType="pubmed">33977814</ArticleId></ArticleIdList></Reference><Reference><Citation>McSweeney, K. R. et al. Mechanisms of cisplatin-induced acute kidney injury: Pathological mechanisms, pharmacological interventions, and genetic mitigations. Cancers13, 1572 (2021). 10.3390/cancers13071572</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13071572</ArticleId><ArticleId IdType="pmc">PMC8036620</ArticleId><ArticleId IdType="pubmed">33805488</ArticleId></ArticleIdList></Reference><Reference><Citation>Anker, A. M., Prantl, L. &amp; Klein, S. M. ASO author reflections: The silent force behind microsurgery. Ann. Surg. Oncol.27, 407&#x2013;408 (2020). 10.1245/s10434-019-08001-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-019-08001-7</ArticleId><ArticleId IdType="pubmed">31667724</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashani, K. et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit. Care Lond. Engl.17, R25 (2013).10.1186/cc12503</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc12503</ArticleId><ArticleId IdType="pmc">PMC4057242</ArticleId><ArticleId IdType="pubmed">23388612</ArticleId></ArticleIdList></Reference><Reference><Citation>Husain-Syed, F. et al. Persistent decrease of renal functional reserve in patients after cardiac surgery-associated acute kidney injury despite clinical recovery. Nephrol. Dial. Transplant.34, 308&#x2013;317 (2019). 10.1093/ndt/gfy227</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfy227</ArticleId><ArticleId IdType="pubmed">30053231</ArticleId></ArticleIdList></Reference><Reference><Citation>Siew, E. D., Ware, L. B. &amp; Ikizler, T. A. Biological markers of acute kidney injury. J. Am. Soc. Nephrol.22, 810&#x2013;820 (2011). 10.1681/ASN.2010080796</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2010080796</ArticleId><ArticleId IdType="pubmed">21493774</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco, C., Bellomo, R. &amp; Kellum, J. A. Acute kidney injury. The Lancet394, 1949&#x2013;1964 (2019).10.1016/S0140-6736(19)32563-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)32563-2</ArticleId><ArticleId IdType="pubmed">31777389</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco, C., Kellum, J. A. &amp; Haase, M. Subclinical AKI is still AKI. Crit. Care Lond. Engl.16, 313 (2012).10.1186/cc11240</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11240</ArticleId><ArticleId IdType="pmc">PMC3580601</ArticleId><ArticleId IdType="pubmed">22721504</ArticleId></ArticleIdList></Reference><Reference><Citation>Gocze, I. et al. Urinary biomarkers TIMP-2 and IGFBP7 early predict acute kidney injury after major surgery. PLoS ONE10, e0120863 (2015). 10.1371/journal.pone.0120863</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0120863</ArticleId><ArticleId IdType="pmc">PMC4370650</ArticleId><ArticleId IdType="pubmed">25798585</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersch, M. et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: The PrevAKI randomized controlled trial. Intens. Care Med43, 1551&#x2013;1561 (2017).10.1007/s00134-016-4670-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4670-3</ArticleId><ArticleId IdType="pmc">PMC5633630</ArticleId><ArticleId IdType="pubmed">28110412</ArticleId></ArticleIdList></Reference><Reference><Citation>Jufar, A. H. et al. Renal functional reserve: From physiological phenomenon to clinical biomarker and beyond. Am. J. Physiol. Regul. Integr. Comp. Physiol.319, R690&#x2013;R702 (2020). 10.1152/ajpregu.00237.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpregu.00237.2020</ArticleId><ArticleId IdType="pubmed">33074016</ArticleId></ArticleIdList></Reference><Reference><Citation>Fawcett, W. J. &amp; Thomas, M. Pre-operative fasting in adults and children: Clinical practice and guidelines. Anaesthesia74, 83&#x2013;88 (2019). 10.1111/anae.14500</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.14500</ArticleId><ArticleId IdType="pubmed">30500064</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36052899</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1522-6662</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>12</Day></PubDate></JournalIssue><Title>The heart surgery forum</Title><ISOAbbreviation>Heart Surg Forum</ISOAbbreviation></Journal><ArticleTitle>Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI) in Adults and Pediatrics; Prevention is the Optimal Management.</ArticleTitle><Pagination><StartPage>E504</StartPage><EndPage>E509</EndPage><MedlinePgn>E504-E509</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1532/hsf.4881</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cardiac surgery-associated acute kidney injury (CSA-AKI) is a significant and severe complication that affects morbidity and mortality. We studied both pediatric and adult patients using the Acute Kidney Injury Network (AKIN) definition.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was an observational retrospective cohort study done at King Abdulaziz University Hospital in Jeddah, Saudi Arabia, and approved by the ethical committee. The exclusion criteria were baseline serum creatinine (SCr) &#x2265; 4 mg/dL or preexisting renal failure requiring dialysis, reoperation, death within 24 hours postoperatively, and operative mortality or missing data. We included 941 patients in the analysis using statistical software SPSS, version 15.0.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the total number of patients, 28.68% in the adult group and 20.07% in the pediatric group developed CSA-AKI. Adult risk factors included the age group 60-69 years, cardiopulmonary bypass (CPB), number of grafts, and hypertension. In the pediatric group, CPB, aortic cross-clamping (ACX), and the lower preoperative SCr were the main risk factors Conclusion: Conventional conservative management and preoperative identification of predictor risk factors are essential for preventing CSA-AKI, constituting the primary strategy for optimal management.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alghamdi</LastName><ForeName>Abdulaziz A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Surgery, King Abdulaziz University, Jeddah, Saudi Arabia. aqeeli@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aqeeli</LastName><ForeName>Mohammed Omar</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>Department of Surgery, King Abdulaziz University, Jeddah, Saudi Arabia. moa.aqeeli@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshammari</LastName><ForeName>Fahad K</ForeName><Initials>FK</Initials><AffiliationInfo><Affiliation>Department of Surgery, King Abdulaziz University, Jeddah, Saudi Arabia. aqeeli@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altalhi</LastName><ForeName>Saud M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Surgery, King Abdulaziz University, Jeddah, Saudi Arabia. aqeeli@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bajebair</LastName><ForeName>Abdullah M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Surgery, King Abdulaziz University, Jeddah, Saudi Arabia. aqeeli@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Ebrahim Frcsc</LastName><ForeName>Khalid E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Department of Surgery, King Abdulaziz University, Jeddah, Saudi Arabia. aqeeli@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Heart Surg Forum</MedlineTA><NlmUniqueID>100891112</NlmUniqueID><ISSNLinking>1098-3511</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="N">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010372" MajorTopicYN="Y">Pediatrics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36052899</ArticleId><ArticleId IdType="doi">10.1532/hsf.4881</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25952257</PMID><DateCompleted><Year>2016</Year><Month>03</Month><Day>28</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1533-3450</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>12</Issue><PubDate><Year>2015</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of the American Society of Nephrology : JASN</Title><ISOAbbreviation>J Am Soc Nephrol</ISOAbbreviation></Journal><ArticleTitle>Intraoperative High-Dose Dexamethasone and Severe AKI after Cardiac Surgery.</ArticleTitle><Pagination><StartPage>2947</StartPage><EndPage>2951</EndPage><MedlinePgn>2947-51</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1681/ASN.2014080840</ELocationID><Abstract><AbstractText>Administration of prophylactic glucocorticoids has been suggested as a strategy to reduce postoperative AKI and other adverse events after cardiac surgery requiring cardiopulmonary bypass. In this post hoc analysis of a large placebo-controlled randomized trial of dexamethasone in 4465 adult patients undergoing cardiac surgery, we examined severe AKI, defined as use of RRT, as a primary outcome. Secondary outcomes were doubling of serum creatinine level or AKI-RRT, as well as AKI-RRT or in-hospital mortality (RRT/death). The primary outcome occurred in ten patients (0.4%) in the dexamethasone group and in 23 patients (1.0%) in the placebo group (relative risk, 0.44; 95% confidence interval, 0.19 to 0.96). In stratified analyses, the strongest signal for potential benefit of dexamethasone was in patients with an eGFR&lt;15 ml/min per 1.73 m(2). In conclusion, compared with placebo, intraoperative dexamethasone appeared to reduce the incidence of severe AKI after cardiac surgery in those with advanced CKD.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015 by the American Society of Nephrology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jacob</LastName><ForeName>Kirolos A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Departments of Anesthesiology and Intensive Care Medicine and Cardiothoracic Surgery, University Medical Center Utrecht, Utrecht, The Netherlands; k.a.jacob@umcutrecht.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leaf</LastName><ForeName>David E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Division of Renal Medicine, the Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dieleman</LastName><ForeName>Jan M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Departments of Anesthesiology and Intensive Care Medicine and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Dijk</LastName><ForeName>Diederik</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Departments of Anesthesiology and Intensive Care Medicine and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nierich</LastName><ForeName>Arno P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Isala Klinieken, Zwolle, The Netherlands;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosseel</LastName><ForeName>Peter M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology Amphia Ziekenhuis, Breda, The Netherlands;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Maaten</LastName><ForeName>Joost M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology University Medical Center, Groningen, The Netherlands;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hofland</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology Erasmus Medical Center, Rotterdam, The Netherlands;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diephuis</LastName><ForeName>Jan C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology Medisch Spectrum Twente, Enschede, The Netherlands;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Lange</LastName><ForeName>Fellery</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiac Anesthesiology Medical Center Leeuwarden, Leeuwarden, The Netherlands; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boer</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology Vrije Universiteit University Medical Center, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kluin</LastName><ForeName>Jolanda</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery, University Medical Center Utrecht, Utrecht, The Netherlands;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waikar</LastName><ForeName>Sushrut S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Division of Renal Medicine, the Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Dexamethasone for Cardiac Surgery (DECS) Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00293592</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>R01 DK093574</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>05</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Soc Nephrol</MedlineTA><NlmUniqueID>9013836</NlmUniqueID><ISSNLinking>1046-6673</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>7S5I7G3JQL</RegistryNumber><NameOfSubstance UI="D003907">Dexamethasone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Nephrol. 2015 Sep;11(9):509-10. doi: 10.1038/nrneph.2015.106.</RefSource><PMID Version="1">26122731</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="N">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003907" MajorTopicYN="N">Dexamethasone</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005919" MajorTopicYN="N">Glomerular Filtration Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007430" MajorTopicYN="N">Intraoperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="N">Renal Replacement Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute renal failure</Keyword><Keyword MajorTopicYN="N">cardiovascular</Keyword><Keyword MajorTopicYN="N">clinical trial</Keyword><Keyword MajorTopicYN="N">creatinine</Keyword><Keyword MajorTopicYN="N">dialysis</Keyword><Keyword MajorTopicYN="N">ischemia&#x2013;reperfusion</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25952257</ArticleId><ArticleId IdType="pmc">PMC4657835</ArticleId><ArticleId IdType="doi">10.1681/ASN.2014080840</ArticleId><ArticleId IdType="pii">ASN.2014080840</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mariscalco G, Lorusso R, Dominici C, Renzulli A, Sala A: Acute kidney injury: a relevant complication after cardiac surgery. Ann Thorac Surg 92: 1539&#x2013;1547, 2011</Citation><ArticleIdList><ArticleId IdType="pubmed">21872837</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh CR, Devarajan P, Zappitelli M, Sint K, Thiessen-Philbrook H, Li S, Kim RW, Koyner JL, Coca SG, Edelstein CL, Shlipak MG, Garg AX, Krawczeski CD, TRIBE-AKI Consortium : Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery. J Am Soc Nephrol 22: 1737&#x2013;1747, 2011</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3171944</ArticleId><ArticleId IdType="pubmed">21836147</ArticleId></ArticleIdList></Reference><Reference><Citation>Scrascia G, Guida P, Rotunno C, de Luca Tupputi Schinosa L, Paparella D: Anti-inflammatory strategies to reduce acute kidney injury in cardiac surgery patients: a meta-analysis of randomized controlled trials. Artif Organs 38: 101&#x2013;112, 2014</Citation><ArticleIdList><ArticleId IdType="pubmed">23876045</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW: Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16: 3365&#x2013;3370, 2005</Citation><ArticleIdList><ArticleId IdType="pubmed">16177006</ArticleId></ArticleIdList></Reference><Reference><Citation>Waikar SS, Bonventre JV: Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol 20: 672&#x2013;679, 2009</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2653692</ArticleId><ArticleId IdType="pubmed">19244578</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosner MH, Okusa MD: Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol 1: 19&#x2013;32, 2006</Citation><ArticleIdList><ArticleId IdType="pubmed">17699187</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakar CV, Arrigain S, Worley S, Yared JP, Paganini EP: A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol 16: 162&#x2013;168, 2005</Citation><ArticleIdList><ArticleId IdType="pubmed">15563569</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeysundera DN, Karkouti K, Dupuis JY, Rao V, Chan CT, Granton JT, Beattie WS: Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. JAMA 297: 1801&#x2013;1809, 2007</Citation><ArticleIdList><ArticleId IdType="pubmed">17456822</ArticleId></ArticleIdList></Reference><Reference><Citation>Boodhwani M, Rubens FD, Wozny D, Nathan HJ: Effects of mild hypothermia and rewarming on renal function after coronary artery bypass grafting. Ann Thorac Surg 87: 489&#x2013;495, 2009</Citation><ArticleIdList><ArticleId IdType="pubmed">19161766</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranucci M, Pavesi M, Mazza E, Bertucci C, Frigiola A, Menicanti L, Ditta A, Boncilli A, Conti D: Risk factors for renal dysfunction after coronary surgery: the role of cardiopulmonary bypass technique. Perfusion 9: 319&#x2013;326, 1994</Citation><ArticleIdList><ArticleId IdType="pubmed">7833539</ArticleId></ArticleIdList></Reference><Reference><Citation>Valeri CR, MacGregor H, Ragno G, Healey N, Fonger J, Khuri SF: Effects of centrifugal and roller pumps on survival of autologous red cells in cardiopulmonary bypass surgery. Perfusion 21: 291&#x2013;296, 2006</Citation><ArticleIdList><ArticleId IdType="pubmed">17201084</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeulen Windsant IC, Snoeijs MG, Hanssen SJ, Altintas S, Heijmans JH, Koeppel TA, Schurink GW, Buurman WA, Jacobs MJ: Hemolysis is associated with acute kidney injury during major aortic surgery. Kidney Int 77: 913&#x2013;920, 2010</Citation><ArticleIdList><ArticleId IdType="pubmed">20182411</ArticleId></ArticleIdList></Reference><Reference><Citation>Dieleman JM, Nierich AP, Rosseel PM, van der Maaten JM, Hofland J, Diephuis JC, Schepp RM, Boer C, Moons KG, van Herwerden LA, Tijssen JG, Numan SC, Kalkman CJ, van Dijk D, Dexamethasone for Cardiac Surgery (DECS) Study Group : Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial. JAMA 308: 1761&#x2013;1767, 2012</Citation><ArticleIdList><ArticleId IdType="pubmed">23117776</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative workgroup : Acute renal failure&#x2014;definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8: R204&#x2013;R212, 2004</Citation><ArticleIdList><ArticleId IdType="pmc">PMC522841</ArticleId><ArticleId IdType="pubmed">15312219</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase M, Bellomo R, Haase-Fielitz A: Novel biomarkers, oxidative stress, and the role of labile iron toxicity in cardiopulmonary bypass-associated acute kidney injury. J Am Coll Cardiol 55: 2024&#x2013;2033, 2010</Citation><ArticleIdList><ArticleId IdType="pubmed">20447525</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheridan AM, Bonventre JV: Cell biology and molecular mechanisms of injury in ischemic acute renal failure. Curr Opin Nephrol Hypertens 9: 427&#x2013;434, 2000</Citation><ArticleIdList><ArticleId IdType="pubmed">10926180</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, YF, Tsai, WC, Lin, CC, Tsai, LY, Lee, CS, Huang, CH, Pan, PC, Chen, ML: Effect of leukocyte depletion on endothelial cell activation and transendothelial migration of leukocytes during cardiopulmonary bypass. Ann Thorac Surg 78: 634&#x2013;642; discussion 642&#x2013;633, 2004</Citation><ArticleIdList><ArticleId IdType="pubmed">15276536</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutton TA, Fisher CJ, Molitoris BA: Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int 62: 1539&#x2013;1549, 2002</Citation><ArticleIdList><ArticleId IdType="pubmed">12371954</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Garvin LM, Nickola TJ, Watson AM, Colberg-Poley AM, Rose MC: IL-1&#x3b2; induction of MUC5AC gene expression is mediated by CREB and NF-&#x3ba;B and repressed by dexamethasone. Am J Physiol Lung Cell Mol Physiol 306: L797&#x2013;L807, 2014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3989721</ArticleId><ArticleId IdType="pubmed">24487386</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannon R, Croxtall JD, Getting SJ, Roviezzo F, Yona S, Paul-Clark MJ, Gavins FN, Perretti M, Morris JF, Buckingham JC, Flower RJ: Aberrant inflammation and resistance to glucocorticoids in annexin 1&#x2013;/&#x2013; mouse. FASEB J 17: 253&#x2013;255, 2003</Citation><ArticleIdList><ArticleId IdType="pubmed">12475898</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafezi-Moghadam A, Simoncini T, Yang Z, Limbourg FP, Plumier JC, Rebsamen MC, Hsieh CM, Chui DS, Thomas KL, Prorock AJ, Laubach VE, Moskowitz MA, French BA, Ley K, Liao JK: Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med 8: 473&#x2013;479, 2002</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2668717</ArticleId><ArticleId IdType="pubmed">11984591</ArticleId></ArticleIdList></Reference><Reference><Citation>Harling L, Punjabi PP, Athanasiou T: Miniaturized extracorporeal circulation vs. off-pump coronary artery bypass grafting: what the evidence shows? Perfusion 26[Suppl 1]: 40&#x2013;47, 2011</Citation><ArticleIdList><ArticleId IdType="pubmed">21933821</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaer DJ, Schaer CA, Buehler PW, Boykins RA, Schoedon G, Alayash AI, Schaffner A: CD163 is the macrophage scavenger receptor for native and chemically modified hemoglobins in the absence of haptoglobin. Blood 107: 373&#x2013;380, 2006</Citation><ArticleIdList><ArticleId IdType="pubmed">16189277</ArticleId></ArticleIdList></Reference><Reference><Citation>Buechler C, Ritter M, Ors&#xf3; E, Langmann T, Klucken J, Schmitz G: Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J Leukoc Biol 67: 97&#x2013;103, 2000</Citation><ArticleIdList><ArticleId IdType="pubmed">10648003</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf6;gger P, Dreier J, Droste A, Buck F, Sorg C: Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163). J Immunol 161: 1883&#x2013;1890, 1998</Citation><ArticleIdList><ArticleId IdType="pubmed">9712057</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Z, Niven-Fairchild T, Tadesse S, Norwitz ER, Buhimschi CS, Buhimschi IA, Guller S: Glucocorticoids enhance CD163 expression in placental Hofbauer cells. Endocrinology 154: 471&#x2013;482, 2013</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3529384</ArticleId><ArticleId IdType="pubmed">23142809</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel UD, Garg AX, Krumholz HM, Shlipak MG, Coca SG, Sint K, Thiessen-Philbrook H, Koyner JL, Swaminathan M, Passik CS, Parikh CR, Translational Research Investigating Biomarker Endpoints in Acute Kidney Injury (TRIBE-AKI) Consortium : Preoperative serum brain natriuretic peptide and risk of acute kidney injury after cardiac surgery. Circulation 125: 1347&#x2013;1355, 2012</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3312808</ArticleId><ArticleId IdType="pubmed">22322531</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) : A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604&#x2013;612, 2009</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2763564</ArticleId><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R: European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16: 9&#x2013;13, 1999</Citation><ArticleIdList><ArticleId IdType="pubmed">10456395</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39214800</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Analysis of Perioperative Factors Leading to Postoperative Pulmonary Complications, Graft Injury and Increased Postoperative Mortality in Lung Transplantation.</ArticleTitle><Pagination><StartPage>2712</StartPage><EndPage>2721</EndPage><MedlinePgn>2712-2721</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2024.08.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(24)00521-4</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Postoperative complications such as postoperative pulmonary complications (PPCs) and other organ complications are associated with increased morbidity and mortality after successful lung transplantation and have a detrimental effect on patient recovery. The aim of this study was to investigate perioperative risk factors for in-hospital mortality and postoperative complications with a focus on PPC and graft injury in patients undergoing lung transplantation DESIGN: Single-center retrospective cohort study of 173 patients undergoing lung transplantation SETTING: University Hospital, Medical Center Freiburg.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">In the stepwise multivariate regression analysis, donor age &gt;60 years (odds ratio [OR], 1.85; 95% confidence interval [CI], 1.27-2.81), intraoperative extracorporeal membrane oxygenation (OR, 2.4; 95% CI, 1.7-3.3), transfusion of &gt;4 red blood cell concentrates (OR, 3.1; 95% CI, 1.82-5.1), mean pulmonary artery pressure of &gt;30 mmHg at the end of surgery (OR, 3.5; 95% CI, 2-6.3), the occurrence of postoperative graft injury (OR, 4.1; 95% CI, 2.8-5.9), PPCs (OR, 2.1; 95% CI, 1.7-2.6), sepsis (OR, 4.5; 95% CI, 2.8-7.3), and Kidney disease Improving Outcome grading system stage 3 acute renal failure (OR, 4.3; 95% CI, 2.4-7.7) were associated with increased in hospital mortality, whereas patients with chronic obstructive pulmonary disease had a lower in-hospital mortality (OR, 1.6; 95% CI, 1.4-1.9). The frequency and number of PPCs correlated with postoperative mortality.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Clinical management and risk stratification focusing on the underlying identified factors that could help to improve patient outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Axel</LastName><ForeName>Semmelmann</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Freiburg, Germany. Electronic address: axel.semmelmann@uniklinik-freiburg.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moneke</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Autenrieth</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baar</LastName><ForeName>Wolfgang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loop</LastName><ForeName>Torsten</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016040" MajorTopicYN="Y">Lung Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Lung transplantation</Keyword><Keyword MajorTopicYN="N">anesthesia</Keyword><Keyword MajorTopicYN="N">anesthesia for lung transplantation</Keyword><Keyword MajorTopicYN="N">perioperative medicine</Keyword><Keyword MajorTopicYN="N">postoperative pulmonary complications</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>30</Day><Hour>22</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39214800</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2024.08.002</ArticleId><ArticleId IdType="pii">S1053-0770(24)00521-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34822023</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>30</Day></DateCompleted><DateRevised><Year>2022</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1863-4362</ISSN><JournalIssue CitedMedium="Internet"><Volume>191</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Irish journal of medical science</Title><ISOAbbreviation>Ir J Med Sci</ISOAbbreviation></Journal><ArticleTitle>Neutrophil gelatinase associated lipocalin in predicting postoperative acute kidney injury in elderly.</ArticleTitle><Pagination><StartPage>1297</StartPage><EndPage>1303</EndPage><MedlinePgn>1297-1303</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11845-021-02865-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Elderly patients are at increased risk of developing acute kidney injury (AKI) following major surgery and rapid diagnosis is essential.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">This study aimed to examine the potential utility of plasma neutrophil gelatinase associated lipocalin levels in early prediction of AKI in geriatric patients undergoing laparotomic oncological surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This prospective single-center cohort study included 60 geriatric patients (&#x2265;&#x2009;65&#xa0;years of age) that underwent major oncologic surgery with laparotomy. Perioperative measurements of plasma creatinine, blood urinary nitrogen, plasma lactate, urine output, and neutrophil gelatinase associated lipocalin (NGAL) were made. Patients were followed for AKI development, which is the primary outcome measure, and predictive role of NGAL was investigated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">At 48&#xa0;h follow-up, AKI developed in 13 patients (21.7%). Significant differences in creatinine (p&#x2009;&lt;&#x2009;0.001), NGAL (p&#x2009;&lt;&#x2009;0.001), and urine output levels (p&#x2009;=&#x2009;0.001) were evident over time between the two groups. High NGAL measurements at 6 and 24&#xa0;h after surgery seem to be highly predictive of AKI development. At 6&#xa0;h, a plasma NGAL level greater than 71.8&#xa0;ng/mL has a sensitivity and specificity of 85% and 81% in predicting subsequent AKI development.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Plasma NGAL levels seem to represent an early and reliable marker for AKI in elderly patients undergoing laparotomic surgery with the potential to allow early diagnosis and prevent further renal deterioration. Further confirmatory studies are warranted.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">The study was registered to ClinicalTrials.gov (number, NCT05030727).</AbstractText><AbstractText Label="IMPLICATION STATEMENT" NlmCategory="CONCLUSIONS">Elderly patients are at increased risk of postoperative acute kidney injury (AKI). This study shows that plasma neutrophil gelatinase associated lipocalin is a helpful marker to predict AKI in elderly patients undergoing laparotomic major surgery, which will allow early diagnosis and prevent further renal deterioration in this vulnerable patient group.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Orhon Ergun</LastName><ForeName>Meliha</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8158-1393</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Reanimation, Pendik Research and Training Hospital, Marmara University Medical Faculty, Fevzi Cakmak Mah, Muhsin Yazicioglu Cad. No: 10, 34899, Ustkaynarca, Pendik, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zengin</LastName><ForeName>Seniyye Ulgen</ForeName><Initials>SU</Initials><Identifier Source="ORCID">0000-0003-1795-6597</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Reanimation, Pendik Research and Training Hospital, Marmara University Medical Faculty, Fevzi Cakmak Mah, Muhsin Yazicioglu Cad. No: 10, 34899, Ustkaynarca, Pendik, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mustafayeva</LastName><ForeName>Aynur</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0047-7568</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Reanimation, Pendik Research and Training Hospital, Marmara University Medical Faculty, Fevzi Cakmak Mah, Muhsin Yazicioglu Cad. No: 10, 34899, Ustkaynarca, Pendik, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Umuroglu</LastName><ForeName>Tumay</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-6887-1740</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Reanimation, Pendik Research and Training Hospital, Marmara University Medical Faculty, Fevzi Cakmak Mah, Muhsin Yazicioglu Cad. No: 10, 34899, Ustkaynarca, Pendik, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05030727</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Ir J Med Sci</MedlineTA><NlmUniqueID>7806864</NlmUniqueID><ISSNLinking>0021-1265</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071068">Lipocalin-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071068" MajorTopicYN="N">Lipocalin-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Abdominal surgery</Keyword><Keyword MajorTopicYN="N">Acute kidney injury (AKI)</Keyword><Keyword MajorTopicYN="N">Elderly</Keyword><Keyword MajorTopicYN="N">Laparotomy</Keyword><Keyword MajorTopicYN="N">Oncologic surgery</Keyword><Keyword MajorTopicYN="N">Plasma neutrophil gelatinase associated lipocalin (pNGAL)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>25</Day><Hour>12</Hour><Minute>20</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34822023</ArticleId><ArticleId IdType="doi">10.1007/s11845-021-02865-z</ArticleId><ArticleId IdType="pii">10.1007/s11845-021-02865-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Morgera S, Kraft AK, Siebert G, Luft FC, Neumayer HH (2002) Long-term outcomes in acute renal failure patients treated with continuous renal replacement therapies. Am J Kidney Dis 40:275&#x2013;279. https://doi.org/10.1053/ajkd.2002.34505</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/ajkd.2002.34505</ArticleId><ArticleId IdType="pubmed">12148099</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Hoste EA (2008) Acute kidney injury: epidemiology and assessment. Scand J Clin Lab Invest Suppl 241:6&#x2013;11. https://doi.org/10.1080/00365510802144813</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00365510802144813</ArticleId><ArticleId IdType="pubmed">18569958</ArticleId></ArticleIdList></Reference><Reference><Citation>Chronopoulos A, Cruz DN, Ronco C (2010) Hospital-acquired acute kidney injury in the elderly. Nat Rev Nephrol 6:141&#x2013;149. https://doi.org/10.1038/nrneph.2009.234</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2009.234</ArticleId><ArticleId IdType="pubmed">20125094</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishani A, Xue JL, Himmelfarb J et al (2009) Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 20:223&#x2013;228. https://doi.org/10.1681/ASN.2007080837</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2007080837</ArticleId><ArticleId IdType="pubmed">19020007</ArticleId><ArticleId IdType="pmc">2615732</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindeman RD (1990) Overview: renal physiology and pathophysiology of aging. Am J Kidney Dis 16:275&#x2013;282. https://doi.org/10.1016/s0272-6386(12)80002-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0272-6386(12)80002-3</ArticleId><ArticleId IdType="pubmed">2220770</ArticleId></ArticleIdList></Reference><Reference><Citation>Albert C, Zapf A, Haase M et al (2020) Neutrophil gelatinase-associated lipocalin measured on clinical laboratory platforms for the prediction of acute kidney &#x131;njury and the associated need for dialysis therapy: a systematic review and meta-analysis. Am J Kidney Dis 76(826&#x2013;841):e821. https://doi.org/10.1053/j.ajkd.2020.05.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2020.05.015</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonucci E, Lippi G, Ticinesi A et al (2014) Neutrophil gelatinase-associated lipocalin (NGAL): a promising biomarker for the early diagnosis of acute kidney injury (AKI). Acta Biomed 85:289&#x2013;294 (PMID: 25567470)</Citation><ArticleIdList><ArticleId IdType="pubmed">25567470</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra J, Ma Q, Prada A et al (2003) Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14:2534&#x2013;2543. https://doi.org/10.1097/01.ASN.0000088027.54400.C6</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ASN.0000088027.54400.C6</ArticleId><ArticleId IdType="pubmed">14514731</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh CR, Devarajan P, Zappitelli M et al (2011) Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery. J Am Soc Nephrol 22:1737&#x2013;1747. https://doi.org/10.1681/ASN.2010121302</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2010121302</ArticleId><ArticleId IdType="pubmed">21836147</ArticleId><ArticleId IdType="pmc">3171944</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutlu H, Gunduz E, Titiz TA, Kucukcetin IO (2020) Investigation of AKI with Early Biomarkers After Cardiac Surgery. Braz J Cardiovasc Surg 35:722&#x2013;731. https://doi.org/10.21470/1678-9741-2019-0178</Citation><ArticleIdList><ArticleId IdType="doi">10.21470/1678-9741-2019-0178</ArticleId><ArticleId IdType="pubmed">33118738</ArticleId><ArticleId IdType="pmc">7598966</ArticleId></ArticleIdList></Reference><Reference><Citation>Tidbury N, Browning N, Shaw M, Morgan M, Kemp I, Matata B (2019) Neutrophil gelatinase-associated lipocalin as a marker of postoperative acute kidney &#x131;njury following cardiac surgery in patients with preoperative kidney &#x131;mpairment. Cardiovasc Hematol Disord Drug Targets 19:239&#x2013;248. https://doi.org/10.2174/1871529X19666190415115106</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871529X19666190415115106</ArticleId><ArticleId IdType="pubmed">30987577</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeder LW, Buckley JR, Stroud RE et al (2019) Plasma neutrophil gelatinase-associated lipocalin &#x131;s associated with acute kidney &#x131;njury and clinical outcomes in neonates undergoing cardiopulmonary bypass. Pediatr Crit Care Med 20:957&#x2013;962. https://doi.org/10.1097/PCC.0000000000002035</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0000000000002035</ArticleId><ArticleId IdType="pubmed">31206501</ArticleId><ArticleId IdType="pmc">6776671</ArticleId></ArticleIdList></Reference><Reference><Citation>Miah OF, Roy DK, Chowdhury AA et al (2018) Plasma neutrophil gelatinase associated lipocalin (pNGAL) level to &#x131;dentify AKI early in patients undergoing cardiac valve surgery. Mymensingh Med J 27:263&#x2013;269 (PMID: 29769488)</Citation><ArticleIdList><ArticleId IdType="pubmed">29769488</ArticleId></ArticleIdList></Reference><Reference><Citation>Balkanay OO, Goksedef D, Omeroglu SN, Ipek G (2018) The reliability of the use of serum neutrophil gelatinase-associated lipocalin levels in the assessment of renal functions after coronary artery bypass grafting. Cardiol Res Pract 2018:7291254. https://doi.org/10.1155/2018/7291254</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/7291254</ArticleId><ArticleId IdType="pubmed">29692931</ArticleId><ArticleId IdType="pmc">5859916</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanchi M, Manjunath R, Massen J, Vincent L, Belani K (2017) Neutrophil gelatinase-associated lipocalin as a biomarker for predicting acute kidney injury during off-pump coronary artery bypass grafting. Ann Card Anaesth 20:297&#x2013;302. https://doi.org/10.4103/aca.ACA_48_17</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/aca.ACA_48_17</ArticleId><ArticleId IdType="pubmed">28701593</ArticleId><ArticleId IdType="pmc">5535569</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Luo Q, Wang L, Han L (2016) Diagnostic value of neutrophil gelatinase-associated lipocalin for early diagnosis of cardiac surgery-associated acute kidney injury: a meta-analysis. Eur J Cardiothorac Surg 49:746&#x2013;755. https://doi.org/10.1093/ejcts/ezv199</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezv199</ArticleId><ArticleId IdType="pubmed">26094017</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain V, Mehta Y, Gupta A, Sharma R, Raizada A, Trehan N (2016) The role of neutrophil gelatinase-associated lipocalin in predicting acute kidney injury in patients undergoing off-pump coronary artery bypass graft: a pilot study. Ann Card Anaesth 19:225&#x2013;230. https://doi.org/10.4103/0971-9784.179590</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0971-9784.179590</ArticleId><ArticleId IdType="pubmed">27052061</ArticleId><ArticleId IdType="pmc">4900357</ArticleId></ArticleIdList></Reference><Reference><Citation>de Geus HR, Ronco C, Haase M, Jacob L, Lewington A, Vincent JL (2016) The cardiac surgery-associated neutrophil gelatinase-associated lipocalin (CSA-NGAL) score: a potential tool to monitor acute tubular damage. J Thorac Cardiovasc Surg 151:1476&#x2013;1481. https://doi.org/10.1016/j.jtcvs.2016.01.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2016.01.037</ArticleId><ArticleId IdType="pubmed">26952930</ArticleId></ArticleIdList></Reference><Reference><Citation>Park CM, Kim JS, Moon HW et al (2015) Usefulness of plasma neutrophil gelatinase-associated lipocalin as an early marker of acute kidney injury after cardiopulmonary bypass in Korean cardiac patients: a prospective observational study. Clin Biochem 48:44&#x2013;49. https://doi.org/10.1016/j.clinbiochem.2014.09.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinbiochem.2014.09.019</ArticleId><ArticleId IdType="pubmed">25284002</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumida M, Doi K, Kinoshita O et al (2014) Perioperative plasma neutrophil gelatinase-associated lipocalin measurement in patients who undergo left ventricular assist device implantation surgery. Circ J 78:1891&#x2013;1899.&#xa0; https://doi.org/10.1253/circj.CJ-14-0008</Citation></Reference><Reference><Citation>Kim JD, Chee HK, Shin JK et al (2014) Novel early predictor of acute kidney &#x131;njury after open heart surgery under cadiopulmonary bypass using plasma neutrophil gelatinase-associated lipocalin. Korean J Thorac Cardiovasc Surg 47:240&#x2013;248. https://doi.org/10.5090/kjtcs.2014.47.3.240</Citation><ArticleIdList><ArticleId IdType="doi">10.5090/kjtcs.2014.47.3.240</ArticleId><ArticleId IdType="pubmed">25207221</ArticleId><ArticleId IdType="pmc">4157474</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidher E, Harling L, Ashrafian H et al (2014) Pulse wave velocity and neutrophil gelatinase-associated lipocalin as predictors of acute kidney injury following aortic valve replacement. J Cardiothorac Surg 9:89. https://doi.org/10.1186/1749-8090-9-89</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-8090-9-89</ArticleId><ArticleId IdType="pubmed">24886694</ArticleId><ArticleId IdType="pmc">4057558</ArticleId></ArticleIdList></Reference><Reference><Citation>Buelow MW, Dall A, Regner K et al (2012) Urinary interleukin-18 and urinary neutrophil gelatinase-associated lipocalin predict acute kidney injury following pulmonary valve replacement prior to serum creatinine. Congenit Heart Dis 7:441&#x2013;447. https://doi.org/10.1111/j.1747-0803.2012.00662.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1747-0803.2012.00662.x</ArticleId><ArticleId IdType="pubmed">22537138</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham BP, Frazier EA, Morrow WR et al (2011) Cystatin C and neutrophil gelatinase-associated lipocalin as markers of renal function in pediatric heart transplant recipients. Pediatr Transplant 15:564&#x2013;569. https://doi.org/10.1111/j.1399-3046.2011.01502.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-3046.2011.01502.x</ArticleId><ArticleId IdType="pubmed">21518160</ArticleId></ArticleIdList></Reference><Reference><Citation>Shum HP, Leung NY, Chang LL et al (2015) Predictive value of plasma neutrophil gelatinase-associated lipocalin for acute kidney injury in intensive care unit patients after major non-cardiac surgery. Nephrology (Carlton) 20:375&#x2013;382. https://doi.org/10.1111/nep.12400</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nep.12400</ArticleId></ArticleIdList></Reference><Reference><Citation>Martensson J, Glassford NJ, Jones S et al (2015) Urinary neutrophil gelatinase-associated lipocalin to hepcidin ratio as a biomarker of acute kidney injury in intensive care unit patients. Minerva Anestesiol 81:1192&#x2013;1200 (PMID: 25479470)</Citation><ArticleIdList><ArticleId IdType="pubmed">25479470</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaolanis G, Moris D, Palla VV, Karanikola E, Bakoyiannis C, Georgopoulos S (2015) Neutrophil gelatinase associated lipocalin (NGAL) as a biomarker. Does &#x131;t apply in abdominal aortic aneurysms? A review of literature. Indian J Surg 77:1313&#x2013;1317. https://doi.org/10.1007/s12262-014-1099-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12262-014-1099-1</ArticleId><ArticleId IdType="pubmed">27011557</ArticleId></ArticleIdList></Reference><Reference><Citation>Thanakitcharu P, Jirajan B (2014) Determination of urinary neutrophil gelatinase-associated lipocalin (NGAL) cut-off level for early detection of acute kidney injury in Thai adult patients undergoing open cardiac surgery. J Med Assoc Thai 97(Suppl 11):S48-55 (PMID: 25509695)</Citation><ArticleIdList><ArticleId IdType="pubmed">25509695</ArticleId></ArticleIdList></Reference><Reference><Citation>Koukoulaki M, Spyropoulos C, Hondrogiannis P et al (2013) Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney &#x131;njury in patients with morbid obesity who underwent bariatric surgery. Nephron Extra 3:101&#x2013;105. https://doi.org/10.1159/000354892</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000354892</ArticleId><ArticleId IdType="pubmed">24348505</ArticleId><ArticleId IdType="pmc">3843911</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjortrup PB, Haase N, Wetterslev M, Perner A (2013) Clinical review: Predictive value of neutrophil gelatinase-associated lipocalin for acute kidney injury in intensive care patients. Crit Care 17:211. https://doi.org/10.1186/cc11855</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11855</ArticleId><ArticleId IdType="pubmed">23680259</ArticleId><ArticleId IdType="pmc">3672520</ArticleId></ArticleIdList></Reference><Reference><Citation>Shavit L, Dolgoker I, Ivgi H, Assous M, Slotki I (2011) Neutrophil gelatinase-associated lipocalin as a predictor of complications and mortality in patients undergoing non-cardiac major surgery. Kidney Blood Press Res 34:116&#x2013;124. https://doi.org/10.1159/000323897</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000323897</ArticleId><ArticleId IdType="pubmed">21311195</ArticleId></ArticleIdList></Reference><Reference><Citation>Portal AJ, McPhail MJ, Bruce M et al (2010) Neutrophil gelatinase&#x2013;associated lipocalin predicts acute kidney injury in patients undergoing liver transplantation. Liver Transpl 16:1257&#x2013;1266. https://doi.org/10.1002/lt.22158</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lt.22158</ArticleId><ArticleId IdType="pubmed">21031541</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL, Kellum JA, Shah SV et al (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31. https://doi.org/10.1186/cc5713</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc5713</ArticleId><ArticleId IdType="pubmed">17331245</ArticleId><ArticleId IdType="pmc">2206446</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldemir M, Koca HB, Dogan Baki E et al (2016) Effects of N-acetyl cysteine on renal functions evaluated by blood neutrophil gelatinase-associated lipocalin levels in geriatric patients undergoing coronary artery bypass grafting. Anatol J Cardiol 16:504&#x2013;511. https://doi.org/10.5152/AnatolJCardiol.2015.6287</Citation><ArticleIdList><ArticleId IdType="doi">10.5152/AnatolJCardiol.2015.6287</ArticleId><ArticleId IdType="pubmed">27004703</ArticleId></ArticleIdList></Reference><Reference><Citation>Savran Karadeniz M, Alp Eniste I, Senturk Ciftci H et al (2019) Neutrophil gelatinase-associated lipocalin significantly correlates with &#x131;schemic damage in patients undergoing laparoscopic partial nephrectomy. Balkan Med J 36:121&#x2013;128. https://doi.org/10.4274/balkanmedj.galenos.2018.2018.0852</Citation><ArticleIdList><ArticleId IdType="doi">10.4274/balkanmedj.galenos.2018.2018.0852</ArticleId><ArticleId IdType="pubmed">30417831</ArticleId><ArticleId IdType="pmc">6409963</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiter K, Balling G, Bonelli V et al (2018) Neutrophil gelatinase-associated lipocalin reflects inflammation and is not a reliable renal biomarker in neonates and infants after cardiopulmonary bypass: a prospective case-control study. Cardiol Young 28:243&#x2013;251. https://doi.org/10.1017/S1047951117001767</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1047951117001767</ArticleId><ArticleId IdType="pubmed">28889829</ArticleId></ArticleIdList></Reference><Reference><Citation>Rampoldi B, Tessarolo S, Giubbilini P et al (2018) Neutrophil gelatinase-associated lipocalin and acute kidney injury in endovascular aneurysm repair or open aortic repair: a pilot study. Biochem Med (Zagreb) 28:010904. https://doi.org/10.11613/BM.2018.010904</Citation><ArticleIdList><ArticleId IdType="doi">10.11613/BM.2018.010904</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerci P, Claudot JL, Novy E, Settembre N, Lalot JM, Losser MR (2018) Immediate postoperative plasma neutrophil gelatinase-associated lipocalin to predict acute kidney injury after major open abdominal aortic surgery: a prospective observational study. Anaesth Crit Care Pain Med 37:327&#x2013;334. https://doi.org/10.1016/j.accpm.2017.09.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.accpm.2017.09.006</ArticleId><ArticleId IdType="pubmed">29033359</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalisnik JM, Hrovat E, Hrastovec A et al (2017) Creatinine, Neutrophil gelatinase-associated lipocalin, and cystatin C in determining acute kidney &#x131;njury after heart operations using cardiopulmonary bypass. Artif Organs 41:481&#x2013;489. https://doi.org/10.1111/aor.12779</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aor.12779</ArticleId><ArticleId IdType="pubmed">27862029</ArticleId></ArticleIdList></Reference><Reference><Citation>Welborn MB, Oldenburg HS, Hess PJ et al (2000) The relationship between visceral ischemia, proinflammatory cytokines, and organ injury in patients undergoing thoracoabdominal aortic aneurysm repair. Crit Care Med 28(9):3191&#x2013;3197</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200009000-00013</ArticleId><ArticleId IdType="pubmed">11008981</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33781118</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-0879</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Season>Jul-Aug</Season></PubDate></JournalIssue><Title>Innovations (Philadelphia, Pa.)</Title><ISOAbbreviation>Innovations (Phila)</ISOAbbreviation></Journal><ArticleTitle>Minimally Invasive Versus Sternotomy for Mitral Surgery in the Elderly: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>310</StartPage><EndPage>316</EndPage><MedlinePgn>310-316</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/15569845211000332</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The safety of minimally invasive mitral valve surgery (MIMVS) in elderly patients is still debated. Our objective was to perform a systematic review and meta-analysis of studies comparing MIMVS with conventional sternotomy (CS) in elderly patients (&#x2265;65 years old).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched PubMed, EMBASE, Web of Science, clinicaltrials.gov, and Cochrane Central Register of Controlled Trials for trials and observational studies comparing MIMVS with CS in patients &#x2265;65 years old presenting for mitral valve surgery. We performed a random-effects meta-analysis of all outcomes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The MIMVS group had lower odds of acute renal failure (odds ratio [OR] 0.27; 95% CI 0.10 to 0.78), prolonged intubation (&gt;48 h; OR 0.47; 95% CI 0.31 to 0.70), less blood product transfusion (weighted mean difference [WMD] -0.82 units; 95% CI -1.29 to -0.34 units), shorter ICU length of stay (LOS; WMD -2.57 days; 95% CI -3.24 to -1.90 days) and hospital LOS (WMD -4.06 days; 95% CI -5.19 to -2.94 days). There were no significant differences in the odds of mortality, stroke, respiratory infection, reoperation for bleeding, and postoperative atrial fibrillation. MIMVS was associated with longer cross-clamp (WMD 11.8 min; 95% CI 3.5 to 20.1 min) and cardiopulmonary bypass times (WMD 23.0 min; 95% CI 10.4 to 35.6 min).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">MIMVS in elderly patients is associated with lower postoperative complications, blood transfusion, shorter ICU, and hospital LOS, and longer cross-clamp and bypass times.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hage</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>622170384 Western University, London, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>1857 Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hage</LastName><ForeName>Fadi</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>622170384 Western University, London, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>1857 Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Amodi</LastName><ForeName>Hussein</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>622170384 Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Suruchi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>1857 Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papatheodorou</LastName><ForeName>Stefania I</ForeName><Initials>SI</Initials><AffiliationInfo><Affiliation>1857 Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hawkins</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>235821614 University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ailawadi</LastName><ForeName>Gorav</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>235821614 University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mittleman</LastName><ForeName>Murray A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>1857 Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Michael W A</ForeName><Initials>MWA</Initials><AffiliationInfo><Affiliation>622170384 Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Innovations (Phila)</MedlineTA><NlmUniqueID>101257528</NlmUniqueID><ISSNLinking>1556-9845</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019060" MajorTopicYN="N">Minimally Invasive Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008943" MajorTopicYN="N">Mitral Valve</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056346" MajorTopicYN="Y">Sternotomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">minimally invasive</Keyword><Keyword MajorTopicYN="N">mitral surgery</Keyword></KeywordList><CoiStatement><b>Declaration of Conflicting Interests:</b> The author(s) declared the following potential conflicts of interest with respect
to the research, authorship, and/or publication of this article: MWC has
received speaker&#x2019;s honoraria from Medtronic, Edwards Lifesciences, Boston
Scientific, and Abbott Vascular.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>30</Day><Hour>5</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33781118</ArticleId><ArticleId IdType="pmc">PMC8414825</ArticleId><ArticleId IdType="doi">10.1177/15569845211000332</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hawkins RB., Mehaffey JH., Mullen MGet al.. A propensity matched analysis of robotic, minimally invasive, and conventional mitral valve surgery. Heart 2018; 104: 1970&#x2013;1975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6237642</ArticleId><ArticleId IdType="pubmed">29915143</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagendran J., Catrip J., Losenno KLet al.. Minimally invasive mitral repair surgery: why does controversy still persist? Expert Rev Cardiovasc Ther 2017; 15: 15&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">27905211</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh JP., Evans JC., Levy Det al.. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 1999; 83: 897&#x2013;902.</Citation><ArticleIdList><ArticleId IdType="pubmed">10190406</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamelas J., Sarria A., Santana Oet al.. Outcomes of minimally invasive valve surgery versus median sternotomy in patients age 75 years or greater. Ann Thorac Surg 2011; 91: 79&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">21172490</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolh P., Kerzmann A., Lahaye Let al.. Cardiac surgery in octogenarians; peri-operative outcome and long-term results. Eur Heart J 2001; 22: 1235&#x2013;1243.</Citation><ArticleIdList><ArticleId IdType="pubmed">11440496</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkins RB., Mehaffey JH., Kessel SMet al.. Minimally invasive mitral valve surgery is associated with excellent resource utilization, cost, and outcomes. J Thorac Cardiovasc Surg 2018; 156: 611&#x2013;616.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6100741</ArticleId><ArticleId IdType="pubmed">29709359</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells GA., Shea B,., O&#x2019;Connell D, et al. The Newcastle-Ottawa Scale (NOS) for
assessing the quality if nonrandomized studies in meta-analyses.
ScienceOpen
, https://www.scienceopen.com/document?vid=54b48470-4655-4081-b5d4-e8ebe8d1792e
(2020, accessed 27 May
2020).</Citation></Reference><Reference><Citation>Holzhey DM., Shi W., Borger MAet al.. Minimally invasive versus sternotomy approach for mitral valve surgery in patients greater than 70 years old: a propensity-matched comparison. Ann Thorac Surg 2011; 91: 401&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pubmed">21256279</ArticleId></ArticleIdList></Reference><Reference><Citation>Santana O., Reyna J., Grana Ret al.. Outcomes of minimally invasive valve surgery versus standard sternotomy in obese patients undergoing isolated valve surgery. Ann Thorac Surg 2011; 91: 406&#x2013;410.</Citation><ArticleIdList><ArticleId IdType="pubmed">21256280</ArticleId></ArticleIdList></Reference><Reference><Citation>Iribarne A., Easterwood R., Russo MJet al.. Comparative effectiveness of minimally invasive versus traditional sternotomy mitral valve surgery in elderly patients. J Thorac Cardiovasc Surg 2012; 143(4 Suppl): S86&#x2013;S90.</Citation><ArticleIdList><ArticleId IdType="pubmed">22423605</ArticleId></ArticleIdList></Reference><Reference><Citation>Losenno KL., Jones PM., Valdis Met al.. Higher-risk mitral valve operations after previous sternotomy: endoscopic, minimally invasive approach improves patient outcomes. Can J Surg 2016; 59: 399&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5125922</ArticleId><ArticleId IdType="pubmed">28234615</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q., Yu L-L., Zhang Q-Let al.. Minimally invasive video-assisted mitral valve replacement with a right chest small incision in patients aged over 65 years. Braz J Cardiovasc Surg 2019; 34: 428&#x2013;435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6713364</ArticleId><ArticleId IdType="pubmed">31454196</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CW., Chung JJ., Gaffey AC. The advantages of minimally-invasive mitral valve surgery can be safely translated to the elderly: a propensity-matched analysis. Innovations 2017; 12(Suppl 4): S172.</Citation></Reference><Reference><Citation>Chen CW., Auvil BJ,., Chung JJ, et al. The advantages of minimally-invasive
mitral valve surgery can be safely translated to the elderly: a propensity
score matched analysis. ePostersOnline
, https://epostersonline.com/ismics2017/node/250
(2017, accessed 27 May
2020).</Citation></Reference><Reference><Citation>Petersen J., Naito S., Neumann Net al.. Impact of minimally invasive mitral valve surgery in elderly patients. Thorac Cardiovasc Surg 2018; 66(S 01): S1&#x2013;S110.</Citation></Reference><Reference><Citation>Van laeken E., Bov&#xe9; T,., Vandewiele K, et al. Minimally invasive thoracotomy is a ICU proven alternative approach for mitral valve surgery. Crit Care 2019; 23(Suppl 2): P122.</Citation></Reference><Reference><Citation>Grossi EA., LaPietra A., Ribakove GHet al.. Minimally invasive versus sternotomy approaches for mitral reconstruction: comparison of intermediate-term results. J Thorac Cardiovasc Surg 2001; 121: 708&#x2013;713.</Citation><ArticleIdList><ArticleId IdType="pubmed">11279412</ArticleId></ArticleIdList></Reference><Reference><Citation>Suri RM., Schaff HV., Meyer SRet al.. Thoracoscopic versus open mitral valve repair: a propensity score analysis of early outcomes. Ann Thorac Surg 2009; 88: 1185&#x2013;1190.</Citation><ArticleIdList><ArticleId IdType="pubmed">19766804</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan WH., Brinkman WT., Dewey TMet al.. Mitral valve surgery: comparison of outcomes in matched sternotomy and port access groups. J Heart Valve Dis 2010; 19: 51&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">20329490</ArticleId></ArticleIdList></Reference><Reference><Citation>Raanani E., Spiegelstein D., Sternik Let al.. Quality of mitral valve repair: median sternotomy versus port-access approach. J Thorac Cardiovasc Surg 2010; 140: 86&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">19969315</ArticleId></ArticleIdList></Reference><Reference><Citation>Speziale G., Nasso G., Esposito Get al.. Results of mitral valve repair for Barlow disease (bileaflet prolapse) via right minithoracotomy versus conventional median sternotomy: a randomized trial. J Thorac Cardiovasc Surg 2011; 142: 77&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">20926105</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstone AB., Atluri P., Szeto WYet al.. Minimally invasive approach provides at least equivalent results for surgical correction of mitral regurgitation: a propensity-matched comparison. J Thorac Cardiovasc Surg 2013; 145: 748&#x2013;756.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4041091</ArticleId><ArticleId IdType="pubmed">23414991</ArticleId></ArticleIdList></Reference><Reference><Citation>Gammie JS., Zhao Y., Peterson EDet al.. Less-invasive mitral valve operations: trends and outcomes from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg 2010; 90: 1401&#x2013;1410.</Citation><ArticleIdList><ArticleId IdType="pubmed">20971230</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26159745</PMID><DateCompleted><Year>2016</Year><Month>10</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>6</Issue><PubDate><Year>2015</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Vascular Surgery Kidney Injury Predictive Score: A Historical Cohort Study.</ArticleTitle><Pagination><StartPage>1588</StartPage><EndPage>1595</EndPage><MedlinePgn>1588-95</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2015.04.013</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(15)00262-1</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To develop a risk-prediction model for acute kidney injury (AKI) in patients undergoing vascular surgery.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A retrospective cohort study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">A tertiary referral center.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Participants included 845 adult patients who underwent vascular surgery between January 3, 2003, and May 29, 2008.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">None.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">The median age of patients was 72 years (interquartile range 65-80 years), and 653 patients (77%) were male. AKI developed in 258 (30.5%) patients. Patients with AKI had lower estimated glomerular filtration rates (60&#xb1;21 v 72&#xb1;21, p&lt;0.001), were older (73 [68-78] years v 71 [65-80] years, p = 0.01), had a higher prevalence of hypertension (81% v 73%, p = 0.02), and were more likely to undergo emergency surgery (5% v 2%, p = 0.02). Patients with AKI also received more diuretics (p&lt;0.001) and &#x3b2;-blockers (p = 0.003) prior to surgery. The multivariate AKI risk-prediction model with preoperative variables (estimated glomerular filtration rate, previous vascular interventions, use of preoperative diuretics and &#x3b2;-blockers, and emergency surgery) showed an area under the receiver operating characteristic curve of 0.67 (95% confidence interval, 0.628-0.710); a model with additional intraoperative variables (procedure duration, fluid balance, and plasma and platelet transfusion) had an area under the receiver operating characteristic curve of 0.72 (95% confidence interval, 0.685-0.760).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">As AKI is a very common complication after vascular surgery, a risk-prediction model was derived to assess the likelihood of postoperative AKI. If validated in an independent cohort, this model may be used to facilitate targeted interventions in vascular surgery patients at high risk for AKI.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kashani</LastName><ForeName>Kianoush</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Divisions of Nephrology and Hypertension; Division of Pulmonary and Critical Care, Department of Medicine. Electronic address: kashani.kianoush@mayo.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steuernagle</LastName><ForeName>Jon H</ForeName><Initials>JH</Initials><Suffix>4th</Suffix><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care, Department of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akhoundi</LastName><ForeName>Abbasali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alsara</LastName><ForeName>Anas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care, Department of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanson</LastName><ForeName>Andrew C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Division of Biomedical Statistics &amp; Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kor</LastName><ForeName>Daryl J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>04</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Cardiothorac Vasc Anesth. 2016 Jan;30(1):e5-6. doi: 10.1053/j.jvca.2015.08.021.</RefSource><PMID Version="1">26520029</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Cardiothorac Vasc Anesth. 2016 Jan;30(1):e6. doi: 10.1053/j.jvca.2015.08.020.</RefSource><PMID Version="1">26847754</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014656" MajorTopicYN="N">Vascular Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">fluid overload</Keyword><Keyword MajorTopicYN="N">predictive model</Keyword><Keyword MajorTopicYN="N">vascular surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26159745</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2015.04.013</ArticleId><ArticleId IdType="pii">S1053-0770(15)00262-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38580478</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Outcomes of Vasopressin-Receptor Agonists Versus Norepinephrine in Adults With Perioperative Hypotension: A Systematic Review.</ArticleTitle><Pagination><StartPage>1577</StartPage><EndPage>1586</EndPage><MedlinePgn>1577-1586</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2024.03.014</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(24)00178-2</ELocationID><Abstract><AbstractText>Consensus statements recommend the use of norepinephrine and/or vasopressin for hypotension in cardiac surgery. However, there is a paucity of data among other surgical subgroups and vasopressin analogs. Therefore, the authors conducted a systematic review of randomized controlled trials (RCTs) to compare vasopressin-receptor agonists with norepinephrine for hypotension among those undergoing surgery with general anesthesia. This review was registered prospectively (CRD42022316328). Literature searches were conducted by a medical librarian to November 28, 2023, across MEDLINE, EMBASE, CENTRAL, and Web of Science. The authors included RCTs enrolling adults (&#x2265;18 years of age) undergoing any surgery under general anesthesia who developed perioperative hypotension and comparing vasopressin receptor agonists with norepinephrine. The risk of bias was assessed by the Cochrane risk of bias tool for randomized trials (RoB-2). Thirteen (N = 719) RCTs were included, of which 8 (n = 585) enrolled patients undergoing cardiac surgery. Five trials compared norepinephrine with vasopressin, 4 trials with terlipressin, 1 trial with ornipressin, and the other 3 trials used vasopressin as adjuvant therapy. There was no significant difference in all-cause mortality. Among patients with vasoplegic shock after cardiac surgery, vasopressin was associated with significantly lower intensive care unit (N = 385; 2 trials; mean 100.8 v 175.2 hours, p &lt; 0.005; median 120 [IQR 96-168] v 144 [96-216] hours, p = 0.007) and hospital lengths of stay, as well as fewer cases of acute kidney injury and atrial fibrillation compared with norepinephrine. One trial also found that terlipressin was associated with a significantly lower incidence of acute kidney injury versus norepinephrine overall. Vasopressin and norepinephrine restored mean arterial blood pressure with no significant differences; however, the use of vasopressin with norepinephrine was associated with significantly higher mean arterial blood pressure versus norepinephrine alone. Further high-quality trials are needed to determine pooled treatment effects, especially among noncardiac surgical patients and those treated with vasopressin analogs.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Heybati</LastName><ForeName>Kiyan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Guozhen</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellythy</LastName><ForeName>Luqman</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poudel</LastName><ForeName>Keshav</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Jiawen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Fangwen</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chelf</LastName><ForeName>Cynthia J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Mayo Clinic Libraries, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ripoll</LastName><ForeName>Juan G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramakrishna</LastName><ForeName>Harish</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN. Electronic address: ramakrishna.harish@mayo.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>X4W3ENH1CV</RegistryNumber><NameOfSubstance UI="D009638">Norepinephrine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>11000-17-2</RegistryNumber><NameOfSubstance UI="D014667">Vasopressins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017483">Receptors, Vasopressin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009638" MajorTopicYN="Y">Norepinephrine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="Y">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014667" MajorTopicYN="N">Vasopressins</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017483" MajorTopicYN="N">Receptors, Vasopressin</DescriptorName><QualifierName UI="Q000819" MajorTopicYN="N">agonists</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">hypotension</Keyword><Keyword MajorTopicYN="N">norepinephrine</Keyword><Keyword MajorTopicYN="N">outcomes</Keyword><Keyword MajorTopicYN="N">perioperative</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword><Keyword MajorTopicYN="N">vasopressin</Keyword></KeywordList><CoiStatement>Declaration of competing interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>14</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>6</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>5</Day><Hour>22</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38580478</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2024.03.014</ArticleId><ArticleId IdType="pii">S1053-0770(24)00178-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32299694</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-685X</ISSN><JournalIssue CitedMedium="Internet"><Volume>162</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>The Journal of thoracic and cardiovascular surgery</Title><ISOAbbreviation>J Thorac Cardiovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Costs and consequences of acute kidney injury after cardiac surgery: A cohort study.</ArticleTitle><Pagination><StartPage>880</StartPage><EndPage>887</EndPage><MedlinePgn>880-887</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jtcvs.2020.01.101</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-5223(20)30516-X</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Acute kidney injury (AKI) is common after cardiac surgery. We quantified the mortality and costs of varying degrees of AKI using a population-based cohort in Alberta, Canada.</AbstractText><AbstractText Label="METHODS">A cohort of patients undergoing cardiac surgery from 2004 to 2009 was assembled from linked Alberta administrative databases. AKI was classified by Kidney Disease Improving Global Outcomes stages of severity. Our outcomes were in-hospital mortality, length of stay, and costs; among survivors, we also examined mortality and costs at 365&#xa0;days. Estimates were adjusted for demographic characteristics, comorbidities, and other covariates.</AbstractText><AbstractText Label="RESULTS">Ten thousand one hundred seventy participants were included, of whom 9771 patients were discharged to community. Overall in-hospital mortality, costs, and length of stay were 4%, 7&#xa0;days, and Can $34,000, respectively. Postcardiac surgery, AKI occurred in 25%. Compared with those without AKI, AKI was independently associated with increased in-hospital mortality across severity categories, with the highest risk (adjusted odds ratio, 37.1; 95% confidence interval, 26.3-52.1; P&#xa0;&lt;&#xa0;.001) in patients who required acute dialysis. AKI severity was associated with increased hospital days and costs, with costs ranging from 1.21 for stage 1 AKI (95% confidence interval, 1.17-1.23) to 2.74 for acute dialysis (95% confidence interval, 2.49-3.00) (P&#xa0;&lt;&#xa0;.001) times higher than in patients without AKI, after covariate adjustment. Postdischarge to 365&#xa0;days, patients with AKI continued to experience increased costs up to 1.35-fold, and patients who required dialysis acutely continued to experience a 2.86-fold increased mortality.</AbstractText><AbstractText Label="CONCLUSIONS">AKI remains an important indicator of mortality and health care costs postcardiac surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lau</LastName><ForeName>Darren</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pannu</LastName><ForeName>Neesh</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>James</LastName><ForeName>Matthew T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hemmelgarn</LastName><ForeName>Brenda R</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kieser</LastName><ForeName>Teresa M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Department of Cardiac Sciences, Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyer</LastName><ForeName>Steven R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Division of Cardiac Surgery, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klarenbach</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. Electronic address: swk@ualberta.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Thorac Cardiovasc Surg</MedlineTA><NlmUniqueID>0376343</NlmUniqueID><ISSNLinking>0022-5223</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Thorac Cardiovasc Surg. 2021 Sep;162(3):888-889. doi: 10.1016/j.jtcvs.2020.02.043.</RefSource><PMID Version="1">32164947</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Thorac Cardiovasc Surg. 2021 Sep;162(3):889-891. doi: 10.1016/j.jtcvs.2020.02.081.</RefSource><PMID Version="1">32336513</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Thorac Cardiovasc Surg. 2021 Sep;162(3):891-892. doi: 10.1016/j.jtcvs.2020.05.070.</RefSource><PMID Version="1">32682588</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000416" MajorTopicYN="N" Type="Geographic">Alberta</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017721" MajorTopicYN="Y">Hospital Costs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">perioperative care</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32299694</ArticleId><ArticleId IdType="doi">10.1016/j.jtcvs.2020.01.101</ArticleId><ArticleId IdType="pii">S0022-5223(20)30516-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26351826</PMID><DateCompleted><Year>2016</Year><Month>09</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1365-2346</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Jan</Month></PubDate></JournalIssue><Title>European journal of anaesthesiology</Title><ISOAbbreviation>Eur J Anaesthesiol</ISOAbbreviation></Journal><ArticleTitle>Comparison of hydroxyethyl starch colloids with crystalloids for surgical patients: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>42</StartPage><EndPage>48</EndPage><MedlinePgn>42-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/EJA.0000000000000328</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Fluid therapy is one of the most ubiquitous medical therapeutic interventions. There is a debate over whether colloids or crystalloids are better for fluid resuscitation. Recent large trials and meta-analyses suggest no mortality benefit and possible harm with hydroxyethyl starch (HES) use. However, these trials were conducted in critically ill and septic patients and their applicability to perioperative patients has been challenged.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We aimed to evaluate the impact of HES use in scheduled and elective surgical patients.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Systematic review and meta-analysis of randomised controlled trials (RCTs).</AbstractText><AbstractText Label="ELIGIBILITY CRITERIA" NlmCategory="METHODS">Only RCTs comparing the use of the synthetic colloid HES with any crystalloid in adults undergoing noncardiac surgery (up to 24&#x200a;h postop) were considered eligible. For each eligible trial, we extracted the outcomes of all-cause mortality within 90 days, length of hospital stay, major infectious complications, acute kidney injury (AKI) and renal replacement therapy (RRT).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 1555 citations, selected 90 for full-text evaluation, and identified 13 eligible RCTs. Trials were small (n&#x200a;=&#x200a;20 to 202) with low event rates. There was a trend to increased mortality with HES within 90 days [13/373 vs. 3/368; risk ratio 2.97; 95% confidence interval (95% CI) 0.96 to 9.19; I&#x200a;=&#x200a;0%], no difference in AKI and RRT (risk ratio 1.11; 95% CI 0.26 to 4.69; I&#x200a;=&#x200a;34%), and no difference in major infectious complications (risk ratio 1.19; 95% CI 0.59 to 2.39; I&#x200a;=&#x200a;0%). Patients resuscitated with HES had a shorter length of hospital stay (mean difference -1.52 days; 95% CI -2.87 to -0.18), although heterogeneity was high (I&#x200a;=&#x200a;90%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This meta-analysis, based on small studies with low event rates, suggests that there are currently insufficient data to identify a difference in outcomes associated with crystalloids and HES in scheduled or elective noncardiac surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Raiman</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Department of Anaesthesia, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban (MR), Department of Anaesthesia, Grey's Hospital, Pietermaritzburg (CGM), Perioperative Research Group, Department of Anaesthesia, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban (BMB), Perioperative Research Group, Department of Anaesthesia, Grey's Hospital, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Pietermaritzburg, South Africa, and Department of Outcomes Research, Cleveland Clinic, Cleveland, Ohio, USA (RNR).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitchell</LastName><ForeName>Colin G</ForeName><Initials>CG</Initials></Author><Author ValidYN="Y"><LastName>Biccard</LastName><ForeName>Bruce M</ForeName><Initials>BM</Initials></Author><Author ValidYN="Y"><LastName>Rodseth</LastName><ForeName>Reitze N</ForeName><Initials>RN</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Anaesthesiol</MedlineTA><NlmUniqueID>8411711</NlmUniqueID><ISSNLinking>0265-0215</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077324">Crystalloid Solutions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006895">Hydroxyethyl Starch Derivatives</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007552">Isotonic Solutions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010952">Plasma Substitutes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Eur J Anaesthesiol. 2017 Jan;34(1):28-29. doi: 10.1097/EJA.0000000000000464.</RefSource><PMID Version="1">27136489</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000077324" MajorTopicYN="N">Crystalloid Solutions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006895" MajorTopicYN="N">Hydroxyethyl Starch Derivatives</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007552" MajorTopicYN="N">Isotonic Solutions</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010952" MajorTopicYN="N">Plasma Substitutes</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26351826</ArticleId><ArticleId IdType="doi">10.1097/EJA.0000000000000328</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39490985</PMID><DateCompleted><Year>2025</Year><Month>01</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1523-1755</ISSN><JournalIssue CitedMedium="Internet"><Volume>107</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Kidney international</Title><ISOAbbreviation>Kidney Int</ISOAbbreviation></Journal><ArticleTitle>A sub-study of the POISE-3 randomized trial examined effects of a perioperative hypotension-avoidance strategy versus a hypertension-avoidance strategy on the risk of acute kidney injury.</ArticleTitle><Pagination><StartPage>155</StartPage><EndPage>168</EndPage><MedlinePgn>155-168</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.kint.2024.10.007</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0085-2538(24)00717-8</ELocationID><Abstract><AbstractText>In this pre-specified sub-study of the POISE-3 trial, we examined the effect of a perioperative hypotension-avoidance strategy versus a hypertension-avoidance strategy on the risk of postoperative acute kidney injury (AKI). Altogether, 7307 patients were included from 110 hospitals in 22 countries. Patients were 45 years and older, had or were at risk of atherosclerotic disease, took at least one antihypertensive medication, and were scheduled for noncardiac surgery. Hypotension-avoidance strategy: (i) target intraoperative mean arterial pressure (MAP) 80 mm&#xa0;Hg or over, (ii) on day of surgery and for two days after, hold renin-angiotensin-aldosterone system inhibitors and use other antihypertensives in stepwise fashion if systolic blood pressure (SBP) 130 mm&#xa0;Hg or more. Hypertension-avoidance strategy: (i) target intraoperative MAP 60 mm&#xa0;Hg or more, (ii) continue all antihypertensives before and after surgery. Primary outcome: postoperative AKI, an increase in serum creatinine concentration of either 26.5 &#x3bc;mol/L or more (0.3 mg/dL or more) within 48 hours of randomization or 50% or more within seven days of randomization. The hypotension-avoidance group (3654 patients) used fewer antihypertensive medications than the hypertension-avoidance group (3653 patients); specifically, 6% vs. 38% used an ACEI or ARB on the day of surgery, and 6% vs. 47% and 7% vs. 50% one and two days after surgery, respectively. Patients also spent about half as much intraoperative time with a MAP under 80 mm&#xa0;Hg (27 vs. 60 minutes, respectively), but had little difference in average BP before or after surgery. There was no significant difference in AKI risk (15.1% vs. 14.4%). Results were consistent with other definitions of AKI and in patients with preexisting chronic kidney disease. Thus, a hypotension-avoidance strategy targeting a MAP greater than 80 mm&#xa0;Hg in the operating room and discontinued blood pressure medication during the perioperative period did not confer a lower risk of AKI compared to a hypertension avoidance strategy. Clinical trial registration number: NCT03505723.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><CollectiveName>POISE-3 Trial Investigators and Study Groups</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03505723</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Kidney Int</MedlineTA><NlmUniqueID>0323470</NlmUniqueID><ISSNLinking>0085-2538</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000959">Antihypertensive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="Y">Hypertension</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000959" MajorTopicYN="Y">Antihypertensive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062186" MajorTopicYN="N">Arterial Pressure</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">antihypertensive medication</Keyword><Keyword MajorTopicYN="N">hypotension</Keyword><Keyword MajorTopicYN="N">mean arterial pressure</Keyword><Keyword MajorTopicYN="N">noncardiac surgery</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Garg</LastName><ForeName>Amit X</ForeName><Initials>AX</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marcucci</LastName><ForeName>Maura</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cuerden</LastName><ForeName>Meaghan S</ForeName><Initials>MS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sontrop</LastName><ForeName>Jessica M</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Painter</LastName><ForeName>Thomas W</ForeName><Initials>TW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lomivorotov</LastName><ForeName>Vladimir</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sessler</LastName><ForeName>Daniel I</ForeName><Initials>DI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chan</LastName><ForeName>Matthew T V</ForeName><Initials>MTV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Borges</LastName><ForeName>Flavia K</ForeName><Initials>FK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leslie</LastName><ForeName>Kate</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Duceppe</LastName><ForeName>Emmanuelle</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parikh</LastName><ForeName>Chirag R</ForeName><Initials>CR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roshanov</LastName><ForeName>Pavel</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mart&#xed;nez-Zapata</LastName><ForeName>Mar&#xed;a Jos&#xe9;</ForeName><Initials>MJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wang</LastName><ForeName>Chew Yin</ForeName><Initials>CY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Xavier</LastName><ForeName>Denis</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Efremov</LastName><ForeName>Sergey</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kleinlugtenbelt</LastName><ForeName>Ydo V</ForeName><Initials>YV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Szczeklik</LastName><ForeName>Wojciech</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schmartz</LastName><ForeName>Denis</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meyhoff</LastName><ForeName>Christian S</ForeName><Initials>CS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Short</LastName><ForeName>Timothy G</ForeName><Initials>TG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Amir</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Torres</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wittmann</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patel</LastName><ForeName>Ameen</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ruetzler</LastName><ForeName>Kurt</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parlow</LastName><ForeName>Joel L</ForeName><Initials>JL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jayaram</LastName><ForeName>Raja</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Polanczyk</LastName><ForeName>Carisi A</ForeName><Initials>CA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fleischmann</LastName><ForeName>Edith</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tandon</LastName><ForeName>Vikas</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Astrakov</LastName><ForeName>Sergey V</ForeName><Initials>SV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Conen</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kei Wu</LastName><ForeName>William Ka</ForeName><Initials>WK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cheong</LastName><ForeName>Chao Chia</ForeName><Initials>CC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ayad</LastName><ForeName>Sabry</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kirov</LastName><ForeName>Mikhail</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Nadal</LastName><ForeName>Miriam</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Likhvantsev</LastName><ForeName>Valery V</ForeName><Initials>VV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Paniagua</LastName><ForeName>Pilar</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aguado</LastName><ForeName>Hector J</ForeName><Initials>HJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ofori</LastName><ForeName>Sandra N</ForeName><Initials>SN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vincent</LastName><ForeName>Jessica</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Copland</LastName><ForeName>Ingrid</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Balasubramanian</LastName><ForeName>Kumar</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Biccard</LastName><ForeName>Bruce M</ForeName><Initials>BM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Srinathan</LastName><ForeName>Sadeesh</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ismoilov</LastName><ForeName>Samandar</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wang</LastName><ForeName>Michael Ke</ForeName><Initials>MK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kurz</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Belley-Cote</LastName><ForeName>Emilie P</ForeName><Initials>EP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bhatt</LastName><ForeName>Keyur</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eikelboom</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gross</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lamy</LastName><ForeName>Andre</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>McGillion</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>McIntyre</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Richards</LastName><ForeName>Toby</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Spence</LastName><ForeName>Jessica</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Van Helder</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Whitlock</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Devereaux</LastName><ForeName>P J</ForeName><Initials>PJ</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>1</Month><Day>3</Day><Hour>0</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39490985</ArticleId><ArticleId IdType="doi">10.1016/j.kint.2024.10.007</ArticleId><ArticleId IdType="pii">S0085-2538(24)00717-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28738447</PMID><DateCompleted><Year>2019</Year><Month>02</Month><Day>04</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1522-726X</ISSN><JournalIssue CitedMedium="Internet"><Volume>91</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography &amp; Interventions</Title><ISOAbbreviation>Catheter Cardiovasc Interv</ISOAbbreviation></Journal><ArticleTitle>Comparison of local versus general anesthesia in patients undergoing transcatheter aortic valve replacement: A meta-analysis.</ArticleTitle><Pagination><StartPage>330</StartPage><EndPage>342</EndPage><MedlinePgn>330-342</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ccd.27207</ELocationID><Abstract><AbstractText Label="BACKGROUND">Transcatheter aortic valve replacement (TAVR) is typically performed under general anesthesia (GA). However, there is increasing data supporting the safety of performing TAVR under local anesthesia/conscious sedation (LA). We performed a meta-analysis to gain better understanding of the safety and efficacy of LA versus GA in patients with severe aortic stenosis undergoing TAVR.</AbstractText><AbstractText Label="METHODS AND RESULTS">We comprehensively searched EMBASE, PubMed, and Web of Science. Effect sizes were summarized using risk ratios (RRs) difference of the mean (DM), and 95% CIs (confidence intervals) for dichotomous and continuous variables respectively. Twenty-six studies and 10,572 patients were included in the meta-analysis. The use of LA for TAVR was associated with lower overall 30-day mortality (RR, 0.73; 95% CI, 0.57-0.93; P&#x2009;=&#x2009;0.01), use of inotropic/vasopressor drugs (RR, 0.45; 95% CI, 0.28-0.72; P&#x2009;&lt;&#x2009;0.001), hospital length of stay (LOS) (DM, -2.09; 95% CI, -3.02 to -1.16; P&#x2009;&lt;&#x2009;0.001), intensive care unit LOS (DM, -0.18; 95% CI, -0.31 to -0.04; P&#x2009;=&#x2009;0.01), procedure time (DM, -25.02; 95% CI, -32.70 to -17.35; P&#x2009;&lt;&#x2009;0.001); and fluoroscopy time (DM, -1.63; 95% CI, -3.02 to -0.24; P&#x2009;=&#x2009;0.02). No differences were observed between LA and GA for stroke, cardiovascular mortality, myocardial infarction, permanent pacemaker implantation, acute kidney injury, paravalvular leak, vascular complications, major bleeding, procedural success, conduction abnormalities, and annular rupture.</AbstractText><AbstractText Label="CONCLUSION">Our meta-analysis suggests that use of LA for TAVR is associated with a lower 30-day mortality, shorter procedure time, fluoroscopy time, ICU LOS, hospital length of stay, and reduced need for inotropic support.</AbstractText><CopyrightInformation>&#xa9; 2017 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Villablanca</LastName><ForeName>Pedro A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Diseases, Montefiore Medical Center/Albert Einstein College of Medicine, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohananey</LastName><ForeName>Divyanshu</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-2815-2949</Identifier><AffiliationInfo><Affiliation>Department of Hospital Medicine, Cleveland Clinic, Cleveland, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nikolic</LastName><ForeName>Katarina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Mayo Clinic, Scottsdale, Arizona.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bangalore</LastName><ForeName>Sripal</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>New York University School of Medicine, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slovut</LastName><ForeName>David P</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Diseases, Montefiore Medical Center/Albert Einstein College of Medicine, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiothoracic and Vascular Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathew</LastName><ForeName>Verghese</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Loyola University Stritch School of Medicine, Maywood, Illinois.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thourani</LastName><ForeName>Vinod H</ForeName><Initials>VH</Initials><AffiliationInfo><Affiliation>Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rode's-Cabau</LastName><ForeName>Josep</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Qu&#xe9;bec Heart and Lung Institute, Quebec City, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>N&#xfa;&#xf1;ez-Gil</LastName><ForeName>Iv&#xe1;n J</ForeName><Initials>IJ</Initials><Identifier Source="ORCID">0000-0002-1779-3102</Identifier><AffiliationInfo><Affiliation>Instituto Cardiovascular Hospital Cl&#xed;nico San Carlos, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Tina</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Montefiore Medical Center/Albert Einstein College of Medicine, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Tanush</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Diseases, Montefiore Medical Center/Albert Einstein College of Medicine, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briceno</LastName><ForeName>David F</ForeName><Initials>DF</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Diseases, Montefiore Medical Center/Albert Einstein College of Medicine, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia</LastName><ForeName>Mario J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Diseases, Montefiore Medical Center/Albert Einstein College of Medicine, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gutsche</LastName><ForeName>Jacob T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Augoustides</LastName><ForeName>John G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramakrishna</LastName><ForeName>Harish</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Mayo Clinic, Scottsdale, Arizona.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Catheter Cardiovasc Interv</MedlineTA><NlmUniqueID>100884139</NlmUniqueID><ISSNLinking>1522-1946</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Catheter Cardiovasc Interv. 2018 Feb 1;91(2):343-344. doi: 10.1002/ccd.27501.</RefSource><PMID Version="1">29405600</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000772" MajorTopicYN="Y">Anesthesia, Local</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001021" MajorTopicYN="N">Aortic Valve</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="N">Aortic Valve Stenosis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065467" MajorTopicYN="N">Transcatheter Aortic Valve Replacement</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">general anesthesia</Keyword><Keyword MajorTopicYN="N">local anesthesia</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">severe aortic stenosis</Keyword><Keyword MajorTopicYN="N">transcatheter aortic valve replacement</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28738447</ArticleId><ArticleId IdType="doi">10.1002/ccd.27207</ArticleId></ArticleIdList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39922683</PMID><DateCompleted><Year>2025</Year><Month>02</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>The Potential Role of Albumin in Reducing Cardiac Surgery-Associated Acute Kidney Injury: A Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>453</StartPage><EndPage>460</EndPage><MedlinePgn>453-460</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2024.10.012</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(24)00790-0</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Cardiac surgery-associated acute kidney injury (CSA-AKI) is a common complication with high morbidity and mortality. This study was designed to determine whether adding human albumin to the cardiopulmonary bypass (CPB) priming solution reduces the incidence of CSA-AKI.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A double-blind, randomized controlled trial (RCT) involving 248 patients scheduled for cardiac surgery with CPB.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">A single-center tertiary university hospital.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Adults with a baseline estimated glomerular filtration rate (eGFR) of &#x2265;60 mL/min/1.73 m<sup>2</sup> and left ventricular ejection fraction &#x2265;40%.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Patients were randomized to receive either a crystalloid priming solution (Plasma-Lyte) plus 4% albumin (intervention group, n&#x202f;=&#x202f;126) or a crystalloid solution alone (control group, n&#x202f;=&#x202f;122) for CPB.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">Data analyses were performed using the Chi-square test and Student's t-test, or their nonparametric equivalent. The primary outcome was the incidence of CSA-AKI, as defined by the Kidney Disease Improving Global Outcomes criteria, within 5 days postoperatively. Both cohorts were comparable in baseline and perioperative characteristics, including preoperative albumin levels. The incidence of CSA-AKI was 29.3% (n&#x202f;=&#x202f;37) in the intervention group compared with 31.2% (n&#x202f;=&#x202f;38) in the control group (odds ratio: 0.91, 95% confidence interval: 0.53-1.58). The observed difference in CSA-AKI incidence between the groups was not statistically significant. A post-hoc subgroup analysis of patients with a baseline eGFR of 60 to 70 mL/min/1.73 m&#xb2; indicated a trend toward a reduced incidence of CSA-AKI in the intervention group compared with the control group (35.7% v 57.6%; odds ratio: 0.41, 95% confidence interval: 0.16-1.03). This trend was not observed in patients with an eGFR greater than 70 mL/min/1.73 m&#xb2;. No significant differences were observed between groups for the need for inotropes or vasoconstrictors, incidence of cardiogenic or distributive shock, bleeding, need for transfusion, or use of nephrotoxic drugs.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Adding albumin to the CPB priming solution did not decrease the incidence of CSA-AKI in patients with normal preoperative renal function. These findings suggest that albumin might benefit patients with impaired renal function, warranting further investigation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Miralles Bag&#xe1;n</LastName><ForeName>Jordi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Reanimation and Pain Therapy, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Electronic address: jmiralles@santpau.cat.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parrilla Quiles</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Reanimation and Pain Therapy, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paniagua Iglesias</LastName><ForeName>Pilar</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Reanimation and Pain Therapy, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Betbes&#xe9; Roig</LastName><ForeName>Antoni J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabat&#xe9; Tenas</LastName><ForeName>Sergi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Reanimation and Pain Therapy, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;rez Garc&#xed;a</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Reanimation and Pain Therapy, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a &#xc1;lvarez</LastName><ForeName>Mercedes</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Reanimation and Pain Therapy, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000418">Albumins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077324">Crystalloid Solutions</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="Y">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000418" MajorTopicYN="Y">Albumins</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077324" MajorTopicYN="N">Crystalloid Solutions</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">albumin</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">priming solution</Keyword><Keyword MajorTopicYN="N">randomized controlled trial</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>2</Month><Day>8</Day><Hour>20</Hour><Minute>59</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39922683</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2024.10.012</ArticleId><ArticleId IdType="pii">S1053-0770(24)00790-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26181335</PMID><DateCompleted><Year>2015</Year><Month>11</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1175</ISSN><JournalIssue CitedMedium="Internet"><Volume>123</Volume><Issue>3</Issue><PubDate><Year>2015</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery.</ArticleTitle><Pagination><StartPage>515</StartPage><EndPage>523</EndPage><MedlinePgn>515-23</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ALN.0000000000000765</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Intraoperative hypotension (IOH) may be associated with postoperative acute kidney injury (AKI), but the duration of hypotension for triggering harm is unclear. The authors investigated the association between varying periods of IOH with mean arterial pressure (MAP) less than 55, less than 60, and less than 65 mmHg with AKI.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The authors conducted a retrospective cohort study of 5,127 patients undergoing noncardiac surgery (2009 to 2012) with invasive MAP monitoring and length of stay of 1 or more days. Exclusion criteria were preoperative MAP less than 65 mmHg, dialysis dependence, urologic surgery, and surgical duration less than 30 min. The primary exposure was IOH. The primary outcome was AKI (50% or 0.3 mg/dl increase in creatinine) during the first 2 postoperative days. Multivariable logistic regression was used to model the exposure-outcome relationship.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">AKI occurred in 324 (6.3%) patients and was associated with MAP less than 60 mmHg for 11 to 20 min and MAP less than 55 mmHg for more than 10 min in a graded fashion. The adjusted odds ratio of AKI for MAP less than 55 mmHg was 2.34 (1.35 to 4.05) for 11- to 20-min exposure and 3.53 (1.51 to 8.25) for more than 20 min. For MAP less than 60 mmHg, the adjusted odds ratio for AKI was 1.84 (1.11 to 3.06) for 11- to 20-min exposure.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In this analysis, postoperative AKI is associated with sustained intraoperative periods of MAP less than 55 and less than 60 mmHg. This study provides an impetus for clinical trials to determine whether interventions that promptly treat IOH and are tailored to individual patient physiology could help reduce the risk of AKI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Louise Y</ForeName><Initials>LY</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia, Toronto General Hospital and University of Toronto, Toronto, Ontario, Canada (L.Y.S., D.N.W., G.A.T., W.S.B.); Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Ontario, Canada (D.N.W.); Institute of Health Policy Management and Evaluation, Toronto, Ontario, Canada (D.N.W.); and Cardiovascular Research Program, Institute for Clinical Evaluative Sciences, Totonto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wijeysundera</LastName><ForeName>Duminda N</ForeName><Initials>DN</Initials></Author><Author ValidYN="Y"><LastName>Tait</LastName><ForeName>Gordon A</ForeName><Initials>GA</Initials></Author><Author ValidYN="Y"><LastName>Beattie</LastName><ForeName>W Scott</ForeName><Initials>WS</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Canadian Institutes of Health Research</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Ren Fail. 2016;38(1):168-9. doi: 10.3109/0886022X.2015.1128448.</RefSource><PMID Version="1">26727185</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="N">Monitoring, Intraoperative</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>11</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26181335</ArticleId><ArticleId IdType="doi">10.1097/ALN.0000000000000765</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38865746</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-8673</ISSN><JournalIssue CitedMedium="Internet"><Volume>300</Volume><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>The Journal of surgical research</Title><ISOAbbreviation>J Surg Res</ISOAbbreviation></Journal><ArticleTitle>Intraoperative Glucose and Kidney Injury After On-Pump Cardiac Surgery: A Retrospective Cohort Study.</ArticleTitle><Pagination><StartPage>439</StartPage><EndPage>447</EndPage><MedlinePgn>439-447</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jss.2024.04.080</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-4804(24)00281-6</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Acute kidney injury (AKI) is a common complication after on-pump cardiac surgery, and previous studies have suggested that blood glucose is associated with postoperative AKI. However, limited evidence is available regarding intraoperative glycemic thresholds in cardiac surgery. The aim of this study was to explore the association between peak intraoperative blood glucose and postoperative AKI, and determine the cut-off values for intraoperative glucose concentration associated with an increased risk of AKI.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study was retrospective and single-centered. Adult patients in West China Hospital of Sichuan University who underwent on-pump cardiac surgery (n&#xa0;=&#xa0;3375) were included. The primary outcome was the incidence of AKI. Multivariable logistic analysis using restricted cubic spline was performed to explore the association between intraoperative blood glucose and postoperative AKI.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The incidence of AKI in the study population was 18.0% (607 of 3375). Patients who developed AKI had a significantly higher peak intraoperative glucose during the surgery compared to those without AKI. After adjustment for confounders, the incidence of AKI increased with peak intraoperative blood glucose (adjusted odds ratio, 1.08, 95% confidence interval 1.03, 1.12). Furthermore, it was demonstrated that the possibility of AKI was relatively &#xfb02;at till 127.8&#xa0;mg/dL (7.1&#xa0;mmol/L) glucose levels which started to rapidly increase afterward.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Increased intraoperative blood glucose was associated with an increased risk of AKI. Among patients undergoing on-pump cardiac surgery, avoiding a high glucose peak (i.e., below 127.8&#xa0;mg/dL [7.1&#xa0;mmol/L]) may reduce the risk of postoperative AKI.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yuyang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital of Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Shuang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital of Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Xinglong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Leng</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital of Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Dongxu</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Second Hospital of Sichuan University, Chengdu, China; Sichuan University West China Second University Hospital Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Chengdu, China. Electronic address: scucdx@foxmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Surg Res</MedlineTA><NlmUniqueID>0376340</NlmUniqueID><ISSNLinking>0022-4804</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="Y">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007432" MajorTopicYN="N">Intraoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Cut-off value</Keyword><Keyword MajorTopicYN="N">Intraoperative blood glucose</Keyword><Keyword MajorTopicYN="N">On-pump</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>15</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>12</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>12</Day><Hour>17</Hour><Minute>59</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38865746</ArticleId><ArticleId IdType="doi">10.1016/j.jss.2024.04.080</ArticleId><ArticleId IdType="pii">S0022-4804(24)00281-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25622933</PMID><DateCompleted><Year>2015</Year><Month>12</Month><Day>29</Day></DateCompleted><DateRevised><Year>2015</Year><Month>03</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1496-8975</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>4</Issue><PubDate><Year>2015</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Canadian journal of anaesthesia = Journal canadien d'anesthesie</Title><ISOAbbreviation>Can J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Combined general and neuraxial anesthesia versus general anesthesia: a population-based cohort study.</ArticleTitle><Pagination><StartPage>356</StartPage><EndPage>368</EndPage><MedlinePgn>356-68</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12630-015-0315-1</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To determine whether combining spinal or epidural anesthesia with general anesthesia (combined anesthesia) reduces major medical complications of elective surgery compared with general anesthesia alone.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a propensity-matched population-based historical cohort study using large healthcare databases from Ontario, Canada. We identified patients undergoing 21 different elective procedures that were amenable to either combined anesthesia or general anesthesia alone in 108 hospitals from 2004 to 2011. We assessed the following four outcomes together as a composite and individually in the 30&#xa0;days following surgery: acute kidney injury, stroke, myocardial infarction, and all-cause mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Prior to matching, we identified 21,701 patients receiving general anesthesia and 8,042 patients receiving combined anesthesia. After matching, our cohort included 12,379 patients. Twenty-eight baseline characteristics were well-matched between the combined (n&#xa0;=&#xa0;4,773) and general anesthesia groups (n&#xa0;=&#xa0;7,606). Mean patient age was 66&#xa0;yr. Relative to general anesthesia alone, combined anesthesia was not associated with a reduced risk for the composite outcome [104/4,773 (2.2%) vs 162/7,606 (2.1%); odds ratio (OR) 0.97; 95% confidence interval (CI) 0.75 to 1.24] or for any of the four component outcomes when examined separately: acute kidney injury (OR 0.93; 95% CI 0.58 to 1.51), stroke (OR 0.79; 95% CI 0.36 to 1.73), myocardial infarction (OR 1.04; 95% CI 0.69 to 1.57), and all-cause mortality (OR 0.91; 95% CI 0.59 to 1.42).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The addition of spinal or epidural anesthesia to general anesthesia was not associated with a reduced risk of major medical complications among 21 different elective procedures when compared with general anesthesia alone.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nash</LastName><ForeName>Danielle M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Institute for Clinical Evaluative Sciences Western, London Health Sciences Centre, 800 Commissioners Rd. E, Room ELL-113A, London, ON, N6A 4G5, Canada, danielle.nash@ices.on.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mustafa</LastName><ForeName>Reem A</ForeName><Initials>RA</Initials></Author><Author ValidYN="Y"><LastName>McArthur</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Wijeysundera</LastName><ForeName>Duminda N</ForeName><Initials>DN</Initials></Author><Author ValidYN="Y"><LastName>Paterson</LastName><ForeName>J Michael</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Sharan</LastName><ForeName>Sumit</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Vinden</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Wald</LastName><ForeName>Ron</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Welk</LastName><ForeName>Blayne</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Sessler</LastName><ForeName>Daniel I</ForeName><Initials>DI</Initials></Author><Author ValidYN="Y"><LastName>Devereaux</LastName><ForeName>P J</ForeName><Initials>PJ</Initials></Author><Author ValidYN="Y"><LastName>Walsh</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Garg</LastName><ForeName>Amit X</ForeName><Initials>AX</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>01</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Can J Anaesth</MedlineTA><NlmUniqueID>8701709</NlmUniqueID><ISSNLinking>0832-610X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000767" MajorTopicYN="N">Anesthesia, Epidural</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000775" MajorTopicYN="N">Anesthesia, Spinal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009864" MajorTopicYN="N" Type="Geographic">Ontario</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>12</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25622933</ArticleId><ArticleId IdType="doi">10.1007/s12630-015-0315-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36912515</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-9159</ISSN><JournalIssue CitedMedium="Internet"><Volume>109</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of surgery (London, England)</Title><ISOAbbreviation>Int J Surg</ISOAbbreviation></Journal><ArticleTitle>The correlation of intraoperative oliguria with acute kidney injury after noncardiac surgery: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>449</StartPage><EndPage>457</EndPage><MedlinePgn>449-457</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/JS9.0000000000000284</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute kidney injury (AKI) occurs commonly after major surgery and is correlated with increased in-hospital morbidity and mortality. There is no consensus on whether intraoperative oliguria affects postoperative AKI. We conducted a meta-analysis to systematically assess the correlation of intraoperative oliguria with postoperative AKI.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed, Embase, Web of Science, and Cochrane Library databases were searched to identify reports on the relationship between intraoperative oliguria and postoperative AKI. Quality was assessed using the Newcastle-Ottawa Scale. The primary outcomes were the unadjusted and multivariate-adjusted odds ratios (ORs) for intraoperative oliguria to correlate with postoperative AKI. The secondary outcomes included intraoperative urine output in the AKI and non-AKI groups, the demand for postoperative renal replacement therapy (RRT), in-hospital mortality, and length of hospital stay in the oliguria and non-oliguria groups.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Nine eligible studies with 18&#xa0;473 patients were included. The meta-analysis revealed that patients with intraoperative oliguria had a considerably greater risk of postoperative AKI (unadjusted OR: 2.03, 95% CI: 1.60-2.58, I2 =63%, P &lt;0.00001; multivariate-adjusted OR: 2.00, 95% CI: 1.64-2.44, I2 =40%, P &lt;0.00001). Further subgroup analysis did not find differences between different oliguria criteria or surgical types. Furthermore, the AKI group's pooled intraoperative urine output was less (mean differences: -0.16, 95% CI: -0.26 to -0.07, P &lt;0.001). Intraoperative oliguria was associated with increased demand for postoperative RRT (risk ratios: 4.71, 95% CI: 2.83-7.84, P &lt;0.001) and in-hospital mortality (risk ratios: 1.83, 95% CI: 1.24-2.69, P =0.002), but not with prolonged length of hospital stay (mean differences: 0.55, 95% CI: -0.27 to 1.38, P =0.19).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Intraoperative oliguria was significantly associated with a higher incidence of postoperative AKI, as well as increased in-hospital mortality and demand for postoperative RRT, but not with prolonged hospitalization.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pang</LastName><ForeName>Zhaohua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Shuang</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3899-0145</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xing</LastName><ForeName>Manyu</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3897-1622</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Nannan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Qulian</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0002-5636-8491</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Wangyuan</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-4813-2806</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Centre for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Surg</MedlineTA><NlmUniqueID>101228232</NlmUniqueID><ISSNLinking>1743-9159</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="Y">Renal Replacement Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest. Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>13</Day><Hour>9</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36912515</ArticleId><ArticleId IdType="pmc">PMC10389605</ArticleId><ArticleId IdType="doi">10.1097/JS9.0000000000000284</ArticleId><ArticleId IdType="pii">01279778-202303000-00030</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Garg AX, Kurz A, Sessler DI, et al. . Perioperative aspirin and clonidine and risk of acute kidney injury: a randomized clinical trial. JAMA 2014;312:2254&#x2013;2264.</Citation><ArticleIdList><ArticleId IdType="pubmed">25399007</ArticleId></ArticleIdList></Reference><Reference><Citation>Biteker M, Dayan A, Tekkesin AI, et al. . Incidence, risk factors, and outcomes of perioperative acute kidney injury in noncardiac and nonvascular surgery. Am J Surg 2014;207:53&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">24050540</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor ME, Kirwan CJ, Pearse RM, et al. . Incidence and associations of acute kidney injury after major abdominal surgery. Intensive Care Med 2016;42:521&#x2013;530.</Citation><ArticleIdList><ArticleId IdType="pubmed">26602784</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow GM, Burdick E, Honour M, et al. . Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005;16:3365&#x2013;3370.</Citation><ArticleIdList><ArticleId IdType="pubmed">16177006</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaara ST, Bellomo R. Postoperative renal dysfunction after noncardiac surgery. Curr Opin Crit Care 2017;23:440&#x2013;446.</Citation><ArticleIdList><ArticleId IdType="pubmed">28820797</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012;120:c179&#x2013;c184.</Citation><ArticleIdList><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Zacharias M, Mugawar M, Herbison GP, et al. . Interventions for protecting renal function in the perioperative period. Cochrane Database Syst Rev 2013;9:CD003590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7154582</ArticleId><ArticleId IdType="pubmed">24027097</ArticleId></ArticleIdList></Reference><Reference><Citation>Goren O, Matot I. Perioperative acute kidney injury. Br J Anaesth 2015;115(Suppl 2):ii3&#x2013;ii14.</Citation><ArticleIdList><ArticleId IdType="pubmed">26658199</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Tremper KK, Englesbe MJ, et al. . Predictors of postoperative acute renal failure after noncardiac surgery in patients with previously normal renal function. Anesthesiology 2007;107:892&#x2013;902.</Citation><ArticleIdList><ArticleId IdType="pubmed">18043057</ArticleId></ArticleIdList></Reference><Reference><Citation>Romagnoli S, Zagli G, Tuccinardi G, et al. . Postoperative acute kidney injury in high-risk patients undergoing major abdominal surgery. J Crit Care 2016;35:120&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pubmed">27481746</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Tremper KK, Heung M, et al. . Development and validation of an acute kidney injury risk index for patients undergoing general surgery: results from a national data set. Anesthesiology 2009;110:505&#x2013;515.</Citation><ArticleIdList><ArticleId IdType="pubmed">19212261</ArticleId></ArticleIdList></Reference><Reference><Citation>Long TE, Helgason D, Helgadottir S, et al. . Acute kidney injury after abdominal surgery: incidence, risk factors, and outcome. Anesth Analg 2016;122:1912&#x2013;1920.</Citation><ArticleIdList><ArticleId IdType="pubmed">27195635</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafsson UO, Scott MJ, Hubner M, et al. . Guidelines for perioperative care in elective colorectal surgery: Enhanced Recovery After Surgery (ERAS(R)) Society Recommendations: 2018. World J Surg 2019;43:659&#x2013;695.</Citation><ArticleIdList><ArticleId IdType="pubmed">30426190</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmichael JC, Keller DS, Baldini G, et al. . Clinical practice guidelines for enhanced recovery after colon and rectal surgery from the American Society of Colon and Rectal Surgeons and Society of American Gastrointestinal and Endoscopic Surgeons. Dis Colon Rectum 2017;60:761&#x2013;784.</Citation><ArticleIdList><ArticleId IdType="pubmed">28682962</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Kirwan CJ, Bellomo R. Fluid management for the prevention and attenuation of acute kidney injury. Nat Rev Nephrol 2014;10:37&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">24217464</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiba A, Uchino S, Fujii T, et al. . Association between intraoperative oliguria and acute kidney injury after major noncardiac surgery. Anesth Analg 2018;127:1229&#x2013;1235.</Citation><ArticleIdList><ArticleId IdType="pubmed">29933276</ArticleId></ArticleIdList></Reference><Reference><Citation>Slankamenac K, Beck-Schimmer B, Breitenstein S, et al. . Novel prediction score including pre- and intraoperative parameters best predicts acute kidney injury after liver surgery. World J Surg 2013;37:2618&#x2013;2628.</Citation><ArticleIdList><ArticleId IdType="pubmed">23959337</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizota T, Yamamoto Y, Hamada M, et al. . Intraoperative oliguria predicts acute kidney injury after major abdominal surgery. Br J Anaesth 2017;119:1127&#x2013;1134.</Citation><ArticleIdList><ArticleId IdType="pubmed">29136086</ArticleId></ArticleIdList></Reference><Reference><Citation>Myles PS, Mcilroy DR, Bellomo R, et al. . Importance of intraoperative oliguria during major abdominal surgery: findings of the Restrictive versus Liberal Fluid Therapy in Major Abdominal Surgery trial. Br J Anaesth 2019;122:726&#x2013;733.</Citation><ArticleIdList><ArticleId IdType="pubmed">30916001</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng ZT, Mu DL. Impact of oliguria during lung surgery on postoperative acute kidney injury. Beijing Da Xue Xue Bao Yi Xue Ban 2020;53:188&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7867982</ArticleId><ArticleId IdType="pubmed">33550355</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim JW, Kim KR, Jung Y, et al. . Role of intraoperative oliguria in risk stratification for postoperative acute kidney injury in patients undergoing colorectal surgery with an enhanced recovery protocol: a propensity score matching analysis. PLoS One 2020;15:e0231447.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164643</ArticleId><ArticleId IdType="pubmed">32302336</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao BC, Lei SH, Yang X, et al. . Assessment of prognostic value of intraoperative oliguria for postoperative acute kidney injury: a retrospective cohort study. Br J Anaesth 2021;126:799&#x2013;807.</Citation><ArticleIdList><ArticleId IdType="pubmed">33342539</ArticleId></ArticleIdList></Reference><Reference><Citation>Alpert RA, Roizen MF, Hamilton WK, et al. . Intraoperative urinary output does not predict postoperative renal function in patients undergoing abdominal aortic revascularization. Surgery 1984;95:707&#x2013;711.</Citation><ArticleIdList><ArticleId IdType="pubmed">6427960</ArticleId></ArticleIdList></Reference><Reference><Citation>Knos GB, Berry AJ, Isaacson IJ, et al. . Intraoperative urinary output and postoperative blood urea nitrogen and creatinine levels in patients undergoing aortic reconstructive surgery. J Clin Anesth 1989;1:181&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">2627385</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, Koyner JL, Hoste E, et al. . Update on perioperative acute kidney injury. Anesth Analg 2018;127:1236&#x2013;1245.</Citation><ArticleIdList><ArticleId IdType="pubmed">30138176</ArticleId></ArticleIdList></Reference><Reference><Citation>Goren O, Levy A, Cattan A, et al. . Acute kidney injury in pancreatic surgery; association with urine output and intraoperative fluid administration. Am J Surg 2017;214:246&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="pubmed">28223046</ArticleId></ArticleIdList></Reference><Reference><Citation>Inacio R, Gameiro J, Amaro S, et al. . Intraoperative oliguria does not predict postoperative acute kidney injury in major abdominal surgery: a cohort analysis. J Bras Nefrol 2021;43:9&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8061965</ArticleId><ArticleId IdType="pubmed">32779689</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, Mckenzie JE, Bossuyt PM, et al. . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg 2021;88:105906.</Citation><ArticleIdList><ArticleId IdType="pubmed">33789826</ArticleId></ArticleIdList></Reference><Reference><Citation>Susantitaphong P, Cruz DN, Cerda J, et al. . World incidence of AKI: a meta-analysis. Clin J Am Soc Nephrol 2013;8:1482&#x2013;1493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3805065</ArticleId><ArticleId IdType="pubmed">23744003</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo D, Wan X, Liu J, et al. . Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res 2018;27:1785&#x2013;1805.</Citation><ArticleIdList><ArticleId IdType="pubmed">27683581</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X, Wang W, Liu J, et al. . Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 2014;14:135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Zou W. Research progress in influence of perioperative hypotension on postoperative outcome of patients. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2021;46:84&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10878287</ArticleId><ArticleId IdType="pubmed">33678641</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang S, Zou W. Effect of the intraoperative use of the Hypotension Prediction Index on postoperative hypotension in the postanaesthesia care unit. Comment on Br J Anaesth 2021; 127: 681&#x2013;8. Br J Anaesth 2022;128:E340&#x2013;E341.</Citation><ArticleIdList><ArticleId IdType="pubmed">35331545</ArticleId></ArticleIdList></Reference><Reference><Citation>Sear JW. Kidney dysfunction in the postoperative period. Br J Anaesth 2005;95:20&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">15531622</ArticleId></ArticleIdList></Reference><Reference><Citation>Abelha FJ, Botelho M, Fernandes V, et al. . Determinants of postoperative acute kidney injury. Crit Care 2009;13:R79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2717442</ArticleId><ArticleId IdType="pubmed">19463152</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Liu YL, Licari E, et al. . Oliguria as predictive biomarker of acute kidney injury in critically ill patients. Crit Care 2011;15:R172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3387614</ArticleId><ArticleId IdType="pubmed">21771324</ArticleId></ArticleIdList></Reference><Reference><Citation>Small RG, Witt RE. Major and minor surgery. JAMA 1965;191:180&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pubmed">14233251</ArticleId></ArticleIdList></Reference><Reference><Citation>Macedo E, Malhotra R, Bouchard J, et al. . Oliguria is an early predictor of higher mortality in critically ill patients. Kidney Int 2011;80:760&#x2013;767.</Citation><ArticleIdList><ArticleId IdType="pubmed">21716258</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccinni P, Cruz DN, Gramaticopolo S, et al. . Prospective multicenter study on epidemiology of acute kidney injury in the ICU: a critical care nephrology Italian collaborative effort (NEFROINT). Minerva Anestesiol 2011;77:1072&#x2013;1083.</Citation><ArticleIdList><ArticleId IdType="pubmed">21597441</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostermann M, Liu K. Pathophysiology of AKI. Best Pract Res Clin Anaesthesiol 2017;31:305&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pubmed">29248138</ArticleId></ArticleIdList></Reference><Reference><Citation>Grams ME, Sang Y, Coresh J, et al. . Acute kidney injury after major surgery: a retrospective analysis of veterans health administration data. Am J Kidney Dis 2016;67:872&#x2013;880.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4775458</ArticleId><ArticleId IdType="pubmed">26337133</ArticleId></ArticleIdList></Reference><Reference><Citation>du Toit L, Biccard BM. The relationship between intraoperative oliguria and acute kidney injury. Br J Anaesth 2019;122:707&#x2013;710.</Citation><ArticleIdList><ArticleId IdType="pubmed">30961912</ArticleId></ArticleIdList></Reference><Reference><Citation>Egal M, de Geus HR, van Bommel J, et al. . Targeting oliguria reversal in perioperative restrictive fluid management does not influence the occurrence of renal dysfunction: a systematic review and meta-analysis. Eur J Anaesthesiol 2016;33:425&#x2013;435.</Citation><ArticleIdList><ArticleId IdType="pubmed">26840829</ArticleId></ArticleIdList></Reference><Reference><Citation>Egal M, Erler NS, de Geus HR, et al. . Targeting oliguria reversal in goal-directed hemodynamic management does not reduce renal dysfunction in perioperative and critically ill patients: a systematic review and meta-analysis. Anesth Analg 2016;122:173&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">26505575</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho KM, Sheridan DJ. Meta-analysis of frusemide to prevent or treat acute renal failure. BMJ 2006;333:420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1553510</ArticleId><ArticleId IdType="pubmed">16861256</ArticleId></ArticleIdList></Reference><Reference><Citation>Matot I, Paskaleva R, Eid L, et al. . Effect of the volume of fluids administered on intraoperative oliguria in laparoscopic bariatric surgery: a randomized controlled trial. Arch Surg 2012;147:228&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pubmed">22106246</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SJ, Lehner GF, Forni LG, et al. . Oliguria in critically ill patients: a narrative review. J Nephrol 2018;31:855&#x2013;862.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6244549</ArticleId><ArticleId IdType="pubmed">30298272</ArticleId></ArticleIdList></Reference><Reference><Citation>Kambhampati G, Ross EA, Alsabbagh MM, et al. . Perioperative fluid balance and acute kidney injury. Clin Exp Nephrol 2012;16:730&#x2013;738.</Citation><ArticleIdList><ArticleId IdType="pubmed">22457087</ArticleId></ArticleIdList></Reference><Reference><Citation>Nisanevich V, Felsenstein I, Almogy G, et al. . Effect of intraoperative fluid management on outcome after intraabdominal surgery. Anesthesiology 2005;103:25&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">15983453</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira C, Garzotto F, Piccinni P, et al. . Fluid balance and urine volume are independent predictors of mortality in acute kidney injury. Crit Care 2013;17:R14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4057508</ArticleId><ArticleId IdType="pubmed">23347825</ArticleId></ArticleIdList></Reference><Reference><Citation>Schortgen F, Schetz M. Does this critically ill patient with oliguria need more fluids, a vasopressor, or neither? Intensive Care Med 2017;43:907&#x2013;910.</Citation><ArticleIdList><ArticleId IdType="pubmed">28293703</ArticleId></ArticleIdList></Reference><Reference><Citation>Perner A, Prowle J, Joannidis M, et al. . Fluid management in acute kidney injury. Intensive Care Med 2017;43:807&#x2013;815.</Citation><ArticleIdList><ArticleId IdType="pubmed">28470347</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Yang R, Xu J, et al. . Effects of intraoperative fluid management on postoperative outcomes after lobectomy. Ann Thorac Surg 2019;107:1663&#x2013;1669.</Citation><ArticleIdList><ArticleId IdType="pubmed">30641068</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37996826</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2318</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>23</Day></PubDate></JournalIssue><Title>BMC geriatrics</Title><ISOAbbreviation>BMC Geriatr</ISOAbbreviation></Journal><ArticleTitle>Impact of frailty on the outcomes of patients undergoing degenerative spine surgery: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>771</StartPage><MedlinePgn>771</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">771</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12877-023-04448-2</ELocationID><Abstract><AbstractText Label="BACKGROUND">Degenerative spinal diseases are common in older adults with concurrent frailty. Preoperative frailty is a strong predictor of adverse clinical outcomes after surgery. This study aimed to investigate the association between health-related outcomes and frailty in patients undergoing spine surgery for degenerative spine diseases.</AbstractText><AbstractText Label="METHODS">A systematic review and meta-analysis were performed by electronically searching Ovid-MEDLINE, Ovid-Embase, Cochrane Library, and CINAHL for eligible studies until July 16, 2022. We reviewed all studies, excluding spinal tumours, non-surgical procedures, and experimental studies that examined the association between preoperative frailty and related outcomes after spine surgery. A total of 1,075 articles were identified in the initial search and were reviewed by two reviewers, independently. Data were subjected to qualitative and quantitative syntheses by meta-analytic methods.</AbstractText><AbstractText Label="RESULTS">Thirty-eight articles on 474,651 patients who underwent degenerative spine surgeries were included and 17 papers were quantitatively synthesized. The health-related outcomes were divided into clinical outcomes and patient-reported outcomes; clinical outcomes were further divided into postoperative complications and supportive management procedures. Compared to the non-frail group, the frail group was significantly associated with a greater risk of high mortality, major complications, acute renal failure, myocardial infarction, non-home discharge, reintubation, and longer length of hospital stay. Regarding patient-reported outcomes, changes in scores between the preoperative and postoperative Oswestry Disability Index scores were not associated with preoperative frailty.</AbstractText><AbstractText Label="CONCLUSIONS">In degenerative spinal diseases, frailty is a strong predictor of adverse clinical outcomes after spine surgery. The relationship between preoperative frailty and patient-reported outcomes is still inconclusive. Further research is needed to consolidate the evidence from patient-reported outcomes.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Baek</LastName><ForeName>Wonhee</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>College of Nursing, Gyeongsang National University, Jinju-si, Gyeongsangnam-do, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sun-Young</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>College of Nursing, Daegu Catholic University, Daegu-si, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Yoonjoo</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Nursing, College of Healthcare Sciences, Far East University, Eumseong-gun, Chungcheongbuk-do, South Korea. yjbaraem@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NRF-2021R1G1A1093450</GrantID><Agency>the Korea government [Ministry of Science and ICT</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Geriatr</MedlineTA><NlmUniqueID>100968548</NlmUniqueID><ISSNLinking>1471-2318</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073496" MajorTopicYN="Y">Frailty</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013122" MajorTopicYN="Y">Spinal Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Frailty</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Patient-reported outcome measures</Keyword><Keyword MajorTopicYN="N">Spine surgery</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>27</Day><Hour>16</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>24</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>23</Day><Hour>23</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37996826</ArticleId><ArticleId IdType="pmc">PMC10668507</ArticleId><ArticleId IdType="doi">10.1186/s12877-023-04448-2</ArticleId><ArticleId IdType="pii">10.1186/s12877-023-04448-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yolcu YU, Helal A, Alexander AY, Bhatti AU, Alvi MA, Abode-Iyamah K, Bydon M. Minimally invasive Versus Open Surgery for degenerative spine disorders for Elderly patients: experiences from a single Institution. World Neurosurg. 2021;146:e1262&#x2013;9. doi: 10.1016/j.wneu.2020.11.145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2020.11.145</ArticleId><ArticleId IdType="pubmed">33276177</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin BI, Mirza SK, Spina N, Spiker WR, Lawrence B, Brodke DS. Trends in lumbar Fusion Procedure Rates and Associated Hospital costs for degenerative spinal Diseases in the United States, 2004 to 2015. Spine (Phila Pa 1976) 2019;44(5):369&#x2013;76. doi: 10.1097/brs.0000000000002822.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/brs.0000000000002822</ArticleId><ArticleId IdType="pubmed">30074971</ArticleId></ArticleIdList></Reference><Reference><Citation>Beschloss A, Dicindio C, Lombardi J, Varthi A, Ozturk A, Lehman R, Lenke L, Saifi C. Marked increase in spinal deformity Surgery throughout the United States. Spine (Phila Pa 1976) 2021;46(20):1402&#x2013;8. doi: 10.1097/brs.0000000000004041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/brs.0000000000004041</ArticleId><ArticleId IdType="pubmed">33769412</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K, Ando K, Nishida Y, Ishiguro N, Imagama S. Epidemiological trends in spine Surgery over 10 years in a multicenter database. Eur Spine J. 2018;27(8):1698&#x2013;703. doi: 10.1007/s00586-018-5513-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-018-5513-4</ArticleId><ArticleId IdType="pubmed">29435653</ArticleId></ArticleIdList></Reference><Reference><Citation>Neifert SN, Martini ML, Yuk F, McNeill IT, Caridi JM, Steinberger J, Oermann EK. Predicting trends in cervical spinal Surgery in the United States from 2020 to 2040. World Neurosurg. 2020;141:e175&#x2013;81. doi: 10.1016/j.wneu.2020.05.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2020.05.055</ArticleId><ArticleId IdType="pubmed">32416237</ArticleId></ArticleIdList></Reference><Reference><Citation>Puvanesarajah V, Jain A, Kebaish K, Shaffrey CI, Sciubba DM, De la Garza-Ramos R, Khanna AJ, Hassanzadeh H. Poor Nutrition status and lumbar Spine Fusion Surgery in the Elderly: readmissions, Complications, and Mortality. Spine (Phila Pa 1976) 2017;42(13):979&#x2013;83. doi: 10.1097/brs.0000000000001969.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/brs.0000000000001969</ArticleId><ArticleId IdType="pubmed">27831968</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan V, Witiw CD, Wilson JR, Wilson JR, Coyte P, Fehlings MG. Frailty is an important predictor of 30-day morbidity in patients treated for lumbar spondylolisthesis using a posterior surgical approach. Spine J. 2021 doi: 10.1016/j.spinee.2021.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.spinee.2021.08.008</ArticleId><ArticleId IdType="pubmed">34500077</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirase T, Haghshenas V, Bratescu R, Dong D, Kuo PH, Rashid A, Kavuri V, Hanson DS, Meyer BC, Marco RAW. Sarcopenia predicts perioperative adverse events following complex revision Surgery for the thoracolumbar spine. Spine J. 2021;21(6):1001&#x2013;9. doi: 10.1016/j.spinee.2021.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.spinee.2021.02.001</ArticleId><ArticleId IdType="pubmed">33561547</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna K, Ditillo M, Joseph B. The role of frailty and prehabilitation in Surgery. Curr Opin Crit Care. 2019;25(6):717&#x2013;22. doi: 10.1097/mcc.0000000000000669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/mcc.0000000000000669</ArticleId><ArticleId IdType="pubmed">31689246</ArticleId></ArticleIdList></Reference><Reference><Citation>Leven DM, Lee NJ, Kothari P, Steinberger J, Guzman J, Skovrlj B, Shin JI, Caridi JM, Cho SK. Frailty Index is a significant predictor of Complications and mortality after Surgery for adult spinal deformity. Spine (Phila Pa 1976) 2016;41(23):E1394&#x2013;e1401. doi: 10.1097/brs.0000000000001886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/brs.0000000000001886</ArticleId><ArticleId IdType="pubmed">27584671</ArticleId></ArticleIdList></Reference><Reference><Citation>Susano MJ, Grasfield RH, Friese M, Rosner B, Crosby G, Bader AM, Kang JD, Smith TR, Lu Y, Groff MW, et al. Brief preoperative screening for Frailty and Cognitive Impairment predicts delirium after spine Surgery. Anesthesiology. 2020;133(6):1184&#x2013;91. doi: 10.1097/aln.0000000000003523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/aln.0000000000003523</ArticleId><ArticleId IdType="pmc">PMC7657972</ArticleId><ArticleId IdType="pubmed">32898243</ArticleId></ArticleIdList></Reference><Reference><Citation>Charest-Morin R, Street J, Zhang H, Roughead T, Ailon T, Boyd M, Dvorak M, Kwon B, Paquette S, Dea N, et al. Frailty and Sarcopenia do not predict adverse events in an elderly population undergoing non-complex primary elective Surgery for degenerative conditions of the lumbar spine. Spine J. 2018;18(2):245&#x2013;54. doi: 10.1016/j.spinee.2017.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.spinee.2017.07.003</ArticleId><ArticleId IdType="pubmed">28709946</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown AE, Lebovic J, Alas H, Pierce KE, Bortz CA, Ahmad W, Naessig S, Hassanzadeh H, Labaran LA, Puvanesarajah V, et al. A cost utility analysis of treating different adult spinal deformity frailty states. J Clin Neurosci. 2020;80:223&#x2013;8. doi: 10.1016/j.jocn.2020.07.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2020.07.047</ArticleId><ArticleId IdType="pubmed">33099349</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannah TC, Neifert SN, Caridi JM, Martini ML, Lamb C, Rothrock RJ, Yuk FJ, Gilligan J, Genadry L, Gal JS. Utility of the Hospital Frailty Risk score for Predicting adverse outcomes in degenerative spine Surgery cohorts. Neurosurgery. 2020;87(6):1223&#x2013;30. doi: 10.1093/neuros/nyaa248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/neuros/nyaa248</ArticleId><ArticleId IdType="pubmed">32542353</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw JF, Budiansky D, Sharif F, McIsaac DI. The Association of Frailty with outcomes after Cancer Surgery: a systematic review and metaanalysis. Ann Surg Oncol. 2022 doi: 10.1245/s10434-021-11321-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-021-11321-2</ArticleId><ArticleId IdType="pubmed">35072860</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, Meng X, Zhang X, Hai Y. Frailty as a risk factor for postoperative Complications in adult patients with degenerative scoliosis administered posterior single approach, long-segment corrective Surgery: a retrospective cohort study. BMC Musculoskelet Disord. 2021;22(1):333. doi: 10.1186/s12891-021-04186-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12891-021-04186-9</ArticleId><ArticleId IdType="pmc">PMC8025316</ArticleId><ArticleId IdType="pubmed">33823827</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan V, Wilson JRF, Ravinsky R, Badhiwala JH, Jiang F, Anderson M, Yee A, Wilson JR, Fehlings MG. Frailty adversely affects outcomes of patients undergoing spine Surgery: a systematic review. Spine J. 2021;21(6):988&#x2013;1000. doi: 10.1016/j.spinee.2021.01.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.spinee.2021.01.028</ArticleId><ArticleId IdType="pubmed">33548521</ArticleId></ArticleIdList></Reference><Reference><Citation>Handforth C, Clegg A, Young C, Simpkins S, Seymour MT, Selby PJ, Young J. The prevalence and outcomes of frailty in older cancer patients: a systematic review. Ann Oncol. 2015;26(6):1091&#x2013;101. doi: 10.1093/annonc/mdu540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/annonc/mdu540</ArticleId><ArticleId IdType="pubmed">25403592</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai S, Yang M, Song J, Dai S, Wu J. Impacts of Frailty on Prognosis in Lung Cancer patients: a systematic review and Meta-analysis. Front Med (Lausanne) 2021;8:715513. doi: 10.3389/fmed.2021.715513.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.715513</ArticleId><ArticleId IdType="pmc">PMC8339469</ArticleId><ArticleId IdType="pubmed">34368203</ArticleId></ArticleIdList></Reference><Reference><Citation>Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146&#x2013;156. doi: 10.1093/gerona/56.3.m146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/56.3.m146</ArticleId><ArticleId IdType="pubmed">11253156</ArticleId></ArticleIdList></Reference><Reference><Citation>Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, Mitnitski A. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173(5):489&#x2013;95. doi: 10.1503/cmaj.050051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.050051</ArticleId><ArticleId IdType="pmc">PMC1188185</ArticleId><ArticleId IdType="pubmed">16129869</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller EK, Ailon T, Neuman BJ, Klineberg EO, Mundis GM, Jr, Sciubba DM, Kebaish KM, Lafage V, Scheer JK, Smith JS, et al. Assessment of a Novel Adult Cervical deformity Frailty Index as a component of preoperative risk stratification. World Neurosurg. 2018;109:e800&#x2013;6. doi: 10.1016/j.wneu.2017.10.092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2017.10.092</ArticleId><ArticleId IdType="pubmed">29107159</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali R, Schwalb JM, Nerenz DR, Antoine HJ, Rubinfeld I. Use of the modified frailty index to predict 30-day morbidity and mortality from spine Surgery. J Neurosurg Spine. 2016;25(4):537&#x2013;41. doi: 10.3171/2015.10.Spine14582.</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2015.10.Spine14582</ArticleId><ArticleId IdType="pubmed">27153143</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahrestani S, Ton A, Chen XT, Ballatori AM, Wang JC, Buser Z. The influence of frailty on postoperative Complications in geriatric patients receiving single-level lumbar fusion Surgery. Eur Spine J. 2021;30(12):3755&#x2013;62. doi: 10.1007/s00586-021-06960-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-021-06960-8</ArticleId><ArticleId IdType="pubmed">34398335</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA. Cochrane handbook for systematic reviews of interventions version 6.3. (updated Feburary 2022). In.: Cochrane Handbook; 2022.</Citation></Reference><Reference><Citation>Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. doi: 10.1186/s13643-016-0384-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-016-0384-4</ArticleId><ArticleId IdType="pmc">PMC5139140</ArticleId><ArticleId IdType="pubmed">27919275</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SY, Park JE, Lee YJ, Seo HJ, Sheen SS, Hahn S, Jang BH, Son HJ. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol. 2013;66(4):408&#x2013;14. doi: 10.1016/j.jclinepi.2012.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2012.09.016</ArticleId><ArticleId IdType="pubmed">23337781</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557&#x2013;60. doi: 10.1136/bmj.327.7414.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Passias PG, Bortz CA, Segreto FA, Horn SR, Lafage R, Lafage V, Smith JS, Line B, Kim HJ, Eastlack R, et al. Development of a modified cervical deformity Frailty Index: a Streamlined Clinical Tool for Preoperative Risk Stratification. Spine (Phila Pa 1976) 2019;44(3):169&#x2013;76. doi: 10.1097/brs.0000000000002778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/brs.0000000000002778</ArticleId><ArticleId IdType="pubmed">30005037</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang SY, Son J, Park SM, Chang BS, Lee CK, Kim H. Predictive Value of Comprehensive Geriatric Assessment on early postoperative Complications following lumbar spinal stenosis Surgery: a prospective cohort study. Spine (Phila Pa 1976) 2020;45(21):1498&#x2013;505. doi: 10.1097/brs.0000000000003597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/brs.0000000000003597</ArticleId><ArticleId IdType="pubmed">32694487</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsamadicy AA, Freedman IG, Koo AB, David WB, Reeves BC, Havlik J, Pennington Z, Kolb L, Shin JH, Sciubba DM. Modified-frailty index does not independently predict Complications, hospital length of stay or 30-day readmission rates following posterior lumbar decompression and fusion for spondylolisthesis. Spine J. 2021;21(11):1812&#x2013;21. doi: 10.1016/j.spinee.2021.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.spinee.2021.05.011</ArticleId><ArticleId IdType="pubmed">34010683</ArticleId></ArticleIdList></Reference><Reference><Citation>Flexman AM, Charest-Morin R, Stobart L, Street J, Ryerson CJ. Frailty and postoperative outcomes in patients undergoing Surgery for degenerative spine Disease. Spine J. 2016;16(11):1315&#x2013;23. doi: 10.1016/j.spinee.2016.06.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.spinee.2016.06.017</ArticleId><ArticleId IdType="pubmed">27374110</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung JM, Chung CK, Kim CH, Yang SH, Ko YS. The modified 11-Item Frailty Index and postoperative outcomes in patients undergoing lateral lumbar Interbody Fusion. Spine (Phila Pa 1976) 2022;47(5):396&#x2013;404. doi: 10.1097/brs.0000000000004260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/brs.0000000000004260</ArticleId><ArticleId IdType="pubmed">34669672</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang T, Park SY, Lee JS, Lee SH, Park JH, Suh SW. Predicting postoperative Complications in patients undergoing lumbar spinal fusion by using the modified five-item frailty index and nutritional status. Bone Joint J. 2020;102&#x2013;b(12):1717&#x2013;22. doi: 10.1302/0301-620x.102b12.Bjj-2020-0874.R1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620x.102b12.Bjj-2020-0874.R1</ArticleId><ArticleId IdType="pubmed">33249905</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JY, Park IS, Kang DH, Lee YS, Kim KT, Hong SJ. Prediction of risk factors after spine Surgery in patients aged &gt; 75 years using the modified Frailty Index. J Korean Neurosurg Soc. 2020;63(6):827&#x2013;33. doi: 10.3340/jkns.2020.0019.</Citation><ArticleIdList><ArticleId IdType="doi">10.3340/jkns.2020.0019</ArticleId><ArticleId IdType="pmc">PMC7671779</ArticleId><ArticleId IdType="pubmed">32898965</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DU, Park HK, Lee GH, Chang JC, Park HR, Park SQ, Cho SJ. Central Sarcopenia, Frailty and Comorbidity as Predictor of Surgical Outcome in Elderly patients with degenerative spine Disease. J Korean Neurosurg Soc. 2021;64(6):995&#x2013;1003. doi: 10.3340/jkns.2021.0074.</Citation><ArticleIdList><ArticleId IdType="doi">10.3340/jkns.2021.0074</ArticleId><ArticleId IdType="pmc">PMC8590910</ArticleId><ArticleId IdType="pubmed">34614555</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller EK, Neuman BJ, Jain A, Daniels AH, Ailon T, Sciubba DM, Kebaish KM, Lafage V, Scheer JK, Smith JS, et al. An assessment of frailty as a tool for risk stratification in adult spinal deformity Surgery. Neurosurg Focus. 2017;43(6):E3. doi: 10.3171/2017.10.Focus17472.</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2017.10.Focus17472</ArticleId><ArticleId IdType="pubmed">29191099</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller EK, Vila-Casademunt A, Neuman BJ, Sciubba DM, Kebaish KM, Smith JS, Alanay A, Acaroglu ER, Kleinst&#xfc;ck F, Obeid I, et al. External validation of the adult spinal deformity (ASD) frailty index (ASD-FI) Eur Spine J. 2018;27(9):2331&#x2013;8. doi: 10.1007/s00586-018-5575-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-018-5575-3</ArticleId><ArticleId IdType="pubmed">29603013</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller EK, Lenke LG, Neuman BJ, Sciubba DM, Kebaish KM, Smith JS, Qiu Y, Dahl BT, Pellis&#xe9; F, Matsuyama Y, et al. External validation of the adult spinal deformity (ASD) Frailty Index (ASD-FI) in the Scoli-RISK-1 patient database. Spine (Phila Pa 1976) 2018;43(20):1426&#x2013;31. doi: 10.1097/brs.0000000000002717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/brs.0000000000002717</ArticleId><ArticleId IdType="pubmed">29762340</ArticleId></ArticleIdList></Reference><Reference><Citation>Passias PG, Moattari K, Pierce KE, Passfall L, Krol O, Naessig S, Ahmad W, Schoenfeld AJ, Ahmad S, Singh V, et al. Performance of the modified adult spinal deformity Frailty Index (mASD-FI) in Preoperative Risk Assessment. Spine (Phila Pa 1976) 2022 doi: 10.1097/brs.0000000000004342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/brs.0000000000004342</ArticleId><ArticleId IdType="pubmed">35125455</ArticleId></ArticleIdList></Reference><Reference><Citation>Phan K, Kim JS, Lee NJ, Somani S, Di Capua J, Kothari P, Leven D, Cho SK. Frailty is associated with morbidity in adults undergoing elective anterior lumbar interbody fusion (ALIF) Surgery. Spine J. 2017;17(4):538&#x2013;44. doi: 10.1016/j.spinee.2016.10.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.spinee.2016.10.023</ArticleId><ArticleId IdType="pubmed">27989724</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce KE, Passias PG, Alas H, Brown AE, Bortz CA, Lafage R, Lafage V, Ames C, Burton DC, Hart R, et al. Does patient Frailty Status Influence Recovery following spinal Fusion for adult spinal deformity? An analysis of patients with 3-Year follow-up. Spine (Phila Pa 1976) 2020;45(7):E397&#x2013;e405. doi: 10.1097/brs.0000000000003288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/brs.0000000000003288</ArticleId><ArticleId IdType="pubmed">31651683</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce KE, Passias PG, Daniels AH, Lafage R, Ahmad W, Naessig S, Lafage V, Protopsaltis T, Eastlack R, Hart R, et al. Baseline Frailty Status influences recovery patterns and outcomes following alignment correction of cervical deformity. Neurosurgery. 2021;88(6):1121&#x2013;7. doi: 10.1093/neuros/nyab039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/neuros/nyab039</ArticleId><ArticleId IdType="pubmed">33611600</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce KE, Naessig S, Kummer N, Larsen K, Ahmad W, Passfall L, Krol O, Bortz C, Alas H, Brown A, et al. The five-item modified Frailty Index is predictive of 30-day postoperative Complications in patients undergoing spine Surgery. Spine (Phila Pa 1976) 2021;46(14):939&#x2013;43. doi: 10.1097/brs.0000000000003936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/brs.0000000000003936</ArticleId><ArticleId IdType="pubmed">34160372</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce KE, Kapadia BH, Bortz C, Alas H, Brown AE, Diebo BG, Raman T, Jain D, Lebovic J, Passias PG. Frailty Severity impacts Development of Hospital-acquired conditions in patients undergoing corrective Surgery for adult spinal deformity. Clin Spine Surg. 2021;34(7):E377&#x2013;e381. doi: 10.1097/bsd.0000000000001219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/bsd.0000000000001219</ArticleId><ArticleId IdType="pubmed">34121072</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulido LC, Meyer M, Reinhard J, Kappenschneider T, Grifka J, Weber M. Hospital frailty risk score predicts adverse events in spine Surgery. Eur Spine J. 2022;31(7):1621&#x2013;9. doi: 10.1007/s00586-022-07211-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-022-07211-0</ArticleId><ArticleId IdType="pubmed">35437638</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid DBC, Daniels AH, Ailon T, Miller E, Sciubba DM, Smith JS, Shaffrey CI, Schwab F, Burton D, Hart RA, et al. Frailty and Health-Related Quality of Life Improvement following adult spinal deformity Surgery. World Neurosurg. 2018;112:e548&#x2013;54. doi: 10.1016/j.wneu.2018.01.079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2018.01.079</ArticleId><ArticleId IdType="pubmed">29360585</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothrock RJ, Steinberger JM, Badgery H, Hecht AC, Cho SK, Caridi JM, Deiner S. Frailty status as a predictor of 3-month cognitive and functional recovery following spinal Surgery: a prospective pilot study. Spine J. 2019;19(1):104&#x2013;12. doi: 10.1016/j.spinee.2018.05.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.spinee.2018.05.026</ArticleId><ArticleId IdType="pmc">PMC6358015</ArticleId><ArticleId IdType="pubmed">29792992</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin JI, Kothari P, Phan K, Kim JS, Leven D, Lee NJ, Cho SK. Frailty Index as a predictor of adverse postoperative outcomes in patients undergoing cervical spinal Fusion. Spine (Phila Pa 1976) 2017;42(5):304&#x2013;10. doi: 10.1097/brs.0000000000001755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/brs.0000000000001755</ArticleId><ArticleId IdType="pubmed">27379416</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun W, Lu S, Kong C, Li Z, Wang P, Zhang S. Frailty and post-operative outcomes in the older patients undergoing elective posterior Thoracolumbar Fusion Surgery. Clin Interv Aging. 2020;15:1141&#x2013;50. doi: 10.2147/cia.S245419.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/cia.S245419</ArticleId><ArticleId IdType="pmc">PMC7369366</ArticleId><ArticleId IdType="pubmed">32764901</ArticleId></ArticleIdList></Reference><Reference><Citation>Ton A, Shahrestani S, Saboori N, Ballatori AM, Chen XT, Wang JC, Buser Z. The impact of frailty on postoperative Complications in geriatric patients undergoing multi-level lumbar fusion Surgery. Eur Spine J. 2022;31(7):1745&#x2013;53. doi: 10.1007/s00586-022-07237-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-022-07237-4</ArticleId><ArticleId IdType="pubmed">35552820</ArticleId></ArticleIdList></Reference><Reference><Citation>Weaver DJ, Malik AT, Jain N, Yu E, Kim J, Khan SN. The modified 5-Item Frailty Index: a concise and useful Tool for assessing the impact of Frailty on postoperative morbidity following elective posterior lumbar fusions. World Neurosurg. 2019 doi: 10.1016/j.wneu.2018.12.168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2018.12.168</ArticleId><ArticleId IdType="pubmed">30639495</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson JRF, Badhiwala JH, Moghaddamjou A, Yee A, Wilson JR, Fehlings MG. Frailty is a better predictor than age of mortality and perioperative Complications after Surgery for degenerative cervical myelopathy: an analysis of 41,369 patients from the NSQIP database 2010&#x2013;2018. J Clin Med. 2020;9(11). 10.3390/jcm9113491.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7692707</ArticleId><ArticleId IdType="pubmed">33137985</ArticleId></ArticleIdList></Reference><Reference><Citation>Yagi M, Fujita N, Okada E, Tsuji O, Nagoshi N, Tsuji T, Asazuma T, Nakamura M, Matsumoto M, Watanabe K. Impact of Frailty and Comorbidities on Surgical outcomes and Complications in adult spinal disorders. Spine (Phila Pa 1976) 2018;43(18):1259&#x2013;67. doi: 10.1097/brs.0000000000002596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/brs.0000000000002596</ArticleId><ArticleId IdType="pubmed">29481382</ArticleId></ArticleIdList></Reference><Reference><Citation>Yagi M, Michikawa T, Hosogane N, Fujita N, Okada E, Suzuki S, Tsuji O, Nagoshi N, Asazuma T, Tsuji T, et al. The 5-Item modified Frailty Index is predictive of severe adverse events in patients undergoing Surgery for adult spinal deformity. Spine (Phila Pa 1976) 2019;44(18):E1083&#x2013;e1091. doi: 10.1097/brs.0000000000003063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/brs.0000000000003063</ArticleId><ArticleId IdType="pubmed">30994601</ArticleId></ArticleIdList></Reference><Reference><Citation>Zreik J, Alvi MA, Yolcu YU, Sebastian AS, Freedman BA, Bydon M. Utility of the 5-Item modified Frailty Index for Predicting adverse outcomes following elective Anterior Cervical Discectomy and Fusion. World Neurosurg. 2021;146:e670&#x2013;7. doi: 10.1016/j.wneu.2020.10.154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2020.10.154</ArticleId><ArticleId IdType="pubmed">33152490</ArticleId></ArticleIdList></Reference><Reference><Citation>Dindo D, Demartines N, Clavien PA. Classification of Surgical Complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205&#x2013;13. doi: 10.1097/01.sla.0000133083.54934.ae.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.sla.0000133083.54934.ae</ArticleId><ArticleId IdType="pmc">PMC1360123</ArticleId><ArticleId IdType="pubmed">15273542</ArticleId></ArticleIdList></Reference><Reference><Citation>Glassman SD, Hamill CL, Bridwell KH, Schwab FJ, Dimar JR, Lowe TG. The impact of perioperative Complications on clinical outcome in adult deformity Surgery. Spine (Phila Pa 1976) 2007;32(24):2764&#x2013;70. doi: 10.1097/BRS.0b013e31815a7644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0b013e31815a7644</ArticleId><ArticleId IdType="pubmed">18007258</ArticleId></ArticleIdList></Reference><Reference><Citation>Glassman SD, Alegre G, Carreon L, Dimar JR, Johnson JR. Perioperative Complications of lumbar instrumentation and fusion in patients with Diabetes Mellitus. Spine J. 2003;3(6):496&#x2013;501. doi: 10.1016/s1529-9430(03)00426-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1529-9430(03)00426-1</ArticleId><ArticleId IdType="pubmed">14609695</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JA, Yanagawa B, An KR, Arora RC, Verma S, Friedrich JO. Frailty and pre-frailty in cardiac Surgery: a systematic review and meta-analysis of 66,448 patients. J Cardiothorac Surg. 2021;16(1):184. doi: 10.1186/s13019-021-01541-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13019-021-01541-8</ArticleId><ArticleId IdType="pmc">PMC8229742</ArticleId><ArticleId IdType="pubmed">34172059</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezzina K, Fehlmann CA, Guo MH, Visintini SM, Rubens FD, Wells GA, Mazzola R, McGuinty C, Huang A, Khoury L, et al. Influence of preoperative frailty on quality of life after cardiac Surgery: protocol for a systematic review and meta-analysis. PLoS ONE. 2022;17(2):e0262742. doi: 10.1371/journal.pone.0262742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0262742</ArticleId><ArticleId IdType="pmc">PMC8815968</ArticleId><ArticleId IdType="pubmed">35120151</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkadri J, Hage D, Nickerson LH, Scott LR, Shaw JF, Aucoin SD, McIsaac DI. 2021. A Systematic Review and Meta-Analysis of Preoperative Frailty Instruments Derived From Electronic Health Data.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0000000000005595</ArticleId><ArticleId IdType="pubmed">33999880</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy CA, Shipway D, Barry K. Frailty and emergency abdominal Surgery: a systematic review and meta-analysis. Surgeon. 2021 doi: 10.1016/j.surge.2021.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.surge.2021.11.009</ArticleId><ArticleId IdType="pubmed">34980559</ArticleId></ArticleIdList></Reference><Reference><Citation>Nidadavolu LS, Ehrlich AL, Sieber FE, Oh ES. Preoperative evaluation of the Frail patient. Anesth Analg. 2020;130(6):1493&#x2013;503. doi: 10.1213/ane.0000000000004735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0000000000004735</ArticleId><ArticleId IdType="pmc">PMC7362306</ArticleId><ArticleId IdType="pubmed">32384339</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill TM, Baker DI, Gottschalk M, Gahbauer EA, Charpentier PA, de Regt PT, Wallace SJ. A prehabilitation program for physically frail community-living older persons. Arch Phys Med Rehabil. 2003;84(3):394&#x2013;404. doi: 10.1053/apmr.2003.50020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/apmr.2003.50020</ArticleId><ArticleId IdType="pubmed">12638108</ArticleId></ArticleIdList></Reference><Reference><Citation>Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381(9868):752&#x2013;62. doi: 10.1016/s0140-6736(12)62167-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(12)62167-9</ArticleId><ArticleId IdType="pmc">PMC4098658</ArticleId><ArticleId IdType="pubmed">23395245</ArticleId></ArticleIdList></Reference><Reference><Citation>Picca A, Coelho-Junior HJ, Calvani R, Marzetti E, Vetrano DL. Biomarkers shared by frailty and sarcopenia in older adults: a systematic review and meta-analysis. Ageing Res Rev. 2022;73:101530. doi: 10.1016/j.arr.2021.101530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2021.101530</ArticleId><ArticleId IdType="pubmed">34839041</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva VD, Tribess S, Meneguci J, Sasaki JE, Garcia-Meneguci CA, Carneiro JAO, Virtuoso JS. Jr. Association between frailty and the combination of physical activity level and sedentary behavior in older adults. BMC Public Health. 2019;19(1):709. doi: 10.1186/s12889-019-7062-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-019-7062-0</ArticleId><ArticleId IdType="pmc">PMC6555975</ArticleId><ArticleId IdType="pubmed">31174515</ArticleId></ArticleIdList></Reference><Reference><Citation>Ap&#xf3;stolo J, Cooke R, Bobrowicz-Campos E, Santana S, Marcucci M, Cano A, Vollenbroek-Hutten M, Germini F, D&#x2019;Avanzo B, Gwyther H, et al. Effectiveness of interventions to prevent pre-frailty and frailty progression in older adults: a systematic review. JBI Database System Rev Implement Rep. 2018;16(1):140&#x2013;232. doi: 10.11124/jbisrir-2017-003382.</Citation><ArticleIdList><ArticleId IdType="doi">10.11124/jbisrir-2017-003382</ArticleId><ArticleId IdType="pmc">PMC5771690</ArticleId><ArticleId IdType="pubmed">29324562</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida G, Boissiere L, Larrieu D, Bourghli A, Vital JM, Gille O, Pointillart V, Challier V, Mariey R, Pellis&#xe9; F, et al. Advantages and disadvantages of adult spinal deformity Surgery and its impact on Health-Related Quality of Life. Spine (Phila Pa 1976) 2017;42(6):411&#x2013;9. doi: 10.1097/brs.0000000000001770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/brs.0000000000001770</ArticleId><ArticleId IdType="pubmed">27398887</ArticleId></ArticleIdList></Reference><Reference><Citation>Blondel B, Schwab F, Ungar B, Smith J, Bridwell K, Glassman S, Shaffrey C, Farcy JP, Lafage V. Impact of magnitude and percentage of global sagittal plane correction on health-related quality of life at 2-years follow-up. Neurosurgery. 2012;71(2):341&#x2013;8. doi: 10.1227/NEU.0b013e31825d20c0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1227/NEU.0b013e31825d20c0</ArticleId><ArticleId IdType="pubmed">22596038</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith MA. The Role of Shared decision making in patient-centered care and Orthopaedics. Orthop Nurs. 2016;35(3):144&#x2013;9. doi: 10.1097/nor.0000000000000243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/nor.0000000000000243</ArticleId><ArticleId IdType="pubmed">27187217</ArticleId></ArticleIdList></Reference><Reference><Citation>Charles C, Whelan T, Gafni A. What do we mean by partnership in making decisions about treatment? BMJ. 1999;319(7212):780&#x2013;2. doi: 10.1136/bmj.319.7212.780.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.319.7212.780</ArticleId><ArticleId IdType="pmc">PMC1116606</ArticleId><ArticleId IdType="pubmed">10488014</ArticleId></ArticleIdList></Reference><Reference><Citation>Moskven E, Charest-Morin R, Flexman AM, Street JT. The measurements of frailty and their possible application to spinal conditions: a systematic review. Spine J. 2022 doi: 10.1016/j.spinee.2022.03.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.spinee.2022.03.014</ArticleId><ArticleId IdType="pubmed">35385787</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39657393</PMID><DateCompleted><Year>2025</Year><Month>01</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>101</Volume><PubDate><Year>2025</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Mitochondrial oxygenation monitoring and acute kidney injury risk in cardiac surgery: A prospective cohort study.</ArticleTitle><Pagination><StartPage>111715</StartPage><MedlinePgn>111715</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2024.111715</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(24)00345-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cardiac surgery-associated acute kidney injury (CSA-AKI) is a common complication of cardiac surgery and is associated with increased morbidity and mortality. Recent guidelines emphasize the need for new monitoring methods to facilitate targeted CSA-AKI prevention and treatment strategies. In vivo real-time measurement of mitochondrial oxygen tension (mitoPO<sub>2</sub>), could potentially fulfil this role during cardiac surgery, as suggested in our previous pilot study.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this prospective observational study, we investigated 75 cardiac surgery patients with an increased preoperative CSA-AKI risk. The primary aim of this study was to assess whether patients who developed CSA-AKI experienced prolonged periods of mitoPO<sub>2</sub>&#xa0;&lt;&#xa0;20&#xa0;mmHg during surgery. mitoPO<sub>2</sub> was measured intraoperatively, and CSA-AKI was defined according to the Kidney Disease: Improving Global Outcomes criteria. Four additional mitoPO<sub>2</sub> thresholds (&lt;25, &lt;30, &lt;35, and&#xa0;&lt;&#xa0;40&#xa0;mmHg) were analyzed, including the predictive capacity of all thresholds for CSA-AKI.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">This study found that patients who developed CSA-AKI had a significantly longer intraoperative time with mitoPO<sub>2</sub>&#xa0;&lt;20&#xa0;mmHg and&#xa0;&lt;25, &lt;30, &lt;35, and&#xa0;&lt;40&#xa0;mmHg. Subsequently, we tested all thresholds for their association with the risk of CSA-AKI, with the &lt;25&#xa0;mmHg threshold demonstrating the highest significant odds ratio. Every minute spent below &lt;25&#xa0;mmHg increased the risk of CSA-AKI by 0.7&#xa0;% (P&#xa0;=&#xa0;0.021).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study highlighted the association between mitoPO<sub>2</sub> and the onset of CSA-AKI. Extended durations below the mitoPO<sub>2</sub> threshold of 25&#xa0;mmHg significantly correlate with an elevated CSA-AKI risk. Using mitoPO<sub>2</sub> as a monitoring tool shows promise in potentially predicting and possibly preventing CSA-AKI when used as a treatment trigger in cardiac surgery patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Wijs</LastName><ForeName>Calvin J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Laboratory of Experimental Anesthesiology, Department of Anesthesiology, Erasmus MC, Rotterdam, the Netherlands. Electronic address: c.dewijs@erasmusmc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Streng</LastName><ForeName>Lucia W J M</ForeName><Initials>LWJM</Initials><AffiliationInfo><Affiliation>Laboratory of Experimental Anesthesiology, Department of Anesthesiology, Erasmus MC, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stolker</LastName><ForeName>Robert Jan</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Laboratory of Experimental Anesthesiology, Department of Anesthesiology, Erasmus MC, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ter Horst</LastName><ForeName>Maarten</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Experimental Anesthesiology, Department of Anesthesiology, Erasmus MC, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoorn</LastName><ForeName>Ewout J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahtab</LastName><ForeName>Edris A F</ForeName><Initials>EAF</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Erasmus MC, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mik</LastName><ForeName>Egbert G</ForeName><Initials>EG</Initials><AffiliationInfo><Affiliation>Laboratory of Experimental Anesthesiology, Department of Anesthesiology, Erasmus MC, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harms</LastName><ForeName>Floor A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Laboratory of Experimental Anesthesiology, Department of Anesthesiology, Erasmus MC, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="Y">Monitoring, Intraoperative</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="Y">Oxygen</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="Y">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010101" MajorTopicYN="N">Oxygen Consumption</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Coronary artery bypass grafting</Keyword><Keyword MajorTopicYN="N">Mitochondrial oxygenation</Keyword></KeywordList><CoiStatement>Declaration of competing interest Egbert G. Mik is listed as an inventor of patents related to mitochondrial oxygen measurements held by the Academic Medical Centre Amsterdam and the Erasmus Medical Centre Rotterdam, the Netherlands. He is the founder and shareholder of Photonics Healthcare, a company that holds exclusive licenses to these patents and that markets the COMET&#xae; system. He was not involved in the data analysis. All other authors declare no relevant conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>1</Month><Day>21</Day><Hour>9</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>11</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>10</Day><Hour>18</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39657393</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2024.111715</ArticleId><ArticleId IdType="pii">S0952-8180(24)00345-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40305034</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>11</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2168-6262</ISSN><JournalIssue CitedMedium="Internet"><Volume>160</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA surgery</Title><ISOAbbreviation>JAMA Surg</ISOAbbreviation></Journal><ArticleTitle>Postoperative Outcomes Among Sodium-Glucose Cotransporter 2 Inhibitor Users.</ArticleTitle><Pagination><StartPage>681</StartPage><EndPage>689</EndPage><MedlinePgn>681-689</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamasurg.2025.0940</ELocationID><Abstract><AbstractText Label="IMPORTANCE" NlmCategory="UNASSIGNED">Case reports and small retrospective studies have suggested that there is an increased risk of postoperative euglycemic ketoacidosis (eKA) and acute kidney injury (AKI) among patients using sodium-glucose cotransporter 2 inhibitors (SGLT2i) preoperatively. However, there has not been a representative assessment of the risks of these agents among patients undergoing surgery.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To evaluate the risk of postoperative eKA, AKI, and mortality within 30 days after surgery among preoperative long-term SGLT2i users compared with nonusers.</AbstractText><AbstractText Label="DESIGN, SETTINGS, AND PARTICIPANTS" NlmCategory="UNASSIGNED">This is a multicenter, propensity-matched, retrospective case-control study from the Veterans Affairs Health Care System (VAHCS) National Registry performed from January 1, 2014, to December 31, 2022. Adult patients using SGLT2i preoperatively who underwent inpatient surgical procedures were compared with a 1:5 matched control group using propensity score matching, including the patient's demographic characteristics, comorbidities, and surgical characteristics. Data analysis was performed from June 2023 to August 2024.</AbstractText><AbstractText Label="EXPOSURE" NlmCategory="UNASSIGNED">Long-term use of SGLT2i, defined as having more than 3 fills of outpatient prescription or less than a 180-day gap of the last fill according to the VAHCS pharmacy registries.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES" NlmCategory="UNASSIGNED">The primary outcome was the rate of postoperative eKA among SGLT2i users vs control patients. Secondary outcomes included postoperative AKI and 30-day mortality after surgery.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Among 462&#x202f;968 patients undergoing surgery, 7448 SGLT2i users (mean [SD] age, 67.7 [8.1] years; 7204 [96.7%] male) and 455&#x202f;520 nonusers (mean [SD] age, 65.8 [11.0] years; 424&#x202f;785 [93.3%] male) were identified. After propensity score matching, 7439 patients were identified as SGLT2i users and compared with 33&#x202f;489 control patients. SGLT2i use was associated with an increased risk of eKA (odds ratio [OR], 1.11; 95% CI, 1.05-1.17) but reduced risks of perioperative AKI (OR, 0.69; 95% CI, 0.62-0.78) and 30-day mortality (OR, 0.70; 95% CI, 0.55-0.88). The mortality rate 30 days after surgery was 1.1% among SGLT2i users vs 1.6% among control patients. The median hospital length of stay among the patients presenting with eKA increased by 3 days (median [IQR], 6 [3-10] days for those with eKA vs 3 [2-6] days for those without eKA).</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE" NlmCategory="UNASSIGNED">Patients treated with SGLT2i had a small but significantly higher risk of postoperative eKA but lower risks of postoperative AKI and 30-day mortality.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tallarico</LastName><ForeName>Roberta Teixeira</ForeName><Initials>RT</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine in St Louis, St Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jing</LastName><ForeName>Bocheng</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Geriatrics, University of California, San Francisco.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Northern California Institute for Research and Education, San Francisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Kaiwei</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Northern California Institute for Research and Education, San Francisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chawla</LastName><ForeName>Shweta Amy</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>School of Medicine, University of California, San Francisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Yanting</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badathala</LastName><ForeName>Anusha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Veterans Affairs Medical Center, San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Catherine L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wallace</LastName><ForeName>Arthur W</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veterans Affairs Medical Center, San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Legrand</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Surg</MedlineTA><NlmUniqueID>101589553</NlmUniqueID><ISSNLinking>2168-6254</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077203">Sodium-Glucose Transporter 2 Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077203" MajorTopicYN="Y">Sodium-Glucose Transporter 2 Inhibitors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="Y">Surgical Procedures, Operative</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Tallarico reported receiving grants from the National Institute of General Medical Sciences and the Department of Anesthesia and Perioperative Care and Department of Epidemiology and Biostatistics at the University of California, San Francisco (UCSF) during the conduct of the study. Dr Chen reported receiving grants from the National Institute on Aging, Patricia Sander Awards for Anesthesia Researchers, and UCSF Anesthesia Research outside the submitted work. Dr Legrand reported receiving grants from the National Institute of General Medical Sciences and National Institute of Diabetes and Digestive and Kidney Diseases during the conduct of the study; and receiving personal fees from La Jolla, Viatris, Radiometer, and Alexion outside the submitted work. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>11</Day><Hour>12</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>30</Day><Hour>12</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>30</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40305034</ArticleId><ArticleId IdType="pmc">PMC12044541</ArticleId><ArticleId IdType="doi">10.1001/jamasurg.2025.0940</ArticleId><ArticleId IdType="pii">2833369</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Burke KR, Schumacher CA, Harpe SE. SGLT2 inhibitors: a systematic review of diabetic ketoacidosis and related risk factors in the primary literature. Pharmacotherapy. 2017;37(2):187-194. doi: 10.1002/phar.1881</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/phar.1881</ArticleId><ArticleId IdType="pubmed">27931088</ArticleId></ArticleIdList></Reference><Reference><Citation>Morace C, Lorello G, Bellone F, et al. Ketoacidosis and SGLT2 inhibitors: a narrative review. Metabolites. 2024;14(5):264. doi: 10.3390/metabo14050264</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo14050264</ArticleId><ArticleId IdType="pmc">PMC11122992</ArticleId><ArticleId IdType="pubmed">38786741</ArticleId></ArticleIdList></Reference><Reference><Citation>Bardia A, Wai M, Fontes ML. Sodium-glucose cotransporter-2 inhibitors: an overview and perioperative implications. Curr Opin Anaesthesiol. 2019;32(1):80-85. doi: 10.1097/ACO.0000000000000674</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0000000000000674</ArticleId><ArticleId IdType="pubmed">30531609</ArticleId></ArticleIdList></Reference><Reference><Citation>Braunwald E. Gliflozins in the management of cardiovascular disease. N Engl J Med. 2022;386(21):2024-2034. doi: 10.1056/NEJMra2115011</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2115011</ArticleId><ArticleId IdType="pubmed">35613023</ArticleId></ArticleIdList></Reference><Reference><Citation>Madhok J, Vanneman MW. SGLT-2 inhibitors: proliferating indications and perioperative pitfalls. J Cardiothorac Vasc Anesth. 2022;36(7):1815-1819. doi: 10.1053/j.jvca.2022.02.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2022.02.019</ArticleId><ArticleId IdType="pubmed">35331629</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallik R, Chowdhury TA. Pharmacotherapy to delay the progression of diabetic kidney disease in people with type 2 diabetes: past, present and future. Ther Adv Endocrinol Metab. 2022;13:20420188221081601. doi: 10.1177/20420188221081601</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20420188221081601</ArticleId><ArticleId IdType="pmc">PMC8905210</ArticleId><ArticleId IdType="pubmed">35281302</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavrakanas TA, Tsoukas MA, Brophy JM, Sharma A, Gariani K. SGLT-2 inhibitors improve cardiovascular and renal outcomes in patients with CKD: a systematic review and meta-analysis. Sci Rep. 2023;13(1):15922. doi: 10.1038/s41598-023-42989-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-42989-z</ArticleId><ArticleId IdType="pmc">PMC10517929</ArticleId><ArticleId IdType="pubmed">37741858</ArticleId></ArticleIdList></Reference><Reference><Citation>Neal B, Perkovic V, Mahaffey KW, et al. ; CANVAS Program Collaborative Group . Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med. 2017;377(7):644-657. doi: 10.1056/NEJMoa1611925</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1611925</ArticleId><ArticleId IdType="pubmed">28605608</ArticleId></ArticleIdList></Reference><Reference><Citation>Nespoux J, Vallon V. Renal effects of SGLT2 inhibitors: an update. Curr Opin Nephrol Hypertens. 2020;29(2):190-198. doi: 10.1097/MNH.0000000000000584</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MNH.0000000000000584</ArticleId><ArticleId IdType="pmc">PMC7224333</ArticleId><ArticleId IdType="pubmed">31815757</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuen BL, Young T, Heerspink HJL, et al. SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2019;7(11):845-854. doi: 10.1016/S2213-8587(19)30256-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(19)30256-6</ArticleId><ArticleId IdType="pubmed">31495651</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni L, Yuan C, Chen G, Zhang C, Wu X. SGLT2i: beyond the glucose-lowering effect. Cardiovasc Diabetol. 2020;19(1):98. doi: 10.1186/s12933-020-01071-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-020-01071-y</ArticleId><ArticleId IdType="pmc">PMC7320582</ArticleId><ArticleId IdType="pubmed">32590982</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahtta D, Ramsey DJ, Lee MT, et al. Utilization rates of SGLT2 inhibitors and GLP-1 receptor agonists and their facility-level variation among patients with atherosclerotic cardiovascular disease and type 2 diabetes: insights from the Department of Veterans Affairs. Diabetes Care. 2022;45(2):372-380. doi: 10.2337/dc21-1815</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc21-1815</ArticleId><ArticleId IdType="pmc">PMC8914426</ArticleId><ArticleId IdType="pubmed">35015080</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta S, Kumar T, Singh S, Ambwani S, Charan J, Varthya SB. Euglycemic diabetic ketoacidosis associated with SGLT2 inhibitors: a systematic review and quantitative analysis. J Family Med Prim Care. 2022;11(3):927-940. doi: 10.4103/jfmpc.jfmpc_644_21</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jfmpc.jfmpc_644_21</ArticleId><ArticleId IdType="pmc">PMC9051698</ArticleId><ArticleId IdType="pubmed">35495849</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampani E, Sarafidis P, Dimitriadis C, et al. Severe euglycemic diabetic ketoacidosis of multifactorial etiology in a type 2 diabetic patient treated with empagliflozin: case report and literature review. BMC Nephrol. 2020;21(1):276. doi: 10.1186/s12882-020-01930-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12882-020-01930-6</ArticleId><ArticleId IdType="pmc">PMC7364613</ArticleId><ArticleId IdType="pubmed">32669085</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki Y, Sasabuchi Y, Horikita S, et al. The effect of preoperative sodium-glucose cotransporter 2 inhibitors on the incidence of perioperative metabolic acidosis: a retrospective cohort study. BMC Endocr Disord. 2022;22(1):209. doi: 10.1186/s12902-022-01126-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12902-022-01126-z</ArticleId><ArticleId IdType="pmc">PMC9392326</ArticleId><ArticleId IdType="pubmed">35987618</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta PB, Robinson A, Burkhardt D, Rushakoff RJ. Inpatient perioperative euglycemic diabetic ketoacidosis due to sodium-glucose cotransporter-2 inhibitors&#x2014;lessons from a case series and strategies to decrease incidence. Endocr Pract. 2022;28(9):884-888. doi: 10.1016/j.eprac.2022.06.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eprac.2022.06.006</ArticleId><ArticleId IdType="pubmed">35753675</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia B, Ostermann M, Legrand M. How to manage sodium-glucose cotransporter-2 inhibitors in the critically ill patient? Intensive Care Med. 2025;51(1):143-145. doi: 10.1007/s00134-024-07704-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-024-07704-0</ArticleId><ArticleId IdType="pubmed">39621048</ArticleId></ArticleIdList></Reference><Reference><Citation>Chacko B, Whitley M, Beckmann U, Murray K, Rowley M. Postoperative euglycaemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitors (gliflozins): a report of two cases and review of the literature. Anaesth Intensive Care. 2018;46(2):215-219. doi: 10.1177/0310057X1804600212</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0310057X1804600212</ArticleId><ArticleId IdType="pubmed">29519226</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau A, Bruce S, Wang E, Ree R, Rondi K, Chau A. Perioperative implications of sodium-glucose cotransporter-2 inhibitors: a case series of euglycemic diabetic ketoacidosis in three patients after cardiac surgery. Can J Anaesth. 2018;65(2):188-193. doi: 10.1007/s12630-017-1018-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-017-1018-6</ArticleId><ArticleId IdType="pubmed">29168157</ArticleId></ArticleIdList></Reference><Reference><Citation>Darwish AM. Metabolic acidosis in postsurgical patient on canagliflozin and metformin: a case report. A A Pract. 2019;12(7):221-222. doi: 10.1213/XAA.0000000000000888</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/XAA.0000000000000888</ArticleId><ArticleId IdType="pubmed">30234515</ArticleId></ArticleIdList></Reference><Reference><Citation>Goto S, Ishikawa JY, Idei M, Iwabuchi M, Namekawa M, Nomura T. Life-threatening complications related to delayed diagnosis of euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitors: a report of 2 cases. Am J Case Rep. 2021;22:e929773. doi: 10.12659/AJCR.929773</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/AJCR.929773</ArticleId><ArticleId IdType="pmc">PMC7980085</ArticleId><ArticleId IdType="pubmed">33723205</ArticleId></ArticleIdList></Reference><Reference><Citation>Kietaibl AT, Fasching P, Glaser K, Petter-Puchner AH. New diabetic medication sodium-glucose cotransporter-2 inhibitors can induce euglycemic ketoacidosis and mimic surgical diseases: a case report and review of literature. Front Surg. 2022;9:828649. doi: 10.3389/fsurg.2022.828649</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fsurg.2022.828649</ArticleId><ArticleId IdType="pmc">PMC8987984</ArticleId><ArticleId IdType="pubmed">35402477</ArticleId></ArticleIdList></Reference><Reference><Citation>Yared KE, Mancini GJ. euglycemic diabetic ketoacidosis associated with use of SGLT2 inhibitor after laparoscopic Roux-en-Y gastric bypass. Am Surg. 2021;87(12):1997-1999. doi: 10.1177/0003134820940286</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0003134820940286</ArticleId><ArticleId IdType="pubmed">32812784</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang KM, Isom RT. SGLT2 inhibitor-induced euglycemic diabetic ketoacidosis: a case report. Kidney Med. 2020;2(2):218-221. doi: 10.1016/j.xkme.2019.12.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xkme.2019.12.006</ArticleId><ArticleId IdType="pmc">PMC7380362</ArticleId><ArticleId IdType="pubmed">32734242</ArticleId></ArticleIdList></Reference><Reference><Citation>van Niekerk C, Wallace J, Takata M, Yu R. Euglycaemic diabetic ketoacidosis in bariatric surgery patients with type 2 diabetes taking canagliflozin. <i>BMJ Case Rep</i>. Published online August 20, 2018. doi: 10.1136/bcr-2017-221527</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2017-221527</ArticleId><ArticleId IdType="pmc">PMC6109719</ArticleId><ArticleId IdType="pubmed">30131409</ArticleId></ArticleIdList></Reference><Reference><Citation>Seki H, Watanabe H, Yorozu T. Postoperative ketoacidosis with hypoglycemia in a nondiabetic patient taking dapagliflozin for heart failure: a case report. A A Pract. 2022;16(3):e01570. doi: 10.1213/XAA.0000000000001570</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/XAA.0000000000001570</ArticleId><ArticleId IdType="pmc">PMC9323548</ArticleId><ArticleId IdType="pubmed">35285818</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown F, McColl T. Euglycemic diabetic ketoacidosis secondary to dapagliflozin use: a case report. J Emerg Med. 2018;54(1):109-111. doi: 10.1016/j.jemermed.2017.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jemermed.2017.10.001</ArticleId><ArticleId IdType="pubmed">29157798</ArticleId></ArticleIdList></Reference><Reference><Citation>Lane S, Paskar D, Hamed S, Goffi A. When guidelines fail: euglycemic diabetic ketoacidosis after bariatric surgery in a patient taking a sodium-glucose cotransporter-2 inhibitor: a case report. A A Pract. 2018;11(2):46-48. doi: 10.1213/XAA.0000000000000734</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/XAA.0000000000000734</ArticleId><ArticleId IdType="pubmed">29634546</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonanni FB, Fei P, Fitzpatrick LL. Normoglycemic ketoacidosis in a postoperative gastric bypass patient taking canagliflozin. Surg Obes Relat Dis. 2016;12(1):e11-e12. doi: 10.1016/j.soard.2015.08.502</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.soard.2015.08.502</ArticleId><ArticleId IdType="pubmed">26686305</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuchay MS, Mishra SK, Mehta Y. Empagliflozin induced euglycemic diabetic ketoacidosis in a patient undergoing coronary artery bypass graft despite discontinuation of the drug 48 hours prior to the surgery. Diabetes Metab Syndr. 2021;15(3):909-911. doi: 10.1016/j.dsx.2021.04.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.016</ArticleId><ArticleId IdType="pubmed">33915345</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackintosh C, Tewari A, Siegel J, Wang RD, Freeman W. Postoperative euglycemic diabetic ketoacidosis and encephalopathy related to SGLT-2 inhibitors: a case report and discussion of diabetes treatment and &#x201c;sweet pee encephalopathy&#x201d; in perioperative hospital management. Neurohospitalist. 2020;10(1):51-54. doi: 10.1177/1941874419835035</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1941874419835035</ArticleId><ArticleId IdType="pmc">PMC6900651</ArticleId><ArticleId IdType="pubmed">31839866</ArticleId></ArticleIdList></Reference><Reference><Citation>Osafehinti DA, Okoli OJ, Karam JG. A case of SGLT2 inhibitor-associated euglycemic diabetic ketoacidosis following coronary artery bypass surgery. AACE Clin Case Rep. 2020;7(1):20-22. doi: 10.1016/j.aace.2020.11.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aace.2020.11.014</ArticleId><ArticleId IdType="pmc">PMC7924150</ArticleId><ArticleId IdType="pubmed">33851014</ArticleId></ArticleIdList></Reference><Reference><Citation>Szalat A, Perlman A, Muszkat M, Khamaisi M, Abassi Z, Heyman SN. Can SGLT2 inhibitors cause acute renal failure? plausible role for altered glomerular hemodynamics and medullary hypoxia. Drug Saf. 2018;41(3):239-252. doi: 10.1007/s40264-017-0602-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-017-0602-6</ArticleId><ArticleId IdType="pubmed">28952138</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayhew D, Mendonca V, Murthy BVS. A review of ASA physical status&#x2014;historical perspectives and modern developments. Anaesthesia. 2019;74(3):373-379. doi: 10.1111/anae.14569</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.14569</ArticleId><ArticleId IdType="pubmed">30648259</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . International Statistical Classification of Diseases, Tenth Revision (ICD-10). World Health Organization; 1992.</Citation></Reference><Reference><Citation>Barski L, Eshkoli T, Brandstaetter E, Jotkowitz A. Euglycemic diabetic ketoacidosis. Eur J Intern Med. 2019;63:9-14. doi: 10.1016/j.ejim.2019.03.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2019.03.014</ArticleId><ArticleId IdType="pubmed">30910328</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens PE, Ahmed SB, Carrero JJ, et al. ; Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group . KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4S):S117-S314. doi: 10.1016/j.kint.2023.10.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2023.10.018</ArticleId><ArticleId IdType="pubmed">38490803</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui DTW, Wu T, Au ICH, et al. A population-based study of SGLT2 inhibitor-associated postoperative diabetic ketoacidosis in patients with type 2 diabetes. Drug Saf. 2023;46(1):53-64. doi: 10.1007/s40264-022-01247-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-022-01247-3</ArticleId><ArticleId IdType="pubmed">36289137</ArticleId></ArticleIdList></Reference><Reference><Citation>Auerbach JS, Gershengorn HB, Aljure OD, et al. Postcardiac surgery euglycemic diabetic ketoacidosis in patients on sodium-glucose cotransporter 2 inhibitors. J Cardiothorac Vasc Anesth. 2023;37(6):956-963. doi: 10.1053/j.jvca.2023.01.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2023.01.041</ArticleId><ArticleId IdType="pubmed">36872114</ArticleId></ArticleIdList></Reference><Reference><Citation>Handelsman Y, Henry RR, Bloomgarden ZT, et al. American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the association of SGLT-2 inhibitors and diabetic ketoacidosis. Endocr Pract. 2016;22(6):753-762. doi: 10.4158/EP161292.PS</Citation><ArticleIdList><ArticleId IdType="doi">10.4158/EP161292.PS</ArticleId><ArticleId IdType="pubmed">27082665</ArticleId></ArticleIdList></Reference><Reference><Citation>Tallarico RT, McCoy IE, D&#xe9;pret F, Legrand M. Meaning and management of perioperative oliguria. Anesthesiology. 2024;140(2):304-312. doi: 10.1097/ALN.0000000000004746</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000004746</ArticleId><ArticleId IdType="pmc">PMC10843636</ArticleId><ArticleId IdType="pubmed">37812766</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzareschi DV, Fong N, Mavrothalassitis O, et al. ; MPOG Collaborators . Intraoperative use of albumin in major noncardiac surgery: incidence, variability, and association with outcomes. Ann Surg. 2023;278(4):e745-e753.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10481928</ArticleId><ArticleId IdType="pubmed">36521076</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu C, Fong N, Lazzareschi D, et al. Fluids, vasopressors, and acute kidney injury after major abdominal surgery between 2015 and 2019: a multicentre retrospective analysis. Br J Anaesth. 2022;129(3):317-326. doi: 10.1016/j.bja.2022.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2022.05.002</ArticleId><ArticleId IdType="pubmed">35688657</ArticleId></ArticleIdList></Reference><Reference><Citation>Legrand M, Rossignol P. Cardiovascular consequences of acute kidney injury. N Engl J Med. 2020;382(23):2238-2247. doi: 10.1056/NEJMra1916393</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1916393</ArticleId><ArticleId IdType="pubmed">32492305</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xe9;pret F, Prud&#x2019;homme M, Legrand M. A role of remote organs effect in acute kidney injury outcome. Nephron. 2017;137(4):273-276. doi: 10.1159/000476077</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000476077</ArticleId><ArticleId IdType="pubmed">28586768</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39489666</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>25</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Ultrafiltration During Cardiac Surgery Requiring Cardiopulmonary Bypass and Its Effect on Acute Kidney Injury.</ArticleTitle><Pagination><StartPage>104</StartPage><EndPage>111</EndPage><MedlinePgn>104-111</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2024.10.018</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(24)00800-0</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To explore whether ultrafiltration (UF) volume adjusted for weight is associated with an increased risk of acute kidney injury (AKI) after cardiopulmonary bypass (CPB) in cardiac surgery patients.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A retrospective cohort study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Single-center study at a tertiary academic medical center.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">A total of 2369 adult patients (age &#x2265;18 years) who underwent cardiac surgery with CPB between January 2018 and August 2019.</AbstractText><AbstractText Label="INTERVENTION" NlmCategory="METHODS">The cohort was divided into 4 groups based on weight-adjusted conventional UF volume: 0 (no UF), 0.1 to 17.9 mL, 18 to 29.9 mL, and &gt;30 mL ultrafiltration for each kg of body weight. Demographic data, laboratory findings, comorbidities, medications, and surgical details were collected. Postoperative AKI was defined by the KDIGO (Kidney Disease: Improving Global Outcomes) staging criteria and assessed in all UF groups. The association between UF volume and AKI according to nadir hemoglobin (Hb) level and red blood cell transfusion volume was explored.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Postoperative AKI occurred in 840 patients (35.4%). The incidence of AKI post-CPB in patients was similar in patients with 0 mL/kg (34.4%; n = 123), 0.1 to 17.9 mL/kg (34.3%; n = 387), and 18 to 29.9 mL/kg (33.7%; n = 173) of UF volume. The patients with UF volume &gt;30 mL/kg had a higher incidence of AKI (42.7%; n = 157; p = 0.019). For each additional 10 mL/kg increase in UF, the odds ratio (OR) of AKI was 1.14 (95% confidence interval [CI], 1.07-1.20; p &lt; 0.001) following adjustments for preoperative covariates. However, the association was mitigated following adjustments for preoperative and intraoperative covariates (OR, 1.07; 95% CI, 0.99-1.16; p = 0.076). Although higher UF also was associated with an increased risk of AKI in patients with nadir Hb levels of 6 to 8 g/dL (adjusted OR, 1.24 and 1.22; p = 0.02), it was not significantly associated with AKI when nadir Hb was 10 to 12 g/dL. Red blood cell transfusion volume was not related to changes in AKI incidence.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study suggests that conventional UF is a potential risk factor for AKI incidence following surgery with CPB. The results demonstrate an association between higher weight-adjusted ultrafiltration volume and a higher incidence of AKI. Future studies should incorporate a multicenter, prospective approach to test the generalizability of the present findings and validate modified ultrafiltration strategies that use hemodynamic variables to determine fluid removal volume.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Waryaam</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yalamuri</LastName><ForeName>Suraj</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular and Thoracic Anesthesiology, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nikravangolsefid</LastName><ForeName>Nasrin</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN; Department of Internal Medicine, Saint Agnes Medical Center, Fresno, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suppadungsuk</LastName><ForeName>Supawadee</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN; Chakri Naruebodindra Medical Institute, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Samut Prakan, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goyal</LastName><ForeName>Shriya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, LSU Health, Shreveport, LA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanson</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kashani</LastName><ForeName>Kianoush</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN. Electronic address: kashani.kianoush@mayo.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="Y">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014462" MajorTopicYN="N">Ultrafiltration</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">hemoglobin</Keyword><Keyword MajorTopicYN="N">transfusion</Keyword><Keyword MajorTopicYN="N">ultrafiltration</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>1</Month><Day>12</Day><Hour>15</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>0</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>3</Day><Hour>21</Hour><Minute>56</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39489666</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2024.10.018</ArticleId><ArticleId IdType="pii">S1053-0770(24)00800-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39049867</PMID><DateRevised><Year>2024</Year><Month>07</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2321-3868</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Burns &amp; trauma</Title><ISOAbbreviation>Burns Trauma</ISOAbbreviation></Journal><ArticleTitle>Intraoperative hypotension associated with postoperative acute kidney injury in hypertension patients undergoing non-cardiac surgery: a retrospective cohort study.</ArticleTitle><Pagination><StartPage>tkae029</StartPage><MedlinePgn>tkae029</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">tkae029</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/burnst/tkae029</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Acute kidney injury (AKI) is a common surgical complication and is associated with intraoperative hypotension. However, the total duration and magnitude of intraoperative hypotension associated with AKI remains unknown. In this study, the causal relationship between the intraoperative arterial pressure and postoperative AKI was investigated among chronic hypertension patients undergoing non-cardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A retrospective cohort study of 6552 hypertension patients undergoing non-cardiac surgery (2011 to 2019) was conducted. The primary outcome was AKI as diagnosed with the Kidney Disease-Improving Global Outcomes criteria and the primary exposure was intraoperative hypotension. Patients' baseline demographics, pre- and post-operative data were harvested and then analyzed with multivariable logistic regression to assess the exposure-outcome relationship.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Among 6552 hypertension patients, 579 (8.84%) had postoperative AKI after non-cardiac surgery. The proportions of patients admitted to ICU (3.97 vs. 1.24%, <i>p</i>&#x2009;&lt;&#x2009;0.001) and experiencing all-cause death (2.76 vs. 0.80%, <i>p</i>&#x2009;&lt;&#x2009;0.001) were higher in the patients with postoperative AKI. Moreover, the patients with postoperative AKI had longer hospital stays (13.50 vs. 12.00&#xa0;days, <i>p</i>&#x2009;&lt;&#x2009;0.001). Intraoperative mean arterial pressure (MAP) &lt; 60&#xa0;mmHg for &gt;20&#xa0;min was an independent risk factor of postoperative AKI. Furthermore, MAP &lt;60&#xa0;mmHg for &gt;10&#xa0;min was also an independent risk factor of postoperative AKI in patients whose MAP was measured invasively in the subgroup analysis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Our work suggested that MAP &lt; 60&#xa0;mmHg for &gt;10&#xa0;min measured invasively or 20&#xa0;min measured non-invasively during non-cardiac surgery may be the threshold of postoperative AKI development in hypertension patients. This work may serve as a perioperative management guide for chronic hypertension patients.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="UNASSIGNED">clinical trial number: ChiCTR2100050209 (8/22/2021). http://www.chictr.org.cn/showproj.aspx?proj=132277.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2024. Published by Oxford University Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Third Xiangya Hospital, Central South University, 138 Tongzipo Road, Changsha, 410013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Yeshuo</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Geriatrics, Third Xiangya Hospital, Central South University, 138 Tongzipo Road, Changsha, 410013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Third Xiangya Hospital, Central South University, 138 Tongzipo Road, Changsha, 410013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ouyang</LastName><ForeName>Wen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Third Xiangya Hospital, Central South University, 138 Tongzipo Road, Changsha, 410013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zongdao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Geriatrics, Third Xiangya Hospital, Central South University, 138 Tongzipo Road, Changsha, 410013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Third Xiangya Hospital, Central South University, 138 Tongzipo Road, Changsha, 410013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Operation Center, Third Xiangya Hospital, Central South University, 138 Tongzipo Road, Changsha, 410013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Emergency, Third Xiangya Hospital, Central South University, 138 Tongzipo Road, Changsha, 410013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Daqing</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-1235-0537</Identifier><AffiliationInfo><Affiliation>Division of Anesthetics, Pain Medicine &amp; Intensive Care, Department of Surgery and Cancer, Chelsea and Westminster Hospital, Imperial College London, South Kensington Campus, London SW7 2AZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Yongzhong</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0009-0006-0777-6196</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Third Xiangya Hospital, Central South University, 138 Tongzipo Road, Changsha, 410013, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research Center, Third Xiangya Hospital, Central South University, 138 Tongzipo Road, Changsha, 410013, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Burns Trauma</MedlineTA><NlmUniqueID>101651457</NlmUniqueID><ISSNLinking>2321-3868</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Chronic hypertension</Keyword><Keyword MajorTopicYN="N">Intraoperative hypotension</Keyword><Keyword MajorTopicYN="N">Non-cardiac surgery</Keyword></KeywordList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>26</Day><Hour>12</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>26</Day><Hour>12</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>25</Day><Hour>4</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39049867</ArticleId><ArticleId IdType="pmc">PMC11267586</ArticleId><ArticleId IdType="doi">10.1093/burnst/tkae029</ArticleId><ArticleId IdType="pii">tkae029</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zeng X, McMahon GM, Brunelli SM, Bates DW, Waikar SS. Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals. Clin J Am Soc Nephrol. 2014;9:12&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3878695</ArticleId><ArticleId IdType="pubmed">24178971</ArticleId></ArticleIdList></Reference><Reference><Citation>Signe S, Marie SI, Isachsen MS, Nordhuus KM, Tveiten CK, Eken T, et al. &#xa0;Acute kidney injury in trauma patients admitted to the ICU: a systematic review and meta-analysis. Intensive Care Med. 2019;45:407&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">30725141</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulger F, Pehlivanlar Kucuk M, Kucuk AO, Ilkaya NK, Murat N, Bilgic B, et al. &#xa0;Evaluation of acute kidney injury (AKI) with RIFLE, AKIN, CK, and KDIGO in critically ill trauma patients. Eur J Trauma Emerg Surg. 2018;44:597&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pubmed">28717983</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomozawa A, Ishikawa S, Shiota N, Cholvisudhi P, Makita K. Perioperative risk factors for acute kidney injury after liver resection surgery: an historical cohort study. Can J Anaesth. 2015;62:753&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">25925634</ArticleId></ArticleIdList></Reference><Reference><Citation>Slankamenac K, Breitenstein S, Held U, Beck-Schimmer B, Puhan MA, Clavien PA. Development and validation of a prediction score for postoperative acute renal failure following liver resection. Ann Surg. 2009;250:720&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">19809295</ArticleId></ArticleIdList></Reference><Reference><Citation>Graziani MP, Moser M, Bozzola CM, Galvez HM, Irman GJ, Alvarez PG, et al. &#xa0;Acute kidney injury in children after cardiac surgery: risk factors and outcomes. A retrospective, cohort study. Arch Argent Pediatr. 2019;117:e557&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">31758882</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie X, Wan X, Ji X, Chen X, Liu J, Chen W, et al. &#xa0;Reassessment of acute kidney injury after cardiac surgery: a retrospective study. Intern Med. 2017;56:275&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5348450</ArticleId><ArticleId IdType="pubmed">28154270</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore PK, Hsu RK, Liu KD. Management of Acute Kidney Injury: Core curriculum 2018. Am J Kidney Dis. 2018;72:136&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">29478864</ArticleId></ArticleIdList></Reference><Reference><Citation>Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;53:961&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2726041</ArticleId><ArticleId IdType="pubmed">19346042</ArticleId></ArticleIdList></Reference><Reference><Citation>Thanaboriboon C, Vanichvithya P, Jinaworn P. What is the risk of intraoperative cerebral oxygen desaturation in patients undergoing shoulder surgery in the beach chair position? &#xa0;Clin Orthop Relat Res. 2021;479:2677&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8726564</ArticleId><ArticleId IdType="pubmed">34128914</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi JW, Kim DK, Jeong HJ, Kim YR, Chung YJ, Son YH. Risk factors associated with hypotensive bradycardic events during open shoulder surgery in the beach chair position. Korean J Anesthesiol. 2021;74:38&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7862927</ArticleId><ArticleId IdType="pubmed">32013327</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai S, Li X, Yang Y, Cao Y, Wang E, Dong Z. A retrospective cohort analysis for the risk factors of intraoperative hypotension. Int J Clin Pract. 2020;74:e13521.</Citation><ArticleIdList><ArticleId IdType="pubmed">32353902</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y, Bass GA, Ahl R, Pourlotfi A, Geijer H, Montgomery S, et al. &#xa0;The statistical importance of P-POSSUM scores for predicting mortality after emergency laparotomy in geriatric patients. BMC Med Inform Decis Mak. 2020;20:86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7206787</ArticleId><ArticleId IdType="pubmed">32380980</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun LY, Wijeysundera DN, Tait GA, Beattie WS. Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery. Anesthesiology. 2015;123:515&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">26181335</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang YZ, Zhu CN, Liu JB, Wang A, Duan K, Li B, et al. &#xa0;Association of Intraoperative Hypotension with acute kidney injury after noncardiac surgery in patients younger than 60 years old. Kidney Blood Press Res. 2019;44:211&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">30928979</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangasamy V, de &#xa0;GuerreL, Xu X, Schermerhorn ML, Novack V, Subramaniam B. Association between intraoperative hypotension and postoperative adverse outcomes in patients undergoing vascular surgery - a retrospective observational study. J Cardiothorac Vasc Anesth. 2020;S1053&#x2013;0770:31191&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">33293215</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal A, Wei G, Boucher R, Ahmed F, Beddhu S. Modification of the effects of intensive systolic blood pressure control on kidney outcomes by baseline body mass index. Nephrology (Carlton). 2021;26:303&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10324634</ArticleId><ArticleId IdType="pubmed">33538091</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei J, Zhu J, Zhang J, Jiang S, Qu L, Wang L, et al. &#xa0;Aging impairs renal autoregulation in mice. Hypertension. 2020;75:405&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7027982</ArticleId><ArticleId IdType="pubmed">31838907</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan F, Geurts AM, Pabbidi MR, Ge Y, Zhang C, Wang S, et al. &#xa0;A mutation in gamma-Adducin impairs autoregulation of renal blood flow and promotes the development of kidney disease. J Am Soc Nephrol. 2020;31:687&#x2013;700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7191921</ArticleId><ArticleId IdType="pubmed">32029431</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng L, Wang Y, Zhang L, McDonagh DL. Heterogeneity and variability in pressure autoregulation of organ blood flow: lessons learned over 100+ years. Crit Care Med. 2019;47:436&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">30516567</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng L, Yu W, Wang T, Zhang L, Heerdt PM, Gelb AW. Blood pressure targets in perioperative care. Hypertension. 2018;72:806&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">30354725</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y-Z, Zeng P, Liao Y, Qin Z, Zhang H, Li B, et al. &#xa0;Correlation between perioperative parecoxib use and postoperative acute kidney injury in patients undergoing non-cardiac surgery: a retrospective cohort analysis. BMJ Open. 2021;11:e047840.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8388276</ArticleId><ArticleId IdType="pubmed">34433595</ArticleId></ArticleIdList></Reference><Reference><Citation>Long TE, Helgason D, Helgadottir S, Palsson R, Gudbjartsson T, Sigurdsson GH, et al. &#xa0;Acute kidney injury after abdominal surgery: incidence, risk factors, and outcome. Anesth Analg. 2016;122:1912&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">27195635</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JY, Yao YM, Tian Y. Early predictive value of high density lipoprotein cholesterol for secondary acute kidney injury in sepsis patients. Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2022;38:130&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11704516</ArticleId><ArticleId IdType="pubmed">35220701</ArticleId></ArticleIdList></Reference><Reference><Citation>Rewa O, Bagshaw SM. Acute kidney injury-epidemiology, outcomes and economics. Nat Rev Nephrol. 2014;10:193&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">24445744</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Tremper KK, Heung M, Rosenberg AL, Englesbe M, Shanks AM, et al. &#xa0;Development and validation of an acute kidney injury risk index for patients undergoing general surgery: results from a national data set. Anesthesiology. 2009;110:505&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">19212261</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang WW, Zhu WZ, Mu DL, Ji XQ, Li XY, Ma D, et al. &#xa0;Intraoperative hypotension is associated with shortened overall survival after lung cancer surgery. BMC Anesthesiol. 2020;20:160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7322881</ArticleId><ArticleId IdType="pubmed">32600326</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H, Perez JS, Lu K, George AJ, Ma D. Role of toll-like receptor-4 in renal graft ischemia-reperfusion injury. American journal of physiology Renal physiology. 2014;306:F801&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3989634</ArticleId><ArticleId IdType="pubmed">24523386</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J, Sun P, Zhao H, Watts HR, Sanders RD, Terrando N, et al. &#xa0;Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice. Crit Care. 2011;15:R153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3219027</ArticleId><ArticleId IdType="pubmed">21702944</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang Y, Fu Y, Wu W, Tang C, Dong Z. Autophagy in acute kidney injury and maladaptive kidney repair. Burns. Trauma. 2023;11:tkac059.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9867874</ArticleId><ArticleId IdType="pubmed">36694860</ArticleId></ArticleIdList></Reference><Reference><Citation>Ologunde R, Zhao H, Lu K, Ma D. Organ cross talk and remote organ damage following acute kidney injury. Int Urol Nephrol. 2014;46:2337&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">24966098</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka S, Okusa MD. Crosstalk between the nervous system and the kidney. Kidney Int. 2020;97:466&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7039752</ArticleId><ArticleId IdType="pubmed">32001065</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Xu J, Fu P, Ma L. MicroRNAs in septic acute kidney injury. Burns Trauma. 2023;11:tkad008.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10027606</ArticleId><ArticleId IdType="pubmed">36959845</ArticleId></ArticleIdList></Reference><Reference><Citation>Meidert AS, Nold JS, Hornung R, Paulus AC, Zwissler B, Czerner S. The impact of continuous non-invasive arterial blood pressure monitoring on blood pressure stability during general anaesthesia in orthopaedic patients: a randomised trial. Eur J Anaesthesiol. 2017;34:716&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">28922340</ArticleId></ArticleIdList></Reference><Reference><Citation>Turan A, Chang C, Cohen B, Saasouh W, Essber H, Yang D, et al. &#xa0;Incidence, severity, and detection of blood pressure perturbations after abdominal surgery: a prospective blinded observational study. Anesthesiology. 2019;130:550&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30875354</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B, Lin LY, Liu XA, Ling YS, Zhang YY, Luo AQ, et al. &#xa0;Invasive blood pressure measurement and In-hospital mortality in critically ill patients with hypertension. Front Cardiovasc Med. 2021;8:720605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440864</ArticleId><ArticleId IdType="pubmed">34540920</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufmann T, Cox EGM, Wiersema R, Hiemstra B, Eck RJ, Koster G, et al. &#xa0;Non-invasive oscillometric versus invasive arterial blood pressure measurements in critically ill patients: a post hoc analysis of a prospective observational study. J Crit Care. 2020;57:118&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">32109843</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37312156</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1749-799X</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>13</Day></PubDate></JournalIssue><Title>Journal of orthopaedic surgery and research</Title><ISOAbbreviation>J Orthop Surg Res</ISOAbbreviation></Journal><ArticleTitle>Regional versus general anesthesia in older patients for hip fracture surgery: a systematic review and meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>428</StartPage><MedlinePgn>428</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">428</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13018-023-03903-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The optimal anesthesia technique for older patients undergoing hip fracture surgery remains controversial. We performed a systematic review and meta-analysis of updated randomized controlled trials (RCTs) to assess whether regional anesthesia was superior to general anesthesia in hip fracture surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched PubMed, EMBASE, Web of Science, and the Cochrane Central Register of Controlled Trials from January 2000 until April 2022. RCTs directly comparing regional and general anesthesia in hip fracture surgery were included in the analysis. The incidence of delirium and mortality were the primary outcomes and other perioperative outcomes including complications were secondary outcomes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirteen studies involving 3736 patients were included in this study. There was no significant difference in the incidence of delirium (odds ratio [OR] 1.09; 95% confidence interval [CI] 0.86, 1.37) and mortality (OR 1.08; 95% CI 0.71, 1.64) between the two groups. Patients receiving regional anesthesia in hip fracture surgery were associated with a reduction in operative time (weighted mean difference [WMD]: -&#x2009;4.74; 95% CI -&#x2009;8.85, -&#x2009;0.63), intraoperative blood loss (WMD: -&#x2009;0.25; 95% CI -&#x2009;0.37, -&#x2009;0.12), postoperative pain score (WMD: -&#x2009;1.77; 95% CI -&#x2009;2.79, -&#x2009;0.74), length of stay (WMD: -&#x2009;0.10; 95% CI -&#x2009;0.18, -&#x2009;0.02), and risk of acute kidney injury (AKI) (OR 0.56; 95% CI 0.36, 0.87). No significant difference was observed in the other perioperative outcomes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">For older patients undergoing hip fracture surgery, RA did not significantly reduce the incidence of postoperative delirium and mortality compared to GA. Due to the limitations of this study, the evidence on delirium and mortality was still inconclusive and further high-quality studies are needed.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhou</LastName><ForeName>Sheng-Liang</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, No. 37 Guoxue Road, Sichuan Province, 610041, Chengdu, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Shao-Yun</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, No. 37 Guoxue Road, Sichuan Province, 610041, Chengdu, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthopedics, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, Sichuan Province, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Si</LastName><ForeName>Hai-Bo</ForeName><Initials>HB</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, No. 37 Guoxue Road, Sichuan Province, 610041, Chengdu, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, No. 37 Guoxue Road, Sichuan Province, 610041, Chengdu, People's Republic of China. shenbin_1971@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>81974347</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Orthop Surg Res</MedlineTA><NlmUniqueID>101265112</NlmUniqueID><ISSNLinking>1749-799X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003693" MajorTopicYN="Y">Delirium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="Y">Hip Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000765" MajorTopicYN="N">Anesthesia, Conduction</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005592" MajorTopicYN="Y">Fracture Fixation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anesthesia</Keyword><Keyword MajorTopicYN="N">General</Keyword><Keyword MajorTopicYN="N">Hip fracture</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Regional</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>14</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>13</Day><Hour>23</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37312156</ArticleId><ArticleId IdType="pmc">PMC10262548</ArticleId><ArticleId IdType="doi">10.1186/s13018-023-03903-5</ArticleId><ArticleId IdType="pii">10.1186/s13018-023-03903-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17(12):1726&#x2013;1733. doi: 10.1007/s00198-006-0172-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-006-0172-4</ArticleId><ArticleId IdType="pubmed">16983459</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Feng J, Wang S, Gao P, Xu L, Zhu J, Jia J, Liu L, Liu G, Wang J, et al. Incidence of and trends in hip fracture among adults in urban China: a nationwide retrospective cohort study. PLoS Med. 2020;17(8):e1003180. doi: 10.1371/journal.pmed.1003180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003180</ArticleId><ArticleId IdType="pmc">PMC7410202</ArticleId><ArticleId IdType="pubmed">32760065</ArticleId></ArticleIdList></Reference><Reference><Citation>Briot K, Maravic M, Roux C. Changes in number and incidence of hip fractures over 12 years in France. Bone. 2015;81:131&#x2013;137. doi: 10.1016/j.bone.2015.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2015.07.009</ArticleId><ArticleId IdType="pubmed">26164476</ArticleId></ArticleIdList></Reference><Reference><Citation>Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB. Incidence and mortality of hip fractures in the United States. JAMA. 2009;302(14):1573&#x2013;1579. doi: 10.1001/jama.2009.1462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2009.1462</ArticleId><ArticleId IdType="pmc">PMC4410861</ArticleId><ArticleId IdType="pubmed">19826027</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YP, Kuo YJ, Hung SW, Wen TW, Chien PC, Chiang MH, Maffulli N, Lin CY. Loss of skeletal muscle mass can be predicted by sarcopenia and reflects poor functional recovery at 1 year after surgery for geriatric hip fractures. Injury. 2021;52(11):3446&#x2013;3452. doi: 10.1016/j.injury.2021.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2021.08.007</ArticleId><ArticleId IdType="pubmed">34404509</ArticleId></ArticleIdList></Reference><Reference><Citation>Cauley JA, Chalhoub D, Kassem AM. Fuleihan GE-H: geographic and ethnic disparities in osteoporotic fractures. Nat Rev Endocrinol. 2014;10(6):338&#x2013;351. doi: 10.1038/nrendo.2014.51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrendo.2014.51</ArticleId><ArticleId IdType="pubmed">24751883</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsillo E, Pintore A, Asparago G, Oliva F, Maffulli N. Cephalomedullary nailing for reverse oblique intertrochanteric fractures 31A3 (AO/OTA) Orthop Rev. 2022;14(6):38560. doi: 10.52965/001c.38560.</Citation><ArticleIdList><ArticleId IdType="doi">10.52965/001c.38560</ArticleId><ArticleId IdType="pmc">PMC9568432</ArticleId><ArticleId IdType="pubmed">36267220</ArticleId></ArticleIdList></Reference><Reference><Citation>Gargano G, Poeta N, Oliva F, Migliorini F, Maffulli N. Zimmer Natural Nail and ELOS nails in pertrochanteric fractures. J Orthop Surg Res. 2021;16(1):509. doi: 10.1186/s13018-021-02634-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13018-021-02634-9</ArticleId><ArticleId IdType="pmc">PMC8371819</ArticleId><ArticleId IdType="pubmed">34407829</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Fleisher LA, Even-Shoshan O, Mi L, Silber JH. Nonoperative care for hip fracture in the elderly: the influence of race, income, and comorbidities. Med Care. 2010;48(4):314&#x2013;320. doi: 10.1097/MLR.0b013e3181ca4126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e3181ca4126</ArticleId><ArticleId IdType="pmc">PMC4882126</ArticleId><ArticleId IdType="pubmed">20355262</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravi B, Pincus D, Choi S, Jenkinson R, Wasserstein DN, Redelmeier DA. Association of duration of surgery with postoperative delirium among patients receiving hip fracture repair. JAMA Netw Open. 2019;2(2):e190111. doi: 10.1001/jamanetworkopen.2019.0111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2019.0111</ArticleId><ArticleId IdType="pmc">PMC6484601</ArticleId><ArticleId IdType="pubmed">30794305</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai V, Chan PH, Prentice HA, Zohman GL, Diekmann GR, Maletis GB, Fasig BH, Diaz D, Chung E, Qiu CY. Is anesthesia technique associated with a higher risk of mortality or complications within 90 days of surgery for geriatric patients with hip fractures? Clin Orthop Relat Res. 2018;476(6):1178&#x2013;1188. doi: 10.1007/s11999.0000000000000147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11999.0000000000000147</ArticleId><ArticleId IdType="pmc">PMC6263607</ArticleId><ArticleId IdType="pubmed">29601378</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishi T, Maeda T, Imatoh T, Babazono A. Comparison of regional with general anesthesia on mortality and perioperative length of stay in older patients after hip fracture surgery. Int J Qual Health Care: J Int Soc Qual Health Care. 2019;31(9):669&#x2013;675.</Citation><ArticleIdList><ArticleId IdType="pubmed">30452640</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan L, McKeever TM, Nightingale J, Deakin DE, Moppett IK. Spinal or general anaesthesia for surgical repair of hip fracture and subsequent risk of mortality and morbidity: a database analysis using propensity score-matching. Anaesthesia. 2020;75(9):1173&#x2013;1179. doi: 10.1111/anae.15042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.15042</ArticleId><ArticleId IdType="pubmed">32337715</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X, Tan Y, Gao Y, Liu Z. Comparative efficacy of Neuraxial and general anesthesia for hip fracture surgery: a meta-analysis of randomized clinical trials. BMC Anesthesiol. 2020;20(1):162. doi: 10.1186/s12871-020-01074-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-020-01074-y</ArticleId><ArticleId IdType="pmc">PMC7325684</ArticleId><ArticleId IdType="pubmed">32605591</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Li J, Yuan L, Wu J, Jiang C, Daniels J, Mehta RL, Wang M, Yeung J, Jackson T, et al. Effect of regional versus general anesthesia on incidence of postoperative delirium in older patients undergoing hip fracture surgery: the RAGA randomized trial. JAMA. 2022;327(1):50&#x2013;58. doi: 10.1001/jama.2021.22647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.22647</ArticleId><ArticleId IdType="pmc">PMC8689436</ArticleId><ArticleId IdType="pubmed">34928310</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang LL, Fang PP, Fang YX, Lu Y, Xu GH, Liu XS. Comparison of effects between combined lumbar-sacral plexus block plus general anesthesia and unilateral spinal anesthesia in elderly patients undergoing hip fracture surgery: a pilot randomized controlled trial. Evid-Based Complement Altern Med. 2021 doi: 10.1155/2021/6685497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6685497</ArticleId><ArticleId IdType="pmc">PMC8105098</ArticleId><ArticleId IdType="pubmed">34012474</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Feng R, Carson JL, Gaskins LJ, Dillane D, Sessler DI, Sieber F, Magaziner J, Marcantonio ER, Mehta S, et al. Spinal anesthesia or general anesthesia for hip surgery in older adults. N Engl J Med. 2021;385(22):2025&#x2013;2035. doi: 10.1056/NEJMoa2113514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2113514</ArticleId><ArticleId IdType="pubmed">34623788</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ (Clin Res Ed) 2015;350:g7647.</Citation><ArticleIdList><ArticleId IdType="pubmed">25555855</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Altman DG, G&#xf8;tzsche PC, J&#xfc;ni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JAC. The cochrane collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ (Clin Res Ed) 2011;343:d5928. doi: 10.1136/bmj.d5928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135. doi: 10.1186/1471-2288-14-135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-135</ArticleId><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, White IR, Anzures-Cabrera J. Meta-analysis of skewed data: combining results reported on log-transformed or raw scales. Stat Med. 2008;27(29):6072&#x2013;6092. doi: 10.1002/sim.3427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.3427</ArticleId><ArticleId IdType="pmc">PMC2978323</ArticleId><ArticleId IdType="pubmed">18800342</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin Res Ed) 1997;315(7109):629&#x2013;634. doi: 10.1136/bmj.315.7109.629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzimas P, Samara E, Petrou A, Korompilias A, Chalkias A, Papadopoulos G. The influence of anesthetic techniques on postoperative cognitive function in elderly patients undergoing hip fracture surgery: general versus spinal anesthesia. Injury. 2018;49(12):2221&#x2013;2226. doi: 10.1016/j.injury.2018.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2018.09.023</ArticleId><ArticleId IdType="pubmed">30526923</ArticleId></ArticleIdList></Reference><Reference><Citation>Meuret P, Bouvet L, Villet B, Hafez M, Allaouchiche B, Boselli E. Hypobaric unilateral spinal anaesthesia versus general anaesthesia in elderly patients undergoing hip fracture surgical repair: a prospective randomised open trial. Turk J Anaesthesiol Reanim. 2018;46(2):121&#x2013;130. doi: 10.5152/TJAR.2018.90699.</Citation><ArticleIdList><ArticleId IdType="doi">10.5152/TJAR.2018.90699</ArticleId><ArticleId IdType="pmc">PMC5937458</ArticleId><ArticleId IdType="pubmed">29744247</ArticleId></ArticleIdList></Reference><Reference><Citation>Haghighi M, Sedighinejad A, Nabi BN, Mardani-Kivi M, Tehran SG, Mirfazli SA, Mirbolook A, Saheli NA. Is spinal anesthesia with low dose lidocaine better than sevoflorane anesthesia in patients undergoing hip fracture surgery. Arch Bone Jt Surg. 2017;5(4):226&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5592363</ArticleId><ArticleId IdType="pubmed">28913379</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Mehta S, Bannister ER, Hesketh PJ, Horan AD, Elkassabany NM. Pilot randomized controlled trial of spinal versus general anesthesia for hip fracture surgery. J Am Geriatr Soc. 2016;64(12):2604&#x2013;2606. doi: 10.1111/jgs.14373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.14373</ArticleId><ArticleId IdType="pmc">PMC5180205</ArticleId><ArticleId IdType="pubmed">27996117</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker MJ, Griffiths R. General versus regional anaesthesia for hip fractures. A pilot randomised controlled trial of 322 patients. Injury. 2015;46(8):1562&#x2013;1566. doi: 10.1016/j.injury.2015.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2015.05.004</ArticleId><ArticleId IdType="pubmed">26049662</ArticleId></ArticleIdList></Reference><Reference><Citation>Messina A, Frassanito L, Colombo D, Vergari A, Draisci G, Della Corte F, Antonelli M. Hemodynamic changes associated with spinal and general anesthesia for hip fracture surgery in severe ASA III elderly population: a pilot trial. Minerva Anestesiol. 2013;79(9):1021&#x2013;1029.</Citation><ArticleIdList><ArticleId IdType="pubmed">23635998</ArticleId></ArticleIdList></Reference><Reference><Citation>Biboulet P, Jourdan A, Van Haevre V, Morau D, Bernard N, Bringuier S, Capdevila X. Hemodynamic profile of target-controlled spinal anesthesia compared with 2 target-controlled general anesthesia techniques in elderly patients with cardiac comorbidities. Reg Anesth Pain Med. 2012;37(4):433&#x2013;440. doi: 10.1097/AAP.0b013e318252e901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AAP.0b013e318252e901</ArticleId><ArticleId IdType="pubmed">22609644</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoppenstein D, Zohar E, Ramaty E, Shabat S, Fredman B. The effects of general versus spinal anesthesia on frontal cerebral oxygen saturation in geriatric patients undergoing emergency surgical fixation of the neck of femur. J Clin Anesth. 2005;17(6):431&#x2013;438. doi: 10.1016/j.jclinane.2004.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2004.09.013</ArticleId><ArticleId IdType="pubmed">16171663</ArticleId></ArticleIdList></Reference><Reference><Citation>Casati A, Aldegheri G, Vinciguerra E, Marsan A, Fraschini G, Torri G. Randomized comparison between sevoflurane anaesthesia and unilateral spinal anaesthesia in elderly patients undergoing orthopaedic surgery. Eur J Anaesthesiol. 2003;20(8):640&#x2013;646. doi: 10.1097/00003643-200308000-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003643-200308000-00009</ArticleId><ArticleId IdType="pubmed">12932066</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidari SM, Soltani H, Hashemi SJ, Talakoub R, Soleimani B. Comparative study of two anesthesia methods according to postoperative complications and 1 month mortality rate in the candidates of hip surgery. J Res Med Sci. 2011;16(3):323&#x2013;330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3214341</ArticleId><ArticleId IdType="pubmed">22091252</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Donnell CM, McLoughlin L, Patterson CC, Clarke M, McCourt KC, McBrien ME, McAuley DF, Shields MO. Perioperative outcomes in the context of mode of anaesthesia for patients undergoing hip fracture surgery: systematic review and meta-analysis. Br J Anaesth. 2018;120(1):37&#x2013;50. doi: 10.1016/j.bja.2017.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2017.09.002</ArticleId><ArticleId IdType="pubmed">29397135</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim EM, Li G, Kim M. Development of a risk score to predict postoperative delirium in patients with hip fracture. Anesth Analg. 2020;130(1):79&#x2013;86. doi: 10.1213/ANE.0000000000004386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000004386</ArticleId><ArticleId IdType="pmc">PMC6917900</ArticleId><ArticleId IdType="pubmed">31478933</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudolph JL, Marcantonio ER. Review articles: postoperative delirium: acute change with long-term implications. Anesth Analg. 2011;112(5):1202&#x2013;1211. doi: 10.1213/ANE.0b013e3182147f6d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e3182147f6d</ArticleId><ArticleId IdType="pmc">PMC3090222</ArticleId><ArticleId IdType="pubmed">21474660</ArticleId></ArticleIdList></Reference><Reference><Citation>Maffulli N, Aicale R. Proximal femoral fractures in the elderly: a few things to know, and some to forget. Medicina (Kaunas) 2022;58(10):1314. doi: 10.3390/medicina58101314.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58101314</ArticleId><ArticleId IdType="pmc">PMC9612001</ArticleId><ArticleId IdType="pubmed">36295475</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel V, Champaneria R, Dretzke J, Yeung J. Effect of regional versus general anaesthesia on postoperative delirium in elderly patients undergoing surgery for hip fracture: a systematic review. BMJ Open. 2018;8(12):e020757. doi: 10.1136/bmjopen-2017-020757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-020757</ArticleId><ArticleId IdType="pmc">PMC6286489</ArticleId><ArticleId IdType="pubmed">30518580</ArticleId></ArticleIdList></Reference><Reference><Citation>Fong TG, Tulebaev SR, Inouye SK. Delirium in elderly adults: diagnosis, prevention and treatment. Nat Rev Neurol. 2009;5(4):210&#x2013;220. doi: 10.1038/nrneurol.2009.24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2009.24</ArticleId><ArticleId IdType="pmc">PMC3065676</ArticleId><ArticleId IdType="pubmed">19347026</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcantonio ER. Delirium in hospitalized older adults. N Engl J Med. 2017;377(15):1456&#x2013;1466. doi: 10.1056/NEJMcp1605501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcp1605501</ArticleId><ArticleId IdType="pmc">PMC5706782</ArticleId><ArticleId IdType="pubmed">29020579</ArticleId></ArticleIdList></Reference><Reference><Citation>Malhas L, Perlas A, Tierney S, Chan VWS, Beattie S. The effect of anesthetic technique on mortality and major morbidity after hip fracture surgery: a retrospective, propensity-score matched-pairs cohort study. Reg Anesth Pain Med. 2019;44(9):847&#x2013;853. doi: 10.1136/rapm-2019-100417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rapm-2019-100417</ArticleId><ArticleId IdType="pubmed">31300593</ArticleId></ArticleIdList></Reference><Reference><Citation>Guay J, Choi P, Suresh S, Albert N, Kopp S, Pace NL. Neuraxial blockade for the prevention of postoperative mortality and major morbidity: an overview of cochrane systematic reviews. Cochrane Database Syst Rev. 2014;1:CD010108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7087466</ArticleId><ArticleId IdType="pubmed">24464831</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Waesberghe J, Stevanovic A, Rossaint R, Coburn M. General versus neuraxial anaesthesia in hip fracture patients: a systematic review and meta-analysis. BMC Anesthesiol. 2017;17:1&#x2013;025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5490182</ArticleId><ArticleId IdType="pubmed">28659127</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu C-C, Weng S-F, Chen K-T, Chien C-C, Shieh J-P, Chen J-Y, Wang J-J. Propensity score-matched comparison of postoperative adverse outcomes between geriatric patients given a general or a neuraxial anesthetic for hip surgery: a population-based study. Anesthesiology. 2015;123(1):136&#x2013;147. doi: 10.1097/ALN.0000000000000695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000695</ArticleId><ArticleId IdType="pubmed">25955981</ArticleId></ArticleIdList></Reference><Reference><Citation>Richman JM, Rowlingson AJ, Maine DN, Courpas GE, Weller JF, Wu CL. Does neuraxial anesthesia reduce intraoperative blood loss? A meta-analysis. J Clin Anesth. 2006;18(6):427&#x2013;435. doi: 10.1016/j.jclinane.2006.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2006.02.006</ArticleId><ArticleId IdType="pubmed">16980159</ArticleId></ArticleIdList></Reference><Reference><Citation>Ing C, Sun LS, Friend AF, Kim M, Berman MF, Paganelli W, Li G, Williams RK. Differences in intraoperative hemodynamics between spinal and general anesthesia in infants undergoing pyloromyotomy. Paediatr Anaesth. 2017;27(7):733&#x2013;741. doi: 10.1111/pan.13156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.13156</ArticleId><ArticleId IdType="pmc">PMC5461197</ArticleId><ArticleId IdType="pubmed">28419639</ArticleId></ArticleIdList></Reference><Reference><Citation>Modig J. Regional anaesthesia and blood loss. Acta Anaesthesiol Scand Suppl. 1988;89:44&#x2013;48. doi: 10.1111/j.1399-6576.1988.tb02842.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.1988.tb02842.x</ArticleId><ArticleId IdType="pubmed">3067490</ArticleId></ArticleIdList></Reference><Reference><Citation>Quaranta M, Miranda L, Oliva F, Migliorini F, Pezzuti G, Maffulli N. Haemoglobin and transfusions in elderly patients with hip fractures: the effect of a dedicated orthogeriatrician. J Orthop Surg Res. 2021;16(1):387. doi: 10.1186/s13018-021-02524-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13018-021-02524-0</ArticleId><ArticleId IdType="pmc">PMC8207795</ArticleId><ArticleId IdType="pubmed">34134743</ArticleId></ArticleIdList></Reference><Reference><Citation>Mounet B, Choquet O, Swisser F, Biboulet P, Bernard N, Bringuier S, Capdevila X. Impact of multiple nerves blocks anaesthesia on intraoperative hypotension and mortality in hip fracture surgery intermediate-risk elderly patients: a propensity score-matched comparison with spinal and general anaesthesia. Anaesth Crit Care Pain Med. 2021;40(4):100924. doi: 10.1016/j.accpm.2021.100924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.accpm.2021.100924</ArticleId><ArticleId IdType="pubmed">34217841</ArticleId></ArticleIdList></Reference><Reference><Citation>Korhonen A-M, Valanne JV, Jokela RM, Ravaska P, Korttila KT. A comparison of selective spinal anesthesia with hyperbaric bupivacaine and general anesthesia with desflurane for outpatient knee arthroscopy. Anesth Analg. 2004;99(6):1668&#x2013;1673. doi: 10.1213/01.ANE.0000139351.40608.05.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ANE.0000139351.40608.05</ArticleId><ArticleId IdType="pubmed">15562051</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonano C, Leitgeb U, Sitzwohl C, Ihra G, Weinstabl C, Kettner SC. Spinal versus general anesthesia for orthopedic surgery: anesthesia drug and supply costs. Anesth Analg. 2006;102(2):524&#x2013;529. doi: 10.1213/01.ane.0000194292.81614.c6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ane.0000194292.81614.c6</ArticleId><ArticleId IdType="pubmed">16428554</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu SS, Strodtbeck WM, Richman JM, Wu CL. A comparison of regional versus general anesthesia for ambulatory anesthesia: a meta-analysis of randomized controlled trials. Anesth Analg. 2005;101(6):1634&#x2013;1642. doi: 10.1213/01.ANE.0000180829.70036.4F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ANE.0000180829.70036.4F</ArticleId><ArticleId IdType="pubmed">16301234</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant MC, Pio Roda CM, Canner JK, Sommer P, Galante D, Hobson D, Gearhart S, Wu CL, Wick E. The impact of anesthesia-influenced process measure compliance on length of stay: results from an enhanced recovery after surgery for colorectal surgery cohort. Anesth Analg. 2019;128(1):68&#x2013;74. doi: 10.1213/ANE.0000000000003458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000003458</ArticleId><ArticleId IdType="pubmed">29782405</ArticleId></ArticleIdList></Reference><Reference><Citation>Nawi SNM, Wong B, Edwards S, Loh X, Maddison J. A retrospective observational study on the types of anaesthesia in hip fracture surgery. J Perioper Pract. 2021;33(1&#x2013;2):15&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">34197241</ArticleId></ArticleIdList></Reference><Reference><Citation>Kir G, Buget M, Koltka K, Kir MC, Pembeci K. The impact of timing of surgery and the anesthesia technique in hip fracture surgery on in-hospital mortality and length of hospital stay. J Acad Res Med-Jarem. 2020;10(1):82&#x2013;87. doi: 10.4274/jarem.galenos.2019.2076.</Citation><ArticleIdList><ArticleId IdType="doi">10.4274/jarem.galenos.2019.2076</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith LM, Cozowicz C, Uda Y, Memtsoudis SG, Barrington MJ. Neuraxial and combined neuraxial/general anesthesia compared to general anesthesia for major truncal and lower limb surgery: a systematic review and meta-analysis. Anesth Analg. 2017;125(6):1931&#x2013;1945. doi: 10.1213/ANE.0000000000002069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000002069</ArticleId><ArticleId IdType="pubmed">28537970</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Rosenbaum PR, Ludwig JM, Zubizarreta JR, Silber JH. Anesthesia technique, mortality, and length of stay after hip fracture surgery. JAMA. 2014;311(24):2508&#x2013;2517. doi: 10.1001/jama.2014.6499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.6499</ArticleId><ArticleId IdType="pmc">PMC4344128</ArticleId><ArticleId IdType="pubmed">25058085</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H-J, Park H-S, Go Y-J, Koh WU, Kim H, Song J-G, Ro Y-J. Effect of anesthetic technique on the occurrence of acute kidney injury after total knee arthroplasty. J Clin Med. 2019;8(6):778. doi: 10.3390/jcm8060778.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8060778</ArticleId><ArticleId IdType="pmc">PMC6616515</ArticleId><ArticleId IdType="pubmed">31159309</ArticleId></ArticleIdList></Reference><Reference><Citation>Block BM, Liu SS, Rowlingson AJ, Cowan AR, Cowan JA, Wu CL. Efficacy of postoperative epidural analgesia: a meta-analysis. JAMA. 2003;290(18):2455&#x2013;2463. doi: 10.1001/jama.290.18.2455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.290.18.2455</ArticleId><ArticleId IdType="pubmed">14612482</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Xu X, Ni H. Small studies may overestimate the effect sizes in critical care meta-analyses: a meta-epidemiological study. Crit Care. 2013;17(1):R2. doi: 10.1186/cc11919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11919</ArticleId><ArticleId IdType="pmc">PMC4056100</ArticleId><ArticleId IdType="pubmed">23302257</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39269909</PMID><DateCompleted><Year>2025</Year><Month>02</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>140</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Association Between Glycemic Variability and Persistent Acute Kidney Injury After Noncardiac Major Surgery: A Multicenter Retrospective Cohort Study.</ArticleTitle><Pagination><StartPage>636</StartPage><EndPage>645</EndPage><MedlinePgn>636-645</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000007131</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">While the relationship between glycemic variability (GV) and acute kidney injury (AKI) has been a subject of interest, the specific association of GV with persistent AKI beyond 48 hours postoperative after noncardiac surgery is not well-established.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective cohort study aimed to describe the patterns of different GV metrics in the immediate 48 hours after noncardiac surgery, evaluate the association between GV indices and persistent AKI within the 7-day postoperative window, and compare the risk identification capabilities of various GV for persistent AKI. A total of 10,937 patients who underwent major noncardiac surgery across 3 medical centers in eastern China between January 2015 and September 2023 were enrolled. GV was characterized using the coefficient of variations (CV), mean amplitude of glycemic excursions (MAGE), and the blood glucose risk index (BGRI). Multivariable logistic regression was used to examine the relationship between GV and AKI. Optimal cutoff values for GV metrics were calculated through the risk identification models, and an independent cohort from the INformative Surgical Patient dataset for Innovative Research Environment (INSPIRE) database with 7714 eligible cases served to externally validate the risk identification capability.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall, 274 (2.5%) of the 10,937 patients undergoing major noncardiac surgery met the criteria of persistent AKI. Higher GV was associated with an increased risk of persistent AKI (CV: odds ratio [OR] = 1.26, 95% confidence interval [CI], 1.08-1.46; MAGE: OR = 1.31, 95% CI, 1.15-1.49; BGRI: OR = 1.18, 95% CI, 1.08-1.29). Compared to models that did not consider glycemic factors, MAGE and BGRI independently contributed to predicting persistent AKI (MAGE: areas under the curve [AUC] = 0.768, P = .011; BGRI: AUC = 0.764, P = .014), with cutoff points of 3.78 for MAGE, and 3.02 for BGRI. The classification of both the internal and external validation cohorts using cutoffs demonstrated good performance, achieving the best AUC values of 0.768 for MAGE in the internal cohort and 0.777 for MAGE in the external cohort.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">GV measured within 48 hours postoperative period is an independent risk factor for persistent AKI in patients undergoing noncardiac surgery. Specific cutoff points can be used to stratify at-risk patients. These findings indicate that stabilizing GV may potentially mitigate adverse kidney outcomes after noncardiac surgery, highlighting the importance of glycemic control in the perioperative period.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 International Anesthesia Research Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Siyu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the School of International Business, China Pharmaceutical University, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Ke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Nanjing First Hospital, Nanjing Medical University, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Huili</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Fan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>From the School of International Business, China Pharmaceutical University, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Nanjing First Hospital, Nanjing Medical University, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Liu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Nanjing First Hospital, Nanjing Medical University, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Yali</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Nanjing First Hospital, Nanjing Medical University, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Lihai</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Nanjing First Hospital, Nanjing Medical University, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Hongwei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Nanjing First Hospital, Nanjing Medical University, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Jifang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>From the School of International Business, China Pharmaceutical University, Jiangsu, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="Y">Blood Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="Y">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>20</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>13</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39269909</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000007131</ArticleId><ArticleId IdType="pii">00000539-990000000-00945</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Thiele RH, Theodore DJ, Gan TJ. Outcome of organ dysfunction in the perioperative period. Anesth Analg. 2021;133:393&#x2013;405.</Citation></Reference><Reference><Citation>James MT, Bhatt M, Pannu N, Tonelli M. Long-term outcomes of acute kidney injury and strategies for improved care. Nat Rev Nephrol. 2020;16:193&#x2013;205.</Citation></Reference><Reference><Citation>Prowle JR, Forni LG, Bell M, et al. Postoperative acute kidney injury in adult non-cardiac surgery: joint consensus report of the Acute Disease Quality Initiative and PeriOperative Quality Initiative. Nat Rev Nephrol. 2021;17:605&#x2013;618.</Citation></Reference><Reference><Citation>Duff S, Murray PT. Defining early recovery of acute kidney injury. Clin J Am Soc Nephrol. 2020;15:1358&#x2013;1360.</Citation></Reference><Reference><Citation>Chawla LS, Bellomo R, Bihorac A, et al.; Acute Disease Quality Initiative Workgroup 16. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol. 2017;13:241&#x2013;257.</Citation></Reference><Reference><Citation>Kellum JA, Sileanu FE, Bihorac A, Hoste EAJ, Chawla LS. Recovery after acute kidney injury. Am J Respir Crit Care Med. 2017;195:784&#x2013;791.</Citation></Reference><Reference><Citation>Coca SG, King JT, Rosenthal RA, Perkal MF, Parikh CR. The duration of postoperative acute kidney injury is an additional parameter predicting long-term survival in diabetic veterans. Kidney Int. 2010;78:926&#x2013;933.</Citation></Reference><Reference><Citation>Korenkevych D, Ozrazgat-Baslanti T, Thottakkara P, et al. The pattern of longitudinal change in serum creatinine and 90-day mortality after major surgery. Ann Surg. 2016;263:1219&#x2013;1227.</Citation></Reference><Reference><Citation>Ferenbach DA, Bonventre JV. Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD. Nat Rev Nephrol. 2015;11:264&#x2013;276.</Citation></Reference><Reference><Citation>Hapca S, Siddiqui MK, Kwan RSY, et al.; BEAt-DKD Consortium. The relationship between AKI and CKD in patients with type 2 diabetes: an observational cohort study. J Am Soc Nephrol. 2021;32:138&#x2013;150.</Citation></Reference><Reference><Citation>Forni LG, Darmon M, Ostermann M, et al. Renal recovery after acute kidney injury. Intensive Care Med. 2017;43:855&#x2013;866.</Citation></Reference><Reference><Citation>Samoni S, De Rosa S, Ronco C, Castellano G. Update on persistent acute kidney injury in critical illnesses. Clin Kidney J. 2023;16:1813&#x2013;1823.</Citation></Reference><Reference><Citation>Ceriello A, Monnier L, Owens D. Glycaemic variability in diabetes: clinical and therapeutic implications. Lancet Diabetes Endocrinol. 2019;7:221&#x2013;230.</Citation></Reference><Reference><Citation>Ravi R, Balasubramaniam V, Kuppusamy G, Ponnusankar S. Current concepts and clinical importance of glycemic variability. Diabetes Metab Syndr. 2021;15:627&#x2013;636.</Citation></Reference><Reference><Citation>Alfieri V, Myasoedova VA, Vinci MC, et al. The role of glycemic variability in cardiovascular disorders. Int J Mol Sci . 2021;22:8393.</Citation></Reference><Reference><Citation>Nam K, Jeon Y, Kim WH, et al. Intraoperative glucose variability, but not average glucose concentration, may be a risk factor for acute kidney injury after cardiac surgery: a retrospective study. Can J Anaesth. 2019;66:921&#x2013;933.</Citation></Reference><Reference><Citation>Sim MA, Liu W, Ng RRG, Ti LK, Chew STH. Wider perioperative glycemic fluctuations increase risk of postoperative acute kidney injury: a prospective cohort study. Medicine (Baltimore). 2015;94:e1953.</Citation></Reference><Reference><Citation>Park J, Oh AR, Lee SH, et al. Associations between preoperative glucose and hemoglobin A1c level and myocardial injury after noncardiac surgery. J Am Heart Assoc. 2021;10:e019216.</Citation></Reference><Reference><Citation>Yoo S, Lee H-J, Lee H, Ryu H-G. Association between perioperative hyperglycemia or glucose variability and postoperative acute kidney injury after liver transplantation: A retrospective observational study. Anesth Analg. 2017;124:35&#x2013;41.</Citation></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453&#x2013;1457.</Citation></Reference><Reference><Citation>Lim L, Lee H. INSPIRE, a publicly available research dataset for perioperative medicine (version 1.0). PhysioNet. 2023.</Citation></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120:c179&#x2013;c184.</Citation></Reference><Reference><Citation>Harrell F. Introduction to Survival Analysis. Regression Modeling Strategies: With Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis. 2nd ed. Springer International Publishing AG; 2015:399&#x2013;422.</Citation></Reference><Reference><Citation>Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295:1681&#x2013;1687.</Citation></Reference><Reference><Citation>Ellger B, Debaveye Y, Vanhorebeek I, et al. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes. 2006;55:1096&#x2013;1105.</Citation></Reference><Reference><Citation>Dou L, Jourde-Chiche N. Endothelial toxicity of high glucose and its by-products in diabetic kidney disease. Toxins (Basel). 2019;11:578.</Citation></Reference><Reference><Citation>Simha V, Shah P. Perioperative glucose control in patients with diabetes undergoing elective surgery. JAMA. 2019;321:399&#x2013;400.</Citation></Reference><Reference><Citation>Zhang Z-Y, Miao L-F, Qian L-L, et al. Molecular mechanisms of glucose fluctuations on diabetic complications. Front Endocrinol (Lausanne). 2019;10:640.</Citation></Reference><Reference><Citation>Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124:2610&#x2013;2642.</Citation></Reference><Reference><Citation>Boucai L, Southern WN, Zonszein J. Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities. Am J Med. 2011;124:1028&#x2013;1035.</Citation></Reference><Reference><Citation>Godat E, Preiser J-C, Aude J-C, Kalfon P. Dynamic properties of glucose complexity during the course of critical illness: a pilot study. J Clin Monit Comput. 2020;34:361&#x2013;370.</Citation></Reference><Reference><Citation>Rangasamy V, Xu X, Susheela AT, Subramaniam B. Comparison of glycemic variability indices: blood glucose, risk index, and coefficient of variation in predicting adverse outcomes for patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth. 2020;34:1794&#x2013;1802.</Citation></Reference><Reference><Citation>Chao W-C, Tseng C-H, Wu C-L, Shih S-J, Yi C-Y, Chan M-C. Higher glycemic variability within the first day of ICU admission is associated with increased 30-day mortality in ICU patients with sepsis. Ann Intensive Care. 2020;10:17.</Citation></Reference><Reference><Citation>Kovatchev BP, Otto E, Cox D, Gonder-Frederick L, Clarke W. Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care. 2006;29:2433&#x2013;2438.</Citation></Reference><Reference><Citation>Baghurst PA. Calculating the mean amplitude of glycemic excursion from continuous glucose monitoring data: an automated algorithm. Diabetes Technol Ther. 2011;13:296&#x2013;302.</Citation></Reference><Reference><Citation>Carlsson CJ, N&#xf8;rgaard K, Oxb&#xf8;ll A-B, et al. Continuous glucose monitoring reveals perioperative hypoglycemia in most patients with diabetes undergoing major surgery: a prospective cohort study. Ann Surg. 2023;277:603&#x2013;611.</Citation></Reference><Reference><Citation>Perez-Guzman MC, Duggan E, Gibanica S, et al. Continuous glucose monitoring in the operating room and cardiac intensive care unit. Diabetes Care. 2021;44:e50&#x2013;e52.</Citation></Reference><Reference><Citation>Zarbock A, Weiss R, Albert F, et al.; EPIS-AKI Investigators. Epidemiology of surgery associated acute kidney injury (EPIS-AKI): a prospective international observational multi-center clinical study. Intensive Care Med. 2023;49:1441&#x2013;1455.</Citation></Reference><Reference><Citation>Zhuo X-Y, Lei S-H, Sun L, et al. Preoperative risk prediction models for acute kidney injury after noncardiac surgery: an independent external validation cohort study. Br J Anaesth. Published online March 24, 2024.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38241047</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>02</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Automated Electronic Alert for the Care and Outcomes of Adults With Acute Kidney Injury: A Randomized Clinical Trial.</ArticleTitle><Pagination><StartPage>e2351710</StartPage><MedlinePgn>e2351710</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2351710</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2023.51710</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Despite the expansion of published electronic alerts for acute kidney injury (AKI), there are still concerns regarding their effect on the clinical outcomes of patients.</AbstractText><AbstractText Label="OBJECTIVE">To evaluate the effect of the AKI alert combined with a care bundle on the care and clinical outcomes of patients with hospital-acquired AKI.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This single-center, double-blind, parallel-group randomized clinical trial was conducted in a tertiary teaching hospital in Nanjing, China, from August 1, 2019, to December 31, 2021. The inclusion criteria were inpatient adults aged 18 years or older with AKI, which was defined using the Kidney Disease: Improving Global Outcomes creatinine criteria. Participants were randomized 1:1 to either the alert group or the usual care group, which were stratified by medical vs surgical ward and by intensive care unit (ICU) vs non-ICU setting. Analyses were conducted on the modified intention-to-treat population.</AbstractText><AbstractText Label="INTERVENTIONS">A programmatic AKI alert system generated randomization automatically and sent messages to the mobile telephones of clinicians (alert group) or did not send messages (usual care group). A care bundle accompanied the AKI alert and consisted of general, nonindividualized, and nonmandatory AKI management measures.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">The primary outcome was maximum change in estimated glomerular filtration rate (eGFR) within 7 days after randomization. Secondary patient-centered outcomes included death, dialysis, AKI progression, and AKI recovery. Care-centered outcomes included diagnostic and therapeutic interventions for AKI.</AbstractText><AbstractText Label="RESULTS">A total of 2208 patients (median [IQR] age, 65 [54-72] years; 1560 males [70.7%]) were randomized to the alert group (n&#x2009;=&#x2009;1123) or the usual care group (n&#x2009;=&#x2009;1085) and analyzed. Within 7 days of randomization, median (IQR) maximum absolute changes in eGFR were 3.7 (-6.4 to 19.3) mL/min/1.73 m2 in the alert group and 2.9 (-9.2 to 16.9) mL/min/1.73 m2 in the usual care group (P&#x2009;=&#x2009;.24). This result was robust in all subgroups in an exploratory analysis. For care-centered outcomes, patients in the alert group had more intravenous fluids (927 [82.6%] vs 670 [61.8%]; P&#x2009;&lt;&#x2009;.001), less exposure to nonsteroidal anti-inflammatory drugs (56 [5.0%] vs 119 [11.0%]; P&#x2009;&lt;&#x2009;.001), and more AKI documentation at discharge (560 [49.9%] vs 296 [27.3%]; P&#x2009;&lt;&#x2009;.001) than patients in the usual care group. No differences were observed in patient-centered secondary outcomes between the 2 groups.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">Results of this randomized clinical trial showed that the electronic AKI alert did not improve kidney function or other patient-centered outcomes but changed patient care behaviors. The findings warrant the use of a combination of high-quality interventions and AKI alert in future clinical practice.</AbstractText><AbstractText Label="TRIAL REGISTRATION">ClinicalTrials.gov Identifier: NCT03736304.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Buyun</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bian</LastName><ForeName>Ao</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ni</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Kang</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Zhongke</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Yudie</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Yining</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Mengru</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Xinyi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xing</LastName><ForeName>Changying</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Huijuan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03736304</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA Netw Open. 2024 Jan 2;7(1):e2351682. doi: 10.1001/jamanetworkopen.2023.51682.</RefSource><PMID Version="1">38241052</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006784" MajorTopicYN="N">Hospitals, Teaching</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006435" MajorTopicYN="Y">Renal Dialysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056902" MajorTopicYN="Y">Clinical Alarms</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> None reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>19</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>19</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38241047</ArticleId><ArticleId IdType="pmc">PMC10799260</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.51710</ArticleId><ArticleId IdType="pii">2814092</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kellum JA, Romagnani P, Ashuntantang G, Ronco C, Zarbock A, Anders HJ. Acute kidney injury. Nat Rev Dis Primers. 2021;7(1):52. doi:10.1038/s41572-021-00284-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-021-00284-z</ArticleId><ArticleId IdType="pubmed">34267223</ArticleId></ArticleIdList></Reference><Reference><Citation>Chawla LS, Eggers PW, Star RA, Kimmel PL. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med. 2014;371(1):58-66. doi:10.1056/NEJMra1214243</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1214243</ArticleId><ArticleId IdType="pmc">PMC9720902</ArticleId><ArticleId IdType="pubmed">24988558</ArticleId></ArticleIdList></Reference><Reference><Citation>Silver SA, Long J, Zheng Y, Chertow GM. Cost of acute kidney injury in hospitalized patients. J Hosp Med. 2017;12(2):70-76. doi:10.12788/jhm.2683</Citation><ArticleIdList><ArticleId IdType="doi">10.12788/jhm.2683</ArticleId><ArticleId IdType="pubmed">28182800</ArticleId></ArticleIdList></Reference><Reference><Citation>Odutayo A, Wong CX, Farkouh M, et al. . AKI and long-term risk for cardiovascular events and mortality. J Am Soc Nephrol. 2017;28(1):377-387. doi:10.1681/ASN.2016010105</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2016010105</ArticleId><ArticleId IdType="pmc">PMC5198285</ArticleId><ArticleId IdType="pubmed">27297949</ArticleId></ArticleIdList></Reference><Reference><Citation>Colpaert K, Hoste EA, Steurbaut K, et al. . Impact of real-time electronic alerting of acute kidney injury on therapeutic intervention and progression of RIFLE class. Crit Care Med. 2012;40(4):1164-1170. doi:10.1097/CCM.0b013e3182387a6b</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3182387a6b</ArticleId><ArticleId IdType="pubmed">22067631</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S, Baek SH, Ahn S, et al. . Impact of electronic acute kidney injury (AKI) alerts with automated nephrologist consultation on detection and severity of AKI: a quality improvement study. Am J Kidney Dis. 2018;71(1):9-19. doi:10.1053/j.ajkd.2017.06.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2017.06.008</ArticleId><ArticleId IdType="pubmed">28754457</ArticleId></ArticleIdList></Reference><Reference><Citation>Halmy L, Riedel J, Zeman F, et al. . Renal recovery after the implementation of an electronic alert and biomarker-guided kidney-protection strategy following major surgery. J Clin Med. 2021;10(21):5122. doi:10.3390/jcm10215122</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10215122</ArticleId><ArticleId IdType="pmc">PMC8584790</ArticleId><ArticleId IdType="pubmed">34768642</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes J, Donovan K, Geen J, Williams J, Phillips AO. Acute kidney injury demographics and outcomes: changes following introduction of electronic acute kidney injury alerts-an analysis of a national dataset. Nephrol Dial Transplant. 2021;36(8):1433-1439. doi:10.1093/ndt/gfaa071</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfaa071</ArticleId><ArticleId IdType="pubmed">32514532</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Jaghbeer M, Dealmeida D, Bilderback A, Ambrosino R, Kellum JA. Clinical decision support for in-hospital AKI. J Am Soc Nephrol. 2018;29(2):654-660. doi:10.1681/ASN.2017070765</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2017070765</ArticleId><ArticleId IdType="pmc">PMC5791078</ArticleId><ArticleId IdType="pubmed">29097621</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu MJ, Huang SC, Chen CH, Cheng CY, Tsai SF. An early warning system for the differential diagnosis of in-hospital acute kidney injury for better patient outcome: study of a quality improvement initiative. Int J Environ Res Public Health. 2022;19(6):3704. doi:10.3390/ijerph19063704</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19063704</ArticleId><ArticleId IdType="pmc">PMC8953354</ArticleId><ArticleId IdType="pubmed">35329393</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotwal S, Herath S, Erlich J, et al. . Electronic alerts and a care bundle for acute kidney injury - an Australian cohort study. Nephrol Dial Transplant. 2023;38(3):610-617. doi:10.1093/ndt/gfac155</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfac155</ArticleId><ArticleId IdType="pubmed">35438795</ArticleId></ArticleIdList></Reference><Reference><Citation>Baird D, De Souza N, Logan R, Walker H, Guthrie B, Bell S. Impact of electronic alerts for acute kidney injury on patient outcomes: interrupted time-series analysis of population cohort data. Clin Kidney J. 2020;14(2):639-646. doi:10.1093/ckj/sfaa151</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ckj/sfaa151</ArticleId><ArticleId IdType="pmc">PMC7886568</ArticleId><ArticleId IdType="pubmed">33623690</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson FP, Shashaty M, Testani J, et al. . Automated, electronic alerts for acute kidney injury: a single-blind, parallel-group, randomised controlled trial. Lancet. 2015;385(9981):1966-1974. doi:10.1016/S0140-6736(15)60266-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)60266-5</ArticleId><ArticleId IdType="pmc">PMC4475457</ArticleId><ArticleId IdType="pubmed">25726515</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson FP, Martin M, Yamamoto Y, et al. . Electronic health record alerts for acute kidney injury: multicenter, randomized clinical trial. BMJ. 2021;372:m4786. doi:10.1136/bmj.m4786</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4786</ArticleId><ArticleId IdType="pmc">PMC8034420</ArticleId><ArticleId IdType="pubmed">33461986</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Chen Y, Li S, et al. . Value of electronic alerts for acute kidney injury in high-risk wards: a pilot randomized controlled trial. Int Urol Nephrol. 2018;50(8):1483-1488. doi:10.1007/s11255-018-1836-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11255-018-1836-7</ArticleId><ArticleId IdType="pmc">PMC6096658</ArticleId><ArticleId IdType="pubmed">29556903</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendall AC, Tan SJ, See EJ, Toussaint ND. Electronic alerts for early detection of acute kidney injury: considering their implementation in Australian hospitals. Med J Aust. 2021;214(8):347-349.e1. doi:10.5694/mja2.51024</Citation><ArticleIdList><ArticleId IdType="doi">10.5694/mja2.51024</ArticleId><ArticleId IdType="pubmed">33847000</ArticleId></ArticleIdList></Reference><Reference><Citation>World Medical Association . World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-2194. doi:10.1001/jama.2013.281053</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.281053</ArticleId><ArticleId IdType="pubmed">24141714</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter CJ, Juurlink I, Bisset LH, Bavakunji R, Mehta RL, Devonald MA. A real-time electronic alert to improve detection of acute kidney injury in a large teaching hospital. Nephrol Dial Transplant. 2014;29(10):1888-1893. doi:10.1093/ndt/gfu082</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfu082</ArticleId><ArticleId IdType="pubmed">24744280</ArticleId></ArticleIdList></Reference><Reference><Citation>Awdishu L, Coates CR, Lyddane A, et al. . The impact of real-time alerting on appropriate prescribing in kidney disease: a cluster randomized controlled trial. J Am Med Inform Assoc. 2016;23(3):609-616. doi:10.1093/jamia/ocv159</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocv159</ArticleId><ArticleId IdType="pmc">PMC11740753</ArticleId><ArticleId IdType="pubmed">26615182</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanagasundaram NS, Bevan MT, Sims AJ, Heed A, Price DA, Sheerin NS. Computerized clinical decision support for the early recognition and management of acute kidney injury: a qualitative evaluation of end-user experience. Clin Kidney J. 2016;9(1):57-62. doi:10.1093/ckj/sfv130</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ckj/sfv130</ArticleId><ArticleId IdType="pmc">PMC4720208</ArticleId><ArticleId IdType="pubmed">26798462</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin M, Wilson FP. Utility of electronic medical record alerts to prevent drug nephrotoxicity. Clin J Am Soc Nephrol. 2019;14(1):115-123. doi:10.2215/CJN.13841217</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.13841217</ArticleId><ArticleId IdType="pmc">PMC6364537</ArticleId><ArticleId IdType="pubmed">29622668</ArticleId></ArticleIdList></Reference><Reference><Citation>Silversides JA, Major E, Ferguson AJ, et al. . Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis. Intensive Care Med. 2017;43(2):155-170. doi:10.1007/s00134-016-4573-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4573-3</ArticleId><ArticleId IdType="pubmed">27734109</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyhoff TS, Hjortrup PB, Wetterslev J, et al. ; CLASSIC Trial Group . Restriction of intravenous fluid in ICU patients with septic shock. N Engl J Med. 2022;386(26):2459-2470. doi:10.1056/NEJMoa2202707</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2202707</ArticleId><ArticleId IdType="pubmed">35709019</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaudry S, Hajage D, Martin-Lefevre L, et al. . Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial. Lancet. 2021;397(10281):1293-1300. doi:10.1016/S0140-6736(21)00350-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00350-0</ArticleId><ArticleId IdType="pubmed">33812488</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagshaw SM, Wald R, Adhikari NKJ, et al. ; STARRT-AKI Investigators; Canadian Critical Care Trials Group; Australian and New Zealand Intensive Care Society Clinical Trials Group; United Kingdom Critical Care Research Group; Canadian Nephrology Trials Network; Irish Critical Care Trials Group . Timing of initiation of renal-replacement therapy in acute kidney injury. N Engl J Med. 2020;383(3):240-251. doi:10.1056/NEJMoa2000741</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2000741</ArticleId><ArticleId IdType="pubmed">32668114</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, Kellum JA, Schmidt C, et al. . Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial. JAMA. 2016;315(20):2190-2199. doi:10.1001/jama.2016.5828</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.5828</ArticleId><ArticleId IdType="pubmed">27209269</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes J, Rainer T, Geen J, et al. ; Welsh AKI Steering Group . Acute kidney injury in the era of the AKI e-alert. Clin J Am Soc Nephrol. 2016;11(12):2123-2131. doi:10.2215/CJN.05170516</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.05170516</ArticleId><ArticleId IdType="pmc">PMC5142071</ArticleId><ArticleId IdType="pubmed">27793961</ArticleId></ArticleIdList></Reference><Reference><Citation>Tome ACN, Ramalho RJ, Dos Santos KF, et al. . Impact of an electronic alert in combination with a care bundle on the outcomes of acute kidney injury. Diagnostics (Basel). 2022;12(12):3121. doi:10.3390/diagnostics12123121</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12123121</ArticleId><ArticleId IdType="pmc">PMC9777607</ArticleId><ArticleId IdType="pubmed">36553128</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams VL, Smithburger PL, Imhoff AN, et al. . Interventions, barriers, and proposed solutions associated with the implementation of a protocol that uses clinical decision support and a stress biomarker test to identify ICU patients at high-risk for drug associated acute kidney injury. Ann Pharmacother. 2023;57(4):408-415. doi:10.1177/10600280221117993</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10600280221117993</ArticleId><ArticleId IdType="pubmed">35962583</ArticleId></ArticleIdList></Reference><Reference><Citation>Selby NM, Korrodi-Greg&#xf3;rio L, Casula A, et al. . Randomized controlled trial evidence of cost-effectiveness of a multifaceted AKI intervention approach. Kidney Int Rep. 2020;6(3):636-644. doi:10.1016/j.ekir.2020.12.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ekir.2020.12.004</ArticleId><ArticleId IdType="pmc">PMC7938080</ArticleId><ArticleId IdType="pubmed">33732978</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswas A, Parikh CR, Feldman HI, et al. . Identification of patients expected to benefit from electronic alerts for acute kidney injury. Clin J Am Soc Nephrol. 2018;13(6):842-849. doi:10.2215/CJN.13351217</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.13351217</ArticleId><ArticleId IdType="pmc">PMC5989673</ArticleId><ArticleId IdType="pubmed">29599299</ArticleId></ArticleIdList></Reference><Reference><Citation>Robert L, Rousseliere C, Beuscart JB, et al. . Integration of explicit criteria in a clinical decision support system through evaluation of acute kidney injury events. Stud Health Technol Inform. 2021;281:640-644. doi:10.3233/SHTI210249</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SHTI210249</ArticleId><ArticleId IdType="pubmed">34042654</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas ME, Abdelaziz TS, Perkins GD, Sitch AJ, Baharani J, Temple RM. The Acute Kidney Outreach to Prevent Deterioration and Death Trial: a large pilot study for a cluster-randomized trial. Nephrol Dial Transplant. 2021;36(4):657-665. doi:10.1093/ndt/gfz246</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfz246</ArticleId><ArticleId IdType="pubmed">31860096</ArticleId></ArticleIdList></Reference><Reference><Citation>Gama RM, Clark K, Bhaduri M, et al. . Acute kidney injury e-alerts in pregnancy: rates, recognition and recovery. Nephrol Dial Transplant. 2021;36(6):1023-1030. doi:10.1093/ndt/gfaa217</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfaa217</ArticleId><ArticleId IdType="pubmed">33089321</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones A, Holmes J, Stephens M, et al. . Using electronic AKI alerts to define the epidemiology of acute kidney injury in renal transplants. J Nephrol. 2021;34(3):829-838. doi:10.1007/s40620-020-00869-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40620-020-00869-z</ArticleId><ArticleId IdType="pmc">PMC8192326</ArticleId><ArticleId IdType="pubmed">33259046</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan N, Zhang J, Khaki R, et al. . Implementation of an electronic health records-based safe contrast limit for preventing contrast-associated acute kidney injury after percutaneous coronary intervention. Circ Cardiovasc Qual Outcomes. 2023;16(1):e009235. doi:10.1161/CIRCOUTCOMES.122.009235</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.122.009235</ArticleId><ArticleId IdType="pmc">PMC9858238</ArticleId><ArticleId IdType="pubmed">36475471</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29223955</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>20</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2047-9980</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>12</Issue><PubDate><Year>2017</Year><Month>Dec</Month><Day>09</Day></PubDate></JournalIssue><Title>Journal of the American Heart Association</Title><ISOAbbreviation>J Am Heart Assoc</ISOAbbreviation></Journal><ArticleTitle>High-Density Lipoprotein Cholesterol Concentration and Acute Kidney Injury After Cardiac Surgery.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e006975</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1161/JAHA.117.006975</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute kidney injury (AKI) after cardiac surgery is associated with increased short- and long-term mortality. Inflammation, oxidative stress, and endothelial dysfunction and damage play important roles in the development of AKI. High-density lipoproteins (HDLs) have anti-inflammatory and antioxidant properties and improve endothelial function and repair. Statins enhance HDL's anti-inflammatory and antioxidant capacities. We hypothesized that a higher preoperative HDL cholesterol concentration is associated with decreased AKI after cardiac surgery and that perioperative statin exposure potentiates this association.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">We tested our hypothesis in 391 subjects from a randomized clinical trial of perioperative atorvastatin to reduce AKI after cardiac surgery. A 2-component latent variable mixture model was used to assess the association between preoperative HDL cholesterol concentration and postoperative change in serum creatinine, adjusted for known AKI risk factors and suspected confounders. Interaction terms were used to examine the effects of preoperative statin use, preoperative statin dose, and perioperative atorvastatin treatment on the association between preoperative HDL and AKI. A higher preoperative HDL cholesterol concentration was independently associated with a decreased postoperative serum creatinine change (<i>P</i>=0.02). The association between a high HDL concentration and an attenuated increase in serum creatinine was strongest in long-term statin-using patients (<i>P</i>=0.008) and was further enhanced with perioperative atorvastatin treatment (<i>P</i>=0.004) and increasing long-term statin dose (<i>P</i>=0.003).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">A higher preoperative HDL cholesterol concentration was associated with decreased AKI after cardiac surgery. Preoperative and perioperative statin treatment enhanced this association, demonstrating that pharmacological potentiation is possible during the perioperative period.</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION" NlmCategory="BACKGROUND">URL: http://www.clinicaltrials.gov. Unique Identifier: NCT00791648.</AbstractText><CopyrightInformation>&#xa9; 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Loren E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN loren.e.smith@vanderbilt.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Derek K</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blume</LastName><ForeName>Jeffrey D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linton</LastName><ForeName>MacRae F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Billings</LastName><ForeName>Frederic T</ForeName><Initials>FT</Initials><Suffix>4th</Suffix><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00791648</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR000445</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 GM102676</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002243</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 HL116263</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM112871</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM108554</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Heart Assoc</MedlineTA><NlmUniqueID>101580524</NlmUniqueID><ISSNLinking>2047-9980</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008076">Cholesterol, HDL</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019161">Hydroxymethylglutaryl-CoA Reductase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>A0JWA85V8F</RegistryNumber><NameOfSubstance UI="D000069059">Atorvastatin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069059" MajorTopicYN="N">Atorvastatin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008076" MajorTopicYN="N">Cholesterol, HDL</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003324" MajorTopicYN="N">Coronary Artery Disease</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019161" MajorTopicYN="N">Hydroxymethylglutaryl-CoA Reductase Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007677" MajorTopicYN="N">Kidney Function Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057234" MajorTopicYN="N">Preoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">high&#x2010;density lipoproteins</Keyword><Keyword MajorTopicYN="N">renal insufficiency</Keyword><Keyword MajorTopicYN="N">statin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>12</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>12</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29223955</ArticleId><ArticleId IdType="pmc">PMC5779016</ArticleId><ArticleId IdType="doi">10.1161/JAHA.117.006975</ArticleId><ArticleId IdType="pii">JAHA.117.006975</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ryd&#xe9;n L, Ahnve S, Bell M, Hammar N, Ivert T, Sartipy U, Holzmann MJ. Acute kidney injury after coronary artery bypass grafting and long&#x2010;term risk of myocardial infarction and death. Int J Cardiol. 2014;172:190&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pubmed">24502882</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickering JW, James MT, Palmer SC. Acute kidney injury and prognosis after cardiopulmonary bypass: a meta&#x2010;analysis of cohort studies. Am J Kidney Dis. 2015;65:283&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pubmed">25445101</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson C, Ozrazgat&#x2010;Baslanti T, Kuxhausen A, Thottakkara P, Efron PA, Moore FA, Moldawer LL, Segal MS, Bihorac A. Cost and mortality associated with postoperative acute kidney injury. Ann Surg. 2015;261:1207&#x2013;1214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4247993</ArticleId><ArticleId IdType="pubmed">24887982</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J, Chen R, Liu S, Yu X, Zou J, Ding X. Global incidence and outcomes of adult patients with acute kidney injury after cardiac surgery: a systematic review and meta&#x2010;analysis. J Cardiothorac Vasc Anesth. 2016;30:82&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">26482484</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C; The Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators . Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294:813&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pubmed">16106006</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A; The Acute Kidney Injury Network . Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2206446</ArticleId><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon O, Hong S&#x2010;M, Ramesh G. Diminished NO generation by injured endothelium and loss of macula densa nNOS may contribute to sustained acute kidney injury after ischemia&#x2010;reperfusion. Am J Physiol Renal Physiol. 2009;296:F25&#x2013;F33.</Citation><ArticleIdList><ArticleId IdType="pubmed">18971208</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto T, Tada T, Brodsky SV, Tanaka H, Noiri E, Kajiya F, Goligorsky MS. Intravital videomicroscopy of peritubular capillaries in renal ischemia. Am J Physiol Renal Physiol. 2002;282:F1150&#x2013;F1155.</Citation><ArticleIdList><ArticleId IdType="pubmed">11997332</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutton TA, Mang HE, Campos SB, Sandoval RM, Yoder MC, Molitoris BA. Injury of the renal microvascular endothelium alters barrier function after ischemia. Am J Physiol Renal Physiol. 2003;285:F191&#x2013;F198.</Citation><ArticleIdList><ArticleId IdType="pubmed">12684225</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang WR, Garg AX, Coca SG, Devereaux PJ, Eikelboom J, Kavsak P, McArthur E, Thiessen&#x2010;Philbrook H, Shortt C, Shlipak M, Whitlock R, Parikh CR; The TRIBE&#x2010;AKI Consortium . Plasma IL&#x2010;6 and IL&#x2010;10 concentrations predict AKI and long&#x2010;term mortality in adults after cardiac surgery. J Am Soc Nephrol. 2015;26:3123&#x2013;3132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4657830</ArticleId><ArticleId IdType="pubmed">25855775</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FT, Pretorius M, Schildcrout JS, Mercaldo ND, Byrne JG, Ikizler TA, Brown NJ. Obesity and oxidative stress predict AKI after cardiac surgery. J Am Soc Nephrol. 2012;23:1221&#x2013;1228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3380645</ArticleId><ArticleId IdType="pubmed">22626819</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon O, Hong S&#x2010;M, Sutton TA, Temm CJ. Preservation of peritubular capillary endothelial integrity and increasing pericytes may be critical to recovery from postischemic acute kidney injury. Am J Physiol Renal Physiol. 2008;295:F351&#x2013;F359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2519188</ArticleId><ArticleId IdType="pubmed">18562634</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy AJ, Woollard KJ, Hoang A, Mukhamedova N, Stirzaker RA, McCormick SPA, Remaley AT, Sviridov D, Chin&#x2010;Dusting J. High&#x2010;density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol. 2008;28:2071&#x2013;2077.</Citation><ArticleIdList><ArticleId IdType="pubmed">18617650</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuhanna IS, Zhu Y, Cox BE, Hahner LD, Osborne&#x2010;Lawrence S, Lu P, Marcel YL, Anderson RG, Mendelsohn ME, Hobbs HH, Shaul PW. High&#x2010;density lipoprotein binding to scavenger receptor&#x2010;BI activates endothelial nitric oxide synthase. Nat Med. 2001;7:853&#x2013;857.</Citation><ArticleIdList><ArticleId IdType="pubmed">11433352</ArticleId></ArticleIdList></Reference><Reference><Citation>Bisoendial RJ, Hovingh GK, Levels JHM, Lerch PG, Andresen I, Hayden MR, Kastelein JJP, Stroes ESG. Restoration of endothelial function by increasing high&#x2010;density lipoprotein in subjects with isolated low high&#x2010;density lipoprotein. Circulation. 2003;107:2944&#x2013;2948.</Citation><ArticleIdList><ArticleId IdType="pubmed">12771001</ArticleId></ArticleIdList></Reference><Reference><Citation>Tso C, Martinic G, Fan W&#x2010;H, Rogers C, Rye K&#x2010;A, Barter PJ. High&#x2010;density lipoproteins enhance progenitor&#x2010;mediated endothelium repair in mice. Arterioscler Thromb Vasc Biol. 2006;26:1144&#x2013;1149.</Citation><ArticleIdList><ArticleId IdType="pubmed">16528007</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan Ahmad WNH, Sakri F, Mokhsin A, Rahman T, Mohd Nasir N, Abdul&#x2010;Razak S, Md Yasin M, Mohd Ismail A, Ismail Z, Nawawi H. Low serum high density lipoprotein cholesterol concentration is an independent predictor for enhanced inflammation and endothelial activation. PLoS One. 2015;10:e0116867.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4304817</ArticleId><ArticleId IdType="pubmed">25614985</ArticleId></ArticleIdList></Reference><Reference><Citation>Navab M, Hama SY, Cooke CJ, Anantharamaiah GM, Chaddha M, Jin L, Subbanagounder G, Faull KF, Reddy ST, Miller NE, Fogelman AM. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. J Lipid Res. 2000;41:1481&#x2013;1494.</Citation><ArticleIdList><ArticleId IdType="pubmed">10974056</ArticleId></ArticleIdList></Reference><Reference><Citation>Navab M, Berliner JA, Subbanagounder G, Hama S, Lusis AJ, Castellani LW, Reddy S, Shih D, Shi W, Watson AD, Van Lenten BJ, Vora D, Fogelman AM. HDL and the inflammatory response induced by LDL&#x2010;derived oxidized phospholipids. Arterioscler Thromb Vasc Biol. 2001;21:481&#x2013;488.</Citation><ArticleIdList><ArticleId IdType="pubmed">11304461</ArticleId></ArticleIdList></Reference><Reference><Citation>Navab M, Hama SY, Anantharamaiah GM, Hassan K, Hough GP, Watson AD, Reddy ST, Sevanian A, Fonarow GC, Fogelman AM. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3. J Lipid Res. 2000;41:1495&#x2013;1508.</Citation><ArticleIdList><ArticleId IdType="pubmed">10974057</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirstea M, Walley KR, Russell JA, Brunham LR, Genga KR, Boyd JH. Decreased high&#x2010;density lipoprotein cholesterol level is an early prognostic marker for organ dysfunction and death in patients with suspected sepsis. J Crit Care. 2017;38:289&#x2013;294.</Citation><ArticleIdList><ArticleId IdType="pubmed">28013095</ArticleId></ArticleIdList></Reference><Reference><Citation>Chien Y&#x2010;F, Chen C&#x2010;Y, Hsu C&#x2010;L, Chen K&#x2010;Y, Yu C&#x2010;J. Decreased serum level of lipoprotein cholesterol is a poor prognostic factor for patients with severe community&#x2010;acquired pneumonia that required intensive care unit admission. J Crit Care. 2015;30:506&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pubmed">25702844</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferretti G, Bacchetti T, Sahebkar A. Effect of statin therapy on paraoxonase&#x2010;1 status: a systematic review and meta&#x2010;analysis of 25 clinical trials. Prog Lipid Res. 2015;60:50&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">26416579</ArticleId></ArticleIdList></Reference><Reference><Citation>Barter PJ, Brandrup&#x2010;Wognsen G, Palmer MK, Nicholls SJ. Effect of statins on HDL&#x2010;C: a complex process unrelated to changes in LDL&#x2010;C: analysis of the VOYAGER Database. J Lipid Res. 2010;51:1546&#x2013;1553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3035518</ArticleId><ArticleId IdType="pubmed">19965573</ArticleId></ArticleIdList></Reference><Reference><Citation>Stancu C, Sima A. Statins: mechanism of action and effects. J Cell Mol Med. 2001;5:378&#x2013;387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6740083</ArticleId><ArticleId IdType="pubmed">12067471</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansell BJ, Navab M, Hama S, Kamranpour N, Fonarow G, Hough G, Rahmani S, Mottahedeh R, Dave R, Reddy ST, Fogelman AM. Inflammatory/antiinflammatory properties of high&#x2010;density lipoprotein distinguish patients from control subjects better than high&#x2010;density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment. Circulation. 2003;108:2751&#x2013;2756.</Citation><ArticleIdList><ArticleId IdType="pubmed">14638544</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FT, Hendricks PA, Schildcrout JS, Shi Y, Petracek MR, Byrne JG, Brown NJ. High&#x2010;dose perioperative atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial. JAMA. 2016;315:877&#x2013;888.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4843765</ArticleId><ArticleId IdType="pubmed">26906014</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith LE, Smith DK, Blume JD, Siew ED, Billings FT. Latent variable modeling improves AKI risk factor identification and AKI prediction compared to traditional methods. BMC Nephrol. 2017;18:55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5299779</ArticleId><ArticleId IdType="pubmed">28178929</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; The Chronic Kidney Disease Epidemiology Collaboration (CKD&#x2010;EPI) . A new equation&#xa0;to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2763564</ArticleId><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>
FDA Drug Safety Communication: new restrictions, contraindications, and dose limitations for Zocor (simvastatin) to reduce the risk of muscle injury: relative LDL&#x2010;lowering efficacy of statin and statin&#x2010;based therapies. US Food and Drug Administration;  Website. Last updated March 8, 2016. 
https://www.fda.gov/Drugs/DrugSafety/ucm256581.htm. Published June 8, 2011. Accessed June 7, 2017.</Citation></Reference><Reference><Citation>Odden MC, Tager IB, Gansevoort RT, Bakker SJL, Fried LF, Newman AB, Katz R, Satterfield S, Harris TB, Sarnak MJ, Siscovick D, Shlipak MG. Hypertension and low HDL cholesterol were associated with reduced kidney function across the age spectrum: a collaborative study. Ann Epidemiol. 2013;23:106&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3570601</ArticleId><ArticleId IdType="pubmed">23313266</ArticleId></ArticleIdList></Reference><Reference><Citation>Shroff R, Speer T, Colin S, Charakida M, Zewinger S, Staels B, Chinetti&#x2010;Gbaguidi G, Hettrich I, Rohrer L, O'Neill F, McLoughlin E, Long D, Shanahan CM, Landmesser U, Fliser D, Deanfield JE. HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotype. J Am Soc Nephrol. 2014;25:2658&#x2013;2668.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4214534</ArticleId><ArticleId IdType="pubmed">24854267</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalantar&#x2010;Zadeh K, Kopple JD, Kamranpour N, Fogelman AM, Navab M. HDL&#x2010;inflammatory index correlates with poor outcome in hemodialysis patients. Kidney Int. 2007;72:1149&#x2013;1156.</Citation><ArticleIdList><ArticleId IdType="pubmed">17728705</ArticleId></ArticleIdList></Reference><Reference><Citation>
Kennedy DJ, Tang WHW, Fan Y, Wu Y, Mann S, Pepoy M, Hazen SL. Diminished antioxidant activity of high&#x2010;density lipoprotein&#x2013;associated proteins in chronic kidney disease. J Am Heart Assoc. 2013;2:e000104 DOI: 10.1161/JAHA.112.000104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.112.000104</ArticleId><ArticleId IdType="pmc">PMC3647254</ArticleId><ArticleId IdType="pubmed">23557751</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto S, Yancey PG, Ikizler TA, Jerome WG, Kaseda R, Cox B, Bian A, Shintani A, Fogo AB, Linton MF, Fazio S, Kon V. Dysfunctional high&#x2010;density lipoprotein in patients on chronic hemodialysis. J Am Coll Cardiol. 2012;60:2372&#x2013;2379.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9667707</ArticleId><ArticleId IdType="pubmed">23141484</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfs TGAM, Buurman WA, van Schadewijk A, de Vries B, Daemen MARC, Hiemstra PS, van &#x2018;t Veer C. In vivo expression of Toll&#x2010;like receptor 2 and 4 by renal epithelial cells: IFN&#x2010;gamma and TNF&#x2010;alpha mediated up&#x2010;regulation during inflammation. J Immunol. 2002;168:1286&#x2013;1293.</Citation><ArticleIdList><ArticleId IdType="pubmed">11801667</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H, Chen G, Wyburn KR, Yin J, Bertolino P, Eris JM, Alexander SI, Sharland AF, Chadban SJ. TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest. 2007;117:2847&#x2013;2859.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1974864</ArticleId><ArticleId IdType="pubmed">17853945</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon SM, McKenzie B, Kemeh G, Sampson M, Perl S, Young NS, Fessler MB, Remaley AT. Rosuvastatin alters the proteome of high density lipoproteins: generation of alpha&#x2010;1&#x2010;antitrypsin enriched particles with anti&#x2010;inflammatory properties. Mol Cell Proteomics. 2015;14:3247&#x2013;3257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4762624</ArticleId><ArticleId IdType="pubmed">26483418</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JH, Shim J&#x2010;K, Song J&#x2010;W, Soh S, Kwak Y&#x2010;L. Effect of atorvastatin on the incidence of acute kidney injury following valvular heart surgery: a randomized, placebo&#x2010;controlled trial. Intensive Care Med. 2016;42:1398&#x2013;1407.</Citation><ArticleIdList><ArticleId IdType="pubmed">27120082</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z, Jayaram R, Jiang L, Emberson J, Zhao Y, Li Q, Du J, Guarguagli S, Hill M, Chen Z, Collins R, Casadei B. Perioperative rosuvastatin in cardiac surgery. N Engl J Med. 2016;374:1744&#x2013;1753.</Citation><ArticleIdList><ArticleId IdType="pubmed">27144849</ArticleId></ArticleIdList></Reference><Reference><Citation>Heeschen C, Hamm CW, Laufs U, Snapinn S, B&#xf6;hm M, White HD; The Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators . Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation. 2002;105:1446&#x2013;1452.</Citation><ArticleIdList><ArticleId IdType="pubmed">11914253</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Sciascio G, Patti G, Pasceri V, Gaspardone A, Colonna G, Montinaro A. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA&#x2010;RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial. J Am Coll Cardiol. 2009;54:558&#x2013;565.</Citation><ArticleIdList><ArticleId IdType="pubmed">19643320</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FT, Pretorius M, Siew ED, Yu C, Brown NJ. Early postoperative statin therapy is associated with a lower incidence of acute kidney injury after cardiac surgery. J Cardiothorac Vasc Anesth. 2010;24:913&#x2013;920.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2992577</ArticleId><ArticleId IdType="pubmed">20599398</ArticleId></ArticleIdList></Reference><Reference><Citation>Kor DJ, Brown MJ, Iscimen R, Brown DR, Whalen FX, Roy TK, Keegan MT. Perioperative statin therapy and renal outcomes after major vascular surgery: a propensity&#x2010;based analysis. J Cardiothorac Vasc Anesth. 2008;22:210&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">18375322</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzsimons GJ. Death to dichotomizing. J Consum Res. 2008;35:5&#x2013;8.</Citation></Reference><Reference><Citation>Dawson NV, Weiss R. Dichotomizing continuous variables in statistical analysis: a practice to avoid. Med Decis Making. 2012;32:225&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">22457338</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34462528</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>30</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Risk factors and mortality of acute kidney injury within 1&#xa0;month after lung transplantation.</ArticleTitle><Pagination><StartPage>17399</StartPage><MedlinePgn>17399</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">17399</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-96889-1</ELocationID><Abstract><AbstractText>After lung transplantation (LT), some patients are at risk of acute kidney injury (AKI), which is associated with worse outcomes and increased mortality. Previous studies focused on AKI development from 72&#xa0;h to 1&#xa0;week within LT, and reported main risk factors for AKI such as intraoperative hypotension, need of ECMO support, ischemia time or longer time on waiting list. However, this period interval rarely reflects medical risk factors probably happen in longer post-operative period. So, in this study we aimed to describe the incidence and risk factor of AKI within post-operative 1&#xa0;month, which is longer follow up duration. Among 161 patients who underwent LT at Severance hospital in Seoul, Korea from October 2012 to September 2017, 148 patients were retrospectively enrolled. Multivariable logistic regression and Cox proportional hazard models were utilized. Among 148 patients, 59 (39.8%) developed AKI within 1-month after LT. Stage I or II, and stage III AKI were recorded in 26 (17.5%) and 33 (22.2%), respectively. We also classified AKI according to occurrence time, within 1&#xa0;week as early AKI, from 1&#xa0;week within 1&#xa0;month was defined as late AKI. AKI III usually occurred within 7&#xa0;days after transplantation (early vs. late AKI III, 72.5% vs 21.1%). Risk factor for AKI development was pre-operative anemia, higher units of red blood cells transfused during surgery, colistin intravenous infusion for treating multi drug resistant pathogens were independent risk factors for AKI development. Post-operative bleeding, grade 3 PGD within 72&#xa0;h, and sepsis were more common complication in the AKI group. Patients with AKI III ([24/33] 72.7%) had significantly higher 1-year mortality than the no-AKI ([18/89] 20.2%), and AKI I or II group ([9/26] 34.6%), log-rank test, P&#x2009;&lt;&#x2009;0.001). AKI was associated with worse post-operative outcome, 3-month, and 1-year mortality after LT. Severity of AKI was usually determined in early post op period (ex. within 7&#xa0;days) after LT, so optimal post-operative management as well as recipients selection should be considered.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Nam Eun</ForeName><Initials>NE</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Institute of Chest Diseases, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Ewha Womans University College of Medicine, Ewha Womans Seoul Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Chi Young</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Sleep and Critical Care Medicine, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Song Yee</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Institute of Chest Diseases, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ha Eun</ForeName><Initials>HE</Initials><AffiliationInfo><Affiliation>Department of Thoracic and Cardiovascular Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jin Gu</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Department of Thoracic and Cardiovascular Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paik</LastName><ForeName>Hyo Chae</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Department of Thoracic and Cardiovascular Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Moo Suk</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Institute of Chest Diseases, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea. pms70@yuhs.ac.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016040" MajorTopicYN="N">Lung Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>8</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34462528</ArticleId><ArticleId IdType="pmc">PMC8405794</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-96889-1</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-96889-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chambers DC, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth adult lung and heart-lung transplant report&#x2014;2018; Focus theme: Multiorgan Transplantation. J. Heart Lung Transplant. 2018;37:1169&#x2013;1183. doi: 10.1016/j.healun.2018.07.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healun.2018.07.020</ArticleId><ArticleId IdType="pubmed">30293613</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambers DC, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung And Heart-Lung Transplantation Report-2017; Focus Theme: Allograft ischemic time. J. Heart Lung Transplant. 2017;36:1047&#x2013;1059. doi: 10.1016/j.healun.2017.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healun.2017.07.016</ArticleId><ArticleId IdType="pubmed">28784324</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco C, Bellomo R, Kellum JA. Acute kidney injury. Lancet. 2019;394:1949&#x2013;1964. doi: 10.1016/S0140-6736(19)32563-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)32563-2</ArticleId><ArticleId IdType="pubmed">31777389</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnaoutakis GJ, et al. Severe acute kidney injury according to the RIFLE (risk, injury, failure, loss, end stage) criteria affects mortality in lung transplantation. J. Heart Lung Transplant. 2011;30:1161&#x2013;1168. doi: 10.1016/j.healun.2011.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healun.2011.04.013</ArticleId><ArticleId IdType="pmc">PMC3185168</ArticleId><ArticleId IdType="pubmed">21620737</ArticleId></ArticleIdList></Reference><Reference><Citation>Wehbe E, et al. Short-term and long-term outcomes of acute kidney injury after lung transplantation. J. Heart Lung Transplant. 2012;31:244&#x2013;251. doi: 10.1016/j.healun.2011.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healun.2011.08.016</ArticleId><ArticleId IdType="pubmed">21996350</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen AP, Gabriel RA, Golts E, Kistler EB, Schmidt U. Severity of acute kidney injury in the post-lung transplant patient is associated with higher healthcare resources and cost. J. Cardiothorac. Vasc. Anesth. 2017;31:1361&#x2013;1369. doi: 10.1053/j.jvca.2017.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2017.02.004</ArticleId><ArticleId IdType="pubmed">28455097</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacques F, et al. Acute renal failure following lung transplantation: Risk factors, mortality, and long-term consequences. Eur. J. Cardiothorac. Surg. 2011;41:193&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3241081</ArticleId><ArticleId IdType="pubmed">21665487</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa S, Griesdale DE, Lohser J. Acute kidney injury within 72 hours after lung transplantation: Incidence and perioperative risk factors. J. Cardiothorac. Vasc. Anesth. 2014;28:931&#x2013;935. doi: 10.1053/j.jvca.2013.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2013.08.013</ArticleId><ArticleId IdType="pubmed">24360152</ArticleId></ArticleIdList></Reference><Reference><Citation>Balci MK, Vayvada M, Salturk C, Kutlu CA, Ari E. Incidence of early acute kidney injury in lung transplant patients: A single-center experience. Transplant. Proc. 2017;49:593&#x2013;598. doi: 10.1016/j.transproceed.2017.01.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.transproceed.2017.01.031</ArticleId><ArticleId IdType="pubmed">28340839</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha PN, Rocha AT, Palmer SM, Davis RD, Smith SR. Acute renal failure after lung transplantation: Incidence, predictors and impact on perioperative morbidity and mortality. Am. J. Transplant. 2005;5:1469&#x2013;1476. doi: 10.1111/j.1600-6143.2005.00867.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-6143.2005.00867.x</ArticleId><ArticleId IdType="pubmed">15888056</ArticleId></ArticleIdList></Reference><Reference><Citation>Lertjitbanjong P, et al. Acute kidney injury after lung transplantation: A systematic review and meta-analysis. J. Clin. Med. 2019;8:20. doi: 10.3390/jcm8101713.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8101713</ArticleId><ArticleId IdType="pmc">PMC6833042</ArticleId><ArticleId IdType="pubmed">31627379</ArticleId></ArticleIdList></Reference><Reference><Citation>George TJ, et al. Acute kidney injury increases mortality after lung transplantation. Ann. Thorac. Surg. 2012;94:185&#x2013;192. doi: 10.1016/j.athoracsur.2011.11.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2011.11.032</ArticleId><ArticleId IdType="pmc">PMC3601658</ArticleId><ArticleId IdType="pubmed">22325467</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue J, Wang L, Chen CM, Chen JY, Sun ZX. Acute kidney injury influences mortality in lung transplantation. Renal. Fail. 2014;36:541&#x2013;545. doi: 10.3109/0886022X.2013.876350.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/0886022X.2013.876350</ArticleId><ArticleId IdType="pubmed">24742206</ArticleId></ArticleIdList></Reference><Reference><Citation>Palevsky PM, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am. J. Kidney Dis. 2013;61:649&#x2013;672. doi: 10.1053/j.ajkd.2013.02.349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2013.02.349</ArticleId><ArticleId IdType="pubmed">23499048</ArticleId></ArticleIdList></Reference><Reference><Citation>Klinger JR, et al. Therapy for pulmonary arterial hypertension in adults: Update of the CHEST guideline and expert panel report. Chest. 2019;155:565&#x2013;586. doi: 10.1016/j.chest.2018.11.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2018.11.030</ArticleId><ArticleId IdType="pubmed">30660783</ArticleId></ArticleIdList></Reference><Reference><Citation>Ri HS, et al. Inhaled nitric oxide therapy was not associated with postoperative acute kidney injury in patients undergoing lung transplantation: A retrospective pilot study. Medicine (Baltimore) 2018;97:e10915. doi: 10.1097/MD.0000000000010915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000010915</ArticleId><ArticleId IdType="pmc">PMC6392543</ArticleId><ArticleId IdType="pubmed">29851823</ArticleId></ArticleIdList></Reference><Reference><Citation>Christie JD, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction Part II: Definition. A consensus statement of the International Society for Heart and Lung Transplantation. J. Heart Lung Transplant. 2005;24:1454&#x2013;1459. doi: 10.1016/j.healun.2004.11.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healun.2004.11.049</ArticleId><ArticleId IdType="pubmed">16210116</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39:165&#x2013;228. doi: 10.1007/s00134-012-2769-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-012-2769-8</ArticleId><ArticleId IdType="pmc">PMC7095153</ArticleId><ArticleId IdType="pubmed">23361625</ArticleId></ArticleIdList></Reference><Reference><Citation>Basile DP, Anderson MD, Sutton TA. Pathophysiology of acute kidney injury. Compr. Physiol. 2012;2:1303&#x2013;1353. doi: 10.1002/cphy.c110041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cphy.c110041</ArticleId><ArticleId IdType="pmc">PMC3919808</ArticleId><ArticleId IdType="pubmed">23798302</ArticleId></ArticleIdList></Reference><Reference><Citation>Swedko PJ, Clark HD, Paramsothy K, Akbari A. Serum creatinine is an inadequate screening test for renal failure in elderly patients. Arch. Intern. Med. 2003;163:356&#x2013;360. doi: 10.1001/archinte.163.3.356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.163.3.356</ArticleId><ArticleId IdType="pubmed">12578517</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambers DC, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart-lung transplantation Report-2019; Focus theme: Donor and recipient size match. J. Heart Lung Transplant. 2019;38:1042&#x2013;1055. doi: 10.1016/j.healun.2019.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healun.2019.08.001</ArticleId><ArticleId IdType="pmc">PMC6816340</ArticleId><ArticleId IdType="pubmed">31548030</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikma MA, et al. High tacrolimus blood concentrations early after lung transplantation and the risk of kidney injury. Eur. J. Clin. Pharmacol. 2017;73:573&#x2013;580. doi: 10.1007/s00228-017-2204-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00228-017-2204-8</ArticleId><ArticleId IdType="pmc">PMC5384949</ArticleId><ArticleId IdType="pubmed">28132082</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho J, et al. Mass spectrometry-based proteomic analysis of urine in acute kidney injury following cardiopulmonary bypass: A nested case-control study. Am. J. Kidney Dis. 2009;53:584&#x2013;595. doi: 10.1053/j.ajkd.2008.10.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2008.10.037</ArticleId><ArticleId IdType="pubmed">19070948</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzone AL, Baker RA, Gleadle JM. Mending a broken heart but breaking the kidney. Nephrology (Carlton) 2016;21:812&#x2013;820. doi: 10.1111/nep.12799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nep.12799</ArticleId><ArticleId IdType="pubmed">27082229</ArticleId></ArticleIdList></Reference><Reference><Citation>Han SS, et al. Anemia is a risk factor for acute kidney injury and long-term mortality in critically ill patients. Tohoku J. Exp. Med. 2015;237:287&#x2013;295. doi: 10.1620/tjem.237.287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1620/tjem.237.287</ArticleId><ArticleId IdType="pubmed">26607258</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Q, Colgan SP, Shelley CS. Hypoxia: The force that drives chronic kidney disease. Clin. Med. Res. 2016;14:15&#x2013;39. doi: 10.3121/cmr.2015.1282.</Citation><ArticleIdList><ArticleId IdType="doi">10.3121/cmr.2015.1282</ArticleId><ArticleId IdType="pmc">PMC4851450</ArticleId><ArticleId IdType="pubmed">26847481</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg AX, et al. Risk of acute kidney injury in patients randomized to a restrictive versus liberal approach to red blood cell transfusion in cardiac surgery: A substudy protocol of the transfusion requirements in cardiac surgery III noninferiority trial. Can. J. Kidney Health Dis. 2018;5:2054358117749532. doi: 10.1177/2054358117749532.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2054358117749532</ArticleId><ArticleId IdType="pmc">PMC5757433</ArticleId><ArticleId IdType="pubmed">29326843</ArticleId></ArticleIdList></Reference><Reference><Citation>Karkouti K. Transfusion and risk of acute kidney injury in cardiac surgery. Br. J. Anaesth. 2012;109:i29&#x2013;i38. doi: 10.1093/bja/aes422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aes422</ArticleId><ArticleId IdType="pubmed">23242748</ArticleId></ArticleIdList></Reference><Reference><Citation>Miano TA, et al. Attributable risk and time course of colistin-associated acute kidney injury. Clin. J. Am. Soc. Nephrol. 2018;13:542&#x2013;550. doi: 10.2215/CJN.06980717.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.06980717</ArticleId><ArticleId IdType="pmc">PMC5969457</ArticleId><ArticleId IdType="pubmed">29545383</ArticleId></ArticleIdList></Reference><Reference><Citation>Teerawattanapong N, et al. A systematic review of the burden of multidrug-resistant healthcare-associated infections among intensive care unit patients in Southeast Asia: The rise of multidrug-resistant Acinetobacter baumannii. Infect. Control Hosp. Epidemiol. 2018;39:525&#x2013;533. doi: 10.1017/ice.2018.58.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ice.2018.58</ArticleId><ArticleId IdType="pubmed">29580299</ArticleId></ArticleIdList></Reference><Reference><Citation>Husain-Syed F, Slutsky AS, Ronco C. Lung-kidney cross-talk in the critically ill patient. Am. J. Respir. Crit. Care Med. 2016;194:402&#x2013;414. doi: 10.1164/rccm.201602-0420CP.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201602-0420CP</ArticleId><ArticleId IdType="pubmed">27337068</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko GJ, Rabb H, Hassoun HT. Kidney-lung crosstalk in the critically ill patient. Blood Purif. 2009;28:75&#x2013;83. doi: 10.1159/000218087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000218087</ArticleId><ArticleId IdType="pmc">PMC2914422</ArticleId><ArticleId IdType="pubmed">19439927</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38879370</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Postoperative Hypotension After Cardiac Surgery Is Associated With Acute Kidney Injury.</ArticleTitle><Pagination><StartPage>1683</StartPage><EndPage>1688</EndPage><MedlinePgn>1683-1688</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2024.04.024</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(24)00279-9</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To describe the incidence of postoperative hypotension in patients undergoing cardiac surgery during the first 12 hours in the intensive care unit (ICU) and any relationship between hypotension and the development of acute kidney injury (AKI).</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">This was a retrospective, observational cohort study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">The study took place in a single-center tertiary teaching hospital in London, UK.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Adult patients (n = 100) who underwent elective cardiac surgery requiring intraoperative cardiopulmonary bypass between May and November 2021 were enrolled.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">None.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">A hypotensive event was defined as mean arterial pressure &lt;65 mmHg lasting at least 1 minute. Invasive blood pressure data was analyzed for the first 12 hours after surgery, and any association between postoperative hypotension and AKI was assessed. A total of 91% of patients experienced hypotension in the first 12 hours postprocedure. On average, patients experienced 9 hypotensive events, with events lasting an average of 5 minutes. A total of 16 patients (16%) developed at least stage 1 AKI. The average duration of hypotension was significantly higher in the AKI group (4.6 min [IQR 3.3, 8.0] v 8.1 min [IQR 5.2, 14.2], p = 0.029). Those suffering AKI had longer ICU and hospital stays.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study demonstrated that hypotension in the first 12 hours following cardiac surgery is common and prolonged hypotensive events are associated with developing AKI. This emphasizes the importance of treating hypotension aggressively and highlights a target for further research and intervention.</AbstractText><CopyrightInformation>Crown Copyright &#xa9; 2024. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiothoracic Intensive Care Unit, St George's University Hospital NHS Foundation Trust, London, United Kingdom. Electronic address: alexander.smith@nhs.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turoczi</LastName><ForeName>Zsolt</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Cardiothoracic Intensive Care Unit, St George's University Hospital NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Subaie</LastName><ForeName>Nawaf</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Cardiothoracic Intensive Care Unit, St George's University Hospital NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zilahi</LastName><ForeName>Gabor</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cardiothoracic Intensive Care Unit, St George's University Hospital NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">hypotension</Keyword><Keyword MajorTopicYN="N">intensive care</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare the following financial interests and personal relationships that may be considered potential competing interests: Gabor Zilahi has a speaking honorarium with Edwards LifeSciences, Irvine, CA.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>15</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>16</Day><Hour>11</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>15</Day><Hour>21</Hour><Minute>56</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38879370</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2024.04.024</ArticleId><ArticleId IdType="pii">S1053-0770(24)00279-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29124867</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>09</Day></DateCompleted><DateRevised><Year>2019</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1440-1797</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Nephrology (Carlton, Vic.)</Title><ISOAbbreviation>Nephrology (Carlton)</ISOAbbreviation></Journal><ArticleTitle>Acute kidney injury in critically ill surgical patients: Epidemiology, risk factors and outcomes.</ArticleTitle><Pagination><StartPage>39</StartPage><EndPage>46</EndPage><MedlinePgn>39-46</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/nep.13192</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">Acute kidney injury (AKI) is one of the most serious complications seen in intensive care units (ICUs). However, its epidemiology, risk factors and clinical outcomes in surgical critically ill patients remains unclear.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A prospective cohort study was conducted in surgical intensive care unit (ICU) of the university hospital in Bangkok, Thailand. AKI was diagnosed according to the KDIGO 2012 criteria.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 189 of the 400 patients enrolled in our study developed AKI (47.3%). The severity was: stage 1 = 29.6% of all AKI (56 cases), stage 2 = 30.7% (58 cases), and stage 3 = 39.7% (75 cases). Risk factors of AKI development included a higher BMI, a greater APACHE-II score, septic shock, use of mechanical ventilation, acute medical complications during surgical admission, and pre-existing chronic kidney disease. After adjustment for covariates, only the most severe stage of AKI (stage 3) was associated with increasing 28-day ICU mortality compared with no AKI stage, HR = 7.75 (95% CI, 1.46-41.20, P = 0.02).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Acute kidney injury is common and is associated with an increase in mortality in surgical ICU patients. There should be more focus on patients with AKI risk factors to prevent this deleterious event.</AbstractText><CopyrightInformation>&#xa9; 2017 Asian Pacific Society of Nephrology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Trongtrakul</LastName><ForeName>Konlawij</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-2544-7322</Identifier><AffiliationInfo><Affiliation>Critical Care Division, Department of Emergency Medicine, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sawawiboon</LastName><ForeName>Chaiwut</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Critical Care Division, Department of Emergency Medicine, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Amanda Y</ForeName><Initials>AY</Initials><AffiliationInfo><Affiliation>Renal and Metabolic Division, The George Institute for Global Health, Camperdown, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chitsomkasem</LastName><ForeName>Anusang</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Critical Care Division, Department of Emergency Medicine, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Limphunudom</LastName><ForeName>Ploynapas</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurathong</LastName><ForeName>Sathit</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Nephrology Division, Department of Internal Medicine, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prommool</LastName><ForeName>Surazee</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Nephrology Division, Department of Internal Medicine, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trakarnvanich</LastName><ForeName>Thananda</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Nephrology Division, Department of Internal Medicine, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Srisawat</LastName><ForeName>Nattachai</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Excellence Centre for Critical Care Nephrology, King Chulalongkorn Memorial Hospital, Thai Red Cross and Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Research Fund of Navamindradhiraj University, Bangkok, Thailand</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Nephrology (Carlton)</MedlineTA><NlmUniqueID>9615568</NlmUniqueID><ISSNLinking>1320-5358</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013785" MajorTopicYN="N" Type="Geographic">Thailand</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute renal failure</Keyword><Keyword MajorTopicYN="N">clinical epidemiology</Keyword><Keyword MajorTopicYN="N">critically ill patients</Keyword><Keyword MajorTopicYN="N">surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29124867</ArticleId><ArticleId IdType="doi">10.1111/nep.13192</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25027018</PMID><DateCompleted><Year>2015</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2047-9980</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>4</Issue><PubDate><Year>2014</Year><Month>Jul</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of the American Heart Association</Title><ISOAbbreviation>J Am Heart Assoc</ISOAbbreviation></Journal><ArticleTitle>The impact of acute kidney injury on the long-term risk of stroke.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e000933</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1161/JAHA.114.000933</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The incidence of acute kidney injury (AKI) requiring dialysis in hospitalized patients is increasing; however, information on the long-term incidence of stroke in patients surviving to discharge after recovering from AKI after dialysis has not been reported.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">Patients that survived after recovery from dialysis-requiring AKI during index hospitalizations from 1999 to 2008 were identified in nationwide administrative registries. The risk of de novo stroke and death were analyzed with time-varying Cox proportional hazard models. The results were validated by a critical care database. We enrolled 4315 patients in the AKI-recovery group (men, 57.7%; mean age, 62.8&#xb1;16.8 years) and matched 4315 control subjects as the non-AKI group by propensity scores. After a median follow-up period of 3.36 years, the incident stroke rate was 15.6 per 1000 person-years. The AKI-recovery group had higher risk (hazard ratio: 1.25; P=0.037) and higher severity of stroke events than the non-AKI group, regardless of progression to subsequent chronic kidney disease. The rate of incident stroke was not statistically different in those with diabetes alone (without AKI) and in those with AKI alone (without diabetes) after hospital discharge (P=0.086). Furthermore, the risk of mortality in the AKI-recovery group was higher than in the non-AKI group (hazard ratio: 2.4; P&lt;0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The patients who recovered from AKI had a higher incidence of developing incident stroke and mortality than the patients without AKI, and the impact was similar to diabetes. Our results suggest that a public health initiative is needed to enhance postdischarge follow-up of renal function and to control the subsequent incidence of stroke among patients who recover from AKI after dialysis.</AbstractText><CopyrightInformation>&#xa9; 2014 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Vin-Cent</ForeName><Initials>VC</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan (V.C.W., C.H.C., T.S.C., K.D.W.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Pei-Chen</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Da-Chien General Hospital, Miaoli City, Taiwan (P.C.W.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Che-Hsiung</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taipei, Taiwan (C.H.W.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Tao-Min</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Yun-Lin Branch, National Taiwan University Hospital, Taipei, Taiwan (T.M.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Chia-Hsuin</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan (V.C.W., C.H.C., T.S.C., K.D.W.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Pi-Ru</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Department of Traumatology and Surgery, National Taiwan University Hospital, Taipei, Taiwan (P.R.T., W.J.K.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Wen-Je</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>Department of Traumatology and Surgery, National Taiwan University Hospital, Taipei, Taiwan (P.R.T., W.J.K.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Likwang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan (L.C.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Cheng-Yi</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, and Medical Research Center, Cardinal Tien Hospital, School of Medicine, Fu Jen Catholic University, Xindian Dist New Taipei City, Taiwan (C.Y.W.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Tzong-Shinn</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan (V.C.W., C.H.C., T.S.C., K.D.W.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Kwan-Dun</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan (V.C.W., C.H.C., T.S.C., K.D.W.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>National Taiwan University Study Group on Acute Renal Failure (NSARF) Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Heart Assoc</MedlineTA><NlmUniqueID>101580524</NlmUniqueID><ISSNLinking>2047-9980</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="Y">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006435" MajorTopicYN="Y">Renal Dialysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N" Type="Geographic">Taiwan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">dialysis</Keyword><Keyword MajorTopicYN="N">kidney&#x2013;brain interaction</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">recovery</Keyword><Keyword MajorTopicYN="N">stroke</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25027018</ArticleId><ArticleId IdType="pmc">PMC4310379</ArticleId><ArticleId IdType="doi">10.1161/JAHA.114.000933</ArticleId><ArticleId IdType="pii">jah3619</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hsu CY, McCulloch CE, Fan D, Ordonez JD, Chertow GM, Go AS. Community&#x2010;based incidence of acute renal failure. Kidney Int. 2007; 72:208-212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2673495</ArticleId><ArticleId IdType="pubmed">17507907</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafrance JP, Miller DR. Acute kidney injury associates with increased long&#x2010;term mortality. J Am Soc Nephrol. 2010; 21:345-352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2834549</ArticleId><ArticleId IdType="pubmed">20019168</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishani A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA, Collins AJ. Acute kidney injury increases risk of esrd among elderly. J Am Soc Nephrol. 2009; 20:223-228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2615732</ArticleId><ArticleId IdType="pubmed">19020007</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagshaw SM. Epidemiology of renal recovery after acute renal failure. Curr Opin Crit Care. 2006; 12:544-550.</Citation><ArticleIdList><ArticleId IdType="pubmed">17077684</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Renal Data System. USRDS 2012 annual data report: atlas of chronic kidney disease and end&#x2010;stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases; 2012.</Citation></Reference><Reference><Citation>Shlipak MG, Katz R, Kestenbaum B, Siscovick D, Fried L, Newman A, Rifkin D, Sarnak MJ. Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol. 2009; 20:2625-2630.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2794238</ArticleId><ArticleId IdType="pubmed">19892934</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu VC, Wu CH, Huang TM, Wang CY, Lai CF, Shiao CC, Chang CH, Lin SL, Chen YY, Chen YM, Chu TS, Chiang WC, Wu KD, Tsai PR, Chen L, Ko WJ. Long&#x2010;term risk of coronary events after aki. J Am Soc Nephrol. 2014; 25:595-605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3935592</ArticleId><ArticleId IdType="pubmed">24503241</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M, Liang Y, Chigurupati S, Lathia JD, Pletnikov M, Sun Z, Crow M, Ross CA, Mattson MP, Rabb H. Acute kidney injury leads to inflammation and functional changes in the brain. J Am Soc Nephrol. 2008; 19:1360-1370.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2440297</ArticleId><ArticleId IdType="pubmed">18385426</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryden L, Ahnve S, Bell M, Hammar N, Ivert T, Holzmann MJ. Acute kidney injury following coronary artery bypass grafting: early mortality and postoperative complications. Scand Cardiovasc J. 2012; 46:114-120.</Citation><ArticleIdList><ArticleId IdType="pubmed">22324648</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The multicenter study of perioperative ischemia research group. Ann Intern Med. 1998; 128:194-203.</Citation><ArticleIdList><ArticleId IdType="pubmed">9454527</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulugahapitiya U, Siyambalapitiya S, Sithole J, Idris I. Is diabetes a coronary risk equivalent? Systematic review and meta&#x2010;analysis. Diabet Med. 2009; 26:142-148.</Citation><ArticleIdList><ArticleId IdType="pubmed">19236616</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen PC, Muo CH, Lee YT, Yu YH, Sung FC. Lung cancer and incidence of stroke: a population&#x2010;based cohort study. Stroke. 2011; 42:3034-3039.</Citation><ArticleIdList><ArticleId IdType="pubmed">21903961</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou SM, Chen YT, Chao PW, Lee YJ, Liu CJ, Yeh CM, Chen TJ, Chen TW, Yang WC, Li SY. Nonsteroidal anti&#x2010;inflammatory drug use is associated with cancer risk reduction in chronic dialysis patients. Kidney Int. 2013; 84:198-205.</Citation><ArticleIdList><ArticleId IdType="pubmed">23486520</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YC, Lin HY, Li CY, Lee MS, Su YC. A nationwide cohort study suggests that hepatitis C virus infection is associated with increased risk of chronic kidney disease. Kidney Int. 2014; 85:1200-1207.</Citation><ArticleIdList><ArticleId IdType="pubmed">24257691</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu VC, Hu YH, Wu CH, Kao CC, Wang SM, Chen L, Wu KD. Administrative data on diagnosis and mineralocorticoid receptor antagonist prescription identified patients with primary aldosteronism in Taiwan. J Clin Epidemiol. 2014</Citation><ArticleIdList><ArticleId IdType="pubmed">25034196</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40:373-383.</Citation><ArticleIdList><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu YT, Wu SC, Lee YC, Lai MS, Tam SC. Assessing measures of comorbidity using national health insurance databases. Taiwan J Public Health. 2010; 29:191-200.</Citation></Reference><Reference><Citation>Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML. Validation of the national health insurance research database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf. 2011; 20:236-242.</Citation><ArticleIdList><ArticleId IdType="pubmed">21351304</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JT, Chung WT, Lin JD, Peng GS, Muo CH, Lin CC, Wen CP, Wang IK, Tseng CH, Kao CH, Hsu CY. Increased risk of stroke after septicaemia: a population&#x2010;based longitudinal study in Taiwan. PLoS ONE. 2014; 9:e89386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3931764</ArticleId><ArticleId IdType="pubmed">24586739</ArticleId></ArticleIdList></Reference><Reference><Citation>Angus DC, Linde&#x2010;Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the united states: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001; 29:1303-1310.</Citation><ArticleIdList><ArticleId IdType="pubmed">11445675</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai TS, Wang CY, Pan SC, Huang TM, Lin MC, Lai CF, Wu CH, Wu VC, Chien KLon behalf of the National Taiwan University Hospital Study Group on Acute Renal Failure. Risk of developing severe sepsis after acute kidney injury: a population&#x2010;based cohort study. Crit Care. 2013; 17:R231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4056572</ArticleId><ArticleId IdType="pubmed">24119576</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992; 101:1644-1655.</Citation><ArticleIdList><ArticleId IdType="pubmed">1303622</ArticleId></ArticleIdList></Reference><Reference><Citation>Surgeon general's report: The health consequences of smoking&#x2014;50 years of progress.  Available at:  http://www.cdc.gov/tobacco/data_statistics/sgr/50th-anniversary/index.htm. Accessed June 6, 2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5928784</ArticleId><ArticleId IdType="pubmed">24687615</ArticleId></ArticleIdList></Reference><Reference><Citation>Best N, Hansell AL. Geographic variations in risk: adjusting for unmeasured confounders through joint modeling of multiple diseases. Epidemiology. 2009; 20:400-410.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2892360</ArticleId><ArticleId IdType="pubmed">19318951</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao CT, Hou CC, Wu VC, Lu HM, Wang CY, Chen L, Kao TW. The impact of dialysis&#x2010;requiring acute kidney injury on long&#x2010;term prognosis of patients requiring prolonged mechanical ventilation: nationwide population&#x2010;based study. PLoS One. 2012; 7:e50675.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3520952</ArticleId><ArticleId IdType="pubmed">23251377</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HJ, Bai CH, Yeh WT, Chiu HC, Pan WH. Influence of metabolic syndrome and general obesity on the risk of ischemic stroke. Stroke. 2006; 37:1060-1064.</Citation><ArticleIdList><ArticleId IdType="pubmed">16514099</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YH, Kang JH, Lin HC. Patients with traumatic brain injury: population&#x2010;based study suggests increased risk of stroke. Stroke. 2011; 42:2733-2739.</Citation><ArticleIdList><ArticleId IdType="pubmed">21799162</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L, Chen YM, Chuang JH. 
A study of validation on comorbidity derived from claims data National Yangx2010Ming University, Master Thesis 2004;6. Available at: http://ndltd.ncl.edu.tw/cgi-bin/gs32/gsweb.cgi?o=dnclcdr&amp;s=id=%22092YM005058012%005058022.&amp;searchmode=basic Accessed June 6, 2014.</Citation></Reference><Reference><Citation>Leu HB, Chung CM, Chuang SY, Bai CH, Chen JR, Chen JW, Pan WH. Genetic variants of connexin37 are associated with carotid intima&#x2010;medial thickness and future onset of ischemic stroke. Atherosclerosis. 2011; 214:101-106.</Citation><ArticleIdList><ArticleId IdType="pubmed">21044781</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang TM, Wu VC, Young GH, Lin YF, Shiao CC, Wu PC, Li WY, Yu HY, Hu FC, Lin JW, Chen YS, Lin YH, Wang SS, Hsu RB, Chang FC, Chou NK, Chu TS, Yeh YC, Tsai PR, Huang JW, Lin SL, Chen YM, Ko WJ, Wu KD. Preoperative proteinuria predicts adverse renal outcomes after coronary artery bypass grafting. J Am Soc Nephrol. 2011; 22:156-163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3014044</ArticleId><ArticleId IdType="pubmed">21115618</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu VC, Wang CH, Wang WJ, Lin YF, Hu FC, Chen YW, Chen YS, Wu MS, Lin YH, Kuo CC, Huang TM, Chen YM, Tsai PR, Ko WJ, Wu KD. Sustained low&#x2010;efficiency dialysis versus continuous veno&#x2010;venous hemofiltration for postsurgical acute renal failure. Am J Surg. 2009; 199:466-476.</Citation><ArticleIdList><ArticleId IdType="pubmed">19375065</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu VC, Ko WJ, Chang HW, Chen YW, Lin YF, Shiao CC, Chen YM, Chen YS, Tsai PR, Hu FC, Wang JY, Lin YH, Wu KD. Risk factors of early redialysis after weaning from postoperative acute renal replacement therapy. Intensive Care Med. 2008; 34:101-108.</Citation><ArticleIdList><ArticleId IdType="pubmed">17701162</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiao CC, Wu VC, Li WY, Lin YF, Hu FC, Young GH, Kuo CC, Kao TW, Huang DM, Chen YM, Tsai PR, Lin SL, Chou NK, Lin TH, Yeh YC, Wang CH, Chou A, Ko WJ, Wu KD. Late initiation of renal replacement therapy is associated with worse outcomes in acute kidney injury after major abdominal surgery. Crit Care. 2009; 13:R171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2784403</ArticleId><ArticleId IdType="pubmed">19878554</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu VC, Huang TM, Lai CF, Shiao CC, Lin YF, Chu TS, Wu PC, Chao CT, Wang JY, Kao TW, Young GH, Tsai PR, Tsai HB, Wang CL, Wu MS, Chiang WC, Tsai IJ, Hu FC, Lin SL, Chen YM, Tsai TJ, Ko WJ, Wu KD. Acute&#x2010;on&#x2010;chronic kidney injury at hospital discharge is associated with long&#x2010;term dialysis and mortality. Kidney Int. 2011; 80:1222-1230.</Citation><ArticleIdList><ArticleId IdType="pubmed">21832983</ArticleId></ArticleIdList></Reference><Reference><Citation>Bihorac A, Yavas S, Subbiah S, Hobson CE, Schold JD, Gabrielli A, Layon AJ, Segal MS. Long&#x2010;term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg. 2009; 249:851-858.</Citation><ArticleIdList><ArticleId IdType="pubmed">19387314</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou CC, Lien LM, Chen WH, Wu MS, Lin SM, Chiu HC, Chiou HY, Bai CH. Adults with late stage 3 chronic kidney disease are at high risk for prevalent silent brain infarction: a population&#x2010;based study. Stroke. 2011; 42:2120-2125.</Citation><ArticleIdList><ArticleId IdType="pubmed">21700935</ArticleId></ArticleIdList></Reference><Reference><Citation>Seliger SL, Gillen DL, Tirschwell D, Wasse H, Kestenbaum BR, Stehman&#x2010;Breen CO. Risk factors for incident stroke among patients with end&#x2010;stage renal disease. J Am Soc Nephrol. 2003; 14:2623-2631.</Citation><ArticleIdList><ArticleId IdType="pubmed">14514741</ArticleId></ArticleIdList></Reference><Reference><Citation>Li PK, Burdmann EA, Mehta RL. World kidney day 2013: acute kidney injury&#x2010;global health alert. Acta Nephrologica. 2013; 27:5-10.</Citation><ArticleIdList><ArticleId IdType="pubmed">23414727</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu RK, McCulloch CE, Dudley RA, Lo LJ, Hsu CY. Temporal changes in incidence of dialysis&#x2010;requiring aki. J Am Soc Nephrol. 2012; 24:37-42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3537221</ArticleId><ArticleId IdType="pubmed">23222124</ArticleId></ArticleIdList></Reference><Reference><Citation>Liangos O, Wald R, O'Bell JW, Price L, Pereira BJ, Jaber BL. Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol. 2006; 1:43-51.</Citation><ArticleIdList><ArticleId IdType="pubmed">17699189</ArticleId></ArticleIdList></Reference><Reference><Citation>Waikar SS, Curhan GC, Wald R, McCarthy EP, Chertow GM. Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol. 2006; 17:1143-1150.</Citation><ArticleIdList><ArticleId IdType="pubmed">16495376</ArticleId></ArticleIdList></Reference><Reference><Citation>Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta&#x2010;analysis. Kidney Int. 2012; 81:442-448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3788581</ArticleId><ArticleId IdType="pubmed">22113526</ArticleId></ArticleIdList></Reference><Reference><Citation>Pannu N. Bidirectional relationships between acute kidney injury and chronic kidney disease. Curr Opin Nephrol Hypertens. 2013; 22:351-356.</Citation><ArticleIdList><ArticleId IdType="pubmed">23508059</ArticleId></ArticleIdList></Reference><Reference><Citation>Rifkin DE, Coca SG, Kalantar&#x2010;Zadeh K. Does AKI truly lead to CKD? J Am Soc Nephrol. 2012; 23:979-984.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3358766</ArticleId><ArticleId IdType="pubmed">22460531</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonventre JV. Pathophysiology of AKI: injury and normal and abnormal repair. Contrib Nephrol. 2010; 165:9-17.</Citation><ArticleIdList><ArticleId IdType="pubmed">20427950</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu VC, Young GH, Huang PH, Lo SC, Wang KC, Sun CY, Liang CJ, Huang TM, Chen JH, Chang FC, Chen YL, Kuo YS, Chen JB, Chen JW, Chen YM, Ko WJ, Wu KD. The Ng. In acute kidney injury, indoxyl sulfate impairs human endothelial progenitor cells: modulation by statin. Angiogenesis. 2013; 16:609-624.</Citation><ArticleIdList><ArticleId IdType="pubmed">23408148</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, Shannon M, Ando Y, Schnackenberg LK, Khan NA, Portilla D, Beger RD. Serum metabolomic profiles from patients with acute kidney injury: a pilot study. J Chromatogr B Analyt Technol Biomed Life Sci. 2012; 893&#x2013;894:107-113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3325145</ArticleId><ArticleId IdType="pubmed">22429878</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen G, Horl WH. Retinol binding protein isolated from acute renal failure patients inhibits polymorphonuclear leucocyte functions. Eur J Clin Invest. 2004; 34:774-781.</Citation><ArticleIdList><ArticleId IdType="pubmed">15530151</ArticleId></ArticleIdList></Reference><Reference><Citation>Herget&#x2010;Rosenthal S, Glorieux G, Jankowski J, Jankowski V. Uremic toxins in acute kidney injury. Semin Dial. 2009; 22:445-448.</Citation><ArticleIdList><ArticleId IdType="pubmed">19708999</ArticleId></ArticleIdList></Reference><Reference><Citation>Basile DP, Friedrich JL, Spahic J, Knipe N, Mang H, Leonard EC, Changizi&#x2010;Ashtiyani S, Bacallao RL, Molitoris BA, Sutton TA. Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury. Am J Physiol Renal Physiol. 2011; 300:F721-733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3064142</ArticleId><ArticleId IdType="pubmed">21123492</ArticleId></ArticleIdList></Reference><Reference><Citation>Leaf DE, Wolf M, Stern L. Elevated FGF&#x2010;23 in a patient with rhabdomyolysis&#x2010;induced acute kidney injury. Nephrol Dial Transplant. 2010; 25:1335-1337.</Citation><ArticleIdList><ArticleId IdType="pubmed">20037176</ArticleId></ArticleIdList></Reference><Reference><Citation>Kendrick J, Cheung AK, Kaufman JS, Greene T, Roberts WL, Smits G, Chonchol M. FGF&#x2010;23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol. 2011; 22:1913-1922.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3187186</ArticleId><ArticleId IdType="pubmed">21903574</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnlov J, Carlsson AC, Sundstrom J, Ingelsson E, Larsson A, Lind L, Larsson TE. Serum FGF23 and risk of cardiovascular events in relation to mineral metabolism and cardiovascular pathology. Clin J Am Soc Nephrol. 2013; 8:781-786.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3641622</ArticleId><ArticleId IdType="pubmed">23335040</ArticleId></ArticleIdList></Reference><Reference><Citation>Helmersson&#x2010;Karlqvist J, Larsson A, Carlsson AC, Venge P, Sundstrom J, Ingelsson E, Lind L, Arnlov J. Urinary neutrophil gelatinase&#x2010;associated lipocalin (NGAL) is associated with mortality in a community&#x2010;based cohort of older Swedish men. Atherosclerosis. 2013; 227:408-413.</Citation><ArticleIdList><ArticleId IdType="pubmed">23375682</ArticleId></ArticleIdList></Reference><Reference><Citation>Adachi N, Lei B, Deshpande G, Seyfried FJ, Shimizu I, Nagaro T, Arai T. Uraemia suppresses central dopaminergic metabolism and impairs motor activity in rats. Intensive Care Med. 2001; 27:1655-1660.</Citation><ArticleIdList><ArticleId IdType="pubmed">11685308</ArticleId></ArticleIdList></Reference><Reference><Citation>Arieff AI, Massry SG. Calcium metabolism of brain in acute renal failure. Effects of uremia, hemodialysis, and parathyroid hormone. J Clin Investig. 1974; 53:387-392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC301480</ArticleId><ArticleId IdType="pubmed">11344551</ArticleId></ArticleIdList></Reference><Reference><Citation>Nickolas TL, Khatri M, Boden&#x2010;Albala B, Kiryluk K, Luo X, Gervasi&#x2010;Franklin P, Paik M, Sacco RL. The association between kidney disease and cardiovascular risk in a multiethnic cohort: findings from the northern manhattan study (NOMAS). Stroke. 2008; 39:2876-2879.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3035384</ArticleId><ArticleId IdType="pubmed">18617655</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ. Chronic kidney disease as a risk factor for cardiovascular disease and all&#x2010;cause mortality: a pooled analysis of community&#x2010;based studies. J Am Soc Nephrol. 2004; 15:1307-1315.</Citation><ArticleIdList><ArticleId IdType="pubmed">15100371</ArticleId></ArticleIdList></Reference><Reference><Citation>Yatsuya H, Iso H, Yamagishi K, Kokubo Y, Saito I, Suzuki K, Sawada N, Inoue M, Tsugane S. Development of a point&#x2010;based prediction model for the incidence of total stroke: Japan public health center study. Stroke. 2013; 44:1295-1302.</Citation><ArticleIdList><ArticleId IdType="pubmed">23449266</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Ishani A, Johansen K, Kasiske B, Kutner N, Liu J, St Peter W, Ding S, Guo H, Kats A, Lamb K, Li S, Roberts T, Skeans M, Snyder J, Solid C, Thompson B, Weinhandl E, Xiong H, Yusuf A, Zaun D, Arko C, Chen SC, Daniels F, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L. US Renal Data System 2012 Annual Data Report. Am J Kidney Dis. 2013; 61:e1&#x2010;476</Citation><ArticleIdList><ArticleId IdType="pubmed">23253259</ArticleId></ArticleIdList></Reference><Reference><Citation>Grundy SM. Diabetes and coronary risk equivalency: what does it mean? Diabetes Care. 2006; 29:457-460.</Citation><ArticleIdList><ArticleId IdType="pubmed">16443907</ArticleId></ArticleIdList></Reference><Reference><Citation>Liano F, Felipe C, Tenorio MT, Rivera M, Abraira V, Saez&#x2010;de&#x2010;Urturi JM, Ocana J, Fuentes C, Severiano S. Long&#x2010;term outcome of acute tubular necrosis: a contribution to its natural history. Kidney Int. 2007; 71:679-686.</Citation><ArticleIdList><ArticleId IdType="pubmed">17264879</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27530232</PMID><DateCompleted><Year>2017</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2018</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-7716</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>5</Issue><PubDate><Year>2017</Year><Month>Feb</Month><Day>10</Day></PubDate></JournalIssue><Title>Antioxidants &amp; redox signaling</Title><ISOAbbreviation>Antioxid Redox Signal</ISOAbbreviation></Journal><ArticleTitle>Does Furosemide Increase Oxidative Stress in Acute Kidney Injury?</ArticleTitle><Pagination><StartPage>221</StartPage><EndPage>226</EndPage><MedlinePgn>221-226</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/ars.2016.6845</ELocationID><Abstract><AbstractText>Furosemide, a loop diuretic, is used to increase urine output in patients with acute kidney injury (AKI). It remains uncertain whether the benefits of furosemide in AKI outweigh its potential harms. We investigated if furosemide influenced oxidative stress in 30 critically ill patients with AKI by measuring changes in F<sub>2</sub>-isoprostanes (F<sub>2</sub>-IsoPs), markers of in vivo oxidative stress, in plasma and urine following intravenous furosemide. Urine F<sub>2</sub>-IsoPs were higher in sepsis (p&#x2009;=&#x2009;0.001) and increased in proportion to urine furosemide (p&#x2009;=&#x2009;0.001). The furosemide-induced increase in urine F<sub>2</sub>-IsoPs differed depending on AKI severity (p&#x2009;&lt;&#x2009;0.001) and was greatest in those with the most severe AKI. Furosemide had no effect on plasma F<sub>2</sub>-IsoPs. We demonstrate for the first time that furosemide increases renal oxidative stress in AKI and find that patients with the most severe AKI-to whom the largest doses are likely to be administered-showed the greatest increase in oxidative stress. These findings lead to the hypothesis that the common practice of administering high-dose furosemide to convert oliguric to nonoliguric AKI may induce harmful oxidative stress in the kidneys, and an adequately powered, randomized controlled trial is required to determine if clinical benefits of this dosing strategy justify its potential harms. Antioxid. Redox Signal. 26, 221-226.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Silbert</LastName><ForeName>Benjamin I</ForeName><Initials>BI</Initials><AffiliationInfo><Affiliation>1 Department of Intensive Care Medicine, Fiona Stanley Hospital , Murdoch, Australia .</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2 School of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia , Perth, Australia .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Kwok M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>3 Department of Intensive Care Medicine, Royal Perth Hospital , Perth, Australia .</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>4 School of Population Health, University of Western Australia , Crawley, Australia .</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>5 School of Veterinary and Life Sciences, Murdoch University , Murdoch, Australia .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipman</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>6 Burns, Trauma and Critical Care Research Centre, School of Medicine, University of Queensland , Brisbane, Australia .</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>7 Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital , Herston, Australia .</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>8 Faculty of Health, Queensland University of Technology , Brisbane, Australia .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>Jason A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>6 Burns, Trauma and Critical Care Research Centre, School of Medicine, University of Queensland , Brisbane, Australia .</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>7 Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital , Herston, Australia .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corcoran</LastName><ForeName>Tomas B</ForeName><Initials>TB</Initials><AffiliationInfo><Affiliation>2 School of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia , Perth, Australia .</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>9 Department of Anaesthesia and Pain Medicine, Royal Perth Hospital , Perth, Australia .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morgan</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>1 Department of Intensive Care Medicine, Fiona Stanley Hospital , Murdoch, Australia .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pavey</LastName><ForeName>Warren</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>5 School of Veterinary and Life Sciences, Murdoch University , Murdoch, Australia .</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>10 Department of Anaesthesia and Pain Medicine, Fiona Stanley Hospital , Murdoch, Australia .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mas</LastName><ForeName>Emilie</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>2 School of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia , Perth, Australia .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barden</LastName><ForeName>Anne E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>2 School of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia , Perth, Australia .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mori</LastName><ForeName>Trevor A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>2 School of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia , Perth, Australia .</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>09</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Antioxid Redox Signal</MedlineTA><NlmUniqueID>100888899</NlmUniqueID><ISSNLinking>1523-0864</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004232">Diuretics</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D028441">F2-Isoprostanes</NameOfSubstance></Chemical><Chemical><RegistryNumber>7LXU5N7ZO5</RegistryNumber><NameOfSubstance UI="D005665">Furosemide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004232" MajorTopicYN="N">Diuretics</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D028441" MajorTopicYN="N">F2-Isoprostanes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005665" MajorTopicYN="N">Furosemide</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007677" MajorTopicYN="N">Kidney Function Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute renal failure</Keyword><Keyword MajorTopicYN="N">diuretic</Keyword><Keyword MajorTopicYN="N">harms</Keyword><Keyword MajorTopicYN="N">oliguria</Keyword><Keyword MajorTopicYN="N">prevention</Keyword><Keyword MajorTopicYN="N">urine output</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27530232</ArticleId><ArticleId IdType="doi">10.1089/ars.2016.6845</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32681793</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>05</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1643-3750</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><PubDate><Year>2020</Year><Month>Jul</Month><Day>18</Day></PubDate></JournalIssue><Title>Medical science monitor : international medical journal of experimental and clinical research</Title><ISOAbbreviation>Med Sci Monit</ISOAbbreviation></Journal><ArticleTitle>Early Acute Kidney Injury Associated with Liver Transplantation: A Retrospective Case-Control Study.</ArticleTitle><Pagination><StartPage>e923864</StartPage><MedlinePgn>e923864</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.12659/MSM.923864</ELocationID><Abstract><AbstractText>BACKGROUND A retrospective case-control study was carried out to assess the occurrence of acute kidney injury (AKI) in liver transplantation (LT) recipients and its related risk factors. MATERIAL AND METHODS The study enrolled 131 patients undergoing LT from December 2017 to June 2019 at Beijing Tsinghua Chang Gung Hospital, China. AKI and its classification were defined according to KDIGO guidelines. We collected patients' demographic characteristics and perioperative parameters, and identified independent risk factors of AKI by multivariate logistic regression analysis. RESULTS We included 122 patients in analysis. AKI occurred in 52 (42.6%) patients (22.1% stage I, 8.2% stage II, and 12.3% stage III). AKI was notably associated with 12 factors: sex, body mass index (BMI), hepatic etiology, MELD score, ascites, prothrombin time (PT), international normalized ratio of prothrombin time (INR), preoperative total bilirubin (TBIL), operative time, total fluid intake, fresh frozen plasma (FFP), and estimated blood loss (EBL) (P&lt;0.05). The factors independently associated with AKI were BMI (adjusted odds ratio: 0.605, 95% confidence interval: 0.425-0.859; P=0.005) and intraoperative FFP infusion (adjusted odds ratio: 0.998, 95% confidence interval: 0.995-1.000; P=0.047). Compared with the non-AKI group, the AKI group showed higher likelihood of renal replacement therapy (RRT), and longer ICU and hospital stays, higher in-hospital mortality, and higher hospitalization costs (P&lt;0.05). CONCLUSIONS There is a high risk of AKI in patients undergoing LT. BMI and intraoperative FFP infusion are factors independently correlated with AKI. AKI can result in extended hospital stays and higher hospitalization expenses.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Mengzhuo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Yuanchao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Linlin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Haijing</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xian</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Huan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Beijing, China (mainland).</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Med Sci Monit</MedlineTA><NlmUniqueID>9609063</NlmUniqueID><ISSNLinking>1234-1010</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016031" MajorTopicYN="N">Liver Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflicts of interest</b>. None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>7</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32681793</ArticleId><ArticleId IdType="pmc">PMC7387046</ArticleId><ArticleId IdType="doi">10.12659/MSM.923864</ArticleId><ArticleId IdType="pii">923864</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McCauley J, Van Thiel DH, Starzl TE, Puschett JB. Acute and chronic renal failure in liver transplantation. Nephron. 1990;55(2):121&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2957102</ArticleId><ArticleId IdType="pubmed">2362625</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima EQ, Zanetta DM, Castro I, et al. Risk factors for development of acute renal failure after liver transplantation. Ren Fail. 2003;25(4):553&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">12911159</ArticleId></ArticleIdList></Reference><Reference><Citation>Thongprayoon C, Kaewput W, Thamcharoen N, et al. Incidence and impact of acute kidney injury after liver transplantation: A meta-analysis. J Clin Medm. 2019;8(3):372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6463182</ArticleId><ArticleId IdType="pubmed">30884912</ArticleId></ArticleIdList></Reference><Reference><Citation>Tinti F, Melandro F, Umbro I, et al. Female gender and overestimation of glomerular filtration rate: Independent predictors of acute kidney injury after liver transplantation. Clin Nephrol. 2020;93(2):92&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">31793872</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav K, Serrano OK, Peterson KJ, et al. The liver recipient with acute renal dysfunction: A single institution evaluation of the simultaneous liver-kidney transplant candidate. Clin Transplant. 2018;32(1)</Citation><ArticleIdList><ArticleId IdType="pubmed">29105843</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman S, Davidson BR, Mallett SV. Early acute kidney injury after liver transplantation: Predisposing factors and clinical implications. World J Hepatol. 2017;9(18):823&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5491405</ArticleId><ArticleId IdType="pubmed">28706581</ArticleId></ArticleIdList></Reference><Reference><Citation>Barri YM, Sanchez EQ, Jennings LW, et al. Acute kidney injury following liver transplantation: Definition and outcome. Liver Transpl. 2009;15(5):475&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">19399734</ArticleId></ArticleIdList></Reference><Reference><Citation>Angeli P, Gines P, Wong F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites. J Hepatol. 2015;62(4):968&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">25638527</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadim MK, Durand F, Kellum JA, et al. Management of the critically ill patient with cirrhosis: A multidisciplinary perspective. J Hepatol. 2016;64(3):717&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">26519602</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2206446</ArticleId><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirivatanauksorn Y, Parakonthun T, Premasathian N, et al. Renal dysfunction after orthotopic liver transplantation. Transplant Proc. 2014;46(3):818&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">24767356</ArticleId></ArticleIdList></Reference><Reference><Citation>Durand F, Francoz C, Asrani SK, et al. Acute kidney injury after liver transplantation. Transplantation. 2018;102(10):1636&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">29847502</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilbao I, Charco R, Balsells J, et al. Risk factors for acute renal failure requiring dialysis after liver transplantation. Clin Transplant. 1998;12(2):123&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">9575400</ArticleId></ArticleIdList></Reference><Reference><Citation>Maiwall R, Sarin SK, Kumar S, et al. Development of predisposition, injury, response, organ failure model for predicting acute kidney injury in acute on chronic liver failure. Liver Int. 2017;37(10):1497&#x2013;507.</Citation><ArticleIdList><ArticleId IdType="pubmed">28393476</ArticleId></ArticleIdList></Reference><Reference><Citation>Utsumi M, Umeda Y, Sadamori H, et al. Risk factors for acute renal injury in living donor liver transplantation: Evaluation of the RIFLE criteria. Transpl Int. 2013;26(8):842&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">23855657</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlegel A, Linecker M, Kron P, et al. Risk assessment in high- and low-MELD liver transplantation. Am J Transplant. 2017;17(4):1050&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">27676319</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano TG, Schmidtbauer I, Silva FM, et al. Role of MELD score and serum creatinine as prognostic tools for the development of acute kidney injury after liver transplantation. PLoS One. 2013;8(5):e64089.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3662723</ArticleId><ArticleId IdType="pubmed">23717537</ArticleId></ArticleIdList></Reference><Reference><Citation>Lebron Gallardo M, Herrera Gutierrez ME, Seller Perez G, et al. Risk factors for renal dysfunction in the postoperative course of liver transplant. Liver Transpl. 2004;10(11):1379&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">15497160</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SK, Park JB, Kim SJ, et al. Early postoperative renal dysfunction in the adult living donor liver transplantation. Transplant Proc. 2007;39(5):1517&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">17580177</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Singhapricha T, Hu KQ, et al. Postliver transplant acute renal injury and failure by the RIFLE criteria in patients with normal pretransplant serum creatinine concentrations: A matched study. Transplantation. 2011;91(3):348&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">21127462</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilmi IA, Damian D, Al-Khafaji A, et al. Acute kidney injury following orthotopic liver transplantation: Incidence, risk factors, and effects on patient and graft outcomes. Br J Anaesth. 2015;114(6):919&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">25673576</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JY, Park JH, Lee SS, et al. The association of preoperative body mass index with acute kidney injury in liver transplantation recipients: A retrospective study. Korean J Crit Care Med. 2017;32(3):265&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6786735</ArticleId><ArticleId IdType="pubmed">31723645</ArticleId></ArticleIdList></Reference><Reference><Citation>Iglesias JI, DePalma JA, Levine JS. Risk factors for acute kidney injury following orthotopic liver transplantation: The impact of changes in renal function while patients await transplantation. BMC Nephrol. 2010;11:30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2991287</ArticleId><ArticleId IdType="pubmed">21059264</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonard J, Heimbach JK, Malinchoc M, et al. The impact of obesity on long-term outcomes in liver transplant recipients-results of the NIDDK liver transplant database. Am J Transplant. 2008;8(3):667&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">18294163</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong RJ, Cheung R, Perumpail RB, et al. Diabetes mellitus, and not obesity, is associated with lower survival following liver transplantation. Dig Dis Sci. 2015;60(4):1036&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">25596720</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalisvaart M, Schlegel A, Umbro I, et al. The AKI Prediction Score: A new prediction model for acute kidney injury after liver transplantation. HPB (Oxford) 2019;21(12):1707&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">31153834</ArticleId></ArticleIdList></Reference><Reference><Citation>Olthoff KM, Kulik L, Samstein B, et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl. 2010;16(8):943&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">20677285</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon KS, Chen CC, Thorat A, et al. Fibrinolysis after reperfusion of liver graft. Acta Anaesthesiol Taiwan. 2015;53(1):41&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">25649273</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39977357</PMID><DateCompleted><Year>2025</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1873-734X</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Month>Feb</Month><Day>04</Day></PubDate></JournalIssue><Title>European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery</Title><ISOAbbreviation>Eur J Cardiothorac Surg</ISOAbbreviation></Journal><ArticleTitle>Intravenous amino acids for renal protection in patients receiving temporary mechanical circulatory support: a secondary subgroup analysis of the PROTECTION study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">ezaf035</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/ejcts/ezaf035</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">In cardiac surgery patients, acute kidney injury (AKI) frequently occurs in the setting of haemodynamic instability and treatment with temporary mechanical circulatory support (tMCS). Recent evidence suggests amino acids (AA) infusion may reduce AKI rate. However, the effect of AA infusion in patients requiring tMCS may be less effective.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a secondary analysis of the PROTECTION multicentre randomized controlled trial including all patients treated with tMCS. Patients undergoing elective cardiac surgery with cardiopulmonary bypass were randomized to receive 2&#x2009;g/kg ideal body weight/day of intravenous AA to a maximum of 100&#x2009;g/day or matching placebo from operating room admission until up to 3&#x2009;days, receipt of renal-replacement therapy, discharge from ICU or death. The primary outcome of the PROTECTION study was the rate of AKI, as in this secondary analysis. A total of 3511 patients were randomized in the study.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We studied 232 patients who received tMCS, 112 randomized to AA infusion and 120 to placebo. The median preoperative serum creatinine value was significantly higher among AA group patients (AA: 1.08, interquartile range 0.90-1.26; placebo: 0.98, interquartile range 0.85-1.15; P&#x2009;=&#x2009;0.02). The rate of AKI, however, was lower in patients randomized to AA (44.6% vs 60.8%; relative risk 0.73; 95% confidence interval (0.57-0.94); P&#x2009;=&#x2009;0.01; number needed to treat&#x2009;=&#x2009;6). We found no significant differences in secondary outcomes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Short-term AA infusion appears to reduce rate of AKI among patients requiring tMCS. Use of AA in this population at high-risk for renal failure appears justified.</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION NUMBER" NlmCategory="BACKGROUND">ClinicalTrials.gov NCT03709264.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2025. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site&#x2014;for further information please contact journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Belletti</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3131-0565</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pisano</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scandroglio</LastName><ForeName>Anna Mara</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0003-0639-8227</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garofalo</LastName><ForeName>Eugenio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, Department of Medical and Surgical Sciences, Magna Gr&#xe6;cia University of Catanzaro, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calabr&#xf2;</LastName><ForeName>Maria Grazia</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrod</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Torino, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monaco</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-5186-1976</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brambillasca</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baiardo Redaelli</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meroi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Azienda Sanitaria Universitaria Friuli Centrale, Department of Emergency "Santa Maria Della Misericordia", University Hospital of Udine, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fominskiy</LastName><ForeName>Evgeny</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vignale</LastName><ForeName>Rosaria</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiovascular Anesthesia and ICU, San Carlo Hospital, Potenza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ajello</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Venditto</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiac Anesthesia and ICU, AORN "Dei Colli," Monaldi Hospital, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scquizzato</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-1394-8402</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porta</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>S.C. Anestesia e Rianimazione Cardiovascolare, A.O. Ordine Mauriziano Umberto I di Torino, Torino, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Losiggio</LastName><ForeName>Rosario</ForeName><Initials>R</Initials><Identifier Source="ORCID">0009-0001-6181-7976</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suriano</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Dipartimento di Chirurgia Cardiovascolare, Unit&#xe0; Operativa di Anestesia e Terapia Intensiva, IRCCS Centro Cadiologico Monzino, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pontillo</LastName><ForeName>Domenico</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orso</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Azienda Sanitaria Universitaria Friuli Centrale, Department of Emergency "Santa Maria Della Misericordia", University Hospital of Udine, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomasi</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Pharmacy, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paternoster</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Health Science Anesthesia and ICU, School of Medicine, University of Basilicata, San Carlo Hospital, Potenza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lomivorotov</LastName><ForeName>Vladimir</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Penn State Milton S. Hershey Medical Center, Penn State College of Medicine, Hershey, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Longhini</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, Department of Medical and Surgical Sciences, Magna Gr&#xe6;cia University of Catanzaro, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-8594-5980</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zangrillo</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7687-7648</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maisano</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiac Surgery Department, San Raffaele University Hospital, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-1650-8939</Identifier><AffiliationInfo><Affiliation>Department of Critical Care, The University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Data Analytics Research and Evaluation Centre, Austin Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, Austin Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, Royal Melbourne Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pieri</LastName><ForeName>Marina</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4101-800X</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>PROTECTION Study Group Collaborators
</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03709264</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>RF-2016-02363260</GrantID><Agency>Italian Ministry of Health</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Cardiothorac Surg</MedlineTA><NlmUniqueID>8804069</NlmUniqueID><ISSNLinking>1010-7940</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000596">Amino Acids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000596" MajorTopicYN="Y">Amino Acids</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="Y">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007262" MajorTopicYN="N">Infusions, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute heart failure</Keyword><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Cardiogenic shock</Keyword><Keyword MajorTopicYN="N">Extracorporeal membrane oxygenation</Keyword><Keyword MajorTopicYN="N">Micro-axial flow pump</Keyword><Keyword MajorTopicYN="N">Renal-replacement therapy</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>D'Amico</LastName><ForeName>Filippo</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Manazza</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marmiere</LastName><ForeName>Marilena</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marzaroli</LastName><ForeName>Matteo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Monti</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oliva</LastName><ForeName>Federico Mattia</ForeName><Initials>FM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pruna</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Turi</LastName><ForeName>Stefano</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Veneziano</LastName><ForeName>Marta</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vietri</LastName><ForeName>Simone</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zaraca</LastName><ForeName>Luisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fraja</LastName><ForeName>Diana Di</ForeName><Initials>DD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Verniero</LastName><ForeName>Luigi</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bruni</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perrelli</LastName><ForeName>Giulia</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Prezzi</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Massaro</LastName><ForeName>Cristiano</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ferrante</LastName><ForeName>Palma</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arangino</LastName><ForeName>Cristina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Angelini</LastName><ForeName>Filippo</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bacchetti</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vitielli</LastName><ForeName>Michelangelo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gallicchio</LastName><ForeName>Francesca</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bradic</LastName><ForeName>Nikola</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ti</LastName><ForeName>Lian Kah</ForeName><Initials>LK</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>1</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>24</Day><Hour>23</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>2</Month><Day>20</Day><Hour>18</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>2</Month><Day>20</Day><Hour>13</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39977357</ArticleId><ArticleId IdType="doi">10.1093/ejcts/ezaf035</ArticleId><ArticleId IdType="pii">8026694</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">20375494</PMID><DateCompleted><Year>2010</Year><Month>10</Month><Day>12</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1421-9670</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>5</Issue><PubDate><Year>2010</Year></PubDate></JournalIssue><Title>American journal of nephrology</Title><ISOAbbreviation>Am J Nephrol</ISOAbbreviation></Journal><ArticleTitle>Prevention and treatment of acute kidney injury in patients undergoing cardiac surgery: a systematic review.</ArticleTitle><Pagination><StartPage>408</StartPage><EndPage>418</EndPage><MedlinePgn>408-18</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1159/000296277</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute kidney injury (AKI) is common in patients undergoing cardiac surgery and is associated with a high rate of death, long-term sequelae and healthcare costs. We conducted a systematic review of randomized controlled trials for strategies to prevent or treat AKI in cardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We screened Medline, Scopus, Cochrane Renal Library, and Google Scholar for randomized controlled trails in cardiac surgery for prevention or treatment of AKI in adults.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 70 studies that contained a total of 5,554 participants published until November 2008. Most studies were small in sample size, were single-center, focused on preventive strategies, and displayed wide variation in AKI definitions. Only 26% were assessed to be of high quality according to the Jadad criteria. The types of strategies with possible protective efficacy were dopaminergic agents, vasodilators, anti-inflammatory agents, and pump/perfusion strategies. When analyzed separately, dopamine and N-acetylcysteine did not reduce the risk for AKI.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This summary of all the literature on prevention and treatment strategies for AKI in cardiac surgery highlights the need for better information. The results advocate large, good-quality, multicenter studies to determine whether promising interventions reliably reduce rates of acute renal replacement therapy and mortality in the cardiac surgery setting.</AbstractText><CopyrightInformation>2010 S. Karger AG, Basel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Meyeon</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Epidemiology Research Center, Veterans Affairs Medical Center, West Haven, Conn. 06516, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coca</LastName><ForeName>Steven G</ForeName><Initials>SG</Initials></Author><Author ValidYN="Y"><LastName>Nigwekar</LastName><ForeName>Sagar U</ForeName><Initials>SU</Initials></Author><Author ValidYN="Y"><LastName>Garg</LastName><ForeName>Amit X</ForeName><Initials>AX</Initials></Author><Author ValidYN="Y"><LastName>Garwood</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Parikh</LastName><ForeName>Chirag R</ForeName><Initials>CR</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL085757</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HL-085757</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>04</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Am J Nephrol</MedlineTA><NlmUniqueID>8109361</NlmUniqueID><ISSNLinking>0250-8095</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015259">Dopamine Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014665">Vasodilator Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015259" MajorTopicYN="N">Dopamine Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="N">Heart Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000293" MajorTopicYN="N">injuries</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="N">Renal Replacement Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013903" MajorTopicYN="Y">Thoracic Surgery</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014665" MajorTopicYN="N">Vasodilator Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2010</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>10</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2011</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20375494</ArticleId><ArticleId IdType="pmc">PMC2883845</ArticleId><ArticleId IdType="doi">10.1159/000296277</ArticleId><ArticleId IdType="pii">000296277</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998;104:343&#x2013;348.</Citation><ArticleIdList><ArticleId IdType="pubmed">9576407</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasta JF, Kane-Gill SL, Durtschi AJ, Pathak DS, Kellum JA. Costs and outcomes of acute kidney injury (AKI) following cardiac surgery. Nephrol Dial Transplant. 2008;23:1970&#x2013;1974.</Citation><ArticleIdList><ArticleId IdType="pubmed">18178605</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow GM, Christiansen CL, Cleary PD, Munro C, Lazarus JM. Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Arch Intern Med. 1995;155:1505&#x2013;1511.</Citation><ArticleIdList><ArticleId IdType="pubmed">7605152</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanardo G, Michielon P, Paccagnella A, et al. Acute renal failure in the patient undergoing cardiac operation. Prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg. 1994;107:1489&#x2013;1495.</Citation><ArticleIdList><ArticleId IdType="pubmed">8196394</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassnigg A, Schmidlin D, Mouhieddine M, et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004;15:1597&#x2013;1605.</Citation><ArticleIdList><ArticleId IdType="pubmed">15153571</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalysnyk L, Fahrbach K, Reynolds MW, Zhao SZ, Ross S. Adverse events in coronary artery bypass graft (CABG) trials: a systematic review and analysis. Heart. 2003;89:767&#x2013;772.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1767742</ArticleId><ArticleId IdType="pubmed">12807853</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Omar Y, Ratnatunga C. Cardiopulmonary bypass and renal injury. Perfusion. 2006;21:209&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">16939114</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeysundera DN, Beattie WS, Djaiani G, et al. Off-pump coronary artery surgery for reducing mortality and morbidity: meta-analysis of randomized and observational studies. J Am Coll Cardiol. 2005;46:872&#x2013;882.</Citation><ArticleIdList><ArticleId IdType="pubmed">16139139</ArticleId></ArticleIdList></Reference><Reference><Citation>Landoni G, Biondi-Zoccai GG, Marino G, et al. Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis. J Cardiothorac Vasc Anesth. 2008;22:27&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">18249327</ArticleId></ArticleIdList></Reference><Reference><Citation>Zacharias M, Conlon NP, Herbison GP, Sivalingam P, Walker RJ, Hovhannisyan K: Interventions for protecting renal function in the perioperative period. [update of Cochrane Database Syst Rev 2005;3:CD003590.]</Citation><ArticleIdList><ArticleId IdType="pubmed">18843647</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999;354:1896&#x2013;1900.</Citation><ArticleIdList><ArticleId IdType="pubmed">10584742</ArticleId></ArticleIdList></Reference><Reference><Citation>Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">8721797</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Terrin N, Schmid CH, Lau J, Olkin I. Adjusting for publication bias in the presence of heterogeneity. Stat Med. 2003;22:2113&#x2013;2126.</Citation><ArticleIdList><ArticleId IdType="pubmed">12820277</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau J, Ioannidis JP, Terrin N, Schmid CH, Olkin I. The case of the misleading funnel plot. BMJ. 2006;333:597&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1570006</ArticleId><ArticleId IdType="pubmed">16974018</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe K, Fujino Y, Sakakibara T. The effect of prostaglandin E1 during cardiopulmonary bypass on renal function after cardiac surgery. Eur J Clin Pharmacol. 1993;45:217&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">8276044</ArticleId></ArticleIdList></Reference><Reference><Citation>Adabag AS, Ishani A, Koneswaran S, et al. Utility of N-acetylcysteine to prevent acute kidney injury after cardiac surgery: a randomized controlled trial. Am Heart J. 2008;155:1143&#x2013;1149.</Citation><ArticleIdList><ArticleId IdType="pubmed">18513531</ArticleId></ArticleIdList></Reference><Reference><Citation>Amano J, Suzuki A, Sunamori M. Salutary effect of reduced glutathione on renal function in coronary artery bypass operation. J Am Coll Surg. 1994;179:714&#x2013;720.</Citation><ArticleIdList><ArticleId IdType="pubmed">7952483</ArticleId></ArticleIdList></Reference><Reference><Citation>Amano J, Suzuki A, Sunamori M, Tofukuji M. Effect of calcium antagonist diltiazem on renal function in open heart surgery. Chest. 1995;107:1260&#x2013;1265.</Citation><ArticleIdList><ArticleId IdType="pubmed">7750316</ArticleId></ArticleIdList></Reference><Reference><Citation>Ascione R, Lloyd CT, Underwood MJ, Gomes WJ, Angelini GD. On-pump versus off-pump coronary revascularization: evaluation of renal function. Ann Thorac Surg. 1999;68:493&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pubmed">10475418</ArticleId></ArticleIdList></Reference><Reference><Citation>Barr LF, Kolodner K. N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery. Crit Care Med. 2008;36:1427&#x2013;1435.</Citation><ArticleIdList><ArticleId IdType="pubmed">18434903</ArticleId></ArticleIdList></Reference><Reference><Citation>Berendes E, Mollhoff T, Van Aken H, et al. Effects of dopexamine on creatinine clearance, systemic inflammation, and splanchnic oxygenation in patients undergoing coronary artery bypass grafting. Anesth Analg. 1997;84:950&#x2013;957.</Citation><ArticleIdList><ArticleId IdType="pubmed">9141914</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergman AS, Odar-Cederlof I, Westman L, Bjellerup P, Hoglund P, Ohqvist G. Diltiazem infusion for renal protection in cardiac surgical patients with preexisting renal dysfunction. J Cardiothorac Vasc Anesth. 2002;16:294&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">12073199</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolcal C, Akay HT, Bingol H, et al. Leukodepletion improves renal function in patients with renal dysfunction undergoing on-pump coronary bypass surgery: a prospective randomized study. Thorac Cardiovasc Surg. 2007;55:89&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">17377860</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldt J, Brosch C, Rohm K, Lehmann A, Mengistu A, Suttner S. Is albumin administration in hypoalbuminemic elderly cardiac surgery patients of benefit with regard to inflammation, endothelial activation, and long-term kidney function? Anesth Analg. 2008;107:1496&#x2013;1503.</Citation><ArticleIdList><ArticleId IdType="pubmed">18931204</ArticleId></ArticleIdList></Reference><Reference><Citation>Bove T, Landoni G, Calabro MG, et al. Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial. Circulation. 2005;111:3230&#x2013;3235.</Citation><ArticleIdList><ArticleId IdType="pubmed">15967861</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns KE, Chu MW, Novick RJ, et al. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing CABG surgery: a randomized controlled trial. JAMA. 2005;294:342&#x2013;350.</Citation><ArticleIdList><ArticleId IdType="pubmed">16030279</ArticleId></ArticleIdList></Reference><Reference><Citation>Caimmi PP, Pagani L, Micalizzi E, et al. Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2003;17:491&#x2013;494.</Citation><ArticleIdList><ArticleId IdType="pubmed">12968238</ArticleId></ArticleIdList></Reference><Reference><Citation>Carcoana OV, Mathew JP, Davis E, et al. Mannitol and dopamine in patients undergoing cardiopulmonary bypass: a randomized clinical trial. Anesth Analg. 2003;97:1222&#x2013;1229.</Citation><ArticleIdList><ArticleId IdType="pubmed">14570627</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrier M, Perrault LP, Jeanmart H, Martineau R, Cartier R, Page P. Randomized trial comparing off-pump to on-pump coronary artery bypass grafting in high-risk patients. Heart Surg Forum. 2003;6:E89&#x2013;E92.</Citation><ArticleIdList><ArticleId IdType="pubmed">14721990</ArticleId></ArticleIdList></Reference><Reference><Citation>Celik JB, Gormus N, Topal A, Okesli S, Solak H. Effect of off-pump and on-pump coronary artery bypass grafting on renal function. Ren Fail. 2005;27:183&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">15807183</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HH, Sundt TM, Cook DJ, Heublein DM, Burnett JC., Jr Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery: a double-blind placebo-controlled pilot study. Circulation. 2007;116:134&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">17846293</ArticleId></ArticleIdList></Reference><Reference><Citation>Cogliati AA, Vellutini R, Nardini A, et al. Fenoldopam infusion for renal protection in high-risk cardiac surgery patients: a randomized clinical study. J Cardiothorac Vasc Anesth. 2007;21:847&#x2013;850.</Citation><ArticleIdList><ArticleId IdType="pubmed">18068064</ArticleId></ArticleIdList></Reference><Reference><Citation>Colson P, Ribstein J, Mimran A, Grolleau D, Chaptal PA, Roquefeuil B. Effect of angiotensin converting enzyme inhibition on blood pressure and renal function during open heart surgery. Anesthesiology. 1990;72:23&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">2404429</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa P, Ottino GM, Matani A, et al. Low-dose dopamine during cardiopulmonary bypass in patients with renal dysfunction. J Cardiothorac Anesth. 1990;4:469&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="pubmed">2132343</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehne MG, Klein TF, Muhling J, Sablotzki A, Osmer C, Hempelmann G. Impairment of renal function after cardiopulmonary bypass is not influenced by dopexamine. Ren Fail. 2001;23:217&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pubmed">11417953</ArticleId></ArticleIdList></Reference><Reference><Citation>Demirkilic U, Kuralay E, Yenicesu M, et al. Timing of replacement therapy for acute renal failure after cardiac surgery. J Card Surg. 2004;19:17&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">15108784</ArticleId></ArticleIdList></Reference><Reference><Citation>Dural O, Ozkara A, Celebioglu b, Kanbak M, Ciliv G, Aypar U. Comparative study of dopamine and mannitol effects on renal function during cardiopulmonary bypass by using N-acetyl-beta-D-glucosaminidase assay. Turk J Med Sci. 2000;30:453&#x2013;457.</Citation></Reference><Reference><Citation>Durmaz I, Yagdi T, Calkavur T, et al. Prophylactic dialysis in patients with renal dysfunction undergoing on-pump coronary artery bypass surgery. Ann Thorac Surg. 2003;75:859&#x2013;864.</Citation><ArticleIdList><ArticleId IdType="pubmed">12645707</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer UM, Weissenberger WK, Warters RD, Geissler HJ, Allen SJ, Mehlhorn U. Impact of cardiopulmonary bypass management on postcardiac surgery renal function. Perfusion. 2002;17:401&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pubmed">12470028</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi GY, Nuttall GA, Abel MD, et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med. 2007;146:233&#x2013;243.</Citation><ArticleIdList><ArticleId IdType="pubmed">17310047</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatot I, Abramov D, Tsodikov V, et al. Should we give prophylactic renal-dose dopamine after coronary artery bypass surgery? J Card Surg. 2004;19:128&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">15016048</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerrah R, Ehrlich S, Tshori S, Sahar G. Beneficial effect of aspirin on renal function in patients with renal insufficiency postcardiac surgery. J Cardiovasc Surg. 2004;45:545&#x2013;550.</Citation><ArticleIdList><ArticleId IdType="pubmed">15746633</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase M, Haase-Fielitz A, Bagshaw SM, et al. Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients. Crit Care Med. 2007;35:1324&#x2013;1331.</Citation><ArticleIdList><ArticleId IdType="pubmed">17414730</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpenny M, Lakshmi S, O'Donnell A, O'Callaghan-Enright S, Shorten GD. Fenoldopam: renal and splanchnic effects in patients undergoing coronary artery bypass grafting. Anaesthesia. 2001;56:953&#x2013;960.</Citation><ArticleIdList><ArticleId IdType="pubmed">11576097</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashida N, Chihara S, Kashikie H, et al. Effects of intraoperative administration of atrial natriuretic peptide. Ann Thorac Surg. 2000;70:1319&#x2013;1326.</Citation><ArticleIdList><ArticleId IdType="pubmed">11081892</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaya K, Oguz M, Akar AR, et al. The effect of sodium nitroprusside infusion on renal function during reperfusion period in patients undergoing coronary artery bypass grafting: a prospective randomized clinical trial. Eur J Cardiothorac Surg. 2007;31:290&#x2013;297.</Citation><ArticleIdList><ArticleId IdType="pubmed">17174559</ArticleId></ArticleIdList></Reference><Reference><Citation>Kocakulak M, Askin G, Kucukaksu S, Tarcan O, Piskin E. Pulsatile flow improves renal function in high-risk cardiac operations. Blood Purif. 2005;23:263&#x2013;267.</Citation><ArticleIdList><ArticleId IdType="pubmed">15838160</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer BK, Preuner J, Ebenburger A, et al. Lack of renoprotective effect of theophylline during aortocoronary bypass surgery. Nephrol Dial Transplant. 2002;17:910&#x2013;915.</Citation><ArticleIdList><ArticleId IdType="pubmed">11981083</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulka PJ, Tryba M, Zenz M. Preoperative alpha2-adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery: results of a randomized, controlled trial. Crit Care Med. 1996;24:947&#x2013;952.</Citation><ArticleIdList><ArticleId IdType="pubmed">8681596</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol. 2000;11:97&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">10616845</ArticleId></ArticleIdList></Reference><Reference><Citation>Lema G, Urzua J, Jalil R, et al. Renal protection in patients undergoing cardiopulmonary bypass with preoperative abnormal renal function. Anesth Analg. 1998;86:3&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">9428842</ArticleId></ArticleIdList></Reference><Reference><Citation>Loef BG, Henning RH, Epema AH, et al. Effect of dexamethasone on perioperative renal function impairment during cardiac surgery with cardiopulmonary bypass. Br J Anaesth. 2004;93:793&#x2013;798.</Citation><ArticleIdList><ArticleId IdType="pubmed">15377582</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahesh B, Yim B, Robson D, Pillai R, Ratnatunga C, Pigott D. Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial. Eur J Cardiothorac Surg. 2008;33:370&#x2013;376.</Citation><ArticleIdList><ArticleId IdType="pubmed">18243724</ArticleId></ArticleIdList></Reference><Reference><Citation>Marathias KP, Vassili M, Robola A, et al. Preoperative intravenous hydration confers renoprotection in patients with chronic kidney disease undergoing cardiac surgery. Artif Organs. 2006;30:615&#x2013;621.</Citation><ArticleIdList><ArticleId IdType="pubmed">16911315</ArticleId></ArticleIdList></Reference><Reference><Citation>Masoumi M, Saidi MR, Rostami F, Sepahi H, Roushani D. Off-pump coronary artery bypass grafting in left ventricular dysfunction. Asian Cardiovasc Thorac Ann. 2008;16:16&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">18245699</ArticleId></ArticleIdList></Reference><Reference><Citation>McBride WT, Allen S, Gormley SM, et al. Methylprednisolone favourably alters plasma and urinary cytokine homeostasis and subclinical renal injury at cardiac surgery. Cytokine. 2004;27:81&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">15242697</ArticleId></ArticleIdList></Reference><Reference><Citation>Mentzer RM, Jr, Oz MC, Sladen RN, et al. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery: the NAPA Trial. J Am Coll Cardiol. 2007;49:716&#x2013;726.</Citation><ArticleIdList><ArticleId IdType="pubmed">17291938</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer M, Wiebe K, Wahlers T, et al. Urodilatin (INN:ularitide) as a new drug for the therapy of acute renal failure following cardiac surgery. Clin Exp Pharmacol Physiol. 1997;24:374&#x2013;376.</Citation><ArticleIdList><ArticleId IdType="pubmed">9143791</ArticleId></ArticleIdList></Reference><Reference><Citation>Monaco M, Di Tommaso L, Mottola M, Stassano P, Iannelli G. Clinical outcome for on-pump myocardial revascularization in patients with mild renal dysfunction. Thorac Cardiovasc Surg. 2005;53:46&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">15692919</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgera S, Woydt R, Kern H, et al. Low-dose prostacyclin preserves renal function in high-risk patients after coronary bypass surgery. Crit Care Med. 2002;30:107&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">11902251</ArticleId></ArticleIdList></Reference><Reference><Citation>Myles PS, Buckland MR, Schenk NJ, et al. Effect of &#x2018;renal-dose&#x2019; dopamine on renal function following cardiac surgery. Anaesth Intensive Care. 1993;21:56&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">8447608</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuutinen L, Hollmen A. The effect of prophylactic use of furosemide on renal function during open heart surgery. Ann Chir Gynaecol. 1976;65:258&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pubmed">970902</ArticleId></ArticleIdList></Reference><Reference><Citation>Onorati F, Presta P, Fuiano G, et al. A randomized trial of pulsatile perfusion using an intra-aortic balloon pump versus nonpulsatile perfusion on short-term changes in kidney function during cardiopulmonary bypass during myocardial reperfusion. Am J Kidney Dis. 2007;50:229&#x2013;238.</Citation><ArticleIdList><ArticleId IdType="pubmed">17660024</ArticleId></ArticleIdList></Reference><Reference><Citation>Piper SN, Kumle B, Maleck WH, et al. Diltiazem may preserve renal tubular integrity after cardiac surgery. Can J Anaesth. 2003;50:285&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pubmed">12620953</ArticleId></ArticleIdList></Reference><Reference><Citation>Ristikankare A, Kuitunen T, Kuitunen A, et al. Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery. Br J Anaesth. 2006;97:611&#x2013;616.</Citation><ArticleIdList><ArticleId IdType="pubmed">16914459</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryckwaert F, Colson P, Ribstein J, Boccara G, Guillon G. Haemodynamic and renal effects of intravenous enalaprilat during coronary artery bypass graft surgery in patients with ischaemic heart dysfunction. Br J Anaesth. 2001;86:169&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pubmed">11573655</ArticleId></ArticleIdList></Reference><Reference><Citation>Sajja LR, Mannam G, Chakravarthi RM, et al. Coronary artery bypass grafting with or without cardiopulmonary bypass in patients with preoperative non-dialysis dependent renal insufficiency: a randomized study. J Thorac Cardiovasc Surg. 2007;133:378&#x2013;388.</Citation><ArticleIdList><ArticleId IdType="pubmed">17258568</ArticleId></ArticleIdList></Reference><Reference><Citation>Sezai A, Shiono M, Orime Y, et al. Low-dose continuous infusion of human atrial natriuretic peptide during and after cardiac surgery. Ann Thorac Surg. 2000;69:732&#x2013;738.</Citation><ArticleIdList><ArticleId IdType="pubmed">10750752</ArticleId></ArticleIdList></Reference><Reference><Citation>Sezai A, Hata M, Wakui S, et al. Efficacy of continuous low-dose hANP administration in patients undergoing emergent coronary artery bypass grafting for acute coronary syndrome. Circ J. 2007;71:1401&#x2013;1407.</Citation><ArticleIdList><ArticleId IdType="pubmed">17721018</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirivella S, Gielchinsky I, Parsonnet V. Mannitol, furosemide, and dopamine infusion in postoperative renal failure complicating cardiac surgery. Ann Thorac Surg. 2000;69:501&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pubmed">10735688</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisillo E, Ceriani R, Bortone F, et al. N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial. Crit Care Med. 2008;36:81&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">18090169</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith MN, Best D, Sheppard SV, Smith DC. The effect of mannitol on renal function after cardiopulmonary bypass in patients with established renal dysfunction. Anaesthesia. 2008;63:701&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pubmed">18582254</ArticleId></ArticleIdList></Reference><Reference><Citation>Straka Z, Widimsky P, Jirasek K, et al. Off-pump versus on-pump coronary surgery: final results from a prospective randomized study PRAGUE-4. Ann Thorac Surg. 2004;77:789&#x2013;793.</Citation><ArticleIdList><ArticleId IdType="pubmed">14992872</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumeray M, Robertson C, Lapsley M, Bomanji J, Norman AG, Woolfson RG. Low dose dopamine infusion reduces renal tubular injury following cardiopulmonary bypass surgery. J Nephrol. 2001;14:397&#x2013;402.</Citation><ArticleIdList><ArticleId IdType="pubmed">11730274</ArticleId></ArticleIdList></Reference><Reference><Citation>Sward K, Valsson F, Odencrants P, Samuelsson O, Ricksten SE. Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial. Crit Care Med. 2004;32:1310&#x2013;1315.</Citation><ArticleIdList><ArticleId IdType="pubmed">15187512</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang AT, Alexiou C, Hsu J, Sheppard SV, Haw MP, Ohri SK. Leukodepletion reduces renal injury in coronary revascularization: a prospective randomized study. Ann Thorac Surg. 2002;74:372&#x2013;377.</Citation><ArticleIdList><ArticleId IdType="pubmed">12173815</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang AT, Knott J, Nanson J, Hsu J, Haw MP, Ohri SK. A prospective randomized study to evaluate the renoprotective action of beating heart coronary surgery in low risk patients. Eur J Cardiothorac Surg. 2002;22:118&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pubmed">12103384</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang AT, El-Gamel A, Keevil B, Yonan N, Deiraniya AK. The effect of &#x2018;renal-dose&#x2019; dopamine on renal tubular function following cardiac surgery: assessed by measuring retinol binding protein (RBP) Eur J Cardiothorac Surg. 1999;15:717&#x2013;721.</Citation><ArticleIdList><ArticleId IdType="pubmed">10386423</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeysundera DN, Beattie WS, Rao V, Granton JT, Chan CT. N-acetylcysteine for preventing acute kidney injury in cardiac surgery patients with pre-existing moderate renal insufficiency. Can J Anaesth. 2007;54:872&#x2013;881.</Citation><ArticleIdList><ArticleId IdType="pubmed">17975231</ArticleId></ArticleIdList></Reference><Reference><Citation>Witczak BJ, Hartmann A, Geiran OR, Bugge JF. Renal function after cardiopulmonary bypass surgery in patients with impaired renal function. A randomized study of the effect of nifedipine. Eur J Anaesthesiol. 2008;25:319&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pubmed">18182121</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo EB, Tang AT, el-Gamel A, et al. Dopamine therapy for patients at risk of renal dysfunction following cardiac surgery: science or fiction? Eur J Cardiothorac Surg. 2002;22:106&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pubmed">12103382</ArticleId></ArticleIdList></Reference><Reference><Citation>Yallop KG, Sheppard SV, Smith DC. The effect of mannitol on renal function following cardio-pulmonary bypass in patients with normal pre-operative creatinine. Anaesthesia. 2008;63:576&#x2013;582.</Citation><ArticleIdList><ArticleId IdType="pubmed">18477268</ArticleId></ArticleIdList></Reference><Reference><Citation>Yavuz S, Ayabakan N, Dilek K, Ozdemir A. Renal dose dopamine in open heart surgery. Does it protect renal tubular function? J Cardiovasc Surg. 2002;43:25&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">11803323</ArticleId></ArticleIdList></Reference><Reference><Citation>Yavuz S, Ayabakan N, Goncu MT, Ozdemir IA. Effect of combined dopamine and diltiazem on renal function after cardiac surgery. Med Sci Monit. 2002;8:P45&#x2013;P50.</Citation><ArticleIdList><ArticleId IdType="pubmed">12011785</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh CR, Garg AX. Acute kidney injury: Better biomarkers and beyond. Kidney Int. 2008;73:801&#x2013;803.</Citation><ArticleIdList><ArticleId IdType="pubmed">18340352</ArticleId></ArticleIdList></Reference><Reference><Citation>Furnary AP, Wu Y, Hiratzka LF, Grunkemeier GL, Page US., 3rd Aprotinin does not increase the risk of renal failure in cardiac surgery patients. Circulation. 2007;116:127&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">17846292</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve acute kidney injury outcomes. Crit Care. 2007;11:R31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2206446</ArticleId><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31166234</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>07</Day></DateCompleted><DateRevised><Year>2020</Year><Month>05</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>130</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Association of Intraoperative Tidal Volumes and Acute Kidney Injury After Noncardiac Surgery.</ArticleTitle><Pagination><StartPage>925</StartPage><EndPage>932</EndPage><MedlinePgn>925-932</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000004254</ELocationID><Abstract><AbstractText Label="BACKGROUND">Patients with acute lung injury who received lower tidal volume (VT) ventilation had significantly fewer days with acute kidney injury (AKI) when compared to those receiving higher VTs. There is a paucity of studies on the relationship between intraoperative VTs and postoperative AKI in patients undergoing noncardiac surgery. We therefore sought to assess the association of mean delivered intraoperative VT per kilogram based on predicted body weight (PBW) and postoperative AKI.</AbstractText><AbstractText Label="METHODS">This retrospective cohort study was conducted in a large tertiary multispecialty academic medical center. Adult patients who underwent noncardiac surgery between January 2005 and July 2016 under general anesthesia with endotracheal intubation and mechanical ventilation were included. A total of 41,224 patients were included in the study.The relationship between mean intraoperative VT per PBW and AKI was assessed using logistic regression, adjusting for prespecified potential confounding variables. The secondary outcomes were postoperative major pulmonary complications, myocardial injury after noncardiac surgery (MINS), and in-hospital mortality.</AbstractText><AbstractText Label="RESULTS">The incidence of AKI was 10.9% in the study population. Postoperative renal replacement therapy was required in 0.1% of patients. Higher delivered mean intraoperative VT per PBW was significantly associated with increased odds of AKI. The estimated odds ratio for each 1 mL increase in VT per kilogram of PBW (1 unit) was 1.05 (95% confidence interval [CI], 1.02-1.08; P = .001), after adjusting for potential confounding variables. A higher delivered mean intraoperative VT per PBW was significantly associated with increased odds of postoperative myocardial injury and was not significantly associated with major postoperative pulmonary complications or in-hospital mortality after noncardiac surgery.</AbstractText><AbstractText Label="CONCLUSIONS">In adult patients undergoing noncardiac surgery, higher delivered mean intraoperative VTs per PBW are associated with an increased odds of developing AKI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Argalious</LastName><ForeName>Maged Y</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>From the Department of General Anesthesiology and the Center for Anesthesiology Education, Anesthesiology Institute, Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Guangmei</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Davison</LastName><ForeName>Rajeev Krishnaney</ForeName><Initials>RK</Initials></Author><Author ValidYN="Y"><LastName>Chow</LastName><ForeName>Courtney</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Bhavani</LastName><ForeName>Sekar</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006335" MajorTopicYN="N">Heart Injuries</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007432" MajorTopicYN="Y">Intraoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="N">Intubation, Intratracheal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="N">Renal Replacement Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="Y">Tidal Volume</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31166234</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000004254</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26386737</PMID><DateCompleted><Year>2016</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1523-6838</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><Issue>6</Issue><PubDate><Year>2015</Year><Month>Dec</Month></PubDate></JournalIssue><Title>American journal of kidney diseases : the official journal of the National Kidney Foundation</Title><ISOAbbreviation>Am J Kidney Dis</ISOAbbreviation></Journal><ArticleTitle>Urine Biomarkers and Perioperative Acute Kidney Injury: The&#xa0;Impact of Preoperative Estimated GFR.</ArticleTitle><Pagination><StartPage>1006</StartPage><EndPage>1014</EndPage><MedlinePgn>1006-14</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.ajkd.2015.07.027</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0272-6386(15)01063-X</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The interaction between baseline kidney function and the performance of biomarkers of acute kidney injury (AKI) on the development of AKI is unclear.</AbstractText><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Post hoc analysis of prospective cohort study.</AbstractText><AbstractText Label="SETTING &amp; PARTICIPANTS" NlmCategory="METHODS">The 1,219 TRIBE-AKI Consortium adult cardiac surgery cohort participants.</AbstractText><AbstractText Label="PREDICTOR" NlmCategory="METHODS">Unadjusted postoperative urinary biomarkers of AKI measured within 6 hours of surgery.</AbstractText><AbstractText Label="OUTCOME" NlmCategory="RESULTS">AKI was defined as AKI Network stage 1 (any AKI) or higher, as well as a doubling of serum creatinine level from the preoperative value or the need for post-operative dialysis (severe AKI).</AbstractText><AbstractText Label="MEASUREMENTS" NlmCategory="METHODS">Stratified analyses by preoperative estimated glomerular filtration rate (eGFR)&#xa0;&#x2264; 60 versus &gt; 60mL/min/1.73m(2).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">180 (42%) patients with preoperative eGFRs&#x2264;60mL/min/1.73m(2) developed clinical AKI compared with 246 (31%) of those with eGFRs&gt;60mL/min/1.73m(2) (P&lt;0.001). For log2-transformed biomarker concentrations, there was a significant interaction between any AKI and baseline eGFR for interleukin 18 (P=0.007) and borderline significance for liver-type fatty acid binding protein (P=0.06). For all biomarkers, the adjusted relative risk (RR) point estimates for the risk for any AKI were higher in those with elevated baseline eGFRs compared with those with eGFRs&#x2264;60mL/min/1.73m(2). However, the difference in magnitude of these risks was low (adjusted RRs were 1.04 [95% CI, 0.99-1.09] and 1.11 [95% CI, 1.07-1.15] for those with preoperative eGFRs&#x2264;60mL/min/1.73m(2) and those with higher eGFRs, respectively). Although no biomarker displayed an interaction for baseline eGFR and severe AKI, log2-transformed interleukin 18 and kidney injury molecule 1 had significant adjusted RRs for severe AKI in those with and without baseline eGFRs&#x2264;60mL/min/1.73m(2).</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">Limited numbers of patients with severe AKI and post-operative dialysis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The association between early postoperative AKI urinary biomarkers and AKI is modified by preoperative eGFR. The degree of this modification and its impact on the biomarker-AKI association is small across biomarkers. Our findings suggest that distinct biomarker cutoffs for those with and without a preoperative eGFR&#x2264;60mL/min/1.73m(2) is not necessary.</AbstractText><CopyrightInformation>Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Koyner</LastName><ForeName>Jay L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Section of Nephrology, Department of Medicine, University of Chicago, Pritzker School of Medicine, Chicago, IL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coca</LastName><ForeName>Steven G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Clinical Epidemiology Research Center, Yale University School of Medicine, New Haven, CT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thiessen-Philbrook</LastName><ForeName>Heather</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, University of Western Ontario, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Uptal D</ForeName><Initials>UD</Initials><AffiliationInfo><Affiliation>Duke University, School of Medicine, Durham, NC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shlipak</LastName><ForeName>Michael G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, San Francisco VA Medical Center, University of California, San Francisco, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garg</LastName><ForeName>Amit X</ForeName><Initials>AX</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, University of Western Ontario, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parikh</LastName><ForeName>Chirag R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Clinical Epidemiology Research Center, Yale University School of Medicine, New Haven, CT. Electronic address: chirag.parikh@yale.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Translational Research Investigating Biomarker Endpoints for Acute Kidney Injury (TRIBE-AKI) Consortium</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Translational Research Investigating Biomarker Endpoints for Acute Kidney Injury TRIBE-AKI Consortium</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL085757</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23DK081616</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K24DK090203</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 DK079310</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 DK080132</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01HL085757</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 DK081616</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23DK080132</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DK082185</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K24 DK090203</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000430</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01DK082185</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>09</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Kidney Dis</MedlineTA><NlmUniqueID>8110075</NlmUniqueID><ISSNLinking>0272-6386</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D055316">Cystatin C</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000652" MajorTopicYN="Y">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055316" MajorTopicYN="N">Cystatin C</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005919" MajorTopicYN="Y">Glomerular Filtration Rate</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000652" MajorTopicYN="Y">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Urine biomarkers</Keyword><Keyword MajorTopicYN="N">acute kidney injury (AKI)</Keyword><Keyword MajorTopicYN="N">acute renal failure (ARF)</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">effect modification</Keyword><Keyword MajorTopicYN="N">estimated glomerular filtration rate (eGFR)</Keyword><Keyword MajorTopicYN="N">interleukin 18 (IL-18)</Keyword><Keyword MajorTopicYN="N">liver-type fatty acid binding protein (L-FABP)</Keyword><Keyword MajorTopicYN="N">perioperative AKI</Keyword><Keyword MajorTopicYN="N">prognosis</Keyword><Keyword MajorTopicYN="N">surgical complication</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Raman</LastName><ForeName>Jai</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jeevanandam</LastName><ForeName>Valluvan</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Akhter</LastName><ForeName>Shahab</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Devarajan</LastName><ForeName>Prasad</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bennett</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ma</LastName><ForeName>Qing</ForeName><Initials>Q</Initials></Investigator><Investigator ValidYN="Y"><LastName>Griffiths</LastName><ForeName>Rachel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Edelstein</LastName><ForeName>Charles</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Passik</LastName><ForeName>Cary</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nagy</LastName><ForeName>Judy</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Swaminathan</LastName><ForeName>Madhav</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chu</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goldbach</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guo</LastName><ForeName>Lin Ruo</ForeName><Initials>LR</Initials></Investigator><Investigator ValidYN="Y"><LastName>McKenzie</LastName><ForeName>Neil</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Myers</LastName><ForeName>Mary Lee</ForeName><Initials>ML</Initials></Investigator><Investigator ValidYN="Y"><LastName>Novick</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Quantz</LastName><ForeName>Mac</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schumann</LastName><ForeName>Virginia</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Webster</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zappitelli</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Palijan</LastName><ForeName>Ana</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dewar</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Darr</LastName><ForeName>Umer</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hashim</LastName><ForeName>Sabet</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Elefteriades</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Geirsson</LastName><ForeName>Arnar</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garwood</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kemp</LastName><ForeName>Rowena</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Butrymowicz</LastName><ForeName>Isabel</ForeName><Initials>I</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26386737</ArticleId><ArticleId IdType="mid">NIHMS717511</ArticleId><ArticleId IdType="pmc">PMC4658239</ArticleId><ArticleId IdType="doi">10.1053/j.ajkd.2015.07.027</ArticleId><ArticleId IdType="pii">S0272-6386(15)01063-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Koyner JL, Cerda J, Goldstein SL, et al. The Daily Burden of Acute Kidney Injury: A World Kidney Day Survey of U.S. Nephrologists. Journal of the American Society of Nephrology. 2013;24:3A. Oral Abstract Presented at ASN Renal Week - Thursdayvember 7, 2013.</Citation><ArticleIdList><ArticleId IdType="pubmed">24815216</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyner JL, Parikh CR. Clinical Utility of Biomarkers of AKI in Cardiac Surgery and Critical Illness. Clin J Am Soc Nephrol. 2013;8(6):1034&#x2013;1042.</Citation><ArticleIdList><ArticleId IdType="pubmed">23471130</ArticleId></ArticleIdList></Reference><Reference><Citation>Bihorac A, Chawla LS, Shaw AD, et al. Validation of Cell-Cycle Arrest Biomarkers for Acute Kidney Injury Using Clinical Adjudication. Am J Respir Crit Care Med. 2014;189(8):932&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24559465</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashani K, Al-Khafaji A, Ardiles T, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013;17(1):R25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4057242</ArticleId><ArticleId IdType="pubmed">23388612</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyner JL, Garg AX, Coca SG, et al. Biomarkers Predict Progression of Acute Kidney Injury after Cardiac Surgery. J Am Soc Nephrol. 2012;23(5):905&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3338298</ArticleId><ArticleId IdType="pubmed">22383693</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh CR, Coca SG, Thiessen-Philbrook H, et al. Postoperative Biomarkers Predict Acute Kidney Injury and Poor Outcomes after Adult Cardiac Surgery. J Am Soc Nephrol. 2011;22(9):1748&#x2013;1757.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3171945</ArticleId><ArticleId IdType="pubmed">21836143</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. Jama. 2005;294(7):813&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pubmed">16106006</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakar CV, Christianson A, Freyberg R, Almenoff P, Render ML. Incidence and outcomes of acute kidney injury in intensive care units: a Veterans Administration study. Crit Care Med. 2009;37(9):2552&#x2013;2558.</Citation><ArticleIdList><ArticleId IdType="pubmed">19602973</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RH, Grab JD, O&#x2019;Brien SM, et al. Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. Circulation. 2006;114(21):2208&#x2013;2216. quiz 2208.</Citation><ArticleIdList><ArticleId IdType="pubmed">17088458</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakar C, Liangos O, Yared J-P, Nelson D, Hariachar S, Paganini E. Predicting acute renal failure after cardiac surgery: Validation and redefinition of a risk stratification alogorithm. Hemodial Int. 2003;7:143&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pubmed">19379354</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeysundera DN, Karkouti K, Dupuis JY, et al. Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. Jama. 2007;297(16):1801&#x2013;1809.</Citation><ArticleIdList><ArticleId IdType="pubmed">17456822</ArticleId></ArticleIdList></Reference><Reference><Citation>Malyszko J, Malyszko JS, Bachorzewska-Gajewska H, Poniatowski B, Dobrzycki S, Mysliwiec M. Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients. Transplant Proc. 2009;41(1):158&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pubmed">19249502</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolignano D, Lacquaniti A, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol. 2009;4(2):337&#x2013;344.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2637601</ArticleId><ArticleId IdType="pubmed">19176795</ArticleId></ArticleIdList></Reference><Reference><Citation>Dieplinger B, Mueller T, Kollerits B, et al. Pro-A-type natriuretic peptide and pro-adrenomedullin predict progression of chronic kidney disease: the MMKD Study. Kidney Int. 2009;75(4):408&#x2013;414.</Citation><ArticleIdList><ArticleId IdType="pubmed">19052536</ArticleId></ArticleIdList></Reference><Reference><Citation>Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 2002;62(1):237&#x2013;244.</Citation><ArticleIdList><ArticleId IdType="pubmed">12081583</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyner JL, Vaidya VS, Bennett MR, et al. Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol. 2010;5(12):2154&#x2013;2165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2994075</ArticleId><ArticleId IdType="pubmed">20798258</ArticleId></ArticleIdList></Reference><Reference><Citation>McIlroy DR, Wagener G, Lee HT. Neutrophil Gelatinase-Associated Lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance. Clin J Am Soc Nephrol. 2010;5(2):211&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2827603</ArticleId><ArticleId IdType="pubmed">20056755</ArticleId></ArticleIdList></Reference><Reference><Citation>Endre ZH, Pickering JW, Walker RJ, et al. Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int. 2011;79(10):1119&#x2013;1130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3884688</ArticleId><ArticleId IdType="pubmed">21307838</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh CR, Devarajan P, Zappitelli M, et al. Postoperative Biomarkers Predict Acute Kidney Injury and Poor Outcomes after Pediatric Cardiac Surgery. J Am Soc Nephrol. 2011;22(9):1737&#x2013;1747.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3171944</ArticleId><ArticleId IdType="pubmed">21836147</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC522841</ArticleId><ArticleId IdType="pubmed">15312219</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2206446</ArticleId><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2763564</ArticleId><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh CR, Thiessen-Philbrook H, Garg AX, et al. Performance of Kidney Injury Molecule-1 and Liver Fatty Acid-Binding Protein and Combined Biomarkers of AKI after Cardiac Surgery. Clin J Am Soc Nephrol. 2013;8(7):1079&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3700701</ArticleId><ArticleId IdType="pubmed">23599408</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyner JL, Garg AX, Shlipak MG, et al. Urinary cystatin C and acute kidney injury after cardiac surgery. Am J Kidney Dis. 2013;61(5):730&#x2013;738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3627833</ArticleId><ArticleId IdType="pubmed">23332602</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnar AO, Parikh CR, Sint K, et al. Association of postoperative proteinuria with AKI after cardiac surgery among patients at high risk. Clin J Am Soc Nephrol. 2012;7(11):1749&#x2013;1760.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3488955</ArticleId><ArticleId IdType="pubmed">22977220</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou G. A modified poisson regression approach to prospective studies with binary data. American journal of epidemiology. 2004;159(7):702&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pubmed">15033648</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosch JP, Saccaggi A, Lauer A, Ronco C, Belledonne M, Glabman S. Renal functional reserve in humans. Effect of protein intake on glomerular filtration rate. Am J Med. 1983;75(6):943&#x2013;950.</Citation><ArticleIdList><ArticleId IdType="pubmed">6650549</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco C, Rosner MH. Acute kidney injury and residual renal function. Crit Care. 2012;16(4):144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3580707</ArticleId><ArticleId IdType="pubmed">22866976</ArticleId></ArticleIdList></Reference><Reference><Citation>Waikar SS, Betensky RA, Emerson SC, Bonventre JV. Imperfect gold standards for kidney injury biomarker evaluation. J Am Soc Nephrol. 2012;23(1):13&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3695762</ArticleId><ArticleId IdType="pubmed">22021710</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29395421</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>16</Day></DateCompleted><DateRevised><Year>2018</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6809</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><Issue>6</Issue><PubDate><Year>2018</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of vascular surgery</Title><ISOAbbreviation>J Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>Preoperative antihypertensive medication intake and acute kidney injury after major vascular surgery.</ArticleTitle><Pagination><StartPage>1872</StartPage><EndPage>1880.e1</EndPage><MedlinePgn>1872-1880.e1</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvs.2017.10.065</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0741-5214(17)32646-0</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Postoperative acute kidney injury (AKI) is frequent after major vascular surgery and is associated with significant morbidity and mortality. It remains unclear whether the administration of combined oral antihypertensive medications on the day of surgery can increase the risk of postoperative AKI.</AbstractText><AbstractText Label="METHODS">We performed a retrospective cohort study of hypertensive patients undergoing elective major vascular surgery to determine the association between the number of antihypertensive medications continued on the morning of surgery and AKI at 48&#xa0;hours postoperatively.</AbstractText><AbstractText Label="RESULTS">A total of 406 patients who had undergone suprainguinal vascular surgery were included, and 10.3% suffered postoperative AKI. In multivariable analysis, the number of antihypertensive medications taken on the morning of surgery was independently associated with AKI (P&#xa0;= .026). Compared with patients who took no medication, taking one medication (adjusted odds ratio [aOR], 1.58; 95% confidence interval [CI], 0.68-3.75) and taking two or more medications (aOR, 2.70; 95% CI, 1.13-6.44) were associated with a 1.6-fold and 2.7-fold increased risk of postoperative AKI, respectively. Other predictors of AKI were suprarenal surgery (aOR, 3.37; 95% CI, 1.53-7.44), age (aOR, 2.29 per 10&#xa0;years; 95% CI, 1.40-3.74), length of surgery (aOR, 1.40 per 1&#xa0;hour; 95% CI, 1.10-1.76), hemoglobin drop (aOR, 1.37 per 10&#xa0;g/L; 95% CI, 1.10-1.74), and history of coronary artery disease (aOR, 2.33; 95% CI, 1.08-5.00).</AbstractText><AbstractText Label="CONCLUSIONS">In patients undergoing major vascular surgery who are treated with chronic antihypertensive therapy, the administration of antihypertensive drugs on the morning of surgery is independently associated with an increased risk of postoperative AKI. Further prospective studies are needed to confirm this finding.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duceppe</LastName><ForeName>Emmanuelle</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine, Universit&#xe9; de Montr&#xe9;al, Montreal, Quebec, Canada; Centre de Recherche du Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al, Montreal, Quebec, Canada; Department of Medicine and Anesthesia, McMaster University, Hamilton, Ontario, Canada. Electronic address: emmanuelleduceppe@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lussier</LastName><ForeName>Anne-Renee</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Medicine, Universit&#xe9; de Montr&#xe9;al, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beaulieu-Dore</LastName><ForeName>Roxane</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medicine, Universit&#xe9; de Montr&#xe9;al, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>LeManach</LastName><ForeName>Yannick</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Medicine and Anesthesia, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laskine</LastName><ForeName>Mikhael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Universit&#xe9; de Montr&#xe9;al, Montreal, Quebec, Canada; Centre de Recherche du Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fafard</LastName><ForeName>Josee</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine, Universit&#xe9; de Montr&#xe9;al, Montreal, Quebec, Canada; Division of General Internal Medicine, H&#xf4;pital Maisonneuve-Rosemont, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Durand</LastName><ForeName>Madeleine</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Universit&#xe9; de Montr&#xe9;al, Montreal, Quebec, Canada; Centre de Recherche du Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vasc Surg</MedlineTA><NlmUniqueID>8407742</NlmUniqueID><ISSNLinking>0741-5214</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000959">Antihypertensive Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Vasc Surg. 2018 Jun;67(6):1880. doi: 10.1016/j.jvs.2017.11.068.</RefSource><PMID Version="1">29801555</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Vasc Surg. 2019 Feb;69(2):627-628. doi: 10.1016/j.jvs.2018.09.055.</RefSource><PMID Version="1">30683209</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Vasc Surg. 2019 Feb;69(2):628-629. doi: 10.1016/j.jvs.2018.10.056.</RefSource><PMID Version="1">30683210</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Vasc Surg. 2019 Feb;69(2):629. doi: 10.1016/j.jvs.2018.07.070.</RefSource><PMID Version="1">30683211</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Vasc Surg. 2019 Feb;69(2):630. doi: 10.1016/j.jvs.2018.09.002.</RefSource><PMID Version="1">30683212</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000959" MajorTopicYN="N">Antihypertensive Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N">Canada</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009017" MajorTopicYN="N">Morbidity</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="Y">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014656" MajorTopicYN="N">Vascular Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29395421</ArticleId><ArticleId IdType="doi">10.1016/j.jvs.2017.10.065</ArticleId><ArticleId IdType="pii">S0741-5214(17)32646-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">29906382</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>12</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0125-2208</ISSN><JournalIssue CitedMedium="Print"><Volume>99 Suppl 6</Volume><PubDate><Year>2016</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of the Medical Association of Thailand = Chotmaihet thangphaet</Title><ISOAbbreviation>J Med Assoc Thai</ISOAbbreviation></Journal><ArticleTitle>Acute Kidney Injury in Elderly Patients in Thai-Surgical Intensive Care Units (THAI-SICU) Study.</ArticleTitle><Pagination><StartPage>S209</StartPage><EndPage>S218</EndPage><MedlinePgn>S209-S218</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE">To demonstrate prevalence, characteristics and outcomes of the elderly patients who were diagnosed with acute kidney injury (AKI) in surgical intensive care units (ICUs).</AbstractText><AbstractText Label="MATERIAL AND METHOD">AKI data were extracted from multicenter prospective cohort study conducted in 9 university-affiliated surgical ICUs in Thailand (THAI-SICU study) from April 2011 to January 2013. The elderly group was defined as those over 65 years old. Statistical analysis was done comparing baseline characteristics and outcomes between the elderly with AKI and those without.</AbstractText><AbstractText Label="RESULTS">A total of 2,310 elderly patients (49.7%) were identified in our surgical ICUs from a total 4,652 cases. Of this elderly group, AKI was diagnosed in 445 cases (19.3%). The differences in the baseline characteristics of the elderly with AKI group were: older, higher number of males, greater number of smokers, and greater disease severity evaluated with APACHE-II and SOFA score than the elderly without AKI. The ICU mortality and 28-day hospital mortality were higher in the elderly with AKI than those without (28.1% vs. 5.2%, p&lt;0.001 with RR = 5.401, 95% CI 4.231-6.895 and 35.7% vs. 9.4%, p&lt;0.001 with RR = 3.786, 95% CI 3.138-4.569, respectively). Using multivariable logistic regression analysis and after adjustment of covariates, independent potential risk factors of developing AKI in the SICU included: older age, higher APACHE-II and SOFA score, smoking history, emergency surgery, concurrent sepsis, cardiac complications, delirium, and requiring respiratory support during ICU stay.</AbstractText><AbstractText Label="CONCLUSION">Geriatric patients made up almost half of our surgical ICU population and nearly one-fifth of them suffered AKI. Once they had AKI, ICU mortality and 28-day hospital mortality were higher than those without AKI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Trongtrakul</LastName><ForeName>Konlawij</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Poopipatpab</LastName><ForeName>Sujaree</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Pisitsak</LastName><ForeName>Chawika</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Chittawatanarat</LastName><ForeName>Kaweesak</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Morakul</LastName><ForeName>Sunthiti</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><MedlineTA>J Med Assoc Thai</MedlineTA><NlmUniqueID>7507216</NlmUniqueID><ISSNLinking>0125-2208</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D018806" MajorTopicYN="N">APACHE</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003693" MajorTopicYN="N">Delirium</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004630" MajorTopicYN="N">Emergencies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006785" MajorTopicYN="N">Hospitals, University</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="Y">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063305" MajorTopicYN="N">Organ Dysfunction Scores</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011182" MajorTopicYN="N">Postoperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012907" MajorTopicYN="N">Smoking</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013785" MajorTopicYN="N">Thailand</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29906382</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36520229</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1438-8359</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of anesthesia</Title><ISOAbbreviation>J Anesth</ISOAbbreviation></Journal><ArticleTitle>Association between intraoperative oliguria and postoperative acute kidney injury in non-cardiac surgical patients: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>219</StartPage><EndPage>233</EndPage><MedlinePgn>219-233</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00540-022-03150-8</ELocationID><Abstract><AbstractText Label="PURPOSE">This systematic review and meta-analysis aimed to evaluate the association between intraoperative oliguria and the risk of postoperative acute kidney injury (AKI) in patients undergoing non-cardiac surgery.</AbstractText><AbstractText Label="METHODS">The MEDLINE and EMBASE databases were searched up to August 2022 for studies in adult patients undergoing non-cardiac surgery, where the association between intraoperative urine output and the risk of postoperative AKI was assessed. Both randomised and non-randomised studies were eligible for inclusion. Study selection and risk of bias assessment were independently performed by two investigators. The risk of bias was evaluated using the Newcastle-Ottawa scale. We performed meta-analysis of the reported multivariate adjusted odds ratios for the association between intraoperative oliguria (defined as urine output&#x2009;&lt;&#x2009;0.5&#xa0;mL/kg/hr) and the risk of postoperative AKI using the inverse-variance method with random effects models. We conducted sensitivity analyses using varying definitions of oliguria as well as by pooling unadjusted odds ratios to establish the robustness of the primary meta-analysis. We also conducted subgroup analyses according to surgery type and definition of AKI to explore potential sources of clinical or methodological heterogeneity.</AbstractText><AbstractText Label="RESULTS">Eleven studies (total 49,252 patients from 11 observational studies including a post hoc analysis of a randomised controlled trial) met the selection criteria. Seven of these studies contributed data from a total 17,148 patients to the primary meta-analysis. Intraoperative oliguria was associated with a significantly elevated risk of postoperative AKI (pooled adjusted odds ratio [OR] 1.74; 95% confidence interval [CI] 1.36-2.23, p&#x2009;&lt;&#x2009;0.0001, 8 studies). Sensitivity analyses supported the robustness of the primary meta-analysis. There was no evidence of any significant subgroup differences according to surgery type or definition of AKI.</AbstractText><AbstractText Label="CONCLUSIONS">This study demonstrated a significant association between intraoperative oliguria and the risk of postoperative AKI, regardless of the definitions of oliguria or AKI used. Further prospective and multi-centre studies using standardised definitions of intraoperative oliguria are required to define the thresholds of oliguria and establish strategies to minimise the risk of AKI.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s) under exclusive licence to Japanese Society of Anesthesiologists.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Milder</LastName><ForeName>David A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Westmead Hospital, Westmead, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Sophie S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Westmead Hospital, Westmead, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ong</LastName><ForeName>Sharon G K</ForeName><Initials>SGK</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Sengkang General Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgical Intensive Care, Singapore General Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kam</LastName><ForeName>Peter C A</ForeName><Initials>PCA</Initials><Identifier Source="ORCID">0000-0002-8771-5599</Identifier><AffiliationInfo><Affiliation>Discipline of Anaesthesia, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, 2006, Australia. peter.kam@sydney.edu.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>J Anesth</MedlineTA><NlmUniqueID>8905667</NlmUniqueID><ISSNLinking>0913-8668</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009846" MajorTopicYN="Y">Oliguria</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Intraoperative oliguria</Keyword><Keyword MajorTopicYN="N">Mechanisms</Keyword><Keyword MajorTopicYN="N">Thresholds</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>11</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36520229</ArticleId><ArticleId IdType="doi">10.1007/s00540-022-03150-8</ArticleId><ArticleId IdType="pii">10.1007/s00540-022-03150-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kellum JA, Sileanu FE, Murugan R, Lucko N, Shaw AD, Clermont G. Classifying AKI by urine output versus serum creatinine level. J Am Soc Nephrol. 2015;26:2231&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">25568178</ArticleId><ArticleId IdType="pmc">4552117</ArticleId><ArticleId IdType="doi">10.1681/ASN.2014070724</ArticleId></ArticleIdList></Reference><Reference><Citation>Eknoyan G. The origins of nephrology&#x2013;galen, the founding father of experimental renal physiology. Am J Nephrol. 1989;9:66&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">2655450</ArticleId><ArticleId IdType="doi">10.1159/000167939</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersch M, Schmidt C, Hoffmeier A, Van Aken H, Wempe C, Gerss J, Zarbock A. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med. 2017;43:1551&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">28110412</ArticleId><ArticleId IdType="pmc">5633630</ArticleId><ArticleId IdType="doi">10.1007/s00134-016-4670-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Roneo C, Kellum J, Mehta RL, Palevsky P. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute dialysis quality initiative (ADQI) group. Crit Care. 2004;8:R204&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">15312219</ArticleId><ArticleId IdType="pmc">522841</ArticleId><ArticleId IdType="doi">10.1186/cc2872</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL, Kellum JA, Shah SV, Molitoris BA, Warnock DG, Levin A. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.</Citation><ArticleIdList><ArticleId IdType="pubmed">17331245</ArticleId><ArticleId IdType="pmc">2206446</ArticleId><ArticleId IdType="doi">10.1186/cc5713</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Disease: Improving Global Outcomes (KIDGO). Acute Kidney Injury Work Group. KDIGO clinical practice guidelines for acute kidney injury. Kidney Int. 2012; Suppl 2;1&#x2013;138.</Citation></Reference><Reference><Citation>Macedo E, Malhotra R, Claure-Del Granado R, Fedullo P, Mehta RL. Defining urine output criterion for acute kidney injury in critically ill patients. Nephrol Dial Transplant. 2011;26:509&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">20562094</ArticleId><ArticleId IdType="doi">10.1093/ndt/gfq332</ArticleId></ArticleIdList></Reference><Reference><Citation>Gameiro J, Neves JB, Rodrigues N, Bekerman C, Melo MJ, Pereira M, Teixeira C, Mendes I, Jorge S, Rosa R, Lopes JA. Acute kidney injury, long-term renal function and mortality in patients undergoing major abdominal surgery: a cohort analysis. Clin Kidney J. 2016;9:192&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pubmed">26985368</ArticleId><ArticleId IdType="pmc">4792619</ArticleId><ArticleId IdType="doi">10.1093/ckj/sfv144</ArticleId></ArticleIdList></Reference><Reference><Citation>Kullmar M, Meersch M. intraoperative oliguria: physiological or beginning acute kidney injury? Anesth Analg. 2018;127:1109&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">30335658</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000003786</ArticleId></ArticleIdList></Reference><Reference><Citation>du Toit L, Biccard BM. The relationship between intraoperative oliguria and acute kidney injury. Br J Anaesth. 2019;122:707&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">30961912</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2019.03.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukazawa K, Lee HT. Volatile anesthetics and AKI: risks, mechanisms, and a potential therapeutic window. J Am Soc Nephrol. 2014;25:884&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">24511126</ArticleId><ArticleId IdType="pmc">4005317</ArticleId><ArticleId IdType="doi">10.1681/ASN.2013111215</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen NT, Perez RV, Fleming N, Rivers R, Wolfe BM. Effect of prolonged pneumoperitoneum on intraoperative urine output during laparoscopic gastric bypass. J Am Coll Surg. 2002;195:476&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">12375752</ArticleId><ArticleId IdType="doi">10.1016/S1072-7515(02)01321-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Kork F, Balzer F, Spies CD, Wernecke KD, Ginde AA, Janowski J, Eltzchig HK. Minor postoperative increases of creatinine are associated with higher mortality and longer hospital stay in surgical patients. Anesthesiology. 2015;123:1301&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">26492475</ArticleId><ArticleId IdType="doi">10.1097/ALN.0000000000000891</ArticleId></ArticleIdList></Reference><Reference><Citation>McIlroy DR, Belloma R, Billings FT, Karkouti K, Prowle JR, Shaw AD, Myles PS. Systematic review and consensus definitions for the standardised endpoints in perioperative medicine (StEP) initiative: renal endpoints. Br J Anaesth. 2018;121:1013&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">30336845</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2018.08.010</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Neal JB, Shaw AD, Billings FT. Acute kidney injury following cardiac surgery: current understanding and future directions. Crit Care. 2016;20:187.</Citation><ArticleIdList><ArticleId IdType="pubmed">27373799</ArticleId><ArticleId IdType="pmc">4931708</ArticleId><ArticleId IdType="doi">10.1186/s13054-016-1352-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Grams ME, Sang Y, Coresh J, Ballew S, Matsushita K, Molnar MZ, Szabo Z, Kalantar-Zadeh K, Kovesdy CP. Acute kidney injury after major surgery: a retrospective analysis of veterans health administration data. Am J Kidney Dis. 2016;67:872&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">26337133</ArticleId><ArticleId IdType="doi">10.1053/j.ajkd.2015.07.022</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakar CV, Kharat V, Blank S, Leonard AC. Acute kidney injury after gastric bypass surgery. Clin J Am Soc Nephrol. 2007;2:426&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">17699447</ArticleId><ArticleId IdType="doi">10.2215/CJN.03961106</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabezuelo JB, Ramirez P, Rios A, Acosta F, Torres D, Sansano T, Pons JA, Bru M, Montoya M, Bueno FS, Robles R. Risk factors of acute renal failure after liver transplantation. Kidney Int. 2006;69:1073&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">16528257</ArticleId><ArticleId IdType="doi">10.1038/sj.ki.5000216</ArticleId></ArticleIdList></Reference><Reference><Citation>Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 2012;81:442&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22113526</ArticleId><ArticleId IdType="doi">10.1038/ki.2011.379</ArticleId></ArticleIdList></Reference><Reference><Citation>Hultstrom M. Neurohormonal interactions on the renal oxygen delivery and consumption in haemorrhagic shock-induced acute kidney injury. Acta Physiol (Oxf). 2013;209:11&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">23837642</ArticleId><ArticleId IdType="doi">10.1111/apha.12147</ArticleId></ArticleIdList></Reference><Reference><Citation>Fani F, Regolisti G, Delsante M, Cantalappi V, Castellano G, Gesualdo L, Villa G, Fiaccadori E. Recent advances in the pathogenetic mechanisms of sepsis-associated acute kidney injury. J Nephrol. 2018;31:351&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29273917</ArticleId><ArticleId IdType="doi">10.1007/s40620-017-0452-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Prowle JR. Paradigms of acute kidney injury in the intensive care setting. Nat Rev Nephrol. 2018;14:217&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">29355173</ArticleId><ArticleId IdType="doi">10.1038/nrneph.2017.184</ArticleId></ArticleIdList></Reference><Reference><Citation>Goren O, Matot I. (2015) Perioperative acute kidney injury. Br J Anaesth. 115 Suppl 2: ii3&#x2013;14.</Citation></Reference><Reference><Citation>Burton D, Nicholson G, Hall G. Endocrine and metabolic response to surgery. Continuing Education Anaesthesia Critical Care Pain. 2004;4:169&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bjaceaccp/mkh040</ArticleId></ArticleIdList></Reference><Reference><Citation>Philbin DM, Coggins CH. Plasma antidiuretic hormone levels in cardiac surgical patients during morphine and halothane anesthesia. Anesthesiology. 1978;49:95&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">686433</ArticleId><ArticleId IdType="doi">10.1097/00000542-197808000-00007</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozkurt P, Kaya G, Yuksel Y, Fatius A, Bakan M, Hacibekiroglu M, Kavunoblu G. Effects of systemic and epidural morphine on antidiuretic hormone levels in children. Paediatr Anaesth. 2003;13:508&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">12846707</ArticleId><ArticleId IdType="doi">10.1046/j.1460-9592.2003.01096.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Abuelo JG. Normotensive ischemic acute renal failure. N Engl J Med. 2007;357:797&#x2013;805.</Citation><ArticleIdList><ArticleId IdType="pubmed">17715412</ArticleId><ArticleId IdType="doi">10.1056/NEJMra064398</ArticleId></ArticleIdList></Reference><Reference><Citation>Nash DM, Mustafa RA, McArthur E, Wijeysundera DN, Paterson JM, Sharan S, Vinden C, Wald R, Welk B, Sessler DI, Devereaux PJ. Combined general and neuraxial anesthesia versus general anesthesia: a population-based cohort study. Can J Anaesth. 2015;62:356&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">25622933</ArticleId><ArticleId IdType="doi">10.1007/s12630-015-0315-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SJ, Lehner GF, Forni LG, Joannidis M. Oliguria in critically ill patients: a narrative review. J Nephrol. 2018;31:855&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">30298272</ArticleId><ArticleId IdType="pmc">6244549</ArticleId><ArticleId IdType="doi">10.1007/s40620-018-0539-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu AW, Chang LS, Birkett DH, Babayan RK. Changes in urinary output and electrolytes during gaseous and gasless laparoscopy. Urol Res. 1996;24:361&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">9008330</ArticleId><ArticleId IdType="doi">10.1007/BF00389794</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas GNC, Leitao AC, Alencar RL, Xavier RM, Daher ED, Junior GB. Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs. J Bras Nefrol. 2019;41:124&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">30281062</ArticleId><ArticleId IdType="doi">10.1590/2175-8239-jbn-2018-0107</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Novoa JM, Quiros Y, Vicente L, Morales AI, Lopez-Hernandez FJ. New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view. Kidney Int. 2011;79:33&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">20861826</ArticleId><ArticleId IdType="doi">10.1038/ki.2010.337</ArticleId></ArticleIdList></Reference><Reference><Citation>Mingeot-Leclercq MP, Tulkens PM. Aminoglycosides: nephrotoxicity. Antimicrob Agents Chemother. 1999;43:1003&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">10223907</ArticleId><ArticleId IdType="pmc">89104</ArticleId><ArticleId IdType="doi">10.1128/AAC.43.5.1003</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff J, Mulrow C, Moher D. The PRISMA statement for reporting systematic reviews: development of the PRISMA 2020 statement. J Clin Epidemiol. 2021;134:103&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">33577987</ArticleId><ArticleId IdType="doi">10.1016/j.jclinepi.2021.02.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (eds). (2022) Cochrane Handbook for systematic reviews of interventions version 6.3 (updated February 2022). Cochrane</Citation></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">20652370</ArticleId><ArticleId IdType="doi">10.1007/s10654-010-9491-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Myles PS, McIIroy DR, Bellomo R, Wallace S. Importance of intraoperative oliguria during major abdominal surgery: findings of the restrictive versus liberal fluid therapy in major abdominal surgery trial. Br J Anaesth. 2019;122:726&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">30916001</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2019.01.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Tremper KK, Englesbe MJ, O&#x2019;Reilly M, Shanks AM, Fetterman DM, Rosenberg AL, Swartz RD. Predictors of postoperative acute renal failure after noncardiac surgery in patients with previously normal renal function. Anesthesiology. 2007;107:892&#x2013;902.</Citation><ArticleIdList><ArticleId IdType="pubmed">18043057</ArticleId><ArticleId IdType="doi">10.1097/01.anes.0000290588.29668.38</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizota T, Yamamoto Y, Hamada M, Matsukawa S, Shimizu S, Kai S. Intraoperative oliguria predicts acute kidney injury after major abdominal surgery. Br J Anaesth. 2017;119:1127&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">29136086</ArticleId><ArticleId IdType="doi">10.1093/bja/aex255</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao BC, Lei SH, Yang X, Zhang Y, Qiu SD, Liu WF, Li C, Liu KX. Assessment of prognostic value of intraoperative oliguria for postoperative acute kidney injury: a retrospective cohort study. Br J Anaesth. 2020;126:799&#x2013;807.</Citation><ArticleIdList><ArticleId IdType="pubmed">33342539</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2020.11.018</ArticleId></ArticleIdList></Reference><Reference><Citation>Inacio R, Gameiro J, Amaro S, Duarte M. Intraoperative oliguria does not predict postoperative acute kidney injury in major abdominal surgery: a cohort analysis. J Bras Nefrol. 2021;43:9&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">32779689</ArticleId><ArticleId IdType="doi">10.1590/2175-8239-jbn-2019-0244</ArticleId></ArticleIdList></Reference><Reference><Citation>Goren O, Levy A, Cattan A, Lahat G, Matot I. Acute kidney injury in pancreatic surgery; association with urine output and intraoperative fluid administration. Am J Surg. 2017;214:246&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">28223046</ArticleId><ArticleId IdType="doi">10.1016/j.amjsurg.2017.01.040</ArticleId></ArticleIdList></Reference><Reference><Citation>Valencia Morales DJ, Plack DL, Kendrick ML, Schroeder DR, Sprung, J, Weingarten TN. (2022) Urine output and acute kidney injury following laparoscopic pancreas operations. HPB, Article in press</Citation></Reference><Reference><Citation>Kim WH, Lee HC, Lim L, Ryu HG, Jung CW. Intraoperative oliguria with decreased SvO<sub>2</sub> predicts acute kidney injury after living donor liver transplantation. J Clin Med. 2018;8(29):1&#x2013;14.</Citation></Reference><Reference><Citation>Slankamenac K, Beck-Schimmer B, Breitenstein S, Puhan MA, Clavien PA. Novel prediction score including pre- and intraoperative parameters best predicts acute kidney injury after liver surgery. World J Surg. 2013;37(11):2618&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">23959337</ArticleId><ArticleId IdType="doi">10.1007/s00268-013-2159-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Hur M, Park SK, Yoo S, Choi SN, Jeong CW, Kim WH, Kim JT, Kwak C, Bahk JH. The association between intraoperative urine output and postoperative acute kidney injury differs between partial and radical nephrectomy. Sci Rep. 2019;9(760):1&#x2013;9.</Citation></Reference><Reference><Citation>Shiba A, Uchino S, FujiiT Takinami M, Uezono S. Association between intraoperative oliguria and acute kidney injury after major noncardiac surgery. Anesth Analg. 2018;127:1229&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">29933276</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000003576</ArticleId></ArticleIdList></Reference><Reference><Citation>Altman DG, Lausen B, Sauerbrei W, Schumacher M. Dangers of using &#x201c;optimal&#x201d; cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst. 1994;86:829&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">8182763</ArticleId><ArticleId IdType="doi">10.1093/jnci/86.11.829</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, Sutton AJ, Ioannidis JPA, Terrin N, Jones DR, Lau J. Carpenter j, Rucker G, Harbord RM, Schmid CH, Tetzlaff J, Deeks JJ, Peter J, Macaskill P, Schwarzer G, Duval s, Altman DG, Moher d, H'iggins JPT. (2011) Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ.;343 4002</Citation></Reference><Reference><Citation>Puckett JR, Pickering JW, Palmer SC, McCall JL, Kluger MT, De Zoysa J, Endre ZH, Soop M. Low versus standard urine output targets in patients undergoing major abdominal surgery: a randomized noninferiority trial. Ann Surg. 2017;265(5):874&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">27763895</ArticleId><ArticleId IdType="doi">10.1097/SLA.0000000000002044</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Liu YL, Licari E, Bagshaw SM,Egi M, Haase M, Haase-Fielitz A, Kellum JA, Cruz D, Ronco C, Tsutsui K, Oliguria as predictive biomarker of acute kidney injury in critically ill patients. Crit Care. 2011;15:R172. https://doi.org/10.1186/cc10318 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10318</ArticleId><ArticleId IdType="pubmed">21771324</ArticleId><ArticleId IdType="pmc">3387614</ArticleId></ArticleIdList></Reference><Reference><Citation>Md Ralib A, Pickering JW, Shaw GM, Endre ZH. The urine output definition of acute kidney injury is too liberal. Crit Care. 2013;17:R112.</Citation><ArticleIdList><ArticleId IdType="pubmed">23787055</ArticleId><ArticleId IdType="pmc">4056349</ArticleId><ArticleId IdType="doi">10.1186/cc12784</ArticleId></ArticleIdList></Reference><Reference><Citation>Fliser D, Laville M, Covic A, Fouque D, Vanholder R, Juillard L, Van Biesen W. A European Renal Best Practice (ERBP) position statement on Kidney Disease Improving Global Outcome (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast induced nephropathty. Nephrol Dial Transpl. 2012;27:4263&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfs375</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32865720</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1591-9528</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Clinical and experimental medicine</Title><ISOAbbreviation>Clin Exp Med</ISOAbbreviation></Journal><ArticleTitle>A prediction model of sepsis-associated acute kidney injury based on antithrombin III.</ArticleTitle><Pagination><StartPage>89</StartPage><EndPage>100</EndPage><MedlinePgn>89-100</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10238-020-00656-x</ELocationID><Abstract><AbstractText>The incidence of sepsis-associated acute kidney injury (AKI) is on the rise. Recent studies have found a correlation between antithrombin III and AKI. We established a predictive model for sepsis-associated AKI based on plasma ATIII levels. A prospective study (March 2018-January 2020) was conducted in sepsis patients admitted to the Critical Care Medicine Department at Shanghai General Hospital. ATIII levels were obtained within 48&#xa0;h after admission to the ICU and before the diagnosis of sepsis-associated AKI was recorded. Renal function was assessed by measuring serum creatinine levels and urine volume. Male sex, other cardiovascular disease, and low ATIII levels were identified as independent risk factors for AKI. Age, immune disease, and low ATIII levels were identified as independent risk factors for death. Plasma ATIII levels in the non-AKI group were higher than those in the AKI group, plasma ATIII levels were higher in the survival group than in the non-survival group, plasma ATIII levels in the non-CRRT group were higher than those in the CRRT group, and plasma ATIII levels in the non-CKD group were higher than those in the CKD group. ATIII was significantly higher in the group with pulmonary infection than in the group without pulmonary infection. ATIII was significantly lower in the celiac infection group than in the nonceliac infection group. There was no statistically significant difference between the ATIII in the gram-positive group and the gram-negative group. ATIII was significantly higher in medical patients than in surgical patients. The predictive model of sepsis-associated AKI established based on ATIII was ln[P/(1&#x2009;-&#x2009;p)]&#x2009;=&#x2009;-1.211&#x2009;&#xd7;&#x2009;sex&#x2009;-&#x2009;0.017&#x2009;&#xd7;&#x2009;ATIII&#x2009;+&#x2009;0.022&#x2009;&#xd7;&#x2009;Cr&#x2009;+&#x2009;0.004&#x2009;&#xd7;&#x2009;BUN&#x2009;-&#x2009;2.8192. The model goodness-of-fit test (p&#x2009;=&#x2009;0.000) and the area under the ROC curve of the model (0.9862) suggested that the model has a high degree of discrimination and calibration. ATIII reduction was closely related to the prognosis of patients with sepsis. ATIII reduction was an independent risk factor for sepsis-associated AKI and an independent risk factor for mortality in patients with sepsis. ATIII reduction could predict sepsis-associated AKI. Low ATIII predicted a poor prognosis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Xie</LastName><ForeName>Yun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 650 New Songjiang Road, Songjiang, 201600, Shanghai, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, The Second Affiliated Hospital of Soochow University, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Tian</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 650 New Songjiang Road, Songjiang, 201600, Shanghai, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 650 New Songjiang Road, Songjiang, 201600, Shanghai, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Jiang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 650 New Songjiang Road, Songjiang, 201600, Shanghai, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Zhigang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 650 New Songjiang Road, Songjiang, 201600, Shanghai, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ruilan</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-9129-8337</Identifier><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 650 New Songjiang Road, Songjiang, 201600, Shanghai, People's Republic of China. wangyusun@hotmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Clin Exp Med</MedlineTA><NlmUniqueID>100973405</NlmUniqueID><ISSNLinking>1591-8890</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>9000-94-6</RegistryNumber><NameOfSubstance UI="D000990">Antithrombin III</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000990" MajorTopicYN="N">Antithrombin III</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="Y">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Antithrombin III</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32865720</ArticleId><ArticleId IdType="doi">10.1007/s10238-020-00656-x</ArticleId><ArticleId IdType="pii">10.1007/s10238-020-00656-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Godin M, Murray P, Mehta RL. Clinical approach to the patient with AKI and sepsis. Semin Nephrol. 2015;35(1):12&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semnephrol.2015.01.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Liarte S, Chaves-Pozo E, Abell&#xe1;n E, Garc&#xed;a-Ayala A. 17&#x3b2;-Estradiol regulates gilthead seabream professional phagocyte responses through macrophage activation. Dev Comp Immunol. 2011;35(1):19&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dci.2010.07.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman F, Christian HC. Non-classical actions of testosterone: an update. Trends Endocrinol Metab (TEM). 2007;18(10):371&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2007.09.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss M. Epidemiology of sepsis: race, sex, and chronic alcohol abuse. Clin Infect Dis. 2005;41(Suppl 7):S490&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/432003</ArticleId></ArticleIdList></Reference><Reference><Citation>George RL, Mcgwin G, Windham ST, et al. Age-related gender differential in outcome after blunt or penetrating trauma. Shock. 2003;19(1):28&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00024382-200301000-00006</ArticleId></ArticleIdList></Reference><Reference><Citation>Angstwurm MW, Gaertner R, Schopohl J. Outcome in elderly patients with severe infection is influenced by sex hormones but not gender. Crit Care Med. 2005;33:2786&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000190242.24410.17</ArticleId></ArticleIdList></Reference><Reference><Citation>Fourrier F, Jallot A, Leclerc L, et al. Sex steroid hormones in circulatory shock, sepsis syndrome, and septic shock. Circ Shock. 1994;43:171&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">7895322</ArticleId></ArticleIdList></Reference><Reference><Citation>Christeff N, Carli A, Benassayag C, Bleichner G, Vaxelaire JF, Nunez EA. Relationship between changes in serum estrone levels and outcome in human males with septic shock. Circ Shock. 1992;36:249&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">1623570</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez H, Ince C, De Backer D, Payen D, Hotchkiss J, Kellum JA. A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock. 2014;41(1):3&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0000000000000052</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X, Peng Z, Kellum JA. Pathogenesis of acute kidney injury: effects of remote tissue damage on the kidney. Contrib Nephrol. 2011;174:129&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000329382</ArticleId></ArticleIdList></Reference><Reference><Citation>Post EH, Kellum JA, Bellomo R, Vincent JL. Renal perfusion in sepsis: from macro- to microcirculation. Kidney Int. 2016;91:45&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2016.07.032</ArticleId></ArticleIdList></Reference><Reference><Citation>Regueira T, Andresen M, Mercado M, Downey P. Physiopathology of acute renal failure during sepsis. Med Intensiva. 2011;35(7):424&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medin.2011.03.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaifei W, Sheling X, Kun X, Yan P, He W, Xie L. Biomarkers of sepsis-induced acute kidney injury. Biomed Res Int. 2018;2018:1&#x2013;7.</Citation></Reference><Reference><Citation>Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):762&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0288</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith LE, Smith DK, Blume JD, Siew ED, Billings FT. Latent variable modeling improves AKI risk factor identification and AKI prediction compared to traditional methods. BMC Nephrol. 2017;18(1):55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12882-017-0465-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyner JL, Adhikari R, Edelson DP, Churpek MM. Development of a multicenter ward-based AKI prediction model. Clin J Am Soc Nephrol. 2016;11:1935&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.00280116</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalisvaart M, Schlegel A, Umbro I, et al. The AKI-predict-score: a new prediction model for acute kidney injury after liver transplantation. Transplantation. 2018;102:S414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.tp.0000543190.95479.4f</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes Andrew, Evans Laura E, Levy MM, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock. Crit Care Med. 2017;45(3):1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000002255</ArticleId></ArticleIdList></Reference><Reference><Citation>Singbartl K, Kellum JA. AKI in the ICU: definition, epidemiology, risk stratification, and outcomes. Kidney Int. 2012;81(9):819&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2011.339</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafez T. Modification of diet in renal disease (MDRD) estimated glomerular filtration rate (eGFR) formula. Am J Cardiol. 2007;99(4):584&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2006.10.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Okusa MD, Davenport A. Reading between the (guide)lines&#x2014;the KDIGO practice guideline on acute kidney injury in the individual patient. Kidney Int. 2014;85(1):39&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2013.378</ArticleId></ArticleIdList></Reference><Reference><Citation>Louren&#xe7;o DM, Noguti MA, Juliano L. Antithrombin III dosage using the chromogenic substrate Tos-Gly-Pro-Arg-NAN, in several pathological situations. Rev Assoc Med Bras. 1992;41(6):373&#x2013;8.</Citation></Reference><Reference><Citation>Alharbi A, Thompson JP, Brindle NP, Stover CM. Ex vivo modelling of the formation of inflammatory platelet-leucocyte aggregates and their adhesion on endothelial cells, an early event in sepsis. Clin Exp Med. 2019;19(3):321&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-018-0526-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Vavrova L, Rychlikova J, Mrackova M, Novakova O, Zak A, Novak F. Increased inflammatory markers with altered antioxidant status persist after clinical recovery from severe sepsis: a correlation with low HDL cholesterol and albumin. Clin Exp Med. 2016;16(4):557&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-015-0390-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Allingstrup M, Wetterslev J, Ravn FB, et al. Antithrombin III for critically ill patients: a systematic review with meta-analysis and trial sequential analysis. Intensiv Care Med. 2016;42(4):505&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4225-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Katayama S, Nunomiya S, Koyama K, et al. Markers of acute kidney injury in patients with sepsis: the role of soluble thrombomodulin. Crit Care. 2017;21(1):229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-017-1815-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin J, Wang F, Kong Y, et al. Antithrombin III prevents progression of chronic kidney disease following experimental ischaemic-reperfusion injury. J Cell Mol Med. 2017;21(12):3506&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.13261</ArticleId></ArticleIdList></Reference><Reference><Citation>Samejima T, Yamashita T, Takeda Y, Adachi T. Low antithrombin levels accompanied by high urine protein/creatinine ratios are predictive of acute kidney injury among CS patients with preeclampsia. J Matern Fetal Neonatal Med. 2019;1:1&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14767058.2019.1639662</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong Y, Yin J, Cheng D, et al. Antithrombin III attenuates AKI following acute severe pancreatitis. Shock. 2017;49:1.</Citation></Reference><Reference><Citation>Poston JT, Koyner JL. Sepsis associated acute kidney injury. BMJ. 2019;364:k4891.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.k4891</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsushida K, Tanabe K, Masuda K, et al. Estrogen-related receptor &#x3b1; is essential for maintaining mitochondrial integrity in cisplatin-induced acute kidney injury. Biochem Biophys Res Commun. 2018;498:918&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2018.03.080</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang K, Lee J, Lee A, et al. Effect of gender differences on the regulation of renal ischemia-reperfusion-induced inflammation in mice. Mol Med Rep. 2014;9(6):2061&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2014.2089</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda M, Swide T, Vayl A, Lahm T, Anderson S, Hutchens MP. Estrogen administered after cardiac arrest and cardiopulmonary resuscitation ameliorates acute kidney injury in a sex- and age-specific manner. Crit Care. 2015;19:332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-1049-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Cela E, Gagnon S, Sweezey NB. Estrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice. Respir Res. 2010;11:166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1465-9921-11-166</ArticleId></ArticleIdList></Reference><Reference><Citation>Bengtsson AK, Ryan EJ, Giordano D, Magaletti DM, Clark EA. 17beta-estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cells. Blood. 2004;104(5):1404&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2003-10-3380</ArticleId></ArticleIdList></Reference><Reference><Citation>Asai K, Hiki N, Mimura Y, Ogawa T, Unou K, Kaminishi M. Gender differences in cytokine secretion by human peripheral blood mononuclear cells: role of estrogen in modulating LPS-induced cytokine secretion in an ex vivo septic model. Shock. 2001;16:340&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00024382-200116050-00003</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes GC. Progesterone and autoimmune disease. Autoimmun Rev. 2012;11:A502&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2011.12.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Benten WP, Wang L, et al. Modulation of Leishmania donovani infection and cell viability by testosterone in bone marrow-derived macrophages: signaling via surface binding sites. Steroids. 2005;70:604&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.steroids.2005.02.020</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27312130</PMID><DateCompleted><Year>2018</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1440-1797</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>9</Issue><PubDate><Year>2017</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Nephrology (Carlton, Vic.)</Title><ISOAbbreviation>Nephrology (Carlton)</ISOAbbreviation></Journal><ArticleTitle>Hyperchloremic acidosis is associated with acute kidney injury after abdominal surgery.</ArticleTitle><Pagination><StartPage>720</StartPage><EndPage>727</EndPage><MedlinePgn>720-727</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/nep.12840</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">Hyperchloremic acidosis may have an important role as a precursor of acute kidney injury (AKI) in the hyperchloremic environment induced by chloride-rich fluids, but this remains unclear. We tested the hypothesis that hyperchloremic acidosis assessed by the Stewart approach is associated with postoperative AKI.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A historical cohort study was conducted in adult patients who had normal renal function preoperatively and required admission to the intensive care unit after elective abdominal surgery. The Risk, Injury, Failure, Loss of kidney function, End stage kidney disease (RIFLE) classification was used for definition of AKI.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 206 patients (144 male, 69.9%) included in the study, 42 (20.4%) had postoperative AKI (AKI group) and 164 (79.6%) did not (non-AKI group). Base excess-chloride (BE-Cl) and strong ion difference (SID, approximated as Na-Cl) decreased, and the chloride level on postoperative day 1 increased compared with preoperative values in both groups (P &lt; 0.05). In the AKI group, BE-Cl and SID were lower, and chloride was higher than in the non-AKI group (P &lt; 0.05). The intraoperative load of chloride ions in fluids increased the risk of postoperative AKI (P &lt; 0.01). In multivariate logistic regression analysis, postoperative BE-Cl &lt; -7 mEq/L (i.e. SID &lt;31 mEq/L) was an independent risk factor for AKI (odds ratio; 2.8, 95% CI; 1.2-6.4, P = 0.01). In the AKI group, stays in the intensive care unit and in hospital were longer than those in the non-AKI group (P &lt; 0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Hyperchloremic acidosis is associated with postoperative AKI, and this may be attenuated by reducing the intraoperative chloride load.</AbstractText><CopyrightInformation>&#xa9; 2016 Asian Pacific Society of Nephrology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Toyonaga</LastName><ForeName>Yosuke</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, National Center for Global Health and Medicine, Toyama, Shinjuku, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kikura</LastName><ForeName>Mutsuhito</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hamamatsu Rosai Hospital, Japan Organizaition of Occupational Health and Safety, Higashi-ku, Hamamatsu, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Nephrology (Carlton)</MedlineTA><NlmUniqueID>9615568</NlmUniqueID><ISSNLinking>1320-5358</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002712">Chlorides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="N">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000136" MajorTopicYN="Y">Acid-Base Equilibrium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000138" MajorTopicYN="N">Acidosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002712" MajorTopicYN="N">Chlorides</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Stewart approach</Keyword><Keyword MajorTopicYN="N">abdominal surgery</Keyword><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">hyperchloremic acidosis</Keyword><Keyword MajorTopicYN="N">intraoperative chloride load</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27312130</ArticleId><ArticleId IdType="doi">10.1111/nep.12840</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34579622</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1525-6049</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Renal failure</Title><ISOAbbreviation>Ren Fail</ISOAbbreviation></Journal><ArticleTitle>The effects of acute kidney injury in a multicenter cohort of high-risk surgical patients.</ArticleTitle><Pagination><StartPage>1338</StartPage><EndPage>1348</EndPage><MedlinePgn>1338-1348</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/0886022X.2021.1977318</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES" NlmCategory="OBJECTIVE">Patients who develop post-operative acute kidney injury (AKI) have a poor prognosis, especially when undergoing high-risk surgery. Therefore, the objective of this study was to evaluate the outcome of patients with AKI acquired after non-cardiac surgery and the possible risk factors for this complication.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A multicenter, prospective cohort study with patients admitted to intensive care units (ICUs) after non-cardiac surgery was conducted to assess whether they developed AKI. The patients who developed AKI were then compared to non-AKI patients.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 29 ICUs participated, of which 904 high-risk surgical patients were involved in the study. The occurrence of AKI in the post-operative period was 15.8%, and the mortality rate of post-operative AKI patients at 28&#x2009;days was 27.6%. AKI was strongly associated with 28-day mortality (OR = 2.91; 95% CI 1.51-5.62; <i>p</i>&#x2009;=&#x2009;0.001), and a higher length of ICU and hospital stay (<i>p</i>&#x2009;&lt;&#x2009;0.001). Independent factors for the risk of developing AKI were pre-operative anemia (OR = 7.01; 95% CI 1.69-29.07), elective surgery (OR = 0.45; 95% CI 0.21-0.97), SAPS 3 (OR = 1.04; 95% CI 1.02-1.06), post-operative vasopressor use (OR = 2.47; 95% CI 1.34-4.55), post-operative infection (OR = 8.82; 95% CI 2.43-32.05) and the need for reoperation (OR= 7.15; 95% CI 2.58-19.79).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">AKI was associated with the risk of death in surgical patients and those with anemia before surgery, who had a higher SAPS 3, needed a post-operative vasopressor, or had a post-operative infection or needed reoperation were more likely to develop AKI post-operatively.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Katayama</LastName><ForeName>Henrique Tadashi</ForeName><Initials>HT</Initials><AffiliationInfo><Affiliation>Faculdade de Medicina, Hospital das Cl&#xed;nicas, Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomes</LastName><ForeName>Brenno Cardoso</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Universidade Federal do Paran&#xe1;, Curitiba, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lobo</LastName><ForeName>Suzana Margareth Ajeje</ForeName><Initials>SMA</Initials><AffiliationInfo><Affiliation>Faculdade de Medicina de S&#xe3;o Jos&#xe9; do Rio Preto, Hospital de Base, S&#xe3;o Jos&#xe9; do Rio Preto, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaves</LastName><ForeName>Renato Carneiro de Freitas</ForeName><Initials>RCF</Initials><AffiliationInfo><Affiliation>Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corr&#xea;a</LastName><ForeName>Thiago Domingos</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assun&#xe7;&#xe3;o</LastName><ForeName>Murillo Santucci Cesar</ForeName><Initials>MSC</Initials><AffiliationInfo><Affiliation>Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serpa Neto</LastName><ForeName>Ary</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malbouisson</LastName><ForeName>Luiz Marcelo S&#xe1;</ForeName><Initials>LMS</Initials><AffiliationInfo><Affiliation>Faculdade de Medicina, Hospital das Cl&#xed;nicas, Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva-Jr</LastName><ForeName>Jo&#xe3;o Manoel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Faculdade de Medicina, Hospital das Cl&#xed;nicas, Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>BraSIS study group Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ren Fail</MedlineTA><NlmUniqueID>8701128</NlmUniqueID><ISSNLinking>0886-022X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="Y">Elective Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012086" MajorTopicYN="N">Reoperation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">high risk</Keyword><Keyword MajorTopicYN="N">intensive care unit</Keyword><Keyword MajorTopicYN="N">perioperative</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword><Keyword MajorTopicYN="N">surgery</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>28</Day><Hour>5</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34579622</ArticleId><ArticleId IdType="pmc">PMC8477947</ArticleId><ArticleId IdType="doi">10.1080/0886022X.2021.1977318</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Acedillo RR, Wald R, McArthur E, et al. . Characteristics and outcomes of patients discharged home from an emergency department with AKI. Clin J Am Soc Nephrol. 2017;12(8):1215&#x2013;1225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5544515</ArticleId><ArticleId IdType="pubmed">28729384</ArticleId></ArticleIdList></Reference><Reference><Citation>Causey MW, Maykel JA, Hatch Q, et al. . Identifying risk factors for renal failure and myocardial infarction following colorectal surgery. J Surg Res. 2011;170(1):32&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">21601222</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho A, Lee JE, Kwon GY, et al. . Post-operative acute kidney injury in patients with renal cell carcinoma is a potent risk factor for new-onset chronic kidney disease after radical nephrectomy. Nephrol Dial Transplant. 2011;26(11):3496&#x2013;3501.</Citation><ArticleIdList><ArticleId IdType="pubmed">21406544</ArticleId></ArticleIdList></Reference><Reference><Citation>Amendola CP, SilvaJM, JrCarvalho T, et al. . Goal-directed therapy in patients with early acute kidney injury: a multicenter randomized controlled trial. Clinics. 2018;73:e327.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6201149</ArticleId><ArticleId IdType="pubmed">30379222</ArticleId></ArticleIdList></Reference><Reference><Citation>Golden D, Corbett J, Forni LG.. Peri-operative renal dysfunction: prevention and management. Anaesthesia. 2016;71 Suppl 1:51&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">26620147</ArticleId></ArticleIdList></Reference><Reference><Citation>Romagnoli S, Ricci Z.. Postoperative acute kidney injury. Minerva Anestesiol. 2015;81(6):684&#x2013;696.</Citation><ArticleIdList><ArticleId IdType="pubmed">25057935</ArticleId></ArticleIdList></Reference><Reference><Citation>Gameiro J, Fonseca JA, Neves M, et al. . Acute kidney injury in major abdominal surgery: incidence, risk factors, pathogenesis and outcomes. Ann Intensive Care. 2018;8(1):22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5807256</ArticleId><ArticleId IdType="pubmed">29427134</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva Junior JM, Chaves RCF, Correa TD, et al. . Epidemiology and outcome of high-surgical-risk patients admitted to an intensive care unit in Brazil. Rev Bras Ter Intensiva. 2020;32(1):17&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7206944</ArticleId><ArticleId IdType="pubmed">32401988</ArticleId></ArticleIdList></Reference><Reference><Citation>Lameire N, Vanmassenhove J, Lewington A.. Did KDIGO guidelines on acute kidney injury improve patient outcome? Intensive Care Med. 2017;43(6):921&#x2013;923.</Citation><ArticleIdList><ArticleId IdType="pubmed">28352976</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, John S, J&#xf6;rres A, et al. . [New KDIGO guidelines on acute kidney injury. Practical recommendations]. Anaesthesist. 2014;63(7):578&#x2013;588.</Citation><ArticleIdList><ArticleId IdType="pubmed">24981152</ArticleId></ArticleIdList></Reference><Reference><Citation>Chanques G, Ely EW, Garnier O.. The 2014 updated version of the confusion assessment method for the intensive care unit compared to the 5th version of the diagnostic and statistical manual of mental disorders and other current methods used by intensivists. Ann Intensive Care. 2018;8(1):33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5833335</ArticleId><ArticleId IdType="pubmed">29492696</ArticleId></ArticleIdList></Reference><Reference><Citation>Gumbert SD, Kork F, Jackson ML, et al. . Perioperative acute kidney injury. Anesthesiology. 2020;132(1):180&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10924686</ArticleId><ArticleId IdType="pubmed">31687986</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakar CV.Perioperative acute kidney injury. Adv Chronic Kidney Dis. 2013;20(1):67&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">23265598</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosner MH, Okusa MD.. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006;1(1):19&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">17699187</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M, Brady JE, Li G.. Variations in the risk of acute kidney injury across intraabdominal surgery procedures. Anesth Analg. 2014;119(5):1121&#x2013;1132.</Citation><ArticleIdList><ArticleId IdType="pubmed">25191972</ArticleId></ArticleIdList></Reference><Reference><Citation>Canet E, Bellomo R.. Perioperative renal protection. Curr Opin Crit Care. 2018;24(6):568&#x2013;574.</Citation><ArticleIdList><ArticleId IdType="pubmed">30308540</ArticleId></ArticleIdList></Reference><Reference><Citation>Payen D, de Pont AC, Sakr Y, et al. . A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care. 2008;12(3):R74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2481469</ArticleId><ArticleId IdType="pubmed">18533029</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudery H, MacDonald N, Ahmad T, et al. . Acute kidney injury and risk of death after elective surgery: prospective analysis of data from an international cohort study. Anesth Analg. 2019;128(5):1022&#x2013;1029.</Citation><ArticleIdList><ArticleId IdType="pubmed">30418232</ArticleId></ArticleIdList></Reference><Reference><Citation>Bihorac A, Hobson CE.. Acute kidney injury: precision perioperative care protects the kidneys. Nat Rev Nephrol. 2017;14(1):8&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6029882</ArticleId><ArticleId IdType="pubmed">29234162</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson C, Ruchi R, Bihorac A.. Perioperative acute kidney injury: risk factors and predictive strategies. Crit Care Clin. 2017;33(2):379&#x2013;396.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5617733</ArticleId><ArticleId IdType="pubmed">28284301</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Y, Yuan J, Chi R, et al. . The incidence, risk factors and outcomes of postoperative acute kidney injury in neurosurgical critically ill patients. Sci Rep. 2017;7(1):4245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5484679</ArticleId><ArticleId IdType="pubmed">28652590</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchino S, Kellum JA, Bellomo R, et al. . Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294(7):813&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pubmed">16106006</ArticleId></ArticleIdList></Reference><Reference><Citation>Giglio M, Dalfino L, Puntillo F, et al. . Hemodynamic goal-directed therapy and postoperative kidney injury: an updated meta-analysis with trial sequential analysis. Crit Care. 2019;23(1):232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6593609</ArticleId><ArticleId IdType="pubmed">31242941</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Lefrant JY, Guinot PG, et al. . Effect of individualized vs standard blood pressure management strategies on postoperative organ dysfunction among high-risk patients undergoing major surgery: a randomized clinical trial. JAMA. 2017;318(14):1346&#x2013;1357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5710560</ArticleId><ArticleId IdType="pubmed">28973220</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera-Anazco P, Taype-Rondan A, Pacheco-Mendoza J, et al. . Factors associated with mortality in a population with acute kidney injury undergoing hemodialysis in Peru. J Brasil Nefrol. 2017;39(2):119&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pubmed">29069239</ArticleId></ArticleIdList></Reference><Reference><Citation>Depret F, Boutin L, Jarkovsky J, et al. . Prediction of major adverse kidney events in critically ill burn patients. Burns. 2018;44(8):1887&#x2013;1894.</Citation><ArticleIdList><ArticleId IdType="pubmed">30322739</ArticleId></ArticleIdList></Reference><Reference><Citation>Palevsky PM.Dialysis modality and dosing strategy in acute renal failure. Semin Dial. 2006;19(2):165&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pubmed">16551296</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler AJ, Ahmad T, Phull MK, et al. . Meta-analysis of the association between preoperative anaemia and mortality after surgery. Br J Surg. 2015;102(11):1314&#x2013;1324.</Citation><ArticleIdList><ArticleId IdType="pubmed">26349842</ArticleId></ArticleIdList></Reference><Reference><Citation>Butcher BW, Liu KD.. Fluid overload in AKI: epiphenomenon or putative effect on mortality? Curr Opin Crit Care. 2012;18(6):593&#x2013;598.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3782260</ArticleId><ArticleId IdType="pubmed">23037878</ArticleId></ArticleIdList></Reference><Reference><Citation>Patil VP, Salunke BG.. Fluid overload and acute kidney Injury. Indian J Crit Care Med. 2020;24(Suppl 3):S94&#x2013;S97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7347067</ArticleId><ArticleId IdType="pubmed">32704211</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Echeverri JE, Ligabo EV, et al. . Fluid balance and acute kidney injury. Nat Rev Nephrol. 2010;6(2):107&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pubmed">20027192</ArticleId></ArticleIdList></Reference><Reference><Citation>SilvaJM, Jr., de Oliveira AM, Nogueira FA, et al. . The effect of excess fluid balance on the mortality rate of surgical patients: a multicenter prospective study. Crit Care. 2013;17(6):R288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4057181</ArticleId><ArticleId IdType="pubmed">24326085</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahan BC, Koulenti D, Arvaniti K, et al. . Critical care admission following elective surgery was not associated with survival benefit: prospective analysis of data from 27 countries. Intensive Care Med. 2017;43(7):971&#x2013;979.</Citation><ArticleIdList><ArticleId IdType="pubmed">28439646</ArticleId></ArticleIdList></Reference><Reference><Citation>Messina A, Robba C, Calabr&#xf2; L, et al. . Association between perioperative fluid administration and postoperative outcomes: a 20-year systematic review and a meta-analysis of randomized goal-directed trials in major visceral/noncardiac surgery. Crit Care. 2021;25(1):43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7849093</ArticleId><ArticleId IdType="pubmed">33522953</ArticleId></ArticleIdList></Reference><Reference><Citation>Myles PS, Andrews S, Nicholson J, et al. . Contemporary approaches to perioperative IV fluid therapy. World J Surg. 2017;41(10):2457&#x2013;2463.</Citation><ArticleIdList><ArticleId IdType="pubmed">28484814</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin BR, Liu KD, Teixeira JP.. Critical care nephrology: core curriculum 2020. Am J Kidney Dis. 2020;75(3):435&#x2013;452.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7333544</ArticleId><ArticleId IdType="pubmed">31982214</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitz JD, Shoham MH, Fang Y, et al. . Preoperative renal insufficiency: underreporting and association with readmission and major postoperative morbidity in an academic medical center. Anesth Anal. 2016;123(6):1500&#x2013;1515.</Citation><ArticleIdList><ArticleId IdType="pubmed">27861446</ArticleId></ArticleIdList></Reference><Reference><Citation>Kendale SM, Lapis PN, Melhem SM, et al. . The association between pre-operative variables, including blood pressure, and postoperative kidney function. Anaesthesia. 2016;71(12):1417&#x2013;1423.</Citation><ArticleIdList><ArticleId IdType="pubmed">27704535</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopitko C, Medve L, Gondos T.. The value of combined hemodynamic, respiratory and intra-abdominal pressure monitoring in predicting acute kidney injury after major intraabdominal surgeries. Ren Fail. 2019;41(1):150&#x2013;158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6442204</ArticleId><ArticleId IdType="pubmed">30909772</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34034633</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>30</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2165-5987</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Bioengineered</Title><ISOAbbreviation>Bioengineered</ISOAbbreviation></Journal><ArticleTitle>The prevalence and risk factors of acute kidney injury in patients undergoing hip fracture surgery: a meta-analysis.</ArticleTitle><Pagination><StartPage>1976</StartPage><EndPage>1985</EndPage><MedlinePgn>1976-1985</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21655979.2021.1926200</ELocationID><Abstract><AbstractText>Acute kidney injury (AKI) was a frequent complication following hip fracture surgery, but recent studies reported inconsistent findings. Our study was aimed at clarifying the prevalence and risk factors of AKI after hip fracture surgery. Pubmed, Embase, and Web of Science were systematically searched from the inception to March 2020 to identify observational studies investigating the prevalence and risk factors of AKI in patients undergoing hip fracture surgery. Pooled prevalence and odds ratios (ORs) with 95% confidence intervals (CIs) were estimated using a random-effects model. Publication bias was evaluated with a funnel plot and statistical test. All the statistical analyses were performed using Stata version 12.0. A total of 11 studies with 16,421 patients was included in the current meta-analysis. The pooled prevalence of AKI in patients undergoing hip fracture surgery was 17% (95%CI, 14%-21%) with substantial heterogeneity (I<sup>2</sup>&#xa0;=&#xa0;95%). Postoperative serum albumin (OR 1.80; 95%CI, 1.38-2.36) was a significant predictor for AKI. Age (OR 1.01; 95%CI, 0.95-1.07) and ACE inhibitors (OR 1.38; 95%CI, 0.92-2.07) were associated with increased the risk of AKI, but the results were not statistically significant. No significant publication bias was identified through statistical tests (Egger's test, <i>p</i> =&#xa0;0.258 and Begg's test, <i>p</i> =&#xa0;0.087). In conclusion, our findings indicated that <b>t</b>he pooled AKI following hip fracture surgery was approximately 17%. Postoperative serum albumin was a potential significant risk factor for AKI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zi-Cai</ForeName><Initials>ZC</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Wuwei People's Hospital, Wuwei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pu</LastName><ForeName>Yan-Chuan</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Wuwei People's Hospital, Wuwei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Wuwei People's Hospital, Wuwei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hu-Lin</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Wuwei People's Hospital, Wuwei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yan-Li</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Wuwei People's Hospital, Wuwei, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Bioengineered</MedlineTA><NlmUniqueID>101581063</NlmUniqueID><ISSNLinking>2165-5979</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="Y">Hip Fractures</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019637" MajorTopicYN="Y">Orthopedic Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">hip fracture</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">prevalence</Keyword><Keyword MajorTopicYN="N">risk factor</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>26</Day><Hour>5</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>5</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34034633</ArticleId><ArticleId IdType="pmc">PMC8806851</ArticleId><ArticleId IdType="doi">10.1080/21655979.2021.1926200</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Maxwell BG, Spitz W, Porter J.. Association of increasing use of spinal anesthesia in hip fracture repair with treating an aging patient population. JAMA Surg. 2019;155:167&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6902104</ArticleId><ArticleId IdType="pubmed">31746959</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuerburg C, F&#xf6;rch S, Gleich J, et al. Improved outcome in hip fracture patients in the aging population following co-managed care compared to conventional surgical treatment: a retrospective, dual-center cohort study. BMC Geriatr. 2019;19(1):330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6880371</ArticleId><ArticleId IdType="pubmed">31775659</ArticleId></ArticleIdList></Reference><Reference><Citation>Marty P, Ferre F, Labaste F, et al. The doppler renal resistive index for early detection of acute kidney injury after hip fracture. Anaesth Crit Care Pain Med. 2016;35(6):377&#x2013;382.</Citation><ArticleIdList><ArticleId IdType="pubmed">27133237</ArticleId></ArticleIdList></Reference><Reference><Citation>Lertjitbanjong P, Thongprayoon C, Cheungpasitporn W.. Acute kidney injury after lung transplantation: a systematic review and meta-analysis. J Clin Med. 2019;8(10):1713.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6833042</ArticleId><ArticleId IdType="pubmed">31627379</ArticleId></ArticleIdList></Reference><Reference><Citation>Thongprayoon C, Kaewput W, Thamcharoen N, et al. Acute kidney injury in patients undergoing total hip arthroplasty: a systematic review and meta-analysis. J Clin Med. 2019;8(1):66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6352044</ArticleId><ArticleId IdType="pubmed">30634487</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin KH, Han SB. Early postoperative hypoalbuminemia is a risk factor for postoperative acute kidney injury following hip fracture surgery. Injury. 2018;49(8):1572&#x2013;1576.</Citation><ArticleIdList><ArticleId IdType="pubmed">29908852</ArticleId></ArticleIdList></Reference><Reference><Citation>Partridge T, Jameson S, Baker P, et al. Ten-year trends in medical complications following 540,623 primary total hip replacements from a national database. J bone joint surg Am volume. 2018;100(5):360&#x2013;367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5882289</ArticleId><ArticleId IdType="pubmed">29509612</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang JS, Moon KH, Youn YH, et al. Factors associated with postoperative acute kidney injury after hip fractures in elderly patients. J Orthop Surg (Hong Kong). 2020;28:2309499019896237.</Citation><ArticleIdList><ArticleId IdType="pubmed">31903858</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the prisma statement. PLoS Med. 2009;6(7):e1000097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (moose) group. Jama. 2000;283:2008&#x2013;2012.</Citation><ArticleIdList><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ (Clinical research ed.). 2003;327(7414):557&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Huedo-Medina TB, S&#xe1;nchez-Meca J, Mar&#xed;n-Mart&#xed;nez F, et al. Assessing heterogeneity in meta-analysis: q statistic or I&#xb2; index? Psychol Methods. 2006;11(2):193&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pubmed">16784338</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical research ed.). 1997;315(7109):629&#x2013;634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088&#x2013;1101.</Citation><ArticleIdList><ArticleId IdType="pubmed">7786990</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig P, Starks I, Bancroft G, et al. Is prophylactic gentamicin associated with acute kidney injury in patients undergoing surgery for fractured neck of femur? Injury. 2012;43(12):2152&#x2013;2155.</Citation><ArticleIdList><ArticleId IdType="pubmed">22906918</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulucay C, Eren Z, Kaspar EC, et al. Risk factors for acute kidney injury after hip fracture surgery in the elderly individuals. Geriatr Orthop Surg Rehabil. 2012;3(4):150&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3598517</ArticleId><ArticleId IdType="pubmed">23569709</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong SE, Kim TY, Yoo JH, et al. Acute kidney injury can predict in-hospital and long-term mortality in elderly patients undergoing hip fracture surgery. PloS One. 2017;12(4):e0176259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5398695</ArticleId><ArticleId IdType="pubmed">28426743</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen AB, Gammelager H, Kahlert J, et al. Impact of body mass index on risk of acute kidney injury and mortality in elderly patients undergoing hip fracture surgery. Osteoporos Int. 2017;28(3):1087&#x2013;1097.</Citation><ArticleIdList><ArticleId IdType="pubmed">27866215</ArticleId></ArticleIdList></Reference><Reference><Citation>Frenkel Rutenberg T, Bdeir A, Rozen-Zvi B, et al. Rate and outcome of acute kidney injury following hip fracture surgery in diabetic older patients treated with renin-angiotensin-aldosterone antagonists. Drugs Aging. 2019;36(7):667&#x2013;674.</Citation><ArticleIdList><ArticleId IdType="pubmed">30949984</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang WY, Jung JK, Lee DK, et al. Intraoperative hypotension is a risk factor for postoperative acute kidney injury after femoral neck fracture surgery: a retrospective study. BMC Musculoskelet Disord. 2019;20(1):131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6438026</ArticleId><ArticleId IdType="pubmed">30917804</ArticleId></ArticleIdList></Reference><Reference><Citation>Rantalaiho I, Gunn J, Kukkonen J, et al. Acute kidney injury following hip fracture. Injury. 2019;50(12):2268&#x2013;2271.</Citation><ArticleIdList><ArticleId IdType="pubmed">31623901</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;peli &#x130;, &#xdc;nver S. The correlation between preoperative and postoperative hypoalbuminaemia and the development of acute kidney injury with respect to the kdigo criteria in the hip fracture surgery in elderly patients. Turk J Anaesthesiol Reanim. 2020;48(1):38&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7001803</ArticleId><ArticleId IdType="pubmed">32076678</ArticleId></ArticleIdList></Reference><Reference><Citation>Thongprayoon C, Cheungpasitporn W, Mao MA, et al. U-shape association of serum albumin level and acute kidney injury risk in hospitalized patients. PloS One. 2018;13(6):e0199153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6013099</ArticleId><ArticleId IdType="pubmed">29927987</ArticleId></ArticleIdList></Reference><Reference><Citation>Dos Santos RP, Carvalho A, Peres LAB. Incidence and risk factors of acute kidney injury in critically ill patients from a single centre in brazil: a retrospective cohort analysis. Sci Rep. 2019;9(1):18141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6889393</ArticleId><ArticleId IdType="pubmed">31792326</ArticleId></ArticleIdList></Reference><Reference><Citation>Landgraf SS, Silva LS, Peruchetti DB, et al. 5-lypoxygenase products are involved in renal tubulointerstitial injury induced by albumin overload in proximal tubules in mice. PloS One. 2014;9(10):e107549.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4193734</ArticleId><ArticleId IdType="pubmed">25302946</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain A, McDonald HI, Nitsch D, et al. Risk factors for developing acute kidney injury in older people with diabetes and community-acquired pneumonia: a population-based UK cohort study. BMC Nephrol. 2017;18(1):142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5412062</ArticleId><ArticleId IdType="pubmed">28460637</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Pei YY, Ma YH, et al. Risk factors for acute kidney injury in patients with acute myocardial infarction. Chin Med J (Engl). 2019;132(14):1660&#x2013;1665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6759102</ArticleId><ArticleId IdType="pubmed">31261199</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinson JS, Ehmann MR, Al Jalbout N, et al. Risk of acute kidney injury associated with medication administration in the emergency department. J Emerg Med. 2020;58(3):487&#x2013;496.</Citation><ArticleIdList><ArticleId IdType="pubmed">31952871</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35304919</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1399-0012</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Clinical transplantation</Title><ISOAbbreviation>Clin Transplant</ISOAbbreviation></Journal><ArticleTitle>Perioperative fluid management and outcomes in adult deceased donor liver transplantation - A systematic review of the literature and expert panel recommendations.</ArticleTitle><Pagination><StartPage>e14651</StartPage><MedlinePgn>e14651</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ctr.14651</ELocationID><Abstract><AbstractText Label="BACKGROUND">Fluid management practices during and after liver transplantation vary widely among centers despite better understanding of the pathophysiology of end-stage liver disease and of the effects of commonly used fluids. This reflects a lack of high quality trials in this setting, but also provides a rationale for both systematic review of all relevant studies in liver recipients and evaluation of new evidence from closely related domains, including hepatology, non-transplant abdominal surgery, and critical care.</AbstractText><AbstractText Label="OBJECTIVES">To develop evidence-based recommendations for perioperative fluid management to optimize immediate and short-term outcomes following liver transplantation.</AbstractText><AbstractText Label="DATA SOURCES">Ovid MEDLINE, Embase, Scopus, Google Scholar, and Cochrane Central.</AbstractText><AbstractText Label="METHODS">Systematic review following PRISMA guidelines and recommendations using the GRADE approach derived from an international expert panel. Studies included those evaluating the following postoperative outcomes: acute kidney injury, respiratory complications, operative blood loss/red cell units required, and intensive care length of stay. PROSPERO protocol ID: CRD42021241392 RESULTS: Following expert panel review, 18 of 1624 screened studies met eligibility criteria for inclusion in the final quantitative synthesis. These included six single center RCTs, 11 single center observational studies, and one observational study comparing centers with different fluid management techniques. Definitions of interventions and outcomes varied between studies. Recommendations are therefore based substantially on expert opinion and evidence from other clinical settings.</AbstractText><AbstractText Label="CONCLUSIONS">A moderately restrictive or "replacement only" fluid regime is recommended, especially during the dissection phase of the transplant procedure. Sustained hypervolemia, based on absence of fluid responsiveness, elevated filling pressures and/or echocardiographic findings, should be avoided (Quality of Evidence: Moderate | Grade of Recommendation: Weak for restrictive fluid regime. Strong for avoidance of hypervolemia). Mean Arterial Pressure (MAP) should be maintained at &gt;60-65 mmHg in all cases (Quality of Evidence: Low | Grade of Recommendation: Strong). There is insufficient evidence in this population to support preferential use of any specific colloid or crystalloid for routine volume replacement. However, we recommend against the use of 130/.4 HES given the high incidence of AKI in this population.</AbstractText><CopyrightInformation>&#xa9; 2022 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Morkane</LastName><ForeName>Clare M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Kings College Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sapisochin</LastName><ForeName>Gonzalo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Multio-Organ Transplant &amp; HPB Surgical Oncology, Division of General Surgery, University Health Network, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mukhtar</LastName><ForeName>Ahmed M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Cairo University, Giza, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reyntjens</LastName><ForeName>Koen M E M</ForeName><Initials>KMEM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Rijksuniversiteit, University Medical Center Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wagener</LastName><ForeName>Gebhard</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Columbia University Medical Center, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spiro</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care Medicine, Royal Free Hospital, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Surgery &amp; Interventional Science, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raptis</LastName><ForeName>Dimitri A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Clinical Service of HPB Surgery and Liver Transplantation, Royal Free Hospital, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Surgery &amp; Interventional Science, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klinck</LastName><ForeName>John R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Division of Perioperative Care, Addenbrooke's Hospital, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>ERAS4OLT.org Working Group</CollectiveName><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Kings College Hospital, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Clin Transplant</MedlineTA><NlmUniqueID>8710240</NlmUniqueID><ISSNLinking>0902-0063</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016031" MajorTopicYN="Y">Liver Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019520" MajorTopicYN="N">Living Donors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">albumin</Keyword><Keyword MajorTopicYN="N">cardiac output</Keyword><Keyword MajorTopicYN="N">central venous pressure</Keyword><Keyword MajorTopicYN="N">colloid</Keyword><Keyword MajorTopicYN="N">crystalloid</Keyword><Keyword MajorTopicYN="N">fluid</Keyword><Keyword MajorTopicYN="N">goal-directed fluid</Keyword><Keyword MajorTopicYN="N">inotropes</Keyword><Keyword MajorTopicYN="N">intraoperative</Keyword><Keyword MajorTopicYN="N">liver transplant</Keyword><Keyword MajorTopicYN="N">perioperative</Keyword><Keyword MajorTopicYN="N">vasopressors</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Niemann</LastName><ForeName>Claus</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pollok</LastName><ForeName>Joerg-Matthias</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berenguer</LastName><ForeName>Marina</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tinguely</LastName><ForeName>Pascale</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vailas</LastName><ForeName>Michail</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Milan</LastName><ForeName>Michele Mazza</ForeName><Initials>MM</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>19</Day><Hour>8</Hour><Minute>35</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35304919</ArticleId><ArticleId IdType="doi">10.1111/ctr.14651</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Guyatt G, Oxman AD, Akl EA, et&#xa0;al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383-394. https://doi.org/10.1016/j.jclinepi.2010.04.026</Citation></Reference><Reference><Citation>Murad MH, Mustafa RA, Sch&#xfc;nemann HJ, Sultan S, Santesso N. Rating the certainty in evidence in the absence of a single estimate of effect. Evid Based Med. 2017;22(3):85-87. https://doi.org/10.1136/ebmed-2017-110668</Citation></Reference><Reference><Citation>Andrews J, Guyatt G, Oxman AD, et&#xa0;al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol. 2013;66(7):719-725. https://doi.org/10.1016/j.jclinepi.2012.03.013</Citation></Reference><Reference><Citation>Andrews JC, Sch&#xfc;nemann HJ, Oxman AD, et&#xa0;al. GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. J Clin Epidemiol. 2013;66(7):726-735. https://doi.org/10.1016/j.jclinepi.2013.02.003</Citation></Reference><Reference><Citation>Joosten A, Lucidi V, Ickx B, et&#xa0;al. Intraoperative hypotension during liver transplant surgery is associated with postoperative acute kidney injury: a historical cohort study. BMC Anesthesiol. 2021;21(1):12. https://doi.org/10.1186/s12871-020-01228-y</Citation></Reference><Reference><Citation>Jun I-G, Kwon H-M, Jung K-W, et&#xa0;al. The impact of postreperfusion syndrome on acute kidney injury in living donor liver transplantation: a propensity score analysis. Anesth Analg.. 2018;127(2):369-378. https://doi.org/10.1213/ANE.0000000000003370</Citation></Reference><Reference><Citation>Reydellet L, Blasco V, Mercier MF, et&#xa0;al. Impact of a goal-directed therapy protocol on postoperative fluid balance in patients undergoing liver transplantation: a retrospective study. Ann Fr Anesth Reanim. 2014;33(4):e47-e54. https://doi.org/10.1016/j.annfar.2013.12.016</Citation></Reference><Reference><Citation>Martin D, Koti R, Gurusamy K, et&#xa0;al. The cardiac output optimisation following liver transplant (COLT) trial: a feasibility randomised controlled trial. Hpb. 2020;22(8):1112-1120. https://doi.org/10.1016/j.hpb.2019.11.011</Citation></Reference><Reference><Citation>Reviewers CIGA, Reviewers CIGA. Human albumin administration in critically ill patients: systematic review of randomised controlled trials Why albumin may not work. BMJ. 1998;317(7153):235-240. https://doi.org/10.1136/bmj.317.7153.235</Citation></Reference><Reference><Citation>Roberts I, Blackhall K, Alderson P, Bunn F, Schierhout G. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev. 2011. https://doi.org/10.1002/14651858.CD001208.pub4</Citation></Reference><Reference><Citation>Haase N, Perner A. Colloid solutions in the perioperative setting. BMJ. 2015;350(mar27 6):h1656-h1656. https://doi.org/10.1136/bmj.h1656</Citation></Reference><Reference><Citation>Hadengue A, Moreau R, Gaudin C, Bacq Y, Champigneulle B, Lebrec D. Total effective vascular compliance in patients with cirrhosis: a study of the response to acute blood volume expansion. Hepatology. 1992;15(5):809-815. https://doi.org/10.1002/hep.1840150511</Citation></Reference><Reference><Citation>M&#xf8;ller S, Bendtsen F, Henriksen JH. Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis. Gastroenterology. 1995;109(6):1917-1925. https://doi.org/10.1016/0016-5085(95)90759-9</Citation></Reference><Reference><Citation>Massicotte L, Perrault M-A, Denault AY, et&#xa0;al. Effects of phlebotomy and phenylephrine infusion on portal venous pressure and systemic hemodynamics during liver transplantation. Transplantation. 2010;89(8):920-927. https://doi.org/10.1097/TP.0b013e3181d7c40c</Citation></Reference><Reference><Citation>Wagener G, Gubitosa G, Renz J, et&#xa0;al. Vasopressin decreases portal vein pressure and flow in the native liver during liver transplantation. Liver Transpl. 2008;14(11):1664-1670. https://doi.org/10.1002/lt.21602</Citation></Reference><Reference><Citation>Narahara Y, Kanazawa H, Taki Y, et&#xa0;al. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis. J Gastroenterol Hepatol. 2009;24(11):1791-1797. https://doi.org/10.1111/j.1440-1746.2009.05873.x</Citation></Reference><Reference><Citation>Mukhtar A, Salah M, Aboulfetouh F, et&#xa0;al. The use of terlipressin during living donor liver transplantation: effects on systemic and splanchnic hemodynamics and renal function*: Crit Care Med. 2011;39(6):1329-1334. https://doi.org/10.1097/CCM.0b013e3182120842</Citation></Reference><Reference><Citation>Martin GS, Kaufman DA, Marik PE, et&#xa0;al. Perioperative Quality Initiative (POQI) consensus statement on fundamental concepts in perioperative fluid management: fluid responsiveness and venous capacitance. Perioper Med. 2020;9(1):12. https://doi.org/10.1186/s13741-020-00142-8</Citation></Reference><Reference><Citation>Villanueva C, Colomo A, Bosch A, et&#xa0;al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368(1):11-21. https://doi.org/10.1056/NEJMoa1211801</Citation></Reference><Reference><Citation>Odutayo A, Desborough MJR, Trivella M, et&#xa0;al. Restrictive versus liberal blood transfusion for gastrointestinal bleeding: a systematic review and meta-analysis of randomised controlled trials. Lancet Gastroenterol Hepatol. 2017;2(5):354-360. https://doi.org/10.1016/S2468-1253(17)30054-7</Citation></Reference><Reference><Citation>Hong SH, Park CS, Jung HS, et&#xa0;al. A comparison of intra-operative blood loss and acid-base balance between vasopressor and inotrope strategy during living donor liver transplantation: a randomised, controlled study: vasopressor vs inotrope strategy for liver transplantation. Anaesthesia. 2012;67(10):1091-1100. https://doi.org/10.1111/j.1365-2044.2012.07198.x</Citation></Reference><Reference><Citation>Wang B, He HK, Cheng B, Wei K, Min S. Effect of low central venous pressure on postoperative pulmonary complications in patients undergoing liver transplantation. Surg. 2013;43(7):777-781. https://doi.org/10.1007/s00595-012-0419-y</Citation></Reference><Reference><Citation>Massicotte L, Denault AY, Beaulieu D, et&#xa0;al. Transfusion rate for 500 consecutive liver transplantations: experience of one liver transplantation center. Transplantation. 2012;93(12):1276-1281. https://doi.org/10.1097/TP.0b013e318250fc25</Citation></Reference><Reference><Citation>Paulsen AW, Whitten CW, Ramsay MA, Klintmalm GB. Considerations for anesthetic management during veno-venous bypass in adult hepatic transplantation. Anesth Analg. 1989;68(4):489-496.</Citation></Reference><Reference><Citation>Sahmeddini MA, Janatmakan F, Khosravi MB, et&#xa0;al. Restricted crystalloid fluid therapy during orthotopic liver transplant surgery and its effect on respiratory and renal insufficiency in the early post-operative period: a randomized clinical trial. Int. 2014;5(3):113-119.</Citation></Reference><Reference><Citation>Jiang GQ, Peng MH, Yang DH. Effect of perioperative fluid therapy on early phase prognosis after liver transplantation. Hepatobiliary Pancreat Dis Int. 2008;7(4):367-372.</Citation></Reference><Reference><Citation>Jipa LN, Droc G, Diculescu M. The influence of intraoperative fluid management on postoperative pulmonary complications in liver-transplant patients. Archives of the Balkan Medical Union. 2017;52(3):278-284.</Citation></Reference><Reference><Citation>Schroeder RA, Collins BH, Tuttle-Newhall E, et&#xa0;al. Intraoperative fluid management during orthotopic liver transplantation. J Cardiothorac Vasc Anesth. 2004;18(4):438-441.</Citation></Reference><Reference><Citation>Carrier FM, Sylvestre MP, Massicotte L, Bilodeau M, Chasse M. Effects of intraoperative hemodynamic management on postoperative acute kidney injury in liver transplantation: an observational cohort study. PLoS One. 2020;15(8):e0237503. https://doi.org/10.1371/journal.pone.0237503</Citation></Reference><Reference><Citation>Myles PS, Bellomo R, Corcoran T, et&#xa0;al. Restrictive versus liberal fluid therapy for major abdominal surgery. N Engl J Med. 2018;378(24):2263-2274. https://doi.org/10.1056/NEJMoa1801601</Citation></Reference><Reference><Citation>Pearse RM, Harrison DA, MacDonald N, et&#xa0;al. Effect of a perioperative, cardiac output-guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery: a randomized clinical trial and systematic review. JAMA. 2014;311(21):2181. https://doi.org/10.1001/jama.2014.5305</Citation></Reference><Reference><Citation>Wrzosek A, Jakowicka-Wordliczek J, Zajaczkowska R, et&#xa0;al. Perioperative restrictive versus goal-directed fluid therapy for adults undergoing major non-cardiac surgery. Cochrane Database Syst Rev. 2019. https://doi.org/10.1002/14651858.CD012767.pub2</Citation></Reference><Reference><Citation>Diaper J, Schiffer E, Barcelos GK, et&#xa0;al. Goal-directed hemodynamic therapy versus restrictive normovolemic therapy in major open abdominal surgery: A randomized controlled trial. Surgery. 2021;169(5):1164-1174. https://doi.org/10.1016/j.surg.2020.09.035</Citation></Reference><Reference><Citation>Joosten A, Delaporte A, Ickx B, et&#xa0;al. Crystalloid versus colloid for intraoperative goal-directed fluid therapy using a closed-loop system. Anesthesiology. 2018;128(1):55-66. https://doi.org/10.1097/ALN.0000000000001936</Citation></Reference><Reference><Citation>Reiterer C, Kabon B, Zotti O, Obradovic M, Kurz A, Fleischmann E. Effect of goal-directed crystalloid- versus colloid-based fluid strategy on tissue oxygen tension: a randomised controlled trial. Br J Anaesth. 2019;123(6):768-776. https://doi.org/10.1016/j.bja.2019.08.027</Citation></Reference><Reference><Citation>Joosten A, Coeckelenbergh S, Alexander B, et&#xa0;al. Hydroxyethyl starch for perioperative goal-directed fluid therapy in 2020: a narrative review. BMC Anesthesiol. 2020;20(1):209. https://doi.org/10.1186/s12871-020-01128-1</Citation></Reference><Reference><Citation>Umbro I, Tinti F, Scalera I, et&#xa0;al. Acute kidney injury and post-reperfusion syndrome in liver transplantation. WJG. 2016;22(42):9314. https://doi.org/10.3748/wjg.v22.i42.9314</Citation></Reference><Reference><Citation>Mizota T, Hamada M, Matsukawa S, Seo H, Tanaka T, Segawa H. Relationship between intraoperative hypotension and acute kidney injury after living donor liver transplantation: a retrospective analysis. J Cardiothorac Vasc Anesth. 2017;31(2):582-589. https://doi.org/10.1053/j.jvca.2016.12.002</Citation></Reference><Reference><Citation>Walsh M, Devereaux PJ, Garg AX, et&#xa0;al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery. Anesthesiology. 2013;119(3):507-515. https://doi.org/10.1097/ALN.0b013e3182a10e26</Citation></Reference><Reference><Citation>Futier E, Lefrant J-Y, Guinot P-G, et&#xa0;al. Effect of individualized vs standard blood pressure management strategies on postoperative organ dysfunction among high-risk patients undergoing major surgery: a randomized clinical trial. JAMA. 2017;318(14):1346. https://doi.org/10.1001/jama.2017.14172</Citation></Reference><Reference><Citation>Nygren A, Thor&#xe9;n A, Ricksten S-E. Norepinephrine and intestinal mucosal perfusion in vasodilatory shock after cardiac surgery. Shock. 2007;28(5):536-543. https://doi.org/10.1097/shk.0b013e318063e71f</Citation></Reference><Reference><Citation>Nygren A, Thor&#xe9;n A, Ricksten S-E. Vasopressors and intestinal mucosal perfusion after cardiac surgery: Norepinephrine vs. phenylephrine: Crit Care Med. 2006;34(3):722-729. https://doi.org/10.1097/01.CCM.0000201879.20281.C6</Citation></Reference><Reference><Citation>Fuda G, Denault A, Deschamps A, et&#xa0;al. Risk factors involved in central-to-radial arterial pressure gradient during cardiac surgery. Anesth Analg. 2016;122(3):624-632. https://doi.org/10.1213/ANE.0000000000001096</Citation></Reference><Reference><Citation>Lakhal K, Macq C, Ehrmann S, Boulain T, Capdevila X. Noninvasive monitoring of blood pressure in the critically ill: Reliability according to the cuff site (arm, thigh, or ankle). Crit Care Med. 2012;40(4):1207-1213. https://doi.org/10.1097/CCM.0b013e31823dae42</Citation></Reference><Reference><Citation>Weinberg L, Broad J, Pillai P, et&#xa0;al. Sodium bicarbonate infusion in patients undergoing orthotopic liver transplantation: a single center randomized controlled pilot trial. Clin Transplant. 2016;30(5):556-565. https://doi.org/10.1111/ctr.12721</Citation></Reference><Reference><Citation>Hand WR, Whiteley JR, Epperson TI, et&#xa0;al. Hydroxyethyl starch and acute kidney injury in orthotopic liver transplantation: a single-center retrospective review. Anesth Analg. 2015;120(3):619-626. https://doi.org/10.1213/ANE.0000000000000374</Citation></Reference><Reference><Citation>Zarychanski R, Abou-Setta AM, Turgeon AF, et&#xa0;al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically Ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA. 2013;309(7):678. https://doi.org/10.1001/jama.2013.430</Citation></Reference><Reference><Citation>Mutter TC, Ruth CA, Dart AB. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev. 2013. https://doi.org/10.1002/14651858.CD007594.pub3</Citation></Reference><Reference><Citation>Wagener G, Bezinover D, Wang C, et&#xa0;al. Fluid management during kidney transplantation: a consensus statement of the committee on transplant anesthesia of the American Society of anesthesiologists. Transplantation. 2021;105(8):1677-1684. https://doi.org/10.1097/TP.0000000000003581</Citation></Reference><Reference><Citation>Mukhtar A, Aboulfetouh F, Obayah G, et&#xa0;al. The safety of modern hydroxyethyl starch in living donor liver transplantation: a comparison with human albumin. Anesthesia &amp; Analgesia. 2009;109(3):924-930. https://doi.org/10.1213/ane.0b013e3181aed54f</Citation></Reference><Reference><Citation>Kabon B, Sessler DI, Kurz A, the Crystalloid-Colloid Study Team. Effect of Intraoperative goal-directed balanced crystalloid versus colloid administration on major postoperative morbidity. Anesthesiology. 2019;130(5):728-744. https://doi.org/10.1097/ALN.0000000000002601</Citation></Reference><Reference><Citation>Lobo DN, Stanga Z, Aloysius MM, et&#xa0;al. Effect of volume loading with 1 liter intravenous infusions of 0.9% saline, 4% succinylated gelatine (Gelofusine) and 6% hydroxyethyl starch (Voluven) on blood volume and endocrine responses: a randomized, three-way crossover study in healthy volunteers. Crit Care Med. 2010;38(2):464-470. https://doi.org/10.1097/CCM.0b013e3181bc80f1</Citation></Reference><Reference><Citation>Awad S, Dharmavaram S, Wearn CS, Dube MG, Lobo DN. Effects of an intraoperative infusion of 4% succinylated gelatine (Gelofusine &#xae;) and 6% hydroxyethyl starch (Voluven &#xae;) on blood volume &#x2020;. Br J Anaesth. 2012;109(2):168-176. https://doi.org/10.1093/bja/aes098</Citation></Reference><Reference><Citation>China L, Freemantle N, Forrest E, et&#xa0;al. A randomized trial of albumin infusions in hospitalized patients with cirrhosis. N Engl J Med. 2021;384(9):808-817. https://doi.org/10.1056/NEJMoa2022166</Citation></Reference><Reference><Citation>A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350(22):2247-2256. https://doi.org/10.1056/NEJMoa040232</Citation></Reference><Reference><Citation>Patel A, Laffan MA, Waheed U, Brett SJ. Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality. BMJ. 2014;349(jul22 10):g4561-g4561. https://doi.org/10.1136/bmj.g4561</Citation></Reference><Reference><Citation>Amouzandeh M, Nowak G, Januszkiewicz A, Wernerman J, Rooyackers O, Norberg &#xc5;. Albumin mass balance and kinetics in liver transplantation. Crit Care. 2018;22(1):152. https://doi.org/10.1186/s13054-018-2053-6</Citation></Reference><Reference><Citation>Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and Plasma-Lyte&#xae; 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg. 2012;256(1):18-24. https://doi.org/10.1097/SLA.0b013e318256be72</Citation></Reference><Reference><Citation>Yunos NM, Bellomo R, Glassford N, Sutcliffe H, Lam Q, Bailey M. Chloride-liberal vs. chloride-restrictive intravenous fluid administration and acute kidney injury: an extended analysis. Intensive Care Med. 2015;41(2):257-264. https://doi.org/10.1007/s00134-014-3593-0</Citation></Reference><Reference><Citation>Nadeem A, Salahuddin N, El Hazmi A, et&#xa0;al. Chloride-liberal fluids are associated with acute kidney injury after liver transplantation. Crit Care. 2014;18(6):625. https://doi.org/10.1186/s13054-014-0625-7</Citation></Reference><Reference><Citation>Sen A, Keener CM, Sileanu FE, et&#xa0;al. Chloride content of fluids used for large-volume resuscitation is associated with reduced survival. Crit Care Med. 2017;45(2):e146-e153. https://doi.org/10.1097/CCM.0000000000002063</Citation></Reference><Reference><Citation>Masevicius FD, Rubatto Birri PN, Risso Vazquez A, et&#xa0;al. Relationship of at admission lactate, unmeasured anions, and chloride to the outcome of critically Ill patients. Crit Care Med. 2017;45(12):e1233-e1239. https://doi.org/10.1097/CCM.0000000000002730</Citation></Reference><Reference><Citation>Morard I, Gasche Y, Kneteman M, et&#xa0;al. Identifying risk factors for central pontine and extrapontine myelinolysis after liver transplantation: a case-control study. Neurocrit Care. 2014;20(2):287-295. https://doi.org/10.1007/s12028-013-9928-9</Citation></Reference><Reference><Citation>Finfer S, Micallef BN, Hammond S, et&#xa0;al. Balanced Multielectrolyte Solution versus Saline in Critically Ill Adults. N Engl J Med 2022;386:815-826. https://doi.org/10.1056/NEJMoa2114464. Epub 2022 Jan 18.</Citation></Reference><Reference><Citation>Nishimura A, Tabuchi Y, Kikuchi M, Masuda R, Goto K, Iijima T. The amount of fluid given during surgery that leaks into the interstitium correlates with infused fluid volume and varies widely between patients: Anesth Analg. 2016;123(4):925-932. https://doi.org/10.1213/ANE.0000000000001505</Citation></Reference><Reference><Citation>Chappell D, Jacob M, Hofmann-Kiefer K, Conzen P, Rehm M. A rational approach to perioperative fluid management. Anesthesiology. 2008;109(4):723-740. https://doi.org/10.1097/ALN.0b013e3181863117</Citation></Reference><Reference><Citation>Chappell D, Bruegger D, Potzel J, et&#xa0;al. Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyx. Crit Care. 2014;18(5):538. https://doi.org/10.1186/s13054-014-0538-5</Citation></Reference><Reference><Citation>Zitek T, Skaggs ZD, Rahbar A, Patel J, Khan M. Does intravenous lactated Ringer's solution raise serum lactate? J Emerg Med. 2018;55(3):313-318. https://doi.org/10.1016/j.jemermed.2018.05.031</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32201917</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1437-7799</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>7</Issue><PubDate><Year>2020</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Clinical and experimental nephrology</Title><ISOAbbreviation>Clin Exp Nephrol</ISOAbbreviation></Journal><ArticleTitle>Occurrence and predictive factors of acute renal injury following hip and knee arthroplasty.</ArticleTitle><Pagination><StartPage>598</StartPage><EndPage>605</EndPage><MedlinePgn>598-605</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10157-020-01874-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To analyze the incidence of early acute kidney injury (AKI) and perioperative factors following hip and knee joint replacement.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 6281 patients from the department of orthopedics from January 2016 to July 2018 were enrolled, and 1490 patients undergoing hip and knee arthroplasty met the inclusion criteria. The preoperative, intraoperative and postoperative parameters were recorded. The retrospective cohort study was carried out to analyze predictors for AKI and postoperative creatinine elevation following hip and knee joint replacement.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eighty patients (5.4%) met AKI criteria. Age, American Society of Anesthesiologists (ASA) physical status and preoperative diabetes were identified as independent predictors for postoperative AKI in patients undergoing hip and knee arthroplasty (p&#x2009;&lt;&#x2009;0.05). Age, male, preoperative diabetes, hypertension, and preoperative creatinine were identified as independent predictors for postoperative creatinine elevation (p&#x2009;&lt;&#x2009;0.05). Patients with AKI were more likely to enter the ICU than non-AKI patients (25% vs 5.6%, p&#x2009;&lt;&#x2009;0.05). Compared with non-AKI patients, the total hospital stay (16 [11-22] vs 13 [10-16] days) and postoperative hospital stay (11 [8-14] vs 8 [7-11] days) for AKI patients were significantly prolonged (p&#x2009;&lt;&#x2009;0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The study shows age, male, preoperative diabetes, hypertension, and preoperative creatinine were independent predictors for postoperative creatinine elevation. In addition, age, ASA physical status and preoperative diabetes are independent predictors for postoperative AKI in patients undergoing hip and knee joint replacement. Postoperative AKI seems to increase ICU admission and significantly prolonged hospital stay.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Guizhou Provincial People's Hospital, Guiyang, 55004, Guizhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Kaiyun</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Guizhou Provincial People's Hospital, Guiyang, 55004, Guizhou, China. fangkaiyun@sina.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gang</LastName><ForeName>Shaopeng</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Guizhou Provincial People's Hospital, Guiyang, 55004, Guizhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Guizhou Provincial People's Hospital, Guiyang, 55004, Guizhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Guizhou Provincial People's Hospital, Guiyang, 55004, Guizhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Fujuan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Guizhou Provincial People's Hospital, Guiyang, 55004, Guizhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhenghua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Guizhou Provincial People's Hospital, Guiyang, 55004, Guizhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Guizhou Provincial People's Hospital, Guiyang, 55004, Guizhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Statistics, School of Public Health, University of Guizhou Medical University, Guiyang, 55002, Guizhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>[2016]1089</GrantID><Agency>Guizhou Provincial Science and Technology Project</Agency><Country/></Grant><Grant><GrantID>[2019]2815</GrantID><Agency>Guizhou Provincial Science and Technology Project</Agency><Country/></Grant><Grant><GrantID>GZSYBS[2015]05</GrantID><Agency>Guizhou Provincial People's Hospital Doctor Grant</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Clin Exp Nephrol</MedlineTA><NlmUniqueID>9709923</NlmUniqueID><ISSNLinking>1342-1751</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019644" MajorTopicYN="Y">Arthroplasty, Replacement, Hip</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="Y">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="N">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057234" MajorTopicYN="N">Preoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056987" MajorTopicYN="N">Vasoplegia</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Hip and knee arthroplasty</Keyword><Keyword MajorTopicYN="N">Predictive factors</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32201917</ArticleId><ArticleId IdType="doi">10.1007/s10157-020-01874-z</ArticleId><ArticleId IdType="pii">10.1007/s10157-020-01874-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kheterpal S, Tremper KK, Englesbe MJ, O'Reilly M, Shanks AM, Fetterman DM, et al. Predictors of postoperative acute renal failure after noncardiac surgery in patients with previously normal renal function. Anesthesiology. 2007;107(6):892&#x2013;902. https://doi.org/10.1097/01.anes.0000290588.29668.38 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.anes.0000290588.29668.38</ArticleId><ArticleId IdType="pubmed">18043057</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. Journal of the American Society of Nephrology : JASN. 2005;16(11):3365&#x2013;70. https://doi.org/10.1681/ASN.2004090740 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2004090740</ArticleId><ArticleId IdType="pubmed">16177006</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson KB, Winter A, Russo L, Khan A, Hair M, MacGregor MS, et al. Acute kidney injury following primary hip and knee arthroplasty surgery. Ann R Coll Surg Engl. 2017;99(4):307&#x2013;12. https://doi.org/10.1308/rcsann.2016.0324 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1308/rcsann.2016.0324</ArticleId><ArticleId IdType="pubmed">27809577</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafari SM, Huang R, Joshi A, Parvizi J, Hozack WJ. Renal impairment following total joint arthroplasty: who is at risk? The Journal of arthroplasty. 2010;25(6 Suppl):49&#x2013;53, e1&#x2013;2. doi:10.1016/j.arth.2010.04.008.</Citation></Reference><Reference><Citation>Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;53(6):961&#x2013;73. https://doi.org/10.1053/j.ajkd.2008.11.034 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2008.11.034</ArticleId><ArticleId IdType="pubmed">19346042</ArticleId><ArticleId IdType="pmc">2726041</ArticleId></ArticleIdList></Reference><Reference><Citation>Bihorac A, Yavas S, Subbiah S, Hobson CE, Schold JD, Gabrielli A, et al. Long-term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg. 2009;249(5):851&#x2013;8. https://doi.org/10.1097/SLA.0b013e3181a40a0b .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e3181a40a0b</ArticleId><ArticleId IdType="pubmed">19387314</ArticleId></ArticleIdList></Reference><Reference><Citation>Weingarten TN, Gurrieri C, Jarett PD, Brown DR, Berntson NJ, Calaro RD, Jr. et al. Acute kidney injury following total joint arthroplasty: retrospective analysis. Canadian journal of anaesthesia = Journal canadien d'anesthesie. 2012;59(12):1111&#x2013;8. doi:10.1007/s12630&#x2013;012&#x2013;9797&#x2013;2.</Citation></Reference><Reference><Citation>Gharaibeh KA, Hamadah AM, Sierra RJ, Leung N, Kremers WK, El-Zoghby ZM. The Rate of Acute Kidney Injury After Total Hip Arthroplasty Is Low but Increases Significantly in Patients with Specific Comorbidities. The Journal of bone and joint surgery American volume. 2017;99(21):1819&#x2013;26. https://doi.org/10.2106/JBJS.16.01027 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.16.01027</ArticleId><ArticleId IdType="pubmed">29088036</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh TK, Park JW, Shin HJ, Na HS, Oh AY, Hwang JW. Perioperative sedative use is not associated with acute kidney injury after total hip or knee arthroplasty. Annals of translational medicine. 2019;7(11):237. https://doi.org/10.21037/atm.2019.04.66 .</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm.2019.04.66</ArticleId><ArticleId IdType="pubmed">31317007</ArticleId><ArticleId IdType="pmc">6603358</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Lameire N, Group KAGW. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013;17(1):204. https://doi.org/10.1186/cc11454 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11454</ArticleId></ArticleIdList></Reference><Reference><Citation>Parvizi J, Mui A, Purtill JJ, Sharkey PF, Hozack WJ, Rothman RH. Total joint arthroplasty: When do fatal or near-fatal complications occur? The Journal of bone and joint surgery American volume. 2007;89(1):27&#x2013;322. https://doi.org/10.2106/jbjs.e.01443 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/jbjs.e.01443</ArticleId><ArticleId IdType="pubmed">17200306</ArticleId></ArticleIdList></Reference><Reference><Citation>Perregaard H, Damholt MB, Solgaard S, Petersen MB. Renal function after elective total hip replacement. Acta Orthop. 2016;87(3):235&#x2013;8. https://doi.org/10.3109/17453674.2016.1155130 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17453674.2016.1155130</ArticleId><ArticleId IdType="pubmed">26937782</ArticleId><ArticleId IdType="pmc">4900085</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimmel LA, Wilson S, Janardan JD, Liew SM, Walker RG. Incidence of acute kidney injury following total joint arthroplasty: a retrospective review by RIFLE criteria. Clinical kidney journal. 2014;7(6):546&#x2013;51. https://doi.org/10.1093/ckj/sfu108 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ckj/sfu108</ArticleId><ArticleId IdType="pubmed">25859370</ArticleId><ArticleId IdType="pmc">4389144</ArticleId></ArticleIdList></Reference><Reference><Citation>Aveline C, Leroux A, Vautier P, Cognet F, Le Hetet H, Bonnet F. Risk factors for renal dysfunction after total hip arthroplasty. Ann Fr Anesth Reanim. 2009;28(9):728&#x2013;34. https://doi.org/10.1016/j.annfar.2009.07.077 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annfar.2009.07.077</ArticleId><ArticleId IdType="pubmed">19709848</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan BK, Sahlstrom A, Dessau RB. Risk factors for renal dysfunction after total hip joint replacement; a retrospective cohort study. Journal of orthopaedic surgery and research. 2015;10:158. https://doi.org/10.1186/s13018-015-0299-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13018-015-0299-0</ArticleId><ArticleId IdType="pubmed">26429725</ArticleId><ArticleId IdType="pmc">4591710</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell S, Dekker FW, Vadiveloo T, Marwick C, Deshmukh H, Donnan PT, et al. Risk of postoperative acute kidney injury in patients undergoing orthopaedic surgery&#x2013;development and validation of a risk score and effect of acute kidney injury on survival: observational cohort study. BMJ (Clinical research ed). 2015;351:h5639. https://doi.org/10.1136/bmj.h5639 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h5639</ArticleId></ArticleIdList></Reference><Reference><Citation>Kateros K, Doulgerakis C, Galanakos SP, Sakellariou VI, Papadakis SA, Macheras GA. Analysis of kidney dysfunction in orthopaedic patients. BMC nephrology. 2012;13:101. https://doi.org/10.1186/1471-2369-13-101 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2369-13-101</ArticleId><ArticleId IdType="pubmed">22943390</ArticleId><ArticleId IdType="pmc">3483193</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter CJ, Moppett IK, Juurlink I, Nightingale J, Moran CG, Devonald MA. Acute and chronic kidney disease in elderly patients with hip fracture: prevalence, risk factors and outcome with development and validation of a risk prediction model for acute kidney injury. BMC nephrology. 2017;18(1):20. https://doi.org/10.1186/s12882-017-0437-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12882-017-0437-5</ArticleId><ArticleId IdType="pubmed">28088181</ArticleId><ArticleId IdType="pmc">5237525</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucaloiu ID, Kirchner HL, Norfolk ER, Hartle JE 2nd, Perkins RM. Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury. Kidney Int. 2012;81(5):477&#x2013;85. https://doi.org/10.1038/ki.2011.405 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2011.405</ArticleId><ArticleId IdType="pubmed">22157656</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204&#x2013;R212212. https://doi.org/10.1186/cc2872 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc2872</ArticleId><ArticleId IdType="pubmed">15312219</ArticleId><ArticleId IdType="pmc">522841</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Neal JB, Shaw AD, Billings FTT. Acute kidney injury following cardiac surgery: current understanding and future directions. Crit Care. 2016;20(1):187. https://doi.org/10.1186/s13054-016-1352-z .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1352-z</ArticleId><ArticleId IdType="pubmed">27373799</ArticleId><ArticleId IdType="pmc">4931708</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39878550</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-9159</ISSN><JournalIssue CitedMedium="Internet"><Volume>111</Volume><Issue>4</Issue><PubDate><Year>2025</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of surgery (London, England)</Title><ISOAbbreviation>Int J Surg</ISOAbbreviation></Journal><ArticleTitle>Individualized blood pressure regulation and acute kidney injury in older patients having major abdominal surgery: a pilot randomized trial.</ArticleTitle><Pagination><StartPage>2894</StartPage><EndPage>2902</EndPage><MedlinePgn>2894-2902</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/JS9.0000000000002289</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute kidney injury (AKI) is a common postoperative complication, and hypotension may contribute. We therefore tested the primary hypothesis that individualized intraoperative blood pressure regulation reduces postoperative AKI in older surgical patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We enrolled patients &#x2265;60&#xa0;years old scheduled for elective major abdominal surgery with invasive arterial pressure monitoring. All had goal-directed fluid management based on stroke volume variation cardiac output, and administration of a starch. Participants were randomly assigned to: (1) individualized blood pressure management targeting a systolic blood pressure (SBP) within -20% and&#xa0;+10% if baseline SBP was &#x2265;130&#xa0;mmHg or diastolic blood pressure was &#x2265;80&#xa0;mmHg, or otherwise, to target SBP within&#xa0;&#xb1;10% of the baseline value; (2) maintenance of SBP &#x2265;90&#xa0;mmHg and MAP &#x2265;65&#xa0;mmHg. Metaraminol was used to achieve the blood pressure target. AKI incidence was assessed by Kidney Disease Improving Global Outcomes criteria during the initial 7 postoperative days.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">192 patients were assigned to individualized ( n =&#xa0;96) or routine ( n =&#xa0;96) pressure management. 179 patients were included in the intention-to-treat analysis. Age averaged 68&#xa0;&#xb1;&#xa0;5 (SD) years and 64% were male. Randomization to the individualized management reduced the area under MAP &lt;65&#xa0;mmHg (median difference:&#xa0;-37 [-47 to -25] mmHg-minute, P &lt; 0.001]. The incidence of the AKI was 11% in patients assigned to individualized management vs. 16 % in those assigned to routine management: relative risk 0.72 (95% confidence interval, 0.34-1.54), P =&#xa0;0.396. Patients assigned to individualized pressure management had more urine output, a shorter postoperative mechanical ventilation duration, and faster recovery of bowel function.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Individualized blood pressure management markedly reduced hypotension. As expected in a pilot trial, the 28% reduction in AKI was not statistically significant. However, the reduction was clinically meaningful and suggests that a full trial is warranted.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pang</LastName><ForeName>Zhaohua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Zhujiang Hospital of Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Shuang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Nannan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Xiaoyan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Qulian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sessler</LastName><ForeName>Daniel I</ForeName><Initials>DI</Initials><AffiliationInfo><Affiliation>Center for Outcomes Research and Department of Anesthesiology, UTHealth, Houston, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Wangyuan</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Centre for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Surg</MedlineTA><NlmUniqueID>101228232</NlmUniqueID><ISSNLinking>1743-9159</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="Y">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001794" MajorTopicYN="Y">Blood Pressure</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="N">Monitoring, Intraoperative</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">anesthesia</Keyword><Keyword MajorTopicYN="N">individualized</Keyword><Keyword MajorTopicYN="N">intraoperative hypotension</Keyword><Keyword MajorTopicYN="N">major abdominal surgery</Keyword><Keyword MajorTopicYN="N">older patients</Keyword></KeywordList><CoiStatement>DIS is an advisor for perceptive medical.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>16</Day><Hour>18</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>1</Month><Day>29</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>1</Month><Day>29</Day><Hour>9</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39878550</ArticleId><ArticleId IdType="pmc">PMC12175809</ArticleId><ArticleId IdType="doi">10.1097/JS9.0000000000002289</ArticleId><ArticleId IdType="pii">01279778-990000000-02134</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yokota LG, Sampaio BM, Rocha EP, et al. Acute kidney injury in elderly patients: narrative review on incidence, risk factors, and mortality. Int J Nephrol Renovasc Dis 2018;11:217&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6097506</ArticleId><ArticleId IdType="pubmed">30147352</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg AX, Kurz A, Sessler DI, et al. Perioperative aspirin and clonidine and risk of acute kidney injury: a randomized clinical trial. Jama 2014;312:2254&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">25399007</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco C, Bellomo R, Kellum JA. Acute kidney injury. Lancet (London, England) 2019;394:1949&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">31777389</ArticleId></ArticleIdList></Reference><Reference><Citation>French WB, Shah PR, Fatani YI, et al. Mortality and costs associated with acute kidney injury following major elective, non-cardiac surgery. J Clin Anesth 2022;82:110933.</Citation><ArticleIdList><ArticleId IdType="pubmed">35933842</ArticleId></ArticleIdList></Reference><Reference><Citation>Turan A, Cohen B, Adegboye J, et al. Mild acute kidney injury after noncardiac surgery is associated with long-term renal dysfunction: a retrospective cohort study. Anesthesiology 2020;132:1053&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">31929326</ArticleId></ArticleIdList></Reference><Reference><Citation>Gumbert SD, Kork F, Jackson ML, et al. Perioperative acute kidney injury. Anesthesiology 2020;132:180&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10924686</ArticleId><ArticleId IdType="pubmed">31687986</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok V, Nixon J, Hu J, et al. The impact of perioperative acute kidney injury/failure on short and long surgical outcomes. Anesthesiol Perioper Sci 2023;1:9.</Citation></Reference><Reference><Citation>Kouz K, Hoppe P, Briesenick L, et al. Intraoperative hypotension: pathophysiology, clinical relevance, and therapeutic approaches. Indian J Anaesth 2020;64:90&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7017666</ArticleId><ArticleId IdType="pubmed">32139925</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory A, Stapelfeldt WH, Khanna AK, et al. Intraoperative hypotension is associated with adverse clinical outcomes after noncardiac surgery. Anesthesia Analg 2021;132:1654&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8115733</ArticleId><ArticleId IdType="pubmed">33177322</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijnberge M, Geerts BF, Hol L, et al. Effect of a machine learning-derived early warning system for intraoperative hypotension vs standard care on depth and duration of intraoperative hypotension during elective noncardiac surgery: the HYPE randomized clinical trial. Jama 2020;323:1052&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7078808</ArticleId><ArticleId IdType="pubmed">32065827</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Lefrant JY, Guinot PG, et al. Effect of individualized vs standard blood pressure management strategies on postoperative organ dysfunction among high-risk patients undergoing major surgery: a randomized clinical trial. Jama 2017;318:1346&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5710560</ArticleId><ArticleId IdType="pubmed">28973220</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanner PM, Wulff DU, Djurdjevic M, et al. Targeting higher intraoperative blood pressures does not reduce adverse cardiovascular events following noncardiac surgery. J Am Coll Cardiol 2021;78:1753&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">34711333</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis MR, Naik BI, Freundlich RE, et al. Preoperative risk and the association between hypotension and postoperative acute kidney injury. Anesthesiology 2020;132:461&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7015776</ArticleId><ArticleId IdType="pubmed">31794513</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackland GL, Brudney CS, Cecconi M, et al. Perioperative quality initiative consensus statement on the physiology of arterial blood pressure control in perioperative medicine. Br J Anaesth 2019;122:542&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">30916002</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng L, Yu W, Wang T, et al. Blood pressure targets in perioperative care. Hypertension (Dallas, Tex: 1979) 2018;72:806&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">30354725</ArticleId></ArticleIdList></Reference><Reference><Citation>Langer T, Santini A, Zadek F, et al. Intraoperative hypotension is not associated with postoperative cognitive dysfunction in elderly patients undergoing general anesthesia for surgery: results of a randomized controlled pilot trial. J Clin Anesth 2019;52:111&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">30243062</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson S, Eldadah B, Halter JB, et al. Acute kidney injury in older adults. J Am Soc Nephrol 2011;22:28&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">21209252</ArticleId></ArticleIdList></Reference><Reference><Citation>Coca SG. Acute kidney injury in elderly persons. Am J Kidney Dis 2010;56:122&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2902696</ArticleId><ArticleId IdType="pubmed">20346560</ArticleId></ArticleIdList></Reference><Reference><Citation>Butcher NJ, Monsour A, Mew EJ, et al. Guidelines for reporting outcomes in trial reports: the CONSORT-outcomes 2022 extension. Jama 2022;328:2252&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">36511921</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou LC, Li SZ, Xiong LZ, et al. Effect of dopamine and metaraminol on the renal function of patients with septic shock. Chinese Med J 2007;120:680&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">17517184</ArticleId></ArticleIdList></Reference><Reference><Citation>Lankadeva YR, Cochrane AD, Marino B, et al. Strategies that improve renal medullary oxygenation during experimental cardiopulmonary bypass may mitigate postoperative acute kidney injury. Kidney Int 2019;95:1338&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">31005272</ArticleId></ArticleIdList></Reference><Reference><Citation>Sessler DI, Bloomstone JA, Aronson S, et al. Perioperative quality initiative consensus statement on intraoperative blood pressure, risk and outcomes for elective surgery. Br J Anaesth 2019;122:563&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">30916004</ArticleId></ArticleIdList></Reference><Reference><Citation>Bijker JB, van Klei WA, Kappen TH, et al. Incidence of intraoperative hypotension as a function of the chosen definition: literature definitions applied to a retrospective cohort using automated data collection. Anesthesiology 2007;107:213&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">17667564</ArticleId></ArticleIdList></Reference><Reference><Citation>Inker LA, Eneanya ND, Coresh J, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. New Engl J Med 2021;385:1737&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8822996</ArticleId><ArticleId IdType="pubmed">34554658</ArticleId></ArticleIdList></Reference><Reference><Citation>Ely EW, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 2001;286:2703&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">11730446</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Wu Y, Yue P, et al. Delirium assessment using confusion assessment method for the intensive care unit in Chinese critically ill patients. J Crit Care 2013;28:223&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">23159138</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012;120:c179&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Biteker M, Dayan A, Tekke&#x15f;in A, et al. Incidence, risk factors, and outcomes of perioperative acute kidney injury in noncardiac and nonvascular surgery. Am J Surg 2014;207:53&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">24050540</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge S, Nie S, Liu Z, et al. Epidemiology and outcomes of acute kidney injury in elderly Chinese patients: a subgroup analysis from the EACH study. BMC Nephrol 2016;17:136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5041437</ArticleId><ArticleId IdType="pubmed">27682843</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor ME, Kirwan CJ, Pearse RM, et al. Incidence and associations of acute kidney injury after major abdominal surgery. Intensive Care Med 2016;42:521&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">26602784</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocks K, Torgerson DJ. Sample size calculations for pilot randomized trials: a confidence interval approach. J Clin Epidemiol 2013;66:197&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">23195919</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesselink EM, Wagemakers SH, van Waes JAR, et al. Associations between intraoperative hypotension, duration of surgery and postoperative myocardial injury after noncardiac surgery: a retrospective single-centre cohort study. Br J Anaesth 2022;129:487&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">36064492</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun LY, Wijeysundera DN, Tait GA, et al. Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery. Anesthesiology 2015;123:515&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">26181335</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimada T, Mascha EJ, Yang D, et al. Intra-operative hypertension and myocardial injury and/or mortality and acute kidney injury after noncardiac surgery: a retrospective cohort analysis. Eur J Anaesthesiol 2022;39:315&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">35066561</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidebotham D, Barlow CJ. The winner&#x2019;s curse: why large effect sizes in discovery trials always get smaller and often disappear completely. Anaesthesia 2024;79:86&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">37889911</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P, Ware JH, Mehta C. Sample size re-estimation for adaptive sequential design in clinical trials. J Biopharm Stat 2008;18:1184&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">18991116</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesselink EM, Kappen TH, Torn HM, et al. Intraoperative hypotension and the risk of postoperative adverse outcomes: a systematic review. Br J Anaesth 2018;121:706&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">30236233</ArticleId></ArticleIdList></Reference><Reference><Citation>Lankadeva YR, May CN, Bellomo R, et al. Role of perioperative hypotension in postoperative acute kidney injury: a narrative review. Br J Anaesth 2022;128:931&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">35465952</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y, Zhu C, Liu J, et al. Association of intraoperative hypotension with acute kidney injury after noncardiac surgery in patients younger than 60 years old. Kidney Blood Pressure Res 2019;44:211&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">30928979</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang Z, Liang S, Xing M, et al. The correlation of intraoperative oliguria with acute kidney injury after noncardiac surgery: a systematic review and meta-analysis. International J Surg (London, England) 2023;109:449&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10389605</ArticleId><ArticleId IdType="pubmed">36912515</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Kirwan CJ, Bellomo R. Fluid management for the prevention and attenuation of acute kidney injury. Nat Rev Nephrol 2014;10:37&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">24217464</ArticleId></ArticleIdList></Reference><Reference><Citation>Legrand M, Kothari R, Fong N, et al. Norepinephrine versus phenylephrine for treating hypotension during general anaesthesia in adult patients undergoing major noncardiac surgery: a multicentre, open-label, cluster-randomised, crossover, feasibility, and pilot trial. Br J Anaesth 2023;130:519&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">36925330</ArticleId></ArticleIdList></Reference><Reference><Citation>Devereaux PJ, Biccard BM, Sigamani A, et al. Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery. Jama 2017;317:1642&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">28444280</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmasi V, Maheshwari K, Yang D, et al. Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery: a retrospective cohort analysis. Anesthesiology 2017;126:47&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">27792044</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarychanski R, Abou-Setta AM, Turgeon AF, et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. Jama 2013;309:678&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">23423413</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagore D, Candela A, B&#xfc;rge M, et al. Hydroxyethyl starch and acute kidney injury in high-risk patients undergoing cardiac surgery: a prospective multicenter study. J Clin Anesth 2021;73:110367.</Citation><ArticleIdList><ArticleId IdType="pubmed">34090184</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang MJ, Chen N, Ye CY, et al. Association between hydroxyethyl starch 130/0.4 administration during noncardiac surgery and postoperative acute kidney injury: a propensity score-matched analysis of a large cohort in China. J Clin Anesth 2024;96:111493.</Citation><ArticleIdList><ArticleId IdType="pubmed">38723416</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34553259</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-2323</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>World journal of surgery</Title><ISOAbbreviation>World J Surg</ISOAbbreviation></Journal><ArticleTitle>Identification of Risk Factors for Acute Kidney Injury from Intravenous Ketorolac in Geriatric Trauma Patients.</ArticleTitle><Pagination><StartPage>98</StartPage><EndPage>103</EndPage><MedlinePgn>98-103</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00268-021-06320-z</ELocationID><Abstract><AbstractText Label="BACKGROUND">Ketorolac is an effective analgesic but the potential for acute kidney injury (AKI) is concerning, particularly in geriatric "G-60 trauma" patients. The objectives of this study are to report the incidence of AKI in patients who receive ketorolac, identify risk factors for AKI, and develop a risk factor-guided algorithm for safe utilization.</AbstractText><AbstractText Label="METHODS">This retrospective cohort study included trauma patients age 60&#xa0;years and older who received intravenous ketorolac. The primary endpoint was the incidence of AKI.</AbstractText><AbstractText Label="RESULTS">Among 316 patients evaluated, the incidence of AKI was 2.5%. Patients with AKI received more nephrotoxins, had more comorbidities, and higher use of loop diuretics or vasopressors. Loop diuretic therapy and number of comorbidities were independent predictors of AKI.</AbstractText><AbstractText Label="CONCLUSIONS">Risk for AKI with ketorolac was low, being more prevalent with comorbidities or receipt of loop diuretics.</AbstractText><CopyrightInformation>&#xa9; 2021. Soci&#xe9;t&#xe9; Internationale de Chirurgie.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Scott T</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Mayo Clinic Health System, 700 West Avenue South, La Crosse, WI, 54601, USA. hall.scott2@mayo.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mangram</LastName><ForeName>Alicia J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Trauma and Acute Care Surgery, HonorHealth John C. Lincoln Medical Center, 250 E Dunlap Ave, Phoenix, AZ, 85020, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barletta</LastName><ForeName>Jeffrey F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Midwestern University, 19555 N 59th Avenue, Glendale, AZ, 85308, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World J Surg</MedlineTA><NlmUniqueID>7704052</NlmUniqueID><ISSNLinking>0364-2313</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>YZI5105V0L</RegistryNumber><NameOfSubstance UI="D020910">Ketorolac</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020910" MajorTopicYN="Y">Ketorolac</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>23</Day><Hour>7</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34553259</ArticleId><ArticleId IdType="doi">10.1007/s00268-021-06320-z</ArticleId><ArticleId IdType="pii">10.1007/s00268-021-06320-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mangram AJ, Mitchell CD, Shifflette VK, Lorenzo M, Truitt MS, Goel A et al (2012) Geriatric trauma service: a one-year experience. J Trauma Acute Care Surg 72(1):119&#x2013;122</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e318241f0ba</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozar RA, Arbabi S, Stein DM, Shackford SR, Barraco RD, Biffl WL, Brasel KJ, Cooper Z, Fakhry SM, Livingston D, Moore F, Luchette F (2015) Injury in the aged: Geriatric trauma care at the crossroads. J Trauma Acute Care Surg 78(6):1197&#x2013;1209</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0000000000000656</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou R, Gordon DB, de Leon-Casasola OA, Rosenberg JM, Bickler S, Brennan T et al (2016) Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists&#x2019; Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain 17(2):131&#x2013;157</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2015.12.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillis JC, Brogden RN (1997) Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management. Drugs 53(1):139&#x2013;188</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00003495-199753010-00012</ArticleId></ArticleIdList></Reference><Reference><Citation>Boras-Uber LA, Brackett NC (1992) Ketorolac-induced acute renal failure. Am J Med 92(4):450&#x2013;452</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(92)90283-H</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney inter 2:1&#x2013;138</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/kisup.2012.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Chawla LS, Bellomo R, Bihorac A, Goldstein SL, Siew ED, Bagshaw SM et al (2017) Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol 13(4):241&#x2013;257</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2017.2</ArticleId></ArticleIdList></Reference><Reference><Citation>Inouye SK, Westendorp RGJ, Saczynski JS (2014) Delirium in elderly people. Lancet 383(9920):911&#x2013;922</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)60688-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinsella J, Moffat AC, Patrick JA, Prentice JW, McArdle CS, Kenny GNC (1992) Ketorolac trometamol for postoperative analgesia after orthopaedic surgery. Br J Anaesth 69(1):19&#x2013;22</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/69.1.19</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander R, El-Moalem HE, Gan TJ (2002) Comparison of the morphine-sparing effects of diclofenac sodium and ketorolac tromethamine after major orthopedic surgery. J Clin Anesth 14(3):187&#x2013;192</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0952-8180(01)00382-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Oderda GM, Gan TJ, Johnson BH, Robinson SB (2013) Effect of opioid-related adverse events on outcomes in selected surgical patients. J Pain Palliat Care Pharmacother 27(1):62&#x2013;70</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/15360288.2012.751956</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai W-H, Rau C-S, Wu S-C, Chen Y-C, Kuo P-J, Hsu S-Y et al (2016) Post-traumatic acute kidney injury: a cross-sectional study of trauma patients. Scand J Trauma Resusc Emerg Med 24(1):136</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13049-016-0330-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Perkins ZB, Captur G, Bird R, Gleeson L, Singer B, O&#x2019;Brien B (2019) Trauma induced acute kidney injury. PLoS ONE 14(1):e0211001</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0211001</ArticleId></ArticleIdList></Reference><Reference><Citation>Nash K, Hafeez A, Hou S (2002) Hospital-acquired renal insufficiency. Am J Kidney Dis 39(5):930&#x2013;936</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/ajkd.2002.32766</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohli HS, Bhaskaran MC, Muthukumar T, Thennarasu K, Sud K, Jha V et al (2000) Treatment-related acute renal failure in the elderly: a hospital-based prospective study. Nephrol Dial Transplant 15(2):212&#x2013;217</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/15.2.212</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan J, Bajnath A, Fromkin B, Haine D, Paixao R, Sandy D et al (2014) Ketorolac prescribing practices in an acute care hospital and the incidence of renal failure. World J Nephrol Urol 3(3):113&#x2013;117</Citation></Reference><Reference><Citation>Ying T, Chan S, Lane S, Somerville C (2018) Acute kidney injury post-major orthopaedic surgery: a single-Centre case-control study. Nephrology (Carlton) 23(2):126&#x2013;132</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nep.12942</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman HI, Kinman JL, Berlin JA, Hennessy S, Kimmel SE, Farrar J et al (1997) Parenteral ketorolac: the risk for acute renal failure. Ann Intern Med 126:193&#x2013;199</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-126-3-199702010-00003</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrest JB, Camu F, Greer IA, Kehlet H, Abdalla M, Bonnet F et al (2002) Ketorolac, diclofenac, and ketoprofen are equally safe for pain relief after major surgery. Br J Anaesth 88(2):227&#x2013;233</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/88.2.227</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson GL, Mattson AE, Brown CS, Cabrera D, Mara KC, Bellolio MF (2020) Safety of parenteral ketorolac use for analgesia in geriatric emergency department patients. Am J Emerg Med 38(4):727&#x2013;730</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2019.06.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Torabi J, Kaban JM, Lewis E et al (2021) Ketorolac use for pain management in trauma patients with rib fractures does not increase of acute kidney injury or incidence of bleeding. Am Surg 87(5):790&#x2013;795</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0003134820954835</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31183748</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1720-8319</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Aging clinical and experimental research</Title><ISOAbbreviation>Aging Clin Exp Res</ISOAbbreviation></Journal><ArticleTitle>Hospital-acquired acute kidney injury in very elderly men: clinical characteristics and short-term outcomes.</ArticleTitle><Pagination><StartPage>1121</StartPage><EndPage>1128</EndPage><MedlinePgn>1121-1128</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40520-019-01196-5</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">We explored the risk factors for, and the clinical characteristics of, acute kidney injury (AKI), and the causes of death 28&#xa0;days after such injury, in very elderly men.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a retrospective cohort study using data from the Geriatric Department of the Chinese PLA General Hospital. A total of 3464 elderly patients (&#x2265;&#x2009;75&#xa0;years) were enrolled from January 2007 to December 2015. All patients were followed for 28&#xa0;days or until death after AKI.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 668 patients (39.0%) developed AKI, and 623 men were included for the final analysis. The median age was 87&#xa0;years. The 28-day mortality rate was 25.7%. The AKI etiologies were infections (39.6%), hypovolemia (23.8%), cardiovascular events (15.9%), nephrotoxicity (12.0%), and surgery (7.1%). Multiple organ dysfunction syndrome (46.4%) and pulmonary infection (22.5%) were the principal causes of death. Multivariate analysis revealed that time for AKI to develop (HR&#x2009;=&#x2009;0.865; 95% CI 0.799-0.937; P&#x2009;&lt;&#x2009;0.001), low mean arterial pressure (HR&#x2009;=&#x2009;0.970; 95% CI 0.958-0.981; P&#x2009;&lt;&#x2009;0.001), low serum prealbumin (HR&#x2009;=&#x2009;0.924; 95% CI 0.894-0.955; P&#x2009;&lt;&#x2009;0.001) level, oliguria (HR&#x2009;=&#x2009;2.261; 95% CI 1.424-3.590; P&#x2009;=&#x2009;0.001), mechanical ventilation (HR&#x2009;=&#x2009;1.492; 95% CI 1.047-2.124; P&#x2009;=&#x2009;0.027), blood urea nitrogen (HR&#x2009;=&#x2009;1.037; 95% CI 1.025-1.049; P&#x2009;&lt;&#x2009;0.001) level, magnesium (HR&#x2009;=&#x2009;2.512; 95% CI 1.243-5.076; P&#x2009;=&#x2009;0.010) level, and more severe AKI stages (stage 2: HR&#x2009;=&#x2009;3.709; 95% CI 1.926-7.141; P&#x2009;&lt;&#x2009;0.001 and stage 3: HR&#x2009;=&#x2009;5.660; 95% CI 2.990-10.717; P&#x2009;&lt;&#x2009;0.001) were independent risk factors for 28-day mortality.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The incidence of AKI increases significantly as age advanced. Identification of risk factors might lead to more intensive monitoring and early prevention, and might improve AKI patients' outcomes in the very elderly.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qinglin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, the First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Meng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Data Repository, Chinese PLA General Hospital, Beijing, 100853, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Feihu</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, the First Medical Center, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China. feihuzhou301@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NCRCG-PLAGH-2017008</GrantID><Agency>National Clinical Research Center for Geriatric Diseases of China</Agency><Country/></Grant><Grant><GrantID>320.6750.18383</GrantID><Agency>WU JIEPING MEDICAL FOUNDATION</Agency><Country/></Grant><Grant><GrantID>Z161100000116054</GrantID><Agency>Beijing Municipal Capital Specialized Clinical Application Research Program of Science and Technology&#x2003;Commission Foundatio</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Aging Clin Exp Res</MedlineTA><NlmUniqueID>101132995</NlmUniqueID><ISSNLinking>1594-0667</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Incidence</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword><Keyword MajorTopicYN="N">Risk factors</Keyword><Keyword MajorTopicYN="N">Very elderly</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>6</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31183748</ArticleId><ArticleId IdType="pmc">PMC7260277</ArticleId><ArticleId IdType="doi">10.1007/s40520-019-01196-5</ArticleId><ArticleId IdType="pii">10.1007/s40520-019-01196-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Anderson S, Eldadah B, Halter JB, et al. Acute kidney injury in older adults. J Am Soc Nephrol. 2011;22:28&#x2013;38. doi: 10.1681/ASN.2010090934.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2010090934</ArticleId><ArticleId IdType="pubmed">21209252</ArticleId></ArticleIdList></Reference><Reference><Citation>Coca SG. Acute kidney injury in elderly persons. Am J Kidney Dis. 2010;56:122&#x2013;131. doi: 10.1053/j.ajkd.2009.12.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2009.12.034</ArticleId><ArticleId IdType="pmc">PMC2902696</ArticleId><ArticleId IdType="pubmed">20346560</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins AJ, Foley RN, Herzog C, et al. US renal data system 2012 annual data report. Am J Kidney Dis. 2013;61:e1&#x2013;e476. doi: 10.1053/j.ajkd.2012.11.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2012.11.031</ArticleId><ArticleId IdType="pubmed">23253259</ArticleId></ArticleIdList></Reference><Reference><Citation>Pannu N, James M, Hemmelgarn B, et al. Association between AKI, recovery of renal function, and long-term outcomes after hospital discharge. Clin J Am Soc Nephrol. 2013;8:194&#x2013;202. doi: 10.2215/CJN.06480612.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.06480612</ArticleId><ArticleId IdType="pmc">PMC3562863</ArticleId><ArticleId IdType="pubmed">23124779</ArticleId></ArticleIdList></Reference><Reference><Citation>Chawla LS, Kimmel PL. Acute kidney injury and chronic kidney disease: an integrated clinical syndrome. Kidney Int. 2012;82:516&#x2013;524. doi: 10.1038/ki.2012.208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2012.208</ArticleId><ArticleId IdType="pubmed">22673882</ArticleId></ArticleIdList></Reference><Reference><Citation>Rewa O, Bagshaw SM. Acute kidney injury&#x2014;epidemiology, outcomes and economics. Nat Rev Nephrol. 2014;10:193&#x2013;207. doi: 10.1038/nrneph.2013.282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2013.282</ArticleId><ArticleId IdType="pubmed">24445744</ArticleId></ArticleIdList></Reference><Reference><Citation>Nisula S, Kaukonen KM, Vaara ST, et al. Incidence, risk factors and 90-day mortality of patients with acute kidney injury in Finnish intensive care units: the FINNAKI study. Intensive Care Med. 2013;39:420&#x2013;428. doi: 10.1007/s00134-012-2796-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-012-2796-5</ArticleId><ArticleId IdType="pubmed">23291734</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Xing G, Wang L, et al. Acute kidney injury in China: a cross-sectional survey. Lancet. 2015;386:1465&#x2013;1471. doi: 10.1016/S0140-6736(15)00344-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)00344-X</ArticleId><ArticleId IdType="pubmed">26466051</ArticleId></ArticleIdList></Reference><Reference><Citation>Eknoyan G, Lameire N, Eckardt K, et al. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1&#x2013;138. doi: 10.1038/kisup.2012.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/kisup.2012.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu CY, Chertow GM, McCulloch CE, et al. Nonrecovery of kidney function and death after acute on chronic renal failure. Clin J Am Soc Nephrol. 2009;4:891&#x2013;898. doi: 10.2215/CJN.05571008.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.05571008</ArticleId><ArticleId IdType="pmc">PMC2676192</ArticleId><ArticleId IdType="pubmed">19406959</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao CT, Tsai HB, Wu CY, et al. The severity of initial acute kidney injury at admission of geriatric patients significantly correlates with subsequent in-hospital complications. Sci Rep. 2015;5:13925. doi: 10.1038/srep13925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep13925</ArticleId><ArticleId IdType="pmc">PMC4564739</ArticleId><ArticleId IdType="pubmed">26355041</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604&#x2013;612. doi: 10.7326/0003-4819-150-9-200905050-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-150-9-200905050-00006</ArticleId><ArticleId IdType="pmc">PMC2763564</ArticleId><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin A, Stevens PE. Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int. 2014;85:49&#x2013;61. doi: 10.1038/ki.2013.444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2013.444</ArticleId><ArticleId IdType="pubmed">24284513</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao CT, Lin YF, Tsai HB, et al. Acute kidney injury network staging in geriatric postoperative acute kidney injury patients: shortcomings and improvements. J Am Coll Surg. 2013;217:240&#x2013;250. doi: 10.1016/j.jamcollsurg.2013.03.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2013.03.024</ArticleId><ArticleId IdType="pubmed">23870218</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmistekawy E, McDonald B, Hudson C, et al. Clinical impact of mild acute kidney injury after cardiac surgery. Ann Thoracic Surg. 2014;98:815&#x2013;822. doi: 10.1016/j.athoracsur.2014.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2014.05.008</ArticleId><ArticleId IdType="pubmed">25086946</ArticleId></ArticleIdList></Reference><Reference><Citation>Reents W, Hilker M, Borgermann J, et al. Acute kidney injury after on-pump or off-pump coronary artery bypass grafting in elderly patients. Ann Thorac Surg. 2014;98:9&#x2013;14. doi: 10.1016/j.athoracsur.2014.01.088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2014.01.088</ArticleId><ArticleId IdType="pubmed">24881861</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali T, Khan I, Simpson W, et al. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol. 2007;18:1292&#x2013;1298. doi: 10.1681/ASN.2006070756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2006070756</ArticleId><ArticleId IdType="pubmed">17314324</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennen P, Douglas IS, Anderson R. Acute kidney injury in the intensive care unit: an update and primer for the intensivist. Crit Care Med. 2010;38:261&#x2013;275. doi: 10.1097/CCM.0b013e3181bfb0b5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181bfb0b5</ArticleId><ArticleId IdType="pubmed">19829099</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Sabe N, Carratala J, Roson B, et al. Community-acquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes. Medicine. 2003;82:159&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pubmed">12792302</ArticleId></ArticleIdList></Reference><Reference><Citation>Rello J. Demographics, guidelines, and clinical experience in severe community-acquired pneumonia. Crit Care. 2008;12:S2. doi: 10.1186/cc7025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc7025</ArticleId><ArticleId IdType="pmc">PMC2607112</ArticleId><ArticleId IdType="pubmed">19105795</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao CT, Wu VC, Lai CF, et al. Advanced age affects the outcome-predictive power of RIFLE classification in geriatric patients with acute kidney injury. Kidney Int. 2012;82:920&#x2013;927. doi: 10.1038/ki.2012.237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2012.237</ArticleId><ArticleId IdType="pubmed">22763817</ArticleId></ArticleIdList></Reference><Reference><Citation>Akposso K, Hertig A, Couprie R, et al. Acute renal failure in patients over 80&#xa0;years old: 25-years&#x2019; experience. Intensive Care Med. 2000;26:400&#x2013;406. doi: 10.1007/s001340051173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001340051173</ArticleId><ArticleId IdType="pubmed">10872131</ArticleId></ArticleIdList></Reference><Reference><Citation>White LE, Hassoun HT. Inflammatory mechanisms of organ crosstalk during ischemic acute kidney injury. Int J Nephrol. 2012;2012:505197. doi: 10.4061/2012/505197.</Citation><ArticleIdList><ArticleId IdType="doi">10.4061/2012/505197</ArticleId><ArticleId IdType="pmc">PMC3118535</ArticleId><ArticleId IdType="pubmed">21826270</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedermann CJ, Wiedermann W, Joannidis M. Hypoalbuminemia and acute kidney injury: a meta-analysis of observational clinical studies. Intensive Care Med. 2010;36:1657&#x2013;1665. doi: 10.1007/s00134-010-1928-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-010-1928-z</ArticleId><ArticleId IdType="pmc">PMC7728653</ArticleId><ArticleId IdType="pubmed">20517593</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez Valdivieso JR, Bes-Rastrollo M, Monedero P, et al. Impact of prealbumin levels on mortality in patients with acute kidney injury: an observational cohort study. J Renal Nutr. 2008;18:262&#x2013;268. doi: 10.1053/j.jrn.2007.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jrn.2007.11.003</ArticleId><ArticleId IdType="pubmed">18410882</ArticleId></ArticleIdList></Reference><Reference><Citation>Beier K, Eppanapally S, Bazick HS, et al. Elevation of blood urea nitrogen is predictive of long-term mortality in critically ill patients independent of &#x201c;normal&#x201d; creatinine. Crit Care Med. 2011;39:305&#x2013;313. doi: 10.1097/CCM.0b013e3181ffe22a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181ffe22a</ArticleId><ArticleId IdType="pmc">PMC3448784</ArticleId><ArticleId IdType="pubmed">21099426</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu KD, Himmelfarb J, Paganini E, et al. Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol. 2006;1:915&#x2013;919. doi: 10.2215/CJN.01430406.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.01430406</ArticleId><ArticleId IdType="pubmed">17699307</ArticleId></ArticleIdList></Reference><Reference><Citation>Safavi M, Honarmand A. Admission hypomagnesemia&#x2013;impact on mortality or morbidity in critically ill patients. Middle East J Anaesthesiol. 2007;19:645&#x2013;660.</Citation><ArticleIdList><ArticleId IdType="pubmed">18044292</ArticleId></ArticleIdList></Reference><Reference><Citation>Zafar MS, Wani J, Karim R, et al. Significance of serum magnesium levels in critically ill-patients. Int J Appl Basic Med Res. 2014;4:34. doi: 10.4103/2229-516X.125690.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2229-516X.125690</ArticleId><ArticleId IdType="pmc">PMC3931212</ArticleId><ArticleId IdType="pubmed">24600576</ArticleId></ArticleIdList></Reference><Reference><Citation>Limaye CS, Londhey VA, Nadkart MY, et al. Hypomagnesemia in critically ill medical patients. J Assoc Physicians India. 2011;59:19&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">21751660</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves SC, Tomasi CD, Constantino L, et al. Hypomagnesemia as a risk factor for the non-recovery of the renal function in critically ill patients with acute kidney injury. Nephrol Dialysis Transplant. 2013;28:910&#x2013;916. doi: 10.1093/ndt/gfs268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfs268</ArticleId><ArticleId IdType="pubmed">22764195</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25758322</PMID><DateCompleted><Year>2015</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2015</Volume><Issue>3</Issue><PubDate><Year>2015</Year><Month>Mar</Month><Day>11</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass.</ArticleTitle><Pagination><StartPage>CD010480</StartPage><MedlinePgn>CD010480</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">CD010480</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/14651858.CD010480.pub2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute kidney injury (AKI) is common in patients undergoing cardiac surgery among whom it is associated with poor outcomes, prolonged hospital stays and increased mortality. Statin drugs can produce more than one effect independent of their lipid lowering effect, and may improve kidney injury through inhibition of postoperative inflammatory responses.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This review aimed to look at the evidence supporting the benefits of perioperative statins for AKI prevention in hospitalised adults after surgery who require cardiac bypass. The main objectives were to 1) determine whether use of statins was associated with preventing AKI development; 2) determine whether use of statins was associated with reductions in in-hospital mortality; 3) determine whether use of statins was associated with reduced need for RRT; and 4) determine any adverse effects associated with the use of statins.</AbstractText><AbstractText Label="SEARCH METHODS" NlmCategory="METHODS">We searched the Cochrane Renal Group's Specialised Register to 13 January 2015 through contact with the Trials' Search Co-ordinator using search terms relevant to this review.</AbstractText><AbstractText Label="SELECTION CRITERIA" NlmCategory="METHODS">Randomised controlled trials (RCTs) that compared administration of statin therapy with placebo or standard clinical care in adult patients undergoing surgery requiring cardiopulmonary bypass and reporting AKI, serum creatinine (SCr) or need for renal replacement therapy (RRT) as an outcome were eligible for inclusion. All forms and dosages of statins in conjunction with any duration of pre-operative therapy were considered for inclusion in this review.</AbstractText><AbstractText Label="DATA COLLECTION AND ANALYSIS" NlmCategory="METHODS">All authors extracted data independently and assessments were cross-checked by a second author. Likewise, assessment of study risk of bias was initially conducted by one author and then by a second author to ensure accuracy. Disagreements were arbitrated among authors until consensus was reached. Authors from two of the included studies provided additional data surrounding post-operative SCr as well as need for RRT. Meta-analyses were used to assess the outcomes of AKI, SCr and mortality rate. Data for the outcomes of RRT and adverse effects were not pooled. Adverse effects taken into account were those reported by the authors of included studies.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">We included seven studies (662 participants) in this review. All except one study was assessed as being at high risk of bias. Three studies assessed atorvastatin, three assessed simvastatin and one investigated rosuvastatin. All studies collected data during the immediate perioperative period only; data collection to hospital discharge and postoperative biochemical data collection ranged from 24 hours to 7 days. Overall, pre-operative statin treatment was not associated with a reduction in postoperative AKI, need for RRT, or mortality. Only two studies (195 participants) reported postoperative SCr level. In those studies, patients allocated to receive statins had lower postoperative SCr concentrations compared with those allocated to no drug treatment/placebo (MD 21.2 &#xb5;mol/L, 95% CI -31.1 to -11.1). Adverse effects were adequately reported in only one study; no difference was found between the statin group compared to placebo.</AbstractText><AbstractText Label="AUTHORS' CONCLUSIONS" NlmCategory="CONCLUSIONS">Analysis of currently available data did not suggest that preoperative statin use is associated with decreased incidence of AKI in adults after surgery who required cardiac bypass. Although a significant reduction in SCr was seen postoperatively in people treated with statins, this result was driven by results from a single study, where SCr was considered as a secondary outcome. The results of the meta-analysis should be interpreted with caution; few studies were included in subgroup analyses, and significant differences in methodology exist among the included studies. Large high quality RCTs are required to establish the safety and efficacy of statins to prevent AKI after cardiac surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lewicki</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Monash Medical Centre, 246 Clayton Road, Clayton, VIC, Australia, 3168.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Irene</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Antoine G</ForeName><Initials>AG</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005464">Fluorobenzenes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006538">Heptanoic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019161">Hydroxymethylglutaryl-CoA Reductase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011758">Pyrroles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013449">Sulfonamides</NameOfSubstance></Chemical><Chemical><RegistryNumber>83MVU38M7Q</RegistryNumber><NameOfSubstance UI="D000068718">Rosuvastatin Calcium</NameOfSubstance></Chemical><Chemical><RegistryNumber>A0JWA85V8F</RegistryNumber><NameOfSubstance UI="D000069059">Atorvastatin</NameOfSubstance></Chemical><Chemical><RegistryNumber>AGG2FN16EV</RegistryNumber><NameOfSubstance UI="D019821">Simvastatin</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>doi: 10.1002/14651858.CD010480</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069059" MajorTopicYN="N">Atorvastatin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="N">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001026" MajorTopicYN="N">Coronary Artery Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005464" MajorTopicYN="N">Fluorobenzenes</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006538" MajorTopicYN="N">Heptanoic Acids</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019161" MajorTopicYN="N">Hydroxymethylglutaryl-CoA Reductase Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011758" MajorTopicYN="N">Pyrroles</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="N">Renal Replacement Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068718" MajorTopicYN="N">Rosuvastatin Calcium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019821" MajorTopicYN="N">Simvastatin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013449" MajorTopicYN="N">Sulfonamides</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>  Michelle Lewicki: None known.   Irene Ng: None known.   Antoine G Schneider: None known; </CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>3</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25758322</ArticleId><ArticleId IdType="pmc">PMC10788137</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD010480.pub2</ArticleId></ArticleIdList><ReferenceList><Title>References to studies included in this review</Title><ReferenceList><Title>Almansob 2012 {published data only}</Title><Reference><Citation>Almansob MA, Xu B, Zhou L, Hu XX, Chen W, Chang FJ, et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology 2012;32(9):2304&#x2010;13. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">22796581</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chello 2006 {published data only}</Title><Reference><Citation>Chello M, Patti G, Candura D, Mastrobuoni S, Sciascio G, Agro F, et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Critical Care Medicine 2006;34(3):660&#x2010;7. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">16505650</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Christenson 1999 {published data only}</Title><Reference><Citation>Christenson JT. Preoperative lipid control with simvastatin protects coronary artery bypass grafts from obstructive graft disease. American Journal of Cardiology 2001;88(8):896&#x2010;9. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">11676957</ArticleId></ArticleIdList></Reference><Reference><Citation>Christenson JT. Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization. Cardiovascular Surgery 2001;9(1):33&#x2010;43. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">11137806</ArticleId></ArticleIdList></Reference><Reference><Citation>Christenson JT. Preoperative lipid&#x2010;control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. European Journal of Cardio&#x2010;Thoracic Surgery 1999;15(4):394&#x2010;9. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">10371111</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mannacio 2008 {published data only}</Title><Reference><Citation>Mannacio VA, Iorio D, Amicis V, Lello F, Musumeci F. Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. Journal of Thoracic &amp; Cardiovascular Surgery 2008;136(6):1541&#x2010;8. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19114204</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Prowle 2012 {published data only}</Title><Reference><Citation>Prowle JR, Calzavacca P, Licari E, Ligabo EV, Echeverri JE, Haase M, et al. Pilot double&#x2010;blind, randomized controlled trial of short&#x2010;term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology 2012;17(3):215&#x2010;24. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">22117606</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Licari E, Calzavacca P, Ligabo EV, Echeverri JE, Hasse M, et al. Peri&#x2010;operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine 2010;36:S88. [EMBASE: 70290230]</Citation></Reference></ReferenceList><ReferenceList><Title>Spadaccio 2010 {published data only}</Title><Reference><Citation>Spadaccio C, Pollari F, Casacalenda A, Alfano G, Genovese J, Covino E, et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. Journal of Cardiovascular Pharmacology 2010;55(1):30&#x2010;8. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19834333</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tamayo 2009 {published data only}</Title><Reference><Citation>Tamayo E, Alonso O, Alvarez FJ, Castrodeza J, Florez S, Stefano S. Effects of simvastatin on acute&#x2010;phase protein levels after cardiac surgery [Efecto de la simvastatina en la concentracion de las proteinas de fase aguda despues de la cirugia cardiaca]. Medicina Clinica 2008;130(20):773&#x2010;5. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">18579030</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamayo E, Alvarez FJ, Alonso O, Bustamente R, Castrodeza J, Soria S, et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. Journal of Cardiovascular Surgery 2009;50(5):687&#x2010;94. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19741581</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to studies excluded from this review</Title><ReferenceList><Title>Acikel 2010 {published data only}</Title><Reference><Citation>Acikel S, Muderrisoglu H, Yildirir A, Aydinalp A, Sade E, Bayraktar N, et al. Prevention of contrast&#x2010;induced impairment of renal function by short&#x2010;term or long&#x2010;term statin therapy in patients undergoing elective coronary angiography. Blood Coagulation &amp; Fibrinolysis 2010;21(8):750&#x2010;7. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">20962623</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Almeida 2010 {published data only}</Title><Reference><Citation>Almeida R, Coelho OR, Meneses FH, Oliveira G, Molinari G, Franca R, et al. The APVS (atorvastatin in the perioperative of vascular surgery) study [abstract]. Circulation 2010;122(2):e345. [EMBASE: 70233157]</Citation></Reference></ReferenceList><ReferenceList><Title>Antoniades 2010 {published data only}</Title><Reference><Citation>Antoniades C, Bakogiannis C, Tousoulis D, Reilly S, Zhang MH, Paschalis A, et al. Preoperative atorvastatin treatment in CABG patients rapidly improves vein graft redox state by inhibition of Rac1 and NADPH&#x2010;oxidase activity. Circulation 2010;122(11 Suppl):S66&#x2010;73. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">20837928</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniades C, Bakogiannis C, Tousoulis D, Zhang MH, Demosthenous M, Antonopoulos A, et al. Preoperative atorvastatin treatment rapidly improves vein graft redox state by inhibiting rac1 and NADPH oxidase activity in patients undergoing elective CABG [abstract]. European Heart Journal 2010;31(Suppl 1):310. [EMBASE: 70280690]</Citation><ArticleIdList><ArticleId IdType="pubmed">20837928</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniades C, Demosthenous M, Margaritis M, Tousoulis D, Antonopoulos A, Paschalis A, et al. Short&#x2010;term preoperative treatment with atorvastatin improves myocardial redox state in patients undergoing elective CABG by affecting NADPH oxidase activity and NOS coupling [abstract]. European Heart Journal 2010;31(Suppl 1):60. [EMBASE: 70279719]</Citation></Reference></ReferenceList><ReferenceList><Title>Antoniades 2010a {published data only}</Title><Reference><Citation>Antoniades CA, Paschalis A, Tousoulis D, Bakogiannis C, Dimosthenous M, Antonopoulos AS, et al. Atorvastatin rapidly modifies vascular redox and increases nitric oxide bioavailability in human arteries [abstract]. Journal of the American College of Cardiology 2010;55(10 Suppl 1):A123. [EMBASE: 70096347]</Citation></Reference><Reference><Citation>Demosthenous M, Antoniades C, Paschalis A, Tousoulis D, Bakogiannis C, Antonopoulos AS, et al. Atorvastatin rapidly modifies vascular redox state and improves nitric oxide bioavailability in human vessels obtained from patients with advanced atherosclerosis [abstract]. European Heart Journal 2010;31(Suppl 1):1023. [EMBASE: 70283432]</Citation></Reference></ReferenceList><ReferenceList><Title>ARMYDA&#x2010;CIN 2011 {published data only}</Title><Reference><Citation>Patti G, Ricottini E, Nusca A, Colonna G, Pasceri V, D'Ambrosio A, et al. Short&#x2010;term, high&#x2010;dose Atorvastatin pretreatment to prevent contrast&#x2010;induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA&#x2010;CIN [atorvastatin for reduction of myocardial damage during angioplasty&#x2010;&#x2010;contrast&#x2010;induced nephropathy] trial. American Journal of Cardiology 2011;108(1):1&#x2010;7. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">21529740</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Barbir 1994 {published data only}</Title><Reference><Citation>Barbir M, Hunt BJ, Galloway D, Taylor A, Ilsley C, Mitchell A, et al. A randomized pilot trial of low&#x2010;dose combination lipid&#x2010;lowering therapy following coronary artery bypass grafting. Clinical Cardiology 1994;17(2):59&#x2010;64. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">8162627</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Berkan 2009 {published data only}</Title><Reference><Citation>Berkan O, Katrancioglu N, Ozker E, Ozerdem G, Bakici Z, Yilmaz MB. Reduced P&#x2010;selectin in hearts pretreated with fluvastatin: a novel benefit for patients undergoing open heart surgery. Thoracic &amp; Cardiovascular Surgeon 2009;57(2):91&#x2010;5. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19241310</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Caorsi 2008 {published data only}</Title><Reference><Citation>Caorsi C, Pineda F, Munoz C. Pravastatin immunomodulates IL&#x2010;6 and C&#x2010;reactive protein, but not IL&#x2010;1 and TNF&#x2010;alpha, in cardio&#x2010;pulmonary bypass. European Cytokine Network 2008;19(2):99&#x2010;103. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">18632424</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chello 2003 {published data only}</Title><Reference><Citation>Chello M, Mastroroberto P, Patti G, D'Ambrosio A, Morichetti MC, Sciascio G, et al. Simvastatin attenuates leucocyte&#x2010;endothelial interactions after coronary revascularisation with cardiopulmonary bypass. Heart 2003;89(5):538&#x2010;43. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1767656</ArticleId><ArticleId IdType="pubmed">12695460</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chello 2005 {published data only}</Title><Reference><Citation>Chello M, Goffredo C, Patti G, Candura D, Melfi R, Mastrobuoni S, et al. Effects of atorvastatin on arterial endothelial function in coronary bypass surgery. European Journal of Cardio&#x2010;Thoracic Surgery 2005;28(6):805&#x2010;10. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">16274999</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chello 2007 {published data only}</Title><Reference><Citation>Chello M, Anselmi A, Spadaccio C, Patti G, Goffredo C, Sciascio G, et al. Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery. Annals of Thoracic Surgery 2007;83(4):1374&#x2010;80. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">17383342</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chen 2009a {published data only}</Title><Reference><Citation>Chen GL, Su JZ. Atorvastatin attenuated contrast induced renal function damage. Chung&#x2010;Hua Hsin Hsueh Kuan Ping Tsa Chih [Chinese Journal of Cardiology] 2009;37(5):389&#x2010;93. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19781210</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cobbaert 1992 {published data only}</Title><Reference><Citation>Cobbaert C, Sergeant P, Meyns B, Szecsi J, Kesteloot H. Time course of serum Lp(a) in men after coronary artery bypass grafting. Acta Cardiologica 1992;47(6):529&#x2010;42. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">1290314</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Coccia 2007 {published data only}</Title><Reference><Citation>Coccia R, Spadaccio C, Foppoli C, Perluigi M, Covino E, Lusini M, et al. The effect of simvastatin on erythrocyte membrane fluidity during oxidative stress induced by cardiopulmonary bypass: a randomized controlled study. Clinical Therapeutics 2007;29(8):1706&#x2010;17. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">17919551</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dotani 2003 {published data only}</Title><Reference><Citation>Dotani MI, Morise AP, Haque R, Jain AC, Gupta N, Gibson CM. Association between short&#x2010;term simvastatin therapy before coronary artery bypass grafting and postoperative myocardial blood flow as assessed by positron emission tomography. American Journal of Cardiology 2003;91(9):1107&#x2010;9. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">12714156</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dunkelgrun 2009 {published data only}</Title><Reference><Citation>Dunkelgrun M, Boersma E, Schouten O, Koopman&#x2010;van Gemert AW, Poorten F, Bax JJ, et al. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate&#x2010;risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE&#x2010;IV). Annals of Surgery 2009;249(6):921&#x2010;6. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19474688</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Durazzo 2004 {published data only}</Title><Reference><Citation>Caramelli B, Durazzo A, Ikeoka D, Bernoche C, Monachini M, Puech Leao P, et al. Short&#x2010;term treatment with atorvastatin for prevention of cardiac complications after vascular surgery [abstract no: 086]. Atherosclerosis Supplements 2002;3(2):83. [CENTRAL: CN&#x2010;00831428]</Citation></Reference><Reference><Citation>Durazzo AE, Machado FS, Ikeoka DT, Bernoche C, Monachini MC, Puech&#x2010;Leao P, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. Journal of Vascular Surgery 2004;39(5):967&#x2010;75. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">15111846</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Faulkner 2000 {published data only}</Title><Reference><Citation>Faulkner MA, Wadibia EC, Lucas BD, Hilleman DE. Impact of pharmacy counseling on compliance and effectiveness of combination lipid&#x2010;lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial. Pharmacotherapy: The Journal of Human Pharmacology &amp; Drug Therapy 2000;20(4):410&#x2010;6. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">10772372</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Flaker 1999 {published data only}</Title><Reference><Citation>Flaker GC, Warnica JW, Sacks FM, Moye LA, Davis BR, Rouleau JL, et al. Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations. Cholesterol and Recurrent Events CARE Investigators. Journal of the American College of Cardiology 1999;34(1):106&#x2010;12. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">10399998</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>FLARE Study 1999 {published data only}</Title><Reference><Citation>Lloyd GW, Jackson G, Foley DP, Boersma E, Shepherd J, Serruys PW. The influence of plasma lipoprotein (a) on angiographic restenosis and coronary events in patients undergoing planned coronary balloon angioplasty. Ancillary analysis of the Fluvastatin Angioplasty Restenosis (FLARE) trial. Atherosclerosis 2001;158(2):445&#x2010;54. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">11583725</ArticleId></ArticleIdList></Reference><Reference><Citation>Serruys PW, Foley DP, Jackson G, Bonnier H, Macaya C, Vrolix M, et al. A randomized placebo&#x2010;controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial. European Heart Journal 1999;20(1):58&#x2010;69. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">10075142</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Florens 2001 {published data only}</Title><Reference><Citation>Florens E, Salvi S, Peynet J, Elbim C, Mallat Z, Bel A, et al. Can statins reduce the inflammatory response to cardiopulmonary bypass? A clinical study. Journal of Cardiac Surgery 2001;16(3):232&#x2010;9. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">11824669</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Foley 1994 {published data only}</Title><Reference><Citation>Foley DP, Bonnier H, Jackson G, Macaya C, Shepherd J, Vrolix M, et al. Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study Group. American Journal of Cardiology 1994;73(14):50D&#x2010;61D. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">8198025</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Han 2014 {published data only}</Title><Reference><Citation>Han Y, Zhu G, Han L, Hou F, Huang W, Liu H, et al. Short&#x2010;term rosuvastatin therapy for prevention of contrast&#x2010;induced acute kidney injury in patients with diabetes and chronic kidney disease. Journal of the American College of Cardiology 2014;63(1):62&#x2010;70. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">24076297</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ji 2009 {published data only}</Title><Reference><Citation>Ji Q, Mei Y, Wang X, Sun Y, Feng J, Cai J, et al. Effect of preoperative atorvastatin therapy on atrial fibrillation following off&#x2010;pump coronary artery bypass grafting. Circulation Journal 2009;73(12):2244&#x2010;9. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19822977</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kesteloot 1992 {published data only}</Title><Reference><Citation>Kesteloot H, Cobbaert C, Meyns B, Szecsi J, Lesaffre E, Sergeant P. Time course of serum lipid and lipoprotein levels after coronary bypass surgery: modification by pravastatin. Acta Cardiologica 1992;47(6):519&#x2010;28. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">1290313</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kourliouros 2011 {published data only}</Title><Reference><Citation>Kourliouros A, Valencia O, Hosseini MT, Mayr M, Sarsam M, Camm J, et al. Preoperative high&#x2010;dose atorvastatin for prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial. Journal of Thoracic &amp; Cardiovascular Surgery 2011;141(1):244&#x2010;8. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">20624624</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Krivoy 2008 {published data only}</Title><Reference><Citation>Krivoy N, Adler Z, Saloma R, Hawadie A, Azzam ZS. Targeting C&#x2010;reactive protein levels using high&#x2010;dose atorvastatin before coronary artery bypass graft surgery. Experimental &amp; Clinical Cardiology 2008;13(4):171&#x2010;4. [EMBASE: 2009154149]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2663479</ArticleId><ArticleId IdType="pubmed">19343161</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Li 2012a {published data only}</Title><Reference><Citation>Li W, Fu X, Wang Y, Li X, Yang Z, Wang X, et al. Beneficial effects of high&#x2010;dose atorvastatin pretreatment on renal function in patients with acute ST&#x2010;segment elevation myocardial infarction undergoing emergency percutaneous coronary intervention. Cardiology 2012;122(3):195&#x2010;202. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">22854323</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>LIPS Study 2002 {published data only}</Title><Reference><Citation>Arampatzis CA, Goedhart D, Serruys PW, Saia F, Lemos PA, Feyter P, et al. Fluvastatin reduces the impact of diabetes on long&#x2010;term outcome after coronary intervention&#x2010;&#x2010;a Lescol Intervention Prevention Study (LIPS) substudy. American Heart Journal 2005;149(2):329&#x2010;35. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">15846273</ArticleId></ArticleIdList></Reference><Reference><Citation>Serruys PW, Feyter P, Macaya C, Kokott N, Puel J, Vrolix M, et al. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;287(24):3215&#x2010;22. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">12076217</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lotfi 2008 {published data only}</Title><Reference><Citation>Lotfi A, Schweiger MJ, Giugliano GR, Murphy SA, Cannon CP, TIMI 22 Investigators. High&#x2010;dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients&#x2010;&#x2010;a Pravastatin or Atorvastatin Evaluation and Infection Therapy&#x2010;Thrombolysis in Myocardial Infarction 22 (PROVE IT&#x2010;TIMI 22) analysis. American Heart Journal 2008;155(5):954&#x2010;8. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">18440347</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ludman 2010 {published data only}</Title><Reference><Citation>Ludman AJ, Hausenloy DJ, Venugopal V, Babu G, Boston&#x2010;Griffiths E, Lawrence D, et al. The effect of high&#x2010;dose atorvastatin on a background of standard&#x2010;dose chronic statin therapy in patients undergoing cardiac surgery [abstract]. European Heart Journal 2010;31(Suppl 1):70. [EMBASE: 70279760]</Citation></Reference></ReferenceList><ReferenceList><Title>Morawietz 2006 {published data only}</Title><Reference><Citation>Morawietz H, Erbs S, Holtz J, Schubert A, Krekler M, Goettsch W, et al. Endothelial Protection, AT1 blockade and Cholesterol&#x2010;Dependent Oxidative Stress: the EPAS trial. Circulation 2006;114(1 Suppl):1296&#x2010;301. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">16820589</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Nakamura 2006b {published data only}</Title><Reference><Citation>Nakamura K, Masuda H, Kariyazono H, Arima J, Iguro Y, Yamada K, et al. Effects of atorvastatin and aspirin combined therapy on inflammatory responses in patients undergoing coronary artery bypass grafting. Cytokine 2006;36(5&#x2010;6):201&#x2010;10. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">17300951</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ozhan 2010 {published data only}</Title><Reference><Citation>Ozhan H, Erden I, Ordu S, Aydin M, Caglar O, Basar C, et al. Efficacy of short&#x2010;term high&#x2010;dose atorvastatin for prevention of contrast&#x2010;induced nephropathy in patients undergoing coronary angiography. Angiology 2010;61(7):711&#x2010;4. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">20395226</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Post&#x2010;CABG Trial 1997 {published data only}</Title><Reference><Citation>Alaupovic P, Fesmire JD, Hunnighake D, Domanski M, Forman S, Knatterud GL, et al. The effect of aggressive and moderate lowering of LDL&#x2010;cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial. Atherosclerosis 1999;146(2):369&#x2010;79. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">10532693</ArticleId></ArticleIdList></Reference><Reference><Citation>Campeau L, Lesperance J, Bilodeau L, Fortier A, Guertin MC, Knatterud GL. Effect of cholesterol lowering and cardiovascular risk factors on the progression of aortoiliac arteriosclerosis: a quantitative cineangiography study. Angiology 2005;56(2):191&#x2010;9. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">15793608</ArticleId></ArticleIdList></Reference><Reference><Citation>Canner PL, Thompson B, Knatterud GL, Geller N, Campeau L, Zucker D. An application of the Zucker&#x2010;Wittes modified ratio estimate statistic in the Post Coronary Artery Bypass Graft (CABG) clinical trial. Controlled Clinical trials 1997;18(4):318&#x2010;27. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">9257071</ArticleId></ArticleIdList></Reference><Reference><Citation>Domanski M, Tian X, Fleg J, Coady S, Gosen C, Kirby R, et al. Pleiotropic effect of lovastatin, with and without cholestyramine, in the post coronary artery bypass graft (Post CABG) trial. American Journal of Cardiology 2008;102(8):1023&#x2010;7. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">18929703</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunninghake DB. Therapeutic efficacy of the lipid&#x2010;lowering armamentarium: the clinical benefits of aggressive lipid&#x2010;lowering therapy. American Journal of Medicine 1998;104(2A):9S&#x2010;13S. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">9550501</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukamal KJ, Girotra S, Mittleman MA. Alcohol consumption, atherosclerotic progression, and prognosis among patients with coronary artery bypass grafts. American Heart Journal 2006;151(2):368&#x2010;72. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">16442902</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukamal KJ, Smith CC, Karlamangla AS, Moore AA. Moderate alcohol consumption and safety of lovastatin and warfarin among men: the post&#x2010;coronary artery bypass graft trial. American Journal of Medicine 2006;119(5):434&#x2010;40. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">16651056</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukamal KJ, Wellenius GA, Mittleman MA. Hematologic parameters, atherosclerotic progression, and prognosis in patients with previous coronary artery bypass grafting (from the Post CABG Trial). American Journal of Cardiology 2009;103(3):328&#x2010;32. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19166684</ArticleId></ArticleIdList></Reference><Reference><Citation>Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low&#x2010;density lipoprotein cholesterol levels and low&#x2010;dose anticoagulation on obstructive changes in saphenous&#x2010;vein coronary&#x2010;artery bypass grafts [erratum appears in N Engl J Med 1997 Dec 18;337(25):1859]. New England Journal of Medicine 1997;336(3):153&#x2010;62. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">8992351</ArticleId></ArticleIdList></Reference><Reference><Citation>Wee CC, Girotra S, Weinstein AR, Mittleman MA, Mukamal KJ. The relationship between obesity and atherosclerotic progression and prognosis among patients with coronary artery bypass grafts the effect of aggressive statin therapy. Journal of the American College of Cardiology 2008;52(8):620&#x2010;5. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">18702964</ArticleId></ArticleIdList></Reference><Reference><Citation>Wellenius GA, Mukamal KJ, Winkelmayer WC, Mittleman MA. Renal dysfunction increases the risk of saphenous vein graft occlusion: results from the Post&#x2010;CABG trial. Atherosclerosis 2007;193(2):414&#x2010;20. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">16905139</ArticleId></ArticleIdList></Reference><Reference><Citation>White CW, Gobel FL, Campeau L, Knatterud GL, Forman SA, Forrester JS, et al. Effect of an aggressive lipid&#x2010;lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the post coronary artery bypass graft trial. Circulation 2001;104(22):2660&#x2010;5. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">11723015</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>PRATO&#x2010;ACS Study 2014 {published data only}</Title><Reference><Citation>Leoncini M, Toso A, Maioli M, Tropeano F, Villani S, Bellandi F. Early high&#x2010;dose rosuvastatin for contrast&#x2010;induced nephropathy prevention in acute coronary syndrome: Results from the PRATO&#x2010;ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast&#x2010;induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome). Journal of the American College of Cardiology 2014;63(1):71&#x2010;9. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">24076283</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>PROMISS Study 2008 {published data only}</Title><Reference><Citation>Jo SH, Koo BK, Park JS, Kang HJ, Cho YS, Kim YJ, et al. Prevention of radiocontrast medium&#x2010;induced nephropathy using short&#x2010;term high&#x2010;dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial&#x2010;&#x2010;a randomized controlled study. American Heart Journal 2008;155(3):499. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">18294484</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Qian 2008 {published data only}</Title><Reference><Citation>Qian YJ, Xiao XJ, Yuan HS, Tang H, Shao HZ, Wei DM. Combination pharmacological cardioversion of permanent atrial fibrillation in post&#x2010;prosthetic mitral valve replacement outpatients: a novel approach for the treatment of atrial fibrillation. Journal of International Medical Research 2008;36(3):537&#x2010;43. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">18534136</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Radaelli 2007 {published data only}</Title><Reference><Citation>Radaelli A, Loardi C, Cazzaniga M, Balestri G, DeCarlini C, Cerrito MG, et al. Inflammatory activation during coronary artery surgery and its dose&#x2010;dependent modulation by statin/ACE&#x2010;inhibitor combination. Arteriosclerosis, Thrombosis &amp; Vascular Biology 2007;27(12):2750&#x2010;5. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">17823365</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>RAP Study 2010 {published data only}</Title><Reference><Citation>Billings FT 4th, Pretorius M, Siew ED, Yu C, Brown NJ. Early postoperative statin therapy is associated with a lower incidence of acute kidney injury after cardiac surgery. Journal of Cardiothoracic &amp; Vascular Anesthesia 2010;24(6):913&#x2010;20. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2992577</ArticleId><ArticleId IdType="pubmed">20599398</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Riahi 2006 {published data only}</Title><Reference><Citation>Riahi S, Schmidt EB, Amanavicius N, Karmisholt J, Jensen HS, Christoffersen RP, et al. The effect of atorvastatin on heart rate variability and lipoproteins in patients treated with coronary bypass surgery. International Journal of Cardiology 2006;111(3):436&#x2010;41. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">16290290</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sasmazel 2010 {published data only}</Title><Reference><Citation>Sasmazel A, Baysal A, Fedekar A, Buyukbayrak F, Bugra O, Erdem H, et al. The effect of statin therapy on stimulation of endothelium&#x2010;derived nitric oxide before and after coronary artery bypass surgery. Heart Surgery Forum 2010;13(4):E243&#x2010;6. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">20719727</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Schanzer 2008 {published data only}</Title><Reference><Citation>Schanzer A, Hevelone N, Owens CD, Beckman JA, Belkin M, Conte MS. Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia. Journal of Vascular Surgery 2008;47(4):774&#x2010;81. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">18381138</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Schouten 2009 {published data only}</Title><Reference><Citation>Schouten O, Boersma E, Hoeks SE, Benner R, Urk H, Sambeek MR, et al. Fluvastatin and perioperative events in patients undergoing vascular surgery. New England Journal of Medicine 2009;361(10):980&#x2010;9. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19726772</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Song 2008 {published data only}</Title><Reference><Citation>Song YB, On YK, Kim JH, Shin DH, Kim JS, Sung J, et al. The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off&#x2010;pump coronary artery bypass grafting surgery. American Heart Journal 2008;156(2):373&#x2010;16. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">18657672</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>STATIN&#x2010;STEMI Study 2010 {published data only}</Title><Reference><Citation>Kim JS, Kim J, Choi D, Lee CJ, Lee SH, Ko YG, et al. Efficacy of high&#x2010;dose atorvastatin loading before primary percutaneous coronary intervention in ST&#x2010;segment elevation myocardial infarction: the STATIN STEMI trial. [Erratum appears in JACC Cardiovasc Interv. 2012 Feb;5(2):248]. JACC: Cardiovascular Interventions 2010;3(3):332&#x2010;9. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">20298994</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Su 2011 {published data only}</Title><Reference><Citation>Su JZ, Xue Y, Cai WQ, Huang QY, Chai DJ, Chen GL, et al. Association between high sensitivity C&#x2010;reactive protein and contrast induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention: impact of atorvastatin. Chung&#x2010;Hua Hsin Hsueh Kuan Ping Tsa Chih [Chinese Journal of Cardiology] 2011;39(9):807&#x2010;11. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">22321227</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sun 2009a {published data only}</Title><Reference><Citation>Sun YF, Mei YQ, Ji Q, Wang XS, Feng J, Cai JZ, et al. Effect of atorvastatin on postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. Chung&#x2010;Hua i Hsueh Tsa Chih [Chinese Medical Journal] 2009;89(42):2988&#x2010;91. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">20137710</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tetik 2010 {published data only}</Title><Reference><Citation>Tetik S, Ak K, Isbir S, Eksioglu&#x2010;Demiralp E, Arsan S, Iqbal O, et al. Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study. Clinical &amp; Applied Thrombosis/Hemostasis 2010;16(2):189&#x2010;98. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19703819</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Toso 2010 {published data only}</Title><Reference><Citation>Toso A, Leoncini M, Maioli M, Gallopin M, Tedeschi D, Amato M, et al. Short&#x2010;term high&#x2010;dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction. Journal of Cardiovascular Medicine 2011;12(5):318&#x2010;21. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">21045713</ArticleId></ArticleIdList></Reference><Reference><Citation>Toso A, Maioli M, Leoncini M, Gallopin M, Tedeschi D, Micheletti C, et al. Usefulness of atorvastatin (80 mg) in prevention of contrast&#x2010;induced nephropathy in patients with chronic renal disease. American Journal of Cardiology 2010;105(3):288&#x2010;92. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">20102936</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Xinwei 2009 {published data only}</Title><Reference><Citation>Xinwei J, Xianghua F, Jing Z, Xinshun G, Ling X, Weize F, et al. Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast&#x2010;induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention. American Journal of Cardiology 2009;104(4):519&#x2010;24. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19660605</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zhou 2009 {published data only}</Title><Reference><Citation>Zhou X, Jin YZ, Wang Q, Min R, Zhang XY. Efficacy of high dose atorvastatin on preventing contrast induced nephropathy in patients underwent coronary angiography. Chung&#x2010;Hua Hsin Hsueh Kuan Ping Tsa Chih [Chinese Journal of Cardiology] 2009;37(5):394&#x2010;6. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19781211</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zhou 2010 {published data only}</Title><Reference><Citation>Zhou Q, Wang G, Gao C, Chen T. Effect of ulinastatin on perioperative inflammatory response to coronary artery bypass grafting with cardiopulmonary bypass. Zhong Nan da Xue Xue Bao. Yi Xue Ban [Journal of Central South University Medical Sciences] 2010;35(2):107&#x2010;10. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">20197607</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to studies awaiting assessment</Title><ReferenceList><Title>de Oliveira 2012 {published data only}</Title><Reference><Citation>Oliveira MS, Martins KB, Costa JR Jr, Abizaid A, Stadler J, Mattos LA, et al. Impact on renal function of rosuvastatin preload prior to elective percutaneous coronary intervention in chronic statin users [Impacto na funcao renal de uma dose de reforco de rosuvastatina previa a intervencao coronaria percutanea eletiva nos pacientes em uso cronico de estatina]. Revista Brasileira de Cardiologia Invasiva 2012;20(3):303&#x2010;8. [EMBASE: 2013021434]</Citation></Reference></ReferenceList><ReferenceList><Title>Han 2013 {published data only}</Title><Reference><Citation>Han S, Li XM, Mohammed Ali LA, Fu NK, Jin DX, Cong HL. Effect of short&#x2010;term different statins loading dose on renal function and CI&#x2010;AKI incidence in patients undergoing invasive coronary procedures. International Journal of Cardiology 2013;168(5):5101&#x2010;3. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">23972962</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Liu 2013 {published data only}</Title><Reference><Citation>Liu WJ, Zhang BC, Guo R, Wei YD, Li WM, Xu YW. Renoprotective effect of alprostadil in combination with statins in patients with mild to moderate renal failure undergoing coronary angiography. Chinese Medical Journal 2013;126(18):3475&#x2010;80. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">24034093</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>NAPLES II Study 2009 {published data only}</Title><Reference><Citation>Briguori C, Visconti G, Focaccio A, Golia B, Chieffo A, Castelli A, et al. Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction. Journal of the American College of Cardiology 2009;54(23):2157&#x2010;63. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19664895</ArticleId></ArticleIdList></Reference><Reference><Citation>Quintavalle C, Fiore D, Micco F, Visconti G, Focaccio A, Golia B, et al. Impact of a high loading dose of atorvastatin on contrast&#x2010;induced acute kidney injury. Circulation 2012;126(25):3008&#x2010;16. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">23147173</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>ROSA&#x2010;cIN Trial 2013 {published data only}</Title><Reference><Citation>Kaya A, Kurt M, Tanboga IH, Isik T, Ekinci M, Aksakal E, et al. Rosuvastatin versus atorvastatin to prevent contrast induced nephropathy in patients undergoing primary percutaneous coronary intervention (ROSA&#x2010;cIN trial). Acta Cardiologica 2013;68(5):489&#x2010;94. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">24283110</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to ongoing studies</Title><ReferenceList><Title>NCT01547455 {published data only}</Title><Reference><Citation>Zhou S. Anti&#x2010;inflammatory and renoprotective effect of pretreatment loading dose atorvastatin in CABG. www.clinicaltrials.gov/ct2/show/NCT01547455 (accessed 13 January 2015).</Citation></Reference></ReferenceList><ReferenceList><Title>STATIN AKI 2011 {published data only}</Title><Reference><Citation>Billings FT 4th, Ball SK, Roberts LJ 2nd, Pretorius M. Postoperative acute kidney injury is associated with hemoglobinemia and an enhanced oxidative stress response. Free Radical Biology &amp; Medicine 2011;50(11):1480&#x2010;7. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3090463</ArticleId><ArticleId IdType="pubmed">21334433</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>Additional references</Title><ReferenceList><Title>Ali 2005</Title><Reference><Citation>Ali IS, Buth KJ. Preoperative statin use and in&#x2010;hospital outcomes following heart surgery in patients with unstable angina. European Journal of Cardio&#x2010;Thoracic Surgery 2005;27(6):1051&#x2010;6. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">15896616</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Arora 2008</Title><Reference><Citation>Arora P, Rajagopalam S, Ranjan R, Kolli H, Singh M, Venuto R, et al. Preoperative use of angiotensin&#x2010;converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Clinical Journal of the American Society of Nephrology: CJASN 2008;3(5):1266&#x2010;73. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2518804</ArticleId><ArticleId IdType="pubmed">18667735</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Asimakopoulos 2005</Title><Reference><Citation>Asimakopoulos G, Karagounis AP, Valencia O, Alexander N, Howlader M, Sarsam MA, et al. Renal function after cardiac surgery off&#x2010; versus on&#x2010;pump coronary artery bypass: analysis using the Cockroft&#x2010;Gault formula for estimating creatinine clearance. Annals of Thoracic Surgery 2005;79(6):2024&#x2010;31. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">15919303</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Baigent 2005</Title><Reference><Citation>Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Efficacy and safety of cholesterol&#x2010;lowering treatment: prospective meta&#x2010;analysis of data from 90,056 participants in 14 randomised trials of statins. [Erratum appears in Lancet. 2008 Jun 21;371(9630):2084], [Erratum appears in Lancet. 2005 Oct 15&#x2010;21;366(9494):1358]. Lancet 2005;366(9493):1267&#x2010;78. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">16214597</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bellomo 2004</Title><Reference><Citation>Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative workgroup. Acute renal failure &#x2013; definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Critical Care 2004;8(4):R204&#x2010;12. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC522841</ArticleId><ArticleId IdType="pubmed">15312219</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Billings 2010</Title><Reference><Citation>Billings FT 4th, Pretorius M, Siew ED, Yu C, Brown NJ. Early postoperative statin therapy is associated with a lower incidence of acute kidney injury after cardiac surgery. Journal of Cardiothoracic &amp; Vascular Anesthesia 2010;24(6):913&#x2010;20. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2992577</ArticleId><ArticleId IdType="pubmed">20599398</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bove 2004</Title><Reference><Citation>Bove T, Calabr&#xf2; MG, Landoni G, Aletti G, Marino G, Crescenzi G, et al. The incidence and risk of acute renal failure after cardiac surgery. Journal of Cardiothoracic &amp; Vascular Anesthesia 2004;18(4):442&#x2010;5. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">15365924</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Boyle 1997</Title><Reference><Citation>Boyle EM Jr, Pohlman TH, Johnson MC, Verrier ED. Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response. Annals of Thoracic Surgery 1997;63(1):277&#x2010;84. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">8993292</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chawla 2012</Title><Reference><Citation>Chawla LS, Zhao Y, Lough FC, Schroeder E, Seneff MG, Brennan JM. Off&#x2010;pump versus on&#x2010;pump coronary artery bypass grafting outcomes stratified by preoperative renal function. Journal of the American Society of Nephrology 2012;23(8):1389&#x2010;97. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3402290</ArticleId><ArticleId IdType="pubmed">22595302</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chertow 1997</Title><Reference><Citation>Chertow GM, Lazarus JM, Christiansen CL, Cook EF, Hammermeister KE, Grover F, et al. Preoperative renal risk stratification. Circulation 1997;95(4):878&#x2010;84. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">9054745</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chukwuemeka 2005</Title><Reference><Citation>Chukwuemeka A, Weisel A, Maganti M, Nette AF, Wijeysundera DN, Beattie WS, et al. Renal dysfunction in high&#x2010;risk patients after on&#x2010;pump and off&#x2010;pump coronary artery bypass surgery: a propensity score analysis. Annals of Thoracic Surgery 2005;80(6):2148&#x2010;53. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">16305860</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Clark 2006</Title><Reference><Citation>Clark LL, Ikonomidis JS, Crawford FA Jr, Crumbley A 3rd, Kratz JM, Stroud MR, et al. Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: an 8&#x2010;year retrospective cohort study. Journal of Thoracic &amp; Cardiovascular Surgery 2006;131(3):679&#x2010;85. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">16515923</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Coca 2009</Title><Reference><Citation>Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR. Long&#x2010;term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta&#x2010;analysis. American Journal of Kidney Diseases 2009;53(6):961&#x2010;73. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2726041</ArticleId><ArticleId IdType="pubmed">19346042</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Conlon 1999</Title><Reference><Citation>Conlon PJ, Stafford&#x2010;Smith M, White WD, Newman MF, King S, Winn MP, et al. Acute renal failure following cardiac surgery. Nephrology Dialysis Transplantation 1999;14(5):1158&#x2010;62. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">10344355</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>DerSimonian 1986</Title><Reference><Citation>DerSimonian R, Laird N. Meta&#x2010;analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177&#x2010;88. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Devarajan 2006</Title><Reference><Citation>Devarajan P. Update on mechanisms of ischemic acute kidney injury. Journal of the American Society of Nephrology 2006;17(6):1503&#x2010;20. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">16707563</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Egger 1997</Title><Reference><Citation>Egger M, Davey Smith G, Phillips AN. Meta&#x2010;analysis: Principles and procedures. BMJ 1997;315(7121):1533&#x2010;7. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2127925</ArticleId><ArticleId IdType="pubmed">9432252</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Endo 1976</Title><Reference><Citation>Endo A, Kuroda M, Tanzawa K. Competitive inhibition of 3&#x2010;hydroxy&#x2010;3&#x2010;methylglutaryl coenzyme A reductase by ML&#x2010;236A and ML&#x2010;236B fungal metabolites, having hypocholesterolemic activity. FEBS Letters 1976;72(2):323&#x2010;6. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">16386050</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Gueler 2002</Title><Reference><Citation>Gueler F, Rong S, Park JK, Fiebeler A, Menne J, Elger M, et al. Postischemic acute renal failure is reduced by short&#x2010;term statin treatment in a rat model. Journal of the American Society of Nephrology 2002;13(9):2288&#x2010;98. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">12191973</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Haslinger&#x2010;L&#xf6;ffler 2008</Title><Reference><Citation>Haslinger&#x2010;L&#xf6;ffler B. Multiple effects of HMG&#x2010;CoA reductase inhibitors (statins) besides their lipid&#x2010;lowering function. Kidney International 2008;74(5):553&#x2010;5. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">18709024</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Higgins 2003</Title><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta&#x2010;analyses. BMJ 2003;327(7414):557&#x2010;60. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Higgins 2011</Title><Reference><Citation>Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane&#x2010;handbook.org.</Citation></Reference></ReferenceList><ReferenceList><Title>Inman 2005</Title><Reference><Citation>Inman SR, Davis NA, Mazzone ME, Olson KM, Lukaszek VA, Yoder KN. Simvastatin and L&#x2010;arginine preserve renal function after ischemia/reperfusion injury. American Journal of the Medical Sciences 2005;329(1):13&#x2010;7. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">15654174</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Jo 2008</Title><Reference><Citation>Jo SH, Koo BK, Park JS, Kang HJ, Cho YS, Kim YJ, et al. Prevention of radiocontrast medium&#x2010;induced nephropathy using short&#x2010;term high&#x2010;dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial&#x2010;&#x2010;a randomized controlled study. American Heart Journal 2008;155(3):499, e1&#x2010;8. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">18294484</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Karkouti 2009</Title><Reference><Citation>Karkouti K, Wijeysundera DN, Yau TM, Callum JL, Cheng DC, Crowther M, et al. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation 2009;119(4):495&#x2010;502. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19153273</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lafrance 2010</Title><Reference><Citation>Lafrance JP, Miller DR. Acute kidney injury associates with increased long&#x2010;term mortality. Journal of the American Society of Nephrology 2010;21(2):345&#x2010;52. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2834549</ArticleId><ArticleId IdType="pubmed">20019168</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lamy 2012</Title><Reference><Citation>Lamy A, Devereaux PJ, Prabhakaran D, Taggart DP, Hu S, Paolasso E, et al. Off&#x2010;pump or on&#x2010;pump coronary&#x2010;artery bypass grafting at 30 days. New England Journal of Medicine 2012;366(16):1489&#x2010;97. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">22449296</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Li 2012</Title><Reference><Citation>Li Y, Liu Y, Fu L, Mei C, Dai B. Efficacy of short&#x2010;term high&#x2010;dose statin in preventing contrast&#x2010;induced nephropathy: a meta&#x2010;analysis of seven randomized controlled trials. PLoS One 2012;7(4):e34450. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3325242</ArticleId><ArticleId IdType="pubmed">22511942</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Liakopoulos 2008</Title><Reference><Citation>Liakopoulos OJ, Choi YH, Haldenwang PL, Strauch J, Wittwer T, D&#xf6;rge H, et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta&#x2010;analysis of over 30,000 patients. European Heart Journal 2008;29(12):1548&#x2010;59. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">18506053</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Liakopoulos 2012</Title><Reference><Citation>Liakopoulos OJ, Kuhn EW, Slottosch I, Wassmer G, Wahlers T. Preoperative statin therapy for patients undergoing cardiac surgery. Cochrane Database of Systematic Reviews 2012, Issue 4. [DOI: 10.1002/14651858.CD008493.pub2]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD008493.pub2</ArticleId><ArticleId IdType="pubmed">22513959</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mangano 1998</Title><Reference><Citation>Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Annals of Internal Medicine 1998;128(3):194&#x2010;203. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">9454527</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mariscalco 2011</Title><Reference><Citation>Mariscalco G, Lorusso R, Dominici C, Renzulli A, Sala A. Acute kidney injury: a relevant complication after cardiac surgery. Annals of Thoracic Surgery 2011;92(4):1539&#x2010;47. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">21872837</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mehta 2007</Title><Reference><Citation>Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Critical Care 2007;11(2):R31. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2206446</ArticleId><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mistiaen 2009</Title><Reference><Citation>Mistiaen W, Cauwelaert P, Muylaert P, Worm E. A thousand pericardial valves in aortic position: risk factors for postoperative acute renal function impairment in elderly. Journal of Cardiovascular Surgery 2009;50(2):233&#x2010;7. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">18948862</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Morgan 2009</Title><Reference><Citation>Morgan C, Zappitelli M, Gill P. Statin prophylaxis and inflammatory mediators following cardiopulmonary bypass: a systematic review. Critical Care 2009;13(5):R165. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2784396</ArticleId><ArticleId IdType="pubmed">19840397</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ostermann 2000</Title><Reference><Citation>Ostermann ME, Taube D, Morgan CJ, Evans TW. Acute renal failure following cardiopulmonary bypass: a changing picture. Intensive Care Medicine 2000;26(5):565&#x2010;71. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">10923731</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ozan 2010</Title><Reference><Citation>Ozhan H, Erden I, Ordu S, Aydin M, Caglar O, Basar C, et al. Efficacy of short&#x2010;term high&#x2010;dose atorvastatin for prevention of contrast&#x2010;induced nephropathy in patients undergoing coronary angiography. Angiology 2010;61(7):711&#x2010;4. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">20395226</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Pan 2004</Title><Reference><Citation>Pan W, Pintar T, Anton J, Lee VV, Vaughn WK, Collard CD. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation 2004;110(11 Suppl 1):II45&#x2010;9. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">15364837</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Patti 2008</Title><Reference><Citation>Patti G. Short&#x2010;term high&#x2010;dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction. Journal of Cardiovascular Medicine 2011;12(5):305&#x2010;8. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">21451331</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Srisawat 2010</Title><Reference><Citation>Srisawat N, Lawsin L, Uchino S, Bellomo R, Kellum JA, BEST Kidney Investigators. Cost of acute renal replacement therapy in the intensive care unit: results from The Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) study. Critical Care 2010;14(2):R46. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2887158</ArticleId><ArticleId IdType="pubmed">20346163</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sterne 2001</Title><Reference><Citation>Sterne JA, Egger M, Smith GD. Systematic reviews in health care: investigating and dealing with publication and other biases in meta&#x2010;analysis. BMJ 2001;327(7304):101&#x2010;5. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1120714</ArticleId><ArticleId IdType="pubmed">11451790</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Swaminathan 2007</Title><Reference><Citation>Swaminathan M, Shaw AD, Phillips&#x2010;Bute BG, McGugan&#x2010;Clark PL, Archer LE, Talbert S, et al. Trends in acute renal failure associated with coronary artery bypass graft surgery in the United States. Critical Care Medicine 2007;35(10):2286&#x2010;91. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">17944016</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tabata 2007</Title><Reference><Citation>Tabata M, Khalpey Z, Pirundini PA, Byrne ML, Cohn LH, Rawn JD. Renoprotective effect of preoperative statins in coronary artery bypass grafting. American Journal of Cardiology 2007;100(3):442&#x2010;4. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">17659925</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Thakar 2003</Title><Reference><Citation>Thakar CV, Liangos O, Yared JP, Nelson D, Piedmonte MR, Hariachar S, et al. ARF after open&#x2010;heart surgery: Influence of gender and race. American Journal of Kidney Diseases 2003;41(4):742&#x2010;51. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">12666060</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Yokota 2003</Title><Reference><Citation>Yokota N, O'Donnell M, Daniels F, Burne&#x2010;Taney M, Keane W, Kasiske B, et al. Protective effect of HMG&#x2010;CoA reductase inhibitor on experimental renal ischemia&#x2010;reperfusion injury. American Journal of Nephrology 2003;23(1):13&#x2010;7. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">12373076</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to other published versions of this review</Title><ReferenceList><Title>Lewicki 2013</Title><Reference><Citation>Lewicki M, Ng I, Schneider AG. HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass. Cochrane Database of Systematic Reviews 2013, Issue 4. [DOI: 10.1002/14651858.CD010480]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD010480</ArticleId><ArticleId IdType="pmc">PMC10788137</ArticleId><ArticleId IdType="pubmed">25758322</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29373362</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1530-0293</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>5</Issue><PubDate><Year>2018</Year><Month>May</Month></PubDate></JournalIssue><Title>Critical care medicine</Title><ISOAbbreviation>Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Acute Kidney Injury and Subsequent Frailty Status in Survivors of Critical Illness: A Secondary Analysis.</ArticleTitle><Pagination><StartPage>e380</StartPage><EndPage>e388</EndPage><MedlinePgn>e380-e388</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/CCM.0000000000003003</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Acute kidney injury frequently complicates critical illness and is associated with high morbidity and mortality. Frailty is common in critical illness survivors, but little is known about the impact of acute kidney injury. We examined the association of acute kidney injury and frailty within a year of hospital discharge in survivors of critical illness.</AbstractText><AbstractText Label="DESIGN">Secondary analysis of a prospective cohort study.</AbstractText><AbstractText Label="SETTING">Medical/surgical ICU of a U.S. tertiary care medical center.</AbstractText><AbstractText Label="PATIENTS">Three hundred seventeen participants with respiratory failure and/or shock.</AbstractText><AbstractText Label="INTERVENTIONS">None.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS">Acute kidney injury was determined using Kidney Disease Improving Global Outcomes stages. Clinical frailty status was determined using the Clinical Frailty Scale at 3 and 12 months following discharge. Covariates included mean ICU Sequential Organ Failure Assessment score and Acute Physiology and Chronic Health Evaluation II score as well as baseline comorbidity (i.e., Charlson Comorbidity Index), kidney function, and Clinical Frailty Scale score. Of 317 patients, 243 (77%) had acute kidney injury and one in four patients with acute kidney injury was frail at baseline. In adjusted models, acute kidney injury stages 1, 2, and 3 were associated with higher frailty scores at 3 months (odds ratio, 1.92; 95% CI, 1.14-3.24; odds ratio, 2.40; 95% CI, 1.31-4.42; and odds ratio, 4.41; 95% CI, 2.20-8.82, respectively). At 12 months, a similar association of acute kidney injury stages 1, 2, and 3 and higher Clinical Frailty Scale score was noted (odds ratio, 1.87; 95% CI, 1.11-3.14; odds ratio, 1.81; 95% CI, 0.94-3.48; and odds ratio, 2.76; 95% CI, 1.34-5.66, respectively). In supplemental and sensitivity analyses, analogous patterns of association were observed.</AbstractText><AbstractText Label="CONCLUSIONS">Acute kidney injury in survivors of critical illness predicted worse frailty status 3 and 12 months postdischarge. These findings have important implications on clinical decision making among acute kidney injury survivors and underscore the need to understand the drivers of frailty to improve patient-centered outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abdel-Kader</LastName><ForeName>Khaled</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vanderbilt Center for Kidney Disease (VCKD) and Integrated Program for AKI Research (VIP-AKI), Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Girard</LastName><ForeName>Timothy D</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>Clinical Research, Investigation, and Systems Modeling of Acute Illness (CRISMA) Center, Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brummel</LastName><ForeName>Nathan E</ForeName><Initials>NE</Initials><AffiliationInfo><Affiliation>Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Health Services Research, Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Quality Aging, Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saunders</LastName><ForeName>Christina T</ForeName><Initials>CT</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blume</LastName><ForeName>Jeffrey D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clark</LastName><ForeName>Amanda J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vincz</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vanderbilt Center for Kidney Disease (VCKD) and Integrated Program for AKI Research (VIP-AKI), Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ely</LastName><ForeName>E Wesley</ForeName><Initials>EW</Initials><AffiliationInfo><Affiliation>Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Health Services Research, Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Geriatric Research, Education and Clinical Center (GRECC) Service at the Department of Veterans Affairs Medical Center, Tennessee Valley Healthcare System, Nashville, TN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>James C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Health Services Research, Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Divisions of Geriatric Medicine and General Internal Medicine and Public Health, Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bell</LastName><ForeName>Susan P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Center for Quality Aging, Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University, Nashville, TN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Archer</LastName><ForeName>Kristin R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery and Rehabilitation, Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikizler</LastName><ForeName>T Alp</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vanderbilt Center for Kidney Disease (VCKD) and Integrated Program for AKI Research (VIP-AKI), Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pandharipande</LastName><ForeName>Pratik P</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Division of Anesthesiology Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siew</LastName><ForeName>Edward D</ForeName><Initials>ED</Initials><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vanderbilt Center for Kidney Disease (VCKD) and Integrated Program for AKI Research (VIP-AKI), Vanderbilt University Medical Center, Nashville, TN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Geriatric Research, Education and Clinical Center (GRECC) Service at the Department of Veterans Affairs Medical Center, Tennessee Valley Healthcare System, Nashville, TN.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>I01 HX001280</GrantID><Acronym>HX</Acronym><Agency>HSRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>L30 AG048581</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DK082192</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>IIR 13-073</GrantID><Acronym>HX</Acronym><Agency>HSRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>IIR 13-073</GrantID><Acronym>HX</Acronym><Agency>HSRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>K76 AG054864</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 DK090304</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Med</MedlineTA><NlmUniqueID>0355501</NlmUniqueID><ISSNLinking>0090-3493</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Emerg Crit Care Med. 2018 Nov;2:93. doi: 10.21037/jeccm.2018.10.17.</RefSource><PMID Version="1">30662978</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D018806" MajorTopicYN="N">APACHE</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073496" MajorTopicYN="N">Frailty</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflicts of Interest</b>. The authors have no conflicts to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29373362</ArticleId><ArticleId IdType="mid">NIHMS933024</ArticleId><ArticleId IdType="pmc">PMC5899022</ArticleId><ArticleId IdType="doi">10.1097/CCM.0000000000003003</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cerda J, Lameire N, Eggers P, et al. Epidemiology of acute kidney injury. Clin J Am Soc Nephrol. 2008;3(3):881&#x2013;886.</Citation><ArticleIdList><ArticleId IdType="pubmed">18216347</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisoni R, Wille KM, Tolwani AJ. The epidemiology of severe acute kidney injury: from BEST to PICARD, in acute kidney injury: new concepts. Nephron Clin Pract. 2008;109(4):c188&#x2013;191.</Citation><ArticleIdList><ArticleId IdType="pubmed">18802366</ArticleId></ArticleIdList></Reference><Reference><Citation>Waikar SS, Liu KD, Chertow GM. Diagnosis, epidemiology and outcomes of acute kidney injury. Clin J Am Soc Nephrol. 2008;3(3):844&#x2013;861.</Citation><ArticleIdList><ArticleId IdType="pubmed">18337550</ArticleId></ArticleIdList></Reference><Reference><Citation>Rewa O, Bagshaw SM. Acute kidney injury-epidemiology, outcomes and economics. Nature reviews Nephrology. 2014;10(4):193&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">24445744</ArticleId></ArticleIdList></Reference><Reference><Citation>Villeneuve PM, Clark EG, Sikora L, et al. Health-related quality-of-life among survivors of acute kidney injury in the intensive care unit: a systematic review. Intensive care medicine. 2016;42(2):137&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pubmed">26626062</ArticleId></ArticleIdList></Reference><Reference><Citation>Rockwood K, Fox RA, Stolee P, et al. Frailty in elderly people: an evolving concept. CMAJ: Canadian Medical Association journal = journal de l&#x2019;Association medicale canadienne. 1994;150(4):489&#x2013;495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1486322</ArticleId><ArticleId IdType="pubmed">8313261</ArticleId></ArticleIdList></Reference><Reference><Citation>Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pubmed">11253156</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen KL, Chertow GM, Jin C, et al. Significance of frailty among dialysis patients. J Am Soc Nephrol. 2007;18(11):2960&#x2013;2967.</Citation><ArticleIdList><ArticleId IdType="pubmed">17942958</ArticleId></ArticleIdList></Reference><Reference><Citation>Brummel NE, Bell SP, Girard TD, et al. Frailty and Subsequent Disability and Mortality Among Patients With Critical Illness. Am J Respir Crit Care Med. 2016</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5519959</ArticleId><ArticleId IdType="pubmed">27922747</ArticleId></ArticleIdList></Reference><Reference><Citation>Roshanravan B, Khatri M, Robinson-Cohen C, et al. A prospective study of frailty in nephrology-referred patients with CKD. Am J Kidney Dis. 2012;60(6):912&#x2013;921.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3491110</ArticleId><ArticleId IdType="pubmed">22770927</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilhelm-Leen ER, Hall YN, MKT, et al. Frailty and chronic kidney disease: the Third National Health and Nutrition Evaluation Survey. Am J Med. 2009;122(7):664&#x2013;671. e662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4117255</ArticleId><ArticleId IdType="pubmed">19559169</ArticleId></ArticleIdList></Reference><Reference><Citation>Afilalo J. Frailty in Patients with Cardiovascular Disease: Why, When, and How to Measure. Current cardiovascular risk reports. 2011;5(5):467&#x2013;472.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3165117</ArticleId><ArticleId IdType="pubmed">21949560</ArticleId></ArticleIdList></Reference><Reference><Citation>Flint K. Which came first, the frailty or the heart disease?: exploring the vicious cycle. J Am Coll Cardiol. 2015;65(10):984&#x2013;986.</Citation><ArticleIdList><ArticleId IdType="pubmed">25766944</ArticleId></ArticleIdList></Reference><Reference><Citation>Young P, Shah J, Zhang C, et al. Frailty in Postmenopausal African American and Hispanic HIV-Infected Women. The Journal of frailty &amp; aging. 2016;5(4):242&#x2013;246.</Citation><ArticleIdList><ArticleId IdType="pubmed">27883171</ArticleId></ArticleIdList></Reference><Reference><Citation>Jha SR, Hannu MK, Chang S, et al. The Prevalence and Prognostic Significance of Frailty in Patients With Advanced Heart Failure Referred for Heart Transplantation. Transplantation. 2016;100(2):429&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pubmed">26516676</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouillon K, Kivimaki M, Hamer M, et al. Diabetes risk factors, diabetes risk algorithms, and the prediction of future frailty: the Whitehall II prospective cohort study. Journal of the American Medical Directors Association. 2013;14(11):851e851&#x2013;856.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3820037</ArticleId><ArticleId IdType="pubmed">24103860</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagshaw SM, Stelfox HT, Johnson JA, et al. Long-term association between frailty and health-related quality of life among survivors of critical illness: a prospective multicenter cohort study. Critical care medicine. 2015;43(5):973&#x2013;982.</Citation><ArticleIdList><ArticleId IdType="pubmed">25668751</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandharipande PP, Girard TD, Jackson JC, et al. Long-term cognitive impairment after critical illness. N Engl J Med. 2013;369(14):1306&#x2013;1316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3922401</ArticleId><ArticleId IdType="pubmed">24088092</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfaadhel TA, Soroka SD, Kiberd BA, et al. Frailty and mortality in dialysis: evaluation of a clinical frailty scale. Clin J Am Soc Nephrol. 2015;10(5):832&#x2013;840.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4422241</ArticleId><ArticleId IdType="pubmed">25739851</ArticleId></ArticleIdList></Reference><Reference><Citation>Siew ED, Fissell WH, Tripp CM, et al. Acute Kidney Injury as a Risk Factor for Delirium and Coma during Critical Illness. Am J Respir Crit Care Med. 2016</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5476907</ArticleId><ArticleId IdType="pubmed">27854517</ArticleId></ArticleIdList></Reference><Reference><Citation>Siew ED, Ikizler TA, Matheny ME, et al. Estimating baseline kidney function in hospitalized patients with impaired kidney function. Clin J Am Soc Nephrol. 2012;7(5):712&#x2013;719.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3338282</ArticleId><ArticleId IdType="pubmed">22422536</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow GM, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16(11):3365&#x2013;3370.</Citation><ArticleIdList><ArticleId IdType="pubmed">16177006</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2763564</ArticleId><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas ME, Blaine C, Dawnay A, et al. The definition of acute kidney injury and its use in practice. Kidney Int. 2015;87(1):62&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">25317932</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen KL, Smith MW, Unruh ML, et al. Predictors of health utility among 60-day survivors of acute kidney injury in the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network Study. Clin J Am Soc Nephrol. 2010;5(8):1366&#x2013;1372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2924409</ArticleId><ArticleId IdType="pubmed">20507953</ArticleId></ArticleIdList></Reference><Reference><Citation>Pugh J, Aggett J, Goodland A, et al. Frailty and comorbidity are independent predictors of outcome in patients referred for pre-dialysis education. Clin Kidney J. 2016;9(2):324&#x2013;329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4792625</ArticleId><ArticleId IdType="pubmed">26985387</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of chronic diseases. 1987;40(5):373&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive care medicine. 1996;22(7):707&#x2013;710.</Citation><ArticleIdList><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Critical care medicine. 1985;13(10):818&#x2013;829.</Citation><ArticleIdList><ArticleId IdType="pubmed">3928249</ArticleId></ArticleIdList></Reference><Reference><Citation>Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ: Canadian Medical Association journal = journal de l&#x2019;Association medicale canadienne. 2005;173(5):489&#x2013;495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1188185</ArticleId><ArticleId IdType="pubmed">16129869</ArticleId></ArticleIdList></Reference><Reference><Citation>Basic D, Shanley C. Frailty in an older inpatient population: using the clinical frailty scale to predict patient outcomes. Journal of aging and health. 2015;27(4):670&#x2013;685.</Citation><ArticleIdList><ArticleId IdType="pubmed">25414168</ArticleId></ArticleIdList></Reference><Reference><Citation>McIsaac DI, Taljaard M, Bryson GL, et al. Comparative assessment of two frailty instruments for risk-stratification in elderly surgical patients: study protocol for a prospective cohort study. BMC Anesthesiol. 2016;16(1):111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5109639</ArticleId><ArticleId IdType="pubmed">27842511</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Ortuno R, Wallis S, Biram R, et al. Clinical frailty adds to acute illness severity in predicting mortality in hospitalized older adults: An observational study. European journal of internal medicine. 2016;35:24&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">27596721</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimura T, Yamamoto M, Kano S, et al. Impact of the Clinical Frailty Scale on Outcomes After Transcatheter Aortic Valve Replacement. Circulation. 2017;135(21):2013&#x2013;2024.</Citation><ArticleIdList><ArticleId IdType="pubmed">28302751</ArticleId></ArticleIdList></Reference><Reference><Citation>Team RDC. R: A language and environment for statistical computing. R Foundation for Statistical Computing; 2013.</Citation></Reference><Reference><Citation>Butcher BW, Liu KD. Fluid overload in AKI: epiphenomenon or putative effect on mortality? Current opinion in critical care. 2012;18(6):593&#x2013;598.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3782260</ArticleId><ArticleId IdType="pubmed">23037878</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi JS, Kim YA, Kang YU, et al. Clinical impact of hospital-acquired anemia in association with acute kidney injury and chronic kidney disease in patients with acute myocardial infarction. PloS one. 2013;8(9):e75583.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3782440</ArticleId><ArticleId IdType="pubmed">24086579</ArticleId></ArticleIdList></Reference><Reference><Citation>Go AS, Parikh CR, Ikizler TA, et al. The assessment, serial evaluation, and subsequent sequelae of acute kidney injury (ASSESS-AKI) study: design and methods. BMC Nephrol. 2010;11:22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2944247</ArticleId><ArticleId IdType="pubmed">20799966</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox ZL, McCoy AB, Matheny ME, et al. Adverse drug events during AKI and its recovery. Clin J Am Soc Nephrol. 2013;8(7):1070&#x2013;1078.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3700703</ArticleId><ArticleId IdType="pubmed">23539228</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Kolic I, Purdell-Lewis J, et al. Serum creatinine changes associated with critical illness and detection of persistent renal dysfunction after AKI. Clin J Am Soc Nephrol. 2014;9(6):1015&#x2013;1023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4046736</ArticleId><ArticleId IdType="pubmed">24742481</ArticleId></ArticleIdList></Reference><Reference><Citation>de Vries NM, Staal JB, van Ravensberg CD, et al. Outcome instruments to measure frailty: a systematic review. Ageing research reviews. 2011;10(1):104&#x2013;114.</Citation><ArticleIdList><ArticleId IdType="pubmed">20850567</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabb H, Griffin MD, McKay DB, et al. Inflammation in AKI: Current Understanding, Key Questions, and Knowledge Gaps. J Am Soc Nephrol. 2016;27(2):371&#x2013;379.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4731128</ArticleId><ArticleId IdType="pubmed">26561643</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein SL, Jaber BL, Faubel S, et al. AKI transition of care: a potential opportunity to detect and prevent CKD. Clin J Am Soc Nephrol. 2013;8(3):476&#x2013;483.</Citation><ArticleIdList><ArticleId IdType="pubmed">23471414</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu RK, McCulloch CE, Dudley RA, et al. Temporal changes in incidence of dialysis-requiring AKI. J Am Soc Nephrol. 2013;24(1):37&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3537221</ArticleId><ArticleId IdType="pubmed">23222124</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameron ID, Fairhall N, Langron C, et al. A multifactorial interdisciplinary intervention reduces frailty in older people: randomized trial. BMC Med. 2013;11:65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3751685</ArticleId><ArticleId IdType="pubmed">23497404</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen KL, Chertow GM, Jin C, et al. Significance of frailty among dialysis patients. Journal of the American Society of Nephrology. 2007;18(11):2960&#x2013;2967.</Citation><ArticleIdList><ArticleId IdType="pubmed">17942958</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez Villarreal I, Ortega O, Hinostroza J, et al. Geriatric assessment for therapeutic decision-making regarding renal replacement in elderly patients with advanced chronic kidney disease. Nephron Clin Pract. 2014;128(1&#x2013;2):73&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">25378358</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurella Tamura M, Winkelmayer WC. Treated and untreated kidney failure in older adults: what&#x2019;s the right balance? JAMA. 2012;307(23):2545&#x2013;2546.</Citation><ArticleIdList><ArticleId IdType="pubmed">22797456</ArticleId></ArticleIdList></Reference><Reference><Citation>Faller B, Beuscart JB, Frimat L, et al. Competing-risk analysis of death and dialysis initiation among elderly (&gt;/=80 years) newly referred to nephrologists: a French prospective study. BMC Nephrol. 2013;14(1):103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3662583</ArticleId><ArticleId IdType="pubmed">23659341</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemmelgarn BR, James MT, Manns BJ, et al. Rates of treated and untreated kidney failure in older vs younger adults. JAMA. 2012;307(23):2507&#x2013;2515.</Citation><ArticleIdList><ArticleId IdType="pubmed">22797451</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams AW. Older Adults with CKD and Acute Kidney Failure: Do We Know Enough for Critical Shared Decision Making? Journal of the American Society of Nephrology. 2013</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3871786</ArticleId><ArticleId IdType="pubmed">24262792</ArticleId></ArticleIdList></Reference><Reference><Citation>van Loon IN, Goto NA, Boereboom FTJ, et al. Frailty Screening Tools for Elderly Patients Incident to Dialysis. Clin J Am Soc Nephrol. 2017;12(9):1480&#x2013;1488.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5586582</ArticleId><ArticleId IdType="pubmed">28716855</ArticleId></ArticleIdList></Reference><Reference><Citation>Theou O, Brothers TD, Mitnitski A, et al. Operationalization of frailty using eight commonly used scales and comparison of their ability to predict all-cause mortality. J Am Geriatr Soc. 2013;61(9):1537&#x2013;1551.</Citation><ArticleIdList><ArticleId IdType="pubmed">24028357</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294(7):813&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pubmed">16106006</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39494507</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1525-6049</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Renal failure</Title><ISOAbbreviation>Ren Fail</ISOAbbreviation></Journal><ArticleTitle>Intraoperative hyperthermia is associated with increased acute kidney injury following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a retrospective cohort study.</ArticleTitle><Pagination><StartPage>2420835</StartPage><MedlinePgn>2420835</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2420835</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/0886022X.2024.2420835</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Acute kidney injury (AKI) is common after cytoreduction surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) for peritoneal surface malignancies. Herein we analyzed the association between intraoperative hyperthermia and AKI following CRS-HIPEC.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">In this retrospective cohort study, we collected baseline and perioperative data from patients who underwent CRS-HIPEC mainly for pseudomyxoma peritonei between 2014 and 2020. Nasopharyngeal temperature was recorded at 5-min intervals. The area above the threshold was calculated for intraoperative hyperthermia (&gt;37.0&#x2009;&#xb0;C). AKI was diagnosed and classified according to the KDIGO creatinine criteria. A multivariable logistic regression model was established to assess the association between hyperthermia and AKI.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 480 patients were included in the analysis. Of these, 10.6% (51/480) developed AKI within 7 postoperative days. After correction for confounding factors, a larger area above the threshold of hyperthermia was significantly associated with an increased risk of AKI (odds ratio [OR] 1.36, 95% CI 1.14-1.63, <i>p</i>&#x2009;=&#x2009;0.001). Among other factors, older age (OR 1.05, 95% CI 1.02-1.09, <i>p</i>&#x2009;=&#x2009;0.002), postoperative hypotension requiring vasopressors (OR 2.09, 95% CI 1.02-4.27, <i>p</i>&#x2009;=&#x2009;0.042), and intraperitoneal chemotherapy containing cisplatin (OR 2.75, 95% CI 1.20-6.33, <i>p</i>&#x2009;=&#x2009;0.017) were also associated with an increased risk of AKI. Patients with AKI required longer mechanical ventilation, stayed longer in the intensive care unit and hospital, developed more complications, and required more intensive care unit readmission.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Among patients undergoing CRS-HIPEC, intraoperative hyperthermia was independently associated with a higher risk of AKI; this effect was additive to other risk factors including cisplatin-containing chemotherapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Shun-Cai</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Peking University First Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Aerospace Center Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Jia-Hui</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Peking University First Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Peking University First Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Rui-Qing</ForeName><Initials>RQ</Initials><AffiliationInfo><Affiliation>Department of Myxoma, Aerospace Center Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Su-Li</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Aerospace Center Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dong-Xin</ForeName><Initials>DX</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Peking University First Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Outcomes Research Consortium, Houston, TX, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ren Fail</MedlineTA><NlmUniqueID>8701128</NlmUniqueID><ISSNLinking>0886-022X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065426" MajorTopicYN="Y">Cytoreduction Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000084262" MajorTopicYN="Y">Hyperthermic Intraperitoneal Chemotherapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010534" MajorTopicYN="Y">Peritoneal Neoplasms</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006979" MajorTopicYN="Y">Hyperthermia, Induced</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011553" MajorTopicYN="N">Pseudomyxoma Peritonei</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Peritoneal surface malignancies</Keyword><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">cytoreductive surgery</Keyword><Keyword MajorTopicYN="N">hyperthermic intraperitoneal chemotherapy</Keyword><Keyword MajorTopicYN="N">postoperative complications</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>12</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>5</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39494507</ArticleId><ArticleId IdType="pmc">PMC11536636</ArticleId><ArticleId IdType="doi">10.1080/0886022X.2024.2420835</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Macr&#xec; A. New approach to peritoneal surface malignancies. World J Gastrointest Oncol. 2010;2(1):9&#x2013;11. doi: 10.4251/wjgo.v2.i1.9.</Citation><ArticleIdList><ArticleId IdType="doi">10.4251/wjgo.v2.i1.9</ArticleId><ArticleId IdType="pmc">PMC2999159</ArticleId><ArticleId IdType="pubmed">21160811</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua TC, Liauw W, Saxena A, et al. . Evolution of locoregional treatment for peritoneal carcinomatosis: single-center experience of 308 procedures of &#xad;cytoreductive &#xad;surgery and perioperative intraperitoneal chemotherapy. Am J Surg. 2011;201(2):149&#x2013;156. doi: 10.1016/j.amjsurg.2010.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2010.02.012</ArticleId><ArticleId IdType="pubmed">20832051</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugarbaker PH. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Eur J Surg Oncol. 2001;27(3):239&#x2013;243. doi: 10.1053/ejso.2000.1038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/ejso.2000.1038</ArticleId><ArticleId IdType="pubmed">11373099</ArticleId></ArticleIdList></Reference><Reference><Citation>Deraco M, Baratti D, Cabras AD, et al. . Experience with peritoneal mesothelioma at the Milan National Cancer Institute. World J Gastrointest Oncol. 2010;2(2):76&#x2013;84. doi: 10.4251/wjgo.v2.i2.76.</Citation><ArticleIdList><ArticleId IdType="doi">10.4251/wjgo.v2.i2.76</ArticleId><ArticleId IdType="pmc">PMC2999160</ArticleId><ArticleId IdType="pubmed">21160925</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Yu Y, Liu Y.. Report on the 9(th) International Congress on Peritoneal Surface Malignancies. Cancer Biol Med. 2014;11(4):281&#x2013;284. doi: 10.7497/j.issn.2095-3941.2014.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.7497/j.issn.2095-3941.2014.04.008</ArticleId><ArticleId IdType="pmc">PMC4296089</ArticleId><ArticleId IdType="pubmed">25610715</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb CA, Weyker PD, Moitra VK, et al. . An overview of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for the anesthesiologist. Anesth Analg. 2013;116(4):924&#x2013;931. doi: 10.1213/ANE.0b013e3182860fff.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e3182860fff</ArticleId><ArticleId IdType="pubmed">23460568</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheshadri DB, Chakravarthy MR.. Anaesthetic considerations in the perioperative management of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Indian J Surg Oncol. 2016;7(2):236&#x2013;243. doi: 10.1007/s13193-016-0508-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13193-016-0508-2</ArticleId><ArticleId IdType="pmc">PMC4818608</ArticleId><ArticleId IdType="pubmed">27065715</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezu L, Raineau M, Delom&#xe9;nie M, et al. . Haemodynamic management during hyperthermic intraperitoneal chemotherapy: a systematic review. Anaesth Crit Care Pain Med. 2020;39(4):531&#x2013;542. doi: 10.1016/j.accpm.2020.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.accpm.2020.03.019</ArticleId><ArticleId IdType="pubmed">32320757</ArticleId></ArticleIdList></Reference><Reference><Citation>Turan A, Cohen B, Adegboye J, et al. . Mild acute kidney injury after noncardiac surgery is associated with long-term renal dysfunction: a retrospective cohort study. Anesthesiology. 2020;132(5):1053&#x2013;1061. doi: 10.1097/ALN.0000000000003109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003109</ArticleId><ArticleId IdType="pubmed">31929326</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste EA, De Corte W.. AKI patients have worse long-term outcomes, especially in the immediate post-ICU period. Crit Care. 2012;16(4):148. doi: 10.1186/cc11470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11470</ArticleId><ArticleId IdType="pmc">PMC3580744</ArticleId><ArticleId IdType="pubmed">22958588</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson C, Ozrazgat-Baslanti T, Kuxhausen A, et al. . Cost and mortality associated with postoperative acute kidney injury. Ann Surg. 2015;261(6):1207&#x2013;1214. doi: 10.1097/SLA.0000000000000732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000000732</ArticleId><ArticleId IdType="pmc">PMC4247993</ArticleId><ArticleId IdType="pubmed">24887982</ArticleId></ArticleIdList></Reference><Reference><Citation>Biteker M, Dayan A, Tekke&#x15f;in A&#x130;, et al. . Incidence, risk factors, and outcomes of perioperative acute kidney injury in noncardiac and nonvascular surgery. Am J Surg. 2014;207(1):53&#x2013;59. doi: 10.1016/j.amjsurg.2013.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2013.04.006</ArticleId><ArticleId IdType="pubmed">24050540</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Kellum JA, Ronco C.. Acute kidney injury. Lancet. 2012;380(9843):756&#x2013;766. doi: 10.1016/S0140-6736(11)61454-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)61454-2</ArticleId><ArticleId IdType="pubmed">22617274</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Xiao Z, Zhao X, et al. . Incidence, risk factors, and outcomes of the transition of HIPEC-induced acute kidney injury to acute kidney disease: a retrospective study. Ren Fail. 2024;46(1):2338482. doi: 10.1080/0886022X.2024.2338482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/0886022X.2024.2338482</ArticleId><ArticleId IdType="pmc">PMC11011229</ArticleId><ArticleId IdType="pubmed">38604946</ArticleId></ArticleIdList></Reference><Reference><Citation>Sin EI, Chia CS, Tan GHC, et al. . Acute kidney injury in ovarian cancer patients undergoing cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. Int J Hyperthermia. 2017;33(6):690&#x2013;695. doi: 10.1080/02656736.2017.1293304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02656736.2017.1293304</ArticleId><ArticleId IdType="pubmed">28540777</ArticleId></ArticleIdList></Reference><Reference><Citation>Angeles MA, Quenet F, Vieille P, et al. . Predictive risk &#xad;factors of acute kidney injury after cytoreductive surgery and cisplatin-based hyperthermic intra-peritoneal &#xad;chemotherapy for ovarian peritoneal carcinomatosis. Int J Gynecol Cancer. 2019;29(2):382&#x2013;391. doi: 10.1136/ijgc-2018-000099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ijgc-2018-000099</ArticleId><ArticleId IdType="pubmed">30674567</ArticleId></ArticleIdList></Reference><Reference><Citation>Hakeam HA, Breakiet M, Azzam A, et al. . The incidence of cisplatin nephrotoxicity post hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive &#xad;surgery. Ren Fail. 2014;36(10):1486&#x2013;1491. doi: 10.3109/0886022X.2014.949758.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/0886022X.2014.949758</ArticleId><ArticleId IdType="pubmed">25155314</ArticleId></ArticleIdList></Reference><Reference><Citation>Arjona-S&#xe1;nchez A, Cadenas-Febres A, Cabrera-Bermon J, et al. . Assessment of RIFLE and AKIN criteria to define acute renal dysfunction for HIPEC procedures for ovarian and non-ovarian peritoneal malignances. Eur J Surg Oncol. 2016;42(6):869&#x2013;876. doi: 10.1016/j.ejso.2015.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejso.2015.12.016</ArticleId><ArticleId IdType="pubmed">26898841</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye J, Ren Y, Wei Z, et al. . Nephrotoxicity and long-term survival investigations for patients with peritoneal carcinomatosis using hyperthermic intraperitoneal chemotherapy with cisplatin: a retrospective cohort study. Surg Oncol. 2018;27(3):456&#x2013;461. doi: 10.1016/j.suronc.2018.05.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.suronc.2018.05.025</ArticleId><ArticleId IdType="pubmed">30217302</ArticleId></ArticleIdList></Reference><Reference><Citation>Naffouje SA, Tulla KA, Chorley R, et al. . Acute kidney injury increases the rate of major morbidities in cytoreductive surgery and HIPEC. Ann Med Surg. 2018;35:163&#x2013;168. doi: 10.1016/j.amsu.2018.09.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2018.09.036</ArticleId><ArticleId IdType="pmc">PMC6178214</ArticleId><ArticleId IdType="pubmed">30310679</ArticleId></ArticleIdList></Reference><Reference><Citation>Hod T, Freedberg KJ, Motwani SS, et al. . Acute kidney injury after cytoreductive surgery and hyperthermic intraoperative cisplatin chemotherapy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2021;161(4):1510&#x2013;1518. doi: 10.1016/j.jtcvs.2020.05.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2020.05.033</ArticleId><ArticleId IdType="pubmed">32631662</ArticleId></ArticleIdList></Reference><Reference><Citation>Liesenfeld LF, Wagner B, Hillebrecht HC, et al. . HIPEC-induced acute kidney injury: a retrospective clinical study and preclinical model. Ann Surg Oncol. 2022;29(1):139&#x2013;151. doi: 10.1245/s10434-021-10376-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-021-10376-5</ArticleId><ArticleId IdType="pmc">PMC8677640</ArticleId><ArticleId IdType="pubmed">34260006</ArticleId></ArticleIdList></Reference><Reference><Citation>Cata JP, Zavala AM, Van Meter A, et al. . Identification of risk factors associated with postoperative acute kidney injury after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a retrospective study. Int J Hyperthermia. 2018;34(5):538&#x2013;544. doi: 10.1080/02656736.2017.1368096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02656736.2017.1368096</ArticleId><ArticleId IdType="pubmed">28812384</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceresoli M, Coccolini F, Ansaloni L.. HIPEC and nephrotoxicity: a cisplatin induced effect? Eur J Surg Oncol. 2016;42(6):909&#x2013;910. doi: 10.1016/j.ejso.2015.08.174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejso.2015.08.174</ArticleId><ArticleId IdType="pubmed">26965304</ArticleId></ArticleIdList></Reference><Reference><Citation>Coccolini F, Corbella D, Finazzi P, et al. . Time course of cytokines, hemodynamic and metabolic parameters during hyperthermic intraperitoneal chemotherapy. Minerva Anestesiol. 2016;82(3):310&#x2013;319.</Citation><ArticleIdList><ArticleId IdType="pubmed">26184701</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman CL, Johnson BD, Vargas NT, et al. . Both hyperthermia and dehydration during physical work in the heat contribute to the risk of acute kidney injury. J Appl Physiol. 2020;128(4):715&#x2013;728. doi: 10.1152/japplphysiol.00787.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00787.2019</ArticleId><ArticleId IdType="pmc">PMC7191500</ArticleId><ArticleId IdType="pubmed">32078468</ArticleId></ArticleIdList></Reference><Reference><Citation>Boodhwani M, Rubens FD, Wozny D, et al. . Effects of mild hypothermia and rewarming on renal function after coronary artery bypass grafting. Ann Thorac Surg. 2009;87(2):489&#x2013;495. doi: 10.1016/j.athoracsur.2008.10.078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2008.10.078</ArticleId><ArticleId IdType="pubmed">19161766</ArticleId></ArticleIdList></Reference><Reference><Citation>Newland RF, Baker RA, Mazzone AL, et al. . Rewarming temperature during cardiopulmonary bypass and acute kidney injury: a multicenter analysis. Ann Thorac Surg. 2016;101(5):1655&#x2013;1662. doi: 10.1016/j.athoracsur.2016.01.086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2016.01.086</ArticleId><ArticleId IdType="pubmed">27041450</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendrix RJ, Kassira JP, Lambert LA.. Elevated maximum core body temperature during hyperthermic intraperitoneal chemoperfusion (HIPEC) is associated with &#xad;increased postoperative complications. Ann Surg Oncol. 2020;27(1):232&#x2013;239. doi: 10.1245/s10434-019-07495-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-019-07495-5</ArticleId><ArticleId IdType="pubmed">31286314</ArticleId></ArticleIdList></Reference><Reference><Citation>Solanki SL, Mukherjee S, Agarwal V, et al. . Society of Onco-Anaesthesia and Perioperative Care consensus guidelines for perioperative management of patients for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC). Indian J Anaesth. 2019;63(12):972&#x2013;987. doi: 10.4103/ija.IJA_765_19.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ija.IJA_765_19</ArticleId><ArticleId IdType="pmc">PMC6921319</ArticleId><ArticleId IdType="pubmed">31879421</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221(1):29&#x2013;42. doi: 10.1097/00000658-199501000-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-199501000-00004</ArticleId><ArticleId IdType="pmc">PMC1234492</ArticleId><ArticleId IdType="pubmed">7826158</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Zhou Y-F, Liang H, et al. . Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies. World J Gastroenterol. 2016;22(30):6906&#x2013;6916. doi: 10.3748/wjg.v22.i30.6906.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v22.i30.6906</ArticleId><ArticleId IdType="pmc">PMC4974588</ArticleId><ArticleId IdType="pubmed">27570426</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan H, Li B, Couris CM, et al. . Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676&#x2013;682. doi: 10.1093/aje/kwq433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwq433</ArticleId><ArticleId IdType="pubmed">21330339</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr NJ, Cecil TD, Mohamed F, et al. . A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the Peritoneal Surface Oncology Group International (PSOGI) modified Delphi process. Am J Surg Pathol. 2016;40(1):14&#x2013;26. doi: 10.1097/PAS.0000000000000535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PAS.0000000000000535</ArticleId><ArticleId IdType="pubmed">26492181</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacquet P, Sugarbaker PH.. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359&#x2013;374. doi: 10.1007/978-1-4613-1247-5_23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4613-1247-5_23</ArticleId><ArticleId IdType="pubmed">8849962</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179&#x2013;c184. doi: 10.1159/000339789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000339789</ArticleId><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Katayama H, Kurokawa Y, Nakamura K, et al. . Extended Clavien-Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria. Surg Today. 2016;46(6):668&#x2013;685. doi: 10.1007/s00595-015-1236-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00595-015-1236-x</ArticleId><ArticleId IdType="pmc">PMC4848327</ArticleId><ArticleId IdType="pubmed">26289837</ArticleId></ArticleIdList></Reference><Reference><Citation>Valenzuela CD, Levine EA, Mangieri CW, et al. . Repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for cancers with peritoneal metastasis: a 30-year institutional experience. Ann Surg Oncol. 2022;29(6):3436&#x2013;3445. doi: 10.1245/s10434-022-11441-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-022-11441-3</ArticleId><ArticleId IdType="pmc">PMC10088912</ArticleId><ArticleId IdType="pubmed">35286531</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang JF, Lv L, Zhao S, et al. . Hyperthermic intraperitoneal chemotherapy (HIPEC) combined with surgery: a 12-year meta-analysis of this promising treatment strategy for advanced gastric cancer at different stages. Ann Surg Oncol. 2022;29(5):3170&#x2013;3186. doi: 10.1245/s10434-021-11316-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-021-11316-z</ArticleId><ArticleId IdType="pubmed">35175455</ArticleId></ArticleIdList></Reference><Reference><Citation>Balachandran R, Mogensen LZ, Christensen P, et al. . Organ-specific adverse effects after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2022;29(9):6049&#x2013;6083. doi: 10.1245/s10434-022-11356-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-022-11356-z</ArticleId><ArticleId IdType="pubmed">35217973</ArticleId></ArticleIdList></Reference><Reference><Citation>Fakheri RJ, Goldfarb DS.. Ambient temperature as a contributor to kidney stone formation: implications of global warming. Kidney Int. 2011;79(11):1178&#x2013;1185. doi: 10.1038/ki.2011.76.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2011.76</ArticleId><ArticleId IdType="pubmed">21451456</ArticleId></ArticleIdList></Reference><Reference><Citation>Lameire NH, Bagga A, Cruz D, et al. . Acute kidney injury: an increasing global concern. Lancet. 2013;382(9887):170&#x2013;179. doi: 10.1016/S0140-6736(13)60647-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)60647-9</ArticleId><ArticleId IdType="pubmed">23727171</ArticleId></ArticleIdList></Reference><Reference><Citation>Upamalika SWAM, Wannige CT, Vidanagamachchi SM, et al. . A review of molecular mechanisms linked to potential renal injury agents in tropical rural farming communities. Environ Toxicol Pharmacol. 2022;92:103850. doi: 10.1016/j.etap.2022.103850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.etap.2022.103850</ArticleId><ArticleId IdType="pubmed">35301132</ArticleId></ArticleIdList></Reference><Reference><Citation>Hess HW, Stooks JJ, Baker TB, et al. . Kidney injury risk during prolonged exposure to current and projected wet bulb temperatures occurring during extreme heat events in healthy young men. J Appl Physiol. 2022;133(1):27&#x2013;40. doi: 10.1152/japplphysiol.00601.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00601.2021</ArticleId><ArticleId IdType="pmc">PMC9236880</ArticleId><ArticleId IdType="pubmed">35616302</ArticleId></ArticleIdList></Reference><Reference><Citation>Houser MC, Mac V, Smith DJ, et al. . Inflammation-related factors identified as biomarkers of dehydration and &#xad;subsequent acute kidney injury in agricultural workers. Biol Res Nurs. 2021;23(4):676&#x2013;688. doi: 10.1177/10998004211016070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10998004211016070</ArticleId><ArticleId IdType="pmc">PMC8726423</ArticleId><ArticleId IdType="pubmed">34018403</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen KL, Shamavonian R, Karpes JB, et al. . Acute kidney injury following hyperthermic intraperitoneal chemotherapy with cisplatin. Anticancer Res. 2021;41(3):1641&#x2013;1646. doi: 10.21873/anticanres.14926.</Citation><ArticleIdList><ArticleId IdType="doi">10.21873/anticanres.14926</ArticleId><ArticleId IdType="pubmed">33788760</ArticleId></ArticleIdList></Reference><Reference><Citation>Sastry J, Kellie SJ.. Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine. Pediatr Hematol Oncol. 2005;22(5):441&#x2013;445. doi: 10.1080/08880010590964381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08880010590964381</ArticleId><ArticleId IdType="pubmed">16020136</ArticleId></ArticleIdList></Reference><Reference><Citation>Arany I, Safirstein RL.. Cisplatin nephrotoxicity. Semin Nephrol. 2003;23(5):460&#x2013;464. doi: 10.1016/s0270-9295(03)00089-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0270-9295(03)00089-5</ArticleId><ArticleId IdType="pubmed">13680535</ArticleId></ArticleIdList></Reference><Reference><Citation>Madias NE, Harrington JT.. Platinum nephrotoxicity. Am J Med. 1978;65(2):307&#x2013;314. doi: 10.1016/0002-9343(78)90825-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(78)90825-2</ArticleId><ArticleId IdType="pubmed">99034</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein RS, Mayor GH.. Minireview. The nephrotoxicity of cisplatin. Life Sci. 1983;32(7):685&#x2013;690. doi: 10.1016/0024-3205(83)90299-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0024-3205(83)90299-0</ArticleId><ArticleId IdType="pubmed">6338333</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansaloni L, Coccolini F, Morosi L, et al. . Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer. Br J Cancer. 2015;112(2):306&#x2013;312. doi: 10.1038/bjc.2014.602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bjc.2014.602</ArticleId><ArticleId IdType="pmc">PMC4453456</ArticleId><ArticleId IdType="pubmed">25461804</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhadjari N, Gabato W, Calabrese D, et al. . Reply letter to: HIPEC and nephrotoxicity: a cisplatin induced effect? Eur J Surg Oncol. 2016;42(6):907&#x2013;908. doi: 10.1016/j.ejso.2016.02.243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejso.2016.02.243</ArticleId><ArticleId IdType="pubmed">26996250</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohno S, Siddik ZH, Kido Y, et al. . Thermal enhancement of drug uptake and DNA adducts as a possible mechanism for the effect of sequencing hyperthermia on cisplatin-induced cytotoxicity in L1210 cells. Cancer Chemother Pharmacol. 1994;34(4):302&#x2013;306. doi: 10.1007/BF00686037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00686037</ArticleId><ArticleId IdType="pubmed">8033297</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Vaart PJ, van der Vange N, Zoetmulder FA, et al. . Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell lines. Eur J Cancer. 1998;34(1):148&#x2013;154. doi: 10.1016/s0959-8049(97)00370-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0959-8049(97)00370-5</ArticleId><ArticleId IdType="pubmed">9624250</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobamowo H, Prabhakar SS.. The kidney in aging: physiological changes and pathological implications. Prog Mol Biol Transl Sci. 2017;146:303&#x2013;340. doi: 10.1016/bs.pmbts.2016.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.pmbts.2016.12.018</ArticleId><ArticleId IdType="pubmed">28253989</ArticleId></ArticleIdList></Reference><Reference><Citation>Smischney NJ, Shaw AD, Stapelfeldt WH, et al. . Postoperative hypotension in patients discharged to the intensive care unit after non-cardiac surgery is associated with adverse clinical outcomes. Crit Care. 2020;24(1):682. doi: 10.1186/s13054-020-03412-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03412-5</ArticleId><ArticleId IdType="pmc">PMC7720547</ArticleId><ArticleId IdType="pubmed">33287872</ArticleId></ArticleIdList></Reference><Reference><Citation>Liem VGB, Hoeks SE, Mol KHJM, et al. . Postoperative &#xad;hypotension after noncardiac surgery and the &#xad;association with myocardial injury. Anesthesiology. 2020;133(3):510&#x2013;522. doi: 10.1097/ALN.0000000000003368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003368</ArticleId><ArticleId IdType="pubmed">32487822</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow GM, Burdick E, Honour M, et al. . Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16(11):3365&#x2013;3370. doi: 10.1681/ASN.2004090740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2004090740</ArticleId><ArticleId IdType="pubmed">16177006</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhadjari N, Gabato W, Calabrese D, et al. . Hyperthermic intraperitoneal chemotherapy with cisplatin: amifostine prevents acute severe renal impairment. Eur J Surg Oncol. 2016;42(2):219&#x2013;223. doi: 10.1016/j.ejso.2015.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejso.2015.07.016</ArticleId><ArticleId IdType="pubmed">26278017</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurreck A, Gronau F, Alberto Vilchez ME, et al. . Sodium thiosulfate reduces acute kidney injury in patients undergoing cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with cisplatin: a single-center observational study. Ann Surg Oncol. 2022;29(1):152&#x2013;162. doi: 10.1245/s10434-021-10508-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-021-10508-x</ArticleId><ArticleId IdType="pmc">PMC8677645</ArticleId><ArticleId IdType="pubmed">34350529</ArticleId></ArticleIdList></Reference><Reference><Citation>Markowiak T, Kerner N, Neu R, et al. . Adequate nephroprotection reduces renal complications after hyperthermic intrathoracic chemotherapy. J Surg Oncol. 2019;120(7):1220&#x2013;1226. doi: 10.1002/jso.25726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jso.25726</ArticleId><ArticleId IdType="pubmed">31602673</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33549321</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>126</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Mar</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Intraoperative venous congestion and acute kidney injury in cardiac surgery: an observational cohort study.</ArticleTitle><Pagination><StartPage>599</StartPage><EndPage>607</EndPage><MedlinePgn>599-607</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2020.12.028</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(20)31050-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Increased intravascular volume has been associated with protection from acute kidney injury (AKI), but in patients with congestive heart failure, venous congestion is associated with increased AKI. We tested the hypothesis that intraoperative venous congestion is associated with AKI after cardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In patients enrolled in the Statin AKI Cardiac Surgery trial, venous congestion was quantified as the area under the curve (AUC) of central venous pressure (CVP) &gt;12, 16, or 20 mm Hg during surgery (mm Hg min). AKI was defined using Kidney Disease Improving Global Outcomes (KDIGO) criteria and urine concentrations of tissue inhibitor of metalloproteinase-2 and insulin-like growth factor binding protein 7 ([TIMP-2]&#x22c5;[IGFBP7]), a marker of renal stress. We measured associations between venous congestion, AKI and [TIMP-2]&#x22c5;[IGFBP7], adjusted for potential confounders. Values are reported as median (25th-75th percentile).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Based on KDIGO criteria, 104 of 425 (24.5%) patients developed AKI. The venous congestion AUCs were 273 mm Hg min (81-567) for CVP &gt;12 mm Hg, 66 mm Hg min (12-221) for CVP &gt;16 mm Hg, and 11 mm Hg min (1-54) for CVP &gt;20 mm Hg. A 60 mm Hg min increase above the median venous congestion AUC above each threshold was independently associated with increased AKI (odds ratio=1.06; 95% confidence interval [CI], 1.02-1.10; P=0.008; odds ratio=1.12; 95% CI, 1.02-1.23; P=0.013; and odds ratio=1.30; 95% CI, 1.06-1.59; P=0.012 for CVP&gt;12, &gt;16, and &gt;20 mm Hg, respectively). Venous congestion before cardiopulmonary bypass was also associated with increased [TIMP-2]&#x22c5;[IGFBP7] measured during cardiopulmonary bypass and after surgery, but neither venous congestion after cardiopulmonary bypass nor venous congestion throughout surgery was associated with postoperative [TIMP-2]&#x22c5;[IGFBP7].</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Intraoperative venous congestion was independently associated with increased AKI after cardiac surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 British Journal of Anaesthesia. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lopez</LastName><ForeName>Marcos G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Division of Anesthesiology Critical Care Medicine, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: marcos.g.lopez@vumc.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shotwell</LastName><ForeName>Matthew S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morse</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Yafen</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Anesthesia, Department of Anesthesiology, University of Texas Health Science Center at Houston, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wanderer</LastName><ForeName>Jonathan P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Absi</LastName><ForeName>Tarek S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balsara</LastName><ForeName>Keki R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levack</LastName><ForeName>Melissa M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Ashish S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hernandez</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Anesthesiology Critical Care Medicine, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA; Division of Cardiothoracic Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Billings</LastName><ForeName>Frederic T</ForeName><Initials>FT</Initials><Suffix>4th</Suffix><AffiliationInfo><Affiliation>Division of Anesthesiology Critical Care Medicine, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA; Division of Cardiothoracic Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 GM102676</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 GM129662</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>L30 HL133985</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM112871</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Br J Anaesth. 2021 Sep;127(3):e81-e82. doi: 10.1016/j.bja.2021.05.028.</RefSource><PMID Version="1">34176595</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002496" MajorTopicYN="Y">Central Venous Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006940" MajorTopicYN="N">Hyperemia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007432" MajorTopicYN="N">Intraoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">central venous pressure</Keyword><Keyword MajorTopicYN="N">urine biomarkers</Keyword><Keyword MajorTopicYN="N">venous congestion</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>7</Day><Hour>20</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33549321</ArticleId><ArticleId IdType="pmc">PMC8014941</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2020.12.028</ArticleId><ArticleId IdType="pii">S0007-0912(20)31050-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rosner M.H., Okusa M.D. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006;1:19&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">17699187</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersch M., Schmidt C., Zarbock A. Perioperative acute kidney injury: an under-recognized problem. Anesth Analg. 2017;125:1223&#x2013;1232.</Citation><ArticleIdList><ArticleId IdType="pubmed">28787339</ArticleId></ArticleIdList></Reference><Reference><Citation>McIlroy D.R., Lopez M.G., Billings F.T.T. Perioperative clinical trials in AKI. Semin Nephrol. 2020;40:173&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172010</ArticleId><ArticleId IdType="pubmed">32303280</ArticleId></ArticleIdList></Reference><Reference><Citation>Gumbert S.D., Kork F., Jackson M.L. Perioperative acute kidney injury. Anesthesiology. 2020;132:180&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10924686</ArticleId><ArticleId IdType="pubmed">31687986</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullens W., Abrahams Z., Francis G.S. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J&#xa0;Am Coll Cardiol. 2009;53:589&#x2013;596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2856960</ArticleId><ArticleId IdType="pubmed">19215833</ArticleId></ArticleIdList></Reference><Reference><Citation>Damman K., van Deursen V.M., Navis G., Voors A.A., van Veldhuisen D.J., Hillege H.L. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J&#xa0;Am Coll Cardiol. 2009;53:582&#x2013;588.</Citation><ArticleIdList><ArticleId IdType="pubmed">19215832</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelman S. Venous function and central venous pressure: a physiologic story. Anesthesiology. 2008;108:735&#x2013;748.</Citation><ArticleIdList><ArticleId IdType="pubmed">18362606</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombo P.C., Rastogi S., Onat D. Activation of endothelial cells in conduit veins of dogs with heart failure and veins of normal dogs after vascular stretch by acute volume loading. J&#xa0;Card Fail. 2009;15:457&#x2013;463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5657491</ArticleId><ArticleId IdType="pubmed">19477407</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka M., Yoshida H., Furuhashi M. Deterioration of renal function by chronic heart failure is associated with congestion and oxidative stress in the tubulointerstitium. Intern Med. 2011;50:2877&#x2013;2887.</Citation><ArticleIdList><ArticleId IdType="pubmed">22129502</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitaka C., Nagura T., Saknishi N., Tsunoda Y., Amaha K. Two-dimensional echocardiographic evaluation of inferior vena cava, right ventricle, and left ventricle during positive-pressure ventilation with varying levels of positive end-expiratory pressure. Crit Care Med. 1989;17:205&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">2646069</ArticleId></ArticleIdList></Reference><Reference><Citation>Matot I., Paskaleva R., Eid L. Effect of the volume of fluids administered on intraoperative oliguria in laparoscopic bariatric surgery: a randomized controlled trial. Arch Surg. 2012;147:228&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pubmed">22106246</ArticleId></ArticleIdList></Reference><Reference><Citation>Elijaiek R., Cavayas Y., Rodrigue E. High postoperative portal venous flow pulsatility indicates right ventricular dysfunction and predicts complications in cardiac surgery patients. Br J Anaesth. 2018;122:206&#x2013;214.</Citation><ArticleIdList><ArticleId IdType="pubmed">30686306</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Wang X., Honore P.M., Spapen H.D., Liu D. Renal failure in critically ill patients, beware of applying (central venous) pressure on the kidney. Ann Intensive Care. 2018;8:91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6146958</ArticleId><ArticleId IdType="pubmed">30238174</ArticleId></ArticleIdList></Reference><Reference><Citation>Burnett J.C., Jr., Knox F.G. Renal interstitial pressure and sodium excretion during renal vein constriction. Am J Physiol. 1980;238:F279&#x2013;F282.</Citation><ArticleIdList><ArticleId IdType="pubmed">7377299</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadimioglu N., Ertug Z., Yegin A., Sanli S., Gurkan A., Demirbas A. Correlation of peripheral venous pressure and central venous pressure in kidney recipients. Transplant Proc. 2006;38:440&#x2013;442.</Citation><ArticleIdList><ArticleId IdType="pubmed">16549142</ArticleId></ArticleIdList></Reference><Reference><Citation>Palomba H., de Castro I., Neto A.L., Lage S., Yu L. Acute kidney injury prediction following elective cardiac surgery: AKICS score. Kidney Int. 2007;72:624&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pubmed">17622275</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams J.B., Peterson E.D., Wojdyla D. Central venous pressure after coronary artery bypass surgery: does it predict postoperative mortality or renal failure? J&#xa0;Crit Care. 2014;29:1006&#x2013;1010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4315310</ArticleId><ArticleId IdType="pubmed">25035048</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Ma J., Zhao L. High central venous pressure is associated with acute kidney injury and mortality in patients underwent cardiopulmonary bypass surgery. J&#xa0;Crit Care. 2018;48:211&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pubmed">30243200</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings I.V.F.T., Hendricks P.A., Schildcrout J.S. High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial. JAMA. 2016;315:877&#x2013;888.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4843765</ArticleId><ArticleId IdType="pubmed">26906014</ArticleId></ArticleIdList></Reference><Reference><Citation>Roger C., Muller L., Riou B. Comparison of different techniques of central venous pressure measurement in mechanically ventilated critically ill patients. Br J Anaesth. 2017;118:223&#x2013;231.</Citation><ArticleIdList><ArticleId IdType="pubmed">28100526</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman E., Grable E., Fine J. Central venous pressure and direct serial measurements as guides in blood-volume replacement. Lancet. 1966;2:609&#x2013;614.</Citation><ArticleIdList><ArticleId IdType="pubmed">4161963</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmood S.S., Pinsky M.R. Heart-lung interactions during mechanical ventilation: the basics. Ann Transl Med. 2018;6:349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6186561</ArticleId><ArticleId IdType="pubmed">30370276</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey A.S., Stevens L.A., Schmid C.H. A&#xa0;new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2763564</ArticleId><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1&#x2013;138.</Citation></Reference><Reference><Citation>Macedo E., Malhotra R., Claure-Del Granado R., Fedullo P., Mehta R.L. Defining urine output criterion for acute kidney injury in critically ill patients. Nephrol Dial Transplant. 2011;26:509&#x2013;515.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3108356</ArticleId><ArticleId IdType="pubmed">20562094</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashani K., Al-Khafaji A., Ardiles T. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013;17:R25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4057242</ArticleId><ArticleId IdType="pubmed">23388612</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersch M., Schmidt C., Van Aken H. Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery. PloS One. 2014;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3968141</ArticleId><ArticleId IdType="pubmed">24675717</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings J.J., Shaw A.D., Shi J., Lopez M.G., O'Neal J.B., Billings F.T.T. Intraoperative prediction of cardiac surgery-associated acute kidney injury using urinary biomarkers of cell cycle arrest. J&#xa0;Thorac Cardiovasc Surg. 2019;157:1545&#x2013;1553. e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6431272</ArticleId><ArticleId IdType="pubmed">30389130</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilarczyk K., Edayadiyil-Dudasova M., Wendt D. Urinary [TIMP-2]&#x2217;[IGFBP7] for early prediction of acute kidney injury after coronary artery bypass surgery. Ann Intensive Care. 2015;5:50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4679715</ArticleId><ArticleId IdType="pubmed">26669781</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakar C.V., Arrigain S., Worley S., Yared J.P., Paganini E.P. A&#xa0;clinical score to predict acute renal failure after cardiac surgery. J&#xa0;Am Soc Nephrol. 2005;16:162&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pubmed">15563569</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottschalk C.W., Mylle M. Micropuncture study of pressures in proximal tubules and peritubular capillaries of the rat kidney and their relation to ureteral and renal venous pressures. Am J Physiol. 1956;185:430&#x2013;439.</Citation><ArticleIdList><ArticleId IdType="pubmed">13327061</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishimoto T., Maekawa M., Abe Y., Yamamoto K. Intrarenal&#xa0;distribution of blood flow and renin release during renal venous pressure elevation. Kidney Int. 1973;4:259&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pubmed">4752169</ArticleId></ArticleIdList></Reference><Reference><Citation>Kranzhofer R., Schmidt J., Pfeiffer C.A., Hagl S., Libby P., Kubler W. Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1999;19:1623&#x2013;1629.</Citation><ArticleIdList><ArticleId IdType="pubmed">10397679</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombo P.C., Doran A.C., Onat D. Venous congestion, endothelial and neurohormonal activation in acute decompensated heart failure: cause or effect? Curr Heart Fail Rep. 2015;12:215&#x2013;222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4426008</ArticleId><ArticleId IdType="pubmed">25740404</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostreva D.R., Seagard J.L., Castaner A., Kampine J.P. Reflex effects of renal afferents on the heart and kidney. Am J Physiol. 1981;241:R286&#x2013;R292.</Citation><ArticleIdList><ArticleId IdType="pubmed">7304772</ArticleId></ArticleIdList></Reference><Reference><Citation>Afsar B., Ortiz A., Covic A., Solak Y., Goldsmith D., Kanbay M. Focus on renal congestion in heart failure. Clin Kidney J. 2016;9:39&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4720202</ArticleId><ArticleId IdType="pubmed">26798459</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38381960</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1175</ISSN><JournalIssue CitedMedium="Internet"><Volume>140</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Candidate Kidney Protective Strategies for Patients Undergoing Major Abdominal Surgery: A Secondary Analysis of the RELIEF Trial Cohort.</ArticleTitle><Pagination><StartPage>1111</StartPage><EndPage>1125</EndPage><MedlinePgn>1111-1125</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ALN.0000000000004957</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute kidney injury (AKI) is common after major abdominal surgery. Selection of candidate kidney protective strategies for testing in large trials should be based on robust preliminary evidence.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A secondary analysis of the Restrictive versus Liberal Fluid Therapy in Major Abdominal Surgery (RELIEF) trial was conducted in adult patients undergoing major abdominal surgery and randomly assigned to a restrictive or liberal perioperative fluid regimen. The primary outcome was maximum AKI stage before hospital discharge. Two multivariable ordinal regression models were developed to test the primary hypothesis that modifiable risk factors associated with increased maximum stage of postoperative AKI could be identified. Each model used a separate approach to variable selection to assess the sensitivity of the findings to modeling approach. For model 1, variable selection was informed by investigator opinion; for model 2, the Least Absolute Shrinkage and Selection Operator (LASSO) technique was used to develop a data-driven model from available variables.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 2,444 patients analyzed, stage 1, 2, and 3 AKI occurred in 223 (9.1%), 59 (2.4%), and 36 (1.5%) patients, respectively. In multivariable modeling by model 1, administration of a nonsteroidal anti-inflammatory drug or cyclooxygenase-2 inhibitor, intraoperatively only (odds ratio, 1.77 [99% CI, 1.11 to 2.82]), and preoperative day-of-surgery administration of an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker compared to no regular use (odds ratio, 1.84 [99% CI, 1.15 to 2.94]) were associated with increased odds for greater maximum stage AKI. These results were unchanged in model 2, with the additional finding of an inverse association between nadir hemoglobin concentration on postoperative day 1 and greater maximum stage AKI.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Avoiding intraoperative nonsteroidal anti-inflammatory drugs or cyclooxygenase-2 inhibitors is a potential strategy to mitigate the risk for postoperative AKI. The findings strengthen the rationale for a clinical trial comprehensively testing the risk-benefit ratio of these drugs in the perioperative period.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 American Society of Anesthesiologists. All Rights Reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McIlroy</LastName><ForeName>David R</ForeName><Initials>DR</Initials><Identifier Source="ORCID">0000-0002-8919-992X</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee; Monash University, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Xiaoke</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Vanderbilt University, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shotwell</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Vanderbilt University, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wallace</LastName><ForeName>Sophia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Monash University, Melbourne, Australia; Department of Anaesthesia and Perioperative Medicine, Alfred Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Austin Hospital, Melbourne, Australia; Australian and New Zealand Intensive Care Research Centre, Monash University School of Public Health and Preventive Medicine, Melbourne, Australia; Department of Critical Care Critical Care, Department of Medicine and Radiology, University of Melbourne, Melbourne, Australia; Department of Intensive Care, Royal Melbourne Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garg</LastName><ForeName>Amit X</ForeName><Initials>AX</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Departments of Medicine, Epidemiology and Biostatistics, Schulich School of Medicine Dentistry, and the London Health Sciences Centre, London, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leslie</LastName><ForeName>Kate</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Critical Care, University of Melbourne, Melbourne, Australia; Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peyton</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Critical Care, University of Melbourne, Melbourne, Australia; Department of Anaesthesia, Austin Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Story</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Critical Care, University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Myles</LastName><ForeName>Paul S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Monash University, Melbourne, Australia; Department of Anaesthesia and Perioperative Medicine, Alfred Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="Y">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>15</Day><Hour>5</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>21</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>21</Day><Hour>15</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38381960</ArticleId><ArticleId IdType="doi">10.1097/ALN.0000000000004957</ArticleId><ArticleId IdType="pii">139849</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35403562</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1525-6049</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Renal failure</Title><ISOAbbreviation>Ren Fail</ISOAbbreviation></Journal><ArticleTitle>Intraoperative vasopressor use and early postoperative acute kidney injury in elderly patients undergoing elective noncardiac surgery.</ArticleTitle><Pagination><StartPage>648</StartPage><EndPage>659</EndPage><MedlinePgn>648-659</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/0886022X.2022.2061997</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Intraoperative hypotension is a risk factor for postoperative acute kidney injury (AKI). Elderly patients are susceptible due to reduced responses to acute hemodynamic changes.</AbstractText><AbstractText Label="AIMS" NlmCategory="UNASSIGNED">Determine the association between hypotension identified from anesthetic charts and postoperative AKI in elderly patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Retrospective cohort study of elective noncardiac surgery patients &#x2265;65&#x2009;years, at an Australian tertiary hospital (December 2019-March 2021), with the primary outcome of AKI &#x2264;48&#x2009;h of surgery. Factors of interest were intraoperative hypotension determined from anesthetic charts (mean arterial pressure &lt;60&#x2009;mmHg, systolic blood pressure &lt;90&#x2009;mmHg, recorded 5-min) and intraoperative vasopressor use.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">In 830 patients (mean age 75&#x2009;years), systolic hypotension was more frequent than mean arterial hypotension (25.7% vs. 11.9%). Most hypotensive episodes were brief (7.2% of systolic and 4.2% of mean arterial hypotension lasted &gt;10&#x2009;min) but vasopressors were used in 84.7% of cases. The incidence of postoperative AKI was 13.9%. Systolic hypotension &gt;20&#x2009;min was associated with AKI (OR, 3.88; 95% CI: 1.38-10.9), which was not significant after adjusting for vasopressors, creatinine, American Society of Anesthesiologists class, and hemoglobin drop. The cumulative dose of any specific vasopressor &gt;20&#x2009;mg (or &gt;10&#x2009;mg epinephrine) was independently associated with AKI (adjusted OR, 2.47; 95% CI: 1.34-4.58). Every 5&#x2009;mg increase in the total dose of all intraoperative vasopressors used during surgery was associated with 11% increased odds of AKI (95% CI: 3-19%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">High vasopressor use was associated with postoperative AKI in elderly patients undergoing noncardiac surgery, independent of hypotension identified from anesthetic charts.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ariyarathna</LastName><ForeName>Dilshan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Monash Health, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhonsle</LastName><ForeName>Ajinkya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Monash Health, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nim</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Monash Health, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Colin K L</ForeName><Initials>CKL</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Monash Health, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Gabriella H</ForeName><Initials>GH</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Monash Health, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sim</LastName><ForeName>Nicholle</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Monash Health, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Joy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Monash Health, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nan</LastName><ForeName>Kirrolos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Monash Health, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Andy K H</ForeName><Initials>AKH</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Monash Health, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nephrology, Monash Health, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ren Fail</MedlineTA><NlmUniqueID>8701128</NlmUniqueID><ISSNLinking>0886-022X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062606" MajorTopicYN="N">Tertiary Care Centers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="N">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Geriatrics</Keyword><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">hypotension</Keyword><Keyword MajorTopicYN="N">operative</Keyword><Keyword MajorTopicYN="N">surgical procedures</Keyword><Keyword MajorTopicYN="N">vasoconstrictor agents</Keyword></KeywordList><CoiStatement>The authors have no competing interests to declare. We have not received any funding for this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>11</Day><Hour>8</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35403562</ArticleId><ArticleId IdType="pmc">PMC9009951</ArticleId><ArticleId IdType="doi">10.1080/0886022X.2022.2061997</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gu WJ, Hou BL, Kwong JSW, et al. . Association between intraoperative hypotension and 30-day mortality, major adverse cardiac events, and acute kidney injury after non-cardiac surgery: a meta-analysis of cohort studies. Int J Cardiol. 2018;258:68&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">29429638</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijnberge M, Schenk J, Bulle E, et al. . Association of intraoperative hypotension with postoperative morbidity and mortality: systematic review and Meta-analysis. BJS Open. 2021;5(1):zraa018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7893468</ArticleId><ArticleId IdType="pubmed">33609377</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson C, Ozrazgat-Baslanti T, Kuxhausen A, et al. . Cost and mortality associated with postoperative acute kidney injury. Ann Surg. 2015;261(6):1207&#x2013;1214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4247993</ArticleId><ArticleId IdType="pubmed">24887982</ArticleId></ArticleIdList></Reference><Reference><Citation>Grams ME, Sang Y, Coresh J, et al. . Acute kidney injury after major surgery: a retrospective analysis of veterans health administration data. Am J Kidney Dis. 2016;67(6):872&#x2013;880.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4775458</ArticleId><ArticleId IdType="pubmed">26337133</ArticleId></ArticleIdList></Reference><Reference><Citation>Bihorac A, Yavas S, Subbiah S, et al. . Long-term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg. 2009;249(5):851&#x2013;858.</Citation><ArticleIdList><ArticleId IdType="pubmed">19387314</ArticleId></ArticleIdList></Reference><Reference><Citation>Turan A, Cohen B, Adegboye J, et al. . Mild acute kidney injury after noncardiac surgery is associated with long-term renal dysfunction: a retrospective cohort study. Anesthesiology. 2020;132(5):1053&#x2013;1061.</Citation><ArticleIdList><ArticleId IdType="pubmed">31929326</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai X, Hummel SL, Salazar JB, et al. . Cardiovascular physiology in the older adults. J Geriatr Cardiol. 2015;12(3):196&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4460159</ArticleId><ArticleId IdType="pubmed">26089840</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Lameire N, Aspelin P, et al. . Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1&#x2013;138.</Citation></Reference><Reference><Citation>American Society of Anesthesiologists . ASA Physical Status Classification System [updated 2020 Dec 13; cited 2021 Nov 22; Published 2014]. Available from: https://www.asahq.org/standards-and-guidelines/asa-physical-status-classification-system</Citation></Reference><Reference><Citation>Levey AS, Stevens LA, Schmid CH, et al. . A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2763564</ArticleId><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>Abhayaratna WP, Smith WT, Becker NG, et al. . Prevalence of heart failure and systolic ventricular dysfunction in older Australians: the Canberra heart study. Med J Aust. 2006;184(4):151&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pubmed">16489896</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh M, Devereaux PJ, Garg AX, et al. . Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology. 2013;119(3):507&#x2013;515.</Citation><ArticleIdList><ArticleId IdType="pubmed">23835589</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun LY, Wijeysundera DN, Tait GA, et al. . Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery. Anesthesiology. 2015;123(3):515&#x2013;523.</Citation><ArticleIdList><ArticleId IdType="pubmed">26181335</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmasi V, Maheshwari K, Yang D, et al. . Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery: a retrospective cohort analysis. Anesthesiology. 2017;126(1):47&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">27792044</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Jiang Z, Ying J, et al. . Optimal blood pressure decreases acute kidney injury after gastrointestinal surgery in elderly hypertensive patients: a randomized study: optimal blood pressure reduces acute kidney injury. J Clin Anesth. 2017;43:77&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">29055803</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesselink EM, Kappen TH, Torn HM, et al. . Intraoperative hypotension and the risk of postoperative adverse outcomes: a systematic review. Br J Anaesth. 2018;121(4):706&#x2013;721.</Citation><ArticleIdList><ArticleId IdType="pubmed">30236233</ArticleId></ArticleIdList></Reference><Reference><Citation>Giglio M, Dalfino L, Puntillo F, et al. . Hemodynamic goal-directed therapy and postoperative kidney injury: an updated meta-analysis with trial sequential analysis. Crit Care. 2019;23(1):232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6593609</ArticleId><ArticleId IdType="pubmed">31242941</ArticleId></ArticleIdList></Reference><Reference><Citation>Grocott MP, Optimisation Systematic Review Steering Group, Dushianthan A, et al. . Perioperative increase in global blood flow to explicit defined goals and outcomes after surgery: a cochrane systematic review. Br J Anaesth. 2013;111(4):535&#x2013;548.</Citation><ArticleIdList><ArticleId IdType="pubmed">23661403</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Chua HR, Bagshaw SM, et al. . Clinical review: volume of fluid resuscitation and the incidence of acute kidney injury &#x2013; a systematic review. Crit Care. 2012;16(4):230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3580679</ArticleId><ArticleId IdType="pubmed">22866958</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Tremper KK, Englesbe MJ, et al. . Predictors of postoperative acute renal failure after noncardiac surgery in patients with previously normal renal function. Anesthesiology. 2007;107(6):892&#x2013;902.</Citation><ArticleIdList><ArticleId IdType="pubmed">18043057</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu CY, Ordonez JD, Chertow GM, et al. . The risk of acute renal failure in patients with chronic kidney disease. Kidney Int. 2008;74(1):101&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2673528</ArticleId><ArticleId IdType="pubmed">18385668</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh M, Garg AX, Devereaux PJ, et al. . The association between perioperative hemoglobin and acute kidney injury in patients having noncardiac surgery. Anesth Analg. 2013;117(4):924&#x2013;931.</Citation><ArticleIdList><ArticleId IdType="pubmed">24023017</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler AJ, Ahmad T, Phull MK, et al. . Meta-analysis of the association between preoperative anaemia and mortality after surgery. Br J Surg. 2015;102(11):1314&#x2013;1324.</Citation><ArticleIdList><ArticleId IdType="pubmed">26349842</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira C, Rosa R, Rodrigues N, et al. . Acute kidney injury after major abdominal surgery: a retrospective cohort analysis. Crit Care Res Pract. 2014;2014:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3955689</ArticleId><ArticleId IdType="pubmed">24719758</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyigun M, Aykut G, Tosun M, et al. . Perioperative risk factors of acute kidney injury after non-cardiac surgery: a multicenter, prospective, observational study in patients with low grade American society of anesthesiologists physical status. Am J Surg. 2019;218(3):457&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pubmed">30739741</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S, Cho H, Park S, et al. . Simple postoperative AKI risk (SPARK) classification before noncardiac surgery: a prediction index development study with external validation. J Am Soc Nephrol. 2019;30(1):170&#x2013;181.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6317608</ArticleId><ArticleId IdType="pubmed">30563915</ArticleId></ArticleIdList></Reference><Reference><Citation>Abelha FJ, Botelho M, Fernandes V, et al. . Determinants of postoperative acute kidney injury. Crit Care. 2009;13(3):R79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2717442</ArticleId><ArticleId IdType="pubmed">19463152</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Jiang L, Wang B, et al. . Epidemiological characteristics of and risk factors for patients with postoperative acute kidney injury: a multicenter prospective study in 30 Chinese intensive care units. Int Urol Nephrol. 2018;50(7):1319&#x2013;1328.</Citation><ArticleIdList><ArticleId IdType="pubmed">29480442</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourafkari L, Arora P, Porhomayon J, et al. . Acute kidney injury after non-cardiovascular surgery: risk factors and impact on development of chronic kidney disease and long-term mortality. Curr Med Res Opin. 2018;34(10):1829&#x2013;1837.</Citation><ArticleIdList><ArticleId IdType="pubmed">29613817</ArticleId></ArticleIdList></Reference><Reference><Citation>Bijker JB, van Klei WA, Kappen TH, et al. . Incidence of intraoperative hypotension as a function of the chosen definition: literature definitions applied to a retrospective cohort using automated data collection. Anesthesiology. 2007;107(2):213&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">17667564</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30152435</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>21</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1319-2442</ISSN><JournalIssue CitedMedium="Print"><Volume>29</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Season>Jul-Aug</Season></PubDate></JournalIssue><Title>Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia</Title><ISOAbbreviation>Saudi J Kidney Dis Transpl</ISOAbbreviation></Journal><ArticleTitle>Epidemiology and outcome of acute kidney injury from a tertiary care hospital in India.</ArticleTitle><Pagination><StartPage>956</StartPage><EndPage>966</EndPage><MedlinePgn>956-966</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/1319-2442.239633</ELocationID><Abstract><AbstractText>We aimed to study the epidemiology and outcome of acute kidney injury (AKI). This is a prospective study of adults aged 18 years or above diagnosed with AKI over a period of 16 months at a tertiary care hospital. Three hundred and nine patients had AKI. The observed incidence of AKI was eight per 1000 admissions. About 92.2% had community-acquired AKI (CA-AKI), and in 7.8% it was hospital-acquired AKI (HA-AKI). Etiological factors for AKI were medical in 87.4% of the cases, surgical in 9.4%, and obstetric 3.2%. Sepsis was the most common (53.1%) etiology of AKI among the medical cases. Among sepsis, scrub typhus, urosepsis, and pneumonia were the most common causes of AKI. Hypovolemia (9.4%), biological toxins (8.4%), nephrotoxic drugs and chemicals (7.4%), cardiac causes (7.4%), and acute glomerulonephritis (1.9%) were other medical causes of AKI. Nearly 38.2% had multiorgan failure, 20.1% required vasopressors, 6.1 % required Intensive Care Unit support, and 23.3% required dialysis. Mortality was 8.7%. Anemia, use of vasopressor drugs, and need for intensive care support were independent predictive factors for mortality. AKI is common in hospitalized adults in India and leads to significant in-hospital mortality. AKI is largely a CA-AKI and the lesser percentage is due to HA-AKI. Many causes are potentially preventable. Early fluid resuscitation, effective anti-infective treatment, appropriate antidotes, and timely referral of established AKI patients to centers with dialysis facilities can improve AKI outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vikrant</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Indira Gandhi Medical College, Shimla, Himachal Pradesh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Dalip</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medicine, Indira Gandhi Medical College, Shimla, Himachal Pradesh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Mehakinder</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Indira Gandhi Medical College, Shimla, Himachal Pradesh, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Saudi Arabia</Country><MedlineTA>Saudi J Kidney Dis Transpl</MedlineTA><NlmUniqueID>9436968</NlmUniqueID><ISSNLinking>1319-2442</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020896" MajorTopicYN="N">Hypovolemia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007194" MajorTopicYN="N" Type="Geographic">India</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006435" MajorTopicYN="N">Renal Dialysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062606" MajorTopicYN="N">Tertiary Care Centers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>None declared</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30152435</ArticleId><ArticleId IdType="doi">10.4103/1319-2442.239633</ArticleId><ArticleId IdType="pii">SaudiJKidneyDisTranspl_2018_29_4_956_239633</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27034948</PMID><DateCompleted><Year>2016</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2314-6141</ISSN><JournalIssue CitedMedium="Internet"><Volume>2016</Volume><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>BioMed research international</Title><ISOAbbreviation>Biomed Res Int</ISOAbbreviation></Journal><ArticleTitle>Rhabdomyolysis following Cardiac Surgery: A Prospective, Descriptive, Single-Center Study.</ArticleTitle><Pagination><StartPage>7497936</StartPage><MedlinePgn>7497936</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">7497936</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2016/7497936</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Rhabdomyolysis (RML) following cardiac surgery and its relationship with acute kidney injury (AKI) require investigation.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">All patients undergoing cardiac surgery in our hospital were enrolled in this prospective study during a 1-year period. To investigate the occurrence of RML and its association with AKI, all patients in the study underwent serial assessment of serum creatine kinase (CK) and myoglobin levels. Serial renal function, prior statin treatment, and outcome variables were recorded.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 201 patients were included in the study: 185 men and 16 women with a mean age of 52.0 &#xb1; 12.4 years. According to the presence of RML (CK of &#x2265;2,500&#x2009;U/L), the patients were divided into Group I (RML present in 17 patients) and Group II (RML absent in 184 patients). Seven patients in Group I had AKI (41%) where 34 patients in group II had AKI (18.4%), P = 0.025. We observed a significantly longer duration of ventilation, length of stay in the ICU, and hospitalization in Group I (P &lt; 0.001 for all observations).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">An early elevation of serum CK above 2500&#x2009;U/L postoperatively in high-risk cardiac surgery could be used to diagnose RML that may predict the concomitance of early AKI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Omar</LastName><ForeName>Amr S</ForeName><Initials>AS</Initials><Identifier Source="ORCID">0000-0001-8560-2745</Identifier><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery/Cardiac Anaesthesia &amp; ICU Section, Heart Hospital, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar; Department of Critical Care Medicine, Beni-Suef University, P.O. Box 62511, Beni-Suef, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ewila</LastName><ForeName>Hesham</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery/Cardiac Anaesthesia &amp; ICU Section, Heart Hospital, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar; Department of Anesthesia, Suez Canal University, P.O. Box 351-41511, Ismailia, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aboulnaga</LastName><ForeName>Sameh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery/Cardiac Anaesthesia &amp; ICU Section, Heart Hospital, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar; Department of Anesthesia, Ain Shams University, Kasr-El-Zaafaran, P.O. Box 11566, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tuli</LastName><ForeName>Alejandro Kohn</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery/Cardiac Anaesthesia &amp; ICU Section, Heart Hospital, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Rajvir</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiology Research Centre, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>02</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biomed Res Int</MedlineTA><NlmUniqueID>101600173</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009211">Myoglobin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.3.2</RegistryNumber><NameOfSubstance UI="D003402">Creatine Kinase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003402" MajorTopicYN="N">Creatine Kinase</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009211" MajorTopicYN="N">Myoglobin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012206" MajorTopicYN="N">Rhabdomyolysis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>2</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27034948</ArticleId><ArticleId IdType="pmc">PMC4789372</ArticleId><ArticleId IdType="doi">10.1155/2016/7497936</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lane R., Phillips M. Rhabdomyolysis. The British Medical Journal. 2003;327(7407):115&#x2013;116. doi: 10.1136/bmj.327.7407.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7407.115</ArticleId><ArticleId IdType="pmc">PMC1126495</ArticleId><ArticleId IdType="pubmed">12869426</ArticleId></ArticleIdList></Reference><Reference><Citation>Bywaters E. G., Beall D. Crush injuries with impairment of renal function. British Medical Journal. 1941;1, article 427 doi: 10.1136/bmj.1.4185.427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.1.4185.427</ArticleId><ArticleId IdType="pmc">PMC2161734</ArticleId><ArticleId IdType="pubmed">20783577</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren J. D., Blumbergs P. C., Thompson P. D. Rhabdomyolysis: a review. Muscle and Nerve. 2002;25(3):332&#x2013;347. doi: 10.1002/mus.10053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.10053</ArticleId><ArticleId IdType="pubmed">11870710</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccario M., Fumagalli C., Dottori V., et al. Rhabdomyolytic acute renal failure in cardiac surgery. A clinical case. Minerva Anestesiologica. 1995;61(9):397&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pubmed">8919837</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudarsanan S., Omar A. S., Pattath R. A., Al Mulla A. Acute kidney injury associated with rhabdomyolysis after coronary artery bypass graft: a case report and review of the literatures. BMC Research Notes. 2014;7(1, article 152) doi: 10.1186/1756-0500-7-152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-0500-7-152</ArticleId><ArticleId IdType="pmc">PMC3984756</ArticleId><ArticleId IdType="pubmed">24636137</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedetto U., Angeloni E., Luciani R., et al. Acute kidney injury after coronary artery bypass grafting: does rhabdomyolysis play a role? Journal of Thoracic and Cardiovascular Surgery. 2010;140(2):464&#x2013;470. doi: 10.1016/j.jtcvs.2010.03.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2010.03.028</ArticleId><ArticleId IdType="pubmed">20416892</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofmann D., Buettner M., Rissner F., Wahl M., Sakka S. G. Prognostic value of serum myoglobin in patients after cardiac surgery. Journal of Anesthesia. 2007;21(3):304&#x2013;310. doi: 10.1007/s00540-007-0507-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-007-0507-0</ArticleId><ArticleId IdType="pubmed">17680179</ArticleId></ArticleIdList></Reference><Reference><Citation>Huerta-Alard&#xed;n A. L., Varon J., Marik P. E. Bench-to-bedside review: rhabdomyolysis&#x2014;an overview for clinicians. Critical Care. 2005;9(2):158&#x2013;169. doi: 10.1186/cc2978.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc2978</ArticleId><ArticleId IdType="pmc">PMC1175909</ArticleId><ArticleId IdType="pubmed">15774072</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagandr&#xe9; S., Arnalsteen L., Vallet B., et al. Predictive factors for rhabdomyolysis after bariatric surgery. Obesity Surgery. 2006;16(10):1365&#x2013;1370. doi: 10.1381/096089206778663643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1381/096089206778663643</ArticleId><ArticleId IdType="pubmed">17059748</ArticleId></ArticleIdList></Reference><Reference><Citation>Minnema B. J., Neligan P. C., Quraishi N. A., Fehlings M. G., Prakash S. A case of occult compartment syndrome and nonresolving rhabdomyolysis. Journal of General Internal Medicine. 2008;23(6):871&#x2013;874. doi: 10.1007/s11606-008-0569-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-008-0569-1</ArticleId><ArticleId IdType="pmc">PMC2517868</ArticleId><ArticleId IdType="pubmed">18350340</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajjar L., Grande S., Galas F., Roquim A., Sampaio L., Auler J. Risk factors and outcome of rhabdomyolysis after cardiac surgery. Critical Care. 2008;12(supplement 2):p. P470. doi: 10.1186/cc6691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc6691</ArticleId></ArticleIdList></Reference><Reference><Citation>Mognol P., Vignes S., Chosidow D., Marmuse J.-P. Rhabdomyolysis after laparoscopic bariatric surgery. Obesity Surgery. 2004;14(1):91&#x2013;94. doi: 10.1381/096089204772787356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1381/096089204772787356</ArticleId><ArticleId IdType="pubmed">14980040</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta R. L., Kellum J. A., Shah S. V., et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Critical Care. 2007;11(2, article R31) doi: 10.1186/cc5713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc5713</ArticleId><ArticleId IdType="pmc">PMC2206446</ArticleId><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-Capote K., Balion C. M., Hill S. A., Cleve R., Yang L., Sharif A. E. Utility of urine myoglobin for the prediction of acute renal failure in patients with suspected rhabdomyolysis: a systematic review. Clinical Chemistry. 2009;55(12):2190&#x2013;2197. doi: 10.1373/clinchem.2009.128546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2009.128546</ArticleId><ArticleId IdType="pubmed">19797717</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagele P., Brown F., Gage B. F., et al. High-sensitivity cardiac troponin T in prediction and diagnosis of myocardial infarction and long-term mortality after noncardiac surgery. American Heart Journal. 2013;166(2):325.e1&#x2013;332.e1. doi: 10.1016/j.ahj.2013.04.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2013.04.018</ArticleId><ArticleId IdType="pmc">PMC3728677</ArticleId><ArticleId IdType="pubmed">23895816</ArticleId></ArticleIdList></Reference><Reference><Citation>Nashef S. A. M., Roques F., Michel P., Gauducheau E., Lemeshow S., Salamon R. European system for cardiac operative risk evaluation (EuroSCORE) European Journal of Cardio-thoracic Surgery. 1999;16(1):9&#x2013;13. doi: 10.1016/S1010-7940(99)00134-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1010-7940(99)00134-7</ArticleId><ArticleId IdType="pubmed">10456395</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiret L., Hatton F., Desmonts J. M., Vourc'h G. Prediction of outcome of anaesthesia in patients over 40 years: a multifactorial risk index. Statistics in Medicine. 1988;7(9):947&#x2013;954. doi: 10.1002/sim.4780070906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.4780070906</ArticleId><ArticleId IdType="pubmed">3175394</ArticleId></ArticleIdList></Reference><Reference><Citation>Black H. R., Quallich H., Gareleck C. B. Racial differences in serum creatine kinase levels. The American Journal of Medicine. 1986;81(3):479&#x2013;487. doi: 10.1016/0002-9343(86)90303-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(86)90303-7</ArticleId><ArticleId IdType="pubmed">3752149</ArticleId></ArticleIdList></Reference><Reference><Citation>Alterman I., Sidi A., Azamfirei L., Copotoiu S., Ezri T. Rhabdomyolysis: another complication after prolonged surgery. Journal of Clinical Anesthesia. 2007;19(1):64&#x2013;66. doi: 10.1016/j.jclinane.2006.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2006.06.002</ArticleId><ArticleId IdType="pubmed">17321931</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccario M., Fumagalli C., Dottori V., et al. The association between rhabdomyolysis and acute renal failure in patients undergoing cardiopulmonary bypass. Journal of Cardiovascular Surgery. 1996;37(2):153&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pubmed">8675522</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanardo G., Michielon P., Paccagnella A., et al. Acute renal failure in the patient undergoing cardiac operation: prevalence, mortality rate, and main risk factors. Journal of Thoracic and Cardiovascular Surgery. 1994;107(6):1489&#x2013;1495.</Citation><ArticleIdList><ArticleId IdType="pubmed">8196394</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangos G. J., Horton D., Brown M. A., Trew P., Chan W. Y. L., Whitworth J. A. Acute renal failure following cardiac surgery: incidence, outcomes and risk factors. Australian and New Zealand Journal of Medicine. 1995;25(4):284&#x2013;289. doi: 10.1111/j.1445-5994.1995.tb01891.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1445-5994.1995.tb01891.x</ArticleId><ArticleId IdType="pubmed">8540867</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberg M., Stecker J. F., Jr., Scarff J. E., Jr., Wombolt D. G. Rhabdomyolysis associated with urethral stricture repair: report of a case. Journal of Urology. 1980;124(5):730&#x2013;731.</Citation><ArticleIdList><ArticleId IdType="pubmed">7452806</ArticleId></ArticleIdList></Reference><Reference><Citation>Nimmo G. R., Stewart S. M., English P. J. Myoglobinuric acute renal failure associated with major urological surgery&#x2014;an avoidable problem? Intensive Care Medicine. 1988;14(3):244&#x2013;245. doi: 10.1007/bf00718000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/bf00718000</ArticleId><ArticleId IdType="pubmed">3379187</ArticleId></ArticleIdList></Reference><Reference><Citation>de Menezes Ettinger J. E. M. T., Dos Santos Filho P. V., Azaro E., Bastos Melo C. A., Fahel E., Pena Batista P. B. Prevention of rhabdomyolysis in bariatric surgery. Obesity Surgery. 2005;15(6):874&#x2013;879. doi: 10.1381/0960892054222669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1381/0960892054222669</ArticleId><ArticleId IdType="pubmed">15978162</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilhelmi M., Winterhalter M., Fischer S., et al. Massive postoperative rhabdomyolysis following combined CABG/abdominal aortic replacement: a possible association with HMG-CoA reductase inhibitors. Cardiovascular Drugs and Therapy. 2002;16(5):471&#x2013;475. doi: 10.1023/a:1022198705168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/a:1022198705168</ArticleId><ArticleId IdType="pubmed">12652117</ArticleId></ArticleIdList></Reference><Reference><Citation>Antons K. A., Williams C. D., Baker S. K., Phillips P. S. Clinical perspectives of statin-induced rhabdomyolysis. The American Journal of Medicine. 2006;119(5):400&#x2013;409. doi: 10.1016/j.amjmed.2006.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2006.02.007</ArticleId><ArticleId IdType="pubmed">16651050</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulik A., Ruel M. Statins and coronary artery bypass graft surgery: preoperative and postoperative efficacy and safety. Expert Opinion on Drug Safety. 2009;8(5):559&#x2013;571. doi: 10.1517/14740330903188413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14740330903188413</ArticleId><ArticleId IdType="pubmed">19673591</ArticleId></ArticleIdList></Reference><Reference><Citation>Bray R. J. Propofol infusion syndrome in children. Paediatric Anaesthesia. 1998;8(6):491&#x2013;499. doi: 10.1046/j.1460-9592.1998.00282.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1460-9592.1998.00282.x</ArticleId><ArticleId IdType="pubmed">9836214</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh U., Scheld W. M. Infectious etiologies of rhabdomyolysis: three case reports and review. Clinical Infectious Diseases. 1996;22(4):642&#x2013;649. doi: 10.1093/clinids/22.4.642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/22.4.642</ArticleId><ArticleId IdType="pubmed">8729203</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu R.-B., Ho Y.-L., Chen R. J., Wang S.-S., Lin F.-Y., Chu S.-H. Outcome of medical and surgical treatment in patients with acute type B aortic dissection. Annals of Thoracic Surgery. 2005;79(3):790&#x2013;794. doi: 10.1016/j.athoracsur.2004.07.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2004.07.061</ArticleId><ArticleId IdType="pubmed">15734378</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon P. J., Stafford-Smith M., White W. D., et al. Acute renal failure following cardiac surgery. Nephrology Dialysis Transplantation. 1999;14(5):1158&#x2013;1162. doi: 10.1093/ndt/14.5.1158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/14.5.1158</ArticleId><ArticleId IdType="pubmed">10344355</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharp L. S., Rozycki G. S., Feliciano D. V. Rhabdomyolysis and secondary renal failure in critically ill surgical patients. American Journal of Surgery. 2004;188(6):801&#x2013;806. doi: 10.1016/j.amjsurg.2004.08.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2004.08.050</ArticleId><ArticleId IdType="pubmed">15619503</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Abdellati E., Eyselbergs M., Sirimsi H., et al. An observational study on rhabdomyolysis in the intensive care unit. Exploring its risk factors and main complication: acute kidney injury. Annals of Intensive Care. 2013;3(1):1&#x2013;8. doi: 10.1186/2110-5820-3-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2110-5820-3-8</ArticleId><ArticleId IdType="pmc">PMC3614462</ArticleId><ArticleId IdType="pubmed">23497406</ArticleId></ArticleIdList></Reference><Reference><Citation>Laurence A. S. Serum myoglobin and creatine kinase following surgery. British Journal of Anaesthesia. 2000;84(6):763&#x2013;766. doi: 10.1093/oxfordjournals.bja.a013590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.bja.a013590</ArticleId><ArticleId IdType="pubmed">10895753</ArticleId></ArticleIdList></Reference><Reference><Citation>Lappalainen H., Tiula E., Uotila L., M&#xe4;ntt&#xe4;ri M. Elimination kinetics of myoglobin and creatine kinase in rhabdomyolysis: implications for follow-up. Critical Care Medicine. 2002;30(10):2212&#x2013;2215. doi: 10.1097/00003246-200210000-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200210000-00006</ArticleId><ArticleId IdType="pubmed">12394946</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberry C., Stone F., Kalbfleisch K. Rhabdomyolysis-induced severe hyperkalemia. The Western Journal of Emergency Medicine. 2009;10(4, article 302)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2791742</ArticleId><ArticleId IdType="pubmed">20046258</ArticleId></ArticleIdList></Reference><Reference><Citation>Omar A. S., Abouelnagah G. Successful prevention of rhabdomyolysis (RML) after bariatric surgery (BS) in intensive care settings. Critical Care &amp; Shock. 2013;16(1):12&#x2013;18.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">28593413</PMID><DateCompleted><Year>2018</Year><Month>10</Month><Day>01</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-2218</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>9</Issue><PubDate><Year>2017</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Surgical endoscopy</Title><ISOAbbreviation>Surg Endosc</ISOAbbreviation></Journal><ArticleTitle>Effect of ulinastatin on postoperative renal function in patients undergoing robot-assisted laparoscopic partial nephrectomy: a randomized trial.</ArticleTitle><Pagination><StartPage>3728</StartPage><EndPage>3736</EndPage><MedlinePgn>3728-3736</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00464-017-5608-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">Robot-assisted laparoscopic partial nephrectomy (RLPN) is an emerging technique for treating small renal masses. Although RLPN has many advantages, ischemic kidney injury is inevitable during renal artery clamping. The overall incidence of acute kidney injury (AKI) after partial nephrectomy has been reported to be up to 39%. Moreover, effective pharmacological protection against AKI after partial nephrectomy has not yet been demonstrated. Ulinastatin has been shown to protect the kidney from ischemia/reperfusion injury via its anti-inflammatory and anti-oxidant activities. Therefore, this study aimed to evaluate the effect of ulinastatin on postoperative kidney function in patients undergoing RLPN.</AbstractText><AbstractText Label="METHODS">In this randomized, double-blinded, placebo-controlled study, patients undergoing RLPN received either intravenous ulinastatin (100,000&#xa0;units/10&#xa0;kg; ulinastatin group, n&#xa0;=&#xa0;35) or the same volume of normal saline (control group, n&#xa0;=&#xa0;35) for 1&#xa0;h starting 10&#xa0;min before renal artery clamping. The primary outcome was incidence of postoperative AKI. Secondary outcomes were levels of serum creatinine, estimated glomerular filtration rate (eGFR), cystatin C, and inflammatory markers and were measured before operation and at 1, 24, 48, and 72&#xa0;h postoperatively.</AbstractText><AbstractText Label="RESULTS">The incidence of postoperative AKI was 18% in the ulinastatin group, whereas it was 30% in the control group (p&#xa0;=&#xa0;0.251). No significant differences in postoperative changes of serum creatinine, eGFR, or cystatin C were observed between the two groups. Postoperative inflammatory markers including C-reactive protein, white blood cell count, and neutrophil percentage were significantly increased until 72&#xa0;h after operation compared to the preoperative values in both groups, with no significant differences between the groups.</AbstractText><AbstractText Label="CONCLUSIONS">Administration of ulinastatin (100,000&#xa0;units/10&#xa0;kg) during the warm ischemia and reperfusion periods did not show any beneficial effects on postoperative kidney function or inflammatory responses in patients undergoing RLPN.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Bora</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sook Young</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, School of Medicine, Ajou University, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Na Young</ForeName><Initials>NY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rha</LastName><ForeName>Koon Ho</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Young Deuk</ForeName><Initials>YD</Initials><AffiliationInfo><Affiliation>Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sujung</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>So Yeon</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea. KIMSY326@yuhs.ac.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea. KIMSY326@yuhs.ac.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Surg Endosc</MedlineTA><NlmUniqueID>8806653</NlmUniqueID><ISSNLinking>0930-2794</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006023">Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>OR3S9IF86U</RegistryNumber><NameOfSubstance UI="C028665">urinastatin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003250" MajorTopicYN="N">Constriction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005919" MajorTopicYN="N">Glomerular Filtration Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006023" MajorTopicYN="N">Glycoproteins</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007680" MajorTopicYN="N">Kidney Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="Y">Laparoscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009392" MajorTopicYN="Y">Nephrectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065287" MajorTopicYN="Y">Robotic Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D052096" MajorTopicYN="N">Warm Ischemia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Nephrectomy</Keyword><Keyword MajorTopicYN="N">Reperfusion injury</Keyword><Keyword MajorTopicYN="N">Robotic surgical procedures</Keyword><Keyword MajorTopicYN="N">Ulinastatin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28593413</ArticleId><ArticleId IdType="doi">10.1007/s00464-017-5608-8</ArticleId><ArticleId IdType="pii">10.1007/s00464-017-5608-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eur Urol. 2016 Apr;69(4):745-52</Citation><ArticleIdList><ArticleId IdType="pubmed">26525838</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 2003 Feb;98 (2):465-73</Citation><ArticleIdList><ArticleId IdType="pubmed">12552207</ArticleId></ArticleIdList></Reference><Reference><Citation>BJU Int. 2011 Sep;108(6 Pt 2):935-41</Citation><ArticleIdList><ArticleId IdType="pubmed">21917094</ArticleId></ArticleIdList></Reference><Reference><Citation>Korean J Anesthesiol. 2012 Feb;62(2):148-53</Citation><ArticleIdList><ArticleId IdType="pubmed">22379570</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood Transfus. 2014 Jan;12 Suppl 1:s109-18</Citation><ArticleIdList><ArticleId IdType="pubmed">23736923</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 2000 Apr;69(4):1121-6</Citation><ArticleIdList><ArticleId IdType="pubmed">10800804</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2003 Jul;31(7):1987-92</Citation><ArticleIdList><ArticleId IdType="pubmed">12847393</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Pharmacol Sin. 2004 Oct;25(10 ):1334-40</Citation><ArticleIdList><ArticleId IdType="pubmed">15456536</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 2009 Mar;110(3):505-15</Citation><ArticleIdList><ArticleId IdType="pubmed">19212261</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Urol. 2014 Feb;21(2):200-3</Citation><ArticleIdList><ArticleId IdType="pubmed">23819791</ArticleId></ArticleIdList></Reference><Reference><Citation>J Endourol. 2009 Sep;23(9):1457-60</Citation><ArticleIdList><ArticleId IdType="pubmed">19698038</ArticleId></ArticleIdList></Reference><Reference><Citation>Nephrol Dial Transplant. 2011 Nov;26(11):3496-501</Citation><ArticleIdList><ArticleId IdType="pubmed">21406544</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2009 May 5;150(9):604-12</Citation><ArticleIdList><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>Hepatobiliary Pancreat Dis Int. 2009 Feb;8(1):53-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19208516</ArticleId></ArticleIdList></Reference><Reference><Citation>Transplant Proc. 2008 Mar;40(2):387-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18374077</ArticleId></ArticleIdList></Reference><Reference><Citation>Urology. 2013 Feb;81(2):340-5</Citation><ArticleIdList><ArticleId IdType="pubmed">23374797</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 2007 Dec;107(6):892-902</Citation><ArticleIdList><ArticleId IdType="pubmed">18043057</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Urol. 2013 Dec;64(6):988-93</Citation><ArticleIdList><ArticleId IdType="pubmed">23122834</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Urol. 2016 Feb;23(2):122-31</Citation><ArticleIdList><ArticleId IdType="pubmed">26585191</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurol Res. 2010 Nov;32(9):925-32</Citation><ArticleIdList><ArticleId IdType="pubmed">20223106</ArticleId></ArticleIdList></Reference><Reference><Citation>Urology. 2009 May;73(5):1056-60</Citation><ArticleIdList><ArticleId IdType="pubmed">19394503</ArticleId></ArticleIdList></Reference><Reference><Citation>BJU Int. 2013 Jul;112(1):74-80</Citation><ArticleIdList><ArticleId IdType="pubmed">23452148</ArticleId></ArticleIdList></Reference><Reference><Citation>J Urol. 2009 Sep;182(3):844-53</Citation><ArticleIdList><ArticleId IdType="pubmed">19616235</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Urol. 2012 Sep;19(9):823-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22568789</ArticleId></ArticleIdList></Reference><Reference><Citation>Urology. 2012 Apr;79(4):821-5</Citation><ArticleIdList><ArticleId IdType="pubmed">22469577</ArticleId></ArticleIdList></Reference><Reference><Citation>J Endourol. 2015 Apr;29(4):444-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25203268</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiothorac Vasc Anesth. 2013 Jun;27(3):479-84</Citation><ArticleIdList><ArticleId IdType="pubmed">23545347</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Clin Pract Nephrol. 2007 Aug;3(8):439-42</Citation><ArticleIdList><ArticleId IdType="pubmed">17653122</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxid Med Cell Longev. 2015 ;2015 :624819</Citation><ArticleIdList><ArticleId IdType="pubmed">26161241</ArticleId></ArticleIdList></Reference><Reference><Citation>J Urol. 2010 Apr;183(4):1317-23</Citation><ArticleIdList><ArticleId IdType="pubmed">20171688</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Ther Med. 2015 Feb;9(2):411-416</Citation><ArticleIdList><ArticleId IdType="pubmed">25574207</ArticleId></ArticleIdList></Reference><Reference><Citation>BJU Int. 2016 Mar;117(3):531-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26435486</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Anaesth. 2016 Jan;116(1):70-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26675951</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Surg (Torino). 2007 Aug;48(4):497-503</Citation><ArticleIdList><ArticleId IdType="pubmed">17653011</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2016 Feb 17;20:42</Citation><ArticleIdList><ArticleId IdType="pubmed">26884251</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25212718</PMID><DateCompleted><Year>2015</Year><Month>11</Month><Day>09</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>5</Issue><PubDate><Year>2014</Year><Month>Sep</Month><Day>12</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Sodium bicarbonate in the prevention of cardiac surgery-associated acute kidney injury: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>517</StartPage><MedlinePgn>517</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">517</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-014-0517-x</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Sodium bicarbonate (SBIC) was reported to be a promising approach to prevent cardiac surgery-associated acute kidney injury (CSA-AKI). However, the results remain controversial. We conducted a systematic review and meta-analysis to evaluate the efficacy and safety of SBIC on the prevention of CSA-AKI in adult patients undergoing cardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed, EMbase, Web of science, EBSCO, and Cochrane library databases were systematically searched. Randomized controlled trials (RCTs) assessing the effect of SBIC versus placebo on the prevention of CSA-AKI in adult patients undergoing cardiac surgery were included. Two investigators independently searched articles, extracted data, and assessed the quality of included studies. The primary outcome was the incidence of CSA-AKI. Meta-analysis was performed using random-effects models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Five RCTs involving 1079 patients were included in the meta-analysis. Overall, compared with placebo, SBIC was not associated with a reduced risk of CSA-AKI (relative risk [RR] 0.99; 95% confidence interval [CI] 0.78 to 1.24; P&#x2009;=&#x2009;0.911). SBIC failed to alter the clinical outcomes of hospital length of stay (weighted mean difference [WMD] 0.23 days; 95%CI -0.88 to 1.33 days; P&#x2009;=&#x2009;0.688), renal replacement therapy (RR 0.94; 95%CI 0.49 to 1.82; P&#x2009;=&#x2009;0.861), hospital mortality (RR 1.37; 95%CI 0.46 to 4.13; P&#x2009;=&#x2009;0.572), postoperative atrial fibrillation (RR 1.02; 95%CI 0.65 to 1.61; P&#x2009;=&#x2009;0.915). However, SBIC was associated with significant increased risks in longer duration of ventilation (WMD 0.64 hours; 95%CI 0.16 to 1.11 hours; P&#x2009;=&#x2009;0.008), longer ICU length of stay (WMD 2.06 days; 95%CI 0.54 to 3.58 days; P&#x2009;=&#x2009;0.008), and increased incidence of alkalemia (RR 2.21; 95%CI 1.42 to 3.42; P &lt;0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">SBIC could not reduce the incidence of CSA-AKI. Contrarily, SBIC prolongs the duration of ventilation and ICU length of stay, and increases the risk of alkalemia. Thus, SBIC should not be recommended for the prevention of CSA-AKI and perioperative SBIC infusion should be administrated with caution.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tie</LastName><ForeName>Hong-Tao</ForeName><Initials>HT</Initials></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Ming-Zhu</ForeName><Initials>MZ</Initials></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Ming-Jing</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Min</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Qing-Chen</ForeName><Initials>QC</Initials></Author><Author ValidYN="Y"><LastName>Wan</LastName><ForeName>Jing-Yuan</ForeName><Initials>JY</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>8MDF5V39QO</RegistryNumber><NameOfSubstance UI="D017693">Sodium Bicarbonate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care. 2014 Nov 27;18(6):672. doi: 10.1186/s13054-014-0672-0.</RefSource><PMID Version="1">25672967</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="N">Renal Replacement Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017693" MajorTopicYN="N">Sodium Bicarbonate</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>9</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25212718</ArticleId><ArticleId IdType="pmc">PMC4177432</ArticleId><ArticleId IdType="doi">10.1186/s13054-014-0517-x</ArticleId><ArticleId IdType="pii">s13054-014-0517-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mao H, Katz N, Ariyanon W, Blanca-Martos L, Adybelli Z, Giuliani A, Danesi TH, Kim JC, Nayak A, Neri M, Virzi GM, Brocca A, Scalzotto E, Salvador L, Ronco C. Cardiac surgery-associated acute kidney injury. Cardiorenal Med. 2013;3:178&#x2013;199. doi: 10.1159/000353134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000353134</ArticleId><ArticleId IdType="pmc">PMC3884176</ArticleId><ArticleId IdType="pubmed">24454314</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Duca D, Alam A, Tangri N, Albert C, Goldberg P, Iqbal S, de Varennes B. Preventing Acute Renal Failure after Cardiac Surgery in High Risk Patients using Sodium Bicarbonate Therapy (PARACHUTE): interim analysis of a double-blind randomized controlled study [abstract] Circulation. 2010;122</Citation></Reference><Reference><Citation>Haase M, Haase-Fielitz A, Bellomo R, Devarajan P, Story D, Matalanis G, Reade MC, Bagshaw SM, Seevanayagam N, Seevanayagam S, Doolan L, Buxton B, Dragun D. Sodium bicarbonate to prevent increases in serum creatinine after cardiac surgery: a pilot double-blind, randomized controlled trial. Crit Care Med. 2009;37:39&#x2013;47. doi: 10.1097/CCM.0b013e318193216f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318193216f</ArticleId><ArticleId IdType="pubmed">19112278</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase M, Haase-Fielitz A, Plass M, Kuppe H, Hetzer R, Hannon C, Murray PT, Bailey MJ, Bellomo R, Bagshaw SM. Prophylactic perioperative sodium bicarbonate to prevent acute kidney injury following open heart surgery: a multicenter double-blinded randomized controlled trial. PLoS Med. 2013;10:e1001426. doi: 10.1371/journal.pmed.1001426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001426</ArticleId><ArticleId IdType="pmc">PMC3627643</ArticleId><ArticleId IdType="pubmed">23610561</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristeller JL, Zavorsky GS, Prior JE, Keating DA, Brady MA, Romaldini TA, Hickman TL, Stahl RF. Lack of effectiveness of sodium bicarbonate in preventing kidney injury in patients undergoing cardiac surgery: a randomized controlled trial. Pharmacotherapy. 2013;33:710&#x2013;717. doi: 10.1002/phar.1262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/phar.1262</ArticleId><ArticleId IdType="pubmed">23553549</ArticleId></ArticleIdList></Reference><Reference><Citation>McGuinness SP, Parke RL, Bellomo R, Van Haren FMP, Bailey M. Sodium bicarbonate infusion to reduce cardiac surgery-associated acute kidney injury: a phase II multicenter double-blind randomized controlled trial. Crit Care Med. 2013;41:1599&#x2013;1607. doi: 10.1097/CCM.0b013e31828a3f99.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31828a3f99</ArticleId><ArticleId IdType="pubmed">23685640</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Auriemma S, Fabbri A, D&#x2019;Onofrio A, Katz N, McCullough PA, Ricci Z, Shaw A, Ronco C. The pathophysiology of cardiac surgery-associated acute kidney injury (CSA-AKI) Int J Artif Organs. 2008;31:166&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pubmed">18311733</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon PJ, Stafford-Smith M, White WD, Newman MF, King S, Winn MP, Landolfo K. Acute renal failure following cardiac surgery. Nephrol Dial Transplant. 1999;14:1158&#x2013;1162. doi: 10.1093/ndt/14.5.1158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/14.5.1158</ArticleId><ArticleId IdType="pubmed">10344355</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasta JF, Kane-Gill SL, Durtschi AJ, Pathak DS, Kellum JA. Costs and outcomes of acute kidney injury (AKI) following cardiac surgery. Nephrol Dial Transplant. 2008;23:1970&#x2013;1974. doi: 10.1093/ndt/gfm908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfm908</ArticleId><ArticleId IdType="pubmed">18178605</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen MK, Gammelager H, Mikkelsen MM, Hjortdal VE, Layton JB, Johnsen SP, Christiansen CF. Post-operative acute kidney injury and five-year risk of death, myocardial infarction, and stroke among elective cardiac surgical patients: a cohort study. Crit Care. 2013;17:R292. doi: 10.1186/cc13158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc13158</ArticleId><ArticleId IdType="pmc">PMC4057271</ArticleId><ArticleId IdType="pubmed">24330762</ArticleId></ArticleIdList></Reference><Reference><Citation>Karkouti K, Wijeysundera DN, Yau TM, Callum JL, Cheng DC, Crowther M, Dupuis JY, Fremes SE, Kent B, Laflamme C, Lamy A, Legare JF, Mazer CD, McCluskey SA, Rubens FD, Sawchuk C, Beattie WS. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation. 2009;119:495&#x2013;502. doi: 10.1161/CIRCULATIONAHA.108.786913.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.786913</ArticleId><ArticleId IdType="pubmed">19153273</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar AB, Suneja M, Bayman EO, Weide GD, Tarasi M. Association between postoperative acute kidney injury and duration of cardiopulmonary bypass: a meta-analysis. J Cardiothorac Vasc Anesth. 2012;26:64&#x2013;69. doi: 10.1053/j.jvca.2011.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2011.07.007</ArticleId><ArticleId IdType="pubmed">21924633</ArticleId></ArticleIdList></Reference><Reference><Citation>Swaminathan M, Hudson CC, Phillips-Bute BG, Patel UD, Mathew JP, Newman MF, Milano CA, Shaw AD, Stafford-Smith M. Impact of early renal recovery on survival after cardiac surgery-associated acute kidney injury. Ann Thorac Surg. 2010;89:1098&#x2013;1104. doi: 10.1016/j.athoracsur.2009.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2009.12.018</ArticleId><ArticleId IdType="pubmed">20338313</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman MD, Shaefi S, Sladen RN. Preventing acute kidney injury after cardiac surgery. Curr Opin Anaesthesiol. 2011;24:70&#x2013;76. doi: 10.1097/ACO.0b013e3283422ebc.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0b013e3283422ebc</ArticleId><ArticleId IdType="pubmed">21157303</ArticleId></ArticleIdList></Reference><Reference><Citation>Stafford-Smith M, Shaw A, Swaminathan M. Cardiac surgery and acute kidney injury: emerging concepts. Curr Opin Crit Care. 2009;15:498&#x2013;502. doi: 10.1097/MCC.0b013e328332f753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCC.0b013e328332f753</ArticleId><ArticleId IdType="pubmed">19812485</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakris GL, Lass N, Gaber AO, Jones JD, Burnett JC., Jr Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am J Physiol. 1990;258:F115&#x2013;F120.</Citation><ArticleIdList><ArticleId IdType="pubmed">2301588</ArticleId></ArticleIdList></Reference><Reference><Citation>Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 1990;186:1&#x2013;85. doi: 10.1016/0076-6879(90)86093-B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0076-6879(90)86093-B</ArticleId><ArticleId IdType="pubmed">2172697</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. doi: 10.1136/bmj.b2535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2535</ArticleId><ArticleId IdType="pmc">PMC2714657</ArticleId><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Green S: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. Available from www.cochrane-handbook.org</Citation></Reference><Reference><Citation>Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA. The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi: 10.1136/bmj.d5928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13. doi: 10.1186/1471-2288-5-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-5-13</ArticleId><ArticleId IdType="pmc">PMC1097734</ArticleId><ArticleId IdType="pubmed">15840177</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557&#x2013;560. doi: 10.1136/bmj.327.7414.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Heringlake M, Heinze H, Schubert M, Nowak Y, Guder J, Kleinebrahm M, Paarmann H, Hanke T, Schon J. A perioperative infusion of sodium bicarbonate does not improve renal function in cardiac surgery patients: a prospective observational cohort study. Crit Care. 2012;16:R156. doi: 10.1186/cc11476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11476</ArticleId><ArticleId IdType="pmc">PMC3580746</ArticleId><ArticleId IdType="pubmed">22898367</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrestha A, Panagopoulos P, Gupta D, Khoury P, Apostolou D, Al-Baghdadi Y, Safadi L, Patel P, Orlewicz M. Peri-operative sodium bicarbonate infusion (POSBI) in the post-cardiac surgery patient: results of single-institution retrospective study. Crit Care Med. 2011;39:193. doi: 10.1097/CCM.0b013e318202e7d4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318202e7d4</ArticleId><ArticleId IdType="pubmed">21178531</ArticleId></ArticleIdList></Reference><Reference><Citation>Markovic D, Grkovic S, Bradic Z, Mikic A, Tutus V, Putnik S. Sodium bicarbonate in the prevention of AKI in adult cardiac surgical patients with preoperative chronic renal failure. Appl Cardiopulm Pathophysiol. 2012;16:263&#x2013;264.</Citation></Reference><Reference><Citation>Billings FT, 4th, Ball SK, Roberts LJ, 2nd, Pretorius M. Postoperative acute kidney injury is associated with hemoglobinemia and an enhanced oxidative stress response. Free Radic Biol Med. 2011;50:1480&#x2013;1487. doi: 10.1016/j.freeradbiomed.2011.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2011.02.011</ArticleId><ArticleId IdType="pmc">PMC3090463</ArticleId><ArticleId IdType="pubmed">21334433</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006;1:19&#x2013;32. doi: 10.2215/CJN.00240605.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.00240605</ArticleId><ArticleId IdType="pubmed">17699187</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase M, Haase-Fielitz A, Bagshaw SM, Ronco C, Bellomo R. Cardiopulmonary bypass-associated acute kidney injury: a pigment nephropathy? Contrib Nephrol. 2007;156:340&#x2013;353. doi: 10.1159/000102125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000102125</ArticleId><ArticleId IdType="pubmed">17464145</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38658274</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">0219-3108</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Asian journal of surgery</Title><ISOAbbreviation>Asian J Surg</ISOAbbreviation></Journal><ArticleTitle>Effects of dexmedetomidine on renal function after cardiac surgery for infective endocarditis: An interim analysis of a randomized controlled trial.</ArticleTitle><Pagination><StartPage>4322</StartPage><EndPage>4329</EndPage><MedlinePgn>4322-4329</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.asjsur.2024.04.028</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1015-9584(24)00688-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients undergoing cardiac surgery for infective endocarditis (IE) are at a high risk of postoperative acute kidney injury (AKI) owing to heightened systemic inflammation. Therefore, we aimed to investigate the effect of dexmedetomidine on postoperative AKI in patients who underwent cardiac surgery for IE.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 63 patients who underwent cardiac surgery for IE were randomly assigned to receive either intravenous dexmedetomidine infusion of 0.4&#xa0;&#x3bc;g&#xa0;kg<sup>-1</sup>&#xa0;h<sup>-1</sup> (DEX group) or normal saline infusion (control group) for 24&#xa0;h after induction of anesthesia. The occurrence of AKI within seven days postoperation, epinephrine, norepinephrine, and interleukin-6 levels, as well as postoperative morbidities, were assessed. An intertrim analysis was conducted using Pocock's alpha spending function at &#x3b1;&#xa0;=&#xa0;0.05 and &#x3b2;&#xa0;=&#xa0;0.2.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">This trial was early terminated according to the results of interim analysis performed when 60&#xa0;% of the pre-set number of patients have been collected. The incidence of AKI was significantly lower in the DEX group than in the control group (32.3&#xa0;% vs. 9.4&#xa0;%, p&#xa0;=&#xa0;0.025). Patients in the DEX group had significantly lower epinephrine levels than those in the control group, whereas norepinephrine and interleukin-6 levels were similar. Perioperative mean arterial pressure or heart rate did not differ between the groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Dexmedetomidine administration for 24&#xa0;h starting from induction of anesthesia significantly reduced the incidence of postoperative AKI after cardiac surgery for IE (by 29&#xa0;% vs. control) without hemodynamic side effects. This was accompanied by a significant attenuation of postoperative increase in serum epinephrine levels.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Asian Surgical Association and Taiwan Society of Coloproctology. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ham</LastName><ForeName>Sung Yeon</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shim</LastName><ForeName>Jae-Kwang</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sak</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Seo Hee</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soh</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwak</LastName><ForeName>Young-Lan</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address: ylkwak@yuhs.ac.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Asian J Surg</MedlineTA><NlmUniqueID>8900600</NlmUniqueID><ISSNLinking>1015-9584</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>67VB76HONO</RegistryNumber><NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance></Chemical><Chemical><RegistryNumber>X4W3ENH1CV</RegistryNumber><NameOfSubstance UI="D009638">Norepinephrine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>YKH834O4BH</RegistryNumber><NameOfSubstance UI="D004837">Epinephrine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058647">Adrenergic alpha-2 Receptor Agonists</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020927" MajorTopicYN="Y">Dexmedetomidine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004696" MajorTopicYN="Y">Endocarditis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007262" MajorTopicYN="N">Infusions, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009638" MajorTopicYN="N">Norepinephrine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004837" MajorTopicYN="N">Epinephrine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058647" MajorTopicYN="N">Adrenergic alpha-2 Receptor Agonists</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">Dexmedetomidine</Keyword><Keyword MajorTopicYN="N">Infective endocarditis</Keyword></KeywordList><CoiStatement>Declaration of competing interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>25</Day><Hour>0</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>24</Day><Hour>22</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38658274</ArticleId><ArticleId IdType="doi">10.1016/j.asjsur.2024.04.028</ArticleId><ArticleId IdType="pii">S1015-9584(24)00688-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39419173</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-2291</ISSN><JournalIssue CitedMedium="Internet"><Volume>74</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Season>Nov-Dec</Season></PubDate></JournalIssue><Title>Brazilian journal of anesthesiology (Elsevier)</Title><ISOAbbreviation>Braz J Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Intraoperative hypotension during critical phases of liver transplantation and its impact on acute kidney injury: a retrospective cohort study.</ArticleTitle><Pagination><StartPage>844566</StartPage><MedlinePgn>844566</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">844566</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bjane.2024.844566</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0104-0014(24)00088-5</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Acute Kidney Injury (AKI) following Liver Transplantation (LT) is associated with prolonged ICU and hospital stay, increased risk of chronic renal disease, and decreased graft survival. Intraoperative hypotension is a modifiable risk factor associated with postoperative AKI. We aimed to determine in which phase of LT hypotension has the strongest association with AKI: the anhepatic or neohepatic phase.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective cohort study included adult patients undergoing LT between January 2010 and June 2022. Exclusion criteria were re-do or combined transplantations, preoperative dialysis, and early graft failure or death. Primary outcome was AKI as defined by KDIGO. Hypotension was Mean Arterial Pressure (MAP) below predefined thresholds in minutes. Risk adjusted logistic regression analysis considered hypotension in 3 periods: the total procedure, anhepatic phase, and neohepatic phase.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our cohort included 1153 patients. The median MELD-NA score was 19 (IQR 11-28), and 412 (35.9%) were living-related donations. AKI occurred in 544 patients (47.2%). The unadjusted model showed an association with AKI for MAP &lt; 60 mmHg (OR = 1.011 [1.0, 1.022], p = 0.047) and MAP &lt; 55 mmHg (OR = 1.023 [1.002, 1.047], p = 0.040) in the anhepatic phase, and for MAP &lt; 60 mmHg (OR = 1.032 [1.01, 1.056], p = 0.006) in the neohepatic phase. The adjusted model did not reach significance in the subgroups but did in the total procedure: MAP &lt; 60 mmHg (OR = 1.005 [1.002, 1.008], p &lt; 0.001) and MAP &lt; 55 mmHg (OR = 1.008 [1.003-1.013], p = 0.004).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Intraoperative hypotension is independently associated with AKI following LT. This association is seen during the anhepatic phase. Maintaining MAP above 60 mmHg may improve kidney function after LT.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024. Published by Elsevier Espa&#xf1;a S.L.U.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bieze</LastName><ForeName>Matthanja</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Toronto General Hospital, Department of Anesthesia and Pain Management, Toronto, Ontario, Canada; University of Toronto, Temerty Faculty of Medicine, Department of Anesthesiology and Pain Medicine, Toronto, Ontario, Canada. Electronic address: matth.bieze@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zabida</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Toronto General Hospital, Department of Anesthesia and Pain Management, Toronto, Ontario, Canada; University of Toronto, Temerty Faculty of Medicine, Department of Anesthesiology and Pain Medicine, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinelli</LastName><ForeName>Eduarda Schutz</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Toronto General Hospital, Department of Anesthesia and Pain Management, Toronto, Ontario, Canada; University of Toronto, Temerty Faculty of Medicine, Department of Anesthesiology and Pain Medicine, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caragata</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Austin Health, Department of Anesthesia, Melbourne, Australia; University of Melbourne, School of Medicine, Department of Critical Care, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Stella</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Health Network, Department of Biostatistics, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carroll</LastName><ForeName>Jo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Toronto General Hospital, Department of Anesthesia and Pain Management, Toronto, Ontario, Canada; University of Toronto, Temerty Faculty of Medicine, Department of Anesthesiology and Pain Medicine, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Selzner</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Temerty Faculty of Medicine, Toronto General Hospital, Department of Surgery, and the Multi-Organ Transplant Program, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCluskey</LastName><ForeName>Stuart A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Toronto General Hospital, Department of Anesthesia and Pain Management, Toronto, Ontario, Canada; University of Toronto, Temerty Faculty of Medicine, Department of Anesthesiology and Pain Medicine, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Braz J Anesthesiol</MedlineTA><NlmUniqueID>101624623</NlmUniqueID><ISSNLinking>0104-0014</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016031" MajorTopicYN="Y">Liver Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="Y">Intraoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Blood pressure</Keyword><Keyword MajorTopicYN="N">Hypotension</Keyword><Keyword MajorTopicYN="N">Liver transplantation</Keyword><Keyword MajorTopicYN="N">Postoperative complications</Keyword><Keyword MajorTopicYN="N">Reperfusion</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>7</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>19</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39419173</ArticleId><ArticleId IdType="pmc">PMC11541844</ArticleId><ArticleId IdType="doi">10.1016/j.bjane.2024.844566</ArticleId><ArticleId IdType="pii">S0104-0014(24)00088-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Durand F, Francoz C, Asrani SK, et al. Acute Kidney Injury After Liver Transplantation. Transplantation. 2018;102:1636&#x2013;1649.</Citation><ArticleIdList><ArticleId IdType="pubmed">29847502</ArticleId></ArticleIdList></Reference><Reference><Citation>Thongprayoon C, Kaewput W, Thamcharoen N, et al. Incidence and Impact of Acute Kidney Injury after Liver Transplantation: A Meta-Analysis. J Clin Med. 2019;8:372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6463182</ArticleId><ArticleId IdType="pubmed">30884912</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilmi IA, Damian D, Al-Khafaji A, et al. Acute kidney injury following orthotopic liver transplantation: incidence, risk factors, and effects on patient and graft outcomes. Br J Anaesth. 2015;114:919&#x2013;926.</Citation><ArticleIdList><ArticleId IdType="pubmed">25673576</ArticleId></ArticleIdList></Reference><Reference><Citation>Contreras G, Garces G, Quartin AA, et al. An epidemiologic study of early renal replacement therapy after orthotopic liver transplantation. J Am Soc Nephrol. 2002;13:228&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pubmed">11752042</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120:c179&#x2013;c184.</Citation><ArticleIdList><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Locke JE, Shelton B, Orandi B, et al. Obesity is a risk factor for progression to kidney transplant waitlisting after liver transplantation. Clin Transplant. 2021;35:e14317.</Citation><ArticleIdList><ArticleId IdType="pubmed">33866616</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobeika MJ, Saharia A, Mobley CM, et al. Donation after circulatory death liver transplantation: An in-depth analysis and propensity score-matched comparison. Clin Transplant. 2021;35:e14304.</Citation><ArticleIdList><ArticleId IdType="pubmed">33792971</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YJ, Li JH, Guan Y, Xie QH, Hao CM, Wang ZX. Diabetes mellitus is a risk factor of acute kidney injury in liver transplantation patients. Hepatobiliary Pancreat Dis Int. 2021;20:215&#x2013;221.</Citation><ArticleIdList><ArticleId IdType="pubmed">33752999</ArticleId></ArticleIdList></Reference><Reference><Citation>Caragata R, Emerson S, Santema ML, et al. Intraoperative hypotension and the risk of acute kidney injury following liver transplantation. Clin Transplant. 2023;37:e15053.</Citation><ArticleIdList><ArticleId IdType="pubmed">37350742</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaker TM, Eason JD, Davidson BR, et al. Which cava anastomotic techniques are optimal regarding immediate and short-term outcomes after liver transplantation: A systematic review of the literature and expert panel recommendations. Clin Transplant. 2022;36:e14681.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10078200</ArticleId><ArticleId IdType="pubmed">35567584</ArticleId></ArticleIdList></Reference><Reference><Citation>SJr DeMaria, Nolasco L, Igwe D, Jules RS, Bekki Y, Smith NK. Prediction, prevention, and treatment of post reperfusion syndrome in adult orthotopic liver transplant patients. Clin Transplant. 2023;37:e15014.</Citation><ArticleIdList><ArticleId IdType="pubmed">37178452</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh M, Devereaux PJ, Garg AX, et al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology. 2013;119:507&#x2013;515.</Citation><ArticleIdList><ArticleId IdType="pubmed">23835589</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao P, Zhao S, Lyu L, et al. Association of intraoperative hypotension with acute kidney injury after liver resection surgery: an observational cohort study. BMC Nephrol. 2020;21:456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7607844</ArticleId><ArticleId IdType="pubmed">33138788</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmasi V, Maheshwari K, Yang D, et al. Relationship between Intraoperative Hypotension, Defined by Either Reduction from Baseline or Absolute Thresholds, and Acute Kidney and Myocardial Injury after Noncardiac Surgery: A Retrospective Cohort Analysis. Anesthesiology. 2017;126:47&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">27792044</ArticleId></ArticleIdList></Reference><Reference><Citation>Wehrle CJ, Zhang M, Khalil M, et al. Impact of Back-to-Base Normothermic Machine Perfusion on Complications and Costs: A Multi-Center, Real-World Risk-Matched Analysis. Ann Surg. 2024;280:300&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pubmed">38557793</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheruku SR, Raphael J, Neyra JA, Fox AA. Acute Kidney Injury after Cardiac Surgery: Prediction, Prevention, and Management. Anesthesiology. 2023;139:880&#x2013;898.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10841304</ArticleId><ArticleId IdType="pubmed">37812758</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, Weiss R, Albert F, et al. Epidemiology of surgery associated acute kidney injury (EPIS-AKI): a prospective international observational multi-center clinical study. Intensive Care Med. 2023;49:1441&#x2013;1455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10709241</ArticleId><ArticleId IdType="pubmed">37505258</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherqui D, Lauzet JY, Rotman N, et al. Orthotopic liver transplantation with preservation of the caval and portal flows. Technique and results in 62 cases. Transplantation. 1994;58:793&#x2013;796.</Citation><ArticleIdList><ArticleId IdType="pubmed">7940712</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim WH, Oh HW, Yang SM, et al. Intraoperative Hemodynamic Parameters and Acute Kidney Injury After Living Donor Liver Transplantation. Transplantation. 2019;103:1877&#x2013;1886.</Citation><ArticleIdList><ArticleId IdType="pubmed">30720690</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng J, Li Q, Wu Q, et al. A Novel Online Calculator Predicting Acute Kidney Injury After Liver Transplantation: A Retrospective Study. Transpl Int. 2023;36:10887.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9892055</ArticleId><ArticleId IdType="pubmed">36744052</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong HY, Chen F, He Y, et al. Intrarenal resistance index for the assessment of acute renal injury in a rat liver transplantation model. BMC Nephrol. 2013;14:55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3599562</ArticleId><ArticleId IdType="pubmed">23453043</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacoviello M, Monitillo F, Leone M, et al. The Renal Arterial Resistance Index Predicts Worsening Renal Function in Chronic Heart Failure Patients. Cardiorenal Med. 2016;7:42&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5159733</ArticleId><ArticleId IdType="pubmed">27994601</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiorelli S, Biancofiore G, Feltracco P, et al. Acute kidney injury after liver transplantation, perioperative risk factors, and outcome: prospective observational study of 1681 patients (OLTx Study) Minerva Anestesiol. 2022;88:248&#x2013;258.</Citation><ArticleIdList><ArticleId IdType="pubmed">34709014</ArticleId></ArticleIdList></Reference><Reference><Citation>de Haan JE, Hoorn EJ, de Geus HRH. Acute kidney injury after liver transplantation: Recent insights and future perspectives. Best Pract Res Clin Gastroenterol. 2017;31:161&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pubmed">28624104</ArticleId></ArticleIdList></Reference><Reference><Citation>Widmer JD, Schlegel A, Ghazaly M, et al. Piggyback or Cava Replacement: Which Implantation Technique Protects Liver Recipients From Acute Kidney Injury and Complications? Liver Transpl. 2018;24:1746&#x2013;1756.</Citation><ArticleIdList><ArticleId IdType="pubmed">30230686</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih TH, Chen CC, Chen CL, et al. Acute Kidney Injury in Adult Living Donor Liver Transplantation Performed with Different Methods of Inferior Vena Cava Clamping Maneuvers. Transplant Proc. 2020;52:1849&#x2013;1851.</Citation><ArticleIdList><ArticleId IdType="pubmed">32448664</ArticleId></ArticleIdList></Reference><Reference><Citation>Gumbert SD, Kork F, Jackson ML, et al. Perioperative Acute Kidney Injury. Anesthesiology. 2020;132:180&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10924686</ArticleId><ArticleId IdType="pubmed">31687986</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31394251</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>13</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1615-5947</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><PubDate><Year>2020</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Annals of vascular surgery</Title><ISOAbbreviation>Ann Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>Effect of Remote Ischemic Preconditioning on Patients Undergoing Elective Major Vascular Surgery: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>452</StartPage><EndPage>462</EndPage><MedlinePgn>452-462</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.avsg.2019.05.035</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0890-5096(19)30530-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Whether remote ischemic preconditioning (RIPC), through several cycles of ischemia-reperfusion, can generate endogenous protective substances to protect patients undergoing elective major vascular surgery remains unclear. The results derived from many randomized controlled trials (RCTs) have been discrepant.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed (1966 to May 2018) and EMBASE (1966 to May 2018) databases were searched to identify all published RCTs that assessed the effect of RIPC in patients undergoing elective major vascular surgery. Then, we performed a systematic review and meta-analysis to merge the outcomes of RIPC procedures from each RCT, which included all-cause mortality, myocardial infarction (MI), acute kidney injury (AKI), and/or new-onset arrhythmia.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 909 patients were enrolled from 10 eligible studies that were conducted from 2007 through 2016. A fixed effect model was utilized in this study to pool each effect size. Pooled analyses of all RCTs showed that RIPC did not reduce the incidence of all-cause mortality (pooled risk ratio [RR] 1.36, 95% confidence interval [CI] 0.63-2.92, P&#xa0;=&#xa0;0.56), MI (pooled RR 0.77, 95% CI 0.48-1.22, P&#xa0;=&#xa0;0.38), AKI (pooled RR 0.93, 95% CI 0.68-1.27, P&#xa0;=&#xa0;0.10), or new-onset arrhythmia (pooled RR 1.47, 95% CI 0.83-2.60, P&#xa0;=&#xa0;0.52) compared with the control treatment. The publication bias detected by Begg's test was low.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There is no prominent evidence to support the hypothesis that RIPC can provide perioperative protection to patients undergoing elective major vascular surgery. Therefore, the routine use of RIPC to reduce the incidence of perioperative complications of these operations may not be recommended.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ouyang</LastName><ForeName>Huan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Meng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Graduate School, University of Newcastle, Callaghan, Newcastle, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jiahui</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Geriatric Medicine, The First People's Hospital, Jiujiang, Jiangxi Province, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Cuifu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Zhiwei</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jiasheng</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Weimin</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China. Electronic address: drzwm@sina.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ann Vasc Surg</MedlineTA><NlmUniqueID>8703941</NlmUniqueID><ISSNLinking>0890-5096</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019194" MajorTopicYN="N">Ischemic Preconditioning</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012039" MajorTopicYN="N">Regional Blood Flow</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060205" MajorTopicYN="Y">Therapeutic Occlusion</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014656" MajorTopicYN="Y">Vascular Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31394251</ArticleId><ArticleId IdType="doi">10.1016/j.avsg.2019.05.035</ArticleId><ArticleId IdType="pii">S0890-5096(19)30530-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36050776</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1749-8090</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of cardiothoracic surgery</Title><ISOAbbreviation>J Cardiothorac Surg</ISOAbbreviation></Journal><ArticleTitle>Outcomes of surgery for acute type A dissection in octogenarians versus non-octogenarians: a systematic review and meta analysis.</ArticleTitle><Pagination><StartPage>222</StartPage><MedlinePgn>222</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">222</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13019-022-01980-x</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Acute Type A Aortic Dissection (ATAAD) is a cardiothoracic emergency that requires urgent intervention. Elderly status, particularly age over 80, is an independent risk factor for mortality and morbidity. The mid-term outcomes of this age group are also unknown. This systematic review and meta-analysis of observational studies was therefore performed to analyse short- and mid-term mortality and morbidity in octogenarians following surgery for ATAAD.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review was conducted for studies published since January 2000. The primary endpoint was short-term mortality, either reported as 30-day mortality or in-hospital mortality and medium-term (five year) survival. Secondary endpoints were rates of postoperative complications, namely stroke, acute renal failure (ARF), re-exploration and intensive care unit (ICU) length of stay (LOS).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 16 retrospective studies, with a total of 16, 641 patients were included in the systematic review and meta-analysis. Pooled analysis demonstrated that octogenarian cohorts are at significantly higher risk of short-term mortality than non-octogenarians (OR 1.93; 95% CI 1.33-2.81; P&#x2009;&lt;&#x2009;0.001). Actuarial survival was significantly lower in the octogenarian cohort, with a five-year survival in the octogenarian cohort of 54% compared to 76% in the non-octogenarian cohort (P&#x2009;&lt;&#x2009;0.001). There were no significant differences between the cohorts in terms of secondary outcomes: stroke, ARF, re-exploration or ICU LOS.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Octogenarians are twice as likely to die in the short-term following surgery for ATAAD and demonstrate a significantly lower five-year actuarial survival. Patients and family members should be well informed of the risks of surgery and suitable octogenarians selected for surgery.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Eranki</LastName><ForeName>Aditya</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4484-3304</Identifier><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, John Hunter Hospital, Newcastle, Australia. adit.eranki@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merakis</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Medicine and Public Health, University of Newcastle, Newcastle, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Michael L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, John Hunter Hospital, Newcastle, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine and Public Health, University of Newcastle, Newcastle, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flynn</LastName><ForeName>Campbell D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, St George Hospital, Sydney, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Collaborative Research (CORE) Group, Macquarie University, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villanueva</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, John Hunter Hospital, Newcastle, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson-Smith</LastName><ForeName>Ashley</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, John Hunter Hospital, Newcastle, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Collaborative Research (CORE) Group, Macquarie University, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yangsin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, John Hunter Hospital, Newcastle, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mejia</LastName><ForeName>Ross</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, John Hunter Hospital, Newcastle, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Cardiothorac Surg</MedlineTA><NlmUniqueID>101265113</NlmUniqueID><ISSNLinking>1749-8090</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000784" MajorTopicYN="Y">Aortic Dissection</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Mid-term survival</Keyword><Keyword MajorTopicYN="N">Octogenarian</Keyword><Keyword MajorTopicYN="N">Outcomes</Keyword><Keyword MajorTopicYN="N">Type A aortic dissection</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>1</Day><Hour>23</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36050776</ArticleId><ArticleId IdType="pmc">PMC9434858</ArticleId><ArticleId IdType="doi">10.1186/s13019-022-01980-x</ArticleId><ArticleId IdType="pii">10.1186/s13019-022-01980-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Conzelmann L, et al. Mortality in patients with acute aortic dissection type A: analysis of pre- and intraoperative risk factors from the German Registry for Acute Aortic Dissection Type A (GERAADA) Eur J Cardiothorac Surg. 2016;49:P44&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">26510701</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta R, et al. Predicting death in patients with acute type A aortic dissection. Circulation. 2002;195:P200&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pubmed">11790701</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiappini B, et al. Early and Late outcomes of acute type A aortic dissection: analysis of risk factors in 487 consecutive patients. Eur Heart J. 2005;26:P180&#x2013;186.</Citation><ArticleIdList><ArticleId IdType="pubmed">15618075</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue Y, et al. Analysis of acute type A aortic dissection in Japan Registry of Aortic Dissection (JRAD) Ann Thorac Surg. 2020;110(3):790&#x2013;879.</Citation><ArticleIdList><ArticleId IdType="pubmed">32035913</ArticleId></ArticleIdList></Reference><Reference><Citation>Pape L, et al. Presentation, diagnosis, and outcomes of acute aortic dissection: 17-year trends from the International Registry of Acute Aortic Dissection. J Am Coll Cardiol. 2015;66(4):350&#x2013;358.</Citation><ArticleIdList><ArticleId IdType="pubmed">26205591</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmerman K, et al. Improving mortality trends for hospitalization of aortic dissection in the National Inpatient Sample. J Vasc Surg. 2016;64(3):P606&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pubmed">27183856</ArticleId></ArticleIdList></Reference><Reference><Citation>Biancari F, et al. Contemporary results after surgical repair of type A aortic dissection in patients aged 80 years and older: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2011;40:P1058&#x2013;1065.</Citation><ArticleIdList><ArticleId IdType="pubmed">21561787</ArticleId></ArticleIdList></Reference><Reference><Citation>Vm B, et al. Surgical repair of Stanford type A aortic dissection in elderly patients: a contemporary systematic review and meta-analysis. Ann Cardiothorac Surg. 2016;5(4):P257&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4973120</ArticleId><ArticleId IdType="pubmed">27563539</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. PLoS Med. 2009;6(7):e1000097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>National Heart, Lung, and Blood Institute. Study Quality Assessment Tools. Available online:&#xa0;https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools. 2019.</Citation></Reference><Reference><Citation>Hozo SP, et al. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005 doi: 10.1186/1471-2288-5-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-5-13</ArticleId><ArticleId IdType="pmc">PMC1097734</ArticleId><ArticleId IdType="pubmed">15840177</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyot P, et al. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves. BMC Med Res Methodol. 2012;12(1):P9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3313891</ArticleId><ArticleId IdType="pubmed">22297116</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedetto U, et al. Decade-long trends in surgery for acute Type A aortic dissection in England: a retrospective cohort study. Lancet Reginal Health Europe. 2021 doi: 10.1016/j.lanepe.2021.100131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100131</ArticleId><ArticleId IdType="pmc">PMC8454541</ArticleId><ArticleId IdType="pubmed">34557840</ArticleId></ArticleIdList></Reference><Reference><Citation>Bojko M, et al. Midterm outcomes of emergency surgery for acute type A aortic dissection in octogenarians. J Thorac Cardiovasc Surg. 2020 doi: 10.1016/j.jtcvs.2020.03.157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2020.03.157</ArticleId><ArticleId IdType="pubmed">32624307</ArticleId></ArticleIdList></Reference><Reference><Citation>Chavanon O, et al. Preoperative predictive factors for mortality in acute type A aortic dissection: an institutional report on 217 consecutives cases. Interact Cardiovasc Thorac Surg. 2007;6:P43&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">17669765</ArticleId></ArticleIdList></Reference><Reference><Citation>Goda M, et al. Risk analysis for hospital mortality in patients with acute type A aortic dissection. Ann Thorac Surg. 2010;90:P1246&#x2013;P1250.</Citation><ArticleIdList><ArticleId IdType="pubmed">20868821</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu M, et al. Outcomes of acute aortic dissection surgery in octogenarians. J Am Heart Assoc. 2020;9:e017147. doi: 10.1161/JAHA.120.017147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.120.017147</ArticleId><ArticleId IdType="pmc">PMC7726989</ArticleId><ArticleId IdType="pubmed">32912018</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawahito K, Kimura N, Yamaguchi A, Aizawa K, Misawa Y, Adachi H. Early and late surgical outcomes of acute type A aortic dissection in octogenarians. Ann Thorac Surg. 2018;105:138&#x2013;143.</Citation><ArticleIdList><ArticleId IdType="pubmed">29054307</ArticleId></ArticleIdList></Reference><Reference><Citation>Neri E, et al. Operation for acute type A aortic dissection in octogenarians: Is it justified? J Thorac Cardiovasc Surg. 2001;121:259&#x2013;267.</Citation><ArticleIdList><ArticleId IdType="pubmed">11174731</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohnuma T, Shinjo D, Fushimi K. Hospital mortality of patients aged 80 and older after surgical repair for type A acute aortic dissection in Japan. Medicine. 2016;95:31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4979811</ArticleId><ArticleId IdType="pubmed">27495057</ArticleId></ArticleIdList></Reference><Reference><Citation>Omura A, et al. Early and late outcomes of operation for acute type A aortic dissection in patients aged 80 years and older. Ann Thorac Surg. 2017;103:P131&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">27460914</ArticleId></ArticleIdList></Reference><Reference><Citation>Rylski B, et al. Outcome after surgery for acute aortic dissection type A in patients over 70 years: data analysis from the German Registry for Acute Aortic Dissection Type A (GERAADA) Eur J Cardiothorac Surg. 2011;40:P435&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pubmed">21247773</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiono M, Hata M, Sezai A, Iida M, Yagi S, Negishi N. Emergency surgery for acute type A aortic dissection in octogenarians. Ann Thorac Surg. 2006;82:P554&#x2013;559.</Citation><ArticleIdList><ArticleId IdType="pubmed">16863762</ArticleId></ArticleIdList></Reference><Reference><Citation>Suenega E, Sato M, Fumoto H. Ascending aortic replacement for acute type A aortic dissection in octogenarians. Gen Thorac Cardiovasc Surg. 2016;64:P138&#x2013;143.</Citation><ArticleIdList><ArticleId IdType="pubmed">26670778</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki T, Asai T, Kinoshita T. Emergency surgery for acute type A aortic dissection in octogenarians without patient selection. Ann Thorac Surg. 2019;107:P1146&#x2013;P1153.</Citation><ArticleIdList><ArticleId IdType="pubmed">30448481</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang G, Malekan R, Yu C, Kai M, Lansman S, Spielvogel D. Surgery for acute type A aortic dissection in octogenarians is justified. J Thorac Cardiovasc Surg. 2013;145:P186&#x2013;P190.</Citation><ArticleIdList><ArticleId IdType="pubmed">23267524</ArticleId></ArticleIdList></Reference><Reference><Citation>Tochii M, et al. Early and late outcomes of surgical repair for Stanford A acute aortic dissection in octogenarians. Circ J. 2016;80:P2468&#x2013;2472.</Citation><ArticleIdList><ArticleId IdType="pubmed">27803432</ArticleId></ArticleIdList></Reference><Reference><Citation>Trimarchi S, et al. International registry of acute aortic dissection investigators. Role of age in acute type A aortic dissection outcome: report from the International Registry of Acute Aortic Dissection (IRAD). J Thorac Cardiovasc Surg 2010;140:P784&#x2013;789.</Citation><ArticleIdList><ArticleId IdType="pubmed">20176372</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway B, et al. Improved clinical outcomes and survival following repair of acute type A aortic dissection in the current era. Interact Cardiovasc Thorac Surg. 2014;19(6):P971&#x2013;976.</Citation><ArticleIdList><ArticleId IdType="pubmed">25146324</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan L, et al. A systematic review on the quality of life benefits after aortic valve replacement in the elderly. J Thorac Cardiovasc Surg. 2013;145(5):P1173&#x2013;1189.</Citation><ArticleIdList><ArticleId IdType="pubmed">23415689</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan L, Saxena A, McMahon R, Newcomb A. Coronary artery bypass graft surgery in the elderly. Circulation. 2013;128(21):P2333&#x2013;2343.</Citation><ArticleIdList><ArticleId IdType="pubmed">24249619</ArticleId></ArticleIdList></Reference><Reference><Citation>Endlich M, et al. Long-term outcome and quality of life in aortic type A dissection survivors. Thorac Cardiovasc Surg. 2016;64(2):P91&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">25865779</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoyma T, et al. Comparison of surgical and conservative treatment outcomes for type A aortic dissection in elderly patients. J Cardiothorac Surg. 2018;13:129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6299624</ArticleId><ArticleId IdType="pubmed">30563552</ArticleId></ArticleIdList></Reference><Reference><Citation>Hata M, et al. Should emergency surgical intervention be performed for an octogenarian with type A acute aortic dissection? J Thorac Cardiovasc Surg. 2008;135:P1042&#x2013;P1046.</Citation><ArticleIdList><ArticleId IdType="pubmed">18455582</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazui T, et al. Impact of an aggressive surgical approach on surgical outcome in type A aortic dissection. Ann Thorac Surg. 2002;74:S1844&#x2013;S1847.</Citation><ArticleIdList><ArticleId IdType="pubmed">12440678</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon MR, et al. Does the extent of proximal or distal resection influence outcomes for type A aortic dissections? Ann Thorac Surg. 2001;71:P1244&#x2013;1250.</Citation><ArticleIdList><ArticleId IdType="pubmed">11308168</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccardo A, et al. Outcomes after surgical treatment for type A acute aortic dissection in octogenarians: a multicenter study. Ann Thorac Surg. 2009;88:P491&#x2013;497.</Citation><ArticleIdList><ArticleId IdType="pubmed">19632399</ArticleId></ArticleIdList></Reference><Reference><Citation>Hata M, et al. Less invasive quick replacement for octogenarians with type A acute aortic dissection. J Thorac Cardiovasc Surg. 2008;136:P489&#x2013;493.</Citation><ArticleIdList><ArticleId IdType="pubmed">18692662</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghazy T, et al. Quality of life after surgery for Stanford type A aortic dissection: influences of different operative strategies. Heart Surg Forum. 2017;20(3):E102&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">28671865</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacini D, et al. Antegrade selective cerebral perfusion and moderate hypothermia in aortic arch surgery: clinical outcomes in elderly patients. Eur J Cardiothorac Surg. 2012;42(2):P249&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pubmed">22290895</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Eusanio M, et al. Surgery for acute type A aortic dissection: the effect of antegrade selective cerebral perfusion on the early outcome of elderly patients. Ital Heart J. 2005;6(4):P335&#x2013;340.</Citation><ArticleIdList><ArticleId IdType="pubmed">15902933</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacini D, et al. Cerebral perfusion issues in type A aortic dissection. J Vis Surg. 2018;4:77. doi: 10.21037/jovs.2018.03.20.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jovs.2018.03.20</ArticleId><ArticleId IdType="pmc">PMC5945856</ArticleId><ArticleId IdType="pubmed">29780723</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccardo A, et al. Octogenarians with uncomplicated acute type a aortic dissection benefit from emergency operation. Ann Thorac Surg. 2013;96(3):851&#x2013;856.</Citation><ArticleIdList><ArticleId IdType="pubmed">23916804</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe T, et al. Patient trends and outcomes of surgery for type A acute aortic dissection in Japan: an analysis of more than 10 000 patients from the Japan Cardiovascular Surgery Database. Eur J Cardiothorac Surg. 2020;57(4):P660&#x2013;667.</Citation><ArticleIdList><ArticleId IdType="pubmed">31793995</ArticleId></ArticleIdList></Reference><Reference><Citation>Goda M, et al. Differences of patients&#x2019; characteristics in acute type A aortic dissection&#x2014;surgical data from Belgian and Japanese centers. J Cardiothorac Surg. 2018 doi: 10.1186/s13019-018-078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13019-018-078</ArticleId><ArticleId IdType="pmc">PMC6122674</ArticleId><ArticleId IdType="pubmed">30180871</ArticleId></ArticleIdList></Reference><Reference><Citation>Malvindi P, et al. Acute type A aortic dissection repair in elderly patients. Eur J Cardiothorac Surg. 2015;48(5):P664&#x2013;670.</Citation><ArticleIdList><ArticleId IdType="pubmed">25602058</ArticleId></ArticleIdList></Reference><Reference><Citation>Rylski B, et al. Multicenter Prospective Observational Study. Acute aortic dissection type A: age-related management and outcomes reported in the German Registry for Acute Aortic Dissection Type A (GERAADA) of over 2000 patients. Ann Surg. 2014;259(3):P598&#x2013;P604.</Citation><ArticleIdList><ArticleId IdType="pubmed">23657079</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu IH, et al. Is old age a contraindication for surgical treatment in acute aortic dissection? A demographic study of national database registry in Taiwan. J Card Surg. 2008;23(2):P133&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pubmed">18304127</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumfarth J, et al. Acute type A dissection in octogenarians: does emergency surgery impact in-hospital outcome or long-term survival. Eur J Cardiothorac Surg. 2017;51(3):P472&#x2013;477.</Citation><ArticleIdList><ArticleId IdType="pubmed">28364444</ArticleId></ArticleIdList></Reference><Reference><Citation>Adam U, et al. Health-related quality of life of patients after surgery for acute Type A aortic dissection. Interact Cardiovasc Thorac Surg. 2018;27(1):P48&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">29474555</ArticleId></ArticleIdList></Reference><Reference><Citation>Endlich M, et al. Long-term outcome and quality of life in aortic type A dissection survivors. Thorac Cardiovasc Surg. 2015;64:P91&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">25865779</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacini D, Murana G, Di Marco L, et al. Cerebral perfusion issues in type A aortic dissection. J Vis Surg. 2018;4:77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5945856</ArticleId><ArticleId IdType="pubmed">29780723</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsugane S. Why has Japan become the world's most long-lived country: insights from a food and nutrition perspective. Eur J Clin Nutr. 2021;75(6):P921&#x2013;928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8189904</ArticleId><ArticleId IdType="pubmed">32661353</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39622314</PMID><DateCompleted><Year>2024</Year><Month>12</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1525-6049</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Renal failure</Title><ISOAbbreviation>Ren Fail</ISOAbbreviation></Journal><ArticleTitle>High neutrophil-to-lymphocyte ratio as a cost-effective marker of acute kidney injury and in-hospital mortality after cardiac surgery: a case-control study.</ArticleTitle><Pagination><StartPage>2417744</StartPage><MedlinePgn>2417744</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2417744</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/0886022X.2024.2417744</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Inflammation is one of the important pathophysiological characteristics of acute kidney injury (AKI) after cardiac surgery. The aim was to explore the relationship between preoperative neutrophil-to-lymphocyte ratio (NLR), a simple and cost-effective maker of inflammatory response, and AKI after cardiac surgery. Furthermore, whether the NLR affected in-hospital mortality was also investigated.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">The electronic medical records of patients from January 1, 2006 to December 31, 2018 undergoing cardiac surgery were utilized. The interest outcome was AKI, defined as the criteria of Kidney Disease Improving Global Outcomes (KDIGO), and other outcomes were severe AKI (KDIGO stage &#x2265;2) and in-hospital mortality. Logistic regression was utilized to assess the association of preoperative NLR with outcomes while adjust for potential confounders.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Totally, 23,638 patients were included. The incidence of AKI was 27.6%. The NLR was significantly greater in patients with AKI compared to those without. As the nonlinear relationship between NLR and AKI indicated by restricted cubic spline, NLR was analyzed as a categorical variable with the cutoff value of five. Multivariate analysis demonstrated that NLR &gt; 5 was significantly associated with an increased risk of AKI, with an odds ratio of 5.046 (95% confidence interval, 4.589 to 5.548), when compared to patients with NLR &#x2264; 5. Furthermore, high NLR was also an independent risk factor for severe AKI and in-hospital mortality.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">A higher preoperative NLR was increased the risk of AKI, severe AKI, and in-hospital mortality after cardiac surgery, which may be helpful for stratifying patients to develop individualized treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Penghua</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Nephrology, The Affiliated Yixing Hospital of Jiangsu University, Yixing, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Huaban</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Zhi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Geriatric Nephrology, Guangdong Provincial Geriatrics Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Nephrology, The Affiliated Yixing Hospital of Jiangsu University, Yixing, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mo</LastName><ForeName>Zhiming</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhilian</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tao</LastName><ForeName>Yiming</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Shuangxin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Zhiming</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yuanhan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Xinling</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-6764-9571</Identifier><AffiliationInfo><Affiliation>Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yanhua</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Geriatric Nephrology, Guangdong Provincial Geriatrics Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ren Fail</MedlineTA><NlmUniqueID>8701128</NlmUniqueID><ISSNLinking>0886-022X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="Y">Neutrophils</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008214" MajorTopicYN="Y">Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003362" MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">neutrophil-to-lymphocyte ratio</Keyword><Keyword MajorTopicYN="N">risk factor</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>3</Day><Hour>0</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>3</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>2</Day><Hour>19</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>12</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39622314</ArticleId><ArticleId IdType="pmc">PMC11613334</ArticleId><ArticleId IdType="doi">10.1080/0886022X.2024.2417744</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fuhrman DY, Kellum JA.. Epidemiology and pathophysiology of cardiac surgery-associated acute kidney injury. Curr Opin Anaesthesiol. 2017;30(1):60&#x2013;65. doi: 10.1097/ACO.0000000000000412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0000000000000412</ArticleId><ArticleId IdType="pubmed">27820742</ArticleId></ArticleIdList></Reference><Reference><Citation>Noble RA, Lucas BJ, Selby NM.. Long-term outcomes in patients with acute kidney injury. Clin J Am Soc Nephrol. 2020;15(3):423&#x2013;429. doi: 10.2215/CJN.10410919.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.10410919</ArticleId><ArticleId IdType="pmc">PMC7057296</ArticleId><ArticleId IdType="pubmed">32075806</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Bellomo R.. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol. 2017;13(11):697&#x2013;711. doi: 10.1038/nrneph.2017.119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2017.119</ArticleId><ArticleId IdType="pubmed">28869251</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson PH, Cuthbertson BH, Croal BL, et al. . Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting. Am J Cardiol. 2010;105(2):186&#x2013;191. doi: 10.1016/j.amjcard.2009.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2009.09.007</ArticleId><ArticleId IdType="pubmed">20102916</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W, Huang X, Yang L, et al. . Neutrophil-to-lymphocyte ratio as a prognostic marker of mortality and disease severity in septic acute kidney injury patients: a retrospective study. Int Immunopharmacol. 2023;116:109778. doi: 10.1016/j.intimp.2023.109778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2023.109778</ArticleId><ArticleId IdType="pubmed">36738677</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheatley J, Liu Z, Loth J, et al. . The prognostic value of elevated neutrophil-lymphocyte ratio for cardiac surgery-associated acute kidney injury: a systematic review and meta-analysis. Acta Anaesthesiol Scand. 2023;67(2):131&#x2013;141. doi: 10.1111/aas.14170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.14170</ArticleId><ArticleId IdType="pmc">PMC10099461</ArticleId><ArticleId IdType="pubmed">36367845</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian H, Jiang X, Duan G, et al. . Preoperative inflammatory markers predict postoperative clinical outcomes in patients undergoing heart valve surgery: a large-sample retrospective study. Front Immunol. 2023;14:1159089. doi: 10.3389/fimmu.2023.1159089.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1159089</ArticleId><ArticleId IdType="pmc">PMC10102463</ArticleId><ArticleId IdType="pubmed">37063874</ArticleId></ArticleIdList></Reference><Reference><Citation>Weedle RC, Da Costa M, Veerasingam D, et al. . The use of neutrophil lymphocyte ratio to predict complications post cardiac surgery. Ann Transl Med. 2019;7(23):778&#x2013;778. doi: 10.21037/atm.2019.11.17.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm.2019.11.17</ArticleId><ArticleId IdType="pmc">PMC6989975</ArticleId><ArticleId IdType="pubmed">32042794</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim WH, Park JY, Ok SH, et al. . Association between the neutrophil/lymphocyte ratio and acute kidney injury after cardiovascular surgery: a retrospective observational study. Medicine (Baltimore). 2015;94(43):e1867. doi: 10.1097/MD.0000000000001867.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000001867</ArticleId><ArticleId IdType="pmc">PMC4985412</ArticleId><ArticleId IdType="pubmed">26512598</ArticleId></ArticleIdList></Reference><Reference><Citation>Nashef SA, Roques F, Sharples LD, et al. . Euroscore II. Eur J. Eur J Cardiothorac Surg. 2012;41(4):734&#x2013;745; discussion 744-5. doi: 10.1093/ejcts/ezs043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezs043</ArticleId><ArticleId IdType="pubmed">22378855</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, Stevens LA, Schmid CH, et al. . A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604&#x2013;612. doi: 10.7326/0003-4819-150-9-200905050-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-150-9-200905050-00006</ArticleId><ArticleId IdType="pmc">PMC2763564</ArticleId><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et al. . The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801&#x2013;810. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Disease: improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int. 2012;2(suppl):1&#x2013;138.</Citation></Reference><Reference><Citation>White IR, Royston P, Wood AM.. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30(4):377&#x2013;399. doi: 10.1002/sim.4067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.4067</ArticleId><ArticleId IdType="pubmed">21225900</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Zheng Q, Pu Q, et al. . Perioperative and &#xad;oncological outcomes of uniportal versus three-port thoracoscopic segmentectomy for lung cancer: a &#xad;propensity score matching analysis. Transl Lung Cancer Res. 2023;12(3):446&#x2013;459. doi: 10.21037/tlcr-22-635.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/tlcr-22-635</ArticleId><ArticleId IdType="pmc">PMC10088001</ArticleId><ArticleId IdType="pubmed">37057109</ArticleId></ArticleIdList></Reference><Reference><Citation>Barili F, Pacini D, Rosato F, et al. . In-hospital mortality risk assessment in elective and non-elective cardiac surgery: a comparison between euroscore ii and age, creatinine, ejection fraction score. Eur J Cardiothorac Surg. 2014;46(1):44&#x2013;48. doi: 10.1093/ejcts/ezt581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezt581</ArticleId><ArticleId IdType="pubmed">24401691</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng J, Zhang D, Lin S, et al. . Comparative analysis of machine learning versus traditional modeling approaches for predicting in-hospital mortality after cardiac surgery: assessment from temporal and spatial external validation based on a nationwide cardiac surgery registry. Eur Heart J Qual Care Clin Outcomes. 2024;10(2):121&#x2013;131. doi: 10.1093/ehjqcco/qcad028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjqcco/qcad028</ArticleId><ArticleId IdType="pubmed">37218710</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xfa;&#xf1;ez J, N&#xfa;&#xf1;ez E, Bod&#xed; V, et al. . Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol. 2008;101(6):747&#x2013;752. doi: 10.1016/j.amjcard.2007.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2007.11.004</ArticleId><ArticleId IdType="pubmed">18328833</ArticleId></ArticleIdList></Reference><Reference><Citation>Olasi&#x144;ska-Wi&#x15b;niewska A, Perek B, Grygier M, et al. . Increased neutrophil-to-lymphocyte ratio is associated with higher incidence of acute kidney injury and worse survival after transcatheter aortic valve implantation. Cardiol J. 2021;30(6):938&#x2013;945. doi: 10.5603/CJ.a2021.0149.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/CJ.a2021.0149</ArticleId><ArticleId IdType="pmc">PMC10713220</ArticleId><ArticleId IdType="pubmed">34787890</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Li S, Cao H, et al. . The protective role of phloretin against dextran sulfate sodium-induced ulcerative colitis in mice. Food Funct. 2019;10(1):422&#x2013;431. doi: 10.1039/c8fo01699b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c8fo01699b</ArticleId><ArticleId IdType="pubmed">30604787</ArticleId></ArticleIdList></Reference><Reference><Citation>Guangqing Z, Liwei C, Fei L, et al. . Predictive value of neutrophil to lymphocyte ratio on acute kidney injury after on-pump coronary artery bypass: a retrospective, single-center study. Gen Thorac Cardiovasc Surg. 2022;70(7):624&#x2013;633. doi: 10.1007/s11748-022-01772-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11748-022-01772-z</ArticleId><ArticleId IdType="pmc">PMC9206599</ArticleId><ArticleId IdType="pubmed">35103920</ArticleId></ArticleIdList></Reference><Reference><Citation>Haran C, Gimpel D, Clark H, et al. . Preoperative neutrophil and lymphocyte ratio as a predictor of mortality and morbidity after cardiac surgery. Heart Lung Circ. 2021;30(3):414&#x2013;418. doi: 10.1016/j.hlc.2020.05.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2020.05.115</ArticleId><ArticleId IdType="pubmed">32665173</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Lameire N.. The definition of acute kidney injury. Lancet. 2018;391(10117):202&#x2013;203. doi: 10.1016/S0140-6736(17)31630-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31630-6</ArticleId><ArticleId IdType="pubmed">30277883</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34661665</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>10</Issue><PubDate><Year>2021</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>External Validation of a Prediction Model for Acute Kidney Injury Following Noncardiac Surgery.</ArticleTitle><Pagination><StartPage>e2127362</StartPage><MedlinePgn>e2127362</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2127362</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2021.27362</ELocationID><Abstract><AbstractText Label="IMPORTANCE">The Simple Postoperative AKI Risk (SPARK) index is a prediction model for postoperative acute kidney injury (PO-AKI) in patients undergoing noncardiac surgery. External validation has not been performed.</AbstractText><AbstractText Label="OBJECTIVE">To externally validate the SPARK index.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This single-center retrospective cohort study included adults who underwent noncardiac surgery under general anesthesia from 2007 to 2011. Those with obstetric or urological surgery, estimated glomerular filtration rate (eGFR) of less than 15 mL/min/1.73 m2, preoperative dialysis, or an expected surgical duration of less than 1 hour were excluded. The study was conducted at Nara Medical University Hospital. Data analysis was conducted from January to July 2021.</AbstractText><AbstractText Label="EXPOSURES">Risk factors for AKI included in SPARK index.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">PO-AKI, defined as an increase in serum creatinine of at least 0.3 mg/dL within 48 hours or 150% compared with preoperative baseline value or urine output of less than 0.5 mL/kg/h for at least 6 hours within 1 week after surgery, and critical AKI, defined as either AKI stage 2 or greater and/or any AKI connected to postoperative death or requiring kidney replacement therapy before discharge. The discrimination and calibration of the SPARK index were examined with area under the receiver operating characteristic curves (AUC) and calibration plots, respectively.</AbstractText><AbstractText Label="RESULTS">Among 5135 participants (2410 [46.9%] men), 303 (5.9%) developed PO-AKI, and 137 (2.7%) developed critical AKI. Compared with the SPARK cohort, participants in our cohort were older (median [IQR] age, 56 [44-66] years vs 63 [50-73] years), had lower baseline eGFR (median [IQR], 82.1 [71.4-95.1] mL/min/1.73 m2 vs 78.2 [65.6-92.2] mL/min/1.73 m2), and had a higher prevalence of comorbidities (eg, diabetes: 3956 of 51&#x202f;041 [7.8%] vs 802 [15.6%]). The incidence of PO-AKI and critical AKI increased as the scores on the SPARK index increased. For example, 10 of 593 participants (1.7%) in SPARK class A, indicating lowest risk, experienced PO-AKI, while 53 of 332 (16.0%) in SPARK class D, indicating highest risk, experienced PO-AKI. However, AUCs for PO-AKI and critical AKI were 0.67 (95% CI, 0.63-0.70) and 0.62 (95% CI, 0.57-0.67), respectively, and the calibration was poor (PO-AKI: y&#x2009;=&#x2009;0.24x&#x2009;+&#x2009;3.28; R2&#x2009;=&#x2009;0.86; critical AKI: y&#x2009;=&#x2009;0.20x&#x2009;+&#x2009;2.08; R2&#x2009;=&#x2009;0.51). Older age, diabetes, expected surgical duration, emergency surgery, renin-angiotensin-aldosterone system blockade use, and hyponatremia were not associated with PO-AKI in our cohort, resulting in overestimation of the predicted probability of AKI in our cohort.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">In this study, the incidence of PO-AKI increased as the scores on the SPARK index increased. However, the predicted probability might not be accurate in cohorts with older patients with more comorbidities.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nishimoto</LastName><ForeName>Masatoshi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Nara Medical University, Kashihara, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murashima</LastName><ForeName>Miho</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Nara Medical University, Kashihara, Nara, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nephrology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kokubu</LastName><ForeName>Maiko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Nara Prefecture General Medical Center, Nara, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsui</LastName><ForeName>Masaru</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Nara Medical University, Kashihara, Nara, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nephrology, Nara Prefecture General Medical Center, Nara, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eriguchi</LastName><ForeName>Masahiro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Nara Medical University, Kashihara, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samejima</LastName><ForeName>Ken-Ichi</ForeName><Initials>KI</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Nara Medical University, Kashihara, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akai</LastName><ForeName>Yasuhiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Nara Medical University, Kashihara, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsuruya</LastName><ForeName>Kazuhiko</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Nara Medical University, Kashihara, Nara, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="Y">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Akai reported receiving personal fees from commercial sponsors outside the submitted work. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>18</Day><Hour>12</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>10</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34661665</ArticleId><ArticleId IdType="pmc">PMC8524308</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.27362</ArticleId><ArticleId IdType="pii">2785082</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lassnigg A, Schmidlin D, Mouhieddine M, et al. . Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004;15(6):1597-1605. doi:10.1097/01.ASN.0000130340.93930.DD</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ASN.0000130340.93930.DD</ArticleId><ArticleId IdType="pubmed">15153571</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JR, Cochran RP, Dacey LJ, et al. ; Northern New England Cardiovascular Disease Study Group . Perioperative increases in serum creatinine are predictive of increased 90-day mortality after coronary artery bypass graft surgery. Circulation. 2006;114(1)(suppl):I409-I413. doi:10.1161/CIRCULATIONAHA.105.000596</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.105.000596</ArticleId><ArticleId IdType="pubmed">16820609</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998;104(4):343-348. doi:10.1016/S0002-9343(98)00058-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(98)00058-8</ArticleId><ArticleId IdType="pubmed">9576407</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu CY, Chertow GM, McCulloch CE, Fan D, Ordo&#xf1;ez JD, Go AS. Nonrecovery of kidney function and death after acute on chronic renal failure. Clin J Am Soc Nephrol. 2009;4(5):891-898. doi:10.2215/CJN.05571008</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.05571008</ArticleId><ArticleId IdType="pmc">PMC2676192</ArticleId><ArticleId IdType="pubmed">19406959</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishani A, Nelson D, Clothier B, et al. . The magnitude of acute serum creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease, and death. Arch Intern Med. 2011;171(3):226-233. doi:10.1001/archinternmed.2010.514</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2010.514</ArticleId><ArticleId IdType="pubmed">21325112</ArticleId></ArticleIdList></Reference><Reference><Citation>Newsome BB, Warnock DG, McClellan WM, et al. . Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med. 2008;168(6):609-616. doi:10.1001/archinte.168.6.609</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.168.6.609</ArticleId><ArticleId IdType="pubmed">18362253</ArticleId></ArticleIdList></Reference><Reference><Citation>Huen SC, Parikh CR. Predicting acute kidney injury after cardiac surgery: a systematic review. Ann Thorac Surg. 2012;93(1):337-347. doi:10.1016/j.athoracsur.2011.09.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3286599</ArticleId><ArticleId IdType="pubmed">22186469</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S, Cho H, Park S, et al. . Simple Postoperative AKI Risk (SPARK) classification before noncardiac surgery: a prediction index development study with external validation. J Am Soc Nephrol. 2019;30(1):170-181. doi:10.1681/ASN.2018070757</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2018070757</ArticleId><ArticleId IdType="pmc">PMC6317608</ArticleId><ArticleId IdType="pubmed">30563915</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimoto M, Murashima M, Kokubu M, et al. . Positive association between intra-operative fluid balance and post-operative acute kidney injury in non-cardiac surgery: the NARA-AKI cohort study. J Nephrol. 2020;33(3):561-568. doi:10.1007/s40620-019-00688-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40620-019-00688-x</ArticleId><ArticleId IdType="pubmed">31865609</ArticleId></ArticleIdList></Reference><Reference><Citation>Murashima M, Nishimoto M, Kokubu M, et al. . Inflammation as a predictor of acute kidney injury and mediator of higher mortality after acute kidney injury in non-cardiac surgery. Sci Rep. 2019;9(1):20260. doi:10.1038/s41598-019-56615-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-56615-4</ArticleId><ArticleId IdType="pmc">PMC6937243</ArticleId><ArticleId IdType="pubmed">31889082</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagawa M, Nishimoto M, Kokubu M, et al. . Acute kidney injury as an independent predictor of infection and malignancy: the NARA-AKI cohort study. J Nephrol. 2019;32(6):967-975. doi:10.1007/s40620-019-00662-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40620-019-00662-7</ArticleId><ArticleId IdType="pubmed">31617159</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimoto M, Murashima M, Kokubu M, et al. . Pre-operative proteinuria and post-operative acute kidney injury in noncardiac surgery: the NARA-Acute Kidney Injury cohort study. Nephrol Dial Transplant. 2020;35(12):2111-2116. doi:10.1093/ndt/gfz269</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfz269</ArticleId><ArticleId IdType="pubmed">31891400</ArticleId></ArticleIdList></Reference><Reference><Citation>Nara Medical University . Clinical research: a retrospective cohort study of the onset and prognostic predictors of postoperative acute renal failure in non-cardiac surgery. Accessed September 15, 2021. http://nephrology.naramed-u.ac.jp/research/clinical.html</Citation></Reference><Reference><Citation>World Medical Association . World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-2194. doi:10.1001/jama.2013.281053</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.281053</ArticleId><ArticleId IdType="pubmed">24141714</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group . KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl.
2012;2: 1-138. Accessed September 15, 2021. https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2012-AKI-Guideline-English.pdf</Citation></Reference><Reference><Citation>Matsuo S, Imai E, Horio M, et al. ; Collaborators developing the Japanese equation for estimated GFR . Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982-992. doi:10.1053/j.ajkd.2008.12.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2008.12.034</ArticleId><ArticleId IdType="pubmed">19339088</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Tremper KK, Englesbe MJ, et al. . Predictors of postoperative acute renal failure after noncardiac surgery in patients with previously normal renal function. Anesthesiology. 2007;107(6):892-902. doi:10.1097/01.anes.0000290588.29668.38</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.anes.0000290588.29668.38</ArticleId><ArticleId IdType="pubmed">18043057</ArticleId></ArticleIdList></Reference><Reference><Citation>Moons KG, Kengne AP, Grobbee DE, et al. . Risk prediction models: II, external validation, model updating, and impact assessment. Heart. 2012;98(9):691-698. doi:10.1136/heartjnl-2011-301247</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2011-301247</ArticleId><ArticleId IdType="pubmed">22397946</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell S, Dekker FW, Vadiveloo T, et al. . Risk of postoperative acute kidney injury in patients undergoing orthopaedic surgery&#x2014;development and validation of a risk score and effect of acute kidney injury on survival: observational cohort study. BMJ. 2015;351:h5639. doi:10.1136/bmj.h5639</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h5639</ArticleId><ArticleId IdType="pmc">PMC4641433</ArticleId><ArticleId IdType="pubmed">26561522</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EH, Kim HR, Baek SH, et al. . Risk factors of postoperative acute kidney injury in patients undergoing esophageal cancer surgery. J Cardiothorac Vasc Anesth. 2014;28(4):936-942. doi:10.1053/j.jvca.2013.12.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2013.12.006</ArticleId><ArticleId IdType="pubmed">24680132</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagawa M, Ogata A, Hamano T. Pre- and/or intra-operative prescription of diuretics, but not renin-angiotensin-system inhibitors, is significantly associated with acute kidney injury after non-cardiac surgery: a retrospective cohort study. PLoS One. 2015;10(7):e0132507. doi:10.1371/journal.pone.0132507</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0132507</ArticleId><ArticleId IdType="pmc">PMC4492997</ArticleId><ArticleId IdType="pubmed">26146836</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis MR, Naik BI, Freundlich RE, et al. ; Multicenter Perioperative Outcomes Group Investigators . Preoperative risk and the association between hypotension and postoperative acute kidney injury. Anesthesiology. 2020;132(3):461-475. doi:10.1097/ALN.0000000000003063</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003063</ArticleId><ArticleId IdType="pmc">PMC7015776</ArticleId><ArticleId IdType="pubmed">31794513</ArticleId></ArticleIdList></Reference><Reference><Citation>STARSurg Collaborative . Association between peri-operative angiotensin-converting enzyme inhibitors and angiotensin-2 receptor blockers and acute kidney injury in major elective non-cardiac surgery: a multicentre, prospective cohort study. Anaesthesia. 2018;73(10):1214-1222. doi:10.1111/anae.14349</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.14349</ArticleId><ArticleId IdType="pubmed">29984818</ArticleId></ArticleIdList></Reference><Reference><Citation>Rueggeberg A, Boehm S, Napieralski F, et al. . Development of a risk stratification model for predicting acute renal failure in orthotopic liver transplantation recipients. Anaesthesia. 2008;63(11):1174-1180. doi:10.1111/j.1365-2044.2008.05604.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2008.05604.x</ArticleId><ArticleId IdType="pubmed">18803627</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Tremper KK, Heung M, et al. . Development and validation of an acute kidney injury risk index for patients undergoing general surgery: results from a national data set. Anesthesiology. 2009;110(3):505-515. doi:10.1097/ALN.0b013e3181979440</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3181979440</ArticleId><ArticleId IdType="pubmed">19212261</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyle JM, Moualla S, Arrigain S, et al. . Risks and outcomes of acute kidney injury requiring dialysis after cardiac transplantation. Am J Kidney Dis. 2006;48(5):787-796. doi:10.1053/j.ajkd.2006.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2006.08.002</ArticleId><ArticleId IdType="pubmed">17059998</ArticleId></ArticleIdList></Reference><Reference><Citation>Slankamenac K, Breitenstein S, Held U, Beck-Schimmer B, Puhan MA, Clavien PA. Development and validation of a prediction score for postoperative acute renal failure following liver resection. Ann Surg. 2009;250(5):720-728. doi:10.1097/SLA.0b013e3181bdd840</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e3181bdd840</ArticleId><ArticleId IdType="pubmed">19809295</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa S, Griesdale DE, Lohser J. Acute kidney injury after lung resection surgery: incidence and perioperative risk factors. Anesth Analg. 2012;114(6):1256-1262. doi:10.1213/ANE.0b013e31824e2d20</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e31824e2d20</ArticleId><ArticleId IdType="pubmed">22451594</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmasi V, Maheshwari K, Yang D, et al. . Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery: a retrospective cohort analysis. Anesthesiology. 2017;126(1):47-65. doi:10.1097/ALN.0000000000001432</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001432</ArticleId><ArticleId IdType="pubmed">27792044</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M, Li G, Mohan S, Turnbull ZA, Kiran RP, Li G. Intraoperative data enhance the detection of high-risk acute kidney injury patients when added to a baseline prediction model. Anesth Analg. 2021;132(2):430-441. doi:10.1213/ANE.0000000000005057</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005057</ArticleId><ArticleId IdType="pmc">PMC7855510</ArticleId><ArticleId IdType="pubmed">32769380</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23332602</PMID><DateCompleted><Year>2013</Year><Month>06</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1523-6838</ISSN><JournalIssue CitedMedium="Internet"><Volume>61</Volume><Issue>5</Issue><PubDate><Year>2013</Year><Month>May</Month></PubDate></JournalIssue><Title>American journal of kidney diseases : the official journal of the National Kidney Foundation</Title><ISOAbbreviation>Am J Kidney Dis</ISOAbbreviation></Journal><ArticleTitle>Urinary cystatin C and acute kidney injury after cardiac surgery.</ArticleTitle><Pagination><StartPage>730</StartPage><EndPage>738</EndPage><MedlinePgn>730-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.ajkd.2012.12.006</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0272-6386(12)01577-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute kidney injury (AKI) is common after cardiac surgery and is associated with adverse patient outcomes. Urinary cystatin C (CysC) level is a biomarker of proximal tubule function and may increase earlier in AKI than serum creatinine level.</AbstractText><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Prospective cohort study.</AbstractText><AbstractText Label="SETTINGS &amp; PARTICIPANTS" NlmCategory="METHODS">The TRIBE AKI (Translational Research Investigating Biomarker Endpoints in AKI) Consortium prospectively enrolled 1,203 adults and 299 children and adolescents at 8 institutions in 2007-2009.</AbstractText><AbstractText Label="INDEX TEST" NlmCategory="METHODS">Urinary CysC (in milligrams per liter) within the first 12 hours after surgery.</AbstractText><AbstractText Label="OUTCOME" NlmCategory="RESULTS">Serum creatinine-based AKI was defined as AKI Network stage 1 (mild AKI) and doubling of serum creatinine from the preoperative value or need for dialysis during hospitalization (severe AKI).</AbstractText><AbstractText Label="OTHER MEASUREMENTS" NlmCategory="METHODS">Analyses were adjusted for characteristics used clinically for AKI risk stratification, including age, sex, race, estimated glomerular filtration rate, diabetes, hypertension, heart failure, nonelective surgery, cardiac catheterization within 72 hours, type of surgery, myocardial infarction, and cardiopulmonary bypass time longer than 120 minutes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Urinary CysC level measured in the early postoperative period (0-6 and 6-12 hours postoperatively) correlated with both mild and severe AKI in adults and children. However, after analyses were adjusted for other factors, the effect was attenuated for both forms of AKI in both cohorts.</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">Limited numbers of patients with severe AKI and in-hospital dialysis treatment.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Urinary CysC values are not associated significantly with the development of AKI after cardiac surgery in adults and children.</AbstractText><CopyrightInformation>Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Koyner</LastName><ForeName>Jay L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Section of Nephrology, Department of Medicine, University of Chicago, Pritzker School of Medicine, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garg</LastName><ForeName>Amit X</ForeName><Initials>AX</Initials></Author><Author ValidYN="Y"><LastName>Shlipak</LastName><ForeName>Michael G</ForeName><Initials>MG</Initials></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Uptal D</ForeName><Initials>UD</Initials></Author><Author ValidYN="Y"><LastName>Sint</LastName><ForeName>Kyaw</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Kwangik</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Devarajan</LastName><ForeName>Prasad</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Edelstein</LastName><ForeName>Charles L</ForeName><Initials>CL</Initials></Author><Author ValidYN="Y"><LastName>Zappitelli</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Thiessen-Philbrook</LastName><ForeName>Heather</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Parikh</LastName><ForeName>Chirag R</ForeName><Initials>CR</Initials></Author><Author ValidYN="Y"><CollectiveName>Translational Research Investigating Biomarker Endpoints in AKI (TRIBE AKI) Consortium</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01DK082185</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 RR024139</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL085757</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23DK081616</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K24DK090203</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 DK096418</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DK082185</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K24 DK090203</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 DK079310</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>L30 DK084760</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01HL-085757</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 DK081616</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>01</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Kidney Dis</MedlineTA><NlmUniqueID>8110075</NlmUniqueID><ISSNLinking>0272-6386</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D055316">Cystatin C</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000652" MajorTopicYN="Y">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055316" MajorTopicYN="N">Cystatin C</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="Y">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005919" MajorTopicYN="N">Glomerular Filtration Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="N">Heart Diseases</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007677" MajorTopicYN="N">Kidney Function Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Coca</LastName><ForeName>Steven</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Li</LastName><ForeName>Simon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Swaminathan</LastName><ForeName>Madhav</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Krawczeski</LastName><ForeName>Catherine D</ForeName><Initials>CD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Passik</LastName><ForeName>Cary</ForeName><Initials>C</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23332602</ArticleId><ArticleId IdType="mid">NIHMS436842</ArticleId><ArticleId IdType="pmc">PMC3627833</ArticleId><ArticleId IdType="doi">10.1053/j.ajkd.2012.12.006</ArticleId><ArticleId IdType="pii">S0272-6386(12)01577-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chertow G, Levy E, Hammermeister K, Grover F, Daley J. Independent association between acute renal failure and mortality following caridac surgery. Am J Med. 1998;104:343&#x2013;348.</Citation><ArticleIdList><ArticleId IdType="pubmed">9576407</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeysundera DN, Karkouti K, Dupuis JY, et al. Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. Jama. 2007;297:1801&#x2013;1809.</Citation><ArticleIdList><ArticleId IdType="pubmed">17456822</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC522841</ArticleId><ArticleId IdType="pubmed">15312219</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JR, Kramer RS, Coca SG, Parikh CR. Duration of acute kidney injury impacts long-term survival after cardiac surgery. Ann Thorac Surg. 2010;90:1142&#x2013;1148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3819730</ArticleId><ArticleId IdType="pubmed">20868804</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasta JF, Kane-Gill SL, Durtschi AJ, Pathak DS, Kellum JA. Costs and outcomes of acute kidney injury (AKI) following cardiac surgery. Nephrol Dial Transplant. 2008;23:1970&#x2013;1974.</Citation><ArticleIdList><ArticleId IdType="pubmed">18178605</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2206446</ArticleId><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference><Reference><Citation>Han W, Bonventre J. Biological markers for the early detecion of acute kidney injury. Curr Opin Crit Care. 2004;10:476&#x2013;482.</Citation><ArticleIdList><ArticleId IdType="pubmed">15616389</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyner JL, Vaidya VS, Bennett MR, et al. Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol. 2010;5:2154&#x2013;2165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2994075</ArticleId><ArticleId IdType="pubmed">20798258</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh CR, Devarajan P. New biomarkers of acute kidney injury. Crit Care Med. 2008;36:S159&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pubmed">18382188</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaidya VS, Waikar SS, Ferguson MA, et al. Urinary Biomarkers for Sensitive and Specific Detection of Acute Kidney Injury in Humans. Clin Transl Sci. 2008;1:200&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2638059</ArticleId><ArticleId IdType="pubmed">19212447</ArticleId></ArticleIdList></Reference><Reference><Citation>Zappitelli M, Krawczeski CD, Devarajan P, et al. Early postoperative serum cystatin C predicts severe acute kidney injury following pediatric cardiac surgery. Kidney Int. 2011;80:655&#x2013;662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3312809</ArticleId><ArticleId IdType="pubmed">21525851</ArticleId></ArticleIdList></Reference><Reference><Citation>Society of Thoracic Surgeons.  Available at  http://www.ctsnet.org/file/rptDataSpecifications252_1_ForVendorsPGS.pdf.</Citation></Reference><Reference><Citation>Parikh CR, Coca SG, Thiessen-Philbrook H, et al. Postoperative Biomarkers Predict Acute Kidney Injury and Poor Outcomes after Adult Cardiac Surgery. J Am Soc Nephrol. 2011;22:1748&#x2013;1757.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3171945</ArticleId><ArticleId IdType="pubmed">21836143</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh CR, Devarajan P, Zappitelli M, et al. Postoperative Biomarkers Predict Acute Kidney Injury and Poor Outcomes after Pediatric Cardiac Surgery. J Am Soc Nephrol. 2011;22:1737&#x2013;1747.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3171944</ArticleId><ArticleId IdType="pubmed">21836147</ArticleId></ArticleIdList></Reference><Reference><Citation>Endre ZH, Pickering JW, Walker RJ, et al. Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int. 2011;79:1119&#x2013;1130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3884688</ArticleId><ArticleId IdType="pubmed">21307838</ArticleId></ArticleIdList></Reference><Reference><Citation>Heise D, Rentsch K, Braeuer A, Friedrich M, Quintel M. Comparison of urinary neutrophil glucosaminidase-associated lipocalin, cystatin C, and alpha1-microglobulin for early detection of acute renal injury after cardiac surgery. Eur J Cardiothorac Surg. 2010;39:38&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">20650648</ArticleId></ArticleIdList></Reference><Reference><Citation>Herget-Rosenthal S, Poppen D, Husing J, et al. Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin Chem. 2004;50</Citation><ArticleIdList><ArticleId IdType="pubmed">14709451</ArticleId></ArticleIdList></Reference><Reference><Citation>Herget-Rosenthal S, van Wijk JA, Brocker-Preuss M, Bokenkamp A. Increased urinary cystatin C reflects structural and functional renal tubular impairment independent of glomerular filtration rate. Clin Biochem. 2007;40:946&#x2013;951.</Citation><ArticleIdList><ArticleId IdType="pubmed">17537416</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyner JL, Bennett MR, Worcester EM, et al. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int. 2008;23:23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2745082</ArticleId><ArticleId IdType="pubmed">18650797</ArticleId></ArticleIdList></Reference><Reference><Citation>Liangos O, Tighiouart H, Perianayagam MC, et al. Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass. Biomarkers. 2009;14:423&#x2013;431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2743298</ArticleId><ArticleId IdType="pubmed">19572801</ArticleId></ArticleIdList></Reference><Reference><Citation>Nejat M, Pickering JW, Walker RJ, et al. Urinary cystatin C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unit. Crit Care. 2010;14:R85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2911717</ArticleId><ArticleId IdType="pubmed">20459852</ArticleId></ArticleIdList></Reference><Reference><Citation>Herget-Rosenthal S, Feldkamp T, Volbracht L, Kribben A. Measurement of Urinary cystain C by particle-enhanced nephelometric immunoassay: precision, interferences, stability, and reference range. Ann Clin Biochem. 2004;41:111&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pubmed">15025800</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida K, Cotoh A. Measurement of cystatin-C and creatinine in urine. Clin Chim Acta. 2002;323:121&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pubmed">12135813</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyner JL, Garg AX, Coca SG, et al. Biomarkers Predict Progression of Acute Kidney Injury after Cardiac Surgery. J Am Soc Nephrol. 2012;23:905&#x2013;914.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3338298</ArticleId><ArticleId IdType="pubmed">22383693</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2763564</ArticleId><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz GJ, Munoz A, Schneider MF, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009;20:629&#x2013;637.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2653687</ArticleId><ArticleId IdType="pubmed">19158356</ArticleId></ArticleIdList></Reference><Reference><Citation>Piepsz A, Tondeur M, Ham H. Revisiting normal (51)Cr-ethylenediaminetetraacetic acid clearance values in children. Eur J Nucl Med Mol Imaging. 2006;33:1477&#x2013;1482.</Citation><ArticleIdList><ArticleId IdType="pubmed">16865393</ArticleId></ArticleIdList></Reference><Reference><Citation>Dieterle F, Perentes E, Cordier A, et al. Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury. Nat Biotechnol. 2010;28:463&#x2013;469.</Citation><ArticleIdList><ArticleId IdType="pubmed">20458316</ArticleId></ArticleIdList></Reference><Reference><Citation>Siew ED, Ware LB, Ikizler TA. Biological markers of acute kidney injury. J Am Soc Nephrol. 2011;22:810&#x2013;820.</Citation><ArticleIdList><ArticleId IdType="pubmed">21493774</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. The Lancet. 2005;365:1231&#x2013;1238.</Citation><ArticleIdList><ArticleId IdType="pubmed">15811456</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh CR, Abraham E, Ancukiewicz M, Edelstein CL. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol. 2005;16:3046&#x2013;3052.</Citation><ArticleIdList><ArticleId IdType="pubmed">16148039</ArticleId></ArticleIdList></Reference><Reference><Citation>Waikar SS, Betensky RA, Emerson SC, Bonventre JV. Imperfect gold standards for kidney injury biomarker evaluation. J Am Soc Nephrol. 2012;23:13&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3695762</ArticleId><ArticleId IdType="pubmed">22021710</ArticleId></ArticleIdList></Reference><Reference><Citation>Maahs DM, Jalal D, McFann K, Rewers M, Snell-Bergeon JK. Systematic shifts in cystatin C between 2006 and 2010. Clin J Am Soc Nephrol. 2011;6:1952&#x2013;1955.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3156426</ArticleId><ArticleId IdType="pubmed">21784814</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39489662</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>12</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>The Effects of Angiotensin II versus Norepinephrine on Pulmonary Vascular Resistance in Cardiac Surgery: Post Hoc Analysis of a Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>2950</StartPage><EndPage>2958</EndPage><MedlinePgn>2950-2958</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2024.09.148</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(24)00782-1</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To assess whether angiotensin II infusion increases pulmonary vascular resistance (PVR) relative to norepinephrine.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Secondary analysis of a double-blinded randomized feasibility study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Two tertiary metropolitan hospitals in Melbourne, Australia.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Fifty-eight adult patients undergoing cardiac surgery using cardiopulmonary bypass with an elevated risk of acute kidney injury (AKI).</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Angiotensin II infusion compared with norepinephrine infusion.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">There was no significant difference in the primary outcome of PVR both intraoperatively and postoperatively between the angiotensin II group and the norepinephrine group. The study drug (angiotensin II or norepinephrine) infusion rate was associated with a small increase in PVR (&#x3b2; = 0.08; p = 0.01). The strongest association with PVR was the random effect (ie, patient effect) (p &lt; 0.001). This effect was consistent across secondary outcomes. Randomization to norepinephrine instead of to angiotensin II was associated with reduced mean systemic arterial to mean pulmonary arterial pressure ratio postoperatively (&#x3b2; = -0.65; p = 0.01).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The results of this study suggest that in cardiac surgery patients and at doses used in the prior feasibility study, angiotensin II did not have significant effects on the pulmonary vasculature compared with norepinephrine. Moreover, at doses used in this study, neither drug appeared to have a substantial effect on the pulmonary circulation relative to surgical and patient factors.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Jolene</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Perioperative Medicine, Alfred Health and Monash University, Melbourne, Victoria, Australia; Department of Anaesthesia and Pain Medicine, Fiona Stanley Hospital, Western Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Kathy</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Hospital, Heidelberg, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miles</LastName><ForeName>Lachlan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Austin Hospital, Heidelberg, Victoria, Australia; Department of Critical Care, Melbourne Medical School, University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Melbourne Medical School, University of Melbourne, Parkville, Victoria, Australia; Department of Intensive Care, Austin Hospital, Heidelberg, Victoria, Australia; Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia; Data Analytics Research and Evaluation, Austin Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coulson</LastName><ForeName>Tim G</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Perioperative Medicine, Alfred Health and Monash University, Melbourne, Victoria, Australia; Department of Critical Care, Melbourne Medical School, University of Melbourne, Parkville, Victoria, Australia. Electronic address: tim.coulson@unimelb.edu.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>X4W3ENH1CV</RegistryNumber><NameOfSubstance UI="D009638">Norepinephrine</NameOfSubstance></Chemical><Chemical><RegistryNumber>11128-99-7</RegistryNumber><NameOfSubstance UI="D000804">Angiotensin II</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009638" MajorTopicYN="Y">Norepinephrine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000804" MajorTopicYN="Y">Angiotensin II</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014655" MajorTopicYN="Y">Vascular Resistance</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="N">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">angiotensin II</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">norepinephrine</Keyword><Keyword MajorTopicYN="N">pulmonary arterial pressure</Keyword><Keyword MajorTopicYN="N">pulmonary vascular resistance</Keyword><Keyword MajorTopicYN="N">vasopressors</Keyword></KeywordList><CoiStatement>Declaration of competing interest R.B. reports serving as a paid member of medical advisory boards for La Jolla Pharmaceutical, Viatris, and Paion Pharma. All other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>24</Day><Hour>0</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>0</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>3</Day><Hour>21</Hour><Minute>56</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39489662</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2024.09.148</ArticleId><ArticleId IdType="pii">S1053-0770(24)00782-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38723416</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Association between hydroxyethyl starch 130/0.4 administration during noncardiac surgery and postoperative acute kidney injury: A propensity score-matched analysis of a large cohort in China.</ArticleTitle><Pagination><StartPage>111493</StartPage><MedlinePgn>111493</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2024.111493</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(24)00122-3</ELocationID><Abstract><AbstractText Label="STUDY OBJECTIVE">The use of hydroxyethyl starch 130/0.4 has been linked to renal injury in critically ill patients, but its impact on surgical patients remains uncertain.</AbstractText><AbstractText Label="DESIGN">A retrospective cohort study.</AbstractText><AbstractText Label="SETTING">This study was conducted at one tertiary care hospital in China.</AbstractText><AbstractText Label="PATIENTS">We evaluated the records of 51,926 Chinese adults who underwent noncardiac surgery from 2013 to 2022. Patients given a combination of hydroxyethyl starch 130/0.4 and crystalloids were propensity-matched at a 1: 1 ratio of baseline characteristics to patients given only crystalloids (11,725 pairs).</AbstractText><AbstractText Label="INTERVENTIONS">Eligible patients were divided into those given a combination of hydroxyethyl starch 130/0.4 and crystalloid during surgery and a reference crystalloid group consisting of patients who were not given any colloid.</AbstractText><AbstractText Label="MEASUREMENTS">The primary outcome was the incidence of acute kidney injury. Secondarily, acute kidney injury stage, need for renal replacement therapy, intensive care unit transfer rate, and duration of postoperative hospitalization were considered.</AbstractText><AbstractText Label="MAIN RESULTS">After matching, hydroxyethyl starch use [8.5 (IQR: 7.5-10.0) mL/kg] did not increase the incidence of acute kidney injury compared with that in the crystalloid group [2.0 vs. 2.2%, OR: 0.90 (0.74-1.08), P&#xa0;=&#xa0;0.25]. Nor did hydroxyethyl starch use worsen acute kidney injury stage [OR 0.90 (0.75-1.08), P&#xa0;=&#xa0;0.26]. No significant differences between the fluid groups were observed in renal replacement therapy [OR 0.60 (0.41-0.90), P&#xa0;=&#xa0;0.02)] or intensive care unit transfers [OR 1.02 (0.95-1.09), P&#xa0;=&#xa0;0.53] after Bonferroni correction. Even in a subset of patients at high risk of renal injury, hydroxyethyl starch use was not associated with worse outcomes.</AbstractText><AbstractText Label="CONCLUSIONS">Hydroxyethyl starch 130/0.4 use was not significantly associated with a greater incidence of postoperative acute kidney injury compared to receiving crystalloid solutions only.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Min-Jing</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha, China; Clinical Research Center of Hunan Province for Anesthesia and Perioperative Medicine, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Na</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha, China; Clinical Research Center of Hunan Province for Anesthesia and Perioperative Medicine, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Chun-Yan</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha, China; Clinical Research Center of Hunan Province for Anesthesia and Perioperative Medicine, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha, China; Clinical Research Center of Hunan Province for Anesthesia and Perioperative Medicine, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha, China; Clinical Research Center of Hunan Province for Anesthesia and Perioperative Medicine, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jing-Han</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha, China; Clinical Research Center of Hunan Province for Anesthesia and Perioperative Medicine, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xing-Yang</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha, China; Clinical Research Center of Hunan Province for Anesthesia and Perioperative Medicine, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Qulian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha, China; Clinical Research Center of Hunan Province for Anesthesia and Perioperative Medicine, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sessler</LastName><ForeName>Daniel I</ForeName><Initials>DI</Initials><AffiliationInfo><Affiliation>Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, USA; Population Health Research Institute, McMaster University, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha, China; Clinical Research Center of Hunan Province for Anesthesia and Perioperative Medicine, Changsha, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China. Electronic address: ewang324@csu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006895">Hydroxyethyl Starch Derivatives</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077324">Crystalloid Solutions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010952">Plasma Substitutes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Clin Anesth. 2024 Sep;96:111500. doi: 10.1016/j.jclinane.2024.111500.</RefSource><PMID Version="1">38763095</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006895" MajorTopicYN="Y">Hydroxyethyl Starch Derivatives</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="Y">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077324" MajorTopicYN="Y">Crystalloid Solutions</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010952" MajorTopicYN="N">Plasma Substitutes</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="N">Renal Replacement Therapy</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hydroxyethyl starch 130/0.4</Keyword><Keyword MajorTopicYN="N">Noncardiac surgery</Keyword><Keyword MajorTopicYN="N">Postoperative acute kidney injury</Keyword></KeywordList><CoiStatement>Declaration of competing interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>15</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>10</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>9</Day><Hour>18</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38723416</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2024.111493</ArticleId><ArticleId IdType="pii">S0952-8180(24)00122-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40203179</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1528-1175</ISSN><JournalIssue CitedMedium="Internet"><Volume>143</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Perioperative Nitric Oxide Conditioning Reduces Acute Kidney Injury in Cardiac Surgery Patients with Chronic Kidney Disease (the DEFENDER Trial): A Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>287</StartPage><EndPage>299</EndPage><MedlinePgn>287-299</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ALN.0000000000005494</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Postoperative acute kidney injury (AKI) is a significant concern for cardiac surgery patients with chronic kidney disease (CKD). Effective pharmacologic interventions to mitigate these risks are urgently needed. This study aimed to evaluate the efficacy and safety of perioperative nitric oxide (NO) administration in preventing AKI and limiting CKD progression in patients undergoing cardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 136 patients with CKD undergoing elective cardiac surgery with cardiopulmonary bypass were randomized into two equal groups: the NO group (n = 68), receiving 80 parts per million NO during the intraoperative period and for 6&#x2009;h postsurgery, and the control group (n = 68), receiving a sham treatment. The primary outcome was AKI incidence within 7 days postsurgery.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">AKI incidence was significantly lower in the NO group (16 of 68 patients, 23.5%) compared to the control group (27 of 68 patients, 39.7%) with a relative risk of 0.59 (95% CI, 0.35 to 0.99; P = 0.043). Six months postsurgery, the glomerular filtration rate was higher in the NO group (50&#x2009;ml &#xb7; min -1 &#xb7; 1.73 m -2 [45; 54]) compared to the control group (45&#x2009;ml &#xb7; min -1 &#xb7; 1.73 m -2 [41; 51]; P = 0.038). Postoperative pneumonia was significantly less frequent in the NO group: 10 of 68 (14.7%) versus 20 of 68 (29.4%) with a relative risk of 0.5 (95% CI, 0.25 to 0.99; P = 0.039). NO administration was safe: methemoglobin and nitrogen dioxide levels remained within acceptable ranges, oxidative-nitrosyl stress did not increase, and there were no significant differences between the groups in blood transfusion requirements, platelet counts, or postoperative blood loss volumes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Perioperative NO administration in CKD patients undergoing cardiac surgery with cardiopulmonary bypass is safe, reduces the incidence of AKI, and slows the progression of renal dysfunction.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 American Society of Anesthesiologists. All Rights Reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kamenshchikov</LastName><ForeName>Nikolay O</ForeName><Initials>NO</Initials><Identifier Source="ORCID">0000-0003-4289-4439</Identifier><AffiliationInfo><Affiliation>Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tyo</LastName><ForeName>Mark A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berra</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts; Department of Anaesthesia, Harvard Medical School, Boston, Massachusetts; and Respiratory Care Service, Patient Care Services, Massachusetts General Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kravchenko</LastName><ForeName>Igor V</ForeName><Initials>IV</Initials><AffiliationInfo><Affiliation>Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kozlov</LastName><ForeName>Boris N</ForeName><Initials>BN</Initials><AffiliationInfo><Affiliation>Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gusakova</LastName><ForeName>Anna M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Podoksenov</LastName><ForeName>Yuri K</ForeName><Initials>YK</Initials><AffiliationInfo><Affiliation>Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>31C4KY9ESH</RegistryNumber><NameOfSubstance UI="D009569">Nitric Oxide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009569" MajorTopicYN="Y">Nitric Oxide</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="Y">Renal Insufficiency, Chronic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="Y">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>8</Day><Hour>12</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>9</Day><Hour>18</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>9</Day><Hour>14</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40203179</ArticleId><ArticleId IdType="doi">10.1097/ALN.0000000000005494</ArticleId><ArticleId IdType="pii">00000542-202508000-00016</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhang D, Teng J, Luo Z, Ding X, Jiang W: Risk factors and prognosis of acute kidney injury after cardiac surgery in patients with chronic kidney disease. Blood Purif 2023; 52:166&#x2013;73. doi:10.1159/000526120</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000526120</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho JS, Shim JK, Lee S, et al.: Chronic progression of cardiac surgery associated acute kidney injury: Intermediary role of acute kidney disease. J Thorac Cardiovasc Surg 2021; 161:681&#x2013;8.e3. doi:10.1016/j.jtcvs.2019.10.101</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2019.10.101</ArticleId></ArticleIdList></Reference><Reference><Citation>Molinari L, Sakhuja A, Kellum JA: Perioperative renoprotection: General mechanisms and treatment approaches. Anesth Analg 2020; 131:1679&#x2013;92. doi:10.1213/ANE.0000000000005107</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005107</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei C, Berra L, Rezoagli E, et al.: Nitric oxide decreases acute kidney injury and stage 3 chronic kidney disease after cardiac surgery. Am J Respir Crit Care Med 2018; 198:1279&#x2013;87. doi:10.1164/rccm.201710-2150OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201710-2150OC</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamenshchikov NO, Anfinogenova YJ, Kozlov BN, et al.: Nitric oxide delivery during cardiopulmonary bypass reduces acute kidney injury: A randomized trial. J Thorac Cardiovasc Surg 2022; 163:1393&#x2013;403.e9. doi:10.1016/j.jtcvs.2020.03.182</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2020.03.182</ArticleId></ArticleIdList></Reference><Reference><Citation>Baylis C: Nitric oxide deficiency in chronic kidney disease. Am J Physiol Renal Physiol 2008; 294:F1&#x2013;9. doi:10.1152/ajprenal.00424.2007</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.00424.2007</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeulen Windsant IC, de Wit NC, Sertorio JT, et al.: Hemolysis during cardiac surgery is associated with increased intravascular nitric oxide consumption and perioperative kidney and intestinal tissue damage. Front Physiol 2014; 5:340. doi:10.3389/fphys.2014.00340</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2014.00340</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamenshchikov NO, Duong N, Berra L: Nitric oxide in cardiac surgery: A review article. Biomedicines 2023; 11:1085. doi:10.3390/biomedicines11041085</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11041085</ArticleId></ArticleIdList></Reference><Reference><Citation>De Backer D: Detailing the cardiovascular profile in shock patients. Crit Care 2017; 21:311. doi:10.1186/s13054-017-1908-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-017-1908-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersch M, Schmidt C, Hoffmeier A, et al.: Prevention of cardiac surgery&#x2013;associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: The PrevAKI randomized controlled trial. Intensive Care Med 2017; 43:1551&#x2013;61. doi:10.1007/s00134-016-4670-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4670-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghadimi K, Cappiello JL, Wright MC, et al.; INSPIRE-FLO Investigators: Inhaled epoprostenol compared with nitric oxide for right ventricular support after major cardiac surgery. Circulation 2023; 148:1316&#x2013;29. doi:10.1161/CIRCULATIONAHA.122.062464</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.062464</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, K&#xfc;llmar M, Ostermann M, et al.: Prevention of Cardiac surgery&#x2013;associated acute kidney injury by implementing the KDIGO guidelines in high-risk patients identified by biomarkers: The PrevAKI-multicenter randomized controlled trial. Anesth Analg 2021; 133:292&#x2013;302. doi:10.1213/ANE.0000000000005458</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005458</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukaida H, Matsushita S, Yamamoto T, et al.: Oxygen delivery-guided perfusion for the prevention of acute kidney injury: A randomized controlled trial. J Thorac Cardiovasc Surg 2023; 165:750&#x2013;60.e5. doi:10.1016/j.jtcvs.2021.03.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2021.03.032</ArticleId></ArticleIdList></Reference><Reference><Citation>Signori D, Magliocca A, Hayashida K, et al.: Inhaled nitric oxide: Role in the pathophysiology of cardio-cerebrovascular and respiratory diseases. Intensive Care Med Exp 2022; 10:28. doi:10.1186/s40635-022-00455-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40635-022-00455-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Spina S, Lei C, Pinciroli R, Berra L: Hemolysis and kidney injury in cardiac surgery: The protective role of nitric oxide therapy. Semin Nephrol 2019; 39:484&#x2013;95. doi:10.1016/j.semnephrol.2019.06.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semnephrol.2019.06.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenberg JW, Hogue S, Raees MA, et al.: Exogenous nitric oxide delivery protects against cardiopulmonary bypass-associated acute kidney injury: Histologic and serologic evidence from an ovine model. J Thorac Cardiovasc Surg 2023; 166:e164&#x2013;73. doi:10.1016/j.jtcvs.2023.03.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2023.03.030</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamenshchikov NO, Podoksenov YK, Kozlov BN, et al.: The nephroprotective effect of nitric oxide during extracorporeal circulation: An experimental study. Biomedicines 2024; 12:1298. doi:10.3390/biomedicines12061298</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines12061298</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeulen Windsant IC, Snoeijs MG, Hanssen SJ, et al.: Hemolysis is associated with acute kidney injury during major aortic surgery. Kidney Int 2010; 77:913&#x2013;20. doi:10.1038/ki.2010.24</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2010.24</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FT 4th, Ball SK, Roberts LJ 2nd, Pretorius M: Postoperative acute kidney injury is associated with hemoglobinemia and an enhanced oxidative stress response. Free Radic Biol Med 2011; 50:1480&#x2013;7. doi:10.1016/j.freeradbiomed.2011.02.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2011.02.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishi S, Nagasu H, Kidokoro K, Kashihara N: Oxidative stress and the role of redox signalling in chronic kidney disease. Nat Rev Nephrol 2024; 20:101&#x2013;19. doi:10.1038/s41581-023-00775-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-023-00775-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Landoni G, Monaco F, Ti LK, et al.; PROTECTION Study Group: A randomized trial of intravenous amino acids for kidney protection. N Engl J Med 2024; 391:687&#x2013;98. doi:10.1056/NEJMoa2403769</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2403769</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao B, Xu J, Qi Z, Harris RC, Zhang MZ: Role of renal cortical cyclooxygenase-2 expression in hyperfiltration in rats with high-protein intake. Am J Physiol Renal Physiol 2006; 291:F368&#x2013;74. doi:10.1152/ajprenal.00500.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.00500.2005</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheruku SR, Raphael J, Neyra JA, Fox AA: Acute kidney injury after cardiac surgery: Prediction, prevention, and management. A nesthesiology 2023; 139:880&#x2013;98. doi:10.1097/ALN.0000000000004734</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000004734</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Luo Q, Wang L, Han L: Diagnostic value of neutrophil gelatinase-associated lipocalin for early diagnosis of cardiac surgery&#x2013;associated acute kidney injury: A meta-analysis. Eur J Cardiothorac Surg 2016; 49:746&#x2013;55. doi:10.1093/ejcts/ezv199</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezv199</ArticleId></ArticleIdList></Reference><Reference><Citation>Coca SG, Garg AX, Swaminathan M, et al.; TRIBE-AKI Consortium: Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery. Nephrol Dial Transplant 2013; 28:2787&#x2013;99. doi:10.1093/ndt/gft405</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gft405</ArticleId></ArticleIdList></Reference><Reference><Citation>Casanova AG, Sancho-Mart&#xed;nez SM, Vicente-Vicente L, et al.: Diagnosis of cardiac surgery&#x2013;associated acute kidney injury: State of the art and perspectives. J Clin Med 2022; 11:4576. doi:10.3390/jcm11154576</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11154576</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Lu Y, Sun M, et al.: Pneumonia after cardiovascular surgery: Incidence, risk factors and interventions. Front Cardiovasc Med 2022; 9:911878. doi:10.3389/fcvm.2022.911878</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.911878</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalashnikova TP, Arsenyeva IA, Kamenshchikov NO, et al.: Antibacterial effect of nitric oxide on the causative agents of hospital-acquired pneumonia (experimental study). General Reanimatol 2024; 20:32&#x2013;41. doi:10.15360/1813-9779-2024-3-2424</Citation><ArticleIdList><ArticleId IdType="doi">10.15360/1813-9779-2024-3-2424</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Fenza R, Shetty NS, Gianni S, et al.; Nitric Oxide Investigators: High-dose inhaled nitric oxide in acute hypoxemic respiratory failure due to COVID-19: A multicenter phase II trial. Am J Respir Crit Care Med 2023; 208:1293&#x2013;304. doi:10.1164/rccm.202304-0637OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202304-0637OC</ArticleId></ArticleIdList></Reference><Reference><Citation>Gianetti J, Del Sarto P, Bevilacqua S, et al.: Supplemental nitric oxide and its effect on myocardial injury and function in patients undergoing cardiac surgery with extracorporeal circulation. J Thorac Cardiovasc Surg 2004; 127:44&#x2013;50. doi:10.1016/j.jtcvs.2002.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2002.08.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolcz J, Karnas E, Madeja Z, Zuba-Surma EK: The cardioprotective and anti-inflammatory effect of inhaled nitric oxide during Fontan surgery in patients with single ventricle congenital heart defects: A prospective randomized study. J Intensive Care 2022; 10:48. doi:10.1186/s40560-022-00639-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40560-022-00639-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y, Kamenshchikov N, Zheng Z, Lei C: Inhaled nitric oxide and postoperative outcomes in cardiac surgery with cardiopulmonary bypass: A systematic review and meta-analysis. Nitric Oxide 2024; 146:64&#x2013;74. doi:10.1016/j.niox.2024.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.niox.2024.03.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Coutrot M, D&#xe9;pret F, Legrand M: Is nitric oxide nephro- or cardioprotective? Am J Respir Crit Care Med 2019; 199:1441&#x2013;2. doi:10.1164/rccm.201812-2344LE</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201812-2344LE</ArticleId></ArticleIdList></Reference><Reference><Citation>Baaten CCFMJ, Sternkopf M, Henning T, Marx N, Jankowski J, Noels H: Platelet function in CKD: A systematic review and meta-analysis. J Am Soc Nephrol 2021; 32:1583&#x2013;98. doi:10.1681/ASN.2020101440</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2020101440</ArticleId></ArticleIdList></Reference><Reference><Citation>Gwozdzinski K, Pieniazek A, Gwozdzinski L: Reactive oxygen species and their involvement in red blood cell damage in chronic kidney disease. Oxid Med Cell Longev 2021; 2021:6639199. doi:10.1155/2021/6639199</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6639199</ArticleId></ArticleIdList></Reference><Reference><Citation>Schurle A, Koyner JL: CSA-AKI: Incidence, epidemiology, clinical outcomes, and economic impact. J Clin Med 2021; 10:5746. doi:10.3390/jcm10245746</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10245746</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Qi PK, Yang ZL, Huang N: Nitric oxide based strategies for applications of biomedical devices. Biosurf Biotribol 2015; 1:177&#x2013;201. doi:10.1016/j.bsbt.2015.08.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bsbt.2015.08.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlapbach LJ, Gibbons KS, Horton SB, et al.; NITRIC Study Group, the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS CTG), and the ANZICS Paediatric Study Group (PSG): Effect of nitric oxide via cardiopulmonary bypass on ventilator-free days in young children undergoing congenital heart disease surgery: The NITRIC randomized clinical trial. JAMA 2022; 328:38&#x2013;47. doi:10.1001/jama.2022.9376</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.9376</ArticleId></ArticleIdList></Reference><Reference><Citation>Muenster S, Zarragoikoetxea I, Moscatelli A, et al.: Inhaled NO at a crossroads in cardiac surgery: Current need to improve mechanistic understanding, clinical trial design and scientific evidence. Front Cardiovasc Med 2024; 11:1374635. doi:10.3389/fcvm.2024.1374635</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2024.1374635</ArticleId></ArticleIdList></Reference><Reference><Citation>Armenta A, Madero M, Rodriguez-Iturbe B: Functional reserve of the kidney. Clin J Am Soc Nephrol 2022; 17:458&#x2013;66. doi:10.2215/CJN.11070821</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.11070821</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;cze I, Jauch D, G&#xf6;tz M, et al.: Biomarker-guided intervention to prevent acute kidney injury after major surgery: The prospective randomized BigpAK study. Ann Surg 2018; 267:1013&#x2013;20. doi:10.1097/SLA.0000000000002485</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000002485</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38905251</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>6</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Association of frailty with adverse outcomes in surgically treated geriatric patients with hip fracture: A meta-analysis and trial sequential analysis.</ArticleTitle><Pagination><StartPage>e0305706</StartPage><MedlinePgn>e0305706</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0305706</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0305706</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Some studies have associated frailty and prognostic outcomes in geriatric hip fracture patients, but whether frailty can predict postoperative outcomes remains controversial. This review aims to assess the relationship between frailty and adverse postoperative outcomes in geriatric patients with hip fracture.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Based on electronic databases, including PubMed, Embase, Web of Science, Cumulative Index to Nursing and Allied Health Literature, the Cochrane Library, Chinese National Knowledge Infrastructure, and WanFang Data, we systematically searched for studies that investigated the association between frailty and adverse outcomes among patients aged 60 or over after hip fracture surgery. Stata 17.0 and Trial Sequential Analysis viewer software were used to obtain pooled estimates and verify whether the sample size was sufficient and the evidence robust.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-one studies involving 49,196 patients were included for quantitative analysis. Compared with nonfrail patients, frail patients had a higher risk of inpatient mortality (risk ratio [RR] = 1.93, 95% confidence interval [CI]: 1.66-2.23), 30-day mortality (RR = 2.13, 95% CI: 1.23-3.70), and 1-year mortality (RR = 2.44, 95% CI: 1.47-4.04). Frailty can significantly predict postoperative complications (RR = 1.76, 95% CI: 1.38-2.23), including delirium, pneumonia, cardiac complications, urinary tract infection, and surgical site infection; the association between frailty and deep venous thrombosis/pulmonary embolism and acute kidney injury needs further analysis. Trial sequential analysis showed that the findings regarding mortality were reliable and robust.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This meta-analysis provides detailed information indicating that frailty is a substantial predictor of mortality and selected postoperative complications.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2024 Dong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Xiaomeng</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-4415-9182</Identifier><AffiliationInfo><Affiliation>Department of 2nd Operating Room, Hebei Medical University Third Hospital, Shijiazhuang, Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiuguo</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0003-2727-2711</Identifier><AffiliationInfo><Affiliation>Department of Nursing, Hebei Medical University Third Hospital, Shijiazhuang, Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of 2nd Operating Room, Hebei Medical University Third Hospital, Shijiazhuang, Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Shuhong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of 2nd Operating Room, Hebei Medical University Third Hospital, Shijiazhuang, Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Zengchao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of 2nd Operating Room, Hebei Medical University Third Hospital, Shijiazhuang, Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geng</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Nursing, Hebei Medical University Third Hospital, Shijiazhuang, Hebei, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="Y">Hip Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073496" MajorTopicYN="Y">Frailty</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016330" MajorTopicYN="N">Frail Elderly</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>21</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>21</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>21</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38905251</ArticleId><ArticleId IdType="pmc">PMC11192356</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0305706</ArticleId><ArticleId IdType="pii">PONE-D-24-03320</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yan B, Sun W, Wang W, Wu J, Wang G, Dou Q. Prognostic significance of frailty in older patients with hip fracture: a systematic review and meta-analysis. Int Orthop. 2022;46(12):2939&#x2013;2952. doi: 10.1007/s00264-022-05605-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00264-022-05605-9</ArticleId><ArticleId IdType="pubmed">36227383</ArticleId></ArticleIdList></Reference><Reference><Citation>Sing CW, Lin TC, Bartholomew S, Bell JS, Bennett C, Beyene K, et al.. Global Epidemiology of Hip Fractures: Secular Trends in Incidence Rate, Post-Fracture Treatment, and All-Cause Mortality. J Bone Miner Res. 2023;38(8):1064&#x2013;1075. doi: 10.1002/jbmr.4821</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.4821</ArticleId><ArticleId IdType="pubmed">37118993</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen A, Golding D, Brent L, Close J, Gjertsen JE, Holt G, et al.. Using national hip fracture registries and audit databases to develop an international perspective. Injury. 2017;48(10):2174&#x2013;2179. doi: 10.1016/j.injury.2017.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2017.08.001</ArticleId><ArticleId IdType="pubmed">28803651</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen DX, Yang L, Ding L, Li SY, Qi YN, Li Q. Perioperative outcomes in geriatric patients undergoing hip fracture surgery with different anesthesia techniques: A systematic review and meta-analysis. Medicine (Baltimore). 2019;98(49):e18220. doi: 10.1097/MD.0000000000018220</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000018220</ArticleId><ArticleId IdType="pmc">PMC6919429</ArticleId><ArticleId IdType="pubmed">31804347</ArticleId></ArticleIdList></Reference><Reference><Citation>Lian Z, Zhu C, Yuan H, Wang J. Association between changes in depressive symptoms and hip fracture among middle-aged and older Chinese individuals: a prospective cohort study. BMC Geriatr. 2022;22(1):844. doi: 10.1186/s12877-022-03484-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-022-03484-8</ArticleId><ArticleId IdType="pmc">PMC9644634</ArticleId><ArticleId IdType="pubmed">36348273</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin X, Xiong D, Peng YQ, Sheng ZF, Wu XY, Wu XP, et al.. Epidemiology and management of osteoporosis in the People&#x2019;s Republic of China: current perspectives. Clin Interv Aging. 2015;10:1017&#x2013;1033. doi: 10.2147/CIA.S54613</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CIA.S54613</ArticleId><ArticleId IdType="pmc">PMC4485798</ArticleId><ArticleId IdType="pubmed">26150706</ArticleId></ArticleIdList></Reference><Reference><Citation>National Bureau of Statistics of China [Internet]. China: China Statistical Yearbook 2021 [cited 2024 Jan 24]. Available from: https://ghdx.healthdata.org/record/china-statistical-yearbook-2021.</Citation></Reference><Reference><Citation>Partridge JS, Harari D, Dhesi JK. Frailty in the older surgical patient: a review. Age Ageing. 2012;41(2):142&#x2013;147. doi: 10.1093/ageing/afr182</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afr182</ArticleId><ArticleId IdType="pubmed">22345294</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin HY, Liu X, Xue QL, Chen S, Wu C. The Association between Frailty and Healthcare Expenditure among Chinese Older Adults. J Am Med Dir Assoc. 2020;21(6):780&#x2013;785. doi: 10.1016/j.jamda.2020.03.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2020.03.008</ArticleId><ArticleId IdType="pubmed">32331768</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracy BM, Adams MA, Schenker ML, Gelbard RB. The 5 and 11 Factor Modified Frailty Indices are Equally Effective at Outcome Prediction Using TQIP. J Surg Res. 2020;255:456&#x2013;462. doi: 10.1016/j.jss.2020.05.090</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2020.05.090</ArticleId><ArticleId IdType="pubmed">32619861</ArticleId></ArticleIdList></Reference><Reference><Citation>Pioli G, Bendini C, Pignedoli P, Giusti A, Marsh D. Orthogeriatric co-management&#x2014;managing frailty as well as fragility. Injury. 2018;49(8):1398&#x2013;1402. doi: 10.1016/j.injury.2018.04.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2018.04.014</ArticleId><ArticleId IdType="pubmed">29921533</ArticleId></ArticleIdList></Reference><Reference><Citation>Michael A, Lago A, Swingewood N, Rahman M, Siau K. Frailty in hip fracture patients and its impact on the length of stay. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Poster Abstracts. Osteoporos Int. 2020;31(Suppl 1):S171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7925810</ArticleId><ArticleId IdType="pubmed">33656611</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H, Wei PY, Feng Y. Association Between Frailty and Clinical Outcomes and Quality of Life in Older Adults Following Hip Fracture Surgery: A Retrospective Cohort Study. Anesth Analg. 2022;134(5):1035&#x2013;1042. doi: 10.1213/ANE.0000000000005841</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005841</ArticleId><ArticleId IdType="pubmed">34958310</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Y, Hao Q, Zhou J, Dong B. The impact of frailty and sarcopenia on postoperative outcomes in older patients undergoing gastrectomy surgery: a systematic review and meta-analysis. BMC Geriatr. 2017;17(1):188. doi: 10.1186/s12877-017-0569-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-017-0569-2</ArticleId><ArticleId IdType="pmc">PMC5563908</ArticleId><ArticleId IdType="pubmed">28826406</ArticleId></ArticleIdList></Reference><Reference><Citation>Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al.. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146&#x2013;156. doi: 10.1093/gerona/56.3.m146</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/56.3.m146</ArticleId><ArticleId IdType="pubmed">11253156</ArticleId></ArticleIdList></Reference><Reference><Citation>Sang WA, Durrani H, Liu H, Clark JM, Ferber L, Hagan J, et al.. Frailty Score as a Predictor of Outcomes in Geriatric Patients with Isolated Hip Fractures. Am Surg. 2023;89(5):1479&#x2013;1484. doi: 10.1177/00031348211058629</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00031348211058629</ArticleId><ArticleId IdType="pubmed">34905976</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y, Wu Z, Huo H, Zhao P. The Impact of Frailty on Adverse Outcomes in Geriatric Hip Fracture Patients: A Systematic Review and Meta-Analysis. Front Public Health. 2022;10:890652. doi: 10.3389/fpubh.2022.890652</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.890652</ArticleId><ArticleId IdType="pmc">PMC9280195</ArticleId><ArticleId IdType="pubmed">35844855</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Wang A, Lou Y, Peng D, Jiang Z, Xia T. Effects of Frailty on Outcomes Following Surgery Among Patients With Hip Fractures: A Systematic Review and Meta-Analysis. Front Med (Lausanne). 2022;9:829762. doi: 10.3389/fmed.2022.829762</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.829762</ArticleId><ArticleId IdType="pmc">PMC8984086</ArticleId><ArticleId IdType="pubmed">35402430</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo CK, Mertz D, Loeb M. Newcastle-Ottawa Scale: comparing reviewers&#x2019; to authors&#x2019; assessments. BMC Med Res Methodol. 2014;14:45. doi: 10.1186/1471-2288-14-45</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-45</ArticleId><ArticleId IdType="pmc">PMC4021422</ArticleId><ArticleId IdType="pubmed">24690082</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603&#x2013;605. doi: 10.1007/s10654-010-9491-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-010-9491-z</ArticleId><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Liperoti R, Vetrano DL, Palmer K, Targowski T, Cipriani MC, Lo Monaco MR, et al.. Association between frailty and ischemic heart disease: a systematic review and meta-analysis. BMC Geriatr. 2021;21(1):357. doi: 10.1186/s12877-021-02304-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-021-02304-9</ArticleId><ArticleId IdType="pmc">PMC8193864</ArticleId><ArticleId IdType="pubmed">34112104</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539&#x2013;58. doi: 10.1002/sim.1186</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucukseymen S, Iannaccone M, Grantham JA, Sapontis J, Juricic S, Ciardetti N, et al.. Association of Successful Percutaneous Revascularization of Chronic Total Occlusions With Quality of Life: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2023;6(7):e2324522. doi: 10.1001/jamanetworkopen.2023.24522</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.24522</ArticleId><ArticleId IdType="pmc">PMC10359963</ArticleId><ArticleId IdType="pubmed">37471086</ArticleId></ArticleIdList></Reference><Reference><Citation>Dou Q, Wang W, Wang H, Ma Y, Hai S, Lin X, et al.. Prognostic value of frailty in elderly patients with acute coronary syndrome: a systematic review and meta-analysis. BMC Geriatr. 2019;19(1):222. doi: 10.1186/s12877-019-1242-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-019-1242-8</ArticleId><ArticleId IdType="pmc">PMC6694517</ArticleId><ArticleId IdType="pubmed">31416442</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang KL, Detroyer E, Van Grootven B, Tuand K, Zhao DN, Rex S, et al.. Association between preoperative anxiety and postoperative delirium in older patients: a systematic review and meta-analysis. BMC Geriatr. 2023;23(1):198. doi: 10.1186/s12877-023-03923-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-023-03923-0</ArticleId><ArticleId IdType="pmc">PMC10064748</ArticleId><ArticleId IdType="pubmed">36997928</ArticleId></ArticleIdList></Reference><Reference><Citation>Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J Clin Epidemiol. 2008;61(8):763&#x2013;769. doi: 10.1016/j.jclinepi.2007.10.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2007.10.007</ArticleId><ArticleId IdType="pubmed">18411040</ArticleId></ArticleIdList></Reference><Reference><Citation>Wetterslev J, Jakobsen JC, Gluud C. Trial Sequential Analysis in systematic reviews with meta-analysis. BMC Med Res Methodol. 2017;17(1):39. doi: 10.1186/s12874-017-0315-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-017-0315-7</ArticleId><ArticleId IdType="pmc">PMC5397700</ArticleId><ArticleId IdType="pubmed">28264661</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang T, Gong Y, Wang Y. Prognostic values of myosteatosis for overall survival in patients with gastric cancers: A meta-analysis with trial sequential analysis. Nutrition. 2023;105:111866. doi: 10.1016/j.nut.2022.111866</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2022.111866</ArticleId><ArticleId IdType="pubmed">36368263</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel KV, Brennan KL, Brennan ML, Jupiter DC, Shar A, Davis ML. Association of a modified frailty index with mortality after femoral neck fracture in patients aged 60 years and older. Clin Orthop Relat Res. 2014;472(3):1010&#x2013;1017. doi: 10.1007/s11999-013-3334-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11999-013-3334-7</ArticleId><ArticleId IdType="pmc">PMC3916591</ArticleId><ArticleId IdType="pubmed">24166073</ArticleId></ArticleIdList></Reference><Reference><Citation>Kistler EA, Nicholas JA, Kates SL, Friedman SM. Frailty and Short-Term Outcomes in Patients With Hip Fracture. Geriatr Orthop Surg Rehabil. 2015;6(3):209&#x2013;214. doi: 10.1177/2151458515591170</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2151458515591170</ArticleId><ArticleId IdType="pmc">PMC4536514</ArticleId><ArticleId IdType="pubmed">26328238</ArticleId></ArticleIdList></Reference><Reference><Citation>Kua J, Ramason R, Rajamoney G, Chong M, Chong MS. Which frailty measure is a good predictor of early post-operative complications in elderly hip fracture patients? Arch Orthop Trauma Surg. 2016;136(5):639&#x2013;647. doi: 10.1007/s00402-016-2435-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00402-016-2435-7</ArticleId><ArticleId IdType="pubmed">26980097</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J-Y, Cho K-J, Kim S-W, Yoon S-J, Kang M-G, Kim K-I, et al.. Prediction of Mortality and Postoperative Complications using the Hip-Multidimensional Frailty Score in Elderly Patients with Hip Fracture. Sci Rep. 2017;7:42966. doi: 10.1038/srep42966</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep42966</ArticleId><ArticleId IdType="pmc">PMC5324046</ArticleId><ArticleId IdType="pubmed">28233870</ArticleId></ArticleIdList></Reference><Reference><Citation>Gleason LJ, Benton EA, Alvarez-Nebreda ML, Weaver MJ, Harris MB, Javedan H. FRAIL Questionnaire Screening Tool and Short-Term Outcomes in Geriatric Fracture Patients. J Am Med Dir Assoc. 2017;18(12):1082&#x2013;1086. doi: 10.1016/j.jamda.2017.07.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2017.07.005</ArticleId><ArticleId IdType="pmc">PMC6611671</ArticleId><ArticleId IdType="pubmed">28866353</ArticleId></ArticleIdList></Reference><Reference><Citation>Winters AM, Hartog LC, Roijen HIF, Brohet RM, Kamper AM. Relationship between clinical outcomes and Dutch frailty score among elderly patients who underwent surgery for hip fracture. Clin Interv Aging. 2018;13:2481&#x2013;2486. doi: 10.2147/CIA.S181497</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CIA.S181497</ArticleId><ArticleId IdType="pmc">PMC6287424</ArticleId><ArticleId IdType="pubmed">30584288</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorissen RN, Lang C, Visvanathan R, Crotty M, Inacio MC. The effect of frailty on outcomes of surgically treated hip fractures in older people. Bone. 2020;136. doi: 10.1016/j.bone.2020.115327</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2020.115327</ArticleId><ArticleId IdType="pubmed">32209422</ArticleId></ArticleIdList></Reference><Reference><Citation>Narula S, Lawless A, D&#x2019;Alessandro P, Jones CW, Yates P, Seymour H. Clinical Frailty Scale is a good predictor of mortality after proximal femur fracture: A cohort study of 30-day and one-year mortality. Bone Jt Open. 2020;1(8):443&#x2013;449. doi: 10.1302/2633-1462.18.BJO-2020-0089.R1</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/2633-1462.18.BJO-2020-0089.R1</ArticleId><ArticleId IdType="pmc">PMC7667224</ArticleId><ArticleId IdType="pubmed">33215137</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandossi CM, Zambon A, Oliveri G, Codognola M, Szabo H, Cazzulani I, et al.. Frailty, post-operative delirium and functional status at discharge in patients with hip fracture. Int J Geriatr Psychiatry. 2021;36(10):1524&#x2013;1530. doi: 10.1002/gps.5561</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.5561</ArticleId><ArticleId IdType="pmc">PMC8518900</ArticleId><ArticleId IdType="pubmed">33908103</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzonia M, Giannotti C, Carmisciano L, Signori A, Rosa G, Santolini F, et al.. Frailty assessment, hip fracture and long-term clinical outcomes in older adults. Eur J Clin Invest. 2021;51(4). doi: 10.1111/eci.13445</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13445</ArticleId><ArticleId IdType="pubmed">33131066</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen YJ, Hao QK, Wang YT, Chen XY, Jiang JJ, Dong BR, et al.. The association between preoperative modified frailty index and postoperative complications in Chinese elderly patients with hip fractures. BMC Geriatrics. 2021;21(1). doi: 10.1186/s12877-021-02330-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-021-02330-7</ArticleId><ArticleId IdType="pmc">PMC8207648</ArticleId><ArticleId IdType="pubmed">34134662</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorne G, Hodgson L. Performance of the Nottingham Hip Fracture Score and Clinical Frailty Scale as predictors of short and long-term outcomes: a dual-centre 3-year observational study of hip fracture patients. J Bone Miner Metab. 2021;39(3):494&#x2013;500. doi: 10.1007/s00774-020-01187-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00774-020-01187-x</ArticleId><ArticleId IdType="pubmed">33387062</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu A, Maeda K, Fujishima I, Kayashita J, Mori N, Okada K, et al.. Hospital Frailty Risk Score predicts adverse events in older patients with hip fractures after surgery: Analysis of a nationwide inpatient database in Japan. Arch Gerontol Geriatr. 2022;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">34653923</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou YL, Wang L, Cao AY, Luo WJ, Xu ZP, Sheng ZR, et al.. Modified Frailty Index Combined with a Prognostic Nutritional Index for Predicting Postoperative Complications of Hip Fracture Surgery in Elderly. J Invest Surg. 2022;35(10):1739&#x2013;1746. doi: 10.1080/08941939.2022.2101166</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08941939.2022.2101166</ArticleId><ArticleId IdType="pubmed">35906737</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew A, Lukachan GA, Varughese D, Raju N, Mathai AS, Johnson AS. Impact of frailty and comorbidity index on postoperative complications and functional outcomes among elderly patients undergoing hip fracture surgeries under regional anesthesia techniques. Anesthesia, Pain &amp; Intensive Care. 2023;27(2):161&#x2013;169.</Citation></Reference><Reference><Citation>Wong BLL, Chan YH, O&#x2019;Neill GK, Murphy D, Merchant RA. Frailty, length of stay and cost in hip fracture patients. Osteoporos Int. 2023;34(1):59&#x2013;68. doi: 10.1007/s00198-022-06553-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-022-06553-1</ArticleId><ArticleId IdType="pubmed">36197493</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, Deng X, He B, Deng J, Hong Q. Association between properative laboratory frailty index scores and complications after hip fracture surgery in the elders. J Guangdong Med. 2023;44(3):340&#x2013;344.</Citation></Reference><Reference><Citation>You L. Effect of frailty on perioperative risk and prognosis in elderly patients with hip fracture. M.Sc. Thesis, Nanchang University. 2020.</Citation></Reference><Reference><Citation>Zhu S, Xing Y, Zhang L, Chen L, Liu X, Gu E. Predictive value of Frail Scale and CHS index on postoperative outcomes in elderly patients with hip fracture. J Cli Anes. 2020;36(10):962&#x2013;965.</Citation></Reference><Reference><Citation>Roopsawang I, Zaslavsky O, Thompson H, Aree-Ue S, Kwan RYC, Belza B. Frailty measurements in hospitalised orthopaedic populations age 65 and older: A scoping review. J Clin Nurs. 2022;31(9&#x2013;10):1149&#x2013;1163. doi: 10.1111/jocn.16035</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocn.16035</ArticleId><ArticleId IdType="pmc">PMC9293223</ArticleId><ArticleId IdType="pubmed">34622525</ArticleId></ArticleIdList></Reference><Reference><Citation>Kehler DS, Ferguson T, Stammers AN, Bohm C, Arora RC, Duhamel TA, et al.. Prevalence of frailty in Canadians 18&#x2013;79 years old in the Canadian Health Measures Survey. BMC Geriatr. 2017;17(1):28. doi: 10.1186/s12877-017-0423-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-017-0423-6</ArticleId><ArticleId IdType="pmc">PMC5251297</ArticleId><ArticleId IdType="pubmed">28107813</ArticleId></ArticleIdList></Reference><Reference><Citation>Badosa-Collell G, Latorre-Vallbona N, Martori JC, et al.. Capacidad predictiva de mortalidad del &#xed;ndice Fr&#xe1;gil-VIG (IF-VIG) en pacientes ancianos con fractura de f&#xe9;mur. Rev Esp Geriatr Gerontol 2022; 57: 220&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">35660262</ArticleId></ArticleIdList></Reference><Reference><Citation>Egglestone A, Dietz-Collin G, Eardley W, Baker P. Chin-on-Chest in Neck of Femur Fracture (COCNOF) sign: A simple radiographic predictor of frailty and mortality in hip fracture patients. Injury. 2021;52(6):1494&#x2013;1499. doi: 10.1016/j.injury.2020.10.098</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2020.10.098</ArticleId><ArticleId IdType="pubmed">33143868</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Wang A, Lou Y, Peng D, Jiang Z, Xia T. Effects of Frailty on Outcomes Following Surgery Among Patients With Hip Fractures: A Systematic Review and Meta-Analysis. Front Med (Lausanne). 2022;9. doi: 10.3389/fmed.2022.829762</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.829762</ArticleId><ArticleId IdType="pmc">PMC8984086</ArticleId><ArticleId IdType="pubmed">35402430</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitnitski A, Song X, Rockwood K. Trajectories of changes over twelve years in the health status of Canadians from late middle age. Exp Gerontol. 2012;47(12):893&#x2013;899. doi: 10.1016/j.exger.2012.06.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2012.06.015</ArticleId><ArticleId IdType="pubmed">22790020</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, Park YS, Kim MJ, Shin HJ, Roh YH, Kim JH, et al.. Clinical Frailty Scale as a predictor of short-term mortality: A systematic review and meta-analysis of studies on diagnostic test accuracy. Acad Emerg Med. 2022;29(11):1347&#x2013;1356. doi: 10.1111/acem.14493</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acem.14493</ArticleId><ArticleId IdType="pubmed">35349205</ArticleId></ArticleIdList></Reference><Reference><Citation>Albanese AM, Ramazani N, Greene N, Bruse L. Review of Postoperative Delirium in Geriatric Patients After Hip Fracture Treatment. Geriatr Orthop Surg Rehabil. 2022;13:21514593211058947. doi: 10.1177/21514593211058947</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21514593211058947</ArticleId><ArticleId IdType="pmc">PMC8915233</ArticleId><ArticleId IdType="pubmed">35282299</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandossi CM, Zambon A, Oliveri G, Codognola M, Szabo H, Cazzulani I, et al.. Frailty, post-operative delirium and functional status at discharge in patients with hip fracture. Int J Geriatr Psychiatry. 2021;36(10):1524&#x2013;1530. doi: 10.1002/gps.5561</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.5561</ArticleId><ArticleId IdType="pmc">PMC8518900</ArticleId><ArticleId IdType="pubmed">33908103</ArticleId></ArticleIdList></Reference><Reference><Citation>Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet. 2014;383(9920):911&#x2013;922. doi: 10.1016/S0140-6736(13)60688-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)60688-1</ArticleId><ArticleId IdType="pmc">PMC4120864</ArticleId><ArticleId IdType="pubmed">23992774</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao YC, Zhang YW, Shi L, Gao W, Li YJ, Chen H, et al.. What are Risk Factors of Postoperative Pneumonia in Geriatric Individuals after Hip Fracture Surgery: A Systematic Review and Meta-Analysis. Orthop Surg. 2023;15(1):38&#x2013;52. doi: 10.1111/os.13631</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/os.13631</ArticleId><ArticleId IdType="pmc">PMC9837248</ArticleId><ArticleId IdType="pubmed">36519396</ArticleId></ArticleIdList></Reference><Reference><Citation>Park CM, Kim W, Lee ES, Rhim HC, Cho KH, Kim JH, et al.. Comparison of Frailty Index to Pneumonia Severity Measures in Older Patients With Pneumonia. J Am Med Dir Assoc. 2022;23(1):165&#x2013;169. doi: 10.1016/j.jamda.2021.08.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2021.08.044</ArticleId><ArticleId IdType="pubmed">34624243</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang ZC, Jiang W, Chen X, Yang L, Wang H, Liu YH. Systemic immune-inflammation index independently predicts poor survival of older adults with hip fracture: a prospective cohort study. BMC Geriatr. 2021;21(1):155. doi: 10.1186/s12877-021-02102-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-021-02102-3</ArticleId><ArticleId IdType="pmc">PMC7934427</ArticleId><ArticleId IdType="pubmed">33663402</ArticleId></ArticleIdList></Reference><Reference><Citation>Lackner I, Weber B, Pressmar J, Odwarka A, Lam C, Haffner-Luntzer M, et al.. Cardiac alterations following experimental hip fracture&#x2014;inflammaging as independent risk factor. Front Immunol. 2022;13:895888. doi: 10.3389/fimmu.2022.895888</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.895888</ArticleId><ArticleId IdType="pmc">PMC9484325</ArticleId><ArticleId IdType="pubmed">36131923</ArticleId></ArticleIdList></Reference><Reference><Citation>Bugaevsky Y, Levy Y, Hershkovitz A, Ocheretny I, Nissenholtz A, Cooper L, et al.. Characteristics and Outcomes of Hip Fracture Patients Hospitalized in an Orthogeriatric Unit Versus an Orthopedic Department: A Retrospective Cohort Study. Geriatr Orthop Surg Rehabil. 2021;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7804357</ArticleId><ArticleId IdType="pubmed">33489431</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Guo J, Long Y, Yin Y, Hou Z. Risk factors for preoperative deep venous thrombosis in hip fracture patients: a meta-analysis. J Orthop Traumatol. 2022;23(1):19. doi: 10.1186/s10195-022-00639-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10195-022-00639-6</ArticleId><ArticleId IdType="pmc">PMC8991371</ArticleId><ArticleId IdType="pubmed">35391566</ArticleId></ArticleIdList></Reference><Reference><Citation>Nederpelt CJ, Bijman Q, Krijnen P, Schipper IB. Equivalence of DOACS and LMWH for thromboprophylaxis after hip fracture surgery: Systematic review and meta-analysis. Injury. 2022;53(3):1169&#x2013;1176. doi: 10.1016/j.injury.2021.11.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2021.11.052</ArticleId><ArticleId IdType="pubmed">34916036</ArticleId></ArticleIdList></Reference><Reference><Citation>Werneburg GT. Catheter-Associated Urinary Tract Infections: Current Challenges and Future Prospects. Res Rep Urol. 2022;14:109&#x2013;133. doi: 10.2147/RRU.S273663</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/RRU.S273663</ArticleId><ArticleId IdType="pmc">PMC8992741</ArticleId><ArticleId IdType="pubmed">35402319</ArticleId></ArticleIdList></Reference><Reference><Citation>Suen KFK, Low JXY, Charalambous CP. Urinary tract infection is associated with 2.4-fold increased risk of surgical site infection in hip fracture surgery: systematic review and meta-analysis. J Hosp Infect. 2023;139:56&#x2013;66. doi: 10.1016/j.jhin.2023.06.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhin.2023.06.016</ArticleId><ArticleId IdType="pubmed">37343771</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohl DD, Iantorno SE, Saltzman BM, Tetreault MW, Darrith B, Della Valle CJ. Sepsis Within 30 Days of Geriatric Hip Fracture Surgery. J Arthroplasty. 2017;32(10):3114&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">28634098</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31531828</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2020</Year><Month>10</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1496-8975</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><Issue>12</Issue><PubDate><Year>2019</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Canadian journal of anaesthesia = Journal canadien d'anesthesie</Title><ISOAbbreviation>Can J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Perioperative multi-system optimization protocol in elderly hip fracture patients: a randomized-controlled trial.</ArticleTitle><Pagination><StartPage>1472</StartPage><EndPage>1482</EndPage><MedlinePgn>1472-1482</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12630-019-01475-9</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Hip fractures in elderly patients are associated with increased postoperative morbidity and mortality. We evaluated whether a perioperative multi-system optimization protocol can reduce postoperative complications in these patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Immediately after diagnosis of hip fracture, patients &#x2265; 60 yr were randomized to an intervention or control group. Patients in the intervention group were admitted to our postanesthesia care unit where they were treated with goal-directed hemodynamic management, optimized pain therapy, oxygen therapy, and optimized nutrition. Patients in the control group were managed according to our usual standard of care on a regular ward. Postoperative complications during hospital stay included pre-determined cardiovascular, respiratory, neurologic, renal, or surgical events.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The incidence of at least one postoperative complication (primary outcome) was seen in 32 of 65 (49%) controls compared with 24 of 62 (39%) in the intervention group (relative risk [RR], 0.79; 95% confidence interval [CI], 0.53 to 1.17; P = 0.23). The secondary unadjusted outcomes showed that patients in the intervention group received more Ringer's acetate compared with controls (median difference, 1.3 L; 95% CI, 0.6 to 2.1 L; P &lt; 0.001), had more frequently a mean arterial pressure &gt; 70 mmHg (57% control vs 75% intervention; median percentage difference, 16%; 95% CI, 7 to 25%; P = 0.001), better pain control (numeric rating scale &lt; 4 at all postoperative measurements; 25% control vs 81% intervention; RR, 0.26; 95% CI, 0.15 to 0.43; P &lt; 0.001), and possibly a lower incidence of acute renal failure (RR, 0.37; 95% CI, 0.14 to 0.98; P = 0.04).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The implementation of a perioperative multi-system optimization protocol algorithm did not significantly reduce the risk of postoperative complications. Nevertheless, we likely over-estimated the potential treatment effect in our study design and thus were under-powered to show an effect.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">Clinicaltrials.gov (NCT01673776). Registered 23 August, 2012.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schmid</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, School of Medicine, Klinikum rechts der Isar, Technische Universit&#xe4;t M&#xfc;nchen, Ismaninger Str. 22, 81675, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blobner</LastName><ForeName>Manfred</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, School of Medicine, Klinikum rechts der Isar, Technische Universit&#xe4;t M&#xfc;nchen, Ismaninger Str. 22, 81675, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haas</LastName><ForeName>Brigitte</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, School of Medicine, Klinikum rechts der Isar, Technische Universit&#xe4;t M&#xfc;nchen, Ismaninger Str. 22, 81675, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Chirurgisches Klinikum M&#xfc;nchen S&#xfc;d, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucke</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Trauma Surgery and Reconstructive Surgery, Chirurgisches Klinikum M&#xfc;nchen S&#xfc;d, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Trauma Surgery, Klinikum rechts der Isar, Technische Universit&#xe4;t M&#xfc;nchen, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neumaier</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Orthopedics and Trauma Surgery, Klinikum Freising, Freising, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Trauma Surgery, Klinikum rechts der Isar, Technische Universit&#xe4;t M&#xfc;nchen, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anetsberger</LastName><ForeName>Aida</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, School of Medicine, Klinikum rechts der Isar, Technische Universit&#xe4;t M&#xfc;nchen, Ismaninger Str. 22, 81675, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jungwirth</LastName><ForeName>Bettina</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-9749-7460</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, School of Medicine, Klinikum rechts der Isar, Technische Universit&#xe4;t M&#xfc;nchen, Ismaninger Str. 22, 81675, Munich, Germany. bettina.jungwirth@tum.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT01673776</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><VernacularTitle>Un protocole d&#x2019;optimisation p&#xe9;riop&#xe9;ratoire multisyst&#xe9;mique pour les patients &#xe2;g&#xe9;s subissant une fracture de la hanche: une &#xe9;tude randomis&#xe9;e contr&#xf4;l&#xe9;e.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Can J Anaesth</MedlineTA><NlmUniqueID>8701709</NlmUniqueID><ISSNLinking>0832-610X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062186" MajorTopicYN="N">Arterial Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002985" MajorTopicYN="Y">Clinical Protocols</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="N">Hip Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044623" MajorTopicYN="N">Nutrition Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010102" MajorTopicYN="N">Oxygen Inhalation Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059408" MajorTopicYN="N">Pain Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31531828</ArticleId><ArticleId IdType="doi">10.1007/s12630-019-01475-9</ArticleId><ArticleId IdType="pii">10.1007/s12630-019-01475-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26065644</PMID><DateCompleted><Year>2016</Year><Month>03</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1533-4023</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>6</Issue><PubDate><Year>2015</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of cardiovascular pharmacology</Title><ISOAbbreviation>J Cardiovasc Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Efficacy and Safety of Erythropoietin to Prevent Acute Kidney Injury in Patients With Critical Illness or Perioperative Care: A Systematic Review and Meta-analysis of Randomized Controlled Trials.</ArticleTitle><Pagination><StartPage>593</StartPage><EndPage>600</EndPage><MedlinePgn>593-600</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/FJC.0000000000000229</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim was to investigate the efficacy and safety of erythropoietin (EPO) to prevent acute kidney injury (AKI) in patients with critical illness or perioperative care.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Randomized controlled trials comparing EPO with placebo for AKI prevention in adult patients with critical illness or perioperative care were searched in MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, the Web of Science, and Clinical Trials.gov until October 2014. The outcomes of interest included the incidence of AKI, dialysis requirement, mortality, and adverse event. Fixed effect model was used to calculate the pooled risk ratio (RR) and 95% confidence interval (CI) for eligible studies.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Ten randomized controlled trials involving 2759 participants were identified and included in the analysis. Compared with placebo, EPO administration did not reduce the incidence of AKI (RR, 0.97; 95% CI, 0.79-1.19; P = 0.782), dialysis requirement (RR, 0.72; 95% CI, 0.31-1.70; P = 0.457), or mortality (RR, 0.96; 95% CI, 0.78-1.18; P = 0.705). Moreover, EPO had no effect on the risk of adverse events, but estimations of RR were difficult due to their relatively infrequent occurrence.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This meta-analysis suggests that prophylactic administration of EPO in patients with critical illness or perioperative care does not prevent AKI, dialysis requirement, or mortality.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Key Laboratory of Nephrology, Ministry of Health, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Zhenchuan</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Qimei</ForeName><Initials>Q</Initials></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Xi</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Xueqing</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Fengxian</ForeName><Initials>F</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiovasc Pharmacol</MedlineTA><NlmUniqueID>7902492</NlmUniqueID><ISSNLinking>0160-2446</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>11096-26-7</RegistryNumber><NameOfSubstance UI="D004921">Erythropoietin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004921" MajorTopicYN="N">Erythropoietin</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006435" MajorTopicYN="N">Renal Dialysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>6</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26065644</ArticleId><ArticleId IdType="pmc">PMC4461384</ArticleId><ArticleId IdType="doi">10.1097/FJC.0000000000000229</ArticleId><ArticleId IdType="pii">00005344-201506000-00012</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hoste EA, Schurgers M. Epidemiology of acute kidney injury: how big is the problem? Crit Care Med. 2008;36:S146&#x2013;S151.</Citation><ArticleIdList><ArticleId IdType="pubmed">18382186</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera-Guti&#xe9;rrez ME, Seller-P&#xe9;rez G, S&#xe1;nchez-Izquierdo-Riera JA, et al. Prevalence of acute kidney injury in intensive care units: the &#x201c;COrte de prevalencia de disFunci&#xf3;n RenAl y DEpuraci&#xf3;n en cr&#xed;ticos&#x201d; point-prevalence multicenter study. J Crit Care. 2013;28:687&#x2013;694.</Citation><ArticleIdList><ArticleId IdType="pubmed">23845794</ArticleId></ArticleIdList></Reference><Reference><Citation>Coca SG, Yusuf B, Shlipak MG, et al. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;53:961&#x2013;973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2726041</ArticleId><ArticleId IdType="pubmed">19346042</ArticleId></ArticleIdList></Reference><Reference><Citation>Liotta M, Olsson D, Sartipy U, et al. Minimal changes in postoperative creatinine values and early and late mortality and cardiovascular events after coronary artery bypass grafting. Am J Cardiol. 2014;113:70&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">24176074</ArticleId></ArticleIdList></Reference><Reference><Citation>Rewa O, Bagshaw SM. Acute kidney injury-epidemiology, outcomes and economics. Nat Rev Nephrol. 2014;10:193&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">24445744</ArticleId></ArticleIdList></Reference><Reference><Citation>Jelkmann W. Erythropoietin after a century of research: younger than ever. Eur J Haematol. 2007;78:183&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">17253966</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernhardt WM, Eckardt KU. Physiological basis for the use of erythropoietin in critically ill patients at risk for acute kidney injury. Curr Opin Crit Care. 2008;14:621&#x2013;626.</Citation><ArticleIdList><ArticleId IdType="pubmed">19005302</ArticleId></ArticleIdList></Reference><Reference><Citation>Coldewey SM, Khan AI, Kapoor A, et al. Erythropoietin attenuates acute kidney dysfunction in murine experimental sepsis by activation of the &#x3b2;-common receptor. Kidney Int. 2013;84:482&#x2013;490.</Citation><ArticleIdList><ArticleId IdType="pubmed">23594675</ArticleId></ArticleIdList></Reference><Reference><Citation>Corwin HL, Gettinger A, Pearl RG, et al. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA. 2002;288:2827&#x2013;2835.</Citation><ArticleIdList><ArticleId IdType="pubmed">12472324</ArticleId></ArticleIdList></Reference><Reference><Citation>Napolitano LM, Fabian TC, Kelly KM, et al. Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. J Trauma. 2008;65:285&#x2013;297.</Citation><ArticleIdList><ArticleId IdType="pubmed">18695463</ArticleId></ArticleIdList></Reference><Reference><Citation>Endre ZH, Walker RJ, Pickering JW, et al. Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial). Kidney Int. 2010;77:1020&#x2013;1030.</Citation><ArticleIdList><ArticleId IdType="pubmed">20164823</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo YC, Shim JK, Kim JC, et al. Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. Anesthesiology. 2011;115:929&#x2013;937.</Citation><ArticleIdList><ArticleId IdType="pubmed">22027622</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh SW, Chin HJ, Chae DW, et al. Erythropoietin improves long-term outcomes in patients with acute kidney injury after coronary artery bypass grafting. J Korean Med Sci. 2012;27:506&#x2013;511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3342541</ArticleId><ArticleId IdType="pubmed">22563215</ArticleId></ArticleIdList></Reference><Reference><Citation>de Seigneux S, Ponte B, Weiss L, et al. Epoetin administrated after cardiac surgery: effects on renal function and inflammation in a randomized controlled study. BMC Nephrol. 2012;13:132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3506492</ArticleId><ArticleId IdType="pubmed">23033926</ArticleId></ArticleIdList></Reference><Reference><Citation>Tasanarong A, Duangchana S, Sumransurp S, et al. Prophylaxis with erythropoietin versus placebo reduces acute kidney injury and Neutrophil Gelatinase-associated Lipocalin in patients undergoing cardiac surgery: a randomized, double-blind controlled trial. BMC Nephrol. 2013;14:136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3704968</ArticleId><ArticleId IdType="pubmed">23829828</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JH, Shim JK, Song JW, et al. Effect of erythropoietin on the incidence of acute kidney injury following complex valvular heart surgery: a double blind, randomized clinical trial of efficacy and safety. Crit Care. 2013;17:R254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4056185</ArticleId><ArticleId IdType="pubmed">24156702</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JE, Ham SY, Shim YH. Prevention of acute kidney injury by erythropoietin in patients undergoing thoracic aorta surgery with hypothermic circulatory arrest. Eur J Anaesthesiol. 2013;30(suppl 51):63&#x2013;64.</Citation></Reference><Reference><Citation>Dardashti A, Ederoth P, Algotsson L, et al. Erythropoietin and protection of renal function in cardiac surgery (the EPRICS Trial). Anesthesiology. 2014;121:582&#x2013;590.</Citation><ArticleIdList><ArticleId IdType="pubmed">25225746</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2714657</ArticleId><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Green S.
Cochrane handbook for systematic reviews of interventions Version 5.1.0 (updated March 2011). Available at: http://handbook.cochrane.org. Accessed October 1, 2014.</Citation></Reference><Reference><Citation>Song YR, Lee T, You SJ, et al. Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: a pilot study. Am J Nephrol. 2009;30:253&#x2013;260.</Citation><ArticleIdList><ArticleId IdType="pubmed">19494484</ArticleId></ArticleIdList></Reference><Reference><Citation>Clec'h C, Gonzalez F, Lautrette A, et al. Multiple-center evaluation of mortality associated with acute kidney injury in critically ill patients: a competing risks analysis. Crit Care. 2011;15:R128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3218994</ArticleId><ArticleId IdType="pubmed">21586153</ArticleId></ArticleIdList></Reference><Reference><Citation>Singbartl K, Kellum JA. AKI in the ICU: definition, epidemiology, risk stratification, and outcomes. Kidney Int. 2012;81:819&#x2013;825.</Citation><ArticleIdList><ArticleId IdType="pubmed">21975865</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G, Huang H, Wu H, et al. Erythropoietin attenuates cardiopulmonary bypass-induced renal inflammatory injury by inhibiting nuclear factor-&#x3ba;B p65 expression. Eur J Pharmacol. 2012;689:154&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pubmed">22659586</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoyanoff TR, Todaro JS, Aguirre MV, et al. Amelioration of lipopolysaccharide-induced acute kidney injury by erythropoietin: involvement of mitochondria-regulated apoptosis. Toxicology. 2014;318:13&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">24561306</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghaboura N, Tamareille S, Ducluzeau PH, et al. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3&#x3b2; signaling. Basic Res Cardiol. 2011;106:147&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pubmed">20981553</ArticleId></ArticleIdList></Reference><Reference><Citation>Mat&#x11b;jkov&#xe1; &#x160;, Scheuerle A, Wagner F, et al. Carbamylated erythropoietin-FC fusion protein and recombinant human erythropoietin during porcine kidney ischemia/reperfusion injury. Intensive Care Med. 2013;39:497&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pubmed">23291730</ArticleId></ArticleIdList></Reference><Reference><Citation>Zacharias M, Mugawar M, Herbison GP, et al. Interventions for protecting renal function in the perioperative period. Cochrane Database Syst Rev. 2013;9:CD003590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7154582</ArticleId><ArticleId IdType="pubmed">24027097</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26094017</PMID><DateCompleted><Year>2016</Year><Month>11</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-734X</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>3</Issue><PubDate><Year>2016</Year><Month>Mar</Month></PubDate></JournalIssue><Title>European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery</Title><ISOAbbreviation>Eur J Cardiothorac Surg</ISOAbbreviation></Journal><ArticleTitle>Diagnostic value of neutrophil gelatinase-associated lipocalin for early diagnosis of cardiac surgery-associated acute kidney injury: a meta-analysis.</ArticleTitle><Pagination><StartPage>746</StartPage><EndPage>755</EndPage><MedlinePgn>746-55</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/ejcts/ezv199</ELocationID><Abstract><AbstractText>Neutrophil gelatinase-associated lipocalin (NGAL) has been identified as one of the most sensitive and specific biomarkers for predicting cardiac surgery-associated acute kidney injury (CSA-AKI); however, variable performance characteristics have been reported. We therefore performed a diagnostic meta-analysis to investigate the diagnostic accuracy of NGAL in early (within 12 h postoperatively) diagnosis of CSA-AKI using established guidelines. The search was carried out electronically with Medline (through PubMed interface), Embase, Cochrane library, ISI Web of Science, Scopus and ClinicalTrials.gov (up to 5 September 2014), and hand-searching was also done. Two reviewers conducted study inclusion, data extractions and quality assessment of the studies independently. The diagnostic capacity of NGAL for CSA-AKI was assessed using pooled sensitivity and specificity, diagnostic odds ratio (DOR), area under the summary receiver operating characteristic curve (AUC). Meta-Disc 1.4 and STATA 12.0 were used to investigate the source of heterogeneity and to perform the meta-analysis. Twenty-four studies (33 data sets of 4066 patients) were considered, which were all of good methodological quality. The overall pooled sensitivity of NGAL for the diagnosis of AKI was 0.68 [95% confidence interval (CI), 0.65-0.70], and specificity was 0.79 (95% CI, 0.77-0.80). The overall pooled positive likelihood ratio and negative likelihood ratio were 3.98 (95% CI, 3.05-5.20) and 0.33 (95% CI, 0.24-0.45), respectively, with a DOR of 13.05 (95% CI, 7.85-21.70). The receiver operating characteristic analysis showed an AUC [standard error (SE)] of 0.86 (0.02) and with a Q*-value (SE) of 0.79 (0.02). Subgroup analysis showed that NGAL had better predictive ability in neonates/children compared with adults (DOR, 19.37; AUC, 0.89 vs DOR, 8.98; AUC, 0.83), and adults without pre-existing renal insufficiency (PRI) had higher diagnostic value than adults without PRI to predict CSA-AKI (DOR, 15.43; AUC, 0.87 vs DOR, 6.56; AUC, 0.81). Both plasma/serum and urine NGAL had the highly predictive nature for early diagnosis of CSA-AKI (DOR, 13.09; AUC, 0.85 vs DOR, 13.20; AUC, 0.88), while lower DOR and AUC values were shown (DOR, 8.31; AUC, 0.81) when measured using standardized clinical platforms, compared with research-based assays (DOR, 19.22; AUC, 0.89). I(2)-values showed substantial heterogeneity, which mainly stems from characteristics of patient population (P = 0.037). NGAL diagnostic accuracy in early detection of CSA-AKI is high, especially in neonates/children or adults with normal baseline renal function.</AbstractText><CopyrightInformation>&#xa9; The Author 2015. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Fangfang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Ningbo No. 2 Hospital, Affiliated Hospital of Ningbo University School of Medical, Ningbo, Zhejiang, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Qun</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Ningbo No. 2 Hospital, Affiliated Hospital of Ningbo University School of Medical, Ningbo, Zhejiang, P.R. China 85958294@qq.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lailiang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Ningbo No. 2 Hospital, Affiliated Hospital of Ningbo University School of Medical, Ningbo, Zhejiang, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Lina</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Ningbo No. 2 Hospital, Affiliated Hospital of Ningbo University School of Medical, Ningbo, Zhejiang, P.R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>06</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Cardiothorac Surg</MedlineTA><NlmUniqueID>8804069</NlmUniqueID><ISSNLinking>1010-7940</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000209">Acute-Phase Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C489506">LCN2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071068">Lipocalin-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054834">Lipocalins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011518">Proto-Oncogene Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000209" MajorTopicYN="N">Acute-Phase Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071068" MajorTopicYN="N">Lipocalin-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054834" MajorTopicYN="N">Lipocalins</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011518" MajorTopicYN="N">Proto-Oncogene Proteins</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Neutrophil gelatinase-associated lipocalin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>1</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26094017</ArticleId><ArticleId IdType="doi">10.1093/ejcts/ezv199</ArticleId><ArticleId IdType="pii">ezv199</ArticleId></ArticleIdList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23345468</PMID><DateCompleted><Year>2013</Year><Month>09</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-2393</ISSN><JournalIssue CitedMedium="Internet"><Volume>106</Volume><Issue>4</Issue><PubDate><Year>2013</Year><Month>Apr</Month></PubDate></JournalIssue><Title>QJM : monthly journal of the Association of Physicians</Title><ISOAbbreviation>QJM</ISOAbbreviation></Journal><ArticleTitle>Acute kidney injury: outcomes and quality of care.</ArticleTitle><Pagination><StartPage>323</StartPage><EndPage>332</EndPage><MedlinePgn>323-32</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/qjmed/hcs237</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Deficiencies in management have been highlighted as contributory factors in the death of many patients with acute kidney injury (AKI). However, there is little evidence addressing the quality of care provided to patients with milder AKI.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">The aim of this study is to evaluate the quality of care provided to a non-select cohort of patients with AKI and evaluate discrepancies in causation, recognition and management.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective inception cohort study.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Demographic data were collected for all 1577 patients admitted to a University Teaching Hospital during a 1-month period. Baseline, admission and peak creatinine were correlated with mortality and length of hospital admission. AKI was classified according to Kidney Disease Improving Global Outcomes criteria. A retrospective case note review of all patients with AKI was carried out to evaluate quality of documentation and clinical management of AKI. Multivariate analysis was undertaken to determine risk factors for AKI.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Incidence of AKI on admission was 4.6%. A further 10.3% developed AKI while in hospital. All cause mortality was 4-fold higher among patients with AKI compared with those without (19 vs. 3.8%; P &lt; 0.001). Mortality was significantly higher in those patients who developed AKI while an in-patient compared with those with AKI on admission (27.3 vs. 11.8%; P &lt; 0.001). Diabetes, clinician perception of frailty, age and treatment with angiotensin-converting enzyme inhibitor prior to admission were found to be independent risk factors for AKI. AKI was unrecognized in 23.5% of patients, two-thirds of whom were discharged without resolution of renal function. Significant weaknesses in management were poorly kept fluid balance charts (48.2%), failure to withhold nephrotoxic drugs (38.8%) and failure to act upon abnormal biochemistry (41%) in a timely fashion.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">AKI is common in hospitalized patients and associated with a significant increase in hospital stay and mortality. AKI is often found in conjunction with other organ failure and in many cases is not preventable. Nevertheless clinicians need to be more vigilant of small creatinine rises to permit early intervention particularly among elderly and frail patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aitken</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Renal Surgery, Western Infirmary, Glasgow G11 6NY, UK. emmaaitken@nhs.net</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carruthers</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Gall</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Kerr</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Geddes</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Kingsmore</LastName><ForeName>D</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>01</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>QJM</MedlineTA><NlmUniqueID>9438285</NlmUniqueID><ISSNLinking>1460-2393</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000806">Angiotensin-Converting Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000806" MajorTopicYN="N">Angiotensin-Converting Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D048909" MajorTopicYN="N">Diabetes Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004812" MajorTopicYN="N">Epidemiologic Methods</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011787" MajorTopicYN="Y">Quality of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012606" MajorTopicYN="N" Type="Geographic">Scotland</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23345468</ArticleId><ArticleId IdType="doi">10.1093/qjmed/hcs237</ArticleId><ArticleId IdType="pii">hcs237</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">26915851</PMID><DateCompleted><Year>2016</Year><Month>11</Month><Day>07</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1873-2623</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Season>Jan-Feb</Season></PubDate></JournalIssue><Title>Transplantation proceedings</Title><ISOAbbreviation>Transplant Proc</ISOAbbreviation></Journal><ArticleTitle>Effect of Hydroxyethyl Starch on Acute Kidney Injury After Living Donor Hepatectomy.</ArticleTitle><Pagination><StartPage>102</StartPage><EndPage>106</EndPage><MedlinePgn>102-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.transproceed.2015.12.016</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0041-1345(15)01193-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Concerns about the adverse effects of hydroxyethyl starch (HES) on renal function have been raised in recent studies involving critically ill patients. We aimed to evaluate the effect of HES on acute kidney injury (AKI) after living donor right hepatectomy.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a 1:3 propensity score matching analysis of the medical records of 1641 living donors who underwent a donor right hepatectomy. They were divided into the control group (n = 60), who received only crystalloids, and the colloid group (n = 1,581), who received HES 130/0.4 and crystalloids. Postoperative AKI was determined by AKI Network (AKIN) and Risk, Injury, Failure, Loss, End-stage (RIFLE) criteria.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A 1:3 propensity score matching was performed in 206 donors, 54 donors in the control group and 152 donors in the colloid group. For the matched colloid group, the median amount of 7.65 mL/kg (interquartile range, 6.64-9.20) of colloid and 58.19 mL/kg (interquartile range, 45.63-71.51) of crystalloid were given. The median amount of administered crystalloid in the control group was 56.48 mL/kg (interquartile range, 47.94-76.12) after propensity score matching. The incidences of AKI were not different between the control and colloid groups (P = .460 by AKIN criteria; P = .999 by RIFLE criteria).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Intraoperative administration of HES may not be associated with AKI after living donor hepatectomy. This result can provide useful information on perioperative fluid management in living liver donors.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>S-K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>S-S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sim</LastName><ForeName>J-H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baik</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hwang</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Liver Transplantation and Hepatobiliary Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>S-G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Division of Liver Transplantation and Hepatobiliary Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Y-K</ForeName><Initials>YK</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Electronic address: kyk@amc.seoul.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Transplant Proc</MedlineTA><NlmUniqueID>0243532</NlmUniqueID><ISSNLinking>0041-1345</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077324">Crystalloid Solutions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006895">Hydroxyethyl Starch Derivatives</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007552">Isotonic Solutions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010952">Plasma Substitutes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Transplant Proc. 2017 Mar;49(2):386. doi: 10.1016/j.transproceed.2017.01.002.</RefSource><PMID Version="1">28219604</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Transplant Proc. 2017 Mar;49(2):386-387. doi: 10.1016/j.transproceed.2017.01.003.</RefSource><PMID Version="1">28219605</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077324" MajorTopicYN="N">Crystalloid Solutions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006498" MajorTopicYN="N">Hepatectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006895" MajorTopicYN="N">Hydroxyethyl Starch Derivatives</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007552" MajorTopicYN="N">Isotonic Solutions</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016031" MajorTopicYN="N">Liver Transplantation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019520" MajorTopicYN="Y">Living Donors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010952" MajorTopicYN="N">Plasma Substitutes</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020858" MajorTopicYN="N">Tissue and Organ Harvesting</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26915851</ArticleId><ArticleId IdType="doi">10.1016/j.transproceed.2015.12.016</ArticleId><ArticleId IdType="pii">S0041-1345(15)01193-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35440800</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Apr</Month><Day>19</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Utility of plasma NGAL for the diagnosis of AKI following cardiac surgery requiring cardiopulmonary bypass: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>6436</StartPage><MedlinePgn>6436</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">6436</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-022-10477-5</ELocationID><Abstract><AbstractText>The objective of this study was to assess the diagnostic value of plasma neutrophil gelatinase-associated lipocalin (pNGAL) for the early diagnosis of acute kidney injury (AKI) in adult patients following cardiac surgery requiring cardiopulmonary bypass (CPB). Electronic databases and other resources were systematically searched for relevant studies. Risk of bias was assessed using the Quality Assessment for Diagnostic Accuracy Studies 2 (QUADAS-2) tool. Studies were assigned to a sub-group based on the timing of the pNGAL sample in relation to the cessation of CPB. These were&#x2009;&lt;&#x2009;4&#xa0;h, 4-8&#xa0;h, 12&#xa0;h or 24&#xa0;h post-cessation of CPB. Summary values for sensitivity and specificity were estimated using the hierarchical summary receiver operator characteristic (ROC) curve model. A random-effects meta-analysis of each pair of sensitivity and specificity estimates from each included study was performed. In total, 3131 patients from 16&#xa0;studies were included. When taken at 4-8&#xa0;h following CPB, pNGAL had superior performance for the diagnosis of AKI in the defined population when compared to earlier and later time points. Prediction regions and confidence intervals, however, demonstrated significant variability in pooled estimates of sensitivity and specificity. This is likely due to population and study design heterogeneity, lack of standardisation of assays and thresholds, and inability to distinguish the different molecular forms of NGAL. In conclusion, the diagnostic utility of pNGAL in this clinical setting is inconclusive and large individual studies of representative populations of cardiac surgery patients using assays that specifically detect NGAL in its monomeric form are required.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sharrod-Cole</LastName><ForeName>Hayley</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Clinical Biochemistry, Black Country Pathology Services, Wolverhampton, West Midlands, UK. Hayley.Sharrod-cole@nhs.net.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Biochemistry, New Cross Hospital, Wolverhampton, WV10 0QP, UK. Hayley.Sharrod-cole@nhs.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fenn</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Clinical Biochemistry, Black Country Pathology Services, Wolverhampton, West Midlands, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gama</LastName><ForeName>Rousseau</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Clinical Biochemistry, Black Country Pathology Services, Wolverhampton, West Midlands, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine and Clinical Practice, Wolverhampton University, Wolverhampton, West Midlands, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ford</LastName><ForeName>Clare</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Clinical Biochemistry, Black Country Pathology Services, Wolverhampton, West Midlands, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giri</LastName><ForeName>Ramesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiac Anaesthesia, Royal Wolverhampton NHS Trust, Wolverhampton, West Midlands, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luckraz</LastName><ForeName>Heyman</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Cardiac Surgery, Royal Wolverhampton NHS Trust, Wolverhampton, West Midlands, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000209">Acute-Phase Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071068">Lipocalin-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054834">Lipocalins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011518">Proto-Oncogene Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000209" MajorTopicYN="N">Acute-Phase Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="N">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071068" MajorTopicYN="N">Lipocalin-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054834" MajorTopicYN="N">Lipocalins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011518" MajorTopicYN="N">Proto-Oncogene Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>20</Day><Hour>5</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35440800</ArticleId><ArticleId IdType="pmc">PMC9018850</ArticleId><ArticleId IdType="doi">10.1038/s41598-022-10477-5</ArticleId><ArticleId IdType="pii">10.1038/s41598-022-10477-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hoste EA, Cruz DN, Davenport A, et al. The epidemiology of cardiac surgery-associated acute kidney injury. Int. J. Artif. Organs. 2008;31(2):158&#x2013;165. doi: 10.1177/039139880803100209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/039139880803100209</ArticleId><ArticleId IdType="pubmed">18311732</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste EA, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: The multinational AKI-EPI study. Intens. Care Med. 2015;41(8):1411&#x2013;1423. doi: 10.1007/s00134-015-3934-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3934-7</ArticleId><ArticleId IdType="pubmed">26162677</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra PK, Luckraz H, Nandi J, et al. Long-term quality of life postacute kidney injury in cardiac surgery patients. Ann. Card. Anaesth. 2018;21(1):41&#x2013;45. doi: 10.4103/aca.ACA_104_17.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/aca.ACA_104_17</ArticleId><ArticleId IdType="pmc">PMC5791486</ArticleId><ArticleId IdType="pubmed">29336390</ArticleId></ArticleIdList></Reference><Reference><Citation>Luckraz H, Gravenor MB, George R, et al. Long and short-term outcomes in patients requiring continuous renal replacement therapy post cardiopulmonary bypass. Eur. J. Cardiothorac. Surg. 2005;27(5):906&#x2013;909. doi: 10.1016/j.ejcts.2005.01.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2005.01.057</ArticleId><ArticleId IdType="pubmed">15848334</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J. Am. Soc. Nephrol. 2005;16(11):3365&#x2013;3370. doi: 10.1681/asn.2004090740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/asn.2004090740</ArticleId><ArticleId IdType="pubmed">16177006</ArticleId></ArticleIdList></Reference><Reference><Citation>Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR. Long-term risk of mortality and other adverse outcomes after acute kidney injury: A systematic review and meta-analysis. Am. J. Kidney Dis. 2009;53(6):961&#x2013;973. doi: 10.1053/j.ajkd.2008.11.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2008.11.034</ArticleId><ArticleId IdType="pmc">PMC2726041</ArticleId><ArticleId IdType="pubmed">19346042</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson CE, Yavas S, Segal MS, et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation. 2009;119(18):2444&#x2013;2453. doi: 10.1161/circulationaha.108.800011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circulationaha.108.800011</ArticleId><ArticleId IdType="pubmed">19398670</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldt J, Brenner T, Lehmann A, Suttner SW, Kumle B, Isgro F. Is kidney function altered by the duration of cardiopulmonary bypass? Ann. Thorac. Surg. 2003;75(3):906&#x2013;912. doi: 10.1016/s0003-4975(02)04559-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0003-4975(02)04559-9</ArticleId><ArticleId IdType="pubmed">12645715</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranucci M, Pavesi M, Mazza E, et al. Risk factors for renal dysfunction after coronary surgery: The role of cardiopulmonary bypass technique. Perfusion. 1994;9(5):319&#x2013;326. doi: 10.1177/026765919400900503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/026765919400900503</ArticleId><ArticleId IdType="pubmed">7833539</ArticleId></ArticleIdList></Reference><Reference><Citation>Boodhwani M, Rubens FD, Wozny D, Nathan HJ. Effects of mild hypothermia and rewarming on renal function after coronary artery bypass grafting. Ann. Thorac Surg. 2009;87(2):489&#x2013;495. doi: 10.1016/j.athoracsur.2008.10.078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2008.10.078</ArticleId><ArticleId IdType="pubmed">19161766</ArticleId></ArticleIdList></Reference><Reference><Citation>Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur. J. Cardiothorac. Surg. 2002;21(2):232&#x2013;244. doi: 10.1016/s1010-7940(01)01099-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1010-7940(01)01099-5</ArticleId><ArticleId IdType="pubmed">11825729</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreeram GM, Grocott HP, White WD, Newman MF, Stafford-Smith M. Transcranial Doppler emboli count predicts rise in creatinine after coronary artery bypass graft surgery. J. Cardiothorac. Vasc. Anesth. 2004;18(5):548&#x2013;551. doi: 10.1053/j.jvca.2004.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2004.07.010</ArticleId><ArticleId IdType="pubmed">15578463</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickering JW, James MT, Palmer SC. Acute kidney injury and prognosis after cardiopulmonary bypass: A meta-analysis of cohort studies. Am. J. Kidney Dis. 2015;65(2):283&#x2013;293. doi: 10.1053/j.ajkd.2014.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2014.09.008</ArticleId><ArticleId IdType="pubmed">25445101</ArticleId></ArticleIdList></Reference><Reference><Citation>Delanaye P, Cavalier E, Pottel H. Serum creatinine: Not so simple! Nephron. 2017;136(4):302&#x2013;308. doi: 10.1159/000469669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000469669</ArticleId><ArticleId IdType="pubmed">28441651</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu KD, Brakeman PR. Renal repair and recovery. Crit. Care Med. 2008;36(4 Suppl):S187&#x2013;S192. doi: 10.1097/CCM.0b013e318168ca4a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318168ca4a</ArticleId><ArticleId IdType="pubmed">18382192</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, Nakao K. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int. 2007;71(10):967&#x2013;970. doi: 10.1038/sj.ki.5002165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ki.5002165</ArticleId><ArticleId IdType="pubmed">17342180</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: A systematic review and meta-analysis. Am. J. Kidney Dis. 2009;54(6):1012&#x2013;1024. doi: 10.1053/j.ajkd.2009.07.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2009.07.020</ArticleId><ArticleId IdType="pubmed">19850388</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase-Fielitz A, Bellomo R, Devarajan P, et al. Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery&#x2014;A prospective cohort study. Crit. Care Med. 2009;37(2):553&#x2013;560. doi: 10.1097/CCM.0b013e318195846e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318195846e</ArticleId><ArticleId IdType="pubmed">19114878</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall PS, Mitchell ED, Smith AF, et al. The future for diagnostic tests of acute kidney injury in critical care: Evidence synthesis, care pathway analysis and research prioritisation. Health Technol. Assess. 2018;22(32):1&#x2013;274. doi: 10.3310/hta22320.</Citation><ArticleIdList><ArticleId IdType="doi">10.3310/hta22320</ArticleId><ArticleId IdType="pmc">PMC6004543</ArticleId><ArticleId IdType="pubmed">29862965</ArticleId></ArticleIdList></Reference><Reference><Citation>Brazzelli, M. et al. The Architect and Alinity Urine NGAL Assays, Urine NephroCheck Test, and Urine and Plasma NGAL Tests to Help Assess the Risk of Acute Kidney Injury for People Who are Being Considered for Admission to Critical Care (2019).</Citation></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Int. J. Surg. 2021;88:105906. doi: 10.1016/j.ijsu.2021.105906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2021.105906</ArticleId><ArticleId IdType="pubmed">33789826</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin. Pract. 2012;120(4):c179&#x2013;c184. doi: 10.1159/000339789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000339789</ArticleId><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure&#x2014;Definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit. Care. 2004;8(4):R204&#x2013;R212. doi: 10.1186/cc2872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc2872</ArticleId><ArticleId IdType="pmc">PMC522841</ArticleId><ArticleId IdType="pubmed">15312219</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit. Care. 2007;2:R31. doi: 10.1186/cc5713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc5713</ArticleId><ArticleId IdType="pmc">PMC2206446</ArticleId><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: A revised tool for the quality assessment of diagnostic accuracy studies. Ann. Intern. Med. 2011;155(8):529&#x2013;536. doi: 10.7326/0003-4819-155-8-201110180-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-155-8-201110180-00009</ArticleId><ArticleId IdType="pubmed">22007046</ArticleId></ArticleIdList></Reference><Reference><Citation>Macaskill P, Gatsonis C, Deeks JJ, Harbord RMT. Chapter 10: Analysing and presenting results. In: Deeks JJBP, Gatsonis C, editors. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 10. The Cochrane Collaboration; 2010.</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557&#x2013;560. doi: 10.1136/bmj.327.7414.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Othman HMEDM, Hassan AEM, Elsersi MH, Soliman AKMA, Emam DF. Neutrophil gelatinase-associated lipocalin as a biomarker for predicting acute kidney injury after coronary artery bypass grafting. Ain-Shams J. Anesthesiol. 2021;13(1):5. doi: 10.1186/s42077-020-00123-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42077-020-00123-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh CR, Coca SG, Thiessen-Philbrook H, et al. Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J. Am. Soc. Nephrol. 2011;22(9):1748&#x2013;1757. doi: 10.1681/asn.2010121302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/asn.2010121302</ArticleId><ArticleId IdType="pmc">PMC3171945</ArticleId><ArticleId IdType="pubmed">21836143</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghonemy TA, Amro GM. Plasma neutrophil gelatinase-associated lipocalin (NGAL) and plasma cystatin C (CysC) as biomarker of acute kidney injury after cardiac surgery. Saudi J. Kidney Dis. Transpl. 2014;25(3):582&#x2013;588. doi: 10.4103/1319-2442.132194.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1319-2442.132194</ArticleId><ArticleId IdType="pubmed">24821156</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakar CV, Arrigain S, Worley S, Yared JP, Paganini EP. A clinical score to predict acute renal failure after cardiac surgery. J. Am. Soc. Nephrol. 2005;16(1):162&#x2013;168. doi: 10.1681/asn.2004040331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/asn.2004040331</ArticleId><ArticleId IdType="pubmed">15563569</ArticleId></ArticleIdList></Reference><Reference><Citation>Seabra VF, Alobaidi S, Balk EM, Poon AH, Jaber BL. Off-pump coronary artery bypass surgery and acute kidney injury: A meta-analysis of randomized controlled trials. Clin. J. Am. Soc. Nephrol. 2010;5(10):1734&#x2013;1744. doi: 10.2215/cjn.02800310.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/cjn.02800310</ArticleId><ArticleId IdType="pmc">PMC2974371</ArticleId><ArticleId IdType="pubmed">20671222</ArticleId></ArticleIdList></Reference><Reference><Citation>Kjeldsen L, Johnsen AH, Sengel&#xf8;v H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J. Biol. Chem. 1993;268(14):10425&#x2013;10432. doi: 10.1016/S0021-9258(18)82217-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)82217-7</ArticleId><ArticleId IdType="pubmed">7683678</ArticleId></ArticleIdList></Reference><Reference><Citation>Kjeldsen L, Bainton DF, Sengel&#xf8;v H, Borregaard N. Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood. 1994;83(3):799&#x2013;807. doi: 10.1182/blood.V83.3.799.799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V83.3.799.799</ArticleId><ArticleId IdType="pubmed">8298140</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu SY, Carlson M, Engstr&#xf6;m A, Garcia R, Peterson CG, Venge P. Purification and characterization of a human neutrophil lipocalin (HNL) from the secondary granules of human neutrophils. Scand. J. Clin. Lab Investig. 1994;54(5):365&#x2013;376. doi: 10.3109/00365519409088436.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365519409088436</ArticleId><ArticleId IdType="pubmed">7997842</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai L, Rubin J, Han W, Venge P, Xu S. The origin of multiple molecular forms in urine of HNL/NGAL. Clin. J. Am. Soc. Nephrol. 2010;5(12):2229&#x2013;2235. doi: 10.2215/cjn.00980110.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/cjn.00980110</ArticleId><ArticleId IdType="pmc">PMC2994084</ArticleId><ArticleId IdType="pubmed">20829422</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu KD, Thompson BT, Ancukiewicz M, et al. Acute kidney injury in patients with acute lung injury: Impact of fluid accumulation on classification of acute kidney injury and associated outcomes. Crit. Care Med. 2011;39(12):2665&#x2013;2671. doi: 10.1097/CCM.0b013e318228234b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318228234b</ArticleId><ArticleId IdType="pmc">PMC3220741</ArticleId><ArticleId IdType="pubmed">21785346</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase M, Devarajan P, Haase-Fielitz A, et al. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: A multicenter pooled analysis of prospective studies. J. Am. Coll. Cardiol. 2011;57(17):1752&#x2013;1761. doi: 10.1016/j.jacc.2010.11.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2010.11.051</ArticleId><ArticleId IdType="pmc">PMC4866647</ArticleId><ArticleId IdType="pubmed">21511111</ArticleId></ArticleIdList></Reference><Reference><Citation>Nickolas TL, Schmidt-Ott KM, Canetta P, et al. Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: A multicenter prospective cohort study. J. Am. Coll. Cardiol. 2012;59(3):246&#x2013;255. doi: 10.1016/j.jacc.2011.10.854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2011.10.854</ArticleId><ArticleId IdType="pmc">PMC3487165</ArticleId><ArticleId IdType="pubmed">22240130</ArticleId></ArticleIdList></Reference><Reference><Citation>Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J. Clin. Epidemiol. 2005;58(9):882&#x2013;893. doi: 10.1016/j.jclinepi.2005.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2005.01.016</ArticleId><ArticleId IdType="pubmed">16085191</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE . Diagnostics Assessment Programme Manual. NICE; 2011.</Citation><ArticleIdList><ArticleId IdType="pubmed">27466648</ArticleId></ArticleIdList></Reference><Reference><Citation>Merkle J, Daka A, Deppe AC, Wahlers T, Paunel-G&#xf6;rg&#xfc;l&#xfc; A. High levels of cell-free DNA accurately predict late acute kidney injury in patients after cardiac surgery. PLoS ONE. 2019;14(6):e0218548. doi: 10.1371/journal.pone.0218548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0218548</ArticleId><ArticleId IdType="pmc">PMC6581428</ArticleId><ArticleId IdType="pubmed">31211810</ArticleId></ArticleIdList></Reference><Reference><Citation>Introcaso G, Nafi M, Bonomi A, et al. Improvement of neutrophil gelatinase-associated lipocalin sensitivity and specificity by two plasma measurements in predicting acute kidney injury after cardiac surgery. Biochem. Med. (Zagreb) 2018;28(3):030701. doi: 10.11613/bm.2018.030701.</Citation><ArticleIdList><ArticleId IdType="doi">10.11613/bm.2018.030701</ArticleId><ArticleId IdType="pmc">PMC6214698</ArticleId><ArticleId IdType="pubmed">30429668</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerci P, Claudot JL, Novy E, Settembre N, Lalot JM, Losser MR. Immediate postoperative plasma neutrophil gelatinase-associated lipocalin to predict acute kidney injury after major open abdominal aortic surgery: A prospective observational study. Anaesth. Crit. Care Pain Med. 2018;37(4):327&#x2013;334. doi: 10.1016/j.accpm.2017.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.accpm.2017.09.006</ArticleId><ArticleId IdType="pubmed">29033359</ArticleId></ArticleIdList></Reference><Reference><Citation>Schley G, K&#xf6;berle C, Manuilova E, et al. Comparison of plasma and urine biomarker performance in acute kidney injury. PLoS ONE. 2015;10(12):e0145042. doi: 10.1371/journal.pone.0145042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0145042</ArticleId><ArticleId IdType="pmc">PMC4682932</ArticleId><ArticleId IdType="pubmed">26669323</ArticleId></ArticleIdList></Reference><Reference><Citation>Park CM, Kim JS, Moon HW, et al. Usefulness of plasma neutrophil gelatinase-associated lipocalin as an early marker of acute kidney injury after cardiopulmonary bypass in Korean cardiac patients: 2 prospective observational study. Clin. Biochem. 2015;48(1&#x2013;2):44&#x2013;49. doi: 10.1016/j.clinbiochem.2014.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinbiochem.2014.09.019</ArticleId><ArticleId IdType="pubmed">25284002</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidher E, Harling L, Ashrafian H, et al. Pulse wave velocity and neutrophil gelatinase-associated lipocalin as predictors of acute kidney injury following aortic valve replacement. J Cardiothorac. Surg. 2014;9:89. doi: 10.1186/1749-8090-9-89.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-8090-9-89</ArticleId><ArticleId IdType="pmc">PMC4057558</ArticleId><ArticleId IdType="pubmed">24886694</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry TE, Muehlschlegel JD, Liu KY, et al. Plasma neutrophil gelatinase-associated lipocalin and acute postoperative kidney injury in adult cardiac surgical patients. Anesth Analg. 2010;110(6):1541&#x2013;1547. doi: 10.1213/ANE.0b013e3181da938e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e3181da938e</ArticleId><ArticleId IdType="pmc">PMC2999841</ArticleId><ArticleId IdType="pubmed">20435938</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase M, Bellomo R, Devarajan P, et al. Novel biomarkers early predict the severity of acute kidney injury after cardiac surgery in adults. Ann. Thorac. Surg. 2009;88(1):124&#x2013;130. doi: 10.1016/j.athoracsur.2009.04.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2009.04.023</ArticleId><ArticleId IdType="pubmed">19559209</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrotti A, Miltgen G, Chevet-Noel A, et al. Neutrophil gelatinase-associated lipocalin as early predictor of acute kidney injury after cardiac surgery in adults with chronic kidney failure. Ann. Thorac. Surg. 2015;99(3):864&#x2013;869. doi: 10.1016/j.athoracsur.2014.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2014.10.011</ArticleId><ArticleId IdType="pubmed">25595830</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaipov A, Solak Y, Turkmen K, et al. Serum uric acid may predict development of progressive acute kidney injury after open heart surgery. Ren. Fail. 2015;37(1):96&#x2013;102. doi: 10.3109/0886022x.2014.976130.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/0886022x.2014.976130</ArticleId><ArticleId IdType="pubmed">25347234</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabhu A, Sujatha DI, Ninan B, Vijayalakshmi MA. Neutrophil gelatinase associated lipocalin as a biomarker for acute kidney injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Ann. Vasc. Surg. 2010;24(4):525&#x2013;531. doi: 10.1016/j.avsg.2010.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.avsg.2010.01.001</ArticleId><ArticleId IdType="pubmed">20363104</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuladhar SM, P&#xfc;ntmann VO, Soni M, Punjabi PP, Bogle RG. Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass. J. Cardiovasc. Pharmacol. 2009;53(3):261&#x2013;266. doi: 10.1097/FJC.0b013e31819d6139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FJC.0b013e31819d6139</ArticleId><ArticleId IdType="pubmed">19247188</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36036431</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>30</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1525-6049</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Renal failure</Title><ISOAbbreviation>Ren Fail</ISOAbbreviation></Journal><ArticleTitle>Risk factors for acute kidney injury after Stanford type A aortic dissection repair surgery: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1462</StartPage><EndPage>1476</EndPage><MedlinePgn>1462-1476</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/0886022X.2022.2113795</ELocationID><Abstract><AbstractText><b>Background:</b> Risk factors for acute kidney injury (AKI) after Stanford type A aortic dissection (TAAD) repair are inconsistent in different studies. This meta-analysis systematically analyzed the risk factors so as to early identify the therapeutic targets for preventing AKI.<b>Methods:</b> Studies exploring risk factors for AKI after TAAD repair were searched from four databases from inception to June 2022. The synthesized incidence and risk factors of AKI and its impact on mortality were calculated.<b>Results:</b> Twenty studies comprising 8223 patients were included. The synthesized incidence of postoperative AKI was 50.7%. Risk factors for AKI included cardiopulmonary bypass (CPB) time &gt;180&#x2009;min [odds ratio (OR), 4.89, 95% confidence interval (CI), 2.06-11.61, <i>I<sup>2</sup></i>&#x2009;=&#x2009;0%], prolonged operative time (&gt;7&#x2009;h) (OR, 2.73, 95% CI, 1.95-3.82, <i>I<sup>2</sup></i>&#x2009;=&#x2009;0), advanced age (per 10&#x2009;years) (OR, 1.34, 95% CI, 1.21-1.49, <i>I<sup>2</sup></i>&#x2009;=&#x2009;0], increased packed red blood cells (pRBCs) transfusion perioperatively (OR, 1.09, 95% CI, 1.07-1.11, <i>I<sup>2</sup></i>&#x2009;=&#x2009;42%), elevated body mass index (per 5&#x2009;kg/m<sup>2</sup>) (OR, 1.23, 95% CI, 1.18-1.28, <i>I<sup>2</sup></i>&#x2009;=&#x2009;42%) and preoperative kidney injury (OR, 3.61, 95% CI, 2.48-5.28, <i>I<sup>2</sup></i>&#x2009;=&#x2009;45%). All results were meta-analyzed using fixed-effects model finally (<i>p</i>&#x2009;&lt;&#x2009;0.01). The in-hospital or 30-day mortality was higher in patients with postoperative AKI than in that without AKI [risk ratio (RR), 3.12, 95% CI, 2.54-3.85, <i>p</i>&#x2009;&lt;&#x2009;0.01].<b>Conclusions:</b> AKI after TAAD repair increased the in-hospital or 30-day mortality. Reducing CPB time and pRBCs transfusion, especially in elderly or heavier weight patients, or patients with preoperative kidney injury were important to prevent AKI after TAAD repair surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lei</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-4001-6387</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Union Hospital of Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Guodong</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-0942-4497</Identifier><AffiliationInfo><Affiliation>Department of Pathology, the Second People's Hospital, Fujian University of Traditional Chinese Medicine, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Xiaochai</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Union Hospital of Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Union Hospital of Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Yanting</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Union Hospital of Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Xiaofu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Union Hospital of Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Liangwan</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-8317-7412</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Union Hospital of Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fujian Provincial Special Reserve Talents Laboratory, Fuzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ren Fail</MedlineTA><NlmUniqueID>8701128</NlmUniqueID><ISSNLinking>0886-022X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000784" MajorTopicYN="Y">Aortic Dissection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Type A aortic dissection</Keyword><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the authors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>29</Day><Hour>7</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36036431</ArticleId><ArticleId IdType="pmc">PMC9427034</ArticleId><ArticleId IdType="doi">10.1080/0886022X.2022.2113795</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Takagi H, Umemoto T, Group A, ALICE Group A Meta-analysis of total arch replacement with frozen elephant trunk in acute type A aortic dissection. Vasc Endovascular Surg. 2016;50(1):33&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">26767803</ArticleId></ArticleIdList></Reference><Reference><Citation>Castrovinci S, Pacini D, Di Marco L, et al. . Surgical management of aortic root in type A acute aortic dissection: a propensity-score analysis. Eur J Cardiothorac Surg. 2016;50(2):223&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pubmed">26941248</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori Y, Sato N, Kobayashi Y, et al. . Acute kidney injury during aortic arch surgery under deep hypothermic circulatory arrest. J Anesth. 2011;25(6):799&#x2013;804.</Citation><ArticleIdList><ArticleId IdType="pubmed">21847704</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim WH, Lee JH, Kim E, et al. . Can We really predict postoperative acute kidney injury after aortic surgery? Diagnostic accuracy of risk scores using gray zone approach. Thorac Cardiovasc Surg. 2016;64(4):281&#x2013;289.</Citation><ArticleIdList><ArticleId IdType="pubmed">25686298</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko T, Higashitani M, Sato A, et al. . Impact of acute kidney injury on early to Long-Term outcomes in patients who underwent surgery for type A acute aortic dissection. Am J Cardiol. 2015;116(3):463&#x2013;468.</Citation><ArticleIdList><ArticleId IdType="pubmed">26026862</ArticleId></ArticleIdList></Reference><Reference><Citation>Roh GU, Lee JW, Nam SB, et al. . Incidence and risk factors of acute kidney injury after thoracic aortic surgery for acute dissection. Ann Thorac Surg. 2012;94(3):766&#x2013;771.</Citation><ArticleIdList><ArticleId IdType="pubmed">22727320</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Yu W, Zhai G, et al. . Independent risk factors for postoperative AKI and the impact of the AKI on 30-day postoperative outcomes in patients with type A acute aortic dissection: an updated Meta-analysis and Meta-regression. J. Thorac. Dis. 2018;10(5):2590&#x2013;2598.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6006120</ArticleId><ArticleId IdType="pubmed">29997920</ArticleId></ArticleIdList></Reference><Reference><Citation>Joannidis M, Druml W, Forni LG, et al. . Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017: Expert opinion of the working group on prevention, AKI section, European Society of Intensive Care Medicine. Intensive Care Med. 2017;43(6):730&#x2013;749.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5487598</ArticleId><ArticleId IdType="pubmed">28577069</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang ZG, Ge M, Chen T, et al. . Independent risk factors and the long-term outcomes for postoperative continuous renal replacement treatment in patients who underwent emergency surgery for type A acute aortic dissection. J Cardiothorac Surg. 2020;15(1):100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7226713</ArticleId><ArticleId IdType="pubmed">32414388</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai HS, Tsai FC, Chen YC, et al. . Impact of acute kidney injury on One-Year survival after surgery for aortic dissection. Ann Thorac Surg. 2012;94(5):1407&#x2013;1412.</Citation><ArticleIdList><ArticleId IdType="pubmed">22939248</ArticleId></ArticleIdList></Reference><Reference><Citation>iraoka H, Chikazawa A, Totsugawa G, et al. . Acute kidney injury after total aortic arch repair with moderate hypothermic circulatory arrest. J Card Surg. 2014;29(2):218&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pubmed">24330125</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim WH, Lee SM, Choi JWoKim EH, et al. . Simplified clinical risk score to predict acute kidney injury after aortic surgery. Journal of Cardiothoracic and Vascular Anesthesia. 2013;27(6):1158&#x2013;1166.</Citation><ArticleIdList><ArticleId IdType="pubmed">24050856</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim WH, Park MH, Kim HJ, et al. . Potentially modifiable risk factors for acute kidney injury after surgery on the thoracic aorta a propensity score matched Case-Control study. Medicine (Baltimore). 2015;94(2):e273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4602544</ArticleId><ArticleId IdType="pubmed">25590836</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu ZH, Chen LW, Cao H, et al. . Analysis of risk factors for acute kidney injury after ascending aortic replacement combined with open placement of Triple-Branched stent graft in type A aortic dissection: a new technique versus the traditional method in a single Chinese center. Med Sci Monit. 2015;21:674&#x2013;680.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4357483</ArticleId><ArticleId IdType="pubmed">25737240</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan C, Shang W, Liu Y, et al. . Postoperative hyperlactatemia is linked to acute kidney injury after type A aortic dissection surgery: a retrospective study. Int J Clin Exp Med. 2016;9:14404&#x2013;14410.</Citation></Reference><Reference><Citation>Arnaoutakis Arnaoutakis GJ, Vallabhajosyula Bavaria JE, Sultan I, et al. . The impact of deep versus moderate hypothermia on postoperative kidney function after elective aortic hemiarch repair. Ann Thorac Surg. 2016;102(4):1313&#x2013;1321.</Citation><ArticleIdList><ArticleId IdType="pubmed">27318775</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H, Wang G, Yang L, et al. . Acute kidney injury after total arch replacement combined with frozen elephant trunk implantation: Incidence, risk factors, and outcome. J Cardiothorac Vasc Anesth. 2018;32(5):2210&#x2013;2217.</Citation><ArticleIdList><ArticleId IdType="pubmed">29571643</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang ZR, Wang GY, Liu Q, et al. . Moderate and deep hypothermic circulatory arrest has a comparable effect on acute kidney injury after total arch replacement with frozen elephant trunk procedure in type A aortic dissection. Interact Cardiovasc Thorac Surg. 2019;29(1):130&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pubmed">30977797</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S, Liu J, Li L, et al. . Cardiopulmonary bypass time is an independent risk factor for acute kidney injury in emergent thoracic aortic surgery: a retrospective cohort study. J Cardiothorac Surg. 2019;14(1):90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6505293</ArticleId><ArticleId IdType="pubmed">31064409</ArticleId></ArticleIdList></Reference><Reference><Citation>Li LJ, Zhou JJ, Hao XC, et al. . The incidence, risk factors and in-Hospital mortality of acute kidney injury in patients after surgery for acute type a aortic dissection: a Single-Center retrospective analysis of 335 patients. Front Med (Lausanne). 2020;7:557044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7593546</ArticleId><ArticleId IdType="pubmed">33178711</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Shang Y, Long D, et al. . Intraoperative blood transfusion volume is an independent risk factor for postoperative acute kidney injury in type a acute aortic dissection. BMC Cardiovasc Disord. 2020;20(1):446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7557070</ArticleId><ArticleId IdType="pubmed">33054744</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Ge M, Chen T, et al. . Acute kidney injury in patients operated on for type a acute aortic dissection: incidence, risk factors and short-term outcomes. Interact Cardiovasc Thorac Surg. 2020;31(5):697&#x2013;703.</Citation><ArticleIdList><ArticleId IdType="pubmed">32851399</ArticleId></ArticleIdList></Reference><Reference><Citation>Helgason D, Helgadottir S, Ahlsson A, et al. . Acute kidney injury after acute repair of type a aortic dissection. Ann Thorac Surg. 2021;111(4):1292&#x2013;1298.</Citation><ArticleIdList><ArticleId IdType="pubmed">32961133</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong J, Cao L, Liu L, et al. . Impact of autologous platelet rich plasma use on postoperative acute kidney injury in type a acute aortic dissection repair: a retrospective cohort analysis. J Cardiothorac Surg. 2021;16(1):9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7792293</ArticleId><ArticleId IdType="pubmed">33413497</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma X, Chen S, Yun Y, et al. . The predictive role of lymphocyte-to-Monocyte ratio in acute kidney injury in acute Debakey type I aortic dissection. Front Surg. 2021;8:704345.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8384963</ArticleId><ArticleId IdType="pubmed">34458315</ArticleId></ArticleIdList></Reference><Reference><Citation>Li CN, Ge YP, Liu H, et al. . Blood transfusion and acute kidney injury after total aortic arch replacement for acute Stanford type a aortic dissection. Heart Lung Circ. 2022;31(1):136&#x2013;143.</Citation><ArticleIdList><ArticleId IdType="pubmed">34120843</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, Hou P, Wang D, et al. . Serum myoglobin is associated with postoperative acute kidney injury in Stanford type a aortic dissection. Front Med (Lausanne). 2022;9:821418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8902311</ArticleId><ArticleId IdType="pubmed">35273980</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SC, et al. . Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283(15):2008&#x2013;2012.</Citation><ArticleIdList><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamseer L, Moher D, Clarke M, PRISMA-P Group, et al.. Preferred reporting items for systematic review and Meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;350:g7647.</Citation><ArticleIdList><ArticleId IdType="pubmed">25555855</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G, Shea B, O&#x2019;Connel D, et al. . 
The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in Meta-analyses [webpage on the internet]. Ottawa, ON: Ottawa Hospital Research Institute; 2011. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed August 10, 2016.</Citation></Reference><Reference><Citation>McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012;22(3):276&#x2013;282.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3900052</ArticleId><ArticleId IdType="pubmed">23092060</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, et al. . Measuring inconsistency in Meta-analyses. BMJ. 2003;327(7414):557&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Davey Smith G, Schneider M, et al. . Bias in Meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629&#x2013;634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Begg CB, Mazumdar M.. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088&#x2013;1101.</Citation><ArticleIdList><ArticleId IdType="pubmed">7786990</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar AB, Suneja M, Bayman EO, et al. . Association between postoperative acute kidney injury and duration of cardiopulmonary bypass: a Meta-Analysis. J Cardiothorac Vasc Anesth. 2012;26(1):64&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">21924633</ArticleId></ArticleIdList></Reference><Reference><Citation>Harel Z, Bell CM, Dixon SN, et al. . Predictors of progression to chronic dialysis in survivors of severe acute kidney injury a competing risk study. BMC Nephrol. 2014;15:114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4105112</ArticleId><ArticleId IdType="pubmed">25012724</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FT, Yu C, Byrne JG, et al. . Heme oxygenase-1 and acute kidney injury following cardiac surgery. Cardiorenal Med. 2014;4(1):12&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4024967</ArticleId><ArticleId IdType="pubmed">24847330</ArticleId></ArticleIdList></Reference><Reference><Citation>Vercaemst L. Hemolysis in cardiac surgery patients undergoing cardiopulmonary bypass: a review in search of a treatment algorithm. J Extra Corpor Technol. 2008;40(4):257&#x2013;267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4680715</ArticleId><ArticleId IdType="pubmed">19192755</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamikonian LS, Mamo LB, Smith PB, et al. . Cardiopulmonary bypass is associated with hemolysis and acute kidney injury in neonates, infants, and children. Pediatr Crit Care Med. 2014;15(3):e111-9&#x2013;e119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3951557</ArticleId><ArticleId IdType="pubmed">24394997</ArticleId></ArticleIdList></Reference><Reference><Citation>Lannemyr L, Lundin E, Reinsfelt B, et al. . Renal tubular injury during cardiopulmonary bypass as assessed by urinary release of N-acetyl-ss-D glucosaminidase. Acta Anaesthesiol. Scand. 2017;61(9):1075&#x2013;1083.</Citation><ArticleIdList><ArticleId IdType="pubmed">28748536</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Sullivan ED, Hughes J, Ferenbach DA.. Renal aging: causes and consequences. J Am Soc Nephrol. 2017;28(2):407&#x2013;417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5280008</ArticleId><ArticleId IdType="pubmed">28143966</ArticleId></ArticleIdList></Reference><Reference><Citation>Formica M, Politano P, Marazzi F, et al. . Acute kidney injury and chronic kidney disease in the elderly and polypharmacy. Blood Purif. 2018;46(4):332&#x2013;336.</Citation><ArticleIdList><ArticleId IdType="pubmed">30176676</ArticleId></ArticleIdList></Reference><Reference><Citation>Amano K, Takami Y, Ishikawa H, et al. . Lower body ischaemic time is a risk factor for acute kidney injury after surgery for type a acute aortic dissection. Interact Cardiovasc Thorac Surg. 2020;30(1):107&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">31501854</ArticleId></ArticleIdList></Reference><Reference><Citation>Kindzelski BA, Corcoran P, Siegenthaler MP, et al. . Postoperative acute kidney injury following intraoperative blood product transfusions during cardiac surgery. Perfusion. 2018;33(1):62&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">28581343</ArticleId></ArticleIdList></Reference><Reference><Citation>Naeem SS, Sodha NR, Sellke FW, et al. . Impact of packed red blood cell and platelet transfusions in patients undergoing dissection repair. J Surg Res. 2018;232:338&#x2013;345.</Citation><ArticleIdList><ArticleId IdType="pubmed">30463739</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch CG, Li L, Duncan AI, et al. . Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Caer Med. 2006;34:1608&#x2013;1616.</Citation><ArticleIdList><ArticleId IdType="pubmed">16607235</ArticleId></ArticleIdList></Reference><Reference><Citation>Karkouti K. Transfusion and risk of acute kidney injury in cardiac surgery. Br J Anaesth. 2012;109:I29&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">23242748</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H, Pan X, Gong Z, et al. . Risk factors for acute kidney injury in overweight patients with acute type a aortic dissection: a retrospective study. J Thorac Dis. 2015;7(8):1385&#x2013;1390.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4561257</ArticleId><ArticleId IdType="pubmed">26380764</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi N, Liu K, Fan Y, et al. . The association between obesity and risk of acute kidney injury after cardiac surgery. Front Endocrinol (Lausanne). 2020;11:534294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7573233</ArticleId><ArticleId IdType="pubmed">33123083</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju S, Lee TW, Yoo JW, et al. . Body mass index as a predictor of acute kidney injury in critically ill patients: a retrospective Single-Center study. Tuberc Respir Dis. 2018;81(4):311&#x2013;318.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6148097</ArticleId><ArticleId IdType="pubmed">29926539</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Lyu L, Zhu L, et al. . Association of overweight with postoperative acute kidney injury among patients receiving orthotopic liver transplantation: an observational cohort study. BMC Nephrol. 2020;21(1):223.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7291754</ArticleId><ArticleId IdType="pubmed">32527305</ArticleId></ArticleIdList></Reference><Reference><Citation>Suneja M, Kumar AB.. Obesity and perioperative acute kidney injury: a focused review. J Crit Care. 2014;29(4):694.e1-6&#x2013;694.e6.</Citation><ArticleIdList><ArticleId IdType="pubmed">24666959</ArticleId></ArticleIdList></Reference><Reference><Citation>Hostetter TH, Olson JL, Rennke HG, et al. . Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. J Am Soc Nephrol. 2001;12:1315&#x2013;1325.</Citation><ArticleIdList><ArticleId IdType="pubmed">11373357</ArticleId></ArticleIdList></Reference><Reference><Citation>Chander PN, Gealekman O, Brodsky SV, et al. . Nephropathy in Zucker diabetic fat rat is associated with oxidative and nitrosative stress: prevention by chronic therapy with a peroxynitrite scavenger ebselen. J Am Soc Nephrol. 2004;15(9):2391&#x2013;2403.</Citation><ArticleIdList><ArticleId IdType="pubmed">15339988</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu AYL, Wang J, Nikam M, et al. . Low, rather than high, body mass index is a risk factor for acute kidney injury in multiethnic Asian patients: a retrospective observational study. Int J Nephrol. 2018;2018:1&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5818948</ArticleId><ArticleId IdType="pubmed">29552359</ArticleId></ArticleIdList></Reference><Reference><Citation>Amundson DE, Djurkovic S, Matwiyoff GN.. The obesity paradox. Crit Care Clin. 2010;26(4):583&#x2013;596.</Citation><ArticleIdList><ArticleId IdType="pubmed">20970043</ArticleId></ArticleIdList></Reference><Reference><Citation>Czerny M, Schoenhoff F, Etz C, et al. . The impact of preoperative malperfusion on outcome in acute type a aortic dissection: results from the GERAADA registry. J Am Coll Cardiol. 2015;65(24):2628&#x2013;2635.</Citation><ArticleIdList><ArticleId IdType="pubmed">26088302</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaudino M, Luciani N, Giungi S, et al. . Different profiles of patients who require dialysis after cardiac surgery. Ann Thorac Surg. 2005;79(3):825&#x2013;829.</Citation><ArticleIdList><ArticleId IdType="pubmed">15734386</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32129217</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>11</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1319-2442</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Season>Jan-Feb</Season></PubDate></JournalIssue><Title>Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia</Title><ISOAbbreviation>Saudi J Kidney Dis Transpl</ISOAbbreviation></Journal><ArticleTitle>Clinical spectrum of community-acquired acute kidney injury: A prospective study from central India.</ArticleTitle><Pagination><StartPage>224</StartPage><EndPage>234</EndPage><MedlinePgn>224-234</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/1319-2442.279945</ELocationID><Abstract><AbstractText>The aim is to study the epidemiology of acute kidney injury (AKI), since it differs from country to country and varies from center to center within a country. Owing to the absence of a central registry, data on overall epidemiology of AKI are scanty from India. This study was conducted in an urban tertiary care center in central India with the aim to identify the etiology and outcomes as well as the factors associated with in-hospital mortality of community-acquired AKI (CAAKI) patients. A two-year prospective study of all patients with CAAKI admitted to the Nephrology Department from January 2014 to December 2015 was performed. Of the 9800 admitted patients, 286 patients (2.9%), with a mean age of 48 &#xb1; 17.1 years, were diagnosed to have CAAKI as per our specified criteria. The most common cause of CAAKI was medical (77.27%), followed by obstetrical (13.98%) and surgical (9%) causes. Among the medical causes, hypoperfusion (57.4%) was the most common, followed by sepsis (26.69%), glomerulonephritis (8.14%), and drugs (7%). Nephrolithiasis was the most common surgical cause. Puerperal sepsis (52.5%), preeclampsia (20%), hemorrhage (17.5%), and thrombotic microangiopathy (10%) were the obstetric causes of CAAKI. The overall in-hospital mortality among patients with CAAKI was 20% and 8% of patients became dialysis dependent. Sepsis had the highest in-hospital mortality (44%). The epidemiological characteristics of CAAKI are changing rapidly. There has been an increase in the overall incidence of AKI with changing etiology in recent years. In contrast to developed nations, CAAKI is more common in developing countries. It often affects younger individuals. For early diagnosis of kidney injury and reducing the risk of poor outcome, patients should be referred to nephrologists early in the course of disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Goswami</LastName><ForeName>Shraddha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Sri Aurobindo Medical College and Post Graduate Institute, Indore, Madhya Pradesh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raju</LastName><ForeName>Bhavani M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Sri Aurobindo Medical College and Post Graduate Institute, Indore, Madhya Pradesh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Purohit</LastName><ForeName>Ashish</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Sri Aurobindo Medical College and Post Graduate Institute, Indore, Madhya Pradesh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pahwa</LastName><ForeName>Naresh</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Sri Aurobindo Medical College and Post Graduate Institute, Indore, Madhya Pradesh, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Saudi Arabia</Country><MedlineTA>Saudi J Kidney Dis Transpl</MedlineTA><NlmUniqueID>9436968</NlmUniqueID><ISSNLinking>1319-2442</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007194" MajorTopicYN="N" Type="Geographic">India</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062606" MajorTopicYN="N">Tertiary Care Centers</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32129217</ArticleId><ArticleId IdType="doi">10.4103/1319-2442.279945</ArticleId><ArticleId IdType="pii">SaudiJKidneyDisTranspl_2020_31_1_224_279945</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39954384</PMID><DateCompleted><Year>2025</Year><Month>03</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>102</Volume><PubDate><Year>2025</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Perioperative goal-directed therapy with artificial intelligence to reduce the incidence of intraoperative hypotension and renal failure in patients undergoing lung surgery: A pilot study.</ArticleTitle><Pagination><StartPage>111777</StartPage><MedlinePgn>111777</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2025.111777</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(25)00037-6</ELocationID><Abstract><AbstractText Label="STUDY OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this study was to investigate whether goal-directed treatment using artificial intelligence, compared to standard care, can reduce the frequency, duration, and severity of intraoperative hypotension in patients undergoing single lung ventilation, with a potential reduction of postoperative acute kidney injury (AKI).</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">single center, single-blinded randomized controlled trial.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">University hospital operating room.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">150 patients undergoing lung surgery with single lung ventilation were included.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Patients were randomly assigned to two groups: the Intervention group, where a goal-directed therapy based on the Hypotension Prediction Index (HPI) was implemented; the Control group, without a specific hemodynamic protocol.</AbstractText><AbstractText Label="MEASUREMENTS" NlmCategory="METHODS">The primary outcome measures include the frequency, duration of intraoperative hypotension, furthermore the Area under MAP 65 and the time-weighted average (TWA) of MAP of 65. Other outcome parameters are the incidence of AKI and myocardial injury after non-cardiac surgery (MINS).</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">The number of hypotensive episodes was lower in the intervention group compared to the control group (0 [0-1] vs. 1 [0-2]; p&#xa0;=&#xa0;0.01), the duration of hypotension was shorter in the intervention group (0&#xa0;min [0-3.17] vs. 2.33&#xa0;min [0-7.42]; p&#xa0;=&#xa0;0.01). The area under the MAP of 65 (0&#xa0;mmHg * min [0-12] vs. 10.67&#xa0;mmHg * min [0-44.16]; p&#xa0;&lt;&#xa0;0.01) and the TWA of MAP of 65 (0&#xa0;mmHg [0-0.08] vs. 0.07&#xa0;mmHg [0-0.25]; p&#xa0;&lt;&#xa0;0.01) were lower in the intervention group. The incidence of postoperative AKI showed no differences between the groups (6.7&#xa0;% vs.4.2&#xa0;%; p&#xa0;=&#xa0;0.72). There was a trend to lower incidence of MINS in the intervention group (17.1&#xa0;% vs. 31.8&#xa0;%; p&#xa0;=&#xa0;0.07). A tendency towards reduced postoperative infection was seen in the intervention group (16.0&#xa0;% vs. 26.8&#xa0;%; p&#xa0;=&#xa0;0.16).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The implementation of a treatment algorithm based on HPI allowed us to decrease the duration and severity of hypotension in patients undergoing lung surgery. It did not result in a significant reduction in the incidence of AKI, however we observed a tendency towards lower incidence of MINS in the intervention group, along with a slight reduction in postoperative infections.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Habicher</LastName><ForeName>Marit</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Justus Liebig University of Giessen, Rudolf-Buchheim-Street 7, 35392 Giessen, Germany. Electronic address: Marit.Habicher@chiru.med.uni-giessen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denn</LastName><ForeName>Sara Marie</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Justus Liebig University of Giessen, Rudolf-Buchheim-Street 7, 35392 Giessen, Germany. Electronic address: Sara.M.Denn@chiru.med.uni-giessen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schneck</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Justus Liebig University of Giessen, Rudolf-Buchheim-Street 7, 35392 Giessen, Germany. Electronic address: Emmanuel.Schneck@chiru.med.uni-giessen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akbari</LastName><ForeName>Amir Ali</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Justus Liebig University of Giessen, Rudolf-Buchheim-Street 7, 35392 Giessen, Germany. Electronic address: Amir.Ali-Akbari@chiru.med.uni-giessen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>G&#xf6;tz</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Justus Liebig University of Giessen, Rudolf-Buchheim-Street 7, 35392 Giessen, Germany. Electronic address: Goetz.f.Schmidt@chiru.med.uni-giessen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Markmann</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Justus Liebig University of Giessen, Rudolf-Buchheim-Street 7, 35392 Giessen, Germany. Electronic address: Melanie.Markmann@chiru.med.uni-giessen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alkoudmani</LastName><ForeName>Ibrahim</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of General, Visceral, Thoracic, Transplant and Pediatric Surgery, University Hospital of Giessen, Rudolf-Buchheim Street 7, 35392 Giessen, Germany. Electronic address: Ibrahim.Alkoudmani@chiru.med.uni-giessen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koch</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Justus Liebig University of Giessen, Rudolf-Buchheim-Street 7, 35392 Giessen, Germany. Electronic address: Christian.Koch@chiru.med.uni-giessen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sander</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Justus Liebig University of Giessen, Rudolf-Buchheim-Street 7, 35392 Giessen, Germany. Electronic address: Michael.Sander@chiru.med.uni-giessen.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="Y">Intraoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="Y">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061810" MajorTopicYN="Y">One-Lung Ventilation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013510" MajorTopicYN="Y">Pulmonary Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Artificial intelligence</Keyword><Keyword MajorTopicYN="N">Hypotension prediction index</Keyword><Keyword MajorTopicYN="N">Intraoperative hypotension</Keyword><Keyword MajorTopicYN="N">Thoracic surgery</Keyword></KeywordList><CoiStatement>Declaration of competing interest SD, GS, MM, IA and CK declare that they have no conflict of interest related to this trial. MH has received honoraria for giving lectures from Edwards Lifesciences (Irvine, CA, USA). MH has received honoraria for giving lectures from Baxter (Deerfield, IL, USA). ES received an honorarium for lectures from Edwards Lifesciences (Irvine, CA, USA) and Orion Pharma (Hamburg, Germany). AA has received honoraria for giving lectures from Edwards Lifesciences (Irvine, CA, USA). MS is consultant for Edwards Lifesciences and has received institutional research funding for investigator-initiated trials and honoraria for giving lectures from Edwards Lifesciences, has received honoraria for giving lectures from AMOMED (Vienna, Austria), and has received honoraria for giving lectures from Orion Pharma (Hamburg, Germany). MS has received honoraria for giving lectures from Philips Medizin Systeme B&#xf6;blingen (B&#xf6;blingen, Germany).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>3</Month><Day>3</Day><Hour>0</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>2</Month><Day>16</Day><Hour>1</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>2</Month><Day>15</Day><Hour>18</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39954384</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2025.111777</ArticleId><ArticleId IdType="pii">S0952-8180(25)00037-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25989324</PMID><DateCompleted><Year>2016</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8191</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>7</Issue><PubDate><Year>2015</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of cardiac surgery</Title><ISOAbbreviation>J Card Surg</ISOAbbreviation></Journal><ArticleTitle>Levosimendan Reduces Mortality in Adults with Left Ventricular Dysfunction Undergoing Cardiac Surgery: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>547</StartPage><EndPage>554</EndPage><MedlinePgn>547-54</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jocs.12562</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Levosimendan is implemented in patients with low cardiac output after cardiac surgery. However, the strength of evidence is limited by randomized controlled trials enrolling a small number of patients. Hence we have conducted a systematic review to determine the role of levosimendan in adult cardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PUBMED, WoS, Cochrane database, and SCOPUS were systematically queried to identify original English language peer-reviewed literature (inception-October 2014) comparing clinical results of adult cardiac surgery between levosimendan and control. Pooled odds ratio (OR) was calculated using the Peto method; p&#x2009;&lt;&#x2009;0.05 is significant; results are presented within 95% confidence intervals. Continuous data was compared using standardized mean difference/mean difference.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fourteen studies were included in the analysis. Levosimendan reduced early mortality in patients with reduced ejection fraction (5.5% vs. 9.1%) (OR 0.48 [0.23-0.76]; p&#x2009;=&#x2009;0.004). This result was confirmed using sensitivity analysis. Postoperative acute renal failure was lower with levosimendan therapy (7.4% vs. 11.5%). Intensive care unit stay was shorter in the levosimendan cohort comparable in both groups (standardized mean difference -0.31 [-0.53, -0.09]; p&#x2009;=&#x2009;0.006; I(2) &#x2009;=&#x2009;33.6%). Levosimendan-treated patients stayed 1.01 (1.61-0.42) days shorter when compared to control (p&#x2009;=&#x2009;0.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our meta-analysis demonstrates that Levosimendan improves clinical outcomes in patients with left ventricular dysfunction undergoing cardiac surgery. Results of the ongoing multicenter randomized controlled trial are awaited to provide more conclusive evidence regarding the benefit of this drug.</AbstractText><CopyrightInformation>&#xa9; 2015 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Ju Yong</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Asan Medical Center, Ulsan School of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deo</LastName><ForeName>Salil V</ForeName><Initials>SV</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Surgery, Case Medical Center, Case Western Reserve University, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rababa'h</LastName><ForeName>Abeer</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altarabsheh</LastName><ForeName>Salah E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Queen Alia Heart Institute, Amman, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Yang Hyun</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Samsung Hospital, Sungkyunkwan School of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hang</LastName><ForeName>Dustin</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Medicine, Case Western Reserve University, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGraw</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Health Sciences Library, Case Western Reserve University, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avery</LastName><ForeName>Edwin G</ForeName><Initials>EG</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Peri-operative Medicine, Case Medical Center, Case Western Reserve University, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Markowitz</LastName><ForeName>Alan H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Surgery, Case Medical Center, Case Western Reserve University, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Soon J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Surgery, Case Medical Center, Case Western Reserve University, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02025621</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>05</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Card Surg</MedlineTA><NlmUniqueID>8908809</NlmUniqueID><ISSNLinking>0886-0440</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002316">Cardiotonic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006835">Hydrazones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011724">Pyridazines</NameOfSubstance></Chemical><Chemical><RegistryNumber>349552KRHK</RegistryNumber><NameOfSubstance UI="D000077464">Simendan</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002303" MajorTopicYN="N">Cardiac Output, Low</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002316" MajorTopicYN="N">Cardiotonic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016206" MajorTopicYN="N">Databases, Bibliographic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006835" MajorTopicYN="N">Hydrazones</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011724" MajorTopicYN="N">Pyridazines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077464" MajorTopicYN="N">Simendan</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018487" MajorTopicYN="N">Ventricular Dysfunction, Left</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25989324</ArticleId><ArticleId IdType="doi">10.1111/jocs.12562</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29210843</PMID><DateCompleted><Year>2019</Year><Month>05</Month><Day>23</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1365-2346</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>Apr</Month></PubDate></JournalIssue><Title>European journal of anaesthesiology</Title><ISOAbbreviation>Eur J Anaesthesiol</ISOAbbreviation></Journal><ArticleTitle>Intraoperative hypotension is associated with acute kidney injury in noncardiac surgery: An observational study.</ArticleTitle><Pagination><StartPage>273</StartPage><EndPage>279</EndPage><MedlinePgn>273-279</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/EJA.0000000000000735</ELocationID><Abstract><AbstractText Label="BACKGROUND">Perioperative acute kidney injury (AKI) is common and increases the risk of morbidity and mortality.</AbstractText><AbstractText Label="OBJECTIVES">To determine the association between intraoperative hypotension, defined as an individual decrease from baseline and the risk of perioperative AKI.</AbstractText><AbstractText Label="DESIGN">Observational cohort study.</AbstractText><AbstractText Label="SETTING">Karolinska University Hospital, Stockholm, Sweden, from October 2012 to May 2013 and October 2015 and April 2016.</AbstractText><AbstractText Label="PATIENTS">All adult patients undergoing major elective noncardiac surgery who were scheduled for an overnight admission in the postoperative unit were included. Patients undergoing phaeochromocytoma surgery were excluded.</AbstractText><AbstractText Label="DATA COLLECTION">Preoperative risk factors (comorbidities), intraoperative events (hypotension defined as a more than 40 or 50% decrease in SBP relative to each patient's baseline and lasting more than 5&#x200a;min) and postoperative data were collected from medical records.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">AKI within the first two postoperative days.</AbstractText><AbstractText Label="RESULTS">Of the final cohort of 470 patients, 127 (27%) developed AKI in the perioperative period. AKI was associated with male sex [(66 vs. 48%) P&#x200a;&lt;&#x200a;0.001], a higher preoperative creatinine (81 vs. 73&#x200a;&#x3bc;mol l, P&#x200a;=&#x200a;0.003), American Society of Anaesthesiologists class more than two (54 vs. 42%, P&#x200a;=&#x200a;0.014) and preoperative hypertension (54 vs. 40%, P&#x200a;=&#x200a;0.005). During surgery, the AKI subgroup had more hypotensive events (&gt;40%, 70 vs. 57%, P&#x200a;=&#x200a;0.013; &gt;50%, 20 vs. 12%, P&#x200a;=&#x200a;0.024) and greater blood loss (800 vs. 400&#x200a;ml, P&#x200a;&lt;&#x200a;0.001). Postoperatively, in AKI patients a positive fluid balance was more common (3123 vs. 2700&#x200a;ml, P&#x200a;&lt;&#x200a;0.001), as was 30-day mortality (4 vs. 1%, P&#x200a;&lt;&#x200a;0.005). Multivariate analyses demonstrated that an intraoperative reduction of SBP more than 50% was associated with a more than doubled risk of AKI, adjusted odds ratio 2.27; 95% CI, 1.20 to 4.30, P&#x200a;=&#x200a;0.013.</AbstractText><AbstractText Label="CONCLUSION">In patients undergoing noncardiac surgery, there was a high incidence of perioperative AKI. Intraoperative avoidance of hypotension may decrease the risk of AKI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hallqvist</LastName><ForeName>Linn</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>From the Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital (LH, MB) and Clinical Epidemiology Unit, Department of Medicine, Karolinska Institute, Solna, Stockholm, Sweden (FG, EH).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Granath</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Huldt</LastName><ForeName>Elin</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Bell</LastName><ForeName>Max</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Anaesthesiol</MedlineTA><NlmUniqueID>8411711</NlmUniqueID><ISSNLinking>0265-0215</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="N">Monitoring, Intraoperative</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29210843</ArticleId><ArticleId IdType="doi">10.1097/EJA.0000000000000735</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33123083</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2392</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Frontiers in endocrinology</Title><ISOAbbreviation>Front Endocrinol (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>The Association Between Obesity and Risk of Acute Kidney Injury After Cardiac Surgery.</ArticleTitle><Pagination><StartPage>534294</StartPage><MedlinePgn>534294</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">534294</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fendo.2020.534294</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To determine the relationship between obesity and the risk of AKI after cardiac surgery (CS-AKI) in a cohort study.</AbstractText><AbstractText Label="METHODS">A total of 1,601 patients undergoing cardiac surgery were collected and their incidence of CS-AKI was recorded. They were divided into underweight, normal weight, overweight, and obese groups. Logistic regression was used to estimate the association between BMI (body mass index) and CS-AKI risk. Then, a meta-analysis of published cohort studies was conducted to confirm this result using PubMed and Embase databases.</AbstractText><AbstractText Label="RESULTS">A significant association was observed in this independent cohort after adjusting age, gender, hypertension and New York Heart Association classification (NYHA) class. Compared with normal BMI group (18.5 &#x2264; BMI &lt; 24.0), the individuals with aberrant BMI level had an increased AKI risk (OR: 1.68, 95% CI: 1.01-2.78) for BMI &lt; 18.5 group and (OR: 1.43, 95% CI: 0.96-2.15) for BMI &#x2265; 28.0. Interestingly, the U-shape curve showed the CS-AKI risk reduced with the increasing of BMI when BMI &#x2264; 24.0. As BMI increases with BMI &gt; 24.0, the risk of developing CS-AKI increased significantly. In the confirmed meta-analysis, compared with normal weight, overweight group with cardiac surgery had higher AKI risk (OR: 1.28, 95% CI: 1.16-1.41, <i>P</i><sub>heterogeneity</sub> = 0.49). The similar association was found in obesity subgroup (OR: 1.79, 95% CI: 1.57-2.03, <i>P</i><sub>heterogeneity</sub> = 0.42).</AbstractText><AbstractText Label="CONCLUSION">In conclusion, the results suggested that abnormal BMI was a risk factor for CS-AKI independently.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Shi, Liu, Fan, Yang, Zhang, Li, Wu, Li, Mao, Xu, Ma, Xiao and Jiang.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Ning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Clinical Metabolomics Center, China Pharmaceutical University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Kang</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Jiangsu Province Hospital, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Yuanming</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Clinical Metabolomics Center, China Pharmaceutical University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Lulu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Clinical Metabolomics Center, China Pharmaceutical University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Song</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinical Metabolomics Center, China Pharmaceutical University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Clinical Metabolomics Center, China Pharmaceutical University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Hanzhang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Jiangsu Province Hospital, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Meiyuan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Jiangsu Province Hospital, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Huijuan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Jiangsu Province Hospital, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Xueqiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Jiangsu Province Hospital, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Shi-Ping</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Pingxi</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The Affiliated Sir Run Run Hospital of Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Shujun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinical Metabolomics Center, China Pharmaceutical University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Endocrinol (Lausanne)</MedlineTA><NlmUniqueID>101555782</NlmUniqueID><ISSNLinking>1664-2392</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">body mass index</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">creatinine</Keyword><Keyword MajorTopicYN="N">obesity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>30</Day><Hour>5</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33123083</ArticleId><ArticleId IdType="pmc">PMC7573233</ArticleId><ArticleId IdType="doi">10.3389/fendo.2020.534294</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kellum JA, Prowle JR. Paradigms of acute kidney injury in the intensive care setting. Nat Rev Nephrol (2018) 14(4):217&#x2013;30. 10.1038/nrneph.2017.184</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2017.184</ArticleId><ArticleId IdType="pubmed">29355173</ArticleId></ArticleIdList></Reference><Reference><Citation>Kork F, Balzer F, Spies CD, Wernecke KD, Ginde AA, Jankowski J, et al. Minor Postoperative Increases of Creatinine Are Associated with Higher Mortality and Longer Hospital Length of Stay in Surgical Patients. Anesthesiology (2015) 123(6):1301&#x2013;11. 10.1097/ALN.0000000000000891</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000891</ArticleId><ArticleId IdType="pmc">PMC4679549</ArticleId><ArticleId IdType="pubmed">26492475</ArticleId></ArticleIdList></Reference><Reference><Citation>Grams ME, Sang Y, Coresh J, Ballew SH, Matsushita K, Levey AS, et al. Candidate Surrogate End Points for ESRD after AKI. J Am Soc Nephrol JASN (2016) 27(9):2851&#x2013;9. 10.1681/ASN.2015070829</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2015070829</ArticleId><ArticleId IdType="pmc">PMC5004655</ArticleId><ArticleId IdType="pubmed">26857682</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor ME, Hewson RW, Kirwan CJ, Ackland GL, Pearse RM, Prowle JR. Acute kidney injury and mortality 1 year after major non-cardiac surgery. Br J Surgery (2017) 104(7):868&#x2013;76. 10.1002/bjs.10498</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.10498</ArticleId><ArticleId IdType="pubmed">28218392</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor ME, Kirwan CJ, Pearse RM, Prowle JR. Incidence and associations of acute kidney injury after major abdominal surgery. Intensive Care Med (2016) 42(4):521&#x2013;30. 10.1007/s00134-015-4157-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-4157-7</ArticleId><ArticleId IdType="pubmed">26602784</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiele RH, Isbell JM, Rosner MH. AKI associated with cardiac surgery. Clin J Am Soc Nephrol CJASN (2015) 10(3):500&#x2013;14. 10.2215/CJN.07830814</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.07830814</ArticleId><ArticleId IdType="pmc">PMC4348689</ArticleId><ArticleId IdType="pubmed">25376763</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisse AB. Cardiac surgery: a century of progress. Texas Heart Institute J (2011) 38(5):486&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3231540</ArticleId><ArticleId IdType="pubmed">22163121</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson CE, Yavas S, Segal MS, Schold JD, Tribble CG, Layon AJ, et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation (2009) 119(18):2444&#x2013;53. 10.1161/CIRCULATIONAHA.108.800011</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.800011</ArticleId><ArticleId IdType="pubmed">19398670</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Bellomo R. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol (2017) 13(11):697&#x2013;711. 10.1038/nrneph.2017.119</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2017.119</ArticleId><ArticleId IdType="pubmed">28869251</ArticleId></ArticleIdList></Reference><Reference><Citation>Peitz GW, Troyer J, Jones AE, Shapiro NI, Nelson RD, Hernandez J, et al. Association of body mass index with increased cost of care and length of stay for emergency department patients with chest pain and dyspnea. Circulation Cardiovasc Qual Outcomes (2014) 7(2):292&#x2013;8. 10.1161/CIRCOUTCOMES.113.000702</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.113.000702</ArticleId><ArticleId IdType="pubmed">24594550</ArticleId></ArticleIdList></Reference><Reference><Citation>
BMI classification Electronic resource.
World health organization;  Available at: https://www.who.int/topics/obesity/en/. Title from the screen.
</Citation></Reference><Reference><Citation>Amann K, Benz K. Structural renal changes in obesity and diabetes. Semin Nephrol (2013) 33(1):23&#x2013;33. 10.1016/j.semnephrol.2012.12.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semnephrol.2012.12.003</ArticleId><ArticleId IdType="pubmed">23374891</ArticleId></ArticleIdList></Reference><Reference><Citation>Glance LG, Wissler R, Mukamel DB, Li Y, Diachun CAB, Salloum R, et al. Perioperative outcomes among patients with the modified metabolic syndrome who are undergoing noncardiac surgery. Anesthesiology (2010) 113(4):859&#x2013;72. 10.1097/ALN.0b013e3181eff32e</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3181eff32e</ArticleId><ArticleId IdType="pubmed">20808207</ArticleId></ArticleIdList></Reference><Reference><Citation>Druml W, Metnitz B, Schaden E, Bauer P, Metnitz PG. Impact of body mass on incidence and prognosis of acute kidney injury requiring renal replacement therapy. Intensive Care Med (2010) 36(7):1221&#x2013;8. 10.1007/s00134-010-1844-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-010-1844-2</ArticleId><ArticleId IdType="pubmed">20232041</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakar CV, Kharat V, Blanck S, Leonard AC. Acute kidney injury after gastric bypass surgery. Clin J Am Soc Nephrol CJASN (2007) 2(3):426&#x2013;30. 10.2215/CJN.03961106</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.03961106</ArticleId><ArticleId IdType="pubmed">17699447</ArticleId></ArticleIdList></Reference><Reference><Citation>Silver AE, Beske SD, Christou DD, Donato AJ, Moreau KL, Eskurza I, et al. Overweight and obese humans demonstrate increased vascular endothelial NAD(P)H oxidase-p47(phox) expression and evidence of endothelial oxidative stress. Circulation (2007) 115(5):627&#x2013;37. 10.1161/CIRCULATIONAHA.106.657486</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.657486</ArticleId><ArticleId IdType="pubmed">17242275</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr (2006) 83(2):461S&#x2013;5S. 10.1093/ajcn/83.2.461S</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/83.2.461S</ArticleId><ArticleId IdType="pubmed">16470013</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Der Boon R, Chieffo A, Dumonteil N, Tchetche D, Van Mieghem N, Vahdat O, et al. Effect of body mass index on short- and long-term outcomes after transcatheter aortic valve implantation. Am J Cardiol (2013) 111(2):231&#x2013;6. 10.1016/j.amjcard.2012.09.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2012.09.022</ArticleId><ArticleId IdType="pubmed">23102879</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang WH, Teng J, Xu JR, Shen YM, Wang Y, Fang ZP, et al. Dynamic Predictive Scores for Cardiac Surgery-Associated Acute Kidney Injury. J Am Heart Assoc (2016) 5(8):1&#x2013;10. 10.1161/JAHA.116.003754</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.116.003754</ArticleId><ArticleId IdType="pmc">PMC5015294</ArticleId><ArticleId IdType="pubmed">27491837</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Lu FC. Department of Disease Control Ministry of Health PRC. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci BES (2004) 17 Suppl:1&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">15807475</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FT, Pretorius M, Schildcrout JS, Mercaldo FT, Byrne JG, Ikizler TA, et al. Obesity and oxidative stress predict AKI after cardiac surgery. J Am Soc Nephrol JASN (2012) 23(7):1221&#x2013;8. 10.1681/ASN.2011090940</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2011090940</ArticleId><ArticleId IdType="pmc">PMC3380645</ArticleId><ArticleId IdType="pubmed">22626819</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar AB, Bridget Zimmerman M, Suneja M. Obesity and post-cardiopulmonary bypass-associated acute kidney injury: a single-center retrospective analysis. J Cardiothoracic Vasc Anesthesia (2014) 28(3):551&#x2013;6. 10.1053/j.jvca.2013.05.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2013.05.037</ArticleId><ArticleId IdType="pubmed">24075942</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou ZP, Zhuang YM, Liu L, Shen B, Ding XQ, et al. Role of Body Mass Index in Acute Kidney Injury Patients after Cardiac Surgery. Cardiorenal Med (2017) 8(1):9&#x2013;17. 10.1159/000477824</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000477824</ArticleId><ArticleId IdType="pmc">PMC5757531</ArticleId><ArticleId IdType="pubmed">29344022</ArticleId></ArticleIdList></Reference><Reference><Citation>Wigfield CH, Lindsey JD, Munoz A, Chopra PS, Edwards NM, Love RB. Is extreme obesity a risk factor for cardiac surgery? An analysis of patients with a BMI &gt; or = 40. Eur J Cardio-thoracic Surg Off J Eur Assoc Cardio-thoracic Surgery (2006) 29(4):434&#x2013;40. 10.1016/j.ejcts.2006.01.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2006.01.016</ArticleId><ArticleId IdType="pubmed">16504529</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Sullivan KE, Byrne JS, Hudson A, Murphy AM, Sadlier DM, Hurley JP. The effect of obesity on acute kidney injury after cardiac surgery. J Thoracic Cardiovasc Surgery (2015) 150(6):1622&#x2013;8. 10.1016/j.jtcvs.2015.08.082</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2015.08.082</ArticleId><ArticleId IdType="pubmed">26409993</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapetto F, Bruno VD, King M, Benedetto U, Caputo M, Angelini GD, et al. Impact of body mass index on outcomes following mitral surgery: does an obesity paradox exist? Interact Cardiovasc Thoracic Surgery (2018) 26(4):590&#x2013;5. 10.1093/icvts/ivx383</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivx383</ArticleId><ArticleId IdType="pubmed">29228212</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko T, Higashitani M, Sato A, Uemura Y, Norimatsu T, Mahara K, et al. Impact of Acute Kidney Injury on Early to Long-Term Outcomes in Patients Who Underwent Surgery for Type A Acute Aortic Dissection. Am J Cardiol (2015) 116(3):463&#x2013;8. 10.1016/j.amjcard.2015.04.043</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2015.04.043</ArticleId><ArticleId IdType="pubmed">26026862</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis C, Barbiero SM, Ribas L. The effect of the body mass index on postoperative complications of coronary artery bypass grafting in elderly. Rev Bras Cirurgia Cardiovasc orgao oficial da Sociedade Bras Cirurgia Cardiovasc (2008) 23(4):524&#x2013;9. 10.1016/j.pmn.2017.10.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pmn.2017.10.018</ArticleId><ArticleId IdType="pubmed">19229425</ArticleId></ArticleIdList></Reference><Reference><Citation>Roh GU, Lee JW, Nam SB, Lee J, Choi JR, Shim YH. Incidence and risk factors of acute kidney injury after thoracic aortic surgery for acute dissection. Ann Thorac Surg (2012) 94(3):766&#x2013;71. 10.1016/j.athoracsur.2012.04.057</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2012.04.057</ArticleId><ArticleId IdType="pubmed">22727320</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JR, Kramer RS, MacKenzie TA, Coca SG, Sint K, Parikh CR. Determinants of acute kidney injury duration after cardiac surgery: an externally validated tool. Ann Thoracic Surgery (2012) 93(2):570&#x2013;6. 10.1016/j.athoracsur.2011.11.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2011.11.004</ArticleId><ArticleId IdType="pmc">PMC3761881</ArticleId><ArticleId IdType="pubmed">22206952</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu RK, McCulloch CE, Ku E, Dudley RA, Hsu CY. Regional variation in the incidence of dialysis-requiring AKI in the United States. Clin J Am Soc Nephrol CJASN (2013) 8(9):1476&#x2013;81. 10.2215/CJN.12611212</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.12611212</ArticleId><ArticleId IdType="pmc">PMC3805086</ArticleId><ArticleId IdType="pubmed">23929923</ArticleId></ArticleIdList></Reference><Reference><Citation>Chagnac A, Weinstein T, Korzets A, Ramadan E, Hirsch J, Gafter U. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol (2000) 278(5):F817&#x2013;822. 10.1152/ajprenal.2000.278.5.F817</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.2000.278.5.F817</ArticleId><ArticleId IdType="pubmed">10807594</ArticleId></ArticleIdList></Reference><Reference><Citation>Chagnac A, Weinstein T, Herman M, Hirsh J, Gafter U, Ori Y. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol JASN (2003) 14(6):1480&#x2013;6. 10.1097/01.ASN.0000068462.38661.89</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ASN.0000068462.38661.89</ArticleId><ArticleId IdType="pubmed">12761248</ArticleId></ArticleIdList></Reference><Reference><Citation>Marik PE, Desai H. The emergent malignant obesity hypoventilation syndrome: a new critical care syndrome. Author reply. J Intensive Care Med (2013) 28(3):200. 10.1177/0885066612464343</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066612464343</ArticleId><ArticleId IdType="pubmed">23814888</ArticleId></ArticleIdList></Reference><Reference><Citation>Marik PE, Desai H. Characteristics of patients with the &#x201c;malignant obesity hypoventilation syndrome&#x201d; admitted to an ICU. J Intensive Care Med (2013) 28(2):124&#x2013;30. 10.1177/0885066612444261</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066612444261</ArticleId><ArticleId IdType="pubmed">22564878</ArticleId></ArticleIdList></Reference><Reference><Citation>Danziger J, Chen KP, Lee J, Feng ML, Mukama KJ. Obesity, Acute Kidney Injury, and Mortality in Critical Illness. Crit Care Med (2016) 44(2):328&#x2013;34. 10.1097/CCM.0000000000001398</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000001398</ArticleId><ArticleId IdType="pmc">PMC4715729</ArticleId><ArticleId IdType="pubmed">26496453</ArticleId></ArticleIdList></Reference><Reference><Citation>Medico CJ, Walsh P. Pharmacotherapy in the critically ill obese patient. Crit Care Clin (2010) 26(4):679&#x2013;88. 10.1016/j.ccc.2010.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2010.07.003</ArticleId><ArticleId IdType="pubmed">20970057</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullens W, Abrahams Z, Francis GS, Taylor DO, Starling RC. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J&#xa0;Am Coll Cardiol (2009) 53(7):589&#x2013;96. 10.1016/j.jacc.2008.05.068</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2008.05.068</ArticleId><ArticleId IdType="pmc">PMC2856960</ArticleId><ArticleId IdType="pubmed">19215833</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim IB, Prowle J, Baldwin I, Bellomo R. Incidence, risk factors and outcome associations of intra-abdominal hypertension in critically ill patients. Anaesthesia Intensive Care (2012) 40(1):79&#x2013;89. 10.1177/0310057X1204000107</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0310057X1204000107</ArticleId><ArticleId IdType="pubmed">22313065</ArticleId></ArticleIdList></Reference><Reference><Citation>McGavock JM, Victor RG, Unger RH, Szczepaniak LS. American College of P, the American Physiological S. Adiposity of the heart, revisited. Ann Internal Med (2006) 144(7):517&#x2013;24. 10.7326/0003-4819-144-7-200604040-00011</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-144-7-200604040-00011</ArticleId><ArticleId IdType="pubmed">16585666</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobias DK, Hu FB. Does being overweight really reduce mortality? Obesity (2013) 21(9):1746&#x2013;9. 10.1002/oby.20602</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/oby.20602</ArticleId><ArticleId IdType="pmc">PMC3806201</ArticleId><ArticleId IdType="pubmed">24078231</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamou SC, Nussbaum M, Stiegel RM, Reames MK, Skipper ER, Robicsek F, et al. Effect of body mass index on outcomes after cardiac surgery: is there an obesity paradox? Ann Thoracic Surgery (2011) 91(1):42&#x2013;7. 10.1016/j.athoracsur.2010.08.047</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2010.08.047</ArticleId><ArticleId IdType="pubmed">21172483</ArticleId></ArticleIdList></Reference><Reference><Citation>Reeves BC, Ascione R, Chamberlain MH, Angelini GD. Effect of body mass index on early outcomes in patients undergoing coronary artery bypass surgery. J Am Coll Cardiol (2003) 42(4):668&#x2013;76. 10.1016/S0735-1097(03)00777-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(03)00777-0</ArticleId><ArticleId IdType="pubmed">12932599</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson AP, Parlow JL, Whitehead M, Xu J, Rohland S, Milne B. Body Mass Index, Outcomes, and Mortality Following Cardiac Surgery in Ontario, Canada. J Am Heart Assoc (2015) 4(7):e002140. 10.1161/JAHA.115.002140</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.115.002140</ArticleId><ArticleId IdType="pmc">PMC4608091</ArticleId><ArticleId IdType="pubmed">26159363</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghanta RK, LaPar DJ, Zhang Q, Devarkonda V, Isbell JM, Yarboro LT, et al. Obesity Increases Risk-Adjusted Morbidity, Mortality, and Cost Following Cardiac Surgery. J Am Heart Assoc (2017) 6(3):e003831. 10.1161/JAHA.116.003831</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.116.003831</ArticleId><ArticleId IdType="pmc">PMC5523989</ArticleId><ArticleId IdType="pubmed">28275064</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S, Youn YN, Yoo KJ. Metabolic syndrome as a risk factor for postoperative kidney injury after off-pump coronary artery bypass surgery. Circ J (2010) 74(6):1121&#x2013;6. 10.1253/circj.CJ-09-0842</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-09-0842</ArticleId><ArticleId IdType="pubmed">20410619</ArticleId></ArticleIdList></Reference><Reference><Citation>Forni LG, Joannidis M. Blood pressure deficits in acute kidney injury: not all about the mean arterial pressure? Crit Care (2017) 21(1):102. 10.1186/s13054-017-1683-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-017-1683-4</ArticleId><ArticleId IdType="pmc">PMC5415755</ArticleId><ArticleId IdType="pubmed">28468676</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatachalam MA, Weinberg JM, Kriz W, Bidani AK. Failed Tubule Recovery, AKI-CKD Transition, and Kidney Disease Progression. J Am Soc Nephrol (2015) 26(8):1765&#x2013;76. 10.1681/ASN.2015010006</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2015010006</ArticleId><ArticleId IdType="pmc">PMC4520181</ArticleId><ArticleId IdType="pubmed">25810494</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38918723</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2318</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>25</Day></PubDate></JournalIssue><Title>BMC geriatrics</Title><ISOAbbreviation>BMC Geriatr</ISOAbbreviation></Journal><ArticleTitle>A simple machine learning model for the prediction of acute kidney injury following noncardiac surgery in geriatric patients: a prospective cohort study.</ArticleTitle><Pagination><StartPage>549</StartPage><MedlinePgn>549</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">549</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12877-024-05148-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Surgery in geriatric patients often poses risk of major postoperative complications. Acute kidney injury (AKI) is a common complication following noncardiac surgery and is associated with increased mortality. Early identification of geriatric patients at high risk of AKI could facilitate preventive measures and improve patient prognosis. This study used machine learning methods to identify important features and predict AKI following noncardiac surgery in geriatric patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The data for this study were obtained from a prospective cohort. Patients aged&#x2009;&#x2265;&#x2009;65 years who received noncardiac surgery from June 2019 to December 2021 were enrolled. Data were split into training set (from June 2019 to March 2021) and internal validation set (from April 2021 to December 2021) by time. The least absolute shrinkage and selection operator (LASSO) regularization algorithm and the random forest recursive feature elimination algorithm (RF-RFE) were used to screen important predictors. Models were trained through extreme gradient boosting (XGBoost), random forest, and LASSO. The SHapley Additive exPlanations (SHAP) package was used to interpret the machine learning model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The training set included 6753 geriatric patients. Of these, 250 (3.70%) patients developed AKI. The XGBoost model with RF-RFE selected features outperformed other models with an area under the precision-recall curve (AUPRC) of 0.505 (95% confidence interval [CI]: 0.369-0.626) and an area under the receiver operating characteristic curve (AUROC) of 0.806 (95%CI: 0.733-0.875). The model incorporated ten predictors, including operation site and hypertension. The internal validation set included 3808 geriatric patients, and 96 (2.52%) patients developed AKI. The model maintained good predictive performance with an AUPRC of 0.431 (95%CI: 0.331-0.524) and an AUROC of 0.845 (95%CI: 0.796-0.888) in the internal validation.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study developed a simple machine learning model and a web calculator for predicting AKI following noncardiac surgery in geriatric patients. This model may be a valuable tool for guiding preventive measures and improving patient prognosis.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">The protocol of this study was approved by the Committee of Ethics from West China Hospital of Sichuan University (2019-473) with a waiver of informed consent and registered at www.chictr.org.cn (ChiCTR1900025160, 15/08/2019).</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Xiran</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, 610041, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit for Perioperative Stress Assessment and Clinical Decision, Chinese Academy of Medical Sciences (2018RU012), West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, 610041, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit for Perioperative Stress Assessment and Clinical Decision, Chinese Academy of Medical Sciences (2018RU012), West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Qixu</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Center of Statistical Research, School of Statistics, Southwestern University of Finance and Economics, Chengdu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint Lab of Data Science and Business Intelligence, School of Statistics, Southwestern University of Finance and Economics, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yuewen</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Center of Statistical Research, School of Statistics, Southwestern University of Finance and Economics, Chengdu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint Lab of Data Science and Business Intelligence, School of Statistics, Southwestern University of Finance and Economics, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Ruihao</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, 610041, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit for Perioperative Stress Assessment and Clinical Decision, Chinese Academy of Medical Sciences (2018RU012), West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center of Statistical Research, School of Statistics, Southwestern University of Finance and Economics, Chengdu, China. likec@swufe.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint Lab of Data Science and Business Intelligence, School of Statistics, Southwestern University of Finance and Economics, Chengdu, China. likec@swufe.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hao</LastName><ForeName>Xuechao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, 610041, China. aneshxc@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Unit for Perioperative Stress Assessment and Clinical Decision, Chinese Academy of Medical Sciences (2018RU012), West China Hospital, Sichuan University, Chengdu, China. aneshxc@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Geriatr</MedlineTA><NlmUniqueID>100968548</NlmUniqueID><ISSNLinking>1471-2318</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Geriatric assessment</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Noncardiac surgery</Keyword><Keyword MajorTopicYN="N">Risk assessment</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>26</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>25</Day><Hour>23</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38918723</ArticleId><ArticleId IdType="pmc">PMC11197315</ArticleId><ArticleId IdType="doi">10.1186/s12877-024-05148-1</ArticleId><ArticleId IdType="pii">10.1186/s12877-024-05148-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nepogodiev D, Martin J, Biccard B, Makupe A, Bhangu A, Nepogodiev D, et al. Global burden of postoperative death. The Lancet. 2019;393:401. doi: 10.1016/S0140-6736(18)33139-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)33139-8</ArticleId><ArticleId IdType="pubmed">30722955</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahli Z, Shelley RM, Richard S, Jeffrey B, Sandhya LD, Mitchell TH. Preoperative Cognitive Impairment As a Predictor of Postoperative Outcomes in a Collaborative Care Model. JAGS. 2018;66:584&#x2013;589. doi: 10.1111/jgs.15261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.15261</ArticleId><ArticleId IdType="pmc">PMC5849502</ArticleId><ArticleId IdType="pubmed">29332302</ArticleId></ArticleIdList></Reference><Reference><Citation>Oresanya LB, Lyons WL, Finlayson E. Preoperative assessment of the older patient: a narrative review. JAMA. 2014;311(20):2110&#x2013;2120. doi: 10.1001/jama.2014.4573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.4573</ArticleId><ArticleId IdType="pubmed">24867014</ArticleId></ArticleIdList></Reference><Reference><Citation>Shigehiko U, John AK, Rinaldo B, Gordon SD, Hiroshi M, Stanislao M, et al. Acute Renal Failure in Critically ill Patients. JAMA. 2005;294:813&#x2013;818. doi: 10.1001/jama.294.7.813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.294.7.813</ArticleId><ArticleId IdType="pubmed">16106006</ArticleId></ArticleIdList></Reference><Reference><Citation>Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 2012;81(5):442&#x2013;448. doi: 10.1038/ki.2011.379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2011.379</ArticleId><ArticleId IdType="pmc">PMC3788581</ArticleId><ArticleId IdType="pubmed">22113526</ArticleId></ArticleIdList></Reference><Reference><Citation>Bihorac A, Yavas S, Subbiah S, Hobson CE, Schold JD, Gabrielli A, et al. Long-term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg. 2009;249(5):851&#x2013;858. doi: 10.1097/SLA.0b013e3181a40a0b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e3181a40a0b</ArticleId><ArticleId IdType="pubmed">19387314</ArticleId></ArticleIdList></Reference><Reference><Citation>Gumbert SD, Kork F, Jackson ML, Vanga N, Ghebremichael SJ, Wang CY, et al. Perioperative Acute Kidney Injury. Anesthesiology. 2020;132(1):180&#x2013;204. doi: 10.1097/ALN.0000000000002968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000002968</ArticleId><ArticleId IdType="pmc">PMC10924686</ArticleId><ArticleId IdType="pubmed">31687986</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Connor ME, Hewson RW, Kirwan CJ, Ackland GL, Pearse RM, Prowle JR. Acute kidney injury and mortality 1 year after major non-cardiac surgery. Br J Surg. 2017;104(7):868&#x2013;876. doi: 10.1002/bjs.10498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.10498</ArticleId><ArticleId IdType="pubmed">28218392</ArticleId></ArticleIdList></Reference><Reference><Citation>Steven CY, Lee HT. Acute Kidney Injury and Extrarenal Organ Dysfunction. Anesthesiology. 2012;116:1139&#x2013;1148. doi: 10.1097/ALN.0b013e31824f951b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e31824f951b</ArticleId><ArticleId IdType="pubmed">22415388</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell S, Dekker FW, Vadiveloo T, Marwick C, Deshmukh H, Donnan PT, et al. Risk of postoperative acute kidney injury in patients undergoing orthopaedic surgery&#x2013;development and validation of a risk score and effect of acute kidney injury on survival: observational cohort study. BMJ (Clinical research ed) 2015;351:h5639.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4641433</ArticleId><ArticleId IdType="pubmed">26561522</ArticleId></ArticleIdList></Reference><Reference><Citation>Duminda NW, Keyvan K, Jean YD, Vivek R, Christopher TC, John TG, et al. Derivation and Validation of a Simplified Predictive Index for Renal Replacement Therapy After Cardiac Surgery. JAMA. 2007;297:1801&#x2013;1809. doi: 10.1001/jama.297.16.1801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.297.16.1801</ArticleId><ArticleId IdType="pubmed">17456822</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JR, Cochran RP, Leavitt BJ, Dacey LJ, Ross CS, MacKenzie TA, et al. Multivariable prediction of renal insufficiency developing after cardiac surgery. Circulation. 2007;116(11 Suppl):I139&#x2013;I143.</Citation><ArticleIdList><ArticleId IdType="pubmed">17846294</ArticleId></ArticleIdList></Reference><Reference><Citation>Kate B, Veerle V, Domenico P, Moninder B, Kate T, Jonathan AS. Predictive models for kidney disease: improving global outcomes (KDIGO) defined acute kidney injury in UK cardiac surgery. Crit Care. 2014;18:606. doi: 10.1186/s13054-014-0606-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-014-0606-x</ArticleId><ArticleId IdType="pmc">PMC4258283</ArticleId><ArticleId IdType="pubmed">25673427</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S, Cho H, Park S, Lee S, Kim K, Yoon HJ, et al. Simple Postoperative AKI Risk (SPARK) Classification before Noncardiac Surgery: A Prediction Index Development Study with External Validation. J Am Soc Nephrol. 2019;30(1):170&#x2013;181. doi: 10.1681/ASN.2018070757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2018070757</ArticleId><ArticleId IdType="pmc">PMC6317608</ArticleId><ArticleId IdType="pubmed">30563915</ArticleId></ArticleIdList></Reference><Reference><Citation>Grams ME, Sang Y, Coresh J, Ballew S, Matsushita K, Molnar MZ, et al. Acute Kidney Injury After Major Surgery: A Retrospective Analysis of Veterans Health Administration Data. Am J Kidney Dis. 2016;67(6):872&#x2013;880. doi: 10.1053/j.ajkd.2015.07.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2015.07.022</ArticleId><ArticleId IdType="pmc">PMC4775458</ArticleId><ArticleId IdType="pubmed">26337133</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Tremper KK, Heung M, Rosenberg AL, Englesbe M, Shanks AM, et al. Development and validation of an acute kidney injury risk index for patients undergoing general surgery: Results from a national data set. Anesthesiology. 2009;110:505&#x2013;515. doi: 10.1097/ALN.0b013e3181979440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3181979440</ArticleId><ArticleId IdType="pubmed">19212261</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirracchio R, Petersen ML, Carone M, Rigon MR, Chevret S, van der Laan MJ. Mortality prediction in intensive care units with the Super ICU Learner Algorithm (SICULA): a population-based study. Lancet Respir Med. 2015;3(1):42&#x2013;52. doi: 10.1016/S2213-2600(14)70239-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(14)70239-5</ArticleId><ArticleId IdType="pmc">PMC4321691</ArticleId><ArticleId IdType="pubmed">25466337</ArticleId></ArticleIdList></Reference><Reference><Citation>Rashidi P, Bihorac A. Artificial intelligence approaches to improve kidney care. Nat Rev Nephrol. 2020;16(2):71&#x2013;72. doi: 10.1038/s41581-019-0243-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-019-0243-3</ArticleId><ArticleId IdType="pmc">PMC7591106</ArticleId><ArticleId IdType="pubmed">31873197</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei VJ, Luong T, Shan E, Chen X, Neuman MD, Eneanya ND, et al. Risk Stratification for Postoperative Acute Kidney Injury in Major Noncardiac Surgery Using Preoperative and Intraoperative Data. JAMA Netw Open. 2019;2(12):e1916921. doi: 10.1001/jamanetworkopen.2019.16921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2019.16921</ArticleId><ArticleId IdType="pmc">PMC6902769</ArticleId><ArticleId IdType="pubmed">31808922</ArticleId></ArticleIdList></Reference><Reference><Citation>Rank N, Pfahringer B, Kempfert J, Stamm C, Kuhne T, Schoenrath F, et al. Deep-learning-based real-time prediction of acute kidney injury outperforms human predictive performance. NPJ Digit Med. 2020;3:139. doi: 10.1038/s41746-020-00346-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-020-00346-8</ArticleId><ArticleId IdType="pmc">PMC7588492</ArticleId><ArticleId IdType="pubmed">33134556</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko S, Jo C, Chang CB, Lee YS, Moon YW, Youm JW, et al. A web-based machine-learning algorithm predicting postoperative acute kidney injury after total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2022;30(2):545&#x2013;554. doi: 10.1007/s00167-020-06258-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00167-020-06258-0</ArticleId><ArticleId IdType="pubmed">32880677</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q, Zhang Y, Zhang M, Li Z, Liu J. Application of Machine Learning Algorithms to Predict Acute Kidney Injury in Elderly Orthopedic Postoperative Patients. Clin Interv Aging. 2022;17:317&#x2013;330. doi: 10.2147/CIA.S349978.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CIA.S349978</ArticleId><ArticleId IdType="pmc">PMC8979591</ArticleId><ArticleId IdType="pubmed">35386749</ArticleId></ArticleIdList></Reference><Reference><Citation>Saydy N, Mazine A, Stevens LM, Jeamart H, Demers P, Page P, et al. Differences and similarities in risk factors for postoperative acute kidney injury between younger and older adults undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2018;155(1):256&#x2013;265. doi: 10.1016/j.jtcvs.2017.08.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2017.08.039</ArticleId><ArticleId IdType="pubmed">28942979</ArticleId></ArticleIdList></Reference><Reference><Citation>Alrezk R, Jackson N, Al Rezk M, Elashoff R, Weintraub N, Elashoff D, et al. Derivation and Validation of a Geriatric-Sensitive Perioperative Cardiac Risk Index. J Am Heart Assoc. 2017;6(11):1&#x2013;10. doi: 10.1161/JAHA.117.006648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.117.006648</ArticleId><ArticleId IdType="pmc">PMC5721761</ArticleId><ArticleId IdType="pubmed">29146612</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew G and Agha R for the STROCSS Group. STROCSS Strengthening the Reporting of cohort, cross-sectional and case-control studies in Surgery. Int J Surg. 2021;2021(96):106165.</Citation><ArticleIdList><ArticleId IdType="pubmed">34774726</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins GS, Moons KGM, Dhiman P, Riley RD, Beam AL, Van Calster B, et al. TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ (Clinical research ed) 2024;385:e078378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11019967</ArticleId><ArticleId IdType="pubmed">38626948</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179&#x2013;c184. doi: 10.1159/000339789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000339789</ArticleId><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Mironchyk P, Tchistiakov V. Monotone optimal binning algorithm for credit risk modeling. Financ Econ. 2017:1&#x2013;15. 10.13140/RG.2.2.31885.44003.</Citation></Reference><Reference><Citation>Saito T, Rehmsmeier M. The precision-recall plot is more informative than the ROC plot when evaluating binary classifiers on imbalanced datasets. PLoS ONE. 2015;10(3):1&#x2013;21. doi: 10.1371/journal.pone.0118432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0118432</ArticleId><ArticleId IdType="pmc">PMC4349800</ArticleId><ArticleId IdType="pubmed">25738806</ArticleId></ArticleIdList></Reference><Reference><Citation>Staffa SJ, Zurakowski D. Statistical Development and Validation of Clinical Prediction Models. Anesthesiology. 2021;135(3):396&#x2013;405. doi: 10.1097/ALN.0000000000003871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003871</ArticleId><ArticleId IdType="pubmed">34330146</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg SM, Erion G, Chen H, DeGrave A, Prutkin JM, Nair B, et al. From Local Explanations to Global Understanding with Explainable AI for Trees. Nat Mach Intell. 2020;2(1):56&#x2013;67. doi: 10.1038/s42256-019-0138-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42256-019-0138-9</ArticleId><ArticleId IdType="pmc">PMC7326367</ArticleId><ArticleId IdType="pubmed">32607472</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Z, Bo L, Xu Z, Song Y, Wang J, Wen P, et al. An explainable machine learning algorithm for risk factor analysis of in-hospital mortality in sepsis survivors with ICU readmission. Comput Methods Programs Biomed. 2021;204:106040. doi: 10.1016/j.cmpb.2021.106040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmpb.2021.106040</ArticleId><ArticleId IdType="pubmed">33780889</ArticleId></ArticleIdList></Reference><Reference><Citation>Goren O, Matot I. Perioperative acute kidney injury. Br J Anaesth. 2015;115:ii3&#x2013;ii14. doi: 10.1093/bja/aev380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aev380</ArticleId><ArticleId IdType="pubmed">26658199</ArticleId></ArticleIdList></Reference><Reference><Citation>Spahillari A, Parikh CR, Sint K, Koyner JL, Patel UD, Edelstein CL, et al. Serum Cystatin C&#x2013; Versus Creatinine-Based Definitions of Acute Kidney Injury Following Cardiac Surgery: A Prospective Cohort Study. Am J Kidney Dis. 2012;60(6):922&#x2013;929. doi: 10.1053/j.ajkd.2012.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2012.06.002</ArticleId><ArticleId IdType="pmc">PMC3496012</ArticleId><ArticleId IdType="pubmed">22809763</ArticleId></ArticleIdList></Reference><Reference><Citation>Shlipak MG, Matsushita K, &#xc4;rnl&#xf6;v J, Inker LA, Katz R, Polkinghorne KR, et al. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med. 2013;369(10):932&#x2013;943. doi: 10.1056/NEJMoa1214234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1214234</ArticleId><ArticleId IdType="pmc">PMC3993094</ArticleId><ArticleId IdType="pubmed">24004120</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Yang B, Liu M, You T, Shen H, Chen Y, et al. Serum cystatin C is a potential predictor of short-term mortality and acute kidney injury in acute aortic dissection patients: a retrospective cohort study. J Thorac Dis. 2022;14(8):2977&#x2013;2986. doi: 10.21037/jtd-22-937.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd-22-937</ArticleId><ArticleId IdType="pmc">PMC9442520</ArticleId><ArticleId IdType="pubmed">36071756</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudasill SE, Liu J, Kamath AF. Revisiting the International Normalized Ratio (INR) Threshold for Complications in Primary Total Knee Arthroplasty: An Analysis of 21,239 Cases. J Bone Joint Surg Am. 2019;101(6):514&#x2013;522. doi: 10.2106/JBJS.18.00771.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.18.00771</ArticleId><ArticleId IdType="pubmed">30893232</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo M, Gao Y, Wang L, Zhang H, Liu X, Zhang H. Early Acute Kidney Injury Associated with Liver Transplantation: A Retrospective Case-Control Study. Med Sci Monit. 2020;26:e923864. doi: 10.12659/MSM.923864.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.923864</ArticleId><ArticleId IdType="pmc">PMC7387046</ArticleId><ArticleId IdType="pubmed">32681793</ArticleId></ArticleIdList></Reference><Reference><Citation>Duchnowski P, Hryniewiecki T, Ku&#x15b;mierczyk M, Szyma&#x144;ski P. Anisocytosis predicts postoperative renal replacement therapy in patients undergoing heart valve surgery. Cardiol J. 2020;27(4):362&#x2013;367. doi: 10.5603/CJ.a2019.0020.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/CJ.a2019.0020</ArticleId><ArticleId IdType="pmc">PMC8016011</ArticleId><ArticleId IdType="pubmed">30799549</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan DXH, Sim YE, Chan YH, Poopalalingam R, Abdullah HR. Development of the Combined Assessment of Risk Encountered in Surgery (CARES) surgical risk calculator for prediction of postsurgical mortality and need for intensive care unit admission risk: a single-center retrospective study. BMJ Open. 2018;8(3):e019427. doi: 10.1136/bmjopen-2017-019427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-019427</ArticleId><ArticleId IdType="pmc">PMC5875658</ArticleId><ArticleId IdType="pubmed">29574442</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalfino L, Tullo L, Donadio I, Malcangi V, Brienza N. Intra-abdominal hypertension and acute renal failure in critically ill patients. Intensive Care Med. 2008;34(4):707&#x2013;713. doi: 10.1007/s00134-007-0969-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-007-0969-4</ArticleId><ArticleId IdType="pubmed">18157662</ArticleId></ArticleIdList></Reference><Reference><Citation>Demarchi AC, de Almeida CT, Ponce D, e Castro MC, Danaga AR, Yamaguti FA, et al. Intra-abdominal pressure as a predictor of acute kidney injury in postoperative abdominal surgery. Ren Fail. 2014;36(4):557&#x2013;61. doi: 10.3109/0886022X.2013.876353.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/0886022X.2013.876353</ArticleId><ArticleId IdType="pubmed">24456177</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Bellomo R. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol. 2017;13(11):697&#x2013;711. doi: 10.1038/nrneph.2017.119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2017.119</ArticleId><ArticleId IdType="pubmed">28869251</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimoto M, Murashima M, Kokubu M, Matsui M, Eriguchi M, Samejima K-I, et al. Pre-operative proteinuria and post-operative acute kidney injury in noncardiac surgery: the NARA-Acute Kidney Injury cohort study. Nephrol Dial Transplant. 2020;35(12):2111&#x2013;2116. doi: 10.1093/ndt/gfz269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfz269</ArticleId><ArticleId IdType="pubmed">31891400</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkins J, Mpody C, Corridore M, Cambier G, Tobias JD, Nafiu OO. Risk Factors and Consequences of Acute Kidney Injury After Noncardiac Surgery in Children. Anesth Analg. 2022;135(3):625&#x2013;632. doi: 10.1213/ANE.0000000000005901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005901</ArticleId><ArticleId IdType="pubmed">35086116</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38230449</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>09</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2346</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>European journal of anaesthesiology</Title><ISOAbbreviation>Eur J Anaesthesiol</ISOAbbreviation></Journal><ArticleTitle>Association of sleep quality on the night of operative day with postoperative delirium in elderly patients: A prospective cohort study.</ArticleTitle><Pagination><StartPage>226</StartPage><EndPage>233</EndPage><MedlinePgn>226-233</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/EJA.0000000000001952</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Sleep disturbances in the peri-operative period have been associated with adverse outcomes, including postoperative delirium (POD). However, research on sleep quality during the immediate postoperative period is limited.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This study aimed to investigate the association between sleep quality on the night of the operative day assessed using the Sleep Quality Numeric Rating Scale (SQ-NRS), and the incidence of POD in a large cohort of surgical patients.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A prospective cohort study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">A tertiary hospital in China.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">This study enrolled patients aged 65&#x200a;years or older undergoing elective surgery under general anaesthesia. The participants were categorised into the sleep disturbance and no sleep disturbance groups according to their operative night SQ-NRS.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">The primary outcome was delirium incidence, whereas the secondary outcomes included acute kidney injury, stroke, pulmonary infection, cardiovascular complications and all-cause mortality within 1 year postoperatively.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 3072 patients were included in the analysis of this study. Among them, 791 (25.72%) experienced sleep disturbances on the night of operative day. Patients in the sleep disturbance group had a significantly higher risk of developing POD (adjusted OR 1.43, 95% CI 1.11 to 1.82, P &#x200a;=&#x200a;0.005). Subgroup analysis revealed that age 65-75&#x200a;years; male sex; ASA III and IV; haemoglobin more than 12&#x200a;g&#x200a;l -1 ; intra-operative hypotension; surgical duration more than 120&#x200a;min; and education 9&#x200a;years or less were significantly associated with POD. No interaction was observed between the subgroups. No significant differences were observed in the secondary outcomes, such as acute kidney injury, stroke, pulmonary infection, cardiovascular complications and all-cause mortality within 1 year postoperatively.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The poor subjective sleep quality on the night of operative day was independently associated with increased POD risk, especially in certain subpopulations. Optimising peri-operative sleep may reduce POD. Further research should investigate potential mechanisms and causal relationships.</AbstractText><AbstractText Label="TRIAL REGISTRY" NlmCategory="BACKGROUND">chictr.org.cn: ChiCTR1900028545.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Society of Anaesthesiology and Intensive Care.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ou-Yang</LastName><ForeName>Chun-Lei</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>From the Department of Anaesthesiology, The First Medical Centre of Chinese People's Liberation Army (PLA) General Hospital (CO-Y, LM, XW, YM, YL, LT, HLi, JL, JC, WM), Medical School of Chinese People's Liberation Army (CO, WM), Department of Anaesthesiology, The Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital (CO), National Clinical Research Centre for Geriatric Diseases, People's Liberation Army General Hospital, Beijing, China (JC, WM).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Li-Bin</ForeName><Initials>LB</Initials></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xiao-Dong</ForeName><Initials>XD</Initials></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Yu-Long</ForeName><Initials>YL</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yan-Hong</ForeName><Initials>YH</Initials></Author><Author ValidYN="Y"><LastName>Tong</LastName><ForeName>Li</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Hao</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Lou</LastName><ForeName>Jing-Sheng</ForeName><Initials>JS</Initials></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Jiang-Bei</ForeName><Initials>JB</Initials></Author><Author ValidYN="Y"><LastName>Mi</LastName><ForeName>Wei-Dong</ForeName><Initials>WD</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Anaesthesiol</MedlineTA><NlmUniqueID>8411711</NlmUniqueID><ISSNLinking>0265-0215</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053821" MajorTopicYN="Y">Cardiovascular Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003693" MajorTopicYN="Y">Delirium</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071257" MajorTopicYN="Y">Emergence Delirium</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000089943" MajorTopicYN="N">Sleep Quality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>17</Day><Hour>4</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38230449</ArticleId><ArticleId IdType="pmc">PMC10842671</ArticleId><ArticleId IdType="doi">10.1097/EJA.0000000000001952</ArticleId><ArticleId IdType="pii">00003643-202403000-00008</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aldecoa C, Bettelli G, Bilotta F, et al. European Society of Anaesthesiology evidence-based and consensus-based guideline on postoperative delirium. <i>Eur J Anaesthesiol</i>
2017; 34:192&#x2013;214.
</Citation><ArticleIdList><ArticleId IdType="pubmed">28187050</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes CG, Boncyk CS, Culley DJ, et al. American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Postoperative Delirium Prevention. <i>Anesth Analg</i>
2020; 130:1572&#x2013;1590.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7379173</ArticleId><ArticleId IdType="pubmed">32022748</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisani MA, Friese RS, Gehlbach BK, et al. Sleep in the intensive care unit. <i>Am J Respir Crit Care Med</i>
2015; 191:731&#x2013;738.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5447310</ArticleId><ArticleId IdType="pubmed">25594808</ArticleId></ArticleIdList></Reference><Reference><Citation>Vacas S, McInrue E, Gropper MA, et al. The feasibility and utility of continuous sleep monitoring in critically ill patients using a portable electroencephalography monitor. <i>Anesth Analg</i>
2016; 123:206&#x2013;212.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5493322</ArticleId><ArticleId IdType="pubmed">27159066</ArticleId></ArticleIdList></Reference><Reference><Citation>Park MJ, Yoo JH, Cho BW, et al. Noise in hospital rooms and sleep disturbance in hospitalized medical patients. <i>Environ Health Toxicol</i>
2014; 29:e2014006.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4152942</ArticleId><ArticleId IdType="pubmed">25163680</ArticleId></ArticleIdList></Reference><Reference><Citation>Flink BJ, Rivelli SK, Cox EA, et al. Obstructive sleep apnea and incidence of postoperative delirium after elective knee replacement in the nondemented elderly. <i>Anesthesiology</i>
2012; 116:788&#x2013;796.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3321273</ArticleId><ArticleId IdType="pubmed">22337162</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung JM, Sands LP, Newman S, et al. Preoperative sleep disruption and postoperative delirium. <i>J Clin Sleep Med</i>
2015; 11:907&#x2013;913.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4513268</ArticleId><ArticleId IdType="pubmed">25979094</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohara T, Honda T, Hata J, et al. Association between daily sleep duration and risk of dementia and mortality in a Japanese community. <i>J Am Geriatr Soc</i>
2018; 66:1911&#x2013;1918.
</Citation><ArticleIdList><ArticleId IdType="pubmed">29873398</ArticleId></ArticleIdList></Reference><Reference><Citation>Todd OM, Gelrich L, MacLullich AM, et al. Sleep disruption at home as an independent risk factor for postoperative delirium. <i>J Am Geriatr Soc</i>
2017; 65:949&#x2013;957.
</Citation><ArticleIdList><ArticleId IdType="pubmed">28306148</ArticleId></ArticleIdList></Reference><Reference><Citation>Akpinar RB, Aksoy M, Kant E. Effect of earplug/eye mask on sleep and delirium in intensive care patients. <i>Nurs Crit Care</i>
2022; 27:537&#x2013;545.
</Citation><ArticleIdList><ArticleId IdType="pubmed">35021263</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Li Z, Yu Y, et al. Risk factors contributing to postoperative delirium in geriatric patients postorthopedic surgery. <i>Asia Pac Psychiatry</i>
2015; 7:375&#x2013;382.
</Citation><ArticleIdList><ArticleId IdType="pubmed">26097170</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang WY, Wu WL, Gu JJ, et al. Risk factors for postoperative delirium in patients after coronary artery bypass grafting: a prospective cohort study. <i>J Crit Care</i>
2015; 30:606&#x2013;612.
</Citation><ArticleIdList><ArticleId IdType="pubmed">25708120</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q, Zhu H, Zhen Z, Gu D. Self-rated health, interviewer-rated health, and their predictive powers on mortality in old age. <i>J Gerontol B Psychol Sci Soc Sci</i>
2016; 71:538&#x2013;550.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6366535</ArticleId><ArticleId IdType="pubmed">25617400</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng Y, Feng Q, Hesketh T, et al. Survival, disabilities in activities of daily living, and physical and cognitive functioning among the oldest-old in China: a cohort study. <i>Lancet</i>
2017; 389:1619&#x2013;1629.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5406246</ArticleId><ArticleId IdType="pubmed">28285816</ArticleId></ArticleIdList></Reference><Reference><Citation>Beigiene A, Petruseviciene D, Barasaite V, et al. Frailty and different exercise interventions to improve gait speed in older adults after acute coronary syndrome. <i>Medicina (Kaunas)</i>
2021; 57:1344.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8705993</ArticleId><ArticleId IdType="pubmed">34946289</ArticleId></ArticleIdList></Reference><Reference><Citation>Aceto P, Lai C, De Crescenzo F, et al. Cognitive decline after carotid endarterectomy: systematic review and meta-analysis. <i>Eur J Anaesthesiol</i>
2020; 37:1066&#x2013;1074.
</Citation><ArticleIdList><ArticleId IdType="pubmed">31860600</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Cao M, Zhang J, et al. Structural and functional brain changes in the default mode network in subtypes of amnestic mild cognitive impairment. <i>J Geriatr Psychiatry Neurol</i>
2014; 27:188&#x2013;198.
</Citation><ArticleIdList><ArticleId IdType="pubmed">24614201</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutchins JL, Leiman D, Minkowitz HS, et al. An open-label study of sufentanil sublingual tablet 30 mcg in patients with postoperative pain. <i>Pain Med</i>
2018; 19:2058&#x2013;2068.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6176750</ArticleId><ArticleId IdType="pubmed">29126259</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan G, Guo S, Zhang Y, et al. Effects of epidemiological factors and pressure pain measurements in predicting postoperative pain: a prospective survey of 1,002 Chinese patients. <i>Pain Physician</i>
2017; 20:E903&#x2013;E914.
</Citation><ArticleIdList><ArticleId IdType="pubmed">28934794</ArticleId></ArticleIdList></Reference><Reference><Citation>Su X, Meng ZT, Wu XH, et al. Dexmedetomidine for prevention of delirium in elderly patients after noncardiac surgery: a randomised, double-blind, placebo-controlled trial. <i>Lancet</i>
2016; 388:1893&#x2013;1902.
</Citation><ArticleIdList><ArticleId IdType="pubmed">27542303</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Z, Liao W, Tan KS, et al. Decreased hospital charges and postoperative pain in septoplasty by application of enhanced recovery after surgery. <i>Ther Clin Risk Manag</i>
2018; 14:1871&#x2013;1877.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6174903</ArticleId><ArticleId IdType="pubmed">30323609</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin S, Chandran A, Zografos L, Zlateva G. Evaluation of the impact of fibromyalgia on patients&#x2019; sleep and the content validity of two sleep scales. <i>Health Qual Life Outcomes</i>
2009; 7:64.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2717926</ArticleId><ArticleId IdType="pubmed">19591683</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai J, Chen Y, Hao X, et al. Effect of intraoperative dexmedetomidine dose on postoperative first night sleep quality in elderly surgery patients: a retrospective study with propensity score-matched analysis. <i>Front Med (Lausanne)</i>
2020; 7:528.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7574233</ArticleId><ArticleId IdType="pubmed">33117823</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan G, Wang K, Peng T, et al. The effects of intraoperative dexmedetomidine use and its different dose on postoperative sleep disturbance in patients who have undergone non-cardiac major surgery: a real-world cohort study. <i>Nat Sci Sleep</i>
2020; 12:209&#x2013;219.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7075348</ArticleId><ArticleId IdType="pubmed">32210652</ArticleId></ArticleIdList></Reference><Reference><Citation>Rood P, Frenzel T, Verhage R, et al. Development and daily use of a numeric rating score to assess sleep quality in ICU patients. <i>J Crit Care</i>
2019; 52:68&#x2013;74.
</Citation><ArticleIdList><ArticleId IdType="pubmed">30981928</ArticleId></ArticleIdList></Reference><Reference><Citation>Inouye SK, van Dyck CH, Alessi CA, et al. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. <i>Ann Intern Med</i>
1990; 113:941&#x2013;948.
</Citation><ArticleIdList><ArticleId IdType="pubmed">2240918</ArticleId></ArticleIdList></Reference><Reference><Citation>KDIGO Clinical Practice Guideline for Acute Kidney Injury. <i>Kidney Int</i>
2012; 2: (Suppl): 1&#x2013;138.</Citation></Reference><Reference><Citation>Bramley P, McArthur K, Blayney A, McCullagh I. Risk factors for postoperative delirium: an umbrella review of systematic reviews. <i>Int J Surg</i>
2021; 93:106063.
</Citation><ArticleIdList><ArticleId IdType="pubmed">34411752</ArticleId></ArticleIdList></Reference><Reference><Citation>Travica N, Lotfaliany M, Marriott A, et al. Peri-operative risk factors associated with post-operative cognitive dysfunction (POCD): an umbrella review of meta-analyses of observational studies. <i>J Clin Med</i>
2023; 12:1610.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9965885</ArticleId><ArticleId IdType="pubmed">36836145</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Zanden V, Beishuizen SJ, Swart LM, et al. The effect of treatment of anemia with blood transfusion on delirium: a systematic review. <i>J Am Geriatr Soc</i>
2017; 65:728&#x2013;737.
</Citation><ArticleIdList><ArticleId IdType="pubmed">28205243</ArticleId></ArticleIdList></Reference><Reference><Citation>Fadayomi AB, Ibala R, Bilotta F, et al. A systematic review and meta-analysis examining the impact of sleep disturbance on postoperative delirium. <i>Crit Care Med</i>
2018; 46:e1204&#x2013;e1212.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6274586</ArticleId><ArticleId IdType="pubmed">30222634</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin D, Huang X, Sun Y, et al. Perioperative sleep disorder: a review. <i>Front Med (Lausanne)</i>
2021; 8:640416.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8215143</ArticleId><ArticleId IdType="pubmed">34164409</ArticleId></ArticleIdList></Reference><Reference><Citation>Wibrow B, Martinez FE, Ford A, et al. Statistical analysis plan for the Prophylactic Melatonin for Delirium in Intensive Care (ProMEDIC): a randomised controlled trial. <i>Trials</i>
2021; 22:7.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7783704</ArticleId><ArticleId IdType="pubmed">33402209</ArticleId></ArticleIdList></Reference><Reference><Citation>Khaing K, Nair BR. Melatonin for delirium prevention in hospitalized patients: a systematic review and meta-analysis. <i>J Psychiatr Res</i>
2021; 133:181&#x2013;190.
</Citation><ArticleIdList><ArticleId IdType="pubmed">33348252</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatta K, Kishi Y, Wada K, et al. Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial. <i>JAMA Psychiatry</i>
2014; 71:397&#x2013;403.
</Citation><ArticleIdList><ArticleId IdType="pubmed">24554232</ArticleId></ArticleIdList></Reference><Reference><Citation>Rampes S, Ma K, Divecha YA, et al. Postoperative sleep disorders and their potential impacts on surgical outcomes. <i>J Biomed Res</i>
2019; 34:271&#x2013;280.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7386412</ArticleId><ArticleId IdType="pubmed">32519977</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado FS, Souza R, Poveda VB, Costa ALS. Nonpharmacological interventions to promote the sleep of patients after cardiac surgery: a systematic review. <i>Rev Lat Am Enfermagem</i>
2017; 25:e2926.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5599071</ArticleId><ArticleId IdType="pubmed">28902932</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim AS, Kowgier M, Yu L, et al. Sleep fragmentation and the risk of incident Alzheimer's disease and cognitive decline in older persons. <i>Sleep</i>
2013; 36:1027&#x2013;1032.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3669060</ArticleId><ArticleId IdType="pubmed">23814339</ArticleId></ArticleIdList></Reference><Reference><Citation>Spira AP, Gamaldo AA, An Y, et al. Self-reported sleep and beta-amyloid deposition in community-dwelling older adults. <i>JAMA Neurol</i>
2013; 70:1537&#x2013;1543.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3918480</ArticleId><ArticleId IdType="pubmed">24145859</ArticleId></ArticleIdList></Reference><Reference><Citation>Dooijeweerd S, Torensma B, Faraj D, Eldawlatly AA. Incidence of postoperative delirium in patients with preoperative and postoperative obstructive sleep apnea syndrome. A systematic review of the literature. <i>Saudi J Anaesth</i>
2022; 16:94&#x2013;103.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8846253</ArticleId><ArticleId IdType="pubmed">35261596</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong JC, Crawford MR, Wallace DM. Sleep apnea and insomnia: emerging evidence for effective clinical management. <i>Chest</i>
2021; 159:2020&#x2013;2028.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129729</ArticleId><ArticleId IdType="pubmed">33309524</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Gara BP, Gao L, Marcantonio ER, Subramaniam B. Sleep, pain, and cognition: modifiable targets for optimal perioperative brain health. <i>Anesthesiology</i>
2021; 135:1132&#x2013;1152.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8578455</ArticleId><ArticleId IdType="pubmed">34731233</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans JL, Nadler JW, Preud&#x2019;homme XA, et al. Pilot prospective study of postsurgery sleep and EEG predictors of postoperative delirium. <i>Clin Neurophysiol</i>
2017; 128:1421&#x2013;1425.
</Citation><ArticleIdList><ArticleId IdType="pubmed">28618293</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35014001</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1496-8975</ISSN><JournalIssue CitedMedium="Internet"><Volume>69</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Canadian journal of anaesthesia = Journal canadien d'anesthesie</Title><ISOAbbreviation>Can J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Morbidity and mortality in patients managed with high compared with low blood pressure targets during on-pump cardiac surgery: a systematic review and meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>374</StartPage><EndPage>386</EndPage><MedlinePgn>374-386</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12630-021-02171-3</ELocationID><Abstract><AbstractText Label="PURPOSE">Many believe that blood pressure management during cardiac surgery is associated with postoperative outcomes. We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) to determine the impact of high compared with low intraoperative blood pressure targets on postoperative morbidity and mortality in adults undergoing cardiac surgery on cardiopulmonary bypass (CPB). Our primary objective was to inform the design of a future large RCT.</AbstractText><AbstractText Label="SOURCE">We searched MEDLINE, EMBASE, Web of Science, CINAHL, and CENTRAL for RCTs comparing high with low intraoperative blood pressure targets in adult patients undergoing any cardiac surgical procedure on CPB. We screened reference lists, grey literature, and conference proceedings.</AbstractText><AbstractText Label="PRINCIPAL FINDINGS">We included eight RCTs (N =1,116 participants); all examined the effect of blood pressure management only during the CPB. Trial definitions of high compared with low blood pressure varied and, in some, there was a discrepancy between the target and achieved mean arterial pressure. We observed no difference in delirium, cognitive decline, stroke, acute kidney injury, or mortality between high and low blood pressure targets (very-low to low quality evidence). Higher blood pressure targets may have increased the risk of requiring a blood transfusion (three trials; n = 456 participants; relative risk, 1.4; 95% confidence interval, 1.1 to 1.9; P = 0.01; moderate quality evidence) but this finding was based on a small number of trials.</AbstractText><AbstractText Label="CONCLUSION">Individual trial definitions of high and low blood pressure targets varied, limiting inferences. The effect of high (compared with low) blood pressure targets on other morbidity and mortality after cardiac surgery remains unclear because of limitations with the body of existing evidence. Research to determine the optimal management of blood pressure during cardiac surgery is required.</AbstractText><AbstractText Label="STUDY REGISTRATION">PROSPERO (CRD42020177376); registered: 5 July 2020.</AbstractText><CopyrightInformation>&#xa9; 2022. Canadian Anesthesiologists' Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McEwen</LastName><ForeName>Charlotte C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Surgery (Cardiac Surgery), McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amir</LastName><ForeName>Takhliq</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Jack</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Health Sciences Library, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kennedy</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evaluation, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grocott</LastName><ForeName>Hilary P</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kashani</LastName><ForeName>Hessam</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazer</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brudney</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Critical Care) and Anesthesia and Perioperative Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kavosh</LastName><ForeName>Morvarid</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobsohn</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Critical Care) and Anesthesia and Perioperative Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vedel</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Anesthesiology, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Eugene</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitlock</LastName><ForeName>Richard P</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>Departments of Surgery (Cardiac Surgery) and Health Research Methods, Evaluation, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Perioperative Research Division, Population Health Research Institute, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belley-Cot&#xe9;</LastName><ForeName>Emilie P</ForeName><Initials>EP</Initials><AffiliationInfo><Affiliation>Perioperative Research Division, Population Health Research Institute, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Medicine (Cardiology and Critical Care) and Health Research Methods, Evaluation, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spence</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1267-9455</Identifier><AffiliationInfo><Affiliation>Perioperative Research Division, Population Health Research Institute, Hamilton, ON, Canada. jessicaspence13@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Anesthesia and Critical Care and Health Research Methods, Evaluation, and Impact, McMaster University, Hamilton, ON, Canada. jessicaspence13@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><VernacularTitle>Morbidit&#xe9; et mortalit&#xe9; des patients pris en charge avec des cibles &#xe9;lev&#xe9;es ou basses de pression art&#xe9;rielle pendant la chirurgie cardiaque sous circulation extracorporelle&#xa0;: une revue syst&#xe9;matique et une m&#xe9;ta-analyse d&#x2019;&#xe9;tudes randomis&#xe9;es contr&#xf4;l&#xe9;es.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Can J Anaesth</MedlineTA><NlmUniqueID>8701709</NlmUniqueID><ISSNLinking>0832-610X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Can J Anaesth. 2022 Jun;69(6):799-800. doi: 10.1007/s12630-022-02205-4.</RefSource><PMID Version="1">35165836</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="N">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009017" MajorTopicYN="N">Morbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="fre"><AbstractText Label="UNLABELLED">R&#xe9;SUM&#xe9;: OBJECTIF: Pour beaucoup, la prise en charge de la pression art&#xe9;rielle pendant la chirurgie cardiaque serait associ&#xe9;e aux issues postop&#xe9;ratoires. Nous avons r&#xe9;alis&#xe9; une revue syst&#xe9;matique et une m&#xe9;ta-analyse d&#x2019;&#xe9;tudes randomis&#xe9;es contr&#xf4;l&#xe9;es (ERC) afin de d&#xe9;terminer l&#x2019;impact de cibles perop&#xe9;ratoires de pression art&#xe9;rielle &#xe9;lev&#xe9;es par rapport &#xe0; des cibles basses sur la morbidit&#xe9; et la mortalit&#xe9; postop&#xe9;ratoires d&#x2019;adultes b&#xe9;n&#xe9;ficiant d&#x2019;une chirurgie cardiaque sous circulation extracorporelle (CEC). Notre objectif principal &#xe9;tait d&#x2019;orienter la conception d&#x2019;une future ERC d&#x2019;envergure.</AbstractText><AbstractText Label="SOURCES" NlmCategory="METHODS">Nous avons analys&#xe9; les bases de donn&#xe9;es MEDLINE, EMBASE, Web of Science, CINAHL et CENTRAL afin d&#x2019;en tirer les ERC comparant des cibles de pression art&#xe9;rielle perop&#xe9;ratoire &#xe9;lev&#xe9;es &#xe0; des cibles basses chez des patients adultes b&#xe9;n&#xe9;ficiant d&#x2019;une intervention chirurgicale cardiaque sous CEC. Nous avons pass&#xe9; au crible les listes de r&#xe9;f&#xe9;rences, la litt&#xe9;rature grise et les travaux de congr&#xe8;s.</AbstractText><AbstractText Label="CONSTATATIONS PRINCIPALES" NlmCategory="UNASSIGNED">Nous avons inclus huit ERC (N = 1116 participants); toutes les &#xe9;tudes ont examin&#xe9; l&#x2019;effet de la prise en charge de la pression art&#xe9;rielle uniquement pendant la CEC. Les d&#xe9;finitions d&#x2019;une pression art&#xe9;rielle &#xe9;lev&#xe9;e ou basse variaient d&#x2019;une &#xe9;tude &#xe0; l&#x2019;autre et, dans certains cas, un &#xe9;cart a &#xe9;t&#xe9; not&#xe9; entre la pression art&#xe9;rielle cible et la pression art&#xe9;rielle moyenne atteinte. Nous n&#x2019;avons observ&#xe9; aucune diff&#xe9;rence dans les taux de delirium, de d&#xe9;clin cognitif, d&#x2019;accident vasculaire c&#xe9;r&#xe9;bral, d&#x2019;insuffisance r&#xe9;nale aigu&#xeb; ou de mortalit&#xe9; entre les cibles de pression art&#xe9;rielle &#xe9;lev&#xe9;e et basse (donn&#xe9;es probantes de qualit&#xe9; tr&#xe8;s faible &#xe0; faible). Des cibles de pression art&#xe9;rielle plus &#xe9;lev&#xe9;es pourraient avoir augment&#xe9; le risque de transfusion sanguine (trois &#xe9;tudes; n = 456 participants; risque relatif, 1,4; intervalle de confiance &#xe0; 95 %, 1,1 &#xe0; 1,9; P = 0,01; donn&#xe9;es probantes de qualit&#xe9; mod&#xe9;r&#xe9;e), mais ce r&#xe9;sultat se fondait sur un petit nombre d&#x2019;&#xe9;tudes.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Les d&#xe9;finitions individuelles des cibles d&#x2019;hypertension et d&#x2019;hypotension art&#xe9;rielle variaient, ce qui a limit&#xe9; les inf&#xe9;rences. L&#x2019;effet de cibles de pression art&#xe9;rielle &#xe9;lev&#xe9;e (par rapport &#xe0; une pression art&#xe9;rielle basse) sur d&#x2019;autres mesures de la morbidit&#xe9; et de la mortalit&#xe9; apr&#xe8;s une chirurgie cardiaque demeure incertain en raison des limites de l&#x2019;ensemble des donn&#xe9;es probantes existantes. Des recherches visant &#xe0; d&#xe9;terminer la prise en charge optimale de la pression art&#xe9;rielle pendant la chirurgie cardiaque sont n&#xe9;cessaires. ENREGISTREMENT DE L&#x2019;&#xe9;TUDE: PROSPERO (CRD42020177376); enregistr&#xe9;e le 5 juillet 2020.</AbstractText><CopyrightInformation>&#xa9; 2022. Canadian Anesthesiologists' Society.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Blood pressure targets</Keyword><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">Morbidity and mortality</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>59</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35014001</ArticleId><ArticleId IdType="doi">10.1007/s12630-021-02171-3</ArticleId><ArticleId IdType="pii">10.1007/s12630-021-02171-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Murphy GS, Hessel EA 2<sup>nd</sup>, Groom RC. Optimal perfusion during cardiopulmonary bypass: an evidence-based approach. Anesth Analg 2009; 108: 1394-417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0b013e3181875e2e</ArticleId><ArticleId IdType="pubmed">19372313</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono M, Brady K, Easley RB, et al. Duration and magnitude of blood pressure below cerebral autoregulation threshold during cardiopulmonary bypass is associated with major morbidity and operative mortality. J Thorac Cardiovasc Surg 2014; 147: 483-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2013.07.069</ArticleId><ArticleId IdType="pubmed">24075467</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudiger A, Begdeda H, Babic D, et al. Intra-operative events during cardiac surgery are risk factors for the development of delirium in the ICU. Crit Care 2016; DOI: https://doi.org/10.1186/s13054-016-1445-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1445-8</ArticleId><ArticleId IdType="pubmed">27716402</ArticleId><ArticleId IdType="pmc">5084342</ArticleId></ArticleIdList></Reference><Reference><Citation>Siepe M, Pfeiffer T, Gieringer A, et al. Increased systemic perfusion pressure during cardiopulmonary bypass is associated with less early postoperative cognitive dysfunction and delirium. Eur J Cardiothorac Surg 2011; 40: 200-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2010.11.024</ArticleId><ArticleId IdType="pubmed">21168339</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold JP, Charlson ME, Williams-Russo P, et al. Improvement of outcomes after coronary artery bypass. A randomized trial comparing intraoperative high versus low mean arterial pressure. J Thorac Cardiovasc Surg 1995; 110: 1302-11.</Citation></Reference><Reference><Citation>Vedel AG, Holmgaard F, Rasmussen LS, et al. High-target versus low-target blood pressure management during cardiopulmonary bypass to prevent cerebral injury in cardiac surgery patients: a randomized controlled trial. Circulation 2018; 137: 1770-80.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.117.030308</ArticleId><ArticleId IdType="pubmed">29339351</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronson S, Stafford-Smith M, Phillips-Bute B, et al. Intraoperative systolic blood pressure variability predicts 30-day mortality in aortocoronary bypass surgery patients. Anesthesiology 2010; 113: 305-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3181e07ee9</ArticleId><ArticleId IdType="pubmed">20571360</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Peterson JC, Krieger KH, et al. Improvement of outcomes after coronary artery bypass II: a randomized trial comparing intraoperative high versus customized mean arterial pressure. J Card Surg 2007; 22: 465-72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8191.2007.00471.x</ArticleId><ArticleId IdType="pubmed">18039205</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Akiyoshi K, Nakano M, et al. Determining thresholds for three indices of autoregulation to identify the lower limit of autoregulation during cardiac surgery. Crit Care Med 2021; 49: 650-60.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004737</ArticleId><ArticleId IdType="pubmed">33278074</ArticleId><ArticleId IdType="pmc">7979429</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thomas J, Chandler J, et al. Cochrane Handbook for Systematic Reviews of Interventions&#xa0;version 6.2&#xa0;(updated February&#xa0;2021). Cochrane, 2021. Available from URL: www.training.cochrane.org/handbook (accessed November 2021).</Citation></Reference><Reference><Citation>Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015; DOI: https://doi.org/10.1186/2046-4053-4-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-4-1</ArticleId><ArticleId IdType="pubmed">26693720</ArticleId><ArticleId IdType="pmc">4688988</ArticleId></ArticleIdList></Reference><Reference><Citation>Veritas Health Innovation. Covidence Systematic Review Software. Melbourne, Australia. Available from ULR: www.covidence.org (accessed November 2021).</Citation></Reference><Reference><Citation>Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; DOI: https://doi.org/10.1136/bmj.d5928 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pubmed">22096256</ArticleId><ArticleId IdType="pmc">3196245</ArticleId></ArticleIdList></Reference><Reference><Citation>The Cochrane Collaboration. Review Manager (RevMan). Computer Program, Version 5.4. 2020.</Citation></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 2014; DOI: https://doi.org/10.1186/1471-2288-14-135 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-135</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId><ArticleId IdType="pmc">4383202</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(86)90046-2</ArticleId><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>IntHout J, Ioannidis JP, Borm GF. The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method. BMC Med Res Methodol 2014; DOI: https://doi.org/10.1186/1471-2288-14-25 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-25</ArticleId><ArticleId IdType="pubmed">24548571</ArticleId><ArticleId IdType="pmc">4015721</ArticleId></ArticleIdList></Reference><Reference><Citation>Deeks JJ, Higgins JP, Altman DG; Cochrane Statistical Methods Group. Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, et al. (Eds). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from URL: training.cochrane.org/handbook (accessed November 2021).</Citation></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId><ArticleId IdType="pmc">2335261</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirvinskas E, Benetis R, Raliene L, Andrejaitiene J. The influence of mean arterial blood pressure during cardiopulmonary bypass on postoperative renal dysfunction in elderly patients. Perfusion 2012; 27: 193-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0267659112436751</ArticleId><ArticleId IdType="pubmed">22337760</ArticleId></ArticleIdList></Reference><Reference><Citation>Urzua J, Troncoso S, Bugedo G, et al. Renal function and cardiopulmonary bypass: effect of perfusion pressure. J Cardiothorac Vasc Anesth 1992; 6: 299-303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/1053-0770(92)90144-V</ArticleId><ArticleId IdType="pubmed">1610995</ArticleId></ArticleIdList></Reference><Reference><Citation>Azau A, Markowicz P, Corbeau JJ, et al. Increasing mean arterial pressure during cardiac surgery does not reduce the rate of postoperative acute kidney injury. Perfusion 2014; 29: 496-504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0267659114527331</ArticleId><ArticleId IdType="pubmed">24619062</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagheri K, Motamedi O, Aghavoudi O, Akbari M. The effects of mean arterial pressure during cardiopulmonary bypass on clinical and paraclinical parameters during and after coronary artery bypass graft surgery. J Isfahan Med Sch 2012; 29: 1-10.</Citation></Reference><Reference><Citation>Kandler K, Nilsson JC, Oturai P, et al. Higher arterial pressure during cardiopulmonary bypass may not reduce the risk of acute kidney injury. J Cardiothorac Surg 2019; DOI: https://doi.org/10.1186/s13019-019-0929-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13019-019-0929-4</ArticleId><ArticleId IdType="pubmed">31196131</ArticleId><ArticleId IdType="pmc">6567467</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen MH, Draegert C, Vedel AG, et al. Long-term survival and cognitive function according to blood pressure management during cardiac surgery. A follow-up. Acta Anaesthesiol Scand 2020; 64: 936-44.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.13595</ArticleId><ArticleId IdType="pubmed">32270483</ArticleId></ArticleIdList></Reference><Reference><Citation>Reich DL, Bodian CA, Krol M, Kuroda M, Osinski T, Thys DM. Intraoperative hemodynamic predictors of mortality, stroke, and myocardial infarction after coronary artery bypass surgery. Anesth Analg 1999; 89: 814-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/00000539-199910000-00002</ArticleId><ArticleId IdType="pubmed">10512249</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown CH 4<sup>th</sup>, Neufeld KJ, Tian J, et al. Effect of targeting mean arterial pressure during cardiopulmonary bypass by monitoring cerebral autoregulation on postsurgical delirium among older patients: a nested randomized clinical trial. JAMA Surg 2019; 154: 819-26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2019.1163</ArticleId><ArticleId IdType="pubmed">31116358</ArticleId><ArticleId IdType="pmc">6537779</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogue CW, Brown CH 4<sup>th</sup>, Hori D, et al. Personalized blood pressure management during cardiac surgery with cerebral autoregulation monitoring: a randomized trial. Semin Thorac Cardiovasc Surg 2021; 33: 429-38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semtcvs.2020.09.032</ArticleId><ArticleId IdType="pubmed">33186735</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijnberge M, Schenk J, Bulle E, et al. Association of intraoperative hypotension with postoperative morbidity and mortality: systematic review and meta-analysis. BJS Open 2021; DOI: https://doi.org/10.1093/bjsopen/zraa018 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bjsopen/zraa018</ArticleId><ArticleId IdType="pubmed">33609377</ArticleId><ArticleId IdType="pmc">7893468</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamontagne F, Day AG, Meade MO, et al. Pooled analysis of higher versus lower blood pressure targets for vasopressor therapy septic and vasodilatory shock. Intensive Care Med 2018; 44: 12-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-5016-5</ArticleId><ArticleId IdType="pubmed">29260272</ArticleId></ArticleIdList></Reference><Reference><Citation>Sessler DI, Bloomstone JA, Aronson S, et al. Perioperative Quality Initiative consensus statement on intraoperative blood pressure, risk and outcomes for elective surgery. Br J Anaesth 2019; 122: 563-74.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2019.01.013</ArticleId><ArticleId IdType="pubmed">30916004</ArticleId></ArticleIdList></Reference><Reference><Citation>Authors/Task Force Members; Kunst G, Milojevic M, et al. 2019 EACTS/EACTA/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery. Br J Anaesth 2019; 123: 713-57.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30857599</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>122</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>Apr</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Vasoactive-inotropic score and the prediction of morbidity and mortality after cardiac surgery.</ArticleTitle><Pagination><StartPage>428</StartPage><EndPage>436</EndPage><MedlinePgn>428-436</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2018.12.019</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(18)31389-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The vasoactive-inotropic score (VIS) predicts mortality and morbidity after paediatric cardiac surgery. Here we examined whether VIS also predicted outcome in adults after cardiac surgery, and compared predictive capability between VIS and three widely used scoring systems.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This single-centre retrospective cohort study included 3213 cardiac surgery patients. Maximal VIS (VIS<sub>max</sub>) was calculated using the highest doses of vasoactive and inotropic medications administered during the first 24 h post-surgery. We established five VIS<sub>max</sub> categories: 0-5, &gt;5-15, &gt;15-30, &gt;30-45, and &gt;45 points. The predictive accuracy of VIS<sub>max</sub> was evaluated for a composite outcome, which included 30-day mortality, mediastinitis, stroke, acute kidney injury, and myocardial infarction.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">VIS<sub>max</sub> showed good prediction accuracy for the composite outcome [area under the curve (AUC), 0.72; 95% confidence interval (CI), 0.69-0.75]. The incidence of the composite outcome was 9.6% overall and 43% in the highest VIS<sub>max</sub> group (&gt;45). VIS<sub>max</sub> predicted 30-day mortality (AUC, 0.76; 95% CI, 0.69-0.83) and 1-yr mortality (AUC, 0.70; 95% CI, 0.65-0.74). Prediction accuracy for unfavourable outcome was significantly better with VIS<sub>max</sub> than with Acute Physiology and Chronic Health Evaluation II (P=0.01) and Simplified Acute Physiological Score II (P=0.048), but not with the Sequential Organ Failure Assessment score (P=0.32).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In adults after cardiac surgery, VIS<sub>max</sub> predicted a composite of unfavourable outcomes and predicted mortality up to 1 yr after surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Koponen</LastName><ForeName>Timo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Kuopio University Hospital, Kuopio, Finland; Department of Anaesthesia and Intensive Care, North Karelia Central Hospital, Joensuu, Finland. Electronic address: timo.koponen@siunsote.fi.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karttunen</LastName><ForeName>Johanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Kuopio University Hospital, Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Musialowicz</LastName><ForeName>Tadeusz</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Kuopio University Hospital, Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pietil&#xe4;inen</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Kuopio University Hospital, Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uusaro</LastName><ForeName>Ari</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Kuopio University Hospital, Kuopio, Finland; School of Medicine, University of Eastern Finland, Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lahtinen</LastName><ForeName>Pasi</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Kuopio University Hospital, Kuopio, Finland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002316">Cardiotonic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D018806" MajorTopicYN="N">APACHE</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002316" MajorTopicYN="N">Cardiotonic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005387" MajorTopicYN="N" Type="Geographic">Finland</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011182" MajorTopicYN="N">Postoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="N">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">cardiovascular system</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">myocardial infarction</Keyword><Keyword MajorTopicYN="N">postoperative outcome</Keyword><Keyword MajorTopicYN="N">risk assessment scoring system</Keyword><Keyword MajorTopicYN="N">stroke</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>11</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>2</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30857599</ArticleId><ArticleId IdType="pmc">PMC6435836</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2018.12.019</ArticleId><ArticleId IdType="pii">S0007-0912(18)31389-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chang C.H., Chen S., Fan P.C. Sequential organ failure assessment score predicts mortality after coronary artery bypass grafting. BMC Surg. 2017;17:22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5339985</ArticleId><ArticleId IdType="pubmed">28264675</ArticleId></ArticleIdList></Reference><Reference><Citation>Doerr F., Badreldin A., Heldwein M.B. A&#xa0;comparative study of four intensive care outcome prediction models in cardiac surgery patients. J&#xa0;Cardiothorac Surg. 2011;6:21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3058022</ArticleId><ArticleId IdType="pubmed">21362175</ArticleId></ArticleIdList></Reference><Reference><Citation>Doerr F., Badreldin A., Can F., Bayer O., Wahlers T., Hekmat K. SAPS 3 is not superior to SAPS 2 in cardiac surgery patients. Scand Cardiovasc J. 2014;48:111&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pubmed">24645642</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent J.L., Moreno R., Takala J. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Aorking Group on Sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707&#x2013;710.</Citation><ArticleIdList><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II: a severity disease classification system. Crit Care Med. 1985;13:818&#x2013;829.</Citation><ArticleIdList><ArticleId IdType="pubmed">3928249</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez J., Tuesta I.D., Plasencia E., Santana M., Mora M.L. Mortality prediction in cardiac surgery patients: comparative performance of Parsonnet and general severity systems. Circulation. 1999;99:2378&#x2013;2382.</Citation><ArticleIdList><ArticleId IdType="pubmed">10318657</ArticleId></ArticleIdList></Reference><Reference><Citation>Nashef S.A.M., Roques F., Sharples L.D. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41:734&#x2013;744.</Citation><ArticleIdList><ArticleId IdType="pubmed">22378855</ArticleId></ArticleIdList></Reference><Reference><Citation>Doerr F., Heldwein M.B., Bayer O. Combination of European System for Cardiac Operative Risk Evaluation (EuroSCORE) and Cardiac Surgery Score (CASUS) to improve outcome prediction in cardiac surgery. Med Sci Monit Basic Res. 2015;21:172&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4559007</ArticleId><ArticleId IdType="pubmed">26279053</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouchoukos N.T., Ebert P.A., Grover F.L., Lindesmith G.G. Report of the Ad Hoc Committee on risk factors for coronary artery bypass surgery. Ann Thorac Surg. 1988;45:348&#x2013;349.</Citation><ArticleIdList><ArticleId IdType="pubmed">3258149</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Agostino R.S., Jacobs J.P., Badhwar V. The society of thoracic surgeons adult cardiac surgery database: 2017 update on outcomes and quality. Ann Thorac Surg. 2017;103:18&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">27884412</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsonnet V., Dean D., Bernstein A.D. A&#xa0;method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation. 1989;79:I3&#x2013;I12.</Citation><ArticleIdList><ArticleId IdType="pubmed">2720942</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynne-Jones K., Jackson M., Grotte G. Limitations of the Parsonnet score for measuring risk stratified mortality in the north west of England. Heart. 2000;84:71&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1729412</ArticleId><ArticleId IdType="pubmed">10862595</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaies M.G., Gurney J.G., Yen A.H. Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass. Pediatr Crit Care Med. 2010;11:234&#x2013;238.</Citation><ArticleIdList><ArticleId IdType="pubmed">19794327</ArticleId></ArticleIdList></Reference><Reference><Citation>Wernovsky G., Wypij D., Jonas R.A. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation. 1995;92:2226&#x2013;2235.</Citation><ArticleIdList><ArticleId IdType="pubmed">7554206</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaies M.G., Jeffries H.E., Niebler R.A. Vasoactive-inotropic score is associated with outcome after infant cardiac surgery: an analysis from the pediatric cardiac critical care consortium and virtual PICU System Registries. Pediatr Crit Care Med. 2014;15:529&#x2013;537.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4159673</ArticleId><ArticleId IdType="pubmed">24777300</ArticleId></ArticleIdList></Reference><Reference><Citation>Favia I., Vitale V., Ricci Z. The vasoactive-inotropic score and levosimendan: time for VIS? J&#xa0;Cardiothorac Vasc Anesth. 2013;27:15&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">23507021</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson J., Tong S., Hancock H., Hauck A., da Cruz E., Kaufman J. Prospective validation of the vasoactive-inotropic score and correlation to short-term outcomes in neonates and infants after cardiothoracic surgery. Intensive Care Med. 2012;38:1184&#x2013;1190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4984395</ArticleId><ArticleId IdType="pubmed">22527067</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia R.U., Walters H.L., Delius R.E., Aggarwal S. Vasoactive inotropic score (VIS) as biomarker of short-term outcomes in adolescents after cardiothoracic surgery. Pediatr Cardiol. 2016;37:271&#x2013;277.</Citation><ArticleIdList><ArticleId IdType="pubmed">26424215</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntosh A.M., Tong S., Deakyne S.J., Davidson J.A., Scott H.F. Validation of the vasoactive-inotropic score in pediatric sepsis. Pediatr Crit Care Med. 2017;18:750&#x2013;757.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5548505</ArticleId><ArticleId IdType="pubmed">28486385</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Omar Y., Kocher G.J., Bosco P. European Association for Cardio-Thoracic Surgery expert consensus statement on the prevention and management of mediastinitis. Eur J Cardiothorac Surg. 2017;51:10&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">28077503</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Gu C., Gao M. Comparison of the incidence of postoperative neurologic complications after on-pump versus off-pump coronary artery bypass grafting in high-risk patients: a meta-analysis of 11 studies. Int J Cardiol. 2015;185:195&#x2013;197.</Citation><ArticleIdList><ArticleId IdType="pubmed">25797677</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryhammer P.K., Tang M., Hoffmann-Petersen J. Colloids in cardiac surgery-friend or foe? J&#xa0;Cardiothorac Vasc Anesth. 2017;31:1639&#x2013;1648.</Citation><ArticleIdList><ArticleId IdType="pubmed">28372955</ArticleId></ArticleIdList></Reference><Reference><Citation>White H. Avatar of the universal definition of periprocedural myocardial infarction. J&#xa0;Am Coll Cardiol. 2013;62:1571&#x2013;1574.</Citation><ArticleIdList><ArticleId IdType="pubmed">24135582</ArticleId></ArticleIdList></Reference><Reference><Citation>Lahtinen P., Pitk&#xe4;nen O., P&#xf6;l&#xf6;nen P., Turpeinen A., Kiviniemi V., Uusaro A. Levosimendan reduces heart failure after cardiac surgery: a prospective, randomized, placebo-controlled trial. Crit Care Med. 2011;39:2263&#x2013;2270.</Citation><ArticleIdList><ArticleId IdType="pubmed">21666445</ArticleId></ArticleIdList></Reference><Reference><Citation>Ettema R.G., Peelen L.M., Kalkman C.J., Nierich A.P., Moons K.M., Schuurmans M.J. Predicting prolonged intensive care unit stays in older cardiac surgery patients: a validation study. Intensive Care Med. 2010;37:1480&#x2013;1487.</Citation><ArticleIdList><ArticleId IdType="pubmed">21805158</ArticleId></ArticleIdList></Reference><Reference><Citation>DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837&#x2013;845.</Citation><ArticleIdList><ArticleId IdType="pubmed">3203132</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahin J., deVarennes B., Tse C.W., Amarica D.A., Dial S. The relationship between inotrope exposure, six-hour postoperative physiological variables, hospital mortality and renal dysfunction in patients undergoing cardiac surgery. Crit Care. 2011;15:R162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3387599</ArticleId><ArticleId IdType="pubmed">21736726</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen D.V., Hansen M.K., Johnsen S.P., Hansen M., Hindsholm K., Jakobsen C.J. Health outcomes with and without use of inotropic therapy in cardiac surgery: results of a propensity score-matched analysis. Anesthesiology. 2014;120:1098&#x2013;1108.</Citation><ArticleIdList><ArticleId IdType="pubmed">24614322</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams J.B., Hernandez A.F., Li S. Postoperative inotrope and vasopressor use following CABG: outcome data from the CAPS-care study. J&#xa0;Card Surg. 2011;26:572&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3677728</ArticleId><ArticleId IdType="pubmed">21951076</ArticleId></ArticleIdList></Reference><Reference><Citation>Belletti A., Castro M.L., Silvetti S. The Effect of inotropes and vasopressors on mortality: a meta-analysis of randomized clinical trials. Br J Anaesth. 2015;115:656&#x2013;675.</Citation><ArticleIdList><ArticleId IdType="pubmed">26475799</ArticleId></ArticleIdList></Reference><Reference><Citation>Schumann J., Henrich E.C., Strobl H. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome. Cochrane Database Syst Rev. 2018;(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6491099</ArticleId><ArticleId IdType="pubmed">29376560</ArticleId></ArticleIdList></Reference><Reference><Citation>Doerr F., Badreldin A., Bender E. Outcome prediction in cardiac surgery: the first logistic scoring model for cardiac surgical intensive care patients. Minerva Anestesiol. 2012;78:879&#x2013;886.</Citation><ArticleIdList><ArticleId IdType="pubmed">22475805</ArticleId></ArticleIdList></Reference><Reference><Citation>Hekmat K., Doerr F., Kroener A. Prediction of mortality in intensive care unit cardiac surgical patients. Eur J Cardiothorac Surg. 2010;38:104&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pubmed">20219387</ArticleId></ArticleIdList></Reference><Reference><Citation>Siregar S., Groenwold R.H., de Mol B.A. Evaluation of cardiac surgery mortality rates: 30-day mortality or longer follow-up? Eur J Cardiothorac Surg. 2013;44:875&#x2013;883.</Citation><ArticleIdList><ArticleId IdType="pubmed">23471150</ArticleId></ArticleIdList></Reference><Reference><Citation>Crow S.S., Robinson J.A., Bukhart H.M., Dearani J.A., Golden A.W. Duration and magnitude of vasopressor support predicts poor outcome after infant cardiac operations. Ann Thorac Surg. 2014;98:655&#x2013;661.</Citation><ArticleIdList><ArticleId IdType="pubmed">24906599</ArticleId></ArticleIdList></Reference><Reference><Citation>Bangalore H., Gaies M., Ocampo E.C. The Total Inotrope Exposure Score: an extension of the Vasoactive Inotrope Score as a predictor of adverse outcomes after paediatric cardiac surgery. Cardiol Young. 2017;27:1146&#x2013;1152.</Citation><ArticleIdList><ArticleId IdType="pubmed">28287056</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31804347</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>26</Day></DateCompleted><DateRevised><Year>2020</Year><Month>01</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>98</Volume><Issue>49</Issue><PubDate><Year>2019</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Perioperative outcomes in geriatric patients undergoing hip fracture surgery with different anesthesia techniques: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>e18220</StartPage><MedlinePgn>e18220</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e18220</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000018220</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Previous meta-analyses assessing anesthetic techniques in adult patients undergoing hip fractures surgery are available. However, whether the anesthetic technique is associated with risk of mortality and complications in geriatric patients with hip fractures remains unclear. This study was conducted to assess postoperative outcomes of anesthesia technique in geriatric patients undergoing hip fracture surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Cochrane Library, PubMed, EMBASE, MEDLINE, CNKI, and CBM were searched from inception up to May 25, 2018. Observational studies and randomized controlled trials (RCTs) that assessed the perioperative outcomes of technique of anesthesia (general or regional [epidural/spinal/neuraxial]) in geriatric patients (&#x2265;60 years old) undergoing hip fracture surgery were included. Two investigators independently screened studies for inclusion and performed data extraction. Heterogeneity was assessed by the I and Chi-square tests. The odds ratio (OR) of the dichotomous data, mean difference (MD) of continuous data, and 95% confidence intervals (CI) were calculated to assess the pooled data.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eleven retrospective and 2 RCTs were included. There was no difference in 30-day mortality (OR&#x200a;=&#x200a;0.96; 95% CI 0.86-1.08; P&#x200a;=&#x200a;.51) between the general and regional anesthesia groups. In-hospital mortality (OR&#x200a;=&#x200a;1.26; 95% CI 1.17-1.36; P&#x200a;&lt;&#x200a;.001), acute respiratory failure (OR&#x200a;=&#x200a;2.66; 95% CI 2.34-3.02; P&#x200a;&lt;&#x200a;.001), length of hospital stay (MD&#x200a;=&#x200a;0.33; 95% CI 0.24-0.42; P&#x200a;&lt;&#x200a;.001), and readmission (OR&#x200a;=&#x200a;1.09; 95% CI 1.01-1.18; P&#x200a;=&#x200a;.03) were significantly reduced in the regional anesthesia group. Pneumonia (OR&#x200a;=&#x200a;0.99; 95% CI 0.91-1.07; P&#x200a;=&#x200a;.79), heart failure (OR&#x200a;=&#x200a;0.97; 95% CI 0.86-1.09; P&#x200a;=&#x200a;.62), acute myocardial infraction (OR&#x200a;=&#x200a;1.07; 95% CI 0.99-1.16; P&#x200a;=&#x200a;.10), acute renal failure (OR&#x200a;=&#x200a;1.32; 95% CI 0.97-1.79; P&#x200a;=&#x200a;.07), cerebrovascular accident (OR&#x200a;=&#x200a;1.08; 95% CI 0.82-1.42; P&#x200a;=&#x200a;.58), postoperative delirium (OR&#x200a;=&#x200a;1.51; 95% CI 0.16-13.97; P&#x200a;=&#x200a;.72), and deep vein thrombosis/pulmonary embolism (OR&#x200a;=&#x200a;1.42; 95% CI 0.84-2.38; P&#x200a;=&#x200a;.19) were similar between the two anesthetic techniques.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">General anesthesia is associated with increased risk of in-hospital mortality, acute respiratory failure, longer hospital stays, and higher readmission. There is evidence to suggest that regional anesthesia is associated with improved perioperative outcomes. Large RCTs are needed to explore the most optimal anesthetic techniques for geriatric patients with hip fractures before drawing final conclusions.</AbstractText><AbstractText Label="PROSPERO REGISTRATION NUMBER" NlmCategory="UNASSIGNED">CRD42018093582.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Dong Xu</ForeName><Initials>DX</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital, Sichuan University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital, Sichuan University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital, Sichuan University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shi Yue</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital, Sichuan University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Ya Na</ForeName><Initials>YN</Initials><AffiliationInfo><Affiliation>Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital, Sichuan University.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="N">Hip Fractures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>12</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31804347</ArticleId><ArticleId IdType="pmc">PMC6919429</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000018220</ArticleId><ArticleId IdType="pii">00005792-201912060-00046</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int 1997;5:407&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">9425497</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes WC, Myers ER, Robinovitch SN, et al. Etiology and prevention of age-related hip fractures. Bone 1996;18:77&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">8717551</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtis EM, van der Velde R, Moon RJ, et al. Epidemiology of fractures in the United Kingdom 1988-2012: variation with age, sex, geography, ethnicity and socioeconomic status. Bone 2016;87:19&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4890652</ArticleId><ArticleId IdType="pubmed">26968752</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Waesberghe J, Stevanovic A, Rossaint R, et al. General vs. neuraxial anaesthesia in hip fracture patients: a systematic review and meta-analysis. BMC Anesthesiol 2017;17:1&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5490182</ArticleId><ArticleId IdType="pubmed">28659127</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Donnell CM, McLoughlin L, Patterson CC, et al. Perioperative outcomes in the context of mode of anaesthesia for patients undergoing hip fracture surgery: systematic review and meta-analysis. Br J Anaesth 2018;120:37&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">29397135</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths R, Alper J, Beckingsale A, et al. Management of proximal femoral fractures 2011: association of anaesthetists of Great Britain and Ireland. Anaesthesia 2012;67:85&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">22150501</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen A, Boulton C, Hertz K, et al. The National Hip Fracture Database (NHFD) &#x2013; using a national clinical audit to raise standards of nursing care. Int J Orthop Trauma Nurs 2017;26:3&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">28237620</ArticleId></ArticleIdList></Reference><Reference><Citation>Brauer CA, Coca-Perraillon M, Cutler DM, et al. Incidence and mortality of hip fractures in the United States. JAMA 2009;302:1573&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4410861</ArticleId><ArticleId IdType="pubmed">19826027</ArticleId></ArticleIdList></Reference><Reference><Citation>Seitz DP, Gill SS, Bell CM, et al. Postoperative medical complications associated with anesthesia in older adults with dementia. J Am Geriatr Soc 2014;62:2102&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">25370019</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai V, Chan PH, Prentice HA, et al. Is anesthesia technique associated with a higher risk of mortality or complications within 90 days of surgery for geriatric patients with hip fractures? Clin Orthop Relat Res 2018;476:1178&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6263607</ArticleId><ArticleId IdType="pubmed">29601378</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvani R, Martone AM, Marzetti E, et al. Pre-hospital dietary intake correlates with muscle mass at the time of fracture in older hip fractured patients. Front Aging Neurosci 2014;6:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4236534</ArticleId><ArticleId IdType="pubmed">25477815</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Rosenbaum PR, Ludwig JM, et al. Anesthesia technique, mortality, and length of stay after hip fracture surgery. JAMA 2014;24:2508&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4344128</ArticleId><ArticleId IdType="pubmed">25058085</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker MJ, Griffiths R. General versus regional anaesthesia for hip fractures. A pilot randomised controlled trial of 322 patients. Injury 2015;46:1562&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">26049662</ArticleId></ArticleIdList></Reference><Reference><Citation>Luger TJ, Kammerlander C, Gosch M, et al. Neuroaxial versus general anaesthesia in geriatric patients for hip fracture surgery: does it matter? Osteoporos Int 2010;21:555&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">21057995</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Hara DA, Duff A, Berlin JA, et al. The effect of anesthetic technique on postoperative outcomes in hip fracture repair. Anesthesiology 2000;92:947&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">10754613</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson RL, Kopp SL, Burkle CM, et al. Neuraxial vs general anaesthesia for total hip and total knee arthroplasty: a systematic review of comparative-effectiveness research. Br J Anaesth 2016;116:163&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">26787787</ArticleId></ArticleIdList></Reference><Reference><Citation>White SM, Moppett IK, Griffiths R. Outcome by mode of anaesthesia for hip fracture surgery. An observational audit of 65 535 patients in a national dataset. Anaesthesia 2014;69:224&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">24428375</ArticleId></ArticleIdList></Reference><Reference><Citation>White SM, Altermatt F, Barry J, et al. International fragility fracture network delphi consensus statement on the principles of anaesthesia for patients with hip fracture. Anaesthesia 2018;73:863&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">29508382</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015;4:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. BMJ 2009;339:b2700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2714672</ArticleId><ArticleId IdType="pubmed">19622552</ArticleId></ArticleIdList></Reference><Reference><Citation> Wells GA, Shea B, O&#x2019;Connell D, et al. The Newcastle&#x2013;Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses. Available at:  http://wwwohrica/programs/clinicalepidemiology/oxfordasp. [Accessed May 5, 2012]</Citation></Reference><Reference><Citation>Higgins JP, Altman DG, G&#xf8;tzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Hekimo&#x11f;lu &#x15e;S, Heybeli N, &#xc7;olak A, et al. Comparison of different anesthetic techniques on postoperative outcomes in elderly patients with hip fracture. Turkiye Klin J Med Sci 2012;32:623&#x2013;9.</Citation></Reference><Reference><Citation>Biboulet P, Jourdan A, Van Haevre V, et al. Hemodynamic profile of target-controlled spinal anesthesia compared with 2 target-controlled general anesthesia techniques in elderly patients with cardiac comorbidities. Reg Anesth Pain Med 2012;37:433&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">22609644</ArticleId></ArticleIdList></Reference><Reference><Citation>Le-Wendling L, Bihorac A, Baslanti TO, et al. Regional anesthesia as compared with general anesthesia for surgery in geriatric patients with hip fracture: does it decrease morbidity, mortality, and health care costs? Results of a single-centered study. Pain Med 2012;13:948&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3730262</ArticleId><ArticleId IdType="pubmed">22758782</ArticleId></ArticleIdList></Reference><Reference><Citation>Basques BA, Bohl DD, Golinvaux NS, et al. General versus spinal anaesthesia for patients aged 70 years and older with a fracture of the hip. Bone Jt J 2015;97-B:689&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">25922465</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu CC, Weng SF, Chen KT, et al. Propensity score &#x2013; matched comparison of postoperative adverse outcomes between geriatric patients given a general or a neuraxial anesthetic for hip surgery: a population-based study. Anesthesiology 2015;123:136&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">25955981</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu C, Chan PH, Zohman GL, et al. Impact of anesthesia on hospital mortality and morbidities in geriatric patients following emergency hip fracture surgery. J Orthop Trauma 2018;32:116&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">29461445</ArticleId></ArticleIdList></Reference><Reference><Citation>Casati A, Aldegheri G, Vinciguerra E, et al. Randomized comparison between sevoflurane anaesthesia and unilateral spinal anaesthesia in elderly patients undergoing orthopaedic surgery. Eur J Anaesthesiol 2003;20:640&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">12932066</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda T, Imai S, Nakadera M, et al. Postoperative daily living activities of geriatric patients administered general or spinal anesthesia for hip fracture surgery: a retrospective cohort study. J Orthop Surg (Hong Kong) 2018;26:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29366390</ArticleId></ArticleIdList></Reference><Reference><Citation>Radcliff TA, Henderson WG, Stoner TJ, et al. Patient risk factors, operative care, and outcomes among older community-dwelling male veterans with hip fracture. J Bone Joint Surg Am 2008;90:34&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">18171955</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih YJ, Hsieh CH, Kang TW, et al. General versus spinal anesthesia: which is a risk factor for octogenarian hip fracture repair patients? Int J Gerontol 2010;4:37&#x2013;42.</Citation></Reference><Reference><Citation>Guay J, Parker MJ, Gajendragadkar PR, et al. Anaesthesia for hip fracture surgery in adults. Cochrane Database Syst Rev 2016;2:CD000521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6464323</ArticleId><ArticleId IdType="pubmed">26899415</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Silber JH, Elkassabany NM, et al. Comparative effectiveness of regional versus general anesthesia for hip fracture surgery in adults. Anesthesiology 2012;117:72&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">22713634</ArticleId></ArticleIdList></Reference><Reference><Citation>Sieber FE, Gottshalk A, Zakriya KJ, et al. General anesthesia occurs frequently in elderly patients during propofol-based sedation and spinal anesthesia. J Clin Anesth 2010;22:179&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">20400003</ArticleId></ArticleIdList></Reference><Reference><Citation>Memtsoudis SG, Poeran J, Zubizarreta N, et al. Do hospitals performing frequent neuraxial anesthesia for hip and knee replacements have better outcomes? Anesthesiology 2018;129:428&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">29878899</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak JC, Cameron ID, March LM. Evidence-based guidelines for the management of hip fractures in older persons: an update. Med J Aust 2010;192:37&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">20047547</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowark A, Adam C, Ahrens J, et al. Improve hip fracture outcome in the elderly patient (iHOPE): a study protocol for a pragmatic, multicentre randomised controlled trial to test the efficacy of spinal versus general anaesthesia. BMJ Open 2018;8:e023609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6196806</ArticleId><ArticleId IdType="pubmed">30341135</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">17276098</PMID><DateCompleted><Year>2007</Year><Month>06</Month><Day>20</Day></DateCompleted><DateRevised><Year>2014</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1078-5884</ISSN><JournalIssue CitedMedium="Print"><Volume>33</Volume><Issue>5</Issue><PubDate><Year>2007</Year><Month>May</Month></PubDate></JournalIssue><Title>European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery</Title><ISOAbbreviation>Eur J Vasc Endovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Acute renal injury and dysfunction following elective abdominal aortic surgery.</ArticleTitle><Pagination><StartPage>550</StartPage><EndPage>555</EndPage><MedlinePgn>550-5</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To evaluate the incidence of kidney injury and acute renal dysfunction (ARD) and associated risk factors in open abdominal aortic surgery.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">69 patients undergoing elective infrarenal aortic repair were included in a prospective study. Anaesthesia and haemodynamic management were standardised targeting a mean arterial pressure (MAP) of 70-90 mmHg, pulmonary artery occlusion pressure of 12-14 mmHg and cardiac index &gt;or=2.4 l/min/m(2). Urinary albumin-creatinine and N-acetyl-B-D-glucosaminidase-creatinine ratios were measured as indicators of kidney injury. The definition of ARD was based on the RIFLE criteria.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Kidney injury was found in most patients. ARD developed in 22% of the patients, and acute renal failure in 4%. The patients with ARD were older, and had lower plasma creatinine and estimated GFR before surgery. ARD was associated with intraoperative hypotension (MAP &lt;60 mmHg &gt;15 min), low cardiac index (&lt;2.4 l/min/m(2)), rhabdomyolysis, and early reoperation. Intraoperative hypotension and postoperative low cardiac output were independent risk factors for ARD in multivariate analysis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Kidney injury occurs in most patients undergoing infrarenal aortic surgery, but only 22% develop acute renal dysfunction. Hypotension and low cardiac output are risk factors that could be avoided by optimizing perioperative management.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tallgren</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care Medicine, Helsinki University Hospital, Helsinki, Finland. minna.tallgren@hus.fi</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niemi</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>P&#xf6;yhi&#xe4;</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Raininko</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Railo</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Salmenper&#xe4;</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Lep&#xe4;ntalo</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Hynninen</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2007</Year><Month>02</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Vasc Endovasc Surg</MedlineTA><NlmUniqueID>9512728</NlmUniqueID><ISSNLinking>1078-5884</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.1.52</RegistryNumber><NameOfSubstance UI="D000118">Acetylglucosaminidase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000118" MajorTopicYN="N">Acetylglucosaminidase</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000419" MajorTopicYN="N">Albuminuria</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017544" MajorTopicYN="N">Aortic Aneurysm, Abdominal</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002303" MajorTopicYN="N">Cardiac Output, Low</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005919" MajorTopicYN="N">Glomerular Filtration Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014656" MajorTopicYN="N">Vascular Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2006</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2006</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>2</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>6</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>2</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17276098</ArticleId><ArticleId IdType="doi">10.1016/j.ejvs.2006.12.005</ArticleId><ArticleId IdType="pii">S1078-5884(06)00738-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39147607</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>17</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>The Effects of Corticosteroids on Survival in Pediatric and Nonelderly Adult Patients Undergoing Cardiac Surgery: A Meta-analysis of Randomized Studies.</ArticleTitle><Pagination><StartPage>2783</StartPage><EndPage>2791</EndPage><MedlinePgn>2783-2791</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2024.07.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(24)00438-5</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Cardiac surgery can be complicated by the development of a systemic inflammatory response syndrome related to cardiopulmonary bypass. This potentially contributes to the occurrence of postoperative morbidity and mortality. Corticosteroids can be used to reduce such inflammation, but the overall balance between potential harm and benefit is unknown and may be age-dependent. The present meta-analysis aims to evaluate the effects of prophylactic corticosteroids in pediatric and non-elderly adult cardiac surgery patients.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Systematic review and meta-analysis of randomized trials.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Cardiac surgery with cardiopulmonary bypass.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Patients younger than 65 years old (pediatric and non-elderly adults).</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Perioperative use of corticosteroids versus placebo or standard care.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">Two independent investigators searched PubMed, EMBASE and the Cochrane Library from inception to January 20, 2024. The primary outcome was mortality at the longest follow-up available. Secondary outcomes included acute kidney injury, atrial fibrillation, myocardial injury, cerebrovascular events, and infections. Our search strategy identified a total of 17 randomized trials involving 6,598 patients. Mortality was significantly reduced in the corticosteroid group (78/3321 [2.3%] vs. 116/3277 [3.5%]; risk ratio = 0.69; 95% confidence interval, 0.52 to 0.92; P = 0.01; I2 = 0%; NNT = 91). Moreover, the highest postoperative vasoactive inotropic score (VIS) was significantly lower in corticosteroid group (MD: -2.07, 95% CI -3.69 to -0.45, P = 0.01, I2 = 0%). No significant differences in secondary outcomes between the two treatment groups were recorded.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This meta-analysis of randomized trials highlights the potential benefits of corticosteroids on survival in cardiac surgery for patients younger than 65 years old.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Losiggio</LastName><ForeName>Rosario</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lomivorotov</LastName><ForeName>Vladimir</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Penn State College of Medicine, Penn State Milton S. Hershey Medical Centre, Hershey, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Andria Ursoleo</LastName><ForeName>Jacopo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotani</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Kameda Medical Centre, Kamogawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monaco</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milojevic</LastName><ForeName>Milan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Erasmus University Medical Centre, Rotterdam, Netherlands; Department of Cardiac Surgery and Cardiovascular Research, Dedinje Cardiovascular Institute, Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yavorovskiy</LastName><ForeName>Andrey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, I.M. Sechenov First Moscow State Medical University of the Russian Ministry of Health, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Todd C</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy; School of Medicine, Vita-Salute San Raffaele University, Milan, Italy. Electronic address: landoni.giovanni@hsr.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Steroids Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="Y">Adrenal Cortex Hormones</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="N">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anesthesia</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">corticosteroids</Keyword><Keyword MajorTopicYN="N">glucocorticoids</Keyword><Keyword MajorTopicYN="N">steroids</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Oriani</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department. of Anesthesia and Intensive Care, IRCCS San Raffaele&#x2009;Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Prima</LastName><ForeName>Ambra Licia Di</ForeName><Initials>ALD</Initials><AffiliationInfo><Affiliation>Department. of Anesthesia and Intensive Care, IRCCS San Raffaele&#x2009;Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mucchetti</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department. of Anesthesia and Intensive Care, IRCCS San Raffaele&#x2009;Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ortalda</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department. of Anesthesia and Intensive Care, IRCCS San Raffaele&#x2009;Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Calabr&#xf2;</LastName><ForeName>Maria Grazia</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department. of Anesthesia and Intensive Care, IRCCS San Raffaele&#x2009;Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zangrillo</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department. of Anesthesia and Intensive Care, IRCCS San Raffaele&#x2009;Scientific Institute, Milan, Italy; School of Medicine, Vita-Salute San Raffaele.&#x2009;University, Milan, Italy.</Affiliation></AffiliationInfo></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>16</Day><Hour>1</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>15</Day><Hour>21</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39147607</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2024.07.001</ArticleId><ArticleId IdType="pii">S1053-0770(24)00438-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">26700609</PMID><DateCompleted><Year>2016</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8615</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of critical care</Title><ISOAbbreviation>J Crit Care</ISOAbbreviation></Journal><ArticleTitle>Kinetic estimated glomerular filtration rate and acute kidney injury in cardiac surgery patients.</ArticleTitle><Pagination><StartPage>249</StartPage><EndPage>254</EndPage><MedlinePgn>249-54</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrc.2015.11.006</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0883-9441(15)00557-2</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To determine how a formula to estimate kinetically changing glomerular filtration rate (keGFR) relates to serum creatinine changes and to compare the discriminatory ability of keGFR to that of perioperative change in serum creatinine to predict acute kidney injury (AKI) and mortality.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Retrospective cohort study at a single-tertiary-care Midwestern university hospital of 4022 patients admitted to the intensive care unit between January 2006 and January 2012 immediately after cardiac surgery.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">Of 4022 patients, 1031 (25.6%) developed at least AKI stage 1 and 1106 (27.5%) developed AKI-min. Patients who developed AKI stage 1 or AKI-min had a greater decrease in keGFR, both by absolute amounts and by percentage. After adjusting for other factors with logistic regression, keGFR had good discrimination (c statistic = 0.787 and 0.749, respectively) in predicting AKI and operative mortality.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Despite no change in immediate perioperative serum creatinine levels, keGFR fell and this predicted subsequent AKI. Using keGFR enables identification of patients who, despite unchanged postoperative creatinine, incur clinically significant kidney injury based on reduction in GFR and increased mortality.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Seelhammer</LastName><ForeName>Troy G</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>Anesthesiology &amp; Critical Care, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maile</LastName><ForeName>Michael D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>University of Michigan, Ann Arbor, MI.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heung</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Anesthesiology &amp; Critical Care, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haft</LastName><ForeName>Jonathan W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>University of Michigan, Ann Arbor, MI.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jewell</LastName><ForeName>Elizabeth S</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>University of Michigan, Ann Arbor, MI.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Engoren</LastName><ForeName>Milo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Michigan, Ann Arbor, MI. Electronic address: engorenm@med.umich.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>11</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Crit Care</MedlineTA><NlmUniqueID>8610642</NlmUniqueID><ISSNLinking>0883-9441</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="N">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005919" MajorTopicYN="Y">Glomerular Filtration Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006785" MajorTopicYN="N">Hospitals, University</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007677" MajorTopicYN="N">Kidney Function Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062606" MajorTopicYN="N">Tertiary Care Centers</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Creatinine clearance</Keyword><Keyword MajorTopicYN="N">Glomerular filtration rate</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Prediction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>11</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26700609</ArticleId><ArticleId IdType="doi">10.1016/j.jcrc.2015.11.006</ArticleId><ArticleId IdType="pii">S0883-9441(15)00557-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36345680</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8191</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>12</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of cardiac surgery</Title><ISOAbbreviation>J Card Surg</ISOAbbreviation></Journal><ArticleTitle>Furosemide does not reduce the incidence of postoperative acute kidney injury in adult patients undergoing cardiac surgery: A PRISMA-compliant systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>4850</StartPage><EndPage>4860</EndPage><MedlinePgn>4850-4860</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jocs.17120</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Acute kidney injury (AKI) is a common complication of cardiac surgical patients, the occurrence of which is multifactorial. Furosemide is the most common loop diuretic and widely used in cardiac surgery to reduce fluid overload, increase tubular flow and urine output. It remains unknown whether furosemide affects the incidence or prognosis of cardiac surgery-induced acute kidney injury (CS-AKI). Therefore, the current study was performed to address this question.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed, Embase, Scopus, Cochrane Library, and Web of Science databases were searched for relevant studies. Primary outcomes of interest included postoperative CS-AKI incidence, need for renal replacement therapy (RRT) rate. Secondary outcomes of interest included postoperative serum creatinine (Scr) and blood urea nitrogen (BUN) levels, postoperative mechanical ventilation duration (MVD), length of stay (LOS) in intensive care unit (ICU) and in hospital, and mortality. The odds ratio (OR) and/or the weighted mean difference (WMD) with 95% confidence interval (CI) were used to pool the data.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Database search yielded six studies including 566 adult patients, and 283 patients were allocated into Group Furosemide and 283 into Group Control (Placebo). Heterogeneity between studies was deemed acceptable, and the publication bias was low. Meta-analysis suggested that furosemide administration in adult cardiac surgical patients had no effect on CS-AKI incidence (n&#x2009;=&#x2009;4 trials; OR&#x2009;=&#x2009;0.92; 95% CI: 0.37-2.30; p&#x2009;=&#x2009;.86; I<sup>2</sup> &#x2009;=&#x2009;57%) and need for RRT rate (n&#x2009;=&#x2009;2 trials; OR&#x2009;=&#x2009;4.13; 95% CI: 0.44-38.51; p&#x2009;=&#x2009;.21; I<sup>2</sup> &#x2009;=&#x2009;0%). Diversely, furosemide administration in adult cardiac surgical patients significantly decreased postoperative BUN level (n&#x2009;=&#x2009;3 trials; WMD&#x2009;=&#x2009;0.71; 95% CI: 0.10-1.33; p&#x2009;=&#x2009;.02; I<sup>2</sup> &#x2009;=&#x2009;0%), postoperative MVD (n&#x2009;=&#x2009;2 trials; WMD&#x2009;=&#x2009;-3.13; 95% CI: -3.78 to -2.49; p&#x2009;&lt;&#x2009;.00001; I<sup>2</sup> &#x2009;=&#x2009;0%) and postoperative LOS in ICU (n&#x2009;=&#x2009;3 trials; WMD&#x2009;=&#x2009;-0.47; 95% CI:&#xa0;-0.76 to -0.18; p&#x2009;=&#x2009;.001; I<sup>2</sup> &#x2009;=&#x2009;0%). However, it had no significant impact on postoperative Scr level, postoperative LOS in hospital, and postoperative mortality.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This meta-analysis suggested that furosemide administration in adult cardiac surgical patients had no significant effect on CS-AKI incidence, need for RRT rate, postoperative Scr level, LOS in hospital and mortality, but could reduce postoperative BUN level, MVD, and LOS in ICU. As only a limited number of studies were included, these results should be interpreted carefully and cautiously. Future high-quality randomized controlled trials are needed to define the role of furosemide in CS-AKI prevention and management.</AbstractText><CopyrightInformation>&#xa9; 2022 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Chun-Mei</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0001-8821-3198</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Fuwai Yunnan Cardiovascular Hospital, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Yun-Tai</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Ke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Fuwai Yunnan Cardiovascular Hospital, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Meng-Qi</ForeName><Initials>MQ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Fuwai Yunnan Cardiovascular Hospital, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Li-Xian</ForeName><Initials>LX</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Fuwai Yunnan Cardiovascular Hospital, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Fuwai Yunnan Cardiovascular Hospital, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Evidence in Cardiovascular Anesthesia (EICA) Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>CAMS Innovation Fund for Medical Sciences (CIFMS)-2021-I2M-C&amp;T-B-038</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Card Surg</MedlineTA><NlmUniqueID>8908809</NlmUniqueID><ISSNLinking>0886-0440</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>7LXU5N7ZO5</RegistryNumber><NameOfSubstance UI="D005665">Furosemide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005665" MajorTopicYN="N">Furosemide</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="N">Renal Replacement Therapy</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute renal injury</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">furosemide</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>8</Day><Hour>3</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36345680</ArticleId><ArticleId IdType="doi">10.1111/jocs.17120</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Hobson CE, Yavas S, Segal MS, et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation. 2009;119(18):2444-2453.</Citation></Reference><Reference><Citation>Mao H, Katz N, Ariyanon W, et al. Cardiac surgery-associated acute kidney injury. Cardiorenal Med. 2013;3(3):178-199.</Citation></Reference><Reference><Citation>Ortega-Loubon C, Fern&#xe1;ndez-Molina M, Carrascal-Hinojal Y, Fulquet-Carreras E. Cardiac surgery-associated acute kidney injury. Ann Card Anaesth. 2016;19(4):687-698.</Citation></Reference><Reference><Citation>Massoudy P, Wagner S, Thielmann M, et al. Coronary artery bypass surgery and acute kidney injury-impact of the off-pump technique. Nephrol Dial Transplant. 2008;23(9):2853-2860.</Citation></Reference><Reference><Citation>Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006;1(1):19-32.</Citation></Reference><Reference><Citation>Shaw A. Update on acute kidney injury after cardiac surgery. J Thorac Cardiovasc Surg. 2012;143(3):676-681.</Citation></Reference><Reference><Citation>Bagshaw SM, Delaney A, Jones D, Ronco C, Bellomo R. Diuretics in the management of acute kidney injury: a multinational survey. Contrib Nephrol. 2007;156:236-249.</Citation></Reference><Reference><Citation>Aravindan N, Shaw A. Effect of furosemide infusion on renal hemodynamics and angiogenesis gene expression in acute renal ischemia/reperfusion. Ren Fail. 2006;28(1):25-35.</Citation></Reference><Reference><Citation>Aravindan N, Aravindan S, Riedel BJ, Weng HR, Shaw AD. Furosemide prevents apoptosis and associated gene expression in a rat model of surgical ischemic acute renal failure. Ren Fail. 2007;29(4):399-407.</Citation></Reference><Reference><Citation>Mehta RL. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA. 2002;288(20):2547-2553.</Citation></Reference><Reference><Citation>Uchino S, Doig GS, Bellomo R, et al. Diuretics and mortality in acute renal failure. Crit Care Med. 2004;32(8):1669-1677.</Citation></Reference><Reference><Citation>Kunt AT, Akg&#xfc;n S, Atalan N, Bitir N, Arsan S. Furosemide infusion prevents the requirement of renal replacement therapy after cardiac surgery. Anatol&#xa0;J&#xa0;Cardiol. 2009;9(6):499-504.</Citation></Reference><Reference><Citation>Fakhari S, Mirzaei Bavil F, Bilehjani E, Abolhasani S, Mirinazhad M, Naghipour B. Prophylactic furosemide infusion decreasing early major postoperative renal dysfunction in on-pump adult cardiac surgery: a randomized clinical trial. Res Rep Urol. 2017;9:5-13.</Citation></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179-c184.</Citation></Reference><Reference><Citation>Silbert BI, Ho KM, Lipman J, et al. Does furosemide increase oxidative stress in acute kidney injury? Antioxid Redox Signal. 2017;26(5):221-226.</Citation></Reference><Reference><Citation>Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol. 2000;11(1):97-104.</Citation></Reference><Reference><Citation>Zheng H, Liu L, Fan G, Liu Z, Wang Z, Chang B. Preoperative use of furosemide May increase the incidence of acute kidney injury after coronary artery bypass grafting: a propensity score-matched study. Gen Thorac Cardiovasc Surg. 2021;69(10):1392-1399.</Citation></Reference><Reference><Citation>Winther-Olesen M, M&#xf8;ller MH, Johansen KK, Aasvang EK. Effects of post-operative furosemide in adult surgical patients: a systematic review and meta-analysis of randomised clinical trials. Acta Anaesthesiol Scand. 2020;64(3):282-291.</Citation></Reference><Reference><Citation>Page MJ, Moher D. Evaluations of the uptake and impact of the preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and extensions: a scoping review. Syst Rev. 2017;6(1):263.</Citation></Reference><Reference><Citation>Higgins JPT, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.</Citation></Reference><Reference><Citation>Luo X, Jiang L, Du B, Wen Y, Wang M, Xi X. Beijing acute kidney injury trial: a comparison of different diagnostic criteria of acute kidney injury in critically ill patients. Crit Care. 2014;18(4):R144.</Citation></Reference><Reference><Citation>Cumpston M, Li T, Page MJ, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019;10:ED000142.</Citation></Reference><Reference><Citation>Lassnigg A. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004;15(6):1597-1605.</Citation></Reference><Reference><Citation>Luckraz H, Giri R, Wrigley B, et al. Reduction in acute kidney injury post cardiac surgery using balanced forced diuresis: a randomized, controlled trial. Eur J Cardiothorac Surg. 2021;59(3):562-569.</Citation></Reference><Reference><Citation>Choudhury M, Narula J, Saini K, Kapoor PM, Kiran U. Does intraoperative diuretic therapy affect the thoracic fluid content and clinical outcome in patients undergoing mitral valve surgery? J Cardiac Crit Care TSS. 2020;4(02):86-90.</Citation></Reference><Reference><Citation>Bayat F, Faritous Z, Aghdaei N, Dabbagh A. A study of the efficacy of furosemide as a prophylaxis of acute renal failure in coronary artery bypass grafting patients: a clinical trial. ARYA Atheroscler. 2015;11(3):173-178.</Citation></Reference><Reference><Citation>Mahesh B, Yim B, Robson D, Pillai R, Ratnatunga C, Pigott D. Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial. Eur J Cardiothorac Surg. 2008;33(3):370-376.</Citation></Reference><Reference><Citation>Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute dialysis quality initiative - acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204-R212.</Citation></Reference><Reference><Citation>Wang Y, Bellomo R. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nature Reviews Nephrology. 2017;13(11):697-711.</Citation></Reference><Reference><Citation>Joannidis M, Druml W, Forni LG, et al. Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017: expert opinion of the -Working Group on Prevention, AKI section, European Society of Intensive Care Medicine. Intensive Care Med. 2017;43(6):730-749.</Citation></Reference><Reference><Citation>Kellum JA, Lameire N. Group KAGW Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013;17(1):204.</Citation></Reference><Reference><Citation>Ichai C, Vinsonneau C, Souweine B, et al. Acute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies). Ann Intensive Care. 2016;6(1):48.</Citation></Reference><Reference><Citation>Ho KM. Meta-analysis of frusemide to prevent or treat acute renal failure. BMJ. 2006;333(7565):420.</Citation></Reference><Reference><Citation>Krzych &#x141;J, Czempik PF. Impact of furosemide on mortality and the requirement for renal replacement therapy in acute kidney injury: a systematic review and meta-analysis of randomised trials. Ann Intensive Care. 2019;9(1):85.</Citation></Reference><Reference><Citation>Perner A, Prowle J, Joannidis M, Young P, Hjortrup PB, Pettil&#xe4; V. Fluid management in acute kidney injury. Intensive Care Med. 2017;43(6):807-815.</Citation></Reference><Reference><Citation>Prowle JR, Kirwan CJ, Bellomo R. Fluid management for the prevention and attenuation of acute kidney injury. Nature Reviews Nephrology. 2014;10(1):37-47.</Citation></Reference><Reference><Citation>Mitter N, Shah A, Yuh D, et al. Renal injury is associated with operative mortality after cardiac surgery for women and men. J Thorac Cardiovasc Surg. 2010;140(6):1367-1373.</Citation></Reference><Reference><Citation>Wen J, Cheng Q, Zhao J, et al. Hospital-acquired acute kidney injury in Chinese very elderly persons. J Nephrol. 2013;26(3):572-579.</Citation></Reference><Reference><Citation>Coleman MD, Shaefi S, Sladen RN. Preventing acute kidney injury after cardiac surgery. Curr Opin Anaesthesiol. 2011;24(1):70-76.</Citation></Reference><Reference><Citation>Haase M, Bellomo R, Story D, et al. Effect of mean arterial pressure, haemoglobin and blood transfusion during cardiopulmonary bypass on post-operative acute kidney injury. Nephrol Dial Transplant. 2012;27(1):153-160.</Citation></Reference><Reference><Citation>Cheungpasitporn W, Thongprayoon C, Kittanamongkolchai W, et al. Comparison of renal outcomes in off-pump versus on-pump coronary artery bypass grafting: a systematic review and meta-analysis of randomized controlled trials. Nephrology. 2015;20(10):727-735.</Citation></Reference><Reference><Citation>Khan UA, Coca SG, Hong K, et al. Blood transfusions are associated with urinary biomarkers of kidney injury in cardiac surgery. J Thorac Cardiovasc Surg. 2014;148(2):726-732.</Citation></Reference><Reference><Citation>Zarbock A, Milles K. Novel therapy for renal protection. Curr Opin Anaesthesiol. 2015;28(4):431-438.</Citation></Reference><Reference><Citation>Greco T, Zangrillo A, Biondi-Zoccai G, Landoni G. Meta-analysis: pitfalls and hints. Heart Lung Vessel. 2013;5(4):219-225.</Citation></Reference><Reference><Citation>Frieden TR. Evidence for health decision making - beyond randomized, controlled trials. N Engl J Med. 2017;377(5):465-475.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35736797</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>04</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8674</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Surgical infections</Title><ISOAbbreviation>Surg Infect (Larchmt)</ISOAbbreviation></Journal><ArticleTitle>Kidney Injury in Critically Ill Patients Treated with Vancomycin and Zosyn or an Alternative: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>516</StartPage><EndPage>524</EndPage><MedlinePgn>516-524</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/sur.2022.128</ELocationID><Abstract><AbstractText><b><i>Background:</i></b> Zosyn<sup>&#xae;</sup> (piperacillin-tazobactam; Pfizer Medical, New York, NY), a valuable antibiotic against gram-negative bacteria, combined with vancomycin (Z+V) is known for its high incidence of acute kidney injury (AKI), particularly in the intensive care unit (ICU), leading to the frequent use of alternatives for gram-negative coverage (Alt+V). Because there are limited data describing AKI on these alternative antibiotic agents, a systematic review and meta-analysis was conducted to determine if these regimens were indeed associated with decreased rates of AKI. <b><i>Patients and Methods:</i></b> A literature review was performed electronically from its inception to November 1, 2018, screening for relevant literature by title, abstract and full text according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines within the following databases: PubMed/Medline, CINAHL, Scopus, and Cochrane Central Register of Controlled Trials. Studies were included if they contained adults who had been admitted to the ICU for treatment and had received a combination of intravenous Z&#x2009;+&#x2009;V or Alt+V as well as had AKI measured during administration of these antibiotic agents. Studies were excluded if they represented pediatric populations, did not receive care in an ICU during their hospital admission, only received monotherapy for antibiotic treatment or received antibiotic treatment for less than 48 hours. Independent extraction was performed by two reviewers. Risk of bias was assessed using the Risk of Bias in Non-randomised Studies of Interventions (ROBINS-I) methodology for retrospective studies. Random-effects models were used to calculate any differences between rates of AKI after Z&#x2009;+&#x2009;V or Alt&#x2009;+&#x2009;V. <b><i>Results:</i></b> Fourteen articles (totaling 30,399 patients) were included. All studies available were retrospective in design. Compared with Alt&#x2009;+&#x2009;V, Z&#x2009;+&#x2009;V was associated with a higher risk ratio of AKI (1.79; 95% confidence interval [CI], 1.46-2.19; p&#x2009;&lt;&#x2009;0.001). Cefepime (C&#x2009;+&#x2009;V) was the most common alternative to Zosyn, and Z&#x2009;+&#x2009;V was associated with higher rates of kidney injury compared with C&#x2009;+&#x2009;V (1.70; 95% CI, 1.36-2.12; p&#x2009;&lt;&#x2009;0.00001). However, there was substantial heterogeneity in the data collected as well as high risk of bias. <b><i>Conclusions:</i></b> Zosyn plus vancomycin is associated with more risk of AKI compared with Alt+V coverage in ICU adult populations. However, the conclusions were limited by the retrospective nature of the studies, high bias of included articles, and heterogeneity of the included studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Blears</LastName><ForeName>Elizabeth E</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>University of Texas-Medical Branch, Galveston, Texas, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shriners Hospital for Children, Galveston, Texas, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Allegheny Health Network, Pittsburgh, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Texas-Medical Branch, Galveston, Texas, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shriners Hospital for Children, Galveston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Popp</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of Texas-Medical Branch, Galveston, Texas, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shriners Hospital for Children, Galveston, Texas, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Hand, Plastic and Reconstructive Surgery, Department of Surgery, Medical University of Graz, Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jong O</ForeName><Initials>JO</Initials><AffiliationInfo><Affiliation>University of Texas-Medical Branch, Galveston, Texas, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shriners Hospital for Children, Galveston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norbury</LastName><ForeName>William B</ForeName><Initials>WB</Initials><AffiliationInfo><Affiliation>University of Texas-Medical Branch, Galveston, Texas, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shriners Hospital for Children, Galveston, Texas, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Surg Infect (Larchmt)</MedlineTA><NlmUniqueID>9815642</NlmUniqueID><ISSNLinking>1096-2964</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>157044-21-8</RegistryNumber><NameOfSubstance UI="D000077725">Piperacillin, Tazobactam Drug Combination</NameOfSubstance></Chemical><Chemical><RegistryNumber>6Q205EH1VU</RegistryNumber><NameOfSubstance UI="D014640">Vancomycin</NameOfSubstance></Chemical><Chemical><RegistryNumber>X00B0D5O0E</RegistryNumber><NameOfSubstance UI="D010878">Piperacillin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010878" MajorTopicYN="N">Piperacillin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077725" MajorTopicYN="N">Piperacillin, Tazobactam Drug Combination</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014640" MajorTopicYN="Y">Vancomycin</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute renal failure</Keyword><Keyword MajorTopicYN="N">intensive care</Keyword><Keyword MajorTopicYN="N">piperacillin-tazobactam</Keyword><Keyword MajorTopicYN="N">vancomycin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>23</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35736797</ArticleId><ArticleId IdType="doi">10.1089/sur.2022.128</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35532809</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1615-2573</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Heart and vessels</Title><ISOAbbreviation>Heart Vessels</ISOAbbreviation></Journal><ArticleTitle>The early and long-term outcomes of coronary artery bypass grafting added to aortic valve replacement compared to isolated aortic valve replacement in elderly patients: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1647</StartPage><EndPage>1661</EndPage><MedlinePgn>1647-1661</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00380-022-02073-4</ELocationID><Abstract><AbstractText>In aged population, the early and long-term outcomes of coronary revascularization (CABG) added to surgical aortic valve replacement (SAVR) compared to isolated SAVR (i-SAVR) are conflicting. To address this limitation, a meta-analysis comparing the early and late outcomes of SAVR plus CABG with i-SAVR was performed. Electronic databases from January 2000 to November 2021 were screened. Studies reporting early-term and long-term comparison between the two treatments in patients over 75&#xa0;years were analyzed. The primary endpoints were in-hospital/30-day mortality and overall long-term survival. The pooled odd ratio (OR) and hazard ratio (HR) with 95% confidence interval (CI) were calculated for in-early outcome and long-term survival, respectively. Random-effect model was used in all analyses. Forty-four retrospective observational studies reporting on 74,560 patients (i-SAVR&#x2009;=&#x2009;36,062; SAVR&#x2009;+&#x2009;CABG&#x2009;=&#x2009;38,498) were included for comparison. The pooled analysis revealed that i-SAVR was significantly associated with lower rate of early mortality compared to SAVR plus CABG (OR&#x2009;=&#x2009;0.70, 95% CI 0.66-0.75; p&#x2009;&lt;&#x2009;0.0001) and with lower incidence of postoperative acute renal failure (OR&#x2009;=&#x2009;0.65; 95% CI 0.50-0.91; p&#x2009;=&#x2009;0.02), need for dialysis (OR&#x2009;=&#x2009;0.65; 95% CI 0.50-0.86; p&#x2009;=&#x2009;0.002) and prolonged mechanical ventilation (OR&#x2009;=&#x2009;0.57; 95% CI 0.42-0.77; p&#x2009;&lt;&#x2009;0.0001). Twenty-two studies reported data of long-term follow-up. No differences were reported between the two groups in long-term survival (HR&#x2009;=&#x2009;0.95; 95% CI&#x2009; 0.87-1.03; p&#x2009;=&#x2009;0.23). CABG added to SAVR is associated with worse early outcomes in terms of early mortality, postoperative acute renal failure, and prolonged mechanical ventilation. Long-term survival was comparable between the two treatments.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>D'Alessandro</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiac Surgery Unit, San Gerardo Hospital, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tuttolomondo</LastName><ForeName>Domenico</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cardiology Unit, University Hospital of Parma, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Gurmeet</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine and Division of Cardiac Surgery, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hernandez-Vaquero</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cardiac Surgery Department, Hospital Universitario Central de Asturias, Oviedo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pattuzzi</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Cardiac Surgery Unit, University Hospital of Parma, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallingani</LastName><ForeName>Alan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiac Surgery Unit, University Hospital of Parma, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maestri</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Cardiac Surgery Unit, University Hospital of Parma, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicolini</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Cardiac Surgery Unit, University Hospital of Parma, Parma, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Parma, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Formica</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-3989-6134</Identifier><AffiliationInfo><Affiliation>Cardiac Surgery Unit, University Hospital of Parma, Parma, Italy. francescoformica.hs@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Parma, Parma, Italy. francescoformica.hs@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UOC Cardiochirurgia, Azienda Ospedaliera Universitaria di Parma, Via A. Gramsci, 14, 43126, Parma, Italy. francescoformica.hs@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Heart Vessels</MedlineTA><NlmUniqueID>8511258</NlmUniqueID><ISSNLinking>0910-8327</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001021" MajorTopicYN="N">Aortic Valve</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="Y">Aortic Valve Stenosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001026" MajorTopicYN="N">Coronary Artery Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019918" MajorTopicYN="Y">Heart Valve Prosthesis Implantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065467" MajorTopicYN="Y">Transcatheter Aortic Valve Replacement</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aortic valve replacement</Keyword><Keyword MajorTopicYN="N">Coronary artery bypass grafting</Keyword><Keyword MajorTopicYN="N">Elderly</Keyword><Keyword MajorTopicYN="N">Long-term outcomes</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword></KeywordList><CoiStatement>The authors declare that have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>9</Day><Hour>11</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35532809</ArticleId><ArticleId IdType="pmc">PMC9399049</ArticleId><ArticleId IdType="doi">10.1007/s00380-022-02073-4</ArticleId><ArticleId IdType="pii">10.1007/s00380-022-02073-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>https://appsso.eurostat.ec.europa.eu/nui/show.do?dataset=demo_pjan&amp;lang=en (21/11/2021)</Citation></Reference><Reference><Citation>https://www.jchs.harvard.edu/sites/default/files/jchs housing_americas_older_adults_2014-ch2_0.pdf. (21/11/2021)</Citation></Reference><Reference><Citation>Ortaman JM, Velkoff VA, Hogan H (2021) An aging nation: the older population in the United States. https://www.census.gov/library/publications/2014/demo/p25-1140.html. 21/11/2021</Citation></Reference><Reference><Citation>Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, Capodanno D, Conradi L, De Bonis M, De Paulis R, Delgado V, Freemantle N, Gilard M, Haugaa KH, Jeppsson A, J&#xfc;ni P, Pierard L, Prendergast BD, S&#xe1;daba JR, Tribouilloy C, Wojakowski W, ESC/EACTS Scientific Document Group; ESC Scientific Document Group ESC/EACTS guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg. 2021;60:727&#x2013;800. doi: 10.1093/ejcts/ezab389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezab389</ArticleId><ArticleId IdType="pubmed">34453161</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolaidis N, Pousios D, Haw MP, Kaarne M, Barlow CW, Livesey SA, Tsang GM, Ohri SK. Long-term outcomes in octogenarians following aortic valve replacement. J Card Surg. 2011;26:466&#x2013;471. doi: 10.1111/j.1540-8191.2011.01299.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8191.2011.01299.x</ArticleId><ArticleId IdType="pubmed">21951033</ArticleId></ArticleIdList></Reference><Reference><Citation>Litmathe J, Boeken U, Feindt P, Gams E. Concomitant CABG-procedures in elderly patients undergoing aortic valve replacement. An additional risk factor? Z Kardiol. 2003;92:947&#x2013;952. doi: 10.1007/s00392-003-0994-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-003-0994-4</ArticleId><ArticleId IdType="pubmed">14634764</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts WC, Ko JM, Filardo G, Kitchens BL, Henry AC, Hebeler RF, Jr, Cheung EH, Matter GJ, Hamman BL. Valve structure and survival in quadragenarians having aortic valve replacement for aortic stenosis (+/-aortic regurgitation) with versus without coronary artery bypass grafting at a single US medical center (1993 to 2005) Am J Cardiol. 2007;100:1683&#x2013;1690. doi: 10.1016/j.amjcard.2007.08.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2007.08.027</ArticleId><ArticleId IdType="pubmed">18036369</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris RS, Yan TD, Black D, Black D, Bannon PG, Bayfield MS, Hendel PN, Wilson MK, Vallely MP. Outcomes of surgical aortic valve replacement in octogenarians. Heart Lung Circ. 2013;22:618&#x2013;626. doi: 10.1016/j.hlc.2013.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2013.01.008</ArticleId><ArticleId IdType="pubmed">23422500</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo K, Shah P, Hiebert B, Love K, Menkis AH, Manji RA, Arora RC. Predictors of survival, functional survival, and hospital readmission in octogenarians after surgical aortic valve replacement. J Thorac Cardiovasc Surg. 2017;154:1544&#x2013;1553.e1. doi: 10.1016/j.jtcvs.2017.05.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2017.05.047</ArticleId><ArticleId IdType="pubmed">28673707</ArticleId></ArticleIdList></Reference><Reference><Citation>Formica F, Mariani S, D'Alessandro S, Singh G, Di Mauro M, Cerrito MG, Messina LA, Scianna S, Papesso F, Sangalli F. Does additional coronary artery bypass grafting to aortic valve replacement in elderly patients affect the early and long-term outcome? Heart Vessels. 2020;35:487&#x2013;501. doi: 10.1007/s00380-019-01519-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00380-019-01519-6</ArticleId><ArticleId IdType="pmc">PMC7222122</ArticleId><ArticleId IdType="pubmed">31642980</ArticleId></ArticleIdList></Reference><Reference><Citation>Folkmann S, Gorlitzer M, Weiss G, Harrer M, Thalmann M, Poslussny P, Grabenwoger M. Quality of life in octogenarians one year after aortic valve replacement with or without coronary artery bypass surgery. Interact Cardiovasc Thorac Surg. 2010;11:750&#x2013;753. doi: 10.1510/icvts.2010.240085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1510/icvts.2010.240085</ArticleId><ArticleId IdType="pubmed">20847067</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolh P, Kerzmann A, Honore C, Comte L, Limet R. Aortic valve surgery in octogenarians: predictive factors for operative and long-term results. Eur J Cardiothorac Surg. 2007;31:600&#x2013;606. doi: 10.1016/j.ejcts.2007.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2007.01.003</ArticleId><ArticleId IdType="pubmed">17307362</ArticleId></ArticleIdList></Reference><Reference><Citation>Likosky DS, Sorensen MJ, Dacey LJ, Baribeau YR, Leavitt BJ, Di Scipio AW, Hernandez Jr F, Cochran RP, Quinn R, Helm RE, Charlesworth DC, Clough RA, Malenka DJ, Sisto DA, Sardella G, Olmstead EM, Ross CS, O&#x2019;Connor GT, Northern New England Cardiovascular Disease Study Group Long-term survival of the very elderly undergoing aortic valve surgery. Circulation. 2009;120(11 Suppl):S127&#x2013;S133.</Citation><ArticleIdList><ArticleId IdType="pubmed">19752357</ArticleId></ArticleIdList></Reference><Reference><Citation>Langanay T, Fl&#xe9;cher E, Fouquet O, Ruggieri VG, De La Tour B, F&#xe9;lix C, Lelong B, Verhoye JP, Corbineau H, Leguerrier A. Aortic valve replacement in the elderly: the real life. Ann Thorac Surg. 2012;93:70&#x2013;77. doi: 10.1016/j.athoracsur.2011.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2011.07.033</ArticleId><ArticleId IdType="pubmed">21982149</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal S, Garg A, Parashar A, Svensson LG, Tuzcu EM, Navia JL, Mick S, Kapadia SR. In-hospital mortality and stroke after surgical aortic valve replacement: a nationwide perspective. J Thorac Cardiovasc Surg. 2015;150:571&#x2013;8.e8. doi: 10.1016/j.jtcvs.2015.05.068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2015.05.068</ArticleId><ArticleId IdType="pubmed">26183193</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimagli A, Sinha S, Caputo M, Angelini GD, Benedetto U. Trend in morbidity and mortality in surgical aortic valve re-placement: a retrospective, observational, single centre study. Interact Cardiovasc Thorac Surg. 2020;31:796&#x2013;802. doi: 10.1093/icvts/ivaa189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivaa189</ArticleId><ArticleId IdType="pmc">PMC7723024</ArticleId><ArticleId IdType="pubmed">33150396</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiappini B, Camurri N, Loforte A, Di Marco L, Di Bartolomeo R, Marinelli G. Outcome after aortic valve replacement in octogenarians. Ann Thorac Surg. 2004;78:85&#x2013;89. doi: 10.1016/j.athoracsur.2003.12.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2003.12.060</ArticleId><ArticleId IdType="pubmed">15223409</ArticleId></ArticleIdList></Reference><Reference><Citation>Dell'Amore A, Aquino TM, Pagliaro M, Lamarra M, Zussa C. Aortic valve replacement with and without combined coronary bypass grafts in very elderly patients: early and long-term results. Eur J Cardiothorac Surg. 2012;41:491&#x2013;498. doi: 10.1093/ejcts/ezr029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezr029</ArticleId><ArticleId IdType="pubmed">22345174</ArticleId></ArticleIdList></Reference><Reference><Citation>Krane M, Voss B, Hiebinger A, Deutsch MA, Wottke M, Hapfelmeier A, Badiu CC, Bauernschmitt R, Lange R. Twenty years of cardiac surgery in patients aged 80 years and older: risks and benefits. Ann Thorac Surg. 2011;91:506&#x2013;513. doi: 10.1016/j.athoracsur.2010.10.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2010.10.041</ArticleId><ArticleId IdType="pubmed">21256302</ArticleId></ArticleIdList></Reference><Reference><Citation>Melby SJ, Zierer A, Kaiser SP, Guthrie TJ, Keune JD, Schuessler RB, Pasque MK, Lawton JS, Moazami N, Moon MR, Damiano RJ., Jr Aortic valve replacement in octogenarians: risk factors for early and late mortality. Ann Thorac Surg. 2007;83:1651&#x2013;1656. doi: 10.1016/j.athoracsur.2006.09.068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2006.09.068</ArticleId><ArticleId IdType="pubmed">17462374</ArticleId></ArticleIdList></Reference><Reference><Citation>Grau JB, Mak AW, Ferrari G, Johnson CK, Shaw RE, Sperling J, Brizzio ME, Zapolanski A. Perioperative predictors of mid-term survival after aortic valve replacement. Asian Cardiovasc Thorac Ann. 2014;22:566&#x2013;573. doi: 10.1177/0218492313501509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0218492313501509</ArticleId><ArticleId IdType="pubmed">24867031</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and me-ta-analyses: the PRISMA statement. Open Med. 2009;3:e123&#x2013;e130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3090117</ArticleId><ArticleId IdType="pubmed">21603045</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27:1785&#x2013;1805. doi: 10.1177/0962280216669183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280216669183</ArticleId><ArticleId IdType="pubmed">27683581</ArticleId></ArticleIdList></Reference><Reference><Citation>Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16. doi: 10.1186/1745-6215-8-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1745-6215-8-16</ArticleId><ArticleId IdType="pmc">PMC1920534</ArticleId><ArticleId IdType="pubmed">17555582</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539&#x2013;1558. doi: 10.1002/sim.1186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Viechtbauer W, Cheung MW. Outlier and influence diagnostics for meta-analysis. Res Synth Methods. 2010;1:112&#x2013;125. doi: 10.1002/jrsm.11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.11</ArticleId><ArticleId IdType="pubmed">26061377</ArticleId></ArticleIdList></Reference><Reference><Citation>Thulin LI, Sjogren JL. Aortic valve replacement with and without concomitant coronary artery bypass surgery in the elderly: risk factors related to long-term survival. Croat Med J. 2000;41:406&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pubmed">11063764</ArticleId></ArticleIdList></Reference><Reference><Citation>Ennker J, Mortasawi A, Gehle S, Yaghmaie M, Schr&#xf6;der T, Rosendahl U, Ennker IC. Aortic valve replacement with or with-out concomitant coronary artery bypass grafting in the ninth decade of life. Langenbecks Arch Surg. 2001;386:272&#x2013;277. doi: 10.1007/s004230100221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004230100221</ArticleId><ArticleId IdType="pubmed">11466569</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunvand H, Offstad J, Nitter-Hauge S, Svennevig JL. Coronary artery bypass grafting combined with aortic valve replacement in healthy octogenarians does not increase postoperative risk. Scand Cardiovasc J. 2002;36:297&#x2013;301. doi: 10.1080/140174302320774519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/140174302320774519</ArticleId><ArticleId IdType="pubmed">12470398</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam BK, Hendry PJ. Patients over 80 years: quality of life after aortic valve replacement. Age Ageing. 2004;33:307&#x2013;309. doi: 10.1093/ageing/afh014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afh014</ArticleId><ArticleId IdType="pubmed">15082439</ArticleId></ArticleIdList></Reference><Reference><Citation>Unic D, Leacche M, Paul S, Rawn JD, Aranki SF, Couper GS, Mihaljevic T, Rizzo RJ, Cohn LH, O'Gara PT, Byrne JG. Early and late results of isolated and combined heart valve surgery in patients &gt; or =80 years of age. Am J Cardiol. 2005;95:1500&#x2013;1503. doi: 10.1016/j.amjcard.2005.02.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2005.02.024</ArticleId><ArticleId IdType="pubmed">15950583</ArticleId></ArticleIdList></Reference><Reference><Citation>Urso S, Sadaba R, Greco E, Pulitani I, Alvarez L, Juaristi A, Goiti JJ. One-hundred aortic valve replacements in octogenarians: outcomes and risk factors for early mortality. J Heart Valve Dis. 2007;16:139&#x2013;144.</Citation><ArticleIdList><ArticleId IdType="pubmed">17484461</ArticleId></ArticleIdList></Reference><Reference><Citation>Bose AK, Aitchison JD, Dark JH. Aortic valve replacement in octogenarians. J Cardiothorac Surg. 2007;2:33. doi: 10.1186/1749-8090-2-33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-8090-2-33</ArticleId><ArticleId IdType="pmc">PMC1947977</ArticleId><ArticleId IdType="pubmed">17629905</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber CH, Goeber V, Berdat P, Carrel T, Eckstein F. Benefits of cardiac surgery in octogenarians&#x2014;a postoperative quality of life assessment. Eur J Cardiothorac Surg. 2007;31:1099&#x2013;1105. doi: 10.1016/j.ejcts.2007.01.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2007.01.055</ArticleId><ArticleId IdType="pubmed">17369044</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngaage DL, Cowen ME, Griffin S, Guvendik L, Cale AR. Early neurological complications after coronary artery bypass grafting and valve surgery in octogenarians. Eur J Cardiothorac Surg. 2008;33:653&#x2013;659. doi: 10.1016/j.ejcts.2008.01.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2008.01.017</ArticleId><ArticleId IdType="pubmed">18276149</ArticleId></ArticleIdList></Reference><Reference><Citation>Filsoufi F, Rahmanian PB, Castillo JG, Chikwe J, Silvay G, Adams DH. Excellent early and late outcomes of aortic valve replacement in people aged 80 and older. J Am Geriatr Soc. 2008;56:255&#x2013;261. doi: 10.1111/j.1532-5415.2007.01535.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2007.01535.x</ArticleId><ArticleId IdType="pubmed">18047491</ArticleId></ArticleIdList></Reference><Reference><Citation>Maillet JM, Somme D, Hennel E, Lessana A, Saint-Jean O, Brodaty D. Frailty after aortic valve replacement (AVR) in octogenarians. Arch Gerontol Geriatr. 2009;48:391&#x2013;396. doi: 10.1016/j.archger.2008.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.archger.2008.03.010</ArticleId><ArticleId IdType="pubmed">18456353</ArticleId></ArticleIdList></Reference><Reference><Citation>Florath I, Albert A, Boening A, Ennker IC, Ennker J. Aortic valve replacement in octogenarians: identification of high-risk patients. Eur J Cardiothorac Surg. 2010;37:1304&#x2013;1310. doi: 10.1016/j.ejcts.2009.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2009.12.025</ArticleId><ArticleId IdType="pubmed">20117941</ArticleId></ArticleIdList></Reference><Reference><Citation>Maslow A, Casey P, Poppas A, Schwartz C, Singh A. Aortic valve replacement with or without coronary artery bypass graft surgery: the risk of surgery in patients &gt; or =80 years old. J Cardiothorac Vasc Anesth. 2010;24:18&#x2013;24. doi: 10.1053/j.jvca.2009.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2009.07.010</ArticleId><ArticleId IdType="pubmed">19819729</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamane K, Hirose H, Youdelman BA, Bogar LJ, Diehl JT. Conventional aortic valve replacement for elderly patients in the current era. Circ J. 2011;75:2692&#x2013;2698. doi: 10.1253/circj.CJ-11-0541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-11-0541</ArticleId><ArticleId IdType="pubmed">21857141</ArticleId></ArticleIdList></Reference><Reference><Citation>Kesavan S, Iqbal A, Khan Y, Hutter J, Pike K, Rogers C, Turner M, Townsend M, Baumbach A. Risk profile and outcomes of aortic valve replacement in octogenarians. World J Cardiol. 2011;3:359&#x2013;366. doi: 10.4330/wjc.v3.i11.359.</Citation><ArticleIdList><ArticleId IdType="doi">10.4330/wjc.v3.i11.359</ArticleId><ArticleId IdType="pmc">PMC3224869</ArticleId><ArticleId IdType="pubmed">22125671</ArticleId></ArticleIdList></Reference><Reference><Citation>Raja SG, Navaratnarajah M, Husain M, Walker CP, Ilsley CD, Bahrami TT, Gaer JA, Amrani M. Impact of concomitant coronary artery bypass grafting on in-hospital outcome in octogenarians undergoing aortic valve replacement. J Heart Valve Dis. 2013;22:177&#x2013;183.</Citation><ArticleIdList><ArticleId IdType="pubmed">23798205</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel NJ, Rogal GJ, Burns P, Saunders CR, Chamberlain RS. Aortic valve replacement with and without coronary artery by-pass graft surgery in octogenarians: is it safe and feasible? Cardiology. 2013;124:163&#x2013;173. doi: 10.1159/000346153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000346153</ArticleId><ArticleId IdType="pubmed">23467192</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell AE, Mitchell IM. The hidden risks of advancing age and concomitant ischemic heart disease after aortic valve re-placement. Clin Cardiol. 2013;36:129&#x2013;132. doi: 10.1002/clc.22097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.22097</ArticleId><ArticleId IdType="pmc">PMC6649450</ArticleId><ArticleId IdType="pubmed">23378071</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki Y, Hirai H, Hosono M, Bito Y, Nakahira A, Suehiro Y, Kaku D, Okada Y, Suehiro S. Adding coronary artery bypass grafting to aortic valve replacement increases operative mortality for elderly (70 years and older) patients with aortic steno-sis. Gen Thorac Cardiovasc Surg. 2013;61:626&#x2013;631. doi: 10.1007/s11748-013-0232-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11748-013-0232-6</ArticleId><ArticleId IdType="pubmed">23494627</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis JP, LaPar DJ, Crosby IK, Kern JA, Lau CL, Kron IL, Ailawadi G. Nonagenarians undergoing cardiac surgery. J Card Surg. 2014;29:600&#x2013;604. doi: 10.1111/jocs.12391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocs.12391</ArticleId><ArticleId IdType="pubmed">25039683</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho E, Mathur MN, Brady PW, Marshman D, Brereton RJ, Ross DE, Bhindi R, Hansen PS. Surgical aortic valve replacement in very elderly patients aged 80 years and over: evaluation of early clinical outcomes. Heart Lung Circ. 2014;23:242&#x2013;248. doi: 10.1016/j.hlc.2013.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2013.08.001</ArticleId><ArticleId IdType="pubmed">24021233</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamiya H, Tanzeem N, Akhyari P, Pedraza A, Kallenbach K, Lichtenberg A, Karck M. Impact of severe postoperative complications after cardiac surgery on mortality in patients aged over 80 years. Ann Thorac Cardiovasc Surg. 2014;20:383&#x2013;389. doi: 10.5761/atcs.oa.13-02268.</Citation><ArticleIdList><ArticleId IdType="doi">10.5761/atcs.oa.13-02268</ArticleId><ArticleId IdType="pubmed">23903712</ArticleId></ArticleIdList></Reference><Reference><Citation>Budniak W, Buczkowski P, Perek B, Katy&#x144;ska I, Jemielity M. Early and long-term results of cardiosurgical treatment of coronary artery disease and aortic stenosis in patients over 80 years old. Kardiochir Torakochirurgia Pol. 2014;11:246&#x2013;251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4283889</ArticleId><ArticleId IdType="pubmed">26336430</ArticleId></ArticleIdList></Reference><Reference><Citation>Salsano A, Regesta T, Vigan&#xf2; G, Rapetto F, Boeddu S, Sportelli E, Pansini S, Risso P, Onorati F, Passerone G, Santini F. Expectation and quality of life after aortic valve replacement over 85 years of age match those of the contemporary general population. Int J Artif Organs. 2016;39:56&#x2013;62. doi: 10.5301/ijao.5000473.</Citation><ArticleIdList><ArticleId IdType="doi">10.5301/ijao.5000473</ArticleId><ArticleId IdType="pubmed">26953896</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang TK, Choi DH, Ramanathan T, Ruygrok PN. Aortic valve replacement with or without concurrent coronary artery bypass grafting in octogenarians: eight-year cohort study. Heart Lung Circ. 2017;26:82&#x2013;87. doi: 10.1016/j.hlc.2016.04.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2016.04.028</ArticleId><ArticleId IdType="pubmed">27432737</ArticleId></ArticleIdList></Reference><Reference><Citation>Ennker J, Zadeh B, Pons-Kuehnemann J, Niemann B, Grieshaber P, Ennker IC, Boening A. Stentless bioprostheses for aortic valve replacement in octogenarians: the influence of coronary artery disease. Thorac Cardiovasc Surg. 2018;66:322&#x2013;327. doi: 10.1055/s-0037-1604048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0037-1604048</ArticleId><ArticleId IdType="pubmed">28675910</ArticleId></ArticleIdList></Reference><Reference><Citation>Takagi K, Arinaga K, Takaseya T, Otsuka H, Shojima T, Shintani Y, Zaima Y, Saku K, Oryoji A, Hiromatsu S. Aortic valve replacement with or without concomitant coronary artery bypass grafting in very elderly patients aged 85 years and older. Heart Vessels. 2020;35:1409&#x2013;1418. doi: 10.1007/s00380-020-01620-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00380-020-01620-1</ArticleId><ArticleId IdType="pubmed">32394242</ArticleId></ArticleIdList></Reference><Reference><Citation>Carabello BA, Paulus WJ. Aortic stenosis. Lancet. 2009;373:956&#x2013;966. doi: 10.1016/S0140-6736(09)60211-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(09)60211-7</ArticleId><ArticleId IdType="pubmed">19232707</ArticleId></ArticleIdList></Reference><Reference><Citation>Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol. 2011;8:162&#x2013;172. doi: 10.1038/nrcardio.2010.202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrcardio.2010.202</ArticleId><ArticleId IdType="pubmed">21263455</ArticleId></ArticleIdList></Reference><Reference><Citation>Barreto-Filho JA, Wang Y, Dodson JA, Desai MM, Sugeng L, Geirsson A, Krumholz HM. Trends in aortic valve replacement for elderly patients in the United States, 1999&#x2013;2011. JAMA. 2013;310:2078&#x2013;2085. doi: 10.1001/jama.2013.282437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.282437</ArticleId><ArticleId IdType="pmc">PMC4089974</ArticleId><ArticleId IdType="pubmed">24240935</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasques F, Lucenteforte E, Paone R, Mugelli A, Biancari F. Outcome of patients aged &gt;80 years undergoing combined aortic valve replacement and coronary artery bypass grafting: a systematic review and meta-analysis of 40 studies. Am Heart J. 2012;164:410&#x2013;418.e1. doi: 10.1016/j.ahj.2012.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2012.06.019</ArticleId><ArticleId IdType="pubmed">22980309</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashikhmina EA, Schaff HV, Dearani JA, Sundt TM, 3rd, Suri RM, Park SJ, Burkhart HM, Li Z, Daly RC. Aortic valve re-placement in the elderly: determinants of late outcome. Circulation. 2011;124:1070&#x2013;1078. doi: 10.1161/CIRCULATIONAHA.110.987560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.110.987560</ArticleId><ArticleId IdType="pubmed">21824918</ArticleId></ArticleIdList></Reference><Reference><Citation>Croal BL, Hillis GS, Gibson PH, Fazal MT, El-Shafei H, Gibson G, Jeffrey RR, Buchan KG, West D, Cuthbertson BH. Relationship between postoperative cardiac troponin I levels and outcome of cardiac surgery. Circulation. 2006;114:1468&#x2013;1475. doi: 10.1161/CIRCULATIONAHA.105.602370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.105.602370</ArticleId><ArticleId IdType="pubmed">17000912</ArticleId></ArticleIdList></Reference><Reference><Citation>Domanski MJ, Mahaffey K, Hasselblad V, Brener SJ, Smith PK, Hillis G, Engoren M, Alexander JH, Levy JH, Chaitman BR, Broderick S, Mack MJ, Pieper KS, Farkouh ME. Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. JAMA. 2011;305:585&#x2013;591. doi: 10.1001/jama.2011.99.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2011.99</ArticleId><ArticleId IdType="pubmed">21304084</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ, PARTNER Trial Investigators Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187&#x2013;2198. doi: 10.1056/NEJMoa1103510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1103510</ArticleId><ArticleId IdType="pubmed">21639811</ArticleId></ArticleIdList></Reference><Reference><Citation>Sondergaard L, Popma JJ, Reardon MJ, Van Mieghem NM, Deeb GM, Kodali S, George I, Williams MR, Yakubov SJ, Kappetein AP, Serruys PW, Grube E, Schiltgen MB, Chang Y, Engstr&#xf8;m T, SURTAVI Trial Investigators Comparison of a complete percutaneous versus surgical approach to aortic valve replacement and revascularization in patients at intermediate surgical risk: results from the randomized SURTAVI trial. Circulation. 2019;140:1296&#x2013;1305. doi: 10.1161/CIRCULATIONAHA.118.039564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.118.039564</ArticleId><ArticleId IdType="pubmed">31476897</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, J&#xfc;ni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO, ESC Scientific Document Group ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2019;40:87&#x2013;165. doi: 10.1093/eurheartj/ehy394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy394</ArticleId><ArticleId IdType="pubmed">30165437</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita B, Ensminger S, Bauer T, M&#xf6;llmann H, Beckmann A, Bekeredjian R, Bleiziffer S, Sch&#xe4;fer E, Hamm CW, Mohr FW, Katus HA, Harringer W, Walther T, Frerker C, GARY Executive Board Trends in practice and outcomes from 2011 to 2015 for surgical aortic valve replacement: an update from the German Aortic Valve Registry on 42 776 patients. Eur J Cardio-thorac Surg. 2018;53:552&#x2013;559. doi: 10.1093/ejcts/ezx408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezx408</ArticleId><ArticleId IdType="pubmed">29190355</ArticleId></ArticleIdList></Reference><Reference><Citation>Thalji NM, Suri RM, Daly RC, Greason KL, Dearani JA, Stulak JM, Joyce LD, Burkhart HM, Pochettino A, Li Z, Frye RL, Schaff HV. The prognostic impact of concomitant coronary artery bypass grafting during aortic valve surgery: implications for revascularization in the transcatheter era. J Thorac Cardiovasc Surg. 2015;149:451&#x2013;460. doi: 10.1016/j.jtcvs.2014.08.073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2014.08.073</ArticleId><ArticleId IdType="pubmed">25308117</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel KP, Michail M, Treibel TA, Rathod K, Jones DA, Ozkor M, Kennon S, Forrest JK, Mathur A, Mullen MJ, Lansky A, Baumbach A. Coronary revascularization in patients undergoing aortic valve replacement for severe aortic stenosis. JACC Cardiovasc Interv. 2021;14:2083&#x2013;2096. doi: 10.1016/j.jcin.2021.07.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2021.07.058</ArticleId><ArticleId IdType="pubmed">34620388</ArticleId></ArticleIdList></Reference><Reference><Citation>Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr&#xf6;m-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL, ESC Scientific Document Group 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42:373&#x2013;498. doi: 10.1093/eurheartj/ehaa612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa612</ArticleId><ArticleId IdType="pubmed">32860505</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone K, Fryer S, Faulkner J, Meyer ML, Heffernan K, Kucharska-Newton A, Zieff G, Paterson C, Matsushita K, Hughes TM, Tanaka H, Stoner L. Associations of lower-limb atherosclerosis and arteriosclerosis with cardiovascular risk factors and disease in older adults: the atherosclerosis risk in communities (ARIC) study. Atherosclerosis. 2022;340:53&#x2013;60. doi: 10.1016/j.atherosclerosis.2021.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2021.10.014</ArticleId><ArticleId IdType="pmc">PMC10167791</ArticleId><ArticleId IdType="pubmed">34799100</ArticleId></ArticleIdList></Reference><Reference><Citation>Axtell AL, Fiedler AG, Melnitchouk S, D'Alessandro DA, Villavicencio MA, Jassar AS, Sundt TM., 3rd Correlation of cardiopulmonary bypass duration with acute renal failure after cardiac surgery. J Thorac Cardiovasc Surg. 2020;159:170&#x2013;178. doi: 10.1016/j.jtcvs.2019.01.072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2019.01.072</ArticleId><ArticleId IdType="pubmed">30826102</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JR, Kramer RS, MacKenzie TA, Coca SG, Sint K, Parikh CR. Determinants of acute kidney injury duration after cardiac surgery: an externally validated tool. Ann Thorac Surg. 2012;93:570&#x2013;576. doi: 10.1016/j.athoracsur.2011.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2011.11.004</ArticleId><ArticleId IdType="pmc">PMC3761881</ArticleId><ArticleId IdType="pubmed">22206952</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar AB, Suneja M, Bayman EO, Weide GD, Tarasi M. Association between postoperative acute kidney injury and duration of cardiopulmonary bypass: a meta-analysis. J Cardiothorac Vasc Anesth. 2012;26:64&#x2013;69. doi: 10.1053/j.jvca.2011.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2011.07.007</ArticleId><ArticleId IdType="pubmed">21924633</ArticleId></ArticleIdList></Reference><Reference><Citation>Erg&#xfc;ne&#x15f; K, Yurekli I, Celik E, Yetkin U, Yilik L, Gurbuz A. Predictors of intra-aortic balloon pump insertion in coronary surgery and mid-term results. Korean J Thorac Cardiovasc Surg. 2013;46:444&#x2013;448. doi: 10.5090/kjtcs.2013.46.6.444.</Citation><ArticleIdList><ArticleId IdType="doi">10.5090/kjtcs.2013.46.6.444</ArticleId><ArticleId IdType="pmc">PMC3868692</ArticleId><ArticleId IdType="pubmed">24368971</ArticleId></ArticleIdList></Reference><Reference><Citation>Parissis H, Leotsinidis M, Akbar MT, Apostolakis E, Dougenis D. The need for intra-aortic balloon pump support following open heart surgery: risk analysis and outcome. J Cardiothorac Surg. 2010;5:20. doi: 10.1186/1749-8090-5-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-8090-5-20</ArticleId><ArticleId IdType="pmc">PMC2855563</ArticleId><ArticleId IdType="pubmed">20367880</ArticleId></ArticleIdList></Reference><Reference><Citation>Zainab A, Nguyen DT, Graviss EA, Fatima S, Masud FN, MacGillivray TE. Development and validation of a risk score for respiratory failure after cardiac surgery. Ann Thorac Surg. 2022;113:577&#x2013;584. doi: 10.1016/j.athoracsur.2021.03.082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2021.03.082</ArticleId><ArticleId IdType="pubmed">33839130</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksoy R, Karakoc AZ, Cevirme D, Elibol A, Yigit F, Yilmaz &#xdc;, Rabus MB. Predictive factors of prolonged ventilation following cardiac surgery with cardiopulmonary bypass. Braz J Cardiovasc Surg. 2021;36:780&#x2013;787. doi: 10.21470/1678-9741-2020-0164.</Citation><ArticleIdList><ArticleId IdType="doi">10.21470/1678-9741-2020-0164</ArticleId><ArticleId IdType="pmc">PMC8641772</ArticleId><ArticleId IdType="pubmed">34236782</ArticleId></ArticleIdList></Reference><Reference><Citation>Sultan I, Bianco V, Kilic A, Jovin T, Jadhav A, Jankowitz B, Aranda-Michel E, D'angelo MP, Navid F, Wang Y, Thoma F, Gleason TG. Predictors and outcomes of ischemic stroke after cardiac surgery. Ann Thorac Surg. 2020;110:448&#x2013;456. doi: 10.1016/j.athoracsur.2020.02.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2020.02.025</ArticleId><ArticleId IdType="pubmed">32199830</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler CG, Ho Luxford JM, Huang CC, Ejiofor JI, Rawn JD, Wilusz K, Fox JA, Shernan SK, Muehlschlegel JD. Aortic atheroma increases the risk of long-term mortality in 20,000 patients. Ann Thorac Surg. 2017;104:1325&#x2013;1331. doi: 10.1016/j.athoracsur.2017.02.082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2017.02.082</ArticleId><ArticleId IdType="pmc">PMC6009825</ArticleId><ArticleId IdType="pubmed">28577841</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30389130</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-685X</ISSN><JournalIssue CitedMedium="Internet"><Volume>157</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>Apr</Month></PubDate></JournalIssue><Title>The Journal of thoracic and cardiovascular surgery</Title><ISOAbbreviation>J Thorac Cardiovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Intraoperative prediction of cardiac surgery-associated acute kidney injury using urinary biomarkers of cell cycle arrest.</ArticleTitle><Pagination><StartPage>1545</StartPage><EndPage>1553.e5</EndPage><MedlinePgn>1545-1553.e5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jtcvs.2018.08.090</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-5223(18)32484-X</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Tissue inhibitor of metalloproteinases 2 (TIMP-2) and insulin-like growth factor-binding protein 7 (IGFBP7) are postoperative urinary biomarkers of renal stress and acute kidney injury (AKI). We conducted this study to test the hypothesis that intraoperative concentrations of urinary [TIMP-2]&#xb7;[IGFBP7] are associated with postoperative AKI.</AbstractText><AbstractText Label="METHODS">We measured urinary [TIMP-2]&#xb7;[IGFBP7] at 8 perioperative timepoints in 400 patients who participated in a randomized controlled trial of atorvastatin for AKI in cardiac surgery. We compared [TIMP-2]&#xb7;[IGFBP7] between subjects who did and did not develop KDIGO stage 2 or 3 AKI within 48&#xa0;hours of surgery, adjusted for AKI risk factors.</AbstractText><AbstractText Label="RESULTS">Fourteen patients (3.5%) met the primary endpoint of stage 2 or 3 AKI within 48&#xa0;hours of surgery, and an additional 77 patients (19.3%) developed stage 1 AKI. Patients who developed stage 2 or 3 AKI displayed bimodal elevations of [TIMP-2]&#xb7;[IGFBP7], with a first elevation (median, 0.45 [ng/mL]<sup>2</sup>/1000) intraoperatively and a second elevation (1.45 [ng/mL]<sup>2</sup>/1000) 6&#xa0;hours postoperatively. Patients who did not develop AKI did not have any elevations in [TIMP-2]&#xb7;[IGFBP7]. Each 10-fold increase in intraoperative [TIMP-2]&#xb7;[IGFBP7] was independently associated with a 290% increase in the odds of stage 2 or 3 AKI (P&#xa0;=&#xa0;.01), and each 10-fold increase in the 6 hours postoperative [TIMP-2]&#xb7;[IGFBP7] was independently associated with a 650% increase in the odds of stage 2 or 3 AKI (P&#xa0;&lt;&#xa0;.001). The maximum [TIMP-2]&#xb7;[IGFBP7] between these 2 timepoints provided an area under the receiver operating characteristic curve of 0.82 (95% confidence interval [CI], 0.73-0.90), 100% sensitivity, and 100% negative predictive value using the &gt;0.3 cutoff to predict stage 2 or 3 AKI.</AbstractText><AbstractText Label="CONCLUSIONS">Intraoperative elevations of [TIMP-2]&#xb7;[IGFBP7] can predict moderate or severe AKI and could provide an opportunity to alter postoperative management to prevent kidney injury.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cummings</LastName><ForeName>Jared J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Division of Cardiothoracic Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tenn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Andrew D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Division of Cardiothoracic Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tenn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Statistics, Walker Bioscience, Carlsbad, Calif.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez</LastName><ForeName>Marcos G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Division of Critical Care Medicine, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tenn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Neal</LastName><ForeName>Jason B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Division of Cardiothoracic Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tenn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Billings</LastName><ForeName>Frederic T</ForeName><Initials>FT</Initials><Suffix>4th</Suffix><AffiliationInfo><Affiliation>Division of Cardiothoracic Anesthesiology, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tenn; Division of Critical Care Medicine, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tenn. Electronic address: frederic.t.billings@vanderbilt.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR000445</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 GM102676</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002243</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM112871</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM108554</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Thorac Cardiovasc Surg</MedlineTA><NlmUniqueID>0376343</NlmUniqueID><ISSNLinking>0022-5223</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018969">Insulin-Like Growth Factor Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C560823">TIMP2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C102529">insulin-like growth factor binding protein-related protein 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>127497-59-0</RegistryNumber><NameOfSubstance UI="D019716">Tissue Inhibitor of Metalloproteinase-2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Thorac Cardiovasc Surg. 2019 Apr;157(4):1554-1555. doi: 10.1016/j.jtcvs.2018.08.119.</RefSource><PMID Version="1">30447967</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059447" MajorTopicYN="Y">Cell Cycle Checkpoints</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018969" MajorTopicYN="N">Insulin-Like Growth Factor Binding Proteins</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="Y">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007432" MajorTopicYN="N">Intraoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019716" MajorTopicYN="N">Tissue Inhibitor of Metalloproteinase-2</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="Y">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016482" MajorTopicYN="N">Urinalysis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">IGFBP7</Keyword><Keyword MajorTopicYN="N">NephroCheck, prediction</Keyword><Keyword MajorTopicYN="N">TIMP-2</Keyword><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">biomarker</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword></KeywordList><CoiStatement>Conflict of interest: Dr. Shaw and Dr. Shi are consultants for Astute Medical, which developed the [TIMP-2]&#x2022;[IGFBP7] NephroCheck assay and performed urinary [TIMP-2]&#x2022;[IGFBP7] measurements blinded to all subject characteristics. Astute Medical did not participate in the design of the study or decision to <b>submit</b> the findings for publication. Dr. Shi completed the statistical analysis. Dr. Cummings, Shaw, Shi, and Billings wrote the manuscript. The authors declare no other conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>4</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30389130</ArticleId><ArticleId IdType="mid">NIHMS1516612</ArticleId><ArticleId IdType="pmc">PMC6431272</ArticleId><ArticleId IdType="doi">10.1016/j.jtcvs.2018.08.090</ArticleId><ArticleId IdType="pii">S0022-5223(18)32484-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hu J, Chen R, Liu S, Yu X, Zou J, Ding X. Global Incidence and Outcomes of Adult Patients With Acute Kidney Injury After Cardiac Surgery: A Systematic Review and Meta-Analysis. J Cardiothorac Vasc Anesth. 2016;30:82&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">26482484</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuhrman DY, Kellum JA. Epidemiology and pathophysiology of cardiac surgery-associated acute kidney injury. Curr Opin Anaesthesiol. 2017;30:60&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">27820742</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Agostino RS, Jacobs JP, Badhwar V, Fernandez FG, Paone G, Wormuth DW, et al. The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2018 Update on Outcomes and Quality. Ann Thorac Surg. 2018;105:15&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">29233331</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Bellomo R. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol. 2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">28869251</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakkar M, Bruno VD, Guida G, Angelini GD, Chivasso P, Suleiman MS, et al. Postoperative acute kidney injury defined by RIFLE criteria predicts early health outcome and long-term survival in patients undergoing redo coronary artery bypass graft surgery. J Thorac Cardiovasc Surg. 2016;152:235&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4915911</ArticleId><ArticleId IdType="pubmed">27016793</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Neal JB, Shaw AD, Billings FTt. Acute kidney injury following cardiac surgery: current understanding and future directions. Crit Care. 2016;20:187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4931708</ArticleId><ArticleId IdType="pubmed">27373799</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Kellum JA, Ronco C. Defining acute renal failure: physiological principles. Intensive Care Med. 2004;30:33&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">14618231</ArticleId></ArticleIdList></Reference><Reference><Citation>Albert C, Albert A, Kube J, Bellomo R, Wettersten N, Kuppe H, et al. Urinary biomarkers may provide prognostic information for subclinical acute kidney injury after cardiac surgery. J Thorac Cardiovasc Surg. 2018;155:2441&#x2013;2452 e2413.</Citation><ArticleIdList><ArticleId IdType="pubmed">29366580</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyner JL, Bennett MR, Worcester EM, Ma Q, Raman J, Jeevanandam V, et al. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int. 2008;74:1059&#x2013;1069.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2745082</ArticleId><ArticleId IdType="pubmed">18650797</ArticleId></ArticleIdList></Reference><Reference><Citation>Han WK, Wagener G, Zhu Y, Wang S, Lee HT. Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery. Clin J Am Soc Nephrol. 2009;4:873&#x2013;882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2676184</ArticleId><ArticleId IdType="pubmed">19406962</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013;17:R25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4057242</ArticleId><ArticleId IdType="pubmed">23388612</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrezenmeier EV, Barasch J, Budde K, Westhoff T, Schmidt-Ott KM. Biomarkers in acute kidney injury - pathophysiological basis and clinical performance. Acta Physiol (Ox&#xed;). 2017;219:554&#x2013;572.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5575831</ArticleId><ArticleId IdType="pubmed">27474473</ArticleId></ArticleIdList></Reference><Reference><Citation>Group KW. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney International Supplements. 2012;2.</Citation></Reference><Reference><Citation>Pilarczyk K, Edayadiyil-Dudasova M, Wendt D, Demircioglu E, Benedik J, Dohle DS, et al. Urinary [TIMP-2]*[IGFBP7] for early prediction of acute kidney injury after coronary artery bypass surgery. Ann Intensive Care. 2015;5:50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4679715</ArticleId><ArticleId IdType="pubmed">26669781</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersch M, Schmidt C, Van Aken H, Martens S, Rossaint J, Singbartl K, et al. Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery. PLoS One. 2014;9:e93460.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3968141</ArticleId><ArticleId IdType="pubmed">24675717</ArticleId></ArticleIdList></Reference><Reference><Citation>Gocze I, Jauch D, Gotz M, Kennedy P, Jung B, Zeman F, et al. Biomarker-guided Intervention to Prevent Acute Kidney Injury After Major Surgery: The Prospective Randomized BigpAK Study. Ann Surg. 2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">28857811</ArticleId></ArticleIdList></Reference><Reference><Citation>Gocze I, Koch M, Renner P, Zeman F, Graf BM, Dahlke MH, et al. Urinary biomarkers TIMP-2 and IGFBP7 early predict acute kidney injury after major surgery. PLoS One.2015;10:e0120863.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4370650</ArticleId><ArticleId IdType="pubmed">25798585</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste EA, McCullough PA, Kashani K, Chawla LS, Joannidis M, Shaw AD, et al. Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers. Nephrol Dial Transplant. 2014;29:2054&#x2013;2061.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4209880</ArticleId><ArticleId IdType="pubmed">25237065</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FTt, Pretorius M, Schildcrout JS, Mercaldo ND, Byrne JG, Ikizler TA, et al. Obesity and oxidative stress predict AKI after cardiac surgery. JAm Soc Nephrol. 2012;23:1221&#x2013;1228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3380645</ArticleId><ArticleId IdType="pubmed">22626819</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FTt, Ball SK, Roberts LJ 2nd, Pretorius M. Postoperative acute kidney injury is associated with hemoglobinemia and an enhanced oxidative stress response. Free Radic Biol Med. 2011;50:1480&#x2013;1487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3090463</ArticleId><ArticleId IdType="pubmed">21334433</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FTt, Hendricks PA, Schildcrout JS, Shi Y, Petracek MR, Byrne JG, et al. High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial. JAMA. 2016;315:877&#x2013;888.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4843765</ArticleId><ArticleId IdType="pubmed">26906014</ArticleId></ArticleIdList></Reference><Reference><Citation>Pohlert T The Pairwise Multiple Comparison of Mean Ranks Package (PMCMR). 2014;R package.</Citation></Reference><Reference><Citation>Thakar CV, Arrigain S, Worley S, Yared JP, Paganini EP. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol. 2005;16:162&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pubmed">15563569</ArticleId></ArticleIdList></Reference><Reference><Citation>Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011; 12:77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3068975</ArticleId><ArticleId IdType="pubmed">21414208</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrell Jr FD C; et al. Hmisc: Harrell Miscellaneous. 4.1&#x2013;1 ed2018.</Citation></Reference><Reference><Citation>Team RC. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. 2014.</Citation></Reference><Reference><Citation>Mayer T, Bolliger D, Scholz M, Reuthebuch O, Gregor M, Meier P, et al. Urine Biomarkers of Tubular Renal Cell Damage for the Prediction of Acute Kidney Injury After Cardiac Surgery-A Pilot Study. J Cardiothorac Vasc Anesth. 2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">28803769</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersch M, Schmidt C, Hoffmeier A, Van Aken H, Wempe C, Gerss J, et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med. 2017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5633630</ArticleId><ArticleId IdType="pubmed">28110412</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Zou Z, Jin J, Teng J, Xu J, Shen B, et al. Urinary TIMP-2 and IGFBP7 for the prediction of acute kidney injury following cardiac surgery. BMC Nephrol. 2017; 18:177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5450378</ArticleId><ArticleId IdType="pubmed">28558754</ArticleId></ArticleIdList></Reference><Reference><Citation>Bihorac A, Chawla LS, Shaw AD, Al-Khafaji A, Davison DL, Demuth GE, et al. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am JRespir Crit Care Med. 2014;189:932&#x2013;939.</Citation><ArticleIdList><ArticleId IdType="pubmed">24559465</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28024933</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>06</Day></DateCompleted><DateRevised><Year>2018</Year><Month>04</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>3</Issue><PubDate><Year>2017</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>A Preoperative Multimarker Approach to Evaluate Acute Kidney Injury After Cardiac Surgery.</ArticleTitle><Pagination><StartPage>837</StartPage><EndPage>846</EndPage><MedlinePgn>837-846</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2016.10.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(16)30455-4</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate whether a multimarker strategy combining preoperative biomarkers representing distinct pathophysiologic pathways enhances preoperative risk assessment of acute kidney injury after cardiac surgery (CSA-AKI) and increases knowledge of underlying pathogenesis.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective, cohort study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Single-center tertiary referral hospital.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">The study comprised 1,015 adults undergoing cardiac surgery with cardiopulmonary bypass.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">CSA-AKI was defined as&#x2265;50% increase in serum creatinine concentration, absolute increase&#x2265;26 &#xb5;mol/L, or new requirement for dialysis. Preoperative and perioperative information until hospital discharge was recorded. Preoperative plasma levels of C-reactive protein, terminal complement complex, neopterin, lactoferrin, N-terminal pro-brain natriuretic peptide, and cystatin C were determined using enzyme immunoassays. Biomarkers were selected based on causal hypotheses of underlying mechanisms and were related to inflammatory, hemodynamic, or renal signaling pathways.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">One hundred patients (9.9%) developed CSA-AKI. Higher baseline plasma concentrations of neopterin and N-terminal pro-brain natriuretic peptide were associated independently with CSA-AKI (p = 0.04 and p&lt;0.001, respectively). Lower baseline plasma lactoferrin concentrations were observed in patients with CSA-AKI (p = 0.05). Compared with clinical risk assessment, addition of these biomarkers provided a slight, but significant, increment in predictive utility (area under the curve 0.81-0.83, likelihood ratio test p&lt;0.001). A net of 12% of patients were reclassified correctly, and improved prediction was demonstrated, especially in patients with intermediate risk (56% correct reclassification).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Preoperative hemodynamic, renal, and immunologic function play central roles in the pathogenesis of CSA-AKI. These findings add evidence to the potential of a multimarker approach to improve preoperative prediction of CSA-AKI.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Enger</LastName><ForeName>Tone B</ForeName><Initials>TB</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Children's and Women's Health, Faculty of Medicine, NTNU-Norwegian University of Science and Technology, Trondheim, Norway; Department of Cardiothoracic Anesthesia and Intensive Care, St. Olavs University Hospital, Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pleym</LastName><ForeName>Hilde</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Circulation and Medical Imaging, Faculty of Medicine, NTNU-Norwegian University of Science and Technology, Trondheim, Norway; Clinic of Anesthesia and Intensive Care, St. Olavs University Hospital, Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stenseth</LastName><ForeName>Roar</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Anesthesia and Intensive Care, St. Olavs University Hospital, Trondheim, Norway; Department of Circulation and Medical Imaging, Faculty of Medicine, NTNU-Norwegian University of Science and Technology, Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greiff</LastName><ForeName>Guri</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Anesthesia and Intensive Care, St. Olavs University Hospital, Trondheim, Norway; Department of Circulation and Medical Imaging, Faculty of Medicine, NTNU-Norwegian University of Science and Technology, Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wahba</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Circulation and Medical Imaging, Faculty of Medicine, NTNU-Norwegian University of Science and Technology, Trondheim, Norway; Clinic of Cardiothoracic Surgery, St. Olavs University Hospital, Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Videm</LastName><ForeName>Vibeke</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Children's and Women's Health, Faculty of Medicine, NTNU-Norwegian University of Science and Technology, Trondheim, Norway; Department of Immunology and Transfusion Medicine, St. Olavs University Hospital, Trondheim, Norway. Electronic address: vibeke.videm@ntnu.no.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>10</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009664" MajorTopicYN="N">Norway</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">preoperative biomarkers</Keyword><Keyword MajorTopicYN="N">risk prediction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28024933</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2016.10.005</ArticleId><ArticleId IdType="pii">S1053-0770(16)30455-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24881861</PMID><DateCompleted><Year>2014</Year><Month>09</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-6259</ISSN><JournalIssue CitedMedium="Internet"><Volume>98</Volume><Issue>1</Issue><PubDate><Year>2014</Year><Month>Jul</Month></PubDate></JournalIssue><Title>The Annals of thoracic surgery</Title><ISOAbbreviation>Ann Thorac Surg</ISOAbbreviation></Journal><ArticleTitle>Acute kidney injury after on-pump or off-pump coronary artery bypass grafting in elderly patients.</ArticleTitle><Pagination><StartPage>9</StartPage><EndPage>15</EndPage><MedlinePgn>9-14; discussion 14-5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.athoracsur.2014.01.088</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0003-4975(14)01038-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">An exploratory analysis of the German Off Pump Coronary Artery Bypass Grafting in Elderly Patients (GOPCABE) trial was performed to investigate the effect of off-pump coronary artery bypass grafting (CABG) on kidney function after the operation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Data on kidney function were available from 1,612 patients, representing 67% of the study population. Preoperative kidney function was graded according to the glomerular filtration rate. Acute kidney injury (AKI) within the first week after the operation was defined and classified according to the Acute Kidney Injury Network (AKIN) criteria. The incidence and severity of AKI was compared between patients operated on on-pump or off-pump.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Impaired kidney function was seen in 642 patients (40%), and 19 patients had preexisting end-stage kidney disease. AKI of any severity occurred in half of all patients undergoing CABG, with AKIN stage 1 accounting for most of the cases. The incidence and severity of AKI in patients undergoing on-pump vs off-pump CABG was AKIN stage 1: 298 (37%) vs 329 (42%); AKIN stage 2: 38 (5%) vs 43 (5%); and AKIN stage 3: 44 (6%) vs 44 (6%), which did not differ significantly (p=0.174). New renal replacement therapy was necessary in 3.2% (on-pump) and in 2.7% (off-pump) of all patients. Stratification according to preoperative kidney function yielded comparable frequencies of AKI for on-pump and off-pump CABG.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">AKI was common in elderly patients undergoing CABG, but deterioration of kidney function requiring renal replacement therapy was a rare event. Off-pump CABG was not associated with decreased rates or reduced severity of AKI in elderly patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2014 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reents</LastName><ForeName>Wilko</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Cardiovascular Clinic Bad Neustadt, Bad Neustadt, Germany. Electronic address: wilko.reents@herzchirurgie.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hilker</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, University Medical Center, Regensburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xf6;rgermann</LastName><ForeName>Jochen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Clinic for Heart, Thoracic and Cardiovascular Surgery, Heart and Diabetes Centre NRW, Ruhr University Bochum, Bad Oeynhausen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albert</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiac and Vascular Surgery, Robert Bosch Hospital, Stuttgart, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pl&#xf6;tze</LastName><ForeName>Katrin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, University Heart Center Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zacher</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiovascular Clinic Bad Neustadt, Bad Neustadt, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diegeler</LastName><ForeName>Anno</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiovascular Clinic Bad Neustadt, Bad Neustadt, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xf6;ning</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Justus-Liebig University Gie&#xdf;en, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>06</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ann Thorac Surg</MedlineTA><NlmUniqueID>15030100R</NlmUniqueID><ISSNLinking>0003-4975</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001026" MajorTopicYN="N">Coronary Artery Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047549" MajorTopicYN="N">Coronary Artery Bypass, Off-Pump</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003324" MajorTopicYN="N">Coronary Artery Disease</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005919" MajorTopicYN="N">Glomerular Filtration Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24881861</ArticleId><ArticleId IdType="doi">10.1016/j.athoracsur.2014.01.088</ArticleId><ArticleId IdType="pii">S0003-4975(14)01038-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36905791</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>87</Volume><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Intraoperative renal desaturation and postoperative acute kidney injury in older patients undergoing liver resection: A prospective cohort study.</ArticleTitle><Pagination><StartPage>111084</StartPage><MedlinePgn>111084</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2023.111084</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(23)00034-X</ELocationID><Abstract><AbstractText Label="STUDY OBJECTIVE">To determine the association between intraoperative renal tissue desaturation as measured using near-infrared spectroscopy and increased likelihood of developing postoperative acute kidney injury (AKI) in older patients undergoing hepatectomy.</AbstractText><AbstractText Label="DESIGN">A multicenter prospective cohort study.</AbstractText><AbstractText Label="SETTING">The study was conducted at two tertiary hospitals in China from September 2020 to October 2021.</AbstractText><AbstractText Label="PATIENTS">157 older patients (&#x2265; 60&#xa0;years) undergoing open hepatectomy surgery.</AbstractText><AbstractText Label="INTERVENTIONS AND MEASUREMENTS">Renal tissue oxygen saturation was continuously monitored during operation using near-infrared spectroscopy. The exposure of interest was intraoperative renal desaturation, defined as at least 20% relative decline in renal tissue oxygen saturation from baseline. The primary outcome was postoperative AKI, defined using the Kidney Disease: Improving Global Outcomes criteria according to the serum creatinine criteria.</AbstractText><AbstractText Label="MAIN RESULTS">Renal desaturation occurred in 70 of 157 patients. Postoperative AKI was observed in 23% (16/70) and 8% (7/87) of patients with versus without renal desaturation. Patients with renal desaturation were at higher risk of AKI than patients without renal desaturation (adjusted odds ratio 3.41, 95% confidence interval: 1.12-10.36, p&#xa0;=&#xa0;0.031). Predictive performance was 65.2% sensitivity and 33.6% specificity for hypotension alone, 69.6% sensitivity and 59.7% specificity for renal desaturation alone, and 95.7% sensitivity and 26.9% specificity for combined use of hypotension and renal desaturation.</AbstractText><AbstractText Label="CONCLUSIONS">Intraoperative renal desaturation occurred in &gt;40% in our sample of older patients undergoing liver resection and was associated with increased risk of AKI. Intraoperative near-infrared spectroscopy monitoring enhances the detection of AKI.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Yao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Haotian</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Changsheng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Yuxiang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Yulong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lou</LastName><ForeName>Jingsheng</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yanhong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Jiangbei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Huan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Zhipeng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, the Affiliated Hospital of Medical School, Ningbo University, Ningbo, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>Roger G</ForeName><Initials>RG</Initials><AffiliationInfo><Affiliation>Cardiovascular Disease Program, Biomedicine Discovery Institute and Department of Physiology, Monash University, Melbourne, Australia; Florey Institute of Neurosciences and Mental Health, University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duan</LastName><ForeName>Chongyang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, School of Public Health, Southern Medical University, Guangzhou, China. Electronic address: donyduang@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mi</LastName><ForeName>Weidong</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, China. Electronic address: wwdd1962@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006498" MajorTopicYN="N">Hepatectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hepatectomy</Keyword><Keyword MajorTopicYN="N">Postoperative acute kidney injury</Keyword><Keyword MajorTopicYN="N">Renal desaturation</Keyword><Keyword MajorTopicYN="N">Renal oxygen saturation</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>11</Day><Hour>18</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36905791</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2023.111084</ArticleId><ArticleId IdType="pii">S0952-8180(23)00034-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40373496</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>104</Volume><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Association between intravenous 5&#xa0;% albumin administration and acute kidney injury after partial nephrectomy. A retrospective study.</ArticleTitle><Pagination><StartPage>111873</StartPage><MedlinePgn>111873</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2025.111873</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(25)00133-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute kidney injury (AKI) after partial nephrectomy is a frequent postoperative complication that can affect nearly half of patients, according to various studies. In the current study, we investigated the association of intraoperative administration of 5&#xa0;% albumin, compared with crystalloids alone, with AKI after partial nephrectomy.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This single-center retrospective study included adult patients undergoing partial nephrectomy. The primary endpoint was AKI within 72&#xa0;h after surgery using the KIDGO definition. Secondary endpoints were time-to-AKI, reoperations, AKI severity and length of hospital stay. We used propensity score-based nearest-neighbor methods balance the patient baseline characteristics.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 1688 patients were included in the analysis, with 809 receiving 5&#xa0;% albumin and 879 in the control group. After matching, 729 patients received 5&#xa0;% albumin, while 674 were controls. The incidence of acute kidney injury (AKI) was significantly higher in the 5&#xa0;% albumin group (32.78&#xa0;%) compared to the control group (25.51&#xa0;%). Multivariate analysis revealed that receiving 5&#xa0;% albumin was associated with a 32&#xa0;% increased risk of developing AKI. Furthermore, the analysis indicated that this association was dose-dependent.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our study suggests that intraoperative administration of 5&#xa0;% albumin may not be a risk factor for AKI after partial nephrectomy. Given the discrepancy between these results and previous studies, a future prospective randomized controlled trial is needed to confirm our findings.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guerra-Londo&#xf1;o</LastName><ForeName>Juan Jose</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology &amp; Perioperative Medicine, Henry Ford, Detroit, MI, USA; Anesthesiology and Surgical Oncology Research Group, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno-Lopez</LastName><ForeName>Sergio M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>School of Medicine, Universidad de Los Andes, Bogota, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gundre</LastName><ForeName>Satvik</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jehanzeb</LastName><ForeName>Azzi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Ryan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cortes-Mejia</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pain Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Anesthesiology and Surgical Oncology Research Group, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bejarano-Ramirez</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Transplantation and Hepatobiliary Surgery, Fundaci&#xf3;n Santa Fe de Bogot&#xe1;, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mensah</LastName><ForeName>Cassius K B</ForeName><Initials>CKB</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cata</LastName><ForeName>Juan P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Clinical Sciences, University of Houston, Houston, TX, USA; Anesthesiology and Surgical Oncology Research Group, Houston, TX, USA. Electronic address: jcata@mdanderson.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000418">Albumins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077324">Crystalloid Solutions</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009392" MajorTopicYN="Y">Nephrectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007430" MajorTopicYN="N">Intraoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000418" MajorTopicYN="Y">Albumins</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077324" MajorTopicYN="N">Crystalloid Solutions</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Albumin 5&#xa0;%</Keyword><Keyword MajorTopicYN="N">Partial nephrectomy</Keyword><Keyword MajorTopicYN="N">Propensity score matching</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>8</Day><Hour>3</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>16</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>15</Day><Hour>18</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40373496</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2025.111873</ArticleId><ArticleId IdType="pii">S0952-8180(25)00133-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19463152</PMID><DateCompleted><Year>2009</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>3</Issue><PubDate><Year>2009</Year></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Determinants of postoperative acute kidney injury.</ArticleTitle><Pagination><StartPage>R79</StartPage><MedlinePgn>R79</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/cc7894</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Development of acute kidney injury (AKI) during the perioperative period is associated with increases in morbidity and mortality. Our aim was to evaluate the incidence and determinants of postoperative AKI after major noncardiac surgery in patients with previously normal renal function.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective cohort study was carried out in the multidisciplinary Post-Anaesthesia Care Unit (PACU) with five intensive care beds. The study population consisted of 1166 patients with no previous renal insufficiency who were admitted to these intensive care unit (ICU) beds over 2 years. After admission patients were followed for the development of AKI, defined as proposed by The Acute Kidney Injury Network (increment of serum creatinine [greater than or equal to] 0.3 mg/dL or 50% from baseline within 48 hours or urine output &lt; 0.5 mL/kg/hr for &gt; 6 hours despite fluid resuscitation when applicable). Patient preoperative characteristics, intraoperative management and outcome were evaluated for associations with acute kidney injury using an univariate and multiple logistic regression model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 1597 patients were admitted to the PACU and of these, 1166 met the inclusion criteria. Eighty-seven patients (7.5%) met AKI criteria. Univariate analysis identified age, American Society of Anesthesiologists (ASA) physical status, emergency surgery, high risk surgery, ischemic heart disease, congestive heart disease and Revised Cardiac Risk Index (RCRI) score as independent preoperative determinants for AKI in the postoperative period. Multivariate analysis identified ASA physical status, RCRI score, high risk surgery and congestive heart disease as preoperative determinants for AKI in the postoperative period. Patients that developed AKI had higher Simplified Acute Physiology Score (SAPS) II and Acute Physiology and Chronic Health Evaluation (APACHE) II, higher PACU length of stay (LOS), higher PACU mortality, higher hospital mortality and higher mortality at 6 months follow-up. AKI was an independent risk factor for hospital mortality (OR 3.12, 95% CI 1.41 to 6.93, P = 0.005).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study shows that age, emergency and high risk surgery, ischemic heart disease, congestive heart disease, ASA physical status and RCRI score were considered risk factors for the development of AKI, in patients needing intensive care after surgery. AKI has serious impact on PACU length of stay and mortality. AKI was an independent risk factor for hospital mortality.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abelha</LastName><ForeName>Fernando Jos&#xe9;</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hospital de S&#xe3;o Jo&#xe3;o, Alameda Professor Hernani Monteiro, Porto 4202-451, Portugal. abelha@mail.telepac.pt</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Botelho</LastName><ForeName>Miguela</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Fernandes</LastName><ForeName>Vera</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Barros</LastName><ForeName>Henrique</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>05</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care. 2009;13(4):171. doi: 10.1186/cc7942.</RefSource><PMID Version="1">19678908</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011174" MajorTopicYN="N" Type="Geographic">Portugal</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2009</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2009</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2009</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>5</Month><Day>26</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>5</Month><Day>26</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2009</Year><Month>5</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19463152</ArticleId><ArticleId IdType="pmc">PMC2717442</ArticleId><ArticleId IdType="doi">10.1186/cc7894</ArticleId><ArticleId IdType="pii">cc7894</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kheterpal S, Tremper KK, Englesbe MJ, O'Reilly M, Shanks AM, Fetterman DM, Rosenberg AL, Swartz RD. Predictors of postoperative renal failure after noncardiac surgery in patients with previously normal renal function. Anesthesiology. 2007;107:892&#x2013;902. doi: 10.1097/01.anes.0000290588.29668.38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.anes.0000290588.29668.38</ArticleId><ArticleId IdType="pubmed">18043057</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16:3365&#x2013;3370. doi: 10.1681/ASN.2004090740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2004090740</ArticleId><ArticleId IdType="pubmed">16177006</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakar CV, Arrigain S, Worley S, Yared JP, Paganini EP. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol. 2005;16:12&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">15563569</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P, Hiesmayr M. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: A prospective cohort study. J Am Soc Nephrol. 2004;15:1597&#x2013;1605. doi: 10.1097/01.ASN.0000130340.93930.DD.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ASN.0000130340.93930.DD</ArticleId><ArticleId IdType="pubmed">15153571</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon PJ, Stafford-Smith M, White WD, Newman MF, King S, Winn P, Landolfo K. Acute renal failure following cardiac surgery. Nephrol Dial Transplant. 1999;14:1158&#x2013;1162. doi: 10.1093/ndt/14.5.1158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/14.5.1158</ArticleId><ArticleId IdType="pubmed">10344355</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Tremper KK, Heung M, Rosenberg AL, Englesbe M, Shanks AM, Campbell DA., Jr Development and validation of an acute kidney injury risk index for patients undergoing general surgery: results from a national data set. Anesthesiology. 2009;110:505&#x2013;515. doi: 10.1097/ALN.0b013e3181979440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3181979440</ArticleId><ArticleId IdType="pubmed">19212261</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin A, Kellum JA, Mehta RL, Acute Kidney Injury Network (AKIN) Acute kidney injury: toward an integrated understanding through development of a research agenda. Clin J Am Soc Nephrol. 2008;3:862&#x2013;863. doi: 10.2215/CJN.04841107.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.04841107</ArticleId><ArticleId IdType="pubmed">18322045</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative workgroup Acute renal failure &#x2013; definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204&#x2013;212. doi: 10.1186/cc2872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc2872</ArticleId><ArticleId IdType="pmc">PMC522841</ArticleId><ArticleId IdType="pubmed">15312219</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruberg L, Mintz GS, Mehran R, Gangas G, Lansky AJ, Kent KM, Pichard AD, Satler LF, Leon MB. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol. 2000;36:1542&#x2013;1548. doi: 10.1016/S0735-1097(00)00917-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(00)00917-7</ArticleId><ArticleId IdType="pubmed">11079656</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Ronco C, Kellum JA, Mehta RL, Pavelsky P. Acute renal failure &#x2013; definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care Med. 2004. pp. R204&#x2013;R212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC522841</ArticleId><ArticleId IdType="pubmed">15312219</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT. Hospital-acquired renal insufficiency: a prospective study. Am J Med. 1983;74:243&#x2013;248. doi: 10.1016/0002-9343(83)90618-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(83)90618-6</ArticleId><ArticleId IdType="pubmed">6824004</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchino S, Bellomo R, Goldsmith D, Bates S, Ronco C. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med. 2006;34:1913&#x2013;1917. doi: 10.1097/01.CCM.0000224227.70642.4F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000224227.70642.4F</ArticleId><ArticleId IdType="pubmed">16715038</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrantes F, Tian J, Vazquez R, Amoateng-Adjepong Y, Manthous CA. Acute kidney injury criteria predict outcomes of critically ill patients. Crit Care Med. 2008;36:1397&#x2013;1403. doi: 10.1097/CCM.0b013e318168fbe0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318168fbe0</ArticleId><ArticleId IdType="pubmed">18434915</ArticleId></ArticleIdList></Reference><Reference><Citation>Abosaif NY, Tolba YA, Heap M, Russell J, El Nahas AM. The outcome of acute renal failure in the intensive care unit according to RIFLE: model application, sensitivity, and predictability. Am J Kidney Dis. 2005;46:1038&#x2013;1048. doi: 10.1053/j.ajkd.2005.08.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2005.08.033</ArticleId><ArticleId IdType="pubmed">16310569</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Duca D, Iqbal S, Rahme E, Goldberg P, de Varennes B. Renal failure after cardiac surgery: timing of cardiac catheterization and other perioperative risk factors. Ann Thorac Surg. 2007;84:1264&#x2013;1271. doi: 10.1016/j.athoracsur.2007.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2007.05.016</ArticleId><ArticleId IdType="pubmed">17888981</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuitunen A, Vento A, Suojaranta-Ylinen R, Pettil&#xe4; V. Acute renal failure after cardiac surgery: evaluation of the RIFLE classification. Ann Thorac Surg. 2006;81:542&#x2013;546. doi: 10.1016/j.athoracsur.2005.07.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2005.07.047</ArticleId><ArticleId IdType="pubmed">16427848</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell M, Liljestam E, Granath F, Fryckstedt J, Ekbom A, Martling CR. Optimal follow-up time after continuous renal replacement therapy in actual renal failure patients stratified with the RIFLE criteria. Nephrol Dial Transplant. 2005;20:354&#x2013;360. doi: 10.1093/ndt/gfh581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfh581</ArticleId><ArticleId IdType="pubmed">15598666</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccariello E, Soares M, Valente C, Nogueira L, Valen&#xe7;a RV, Machado JE, Rocha E. RIFLE classification in patients with acute kidney injury in need of renal replacement therapy. Intensive Care Med. 2007;33:597&#x2013;605. doi: 10.1007/s00134-007-0535-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-007-0535-0</ArticleId><ArticleId IdType="pubmed">17310365</ArticleId></ArticleIdList></Reference><Reference><Citation>Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818&#x2013;829. doi: 10.1097/00003246-198510000-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-198510000-00009</ArticleId><ArticleId IdType="pubmed">3928249</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270:2957&#x2013;2963. doi: 10.1001/jama.270.24.2957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.270.24.2957</ArticleId><ArticleId IdType="pubmed">8254858</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, Sugarbaker DJ, Donaldson MC, Poss R, Ho KK, Ludwig LE, Pedan A. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100:1043&#x2013;1049.</Citation><ArticleIdList><ArticleId IdType="pubmed">10477528</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy VG. Prevention of postoperative acute renal failure. J Postgrad Med. 2002;48:64&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">12082335</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL. From acute renal failure to acute kidney injury: emerging concepts. Crit Care Med. 2008;36:1641&#x2013;1642. doi: 10.1097/CCM.0b013e3181701481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181701481</ArticleId><ArticleId IdType="pubmed">18448916</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL, Pascual MT, Soroko S, Savage BR, Himmelfarb J, Ikizler TA, Paganini EP, Chertow GM. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int. 2004;66:1613&#x2013;1621. doi: 10.1111/j.1523-1755.2004.00927.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1523-1755.2004.00927.x</ArticleId><ArticleId IdType="pubmed">15458458</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali T, Khan I, Simpson W, Prescott G, Townend J, Smith W, Macleod A. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol. 2007;18:1292&#x2013;1298. doi: 10.1681/ASN.2006070756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2006070756</ArticleId><ArticleId IdType="pubmed">17314324</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P, Hiesmayr M. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004;15:1597&#x2013;1605. doi: 10.1097/01.ASN.0000130340.93930.DD.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ASN.0000130340.93930.DD</ArticleId><ArticleId IdType="pubmed">15153571</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricci Z, Cruz D, Ronco C. The RIFLE criteria and mortality in acute kidney injury: A systematic review. Kidney Int. 2008;73:538&#x2013;546. doi: 10.1038/sj.ki.5002743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ki.5002743</ArticleId><ArticleId IdType="pubmed">18160961</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow GM, Lazarus JM, Christiansen CL, Cook EF, Hammermeister KE, Grover F, Daley J. Preoperative renal risk stratification. Circulation. 1997;95:878&#x2013;884.</Citation><ArticleIdList><ArticleId IdType="pubmed">9054745</ArticleId></ArticleIdList></Reference><Reference><Citation>Gijsen R, Hoeymans N, Schellevis FG, Ruwaard D, Satariano WA, Bos GA van den. Causes and consequences of comorbidity: a review. J Clin Epidemiol. 2001;54:661&#x2013;674. doi: 10.1016/S0895-4356(00)00363-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0895-4356(00)00363-2</ArticleId><ArticleId IdType="pubmed">11438406</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannice RFE, Poerio A, Marana E, Mancuso S, Scambia G. Perioperative morbidity and mortality in elderly gynecological oncological patients (&gt;/= 70 Years) by the American Society of Anesthesiologists physical status classes. Ann Surg Oncol. 2004;11:219&#x2013;225. doi: 10.1245/ASO.2004.03.080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/ASO.2004.03.080</ArticleId><ArticleId IdType="pubmed">14761928</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;hrig R, Junger A, Hartmann B, Klasen J, Quinzio L, Jost A, Benson M, Hempelmann G. The incidence and prediction of automatically detected intraoperative cardiovascular events in noncardiac surgery. Anesth Analg. 2004;98:569&#x2013;577. doi: 10.1213/01.ANE.0000103262.26387.9C.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ANE.0000103262.26387.9C</ArticleId><ArticleId IdType="pubmed">14980900</ArticleId></ArticleIdList></Reference><Reference><Citation>Drawz PE, Miller RT, Sehgal AR. Predicting hospital-acquired acute kidney injury &#x2013; a case-controlled study. Ren Fail. 2008;30:848&#x2013;855. doi: 10.1080/08860220802356515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08860220802356515</ArticleId><ArticleId IdType="pubmed">18925522</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostermann M, Chang RW. Acute kidney injury in the intensive care unit according to RIFLE. Crit Care Med. 2007;35:1837&#x2013;1843. doi: 10.1097/01.CCM.0000277041.13090.0A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000277041.13090.0A</ArticleId><ArticleId IdType="pubmed">17581483</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P, Hiesmayr M. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004;15:1597&#x2013;1605. doi: 10.1097/01.ASN.0000130340.93930.DD.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ASN.0000130340.93930.DD</ArticleId><ArticleId IdType="pubmed">15153571</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeysundera DN, Karkouti K, Dupuis JY, Rao V, Chan CT, Granton JT, Beattie WS. Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. JAMA. 2007;297:1801&#x2013;1809. doi: 10.1001/jama.297.16.1801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.297.16.1801</ArticleId><ArticleId IdType="pubmed">17456822</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31801657</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-1983</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Clinical nutrition (Edinburgh, Scotland)</Title><ISOAbbreviation>Clin Nutr</ISOAbbreviation></Journal><ArticleTitle>Hyperosmolar dehydration: A predictor of kidney injury and outcome in hospitalised older adults.</ArticleTitle><Pagination><StartPage>2593</StartPage><EndPage>2599</EndPage><MedlinePgn>2593-2599</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clnu.2019.11.030</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0261-5614(19)33157-7</ELocationID><Abstract><AbstractText Label="BACKGROUND &amp; AIMS">Hospitalised older adults are vulnerable to dehydration. However, the prevalence of hyperosmolar dehydration (HD) and its impact on outcome is unknown. Serum osmolality is not measured routinely but osmolarity, a validated alternative, can be calculated using routinely measured serum biochemistry. This study aimed to use calculated osmolarity to measure the prevalence of HD (serum osmolarity &gt;300 mOsm/l) and assess its impact on acute kidney injury (AKI) and outcome in hospitalised older adults.</AbstractText><AbstractText Label="METHODS">This retrospective cohort study used data from a UK teaching hospital retrieved from the electronic database relating to all medical emergency admissions of patients aged&#xa0;&#x2265;&#xa0;65 years admitted between 1st May 2011 and 31st October 2013. Using these data, Charlson comorbidity index (CCI), National Early Warning Score (NEWS), length of hospital stay (LOS) and mortality were determined. Osmolarity was calculated using the equation of Krahn and Khajuria.</AbstractText><AbstractText Label="RESULTS">A total of 6632 patients were identified; 27% had HD, 39% of whom had AKI. HD was associated with a median (Q1, Q3) LOS of 5 (1, 12) days compared with 3 (1, 9) days in the euhydrated group, P&#xa0;&lt;&#xa0;0.001. Adjusted Cox-regression analysis demonstrated that patients with HD were four-times more likely to develop AKI 12-24&#xa0;h after admission [Hazards Ratio (95% Confidence Interval) 4.5 (3.5-5.6), P&#xa0;&lt;&#xa0;0.001], and had 60% greater 30-day mortality [1.6 (1.4-1.9), P&#xa0;&lt;&#xa0;0.001], compared with those who were euhydrated.</AbstractText><AbstractText Label="CONCLUSION">HD is common in hospitalised older adults and is associated with increased LOS, risk of AKI and mortality. Further work is required to assess the validity of osmolality or osmolarity as an early predictor of AKI and the impact of HD on outcome prospectively.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>El-Sharkawy</LastName><ForeName>Ahmed M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Gastrointestinal Surgery, Nottingham Digestive Diseases Centre, National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Queen's Medical Centre, Nottingham, NG7 2UH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devonald</LastName><ForeName>Mark A J</ForeName><Initials>MAJ</Initials><AffiliationInfo><Affiliation>Renal and Transplant Unit, Nottingham University Hospitals NHS Trust, City Campus, Nottingham, NG5 1PB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Humes</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Gastrointestinal Surgery, Nottingham Digestive Diseases Centre, National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Queen's Medical Centre, Nottingham, NG7 2UH, UK; Division of Epidemiology and Public Health, University of Nottingham, City Campus, Nottingham NG5 1PB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahota</LastName><ForeName>Opinder</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Elderly Medicine, Nottingham University Hospitals NHS Trust, Queen's Medical Centre, Nottingham, NG7 2UH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lobo</LastName><ForeName>Dileep N</ForeName><Initials>DN</Initials><AffiliationInfo><Affiliation>Gastrointestinal Surgery, Nottingham Digestive Diseases Centre, National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Queen's Medical Centre, Nottingham, NG7 2UH, UK; MRC Versus Arthritis Centre for Musculoskeletal Ageing Research, School of Life Sciences, University of Nottingham, Queen's Medical Centre, Nottingham, NG7 2UH, UK. Electronic address: Dileep.Lobo@nottingham.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/P021220/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>PDF-2012-05-431</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/K00414X/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Nutr</MedlineTA><NlmUniqueID>8309603</NlmUniqueID><ISSNLinking>0261-5614</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003681" MajorTopicYN="N">Dehydration</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000080162" MajorTopicYN="N">Early Warning Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007297" MajorTopicYN="N">Inpatients</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009994" MajorTopicYN="N">Osmolar Concentration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044967" MajorTopicYN="N">Serum</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Dehydration</Keyword><Keyword MajorTopicYN="N">Hypohydration</Keyword><Keyword MajorTopicYN="N">Older adults</Keyword><Keyword MajorTopicYN="N">Osmolarity</Keyword><Keyword MajorTopicYN="N">Serum biochemistry</Keyword></KeywordList><CoiStatement>Conflict of interest None of the authors has a direct conflict of interest to declare. DNL has received unrestricted research funding from B. Braun and speaker's honoraria from Fresenius Kabi, B. Braun, Shire and Baxter Healthcare for unrelated work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31801657</ArticleId><ArticleId IdType="pmc">PMC7403861</ArticleId><ArticleId IdType="doi">10.1016/j.clnu.2019.11.030</ArticleId><ArticleId IdType="pii">S0261-5614(19)33157-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>El-Sharkawy A.M., Sahota O., Maughan R.J., Lobo D.N. The pathophysiology of fluid and electrolyte balance in the older adult surgical patient. Clin Nutr. 2014;33:6&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">24308897</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Sharkawy A.M., Watson P., Neal K.R., Ljungqvist O., Maughan R.J., Sahota O. Hydration and outcome in older patients admitted to hospital (The HOOP prospective cohort study) Age Ageing. 2015;44:943&#x2013;947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4621229</ArticleId><ArticleId IdType="pubmed">26316508</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Sharkawy A.M., Virdee A., Wahab A., Humes D.J., Sahota O., Devonald M.A. Dehydration and clinical outcome in hospitalised older adults: a cohort study. Eur Geriatr Med. 2017;8:22&#x2013;29.</Citation></Reference><Reference><Citation>Institute of Medicine . National Academy Press; Washington DC: 2005. Dietary Reference Intakes for Dietary reference intakes for water, potassium, sodium, chloride, and sulfate.</Citation></Reference><Reference><Citation>Eaton D., Bannister P., Mulley G.P., Connolly M.J. Axillary sweating in clinical assessment of dehydration in ill elderly patients. BMJ. 1994;308:1271.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2540218</ArticleId><ArticleId IdType="pubmed">8205020</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas D.R., Cote T.R., Lawhorne L., Levenson S.A., Rubenstein L.Z., Smith D.A. Understanding clinical dehydration and its treatment. J&#xa0;Am Med Dir Assoc. 2008;9:292&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pubmed">18519109</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong L.E. Assessing hydration status: the elusive gold standard. J&#xa0;Am Coll Nutr. 2007;26(sup5):575S&#x2013;584S.</Citation><ArticleIdList><ArticleId IdType="pubmed">17921468</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong L.E. Hydration assessment techniques. Nutr Rev. 2005;63(s1):S40&#x2013;S54.</Citation><ArticleIdList><ArticleId IdType="pubmed">16028571</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazekas A.S., Funk G.C., Klobassa D.S., R&#xfc;ther H., Ziegler I., Zander R. Evaluation of 36 formulas for calculating plasma osmolality. Intensive Care Med. 2013;39:302&#x2013;308.</Citation><ArticleIdList><ArticleId IdType="pubmed">23081685</ArticleId></ArticleIdList></Reference><Reference><Citation>Siervo M., Bunn D., Prado C.M., Hooper L. Accuracy of prediction equations for serum osmolarity in frail older people with and without diabetes. Am J Clin Nutr. 2014;100:867&#x2013;876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4135495</ArticleId><ArticleId IdType="pubmed">25030781</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Calderon J.L., Bustos F., Tuesta-Reina L.R., Varona J.M., Caballero L., Solano F. Choice of the best equation for plasma osmolality calculation: comparison of fourteen formulae. Clin Biochem. 2015;48:529&#x2013;533.</Citation><ArticleIdList><ArticleId IdType="pubmed">25794428</ArticleId></ArticleIdList></Reference><Reference><Citation>Stookey J.D. High prevalence of plasma hypertonicity among community-dwelling older adults: results from NHANES III. J&#xa0;Am Diet Assoc. 2005;105:1231&#x2013;1239.</Citation><ArticleIdList><ArticleId IdType="pubmed">16182639</ArticleId></ArticleIdList></Reference><Reference><Citation>Stookey J.D., Pieper C.F., Cohen H.J. Is the prevalence of dehydration among community-dwelling older adults really low? Informing current debate over the fluid recommendation for adults aged 70+years. Public Health Nutr. 2005;8:1275&#x2013;1285.</Citation><ArticleIdList><ArticleId IdType="pubmed">16372923</ArticleId></ArticleIdList></Reference><Reference><Citation>Krahn J., Khajuria A. Osmolality gaps: diagnostic accuracy and long-term variability. Clin Chem. 2006;52:737&#x2013;739.</Citation><ArticleIdList><ArticleId IdType="pubmed">16455871</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuhaci B. More data on epidemiology and outcome of acute kidney injury with AKIN criteria: benefits of standardized definitions, AKIN and RIFLE classifications. Crit Care Med. 2009;37:2659&#x2013;2661.</Citation><ArticleIdList><ArticleId IdType="pubmed">19687640</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter C.J., Juurlink I., Bisset L.H., Bavakunji R., Mehta R.L., Devonald M.A. A&#xa0;real-time electronic alert to improve detection of acute kidney injury in a large teaching hospital. Nephrol Dial Transplant. 2014;29:1888&#x2013;1893.</Citation><ArticleIdList><ArticleId IdType="pubmed">24744280</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren J.L., Bacon W.E., Harris T., McBean A.M., Foley D.J., Phillips C. The burden and outcomes associated with dehydration among US elderly, 1991. Am J Public Health. 1994;84:1265&#x2013;1269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1615468</ArticleId><ArticleId IdType="pubmed">8059883</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindeman R.D., Tobin J., Shock N.W. Longitudinal studies on the rate of decline in renal function with age. J&#xa0;Am Geriatr Soc. 1985;33:278&#x2013;285.</Citation><ArticleIdList><ArticleId IdType="pubmed">3989190</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies D.F., Shock N.W. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J&#xa0;Clin Invest. 1950;29:496&#x2013;507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC436086</ArticleId><ArticleId IdType="pubmed">15415454</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollenberg N.K., Adams D.F., Solomon H.S., Rashid A., Abrams H.L., Merrill J.P. Senescence and the renal vasculature in normal man. Circ Res. 1974;34:309&#x2013;316.</Citation><ArticleIdList><ArticleId IdType="pubmed">4362036</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck L.H. The aging kidney. Defending a delicate balance of fluid and electrolytes. Geriatrics. 2000;55(26&#x2013;8):31&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">10771700</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart J., Findlay G., Smith N., Kelly K., Mason M.  National Confidential Enquiry into Patient Outcome and Death; London: 2009. Adding Insult to Injury: a review of the care of patients who died in hospital with a primary diagnosis of acute kidney injury (acute renal failure)http://www.ncepod.org.uk/2009report1/Downloads/AKI_report.pdf Available at:</Citation></Reference><Reference><Citation>Ftouh S., Thomas M. Acute kidney injury: summary of NICE guidance. BMJ. 2013;347:f4930.</Citation><ArticleIdList><ArticleId IdType="pubmed">23985310</ArticleId></ArticleIdList></Reference><Reference><Citation>Wierenga P.C., Buurman B.M., Parlevliet J.L., van Munster B.C., Smorenburg S.M., Inouye S.K. Association between acute geriatric syndromes and medication-related hospital admissions. Drugs Aging. 2012;29:691&#x2013;699.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3622589</ArticleId><ArticleId IdType="pubmed">22812539</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandhofer A., Kahler C., Heininger D., Bellmann R., Wiedermann C.J., Joannidis M. Severe electrolyte disturbances and renal failure in elderly patients with combined diuretic therapy including xipamid. Wien Klin Wochenschr. 2002;114:938&#x2013;942.</Citation><ArticleIdList><ArticleId IdType="pubmed">12528327</ArticleId></ArticleIdList></Reference><Reference><Citation>Klopotowska J.E., Wierenga P.C., Smorenburg S.M., Stuijt C.C., Arisz L., Kuks P.F. Recognition of adverse drug events in older hospitalized medical patients. Eur J Clin Pharmacol. 2013;69:75&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3536996</ArticleId><ArticleId IdType="pubmed">22673927</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120:c179&#x2013;c184.</Citation><ArticleIdList><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Moran S.M., Myers B.D. Course of acute renal failure studied by a model of creatinine kinetics. Kidney Int. 1985;27:928&#x2013;937.</Citation><ArticleIdList><ArticleId IdType="pubmed">4021321</ArticleId></ArticleIdList></Reference><Reference><Citation>Star R.A. Treatment of acute renal failure. Kidney Int. 1998;54:1817&#x2013;1831.</Citation><ArticleIdList><ArticleId IdType="pubmed">9853246</ArticleId></ArticleIdList></Reference><Reference><Citation>Doctor Foster Intelligence http://myhospitalguide.drfosterintelligence.co.uk/#/mortality Available at:</Citation></Reference><Reference><Citation>Care Quality Commission http://www.cqc.org.uk/provider/RX1/inspection-summary#overall Available at:</Citation></Reference><Reference><Citation>Rohla M., Freynhofer M.K., Tentzeris I., Farhan S., Wojta J., Huber K. Plasma osmolality predicts clinical outcome in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Eur Heart J Acute Cardiovasc Care. 2014;3:84&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3932780</ArticleId><ArticleId IdType="pubmed">24337920</ArticleId></ArticleIdList></Reference><Reference><Citation>Villani A., D'Alessandro A., Magalini S., Barbi S., Bondoli A. Osmolality measurements in heart disease. Resuscitation. 1978;6:77&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">674882</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhalla A., Sankaralingam S., Dundas R., Swaminathan R., Wolfe C.D., Rudd A.G. Influence of raised plasma osmolality on clinical outcome after acute stroke. Stroke. 2000;31:2043&#x2013;2048.</Citation><ArticleIdList><ArticleId IdType="pubmed">10978027</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Sharkawy A.M., Sahota O., Lobo D.N. Acute and chronic effects of hydration status on health. Nutr Rev. 2015;73(Suppl 2):97&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pubmed">26290295</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong L.E., Maresh C.M., Gabaree C.V., Hoffman J.R., Kavouras S.A., Keneflick R.W. Thermal and circulatory responses during exercise: effects of hypohydration, dehydration, and water intake. J&#xa0;Appl Physiol. 1997;82:2028&#x2013;2035.</Citation><ArticleIdList><ArticleId IdType="pubmed">9173973</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheuvront S.N., Kenefick R.W., Charkoudian N., Sawka M.N. Physiologic basis for understanding quantitative dehydration assessment. Am J Clin Nutr. 2013;97:455&#x2013;462.</Citation><ArticleIdList><ArticleId IdType="pubmed">23343973</ArticleId></ArticleIdList></Reference><Reference><Citation>Powell A.G., Paterson-Brown S. FY1 doctors still poor in prescribing intravenous fluids. BMJ. 2011;342:d2741.</Citation><ArticleIdList><ArticleId IdType="pubmed">21586458</ArticleId></ArticleIdList></Reference><Reference><Citation>Leach R.M., Brotherton A., Stroud M., Thompson R. Nutrition and fluid balance must be taken seriously. BMJ. 2013;346:f801.</Citation><ArticleIdList><ArticleId IdType="pubmed">23396386</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37726880</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-6576</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Acta anaesthesiologica Scandinavica</Title><ISOAbbreviation>Acta Anaesthesiol Scand</ISOAbbreviation></Journal><ArticleTitle>The epidemiology and outcomes of acute kidney injury following orthopaedic procedures: A retrospective cohort study.</ArticleTitle><Pagination><StartPage>26</StartPage><EndPage>34</EndPage><MedlinePgn>26-34</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/aas.14332</ELocationID><Abstract><AbstractText Label="BACKGROUND">Acute kidney injury (AKI) is a serious complication following major surgery. This study examined the incidence and risk factors of AKI following orthopaedic surgeries in an Icelandic cohort, as well as the association between AKI and patient- and surgery-related factors.</AbstractText><AbstractText Label="METHODS">This retrospective cohort study comprised all patients 18&#x2009;years and older who underwent orthopaedic surgeries at Landspitali - The National University Hospital in the years 2006-2018 with available serum creatinine (SCr) measurements adjacent to the surgery to stage AKI. AKI was defined according to SCr portion of the KDIGO criteria. Logistic regression was used to identify patient- and surgical factors related to progression of AKI and Poisson-regression was used to explore changes in incidence.</AbstractText><AbstractText Label="RESULTS">A total of 222 cases of AKI following 3208 surgeries (6.9%) were identified in the study period with a rise in the incidence by about 17% per year. Higher age (odds ratio (OR), 1.02, 95% confidence interval (CI), 1.01-1.04 per year) and underlying reduction in kidney function (OR 1.93 (1.30-2.81), 3.24 (2.08-4.96) and 4.08 (2.35-6.96) for estimated glomerular filtration rate (eGFR) of 30-59, 15-29 and &lt;15&#x2009;mL/min/1.73&#x2009;m<sup>2</sup> compared with eGFR &gt;60&#x2009;mL/min/1.73&#x2009;m<sup>2</sup> ) were associated with higher risk of AKI, but female sex was associated with decreased odds (OR&#x2009;=&#x2009;0.73; 95% CI, 0.54-0.98). After correcting for age, sex, preoperative kidney function, emergency surgery and underlying comorbidities and frailty, there was an increased risk of long-term mortality in patients with AKI (HR 1.41, 95% CI 1.08-1.85), and patients who developed AKI also had accelerated progression of chronic kidney disease compared with patients who did not develop AKI.</AbstractText><AbstractText Label="CONCLUSIONS">The incidence of AKI following orthopaedic surgeries is increasing and is associated with adverse outcomes. It is important that elderly individuals and patients who have reduced kidney function receive adequate monitoring and surveillance in the perioperative period.</AbstractText><CopyrightInformation>&#xa9; 2023 Acta Anaesthesiologica Scandinavica Foundation.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thorsdottir</LastName><ForeName>Helga</ForeName><Initials>H</Initials><Identifier Source="ORCID">0009-0005-0028-4204</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Thorir E</ForeName><Initials>TE</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Skane University Hospital, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palsson</LastName><ForeName>Runolfur</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-6763-1702</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Nephrology, Internal Medicine and Emergency Services, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sigurdsson</LastName><ForeName>Martin I</ForeName><Initials>MI</Initials><Identifier Source="ORCID">0000-0001-7054-0844</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Anesthesia and Intensive Care Medicine, Perioperative Services, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Landspitali Science Fund</Agency><Country/></Grant><Grant><Agency>University of Iceland Science Fund</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Anaesthesiol Scand</MedlineTA><NlmUniqueID>0370270</NlmUniqueID><ISSNLinking>0001-5172</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009985" MajorTopicYN="Y">Orthopedics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="Y">Renal Insufficiency, Chronic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005919" MajorTopicYN="N">Glomerular Filtration Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">arthroplasty</Keyword><Keyword MajorTopicYN="N">chronic kidney insufficiency</Keyword><Keyword MajorTopicYN="N">hip replacement</Keyword><Keyword MajorTopicYN="N">knee replacement</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>20</Day><Hour>0</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37726880</ArticleId><ArticleId IdType="doi">10.1111/aas.14332</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Grams ME, Sang Y, Ballew SH, et al. A meta-analysis of the association of estimated GFR, albuminuria, age, race, and sex with acute kidney injury. Am J Kidney Dis. 2015;66:591-601.</Citation></Reference><Reference><Citation>Chawla LS, Eggers PW, Star RA, Kimmel PL. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med. 2014;371:58-66.</Citation></Reference><Reference><Citation>Wang HE, Muntner P, Chertow GM, Warnock DG. Acute kidney injury and mortality in hospitalized patients. Am J Nephrol. 2012;35:349-355.</Citation></Reference><Reference><Citation>Xue JL, Daniels F, Star RA, et al. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol. 2006;17:1135-1142.</Citation></Reference><Reference><Citation>Silver SA, Long J, Zheng Y, Chertow GM. Cost of acute kidney injury in hospitalized patients. J Hosp Med. 2017;12:70-76.</Citation></Reference><Reference><Citation>Ishani A, Nelson D, Clothier B, et al. The magnitude of acute serum creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease, and death. Arch Intern Med. 2011;171:226-233.</Citation></Reference><Reference><Citation>Newsome BB, Warnock DG, McClellan WM, et al. Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med. 2008;168:609-616.</Citation></Reference><Reference><Citation>Susantitaphong P, Cruz DN, Cerda J, et al. World incidence of AKI: a meta-analysis. Clin J Am Soc Nephrol. 2013;8:1482-1493.</Citation></Reference><Reference><Citation>Wonnacott A, Meran S, Amphlett B, Talabani B, Phillips A. Epidemiology and outcomes in community-acquired versus hospital-acquired AKI. Clin J Am Soc Nephrol. 2014;9:1007-1014.</Citation></Reference><Reference><Citation>Lenihan CR, Montez-Rath ME, Mora Mangano CT, Chertow GM, Winkelmayer WC. Trends in acute kidney injury, associated use of dialysis, and mortality after cardiac surgery, 1999 to 2008. Ann Thorac Surg. 2013;95:20-28.</Citation></Reference><Reference><Citation>Long TE, Helgason D, Helgadottir S, et al. Acute kidney injury after abdominal surgery: incidence, risk factors, and outcome. Anesth Analg. 2016;122:1912-1920.</Citation></Reference><Reference><Citation>Bell S, Dekker FW, Vadiveloo T, et al. Risk of postoperative acute kidney injury in patients undergoing orthopaedic surgery-development and validation of a risk score and effect of acute kidney injury on survival: observational cohort study. BMJ. 2015;351:h5639.</Citation></Reference><Reference><Citation>Ulucay C, Eren Z, Kaspar EC, et al. Risk factors for acute kidney injury after hip fracture surgery in the elderly individuals. Geriatr Orthop Surg Rehabil. 2012;3:150-156.</Citation></Reference><Reference><Citation>Calvert S, Shaw A. Perioperative acute kidney injury. Perioper Med (Lond). 2012;1:6.</Citation></Reference><Reference><Citation>Kurth MJ, McBride WT, McLean G, et al. Acute kidney injury risk in orthopaedic trauma patients pre and post surgery using a biomarker algorithm and clinical risk score. Sci Rep. 2020;10:20005.</Citation></Reference><Reference><Citation>Sigurdsson MI, Helgadottir S, Long TE, et al. Association between preoperative opioid and benzodiazepine prescription patterns and mortality after noncardiac surgery. JAMA Surg. 2019;154:e191652.</Citation></Reference><Reference><Citation>Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1-138.</Citation></Reference><Reference><Citation>Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8-27.</Citation></Reference><Reference><Citation>van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care. 2009;47:626-633.</Citation></Reference><Reference><Citation>Gilbert T, Neuburger J, Kraindler J, et al. Development and validation of a hospital frailty risk score focusing on older people in acute care settings using electronic hospital records: an observational study. Lancet. 2018;391:1775-1782.</Citation></Reference><Reference><Citation>French WB, Shah PR, Fatani YI, et al. Mortality and costs associated with acute kidney injury following major elective, non-cardiac surgery. J Clin Anesth. 2022;82:110933.</Citation></Reference><Reference><Citation>Chaudery H, MacDonald N, Ahmad T, et al. Acute kidney injury and risk of death after elective surgery: prospective analysis of data from an international cohort study. Anesth Analg. 2019;128:1022-1029.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27505178</PMID><DateCompleted><Year>2017</Year><Month>03</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1440-1797</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Nephrology (Carlton, Vic.)</Title><ISOAbbreviation>Nephrology (Carlton)</ISOAbbreviation></Journal><ArticleTitle>Initiation time of renal replacement therapy on patients with acute kidney injury: A systematic review and meta-analysis of 8179 participants.</ArticleTitle><Pagination><StartPage>7</StartPage><EndPage>18</EndPage><MedlinePgn>7-18</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/nep.12890</ELocationID><Abstract><AbstractText>The early initiation of renal replacement therapy has been recommended for patients with acute renal failure by some studies, but its effects on mortality and renal recovery are unknown. We conducted an updated meta-analysis to provide quantitative evaluations of the association between the early initiation of renal replacement therapy and mortality for patients with acute kidney injury. After applying inclusion/exclusion criteria, 51 studies, including 10 randomized controlled trials, with a total of 8179 patients were analyzed. Analysis of the included trials showed that patients receiving early renal replacement therapy had a 25% reduction in all-cause mortality compared to those receiving late renal replacement therapy (risk ratio [RR] 0.75, 95% CI [0.69, 0.82]). We also noted a 30% increase in renal recovery (RR 1.30, 95% CI [1.07, 1.56]), a reduction in hospitalization of 5.84&#x2009;days (mean difference [MD], 95% CI [-10.27, -1.41]) and a reduction in the duration of mechanical ventilation of 2.33&#x2009;days (MD, 95% CI [-3.40, -1.26]) in patients assigned to early renal replacement therapy. The early initiation of renal replacement therapy was associated with a decreased risk of all-cause mortality compared with the late initiation of RRT in patients with acute kidney injury. These findings should be interpreted with caution given the heterogeneity between studies. Further studies are needed to identify the causes of mortality and to assess whether mortality differs by dialysis dose.</AbstractText><CopyrightInformation>&#xa9; 2016 Asian Pacific Society of Nephrology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Caixia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Nephrology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Lin-Sheng</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Operation Room, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Guangdong Province Key Laboratory of Arrhythmia and Electrophysiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guan</LastName><ForeName>Jianqiang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Zengchun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Nephrology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shaomin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Nephrology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yanni</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Nephrology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lou</LastName><ForeName>Tanqi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Nephrology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Nephrology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Nephrology (Carlton)</MedlineTA><NlmUniqueID>9615568</NlmUniqueID><ISSNLinking>1320-5358</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002423" MajorTopicYN="N">Cause of Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020127" MajorTopicYN="N">Recovery of Function</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="Y">Renal Replacement Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061665" MajorTopicYN="Y">Time-to-Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">initiation time</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">renal replacement therapy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27505178</ArticleId><ArticleId IdType="doi">10.1111/nep.12890</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38718686</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Perioperative adverse events in adult patients with obstructive sleep apnea undergoing ambulatory surgery: An updated systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>111464</StartPage><MedlinePgn>111464</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2024.111464</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(24)00093-X</ELocationID><Abstract><AbstractText Label="BACKGROUND">The suitability of ambulatory surgery for patients with obstructive sleep apnea (OSA) remains controversial. This systematic review and meta-analysis aimed to evaluate the odds of perioperative adverse events in patients with OSA undergoing ambulatory surgery, compared to patients without OSA.</AbstractText><AbstractText Label="METHODS">Four electronic databases were searched for studies published between January 1, 2011 and July 11, 2023. The inclusion criteria were: adult patients with diagnosed or high-risk of OSA undergoing ambulatory surgery; perioperative adverse events; control group included; general and/or regional anesthesia; and publication on/after February 1, 2011. We calculated effect sizes as odds ratios using a random effects model, and additional sensitivity analyses were conducted.</AbstractText><AbstractText Label="RESULTS">Seventeen studies (375,389 patients) were included. OSA was associated with an increased odds of same-day admission amongst all surgery types (OR 1.94, 95% CI 1.46-2.59, I<sup>2</sup>:79%, P&#xa0;&lt;&#xa0;0.00001, 11 studies, n&#xa0;=&#xa0;347,342), as well as when only orthopedic surgery was considered (OR 2.68, 95% CI 2.05-3.48, I<sup>2</sup>:41%, P&#xa0;&lt;&#xa0;0.00001, 6 studies, n&#xa0;=&#xa0;132,473). Three studies reported that OSA was strongly associated with prolonged post anesthesia care unit (PACU) length of stay (LOS), while one study reported that the association was not statistically significant. In addition, four studies reported that OSA was associated with postoperative respiratory depression/hypoxia, with one large study on shoulder arthroscopy reporting an almost 5-fold increased odds of pulmonary compromise, 5-fold of myocardial infarction, 3-fold of acute renal failure, and 5-fold of intensive care unit (ICU) admission.</AbstractText><AbstractText Label="CONCLUSIONS">Ambulatory surgical patients with OSA had almost two-fold higher odds of same-day admission compared to non-OSA patients. Multiple large studies also reported an association of OSA with prolonged PACU LOS, respiratory complications, and/or ICU admission. Clinicians should screen preoperatively for OSA, optimize comorbidities, adhere to clinical algorithm-based management perioperatively, and maintain a high degree of vigilance in the postoperative period.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ceban</LastName><ForeName>Felicia</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Ellene</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Management, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pivetta</LastName><ForeName>Bianca</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Management, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saripella</LastName><ForeName>Aparna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Management, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Englesakis</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Library &amp; Information Services, University Health Network, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gan</LastName><ForeName>Tong J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Division of Anesthesiology and Perioperative Medicine, Critical Care and Pain Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joshi</LastName><ForeName>Girish P</ForeName><Initials>GP</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Frances</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Management, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, ON, Canada. Electronic address: frances.chung@uhn.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020181" MajorTopicYN="Y">Sleep Apnea, Obstructive</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000556" MajorTopicYN="Y">Ambulatory Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="Y">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000762" MajorTopicYN="N">Anesthesia Recovery Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of competing interest This research did not receive any grants or funding.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>15</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>9</Day><Hour>0</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>8</Day><Hour>18</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38718686</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2024.111464</ArticleId><ArticleId IdType="pii">S0952-8180(24)00093-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39679133</PMID><DateCompleted><Year>2024</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1177-8881</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Drug design, development and therapy</Title><ISOAbbreviation>Drug Des Devel Ther</ISOAbbreviation></Journal><ArticleTitle>Intraoperative Use of Sodium Bicarbonate Ringer's Solution Instead of Sodium Lactate Ringer's Solution to Reduce Endothelial Glycocalyx Degradation and Improve Postoperative Recovery During Cardiopulmonary Bypass Cardiac Surgery: A Single-Center Prospective Cohort Study.</ArticleTitle><Pagination><StartPage>5881</StartPage><EndPage>5893</EndPage><MedlinePgn>5881-5893</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/DDDT.S501657</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To investigate the effect of sodium bicarbonate Ringer's solution (BRS) on the degradation of endothelial glycocalyx components in patients undergoing cardiopulmonary bypass (CPB) during cardiac surgery, and to evaluate its impact on endothelial glycocalyx preservation and postoperative recovery.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="UNASSIGNED">A total of eight patients scheduled for elective CPB heart surgery were included and randomly divided into two groups: the sodium lactate Ringer's solution (LRS) group and the BRS group. ELISA was used to measure plasma concentrations of syndecan-1, matrix metalloproteinase-9 (MMP-9), matrix metalloproteinase-3 (MMP-3), IL-6, IL-8, TNF-&#x3b1;, and TGF-&#x3b2; at predefined time points: T0 (before induction of anesthesia), T3 (immediately after weaning from CPB), T5 and T6 (24 and 72&#xa0;hours postoperatively). Serum creatinine concentrations were measured within 48&#xa0;hours postoperatively. The incidence of postoperative delirium (POD) was assessed three days after surgery. Postoperative mechanical ventilation time, duration of stay in the intensive care unit and hospital stay were also documented.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The BRS group had significantly lower plasma concentrations of syndecan-1 at T3 (7.98 [7.43, 8.92] ng/mL vs 9.54 [8.4, 10.73] ng/mL, <i>P</i> &lt; 0.001) and T5 (4.20 [3.31, 4.96] ng/mL vs 5.40 [3.95, 6.55] ng/mL, <i>P</i> = 0.001) in comparison with the LRS group (<i>P</i>&lt;0.01). Syndecan-1 levels in both groups were similar at T6 (3.18 [2.88, 3.5]ng/mL vs 3.12 [2.77, 3.45] ng/mL, <i>P</i> &gt; 0.05). Additionally, MMP-9, MMP-3, IL-6 and IL-8 were significantly lower at T3 and T5 in the BRS group (<i>P</i>&lt;0.05 and <i>P</i>&lt;0.01, respectively). However, no significant differences were observed between the two groups in the incidence of acute kidney injury (AKI) or POD (<i>P</i> &gt; 0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">BRS has the potential to reduce glycocalyx degradation in patients undergoing heart valve surgery with CPB. However, both groups demonstrated similar post-postoperative clinical outcomes, including the rates of AKI and POD.</AbstractText><CopyrightInformation>&#xa9; 2024 Shi et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Shi</LastName><ForeName>Yujie</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Shi</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Wannan Medical College, Wuhu, Anhui, 241000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tao</LastName><ForeName>Yujia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Bingyan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiaoming</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Yanhu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Drug Des Devel Ther</MedlineTA><NlmUniqueID>101475745</NlmUniqueID><ISSNLinking>1177-8881</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077325">Ringer's Lactate</NameOfSubstance></Chemical><Chemical><RegistryNumber>8MDF5V39QO</RegistryNumber><NameOfSubstance UI="D017693">Sodium Bicarbonate</NameOfSubstance></Chemical><Chemical><RegistryNumber>8026-10-6</RegistryNumber><NameOfSubstance UI="D000077331">Ringer's Solution</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019276" MajorTopicYN="Y">Glycocalyx</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="Y">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077325" MajorTopicYN="Y">Ringer's Lactate</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017693" MajorTopicYN="N">Sodium Bicarbonate</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077331" MajorTopicYN="N">Ringer's Solution</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">endothelial glycocalyx</Keyword><Keyword MajorTopicYN="N">postoperative recovery</Keyword><Keyword MajorTopicYN="N">sodium bicarbonate Ringer&#x2019;s solution</Keyword></KeywordList><CoiStatement>Yujie Shi and Yuan Shi are co-first authors. The authors state that there are no conflicts of interest associated with this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>16</Day><Hour>17</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>16</Day><Hour>17</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>16</Day><Hour>7</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>12</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39679133</ArticleId><ArticleId IdType="pmc">PMC11645961</ArticleId><ArticleId IdType="doi">10.2147/DDDT.S501657</ArticleId><ArticleId IdType="pii">501657</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bartoszko J, Karkouti K. Managing the coagulopathy associated with cardiopulmonary bypass. J Thromb Haemost. 2021;19(3):617&#x2013;632. doi:10.1111/jth.15195</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15195</ArticleId><ArticleId IdType="pubmed">33251719</ArticleId></ArticleIdList></Reference><Reference><Citation>Do-Nguyen CC, Sturmer DL, Yang G, et al. Oxygen delivery thresholds during cardiopulmonary bypass and risk for acute kidney injury. Ann Thorac Surg. 2023;116(3):607&#x2013;613. doi:10.1016/j.athoracsur.2023.04.049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2023.04.049</ArticleId><ArticleId IdType="pubmed">37271444</ArticleId></ArticleIdList></Reference><Reference><Citation>Bangalore H, Carter MJ, Parmar K, et al. Degradation of the endothelial glycocalyx contributes to metabolic acidosis in children following cardiopulmonary bypass surgery. Pediatr Crit Care Med. 2021;22(11):e571&#x2013;e581. doi:10.1097/PCC.0000000000002746</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0000000000002746</ArticleId><ArticleId IdType="pubmed">33950888</ArticleId></ArticleIdList></Reference><Reference><Citation>Xian-Yu CY, Xu JB, Ma YT, et al. Management of priming fluids in cardiopulmonary bypass for adult cardiac surgery: network meta-analysis. Ann Med. 2023;55(2):2246996. doi:10.1080/07853890.2023.2246996</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2023.2246996</ArticleId><ArticleId IdType="pmc">PMC10446774</ArticleId><ArticleId IdType="pubmed">37607247</ArticleId></ArticleIdList></Reference><Reference><Citation>Nam JS, Kim WJ, Seo WW, et al. Effects of balanced versus saline-based solutions on acute kidney injury in off-pump coronary artery bypass surgery: a randomized controlled trial. J Cardiothorac Vasc Anesth. 2024;38(9):1923&#x2013;1931. doi:10.1053/j.jvca.2024.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2024.06.001</ArticleId><ArticleId IdType="pubmed">38960803</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlasov H, Wilkman E, Pet&#xe4;j&#xe4; L, et al. Comparison of 4% albumin and Ringer&#x2019;s acetate on hemodynamics in on-pump cardiac surgery: an exploratory analysis of a randomized clinical trial. J Cardiothorac Vasc Anesth. 2024. doi:10.1053/j.jvca.2024.07.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2024.07.025</ArticleId><ArticleId IdType="pubmed">39098542</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins MG, Fahim MA, Pascoe EM, et al. Balanced crystalloid solution versus saline in deceased donor kidney transplantation (BEST-Fluids): a pragmatic, double-blind, randomised, controlled trial. Lancet. 2023;402(10396):105&#x2013;117. doi:10.1016/S0140-6736(23)00642-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)00642-6</ArticleId><ArticleId IdType="pubmed">37343576</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafique MA, Shaikh NA, Haseeb A, et al. Sodium bicarbonate Ringer&#x2019;s solution for hemorrhagic shock: a meta-analysis comparing crystalloid solutions. Am J Emerg Med. 2024;76:41&#x2013;47. doi:10.1016/j.ajem.2023.11.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2023.11.003</ArticleId><ArticleId IdType="pubmed">37988980</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai S, Li J, Gao J, et al. Prediction models for postoperative delirium after cardiac surgery: systematic review and critical appraisal. Int J Nurs Stud. 2022;136:104340. doi:10.1016/j.ijnurstu.2022.104340</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijnurstu.2022.104340</ArticleId><ArticleId IdType="pubmed">36208541</ArticleId></ArticleIdList></Reference><Reference><Citation>Milam AJ, Liang C, Mi J, et al. Derivation and validation of clinical phenotypes of the cardiopulmonary bypass-induced inflammatory response. Anesth Analg. 2023;136(3):507&#x2013;517. doi:10.1213/ANE.0000000000006247</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000006247</ArticleId><ArticleId IdType="pubmed">36730794</ArticleId></ArticleIdList></Reference><Reference><Citation>Menzenbach J, Frede S, Petras J, et al. Perioperative vascular biomarker profiling in elective surgery patients developing postoperative delirium: a prospective cohort study. Biomedicines. 2021;9(5):553. doi:10.3390/biomedicines9050553</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9050553</ArticleId><ArticleId IdType="pmc">PMC8155907</ArticleId><ArticleId IdType="pubmed">34063403</ArticleId></ArticleIdList></Reference><Reference><Citation>Thudium M, Ellerkmann RK, Heinze I, et al. Relative cerebral hyperperfusion during cardiopulmonary bypass is associated with risk for postoperative delirium: a cross-sectional cohort study. BMC Anesthesiol. 2019;19(1):35. doi:10.1186/s12871-019-0705-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-019-0705-y</ArticleId><ArticleId IdType="pmc">PMC6408763</ArticleId><ArticleId IdType="pubmed">30851736</ArticleId></ArticleIdList></Reference><Reference><Citation>Turgut F, Awad AS, Abdel-Rahman EM. Acute kidney injury: medical causes and pathogenesis. J Clin Med. 2023;12(1):375. doi:10.3390/jcm12010375</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12010375</ArticleId><ArticleId IdType="pmc">PMC9821234</ArticleId><ArticleId IdType="pubmed">36615175</ArticleId></ArticleIdList></Reference><Reference><Citation>Foote CA, Soares RN, Ramirez-Perez FI, et al. Endothelial glycocalyx. Compr Physiol. 2022;12(4):3781&#x2013;3811. doi:10.1002/cphy.c210029</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cphy.c210029</ArticleId><ArticleId IdType="pmc">PMC10214841</ArticleId><ArticleId IdType="pubmed">35997082</ArticleId></ArticleIdList></Reference><Reference><Citation>Piotti A, Novelli D, Meessen J, et al. Endothelial damage in septic shock patients as evidenced by circulating syndecan-1, sphingosine-1-phosphate and soluble VE-cadherin: a substudy of ALBIOS. Crit Care. 2021;25(1):113. doi:10.1186/s13054-021-03545-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03545-1</ArticleId><ArticleId IdType="pmc">PMC7980645</ArticleId><ArticleId IdType="pubmed">33741039</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusuzawa K, Suzuki K, Okada H, et al. Measuring the concentration of serum syndecan-1 to assess vascular endothelial glycocalyx injury during hemodialysis. Front Med. 2021;8:791309. doi:10.3389/fmed.2021.791309</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.791309</ArticleId><ArticleId IdType="pmc">PMC8733596</ArticleId><ArticleId IdType="pubmed">35004758</ArticleId></ArticleIdList></Reference><Reference><Citation>Jufar AH, Lankadeva YR, May CN, et al. Renal and cerebral hypoxia and inflammation during cardiopulmonary bypass. Compr Physiol. 2021;12(1):2799&#x2013;2834. doi:10.1002/cphy.c210019</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cphy.c210019</ArticleId><ArticleId IdType="pubmed">34964119</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X, Hu H, Sun T, et al. Plasma endothelial glycocalyx components as a potential biomarker for predicting the development of disseminated intravascular coagulation in patients with sepsis. J Intensive Care Med. 2021;36(11):1286&#x2013;1295. doi:10.1177/0885066620949131</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066620949131</ArticleId><ArticleId IdType="pubmed">32799720</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Han D, Zhang K, et al. Observation on the effectiveness and safety of sodium bicarbonate Ringer&#x2019;s solution in the early resuscitation of traumatic hemorrhagic shock: a clinical single-center prospective randomized controlled trial. Trials. 2022;23(1):825. doi:10.1186/s13063-022-06752-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-022-06752-5</ArticleId><ArticleId IdType="pmc">PMC9523956</ArticleId><ArticleId IdType="pubmed">36175936</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179&#x2013;c184. doi:10.1159/000339789</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000339789</ArticleId><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamrangsekachaee M, Wen K, Yazdani N, et al. Endothelial glycocalyx sensitivity to chemical and mechanical sub-endothelial substrate properties. Front Bioeng Biotechnol. 2023;11:1250348. doi:10.3389/fbioe.2023.1250348</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fbioe.2023.1250348</ArticleId><ArticleId IdType="pmc">PMC10643223</ArticleId><ArticleId IdType="pubmed">38026846</ArticleId></ArticleIdList></Reference><Reference><Citation>Fei Y, Huang X, Ning F, et al. NETs induce ferroptosis of endothelial cells in LPS-ALI through SDC-1/HS and downstream pathways. Biomed Pharmacother. 2024;175:116621. doi:10.1016/j.biopha.2024.116621</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2024.116621</ArticleId><ArticleId IdType="pubmed">38677244</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao X, Kashiouris MG, L&#x2019;Heureux M, et al. Biological effects of intravenous vitamin C on neutrophil extracellular traps and the endothelial glycocalyx in patients with sepsis-induced ARDS. Nutrients. 2022;14(20):4415. doi:10.3390/nu14204415</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14204415</ArticleId><ArticleId IdType="pmc">PMC9610384</ArticleId><ArticleId IdType="pubmed">36297099</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HB, Soh S, Kwak YL, et al. High preoperative serum syndecan-1, a marker of endothelial glycocalyx degradation, and severe acute kidney injury after valvular heart surgery. J Clin Med. 2020;9(6). doi:10.3390/jcm9061803</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9061803</ArticleId><ArticleId IdType="pmc">PMC7356050</ArticleId><ArticleId IdType="pubmed">32531891</ArticleId></ArticleIdList></Reference><Reference><Citation>Passov A, Schramko A, Salminen US, et al. Endothelial glycocalyx during early reperfusion in patients undergoing cardiac surgery. PLoS One. 2021;16(5):0251747. doi:10.1371/journal.pone.0251747</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0251747</ArticleId><ArticleId IdType="pmc">PMC8128269</ArticleId><ArticleId IdType="pubmed">33999952</ArticleId></ArticleIdList></Reference><Reference><Citation>Han SJ, Zhou ZW, Yang C, et al. Hemorrhagic, hypovolemic shock resuscitated with Ringer&#x2019;s solution using bicarbonate versus lactate: a CONSORT-randomized controlled study comparing patient outcomes and blood inflammatory factors. Medicine. 2022;101(46):e31671. doi:10.1097/MD.0000000000031671</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000031671</ArticleId><ArticleId IdType="pmc">PMC9678593</ArticleId><ArticleId IdType="pubmed">36401445</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S, Qiu Z, Zheng C, et al. Effect of miR-21-3p on lung injury in rats with traumatic hemorrhagic shock resuscitated with sodium bicarbonate Ringer&#x2019;s solution. Ann Transl Med. 2022;10(24):1331. doi:10.21037/atm-22-5148</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm-22-5148</ArticleId><ArticleId IdType="pmc">PMC9843335</ArticleId><ArticleId IdType="pubmed">36660723</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H, Meng G, Zuo C, et al. The effects of sodium bicarbonate Ringer&#x2019;s solution on acute kidney injury and the clinical outcomes after liver transplantation: a randomized controlled trial. Front Pharmacol. 2022;13:982472. doi:10.3389/fphar.2022.982472</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.982472</ArticleId><ArticleId IdType="pmc">PMC9582231</ArticleId><ArticleId IdType="pubmed">36278205</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue Y, Liu W, Su L, et al. Quantitative electroencephalography predicts postoperative delirium in cardiac surgical patients after cardiopulmonary bypass: a prospective observational study. Front Med. 2023;10:1163247. doi:10.3389/fmed.2023.1163247</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1163247</ArticleId><ArticleId IdType="pmc">PMC10641728</ArticleId><ArticleId IdType="pubmed">37964877</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L, Qiu D, Yang F, et al. Hydrogen-rich saline upregulates the Sirt1/NF-&#x3ba;B signaling pathway and reduces vascular endothelial glycocalyx shedding in sepsis-induced acute kidney injury. Shock. 2024;62:416&#x2013;425. doi:10.1097/SHK.0000000000002404</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0000000000002404</ArticleId><ArticleId IdType="pubmed">38888497</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong G, Li D, Liu X, et al. PLD2 deficiency alleviates endothelial glycocalyx degradation in LPS-induced ARDS/ALI. Biochem Biophys Res Commun. 2024;716:150019. doi:10.1016/j.bbrc.2024.150019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2024.150019</ArticleId><ArticleId IdType="pubmed">38703555</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P, Song NC, Zheng ZK, et al. MMP2 and MMP9 contribute to lung ischemia-reperfusion injury via promoting pyroptosis in mice. BMC Pulm Med. 2022;22(1):230. doi:10.1186/s12890-022-02018-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-022-02018-7</ArticleId><ArticleId IdType="pmc">PMC9202153</ArticleId><ArticleId IdType="pubmed">35705936</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Sarmiento J, Molina CF, Salazar-Pelaez LM, et al. Biomarkers of glycocalyx injury and endothelial activation are associated with clinical outcomes in patients with sepsis: a systematic review and meta-analysis. J Intensive Care Med. 2023;38(1):95&#x2013;105. doi:10.1177/08850666221109186</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/08850666221109186</ArticleId><ArticleId IdType="pubmed">35722738</ArticleId></ArticleIdList></Reference><Reference><Citation>Toner AJ, Corcoran TB, Vlaskovsky PS, et al. Inflammation risk before cardiac surgery and the treatment effect of intraoperative dexamethasone. Anaesth Intensive Care. 2024;52(1):28&#x2013;36. doi:10.1177/0310057X231195098</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0310057X231195098</ArticleId><ArticleId IdType="pubmed">38000008</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudetz JA, Gandhi SD, Iqbal Z, et al. Elevated postoperative inflammatory biomarkers are associated with short- and medium-term cognitive dysfunction after coronary artery surgery. J Anesth. 2011;25(1):1&#x2013;9. doi:10.1007/s00540-010-1042-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-010-1042-y</ArticleId><ArticleId IdType="pubmed">21061037</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesonen E, Passov A, Andersson S, et al. Glycocalyx degradation and inflammation in cardiac surgery. J Cardiothorac Vasc Anesth. 2019;33(2):341&#x2013;345. doi:10.1053/j.jvca.2018.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2018.04.007</ArticleId><ArticleId IdType="pubmed">29724540</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X, Lu F, Tian H, et al. Association between plasma glycocalyx component levels and poor prognosis in severe influenza type a (H1N1). Sci Rep. 2022;12(1):163. doi:10.1038/s41598-021-04146-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-04146-2</ArticleId><ArticleId IdType="pmc">PMC8741814</ArticleId><ArticleId IdType="pubmed">34997090</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray CC, Pollack MM, Gai J, et al. The association of the lactate-albumin ratio with mortality and multiple organ dysfunction in PICU patients. Pediatr Crit Care Med. 2023;24(9):760&#x2013;766. doi:10.1097/PCC.0000000000003272</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0000000000003272</ArticleId><ArticleId IdType="pmc">PMC10523881</ArticleId><ArticleId IdType="pubmed">37171215</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong C, Jia Y, Wu X, et al. Early postoperative acetaminophen administration and severe acute kidney injury after cardiac surgery. Am J Kidney Dis. 2023;81(6):675&#x2013;683. doi:10.1053/j.ajkd.2022.11.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2022.11.009</ArticleId><ArticleId IdType="pubmed">36586561</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobasso M, Schneider J, Sanchez-Pinto LN, et al. Acute kidney injury and kidney recovery after cardiopulmonary bypass in children. Pediatr Nephrol. 2022;37(3):659&#x2013;665. doi:10.1007/s00467-021-05179-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00467-021-05179-5</ArticleId><ArticleId IdType="pubmed">34386849</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian Y, Xu T, Le Y, et al. The efficacy and safety of sodium bicarbonate Ringer&#x2019;s solution in critically ill patients: a retrospective cohort study. Front Pharmacol. 2022;13:829394. doi:10.3389/fphar.2022.829394</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.829394</ArticleId><ArticleId IdType="pmc">PMC9006048</ArticleId><ArticleId IdType="pubmed">35431941</ArticleId></ArticleIdList></Reference><Reference><Citation>Ord&#xf3;&#xf1;ez-Velasco LM, Hern&#xe1;ndez-Leiva E. Factors associated with delirium after cardiac surgery: a prospective cohort study. Ann Card Anaesth. 2021;24(2):183&#x2013;189. doi:10.4103/aca.ACA_43_20</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/aca.ACA_43_20</ArticleId><ArticleId IdType="pmc">PMC8253013</ArticleId><ArticleId IdType="pubmed">33884974</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown CH, Kim AS, Yanek L, et al. Association of perioperative plasma concentration of neurofilament light with delirium after cardiac surgery: a nested observational study. Br J Anaesth. 2024;132(2):312&#x2013;319. doi:10.1016/j.bja.2023.10.043</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2023.10.043</ArticleId><ArticleId IdType="pmc">PMC10808824</ArticleId><ArticleId IdType="pubmed">38114355</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwata H, Katoh T, Truong SK, et al. Hydrogen attenuates endothelial glycocalyx damage associated with partial cardiopulmonary bypass in rats. PLoS One. 2023;18(12):e0295862. doi:10.1371/journal.pone.0295862</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0295862</ArticleId><ArticleId IdType="pmc">PMC10729991</ArticleId><ArticleId IdType="pubmed">38113214</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37340972</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1525-6049</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Renal failure</Title><ISOAbbreviation>Ren Fail</ISOAbbreviation></Journal><ArticleTitle>Preoperative and intraoperative risk factors for acute kidney injury after hip fracture surgery: a cohort retrospective study.</ArticleTitle><Pagination><StartPage>2223313</StartPage><MedlinePgn>2223313</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2223313</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/0886022X.2023.2223313</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Hip fractures have several adverse effects on patients' morbidity and mortality. Postoperative Acute kidney injury (AKI) is one of the complications that have a significant impact on the patient's overall prognosis. We aimed to identify AKI risk after hip fracture surgery and the preoperative and intraoperative risk factors.</AbstractText><AbstractText Label="METHODOLOGY" NlmCategory="UNASSIGNED">We conducted a retrospective cohort study in a tertiary care hospital on adult patients who underwent surgery for hip fractures between January 2015 and August 2021. All clinical data were reviewed.</AbstractText><AbstractText Label="RESULT" NlmCategory="UNASSIGNED">A total of 611 patients were included (age = 76.44&#x2009;&#xb1;&#x2009;9.69&#x2009;years). 126 (20.6%) of them developed AKI postoperatively. In multilinear logistic regression analysis, factors associated with postoperative AKI included eGFR [odds ratio (OR): 0.98; 95% confidence interval (CI): 0.97-0.99 with a <i>p</i> value .01], spinal anesthesia [OR: 1.78; 95% CI: 1.1-2.9 with a <i>p</i> value .01], and partial hip replacement (PHR) type of surgery [OR: 0.56; 95% CI: 0.32-0.96 with a <i>p</i> value .036]. The development of postoperative AKI was the strongest factor that increase mortality of the patients as the (HR = 2.42, CI 95% [1.57-3.74]; <i>p</i> value &lt;.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">In this study, we highlight that lower eGFR, and spinal anesthesia were associated with a higher risk of AKI, and PHR surgery has lower odds to develop AKI. Postoperative AKI is associated with a higher mortality rate after hip fracture surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Haddad</LastName><ForeName>Bassem I</ForeName><Initials>BI</Initials><AffiliationInfo><Affiliation>Department of Special Surgery, Division of Orthopedics, School of Medicine, The University of Jordan, Amman, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alhajahjeh</LastName><ForeName>Abdulrahman A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, The University of Jordan, Amman, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altarazi</LastName><ForeName>Abdelrahman</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Special Surgery, Division of Orthopedics, School of Medicine, The University of Jordan, Amman, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Amayreh</LastName><ForeName>Layla</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, The University of Jordan, Amman, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamdan</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Special Surgery, Division of Orthopedics, School of Medicine, The University of Jordan, Amman, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlQuabeh</LastName><ForeName>Batool</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, The University of Jordan, Amman, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abd Ul Ghani</LastName><ForeName>Waid</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, The University of Jordan, Amman, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farah</LastName><ForeName>Randa I</ForeName><Initials>RI</Initials><AffiliationInfo><Affiliation>Affiliation Nephrology Division, Internal Medicine Department, School of Medicine, The University of Jordan, Amman, Jordan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ren Fail</MedlineTA><NlmUniqueID>8701128</NlmUniqueID><ISSNLinking>0886-022X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="Y">Hip Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hip fracture</Keyword><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">orthopedic surgery</Keyword><Keyword MajorTopicYN="N">preoperative</Keyword><Keyword MajorTopicYN="N">retrospective cohort study</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>21</Day><Hour>5</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37340972</ArticleId><ArticleId IdType="pmc">PMC10286670</ArticleId><ArticleId IdType="doi">10.1080/0886022X.2023.2223313</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cooper C, Campion G, Melton L.. Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992;2(6):1&#x2013;7. doi: 10.1007/BF01623184</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01623184</ArticleId><ArticleId IdType="pubmed">1421796</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper C, Cole Z, Holroyd C, et al. . Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int. 2011;22(5):1277&#x2013;1288. doi: 10.1007/s00198-011-1601-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-011-1601-6</ArticleId><ArticleId IdType="pmc">PMC3546313</ArticleId><ArticleId IdType="pubmed">21461721</ArticleId></ArticleIdList></Reference><Reference><Citation>Peeters C, Visser E, Van de Ree C, et al. . Quality of life after hip fracture in the elderly: a systematic literature review. Injury. 2016;47(7):1369&#x2013;1382. doi: 10.1016/j.injury.2016.04.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2016.04.018</ArticleId><ArticleId IdType="pubmed">27178770</ArticleId></ArticleIdList></Reference><Reference><Citation>Pincus D, Ravi B, Wasserstein D, et al. . Association between wait time and 30-day mortality in adults undergoing hip fracture surgery. JAMA. 2017;318(20):1994. doi: 10.1001/jama.2017.17606</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.17606</ArticleId><ArticleId IdType="pmc">PMC5820694</ArticleId><ArticleId IdType="pubmed">29183076</ArticleId></ArticleIdList></Reference><Reference><Citation>Fields AC, Dieterich JD, Buterbaugh K, et al. . Short-term complications in hip fracture surgery using spinal versus general anaesthesia. Injury. 2015;46(4):719&#x2013;723. doi: 10.1016/j.injury.2015.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2015.02.002</ArticleId><ArticleId IdType="pubmed">25704139</ArticleId></ArticleIdList></Reference><Reference><Citation>Rantalaiho I, Gunn J, Kukkonen J, et al. . Acute kidney injury following hip fracture. Injury. 2019;50(12):2268&#x2013;2271. doi: 10.1016/j.injury.2019.10.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2019.10.008</ArticleId><ArticleId IdType="pubmed">31623901</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Bellomo R.. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol. 2017;13(11):697&#x2013;711. doi: 10.1038/nrneph.2017.119</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2017.119</ArticleId><ArticleId IdType="pubmed">28869251</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan SM. Acute kidney injury after cardiac surgery: risk factors and novel biomarkers. Braz J Cardiovasc Surg. 2019;34(3):352&#x2013;360. doi: 10.21470/1678-9741-2018-0212</Citation><ArticleIdList><ArticleId IdType="doi">10.21470/1678-9741-2018-0212</ArticleId><ArticleId IdType="pmc">PMC6629228</ArticleId><ArticleId IdType="pubmed">31310475</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Kuo G, Hung C, et al. . Risk factors and prognosis assessment for acute kidney injury: the 2020 consensus of the Taiwan AKI task force. J Formosan Med Assoc. 2021;120(7):1424&#x2013;1433. doi: 10.1016/j.jfma.2021.02.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfma.2021.02.013</ArticleId><ArticleId IdType="pubmed">33707141</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasin M, Farah R, Hammad Y, et al. . Determining the risk of acute kidney injury in patients who underwent total joint replacement: a retrospective study. J Orthop Sci. 2020;25(6):1029&#x2013;1034. doi: 10.1016/j.jos.2019.12.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jos.2019.12.007</ArticleId><ArticleId IdType="pubmed">32014344</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:S1&#x2013;S138. doi: 10.1159/000339789</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000339789</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennet SJ, Berry OMB, Goddard J, et al. . Acute renal dysfunction following hip fracture. Injury. 2010;41(4):335&#x2013;338. doi: 10.1016/j.injury.2009.07.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2009.07.009</ArticleId><ArticleId IdType="pubmed">19729159</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulucay C, Eren Z, Kaspar EC, et al. . Risk factors for acute kidney injury after hip fracture surgery in the elderly individuals. Geriatr Orthop Surg Rehabil. 2012;3(4):150&#x2013;156. doi: 10.1177/2151458512473827</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2151458512473827</ArticleId><ArticleId IdType="pmc">PMC3598517</ArticleId><ArticleId IdType="pubmed">23569709</ArticleId></ArticleIdList></Reference><Reference><Citation>Azevedo VLF, Silveira MAS, Santos JN, et al. . Post-operative renal function evaluation, through rifle criteria, of elderly patients who underwent femur fracture surgery under spinal anesthesia. Ren Fail. 2008;30(5):485&#x2013;490. doi: 10.1080/08860220802060398</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08860220802060398</ArticleId><ArticleId IdType="pubmed">18569927</ArticleId></ArticleIdList></Reference><Reference><Citation>Skinner DL, Hardcastle TC, Rodseth RN, et al. . The incidence and outcomes of acute kidney injury amongst patients admitted to a level i trauma unit. Injury. 2014;45(1):259&#x2013;264. doi: 10.1016/j.injury.2013.07.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2013.07.013</ArticleId><ArticleId IdType="pubmed">23921194</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksson M, Brattstrom O, Martensson J, et al. . Acute kidney in- jury following severe trauma: risk factors and long-term outcome . J Trauma Acute Care Surg. 2015;79(3):407&#x2013;412. doi: 10.1097/TA.0000000000000727</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0000000000000727</ArticleId><ArticleId IdType="pubmed">26307873</ArticleId></ArticleIdList></Reference><Reference><Citation>Bihorac A, Delano MJ, Schold JD, et al. . Incidence, clinical predictors, genomics, and outcome of acute kidney injury among trauma patients. Ann Surg. 2010;252(1):158&#x2013;165. doi: 10.1097/SLA.0b013e3181deb6bc</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e3181deb6bc</ArticleId><ArticleId IdType="pmc">PMC3357629</ArticleId><ArticleId IdType="pubmed">20562612</ArticleId></ArticleIdList></Reference><Reference><Citation>Abelha FJ, Botelho M, Fernandes V, et al. . Determinants of postoperative acute kidney injury. Crit Care. 2009;13(3):R79. doi: 10.1186/cc7894</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc7894</ArticleId><ArticleId IdType="pmc">PMC2717442</ArticleId><ArticleId IdType="pubmed">19463152</ArticleId></ArticleIdList></Reference><Reference><Citation>Noor S, Usmani A.. Postoperative renal failure. Clin Geriatr Med. 2008;24(4):721&#x2013;729, ix. doi: 10.1016/j.cger.2008.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cger.2008.07.004</ArticleId><ArticleId IdType="pubmed">18984383</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmanian PB, Kwiecien G, Langebartels G, et al. . Logistic risk model predicting postoperative renal failure requiring dialysis in cardiac surgery patients. Eur J Cardiothorac Surg. 2011;40(3):701&#x2013;707. doi: 10.1016/j.ejcts.2010.12.051</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2010.12.051</ArticleId><ArticleId IdType="pubmed">21334918</ArticleId></ArticleIdList></Reference><Reference><Citation>James MT, Bhatt M, Pannu N, et al. . Long-term outcomes of acute kidney injury and strategies for improved care. Nat Rev Nephrol. 2020; 16(4):193&#x2013;205. doi: 10.1038/s41581-019-0247-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-019-0247-z</ArticleId><ArticleId IdType="pubmed">32051567</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippone EJ, Yadav A.. Acute kidney injury after hip or knee replacement: can we lower the risk? Cleve Clin J Med. 2019;86(4):263&#x2013;276. doi: 10.3949/ccjm.86a.18044</Citation><ArticleIdList><ArticleId IdType="doi">10.3949/ccjm.86a.18044</ArticleId><ArticleId IdType="pubmed">30951452</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam A, Lepe A, Wild S, et al. . Diabetes comorbidities in low- and middle-income countries: an umbrella review. J Glob Health. 2021;11:04040. doi: 10.7189/jogh.11.04040</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.11.04040</ArticleId><ArticleId IdType="pmc">PMC8325931</ArticleId><ArticleId IdType="pubmed">34386215</ArticleId></ArticleIdList></Reference><Reference><Citation>Schutte AE, Srinivasapura Venkateshmurthy N, Mohan S, et al. . Hypertension in low- and middle-income countries. Circ Res. 2021;128(7):808&#x2013;826. doi: 10.1161/circresaha.120.318729</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circresaha.120.318729</ArticleId><ArticleId IdType="pmc">PMC8091106</ArticleId><ArticleId IdType="pubmed">33793340</ArticleId></ArticleIdList></Reference><Reference><Citation>Rewa O, Bagshaw SM.. Acute kidney injury&#x2014;epidemiology, outcomes and economics. Nat Rev Nephrol. 2014;10(4):193&#x2013;207. doi: 10.1038/nrneph.2013.282</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2013.282</ArticleId><ArticleId IdType="pubmed">24445744</ArticleId></ArticleIdList></Reference><Reference><Citation>Li PK, Burdmann EA, Mehta RL.. Acute kidney injury: global health alert. Kidney Int. 2013;83(3):372&#x2013;376. doi: 10.1038/ki.2012.427</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2012.427</ArticleId><ArticleId IdType="pubmed">23302721</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H-J, Park H-S, Go Y-J, et al. . Effect of anesthetic technique on the occurrence of acute kidney injury after total knee arthroplasty. JCM. 2019;8(6):778. doi: 10.3390/jcm8060778</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8060778</ArticleId><ArticleId IdType="pmc">PMC6616515</ArticleId><ArticleId IdType="pubmed">31159309</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell S, Dekker FW, Vadiveloo T, et al. . Risk of postoperative acute kidney injury in patients undergoing orthopedic surgery-development and validation of a risk score and effect of acute kidney injury on survival: observational cohort study. BMJ. 2015;351(v11 19):h5639. doi: 10.1136/bmj.h5639</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h5639</ArticleId><ArticleId IdType="pmc">PMC4641433</ArticleId><ArticleId IdType="pubmed">26561522</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis M, Naik B, Freundlich R, et al. . Preoperative risk and the association between hypotension and postoperative acute kidney injury. Anesthesiology. 2020;132(3):461&#x2013;475. doi: 10.1097/ALN.0000000000003063</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003063</ArticleId><ArticleId IdType="pmc">PMC7015776</ArticleId><ArticleId IdType="pubmed">31794513</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaieski DF, Edwards JM, Kallan MJ, et al. . Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med. 2013;41(5):1167&#x2013;1174. doi: 10.1097/CCM.0b013e31827c09f8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31827c09f8</ArticleId><ArticleId IdType="pubmed">23442987</ArticleId></ArticleIdList></Reference><Reference><Citation>Wohlauer MV, Sauaia A, Moore EE, et al. . Acute kidney injury and posttrauma multiple organ failure: the canary in the coal mine. J Trauma Acute Care Surg. 2012;72(2):373&#x2013;380. doi: 10.1097/TA.0b013e318244869b</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e318244869b</ArticleId><ArticleId IdType="pubmed">22327979</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchino S, Kellum JA, Bellomo R, et al. . Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294(7):813&#x2013;818. doi: 10.1001/jama.294.7.813</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.294.7.813</ArticleId><ArticleId IdType="pubmed">16106006</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandt MM, Falvo AJ, Rubinfeld IS, et al. . Renal dysfunction in trauma: even a little costs a lot. J Trauma. 2007;62(6):1362&#x2013;1364. doi: 10.1097/TA.0b013e318047983d</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e318047983d</ArticleId><ArticleId IdType="pubmed">17563649</ArticleId></ArticleIdList></Reference><Reference><Citation>Haentjens P, Magaziner J, Col&#xf3;n-Emeric CS, et al. . Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med. 2010;152(6):380. doi: 10.1059/0003-4819-152-6-201003160-00008.Meta-analysis</Citation><ArticleIdList><ArticleId IdType="doi">10.1059/0003-4819-152-6-201003160-00008.Meta-analysis</ArticleId><ArticleId IdType="pmc">PMC3010729</ArticleId><ArticleId IdType="pubmed">20231569</ArticleId></ArticleIdList></Reference><Reference><Citation>von Friesendorff M, McGuigan FE, Wizert A, et al. . Hip fracture, mortality risk, and cause of death over two decades. Osteoporos Int. 2016;27(10):2945&#x2013;2953. doi: 10.1007/s00198-016-3616-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-016-3616-5</ArticleId><ArticleId IdType="pubmed">27172936</ArticleId></ArticleIdList></Reference><Reference><Citation>Mudgalkar N, Ramesh KV.. Bone cement implantation syndrome: a rare catastrophe. Anesth Essays Res. 2011;5(2):240. doi: 10.4103/0259-1162.94796</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0259-1162.94796</ArticleId><ArticleId IdType="pmc">PMC4173385</ArticleId><ArticleId IdType="pubmed">25885400</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28077532</PMID><DateCompleted><Year>2018</Year><Month>08</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>117</Volume><Issue>4</Issue><PubDate><Year>2016</Year><Month>Oct</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Modern hydroxyethyl starch and acute kidney injury after cardiac surgery: a prospective multicentre cohort.</ArticleTitle><Pagination><StartPage>458</StartPage><EndPage>463</EndPage><MedlinePgn>458-463</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/bja/aew258</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Recent trials have shown hydroxyethyl starch (HES) solutions increase the risk of acute kidney injury (AKI) in critically ill patients. It is uncertain whether these adverse effects also affect surgical patients. We sought to determine the renal safety of modern tetrastarch (6% HES 130/0.4) use in cardiac surgical patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this multicentre prospective cohort study, 1058 consecutive patients who underwent cardiac surgery from 15th September 2012 to 15th December 2012 were recruited in 23 Spanish hospitals.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 350 patients (33%) administered 6% HES 130/0.4 intraoperatively and postoperatively, and 377 (36%) experienced postoperative AKI (AKI Network criteria). In-hospital death occurred in 45 (4.2%) patients. Patients in the non-HES group had higher Euroscore and more comorbidities including unstable angina, preoperative cardiogenic shock, preoperative intra-aortic balloon pump use, peripheral arterial disease, and pulmonary hypertension. The non-HES group received more intraoperative vasopressors and had longer cardiopulmonary bypass times. After multivariable risk-adjustment, 6% HES 130/0.4 use was not associated with significantly increased risks of AKI (adjusted odds ratio 1.01, 95% CI 0.71-1.46, P=0.91). These results were confirmed by propensity score-matched pairs analyses.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The intraoperative and postoperative use of modern hydroxyethyl starch 6% HES 130/0.4 was not associated with increased risks of AKI and dialysis after cardiac surgery in our multicentre cohort.</AbstractText><CopyrightInformation>&#xa9; The Author 2016. Published by Oxford University Press on behalf of the British Journal of Anaesthesia. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vives</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Anaesthesia &amp; Intensive Care, Hospital Universitari Bellvitge, Universitat de Barcelona, C/ Feixa Llarga, s/n. Hospitalet, Barcelona 08907, Spain marcvives50@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Callejas</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Anesthesiology &amp; Critical Care, Clinica Universidad de Navarra, Avenida Pio 12, 36, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duque</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Anesthesiology &amp; Critical Care, Clinica Universidad de Navarra, Avenida Pio 12, 36, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Echarri</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Anesthesiology &amp; Critical Care, Clinica Universidad de Navarra, Avenida Pio 12, 36, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wijeysundera</LastName><ForeName>D N</ForeName><Initials>DN</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Management, Toronto General Hospital, 200 Elizabeth Street, Toronto, ON M5G 2C4, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hernandez</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, University Hospital of South Manchester, Southmoor Rd, Wythenshawe, Manchester M23 9LT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabate</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, Bellvitge University Hospital, C/ Feixa Llarga, s/n. Hospitalet, Barcelona 08907, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bes-Rastrollo</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department Preventive Medicine and Public Health, University of Navarra, Av. Pio XII, 36, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBERobn, Instituto de Salud Carlos III, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IDISNA, Navarra's Health Research Institute, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monedero</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Anesthesiology &amp; Critical Care, Clinica Universidad de Navarra, Avenida Pio 12, 36, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006895">Hydroxyethyl Starch Derivatives</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Br J Anaesth. 2017 Oct 1;119(4):852. doi: 10.1093/bja/aex048.</RefSource><PMID Version="1">28541455</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006895" MajorTopicYN="N">Hydroxyethyl Starch Derivatives</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="N">Renal Replacement Therapy</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">hydroxyethyl starch</Keyword><Keyword MajorTopicYN="N">patient outcomes</Keyword><Keyword MajorTopicYN="N">renal replacement therapy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28077532</ArticleId><ArticleId IdType="doi">10.1093/bja/aew258</ArticleId><ArticleId IdType="pii">S0007-0912(17)30165-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37937943</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2044</ISSN><JournalIssue CitedMedium="Internet"><Volume>77</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Anaesthesia</Title><ISOAbbreviation>Anaesthesia</ISOAbbreviation></Journal><ArticleTitle>A randomised controlled feasibility trial of a clinical protocol to manage hypotension during major non-cardiac surgery.</ArticleTitle><Pagination><StartPage>795</StartPage><EndPage>807</EndPage><MedlinePgn>795-807</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/anae.15715</ELocationID><Abstract><AbstractText>Intra-operative hypotension is a risk factor for postoperative morbidity and mortality. Minimally invasive monitors that derive other haemodynamic parameters, such as stroke volume, may better inform the management of hypotension. As a prelude to a multicentre randomised controlled trial, we conducted a single-centre feasibility trial of a protocol to treat hypotension as informed by minimally invasive haemodynamic monitoring during non-cardiac surgery. We recruited adults aged &#x2265;40&#x2009;years with cardiovascular risk factors who underwent non-cardiac surgery requiring invasive arterial pressure monitoring. Participants were randomly allocated to usual care, or a clinical protocol informed by an arterial waveform contour analysis monitor. Participants, outcome assessors, clinicians outside operating theatres and analysts were blinded to treatment allocation. Feasibility was evaluated based on: consent rate; recruitment rate; structured feedback from anaesthesia providers; and between-group differences in blood pressure, processes-of-care and outcomes. The consent rate among eligible patients was 33%, with 30 participants randomly allocated to the protocol and 30 to usual care. Anaesthesia providers rated the protocol to be feasible and acceptable. The protocol was associated with reduced fluid balance and hypotension exposure in the peri-operative setting. Postoperative complications included: acute myocardial injury in 18 (30%); acute kidney injury in 17 (28%); and surgical site infection in 7 (12%). The severity of complications was rated as moderate or severe in 25 (42%) participants. In summary, this single-centre study confirmed the feasibility of a multicentre trial to assess the efficacy and safety of a physiologically guided treatment protocol for intra-operative hypotension based on minimally invasive haemodynamic monitors.</AbstractText><CopyrightInformation>&#xa9; 2022 Association of Anaesthetists.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wijeysundera</LastName><ForeName>D N</ForeName><Initials>DN</Initials><Identifier Source="ORCID">0000-0002-5897-8605</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia, St. Michael's Hospital, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duncan</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno Garijo</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jerath</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meineri</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Heart Centre Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parotto</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>W&#x105;sowicz</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCluskey</LastName><ForeName>S A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>AMIGO&#x2010;1 Study Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Anaesthesia</MedlineTA><NlmUniqueID>0370524</NlmUniqueID><ISSNLinking>0003-2409</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062186" MajorTopicYN="N">Arterial Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002985" MajorTopicYN="N">Clinical Protocols</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="kor"><AbstractText>&#xc218;&#xc220; &#xc911; &#xc800;&#xd608;&#xc555;&#xc740; &#xc218;&#xc220; &#xd6c4; &#xc774;&#xd658;&#xc728;&#xacfc; &#xc0ac;&#xb9dd;&#xb960;&#xc758; &#xc704;&#xd5d8;&#xc778;&#xc790;&#xc774; &#xb2e4;. 1&#xd68c; &#xbc15;&#xcd9c;&#xb7c9;&#xacfc; &#xac19;&#xc740; &#xb2e4;&#xb978; &#xd608;&#xc5ed;&#xd559;&#xc801; &#xbcc0;&#xc218;&#xb4e4;&#xc744; &#xb3c4;&#xcd9c;&#xd560; &#xb54c;, &#xcd5c; &#xc18c;&#xd55c;&#xc758; &#xce68;&#xc2b5;&#xc131; &#xce21;&#xc815;&#xc740; &#xc800;&#xd608;&#xc555;&#xc758; &#xad00;&#xb9ac;&#xb97c; &#xb354; &#xc798; &#xc54c;&#xb9b4; &#xc218;&#xb3c4; &#xc788;&#xb2e4;. &#xb2e4;&#xc911; &#xc13c;&#xd130; &#xbb34;&#xc791;&#xc704; &#xb300;&#xc870; &#xc2dc;&#xd5d8;&#xc758; &#xc2dc;&#xcd08;&#xb85c;, &#xc800;&#xc790;&#xb4e4;&#xc740; &#xbe44;&#xc2ec;&#xc7a5; &#xc218;&#xc220; &#xc911; &#xcd5c;&#xc18c;&#xc758; &#xce68;&#xc2b5;&#xc801; &#xd608;&#xc5ed;&#xd559;&#xc801; &#xbaa8;&#xb2c8;&#xd130;&#xb9c1;&#xc5d0; &#xc758;&#xd574; &#xace0;&#xc9c0;&#xb41c; &#xb300;&#xb85c; &#xc800; &#xd608;&#xc555;&#xc744; &#xce58;&#xb8cc;&#xd558;&#xae30; &#xc704;&#xd55c; &#xd504;&#xb85c;&#xd1a0;&#xcf5c;&#xc758; &#xb2e8;&#xc77c; &#xc13c;&#xd130; &#xc2e4;&#xd604; &#xac00;&#xb2a5;&#xc131; &#xc2dc; &#xd5d8;&#xc744; &#xc218;&#xd589;&#xd558;&#xc600;&#xb2e4;. &#xc800;&#xc790;&#xb4e4;&#xc740; &#xce68;&#xc2b5;&#xc801; &#xb3d9;&#xb9e5;&#xc555; &#xce21;&#xc815;&#xc774; &#xd544;&#xc694;&#xd558;&#xace0;, &#xbe44;&#xc2ec;&#xc7a5; &#xc218;&#xc220;&#xc744; &#xbc1b;&#xc544; &#xc2ec;&#xd608;&#xad00; &#xc704;&#xd5d8; &#xc694;&#xc778;&#xc774; &#xc788;&#xb294; 40&#xc138; &#xc774;&#xc0c1; &#xc131;&#xc778; &#xc744; &#xbaa8;&#xc9d1;&#xd558;&#xc600;&#xb2e4;. &#xd53c;&#xc2e4;&#xd5d8;&#xc790;&#xb4e4;&#xc740; &#xb3d9;&#xb9e5; &#xd30c;&#xd615; &#xc724;&#xacfd; &#xbd84;&#xc11d; &#xce21;&#xc815;&#xc5d0; &#xc758; &#xd574; &#xc54c;&#xb824;&#xc9c4; &#xc784;&#xc0c1; &#xd504;&#xb85c;&#xd1a0;&#xcf5c; &#xb610;&#xb294; &#xc77c;&#xbc18; &#xce58;&#xb8cc;&#xc5d0; &#xbb34;&#xc791;&#xc704;&#xb85c; &#xbc30;&#xc815;&#xb418; &#xc5c8;&#xb2e4;. &#xce58;&#xb8cc; &#xd560;&#xb2f9;&#xacfc; &#xad00;&#xb828;, &#xd53c;&#xc2e4;&#xd5d8;&#xc790;, &#xacb0;&#xacfc; &#xd3c9;&#xac00;&#xc790;, &#xc218;&#xc220;&#xc2e4; &#xbc16;&#xc758; &#xc784;&#xc0c1; &#xc758;&#xc0ac; &#xbc0f; &#xbd84;&#xc11d;&#xac00;&#xc5d0;&#xac8c; &#xbe14;&#xb77c;&#xc778;&#xb4dc;&#xb85c; &#xc9c4;&#xd589;&#xb418;&#xc5c8;&#xb2e4;. &#xc2e4;&#xd604; &#xac00;&#xb2a5; &#xc131;&#xc740; &#xb3d9;&#xc758;&#xc728;, &#xcc44;&#xc6a9;&#xb960;, &#xb9c8;&#xcde8;&#xacfc; &#xc758;&#xc0ac;&#xc758; &#xad6c;&#xc870;&#xc801; &#xd53c;&#xb4dc;&#xbc31;&#xacfc; &#xd608;&#xc555;, &#xce58;&#xb8cc; &#xacfc;&#xc815; &#xbc0f; &#xacb0;&#xacfc;&#xc758; &#xadf8;&#xb8f9; &#xac04; &#xcc28;&#xc774;&#xc5d0; &#xae30;&#xcd08;&#xd558;&#xc5ec; &#xd3c9;&#xac00;&#xb418;&#xc5c8;&#xb2e4;. &#xb300;&#xc0c1; &#xd658;&#xc790;&#xc758; &#xb3d9;&#xc758;&#xc728;&#xc740; 33%&#xc600;&#xc73c;&#xba70;, 30&#xba85;&#xc758; &#xd53c;&#xc2e4;&#xd5d8;&#xc790;&#xb294; &#xd504;&#xb85c;&#xd1a0;&#xcf5c;&#xc5d0; &#xbb34;&#xc791;&#xc704;&#xb85c; &#xbc30;&#xc815;&#xb418;&#xc5c8;&#xace0;, 30&#xba85;&#xc740; &#xc77c;&#xbc18; &#xce58;&#xb8cc;&#xc5d0; &#xbc30;&#xc815;&#xb418;&#xc5c8;&#xb2e4;. &#xb9c8;&#xcde8; &#xacfc; &#xc758;&#xc0ac;&#xb4e4;&#xc740; &#xc774; &#xd504;&#xb85c;&#xd1a0;&#xcf5c;&#xc774; &#xc2e4;&#xd604; &#xac00;&#xb2a5;&#xd558;&#xba70; &#xc218;&#xc6a9; &#xac00;&#xb2a5;&#xd558;&#xb2e4;&#xace0; &#xd3c9;&#xac00;&#xd558;&#xc600;&#xb2e4;. &#xc774; &#xd504;&#xb85c;&#xd1a0;&#xcf5c;&#xc740; &#xc218;&#xc220; &#xc804; &#xd658;&#xacbd;&#xc5d0;&#xc11c; &#xccb4;&#xc561; &#xade0;&#xd615; &#xac10;&#xc18c; &#xbc0f; &#xc800;&#xd608;&#xc555; &#xb178;&#xcd9c;&#xacfc; &#xad00;&#xb828;&#xc774; &#xc788;&#xc5c8;&#xb2e4;. &#xc218;&#xc220; &#xd6c4; &#xd569;&#xbcd1;&#xc99d;&#xc740; &#xae09;&#xc131; &#xc2ec;&#xadfc; &#xc190;&#xc0c1; 18&#xba85;(30%), &#xae09;&#xc131; &#xc2e0;&#xc7a5; &#xc190;&#xc0c1; 17&#xba85;(28%), &#xc218;&#xc220; &#xbd80;&#xc704; &#xac10;&#xc5fc; 7&#xba85;(12%)&#xc744; &#xd3ec;&#xd568;&#xd55c;&#xb2e4;. &#xd569;&#xbcd1;&#xc99d;&#xc758; &#xc2ec;&#xac01;&#xc131;&#xc740; 25&#xba85;(42%)&#xc758; &#xd53c;&#xc2e4;&#xd5d8; &#xc790;&#xc5d0;&#xc11c; &#xc911;&#xb4f1;&#xb3c4; &#xb610;&#xb294; &#xc911;&#xc99d;&#xc778; &#xac83;&#xc73c;&#xb85c; &#xd3c9;&#xac00;&#xb418;&#xc5c8;&#xb2e4;. &#xc694;&#xc57d;&#xd558;&#xba74;, &#xc774; &#xb2e8;&#xc77c; &#xc13c;&#xd130; &#xc5f0;&#xad6c;&#xb294; &#xcd5c;&#xc18c;&#xd55c;&#xc758; &#xce68;&#xc2b5;&#xc801; &#xd608;&#xd589;&#xb3d9;&#xd0dc;&#xc801; &#xce21;&#xc815;&#xc744; &#xae30;&#xbc18; &#xc73c;&#xb85c; &#xc218;&#xc220; &#xc911; &#xc800;&#xd608;&#xc555;&#xc5d0; &#xb300;&#xd55c; &#xc0dd;&#xb9ac;&#xd559;&#xc801;&#xc73c;&#xb85c; &#xc720;&#xb3c4;&#xb41c; &#xce58;&#xb8cc; &#xd504;&#xb85c; &#xd1a0;&#xcf5c;&#xc758; &#xc720;&#xd6a8;&#xc131;&#xacfc; &#xc548;&#xc804;&#xc131;&#xc744; &#xd3c9;&#xac00;&#xd558;&#xae30; &#xc704;&#xd55c; &#xb2e4;&#xc911; &#xc13c;&#xd130; &#xc2dc;&#xd5d8;&#xc758; &#xc2e4;&#xd604; &#xac00;&#xb2a5;&#xc131;&#xc744; &#xd655;&#xc778;&#xd558;&#xc600;&#xb2e4;.</AbstractText><CopyrightInformation>&#xa9; 2022 Association of Anaesthetists.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">blood pressure</Keyword><Keyword MajorTopicYN="N">haemodynamic monitor</Keyword><Keyword MajorTopicYN="N">intra&#x2010;operative hypotension</Keyword><Keyword MajorTopicYN="N">postoperative complications</Keyword><Keyword MajorTopicYN="N">pulse contour analysis</Keyword><Keyword MajorTopicYN="N">surgery</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Pazmino-Canizares</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carroll</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Poonawalla</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beattie</LastName><ForeName>W S</ForeName><Initials>WS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clarke</LastName><ForeName>H A</ForeName><Initials>HA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jerath</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kulkarni</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meineri</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garijo</LastName><ForeName>J Moreno</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parotto</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sellers</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vidal</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>W&#x105;sowicz</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wei</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>8</Day><Hour>8</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37937943</ArticleId><ArticleId IdType="doi">10.1111/anae.15715</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Gregory A, Stapelfeldt WH, Khanna AK, et&#x2009;al. Intraoperative hypotension is associated with adverse clinical outcomes after noncardiac surgery. Anesthesia and Analgesia 2021; 132: 1654&#x2013;65.</Citation></Reference><Reference><Citation>Wesselink EM, Kappen TH, Torn HM, Slooter AJC, van Klei WA. Intraoperative hypotension and the risk of postoperative adverse outcomes: a systematic review. British Journal of Anaesthesia 2018; 121: 706&#x2013;21.</Citation></Reference><Reference><Citation>Wijnberge M, Schenk J, Bulle E, et&#x2009;al. Association of intraoperative hypotension with postoperative morbidity and mortality: systematic review and meta&#x2010;analysis. British Journal of Surgery Open 2021; 5: zraa018.</Citation></Reference><Reference><Citation>Salmasi V, Maheshwari K, Yang D, et&#x2009;al. Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery: a retrospective cohort analysis. Anesthesiology 2017; 126: 47&#x2013;65.</Citation></Reference><Reference><Citation>Ahuja S, Mascha EJ, Yang D, et&#x2009;al. Associations of intraoperative radial arterial systolic, diastolic, mean, and pulse pressures with myocardial and acute kidney injury after noncardiac surgery: a retrospective cohort analysis. Anesthesiology 2020; 132: 291&#x2013;306.</Citation></Reference><Reference><Citation>Sessler DI, Bloomstone JA, Aronson S, et&#x2009;al. Perioperative quality initiative consensus statement on intraoperative blood pressure, risk and outcomes for elective surgery. British Journal of Anaesthesia 2019; 122: 563&#x2013;74.</Citation></Reference><Reference><Citation>Mathis MR, Naik BI, Freundlich RE, et&#x2009;al. Preoperative risk and the association between hypotension and postoperative acute kidney injury. Anesthesiology 2020; 132: 461&#x2013;75.</Citation></Reference><Reference><Citation>Egal M, de Geus HR, van Bommel J, Groeneveld AB. Targeting oliguria reversal in perioperative restrictive fluid management does not influence the occurrence of renal dysfunction: a systematic review and meta&#x2010;analysis. European Journal of Anaesthesiology 2016; 33: 425&#x2013;35.</Citation></Reference><Reference><Citation>Kouz K, Bergholz A, Timmermann LM, et&#x2009;al. The relation between mean arterial pressure and cardiac index in major abdominal surgery patients: a prospective observational cohort study. Anesthesia and Analgesia 2022; 134: 322&#x2013;9.</Citation></Reference><Reference><Citation>Marik PE, Baram M, Vahid B. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest 2008; 134: 172&#x2013;8.</Citation></Reference><Reference><Citation>Lilot M, Ehrenfeld JM, Lee C, Harrington B, Cannesson M, Rinehart J. Variability in practice and factors predictive of total&#x2009;crystalloid administration during abdominal surgery: retrospective two&#x2010;centre analysis. British Journal of Anaesthesia 2015; 114: 767&#x2013;76.</Citation></Reference><Reference><Citation>Messina A, Pelaia C, Bruni A, et&#x2009;al. Fluid challenge during anesthesia: a systematic review and meta&#x2010;analysis. Anesthesia and Analgesia 2018; 127: 1353&#x2013;64.</Citation></Reference><Reference><Citation>Cannesson M, Le Manach Y, Hofer CK, et&#x2009;al. Assessing the diagnostic accuracy of pulse pressure variations for the prediction of fluid responsiveness: a &#x201c;gray zone&#x201d; approach. Anesthesiology 2011; 115: 231&#x2013;41.</Citation></Reference><Reference><Citation>MacDonald N, Ahmad T, Mohr O, et&#x2009;al. Dynamic preload markers to predict fluid responsiveness during and after major gastrointestinal surgery: an observational substudy of the OPTIMISE trial. British Journal of Anaesthesia 2015; 114: 598&#x2013;604.</Citation></Reference><Reference><Citation>Levey AS, Stevens LA, Schmid CH, et&#x2009;al. A new equation&#x2009;to estimate glomerular filtration rate. Annals of Internal Medicine 2009; 150: 604&#x2013;12.</Citation></Reference><Reference><Citation>Edwards MR, Forbes G, MacDonald N, et&#x2009;al. Optimisation of Perioperative Cardiovascular Management to Improve Surgical Outcome II (OPTIMISE II) trial: study protocol for a multicentre international trial of cardiac output&#x2010;guided fluid therapy with low&#x2010;dose inotrope infusion compared with usual care in patients undergoing major elective gastrointestinal surgery. British Medical Journal Open 2019; 9: e023455.</Citation></Reference><Reference><Citation>Navarro LH, Bloomstone JA, Auler JO, et&#x2009;al. Perioperative fluid therapy: a statement from the international fluid optimization group. PerioperativeMedicine 2015; 4: 3.</Citation></Reference><Reference><Citation>Semler MW, Self WH, Wanderer JP, et&#x2009;al. Balanced crystalloids versus saline in critically ill adults. New England Journal of Medicine 2018; 378: 829&#x2013;39.</Citation></Reference><Reference><Citation>Carson JL, Terrin ML, Noveck H, et&#x2009;al. Liberal or restrictive transfusion in high&#x2010;risk patients after hip surgery. New England Journal of Medicine 2011; 365: 2453&#x2013;62.</Citation></Reference><Reference><Citation>Hovaguimian F, Myles PS. Restrictive versus liberal transfusion strategy in the perioperative and acute care settings: a context&#x2010;specific systematic review and meta&#x2010;analysis of randomized controlled trials. Anesthesiology 2016; 125: 46&#x2013;61.</Citation></Reference><Reference><Citation>Sun LY, Wijeysundera DN, Tait GA, Beattie WS. Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery. Anesthesiology 2015; 123: 515&#x2013;23.</Citation></Reference><Reference><Citation>International Surgical Outcome Study Group. Prospective observational cohort study on grading the severity of postoperative complications in global surgery research. British Journal of Surgery 2019; 106: e73&#x2013;80.</Citation></Reference><Reference><Citation>Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD. Fourth universal definition of myocardial infarction. Circulation 2018; 138: e618&#x2013;51.</Citation></Reference><Reference><Citation>Eldridge SM, Lancaster GA, Campbell MJ, et&#x2009;al. Defining feasibility and pilot studies in preparation for randomised controlled trials: development of a conceptual framework. PLoS One 2016; 11: e0150205.</Citation></Reference><Reference><Citation>Lee EC, Whitehead AL, Jacques RM, Julious SA. The statistical interpretation of pilot trials: should significance thresholds be&#xa0;reconsidered? BMC Medical Research Methodology 2014; 14: 41.</Citation></Reference><Reference><Citation>Lee TH, Marcantonio ER, Mangione CM, et&#x2009;al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100: 1043&#x2013;9.</Citation></Reference><Reference><Citation>Duceppe E, Parlow J, MacDonald P, et&#x2009;al. Canadian Cardiovascular Society guidelines on perioperative cardiac risk assessment and management for patients who undergo noncardiac surgery. Canadian Journal of Cardiology 2017; 33: 17&#x2013;32.</Citation></Reference><Reference><Citation>Chu R, Walter SD, Guyatt G, et&#x2009;al. Assessment and implication of prognostic imbalance in randomized controlled trials with a binary outcome &#x2013; a simulation study. PLoS One 2012; 7: e36677.</Citation></Reference><Reference><Citation>Futier E, Lefrant JY, Guinot PG, et&#x2009;al. Effect of individualized vs standard blood pressure management strategies on postoperative organ dysfunction among high&#x2010;risk patients undergoing major surgery: a randomized clinical trial. Journal of the American Medical Assocation 2017; 318: 1346&#x2013;57.</Citation></Reference><Reference><Citation>Wanner PM, Wulff DU, Djurdjevic M, Korte W, Schnider TW, Filipovic M. Targeting higher intraoperative blood pressures does not reduce adverse cardiovascular events following noncardiac surgery. Journal of the American College of Cardiology 2021; 78: 1753&#x2013;64.</Citation></Reference><Reference><Citation>Panjasawatwong K, Sessler DI, Stapelfeldt WH, et&#x2009;al. A randomized trial of a supplemental alarm for critically low systolic blood pressure. Anesthesia and Analgesia 2015; 121: 1500&#x2013;7.</Citation></Reference><Reference><Citation>Maheshwari K, Shimada T, Yang D, et&#x2009;al. Hypotension prediction index for prevention of hypotension during moderate&#x2010; to high&#x2010;risk noncardiac surgery. Anesthesiology 2020; 133: 1214&#x2013;22.</Citation></Reference><Reference><Citation>Wijnberge M, Geerts BF, Hol L, et&#x2009;al. Effect of a machine learning&#x2010;derived early warning system for intraoperative hypotension vs standard care on depth and duration of intraoperative hypotension during elective noncardiac surgery: the HYPE randomized clinical trial. Journal of the American Medical Association 2020; 323: 1052&#x2013;60.</Citation></Reference><Reference><Citation>Naylor AJ, Sessler DI, Maheshwari K, et&#x2009;al. Arterial catheters for early detection and treatment of hypotension during major noncardiac surgery: a randomized trial. Anesthesia and Analgesia 2020; 131: 1540&#x2013;50.</Citation></Reference><Reference><Citation>Maheshwari K, Khanna S, Bajracharya GR, et&#x2009;al. A randomized trial of continuous noninvasive blood pressure monitoring during noncardiac surgery. Anesthesia and Analgesia 2018; 127: 424&#x2013;31.</Citation></Reference><Reference><Citation>Donovan JL, de Salis I, Toerien M, Paramasivan S, Hamdy FC, Blazeby JM. The intellectual challenges and emotional consequences of equipoise contributed to the fragility of recruitment in six randomized controlled trials. Journal of Clinical Epidemiology 2014; 67: 912&#x2013;20.</Citation></Reference><Reference><Citation>Donovan JL, Rooshenas L, Jepson M, et&#x2009;al. Optimising recruitment and informed consent in randomised controlled trials: the development and implementation of the quintet recruitment intervention (QRI). Trials 2016; 17: 283.</Citation></Reference><Reference><Citation>Donovan JL, Paramasivan S, de Salis I, Toerien M. Clear obstacles and hidden challenges: understanding recruiter perspectives in six pragmatic randomised controlled trials. Trials 2014; 15: 5.</Citation></Reference><Reference><Citation>Arnold DM, Burns KE, Adhikari NK, et&#x2009;al. The design and interpretation of pilot trials in clinical research in critical care. Critical Care Medicine 2009; 37: S69&#x2013;74.</Citation></Reference><Reference><Citation>Abdellatif S, Hladkowicz E, Lalu MM, Boet S, Gagne S, McIsaac DI. Patient prioritization of routine and patient&#x2010;reported postoperative outcome measures: a prospective, nested cross&#x2010;sectional study. Canadian Journal of Anesthesia 2022. Epub 31 Jan. https://doi.org/10.1007/s12630&#x2010;022&#x2010;02191&#x2010;7</Citation></Reference><Reference><Citation>Reiterer C, Kabon B, Halvorson S, et&#x2009;al. Hemodynamic responses to crystalloid and colloid fluid boluses during noncardiac surgery. Anesthesiology 2022; 136: 127&#x2013;37.</Citation></Reference><Reference><Citation>Myles PS, Bellomo R, Corcoran T, et&#x2009;al. Restrictive versus liberal fluid therapy for major abdominal surgery. New England Journal of Medicine 2018; 378: 2263&#x2013;74.</Citation></Reference><Reference><Citation>Aykanat VM, Myles PS, Weinberg L, Burrell A, Bellomo R. Low&#x2010;concentration norepinephrine infusion for major surgery: a safety and feasibility pilot randomized controlled trial. Anesthesia and Analgesia 2022; 134: 410&#x2013;8.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37880500</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1179-1969</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Drugs &amp; aging</Title><ISOAbbreviation>Drugs Aging</ISOAbbreviation></Journal><ArticleTitle>NSAIDs for Pain Control During the Peri-Operative Period of Hip Fracture Surgery: A Systematic Review.</ArticleTitle><Pagination><StartPage>125</StartPage><EndPage>139</EndPage><MedlinePgn>125-139</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40266-023-01074-w</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hip fracture (HF) mostly affects older adults and is responsible for increased morbidity and mortality. Non-steroidal anti-inflammatory drugs (NSAIDs) are part of the peri-operative multimodal analgesic management, but their use could be associated with adverse events in older adults. This systematic review aimed to assess outcomes associated with NSAIDs use in the peri-operative period of HF surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This systematic review was conducted according to the PRISMA guidelines. Three databases (PubMed/EMBASE/Cochrane Central) were used to search for clinical trials and observational studies assessing efficacy, safety and impact of NSAIDs use on non-specific post-operative outcomes, such as functional status and post-operative complications.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among the 1320 references initially identified, four provided data on efficacy, four on safety and six on non-specific post-operative outcomes (three randomized controlled clinical trials, three observational studies). Mean study population ages ranged from 68 to 87 years. Two studies found that NSAIDs were effective on pain control, but two studies found conflicting results on opioid sparing. No increased risk of acute kidney injury was observed, while results concerning bleeding risk and delirium were conflicting. No study has found any effect of NSAIDs use on walk recovery. Quality of evidence was high for pain control, but low to very low for all the other studied outcomes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The use of NSAIDs may be effective for pain control in the peri-operative period of HF surgery. However, safety data were conflicting with low levels of certainty. Further studies are needed to assess their benefit-risk balance in this context. The research protocol was previously registered on PROSPERO (registration number: CRD42021237649).</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pommier</LastName><ForeName>Wilhelm</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Centre Hospitalier Universitaire de Caen Normandie, 14000, Caen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minoc</LastName><ForeName>Elise-Marie</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Normandie Univ, UNICAEN, INSERM U1075, COMETE, Department of Geriatric Medicine, Centre Hospitalier Universitaire de Caen Normandie, 14000, Caen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morice</LastName><ForeName>Pierre-Marie</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Normandie Univ, UNICAEN, INSERM U1086, ANTICIPE, Department of Pharmacology, Centre Hospitalier Universitaire de Caen Normandie, 14000, Caen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lescure</LastName><ForeName>Pascale</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Normandie Univ, UNICAEN, INSERM U1075, COMETE, Department of Geriatric Medicine, Centre Hospitalier Universitaire de Caen Normandie, 14000, Caen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guillaume</LastName><ForeName>Cyril</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Normandie Univ, UNICAEN, INSERM U1075, COMETE, Department of Palliative Care, Centre Hospitalier Universitaire de Caen Normandie, 14000, Caen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lafont</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Centre Hospitalier Universitaire de Caen Normandie, 14000, Caen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fischer</LastName><ForeName>Marc-Olivier</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>Institut Aquitain du C&#x153;ur, Clinique Saint Augustin, 33074, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boddaert</LastName><ForeName>Jacques</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>D&#xe9;partement de G&#xe9;riatrie, Sorbonne Universit&#xe9;, Assistance Publique-H&#xf4;pitaux de Paris (AP-HP), H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, 75013, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thietart</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>D&#xe9;partement de G&#xe9;riatrie, Sorbonne Universit&#xe9;, Assistance Publique-H&#xf4;pitaux de Paris (AP-HP), H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, 75013, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lelong-Boulouard</LastName><ForeName>V&#xe9;ronique</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Normandie Univ, UNICAEN, INSERM U1075, COMETE, Department of Pharmacology, Centre Hospitalier Universitaire de Caen Normandie, 14000, Caen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beauplet</LastName><ForeName>B&#xe9;reng&#xe8;re</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Normandie Univ, UNICAEN, INSERM ANTICIPE, U1086, Department of Geriatric Medicine, Centre Hospitalier Universitaire de Caen Normandie, 14000, Caen, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Normandy Interregional Oncogeriatric Coordination Unit, 28 Rue Bailey, 14000, Caen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villain</LastName><ForeName>C&#xe9;dric</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-2050-2767</Identifier><AffiliationInfo><Affiliation>Normandie Univ, UNICAEN, INSERM U1075, COMETE, Department of Geriatric Medicine, Centre Hospitalier Universitaire de Caen Normandie, 14000, Caen, France. villain-c@chu-caen.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Drugs Aging</MedlineTA><NlmUniqueID>9102074</NlmUniqueID><ISSNLinking>1170-229X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000894">Anti-Inflammatory Agents, Non-Steroidal</NameOfSubstance></Chemical></ChemicalList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="Y">Hip Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000894" MajorTopicYN="Y">Anti-Inflammatory Agents, Non-Steroidal</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059408" MajorTopicYN="Y">Pain Management</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010149" MajorTopicYN="Y">Pain, Postoperative</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059035" MajorTopicYN="N">Perioperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>26</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>25</Day><Hour>23</Hour><Minute>45</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37880500</ArticleId><ArticleId IdType="doi">10.1007/s40266-023-01074-w</ArticleId><ArticleId IdType="pii">10.1007/s40266-023-01074-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kanis JA, Od&#xe9;n A, McCloskey EV, Johansson H, Wahl DA, Cooper C, et al. A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int. 2012;23:2239&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-012-1964-3</ArticleId><ArticleId IdType="pubmed">22419370</ArticleId><ArticleId IdType="pmc">3421108</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17:1726&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-006-0172-4</ArticleId><ArticleId IdType="pubmed">16983459</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannan EL, Magaziner J, Wang JJ, Eastwood EA, Silberzweig SB, Gilbert M, et al. Mortality and locomotion 6 months after hospitalization for hip fracture: risk factors and risk-adjusted hospital outcomes. JAMA. 2001;285:2736&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.285.21.2736</ArticleId><ArticleId IdType="pubmed">11386929</ArticleId></ArticleIdList></Reference><Reference><Citation>Peeters CMM, Visser E, Van de Ree CLP, Gosens T, Den Oudsten BL, De Vries J. Quality of life after hip fracture in the elderly: a systematic literature review. Injury. 2016;47:1369&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2016.04.018</ArticleId><ArticleId IdType="pubmed">27178770</ArticleId></ArticleIdList></Reference><Reference><Citation>Kehlet H. Acute pain control and accelerated postoperative surgical recovery. Surg Clin North Am. 1999;79:431&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0039-6109(05)70390-X</ArticleId><ArticleId IdType="pubmed">10352662</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaurio LE, Sands LP, Wang Y, Mullen EA, Leung JM. Postoperative delirium: the importance of pain and pain management. Anesth Analg. 2006;102:1267&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ane.0000199156.59226.af</ArticleId><ArticleId IdType="pubmed">16551935</ArticleId></ArticleIdList></Reference><Reference><Citation>McCartney CJL, Nelligan K. Postoperative pain management after total knee arthroplasty in elderly patients: treatment options. Drugs Aging. 2014;31:83&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40266-013-0148-y</ArticleId><ArticleId IdType="pubmed">24399578</ArticleId></ArticleIdList></Reference><Reference><Citation>Aubrun F, Nouette-Gaulain K, Fletcher D, Belbachir A, Beloeil H, Carles M, et al. Revision of expert panel&#x2019;s guidelines on postoperative pain management. Anaesth Crit Care Pain Med. 2019;38:405&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.accpm.2019.02.011</ArticleId><ArticleId IdType="pubmed">30822542</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohanty S, Rosenthal RA, Russell MM, Neuman MD, Ko CY, Esnaola NF. Optimal perioperative management of the geriatric patient: a best practices guideline from the American College of Surgeons NSQIP and the American Geriatrics Society. J Am Coll Surg. 2016;222:930&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2015.12.026</ArticleId><ArticleId IdType="pubmed">27049783</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths R, Beech F, Brown A, Dhesi J, Foo I, Goodall J, et al. Peri-operative care of the elderly 2014: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia. 2014;69(Suppl 1):81&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">24303864</ArticleId></ArticleIdList></Reference><Reference><Citation>American Society of Anesthesiologists Task Force on Acute Pain Management. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology. 2012;116:248&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e31823c1030</ArticleId></ArticleIdList></Reference><Reference><Citation>Elia N, Lysakowski C, Tram&#xe8;r MR. Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine offer advantages over morphine alone? Meta-analyses of randomized trials. Anesthesiology. 2005;103:1296&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200512000-00025</ArticleId><ArticleId IdType="pubmed">16306743</ArticleId></ArticleIdList></Reference><Reference><Citation>Derry C, Derry S, Moore RA, McQuay HJ. Single dose oral ibuprofen for acute postoperative pain in adults. Cochrane Database Syst Rev. 2009. https://doi.org/10.1002/14651858.CD001548 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD001548</ArticleId><ArticleId IdType="pubmed">19821429</ArticleId><ArticleId IdType="pmc">6485324</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaskell H, Derry S, Wiffen PJ, Moore RA. Single dose oral ketoprofen or dexketoprofen for acute postoperative pain in adults. Cochrane Database Syst Rev. 2017. https://doi.org/10.1002/14651858.CD007355 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD007355</ArticleId><ArticleId IdType="pubmed">28540716</ArticleId><ArticleId IdType="pmc">6481461</ArticleId></ArticleIdList></Reference><Reference><Citation>McNicol ED, Ferguson MC, Schumann R. Single-dose intravenous ketorolac for acute postoperative pain in adults. Cochrane Database Syst Rev. 2021. https://doi.org/10.1002/14651858.CD013263 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013263</ArticleId><ArticleId IdType="pubmed">34499349</ArticleId><ArticleId IdType="pmc">8428326</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell S, Rennie T, Marwick CA, Davey P. Effects of peri-operative nonsteroidal anti-inflammatory drugs on post-operative kidney function for adults with normal kidney function. Cochrane Database Syst Rev. 2018. https://doi.org/10.1002/14651858.CD011274 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD011274</ArticleId><ArticleId IdType="pubmed">30570761</ArticleId><ArticleId IdType="pmc">6360925</ArticleId></ArticleIdList></Reference><Reference><Citation>George MD, Baker JF, Leonard CE, Mehta S, Miano TA, Hennessy S. Risk of nonunion with nonselective NSAIDs, COX-2 inhibitors, and opioids. J Bone Joint Surg Am. 2020;102:1230&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.19.01415</ArticleId><ArticleId IdType="pubmed">32675672</ArticleId></ArticleIdList></Reference><Reference><Citation>Subendran J, Siddiqui N, Victor JC, McLeod RS, Govindarajan A. NSAID use and anastomotic leaks following elective colorectal surgery: a matched case-control study. J Gastrointest Surg Off J Soc Surg Aliment Tract. 2014;18:1391&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11605-014-2563-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Barkin RL, Beckerman M, Blum SL, Clark FM, Koh E-K, Wu DS. Should nonsteroidal anti-inflammatory drugs (NSAIDs) be prescribed to the older adult? Drugs Aging. 2010;27:775&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/11539430-000000000-00000</ArticleId><ArticleId IdType="pubmed">20883058</ArticleId></ArticleIdList></Reference><Reference><Citation>By the 2019 American Geriatrics Society Beers Criteria&#xae; Update Expert Panel. American Geriatrics Society. Updated AGS Beers Criteria&#xae; for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;2019(67):674&#x2013;94.</Citation></Reference><Reference><Citation>O&#x2019;Mahony D, O&#x2019;Sullivan D, Byrne S, O&#x2019;Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44:213&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afu145</ArticleId><ArticleId IdType="pubmed">25324330</ArticleId></ArticleIdList></Reference><Reference><Citation>Roux B, Berthou-Contreras J, Beuscart J-B, Charenton-Blavignac M, Doucet J, Fournier J-P, et al. REview of potentially inappropriate MEDIcation pr[e]scribing in Seniors (REMEDI[e]S): French implicit and explicit criteria. Eur J Clin Pharmacol. 2021;77:1713&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00228-021-03145-6</ArticleId><ArticleId IdType="pubmed">34115158</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId><ArticleId IdType="pmc">8005924</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, Savovi&#x107; J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366: l4898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l4898</ArticleId><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. Available from: https://www.bmj.com/content/355/bmj.i4919</Citation></Reference><Reference><Citation>McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2020. https://doi.org/10.1002/jrsm.1411 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1411</ArticleId><ArticleId IdType="pubmed">32336025</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;nemann H, Bro&#x17c;ek J, Guyatt G, Oxman A. GRADE handbook for grading quality of evidence and strength of recommendations. Updated October 2013. The GRADE Working Group, 2013. Available from guidelinedevelopment.org/handbook.</Citation></Reference><Reference><Citation>Godoy Monz&#xf3;n D, Vazquez J, Jauregui JR, Iserson KV. Pain treatment in post-traumatic hip fracture in the elderly: regional block vs. systemic non-steroidal analgesics. Int J Emerg Med. 2010;3:321&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12245-010-0234-4</ArticleId><ArticleId IdType="pubmed">21373300</ArticleId></ArticleIdList></Reference><Reference><Citation>Haines KL, Fuller M, Vaughan JG, Krishnamoorthy V, Raghunathan K, Kasotakis G, et al. The impact of nonsteroidal anti-inflammatory drugs on older adult trauma patients with hip fractures. J Surg Res. 2020;255:583&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2020.05.064</ArticleId><ArticleId IdType="pubmed">32650142</ArticleId></ArticleIdList></Reference><Reference><Citation>Thietart S, Baque M, Cohen-Bittan J, Raux M, Riou B, Khiami F, et al. Short-term administration of nonsteroidal anti-inflammatory drugs in older patients with hip fracture: a cohort study. Eur J Anaesthesiol. 2021;38:1003&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000001482</ArticleId><ArticleId IdType="pubmed">34397528</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixit P, Singh V, Verma S, Singh GP, Singh MK, Kumar S. The effect of celecoxib on early postoperative cognitive dysfunction in elderly patients of fracture neck of femur: a prospective randomised double-blind study. Anaesth Pain Intensive Care. 2021;25:287&#x2013;94.</Citation></Reference><Reference><Citation>Kang H, Ha Y-C, Kim J-Y, Woo Y-C, Lee J-S, Jang E-C. Effectiveness of multimodal pain management after bipolar hemiarthroplasty for hip fracture: a randomized, controlled study. J Bone Jt Surg Am. 2013;95:291&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.K.01708</ArticleId></ArticleIdList></Reference><Reference><Citation>Muangpaisan W, Wongprikron A, Srinonprasert V, Suwanpatoomlerd S, Sutipornpalangkul W, Assantchai P. Incidence and risk factors of acute delirium in older patients with hip fracture in Siriraj Hospital. J Med Assoc Thail Chotmaihet Thangphaet. 2015;98:423&#x2013;30.</Citation></Reference><Reference><Citation>Booker SQ, Herr KA. Assessment and measurement of pain in adults in later life. Clin Geriatr Med. 2016;32:677&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cger.2016.06.012</ArticleId><ArticleId IdType="pubmed">27741963</ArticleId><ArticleId IdType="pmc">5444331</ArticleId></ArticleIdList></Reference><Reference><Citation>Abou-Setta AM, Beaupre LA, Rashiq S, Dryden DM, Hamm MP, Sadowski CA, et al. Comparative effectiveness of pain management interventions for hip fracture: a systematic review. Ann Intern Med. 2011;155:234&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-155-4-201108160-00346</ArticleId><ArticleId IdType="pubmed">21844549</ArticleId></ArticleIdList></Reference><Reference><Citation>Guay J, Kopp S. Peripheral nerve blocks for hip fractures in adults. Cochrane Database Syst Rev. 2020. https://doi.org/10.1002/14651858.CD001159 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD001159</ArticleId><ArticleId IdType="pubmed">33238043</ArticleId><ArticleId IdType="pmc">8130997</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu F, Wu G, Zhao Q, Wu J. Evaluation of analgesic effect, joint function recovery and safety of meloxicam in knee osteoarthritis patients who receive total knee arthroplasty: a randomized, controlled, double-blind study. Medicine (Baltimore). 2021;100: e26873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000026873</ArticleId><ArticleId IdType="pubmed">34477120</ArticleId></ArticleIdList></Reference><Reference><Citation>Glassou EN, Kristensen N, M&#xf8;ller BK, Erikstrup C, Hansen TB, Pedersen AB. Impact of preadmission anti-inflammatory drug use on the risk of RBC transfusion in elderly hip fracture patients: a Danish nationwide cohort study, 2005&#x2013;2016. Transfusion (Paris). 2019;59:935&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.15110</ArticleId></ArticleIdList></Reference><Reference><Citation>Jantzen C, Madsen CM, Abrahamsen B, Van Der Mark S, Duus BR, Howland J, et al. Pre-fracture medication use as a predictor of 30-day mortality in hip fracture patients: an analysis of 141,201 patients. Hip Int J Clin Exp Res Hip Pathol Ther. 2020;30:101&#x2013;6.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27852290</PMID><DateCompleted><Year>2018</Year><Month>01</Month><Day>19</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Nov</Month><Day>17</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Acute kidney injury subphenotypes based on creatinine trajectory identifies patients at increased risk of death.</ArticleTitle><Pagination><StartPage>372</StartPage><MedlinePgn>372</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">372</ELocationID><Abstract><AbstractText Label="BACKGROUND">Acute kidney injury (AKI) is common among intensive care unit (ICU) patients. AKI is highly heterogeneous, with variable links to poor outcomes. Current approaches to classify AKI severity and identify patients at highest risk for poor outcomes focus on the maximum change in serum creatinine (SCr) values. However, these scores are hampered by the need for a reliable baseline SCr value and the absence of a component differentiating transient from persistent rises in SCr. We hypothesized that identification of resolving or nonresolving AKI subphenotypes based on the early trajectory of SCr values in the ICU would better differentiate patients at risk of hospital mortality.</AbstractText><AbstractText Label="METHODS">We performed a secondary analysis of two prospective studies of ICU patients admitted to a trauma ICU (group 1; n&#x2009;=&#x2009;1914) or general medical-surgical ICUs (group 2; n&#x2009;=&#x2009;1867). In group 1, we tested definitions for resolving and nonresolving AKI subphenotypes and selected the definitions resulting in subphenotypes with the greatest separation in risk of death relative to non-AKI controls. We applied this definition to group 2 and tested whether the subphenotypes were independently associated with hospital mortality after adjustment for AKI severity.</AbstractText><AbstractText Label="RESULTS">AKI occurred in 46% and 69% of patients in groups 1 and 2, respectively. In group 1, a resolving AKI subphenotype (defined as a decrease in SCr of 0.3&#xa0;mg/dl or 25% from maximum in the first 72&#xa0;h of study enrollment) was associated with a low risk of death. A nonresolving AKI subphenotype (defined as all AKI cases not meeting the "resolving" definition) was associated with a high risk of death. In group 2, the resolving AKI subphenotype was not associated with increased mortality (relative risk [RR] 0.86, 95% CI 0.63-1.17), whereas the nonresolving AKI subphenotype was associated with higher mortality (RR 1.68, 95% CI 1.15-2.44) even after adjustment for AKI severity stage.</AbstractText><AbstractText Label="CONCLUSIONS">The trajectory of SCr levels identifies AKI subphenotypes with different risks for death, even among AKI cases of similar severity. These AKI subphenotypes might better define the patients at risk for poor outcomes who might benefit from novel interventions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bhatraju</LastName><ForeName>Pavan K</ForeName><Initials>PK</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, University of Washington, Harborview Medical Center, 325 9th Avenue, Seattle, WA, 98104, USA. bhatraju@uw.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mukherjee</LastName><ForeName>Paramita</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Kidney Research Institute, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Nephrology, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robinson-Cohen</LastName><ForeName>Cassianne</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Kidney Research Institute, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Nephrology, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Keefe</LastName><ForeName>Grant E</ForeName><Initials>GE</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frank</LastName><ForeName>Angela J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Division, Department of Medicine, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christie</LastName><ForeName>Jason D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyer</LastName><ForeName>Nuala J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Kathleen D</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Research Institute, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matthay</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Research Institute, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calfee</LastName><ForeName>Carolyn S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Research Institute, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christiani</LastName><ForeName>David C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Division, Department of Medicine, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Himmelfarb</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Kidney Research Institute, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Nephrology, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wurfel</LastName><ForeName>Mark M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, University of Washington, Harborview Medical Center, 325 9th Avenue, Seattle, WA, 98104, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F32 DK112532</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 HL007287</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RC2 HL101779</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL060710</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM066946</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>11</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="Y">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Critical care</Keyword><Keyword MajorTopicYN="N">Intensive care unit</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Subphenotypes</Keyword><Keyword MajorTopicYN="N">Trajectory</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>11</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27852290</ArticleId><ArticleId IdType="pmc">PMC5112626</ArticleId><ArticleId IdType="doi">10.1186/s13054-016-1546-4</ArticleId><ArticleId IdType="pii">10.1186/s13054-016-1546-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet. 2012;380:756&#x2013;66. doi: 10.1016/S0140-6736(11)61454-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)61454-2</ArticleId><ArticleId IdType="pubmed">22617274</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotiriou C, Pusztai L. Gene-expression signatures in breast cancer. N Engl J Med. 2009;360:790&#x2013;800. doi: 10.1056/NEJMra0801289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra0801289</ArticleId><ArticleId IdType="pubmed">19228622</ArticleId></ArticleIdList></Reference><Reference><Citation>Sequist LV, Soria JC, Goldman JW, Wakelee HA, Gadgeel SM, Varga A, et al. Rociletinib in EGFR-mutated non-small-cell lung cancer. N Engl J Med. 2015;372:1700&#x2013;9. doi: 10.1056/NEJMoa1413654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1413654</ArticleId><ArticleId IdType="pubmed">25923550</ArticleId></ArticleIdList></Reference><Reference><Citation>Reilly JP, Bellamy S, Shashaty MGS, Gallop R, Meyer NJ, Lanken PN, et al. Heterogeneous phenotypes of acute respiratory distress syndrome after major trauma. Ann Am Thorac Soc. 2014;11:728&#x2013;36. doi: 10.1513/AnnalsATS.201308-280OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.201308-280OC</ArticleId><ArticleId IdType="pmc">PMC4225810</ArticleId><ArticleId IdType="pubmed">24712298</ArticleId></ArticleIdList></Reference><Reference><Citation>Calfee CS, Janz DR, Bernard GR, May AK, Kangelaris KN, Matthay MA, et al. Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies. Chest. 2015;147:1539&#x2013;48. doi: 10.1378/chest.14-2454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.14-2454</ArticleId><ArticleId IdType="pmc">PMC4451708</ArticleId><ArticleId IdType="pubmed">26033126</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2010;181:315&#x2013;23. doi: 10.1164/rccm.200906-0896OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200906-0896OC</ArticleId><ArticleId IdType="pmc">PMC2822971</ArticleId><ArticleId IdType="pubmed">19892860</ArticleId></ArticleIdList></Reference><Reference><Citation>Corren J, Lemanske RF, Hanania NA, Korenblat PE, Parsey MV, Arron JR, et al. Lebrikizumab treatment in adults with asthma. N Engl J Med. 2011;365:1088&#x2013;98. doi: 10.1056/NEJMoa1106469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1106469</ArticleId><ArticleId IdType="pubmed">21812663</ArticleId></ArticleIdList></Reference><Reference><Citation>Miravitlles M, Soler-Catalu&#xf1;a JJ, Calle M, Soriano JB. Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice. Eur Respir J. 2013;41:1252&#x2013;6. doi: 10.1183/09031936.00118912.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00118912</ArticleId><ArticleId IdType="pubmed">23060631</ArticleId></ArticleIdList></Reference><Reference><Citation>Siew ED, Davenport A. The growth of acute kidney injury: a rising tide or just closer attention to detail? Kidney Int. 2015;87:46&#x2013;61. doi: 10.1038/ki.2014.293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2014.293</ArticleId><ArticleId IdType="pmc">PMC4281297</ArticleId><ArticleId IdType="pubmed">25229340</ArticleId></ArticleIdList></Reference><Reference><Citation>Shalhub S, Junker CE, Imahara SD, Mindrinos MN, Dissanaike S, O&#x2019;Keefe GE. Variation in the TLR4 gene influences the risk of organ failure and shock posttrauma: a cohort study. J Trauma. 2009;66:115&#x2013;23. doi: 10.1097/TA.0b013e3181938d50.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e3181938d50</ArticleId><ArticleId IdType="pmc">PMC2740632</ArticleId><ArticleId IdType="pubmed">19131814</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong MN, Zhou W, Williams PL, Thompson BT, Pothier L, Christiani DC. Polymorphisms in the mannose binding lectin-2 gene and acute respiratory distress syndrome. Crit Care Med. 2007;35:48&#x2013;56. doi: 10.1097/01.CCM.0000251132.10689.F3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000251132.10689.F3</ArticleId><ArticleId IdType="pmc">PMC3090269</ArticleId><ArticleId IdType="pubmed">17133182</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson BT, Bernard GR. ARDS Network (NHLBI) studies: successes and challenges in ARDS clinical research. Crit Care Clin. 2011;27:459&#x2013;68. doi: 10.1016/j.ccc.2011.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2011.05.011</ArticleId><ArticleId IdType="pmc">PMC3143063</ArticleId><ArticleId IdType="pubmed">21742211</ArticleId></ArticleIdList></Reference><Reference><Citation>National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354:2564&#x2013;75. doi: 10.1056/NEJMoa062200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa062200</ArticleId><ArticleId IdType="pubmed">16714767</ArticleId></ArticleIdList></Reference><Reference><Citation>National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network Randomized, placebo-controlled clinical trial of an aerosolized &#x3b2;2-agonist for treatment of acute lung injury. Am J Respir Crit Care Med. 2011;184:561&#x2013;8. doi: 10.1164/rccm.201012-2090OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201012-2090OC</ArticleId><ArticleId IdType="pmc">PMC3175548</ArticleId><ArticleId IdType="pubmed">21562125</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice TW, Wheeler AP, Thompson BT, de Boisblanc BP, Steingrub J, Rock P, et al. Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury. JAMA. 2011;306:1574&#x2013;81. doi: 10.1001/jama.2011.1435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2011.1435</ArticleId><ArticleId IdType="pmc">PMC3770348</ArticleId><ArticleId IdType="pubmed">21976613</ArticleId></ArticleIdList></Reference><Reference><Citation>Perinel S, Vincent F, Lautrette A, Dellamonica J, Mariat C, Zeni F, et al. Transient and persistent acute kidney injury and the risk of hospital mortality in critically ill patients: results of a multicenter cohort study. Crit Care Med. 2015;43:e269&#x2013;75. doi: 10.1097/CCM.0000000000001077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000001077</ArticleId><ArticleId IdType="pubmed">25962084</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchino S, Bellomo R, Bagshaw SM, Goldsmith D. Transient azotaemia is associated with a high risk of death in hospitalized patients. Nephrol Dial Transplant. 2010;25:1833&#x2013;9. doi: 10.1093/ndt/gfp624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfp624</ArticleId><ArticleId IdType="pubmed">20054022</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin DB. Multiple imputation for nonresponse in surveys. Hoboken: Wiley-Interscience; 2004.</Citation></Reference><Reference><Citation>Lumley T, Kronmal R, Ma S. Relative risk regression in medical research: models, contrasts, estimators, and algorithms. UW Biostatistics Working Paper Series. Working Paper 293. July 2006; Available from: http://biostats.bepress.com/uwbiostat/paper293. Accessed 8 Nov 2016.</Citation></Reference><Reference><Citation>Joannidis M, Metnitz PGH. Epidemiology and natural history of acute renal failure in the ICU. Crit Care Clin. 2005;21:239&#x2013;49. doi: 10.1016/j.ccc.2004.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2004.12.005</ArticleId><ArticleId IdType="pubmed">15781160</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste EAJ, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41:1411&#x2013;23. doi: 10.1007/s00134-015-3934-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3934-7</ArticleId><ArticleId IdType="pubmed">26162677</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagshaw SM. George C, Bellomo R, ANZICS Database Management Committee. A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients. Nephrol Dial Transplant. 2008;23:1569&#x2013;74. doi: 10.1093/ndt/gfn009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfn009</ArticleId><ArticleId IdType="pubmed">18281319</ArticleId></ArticleIdList></Reference><Reference><Citation>Murugan R, Karajala-Subramanyam V, Lee M, Yende S, Kong L, Carter M, et al. Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival. Kidney Int. 2010;77:527&#x2013;35. doi: 10.1038/ki.2009.502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2009.502</ArticleId><ArticleId IdType="pmc">PMC2871010</ArticleId><ArticleId IdType="pubmed">20032961</ArticleId></ArticleIdList></Reference><Reference><Citation>Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;53:961&#x2013;73. doi: 10.1053/j.ajkd.2008.11.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2008.11.034</ArticleId><ArticleId IdType="pmc">PMC2726041</ArticleId><ArticleId IdType="pubmed">19346042</ArticleId></ArticleIdList></Reference><Reference><Citation>Coca SG, King JT, Rosenthal RA, Perkal MF, Parikh CR. The duration of postoperative acute kidney injury is an additional parameter predicting long-term survival in diabetic veterans. Kidney Int. 2010;78:926&#x2013;33. doi: 10.1038/ki.2010.259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2010.259</ArticleId><ArticleId IdType="pmc">PMC3082138</ArticleId><ArticleId IdType="pubmed">20686452</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas ME, Blaine C, Dawnay A, Devonald MAJ, Ftouh S, Laing C, et al. The definition of acute kidney injury and its use in practice. Kidney Int. 2015;87:62&#x2013;73. doi: 10.1038/ki.2014.328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2014.328</ArticleId><ArticleId IdType="pubmed">25317932</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagshaw SM, Uchino S, Cruz D, Bellomo R, Morimatsu H, Morgera S, et al. A comparison of observed versus estimated baseline creatinine for determination of RIFLE class in patients with acute kidney injury. Nephrol Dial Transplant. 2009;24:2739&#x2013;44. doi: 10.1093/ndt/gfp159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfp159</ArticleId><ArticleId IdType="pubmed">19349297</ArticleId></ArticleIdList></Reference><Reference><Citation>Siew ED, Matheny ME, Ikizler TA, Lewis JB, Miller RA, Waitman LR, et al. Commonly used surrogates for baseline renal function affect the classification and prognosis of acute kidney injury. Kidney Int. 2010;77:536&#x2013;42. doi: 10.1038/ki.2009.479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2009.479</ArticleId><ArticleId IdType="pmc">PMC2929703</ArticleId><ArticleId IdType="pubmed">20042998</ArticleId></ArticleIdList></Reference><Reference><Citation>Siew ED, Ware LB, Gebretsadik T, Shintani A, Moons KGM, Wickersham N, et al. Urine neutrophil gelatinase-associated lipocalin moderately predicts acute kidney injury in critically ill adults. J Am Soc Nephrol. 2009;20:1823&#x2013;32. doi: 10.1681/ASN.2008070673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2008070673</ArticleId><ArticleId IdType="pmc">PMC2723988</ArticleId><ArticleId IdType="pubmed">19628673</ArticleId></ArticleIdList></Reference><Reference><Citation>Nickolas TL, O&#x2019;Rourke MJ, Yang J, Sise ME, Canetta PA, Barasch N, et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med. 2008;148:810&#x2013;9. doi: 10.7326/0003-4819-148-11-200806030-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-148-11-200806030-00003</ArticleId><ArticleId IdType="pmc">PMC2909852</ArticleId><ArticleId IdType="pubmed">18519927</ArticleId></ArticleIdList></Reference><Reference><Citation>de Geus HRH, Bakker J, Lesaffre EMEH, le Noble JLML. Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients. Am J Respir Crit Care Med. 2011;183:907&#x2013;14. doi: 10.1164/rccm.200908-1214OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200908-1214OC</ArticleId><ArticleId IdType="pubmed">20935115</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Sileanu FE, Murugan R, Lucko N, Shaw AD, Clermont G. Classifying AKI by urine output versus serum creatinine level. J Am Soc Nephrol. 2015;26:2231&#x2013;8. doi: 10.1681/ASN.2014070724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2014070724</ArticleId><ArticleId IdType="pmc">PMC4552117</ArticleId><ArticleId IdType="pubmed">25568178</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Liu YL, Licari E, Bagshaw SM, Egi M, Haase M, et al. Oliguria as predictive biomarker of acute kidney injury in critically ill patients. Crit Care. 2011;15:R172. doi: 10.1186/cc10318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10318</ArticleId><ArticleId IdType="pmc">PMC3387614</ArticleId><ArticleId IdType="pubmed">21771324</ArticleId></ArticleIdList></Reference><Reference><Citation>Garzotto F, Ostermann M, Mart&#xed;n-Langerwerf D, S&#xe1;nchez-S&#xe1;nchez M, Teng J, Robert R, et al. The Dose Response Multicentre Investigation on Fluid Assessment (DoReMIFA) in critically ill patients. Crit Care. 2016;20:196. doi: 10.1186/s13054-016-1355-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1355-9</ArticleId><ArticleId IdType="pmc">PMC4918119</ArticleId><ArticleId IdType="pubmed">27334608</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaara ST, Korhonen AM, Kaukonen KM, Nisula S, Inkinen O, Hoppu S, et al. Fluid overload is associated with an increased risk for 90-day mortality in critically ill patients with renal replacement therapy: data from the prospective FINNAKI study. Crit Care. 2012;16:R197. doi: 10.1186/cc11682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11682</ArticleId><ArticleId IdType="pmc">PMC3682299</ArticleId><ArticleId IdType="pubmed">23075459</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39482169</PMID><DateCompleted><Year>2025</Year><Month>01</Month><Day>11</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Levosimendan in Patients with Low Cardiac Output Syndrome After Cardiac Surgery: A Substudy of the Multicenter Randomized CHEETAH Trial.</ArticleTitle><Pagination><StartPage>151</StartPage><EndPage>161</EndPage><MedlinePgn>151-161</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2024.10.003</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(24)00785-7</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To test the hypothesis that levosimendan administration in patients with low cardiac output syndrome after cardiac surgery is associated with improved long-term (5-year follow-up) outcomes.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Single-center subanalysis of the multicenter randomized CHEETAH trial.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Cardiac surgery department of a tertiary hospital.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">A total of 134 adult patients requiring hemodynamic support for a cardiac index &lt;2.5 L/min/m<sup>2</sup> after cardiac surgery with cardiopulmonary bypass (CPB).</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Patients were randomized (1:1 ratio) to receive levosimendan (continuous infusion with a starting dose of 0.05 &#x3bc;g/kg/min) or placebo, in addition to standard inotropic care.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">The primary endpoint was long-term mortality (1-5 years) after randomization. Secondary outcomes were hemodynamic parameters, need for inotropic support, acute kidney injury (AKI), need for renal replacement therapy, duration of mechanical ventilation, intensive care unit (ICU) and hospital stay, and 30-day mortality. No significant between-group difference in long-term mortality (5 years) was observed (hazard ratio, 1.59; 95% confidence interval, 0.81 to 3.11; p = 0.17). There were no significant differences in secondary outcomes, except for the difference in the mean pulmonary artery pressure at 4 to 6 hours after randomization, which was lower in the levosimendan group compared to the placebo group (median, 24 [interquartile range (IQR), 21.8-28] mmHg vs 26 [IQR, 22.2-33] mmHg; p = 0.019).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Among patients requiring hemodynamic support after cardiac surgery with CPB, perioperative levosimendan infusion did not affect long-term survival (1-5 years) compared with placebo. Levosimendan also had no effect on major clinical outcomes such as AKI, ICU stay, hospital stay, and 30-day mortality.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boboshko</LastName><ForeName>Vladimir</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center, Novosibirsk, Russia. Electronic address: vaboboshko@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lomivorotov</LastName><ForeName>Vladimir</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Penn State College of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruzankin</LastName><ForeName>Pavel</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Mathematics and Mechanics, Novosibirsk State University, Novosibirsk, Russia; Sobolev Institute of Mathematics, Novosibirsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khrushchev</LastName><ForeName>Sergey</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sobolev Institute of Mathematics, Novosibirsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lomivorotova</LastName><ForeName>Liudmila</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center, Novosibirsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monaco</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calabr&#xf2;</LastName><ForeName>Maria Grazia</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Comis</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiac and Vascular Department, Ospedale Mauriziano Umberto I, Torino, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bove</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medicine (DMED), University of Udine, Italy; Department of Emergency "Santa Maria della Misericordia", Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine University Hospital, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pisano</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiac Anesthesia and ICU, AORN "Dei Colli", Monaldi Hospital, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belletti</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>349552KRHK</RegistryNumber><NameOfSubstance UI="D000077464">Simendan</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002316">Cardiotonic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006835">Hydrazones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011724">Pyridazines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077464" MajorTopicYN="Y">Simendan</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002303" MajorTopicYN="Y">Cardiac Output, Low</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002316" MajorTopicYN="Y">Cardiotonic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006835" MajorTopicYN="Y">Hydrazones</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011724" MajorTopicYN="Y">Pyridazines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">levosimendan</Keyword><Keyword MajorTopicYN="N">low cardiac output syndrome</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>1</Month><Day>12</Day><Hour>15</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>31</Day><Hour>23</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39482169</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2024.10.003</ArticleId><ArticleId IdType="pii">S1053-0770(24)00785-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40232164</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>18</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2724-6442</ISSN><JournalIssue CitedMedium="Internet"><Volume>77</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Minerva urology and nephrology</Title><ISOAbbreviation>Minerva Urol Nephrol</ISOAbbreviation></Journal><ArticleTitle>Acute kidney injury following retrograde intrarenal surgery (RIRS) with flexible and navigable suction ureteral access sheath (FANS): results from a prospective multicenter study.</ArticleTitle><Pagination><StartPage>356</StartPage><EndPage>364</EndPage><MedlinePgn>356-364</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.23736/S2724-6051.25.06274-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Flexible and navigable suction ureteral access sheaths (FANS) have proven to be effective in reducing operative time and infectious complications and in increasing stone-free rate during retrograde intrarenal surgery (RIRS). FANS may reduce intrarenal pressure, thus reducing parenchymal renal damage. The aim of the present study was to assess acute kidney injury (AKI) rate following RIRS with FANS.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a prospective multicenter study. Patients were enrolled between August 2023 and March 2024. Inclusion criteria were: patients aged &#x2265;18 years with normal urinary anatomy who successfully underwent RIRS using FANS for renal stones. Complete baseline and perioperative data were collected. AKI was assessed at postoperative day 1 or 2 according to the KDIGO criteria. Intra and early postoperative complications, readmissions, and reinterventions up to 30 days post-surgery were documented. Univariable logistic regression (UVA) analysis was performed to identify predictors of AKI.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Two hundred an ten patients were eligible for analysis. The median stone volume was 1320 mm<sup>3</sup>. Median preoperative serum creatinine and eGFR were 0.94 mg/dL and 84 mL/min, respectively. The commonest FANS size used was 11-13 Ch (47%). A disposable scope was used in 55%, and TFL in 53% of surgeries. Median total laser time, ureteroscopy time, and operative times were 16.5, 31, and 49 minutes, respectively. At the end of the surgery, a double-J ureteral stent was placed in 84% of patients. AKI occurred in 13 (6.2%) patients. All cases were stage 1 AKI. At UVA, none of the preoperative or intraoperative variables were statistically associated with the occurrence of AKI (all P&gt;0.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">AKI following RIRS with FANS is a not neglectable event and endourologist should be aware of this eventuality. However, all AKI episodes were mild. This study findings should be validated with a randomized controlled trial comparing outcomes of RIRS with and without FANS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Candela</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Service of Urology, Assistance-Publique H&#xf4;pitaux de Paris, Tenon Hospital, Paris, France - candela.luigi91@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>GRC n&#xb0;20, Clinical Research Group on Urinary Lithiasis, Tenon Hospital, Sorbonne University, Paris, France - candela.luigi91@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gauhar</LastName><ForeName>Vineet</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Urology, Ng Teng Fong General Hospital, National University Health System, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Somani</LastName><ForeName>Bhaskar</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Urology, University Hospital Southampton NHS Trust, Southampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fong</LastName><ForeName>Khi Y</ForeName><Initials>KY</Initials><AffiliationInfo><Affiliation>Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Persaud</LastName><ForeName>Satyndrea</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Clinical Surgical Sciences, University of the West Indies, St. Augustine, Trinidad and Tobago.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castellani</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Urology Unit, Azienda Ospedaliero-Universitaria delle Marche, Polytechnic University of Marche, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gadzhiev</LastName><ForeName>Nariman</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Urology, Saint-Petersburg State University Hospital, St. Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malkhasyan</LastName><ForeName>Vigen</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Urology Unit, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chai</LastName><ForeName>Chu A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Urology Unit, Department of Surgery, Malaya University, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soebhali</LastName><ForeName>Boyke</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Abdul Wahab Sjahranie Hospital, Mulawarman University, Mulawarman, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elshazly</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Urology, Menoufia University Hospitals, Shibin el Kom, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanidir</LastName><ForeName>Yiloren</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Urology, Marmara University School of Medicine, Istanbul, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Karl M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Urology Center of the Philippines (UCPI), Quezon, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bin Hamri</LastName><ForeName>Saeed</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Urology, Department of Surgery, Ministry of the National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuen</LastName><ForeName>Steffi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Urology Center, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tefik</LastName><ForeName>Tzevat</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Urology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Traxer</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Service of Urology, Assistance-Publique H&#xf4;pitaux de Paris, Tenon Hospital, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>GRC n&#xb0;20, Clinical Research Group on Urinary Lithiasis, Tenon Hospital, Sorbonne University, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Minerva Urol Nephrol</MedlineTA><NlmUniqueID>101777299</NlmUniqueID><ISSNLinking>2724-6051</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007669" MajorTopicYN="Y">Kidney Calculi</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013396" MajorTopicYN="N">Suction</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004867" MajorTopicYN="N">Equipment Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014513" MajorTopicYN="N">Ureter</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>15</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>15</Day><Hour>10</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40232164</ArticleId><ArticleId IdType="doi">10.23736/S2724-6051.25.06274-3</ArticleId><ArticleId IdType="pii">S2724-6051.25.06274-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39261226</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>133</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Effect of machine learning models on clinician prediction of postoperative complications: the Perioperative ORACLE randomised clinical trial.</ArticleTitle><Pagination><StartPage>1042</StartPage><EndPage>1050</EndPage><MedlinePgn>1042-1050</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2024.08.004</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(24)00468-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Anaesthesiologists might be able to mitigate risk if they know which patients are at greatest risk for postoperative complications. This trial examined the impact of machine learning models on clinician risk assessment.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This single-centre, prospective, randomised clinical trial enrolled surgical patients aged &#x2265;18 yr. Anaesthesiologists and nurse anaesthetists providing remote telemedicine support reviewed electronic health records with (assisted group) or without (unassisted group) reviewing machine learning predictions. Clinicians predicted the likelihood of postoperative 30-day all-cause mortality and postoperative acute kidney injury (AKI) within 7 days. The primary outcome was area under the receiver operating characteristic curve (AUROC) for clinician predictions of mortality and AKI, comparing AUROCs between assisted and unassisted assessments.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We analysed 5071 patients (mean [range] age: 58 [18-100] yr; 52% female) assessed by 89 clinicians. Of these, 98 (2.2%) patients died within 30 days of surgery and 450 (11.1%) patients sustained AKI. Clinician predictions agreed with the models more strongly in the assisted vs unassisted group (weighted kappa 0.75 vs 0.62 for death, mean difference: 0.13 [95% CI 0.10-0.17]; and 0.79 vs 0.54 for AKI, mean difference: 0.25 [95% CI 0.21-0.29]). Clinical prediction of death was similar between the assisted (AUROC 0.793) and unassisted (AUROC 0.780) groups (mean difference: 0.013 [95% CI -0.070 to 0.097]; P=0.76). Prediction of AKI had an AUROC of 0.734 in the assisted group vs 0.688 in the unassisted group (difference 0.046 [95% CI -0.003 to 0.091]; P=0.06).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Clinician performance was not improved by machine learning assistance. Further work is needed to clarify the role of machine learning in real-time perioperative risk stratification.</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION" NlmCategory="BACKGROUND">NCT05042804.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fritz</LastName><ForeName>Bradley A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine, Saint Louis, MO, USA. Electronic address: bafritz@wustl.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>King</LastName><ForeName>Christopher R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine, Saint Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdelhack</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Engineering, Washington University McKelvey School of Engineering, Saint Louis, MO, USA; Krembil Centre for Neuroinformatics, Centre for Addiction and Mental Health, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yixin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Engineering, Washington University McKelvey School of Engineering, Saint Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kronzer</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine, Saint Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abraham</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine, Saint Louis, MO, USA; Institute for Informatics, Data Science, and Biostatistics, Washington University School of Medicine, Saint Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tripathi</LastName><ForeName>Sandhya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine, Saint Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben Abdallah</LastName><ForeName>Arbi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine, Saint Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kannampallil</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine, Saint Louis, MO, USA; Institute for Informatics, Data Science, and Biostatistics, Washington University School of Medicine, Saint Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Budelier</LastName><ForeName>Thaddeus P</ForeName><Initials>TP</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine, Saint Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helsten</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine, Saint Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montes de Oca</LastName><ForeName>Arianna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine, Saint Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Divya</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine, Saint Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sontha</LastName><ForeName>Pratyush</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine, Saint Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Higo</LastName><ForeName>Omokhaye</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine, Saint Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kerby</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine, Saint Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gregory</LastName><ForeName>Stephen H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine, Saint Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wildes</LastName><ForeName>Troy S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Nebraska Medical Center, Omaha, NE, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avidan</LastName><ForeName>Michael S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine, Saint Louis, MO, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05042804</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>R01 NR017916</GrantID><Acronym>NR</Acronym><Agency>NINR NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>medRxiv. 2024 May 23:2024.05.22.24307754. doi: 10.1101/2024.05.22.24307754.</RefSource><PMID Version="1">38826471</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072080" MajorTopicYN="N">Anesthesiologists</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017216" MajorTopicYN="N">Telemedicine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">anaesthesiology risk assessment</Keyword><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">clinical trial</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">postoperative complications</Keyword><Keyword MajorTopicYN="N">postoperative death</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>0</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>12</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>11</Day><Hour>22</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39261226</ArticleId><ArticleId IdType="pmc">PMC11488162</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2024.08.004</ArticleId><ArticleId IdType="pii">S0007-0912(24)00468-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nepogodiev D., Martin J., Biccard B., Makupe A., Bhangu A. Global burden of postoperative death. Lancet Lond Engl. 2019;393:401.</Citation><ArticleIdList><ArticleId IdType="pubmed">30722955</ArticleId></ArticleIdList></Reference><Reference><Citation>The International Surgical Outcomes Study group Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle- and high-income countries. Br J Anaesth. 2016;117:601&#x2013;609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5091334</ArticleId><ArticleId IdType="pubmed">27799174</ArticleId></ArticleIdList></Reference><Reference><Citation>Spence J., LeManach Y., Chan M.T.V., et al. Association between complications and death within 30 days after noncardiac surgery. CMAJ. 2019;191:E830&#x2013;E837.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6663503</ArticleId><ArticleId IdType="pubmed">31358597</ArticleId></ArticleIdList></Reference><Reference><Citation>Tjeertes E.K.M., Ultee K.H.J., Stolker R.J., et al. Perioperative complications are associated with adverse long-term prognosis and affect the cause of death after general surgery. World J Surg. 2016;40:2581&#x2013;2590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5073115</ArticleId><ArticleId IdType="pubmed">27302465</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle J.R., Forni L.G., Bell M., et al. Postoperative acute kidney injury in adult non-cardiac surgery: joint consensus report of the Acute Disease Quality Initiative and PeriOperative Quality Initiative. Nat Rev Nephrol. 2021;17:605&#x2013;618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8367817</ArticleId><ArticleId IdType="pubmed">33976395</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskovic A., Lumb A.B. Postoperative pulmonary complications. Br J Anaesth. 2017;118:317&#x2013;334.</Citation><ArticleIdList><ArticleId IdType="pubmed">28186222</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller G.A. The magical number seven, plus or minus two: some limits on our capacity for processing information. Psychol Rev. 1956;63:81&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">13310704</ArticleId></ArticleIdList></Reference><Reference><Citation>Buschman T.J., Siegel M., Roy J.E., Miller E.K. Neural substrates of cognitive capacity limitations. Proc Natl Acad Sci U A. 2011;108:11252&#x2013;11255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3131328</ArticleId><ArticleId IdType="pubmed">21690375</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaba D.M., Lee T. Measuring the workload of the anesthesiologist. Anesth Analg. 1990;71:354&#x2013;361.</Citation><ArticleIdList><ArticleId IdType="pubmed">2400118</ArticleId></ArticleIdList></Reference><Reference><Citation>Stiegler M.P., Tung A. Cognitive processes in anesthesiology decision making. Anesthesiology. 2014;120:204&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pubmed">24212195</ArticleId></ArticleIdList></Reference><Reference><Citation>Fritz B.A., Cui Z., Zhang M., et al. Deep-learning model for predicting 30-day postoperative mortality. Br J Anaesth. 2019;123:688&#x2013;695.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6993109</ArticleId><ArticleId IdType="pubmed">31558311</ArticleId></ArticleIdList></Reference><Reference><Citation>Castela Forte J., Yeshmagambetova G., van der Grinten M.L., et al. Comparison of machine learning models including preoperative, intraoperative, and postoperative data and mortality after cardiac surgery. JAMA Netw Open. 2022;5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9606847</ArticleId><ArticleId IdType="pubmed">36287565</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.W., Lee E.H., Choi I.C. An ensemble machine learning approach to predict postoperative mortality in older patients undergoing emergency surgery. BMC Geriatr. 2023;23:262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10155414</ArticleId><ArticleId IdType="pubmed">37131138</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill B.L., Brown R., Gabel E., et al. An automated machine learning-based model predicts postoperative mortality using readily-extractable preoperative electronic health record data. Br J Anaesth. 2019;123:877&#x2013;886.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6883494</ArticleId><ArticleId IdType="pubmed">31627890</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.W., Lee H.-C., Suh J., et al. Multi-center validation of machine learning model for preoperative prediction of postoperative mortality. NPJ Digit Med. 2022;5:91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9276734</ArticleId><ArticleId IdType="pubmed">35821515</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Z., Fritz B.A., King C.R., Avidan M.S., Chen Y. A&#xa0;factored generalized additive model for clinical decision support in the operating room. AMIA Annu Symp Proc. 2019;2019:343&#x2013;352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7153157</ArticleId><ArticleId IdType="pubmed">32308827</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng P.Y., Chen Y.T., Wang C.H., et al. Prediction of the development of acute kidney injury following cardiac surgery by machine learning. Crit Care. 2020;24:478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7395374</ArticleId><ArticleId IdType="pubmed">32736589</ArticleId></ArticleIdList></Reference><Reference><Citation>Karway G.K., Koyner J.L., Caskey J., et al. Development and external validation of multimodal postoperative acute kidney injury risk machine learning models. JAMIA Open. 2023;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10746378</ArticleId><ArticleId IdType="pubmed">38144168</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue B., Li D., Lu C., et al. Use of machine learning to develop and evaluate models using preoperative and intraoperative data to identify risks of postoperative complications. JAMA Netw Open. 2021;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010590</ArticleId><ArticleId IdType="pubmed">33783520</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahajan A., Esper S., Oo T.H., et al. Development and validation of a machine learning model to identify patients before surgery at high risk for postoperative adverse events. JAMA Netw Open. 2023;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10329211</ArticleId><ArticleId IdType="pubmed">37418262</ArticleId></ArticleIdList></Reference><Reference><Citation>CONSORT-AI and SPIRIT-AI Steering Group Reporting guidelines for clinical trials evaluating artificial intelligence interventions are needed. Nat Med. 2019;25:1467&#x2013;1468.</Citation><ArticleIdList><ArticleId IdType="pubmed">31551578</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Food and Drug Administration  . Guiding Principles; 2021. Good Machine Learning Practice for Medical Device Development.https://www.fda.gov/medical-devices/software-medical-device-samd/good-machine-learning-practice-medical-device-development-guiding-principles Available from:</Citation></Reference><Reference><Citation>King C.R., Abraham J., Kannampallil T.G., et al. Protocol for the effectiveness of an anesthesiology control tower system in improving perioperative quality metrics and clinical outcomes: the TECTONICS randomized, pragmatic trial. F1000Res. 2019;8:2032.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7076336</ArticleId><ArticleId IdType="pubmed">32201572</ArticleId></ArticleIdList></Reference><Reference><Citation>Fritz B., King C., Chen Y., et al.  Protocol for the perioperative outcome risk assessment with computer learning enhancement (Periop ORACLE) randomized study (version 2; peer review: 2 approved) F1000Res. 2022;11:653. https://f1000research.com/articles/11-653/v2 Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10397896</ArticleId><ArticleId IdType="pubmed">37547785</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum J.A., Lameire N. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1) Crit Care. 2013;17:204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4057151</ArticleId><ArticleId IdType="pubmed">23394211</ArticleId></ArticleIdList></Reference><Reference><Citation>Fritz B.A., Pugazenthi S., Budelier T.P., et al. User-centered design of a machine learning dashboard for prediction of postoperative complications. Anesth Analg. 2024;138:804&#x2013;813.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10730770</ArticleId><ArticleId IdType="pubmed">37339083</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team . R Foundation for Statistical Computing; Vienna, Austria: 2017. R: a language and environment for statistical computing.</Citation></Reference><Reference><Citation>DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837&#x2013;845.</Citation><ArticleIdList><ArticleId IdType="pubmed">3203132</ArticleId></ArticleIdList></Reference><Reference><Citation>Brennan M., Puri S., Ozrazgat-Baslanti T., et al. Comparing clinical judgment with the MySurgeryRisk algorithm for preoperative risk assessment: a pilot usability study. Surgery. 2019;165:1035&#x2013;1045.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6502657</ArticleId><ArticleId IdType="pubmed">30792011</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Y., Loftus T.J., Datta S., et al. Performance of a machine learning algorithm using electronic health record data to predict postoperative complications and report on a mobile platform. JAMA Netw Open. 2022;5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9112066</ArticleId><ArticleId IdType="pubmed">35576007</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg S.M., Nair B., Vavilala M.S., et al. Explainable machine-learning predictions for the prevention of hypoxaemia during surgery. Nat Biomed Eng. 2018;2:749&#x2013;760.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6467492</ArticleId><ArticleId IdType="pubmed">31001455</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijnberge M., Geerts B.F., Hol L., et al. Effect of a machine learning-derived early warning system for intraoperative hypotension vs standard care on depth and duration of intraoperative hypotension during elective noncardiac surgery: the HYPE randomized clinical trial. JAMA. 2020;323:1052&#x2013;1060.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7078808</ArticleId><ArticleId IdType="pubmed">32065827</ArticleId></ArticleIdList></Reference><Reference><Citation>Maheshwari K., Shimada T., Yang D., et al. Hypotension prediction index for prevention of hypotension during moderate- to high-risk noncardiac surgery: a pilot randomized trial. Anesthesiology. 2020;133:1214&#x2013;1222.</Citation><ArticleIdList><ArticleId IdType="pubmed">32960954</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasey B., Ursprung S., Beddoe B., et al. Association of clinician diagnostic performance with machine learning&#x2013;based decision support systems: a systematic review. JAMA Netw Open. 2021;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7953308</ArticleId><ArticleId IdType="pubmed">33704476</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonelli C., Ringhouse B., Bunn C., Luchette F. The impact of the aging population on surgical diseases. Curr Geriatr Rep. 2021;10:21&#x2013;31.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">18249327</PMID><DateCompleted><Year>2008</Year><Month>05</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2008</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis.</ArticleTitle><Pagination><StartPage>27</StartPage><EndPage>33</EndPage><MedlinePgn>27-33</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2007.07.015</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Acute renal failure is a common and threatening complication in patients undergoing cardiovascular surgery. To determine the efficacy of fenoldopam in the prevention of acute renal failure, the authors performed a systematic review of randomized, controlled trials and propensity-matched studies in patients undergoing cardiovascular surgery.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Meta-analysis.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Hospitals.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">A total of 1,059 patients from 13 randomized and case-matched studies were included in the analysis.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">None.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">Google Scholar, PubMed, and scientific sessions were searched (updated November 2006). Authors and external experts were contacted. Four unblinded reviewers selected controlled trials that used fenoldopam in the prevention or treatment of acute renal failure in cardiovascular surgery. Four reviewers independently abstracted patient data, treatment characteristics, and outcomes. Pooled estimates showed that fenoldopam consistently and significantly reduced the need for renal replacement therapy (odds ratio = 0.37 [0.23-0.59], p &lt; 0.001) and in-hospital death (odds ratio = 0.46 [0.29-0.75], p = 0.01). These benefits were associated with shorter intensive care unit stay (weighted mean difference [WMD] = -0.93 days [-1.27; -0.58], p = 0.002). Sensitivity analyses, tests for small study bias, and heterogeneity assessment further confirmed the main analysis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This meta-analysis provides evidence that fenoldopam may confer significant benefits in preventing renal replacement therapy and reducing mortality in patients undergoing cardiovascular surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Anesthesia and Intensive Care, Universit&#xe0; Vita-Salute San Raffaele, Milano, Italia e Istituto Scientifico San Raffaele, Milan, Italy. landoni.giovanni@hsr.it</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biondi-Zoccai</LastName><ForeName>Giuseppe G L</ForeName><Initials>GG</Initials></Author><Author ValidYN="Y"><LastName>Marino</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Bove</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Fochi</LastName><ForeName>Oliviero</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Maj</LastName><ForeName>Giulia</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Calabr&#xf2;</LastName><ForeName>Maria Grazia</ForeName><Initials>MG</Initials></Author><Author ValidYN="Y"><LastName>Sheiban</LastName><ForeName>Imad</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Tumlin</LastName><ForeName>James A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Ranucci</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Zangrillo</LastName><ForeName>Alberto</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2007</Year><Month>11</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018491">Dopamine Agonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical><Chemical><RegistryNumber>INU8H2KAWG</RegistryNumber><NameOfSubstance UI="D018818">Fenoldopam</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018491" MajorTopicYN="N">Dopamine Agonists</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018818" MajorTopicYN="N">Fenoldopam</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="N">Monitoring, Intraoperative</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="N">Renal Replacement Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>40</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2007</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>2</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>5</Month><Day>24</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>2</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18249327</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2007.07.015</ArticleId><ArticleId IdType="pii">S1053-0770(07)00234-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21334433</PMID><DateCompleted><Year>2011</Year><Month>09</Month><Day>22</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4596</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>11</Issue><PubDate><Year>2011</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>Free radical biology &amp; medicine</Title><ISOAbbreviation>Free Radic Biol Med</ISOAbbreviation></Journal><ArticleTitle>Postoperative acute kidney injury is associated with hemoglobinemia and an enhanced oxidative stress response.</ArticleTitle><Pagination><StartPage>1480</StartPage><EndPage>1487</EndPage><MedlinePgn>1480-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.freeradbiomed.2011.02.011</ELocationID><Abstract><AbstractText>Acute kidney injury (AKI) frequently afflicts patients undergoing cardiopulmonary bypass and independently predicts death. Both hemoglobinemia and myoglobinemia are independent predictors of postoperative AKI. Release of free hemeproteins into the circulation is known to cause oxidative injury to the kidneys. This study tested the hypothesis that postoperative AKI is associated with both enhanced intraoperative hemeprotein release and increased lipid peroxidation assessed by measuring F&#x2082;-isoprostanes and isofurans. In a case-control study nested within an ongoing randomized trial of perioperative statin treatment and AKI, we compared levels of F&#x2082;-isoprostanes and isofurans with plasma levels of free hemoglobin and myoglobin in 10 cardiac surgery AKI patients to those of 10 risk-matched controls. Peak plasma free hemoglobin concentrations were significantly higher in AKI subjects (289.0 &#xb1; 37.8 versus 104.4 &#xb1; 36.5mg/dl, P = 0.01), whereas plasma myoglobin concentrations were similar between groups. The change in plasma F&#x2082;-isoprostane and isofuran levels (repeated-measures ANOVA, P = 0.02 and P = 0.001, respectively) as well as the change in urine isofuran levels (P = 0.04) was significantly greater in AKI subjects. In addition, change in peak plasma isofuran levels correlated not only with peak free plasma hemoglobin concentrations (r&#xb2; = 0.39, P = 0.001) but also with peak change in serum creatinine (r&#xb2; = 0.20, P = 0.01). Postoperative AKI is associated with both enhanced intraoperative hemeprotein release and enhanced lipid peroxidation. The correlations among hemoglobinemia, lipid peroxidation, and AKI indicate a potential role for hemeprotein-induced oxidative damage in the pathogenesis of postoperative AKI.</AbstractText><CopyrightInformation>Copyright &#xa9; 2011 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Billings</LastName><ForeName>Frederic T</ForeName><Initials>FT</Initials><Suffix>4th</Suffix><AffiliationInfo><Affiliation>Division of Clinical Pharmacology, Department of Anesthesiology, Vanderbilt University Medical School, Nashville, TN 37232, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ball</LastName><ForeName>Stephen K</ForeName><Initials>SK</Initials></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>L Jackson</ForeName><Initials>LJ</Initials><Suffix>2nd</Suffix></Author><Author ValidYN="Y"><LastName>Pretorius</LastName><ForeName>Mias</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00791648</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>HL085740</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM042056</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>TL1 RR024978</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>KL2 RR024977</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 GM042056</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 RR024975</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL085740</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>GM42056</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>02</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Free Radic Biol Med</MedlineTA><NlmUniqueID>8709159</NlmUniqueID><ISSNLinking>0891-5849</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D028441">F2-Isoprostanes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005663">Furans</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006454">Hemoglobins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009211">Myoglobin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="Y">Cardiopulmonary Bypass</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D028441" MajorTopicYN="N">F2-Isoprostanes</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005663" MajorTopicYN="N">Furans</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006454" MajorTopicYN="N">Hemoglobins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006456" MajorTopicYN="N">Hemoglobinuria</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015227" MajorTopicYN="N">Lipid Peroxidation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009211" MajorTopicYN="N">Myoglobin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009212" MajorTopicYN="N">Myoglobinuria</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2011</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2012</Year><Month>6</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21334433</ArticleId><ArticleId IdType="mid">NIHMS275818</ArticleId><ArticleId IdType="pmc">PMC3090463</ArticleId><ArticleId IdType="doi">10.1016/j.freeradbiomed.2011.02.011</ArticleId><ArticleId IdType="pii">S0891-5849(11)00101-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Karkouti K, Wijeysundera DN, Yau TM, Callum JL, Cheng DC, Crowther M, Dupuis J-Y, Fremes SE, Kent B, Laflamme C, Lamy A, Legare J-F, Mazer CD, McCluskey SA, Rubens FD, Sawchuk C, Beattie WS. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation. 2009;119:495&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pubmed">19153273</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings F, Siew E, Yu C, Pretorius M, Brown N. Early postoperative statin therapy is associated with a lower incidence of acute kidney injury following cardiac surgery. J Cardiothorac Vasc Anesth. 2010;24:913&#x2013;920.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2992577</ArticleId><ArticleId IdType="pubmed">20599398</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006;1:19&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">17699187</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase M, Bellomo R, Haase-Fielitz A. Novel biomarkers, oxidative stress, and the role of labile iron toxicity in cardiopulmonary bypass-associated acute kidney injury. J Am Coll Cardiol. 2010;55:2024&#x2013;2033.</Citation><ArticleIdList><ArticleId IdType="pubmed">20447525</ArticleId></ArticleIdList></Reference><Reference><Citation>Mack MJ, Pfister A, Bachand D, Emery R, Magee MJ, Connolly M, Subramanian V. Comparison of coronary bypass surgery with and without cardiopulmonary bypass in patients with multivessel disease. J Thorac Cardiovasc Surg. 2004;127:167&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pubmed">14752427</ArticleId></ArticleIdList></Reference><Reference><Citation>Scolari F, Tardanico R, Zani R, Pola A, Viola BF, Movilli E, Maiorca R. Cholesterol crystal embolism: A recognizable cause of renal disease. Am J Kidney Dis. 2000;36:1089&#x2013;1109.</Citation><ArticleIdList><ArticleId IdType="pubmed">11096032</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanardo G, Michielon P, Paccagnella A, Rosi P, Calo M, Salandin V, Da Ros A, Michieletto F, Simini G. Acute renal failure in the patient undergoing cardiac operation. Prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg. 1994;107:1489&#x2013;1495.</Citation><ArticleIdList><ArticleId IdType="pubmed">8196394</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldt J, Brenner T, Lehmann A, Suttner SW, Kumle B, Isgro F. Is kidney function altered by the duration of cardiopulmonary bypass? Ann Thorac Surg. 2003;75:906&#x2013;912.</Citation><ArticleIdList><ArticleId IdType="pubmed">12645715</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedetto U, Angeloni E, Luciani R, Refice S, Stefanelli M, Comito C, Roscitano A, Sinatra R. Acute kidney injury after coronary artery bypass grafting: does rhabdomyolysis play a role? J Thorac Cardiovasc Surg. 2010;140:464&#x2013;470.</Citation><ArticleIdList><ArticleId IdType="pubmed">20416892</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller CC, 3rd, Villa MA, Sutton J, Lau D, Keyhani K, Estrera AL, Azizzadeh A, Coogan SM, Safi HJ. Serum myoglobin and renal morbidity and mortality following thoracic and thoraco-abdominal aortic repair: does rhabdomyolysis play a role? Eur J Vasc Endovasc Surg. 2009;37:388&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pubmed">19232502</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeulen Windsant IC, Snoeijs MG, Hanssen SJ, Altintas S, Heijmans JH, Koeppel TA, Schurink GW, Buurman WA, Jacobs MJ. Hemolysis is associated with acute kidney injury during major aortic surgery. Kidney Int. 2010;77:913&#x2013;920.</Citation><ArticleIdList><ArticleId IdType="pubmed">20182411</ArticleId></ArticleIdList></Reference><Reference><Citation>Vercaemst L. Hemolysis in cardiac surgery patients undergoing cardiopulmonary bypass: a review in search of a treatment algorithm. J Extra Corpor Technol. 2008;40:257&#x2013;267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4680715</ArticleId><ArticleId IdType="pubmed">19192755</ArticleId></ArticleIdList></Reference><Reference><Citation>Inselmann G, Kohler K, Lange V, Silber R, Nellessen U. Lipid peroxidation and cardiac troponin T release during routine cardiac surgery. Cardiology. 1998;89:124&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pubmed">9524013</ArticleId></ArticleIdList></Reference><Reference><Citation>Reeder BJ, Svistunenko DA, Cooper CE, Wilson MT. The radical and redox chemistry of myoglobin and hemoglobin: from in vitro studies to human pathology. Antioxid Redox Signal. 2004;6:954&#x2013;966.</Citation><ArticleIdList><ArticleId IdType="pubmed">15548893</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore KP, Holt SG, Patel RP, Svistunenko DA, Zackert W, Goodier D, Reeder BJ, Clozel M, Anand R, Cooper CE, Morrow JD, Wilson MT, Darley-Usmar V, Roberts LJ., 2nd A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure. J Biol Chem. 1998;273:31731&#x2013;31737.</Citation><ArticleIdList><ArticleId IdType="pubmed">9822635</ArticleId></ArticleIdList></Reference><Reference><Citation>Holt S, Reeder B, Wilson M, Harvey S, Morrow JD, Roberts LJ, 2nd, Moore K. Increased lipid peroxidation in patients with rhabdomyolysis. Lancet. 1999;353:1241.</Citation><ArticleIdList><ArticleId IdType="pubmed">10217088</ArticleId></ArticleIdList></Reference><Reference><Citation>Christen S, Finckh B, Lykkesfeldt J, Gessler P, Frese-Schaper M, Nielsen P, Schmid ER, Schmitt B. Oxidative stress precedes peak systemic inflammatory response in pediatric patients undergoing cardiopulmonary bypass operation. Free Radic Biol Med. 2005;38:1323&#x2013;1332.</Citation><ArticleIdList><ArticleId IdType="pubmed">15855050</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadiiska MB, Gladen BC, Baird DD, Germolec D, Graham LB, Parker CE, Nyska A, Wachsman JT, Ames BN, Basu S, Brot N, Fitzgerald GA, Floyd RA, George M, Heinecke JW, Hatch GE, Hensley K, Lawson JA, Marnett LJ, Morrow JD, Murray DM, Plastaras J, Roberts LJ, 2nd, Rokach J, Shigenaga MK, Sohal RS, Sun J, Tice RR, Van Thiel DH, Wellner D, Walter PB, Tomer KB, Mason RP, Barrett JC. Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med. 2005;38:698&#x2013;710.</Citation><ArticleIdList><ArticleId IdType="pubmed">15721980</ArticleId></ArticleIdList></Reference><Reference><Citation>Fessel JP, Porter NA, Moore KP, Sheller JR, Roberts LJ., 2nd Discovery of lipid peroxidation products formed in vivo with a substituted tetrahydrofuran ring (isofurans) that are favored by increased oxygen tension. Proc Natl Acad Sci U S A. 2002;99:16713&#x2013;16718.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC139209</ArticleId><ArticleId IdType="pubmed">12482927</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutaud O, Moore KP, Reeder BJ, Harry D, Howie AJ, Wang S, Carney CK, Masterson TS, Amin T, Wright DW, Wilson MT, Oates JA, Roberts LJ., 2nd Acetaminophen inhibits hemoprotein-catalyzed lipid peroxidation and attenuates rhabdomyolysis-induced renal failure. Proc Natl Acad Sci U S A. 2010;107:2699&#x2013;2704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2823910</ArticleId><ArticleId IdType="pubmed">20133658</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CL, Hsu YT, Lin TK, Morrow JD, Hsu JC, Hsu YH, Hsieh TC, Tsay PK, Yen HC. Increased levels of F2-isoprostanes following aneurysmal subarachnoid hemorrhage in humans. Free Radic Biol Med. 2006;40:1466&#x2013;1473.</Citation><ArticleIdList><ArticleId IdType="pubmed">16631536</ArticleId></ArticleIdList></Reference><Reference><Citation>Klings ES, Christman BW, McClung J, Stucchi AF, McMahon L, Brauer M, Farber HW. Increased F2 isoprostanes in the acute chest syndrome of sickle cell disease as a marker of oxidative stress. Am J Respir Crit Care Med. 2001;164:1248&#x2013;1252.</Citation><ArticleIdList><ArticleId IdType="pubmed">11673218</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2206446</ArticleId><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference><Reference><Citation>Macedo E, Malhotra R, Claure-Del Granado R, Fedullo P, Mehta RL. Defining urine output criterion for acute kidney injury in critically ill patients. Nephrol Dial Transplant. 2010</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3108356</ArticleId><ArticleId IdType="pubmed">20562094</ArticleId></ArticleIdList></Reference><Reference><Citation>Palomba H, de Castro I, Neto AL, Lage S, Yu L. Acute kidney injury prediction following elective cardiac surgery: AKICS Score. Kidney Int. 2007;72:624&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pubmed">17622275</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pubmed">16908915</ArticleId></ArticleIdList></Reference><Reference><Citation>Unger J, Filippi G, Patsch W. Measurements of Free Hemoglobin and Hemolysis Index: EDTA- or Lithium-Heparinate Plasma? Clin Chem. 2007;53:1717&#x2013;1718.</Citation><ArticleIdList><ArticleId IdType="pubmed">17712012</ArticleId></ArticleIdList></Reference><Reference><Citation>Milne GL, Sanchez SC, Musiek ES, Morrow JD. Quantification of F2-isoprostanes as a biomarker of oxidative stress. Nat Protoc. 2007;2:221&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">17401357</ArticleId></ArticleIdList></Reference><Reference><Citation>De Caterina R, Cipollone F, Filardo FP, Zimarino M, Bernini W, Lazzerini G, Bucciarelli T, Falco A, Marchesani P, Muraro R, Mezzetti A, Ciabattoni G. Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzyme-A inhibitor simvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects: no further effect of vitamin E. Circulation. 2002;106:2543&#x2013;2549.</Citation><ArticleIdList><ArticleId IdType="pubmed">12427649</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, Strauss WE, Oates JA, Roberts LJ., 2nd Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med. 1995;332:1198&#x2013;1203.</Citation><ArticleIdList><ArticleId IdType="pubmed">7700313</ArticleId></ArticleIdList></Reference><Reference><Citation>Miceli A, Capoun R, Fino C, Narayan P, Bryan AJ, Angelini GD, Caputo M. Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol. 2009;54:1178&#x2013;1184.</Citation><ArticleIdList><ArticleId IdType="pubmed">19682819</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulus AT, Aksoyek A, Ozkan M, Katircioglu SF, Basu S. Cardiopulmonary bypass as a cause of free radical-induced oxidative stress and enhanced blood-borne isoprostanes in humans. Free Radic Biol Med. 2003;34:911&#x2013;917.</Citation><ArticleIdList><ArticleId IdType="pubmed">12654480</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts LJ, 2nd, Fessel JP. The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation. Chem Phys Lipids. 2004;128:173&#x2013;186.</Citation><ArticleIdList><ArticleId IdType="pubmed">15037162</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng S, Roberts LJ, 2nd, Cason GW, Curry TS, Manning RD., Jr Superoxide dismutase and oxidative stress in Dahl salt-sensitive and -resistant rats. Am. J. Physiol.-Regul. Integr. Comp. Physiol. 2002;283:R732&#x2013;R738.</Citation><ArticleIdList><ArticleId IdType="pubmed">12185008</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath KA, Grande JP, Croatt AJ, Likely S, Hebbel RP, Enright H. Intracellular targets in heme protein-induced renal injury. Kidney Int. 1998;53:100&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pubmed">9453005</ArticleId></ArticleIdList></Reference><Reference><Citation>Legrand M, Mik EG, Johannes T, Payen D, Ince C. Renal hypoxia and dysoxia after reperfusion of the ischemic kidney. Mol Med. 2008;14:502&#x2013;516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2386087</ArticleId><ArticleId IdType="pubmed">18488066</ArticleId></ArticleIdList></Reference><Reference><Citation>Plotnikov EY, Chupyrkina AA, Pevzner IB, Isaev NK, Zorov DB. Myoglobin causes oxidative stress, increase of NO production and dysfunction of kidney's mitochondria. Biochim Biophys Acta. 2009;1792:796&#x2013;803.</Citation><ArticleIdList><ArticleId IdType="pubmed">19545623</ArticleId></ArticleIdList></Reference><Reference><Citation>Paller MS. Hemoglobin- and myoglobin-induced acute renal failure in rats: role of iron in nephrotoxicity. Am J Physiol Renal Physiol. 1988;255:F539&#x2013;F544.</Citation><ArticleIdList><ArticleId IdType="pubmed">3414810</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyner JL, Sher Ali R, Murray PT Antioxidants. Do they have a place in the prevention or therapy of acute kidney injury? Nephron Exp Nephrol. 2008;109:e109&#x2013;e117.</Citation><ArticleIdList><ArticleId IdType="pubmed">18802373</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts LJ, 2nd, Oates JA, Linton MF, Fazio S, Meador BP, Gross MD, Shyr Y, Morrow JD. The relationship between dose of vitamin E and suppression of oxidative stress in humans. Free Radic Biol Med. 2007;43:1388&#x2013;1393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2072864</ArticleId><ArticleId IdType="pubmed">17936185</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato GJ. Haptoglobin halts hemoglobins havoc. J. Clin. Invest. 2009;119:2140&#x2013;2142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2719939</ArticleId><ArticleId IdType="pubmed">19620777</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan IS, Codispoti M, Sanger K, Mankad PS. Superiority of centrifugal pump over roller pump in paediatric cardiac surgery: prospective randomised trial. Eur J Cardiothorac Surg. 1998;13:526&#x2013;532.</Citation><ArticleIdList><ArticleId IdType="pubmed">9663533</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka K, Kanamori Y, Sato T, Kondo C, Katayama Y, Yada I, Yuasa H, Kusagawa M. Administration of haptoglobin during cardiopulmonary bypass surgery. ASAIO Trans. 1991;37:M482&#x2013;M483.</Citation><ArticleIdList><ArticleId IdType="pubmed">1721515</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt-Ott KM, Mori K, Kalandadze A, Li JY, Paragas N, Nicholas T, Devarajan P, Barasch J. Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia. Curr Opin Nephrol Hypertens. 2006;15:442&#x2013;449.</Citation><ArticleIdList><ArticleId IdType="pubmed">16775460</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365:1231&#x2013;1238.</Citation><ArticleIdList><ArticleId IdType="pubmed">15811456</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry TE, Muehlschlegel JD, Liu KY, Fox AA, Collard CD, Shernan SK, Body SC. Plasma neutrophil gelatinase-associated lipocalin and acute postoperative kidney injury in adult cardiac surgical patients. Anesth Analg. 2010;110:1541&#x2013;1547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2999841</ArticleId><ArticleId IdType="pubmed">20435938</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedetto U, Sciarretta S, Roscitano A, Fiorani B, Refice S, Angeloni E, Sinatra R. Preoperative Angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting. Ann Thorac Surg. 2008;86:1160&#x2013;1165.</Citation><ArticleIdList><ArticleId IdType="pubmed">18805152</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius M, McFarlane JA, Vaughan DE, Brown NJ, Murphey LJ. Angiotensin-converting enzyme inhibition and smoking potentiate the kinin response to cardiopulmonary bypass. Clin Pharmacol Ther. 2004;76:379&#x2013;387.</Citation><ArticleIdList><ArticleId IdType="pubmed">15470338</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang WC, Chien CT, Lin WW, Lin SL, Chen YM, Lai CF, Wu KD, Chao J, Tsai TJ. Early activation of bradykinin B2 receptor aggravates reactive oxygen species generation and renal damage in ischemia/reperfusion injury. Free Radic Biol Med. 2006;41:1304&#x2013;1314.</Citation><ArticleIdList><ArticleId IdType="pubmed">17015177</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19454560</PMID><DateCompleted><Year>2009</Year><Month>08</Month><Day>11</Day></DateCompleted><DateRevised><Year>2010</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0267-6591</ISSN><JournalIssue CitedMedium="Print"><Volume>23</Volume><Issue>6</Issue><PubDate><Year>2008</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Perfusion</Title><ISOAbbreviation>Perfusion</ISOAbbreviation></Journal><ArticleTitle>Cardiopulmonary bypass management and acute renal failure: risk factors and prognosis.</ArticleTitle><Pagination><StartPage>323</StartPage><EndPage>327</EndPage><MedlinePgn>323-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/0267659109105251</ELocationID><Abstract><AbstractText>The aim of the study was to investigate if acute renal failure (ARF) following cardiac surgery is influenced by CPB perfusion pressure and to determine risk factors of ARF. Our research consisted of two studies. In the first study, 179 adult patients with normal preoperative renal function who had been subjected to cardiac surgery on CPB were randomized into three groups. The mean perfusion pressure (PP) during CPB in Group 65 (68 patients) was 60-69.9 mmHg, in Group 55 (59 patients) -- lower than 60 mmHg and in Group 75 (52 patients) -- 70 mmHg and higher. We have analyzed postoperative variables: central venous pressure, the need for diuretics, urine output, fluid balance, acidosis, potassium level in blood serum, the need for hemotransfusions, nephrological, cardiovascular and respiratory complications, duration of artificial lung ventilation, duration of stay in ICU and in hospital, and mortality. In the second study, to identify the risk factors for the development of ARF following CPB, we retrospectively analysed data of all 179 patients, divided into two groups: patients who developed ARF after surgery (group with ARF, n = 19) and patients without ARF (group without ARF, n = 160). We found that urine output during surgery was statistically significantly lower in Group 55 than in Groups 65 and 75. The incidence of ARF in the early postoperative period did not differ among the groups: it developed in 6% of all patients in Group 65, 4% in Group 55 and 6% in Group 75. There were no differences in the rate of other complications (cardiovascular, respiratory, neurological disorders, bleeding, etc) among the groups. There were 19 cases of ARF (10.6%), but none of these patients needed dialysis. We found that age (70.0 +/- 7.51 vs. 63.5 +/- 10.54 [standard deviation, SD], P = 0.016), valve replacement and/or reconstruction surgery (57.9% vs. 27.2%, P = 0,011), combined valve and CABG surgery (15.8% vs. 1.4%, P = 0.004), duration of CPB (134.74 +/- 62.02 vs. 100.59 +/- 43.99 min., P = 0.003) and duration of aortic cross-clamp (75.11 +/- 35.78 vs. 53.45 +/- 24.19 min., P = 0.001) were the most important independent risk factors for ARF. Cardiopulmonary bypass perfusion pressure did not cause postoperative renal failure. The age of patient, valve surgery procedures, duration of cardiopulmonary bypass and duration of aorta cross-clamp are potential causative factors for acute renal failure after cardiac surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sirvinskas</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute for Biomedical Research, Kaunas University of Medicine, Kaunas, Lithuania. sirdiskr@kmu.lt</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrejaitiene</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Raliene</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Nasvytis</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Karbonskiene</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Pilvinis</LastName><ForeName>V</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Sakalauskas</LastName><ForeName>J</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Perfusion</MedlineTA><NlmUniqueID>8700166</NlmUniqueID><ISSNLinking>0267-6591</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="Y">Cardiopulmonary Bypass</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019918" MajorTopicYN="N">Heart Valve Prosthesis Implantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011312" MajorTopicYN="N">Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>5</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>5</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>8</Month><Day>12</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19454560</ArticleId><ArticleId IdType="doi">10.1177/0267659109105251</ArticleId><ArticleId IdType="pii">23/6/323</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26906014</PMID><DateCompleted><Year>2016</Year><Month>03</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-3598</ISSN><JournalIssue CitedMedium="Internet"><Volume>315</Volume><Issue>9</Issue><PubDate><Year>2016</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA</Title><ISOAbbreviation>JAMA</ISOAbbreviation></Journal><ArticleTitle>High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial.</ArticleTitle><Pagination><StartPage>877</StartPage><EndPage>888</EndPage><MedlinePgn>877-88</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2016.0548</ELocationID><Abstract><AbstractText Label="IMPORTANCE" NlmCategory="OBJECTIVE">Statins affect several mechanisms underlying acute kidney injury (AKI).</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To test the hypothesis that short-term high-dose perioperative atorvastatin would reduce AKI following cardiac surgery.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS" NlmCategory="METHODS">Double-blinded, placebo-controlled, randomized clinical trial of adult cardiac surgery patients conducted from November 2009 to October 2014 at Vanderbilt University Medical Center.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Patients naive to statin treatment (n&#x2009;=&#x2009;199) were randomly assigned 80 mg of atorvastatin the day before surgery, 40 mg of atorvastatin the morning of surgery, and 40 mg of atorvastatin daily following surgery (n&#x2009;=&#x2009;102) or matching placebo (n&#x2009;=&#x2009;97). Patients already taking a statin prior to study enrollment (n&#x2009;=&#x2009;416) continued taking the preenrollment statin until the day of surgery, were randomly assigned 80 mg of atorvastatin the morning of surgery and 40 mg of atorvastatin the morning after (n&#x2009;=&#x2009;206) or matching placebo (n&#x2009;=&#x2009;210), and resumed taking the previously prescribed statin on postoperative day 2.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES" NlmCategory="METHODS">Acute kidney injury defined as an increase of 0.3 mg/dL in serum creatinine concentration within 48 hours of surgery (Acute Kidney Injury Network criteria).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The data and safety monitoring board recommended stopping the group naive to statin treatment due to increased AKI among these participants with chronic kidney disease (estimated glomerular filtration rate &lt;60 mL/min/1.73 m2) receiving atorvastatin. The board later recommended stopping for futility after 615 participants (median age, 67 years; 188 [30.6%] were women; 202 [32.8%] had diabetes) completed the study. Among all participants (n&#x2009;=&#x2009;615), AKI occurred in 64 of 308 (20.8%) in the atorvastatin group vs 60 of 307 (19.5%) in the placebo group (relative risk [RR], 1.06 [95% CI, 0.78 to 1.46]; P&#x2009;=&#x2009;.75). Among patients naive to statin treatment (n&#x2009;=&#x2009;199), AKI occurred in 22 of 102 (21.6%) in the atorvastatin group vs 13 of 97 (13.4%) in the placebo group (RR, 1.61 [0.86 to 3.01]; P&#x2009;=&#x2009;.15) and serum creatinine concentration increased by a median of 0.11 mg/dL (10th-90th percentile, -0.11 to 0.56 mg/dL) in the atorvastatin group vs by a median of 0.05 mg/dL (10th-90th percentile, -0.12 to 0.33 mg/dL) in the placebo group (mean difference, 0.08 mg/dL [95% CI, 0.01 to 0.15 mg/dL]; P&#x2009;=&#x2009;.007). Among patients already taking a statin (n&#x2009;=&#x2009;416), AKI occurred in 42 of 206 (20.4%) in the atorvastatin group vs 47 of 210 (22.4%) in the placebo group (RR, 0.91 [0.63 to 1.32]; P&#x2009;=&#x2009;.63).</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE" NlmCategory="CONCLUSIONS">Among patients undergoing cardiac surgery, high-dose perioperative atorvastatin treatment compared with placebo did not reduce the risk of AKI overall, among patients naive to treatment with statins, or in patients already taking a statin. These results do not support the initiation of statin therapy to prevent AKI following cardiac surgery.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">clinicaltrials.gov Identifier: NCT00791648.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Billings</LastName><ForeName>Frederic T</ForeName><Initials>FT</Initials><Suffix>4th</Suffix><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University School of Medicine, Nashville, Tennessee2Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hendricks</LastName><ForeName>Patricia A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Vanderbilt University School of Medicine, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schildcrout</LastName><ForeName>Jonathan S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Yaping</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petracek</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Vanderbilt University School of Medicine, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Byrne</LastName><ForeName>John G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Harvard University School of Medicine, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Nancy J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00791648</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>R01GM112871</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 GM102676</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>KL2 RR024977</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K12 ES015855</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM112871</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K12ES015855</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1RR024975</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>KL2 TR000446</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23GM102676</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 RR024975</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA</MedlineTA><NlmUniqueID>7501160</NlmUniqueID><ISSNLinking>0098-7484</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019161">Hydroxymethylglutaryl-CoA Reductase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>A0JWA85V8F</RegistryNumber><NameOfSubstance UI="D000069059">Atorvastatin</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.6.1.1</RegistryNumber><NameOfSubstance UI="D001219">Aspartate Aminotransferases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2016 Mar 1;315(9):873-4. doi: 10.1001/jama.2016.0245.</RefSource><PMID Version="1">26905755</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Thorac Dis. 2016 Jun;8(6):E451-4. doi: 10.21037/jtd.2016.04.34.</RefSource><PMID Version="1">27294251</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2016 Jul 19;316(3):349. doi: 10.1001/jama.2016.6134.</RefSource><PMID Version="1">27434455</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2016 Jul 19;316(3):349-50. doi: 10.1001/jama.2016.6148.</RefSource><PMID Version="1">27434456</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Thorac Dis. 2016 Jul;8(7):E618-20. doi: 10.21037/jtd.2016.05.45.</RefSource><PMID Version="1">27500739</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Thorac Dis. 2016 Aug;8(8):1883-5. doi: 10.21037/jtd.2016.06.42.</RefSource><PMID Version="1">27618995</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Thorac Dis. 2016 Oct;8(10):E1235-E1237. doi: 10.21037/jtd.2016.10.22.</RefSource><PMID Version="1">27867596</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001219" MajorTopicYN="N">Aspartate Aminotransferases</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069059" MajorTopicYN="N">Atorvastatin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005919" MajorTopicYN="N">Glomerular Filtration Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019161" MajorTopicYN="N">Hydroxymethylglutaryl-CoA Reductase Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="N">Renal Insufficiency, Chronic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000099059" MajorTopicYN="N">Assessment of Medication Adherence</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Potential conflicts of interest: No author reports any relevant conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>4</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26906014</ArticleId><ArticleId IdType="mid">NIHMS778708</ArticleId><ArticleId IdType="pmc">PMC4843765</ArticleId><ArticleId IdType="doi">10.1001/jama.2016.0548</ArticleId><ArticleId IdType="pii">2492851</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006;1:19&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">17699187</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper WA, O&#x2019;Brien SM, Thourani VH, et al. Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation. 2006;113(8):1063&#x2013;1070.</Citation><ArticleIdList><ArticleId IdType="pubmed">16490821</ArticleId></ArticleIdList></Reference><Reference><Citation>Swaminathan M, Shaw AD, Phillips-Bute BG, et al. Trends in acute renal failure associated with coronary artery bypass graft surgery in the United States. Crit Care Med. 2007;35:2286&#x2013;2291.</Citation><ArticleIdList><ArticleId IdType="pubmed">17944016</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqui NF, Coca SG, Devereaux PJ, et al. Secular trends in acute dialysis after elective major surgery--1995 to 2009. CMAJ. 2012;184(11):1237&#x2013;1245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3414596</ArticleId><ArticleId IdType="pubmed">22733671</ArticleId></ArticleIdList></Reference><Reference><Citation>Birnie K, Verheyden V, Pagano D, et al. Predictive models for kidney disease: improving global outcomes (KDIGO) defined acute kidney injury in UK cardiac surgery. Crit Care. 2014;18(6):606.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4258283</ArticleId><ArticleId IdType="pubmed">25673427</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryckwaert F, Boccara G, Frappier JM, Colson PH. Incidence, risk factors, and prognosis of a moderate increase in plasma creatinine early after cardiac surgery. Crit Care Med. 2002;30:1495&#x2013;1498.</Citation><ArticleIdList><ArticleId IdType="pubmed">12130968</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakar CV, Yared J-P, Worley S, Cotman K, Paganini EP. Renal dysfunction and serious infections after open-heart surgery. Kidney Int. 2003;64(1):239&#x2013;246.</Citation><ArticleIdList><ArticleId IdType="pubmed">12787415</ArticleId></ArticleIdList></Reference><Reference><Citation>Layton JB, Kshirsagar AV, Simpson RJ, et al. Effect of statin use on acute kidney injury risk following coronary artery bypass grafting. Am J Cardiol. 2013;111(6):823&#x2013;828.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3637989</ArticleId><ArticleId IdType="pubmed">23273532</ArticleId></ArticleIdList></Reference><Reference><Citation>Argalious M, Xu M, Sun Z, Smedira N, Koch CG. Preoperative statin therapy is not associated with a reduced incidence of postoperative acute kidney injury after cardiac surgery. Anesth Analg. 2010;111(2):324&#x2013;330.</Citation><ArticleIdList><ArticleId IdType="pubmed">20375302</ArticleId></ArticleIdList></Reference><Reference><Citation>Heeschen C, Hamm CW, Laufs U, Snapinn S, Bohm M, White HD. Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation. 2002;105:1446&#x2013;1452.</Citation><ArticleIdList><ArticleId IdType="pubmed">11914253</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Sciascio G, Patti G, Pasceri V, Gaspardone A, Colonna G, Montinaro A. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial. J Am Coll Cardiol. 2009;54:558&#x2013;565.</Citation><ArticleIdList><ArticleId IdType="pubmed">19643320</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FT, Pretorius M, Siew ED, Yu C, Brown NJ. Early Postoperative Statin Therapy Is Associated With a Lower Incidence of Acute Kidney Injury After Cardiac Surgery. J Cardiothorac Vasc Anesth. 2010;24(6):913&#x2013;920.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2992577</ArticleId><ArticleId IdType="pubmed">20599398</ArticleId></ArticleIdList></Reference><Reference><Citation>Kor DJ, Brown MJ, Iscimen R, et al. Perioperative statin therapy and renal outcomes after major vascular surgery: a propensity-based analysis. J Cardiothorac Vasc Anesth. 2008;22(2):210&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">18375322</ArticleId></ArticleIdList></Reference><Reference><Citation>Patti G, Chello M, Candura D, et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation. 2006;114:1455&#x2013;1461.</Citation><ArticleIdList><ArticleId IdType="pubmed">17000910</ArticleId></ArticleIdList></Reference><Reference><Citation>Patti G, Pasceri V, Colonna G, et al. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial. J Am Coll Cardiol. 2007;49:1272&#x2013;1278.</Citation><ArticleIdList><ArticleId IdType="pubmed">17394957</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2206446</ArticleId><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference><Reference><Citation>Ely EW, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU) JAMA. 2001;286:2703&#x2013;2710.</Citation><ArticleIdList><ArticleId IdType="pubmed">11730446</ArticleId></ArticleIdList></Reference><Reference><Citation>Wacholder S. Binomial regression in GLIM: estimating risk ratios and risk differences. Am J Epidemiol. 1986;123(1):174&#x2013;184.</Citation><ArticleIdList><ArticleId IdType="pubmed">3509965</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz KA. The (relative) risks of using odds ratios. Arch Dermatol. 2006;142(6):761&#x2013;764.</Citation><ArticleIdList><ArticleId IdType="pubmed">16785380</ArticleId></ArticleIdList></Reference><Reference><Citation>Wassmann S, Laufs U, Baumer AT, et al. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species. Hypertension. 2001;37:1450&#x2013;1457.</Citation><ArticleIdList><ArticleId IdType="pubmed">11408394</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner AH, Kohler T, Ruckschloss U, Just I, Hecker M. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation. Arterioscler Thromb Vasc Biol. 2000;20:61&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">10634801</ArticleId></ArticleIdList></Reference><Reference><Citation>Laufs U, Fata VL, Liao JK. Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase. J Biol Chem. 1997;272:31725&#x2013;31729.</Citation><ArticleIdList><ArticleId IdType="pubmed">9395516</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwak B, Mulhaupt F, Myit S, Mach F. Statins as a newly recognized type of immunomodulator. Nat Med. 2000;6:1399&#x2013;1402.</Citation><ArticleIdList><ArticleId IdType="pubmed">11100127</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FT4th, Pretorius M, Schildcrout JS, et al. Obesity and oxidative stress predict AKI after cardiac surgery. J Am Soc Nephrol. 2012;23(7):1221&#x2013;1228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3380645</ArticleId><ArticleId IdType="pubmed">22626819</ArticleId></ArticleIdList></Reference><Reference><Citation>Chello M, Patti G, Candura D, et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Crit Care Med. 2006;34:660&#x2013;667.</Citation><ArticleIdList><ArticleId IdType="pubmed">16505650</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Calzavacca P, Licari E, et al. Pilot double-blind, randomized controlled trial of short-term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology (Carlton) 2012;17(3):215&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pubmed">22117606</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204&#x2013;R212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC522841</ArticleId><ArticleId IdType="pubmed">15312219</ArticleId></ArticleIdList></Reference><Reference><Citation>Christenson JT. Preoperative lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. Eur J Cardiothorac Surg. 1999;15:394&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pubmed">10371111</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabata M, Khalpey Z, Pirundini PA, Byrne ML, Cohn LH, Rawn JD. Renoprotective effect of preoperative statins in coronary artery bypass grafting. Am J Cardiol. 2007;100:442&#x2013;444.</Citation><ArticleIdList><ArticleId IdType="pubmed">17659925</ArticleId></ArticleIdList></Reference><Reference><Citation>Huffmyer JL, Mauermann WJ, Thiele RH, Ma JZ, Nemergut EC. Preoperative statin administration is associated with lower mortality and decreased need for postoperative hemodialysis in patients undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2009;23(4):468&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="pubmed">19157909</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan W, Pintar T, Anton J, Lee VV, Vaughn WK, Collard CD. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation. 2004;110:II45&#x2013;II49.</Citation><ArticleIdList><ArticleId IdType="pubmed">15364837</ArticleId></ArticleIdList></Reference><Reference><Citation>Thielmann M, Neuh&#xe4;user M, Marr A, et al. Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2007;134(5):1143&#x2013;1149.</Citation><ArticleIdList><ArticleId IdType="pubmed">17976441</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedoruk LM, Wang H, Conaway MR, Kron IL, Johnston KC. Statin therapy improves outcomes after valvular heart surgery. Ann Thorac Surg. 2008;85(5):1521&#x2013;1525. discussion 1525&#x2013;1526.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2747026</ArticleId><ArticleId IdType="pubmed">18442531</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnar AO, Parikh CR, Coca SG, et al. Association between preoperative statin use and acute kidney injury biomarkers in cardiac surgical procedures. Ann Thorac Surg. 2014;97(6):2081&#x2013;2087.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4068122</ArticleId><ArticleId IdType="pubmed">24725831</ArticleId></ArticleIdList></Reference><Reference><Citation>Lennern&#xe4;s H. Clinical pharmacokinetics of atorvastatin. Clin Pharmacokinet. 2003;42(13):1141&#x2013;1160.</Citation><ArticleIdList><ArticleId IdType="pubmed">14531725</ArticleId></ArticleIdList></Reference><Reference><Citation>National Heart, Lung, and Blood Institute ARDS Clinical Trials Network; Truwit JD, Bernard GR, et al. Rosuvastatin for sepsis-associated acute respiratory distress syndrome. N Engl J Med. 2014;370(23):2191&#x2013;2200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4241052</ArticleId><ArticleId IdType="pubmed">24835849</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Sciascio G, Patti G, Pasceri V, Gaspardone A, Colonna G, Montinaro A. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial. J Am Coll Cardiol. 2009;54(6):558&#x2013;565.</Citation><ArticleIdList><ArticleId IdType="pubmed">19643320</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36332365</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>09</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>83</Volume><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Mild acute kidney injury after pediatric surgery is not-associated with long-term renal dysfunction: A retrospective cohort study.</ArticleTitle><Pagination><StartPage>110985</StartPage><MedlinePgn>110985</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2022.110985</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(22)00343-9</ELocationID><Abstract><AbstractText Label="BACKGROUND AND STUDY OBJECTIVE">Acute kidney injury (AKI) is a sudden deterioration in renal function and is common in pediatric patients undergoing cardiac and non-cardiac surgery. Few studies have investigated the association of postoperative AKI with kidney dysfunction seen long-term and other adverse outcomes in pediatric patients. The study aimed to determine the association between postoperative AKI (mild AKI vs. no AKI and mild AKI vs. moderate-severe AKI) and chronic kidney dysfunction (CKD) seen long-term in pediatric patients undergoing cardiac and non-cardiac major surgery.</AbstractText><AbstractText Label="DESIGN">Restrospective, cohort study.</AbstractText><AbstractText Label="SETTING">Tertiary care hospital.</AbstractText><AbstractText Label="PATIENTS">This retrospective cohort study included patients aged 2-18&#xa0;years who underwent cardiac and non-cardiac major surgery lasting &gt;2&#xa0;h at the Cleveland Clinic Main Campus between June 2005 and December 2020.</AbstractText><AbstractText Label="MEASUREMENTS">Postoperative AKI and CKD seen in long-term were defined and staged according to the Kidney Disease: Improving Global Outcomes criteria.</AbstractText><AbstractText Label="MAIN RESULTS">Among 10,597 children who had cardiac and non-cardiac major surgery, 1,302 were eligible. A total of 682 patients were excluded for missing variables and baseline kidney dysfunction and 620 patients were included. The mean age was 11&#xa0;years, and 307 (49.5%) were female. Postoperative mild AKI was detected in 5.8% of the patients, while moderate-severe AKI was detected in 2.4%. There was no significant difference in CKD seen in long-term between patients with and without postoperative AKI, p&#xa0;=&#xa0;0.83. The CKD seen in long-term developed in 27.7% of patients with postoperative mild AKI and 33.3% of patients with postoperative moderate and severe AKI. Patients without postoperative AKI had an estimated 1.09 times higher odds of having CKD seen in long-term compared with patients who have postoperative mild AKI (odds ratio [95% CI] 1.09 [0.48,2.52]).</AbstractText><AbstractText Label="CONCLUSION">In contrast to adult patients, the authors did not find any association between postoperative AKI and CKD seen in long-term in pediatric patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Onal</LastName><ForeName>Ozkan</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, United States of America; Department of Anesthesiology and Reanimation, Selcuk University Faculty of Medicine, Konya, Turkey; Outcomes Research Consortium, Cleveland, OH, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chhabada</LastName><ForeName>Surendrasingh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, United States of America; Department of Pediatric Anesthesia and Congenital Cardiac Anesthesia, Cleveland Clinic, Cleveland, OH, United States of America; Outcomes Research Consortium, Cleveland, OH, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pu</LastName><ForeName>Xuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, United States of America; Department of Quantitative Health Sciences, Cleveland Clinic, OH, United States of America; Outcomes Research Consortium, Cleveland, OH, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Liu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, United States of America; Department of Quantitative Health Sciences, Cleveland Clinic, OH, United States of America; Outcomes Research Consortium, Cleveland, OH, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimada</LastName><ForeName>Tetsuya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, United States of America; Department of Anesthesiology, National Hospital Organization, Murayama Medical Center, Musashimurayama, Tokyo, Japan; Department of Anesthesiology, National Defense Medical College, Tokorozawa, Saitama, Japan; Outcomes Research Consortium, Cleveland, OH, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruetzler</LastName><ForeName>Kurt</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, United States of America; Department of General Anesthesia, Cleveland Clinic, Cleveland, OH, United States of America; Outcomes Research Consortium, Cleveland, OH, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turan</LastName><ForeName>Alparslan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, United States of America; Department of General Anesthesia, Cleveland Clinic, Cleveland, OH, United States of America; Outcomes Research Consortium, Cleveland, OH, United States of America. Electronic address: turana@ccf.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="Y">Renal Insufficiency, Chronic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Chronic kidney disease</Keyword><Keyword MajorTopicYN="N">Pediatric</Keyword><Keyword MajorTopicYN="N">Renal function</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>4</Day><Hour>19</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36332365</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2022.110985</ArticleId><ArticleId IdType="pii">S0952-8180(22)00343-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31881416</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-6968</ISSN><JournalIssue CitedMedium="Internet"><Volume>190</Volume><PubDate><Year>2020</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Clinical neurology and neurosurgery</Title><ISOAbbreviation>Clin Neurol Neurosurg</ISOAbbreviation></Journal><ArticleTitle>Risk factors and associated complications of acute kidney injury in adult patients undergoing a craniotomy.</ArticleTitle><Pagination><StartPage>105642</StartPage><MedlinePgn>105642</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clineuro.2019.105642</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0303-8467(19)30438-X</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Understanding the risk factors and clinical outcomes associated with acute kidney injury (AKI) after craniotomy may help clinicians identify perioperative patients at risk for AKI and lead clinicians to institute preventive measures. The objective of this study was to identify risk factors associated with AKI after craniotomy and understand whether patients who develop AKI after craniotomy have worse clinical outcomes.</AbstractText><AbstractText Label="PATIENTS AND METHODS">We performed a retrospective, propensity score matched cohort study consisting of 344 patients who developed an AKI or required renal dialysis post-operatively versus those who did not. An AKI was defined using a composite of two NSQIP variables: progressive renal insufficiency and acute renal failure. All data were derived from the American College of Surgeons National Safety Quality Improvement Program (ACS-NSQIP) between 2009-2017.</AbstractText><AbstractText Label="RESULTS">Of the 50,691 patients who underwent a craniotomy, 202 developed post-operative AKI or required post-operative renal dialysis. Male gender, black race, age 65 and older, and a body mass index 30 or greater were associated with AKI. Patients with hypertension (OR [95 % CI] 4.41 [3.21-6.06]; p&#x2009;&lt;&#x2009;0.001), diabetes (OR [95 % CI] 3.5 [2.62-4.69]; p&#x2009;&lt;&#x2009;0.001), chronic obstructive pulmonary disease (OR [95 % CI] 2.27 [1.4-3.69]; p&#x2009;=&#x2009;0.001), congestive heart failure (OR [95 % CI] 8.17 [4.29-15.58]; p&#x2009;&lt;&#x2009;0.001), chronic kidney disease (OR [95 % CI] 10.59 [6.09-18.41]; p&#x2009;&lt;&#x2009;0.001), bleeding disorder (OR [95 % CI] 3.83 [2.59-5.65]; p&#x2009;&lt;&#x2009;0.001), those who developed sepsis (OR [95 % CI] 4.63 [3.33-6.45]; p&#x2009;&lt;&#x2009;0.001), and emergent craniotomy (OR [95 % CI] 5.35 [4.05-7.06); p&#x2009;&lt;&#x2009;0.00) were more likely to develop AKI. The largest association between AKI after surgery was found in patients whose preoperative functional status was totally dependent in activities of daily living (OR [95 % CI] 5.93 [3.53-9.95]; p&#x2009;&lt;&#x2009;0.001). AKI was associated with a higher number of complications experienced by each patient (OR [95 % CI] 1.79 [1.4-2.3; p&#x2009;&lt;&#x2009;0.001]. Patients with higher ASA physical status were more likely to develop AKI, and mortality was significantly higher in the AKI cohort. There was a significant increase in the rates of returning to the operating room, failure to wean from the ventilator, unplanned intubations, number of complications, and length of stay between the two groups. AKI was also associated with a higher rate of perioperative pneumonia, venous thromboembolism, urinary tract infection, and sepsis.</AbstractText><AbstractText Label="CONCLUSION">AKI is associated with significantly worse clinical outcomes after craniotomy. Perioperative strategies for prevention, management and supportive care of AKI for patients undergoing craniotomy may improve clinical outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brovman</LastName><ForeName>Ethan Y</ForeName><Initials>EY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Tufts Medical Center, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aglio</LastName><ForeName>Linda S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States; Division of Neuroanesthesia, Brigham and Women's Hospital, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beutler</LastName><ForeName>Sascha S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urman</LastName><ForeName>Richard D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States; Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, United States; Center for Perioperative Research, Brigham and Women's Hospital, United States. Electronic address: rurman@bwh.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Clin Neurol Neurosurg</MedlineTA><NlmUniqueID>7502039</NlmUniqueID><ISSNLinking>0303-8467</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Clin Neurol Neurosurg. 2020 Jun;193:105784. doi: 10.1016/j.clineuro.2020.105784.</RefSource><PMID Version="1">32203704</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001741" MajorTopicYN="N">Black or African American</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003399" MajorTopicYN="Y">Craniotomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="N">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="N">Pulmonary Disease, Chronic Obstructive</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006435" MajorTopicYN="N">Renal Dialysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="N">Renal Insufficiency, Chronic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012086" MajorTopicYN="N">Reoperation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044465" MajorTopicYN="N">White People</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Complications</Keyword><Keyword MajorTopicYN="N">Craniotomy</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Outcomes</Keyword><Keyword MajorTopicYN="N">Renal failure</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>11</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31881416</ArticleId><ArticleId IdType="doi">10.1016/j.clineuro.2019.105642</ArticleId><ArticleId IdType="pii">S0303-8467(19)30438-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24126568</PMID><DateCompleted><Year>2014</Year><Month>10</Month><Day>06</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1533-4023</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>2</Issue><PubDate><Year>2014</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of cardiovascular pharmacology</Title><ISOAbbreviation>J Cardiovasc Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Perioperative levosimendan therapy is associated with a lower incidence of acute kidney injury after cardiac surgery: a meta-analysis.</ArticleTitle><Pagination><StartPage>107</StartPage><EndPage>112</EndPage><MedlinePgn>107-12</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/FJC.0000000000000028</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Levosimendan is a calcium sensitizer that enhances myocardial contractility without increasing myocardial oxygen use. Limited data are available on its renal-protective effect, and no statistically significant effects have been found. A meta-analysis was conducted for randomized studies to show whether perioperative levosimendan use could reduce acute kidney injury (AKI) in patients undergoing cardiac surgery.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">BioMed Central, PubMed EMBASE, and the Cochrane Central Register of Controlled Trials were searched for pertinent studies.</AbstractText><AbstractText Label="STUDY SELECTION" NlmCategory="METHODS">Randomized trials that compared levosimendan versus placebo or any other control in cardiac surgery with data on AKI were included. Exclusion criteria were duplicate publications, nonadult studies, oral administration of levosimendan, and studies with no data on AKI.</AbstractText><AbstractText Label="DATA EXTRACTION" NlmCategory="METHODS">Study endpoints, study design, population, clinical setting, levosimendan dosage, and treatment duration were extracted.</AbstractText><AbstractText Label="DATA SYNTHESIS" NlmCategory="RESULTS">Data from 529 patients in 5 randomized trials were analyzed. The analysis showed that levosimendan decreased postoperative incidence of AKI in the levosimendan group.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This analysis suggests that levosimendan might reduce renal injury in adult patients undergoing cardiac surgery. More prospective randomized studies are needed to further demonstrate the benefits of levosimendan on renal protection in cardiac surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Niu</LastName><ForeName>Zhao-Zhuo</ForeName><Initials>ZZ</Initials><AffiliationInfo><Affiliation>*Department of Cardiac Surgery, Qilu Hospital, Shandong University, Jinnan, China; and &#x2020;Department of Cardiac Surgery, Qingdao Municipal Hospital, Qingdao, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Shu-Ming</ForeName><Initials>SM</Initials></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Wen-Yu</ForeName><Initials>WY</Initials></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Wen-Ming</ForeName><Initials>WM</Initials></Author><Author ValidYN="Y"><LastName>Chi</LastName><ForeName>Yi-Fan</ForeName><Initials>YF</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiovasc Pharmacol</MedlineTA><NlmUniqueID>7902492</NlmUniqueID><ISSNLinking>0160-2446</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002316">Cardiotonic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006835">Hydrazones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011724">Pyridazines</NameOfSubstance></Chemical><Chemical><RegistryNumber>349552KRHK</RegistryNumber><NameOfSubstance UI="D000077464">Simendan</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002316" MajorTopicYN="N">Cardiotonic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006835" MajorTopicYN="N">Hydrazones</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011724" MajorTopicYN="N">Pyridazines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077464" MajorTopicYN="N">Simendan</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24126568</ArticleId><ArticleId IdType="doi">10.1097/FJC.0000000000000028</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28245793</PMID><DateCompleted><Year>2018</Year><Month>02</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2369</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Feb</Month><Day>28</Day></PubDate></JournalIssue><Title>BMC nephrology</Title><ISOAbbreviation>BMC Nephrol</ISOAbbreviation></Journal><ArticleTitle>Early versus late initiation of renal replacement therapy in patients with acute kidney injury-a systematic review &amp; meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>78</StartPage><MedlinePgn>78</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">78</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12882-017-0486-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute kidney injury (AKI) is a common complication in the critically ill patients and associated with a substantial morbidity and mortality. Severe AKI may be associated with up to 60% hospital mortality. Over the years, renal replacement therapy (RRT) has emerged as the mainstay of the treatment for AKI. However, the exact timing of initiation of RRT for better patient outcome is still debatable with conflicting data from randomized controlled trials. Thus, a systematic review and meta-analysis was performed to assess the impact of "early" versus "late" initiation of RRT.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">All the published literature through the major databases including Medline/Pubmed, Embase, and Google Scholar were searched from 1970 to October 2016. Reference lists from the articles were reviewed to identify additional pertinent articles. Retrieved papers concerning the effect of "early/prophylactic" RRT versus "late/as and when required" RRT were reviewed by the authors, and the data were extracted using a standardized data collection tool. Randomized trials (RCTs) comparing early initiation of RRT or prophylactic RRT with late or as and when required RRT were included. The primary outcome measures were all cause mortality and dialysis dependence on day 90. The secondary outcome measures were: length of ICU stay, length of hospital stay, recovery of renal function and adverse events.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 547 citation retrieved, full text of 44 articles was assessed for eligibility. Of these a total of 10 RCTs with 1,636 participants were included. All the trials were open label; six trials have unclear or high risk of bias for allocation concealment while four trials have low risk of bias for allocation concealment. There was a variable definition of early versus late in different studies. Thus, the definition of early or late was taken according to individual study definition. Compared to late RRT, there was no significant benefit of early RRT on day 30 mortality [6 studies; 1301 participants; RR, 0.92;95% CI: 0.76, 1.12); day 60 mortality [3 trials;1075 participants; RR, 0.94; 95% CI: 0.78, 1.14)]; day 90 mortality [3 trials; 555 participants; RR,0.94;95% CI: 0.67, 1.33)]; overall ICU or hospital mortality; dialysis dependence on day 90 [3 trials; (RR, 1.06; 95% CI:0.53, 2.12)]. There was no significant difference between length of ICU or hospital stay or recovery of renal functions. A subgroup analysis based on modality of RRT or mixed medical and surgical vs. surgical or based on severity of illness showed no difference in outcome measure. The trials with high or unclear risk of bias for allocation concealment showed benefit of early RRT (RR, 0.74; 95% CI: 0.59, 0.91) while the trials with low risk of bias for allocation concealment showed no difference in the mortality (RR, 1.02; 95% CI: 0.89, 1.17). Grade evidence generated for most of the outcomes was "low quality".</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This updated meta-analysis showed no added benefit of early initiation of RRT for patients with AKI. The grade evidence generated was of "low quality" and there was a high heterogeneity in the included trials.</AbstractText><AbstractText Label="PROSPERO REGISTRATION NUMBER" NlmCategory="UNASSIGNED">CRD42016043092 .</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bhatt</LastName><ForeName>Girish Chandra</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, All India Institute of Medical Sciences (AIIMS), Room no.18, OPD Block, Bhopal, Madhya Pradesh, 462024, India. drgcbhatt@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Das</LastName><ForeName>Rashmi Ranjan</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, Odisha, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Nephrol</MedlineTA><NlmUniqueID>100967793</NlmUniqueID><ISSNLinking>1471-2369</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="Y">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="N">Renal Replacement Therapy</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055502" MajorTopicYN="N">Secondary Prevention</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061665" MajorTopicYN="N">Time-to-Treatment</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney Injury (AKI)</Keyword><Keyword MajorTopicYN="N">Renal replacement therapy (RRT)</Keyword><Keyword MajorTopicYN="N">Timing</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>2</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28245793</ArticleId><ArticleId IdType="pmc">PMC5331682</ArticleId><ArticleId IdType="doi">10.1186/s12882-017-0486-9</ArticleId><ArticleId IdType="pii">10.1186/s12882-017-0486-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hoste EAJ, Clermont G, Kersten A, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care. 2006;10:R73. doi: 10.1186/cc4915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc4915</ArticleId><ArticleId IdType="pmc">PMC1550961</ArticleId><ArticleId IdType="pubmed">16696865</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagshaw SM, Laupland KB, Doig CJ, et al. Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study. Crit Care. 2005;9:R700&#x2013;709. doi: 10.1186/cc3879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc3879</ArticleId><ArticleId IdType="pmc">PMC1414056</ArticleId><ArticleId IdType="pubmed">16280066</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahlstr&#xf6;m A, Tallgren M, Peltonen S, R&#xe4;s&#xe4;nen P, Pettil&#xe4; V. Survival and quality of life of patients requiring acute renal replacement therapy. Intensive Care Med. 2005;31:1222&#x2013;1228. doi: 10.1007/s00134-005-2681-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-005-2681-6</ArticleId><ArticleId IdType="pubmed">16049711</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294:813&#x2013;818. doi: 10.1001/jama.294.7.813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.294.7.813</ArticleId><ArticleId IdType="pubmed">16106006</ArticleId></ArticleIdList></Reference><Reference><Citation>Payen D, Mateo J, Cavaillon JM, et al. Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial. Crit Care Med. 2009;37:803&#x2013;810. doi: 10.1097/CCM.0b013e3181962316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181962316</ArticleId><ArticleId IdType="pubmed">19237881</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamale TE, Hase NK, Kulkarni M, et al. Earlier-start versus usual-start dialysis in patients with community-acquired acute kidney injury: a randomized controlled trial. Am J Kidney Dis. 2013;62:1116&#x2013;1121. doi: 10.1053/j.ajkd.2013.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2013.06.012</ArticleId><ArticleId IdType="pubmed">23932821</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouman CSC, Oudemans-Van Straaten HM, Tijssen JGP, Zandstra DF, Kesecioglu J. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med. 2002;30:2205&#x2013;2211. doi: 10.1097/00003246-200210000-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200210000-00005</ArticleId><ArticleId IdType="pubmed">12394945</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaudry S, Hajage D, Schortgen F, et al. Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med. 2016;375(2):122&#x2013;33. doi: 10.1056/NEJMoa1603017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1603017</ArticleId><ArticleId IdType="pubmed">27181456</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, Ger&#xdf; J, Van Aken H, Boanta A, Kellum JA, Meersch M. Early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury (the ELAIN-trial): study protocol for a randomized controlled trial. Trials. 2016;17:148. doi: 10.1186/s13063-016-1249-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-016-1249-9</ArticleId><ArticleId IdType="pmc">PMC4797166</ArticleId><ArticleId IdType="pubmed">26993261</ArticleId></ArticleIdList></Reference><Reference><Citation>Seabra VF, Balk EM, Liangos O, Sosa MA, Cendoroglo M, Jaber BL. Timing of renal replacement therapy initiation in acute renal failure: a meta-analysis. Am J Kidney Dis. 2008;52:272&#x2013;284. doi: 10.1053/j.ajkd.2008.02.371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2008.02.371</ArticleId><ArticleId IdType="pubmed">18562058</ArticleId></ArticleIdList></Reference><Reference><Citation>Karvellas CJ, Farhat MR, Sajjad I, et al. A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis. Crit Care. 2011;15:R72. doi: 10.1186/cc10061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10061</ArticleId><ArticleId IdType="pmc">PMC3222005</ArticleId><ArticleId IdType="pubmed">21352532</ArticleId></ArticleIdList></Reference><Reference><Citation>Wierstra BT, Kadri S, Alomar S, Burbano X, Barrisford GW, Kao RLC. The impact of &#x201c;early&#x201d; versus &#x201c;late&#x201d; initiation of renal replacement therapy in critical care patients with acute kidney injury: a systematic review and evidence synthesis. Crit Care. 2016;20:122. doi: 10.1186/s13054-016-1291-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1291-8</ArticleId><ArticleId IdType="pmc">PMC4858821</ArticleId><ArticleId IdType="pubmed">27149861</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi: 10.1136/bmj.d5928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysisdetected by a simple, graphical test. BMJ. 1997;315:629&#x2013;34. doi: 10.1136/bmj.315.7109.629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Combes A, Br&#xe9;chot N, Amour J, et al. Early high-volume hemofiltration versus standard care for post-cardiac surgery shock. The HEROICS study. Am J Respir Crit Care Med. 2015;192:1179&#x2013;1190. doi: 10.1164/rccm.201503-0516OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201503-0516OC</ArticleId><ArticleId IdType="pubmed">26167637</ArticleId></ArticleIdList></Reference><Reference><Citation>Durmaz I, Yagdi T, Calkavur T, et al. Prophylactic dialysis in patients with renal dysfunction undergoing on-pump coronary artery bypass surgery. Ann Thorac Surg. 2003;75:859&#x2013;864. doi: 10.1016/S0003-4975(02)04635-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-4975(02)04635-0</ArticleId><ArticleId IdType="pubmed">12645707</ArticleId></ArticleIdList></Reference><Reference><Citation>Wald R, Adhikari NKJ, Smith OM, et al. Comparison of standard and accelerated initiation of renal replacement therapy in acute kidney injury. Kidney Int. 2015;88:897&#x2013;904. doi: 10.1038/ki.2015.184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2015.184</ArticleId><ArticleId IdType="pubmed">26154928</ArticleId></ArticleIdList></Reference><Reference><Citation>Pursnani ML, Hazra DK, Singh B, Pandey DN. Early haemodialysis in acute tubular necrosis. J Assoc Physicians India. 1997;45:850&#x2013;852.</Citation><ArticleIdList><ArticleId IdType="pubmed">11229183</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugahara S, Suzuki H. Early start on continuous hemodialysis therapy improves survival rate in patients with acute renal failure following coronary bypass surgery. Hemodialysis international. International Symposium on Home Hemodialysis. 2004;8:320&#x2013;325. doi: 10.1111/j.1492-7535.2004.80404.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1492-7535.2004.80404.x</ArticleId><ArticleId IdType="pubmed">19379436</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibney N, Hoste E, Burdmann EA, et al. Timing of initiation and discontinuation of renal replacement therapy in AKI: unanswered key questions. Clin J. Am Soc Nephrol. 2008;3:876&#x2013;880. doi: 10.2215/CJN.04871107.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.04871107</ArticleId><ArticleId IdType="pubmed">18322044</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersch M, Zarbock A. Timing of renal replacement therapy in acute kidney injury-an issue of importance? J Thoracic Dis. 2016;8:2301&#x2013;2304. doi: 10.21037/jtd.2016.08.09.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2016.08.09</ArticleId><ArticleId IdType="pmc">PMC5059292</ArticleId><ArticleId IdType="pubmed">27746960</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Lv LS, Huang S, et al. Initiation time of renal replacement therapy on patients with acute kidney injury: a systematic review and meta-analysis of 8179 participants. Nephrology (Carlton) 2017;22:7&#x2013;18. doi: 10.1111/nep.12890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nep.12890</ArticleId><ArticleId IdType="pubmed">27505178</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29047417</PMID><DateCompleted><Year>2018</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Oct</Month><Day>19</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Levosimendan for patients with severely reduced left ventricular systolic function and/or low cardiac output syndrome undergoing cardiac surgery: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>252</StartPage><MedlinePgn>252</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">252</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-017-1849-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Previous studies have shown beneficial effects of levosimendan in high-risk patients undergoing cardiac surgery. Two large randomized controlled trials (RCTs), however, showed no advantages of levosimendan.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a systematic review and meta-analysis (MEDLINE and Embase from inception until March 30, 2017), investigating whether levosimendan offers advantages compared with placebo in high-risk cardiac surgery patients, as defined by preoperative left ventricular ejection fraction (LVEF)&#x2009;&#x2264;&#x2009;35% and/or low cardiac output syndrome (LCOS). The primary outcomes were mortality at longest follow-up and need for postoperative renal replacement therapy (RRT). Secondary postoperative outcomes investigated included myocardial injury, supraventricular arrhythmias, development of LCOS, acute kidney injury (AKI), duration of mechanical ventilation, intensive care unit and hospital lengths of stay, and incidence of hypotension during drug infusion.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Six RCTs were included in the meta-analysis, five of which investigated only patients with LVEF&#x2009;&#x2264;&#x2009;35% and one of which included predominantly patients with LCOS. Mortality was similar overall (OR 0.64 [0.37, 1.11], p&#x2009;=&#x2009;0.11) but lower in the subgroup with LVEF&#x2009;&lt;&#x2009;35% (OR 0.51 [0.32, 0.82], p&#x2009;=&#x2009;0.005). Need for RRT was reduced by levosimendan both overall (OR 0.63 [0.42, 0.94], p&#x2009;=&#x2009;0.02) and in patients with LVEF&#x2009;&lt;&#x2009;35% (OR 0.55 [0.31, 0.97], p&#x2009;=&#x2009;0.04). Among secondary outcomes, we found lower postoperative LCOS in patients with LVEF&#x2009;&lt;&#x2009;35% receiving levosimendan (OR 0.49 [0.27, 0.89], p&#x2009;=&#x2009;0.02), lower overall AKI (OR 0.62 [0.42, 0.92], p&#x2009;=&#x2009;0.02), and a trend toward lower mechanical support, both overall (p&#x2009;=&#x2009;0.07) and in patients with LVEF&#x2009;&lt;&#x2009;35% (p&#x2009;=&#x2009;0.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Levosimendan reduces mortality in patients with preoperative severely reduced LVEF but does not affect overall mortality. Levosimendan reduces the need for RRT after high-risk cardiac surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sanfilippo</LastName><ForeName>Filippo</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-5144-0776</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Istituto Mediterraneo per i Trapianti e Terapie ad alta specializzazione (IRCCS-ISMETT), Via Tricomi 5, 90127, Palermo, Italy. fgsanfilippo@ismett.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knight</LastName><ForeName>Joshua B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Istituto Mediterraneo per i Trapianti e Terapie ad alta specializzazione (IRCCS-ISMETT), Via Tricomi 5, 90127, Palermo, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scolletta</LastName><ForeName>Sabino</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Unit of Anesthesia and Critical Care Medicine, Department of Medical Biotechnologies, Azienda Ospedaliera Universitaria Senese, Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santonocito</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Istituto Mediterraneo per i Trapianti e Terapie ad alta specializzazione (IRCCS-ISMETT), Via Tricomi 5, 90127, Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pastore</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Istituto Mediterraneo per i Trapianti e Terapie ad alta specializzazione (IRCCS-ISMETT), Via Tricomi 5, 90127, Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorini</LastName><ForeName>Ferdinando L</ForeName><Initials>FL</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Papa Giovanni XXIII Hospital, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tritapepe</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular, Respiratory, Nephrological, Anaesthetic and Geriatric Sciences, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morelli</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Policlinico Umberto 1, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arcadipane</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Istituto Mediterraneo per i Trapianti e Terapie ad alta specializzazione (IRCCS-ISMETT), Via Tricomi 5, 90127, Palermo, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>10</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002316">Cardiotonic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006835">Hydrazones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011724">Pyridazines</NameOfSubstance></Chemical><Chemical><RegistryNumber>349552KRHK</RegistryNumber><NameOfSubstance UI="D000077464">Simendan</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002303" MajorTopicYN="N">Cardiac Output, Low</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002316" MajorTopicYN="N">Cardiotonic Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006835" MajorTopicYN="N">Hydrazones</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011724" MajorTopicYN="N">Pyridazines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077464" MajorTopicYN="N">Simendan</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="N">Ventricular Function, Left</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ejection fraction</Keyword><Keyword MajorTopicYN="N">Intensive care</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Renal replacement therapy</Keyword></KeywordList><CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: Not applicable. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER&#x2019;S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>10</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29047417</ArticleId><ArticleId IdType="pmc">PMC5648477</ArticleId><ArticleId IdType="doi">10.1186/s13054-017-1849-0</ArticleId><ArticleId IdType="pii">10.1186/s13054-017-1849-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hammon JW. Risk factors for cardiac surgery: the high-risk patient. Semin Cardiothorac Vasc Anesth. 2004;8(1):15&#x2013;7. doi: 10.1177/108925320400800105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/108925320400800105</ArticleId><ArticleId IdType="pubmed">15372123</ArticleId></ArticleIdList></Reference><Reference><Citation>Granton J, Cheng D. Risk stratification models for cardiac surgery. Semin Cardiothorac Vasc Anesth. 2008;12(3):167&#x2013;74. doi: 10.1177/1089253208323681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1089253208323681</ArticleId><ArticleId IdType="pubmed">18805851</ArticleId></ArticleIdList></Reference><Reference><Citation>Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Despres JP, Fullerton HJ, et al. Executive summary: heart disease and stroke statistics&#x2014;2016 update: a report from the American Heart Association. Circulation. 2016;133(4):447&#x2013;54. doi: 10.1161/CIR.0000000000000366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000366</ArticleId><ArticleId IdType="pubmed">26811276</ArticleId></ArticleIdList></Reference><Reference><Citation>Bridgewater B, Grayson AD, Brooks N, Grotte G, Fabri BM, Au J, Hooper T, Jones M, Keogh B. Has the publication of cardiac surgery outcome data been associated with changes in practice in northwest England: an analysis of 25,730 patients undergoing CABG surgery under 30 surgeons over eight years. Heart. 2007;93(6):744&#x2013;8. doi: 10.1136/hrt.2006.106393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/hrt.2006.106393</ArticleId><ArticleId IdType="pmc">PMC1955202</ArticleId><ArticleId IdType="pubmed">17237128</ArticleId></ArticleIdList></Reference><Reference><Citation>Manji RA, Arora RC, Singal RK, Hiebert BM, Menkis AH. Early rehospitalization after prolonged intensive care unit stay post cardiac surgery: outcomes and modifiable risk factors. J Am Heart Assoc. 2017;6(2):e004072. doi: 10.1161/JAHA.116.004072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.116.004072</ArticleId><ArticleId IdType="pmc">PMC5523740</ArticleId><ArticleId IdType="pubmed">28174166</ArticleId></ArticleIdList></Reference><Reference><Citation>Algarni KD, Maganti M, Yau TM. Predictors of low cardiac output syndrome after isolated coronary artery bypass surgery: trends over 20&#xa0;years. Ann Thorac Surg. 2011;92(5):1678&#x2013;84. doi: 10.1016/j.athoracsur.2011.06.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2011.06.017</ArticleId><ArticleId IdType="pubmed">21939957</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamiya H, Schilling M, Akhyari P, Ruhparwar A, Kallenbach K, Karck M, Lichtenberg A. Outcome analysis for prediction of early and long-term survival in patients receiving intra-aortic balloon pumping after cardiac surgery. Gen Thorac Cardiovasc Surg. 2016;64(10):584&#x2013;91. doi: 10.1007/s11748-016-0679-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11748-016-0679-3</ArticleId><ArticleId IdType="pmc">PMC5035315</ArticleId><ArticleId IdType="pubmed">27456851</ArticleId></ArticleIdList></Reference><Reference><Citation>Toller W, Algotsson L, Guarracino F, Hormann C, Knotzer J, Lehmann A, Rajek A, Salmenpera M, Schirmer U, Tritapepe L, et al. Perioperative use of levosimendan: best practice in operative settings. J Cardiothorac Vasc Anesth. 2013;27(2):361&#x2013;6. doi: 10.1053/j.jvca.2012.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2012.04.007</ArticleId><ArticleId IdType="pubmed">22658687</ArticleId></ArticleIdList></Reference><Reference><Citation>Toller W, Heringlake M, Guarracino F, Algotsson L, Alvarez J, Argyriadou H, Ben-Gal T, Cerny V, Cholley B, Eremenko A, et al. Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion. Int J Cardiol. 2015;184:323&#x2013;36. doi: 10.1016/j.ijcard.2015.02.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2015.02.022</ArticleId><ArticleId IdType="pubmed">25734940</ArticleId></ArticleIdList></Reference><Reference><Citation>Tritapepe L, De Santis V, Vitale D, Guarracino F, Pellegrini F, Pietropaoli P, Singer M. Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery. Br J Anaesth. 2009;102(2):198&#x2013;204. doi: 10.1093/bja/aen367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aen367</ArticleId><ArticleId IdType="pubmed">19151048</ArticleId></ArticleIdList></Reference><Reference><Citation>Greco T, Calabro MG, Covello RD, Greco M, Pasin L, Morelli A, Landoni G, Zangrillo A. A Bayesian network meta-analysis on the effect of inodilatory agents on mortality. Br J Anaesth. 2015;114(5):746&#x2013;56. doi: 10.1093/bja/aeu446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aeu446</ArticleId><ArticleId IdType="pubmed">25652947</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison RW, Hasselblad V, Mehta RH, Levin R, Harrington RA, Alexander JH. Effect of levosimendan on survival and adverse events after cardiac surgery: a meta-analysis. J Cardiothorac Vasc Anesth. 2013;27(6):1224&#x2013;32. doi: 10.1053/j.jvca.2013.03.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2013.03.027</ArticleId><ArticleId IdType="pubmed">24050857</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RH, Leimberger JD, van Diepen S, Meza J, Wang A, Jankowich R, Harrison RW, Hay D, Fremes S, Duncan A, et al. Levosimendan in patients with left ventricular dysfunction undergoing cardiac surgery. N Engl J Med. 2017;376(21):2032&#x2013;42. doi: 10.1056/NEJMoa1616218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1616218</ArticleId><ArticleId IdType="pubmed">28316276</ArticleId></ArticleIdList></Reference><Reference><Citation>Landoni G, Lomivorotov VV, Alvaro G, Lobreglio R, Pisano A, Guarracino F, Calabr&#xf2; MG, Grigoryev EV, Likhvantsev VV, Salgado-Filho MF, et al. Levosimendan for hemodynamic support after cardiac surgery. N Engl J Med. 2017;376(21):2021&#x2013;31. doi: 10.1056/NEJMoa1616325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1616325</ArticleId><ArticleId IdType="pubmed">28320259</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700. doi: 10.1136/bmj.b2700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2700</ArticleId><ArticleId IdType="pmc">PMC2714672</ArticleId><ArticleId IdType="pubmed">19622552</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA. The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi: 10.1136/bmj.d5928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomivorotov VV, Boboshko VA, Efremov SM, Kornilov IA, Chernyavskiy AM, Lomivorotov VN, Knazkova LG, Karaskov AM. Levosimendan versus an intra-aortic balloon pump in high-risk cardiac patients. J Cardiothorac Vasc Anesth. 2012;26(4):596&#x2013;603. doi: 10.1053/j.jvca.2011.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2011.09.006</ArticleId><ArticleId IdType="pubmed">22051419</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557&#x2013;60. doi: 10.1136/bmj.327.7414.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Erb J, Beutlhauser T, Feldheiser A, Schuster B, Treskatsch S, Grubitzsch H, Spies C. Influence of levosimendan on organ dysfunction in patients with severely reduced left ventricular function undergoing cardiac surgery. J Int Med Res. 2014;42(3):750&#x2013;64. doi: 10.1177/0300060513516293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300060513516293</ArticleId><ArticleId IdType="pubmed">24781725</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin R, Degrange M, Del Mazo C, Tanus E, Porcile R. Preoperative levosimendan decreases mortality and the development of low cardiac output in high-risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass. Exp Clin Cardiol. 2012;17(3):125&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3628425</ArticleId><ArticleId IdType="pubmed">23620700</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah B, Sharma P, Brahmbhatt A, Shah R, Rathod B, Shastri N, Patel J, Malhotra A. Study of levosimendan during off-pump coronary artery bypass grafting in patients with LV dysfunction: a double-blind randomized study. Indian J Pharm. 2014;46(1):29&#x2013;34. doi: 10.4103/0253-7613.125161.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0253-7613.125161</ArticleId><ArticleId IdType="pmc">PMC3912803</ArticleId><ArticleId IdType="pubmed">24550581</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma P, Malhotra A, Gandhi S, Garg P, Bishnoi A, Gandhi H. Preoperative levosimendan in ischemic mitral valve repair. Asian Cardiovasc Thorac Ann. 2014;22(5):539&#x2013;45. doi: 10.1177/0218492313499352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0218492313499352</ArticleId><ArticleId IdType="pubmed">24867027</ArticleId></ArticleIdList></Reference><Reference><Citation>Baines CP. The mitochondrial permeability transition pore and ischemia-reperfusion injury. Basic Res Cardiol. 2009;104(2):181&#x2013;8. doi: 10.1007/s00395-009-0004-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-009-0004-8</ArticleId><ArticleId IdType="pmc">PMC2671061</ArticleId><ArticleId IdType="pubmed">19242640</ArticleId></ArticleIdList></Reference><Reference><Citation>Scolletta S, Biagioli B. Energetic myocardial metabolism and oxidative stress: let&#x2019;s make them our friends in the fight against heart failure. Biomed Pharmacother. 2010;64(3):203&#x2013;7. doi: 10.1016/j.biopha.2009.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2009.10.002</ArticleId><ArticleId IdType="pubmed">19954925</ArticleId></ArticleIdList></Reference><Reference><Citation>Gross GJ, Peart JN. KATP channels and myocardial preconditioning: an update. Am J Physiol Heart Circ Physiol. 2003;285(3):H921&#x2013;30. doi: 10.1152/ajpheart.00421.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00421.2003</ArticleId><ArticleId IdType="pubmed">12915383</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelli A, Ertmer C, Pietropaoli P, Westphal M. Reducing the risk of major elective non-cardiac surgery: is there a role for levosimendan in the preoperative optimization of cardiac function? Curr Drug Targets. 2009;10(9):863&#x2013;71. doi: 10.2174/138945009789108819.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138945009789108819</ArticleId><ArticleId IdType="pubmed">19799540</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Gonzalez MJ, Jorge-Perez P, Jimenez-Sosa A, Acea AB, Lacalzada Almeida JB, Ferrer Hita JJ. Levosimendan improves hemodynamic status in critically ill patients with severe aortic stenosis and left ventricular dysfunction: an interventional study. Cardiovasc Ther. 2015;33(4):193&#x2013;9. doi: 10.1111/1755-5922.12132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1755-5922.12132</ArticleId><ArticleId IdType="pubmed">25959786</ArticleId></ArticleIdList></Reference><Reference><Citation>Yilmaz MB, Grossini E, Silva Cardoso JC, Edes I, Fedele F, Pollesello P, Kivikko M, Harjola VP, Hasslacher J, Mebazaa A, et al. Renal effects of levosimendan: a consensus report. Cardiovasc Drugs Ther. 2013;27(6):581&#x2013;90. doi: 10.1007/s10557-013-6485-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10557-013-6485-6</ArticleId><ArticleId IdType="pmc">PMC3830192</ArticleId><ArticleId IdType="pubmed">23929366</ArticleId></ArticleIdList></Reference><Reference><Citation>Tritapepe L, De Santis V, Vitale D, Santulli M, Morelli A, Nofroni I, Puddu PE, Singer M, Pietropaoli P. Preconditioning effects of levosimendan in coronary artery bypass grafting&#x2014;a pilot study. Br J Anaesth. 2006;96(6):694&#x2013;700. doi: 10.1093/bja/ael082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/ael082</ArticleId><ArticleId IdType="pubmed">16595616</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarvasmaki T, Lassus J, Varpula M, Sionis A, Sund R, Kober L, Spinar J, Parissis J, Banaszewski M, Silva Cardoso J, et al. Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality. Crit Care. 2016;20(1):208. doi: 10.1186/s13054-016-1387-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1387-1</ArticleId><ArticleId IdType="pmc">PMC4931696</ArticleId><ArticleId IdType="pubmed">27374027</ArticleId></ArticleIdList></Reference><Reference><Citation>Fellahi JL, Parienti JJ, Hanouz JL, Plaud B, Riou B, Ouattara A. Perioperative use of dobutamine in cardiac surgery and adverse cardiac outcome: propensity-adjusted analyses. Anesthesiology. 2008;108(6):979&#x2013;87. doi: 10.1097/ALN.0b013e318173026f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318173026f</ArticleId><ArticleId IdType="pubmed">18497597</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahin J, DeVarennes B, Tse CW, Amarica DA, Dial S. The relationship between inotrope exposure, six-hour postoperative physiological variables, hospital mortality and renal dysfunction in patients undergoing cardiac surgery. Crit Care. 2011;15(4):R162. doi: 10.1186/cc10302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10302</ArticleId><ArticleId IdType="pmc">PMC3387599</ArticleId><ArticleId IdType="pubmed">21736726</ArticleId></ArticleIdList></Reference><Reference><Citation>Pichette M, Liszkowski M, Ducharme A. Preoperative optimization of the heart failure patient undergoing cardiac surgery. Can J Cardiol. 2017;33(1):72&#x2013;9. doi: 10.1016/j.cjca.2016.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2016.08.004</ArticleId><ArticleId IdType="pubmed">27876563</ArticleId></ArticleIdList></Reference><Reference><Citation>Lahtinen P, Pitkanen O, Polonen P, Turpeinen A, Kiviniemi V, Uusaro A. Levosimendan reduces heart failure after cardiac surgery: a prospective, randomized, placebo-controlled trial. Crit Care Med. 2011;39(10):2263&#x2013;70. doi: 10.1097/CCM.0b013e3182227b97.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3182227b97</ArticleId><ArticleId IdType="pubmed">21666445</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik V, Subramanian A, Hote M, Kiran U. Effect of levosimendan on diastolic function in patients undergoing coronary artery bypass grafting: a comparative study. J Cardiovasc Pharmacol. 2015;66(2):141&#x2013;7. doi: 10.1097/FJC.0000000000000256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FJC.0000000000000256</ArticleId><ArticleId IdType="pubmed">25919118</ArticleId></ArticleIdList></Reference><Reference><Citation>Axelsson B, Haggmark S, Svenmarker S, Johansson G, Gupta A, Tyden H, Wouters P, Haney M. Effects of combined milrinone and levosimendan treatment on systolic and diastolic function during postischemic myocardial dysfunction in a porcine model. J Cardiovasc Pharmacol Ther. 2016;21(5):495&#x2013;503. doi: 10.1177/1074248416628675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1074248416628675</ArticleId><ArticleId IdType="pubmed">26837238</ArticleId></ArticleIdList></Reference><Reference><Citation>Couture P, Denault AY, Pellerin M, Tardif JC. Milrinone enhances systolic, but not diastolic function during coronary artery bypass grafting surgery. Can J Anaesth. 2007;54(7):509&#x2013;22. doi: 10.1007/BF03022314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03022314</ArticleId><ArticleId IdType="pubmed">17602036</ArticleId></ArticleIdList></Reference><Reference><Citation>Song JW, Jo YY, Jun NH, Kim HK, Kwak YL. The effect of milrinone on the intraoperative hemodynamics during off-pump coronary bypass surgery in patients with an elevated echocardiographic index of the ventricular filling pressure. Korean J Anesthesiol. 2011;60(3):185&#x2013;91. doi: 10.4097/kjae.2011.60.3.185.</Citation><ArticleIdList><ArticleId IdType="doi">10.4097/kjae.2011.60.3.185</ArticleId><ArticleId IdType="pmc">PMC3071482</ArticleId><ArticleId IdType="pubmed">21490820</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunghetti S, Palmerini E, Urselli R, Maffei S, Guarino E, Focardi M, Mondillo S, Favilli R. Effects of levosimendan without loading dose on systolic and diastolic function in patients with end-stage heart failure. Cardiol J. 2011;18(5):532&#x2013;7. doi: 10.5603/CJ.2011.0009.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/CJ.2011.0009</ArticleId><ArticleId IdType="pubmed">21947989</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergh CH, Andersson B, Dahlstr&#xf6;m U, Forfang K, Kivikko M, Sarapohja T, Ullman B, Wikstr&#xf6;m G. Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers. Eur J Heart Fail. 2010;12(4):404&#x2013;10. doi: 10.1093/eurjhf/hfq032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurjhf/hfq032</ArticleId><ArticleId IdType="pmc">PMC2844760</ArticleId><ArticleId IdType="pubmed">20335355</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891&#x2013;975. doi: 10.1002/ejhf.592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.592</ArticleId><ArticleId IdType="pubmed">27207191</ArticleId></ArticleIdList></Reference><Reference><Citation>Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Jr, Colvin MM, Drazner MH, Filippatos G, Fonarow GC, Givertz MM, et al. 2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2016;68(13):1476&#x2013;88. doi: 10.1016/j.jacc.2016.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2016.05.011</ArticleId><ArticleId IdType="pubmed">27216111</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero Orriach JL, Galan Ortega M, Ramirez Fernandez A, Ariza Villanueva D, Florez Vela A, Moreno Cortes I, Rubio Navarro M, Cruz MJ. Assessing the effect of preoperative levosimendan on renal function in patients with right ventricular dysfunction. J Clin Monit Comput. 2017;31(1):227&#x2013;30. doi: 10.1007/s10877-016-9827-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-016-9827-7</ArticleId><ArticleId IdType="pubmed">26762127</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero-Orriach JL, Ariza-Villanueva D, Florez-Vela A, Garrido-Sanchez L, Moreno-Cortes MI, Galan-Ortega M, Ramirez-Fernandez A, Alcaide Torres J, Fernandez CS, Navarro Arce I, et al. Cardiac, renal, and neurological benefits of preoperative levosimendan administration in patients with right ventricular dysfunction and pulmonary hypertension undergoing cardiac surgery: evaluation with two biomarkers neutrophil gelatinase-associated lipocalin and neuronal enolase. Ther Clin Risk Manag. 2016;12:623&#x2013;30. doi: 10.2147/TCRM.S102772.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/TCRM.S102772</ArticleId><ArticleId IdType="pmc">PMC4844253</ArticleId><ArticleId IdType="pubmed">27143905</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansiroglu AK, Oner E, Erturk M, Karakurt H, Somuncu MU, Birant A, Kalkan AK, Ozturk D, Eksik A. Assessment of sustained effects of levosimendan on right ventricular systolic functions in patients with advanced heart failure. Acta Cardiol. 2016;71(4):411&#x2013;5. doi: 10.1080/AC.71.4.3159693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/AC.71.4.3159693</ArticleId><ArticleId IdType="pubmed">27594356</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28320577</PMID><DateCompleted><Year>2018</Year><Month>01</Month><Day>16</Day></DateCompleted><DateRevised><Year>2018</Year><Month>01</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2165</ISSN><JournalIssue CitedMedium="Internet"><Volume>53</Volume><Issue>5</Issue><PubDate><Year>2017</Year><Month>May</Month></PubDate></JournalIssue><Title>European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery</Title><ISOAbbreviation>Eur J Vasc Endovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Pre-operative Functional Cardiovascular Reserve Is Associated with Acute Kidney Injury after Intervention.</ArticleTitle><Pagination><StartPage>717</StartPage><EndPage>724</EndPage><MedlinePgn>717-724</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejvs.2017.01.014</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1078-5884(17)30062-X</ELocationID><Abstract><AbstractText Label="BACKGROUND">Acute kidney injury (AKI) is a common complication after endovascular intervention, associated with poor short and long-term outcomes. However, the mechanisms underlying AKI development remain poorly understood. The impact of pre-existing cardiovascular disease and low cardiovascular reserve (CVR) in AKI is unclear; it remains unknown whether AKI is primarily related to pre-existing comorbidity or to procedural parameters. The association between CVR and AKI after EVAR was therefore assessed.</AbstractText><AbstractText Label="METHODS">This is a case control study. From a database of 484 patients, 292 undergoing elective endovascular aneurysm repair (EVAR) of an infrarenal abdominal aortic aneurysm (AAA) in two tertiary centres were included. Of these, 73 patients who had developed AKI after EVAR were case matched, based on pre-operative estimated glomerular filtration rate (eGFR; within 5&#xa0;mL/min/1.73&#xa0;m<sup>2</sup>) and age, with patients who had not developed AKI. Cardiopulmonary exercise testing (CPET) was used to assess CVR using the anaerobic threshold (AT). Development of AKI was defined using the Kidney Disease Improving Outcomes (KDIGO) guidance. Associations between CVR (based on AT levels) and AKI development were then analysed.</AbstractText><AbstractText Label="RESULTS">Pre-operative AT levels were significantly different between those who did and did not develop AKI (12.1&#xb1;2.9 SD vs. 14.8&#xb1;3.0&#xa0;mL/min/kg, p&#xa0;&lt;&#xa0;.001). In multivariate analysis, a higher level of AT (per 1&#xa0;mL/min/kg) was associated with a lower odds ratio (OR) of 0.72 (95% CI, 0.63-0.82, p&#xa0;&lt;&#xa0;.001), relative to AKI development. A&#xa0;pre-operative AT level of &lt; 11&#xa0;mL/min/kg was associated with post-operative AKI development in adjusted analysis, with an OR of 7.8 (95% CI, 3.75-16.51, p&#xa0;&lt;&#xa0;.001). The area under the curve (receiver operating characteristic) for AT as a predictor of post-operative AKI was 0.81 (standard error, 0.06, 95% CI, 0.69-0.93, p&#xa0;&lt;&#xa0;.001).</AbstractText><AbstractText Label="CONCLUSIONS">Poor CVR was strongly associated with the development of AKI. This provides pathophysiological insights into the mechanisms underlying AKI.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Saratzis</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>NIHR Leicester Cardiovascular Biomedical Research Unit, University of Leicester, Leicester, UK. Electronic address: as875@le.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shakespeare</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Respiratory Physiology and Sleep, University Hospital Coventry and Warwickshire, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>O</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>NIHR Leicester Cardiovascular Biomedical Research Unit, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bown</LastName><ForeName>M J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Respiratory Physiology and Sleep, University Hospital Coventry and Warwickshire, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahmood</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, University Hospital Coventry and Warwickshire, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Imray</LastName><ForeName>C H E</ForeName><Initials>CHE</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, University Hospital Coventry and Warwickshire, UK; Warwick Medical School, Coventry, UK; Coventry University, Coventry, UK; Royal College of Surgeons, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>British Heart Foundation</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>03</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Vasc Endovasc Surg</MedlineTA><NlmUniqueID>9512728</NlmUniqueID><ISSNLinking>1078-5884</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Eur J Vasc Endovasc Surg. 2017 May;53(5):725. doi: 10.1016/j.ejvs.2017.02.007.</RefSource><PMID Version="1">28285955</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015308" MajorTopicYN="N">Anaerobic Threshold</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017544" MajorTopicYN="N">Aortic Aneurysm, Abdominal</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072599" MajorTopicYN="Y">Cardiorespiratory Fitness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="N">Endovascular Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004739" MajorTopicYN="N">England</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005080" MajorTopicYN="N">Exercise Test</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005919" MajorTopicYN="N">Glomerular Filtration Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006304" MajorTopicYN="N">Health Status</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016014" MajorTopicYN="N">Linear Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062606" MajorTopicYN="N">Tertiary Care Centers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Acute renal failure</Keyword><Keyword MajorTopicYN="N">Cardiovascular reserve</Keyword><Keyword MajorTopicYN="N">Risk factor</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28320577</ArticleId><ArticleId IdType="doi">10.1016/j.ejvs.2017.01.014</ArticleId><ArticleId IdType="pii">S1078-5884(17)30062-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21684023</PMID><DateCompleted><Year>2012</Year><Month>06</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1872-6976</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>2</Issue><PubDate><Year>2012</Year><Season>Mar-Apr</Season></PubDate></JournalIssue><Title>Archives of gerontology and geriatrics</Title><ISOAbbreviation>Arch Gerontol Geriatr</ISOAbbreviation></Journal><ArticleTitle>Elderly patients with acute kidney injury (AKI): clinical features and risk factors for mortality.</ArticleTitle><Pagination><StartPage>e47</StartPage><EndPage>e51</EndPage><MedlinePgn>e47-51</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.archger.2011.05.011</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Elderly patients with AKI are associated with considerable mortality. The clinical features and risk factors predicting poor outcomes of these patients are not known. The aim of this study is to investigate the clinical features and risk factors affecting mortality in elderly patients with AKI.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A prospective study on the elderly patients with AKI (age &#x2265;65 years old) was conducted. A consecutive sample of 99 elderly patients with AKI was evaluated. These patients were divided into survivor group and non-survivor group according their outcomes. Factors including clinical characteristics and laboratory features were compared between these two groups. Analysis of correlations between death and categorized risk factors was done by means of Pearson's chi-squared test (or Fisher's exact test). Multivariate logistic regression was performed to analyze the possible risk factors for death.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The main causes of the elderly patients with AKI were ischemia (53.34%), surgery (33.33%), sepsis/infection (10.10%), nephrotoxic drug (3.03%). The mortality rate of the elderly patients with AKI was 42%. Significant differences were found between the survival group and non-survival group of the elderly patients in concomitant disease, complicated with multiple organ dysfunction syndrome (MODS), albumin, etc. Concomitant disease and MODS were found to be the independent risk factors for death of the elderly patients with AKI after adjusting for age, sex, pre-albumin, sepsis/infection, and serum creatinine (SCr).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study found that concomitant disease and MODS were the independent risk factors for the death of elderly patients with AKI.</AbstractText><CopyrightInformation>Crown Copyright &#xc2;&#xa9; 2011. Published by Elsevier Ireland Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Huashan Hospital, Fudan University, 12 Wulumuqi Road (Middle), Shanghai 200040, China. guyonghs@126.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Feng</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Feng</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Yong</ForeName><Initials>Y</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Arch Gerontol Geriatr</MedlineTA><NlmUniqueID>8214379</NlmUniqueID><ISSNLinking>0167-4943</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012709">Serum Albumin</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009102" MajorTopicYN="N">Multiple Organ Failure</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012709" MajorTopicYN="N">Serum Albumin</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2011</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21684023</ArticleId><ArticleId IdType="doi">10.1016/j.archger.2011.05.011</ArticleId><ArticleId IdType="pii">S0167-4943(11)00121-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39645444</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Prebypass Critical Closing Pressure Predicts Acute Kidney Injury After Cardiopulmonary Bypass.</ArticleTitle><Pagination><StartPage>437</StartPage><EndPage>446</EndPage><MedlinePgn>437-446</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2024.11.010</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(24)00888-7</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Optimal blood pressure goals during cardiopulmonary bypass (CPB) remain uncertain and new metrics to individualize perfusion targets are needed. Critical closing pressure (Pcrit) is a fundamental property of the arterial circulation related to vascular tone and represents the outflow pressure impacting flow across the systemic circulation. We examined Pcrit as a prognostic marker of acute kidney injury (AKI).</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective cohort study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Single tertiary care hospital PARTICIPANTS: We included 1,038 adult cardiac surgery patients who underwent CPB.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Pcrit was calculated using arterial waveform data before initiation of CPB. Pcrit was examined in relation to incidence of stage 2 or higher postoperative AKI according to standard Kidney Disease Improving Global Outcomes definitions.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">Of the 1,038 patients included in the study, 50 (5%) experienced AKI. Patients who suffered AKI had significantly higher preoperative risk factors, including higher incidence of severe chronic kidney disease and higher Society of Thoracic Surgeons risk score (p &lt; 0.01). They also had longer operative times and longer cross-clamp times (p &lt; 0.01). All patients were maintained at similar mean arterial pressure while on CPB. Patients who suffered AKI had a significantly higher prebypass Pcrit than those who did not (49.0 mmHg vs 44.1 mmHg; p = 0.018). In a multivariate regression, Pcrit remained a significant predictor, representing a 16% increased risk of AKI for each 5 mmHg increase in prebypass Pcrit (p = 0.011).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">A higher prebypass Pcrit is associated with a significantly higher incidence of postoperative AKI. Future study is warranted to investigate using intraoperative Pcrit to determine a personalized blood pressure goal during CPB.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ayers</LastName><ForeName>Brian C</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Cardiac Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Padr&#xf3;s-Valls</LastName><ForeName>Raimon</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Bioinformatics and Systems Biology, University of California, San Diego, San Diego, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brownlee</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiac Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steinhorn</LastName><ForeName>Benjamin S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shann</LastName><ForeName>Kenneth</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Cardiac Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osho</LastName><ForeName>Asishana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiac Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sundt</LastName><ForeName>Thoralf M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Cardiac Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguirre</LastName><ForeName>Aaron D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA. Electronic address: aaguirre1@mgh.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="Y">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001794" MajorTopicYN="Y">Blood Pressure</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062186" MajorTopicYN="Y">Arterial Pressure</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">blood pressure</Keyword><Keyword MajorTopicYN="N">cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">critical closing pressure</Keyword><Keyword MajorTopicYN="N">kidney injury</Keyword><Keyword MajorTopicYN="N">perioperative management</Keyword><Keyword MajorTopicYN="N">tissue perfusion pressure</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>8</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>7</Day><Hour>21</Hour><Minute>54</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39645444</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2024.11.010</ArticleId><ArticleId IdType="pii">S1053-0770(24)00888-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">28755257</PMID><DateCompleted><Year>2018</Year><Month>08</Month><Day>27</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1432-2323</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month></PubDate></JournalIssue><Title>World journal of surgery</Title><ISOAbbreviation>World J Surg</ISOAbbreviation></Journal><ArticleTitle>Two-way Interaction Effects of Perioperative Complications on 30-Day Mortality in General Surgery.</ArticleTitle><Pagination><StartPage>2</StartPage><EndPage>11</EndPage><MedlinePgn>2-11</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00268-017-4156-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">Multiple perioperative complications increase mortality risk, and certain complications synergistically increase this risk to a greater degree than might be expected if the complications were independent, but these effects are not well established.</AbstractText><AbstractText Label="METHODS">This is a retrospective cohort study of 422,827 intraabdominal general surgery patients (American College of Surgeons National Surgical Quality Improvement Program 2005-2011). Eight complications were evaluated: acute respiratory failure (ARF), acute kidney injury (AKI), sepsis/septic shock, stroke, cardiac arrest (CA), myocardial infarction (MI), deep vein thrombosis/pulmonary embolus, and transfusion. Each combination of two complications (28 total) was modeled using a Cox model for 30-day mortality, with adjustment for preoperative comorbidities and risk factors. Additive interaction was determined with the relative excess risk due to interaction (RERI). A positive RERI indicates that the mortality risk with both complications is greater than the sum of the individual mortality risks. Bonferroni correction was applied (&#x3b1;&#xa0;=&#xa0;0.05/28&#xa0;=&#xa0;0.0018).</AbstractText><AbstractText Label="RESULTS">Seven combinations demonstrated positive interaction: sepsis-CA (RERI 88.1; p&#xa0;&lt;&#xa0;0.0001), ARF-AKI (RERI 50.5; p&#xa0;&lt;&#xa0;0.0001), AKI-sepsis (RERI 33.9; p&#xa0;&lt;&#xa0;0.0001), sepsis-stroke (RERI 33.9; p&#xa0;&lt;&#xa0;0.0001), ARF-stroke (RERI 32.3; p&#xa0;&lt;&#xa0;0.0001), AKI-MI (RERI 24.5; p&#xa0;=&#xa0;0.0013), and ARF-sepsis (RERI 19.2; p&#xa0;&lt;&#xa0;0.0001). Two combinations demonstrated negative interaction: ARF-CA (RERI -65.1; p&#xa0;=&#xa0;0.0017) and CA-transfusion (RERI -52.0, p&#xa0;&lt;&#xa0;0.0001).</AbstractText><AbstractText Label="CONCLUSIONS">Interaction effects exist between certain complications to increase the risk of short-term mortality. ARF, AKI, sepsis, and stroke were most likely to be involved in positive interactions. Further research into the mechanisms for these effects will be necessary to develop strategies to minimize the compounding effects of multiple complications in the perioperative period.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Minjae</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Columbia University Medical Center, 622 West 168th Street, PH 5 Suite 505C, New York, NY, 10032, USA. mk2767@cumc.columbia.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, USA. mk2767@cumc.columbia.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Guohua</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Columbia University Medical Center, 622 West 168th Street, PH 5 Suite 505C, New York, NY, 10032, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World J Surg</MedlineTA><NlmUniqueID>7704052</NlmUniqueID><ISSNLinking>0364-2313</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="N">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="N">Respiratory Insufficiency</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28755257</ArticleId><ArticleId IdType="doi">10.1007/s00268-017-4156-7</ArticleId><ArticleId IdType="pii">10.1007/s00268-017-4156-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Gen Intern Med. 2006 Feb;21(2):177-80</Citation><ArticleIdList><ArticleId IdType="pubmed">16606377</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266</Citation><ArticleIdList><ArticleId IdType="pubmed">11904577</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Surg. 2015 Sep;221(3):708-16</Citation><ArticleIdList><ArticleId IdType="pubmed">26228016</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Soc Nephrol. 1999 Feb;10(2):429-32</Citation><ArticleIdList><ArticleId IdType="pubmed">10215345</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Epidemiol. 2005;20(7):563-4</Citation><ArticleIdList><ArticleId IdType="pubmed">16119427</ArticleId></ArticleIdList></Reference><Reference><Citation>ISBT Sci Ser. 2015 Apr;10(Suppl 1):188-191</Citation><ArticleIdList><ArticleId IdType="pubmed">26347800</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Public Health. 1998 Jan;88(1):15-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9584027</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2009 May 5;150(9):604-12</Citation><ArticleIdList><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 1994 Dec;220(6):740-4</Citation><ArticleIdList><ArticleId IdType="pubmed">7986140</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2011 Feb;39(2):259-65</Citation><ArticleIdList><ArticleId IdType="pubmed">20975548</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Anaesth. 2015 Dec;115 Suppl 2:ii3-14</Citation><ArticleIdList><ArticleId IdType="pubmed">26658199</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin J Am Soc Nephrol. 2010 Apr;5(4):733-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20167687</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 1980 Oct;112(4):467-70</Citation><ArticleIdList><ArticleId IdType="pubmed">7424895</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerebrovasc Dis. 2012;34(3):175-81</Citation><ArticleIdList><ArticleId IdType="pubmed">22922182</ArticleId></ArticleIdList></Reference><Reference><Citation>Ophthalmic Physiol Opt. 2014 Sep;34(5):502-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24697967</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Epidemiol. 2004 Dec;33(6):1389-97</Citation><ArticleIdList><ArticleId IdType="pubmed">15319402</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2010 Feb;38(2):438-44</Citation><ArticleIdList><ArticleId IdType="pubmed">19789449</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 2015 Dec;121(6):1536-46</Citation><ArticleIdList><ArticleId IdType="pubmed">26273749</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2009 Jun 9;119(22):2936-44</Citation><ArticleIdList><ArticleId IdType="pubmed">19506125</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Crit Care. 2006 Aug;12(4):325-32</Citation><ArticleIdList><ArticleId IdType="pubmed">16810043</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2011 May;39(5):1050-5</Citation><ArticleIdList><ArticleId IdType="pubmed">21317650</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 2012 Jan;114(1):148-51</Citation><ArticleIdList><ArticleId IdType="pubmed">22052982</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Neurol. 2015 Oct;272:41-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26054885</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2002 Sep;236(3):344-53; discussion 353-4</Citation><ArticleIdList><ArticleId IdType="pubmed">12192321</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 2011 Oct;115(4):879-90</Citation><ArticleIdList><ArticleId IdType="pubmed">21862923</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 2014 May;120(5):1168-81</Citation><ArticleIdList><ArticleId IdType="pubmed">24755786</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Heart J. 2005 Aug;150(2):330-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16086939</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Rev Oncol Hematol. 2016 Mar;99:272-85</Citation><ArticleIdList><ArticleId IdType="pubmed">26811138</ArticleId></ArticleIdList></Reference><Reference><Citation>Contrib Nephrol. 2011;174:71-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21921611</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest. 1993 Nov;104(5):1592-6</Citation><ArticleIdList><ArticleId IdType="pubmed">8222829</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroke. 2010 Oct;41(10 Suppl):S3-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20876499</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2009 Oct 1;361(14):1368-75</Citation><ArticleIdList><ArticleId IdType="pubmed">19797283</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Epidemiol. 2005;20(7):575-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16119429</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 1999 Aug;230(2):251-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10450740</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2010 Dec;252(6):1065-71</Citation><ArticleIdList><ArticleId IdType="pubmed">20571363</ArticleId></ArticleIdList></Reference><Reference><Citation>J Crit Care. 2014 Apr;29(2):241-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24332993</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">17954283</PMID><DateCompleted><Year>2007</Year><Month>11</Month><Day>27</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1523-6838</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>5</Issue><PubDate><Year>2007</Year><Month>Nov</Month></PubDate></JournalIssue><Title>American journal of kidney diseases : the official journal of the National Kidney Foundation</Title><ISOAbbreviation>Am J Kidney Dis</ISOAbbreviation></Journal><ArticleTitle>Improved survival in acute kidney injury after cardiac surgery.</ArticleTitle><Pagination><StartPage>703</StartPage><EndPage>711</EndPage><MedlinePgn>703-11</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The overall incidence of acute kidney injury (AKI) or mortality after cardiac surgery is low, but mortality in patients with AKI remains high. Effects of factors such as change in comorbid disease burden, intraoperative factors, or postoperative complications on trends in the incidence of AKI and associated mortality after cardiac surgery were not examined.</AbstractText><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Observational cohort study.</AbstractText><AbstractText Label="SETTING &amp; PARTICIPANTS" NlmCategory="METHODS">34,562 cardiac surgeries were performed from 1993 to 2002; only the first surgical procedure was considered (N = 33,217).</AbstractText><AbstractText Label="PREDICTOR, OUTCOMES, &amp; MEASUREMENTS" NlmCategory="METHODS">AKI was defined as a composite outcome of a 50% or greater decrease in postoperative glomerular filtration rate or requirement of dialysis (AKI-D). Mortality was defined as postoperative hospital mortality. We examined effects of the predictors AKI and year of surgery on mortality after accounting for preoperative risk factors and serious postoperative complications.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Between the first and second halves of the study period (1993 to 2002), the incidence of AKI increased from 5.1% to 6.6%, but the associated mortality rate decreased from 32% to 23% (P &lt; 0.0001). Similarly, the incidence of AKI-D also increased from 1.5% to 2.0%, with a decrease in associated mortality from 61% to 49% (P &lt; 0.01). In a risk-adjusted model, mortality in patients with AKI significantly decreased over time. Patients with AKI-D and with other organ system failures did not show improvement in survival over time. A preoperative history of congestive heart failure was associated significantly with a decrease in mortality risk over time, particularly in patients requiring dialysis.</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">Single-center, retrospective, observational cohort design.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The incidence of AKI after cardiac surgery has increased over time. Although the adjusted risk of mortality decreased in patients with AKI without other postoperative complications, it is unchanged in those with multiorgan system failure.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thakar</LastName><ForeName>Charuhas V</ForeName><Initials>CV</Initials><AffiliationInfo><Affiliation>Department of Nephrology and Hypertension, Cleveland Clinic Foundation, Cleveland, OH, USA. charuhas.thakar@uc.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Worley</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Arrigain</LastName><ForeName>Susana</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Yared</LastName><ForeName>Jean-Pierre</ForeName><Initials>JP</Initials></Author><Author ValidYN="Y"><LastName>Paganini</LastName><ForeName>Emil P</ForeName><Initials>EP</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DK071802-01A</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Kidney Dis</MedlineTA><NlmUniqueID>8110075</NlmUniqueID><ISSNLinking>0272-6386</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2006</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2007</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>10</Month><Day>24</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>12</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>10</Month><Day>24</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17954283</ArticleId><ArticleId IdType="doi">10.1053/j.ajkd.2007.07.021</ArticleId><ArticleId IdType="pii">S0272-6386(07)01128-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27687445</PMID><DateCompleted><Year>2017</Year><Month>08</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><PubDate><Year>2016</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Incidence of acute kidney injury after elective lower limb arthroplasty.</ArticleTitle><Pagination><StartPage>520</StartPage><EndPage>523</EndPage><MedlinePgn>520-3</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2016.06.010</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(16)30284-7</ELocationID><Abstract><AbstractText Label="STUDY OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this study was to establish the incidence of acute kidney injury (AKI) in patients undergoing elective hip and knee arthroplasty.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">This was a retrospective cohort study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">The study was conducted in a district general hospital in the United Kingdom.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">All patients undergoing elective hip and knee arthroplasty over a period of 6 months were included in the study.</AbstractText><AbstractText Label="MEASUREMENT" NlmCategory="METHODS">Preoperative and postoperative serum creatinine concentration was recorded in all patients. AKI was defined according to the Acute Kidney Injury Network classification as an increase of serum creatinine concentration of &gt;26.5 &#x3bc;mol/L (&#x2265;0.3 mg/dL) or increase to 1.5-fold from baseline.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">Three hundred thirty-seven patients were included in the study. Forty-eight had preexisting stage 3 chronic kidney disease (CKD). The overall incidence of AKI in our study was 6.2%. The incidence in patients with preexisting stage 3 CKD (estimated glomerular filtration rate &lt;60 mL/[min 1.73 m(2)]) was 16.3%, whereas in patients without preexisting stage 3 CKD, the incidence was 4.5%.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We identified stage 3 or higher CKD as a major risk factor for developing postoperative AKI. Preexisting CKD raised the risk of developing AKI 4-fold. We recommend that all patients undergoing lower limb arthroplasty should have renal function assessed preoperatively. In the perioperative period, renal function should be monitored in all patients. This is of particular importance in patients with estimated glomerular filtration rate &lt;60.</AbstractText><CopyrightInformation>Crown Copyright &#xa9; 2016. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nowicka</LastName><ForeName>Aleksandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Speciality registrar in anaesthesia, Warwickshire School of Anaesthesia; Department of Anaesthesia and Intensive Care, Warwick Hospital, Lakin Rd, Warwick, CV34 5BW, UK. Electronic address: a.nowicka@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Selvaraj</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Warwick Hospital, Lakin Rd, Warwick, CV34 5BW, UK. Electronic address: thomasselvaraj@doctors.org.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019644" MajorTopicYN="N">Arthroplasty, Replacement, Hip</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="N">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005919" MajorTopicYN="N">Glomerular Filtration Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="N">Renal Insufficiency, Chronic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N">United Kingdom</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Lower limb arthroplasty</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>5</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27687445</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2016.06.010</ArticleId><ArticleId IdType="pii">S0952-8180(16)30284-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25910838</PMID><DateCompleted><Year>2016</Year><Month>09</Month><Day>12</Day></DateCompleted><DateRevised><Year>2015</Year><Month>12</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1477-111X</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Perfusion</Title><ISOAbbreviation>Perfusion</ISOAbbreviation></Journal><ArticleTitle>Miniaturized versus conventional cardiopulmonary bypass and acute kidney injury after cardiac surgery.</ArticleTitle><Pagination><StartPage>60</StartPage><EndPage>67</EndPage><MedlinePgn>60-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/0267659115584418</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Acute kidney injury (AKI) is a serious complication after coronary artery bypass grafting (CABG). There are conflicting reports whether a miniaturized cardiopulmonary bypass (MCPB) system is associated with a lower AKI incidence compared with conventional cardiopulmonary bypass (CCPB). It is unknown if AKI risk factors differ between the two groups. We assessed if MCPB decreases AKI after CABG and compared the risk factors between both groups.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Sixty-eight Asian patients presenting for elective CABG at a tertiary heart centre were enrolled. They were randomly assigned to MCPB (n=34) or CCPB group (n=34) and followed up in a single-blinded, prospective, randomized, controlled trial. The primary outcome was Acute Kidney Injury Network stage 1 AKI.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The AKI incidence was 21.5% and was not significantly different between patients undergoing MCPB versus CCPB (21.9% versus 21.2%, p=0.948). The first CPB haematocrit was independently associated with AKI in the MCPB group (Relative Risk [RR]=0.484, 95% Confidence Interval [CI]=0.268-0.876, p=0.016); post-operative blood loss and inflammation were independently associated with AKI in the CCPB group (RR=1.005, 95%CI=1.003-1.007, p&lt;0.001; RR=1.018, 95%CI=1.010-1.028, p&lt;0.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The MCPB system is not associated with a lower incidence of AKI in Asian patients undergoing CABG. Risk factors for AKI differed between patients using the MCPB and CCPB systems.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2015.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chew</LastName><ForeName>S T H</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Singapore General Hospital, Singapore Department of Cardiovascular and Metabolic Disorders, Duke-National University of Singapore Graduate Medical School, Singapore rnsctlk@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>R R G</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>W</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goh</LastName><ForeName>S G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Department of Cardiac, Thoracic and Vascular Surgery, National University Heart Centre, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caleb</LastName><ForeName>M G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Cardiac, Thoracic and Vascular Surgery, National University Heart Centre, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ti</LastName><ForeName>L K</ForeName><Initials>LK</Initials><AffiliationInfo><Affiliation>Yong Loo Lin School of Medicine, National University of Singapore, Singapore Department of Anaesthesia, National University Health System, Singapore.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>04</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Perfusion</MedlineTA><NlmUniqueID>8700166</NlmUniqueID><ISSNLinking>0267-6591</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="Y">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001026" MajorTopicYN="N">Coronary Artery Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008904" MajorTopicYN="Y">Miniaturization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">coronary artery bypass grafting</Keyword><Keyword MajorTopicYN="N">miniaturized</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25910838</ArticleId><ArticleId IdType="doi">10.1177/0267659115584418</ArticleId><ArticleId IdType="pii">0267659115584418</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24321848</PMID><DateCompleted><Year>2015</Year><Month>01</Month><Day>20</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>3</Issue><PubDate><Year>2014</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Anesthetic technique and acute kidney injury in endovascular abdominal aortic aneurysm repair.</ArticleTitle><Pagination><StartPage>572</StartPage><EndPage>578</EndPage><MedlinePgn>572-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2013.06.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(13)00356-X</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Prior studies suggest that general anesthesia (GA) is associated with worse cardiopulmonary outcomes after endovascular abdominal aortic aneurysm repair (EVAR). Patients undergoing EVAR are at a high risk of developing perioperative acute kidney injury (AKI), and the relationship between anesthetic technique and AKI in these patients is not well-characterized. The authors sought to determine if anesthetic technique affected the risk of AKI in patients undergoing EVAR.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective, observational cohort study analyzed using a multivariate logistic regression model to assess the effects of anesthetic technique on renal outcome.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Multiple institutions, mainly in North America.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Patients in the American College of Surgeons National Surgical Quality Improvement Program from 2005-2010 undergoing EVAR.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">The authors investigated the association between anesthetic techniques, comparing GA to alternative (non-GA) techniques, and AKI.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">AKI was defined as an increase in the creatinine level of&gt;2 mg/dL and/or dialysis. Of 13,026 patients, 84.4% underwent GA and 15.6% underwent non-GA techniques. AKI developed in 2.0% of the GA group and 1.4% of the non-GA group (unadjusted odds ratio [OR] 1.43, p = 0.075; adjusted OR [aOR] 1.00, p = 0.99). Risk factors for AKI include ASA class, ruptured aneurysm, preoperative renal dysfunction, symptomatic cardiovascular disease, and perioperative blood transfusion.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Anesthetic technique is not independently associated with the risk of AKI in patients undergoing EVAR.</AbstractText><CopyrightInformation>Copyright &#xa9; 2014 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Minjae</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Columbia University Medical Center, New York, NY. Electronic address: minjae.kim@columbia.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brady</LastName><ForeName>Joanne E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Columbia University Medical Center, New York, NY; Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Guohua</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Columbia University Medical Center, New York, NY; Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>12</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017542" MajorTopicYN="N">Aneurysm, Ruptured</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017544" MajorTopicYN="N">Aortic Aneurysm, Abdominal</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="N">Endovascular Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006435" MajorTopicYN="N">Renal Dialysis</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">abdominal</Keyword><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">anesthesia</Keyword><Keyword MajorTopicYN="N">aortic aneurysm</Keyword><Keyword MajorTopicYN="N">endovascular procedures</Keyword><Keyword MajorTopicYN="N">postoperative complications</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>12</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>12</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24321848</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2013.06.001</ArticleId><ArticleId IdType="pii">S1053-0770(13)00356-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30097705</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1432-2323</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>11</Issue><PubDate><Year>2018</Year><Month>Nov</Month></PubDate></JournalIssue><Title>World journal of surgery</Title><ISOAbbreviation>World J Surg</ISOAbbreviation></Journal><ArticleTitle>Prognostic Significance of Acute Kidney Injury Following Emergency Laparotomy: A Prospective Observational Cohort Study.</ArticleTitle><Pagination><StartPage>3575</StartPage><EndPage>3580</EndPage><MedlinePgn>3575-3580</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00268-018-4744-1</ELocationID><Abstract><AbstractText Label="AIMS">Post-operative acute kidney injury (AKI) is a common and independent mortality risk factor carrying high clinical and economic cost. This study aimed to establish the incidence of AKI in patients undergoing emergency laparotomy (EL), to determine patients' risk profile and consequent mortality.</AbstractText><AbstractText Label="METHODS">Consecutive 239 patients of median age 68 (IQR 51-76)&#xa0;years, undergoing EL in a UK tertiary hospital, were studied. Primary outcome measure was AKI and in-hospital operative mortality.</AbstractText><AbstractText Label="RESULTS">Ninety-five patients (39.7%) developed AKI, which was associated with in-hospital mortality in 32 patients (33.7%) compared with 7 patients (4.9%) without AKI. AKI occurred in 81.1% of all mortalities, but none occurred when AKI resolved within 48&#xa0;h of EL. AKI was associated with chronic kidney disease, age, serum lactate, white cell count, pre-EL systolic blood pressure and tachycardia (p&#x2009;&lt;&#x2009;0.010). Median length of hospital stay in AKI survivors was 15&#xa0;days compared with 11&#xa0;days in the absence of AKI (p&#x2009;&lt;&#x2009;0.001). On multivariable analysis, only AKI at 48&#xa0;h post-EL was significantly and independently associated with mortality [HR 10.895, 95% CI 3.152-37.659, p&#x2009;&lt;&#x2009;0.001].</AbstractText><AbstractText Label="CONCLUSION">Peri-operative AKI after EL was common and associated with a more than sixfold significant greater mortality. Pre-operative risk profile assessment and prompt protocol-driven intervention should minimise AKI and reduce EL mortality.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dewi</LastName><ForeName>F</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-9269-9044</Identifier><AffiliationInfo><Affiliation>Wales Postgraduate Medical and Dental Education Deanery, Cardiff, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Egan</LastName><ForeName>R J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Wales Postgraduate Medical and Dental Education Deanery, Cardiff, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdelrahman</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Wales Postgraduate Medical and Dental Education Deanery, Cardiff, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Surgery, University Hospital of Wales, Cardiff, CF14 4XW, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stechman</LastName><ForeName>M J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, University Hospital of Wales, Cardiff, CF14 4XW, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lewis</LastName><ForeName>W G</ForeName><Initials>WG</Initials><AffiliationInfo><Affiliation>Department of Surgery, University Hospital of Wales, Cardiff, CF14 4XW, UK. Wyn.Lewis4@wales.nhs.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World J Surg</MedlineTA><NlmUniqueID>7704052</NlmUniqueID><ISSNLinking>0364-2313</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004630" MajorTopicYN="N">Emergencies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007813" MajorTopicYN="N">Laparotomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30097705</ArticleId><ArticleId IdType="doi">10.1007/s00268-018-4744-1</ArticleId><ArticleId IdType="pii">10.1007/s00268-018-4744-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Metnitz P, Krenn C, Steltzer H, Lang T, Ploder J, Lenz K et al (2002) Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 30:2051&#x2013;2058</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200209000-00016</ArticleId></ArticleIdList></Reference><Reference><Citation>Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR (2009) Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 53:961</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2008.11.034</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow GM (2005) Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16:3365</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2004090740</ArticleId></ArticleIdList></Reference><Reference><Citation>Abelha F, Botelho M, Fernandes V, Barros H (2009) Determinants of postoperative acute kidney injury. Crit Care 13:R79</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc7894</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Tremper K, Heung M, Rosenberg A, Englesbe M, Shanks A et al (2009) Development and validation of an acute kidney injury risk index for patients undergoing general surgery. Anesthesiology 110:505&#x2013;515</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3181979440</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H, Wang W, Chen Y, Chen H (2015) The association between the duration of postoperative acute kidney injury and in-hospital mortality in critically ill patients after non-cardiac surgery: an observational cohort study. Ren Fail 37(6):985&#x2013;993</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/0886022X.2015.1044755</ArticleId></ArticleIdList></Reference><Reference><Citation>Disease Kidney (2012) Improving global outcomes (KDIGO) acute kidney injury work group: KDIGO clinical practice guidelines for acute kidney injury. Kidney Int Suppl 2:1&#x2013;138</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/kisup.2012.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Bihorac A, Yavas S, Subbiah S, Hobson CE, Schhold JD, Gabrielli A, Layon J, Segal M (2009) Long-term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg 249:851&#x2013;858</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e3181a40a0b</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M, Brady JE, Li G (2014) Variations in the risk of acute kidney injury across intraabdominal surgery procedures. Anesth Analg 119:1121</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000000425</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Tremper K, Englesbe M, O&#x2019;Reilly M, Shanks A, Fetterman D et al (2007) Predictors of postoperative acute renal failure after noncardiac surgery in patients with previously normal renal function. Anesthesiology 107:892&#x2013;902</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.anes.0000290588.29668.38</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira C, Rosa R, Rodrigues N, Mendes I, Peixoto L, Dias S et al (2014) Acute kidney injury after major abdominal surgery: a retrospective cohort analysis. Crit Care Res Pract 2014:1</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/132175</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M, Brady J, Li G (2015) Interaction effects of acute kidney injury, acute respiratory failure and sepsis on 30-day postoperative mortality in patients undergoing high-risk intraabdominal general surgical procedures. Anesth Analg 121:1536&#x2013;1546</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000000915</ArticleId></ArticleIdList></Reference><Reference><Citation>Symons NRA, Moorthy K, Almoudaris AM, Bottle A, Aylin P, Vincent CA et al (2013) Mortality in high-risk emergency general surgical admissions. Br J Surg 100:1318</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.9208</ArticleId></ArticleIdList></Reference><Reference><Citation>NELA Project Team (2015) First patient report of the national emergency laparotomy audit. Royal College of Anaesthetists, London</Citation></Reference><Reference><Citation>Findlay GP, Goodwin A, Goodwin A, Protopapa K, Smith N, Mason M (2011) NCEPOD: a review of the perioperative care of surgical patients. http://www.ncepod.org.uk/2011report2/downloads/POC_summary.pdf</Citation></Reference><Reference><Citation>Thomas M, Davies A, Dawnay A (2013) Acute kidney injury: prevention, detection and management (CG169). National Institute for Health and Care Excellence. https://www.nice.org.uk/Guidance/CG169</Citation></Reference><Reference><Citation>Egan RJ, Dewi F, Arkell R, Ansell J, Zouwail S, Scott-Coombes D et al (2016) Does elective parathyroidectomy for primary hyperparathyroidism affect renal function? a prospective cohort study. Int J Surg 27:138&#x2013;141</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2016.01.072</ArticleId></ArticleIdList></Reference><Reference><Citation>Howes TE, Cook TM, Corrigan LJ, Dalton SJ, Richards SK, Peden CJ (2015) Postoperative morbidity survey, mortality and length of stay following emergency laparotomy. Anaesthesia 70:1020</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.12991</ArticleId></ArticleIdList></Reference><Reference><Citation>Awad S, Herrod PJJ, Palmer R, Carty H, Abercrombie JF, Brooks A et al (2012) One-and two-year outcomes and predictors of mortality following emergency laparotomy: a consecutive series from a United Kingdom teaching hospital. World J Surg 36:2060. https://doi.org/10.1007/s00268-012-1614-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-012-1614-0</ArticleId><ArticleId IdType="pubmed">22538391</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabat&#xe9; S, Gomar C, Canet J, Sierra P, Castillo J (2011) Risk factors for postoperative acute kidney injury in a cohort of 2378 patients from 59 hospitals. Revista Espa&#xf1;ola de Anestesiolog&#xed;a y Reanimaci&#xf3;n 58(9):548&#x2013;555</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0034-9356(11)70139-6</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24731742</PMID><DateCompleted><Year>2015</Year><Month>01</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>3</Issue><PubDate><Year>2014</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury after cardiac surgery: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>557</StartPage><EndPage>563</EndPage><MedlinePgn>557-63</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2013.12.030</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(13)00699-X</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate the impact of early versus late renal replacement therapy (RRT) on mortality in patients with acute kidney injury (AKI) after cardiac surgery.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Meta-analysis of 9 retrospective cohort studies and 2 randomized clinical trials extracted from the Medline engine from 1950 to 2013.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">University medical school.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">841 Patients.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">None.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">A total of 841 patients were studied. Pooled estimates of the odds ratio with 95% confidence interval using a random-effect model were conducted as well as the heterogeneity, publication bias, and sensitivity analysis. Primary outcome was 28-day mortality, and secondary outcome was the intensive care unit (ICU) length of stay. The 28-days mortality rate was lower in the early RRT group (OR = 0.29, 95% CI, 0.16-0.52, p&lt;0.0001, NNT = 5). Heterogeneity was high (I2 = 56%), and publication bias was low. Secondary outcome suggested 3.9 (1.5-6.3) days shorter ICU stay in the early RRT group, p&lt;0.0001, with extremely high heterogeneity (I(2) = 99%), and low publication bias. Specifically, studies before 2000 and studies with mortality less than 50% in the late RRT group reported significantly higher odds ratio and mean difference than overall value favoring early RRT.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Early initiation of RRT for patients with AKI after cardiac surgery revealed lower 28-days mortality and shorter ICU length of stay. However, this was based on 11 studies of various qualities with very high heterogeneity of results. Defining treatment guidelines needs further research with a larger and better database.</AbstractText><CopyrightInformation>Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>SUNY at Buffalo, Buffalo, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davari-Farid</LastName><ForeName>Sina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>SUNY at Buffalo, Buffalo, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arora</LastName><ForeName>Pradeep</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>SUNY at Buffalo, Buffalo, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porhomayon</LastName><ForeName>Jahan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>SUNY at Buffalo, Buffalo, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nader</LastName><ForeName>Nader D</ForeName><Initials>ND</Initials><AffiliationInfo><Affiliation>SUNY at Buffalo, Buffalo, NY. Electronic address: nnader@buffalo.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>04</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="N">Renal Replacement Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">cardiac surgical procedures</Keyword><Keyword MajorTopicYN="N">critical illness</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">renal replacement therapy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24731742</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2013.12.030</ArticleId><ArticleId IdType="pii">S1053-0770(13)00699-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34153017</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>133</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Associations Between Preoperative Biomarkers and Cardiac Surgery-Associated Acute Kidney Injury in Elderly Patients: A Cohort Study.</ArticleTitle><Pagination><StartPage>570</StartPage><EndPage>577</EndPage><MedlinePgn>570-577</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000005650</ELocationID><Abstract><AbstractText Label="BACKGROUND">Acute kidney injury (AKI) is associated with mortality after cardiac surgery. Novel risk factors may improve identification of patients at risk for renal injury. The authors evaluated the association between preoperative biomarkers that reflect cardiac, inflammatory, renal, and metabolic disorders and cardiac surgery-associated AKI (CSA-AKI) in elderly patients.</AbstractText><AbstractText Label="METHODS">This was a secondary analysis of the 2-center prospective cohort study "Anesthesia Geriatric Evaluation." Twelve biomarkers were determined preoperatively in 539 patients. Primary outcome was CSA-AKI. The association between biomarkers and CSA-AKI was investigated with multivariable logistic regression analysis. Secondary outcomes were 1-year mortality and patient-reported disability and were assessed with relative risks (RR) between patients with and without CSA-AKI.</AbstractText><AbstractText Label="RESULTS">CSA-AKI occurred in 88 (16.3%) patients and was associated with increased risk of mortality (RR, 6.70 [95% confidence interval {CI}, 3.38-13.30]) and disability (RR, 2.13 [95% CI, 1.53-2.95]). Preoperative concentrations of N-terminal pro B-type natriuretic peptide (NT-proBNP), high-sensitive C-reactive protein (hs-CRP), hemoglobin, and magnesium had the strongest association with CSA-AKI. Identification of patients with CSA-AKI improved when a biomarker panel was used (area under the curve [AUC] 0.75 [95% CI, 0.69-0.80]) compared to when only clinical risk factors were used (European System for Cardiac Operative Risk Evaluation [EuroSCORE II] AUC 0.67 [95% CI, 0.62-0.73]).</AbstractText><AbstractText Label="CONCLUSIONS">Preoperative cardiac, inflammatory, renal, and metabolic biomarkers are associated with CSA-AKI and may improve identification of patients at risk.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 International Anesthesia Research Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Verwijmeren</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology, Intensive Care, and Pain Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosma</LastName><ForeName>Madeleen</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Chemistry.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vernooij</LastName><ForeName>Lisette M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology, Intensive Care, and Pain Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linde</LastName><ForeName>Esther M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology, Intensive Care, and Pain Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dijkstra</LastName><ForeName>Ineke M</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>Department of Clinical Chemistry.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daeter</LastName><ForeName>Edgar J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, St. Antonius Hospital, Nieuwegein, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Dongen</LastName><ForeName>Eric P A</ForeName><Initials>EPA</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology, Intensive Care, and Pain Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Klei</LastName><ForeName>Wilton A</ForeName><Initials>WA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care and Emergency Medicine, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noordzij</LastName><ForeName>Peter G</ForeName><Initials>PG</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology, Intensive Care, and Pain Medicine.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02535728</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D057405">Webcast</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006454">Hemoglobins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C109794">pro-brain natriuretic peptide (1-76)</NameOfSubstance></Chemical><Chemical><RegistryNumber>114471-18-0</RegistryNumber><NameOfSubstance UI="D020097">Natriuretic Peptide, Brain</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-41-4</RegistryNumber><NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>I38ZP9992A</RegistryNumber><NameOfSubstance UI="D008274">Magnesium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002097" MajorTopicYN="N">C-Reactive Protein</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004185" MajorTopicYN="N">Disability Evaluation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000085542" MajorTopicYN="N">Functional Status</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015577" MajorTopicYN="N">Geriatric Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006454" MajorTopicYN="N">Hemoglobins</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008274" MajorTopicYN="N">Magnesium</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020097" MajorTopicYN="N">Natriuretic Peptide, Brain</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Conflicts of Interest: See Disclosures at the end of the article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>21</Day><Hour>17</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34153017</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000005650</ArticleId><ArticleId IdType="pii">00000539-202109000-00004</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>O&#x2019;Neal JB, Shaw AD, Billings FT IV. Acute kidney injury following cardiac surgery: current understanding and future directions. Crit Care. 2016;20:187.</Citation></Reference><Reference><Citation>Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006;1:19&#x2013;32.</Citation></Reference><Reference><Citation>Enger TB, Pleym H, Stenseth R, Greiff G, Wahba A, Videm V. A preoperative multimarker approach to evaluate acute kidney injury after cardiac surgery. J Cardiothorac Vasc Anesth. 2017;31:837&#x2013;846.</Citation></Reference><Reference><Citation>Loef BG, Epema AH, Smilde TD, et al. Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J Am Soc Nephrol. 2005;16:195&#x2013;200.</Citation></Reference><Reference><Citation>Lopez-Delgado JC, Esteve F, Torrado H, et al. Influence of acute kidney injury on short- and long-term outcomes in patients undergoing cardiac surgery: risk factors and prognostic value of a modified RIFLE classification. Crit Care. 2013;17:R293.</Citation></Reference><Reference><Citation>Hobson CE, Yavas S, Segal MS, et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation. 2009;119:2444&#x2013;2453.</Citation></Reference><Reference><Citation>Mishra PK, Luckraz H, Nandi J, et al. Long-term quality of life postacute kidney injury in cardiac surgery patients. Ann Card Anaesth. 2018;21:41&#x2013;45.</Citation></Reference><Reference><Citation>Lau D, Pannu N, James MT, et al. Costs and consequences of acute kidney injury after cardiac surgery: a cohort study. J Thorac Cardiovasc Surg. Published online March 3, 2020. DOI: 10.1016/j.jtcvs.2020.01.101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2020.01.101</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe5;rtensson J, Bellomo R. Perioperative renal failure in elderly patients. Curr Opin Anaesthesiol. 2015;28:123&#x2013;130.</Citation></Reference><Reference><Citation>Ostermann M, Liu K. Pathophysiology of AKI. Best Pract Res Clin Anaesthesiol. 2017;31:305&#x2013;314.</Citation></Reference><Reference><Citation>Fuhrman DY, Kellum JA. Epidemiology and pathophysiology of cardiac surgery-associated acute kidney injury. Curr Opin Anaesthesiol. 2017;30:60&#x2013;65.</Citation></Reference><Reference><Citation>Kiers HD, van den Boogaard M, Schoenmakers MC, et al. Comparison and clinical suitability of eight prediction models for cardiac surgery-related acute kidney injury. Nephrol Dial Transplant. 2013;28:345&#x2013;351.</Citation></Reference><Reference><Citation>Berl T, Henrich W. Kidney-heart interactions: epidemiology, pathogenesis, and treatment. Clin J Am Soc Nephrol. 2006;1:8&#x2013;18.</Citation></Reference><Reference><Citation>Patel UD, Garg AX, Krumholz HM, et al.; Translational Research Investigating Biomarker Endpoints in Acute Kidney Injury (TRIBE-AKI) Consortium. Preoperative serum brain natriuretic peptide and risk of acute kidney injury after cardiac surgery. Circulation. 2012;125:1347&#x2013;1355.</Citation></Reference><Reference><Citation>McBride WT, Kurth MJ, McLean G, et al. Stratifying risk of acute kidney injury in pre and post cardiac surgery patients using a novel biomarker-based algorithm and clinical risk score. Sci Rep. 2019;9:16963.</Citation></Reference><Reference><Citation>Verwijmeren L, Peelen LM, van Klei WA, et al. Anaesthesia geriatric evaluation to guide patient selection for preoperative multidisciplinary team care in cardiac surgery. Br J Anaesth. 2020;124:377&#x2013;385.</Citation></Reference><Reference><Citation>Guenancia C, Kahli A, Laurent G, et al. Pre-operative growth differentiation factor 15 as a novel biomarker of acute kidney injury after cardiac bypass surgery. Int J Cardiol. 2015;197:66&#x2013;71.</Citation></Reference><Reference><Citation>Heringlake M, Charitos EI, Gatz N, et al. Growth differentiation factor 15: a novel risk marker adjunct to the EuroSCORE for risk stratification in cardiac surgery patients. J Am Coll Cardiol. 2013;61:672&#x2013;681.</Citation></Reference><Reference><Citation>Levey AS, Stevens LA, Schmid CH, et al.; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604&#x2013;612.</Citation></Reference><Reference><Citation>Barbosa EB, Tomasi CD, de Castro Damasio D, et al. Effects of magnesium supplementation on the incidence of acute kidney injury in critically ill patients presenting with hypomagnesemia. Intensive Care Med. 2016;42:1084&#x2013;1085.</Citation></Reference><Reference><Citation>Singh A, Frid&#xe9;n V, Dasgupta I, et al. High glucose causes dysfunction of the human glomerular endothelial glycocalyx. Am J Physiol Renal Physiol. 2011;300:F40&#x2013;F48.</Citation></Reference><Reference><Citation>WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. 2011 Geneva: World Health Organization; (WHO/NMH/NHD/MNM/11.1). Accessed June 9, 2020. http://www.who.int/vmnis/indicators/haemoglobin.pdf .</Citation></Reference><Reference><Citation>KDIGO AKI Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Inter Suppl. 2012;17:1&#x2013;138.</Citation></Reference><Reference><Citation>Marshall A, Altman DG, Holder RL, Royston P. Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines. BMC Med Res Methodol. 2009;9:57.</Citation></Reference><Reference><Citation>Donders AR, van der Heijden GJ, Stijnen T, Moons KG. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol. 2006;59:1087&#x2013;1091.</Citation></Reference><Reference><Citation>Zelt JGE, Mielniczuk LM, Liu PP, et al. Utility of novel cardiorenal biomarkers in the prediction and early detection of congestive kidney injury following cardiac surgery. J Clin Med. 2018;7:E540.</Citation></Reference><Reference><Citation>Barr ELM, Barzi F, Hughes JT, et al. High baseline levels of tumor necrosis factor receptor 1 are associated with progression of kidney disease in indigenous australians with diabetes: the eGFR follow-up study. Diabetes Care. 2018;41:739&#x2013;747.</Citation></Reference><Reference><Citation>Parodis I, Ding H, Zickert A, et al. Serum soluble tumour necrosis factor receptor-2 (sTNFR2) as a biomarker of kidney tissue damage and long-term renal outcome in lupus nephritis. Scand J Rheumatol. 2017;46:263&#x2013;272.</Citation></Reference><Reference><Citation>Rangaswami J, Bhalla V, Blair JEA, et al.; American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Clinical Cardiology. Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation. 2019;139:e840&#x2013;e878.</Citation></Reference><Reference><Citation>Spahn DR, Schoenrath F, Spahn GH, et al. Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial. Lancet. 2019;393:2201&#x2013;2212.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40446730</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8615</ISSN><JournalIssue CitedMedium="Internet"><Volume>89</Volume><PubDate><Year>2025</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of critical care</Title><ISOAbbreviation>J Crit Care</ISOAbbreviation></Journal><ArticleTitle>Long-term mortality after stage 1 acute kidney injury in critically ill patients - an observational cohort study.</ArticleTitle><Pagination><StartPage>155130</StartPage><MedlinePgn>155130</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrc.2025.155130</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0883-9441(25)00117-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute Kidney Injury (AKI) is prevalent in intensive care units (ICU) and is linked with increased mortality. The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines define AKI using serum creatinine and urinary output criteria. While moderate and severe AKI according the creatinine criterion correlate with increased mortality, the significance of stage 1 AKI remains debated.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Retrospective cohort analysis from two tertiary care centres in Switzerland and Austria (2013-2021) to investigate the association between stage 1 AKI (KDIGO creatinine criterion) in the first seven days after ICU admission and one-year mortality in adult ICU patients. Data were extracted using standardized protocols. Baseline creatinine was determined using estimation formulas. We applied multivariable regression models adjusted for key confounders and conducted sensitivity analyses.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 42,446 patients, 4667 (11&#xa0;%) developed stage 1 AKI, 13&#xa0;% (n&#xa0;=&#xa0;5449) moderate/ severe AKI and 32,330 patients no AKI (76&#xa0;%). Stage 1 AKI associates with one-year mortality (OR 1.6 [95&#xa0;%CI 1.48; 1.73], p&#xa0;&lt;&#xa0;0.001) and increases length of stay in ICU (&#x3b2; 1.4 [95&#xa0;%CI 1.2; 1.5], p&#xa0;&lt;&#xa0;0.001) and hospital (&#x3b2; 2.7 [95&#xa0;%CI 2.1; 3.2], p&#xa0;&lt;&#xa0;0.001). In subgroup-analyses, we observed similar associations in patients with surgery (OR 1.66 [95&#xa0;%CI 1.45;1.89], p&#xa0;&lt;&#xa0;0.001) and without surgery (OR 1.61 [95&#xa0;%CI 1.46;1.78], p&#xa0;&lt;&#xa0;0.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Stage 1 AKI is associated with 1-year mortality in adult ICU patients even in steps below 26.5&#xa0;&#x3bc;mol/L. This highlights the prognostic significance of subclinical renal injury and underlines the need for increased efforts to diagnose AKI in its full spectrum. The analysis is limited by basing the AKI diagnosis on creatinine criterion.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pfortmueller</LastName><ForeName>Carmen A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Electronic address: carmen.pfortmueller@insel.ch.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hahn</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Electronic address: markus.hahn@insel.ch.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eggimann</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Electronic address: angela.eggimann@ksgr.ch.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodemund</LastName><ForeName>Niklas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Perioperative Medicine and Intensive Care Medicine, Paracelsus Medical University of Salzburg, Salzburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kokoefer</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Perioperative Medicine and Intensive Care Medicine, Paracelsus Medical University of Salzburg, Salzburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindner</LastName><ForeName>Gregor</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Kepler Universit&#xe4;tsklinikum GmbH, Johannes Kepler University, Linz, Austria; Department of Emergency Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schefold</LastName><ForeName>Joerg C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Electronic address: joerg.schefold@insel.ch.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waskowski</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Electronic address: jan.waskowski@insel.ch.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Crit Care</MedlineTA><NlmUniqueID>8610642</NlmUniqueID><ISSNLinking>0883-9441</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="Y">Critical Illness</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001317" MajorTopicYN="N" Type="Geographic">Austria</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013557" MajorTopicYN="N" Type="Geographic">Switzerland</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AKI</Keyword><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Critically ill</Keyword><Keyword MajorTopicYN="N">KDIGO</Keyword><Keyword MajorTopicYN="N">Kidney diseases</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword></KeywordList><CoiStatement>Declaration of competing interest MH, CAP, JCS and JW report grants from Orion Pharma, Abbott Nutrition International, B. Braun Medical AG, CSEM AG, Edwards Lifesciences Services GmbH, Kenta Biotech Ltd., Maquet Critical Care AB, Omnicare Clinical Research AG, Nestle, Pierre Fabre Pharma AG, Pfizer, Bard Medica S.A., Abbott AG, Anandic Medical Systems, Pan Gas AG Healthcare, Bracco, Hamilton Medical AG, Fresenius Kabi, Getinge Group Maquet AG, Dr&#xe4;ger AG, Teleflex Medical GmbH, Glaxo Smith Kline, Merck Sharp and Dohme AG, Eli Lilly and Company, Baxter, Astellas, Astra Zeneca, CSL Behring, Novartis, Covidien, Phagenesis Ltd., and Nycomed outside the submitted work. The money was paid into departmental funds; no personal financial gain applied. GL received honoraria from Otsuka Pharma, Daiichi-Sankyo, Bayer Pharmaceuticals. AK is currently receiving funding from the Austrian Research Promotion Agency (FFG). NR and AE reports no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>28</Day><Hour>8</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>31</Day><Hour>0</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>30</Day><Hour>18</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40446730</ArticleId><ArticleId IdType="doi">10.1016/j.jcrc.2025.155130</ArticleId><ArticleId IdType="pii">S0883-9441(25)00117-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30660405</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2020</Year><Month>01</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1523-6838</ISSN><JournalIssue CitedMedium="Internet"><Volume>73</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>Apr</Month></PubDate></JournalIssue><Title>American journal of kidney diseases : the official journal of the National Kidney Foundation</Title><ISOAbbreviation>Am J Kidney Dis</ISOAbbreviation></Journal><ArticleTitle>Lanosterol Synthase Genetic Variants, Endogenous Ouabain, and Both Acute and Chronic Kidney Injury.</ArticleTitle><Pagination><StartPage>504</StartPage><EndPage>512</EndPage><MedlinePgn>504-512</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.ajkd.2018.10.012</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0272-6386(18)31103-X</ELocationID><Abstract><AbstractText Label="RATIONALE &amp; OBJECTIVE">Studies of humans and animals have suggested that endogenous ouabain (EO) and related genes are mediators of acute (AKI) and chronic kidney injury. We sought to examine the relationship among EO levels, genetic variants in lanosterol synthase (LSS; an enzyme that catalyzes synthesis of cholesterol, a precursor of EO), and both AKI and chronic kidney injury.</AbstractText><AbstractText Label="STUDY DESIGN">2 prospective observational cohort studies and a cross-sectional study of kidney tissue.</AbstractText><AbstractText Label="SETTING &amp; PARTICIPANTS">(1) A prospective cohort study of patients undergoing cardiovascular surgery, (2) measurement of EO concentration in kidney tissue removed because of an adjacent tumor, and (3) a prospective cohort study of patients with newly diagnosed essential hypertension.</AbstractText><AbstractText Label="EXPOSURE">Missense variant in LSS (A instead of C allele at rs2254524), which leads to a valine to leucine substitution at amino acid&#xa0;642.</AbstractText><AbstractText Label="OUTCOMES">Development of postoperative AKI in the cardiovascular surgery cohort, EO concentration in kidney tissue, and estimated glomerular filtration rate (eGFR) reductions in the essential hypertension cohort.</AbstractText><AbstractText Label="ANALYTICAL APPROACH">Logistic regression for analysis of postoperative AKI, analysis of variance for EO concentration in kidney tissue, and generalized linear models for changes in eGFR over time.</AbstractText><AbstractText Label="RESULTS">AKI incidence following cardiovascular surgery was greater among those with the LSS rs2254524 AA genotype (30.7%) than in those with the CC genotype (17.4%; P=0.001). LSS rs2254524 AA kidneys had higher EO concentrations than CC kidneys (2.14&#xb1;0.29 vs 1.25&#xb1;0.08ng/g; P&lt;0.001). In the longitudinal study of patients with essential hypertension (median follow-up, 4 years; range, 1-15 years), eGFR decline was greater among the LSS rs2254524 AA genotype group (-4.39&#xb1;1.18mL/min/1.73m<sup>2</sup> per year) than in the AC or CC genotype groups (-1.07&#xb1;0.55 and&#xa0;-2.00&#xb1;0.45mL/min/1.73m<sup>2</sup> per year respectively; P&#xa0;= 0.03).</AbstractText><AbstractText Label="LIMITATIONS">These associations do not necessarily represent causal relationships; LSS rs2254524 variants may have effects on other steroid hormones.</AbstractText><AbstractText Label="CONCLUSIONS">These findings support the potential value of LSS rs2254524 genotype-based risk stratification to identify patients at high risk for AKI before cardiovascular surgery, as well as predict accelerated eGFR in the setting of hypertension. These findings also suggest that LSS may in part drive EO-mediated kidney damage. EO may represent a new potential therapeutic target for the prevention of AKI and slowing of kidney damage in the setting of hypertension.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Iatrino</LastName><ForeName>Rossella</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Nephrology, Universit&#xe0; Vita Salute San Raffaele, Milan, Italy; Genomics of Renal Diseases and Hypertension Unit, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lanzani</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Nephrology, Universit&#xe0; Vita Salute San Raffaele, Milan, Italy; Genomics of Renal Diseases and Hypertension Unit, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bignami</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Anaesthesia and Intensive Care Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy; Universit&#xe0; Vita Salute San Raffaele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casamassima</LastName><ForeName>Nunzia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Nephrology, Universit&#xe0; Vita Salute San Raffaele, Milan, Italy; Genomics of Renal Diseases and Hypertension Unit, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Citterio</LastName><ForeName>Lorena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Nephrology, Universit&#xe0; Vita Salute San Raffaele, Milan, Italy; Genomics of Renal Diseases and Hypertension Unit, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meroni</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Anaesthesia and Intensive Care Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy; Universit&#xe0; Vita Salute San Raffaele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zagato</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Nephrology, Universit&#xe0; Vita Salute San Raffaele, Milan, Italy; Genomics of Renal Diseases and Hypertension Unit, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zangrillo</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Anaesthesia and Intensive Care Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy; Universit&#xe0; Vita Salute San Raffaele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alfieri</LastName><ForeName>Ottavio</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Cardiac Surgery Unit, Universit&#xe0; Vita Salute San Raffaele, Milan, Italy; IRCCS San Raffaele Scientific Institute, Universit&#xe0; Vita Salute San Raffaele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fontana</LastName><ForeName>Simone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Nephrology, Universit&#xe0; Vita Salute San Raffaele, Milan, Italy; Genomics of Renal Diseases and Hypertension Unit, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Macrina</LastName><ForeName>Lorenza</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Nephrology, Universit&#xe0; Vita Salute San Raffaele, Milan, Italy; Genomics of Renal Diseases and Hypertension Unit, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delli Carpini</LastName><ForeName>Simona</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Nephrology, Universit&#xe0; Vita Salute San Raffaele, Milan, Italy; Genomics of Renal Diseases and Hypertension Unit, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messaggio</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Nephrology, Universit&#xe0; Vita Salute San Raffaele, Milan, Italy; Genomics of Renal Diseases and Hypertension Unit, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brioni</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Nephrology, Universit&#xe0; Vita Salute San Raffaele, Milan, Italy; Genomics of Renal Diseases and Hypertension Unit, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dell'Antonio</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>IRCCS San Raffaele Scientific Institute, Universit&#xe0; Vita Salute San Raffaele, Milan, Italy; Department of Pathology, Universit&#xe0; Vita Salute San Raffaele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manunta</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Nephrology, Universit&#xe0; Vita Salute San Raffaele, Milan, Italy; Genomics of Renal Diseases and Hypertension Unit, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamlyn</LastName><ForeName>John M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Physiology Department, School of Medicine, University of Maryland, Baltimore, MD.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simonini</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Nephrology, Universit&#xe0; Vita Salute San Raffaele, Milan, Italy; Genomics of Renal Diseases and Hypertension Unit, Milan, Italy. Electronic address: simonini.marco@hsr.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>01</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Kidney Dis</MedlineTA><NlmUniqueID>8110075</NlmUniqueID><ISSNLinking>0272-6386</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>5ACL011P69</RegistryNumber><NameOfSubstance UI="D010042">Ouabain</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 5.4.-</RegistryNumber><NameOfSubstance UI="D019751">Intramolecular Transferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 5.4.99.7</RegistryNumber><NameOfSubstance UI="C021924">lanosterol synthase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013504" MajorTopicYN="N">Cardiovascular Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014644" MajorTopicYN="N">Genetic Variation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019751" MajorTopicYN="N">Intramolecular Transferases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010042" MajorTopicYN="N">Ouabain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011863" MajorTopicYN="N">Radioimmunoassay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="N">Renal Insufficiency, Chronic</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Lanosterol synthase (LSS)</Keyword><Keyword MajorTopicYN="N">acute kidney injury (AKI)</Keyword><Keyword MajorTopicYN="N">biomarker</Keyword><Keyword MajorTopicYN="N">cardiovascular surgery</Keyword><Keyword MajorTopicYN="N">endogenous ouabain (EO)</Keyword><Keyword MajorTopicYN="N">estimated glomerular filtration rate (eGFR)</Keyword><Keyword MajorTopicYN="N">genetic mutation</Keyword><Keyword MajorTopicYN="N">hypertension</Keyword><Keyword MajorTopicYN="N">renal damage</Keyword><Keyword MajorTopicYN="N">risk factor</Keyword><Keyword MajorTopicYN="N">single-nucleotide polymorphism (SNP)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30660405</ArticleId><ArticleId IdType="doi">10.1053/j.ajkd.2018.10.012</ArticleId><ArticleId IdType="pii">S0272-6386(18)31103-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37921644</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-9159</ISSN><JournalIssue CitedMedium="Internet"><Volume>110</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of surgery (London, England)</Title><ISOAbbreviation>Int J Surg</ISOAbbreviation></Journal><ArticleTitle>Prognostic significance of preoperative nutritional status for postoperative acute kidney injury in older patients undergoing major abdominal surgery: a retrospective cohort study.</ArticleTitle><Pagination><StartPage>873</StartPage><EndPage>883</EndPage><MedlinePgn>873-883</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/JS9.0000000000000861</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The association between malnutrition and postoperative acute kidney injury (AKI) has not been well studied. In this study, the authors examined the association between preoperative nutritional status and postoperative AKI in older patients who underwent major abdominal surgery, as well as the predictive value of malnutrition for AKI.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">The authors retrospectively included patients aged 65 or older who underwent major elective abdominal surgery. The nutritional status of the patient was evaluated using three objective nutritional indices, such as the geriatric nutritional risk index (GNRI), the prognostic nutritional index (PNI), and the controlling nutritional status (CONUT). AKI was determined using the KDIGO criteria. The authors performed logistic regression analysis to investigate the association between preoperative nutritional status and postoperative AKI, as well as the predictive value of nutritional scores for postoperative AKI.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 2775 patients were included in the study, of which 707 (25.5%), 291 (10.5%), and 517 (18.6%) had moderate to severe malnutrition according to GNRI, PNI, and CONUT calculations. After surgery, 144 (5.2%) patients developed AKI, 86.1% at stage 1, 11.1% at stage 2, and 2.8% at stage 3 as determined by KDIGO criteria. After adjustment for traditional risk factors, worse nutritional scores were associated with a higher AKI risk. In addition to traditional risk factors, these nutritional indices improved the predictive ability of AKI prediction models, as demonstrated by significant improvements in integrated discrimination and net reclassification.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Poor preoperative nutritional status, as assessed by GNRI, PNI, and CONUT scores, was associated with an increased risk of postoperative AKI. Incorporating these scores into AKI prediction models improved their performance. These findings emphasize the need for screening surgical patients for malnutrition risk. Further research is needed to determine whether preoperative malnutrition assessment and intervention can reduce postoperative AKI incidence.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Rao</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Zhiqiang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xinhua</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Qiaoqiao</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Biyun</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Honghui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wanjun</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Xiaoxiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shiyong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Ailin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04967872</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Surg</MedlineTA><NlmUniqueID>101228232</NlmUniqueID><ISSNLinking>1743-9159</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009752" MajorTopicYN="N">Nutritional Status</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044342" MajorTopicYN="Y">Malnutrition</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no conflicts of interest. Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>3</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>3</Day><Hour>10</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37921644</ArticleId><ArticleId IdType="pmc">PMC10871641</ArticleId><ArticleId IdType="doi">10.1097/JS9.0000000000000861</ArticleId><ArticleId IdType="pii">01279778-202402000-00027</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gameiro J, Fonseca JA, Neves M, et al. . Acute kidney injury in major abdominal surgery: incidence, risk factors, pathogenesis and outcomes. Ann Intensive Care 2018;8:22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5807256</ArticleId><ArticleId IdType="pubmed">29427134</ArticleId></ArticleIdList></Reference><Reference><Citation>Privratsky JR, Krishnamoorthy V, Raghunathan K, et al. . Postoperative acute kidney injury is associated with progression of chronic kidney disease independent of severity. Anesth Analg 2022;134:49&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">34908546</ArticleId></ArticleIdList></Reference><Reference><Citation>Gameiro J, Duarte I, Marques F, et al. . Transient and persistent AKI and outcomes in patients undergoing major abdominal surgery. Nephron 2020;144:236&#x2013;244.</Citation><ArticleIdList><ArticleId IdType="pubmed">32316024</ArticleId></ArticleIdList></Reference><Reference><Citation>French WB, Shah PR, Fatani YI, et al. . Mortality and costs associated with acute kidney injury following major elective, non-cardiac surgery. J Clin Anesth 2022;82:110933.</Citation><ArticleIdList><ArticleId IdType="pubmed">35933842</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok V, Nixon J, Hu J, et al. . The impact of perioperative acute kidney injury/failure on short and long surgical outcomes. Anesthesiol Periop Sci 2023;1:9.</Citation></Reference><Reference><Citation>Lameire NH, Levin A, Kellum JA, et al. . Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference. Kidney Int 2021;100:516&#x2013;526.</Citation><ArticleIdList><ArticleId IdType="pubmed">34252450</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste EA, Bagshaw SM, Bellomo R, et al. . Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 2015;41:1411&#x2013;1423.</Citation><ArticleIdList><ArticleId IdType="pubmed">26162677</ArticleId></ArticleIdList></Reference><Reference><Citation>Leij-Halfwerk S, Verwijs MH, van Houdt S, et al. . Prevalence of protein-energy malnutrition risk in European older adults in community, residential and hospital settings, according to 22 malnutrition screening tools validated for use in adults &gt;/=65 years: a systematic review and meta-analysis. Maturitas 2019;126:80&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">31239123</ArticleId></ArticleIdList></Reference><Reference><Citation>Dent E, Hoogendijk EO, Visvanathan R, et al. . Malnutrition screening and assessment in hospitalised older people: a review. J Nutr Health Aging 2019;23:431&#x2013;441.</Citation><ArticleIdList><ArticleId IdType="pubmed">31021360</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, He ST, Zhang Y, et al. . Comparison of two malnutrition assessment scales in predicting postoperative complications in elderly patients undergoing noncardiac surgery. Front Public Health 2021;9:694368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8255481</ArticleId><ArticleId IdType="pubmed">34235132</ArticleId></ArticleIdList></Reference><Reference><Citation>Scislo L, Bodys-Cupak I, Walewska E, et al. . Nutritional status indicators as predictors of postoperative complications in the elderly with gastrointestinal cancer. Int J Environ Res Public Health 2022;19:13453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9603671</ArticleId><ArticleId IdType="pubmed">36294035</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E, Lee DH, Jang JY. Effects of preoperative malnutrition on postoperative surgical outcomes and quality of life of elderly patients with periampullary neoplasms: a single-center prospective cohort study. Gut Liver 2019;13:690&#x2013;697.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6860041</ArticleId><ArticleId IdType="pubmed">30970428</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng L, Chen W, Ping P, et al. . Preoperative malnutrition as an independent risk factor for the postoperative mortality in elderly Chinese individuals undergoing hip surgery: a single-center observational study. Ther Adv Chronic Dis 2022;13:20406223221102739.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9243382</ArticleId><ArticleId IdType="pubmed">35782344</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouillanne O, Morineau G, Dupont C, et al. . Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients. Am J Clin Nutr 2005;82:777&#x2013;783.</Citation><ArticleIdList><ArticleId IdType="pubmed">16210706</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzby GP, Mullen JL, Matthews DC, et al. . Prognostic nutritional index in gastrointestinal surgery. Am J Surg 1980;139:160&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pubmed">7350839</ArticleId></ArticleIdList></Reference><Reference><Citation>Ignacio de Ulibarri J, Gonzalez-Madrono A, de Villar NG, et al. . CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp 2005;20:38&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">15762418</ArticleId></ArticleIdList></Reference><Reference><Citation>Sze S, Pellicori P, Kazmi S, et al. . Prevalence and prognostic significance of malnutrition using 3 scoring systems among outpatients with heart failure: a comparison with body mass index. JACC Heart Fail 2018;6:476&#x2013;486.</Citation><ArticleIdList><ArticleId IdType="pubmed">29753673</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang G, Pan Y, Zhang R, et al. . Prevalence and prognostic significance of malnutrition risk in patients with acute ischemic stroke: results from the Third China National Stroke Registry. Stroke 2022;53:111&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pubmed">34645284</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Yang X, Zhu Y, et al. . Malnutrition defined by Geriatric Nutritional Risk Index predicts outcomes in severe stroke patients: a propensity score-matched analysis. Nutrients 2022;14:4786.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9696179</ArticleId><ArticleId IdType="pubmed">36432473</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu HT, Wu SC, Tsai CH, et al. . Association between Geriatric Nutritional Risk Index and mortality in older trauma patients in the intensive care unit. Nutrients 2020;12:3861.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7766904</ArticleId><ArticleId IdType="pubmed">33348716</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao Y, Lai QC, Duan Q, et al. . Nutritional indices at admission are associated with mortality rates of patients in the intensive care unit. Eur J Clin Nutr 2022;76:557&#x2013;563.</Citation><ArticleIdList><ArticleId IdType="pubmed">34404932</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolapoglu A, Avci E, Kiris T, et al. . The predictive value of the prognostic nutritional index for postoperative acute kidney injury in patients undergoing on-pump coronary bypass surgery. J Cardiothorac Surg 2019;14:74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6458745</ArticleId><ArticleId IdType="pubmed">30971264</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim JH, Bang JY, Kim SH, et al. . Association of preoperative Prognostic Nutritional Index and postoperative acute kidney injury in patients with colorectal cancer surgery. Nutrients 2021;13:1604.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8170895</ArticleId><ArticleId IdType="pubmed">34064893</ArticleId></ArticleIdList></Reference><Reference><Citation>Aykut A, Salman N. Poor nutritional status and frailty associated with acute kidney injury after cardiac surgery: a retrospective observational study. J Card Surg 2022;37:4755&#x2013;4761.</Citation><ArticleIdList><ArticleId IdType="pubmed">36352787</ArticleId></ArticleIdList></Reference><Reference><Citation>Min JY, Woo A, Chae MS, et al. . Predictive impact of Modified-Prognostic Nutritional Index for acute kidney injury within 1-week after living donor liver transplantation. Int J Med Sci 2020;17:82&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6945553</ArticleId><ArticleId IdType="pubmed">31929741</ArticleId></ArticleIdList></Reference><Reference><Citation>Gucu A, Ozluk OA, Guvenc O, et al. . The importance of Prognostic Nutritional Index in predicting acute renal failure after on-pump coronary artery bypass operations in patients with insulin-dependent diabetes mellitus. Heart Surg Forum 2021;24:E651&#x2013;e655.</Citation><ArticleIdList><ArticleId IdType="pubmed">34473038</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim JH, Jun IG, Moon YJ, et al. . Association of preoperative Prognostic Nutritional Index and postoperative acute kidney injury in patients who underwent hepatectomy for hepatocellular carcinoma. J Pers Med 2021;11:428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8157861</ArticleId><ArticleId IdType="pubmed">34069960</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew G, Agha R, Albrecht J, et al. . STROCSS 2021: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery. Int J Surg 2021;96:106165.</Citation><ArticleIdList><ArticleId IdType="pubmed">34774726</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizota T, Yamamoto Y, Hamada M, et al. . Intraoperative oliguria predicts acute kidney injury after major abdominal surgery. Br J Anaesth 2017;119:1127&#x2013;1134.</Citation><ArticleIdList><ArticleId IdType="pubmed">29136086</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Garot M, Godet T, et al. . Effect of hydroxyethyl starch vs saline for volume replacement therapy on death or postoperative complications among high-risk patients undergoing major abdominal surgery: the FLASH randomized clinical trial. JAMA 2020;323:225&#x2013;236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6990683</ArticleId><ArticleId IdType="pubmed">31961418</ArticleId></ArticleIdList></Reference><Reference><Citation>Shay D, Ng PY, Dudzinski DM, et al. . Preoperative heart failure treatment prevents postoperative cardiac complications in patients with lower risk: a retrospective cohort study. Ann Surg 2023;277:e33&#x2013;e39.</Citation><ArticleIdList><ArticleId IdType="pubmed">33534230</ArticleId></ArticleIdList></Reference><Reference><Citation>Pincus D, Ravi B, Wasserstein D, et al. . Association between wait time and 30-day mortality in adults undergoing hip fracture surgery. JAMA 2017;318:1994&#x2013;2003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5820694</ArticleId><ArticleId IdType="pubmed">29183076</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley RD, Ensor J, Snell KIE, et al. . Calculating the sample size required for developing a clinical prediction model. BMJ 2020;368:m441.</Citation><ArticleIdList><ArticleId IdType="pubmed">32188600</ArticleId></ArticleIdList></Reference><Reference><Citation>Seron-Arbeloa C, Labarta-Monzon L, Puzo-Foncillas J, et al. . Malnutrition screening and assessment. Nutrients 2022;14:2392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9228435</ArticleId><ArticleId IdType="pubmed">35745121</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubenstein LZ, Harker JO, Salva A, et al. . Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNA-SF). J Gerontol A Biol Sci Med Sci 2001;56:M366&#x2013;M372.</Citation><ArticleIdList><ArticleId IdType="pubmed">11382797</ArticleId></ArticleIdList></Reference><Reference><Citation>Stratton RJ, Hackston A, Longmore D, et al. . Malnutrition in hospital outpatients and inpatients: prevalence, concurrent validity and ease of use of the &#x2018;malnutrition universal screening tool&#x2019; (&#x2018;MUST&#x2019;) for adults. Br J Nutr 2004;92:799&#x2013;808.</Citation><ArticleIdList><ArticleId IdType="pubmed">15533269</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondrup J, Rasmussen HH, Hamberg O, et al. . Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr 2003;22:321&#x2013;336.</Citation><ArticleIdList><ArticleId IdType="pubmed">12765673</ArticleId></ArticleIdList></Reference><Reference><Citation>Cederholm T, Barazzoni R, Austin P, et al. . ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr 2017;36:49&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">27642056</ArticleId></ArticleIdList></Reference><Reference><Citation>Poulia KA, Klek S, Doundoulakis I, et al. . The two most popular malnutrition screening tools in the light of the new ESPEN consensus definition of the diagnostic criteria for malnutrition. Clin Nutr 2017;36:1130&#x2013;1135.</Citation><ArticleIdList><ArticleId IdType="pubmed">27546796</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank M, Sivagnanaratnam A, Bernstein J. Nutritional assessment in elderly care: a MUST!. BMJ Qual Improv Rep 2015;4:u204810.w2031.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4645872</ArticleId><ArticleId IdType="pubmed">26734346</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogawa M, Izawa KP, Satomi-Kobayashi S, et al. . Poor preoperative nutritional status is an important predictor of the retardation of rehabilitation after cardiac surgery in elderly cardiac patients. Aging Clin Exp Res 2017;29:283&#x2013;290.</Citation><ArticleIdList><ArticleId IdType="pubmed">26980452</ArticleId></ArticleIdList></Reference><Reference><Citation>Yagi T, Oshita Y, Okano I, et al. . Controlling nutritional status score predicts postoperative complications after hip fracture surgery. BMC Geriatr 2020;20:243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7359256</ArticleId><ArticleId IdType="pubmed">32660506</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Xia X, Xie D, et al. . Geriatric Nutritional Risk Index can predict postoperative delirium and hospital length of stay in elderly patients undergoing non-cardiac surgery. Geriatr Gerontol Int 2020;20:759&#x2013;764.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7496996</ArticleId><ArticleId IdType="pubmed">32570290</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo YJ, Kong YG, Yu J, et al. . The prognostic nutritional index on postoperative day one is associated with one-year mortality after burn surgery in elderly patients. Burns Trauma 2021;9:tkaa043.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7935376</ArticleId><ArticleId IdType="pubmed">33709002</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng X, Chen W, Yan J, et al. . Association of preoperative nutritional status evaluated by the controlling nutritional status (CONUT) score with walking independence at 180 days postoperatively: a prospective cohort study in Chinese older patients with hip fracture. Int J Surg 2023;109:2660&#x2013;2671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10498878</ArticleId><ArticleId IdType="pubmed">37226868</ArticleId></ArticleIdList></Reference><Reference><Citation>Singbartl K, Formeck CL, Kellum JA. Kidney-immune system crosstalk in AKI. Semin Nephrol 2019;39:96&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">30606411</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckart A, Struja T, Kutz A, et al. . Relationship of nutritional status, inflammation, and serum albumin levels during acute illness: a prospective study. Am J Med 2020;133:713&#x2013;722 e717.</Citation><ArticleIdList><ArticleId IdType="pubmed">31751531</ArticleId></ArticleIdList></Reference><Reference><Citation>Benabe JE, Martinez-Maldonado M. The impact of malnutrition on kidney function. Miner Electrolyte Metab 1998;24:20&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">9397413</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang J, Zhang L, Huang Z, et al. . Implications of malnutrition on contrast-associated acute kidney injury in young and old patients undergoing percutaneous coronary intervention: a multicenter prospective cohort. Front Nutr 2021;8:795068.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8861456</ArticleId><ArticleId IdType="pubmed">35211494</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JL, Oh ES, Lee RW, et al. . Serum albumin and prealbumin in calorically restricted, nondiseased individuals: a systematic review. Am J Med 2015;128:1023 e1021&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pubmed">25912205</ArticleId></ArticleIdList></Reference><Reference><Citation>Cross MB, Yi PH, Thomas CF, et al. . Evaluation of malnutrition in orthopaedic surgery. J Am Acad Orthop Surg 2014;22:193&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pubmed">24603829</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Pereira SL, Luo M, et al. . Evaluation of blood biomarkers associated with risk of malnutrition in older adults: a systematic review and meta-analysis. Nutrients 2017;9:829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5579622</ArticleId><ArticleId IdType="pubmed">28771192</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen GL, Mirtallo J, Compher C, et al. . Adult starvation and disease-related malnutrition: a proposal for etiology-based diagnosis in the clinical practice setting from the International Consensus Guideline Committee. Clin Nutr 2010;29:151&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pubmed">20071059</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen GL. Inflammation as the key interface of the medical and nutrition universes: a provocative examination of the future of clinical nutrition and medicine. JPEN J Parenter Enteral Nutr 2006;30:453&#x2013;463.</Citation><ArticleIdList><ArticleId IdType="pubmed">16931617</ArticleId></ArticleIdList></Reference><Reference><Citation>Limaye K, Yang JD, Hinduja A. Role of admission serum albumin levels in patients with intracerebral hemorrhage. Acta Neurol Belg 2016;116:27&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">26133948</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EH, Baek SH, Chin JH, et al. . Preoperative hypoalbuminemia is a major risk factor for acute kidney injury following off-pump coronary artery bypass surgery. Intensive Care Med 2012;38:1478&#x2013;1486.</Citation><ArticleIdList><ArticleId IdType="pubmed">22618092</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N, Qiao H, Guo JF, et al. . Preoperative hypoalbuminemia was associated with acute kidney injury in high-risk patients following non-cardiac surgery: a retrospective cohort study. BMC Anesthesiol 2019;19:171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6719349</ArticleId><ArticleId IdType="pubmed">31477030</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K, Bang JY, Kim SO, et al. . Association of preoperative hypoalbuminemia with postoperative acute kidney injury in patients undergoing brain tumor surgery: a retrospective study. J Neurosurg 2018;128:1115&#x2013;1122.</Citation><ArticleIdList><ArticleId IdType="pubmed">28474996</ArticleId></ArticleIdList></Reference><Reference><Citation>Weller S, Varrier M, Ostermann M. Lymphocyte function in human acute kidney injury. Nephron 2017;137:287&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pubmed">28662513</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellepiane S, Leventhal JS, Cravedi PT. Cells and acute kidney injury: a two-way relationship. Front Immunol 2020;11:1546.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7379378</ArticleId><ArticleId IdType="pubmed">32765535</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghdaii N, Ferasatkish R, Mohammadzadeh Jouryabi A, et al. . Significance of preoperative total lymphocyte count as a prognostic criterion in adult cardiac surgery. Anesth Pain Med 2014;4:e20331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4183084</ArticleId><ArticleId IdType="pubmed">25289377</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Ye Y, Mi Q, et al. . A Predictive model for assessing surgery-related acute kidney injury risk in hypertensive patients: a retrospective cohort study. PLoS One 2016;11:e0165280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5089779</ArticleId><ArticleId IdType="pubmed">27802302</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith LE, Smith DK, Blume JD, et al. . High-density lipoprotein cholesterol concentration and acute kidney injury after cardiac surgery. J Am Heart Assoc 2017;6:e006975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5779016</ArticleId><ArticleId IdType="pubmed">29223955</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Yang HY, Zhang HL, et al. . High-density lipoprotein cholesterol concentration and acute kidney injury after noncardiac surgery. BMC Nephrol 2020;21:149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7183648</ArticleId><ArticleId IdType="pubmed">32334566</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Forni LG, Bell M, et al. . Postoperative acute kidney injury in adult non-cardiac surgery: joint consensus report of the Acute Disease Quality Initiative and PeriOperative Quality Initiative. Nat Rev Nephrol 2021;17:605&#x2013;618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8367817</ArticleId><ArticleId IdType="pubmed">33976395</ArticleId></ArticleIdList></Reference><Reference><Citation>Weimann A, Braga M, Carli F, et al. . ESPEN practical guideline: clinical nutrition in surgery. Clin Nutr 2021;40:4745&#x2013;4761.</Citation><ArticleIdList><ArticleId IdType="pubmed">34242915</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Ortega AJ, Pinar-Gutierrez A, Serrano-Aguayo P, et al. . Perioperative nutritional support: a review of current literature. Nutrients 2022;14:1601.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9030898</ArticleId><ArticleId IdType="pubmed">35458163</ArticleId></ArticleIdList></Reference><Reference><Citation>Sittitrai P, Ruenmarkkaew D, Booyaprapa S, et al. . Effect of a perioperative immune-enhancing diet in clean-contaminated head and neck cancer surgery: a randomized controlled trial. Int J Surg 2021;93:106051.</Citation><ArticleIdList><ArticleId IdType="pubmed">34371175</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao X, Zhang L, Zhang Y, et al. . Effect of early achievement of energy target by different nutritional support strategies on nosocomial infections in patients undergoing major abdominal surgery: a secondary analysis of 2 randomized clinical trials. Int J Surg 2023;109:2680&#x2013;2688.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10498879</ArticleId><ArticleId IdType="pubmed">37300882</ArticleId></ArticleIdList></Reference><Reference><Citation>Gingrich A, Volkert D, Kiesswetter E, et al. . Prevalence and overlap of sarcopenia, frailty, cachexia and malnutrition in older medical inpatients. BMC Geriatr 2019;19:120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6487020</ArticleId><ArticleId IdType="pubmed">31029082</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou C, Ye Z, Yang S, et al. . Associations between serum 25-hydroxyvitamin D, sun exposure time, dietary vitamin D intake, and new-onset acute kidney injury among 413,169 UK adults. J Nutr 2023;153:713&#x2013;722.</Citation><ArticleIdList><ArticleId IdType="pubmed">36931750</ArticleId></ArticleIdList></Reference><Reference><Citation>Bang JY, Jun IG, Lee JB, et al. . Impact of sarcopenia on acute kidney injury after infrarenal abdominal aortic aneurysm surgery: a propensity matching analysis. Nutrients 2021;13:2212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8308481</ArticleId><ArticleId IdType="pubmed">34199110</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiesisibieke ZL, Tung TH, Xu QY, et al. . Association of acute kidney injury with frailty in elderly population: a systematic review and meta-analysis. Ren Fail 2019;41:1021&#x2013;1027.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6913666</ArticleId><ArticleId IdType="pubmed">31809623</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30348111</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>12</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2369</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Oct</Month><Day>22</Day></PubDate></JournalIssue><Title>BMC nephrology</Title><ISOAbbreviation>BMC Nephrol</ISOAbbreviation></Journal><ArticleTitle>The role of intraoperative parameters on predicting laparoscopic abdominal surgery associated acute kidney injury.</ArticleTitle><Pagination><StartPage>289</StartPage><MedlinePgn>289</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">289</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12882-018-1081-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">Laparoscopic abdominal surgery has been widely used to reduce the length of hospital stay and complications from open abdominal surgery. During the operation, the creation of pneumoperitoneum is used for better visualization of the operating field. However, the effect of pneumoperitoneum on kidney function is unknown. We aimed to identify risk factors and predictors associated with AKI development following laparoscopic abdominal surgery.</AbstractText><AbstractText Label="METHODS">A single-center prospective cohort study of laparoscopic abdominal surgery patients between June 2012 and December 2013. Acute kidney injury (AKI) was identified by Kidney Disease Improving Global Outcome (KDIGO) criteria. Urinary neutrophil gelatinase associated lipocalin (uNGAL) was measured on the first 3&#xa0;days after surgery as a surrogate marker of AKI.</AbstractText><AbstractText Label="RESULTS">Of the 64 patients, 23 (35%) developed postoperative AKI. The mean age, initial blood pressure, and initial glomerular filtration rate were not different between AKI and non-AKI groups. Inflation time and exposure index were significantly higher in the AKI group compared to non-AKI group (192.0 vs 151.1&#xa0;min, p&#x2009;=&#x2009;0.045, and 2325.9 vs 1866.1&#xa0;mmHg-minutes, p&#x2009;=&#x2009;0.035). Operation time, mean intra-abdominal pressure, duration of intraoperative hypotension, amount of blood loss and intravenous fluid were not different between groups. In multivariable analysis adjusted for age, diabetes, baseline estimated glomerular filtration rate, and type of operation (urological surgery), exposure index was significantly associated with postoperative AKI, with odds ratio (95% CI) 1.47 (1.05-2.04), p&#x2009;=&#x2009;0.024. By combining the intraoperative parameters with clinical model the area under the receiver operating characteristic curve was 0.71 (95% CI 0.58-0.84).</AbstractText><AbstractText Label="CONCLUSIONS">AKI was a common condition in laparoscopic abdominal surgery. Exposure index has been proposed as a novel predictor of laparoscopic abdominal surgery associated AKI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Srisawat</LastName><ForeName>Nattachai</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Rama IV Road, Pathumwan, Bangkok, 10330, Thailand. drnattachai@yahoo.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital, the Thai Red Cross Society, Bangkok, Thailand. drnattachai@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kongwibulwut</LastName><ForeName>Manasnun</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laoveeravat</LastName><ForeName>Passisd</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Rama IV Road, Pathumwan, Bangkok, 10330, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital, the Thai Red Cross Society, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lumplertgul</LastName><ForeName>Nuttha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Rama IV Road, Pathumwan, Bangkok, 10330, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital, the Thai Red Cross Society, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chatkaew</LastName><ForeName>Pornlert</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saeyub</LastName><ForeName>Pipat</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Latthaprecha</LastName><ForeName>Krittayot</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peerapornratana</LastName><ForeName>Sadudee</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Rama IV Road, Pathumwan, Bangkok, 10330, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital, the Thai Red Cross Society, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tiranathanagul</LastName><ForeName>Khajohn</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Rama IV Road, Pathumwan, Bangkok, 10330, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital, the Thai Red Cross Society, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eiam-Ong</LastName><ForeName>Somchai</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Rama IV Road, Pathumwan, Bangkok, 10330, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tungsanga</LastName><ForeName>Kriang</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Rama IV Road, Pathumwan, Bangkok, 10330, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>10</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Nephrol</MedlineTA><NlmUniqueID>100967793</NlmUniqueID><ISSNLinking>1471-2369</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="N">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="N">Laparoscopy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="N">Monitoring, Intraoperative</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Exposure index</Keyword><Keyword MajorTopicYN="N">Intra-abdominal hypertension</Keyword><Keyword MajorTopicYN="N">Laparoscopic abdominal surgery</Keyword><Keyword MajorTopicYN="N">NGAL</Keyword></KeywordList><CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: The study was approved by The Institutional Review Board (IRB No. 393/55), Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. All participants accepted the protocol, and provided written informed consent. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER&#x2019;S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>10</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30348111</ArticleId><ArticleId IdType="pmc">PMC6198484</ArticleId><ArticleId IdType="doi">10.1186/s12882-018-1081-4</ArticleId><ArticleId IdType="pii">10.1186/s12882-018-1081-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sanabria JR, Clavien PA, Cywes R, Strasberg SM. Laparoscopic versus open cholecystectomy: a matched study. Can J Surg. 1993;36:330&#x2013;336.</Citation><ArticleIdList><ArticleId IdType="pubmed">8103704</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy KJ, Miller H, Fletcher DR, Jones RM, Shulkes A, McNeil JJ. An evaluation of laparoscopic versus open cholecystectomy. Med J Aust. 1994;160:58&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">8309369</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastava A, Niranjan A. Secrets of safe laparoscopic surgery: Anaesthetic and surgical considerations. J Minim Access Surg. 2010;6:91&#x2013;94. doi: 10.4103/0972-9941.72593.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0972-9941.72593</ArticleId><ArticleId IdType="pmc">PMC2992667</ArticleId><ArticleId IdType="pubmed">21120064</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu AW, Chang LS, Birkett DH, Babayan RK. The impact of pneumoperitoneum, pneumoretroperitoneum, and gasless laparoscopy on the systemic and renal hemodynamics. J Am Coll Surg. 1995;181:397&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pubmed">7582206</ArticleId></ArticleIdList></Reference><Reference><Citation>London ET, Ho HS, Neuhaus AM, Wolfe BM, Rudich SM, Perez RV. Effect of intravascular volume expansion on renal function during prolonged CO2 pneumoperitoneum. Ann Surg. 2000;231:195&#x2013;201. doi: 10.1097/00000658-200002000-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-200002000-00007</ArticleId><ArticleId IdType="pmc">PMC1420986</ArticleId><ArticleId IdType="pubmed">10674610</ArticleId></ArticleIdList></Reference><Reference><Citation>Yavuz Y, Ronning K, Lyng O, Marvik R, Gronbech JE. Effect of increased intraabdominal pressure on cardiac output and tissue blood flow assessed by color-labeled microspheres in the pig. Surg Endosc. 2001;15:149&#x2013;155. doi: 10.1007/s004640000336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004640000336</ArticleId><ArticleId IdType="pubmed">11285958</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali NA, Eubanks WS, Stamler JS, Gow AJ, Lagoo-Deenadayalan SA, Villegas L, El-Moalem HE, Reynolds JD. A method to attenuate pneumoperitoneum-induced reductions in splanchnic blood flow. Ann Surg. 2005;241:256&#x2013;261. doi: 10.1097/01.sla.0000153034.54128.5e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.sla.0000153034.54128.5e</ArticleId><ArticleId IdType="pmc">PMC1356910</ArticleId><ArticleId IdType="pubmed">15650635</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirsch AJ, Hensle TW, Chang DT, Kayton ML, Olsson CA, Sawczuk IS. Renal effects of CO2 insufflation: oliguria and acute renal dysfunction in a rat pneumoperitoneum model. Urology. 1994;43:453&#x2013;459. doi: 10.1016/0090-4295(94)90230-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0090-4295(94)90230-5</ArticleId><ArticleId IdType="pubmed">8154067</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma SK, McCauley J, Cottam D, Mattar SG, Holover S, Dallal R, Lord J, Danner O, Ramanathan R, Eid G, Schauer P. Acute changes in renal function after laparoscopic gastric surgery for morbid obesity. Surg Obes Relat Dis. 2006;2:389&#x2013;392. doi: 10.1016/j.soard.2006.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.soard.2006.02.002</ArticleId><ArticleId IdType="pubmed">16925359</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Disease Improving global outcomes (KDIGO) acute kidney injury work group: KDIGO clinical practice guideline for acute kidney injury. Kidney Int. 2012;2:1&#x2013;138. doi: 10.1038/kisup.2012.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/kisup.2012.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute Dialysis quality initiative workgroup: acute renal failure &#x2013; definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute Dialysis quality initiative (ADQI) group. Crit Care. 2004;8:R204&#x2013;R212. doi: 10.1186/cc2872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc2872</ArticleId><ArticleId IdType="pmc">PMC522841</ArticleId><ArticleId IdType="pubmed">15312219</ArticleId></ArticleIdList></Reference><Reference><Citation>Srisawat N, Sileanu FE, Murugan R, Bellomod R, Calzavacca P, Cartin-Ceba R, Cruz D, Finn J, Hoste EE, Kashani K, Ronco C, Webb S, Kellum JA. Acute Kidney.Injury-6 Study Group: Variation in risk and mortality of acute kidney injury in critically ill patients: a multicenter study. Am J Nephrol. 2015;41(1):81&#x2013;88. doi: 10.1159/000371748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000371748</ArticleId><ArticleId IdType="pubmed">25677982</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdullah HR, Tan TP, Vaez M, Deb C, Farag N, Jackson TD, Wong DT. Predictors of perioperative acute kidney injury in obese patients undergoing laparoscopic bariatric surgery: a single-Centre retrospective cohort study. Obes Surg. 2016;26:1493&#x2013;1499. doi: 10.1007/s11695-015-1938-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11695-015-1938-6</ArticleId><ArticleId IdType="pubmed">26482165</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuto K, Kitano S, Yoshida T, Mitarai Y, Kobayashi M. Hemodynamic and arterial blood gas changes during carbon dioxide and helium pneumoperitoneum in pigs. Surg Endosc. 1995;9:1173&#x2013;1178. doi: 10.1007/BF00210922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00210922</ArticleId><ArticleId IdType="pubmed">8553228</ArticleId></ArticleIdList></Reference><Reference><Citation>Seigneux SD, Klopfenstein CE, Iselin C, Martin PY. The risk of acute kidney injury following laparoscopic surgery in a chronic kidney disease patient. NDT Plus. 2011;4:339&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4421741</ArticleId><ArticleId IdType="pubmed">25984183</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen NT, Cronan M, Braley S, Rivers R, Wolfe BM. Duplex ultrasound assessment of femoral venous flow during laparoscopic and open gastric bypass. Surg Endosc. 2003;17:285&#x2013;290. doi: 10.1007/s00464-002-8812-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-002-8812-z</ArticleId><ArticleId IdType="pubmed">12364988</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer E, Elger A, Elitok S, Kettritz R, Nickolas T, Barasch J, Luft CF, Kai MS. Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predicts outcomes. Kidney Int. 2011;80:405&#x2013;414. doi: 10.1038/ki.2011.41.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2011.41</ArticleId><ArticleId IdType="pmc">PMC3870593</ArticleId><ArticleId IdType="pubmed">21412214</ArticleId></ArticleIdList></Reference><Reference><Citation>Murugan R, Kellum JA. Acute kidney injury: what's the prognosis? Nat Rev Nephrol. 2011;7:209&#x2013;217. doi: 10.1038/nrneph.2011.13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2011.13</ArticleId><ArticleId IdType="pmc">PMC3547642</ArticleId><ArticleId IdType="pubmed">21343898</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi JS, Kim YA, Kim MJ, Kang YU, Kim CS, Bae EH, Ma SK, Ahn YK, Jeong MH, Kim SW. Relation between transient or persistent acute kidney injury and long-term mortality in patients with myocardial infarction. Am J Cardiol. 2013;112:41&#x2013;45. doi: 10.1016/j.amjcard.2013.02.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2013.02.051</ArticleId><ArticleId IdType="pubmed">23558040</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber M, Ozrazgat-Baslanti T, Thottakkara P, Scali S, Bihorac A, Hobson C. Cardiovascular-specific mortality and kidney disease in patients undergoing vascular surgery. JAMA Surg. 2016;151:441&#x2013;450. doi: 10.1001/jamasurg.2015.4526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2015.4526</ArticleId><ArticleId IdType="pmc">PMC4871734</ArticleId><ArticleId IdType="pubmed">26720406</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28698269</PMID><DateCompleted><Year>2017</Year><Month>11</Month><Day>09</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1533-3450</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>11</Issue><PubDate><Year>2017</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of the American Society of Nephrology : JASN</Title><ISOAbbreviation>J Am Soc Nephrol</ISOAbbreviation></Journal><ArticleTitle>Urinary Matrix Metalloproteinase-7 Predicts Severe AKI and Poor Outcomes after Cardiac Surgery.</ArticleTitle><Pagination><StartPage>3373</StartPage><EndPage>3382</EndPage><MedlinePgn>3373-3382</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1681/ASN.2017020142</ELocationID><Abstract><AbstractText>Urinary matrix metalloproteinase-7 (uMMP-7) levels consistently reflect the activity of intrarenal Wnt/<i>&#x3b2;</i>-catenin, which is activated in AKI models. To test the hypothesis that uMMP-7 is a predictor for severe AKI in patients after cardiac surgery, we performed a prospective, multicenter, two-stage cohort study in 721 patients undergoing cardiac surgery. In stage 1, we enrolled 323 children from three academic medical centers. In stage 2, we enrolled 398 adults at six centers. We analyzed levels of uMMP-7 and other injury biomarkers during the perioperative period. Severe AKI was defined as Kidney Disease Improving Global Outcomes stage 2 or 3. uMMP-7 level peaked within 6 hours after surgery in patients who subsequently developed severe AKI. After multivariate adjustment, the highest quintile of postoperative uMMP-7 level, compared with the lowest quintile, associated with 17-fold (in adults) and 36-fold (in children) higher odds of severe AKI. Elevated uMMP-7 level associated with increased risk of composite events (severe AKI, acute dialysis, and in-hospital death) and longer stay in the intensive care unit and hospital. For predicting severe AKI, uMMP-7 had an area under the receiver operating characteristic curve of 0.81 (in children) and 0.76 (in adults), outperforming urinary IL-18, angiotensinogen, neutrophil gelatinase-associated lipocalin, albumin-to-creatinine ratio, and tissue inhibitor of metalloproteinase-2&#xb7;IGF-binding protein-7 and the clinical model. uMMP-7 significantly improved risk reclassification over the clinical model alone, as measured by net reclassification improvement and integrated discrimination improvement. In conclusion, uMMP-7 is a promising predictor for severe AKI and poor in-hospital outcomes in patients after cardiac surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 by the American Society of Nephrology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xiaobing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chunbo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangdong Cardiovascular Institute, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teng</LastName><ForeName>Siyuan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Xiaorui</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zha</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Guizhou Provincial People's Hospital, Guiyang Medical University, Guiyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Huafeng</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Institute of Nephrology, Guangdong Medical College, Zhanjiang, China; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Sichuan Provincial People's Hospital, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Jianwei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiangyan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Guizhou Provincial People's Hospital, Guiyang Medical University, Guiyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Youhua</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nie</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Fan Fan</ForeName><Initials>FF</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangzhou, China; ffhouguangzhou@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>07</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Soc Nephrol</MedlineTA><NlmUniqueID>9013836</NlmUniqueID><ISSNLinking>1046-6673</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.24.23</RegistryNumber><NameOfSubstance UI="D020783">Matrix Metalloproteinase 7</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000652" MajorTopicYN="Y">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020783" MajorTopicYN="N">Matrix Metalloproteinase 7</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="Y">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute Kidney Injury</Keyword><Keyword MajorTopicYN="N">Biomarker</Keyword><Keyword MajorTopicYN="N">Cardiac Surgery</Keyword><Keyword MajorTopicYN="N">Matrix Metalloproteinase-7</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28698269</ArticleId><ArticleId IdType="pmc">PMC5661292</ArticleId><ArticleId IdType="doi">10.1681/ASN.2017020142</ArticleId><ArticleId IdType="pii">ASN.2017020142</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rosner MH, Okusa MD: Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol 1: 19&#x2013;32, 2006</Citation><ArticleIdList><ArticleId IdType="pubmed">17699187</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J: Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 104: 343&#x2013;348, 1998</Citation><ArticleIdList><ArticleId IdType="pubmed">9576407</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanardo G, Michielon P, Paccagnella A, Rosi P, Cal&#xf3; M, Salandin V, Da Ros A, Michieletto F, Simini G: Acute renal failure in the patient undergoing cardiac operation. Prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg 107: 1489&#x2013;1495, 1994</Citation><ArticleIdList><ArticleId IdType="pubmed">8196394</ArticleId></ArticleIdList></Reference><Reference><Citation>Belayev LY, Palevsky PM: The link between acute kidney injury and chronic kidney disease. Curr Opin Nephrol Hypertens 23: 149&#x2013;154, 2014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4179244</ArticleId><ArticleId IdType="pubmed">24384553</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung KC, Tonelli M, James MT: Chronic kidney disease following acute kidney injury-risk and outcomes. Nat Rev Nephrol 9: 77&#x2013;85, 2013</Citation><ArticleIdList><ArticleId IdType="pubmed">23247572</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonventre JV, Basile D, Liu KD, McKay D, Molitoris BA, Nath KA, Nickolas TL, Okusa MD, Palevsky PM, Schnellmann R, Rys-Sikora K, Kimmel PL, Star RA; Kidney Research National Dialogue (KRND) : AKI: A path forward. Clin J Am Soc Nephrol 8: 1606&#x2013;1608, 2013</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3805072</ArticleId><ArticleId IdType="pubmed">23868899</ArticleId></ArticleIdList></Reference><Reference><Citation>Coca SG, Singanamala S, Parikh CR: Chronic kidney disease after acute kidney injury: A systematic review and meta-analysis. Kidney Int 81: 442&#x2013;448, 2012</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3788581</ArticleId><ArticleId IdType="pubmed">22113526</ArticleId></ArticleIdList></Reference><Reference><Citation>Chawla LS, Amdur RL, Amodeo S, Kimmel PL, Palant CE: The severity of acute kidney injury predicts progression to chronic kidney disease. Kidney Int 79: 1361&#x2013;1369, 2011</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3257034</ArticleId><ArticleId IdType="pubmed">21430640</ArticleId></ArticleIdList></Reference><Reference><Citation>Park M, Coca SG, Nigwekar SU, Garg AX, Garwood S, Parikh CR: Prevention and treatment of acute kidney injury in patients undergoing cardiac surgery: A systematic review. Am J Nephrol 31: 408&#x2013;418, 2010</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2883845</ArticleId><ArticleId IdType="pubmed">20375494</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365: 1231&#x2013;1238, 2005</Citation><ArticleIdList><ArticleId IdType="pubmed">15811456</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagener G, Jan M, Kim M, Mori K, Barasch JM, Sladen RN, Lee HT: Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 105: 485&#x2013;491, 2006</Citation><ArticleIdList><ArticleId IdType="pubmed">16931980</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinckerhoff CE, Matrisian LM: Matrix metalloproteinases: A tail of a frog that became a prince. Nat Rev Mol Cell Biol 3: 207&#x2013;214, 2002</Citation><ArticleIdList><ArticleId IdType="pubmed">11994741</ArticleId></ArticleIdList></Reference><Reference><Citation>He W, Tan RJ, Li Y, Wang D, Nie J, Hou FF, Liu Y: Matrix metalloproteinase-7 as a surrogate marker predicts renal Wnt/&#x3b2;-catenin activity in CKD. J Am Soc Nephrol 23: 294&#x2013;304, 2012</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3269179</ArticleId><ArticleId IdType="pubmed">22095947</ArticleId></ArticleIdList></Reference><Reference><Citation>Surendran K, Simon TC, Liapis H, McGuire JK: Matrilysin (MMP-7) expression in renal tubular damage: Association with Wnt4. Kidney Int 65: 2212&#x2013;2222, 2004</Citation><ArticleIdList><ArticleId IdType="pubmed">15149334</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D, Tan RJ, Fu H, Liu Y: Wnt/&#x3b2;-catenin signaling in kidney injury and repair: A double-edged sword. Lab Invest 96: 156&#x2013;167, 2016</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4731262</ArticleId><ArticleId IdType="pubmed">26692289</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D, Li Y, Lin L, Zhou L, Igarashi P, Liu Y: Tubule-specific ablation of endogenous &#x3b2;-catenin aggravates acute kidney injury in mice. Kidney Int 82: 537&#x2013;547, 2012</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3425732</ArticleId><ArticleId IdType="pubmed">22622501</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao L, Zhou D, Tan RJ, Fu H, Zhou L, Hou FF, Liu Y: Sustained activation of Wnt/&#x3b2;-catenin signaling drives AKI to CKD progression. J Am Soc Nephrol 27: 1727&#x2013;1740, 2016</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4884114</ArticleId><ArticleId IdType="pubmed">26453613</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh CR, Devarajan P, Zappitelli M, Sint K, Thiessen-Philbrook H, Li S, Kim RW, Koyner JL, Coca SG, Edelstein CL, Shlipak MG, Garg AX, Krawczeski CD; TRIBE-AKI Consortium : Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery. J Am Soc Nephrol 22: 1737&#x2013;1747, 2011</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3171944</ArticleId><ArticleId IdType="pubmed">21836147</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh CR, Coca SG, Thiessen-Philbrook H, Shlipak MG, Koyner JL, Wang Z, Edelstein CL, Devarajan P, Patel UD, Zappitelli M, Krawczeski CD, Passik CS, Swaminathan M, Garg AX; TRIBE-AKI Consortium : Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol 22: 1748&#x2013;1757, 2011</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3171945</ArticleId><ArticleId IdType="pubmed">21836143</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Chen C, Tian J, Zha Y, Xiong Y, Sun Z, Chen P, Li J, Yang T, Ma C, Liu H, Wang X, Hou FF: Urinary angiotensinogen level predicts AKI in acute decompensated heart failure: A prospective, two-stage study. J Am Soc Nephrol 26: 2032&#x2013;2041, 2015</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4520164</ArticleId><ArticleId IdType="pubmed">25722365</ArticleId></ArticleIdList></Reference><Reference><Citation>Alge JL, Karakala N, Neely BA, Janech MG, Tumlin JA, Chawla LS, Shaw AD, Arthur JM; SAKInet Investigators : Urinary angiotensinogen and risk of severe AKI. Clin J Am Soc Nephrol 8: 184&#x2013;193, 2013</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3562861</ArticleId><ArticleId IdType="pubmed">23143504</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Yang X, Lei Y, Zha Y, Liu H, Ma C, Tian J, Chen P, Yang T, Hou FF: Urinary biomarkers at the time of AKI diagnosis as predictors of progression of AKI among patients with acute cardiorenal syndrome. Clin J Am Soc Nephrol 11: 1536&#x2013;1544, 2016</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5012473</ArticleId><ArticleId IdType="pubmed">27538426</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnar AO, Parikh CR, Sint K, Coca SG, Koyner J, Patel UD, Butrymowicz I, Shlipak M, Garg AX: Association of postoperative proteinuria with AKI after cardiac surgery among patients at high risk. Clin J Am Soc Nephrol 7: 1749&#x2013;1760, 2012</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3488955</ArticleId><ArticleId IdType="pubmed">22977220</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayan A, Faubel S, Askenazi DJ, Cerda J, Fissell WH, Heung M, Humphreys BD, Koyner JL, Liu KD, Mour G, Nolin TD, Bihorac A; American Society of Nephrology Acute Kidney Injury Advisory Group : Clinical use of the urine biomarker [TIMP-2] x [IGFBP7] for acute kidney injury risk assessment. Am J Kidney Dis 68: 19&#x2013;28, 2016</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4921267</ArticleId><ArticleId IdType="pubmed">26948834</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D, Tian Y, Sun L, Zhou L, Xiao L, Tan RJ, Tian J, Fu H, Hou FF, Liu Y: Matrix metalloproteinase-7 is a urinary biomarker and pathogenic mediator of kidney fibrosis. J Am Soc Nephrol 28: 598&#x2013;611, 2017</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5280025</ArticleId><ArticleId IdType="pubmed">27624489</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Disease Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group : KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2: 1&#x2013;138, 2012</Citation></Reference><Reference><Citation>DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 44: 837&#x2013;845, 1988</Citation><ArticleIdList><ArticleId IdType="pubmed">3203132</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook NR: Statistical evaluation of prognostic versus diagnostic models: Beyond the ROC curve. Clin Chem 54: 17&#x2013;23, 2008</Citation><ArticleIdList><ArticleId IdType="pubmed">18024533</ArticleId></ArticleIdList></Reference><Reference><Citation>Pencina MJ, D&#x2019;Agostino Sr. RB, D&#x2019;Agostino Jr. RB, Vasan RS: Evaluating the added predictive ability of a newmarker: From area under the ROC curve to reclassification and beyond. Stat Med 27: 157&#x2013;172; discussion 207&#x2013;112, 2008</Citation><ArticleIdList><ArticleId IdType="pubmed">17569110</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz GJ, Mu&#xf1;oz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL: New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20: 629&#x2013;637, 2009</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2653687</ArticleId><ArticleId IdType="pubmed">19158356</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) : A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604&#x2013;612, 2009</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2763564</ArticleId><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37620639</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1720-8319</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Aging clinical and experimental research</Title><ISOAbbreviation>Aging Clin Exp Res</ISOAbbreviation></Journal><ArticleTitle>Association of preoperative frailty with pulmonary complications after cardiac surgery in elderly individuals: a prospective cohort study.</ArticleTitle><Pagination><StartPage>2453</StartPage><EndPage>2462</EndPage><MedlinePgn>2453-2462</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40520-023-02527-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The relationship between preoperative frailty and pulmonary complications after cardiac surgery in elderly patients is unclear. This study was designed to evaluate the relationship between frailty and postoperative pulmonary complications (PPCs) in elderly patients undergoing cardiac surgery and to provide a basis for their prevention and treatment.</AbstractText><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">This study aimed to investigate the predictive value of preoperative frailty on pulmonary complications after cardiac surgery in elderly patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Frailty was assessed using the CAF. The diagnosis of PPCs was based on the criteria defined by Hulzebos et al., and patients were classified into a PPCs group and a non-PPCs group. Factors with clinical significance and P&#x2009;&lt;&#x2009;0.05 in univariate regression analysis were included in multivariate logistic regression analysis to determine the relationship between preoperative frailty and PPCs. The area under the receiver operating characteristic (ROC) curve (AUC) was used to compare the predictive effects of the CAF, EuroSCORE II, and ASA&#x2009;+&#x2009;age on the occurrence of PPCs.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 205 patients were enrolled in this study, 31.7% of whom developed PPCs. Univariate logistic regression analysis showed that frailty, ASA grade, EuroSCORE II, hemoglobin concentration, FVC, time of operation, and postoperative AKI were associated with the development of PPCs. However, after adjustments for all possible confounding factors, multivariate logistic regression results showed that frailty, prolonged operation time, and postoperative AKI were risk factors for PPCs, and the risk of postoperative PPCs in frail patients was approximately 4.37 times that in nonfrail patients (OR&#x2009;=&#x2009;4.37, 95%CI: 1.6-11.94, P&#x2009;&lt;&#x2009;0.05). The predictive efficacy of the traditional perioperative risk assessment tools EuroSCORE II and ASA&#x2009;+&#x2009;age was lower than that of CAF.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Frailty before surgery, prolonged operation time, and postoperative AKI were independent risk factors for pulmonary complications after heart surgery in elderly individuals, and CAF was more effective than the traditional risk predictors EuroSCORE II and ASA&#x2009;+&#x2009;age.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Guanglei</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Affiliated Hospital of Xuzhou Medical University, NO.99 Huaihai West Road, Xuzhou, 221006, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Shuyang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Affiliated Hospital of Xuzhou Medical University, NO.99 Huaihai West Road, Xuzhou, 221006, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Mingzhu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Affiliated Hospital of Xuzhou Medical University, NO.99 Huaihai West Road, Xuzhou, 221006, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Affiliated Hospital of Xuzhou Medical University, NO.99 Huaihai West Road, Xuzhou, 221006, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Guangyu</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Nanjing University of Chinese Medicine Affiliated Hospital, 155 Hanzhong Road Qinhuai District, Nanjing, 210004, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Fengran</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Affiliated Hospital of Xuzhou Medical University, NO.99 Huaihai West Road, Xuzhou, 221006, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Mingyue</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Affiliated Hospital of Xuzhou Medical University, NO.99 Huaihai West Road, Xuzhou, 221006, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiangjun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Affiliated Hospital of Xuzhou Medical University, NO.99 Huaihai West Road, Xuzhou, 221006, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Wenjing</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-4489-9738</Identifier><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Affiliated Hospital of Xuzhou Medical University, 99 Huaihai West Road, Xuzhou City, 221006, People's Republic of China. fgl3480535933@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>No.2015059</GrantID><Agency>Jiangsu Province Six Talent Peak Category D Fund Project</Agency><Country/></Grant><Grant><GrantID>No.KC16SY150</GrantID><Agency>Xuzhou Science and Technology Bureau</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Aging Clin Exp Res</MedlineTA><NlmUniqueID>101132995</NlmUniqueID><ISSNLinking>1594-0667</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073496" MajorTopicYN="Y">Frailty</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>25</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>24</Day><Hour>23</Hour><Minute>38</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37620639</ArticleId><ArticleId IdType="doi">10.1007/s40520-023-02527-3</ArticleId><ArticleId IdType="pii">10.1007/s40520-023-02527-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Miskovic A, Lumb AB (2017) Postoperative pulmonary complications. Br J Anaesth 118:317&#x2013;334</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aex002</ArticleId><ArticleId IdType="pubmed">28186222</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer MO, Brotons F, Briant AR et al (2022) Postoperative Pulmonary Complications After Cardiac Surgery: The VENICE International Cohort Study. J Cardiothorac Vasc Anesth 36:2344&#x2013;2351</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2021.12.024</ArticleId><ArticleId IdType="pubmed">35094928</ArticleId></ArticleIdList></Reference><Reference><Citation>Weissman C (2004) Pulmonary complications after cardiac surgery. Semin Cardiothorac Vasc Anesth 8:185&#x2013;211</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/108925320400800303</ArticleId><ArticleId IdType="pubmed">15375480</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuplay H, Bayer Erdogan S, Bastopcu M et al (2021) Performance of the EuroSCORE II and the STS score for cardiac surgery in octogenarians. Turk Gogus Kalp Damar Cerrahisi Derg 29:174&#x2013;182</Citation><ArticleIdList><ArticleId IdType="doi">10.5606/tgkdc.dergisi.2021.21403</ArticleId><ArticleId IdType="pubmed">34104511</ArticleId><ArticleId IdType="pmc">8167478</ArticleId></ArticleIdList></Reference><Reference><Citation>Nashef SA, Roques F, Sharples L et al (2012) EuroSCORE II. Eur J Cardiothorac Surg 41:734&#x2013;744</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezs043</ArticleId><ArticleId IdType="pubmed">22378855</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz-Jentoft AJ, Kiesswetter E, Drey M et al (2017) Nutrition, frailty, and sarcopenia. Aging Clin Exp Res 29:43&#x2013;48</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-016-0709-0</ArticleId><ArticleId IdType="pubmed">28155181</ArticleId></ArticleIdList></Reference><Reference><Citation>Dent E, Martin FC, Bergman H et al (2019) Management of frailty: opportunities, challenges, and future directions. Lancet 394:1376&#x2013;1386</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)31785-4</ArticleId><ArticleId IdType="pubmed">31609229</ArticleId></ArticleIdList></Reference><Reference><Citation>Milne B, Lucas de Carvalho J, Ayis S et al (2022) Frailty and perioperative patient-reported disability in patients undergoing cardiac surgery: a pilot study. Br J Anaesth 128:949&#x2013;958</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2022.03.015</ArticleId><ArticleId IdType="pubmed">35465950</ArticleId><ArticleId IdType="pmc">9204662</ArticleId></ArticleIdList></Reference><Reference><Citation>Afilalo J, Mottillo S, Eisenberg MJ et al (2012) Addition of frailty and disability to cardiac surgery risk scores identifies elderly patients at high risk of mortality or major morbidity. Circ Cardiovasc Qual Outcome 5:222e8</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.111.963157</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xfc;ndermann S, Dademasch A, Rastan A et al (2011) One-year follow-up of patients undergoing elective cardiac surgery assessed with the comprehensive assessment of frailty test and its simplified form. Interact Cardiovasc Thorac Surg 13:119&#x2013;123. https://doi.org/10.1510/icvts.2010.251884</Citation><ArticleIdList><ArticleId IdType="doi">10.1510/icvts.2010.251884</ArticleId><ArticleId IdType="pubmed">21378017</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung P, Pereira MA, Hiebert B et al (2015) The impact of frailty on postoperative delirium in cardiac surgery patients. J Thorac Cardiovasc Surg 149:869-875.e862. https://doi.org/10.1016/j.jtcvs.2014.10.118</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2014.10.118</ArticleId><ArticleId IdType="pubmed">25486976</ArticleId></ArticleIdList></Reference><Reference><Citation>Culver BH, Graham BL, Coates AL et al (2017) ATS Committee on Proficiency Standards for Pulmonary Function Laboratories: Recommendations for a standardized pulmonary function report An official American Thoracic Society technical statement. Am J Respir Crit Care Med 196:1463&#x2013;1472</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201710-1981ST</ArticleId><ArticleId IdType="pubmed">29192835</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulzebos EH, Helders PJ, Favi&#xe9; NJ et al (2006) Preoperative intensive inspiratory muscle training to prevent postoperative pulmonary complications in high-risk patients undergoing CABG surgery: a randomized clinical trial. JAMA 296:1851&#x2013;1857. https://doi.org/10.1001/jama.296.15.1851</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.296.15.1851</ArticleId><ArticleId IdType="pubmed">17047215</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier D, Fischer F, Fornier W et al (2019) Effect of open-lung vs conventional perioperative ventilation strategies on postoperative pulmonary complications after on-pump cardiac surgery: the PROVECS randomized clinical trial. Intensive Care Med 45:1401&#x2013;1412</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-019-05741-8</ArticleId><ArticleId IdType="pubmed">31576435</ArticleId><ArticleId IdType="pmc">9889189</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley RD, Ensor J, Snell KIE et al (2020) Calculating the sample size required for developing a clinical prediction model. BMJ 368:m441. https://doi.org/10.1136/bmj.m441</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m441</ArticleId><ArticleId IdType="pubmed">32188600</ArticleId></ArticleIdList></Reference><Reference><Citation>Salim TI, Nestlerode LC, Lucatorto EL et al (2020) Frailty as tested by gait speed is a risk factor for liver transplant respiratory complications. Am J Gastroenterol 115:859&#x2013;866</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000000609</ArticleId><ArticleId IdType="pubmed">32235146</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D, Ding Y, Zhu W et al (2022) Frailty is an independent risk factor for postoperative pulmonary complications in elderly patients undergoing video-assisted thoracoscopic pulmonary resections. Aging Clin Exp Res 34:819&#x2013;826. https://doi.org/10.1007/s40520-021-01988-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-021-01988-8</ArticleId><ArticleId IdType="pubmed">34648174</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanna AK, Kelava M, Ahuja S et al (2021) A nomogram to predict postoperative pulmonary complications after cardiothoracic surgery. J Thorac Cardiovasc Surg. https://doi.org/10.1016/j.jtcvs.2021.08.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2021.08.034</ArticleId><ArticleId IdType="pubmed">34689983</ArticleId></ArticleIdList></Reference><Reference><Citation>Alam M, Shehzad MI, Hussain S et al (2020) Spirometry Assessment and Correlation With Postoperative Pulmonary Complications in Cardiac Surgery Patients. Cureus 12:e11105. https://doi.org/10.7759/cureus.11105</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.11105</ArticleId><ArticleId IdType="pubmed">33240701</ArticleId><ArticleId IdType="pmc">7682508</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagan AL, Melley DD, Evans TW et al (2008) Pathogenesis of the systemic inflammatory syndrome and acute lung injury: role of iron mobilization and decompartmentalization. Am J Physiol Lung Cell Mol Physiol 294:L161&#x2013;L174</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00169.2007</ArticleId><ArticleId IdType="pubmed">18055843</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy JH, Tanaka KA (2003) Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 75:S715&#x2013;S720</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-4975(02)04701-X</ArticleId><ArticleId IdType="pubmed">12607717</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji Q, Mei Y, Wang X et al (2013) Risk factors for pulmonary complications following cardiac surgery with cardiopulmonary bypass. Int J Med Sci 10:1578&#x2013;1583. https://doi.org/10.7150/ijms.6904</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.6904</ArticleId><ArticleId IdType="pubmed">24046535</ArticleId><ArticleId IdType="pmc">3775118</ArticleId></ArticleIdList></Reference><Reference><Citation>Faubel S (2008) Pulmonary complications after acute kidney injury. Adv Chronic Kidney Dis 15:284&#x2013;296. https://doi.org/10.1053/j.ackd.2008.04.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ackd.2008.04.008</ArticleId><ArticleId IdType="pubmed">18565479</ArticleId></ArticleIdList></Reference><Reference><Citation>Covarrubias J, Grigorian A, Schubl S (2021) Obesity associated with increased postoperative pulmonary complications and mortality after trauma laparotomy. Eur J Trauma Emerg Surg 47:1561&#x2013;1568. https://doi.org/10.1007/s00068-020-01329-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00068-020-01329-w</ArticleId><ArticleId IdType="pubmed">32088754</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelosi P, Gregoretti C (2010) Perioperative management of obese patients. Best Pract Res Clin Anaesthesiol 24:211&#x2013;225. https://doi.org/10.1016/j.bpa.2010.02.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpa.2010.02.001</ArticleId><ArticleId IdType="pubmed">20608558</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulkarni SR, Fletcher E, McConnell AK et al (2010) Pre-operative inspiratory muscle training preserves postoperative inspiratory muscle strength following major abdominal surgery - a randomised pilot study. Ann R Coll Surg Engl 92:700&#x2013;707. https://doi.org/10.1308/003588410X12771863936648</Citation><ArticleIdList><ArticleId IdType="doi">10.1308/003588410X12771863936648</ArticleId><ArticleId IdType="pubmed">20663275</ArticleId><ArticleId IdType="pmc">3229384</ArticleId></ArticleIdList></Reference><Reference><Citation>Snowdon D, Haines TP, Skinner EH (2014) Preoperative intervention reduces postoperative pulmonary complications but not length of stay in cardiac surgical patients: a systematic review. J Physiother 60:66&#x2013;77. https://doi.org/10.1016/j.jphys.2014.04.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jphys.2014.04.002</ArticleId><ArticleId IdType="pubmed">24952833</ArticleId></ArticleIdList></Reference><Reference><Citation>Akdogan A, Erturk E, Ozdemir AC et al (2022) The effect of thoracic epidural analgesia on short-term outcome and mortality in geriatric patients undergoing open heart surgery. Ulus Travma Acil CerrahiDerg 28:382&#x2013;389</Citation></Reference><Reference><Citation>Treschan TA, Malbouisson LM, Beiderlinden M (2015) Intraoperative mechanical ventilation strategies to prevent postoperative pulmonary complications in patients with pulmonary and extrapulmonary comorbidities. Best Pract Res Clin Anaesthesiol 29:341&#x2013;355. https://doi.org/10.1016/j.bpa.2015.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpa.2015.08.002</ArticleId><ArticleId IdType="pubmed">26643099</ArticleId></ArticleIdList></Reference><Reference><Citation>Waite I, Deshpande R, Baghai M et al (2017) Home-based preoperative rehabilitation (prehab) to improve physical function and reduce hospital length of stay for frail patients undergoing coronary artery bypass graft and valve surgery(J). J Cardiothorac Surg 12:91. https://doi.org/10.1186/s13019-017-0655-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13019-017-0655-8</ArticleId><ArticleId IdType="pubmed">29073924</ArticleId><ArticleId IdType="pmc">5658994</ArticleId></ArticleIdList></Reference><Reference><Citation>Laghlam D, Naudin C, Srour A (2023) Persistent diaphragm dysfunction after cardiac surgery is associated with adverse respiratory outcomes: a prospective observational ultrasound study. Can J Anaesth 70:228&#x2013;236. https://doi.org/10.1007/s12630-022-02360-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-022-02360-8</ArticleId><ArticleId IdType="pubmed">36513852</ArticleId></ArticleIdList></Reference><Reference><Citation>Soma D, Kawamura YI, Yamashita S et al (2020) Association between sarcopenia and pneumonia in older people. Geriatr Gerontol Int 20:7&#x2013;13. https://doi.org/10.1093/dote/doy092</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/dote/doy092</ArticleId></ArticleIdList></Reference><Reference><Citation>Soysal P, Stubbs B, Lucato P et al (2022) Inflammation and frailty in the elderly: A systematic review and meta-analysis. Ageing Res Rev 31:1&#x2013;8. https://doi.org/10.1016/j.arr.2016.08.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2016.08.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbatecola AM, Paolisso G (2008) Is there a relationship between insulin resistance and frailty syndrome? Curr Pharm Des 14:405&#x2013;410</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138161208783497750</ArticleId><ArticleId IdType="pubmed">18289066</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33725507</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-6968</ISSN><JournalIssue CitedMedium="Internet"><Volume>203</Volume><PubDate><Year>2021</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Clinical neurology and neurosurgery</Title><ISOAbbreviation>Clin Neurol Neurosurg</ISOAbbreviation></Journal><ArticleTitle>Intra-operative fluorescein videoangiography-related nephrotoxicity in intracranial aneurysm surgery: Single center, observational cohort study.</ArticleTitle><Pagination><StartPage>106597</StartPage><MedlinePgn>106597</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clineuro.2021.106597</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0303-8467(21)00124-4</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Intra-operative fluorescein video angiography (FL-VA) has been given increasing attention recently and several studies reported its high utility in neurovascular surgery. The aim of this study was to evaluate the safety of FL-VA in a prospective, single-center cohort of patients operated due to cerebral aneurysms.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">This is an observational cohort study including 150 patients operated due to intracranial aneurysms. The study group consisted of 70 consecutive patients operated with the use of fluorescein video angiography. Post-operative acute kidney injury (AKI) occurrence as well as systemic adverse reactions were reported and further compared with 80 matched controls where FL-VA was not used. Statistical analysis was performed using non-parametric tests (Fisher's exact test).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Post-operative AKI was observed in 17,1% of patients in the study group with only half presenting with acute functional impairment. All of these patients presented initially due to aneurysm rupture. Pre-existing renal dysfunction and hypertension occurred in 16,7% and 33,3%, respectively. No systemic complications following FL-VA were reported. When compared to matched controls, no statistically significant difference regarding AKI occurrence was observed between these two patient populations.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Intra-operative fluorescein video angiography proved to have a good safety profile in our cohort. The results of this study suggest that post-operative acute kidney injury observed in patients with subarachnoid hemorrhage is not related to fluorescein use.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>&#x15a;wi&#x105;tnicki</LastName><ForeName>Wojciech</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Maria Sk&#x142;odowska-Curie Regional Specialist Hospital, District of &#x141;&#xf3;d&#x17a;-North, Zgierz, Poland. Electronic address: wswiatnicki@interia.eu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urbaniak</LastName><ForeName>Filip</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Maria Sk&#x142;odowska-Curie Regional Specialist Hospital, District of &#x141;&#xf3;d&#x17a;-North, Zgierz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szyma&#x144;ski</LastName><ForeName>Jaros&#x142;aw</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Faculty of Economics and Sociology, University of Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szyma&#x144;ska</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Economics and Sociology, University of Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Komu&#x144;ski</LastName><ForeName>Piotr</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Maria Sk&#x142;odowska-Curie Regional Specialist Hospital, District of &#x141;&#xf3;d&#x17a;-North, Zgierz, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Clin Neurol Neurosurg</MedlineTA><NlmUniqueID>7502039</NlmUniqueID><ISSNLinking>0303-8467</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance></Chemical><Chemical><RegistryNumber>TPY09G7XIR</RegistryNumber><NameOfSubstance UI="D019793">Fluorescein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017542" MajorTopicYN="N">Aneurysm, Ruptured</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002533" MajorTopicYN="N">Cerebral Angiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003287" MajorTopicYN="N">Contrast Media</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019793" MajorTopicYN="N">Fluorescein</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002532" MajorTopicYN="N">Intracranial Aneurysm</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016343" MajorTopicYN="N">Monitoring, Intraoperative</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Contrast induced nephropathy</Keyword><Keyword MajorTopicYN="N">Fluorescein fluorescence</Keyword><Keyword MajorTopicYN="N">Fluorescein safety</Keyword><Keyword MajorTopicYN="N">Intra-operative video angiography</Keyword><Keyword MajorTopicYN="N">Intracranial aneurysms</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>16</Day><Hour>20</Hour><Minute>10</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33725507</ArticleId><ArticleId IdType="doi">10.1016/j.clineuro.2021.106597</ArticleId><ArticleId IdType="pii">S0303-8467(21)00124-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39078216</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-6576</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Acta anaesthesiologica Scandinavica</Title><ISOAbbreviation>Acta Anaesthesiol Scand</ISOAbbreviation></Journal><ArticleTitle>Paediatric postoperative acute kidney injury after non-cardiac surgery: Protocol for a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1561</StartPage><EndPage>1564</EndPage><MedlinePgn>1561-1564</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/aas.14505</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Paediatric acute kidney injury (AKI) is associated with significant adverse outcomes such as increased mortality, progression to chronic kidney disease and longer length of stay in hospital. Postoperative AKI is a common and recognized complication after surgery in adults. In the paediatric population, AKI postoperatively to cardiac surgery has been extensively studied. However, the incidence of postoperative AKI after non-cardiac surgery is less clear. Therefore, we aim to assess the available literature on this topic.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We will conduct a systematic review of observational and randomized controlled trials assessing the incidence of paediatric postoperative AKI after non-cardiac surgery. Pairs of reviewers will independently screen the literature and extract data and assess risk of bias from eligible studies. The databases Pubmed, Cochrane and Web of Sciences will be searched. We will conduct the review in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines and the Grading of Recommendation, Assessment, Development and Evaluation (GRADE) approach. If sufficient homogeneity within the included trials we will conduct meta-analyses.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">This systematic review aims to investigate the incidence of postoperative AKI in the paediatric non-cardiac surgery population. The results of this review will provide a foundation for future research in the field of paediatric postoperative AKI.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s). Acta Anaesthesiologica Scandinavica published by John Wiley &amp; Sons Ltd on behalf of Acta Anaesthesiologica Scandinavica Foundation.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Emami</LastName><ForeName>Arash</ForeName><Initials>A</Initials><Identifier Source="ORCID">0009-0001-8916-185X</Identifier><AffiliationInfo><Affiliation>Anesthesiology and Intensive Care, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sivertsson</LastName><ForeName>Ebba</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-6978-1077</Identifier><AffiliationInfo><Affiliation>Anesthesiology and Intensive Care, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Westerbergh</LastName><ForeName>Johan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hultstr&#xf6;m</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4675-1099</Identifier><AffiliationInfo><Affiliation>Anesthesiology and Intensive Care, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Cell Biology, Integrative Physiology, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Danielsson</LastName><ForeName>Johan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-5071-3127</Identifier><AffiliationInfo><Affiliation>Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frykholm</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-6402-136X</Identifier><AffiliationInfo><Affiliation>Anesthesiology and Intensive Care, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frithiof</LastName><ForeName>Robert</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-2278-7951</Identifier><AffiliationInfo><Affiliation>Anesthesiology and Intensive Care, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2014-02569</GrantID><Agency>Swedish Research Council</Agency><Country/></Grant><Grant><GrantID>2014-07606</GrantID><Agency>Swedish Research Council</Agency><Country/></Grant><Grant><GrantID>20230627</GrantID><Agency>Swedish Heart Lung Foundation</Agency><Country/></Grant><Grant><GrantID>20230732</GrantID><Agency>Swedish Heart Lung Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Anaesthesiol Scand</MedlineTA><NlmUniqueID>0370270</NlmUniqueID><ISSNLinking>0001-5172</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000078202" MajorTopicYN="N">Systematic Reviews as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015201" MajorTopicYN="N">Meta-Analysis as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">anaesthesia</Keyword><Keyword MajorTopicYN="N">child</Keyword><Keyword MajorTopicYN="N">creatinine</Keyword><Keyword MajorTopicYN="N">fluid balance</Keyword><Keyword MajorTopicYN="N">postoperative complications</Keyword><Keyword MajorTopicYN="N">renal failure</Keyword><Keyword MajorTopicYN="N">renal replacement therapy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>30</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>30</Day><Hour>9</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39078216</ArticleId><ArticleId IdType="doi">10.1111/aas.14505</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Kellum JA, Uchino S, Aspelin P, et al. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1&#x2010;138.</Citation></Reference><Reference><Citation>Meena J, Mathew G, Kumar J, Chanchlani R. Incidence of acute kidney injury in hospitalized children: a meta&#x2010;analysis. Pediatrics. 2023;151(2):e2022058823. doi:10.1542/peds.2022&#x2010;058823</Citation></Reference><Reference><Citation>Sigurjonsdottir VK, Chaturvedi S, Mammen C, et al. Pediatric acute kidney injury and the subsequent risk for chronic kidney disease: is there cause for alarm? Pediatr Nephrol. 2018;33:2047&#x2010;2055.</Citation></Reference><Reference><Citation>Prowle JR, Forni LG, Bell M, et al. Postoperative acute kidney injury in adult non&#x2010;cardiac surgery: joint consensus report of the acute disease quality initiative and PeriOperative quality initiative. Nat Rev Nephrol. 2021;17(9):605&#x2010;618.</Citation></Reference><Reference><Citation>Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta&#x2010;analysis protocols (PRISMA&#x2010;P) 2015: elaboration and explanation. BMJ. 2015;350:g7647.</Citation></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71</Citation></Reference><Reference><Citation>Zappitelli M, Ambalavanan N, Askenazi D, et al. Developing a neonatal acute kidney injury research definition: a report from the NIDDK neonatal AKI workshop. Pediatr Res. 2017;82:569&#x2010;573.</Citation></Reference><Reference><Citation>Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan &#x2014; a web and mobile app for systematic reviews. Syst Rev. 2016;5:210. doi:10.1186/s13643&#x2010;016&#x2010;0384&#x2010;4</Citation></Reference><Reference><Citation>Sterne JAC, Savovi&#x107; J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;28(366):l4898. doi:10.1136/bmj.l4898</Citation></Reference><Reference><Citation>Sterne JA, Hern&#xe1;n MA, Reeves BC, et al. ROBINS&#x2010;I: a tool for assessing risk of bias in non&#x2010;randomised studies of interventions. BMJ. 2016;355:i4919. doi:10.1136/bmj.i491</Citation></Reference><Reference><Citation>Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36135347</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>135</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Hypobaric Unilateral Spinal Anesthesia Versus General Anesthesia for Hip Fracture Surgery in the Elderly: A Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>1262</StartPage><EndPage>1270</EndPage><MedlinePgn>1262-1270</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000006208</ELocationID><Abstract><AbstractText Label="BACKGROUND">Hypotension during surgery is frequent in the elderly population and is associated with acute kidney and myocardial injury, which are, themselves, associated with increased 30-day mortality. The present study compared the hemodynamic effects of hypobaric unilateral spinal anesthesia (HUSA) to general anesthesia (GA) in patients &#x2265;70 years of age undergoing hip fracture surgery.</AbstractText><AbstractText Label="METHODS">We conducted a single-center, prospective, randomized study. In the HUSA group, patients were positioned with the operated hip above, and the hypobaric anesthetic solution was composed of 9 mg ropivacaine, 5 &#xb5;g sufentanil, and 1 mL of sterile water. Anesthesia was adjusted for the GA group. Mean arterial pressure (MAP) was measured with a noninvasive blood pressure upper arm cuff every 3 minutes. Hypotension was treated with a bolus of ephedrine and then a continuous intravenous of norepinephrine to obtain a MAP &#x2265;65 mm Hg. Primary outcome was the occurrence of severe hypotension, defined as a MAP &lt;65 mm Hg for &gt;12 consecutive minutes.</AbstractText><AbstractText Label="RESULTS">A total of 154 patients were included. Severe hypotension was more frequent in the GA group compared to the HUSA group (odds ratio, 5.6; 95% confidence interval, 2.7-11.7; P &lt; .001). There was no significant difference regarding the short-term outcomes between the HUSA and GA groups: acute kidney injury (respectively, 5.1% vs 11.3%; P = .22), myocardial injury (18.0% vs 14.0%; P = .63), and 30-day mortality (2.4% vs 4.7%; P = .65).</AbstractText><AbstractText Label="CONCLUSIONS">HUSA leads to fewer episodes of severe intraoperative hypotension compared to GA in an elderly population undergoing hip fracture surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 International Anesthesia Research Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Simonin</LastName><ForeName>Marine</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the D&#xe9;partement d'Anesth&#xe9;sie-R&#xe9;animation, H&#xf4;pital &#xc9;douard Herriot, Hospices Civils de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delsuc</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>From the D&#xe9;partement d'Anesth&#xe9;sie-R&#xe9;animation, H&#xf4;pital &#xc9;douard Herriot, Hospices Civils de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meuret</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>From the D&#xe9;partement d'Anesth&#xe9;sie-R&#xe9;animation, H&#xf4;pital &#xc9;douard Herriot, Hospices Civils de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caruso</LastName><ForeName>Liana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>From the D&#xe9;partement d'Anesth&#xe9;sie-R&#xe9;animation, H&#xf4;pital &#xc9;douard Herriot, Hospices Civils de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deleat-Besson</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>From the D&#xe9;partement d'Anesth&#xe9;sie-R&#xe9;animation, H&#xf4;pital &#xc9;douard Herriot, Hospices Civils de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lamblin</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the D&#xe9;partement d'Anesth&#xe9;sie-R&#xe9;animation, H&#xf4;pital &#xc9;douard Herriot, Hospices Civils de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huriaux</LastName><ForeName>Laetitia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>From the D&#xe9;partement d'Anesth&#xe9;sie-R&#xe9;animation, H&#xf4;pital &#xc9;douard Herriot, Hospices Civils de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abraham</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>From the D&#xe9;partement d'Anesth&#xe9;sie-R&#xe9;animation, H&#xf4;pital &#xc9;douard Herriot, Hospices Civils de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bidon</LastName><ForeName>Cyril</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>From the D&#xe9;partement d'Anesth&#xe9;sie-R&#xe9;animation, H&#xf4;pital &#xc9;douard Herriot, Hospices Civils de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giai</LastName><ForeName>Joris</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Lyon, Lyon, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universit&#xe9; Claude Bernard Lyon 1, Villeurbanne, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospices Civils de Lyon, P&#xf4;le Sant&#xe9; Publique, Service de Biostatistique et Bioinformatique, Lyon, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre National de la Recherche Scientifique, UMR 5558, Laboratoire de Biom&#xe9;trie et Biologie &#xc9;volutive, &#xc9;quipe Biostatistique-Sant&#xe9;, Villeurbanne, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riche</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Lyon, Lyon, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universit&#xe9; Claude Bernard Lyon 1, Villeurbanne, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospices Civils de Lyon, P&#xf4;le Sant&#xe9; Publique, Service de Biostatistique et Bioinformatique, Lyon, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre National de la Recherche Scientifique, UMR 5558, Laboratoire de Biom&#xe9;trie et Biologie &#xc9;volutive, &#xc9;quipe Biostatistique-Sant&#xe9;, Villeurbanne, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rimmel&#xe9;</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>From the D&#xe9;partement d'Anesth&#xe9;sie-R&#xe9;animation, H&#xf4;pital &#xc9;douard Herriot, Hospices Civils de Lyon, Lyon, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospices Civils de Lyon-Biom&#xe9;rieux-Universit&#xe9; Claude Bernard Lyon 1, H&#xf4;pital &#xc9;douard Herriot, Lyon, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03373864</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>Y8335394RO</RegistryNumber><NameOfSubstance UI="D002045">Bupivacaine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Anesth Analg. 2023 Jul 1;137(1):e3-e4. doi: 10.1213/ANE.0000000000006528.</RefSource><PMID Version="1">37326872</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Anesth Analg. 2023 Aug 1;137(2):e13. doi: 10.1213/ANE.0000000000006527.</RefSource><PMID Version="1">37450912</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000775" MajorTopicYN="Y">Anesthesia, Spinal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002045" MajorTopicYN="N">Bupivacaine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="Y">Hip Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>22</Day><Hour>8</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36135347</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000006208</ArticleId><ArticleId IdType="pii">00000539-202212000-00020</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Friedman SM, Mendelson DA. Epidemiology of fragility fractures. Clin Geriatr Med. 2014;30:175&#x2013;181.</Citation></Reference><Reference><Citation>Neuman MD, Rosenbaum PR, Ludwig JM, Zubizarreta JR, Silber JH. Anesthesia technique, mortality, and length of stay after hip fracture surgery. JAMA. 2014;311:2508&#x2013;2517.</Citation></Reference><Reference><Citation>Guay J, Parker MJ, Gajendragadkar PR, Kopp S. Anesthesia for hip fracture surgery in adults. Cochrane Database Syst Rev. 2016;2:CD000521.</Citation></Reference><Reference><Citation>Royal College of Physicians. The National Hip Fracture Database. Accessed May 9, 2017. http://www.nhfd.co.uk/</Citation></Reference><Reference><Citation>Grigoryan KV, Javedan H, Rudolph JL. Orthogeriatric care models and outcomes in hip fracture patients: a systematic review and meta-analysis. J Orthop Trauma. 2014;28:e49&#x2013;e55.</Citation></Reference><Reference><Citation>Henderson CY, Shanahan E, Butler A, . Dedicated orthogeriatric service reduces hip fracture mortality. Ir J Med Sci. 2017;186:179&#x2013;184.</Citation></Reference><Reference><Citation>Sanclemente-Boli T, Ponce-Ruiz S, &#xc1;lvarez-Lorenzo C, . Effectiveness of a multidisciplinary educational intervention in patients with hip fracture: SWEET HOME study. Med Clin (Barc). 2019;153:446&#x2013;453.</Citation></Reference><Reference><Citation>Maheshwari K, Planchard J, You J, . Early surgery confers 1-year mortality benefit in hip-fracture patients. J Orthop Trauma. 2018;32:105&#x2013;110.</Citation></Reference><Reference><Citation>Boddaert J, Cohen-Bittan J, Khiami F, . Postoperative admission to a dedicated geriatric unit decreases mortality in elderly patients with hip fracture. PLoS One. 2014;9:e83795.</Citation></Reference><Reference><Citation>Neuman MD, Feng R, Carson JL, ; REGAIN Investigators. Spinal anesthesia or general anesthesia for hip surgery in older adults. N Engl J Med. 2021;385:2025&#x2013;2035.</Citation></Reference><Reference><Citation>Boddaert J, Raux M, Khiami F, Riou B. Perioperative management of elderly patients with hip fracture. Anesthesiology. 2014;121:1336&#x2013;1341.</Citation></Reference><Reference><Citation>Aubrun F, Baillard C, Beauscard JB, et al. Anesth&#xe9;sie du sujet &#xe2;g&#xe9;: l&#x2019;exemple de fracture de l&#x2019;extr&#xe9;mit&#xe9; sup&#xe9;rieure du f&#xe9;mur. Accessed June 11, 2019. https://sfar.org/anesthesie-du-sujet-age-lexemple-de-fracture-de-lextremite-superieure-du-femur/</Citation></Reference><Reference><Citation>Walsh M, Devereaux PJ, Garg AX, . Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology. 2013;119:507&#x2013;515.</Citation></Reference><Reference><Citation>Hallqvist L, M&#xe5;rtensson J, Granath F, Sahl&#xe9;n A, Bell M. Intraoperative hypotension is associated with myocardial damage in noncardiac surgery: an observational study. Eur J Anaesthesiol. 2016;33:450&#x2013;456.</Citation></Reference><Reference><Citation>Salmasi V, Maheshwari K, Yang D, et al. Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery: a retrospective cohort analysis. Anesthesiology. 2016;126:47&#x2013;65.</Citation></Reference><Reference><Citation>Vascular Events in Noncardiac Surgery Patients Cohort Evaluation (VISION) Study Investigators. Association between complications and death within 30 days after noncardiac surgery. CMAJ Can Med Assoc J J Assoc Medicale Can. 2019;191:E830&#x2013;E837.</Citation></Reference><Reference><Citation>Devereaux PJ, Biccard BM, Sigamani A, et al.; Writing Committee for the VISION study investigators. Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery. JAMA. 2017;317:1642&#x2013;1651.</Citation></Reference><Reference><Citation>Meuret P, Bouvet L, Villet B, Hafez M, Allaouchiche B, Boselli E. Hypobaric unilateral spinal anaesthesia versus general anaesthesia in elderly patients undergoing hip fracture surgical repair: a prospective randomised open trial. Turk J Anaesthesiol Reanim. 2018;46:121&#x2013;130.</Citation></Reference><Reference><Citation>Messina A, Frassanito L, Colombo D, . Hemodynamic changes associated with spinal and general anesthesia for hip fracture surgery in severe ASA III elderly population: a pilot trial. Minerva Anestesiol. 2013;79:1021&#x2013;1029.</Citation></Reference><Reference><Citation>Casati A, Aldegheri G, Vinciguerra E, Marsan A, Fraschini G, Torri G. Randomized comparison between sevoflurane anaesthesia and unilateral spinal anaesthesia in elderly patients undergoing orthopaedic surgery. Eur J Anaesthesiol. 2003;20:640&#x2013;646.</Citation></Reference><Reference><Citation>De Castro V, Godet G, Mencia G, Raux M, Coriat P. Target-controlled infusion for remifentanil in vascular patients improves hemodynamics and decreases remifentanil requirement. Anesth Analg. 2003;96:33&#x2013;38.</Citation></Reference><Reference><Citation>Chan MTV, Cheng BCP, Lee TMC, Gin T; CODA Trial Group. BIS-guided anesthesia decreases postoperative delirium and cognitive decline. J Neurosurg Anesthesiol. 2013;25:33&#x2013;42.</Citation></Reference><Reference><Citation>Shin CH, Long DR, McLean D, et al. Effects of intraoperative fluid management on postoperative outcomes: a hospital registry study. Ann Surg. 2018;267:1084&#x2013;1092.</Citation></Reference><Reference><Citation>Culley DJ, Flaherty D, Reddy S, . Preoperative cognitive stratification of older elective surgical patients: a cross-sectional study. Anesth Analg. 2016;123:186&#x2013;192.</Citation></Reference><Reference><Citation>Lilot M, Meuret P, Bouvet L, . Hypobaric spinal anesthesia with ropivacaine plus sufentanil for traumatic femoral neck surgery in the elderly: a dose-response study. Anesth Analg. 2013;117:259&#x2013;264.</Citation></Reference><Reference><Citation>Paventi S, Santevecchi A, Metta E, et al. Bispectral index monitoring in sevoflurane and remifentanil anesthesia. Analysis of drugs management and immediate recovery. Minerva Anestesiol. 2001;67:435&#x2013;439.</Citation></Reference><Reference><Citation>Sharrock NE, Go G, Mineo R. Effect of i.v. low-dose adrenaline and phenylephrine infusions on plasma concentrations of bupivacaine after lumbar extradural anaesthesia in elderly patients. Br J Anaesth. 1991;67:694&#x2013;698.</Citation></Reference><Reference><Citation>Meng L, Gelb AW, Alexander BS, . Impact of phenylephrine administration on cerebral tissue oxygen saturation and blood volume is modulated by carbon dioxide in anaesthetized patients. Br J Anaesth. 2012;108:815&#x2013;822.</Citation></Reference><Reference><Citation>Soeding PF, Hoy S, Hoy G, Evans M, Royse CF. Effect of phenylephrine on the haemodynamic state and cerebral oxygen saturation during anaesthesia in the upright position. Br J Anaesth. 2013;111:229&#x2013;234.</Citation></Reference><Reference><Citation>Rebet O, Andremont O, G&#xe9;rard JL, Fellahi JL, Hanouz JL, Fischer MO. Preload dependency determines the effects of phenylephrine on cardiac output in anaesthetised patients: a prospective observational study. Eur J Anaesthesiol. 2016;33:638&#x2013;644.</Citation></Reference><Reference><Citation>B&#xfc;ttner B, Mansur A, Bauer M, Hinz J, Bergmann I. [Unilateral spinal anesthesia: literature review and recommendations]. Anaesthesist. 2016;65:847&#x2013;865.</Citation></Reference><Reference><Citation>Fuzier R, Bataille B, Fuzier V, . Spinal anesthesia failure after local anesthetic injection into cerebrospinal fluid: a multicenter prospective analysis of its incidence and related risk factors in 1214 patients. Reg Anesth Pain Med. 2011;36:322&#x2013;326.</Citation></Reference><Reference><Citation>Narkhede HH, Kane D, Parekh V, Hemantkumar I. A cohort study of anatomical landmark-guided midline versus pre-procedure ultrasound-guided midline technique of spinal anesthesia in elderly patients undergoing orthopedic surgery. J Anaesthesiol Clin Pharmacol. 2019;35:522&#x2013;527.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31272751</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>22</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-685X</ISSN><JournalIssue CitedMedium="Internet"><Volume>159</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>May</Month></PubDate></JournalIssue><Title>The Journal of thoracic and cardiovascular surgery</Title><ISOAbbreviation>J Thorac Cardiovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Goal-directed resuscitation following cardiac surgery reduces acute kidney injury: A quality initiative pre-post analysis.</ArticleTitle><Pagination><StartPage>1868</StartPage><EndPage>1877.e1</EndPage><MedlinePgn>1868-1877.e1</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jtcvs.2019.03.135</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-5223(19)31029-3</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Acute kidney injury (AKI) occurs in 20% of patients following cardiac surgery. To reduce AKI in our institution, we instituted a quality improvement (QI) initiative using a goal-directed volume resuscitation protocol. Our protocol was designed to achieve quantifiable physiologic goals (eg, cardiac index&#xa0;&gt;&#xa0;2.5 L/min/m<sup>2</sup>, mean arterial pressure&#xa0;&gt;&#xa0;65 mm Hg) using fluid and vasoactive agents. The objective of this study was to evaluate AKI in the pre- and post-QI eras, hypothesizing that AKI incidence would decrease in the post-QI era.</AbstractText><AbstractText Label="METHODS">In this observational retrospective cohort study, we identified patients who underwent cardiac operations from July 2011 to July 2015 with a risk score available. Kidney injury was determined using the lowest postoperative GFR within 7&#xa0;days of surgery and standard Risk, Injury, Failure, Loss of Kidney Function, and End-Stage Kidney Disease (RIFLE) classification criteria. The primary outcome was the rate of AKI, as defined by glomerular filtration rate-based RIFLE classification criteria injury, in the post- versus pre-QI eras.</AbstractText><AbstractText Label="RESULTS">A total of 1979 patients were included, of whom 725 were in the pre-QI cohort, and 1254 in the post-QI cohort. Overall, rates of RIFLE classification criteria risk, injury and failure were 27.5%, 5.9%, and 3.6%, respectively. RIFLE classification criteria injury saw the largest decrease in the post-QI cohort (8.1% vs 4.6%; P&#xa0;=&#xa0;.001). Multivariable analysis demonstrated a 37% reduction in the odds of AKI in the post-QI cohort (adjusted odds ratio, 0.63; 95% confidence interval, 0.43-0.90).</AbstractText><AbstractText Label="CONCLUSIONS">A goal-directed volume resuscitation protocol centered on patient fluid responsiveness is associated with significantly reduced risk for AKI after cardiac surgery. Protocol-driven approaches should be employed in intensive care units to improve outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Johnston</LastName><ForeName>Lily E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Virginia Health System, University of Virginia Health System, Charlottesville, Va.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thiele</LastName><ForeName>Robert H</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Virginia Health System, University of Virginia Health System, Charlottesville, Va.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hawkins</LastName><ForeName>Robert B</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Virginia Health System, University of Virginia Health System, Charlottesville, Va.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Downs</LastName><ForeName>Emily A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Virginia Health System, University of Virginia Health System, Charlottesville, Va.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaeger</LastName><ForeName>James M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Virginia Health System, University of Virginia Health System, Charlottesville, Va.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brooks</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Virginia Health System, University of Virginia Health System, Charlottesville, Va.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghanta</LastName><ForeName>Ravi K</ForeName><Initials>RK</Initials><AffiliationInfo><Affiliation>Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Virginia Health System, University of Virginia Health System, Charlottesville, Va.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ailawadi</LastName><ForeName>Gorav</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Virginia Health System, University of Virginia Health System, Charlottesville, Va.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kron</LastName><ForeName>Irving L</ForeName><Initials>IL</Initials><AffiliationInfo><Affiliation>Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Virginia Health System, University of Virginia Health System, Charlottesville, Va.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isbell</LastName><ForeName>James M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: isbellj@mskcc.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Virginia Interdisciplinary Cardiothoracic Outcomes Research Center</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Thorac Cardiovasc Surg</MedlineTA><NlmUniqueID>0376343</NlmUniqueID><ISSNLinking>0022-5223</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Thorac Cardiovasc Surg. 2020 May;159(5):1878-1879. doi: 10.1016/j.jtcvs.2019.04.044.</RefSource><PMID Version="1">31160108</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Thorac Cardiovasc Surg. 2020 May;159(5):1880-1881. doi: 10.1016/j.jtcvs.2019.04.045.</RefSource><PMID Version="1">31174858</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005919" MajorTopicYN="N">Glomerular Filtration Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058996" MajorTopicYN="N">Quality Improvement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">critical care</Keyword><Keyword MajorTopicYN="N">perioperative care</Keyword><Keyword MajorTopicYN="N">quality</Keyword><Keyword MajorTopicYN="N">regression</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31272751</ArticleId><ArticleId IdType="doi">10.1016/j.jtcvs.2019.03.135</ArticleId><ArticleId IdType="pii">S0022-5223(19)31029-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34358675</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>27</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8615</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of critical care</Title><ISOAbbreviation>J Crit Care</ISOAbbreviation></Journal><ArticleTitle>Predicting successful continuous renal replacement therapy liberation in critically ill patients with acute kidney injury.</ArticleTitle><Pagination><StartPage>6</StartPage><EndPage>13</EndPage><MedlinePgn>6-13</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrc.2021.07.020</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0883-9441(21)00167-2</ELocationID><Abstract><AbstractText Label="PURPOSE">No standardized criteria for continuous renal replacement therapy (CRRT) liberation have been established. We sought to develop and internally validate prediction models for successful CRRT liberation in critically ill patients with acute kidney injury (AKI).</AbstractText><AbstractText Label="MATERIALS AND METHODS">This single-center, retrospective cohort study included adult patients admitted to intensive care units (ICUs) with AKI and treated with CRRT from January 1, 2007, to May 4, 2018, at a tertiary referral hospital. The cohort was randomly divided into derivation and validation sets. The outcomes were successful CRRT liberation, defined as renal replacement therapy (RRT)-free survival within 72 h after the liberation and hospital discharge. Multivariate logistic regression models were developed and internally validated.</AbstractText><AbstractText Label="RESULTS">Of 1135 AKI patients requiring CRRT, successful CRRT liberation and RRT-free survival at hospital discharge were observed in 228 (20%) and 395 (35%) individuals, respectively. The independent predictors included mean hourly urine output within 12 h before liberation, mean serum creatinine value within 24 h before liberation, cumulative fluid balance from ICU admission to liberation, CRRT duration before liberation, and the requirement of vasoactive agents within 24 h before liberation. The models demonstrated good discrimination (AUROC, 0.76 and 0.78; positive predictive value, 36% and 48%; negative predictive value, 92% and 94%; respectively) and calibration in the validation set.</AbstractText><AbstractText Label="CONCLUSIONS">These validated models could assist the decision-making related to the CRRT liberation in critically ill patients with AKI.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Zhiyong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhuo</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Division of Biomedical Statistics and Informatics, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrijasevic</LastName><ForeName>Nicole M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Department of Anesthesia Clinical Research Unit, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albright</LastName><ForeName>Robert C</ForeName><Initials>RC</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kashani</LastName><ForeName>Kianoush B</ForeName><Initials>KB</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, USA; Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, USA. Electronic address: kashani.kianoush@mayo.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Crit Care</MedlineTA><NlmUniqueID>8610642</NlmUniqueID><ISSNLinking>0883-9441</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000079664" MajorTopicYN="Y">Continuous Renal Replacement Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="N">Renal Replacement Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Continuous renal replacement therapy</Keyword><Keyword MajorTopicYN="N">Intensive care units</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword><Keyword MajorTopicYN="N">Recovery of function</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest All authors disclosed that they do not have any conflicts of interest regarding this study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>6</Day><Hour>20</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34358675</ArticleId><ArticleId IdType="doi">10.1016/j.jcrc.2021.07.020</ArticleId><ArticleId IdType="pii">S0883-9441(21)00167-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26083657</PMID><DateCompleted><Year>2016</Year><Month>07</Month><Day>13</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1523-1755</ISSN><JournalIssue CitedMedium="Internet"><Volume>88</Volume><Issue>4</Issue><PubDate><Year>2015</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Kidney international</Title><ISOAbbreviation>Kidney Int</ISOAbbreviation></Journal><ArticleTitle>Genome-wide association study of acute kidney injury after coronary bypass graft surgery identifies susceptibility loci.</ArticleTitle><Pagination><StartPage>823</StartPage><EndPage>832</EndPage><MedlinePgn>823-32</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/ki.2015.161</ELocationID><Abstract><AbstractText>Acute kidney injury (AKI) is a common, serious complication of cardiac surgery. Since prior studies have supported a genetic basis for postoperative AKI, we conducted a genome-wide association study (GWAS) for AKI following coronary bypass graft (CABG) surgery. The discovery data set consisted of 873 nonemergent CABG surgery patients with cardiopulmonary bypass (PEGASUS), while a replication data set had 380 cardiac surgical patients (CATHGEN). Single-nucleotide polymorphism (SNP) data were based on Illumina Human610-Quad (PEGASUS) and OMNI1-Quad (CATHGEN) BeadChips. We used linear regression with adjustment for a clinical AKI risk score to test SNP associations with the postoperative peak rise relative to preoperative serum creatinine concentration as a quantitative AKI trait. Nine SNPs meeting significance in the discovery set were detected. The rs13317787 in GRM7|LMCD1-AS1 intergenic region (3p21.6) and rs10262995 in BBS9 (7p14.3) were replicated with significance in the CATHGEN data set and exhibited significantly strong overall association following meta-analysis. Additional fine mapping using imputed SNPs across these two regions and meta-analysis found genome-wide significance at the GRM7|LMCD1-AS1 locus and a significantly strong association at BBS9. Thus, through an unbiased GWAS approach, we found two new loci associated with post-CABG AKI providing new insights into the pathogenesis of perioperative AKI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stafford-Smith</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yi-Ju</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Molecular Physiology Institute, Duke University Medical Center, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathew</LastName><ForeName>Joseph P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yen-Wei</ForeName><Initials>YW</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Yunqi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phillips-Bute</LastName><ForeName>Barbara G</ForeName><Initials>BG</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milano</LastName><ForeName>Carmelo A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Newman</LastName><ForeName>Mark F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kraus</LastName><ForeName>William E</ForeName><Initials>WE</Initials><AffiliationInfo><Affiliation>Duke Molecular Physiology Institute, Duke University Medical Center, Durham, North Carolina, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kertai</LastName><ForeName>Miklos D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Svati H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Duke Molecular Physiology Institute, Duke University Medical Center, Durham, North Carolina, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Podgoreanu</LastName><ForeName>Mihai V</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Duke Perioperative Genetics and Safety Outcomes (PEGASUS) Investigative Team</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HL092071</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HL108280</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>M01-RR-30</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HL075273</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 HL109971</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HL054316</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HL095987</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL075273</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL096978</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG016762</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL069081</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HL101621</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL095987</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HL069081</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HL096978</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>M01 RR000030</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RC2 HL101621</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG09663</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL092071</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 HL108280</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HL109971</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>06</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Kidney Int</MedlineTA><NlmUniqueID>0323470</NlmUniqueID><ISSNLinking>0085-2538</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005819">Genetic Markers</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001026" MajorTopicYN="N">Coronary Artery Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D030541" MajorTopicYN="N">Databases, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056426" MajorTopicYN="Y">Genetic Loci</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005819" MajorTopicYN="N">Genetic Markers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016014" MajorTopicYN="N">Linear Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="Y">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Davis</LastName><ForeName>R D</ForeName><Initials>RD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Funk</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gaca</LastName><ForeName>J G</ForeName><Initials>JG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ginsburg</LastName><ForeName>G S</ForeName><Initials>GS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Glower</LastName><ForeName>D D</ForeName><Initials>DD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hall</LastName><ForeName>R L</ForeName><Initials>RL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hauser</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kertai</LastName><ForeName>M D</ForeName><Initials>MD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Laskowitz</LastName><ForeName>D T</ForeName><Initials>DT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Li</LastName><ForeName>Y J</ForeName><Initials>YJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lodge</LastName><ForeName>A J</ForeName><Initials>AJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mathew</LastName><ForeName>J P</ForeName><Initials>JP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Milano</LastName><ForeName>C A</ForeName><Initials>CA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Newman</LastName><ForeName>M F</ForeName><Initials>MF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Phillips-Bute</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Podgoreanu</LastName><ForeName>M V</ForeName><Initials>MV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>M P</ForeName><Initials>MP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>P K</ForeName><Initials>PK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stafford-Smith</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Swaminathan</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Welsby</LastName><ForeName>I J</ForeName><Initials>IJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>White</LastName><ForeName>W D</ForeName><Initials>WD</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>4</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26083657</ArticleId><ArticleId IdType="mid">NIHMS690108</ArticleId><ArticleId IdType="pmc">PMC4589439</ArticleId><ArticleId IdType="doi">10.1038/ki.2015.161</ArticleId><ArticleId IdType="pii">S2157-1716(15)32247-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cruz DN, Ricci Z, Ronco C. Clinical review: RIFLE and AKIN--time for reappraisal. Crit Care. 2009;13:211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2717405</ArticleId><ArticleId IdType="pubmed">19638179</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmichael P, Carmichael AR. Acute renal failure in the surgical setting. ANZ J Surg. 2003;73:144&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pubmed">12608979</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. Jama. 2005;294:813&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pubmed">16106006</ArticleId></ArticleIdList></Reference><Reference><Citation>Loef BG, Epema AH, Smilde TD, et al. Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J Am Soc Nephrol. 2005;16:195&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pubmed">15563558</ArticleId></ArticleIdList></Reference><Reference><Citation>Swaminathan M, Hudson CC, Phillips-Bute BG, et al. Impact of early renal recovery on survival after cardiac surgery-associated acute kidney injury. Ann Thorac Surg. 2010;89:1098&#x2013;1104.</Citation><ArticleIdList><ArticleId IdType="pubmed">20338313</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassnigg A, Schmidlin D, Mouhieddine M, et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004;15:1597&#x2013;1605.</Citation><ArticleIdList><ArticleId IdType="pubmed">15153571</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon PJ, Stafford-Smith M, White WD, et al. Acute renal failure following cardiac surgery. Nephrol Dial Transplant. 1999;14:1158&#x2013;1162.</Citation><ArticleIdList><ArticleId IdType="pubmed">10344355</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangano CM, Diamondstone LS, Ramsay JG, et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Annals of internal medicine. 1998;128:194&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pubmed">9454527</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JR, Parikh CR, Ross CS, et al. Impact of perioperative acute kidney injury as a severity index for thirty-day readmission after cardiac surgery. Ann Thorac Surg. 2014;97:111&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4009924</ArticleId><ArticleId IdType="pubmed">24119985</ArticleId></ArticleIdList></Reference><Reference><Citation>Rewa O, Bagshaw SM. Acute kidney injury-epidemiology, outcomes and economics. Nat Rev Nephrol. 2014;10:193&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">24445744</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronson S, Fontes ML, Miao Y, et al. Risk index for perioperative renal dysfunction/failure: critical dependence on pulse pressure hypertension. Circulation. 2007;115:733&#x2013;742.</Citation><ArticleIdList><ArticleId IdType="pubmed">17283267</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen DP, Noyez L, van Druten JA, et al. Predictors of nephrological morbidity after coronary artery bypass surgery. Cardiovasc Surg. 2002;10:222&#x2013;227.</Citation><ArticleIdList><ArticleId IdType="pubmed">12044429</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakeri R, Freemantle N, Barnett V, et al. Relation between mild renal dysfunction and outcomes after coronary artery bypass grafting. Circulation. 2005;112:I270&#x2013;I275.</Citation><ArticleIdList><ArticleId IdType="pubmed">16159830</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw AD, Stafford-Smith M, White WD, et al. The effect of aprotinin on outcome after coronary-artery bypass grafting. N Engl J Med. 2008;358:784&#x2013;793.</Citation><ArticleIdList><ArticleId IdType="pubmed">18287601</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JR, Cochran RP, Leavitt BJ, et al. Multivariable prediction of renal insufficiency developing after cardiac surgery. Circulation. 2007;116:I139&#x2013;I143.</Citation><ArticleIdList><ArticleId IdType="pubmed">17846294</ArticleId></ArticleIdList></Reference><Reference><Citation>Salis S, Mazzanti VV, Merli G, et al. Cardiopulmonary bypass duration is an independent predictor of morbidity and mortality after cardiac surgery. J Cardiothorac Vasc Anesth. 2008;22:814&#x2013;822.</Citation><ArticleIdList><ArticleId IdType="pubmed">18948034</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg AX, Devereaux PJ, Yusuf S, et al. Kidney function after off-pump or on-pump coronary artery bypass graft surgery: a randomized clinical trial. Jama. 2014;311:2191&#x2013;2198.</Citation><ArticleIdList><ArticleId IdType="pubmed">24886787</ArticleId></ArticleIdList></Reference><Reference><Citation>Huen SC, Parikh CR. Predicting acute kidney injury after cardiac surgery: a systematic review. Ann Thorac Surg. 2012;93:337&#x2013;347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3286599</ArticleId><ArticleId IdType="pubmed">22186469</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu JC, Coca SG, Patel UD, et al. Searching for genes that matter in acute kidney injury: a systematic review. Clin J Am Soc Nephrol. 2009;4:1020&#x2013;1031.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2689876</ArticleId><ArticleId IdType="pubmed">19443624</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham PN, Dyanov HM, Park P, et al. Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol. 2002;168:5817&#x2013;5823.</Citation><ArticleIdList><ArticleId IdType="pubmed">12023385</ArticleId></ArticleIdList></Reference><Reference><Citation>Segerer S, Nelson PJ, Schlondorff D. Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol. 2000;11:152&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pubmed">10616852</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyman SN, Darmon D, Goldfarb M, et al. Endotoxin-induced renal failure. I. A role for altered renal microcirculation. Exp Nephrol. 2000;8:266&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pubmed">10940726</ArticleId></ArticleIdList></Reference><Reference><Citation>Stafford-Smith M, Podgoreanu M, Swaminathan M, et al. Association of genetic polymorphisms with risk of renal injury after coronary bypass graft surgery. Am J Kidney Dis. 2005;45:519&#x2013;530.</Citation><ArticleIdList><ArticleId IdType="pubmed">15754274</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew ST, Newman MF, White WD, et al. Preliminary report on the association of apolipoprotein E polymorphisms, with postoperative peak serum creatinine concentrations in cardiac surgical patients. Anesthesiology. 2000;93:325&#x2013;331.</Citation><ArticleIdList><ArticleId IdType="pubmed">10910477</ArticleId></ArticleIdList></Reference><Reference><Citation>Isbir SC, Tekeli A, Ergen A, et al. Genetic polymorphisms contribute to acute kidney injury after coronary artery bypass grafting. Heart Surg Forum. 2007;10:E439&#x2013;E444.</Citation><ArticleIdList><ArticleId IdType="pubmed">17921131</ArticleId></ArticleIdList></Reference><Reference><Citation>Popov AF, Hinz J, Schulz EG, et al. The eNOS 786C/T polymorphism in cardiac surgical patients with cardiopulmonary bypass is associated with renal dysfunction. Eur J Cardiothorac Surg. 2009;36:651&#x2013;656.</Citation><ArticleIdList><ArticleId IdType="pubmed">19523844</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase-Fielitz A, Haase M, Bellomo R, et al. Decreased catecholamine degradation associates with shock and kidney injury after cardiac surgery. J Am Soc Nephrol. 2009;20:1393&#x2013;1403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2689901</ArticleId><ArticleId IdType="pubmed">19406978</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox CS, Yang Q, Cupples LA, et al. Genomewide linkage analysis to serum creatinine, GFR, creatinine clearance in a community-based population: the Framingham Heart Study. J Am Soc Nephrol. 2004;15:2457&#x2013;2461.</Citation><ArticleIdList><ArticleId IdType="pubmed">15339995</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasha DN, Davis JT, Rao F, et al. Heritable influence of DBH on adrenergic and renal function: twin and disease studies. PLoS One. 2013;8:e82956.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3876991</ArticleId><ArticleId IdType="pubmed">24391727</ArticleId></ArticleIdList></Reference><Reference><Citation>Kottgen A, Glazer NL, Dehghan A, et al. Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet. 2009;41:712&#x2013;717.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3039280</ArticleId><ArticleId IdType="pubmed">19430482</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CT, Garnaas MK, Tin A, et al. Genetic Association for Renal Traits among Participants of African Ancestry Reveals New Loci for Renal Function. Plos Genet. 2011;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3169523</ArticleId><ArticleId IdType="pubmed">21931561</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada Y, Sim X, Go MJ, et al. Meta-analysis identifies multiple loci associated with kidney function-related traits in east Asian populations. Nat Genet. 2012;44:904&#x2013;909.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4737645</ArticleId><ArticleId IdType="pubmed">22797727</ArticleId></ArticleIdList></Reference><Reference><Citation>Section 2: AKI Definition. Kidney international supplements. 2012;2:19&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4089595</ArticleId><ArticleId IdType="pubmed">25018918</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyle AP, Hong EL, Hariharan M, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome research. 2012;22:1790&#x2013;1797.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3431494</ArticleId><ArticleId IdType="pubmed">22955989</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic acids research. 2012;40:D930&#x2013;D934.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3245002</ArticleId><ArticleId IdType="pubmed">22064851</ArticleId></ArticleIdList></Reference><Reference><Citation>Langworthy M, Zhou B, de Caestecker M, et al. NFATc1 identifies a population of proximal tubule cell progenitors. J Am Soc Nephrol. 2009;20:311&#x2013;321.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2637056</ArticleId><ArticleId IdType="pubmed">19118153</ArticleId></ArticleIdList></Reference><Reference><Citation>Putoux A, Attie-Bitach T, Martinovic J, et al. Phenotypic variability of Bardet-Biedl syndrome: focusing on the kidney. Pediatric nephrology (Berlin, Germany) 2012;27:7&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">21246219</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura DY, Swiderski RE, Searby CC, et al. Comparative genomics and gene expression analysis identifies BBS9, a new Bardet-Biedl syndrome gene. American journal of human genetics. 2005;77:1021&#x2013;1033.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1285160</ArticleId><ArticleId IdType="pubmed">16380913</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon EG, Malik K, Reynolds P, et al. The parathyroid hormone-responsive B1 gene is interrupted by a t(1;7)(q42;p15) breakpoint associated with Wilms' tumour. Oncogene. 2003;22:1371&#x2013;1380.</Citation><ArticleIdList><ArticleId IdType="pubmed">12618763</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaghloul NA, Katsanis N. Mechanistic insights into Bardet-Biedl syndrome, a model ciliopathy. The Journal of clinical investigation. 2009;119:428&#x2013;437.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2648685</ArticleId><ArticleId IdType="pubmed">19252258</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Hernandez V, Pravincumar P, Diaz-Font A, et al. Bardet-Biedl syndrome proteins control the cilia length through regulation of actin polymerization. Human molecular genetics. 2013;22:3858&#x2013;3868.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3766180</ArticleId><ArticleId IdType="pubmed">23716571</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsythe E, Beales PL. Bardet-Biedl syndrome. Eur J Hum Genet. 2013;21:8&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3522196</ArticleId><ArticleId IdType="pubmed">22713813</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller J, Stoetzel C, Vincent MC, et al. Identification of 28 novel mutations in the Bardet-Biedl syndrome genes: the burden of private mutations in an extensively heterogeneous disease. Human genetics. 2010;127:583&#x2013;593.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3638942</ArticleId><ArticleId IdType="pubmed">20177705</ArticleId></ArticleIdList></Reference><Reference><Citation>Billingsley G, Bin J, Fieggen KJ, et al. Mutations in chaperonin-like BBS genes are a major contributor to disease development in a multiethnic Bardet-Biedl syndrome patient population. Journal of medical genetics. 2010;47:453&#x2013;463.</Citation><ArticleIdList><ArticleId IdType="pubmed">20472660</ArticleId></ArticleIdList></Reference><Reference><Citation>Marion V, Schlicht D, Mockel A, et al. Bardet-Biedl syndrome highlights the major role of the primary cilium in efficient water reabsorption. Kidney international. 2011;79:1013&#x2013;1025.</Citation><ArticleIdList><ArticleId IdType="pubmed">21270763</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Dong Z. Primary cilia and kidney injury: current research status and future perspectives. American journal of physiology Renal physiology. 2013;305:F1085&#x2013;F1098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3798724</ArticleId><ArticleId IdType="pubmed">23904226</ArticleId></ArticleIdList></Reference><Reference><Citation>Weimbs T. Polycystic kidney disease and renal injury repair: common pathways, fluid flow, and the function of polycystin-1. American journal of physiology Renal physiology. 2007;293:F1423&#x2013;F1432.</Citation><ArticleIdList><ArticleId IdType="pubmed">17715262</ArticleId></ArticleIdList></Reference><Reference><Citation>Verghese E, Ricardo SD, Weidenfeld R, et al. Renal primary cilia lengthen after acute tubular necrosis. J Am Soc Nephrol. 2009;20:2147&#x2013;2153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2754102</ArticleId><ArticleId IdType="pubmed">19608704</ArticleId></ArticleIdList></Reference><Reference><Citation>Little J, Higgins JP, Ioannidis JP, et al. Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement. Human genetics. 2009;125:131&#x2013;151.</Citation><ArticleIdList><ArticleId IdType="pubmed">19184668</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobato RL, White WD, Mathew JP, et al. Thrombomodulin gene variants are associated with increased mortality after coronary artery bypass surgery in replicated analyses. Circulation. 2011;124:S143&#x2013;S148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3192987</ArticleId><ArticleId IdType="pubmed">21911804</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah SH, Freedman NJ, Zhang L, et al. Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis. Plos Genet. 2009;5:e1000318.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2602734</ArticleId><ArticleId IdType="pubmed">19119412</ArticleId></ArticleIdList></Reference><Reference><Citation>Voora D, Horton J, Shah SH, et al. Polymorphisms associated with in vitro aspirin resistance are not associated with clinical outcomes in patients with coronary artery disease who report regular aspirin use. Am Heart J. 2011;162:166&#x2013;172. e161.</Citation><ArticleIdList><ArticleId IdType="pubmed">21742104</ArticleId></ArticleIdList></Reference><Reference><Citation>MacKensen GB, Swaminathan M, Ti LK, et al. Preliminary report on the interaction of apolipoprotein E polymorphism with aortic atherosclerosis and acute nephropathy after CABG. Ann Thorac Surg. 2004;78:520&#x2013;526.</Citation><ArticleIdList><ArticleId IdType="pubmed">15276511</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204&#x2013;R212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC522841</ArticleId><ArticleId IdType="pubmed">15312219</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2206446</ArticleId><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Disease: Improving Global O. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int Suppl. 2008:S1&#x2013;S99.</Citation><ArticleIdList><ArticleId IdType="pubmed">18382440</ArticleId></ArticleIdList></Reference><Reference><Citation>Plomin R, Haworth CM, Davis OS. Common disorders are quantitative traits. Nat Rev Genet. 2009;10:872&#x2013;878.</Citation><ArticleIdList><ArticleId IdType="pubmed">19859063</ArticleId></ArticleIdList></Reference><Reference><Citation>Kottgen A, Pattaro C, Boger CA, et al. New loci associated with kidney function and chronic kidney disease. Nat Genet. 2010;42:376&#x2013;384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2997674</ArticleId><ArticleId IdType="pubmed">20383146</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambers JC, Zhang W, Lord GM, et al. Genetic loci influencing kidney function and chronic kidney disease. Nat Genet. 2010;42:373&#x2013;375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3748585</ArticleId><ArticleId IdType="pubmed">20383145</ArticleId></ArticleIdList></Reference><Reference><Citation>Liotta M, Olsson D, Sartipy U, et al. Minimal changes in postoperative creatinine values and early and late mortality and cardiovascular events after coronary artery bypass grafting. Am J Cardiol. 2014;113:70&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">24176074</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassnigg A, Schmid ER, Hiesmayr M, et al. Impact of minimal increases in serum creatinine on outcome in patients after cardiothoracic surgery: do we have to revise current definitions of acute renal failure? Crit Care Med. 2008;36:1129&#x2013;1137.</Citation><ArticleIdList><ArticleId IdType="pubmed">18379238</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Annals of internal medicine. 2009;150:604&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2763564</ArticleId><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. American journal of human genetics. 2007;81:559&#x2013;575.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1950838</ArticleId><ArticleId IdType="pubmed">17701901</ArticleId></ArticleIdList></Reference><Reference><Citation>Price AL, Patterson NJ, Plenge RM, et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38:904&#x2013;909.</Citation><ArticleIdList><ArticleId IdType="pubmed">16862161</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchini J, Howie B, Myers S, et al. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet. 2007;39:906&#x2013;913.</Citation><ArticleIdList><ArticleId IdType="pubmed">17572673</ArticleId></ArticleIdList></Reference><Reference><Citation>Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26:2190&#x2013;2191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2922887</ArticleId><ArticleId IdType="pubmed">20616382</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263&#x2013;265.</Citation><ArticleIdList><ArticleId IdType="pubmed">15297300</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25925634</PMID><DateCompleted><Year>2016</Year><Month>03</Month><Day>03</Day></DateCompleted><DateRevised><Year>2015</Year><Month>06</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1496-8975</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>7</Issue><PubDate><Year>2015</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Canadian journal of anaesthesia = Journal canadien d'anesthesie</Title><ISOAbbreviation>Can J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Perioperative risk factors for acute kidney injury after liver resection surgery: an historical cohort study.</ArticleTitle><Pagination><StartPage>753</StartPage><EndPage>761</EndPage><MedlinePgn>753-61</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12630-015-0397-9</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">This study aimed to identify the incidence and risk factors for acute kidney injury (AKI) after liver resection surgery and to clarify the relationship between postoperative AKI and outcome.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a historical cohort study of patients who underwent liver resection surgery with sevoflurane anesthesia from January 2004 to October 2011. Acute kidney injury was diagnosed based on the Acute Kidney Injury Network classification within 72 hr after the surgery. Patient data, surgical and anesthetic data, and laboratory data were extracted manually from the patients' electronic charts. Multivariable logistic regression analysis was used to identify perioperative risk factors for postoperative AKI.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Acute kidney injury was diagnosed in 78 of 642 patients (12.1%; 95% confidence interval [CI]: 9.7 to 14.9). Multivariable analysis showed an independent association between postoperative AKI and preoperative estimated glomerular filtration rate (adjusted odds ratio [aOR] 0.74; 95% CI: 0.64 to 0.85), preoperative hypertension (aOR 2.10; 95% CI: 1.11 to 3.97), and intraoperative red blood cell transfusion (aOR 1.04; 95% CI: 1.01 to 1.07). Development of AKI within 72 hr after liver resection surgery was associated with increased hospital mortality, prolonged length of stay, and increased rates of mechanical ventilation, reintubation, and renal replacement therapy.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Perioperative risk factors for AKI after liver resection surgery are similar to those established for other surgical procedures. Further studies are needed to establish causality and to determine whether interventions on modifiable risk factors can reduce the incidence of postoperative AKI and improve patient outcome. This study was registered at the University Hospital Medical Information Network (UMIN) Center (UMIN 000008089).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tomozawa</LastName><ForeName>Arisa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishikawa</LastName><ForeName>Seiji</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Shiota</LastName><ForeName>Nobuhiro</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Cholvisudhi</LastName><ForeName>Phantila</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Makita</LastName><ForeName>Koshi</ForeName><Initials>K</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>04</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Can J Anaesth</MedlineTA><NlmUniqueID>8701709</NlmUniqueID><ISSNLinking>0832-610X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Can J Anaesth. 2015 Jul;62(7):727-30. doi: 10.1007/s12630-015-0399-7.</RefSource><PMID Version="1">25902892</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017707" MajorTopicYN="N">Erythrocyte Transfusion</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006498" MajorTopicYN="N">Hepatectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="N">Renal Replacement Therapy</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>11</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25925634</ArticleId><ArticleId IdType="doi">10.1007/s12630-015-0397-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28124458</PMID><DateCompleted><Year>2018</Year><Month>02</Month><Day>27</Day></DateCompleted><DateRevised><Year>2018</Year><Month>04</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-6473</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>5</Issue><PubDate><Year>2017</Year><Month>May</Month></PubDate></JournalIssue><Title>Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society</Title><ISOAbbreviation>Liver Transpl</ISOAbbreviation></Journal><ArticleTitle>Hepatic ischemia/reperfusion injury associates with acute kidney injury in liver transplantation: Prospective cohort study.</ArticleTitle><Pagination><StartPage>634</StartPage><EndPage>644</EndPage><MedlinePgn>634-644</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/lt.24728</ELocationID><Abstract><AbstractText>Solid clinical prospective studies investigating the association between hepatic ischemia/reperfusion injury (HIRI) and acute kidney injury (AKI) after liver transplantation are missing. HIRI, reflected by transaminase release, induces AKI in rodents, and retrospective studies suggest a similar association in humans. This prospective cohort study determined risk factors for AKI in 80 adult liver-only recipients. AKI defined by Risk, Injury, Failure, Loss, and End-Stage Kidney Disease (RIFLE) criteria developed in 21 (26%) recipients at 12 hours after reperfusion (interquartile range, 6 hours to postoperative day [POD] 1); 13 progressed from "risk" to "injury"; 5 progressed to "failure." In AKI patients, creatinine (Cr) increased during liver transplantation and was higher versus baseline at 6 hours to POD 4, whereas perioperative Cr remained stable in those without AKI. Plasma heart-type fatty acid-binding protein was higher 12 hours after reperfusion in AKI patients, though urinary kidney injury molecule 1 and neutrophil gelatinase-associated lipocalin were similar between those with or without AKI. Peak aspartate aminotransferase (AST), occurring at 6 hours, was the only independent risk factor for AKI (adjusted odds ratio, 2.42; 95% confidence interval, 1.24-4.91). Early allograft dysfunction occurred more frequently in AKI patients, and intensive care and hospital stays were longer. Patient survival at 1 year was 90% in those with AKI versus 98% in those without AKI. Chronic kidney disease stage &#x2265; 2 at 1 year was more frequent in patients who had had AKI (89% versus 58%, respectively). In conclusion, AKI is initiated early after liver reperfusion and its association with peak AST suggests HIRI as a determinant. Identifying operating mechanisms is critical to target interventions and to reduce associated morbidity. Liver Transplantation 23 634-644 2017 AASLD.</AbstractText><CopyrightInformation>&#xa9; 2017 by the American Association for the Study of Liver Diseases.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jochmans</LastName><ForeName>Ina</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Laboratory of Abdominal Transplant Surgery, Department of Microbiology and Immunology, Katholieke Universiteit Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Abdominal Transplant Surgery, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meurisse</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Laboratory of Abdominal Transplant Surgery, Department of Microbiology and Immunology, Katholieke Universiteit Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neyrinck</LastName><ForeName>Arne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Algology, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verhaegen</LastName><ForeName>Marleen</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Algology, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monbaliu</LastName><ForeName>Diethard</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Laboratory of Abdominal Transplant Surgery, Department of Microbiology and Immunology, Katholieke Universiteit Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Abdominal Transplant Surgery, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pirenne</LastName><ForeName>Jacques</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratory of Abdominal Transplant Surgery, Department of Microbiology and Immunology, Katholieke Universiteit Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Abdominal Transplant Surgery, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Liver Transpl</MedlineTA><NlmUniqueID>100909185</NlmUniqueID><ISSNLinking>1527-6465</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.6.1.1</RegistryNumber><NameOfSubstance UI="D001219">Aspartate Aminotransferases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001219" MajorTopicYN="N">Aspartate Aminotransferases</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="N">blood supply</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016031" MajorTopicYN="Y">Liver Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015427" MajorTopicYN="N">Reperfusion Injury</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28124458</ArticleId><ArticleId IdType="doi">10.1002/lt.24728</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39753404</PMID><DateCompleted><Year>2025</Year><Month>02</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>134</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Mar</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Effect of telemedicine support for intraoperative anaesthesia care on postoperative outcomes: the TECTONICS randomised clinical trial.</ArticleTitle><Pagination><StartPage>671</StartPage><EndPage>680</EndPage><MedlinePgn>671-680</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2024.11.017</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(24)00694-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Telemedicine may help improve care quality and patient outcomes. Telemedicine for intraoperative decision support has not been rigorously studied.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a single-centre randomised clinical trial of unselected adult surgical patients. Patients were randomised to receive usual care or decision support from a telemedicine service, which provided real-time recommendations to intraoperative anaesthesia clinicians based on case reviews and physiological alerts. ORs were randomised 1:1. The co-primary outcomes were 30-day all-cause mortality, respiratory failure, acute kidney injury, and delirium in the intensive care unit, analysed by intention to treat.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Between July 1, 2019, and January 31, 2023, a total of 35,302 patients were randomised to receive telemedicine support, with 36,625 receiving usual care. Telemedicine clinicians provided review in 11,812/35,302 cases, with alerts delivered to 2044/35,302 patients. Telemedicine support had no effect on any of the co-primary outcomes. Within 30 days, 630/35,302 (1.8%) patients randomised to telemedicine died within 30 days, compared with 649/36,625 (1.8%) receiving usual care (relative risk [RR]1.01, 95% confidence interval [CI] 0.87-1.16, P=0.98). Telemedicine support did not alter postoperative respiratory failure [telemedicine 1071/33,996 (3.2%) vs usual care 1130/35,236 (3.2%), RR 0.98, 95% CI 0.88-1.09, P=0.98], acute kidney injury [telemedicine 2316/33 251 (7.0%) vs usual care 2432/34,441 (7.1%); RR 0.99, 95% CI 0.92-1.06, P=0.98], or delirium [telemedicine 1264/3873 (32.6%) vs usual care 1298/4044 (32.1%), RR 1.02, 95% CI 0.94-1.10, P=0.98].</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In this large randomised clinical trial, intraoperative telemedicine decision support using real-time alerts and case reviews had no impact on adverse postoperative outcomes.</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION" NlmCategory="BACKGROUND">NCT03923699.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>King</LastName><ForeName>Christopher R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA. Electronic address: christopherking@wustl.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fritz</LastName><ForeName>Bradley A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gregory</LastName><ForeName>Stephen H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Budelier</LastName><ForeName>Thaddeus P</ForeName><Initials>TP</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben Abdallah</LastName><ForeName>Arbi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kronzer</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helsten</LastName><ForeName>Daniel L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA; Barnes-Jewish College, Goldfarb School of Nursing in St. Louis, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKinnon</LastName><ForeName>Sherry L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tripathi</LastName><ForeName>Sandhya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdelhack</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA; Krembil Centre for Neuroinformatics, Centre for Addiction and Mental Health, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goswami</LastName><ForeName>Shreya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montes de Oca</LastName><ForeName>Arianna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Divya</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valdez</LastName><ForeName>Miguel A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karanikolas</LastName><ForeName>Evangelos</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Higo</LastName><ForeName>Omokhaye</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kerby</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henrichs</LastName><ForeName>Bernadette</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wildes</LastName><ForeName>Troy S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Nebraska Medical Center, Omaha, NE, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Politi</LastName><ForeName>Mary C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Surgery, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abraham</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA; Institute for Informatics, Data Science and Biostatistics, Washington University School of Medicine in St Louis, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avidan</LastName><ForeName>Michael S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kannampallil</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA; Institute for Informatics, Data Science and Biostatistics, Washington University School of Medicine in St Louis, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>ACTFAST collaborator group</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03923699</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>R01 NR017916</GrantID><Acronym>NR</Acronym><Agency>NINR NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D017428">Clinical Trial, Phase III</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D065007">Pragmatic Clinical Trial</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>01</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>medRxiv. 2024 Nov 26:2024.05.21.24307593. doi: 10.1101/2024.05.21.24307593.</RefSource><PMID Version="1">38826207</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="Y">Anesthesia</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007430" MajorTopicYN="Y">Intraoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017216" MajorTopicYN="Y">Telemedicine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">decision support</Keyword><Keyword MajorTopicYN="N">delirium</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">postoperative mortality</Keyword><Keyword MajorTopicYN="N">randomised trial</Keyword><Keyword MajorTopicYN="N">respiratory failure</Keyword><Keyword MajorTopicYN="N">telemedicine</Keyword></KeywordList><CoiStatement>Declaration of interest The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>21</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>1</Month><Day>4</Day><Hour>0</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>1</Month><Day>3</Day><Hour>21</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>1</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39753404</ArticleId><ArticleId IdType="pmc">PMC11867081</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2024.11.017</ArticleId><ArticleId IdType="pii">S0007-0912(24)00694-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guinemer C., Boeker M., F&#xfc;rstenau D., et al. Telemedicine in intensive care units: scoping review. J&#xa0;Med Internet Res. 2021;23</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8600441</ArticleId><ArticleId IdType="pubmed">34730547</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian S., Pamplin J.C., Hravnak M., et al. Tele-critical care: an update from the Society of Critical Care Medicine Tele-ICU Committee. Crit Care Med. 2020;48:553&#x2013;561.</Citation><ArticleIdList><ArticleId IdType="pubmed">32205602</ArticleId></ArticleIdList></Reference><Reference><Citation>Ofoma U.R., Maddox T.M., Perera C., et al. Characteristics of U.S. acute care hospitals that have implemented telemedicine critical care. Crit Care Explor. 2021;3:e0468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8245115</ArticleId><ArticleId IdType="pubmed">34235456</ArticleId></ArticleIdList></Reference><Reference><Citation>Caples S.M. Intensive care unit telemedicine care models. Crit Care Clin. 2019;35:479&#x2013;482.</Citation><ArticleIdList><ArticleId IdType="pubmed">31076047</ArticleId></ArticleIdList></Reference><Reference><Citation>Spies C.D., Paul N., Adrion C., et al. Effectiveness of an intensive care telehealth programme to improve process quality (ERIC): a multicentre stepped wedge cluster randomised controlled trial. Intensive Care Med. 2023;49:191&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9841931</ArticleId><ArticleId IdType="pubmed">36645446</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn J.M., Le T.Q., Barnato A.E., et al. ICU telemedicine and critical care mortality: a national effectiveness study. Med Care. 2016;54:319&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4752864</ArticleId><ArticleId IdType="pubmed">26765148</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira A.J., Noritomi D.T., Dos Santos M.C., et al. Effect of tele-ICU on clinical outcomes of critically ill patients: the TELESCOPE randomized clinical trial. JAMA. 2024;332:1798&#x2013;1807.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11581649</ArticleId><ArticleId IdType="pubmed">39382244</ArticleId></ArticleIdList></Reference><Reference><Citation>Bridges K.H., McSwain J.R., Wilson P.R. To infinity and beyond: the past, present, and future of tele-anesthesia. Anesth Analg. 2020;130:276&#x2013;284.</Citation><ArticleIdList><ArticleId IdType="pubmed">31397698</ArticleId></ArticleIdList></Reference><Reference><Citation>Cone S.W., Gehr L., Hummel R., Merrell R.C. Remote anesthetic monitoring using satellite telecommunications and the Internet. Anesth Analg. 2006;102:1463&#x2013;1467.</Citation><ArticleIdList><ArticleId IdType="pubmed">16632827</ArticleId></ArticleIdList></Reference><Reference><Citation>Cone S.W., Gehr L., Hummel R., Rafiq A., Doarn C.R., Merrell R.C. Case report of remote anesthetic monitoring using telemedicine. Anesth Analg. 2004;98:386&#x2013;388.</Citation><ArticleIdList><ArticleId IdType="pubmed">14742375</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyashita T., Mizuno Y., Sugawara Y., et al. A&#xa0;pilot study of tele-anaesthesia by virtual private network between an island hospital and a mainland hospital in Japan. J&#xa0;Telemed Telecare. 2015;21:73&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">25488187</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiadjoe J., Gurnaney H., Muralidhar K., et al. Telemedicine consultation and monitoring for pediatric liver transplant. Anesth Analg. 2009;108:1212&#x2013;1214.</Citation><ArticleIdList><ArticleId IdType="pubmed">19299789</ArticleId></ArticleIdList></Reference><Reference><Citation>Saksa D., Shuch B., Donahue T., et al. Telemedicine-based perioperative management of pheochromocytoma in a patient with Von Hippel Lindau disease: a case report. AA Pract. 2021;15</Citation><ArticleIdList><ArticleId IdType="pubmed">33512909</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S., Shanks A., Tremper K.K. Impact of a novel multiparameter decision support system on intraoperative processes of care and postoperative outcomes. Anesthesiology. 2018;128:272&#x2013;282.</Citation><ArticleIdList><ArticleId IdType="pubmed">29337743</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham J., Meng A., Montes de Oca A., et al. An ethnographic study on the impact of a novel telemedicine-based support system in the operating room. J&#xa0;Am Med Inform Assoc JAMIA. 2022;29:1919&#x2013;1930.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10161534</ArticleId><ArticleId IdType="pubmed">35985294</ArticleId></ArticleIdList></Reference><Reference><Citation>King C.R., Gregory S., Fritz B.A., et al. An intraoperative telemedicine program to improve perioperative quality measures: the ACTFAST-3 randomized clinical trial. JAMA Netw Open. 2023;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10517374</ArticleId><ArticleId IdType="pubmed">37738052</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray-Torres T., Casarella A., Bollini M., Wallace F., Avidan M.S., Politi M.C. Anesthesiology Control Tower-Feasibility Assessment to Support Translation (ACTFAST): mixed-methods study of a novel telemedicine-based support system for the operating room. JMIR Hum Factor. 2019;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6658281</ArticleId><ArticleId IdType="pubmed">31012859</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham J., Meng A., Holzer K.J., et al. Exploring patient perspectives on telemedicine monitoring within the operating room. Int J Med Inf. 2021;156</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10627166</ArticleId><ArticleId IdType="pubmed">34627112</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham J., Bartek B., Meng A., et al. Integrating machine&#xa0;learning predictions for perioperative risk management: towards an empirical design of a flexible-standardized risk assessment tool. J&#xa0;Biomed Inform. 2023;137</Citation><ArticleIdList><ArticleId IdType="pubmed">36516944</ArticleId></ArticleIdList></Reference><Reference><Citation>Fritz B.A., Cui Z., Zhang M., et al. Deep-learning model for predicting 30-day postoperative mortality. Br J Anaesth. 2019;123:688&#x2013;695.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6993109</ArticleId><ArticleId IdType="pubmed">31558311</ArticleId></ArticleIdList></Reference><Reference><Citation>Fritz B.A., Pugazenthi S., Budelier T.P., et al. User-centered design of a machine learning dashboard for prediction of postoperative complications. Anesth Analg. 2024;138:804&#x2013;813.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10730770</ArticleId><ArticleId IdType="pubmed">37339083</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue B., Li D., Lu C., et al. Use of machine learning to develop and evaluate models using preoperative and intraoperative data to identify risks of postoperative complications. JAMA Netw Open. 2021;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010590</ArticleId><ArticleId IdType="pubmed">33783520</ArticleId></ArticleIdList></Reference><Reference><Citation>Fritz B.A., King C.R., Abdelhack M., et al. Effect of machine learning models on clinician prediction of postoperative complications: the Perioperative ORACLE randomised clinical trial. Br J Anaesth. 2024;133:1042&#x2013;1050.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11488162</ArticleId><ArticleId IdType="pubmed">39261226</ArticleId></ArticleIdList></Reference><Reference><Citation>King C.R., Abraham J., Kannampallil T.G., et al. Protocol for the effectiveness of an anesthesiology control tower system in improving perioperative quality metrics and clinical outcomes: the TECTONICS randomized, pragmatic trial. F1000Res. 2019;8:2032.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7076336</ArticleId><ArticleId IdType="pubmed">32201572</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeileis A., K&#xf6;ll S., Graham N. Various versatile variances: an object-oriented implementation of clustered covariances in R. J&#xa0;Stat Softw. 2020;95:1&#x2013;36.</Citation></Reference><Reference><Citation>Romano J.P., Wolf M. Efficient computation of adjusted p-values for resampling-based stepdown multiple testing. Stat Probab Lett. 2016;113:38&#x2013;40.</Citation></Reference><Reference><Citation>Ioannidis J.P.A. The proposal to lower P value thresholds to .005. JAMA. 2018;319:1429&#x2013;1430.</Citation><ArticleIdList><ArticleId IdType="pubmed">29566133</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team  . R Foundation for Statistical Computing; Vienna, Austria: 2021. R: a language and environment for statistical computing.https://www.R-project.org/</Citation></Reference><Reference><Citation>van Eijk M.M., van den Boogaard M., van Marum R.J., et al. Routine use of the confusion assessment method for the intensive care unit: a multicenter study. Am J Respir Crit Care Med. 2011;184:340&#x2013;344.</Citation><ArticleIdList><ArticleId IdType="pubmed">21562131</ArticleId></ArticleIdList></Reference><Reference><Citation>Saager L., Ruetzler K., Turan A., et al. Do it often, do it better: association between pairs of experienced subspecialty anesthesia caregivers and postoperative outcomes. a retrospective observational study. Anesth Analg. 2021;132:866&#x2013;877.</Citation><ArticleIdList><ArticleId IdType="pubmed">33433116</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23055035</PMID><DateCompleted><Year>2014</Year><Month>02</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1496-8975</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>12</Issue><PubDate><Year>2012</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Canadian journal of anaesthesia = Journal canadien d'anesthesie</Title><ISOAbbreviation>Can J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Acute kidney injury following total joint arthroplasty: retrospective analysis.</ArticleTitle><Pagination><StartPage>1111</StartPage><EndPage>1118</EndPage><MedlinePgn>1111-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12630-012-9797-2</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Postoperative acute kidney injury (AKI) following arthroplasty has not been well studied. Our aim was to identify factors associated with increased risk of AKI.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The medical records for adult patients who underwent elective total joint arthroplasty during June 1, 2007 to May 31, 2010 at the Mayo Clinic were reviewed to identify patients with normal preoperative kidney function who experienced perioperative AKI, defined as an increase in serum creatinine (sCr) by 26.4&#xa0;&#x3bc;mol&#xb7;L(-1). For each AKI case, two controls were identified and matched for age, sex, and type of operation. Medical records were abstracted for demographics, comorbid conditions, and preoperative, intraoperative, and postoperative variables. Conditional logistic regression analyses were performed to identify risk factors for AKI.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 9,171 patients who underwent joint replacement operations, 167 with normal preoperative renal function developed AKI with a median [25(th), 75(th)] increase in sCr of 35.4 [26.4, 44.2]&#xa0;&#x3bc;mol&#xb7;L(-1). No patient required dialysis. A higher than normal body mass index, diabetes mellitus, the number of baseline antihypertensive medications, cerebral or peripheral vascular disease, use of general anesthesia, and perioperative blood transfusions were independently associated with risk for AKI. Hospital length of stay and intensive care admissions were greater in AKI patients, and in 12.0% of patients, sCr remained at least 26.4&#xa0;&#x3bc;mol&#xb7;L(-1) higher than preoperative baseline at least three months after surgery.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In this case-control investigation, we identified several factors associated with the development of postoperative AKI. Recognition of these risk factors could allow for the adoption of perioperative renal protective strategies in patients undergoing arthroplasty.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Weingarten</LastName><ForeName>Toby N</ForeName><Initials>TN</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Mayo Clinic College of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. weingarten.toby@mayo.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gurrieri</LastName><ForeName>Carmelina</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Jarett</LastName><ForeName>Paul D</ForeName><Initials>PD</Initials></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Deforest R</ForeName><Initials>DR</Initials></Author><Author ValidYN="Y"><LastName>Berntson</LastName><ForeName>Novette J</ForeName><Initials>NJ</Initials></Author><Author ValidYN="Y"><LastName>Calaro</LastName><ForeName>Reynaldo D</ForeName><Initials>RD</Initials><Suffix>Jr</Suffix></Author><Author ValidYN="Y"><LastName>Kor</LastName><ForeName>Daryl J</ForeName><Initials>DJ</Initials></Author><Author ValidYN="Y"><LastName>Berry</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials></Author><Author ValidYN="Y"><LastName>Garovic</LastName><ForeName>Vesna D</ForeName><Initials>VD</Initials></Author><Author ValidYN="Y"><LastName>Nicholson</LastName><ForeName>Wayne T</ForeName><Initials>WT</Initials></Author><Author ValidYN="Y"><LastName>Schroeder</LastName><ForeName>Darrell R</ForeName><Initials>DR</Initials></Author><Author ValidYN="Y"><LastName>Sprung</LastName><ForeName>Juraj</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>KL2 RR024151</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 RR024150</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>09</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Can J Anaesth</MedlineTA><NlmUniqueID>8701709</NlmUniqueID><ISSNLinking>0832-610X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001178" MajorTopicYN="N">Arthroplasty</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23055035</ArticleId><ArticleId IdType="doi">10.1007/s12630-012-9797-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40629778</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>09</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">0974-5181</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>Annals of cardiac anaesthesia</Title><ISOAbbreviation>Ann Card Anaesth</ISOAbbreviation></Journal><ArticleTitle>The Role of Acetaminophen Use in Acute Kidney Injury Prevention in Cardiac Surgery: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>238</StartPage><EndPage>247</EndPage><MedlinePgn>238-247</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/aca.aca_223_24</ELocationID><Abstract><AbstractText>Acute kidney injury (AKI) is a common complication following cardiac surgery, often leading to increased morbidity and mortality. Despite its prevalence, the role of acetaminophen in preventing AKI after cardiac surgery remains uncertain. This meta-analysis sought to clarify whether perioperative administration of acetaminophen could reduce the risk of postoperative AKI in adult patients undergoing cardiac procedures. To address this question, a systematic review and meta-analysis were performed by searching the MEDLINE, Cochrane, and Embase databases. Studies comparing the effects of perioperative acetaminophen to those of no acetaminophen in adult cardiac surgery patients were evaluated, with risk of bias assessed for each study. Sensitivity analyses were also conducted to strengthen the reliability of the findings. In total, 13 studies, including nine randomized controlled trials and four observational studies, involving 11,583 patients, were analyzed. The results showed that acetaminophen administration was associated with a lower incidence of AKI [OR 0.62 (95% CI 0.40-0.97), P = 0.04]. Additionally, acetaminophen use was linked to reduced in-hospital mortality, delirium rates, and shorter ICU stays, though it had no significant effect on overall hospital length of stay. These findings suggest that perioperative acetaminophen administration may play a protective role in reducing both AKI incidence and in-hospital mortality in patients undergoing cardiac surgery. Until large multicenter randomized controlled trials confirm these results, acetaminophen may still be considered as a preventive measure for patients both before cardiopulmonary bypass initiation and in the postoperative period.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Annals of Cardiac Anaesthesia.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ciconini</LastName><ForeName>Luis E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, SUNY Downstate, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perim</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Alabama, Division of Cardiothoracic Anesthesia and Critical Care, University of Alabama, Birmingham, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beck</LastName><ForeName>Theodoro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, SUNY Downstate, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carbonar</LastName><ForeName>Mauren F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, SUNY Downstate, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ejikem</LastName><ForeName>Mazpa M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, SUNY Downstate, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaky</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiothoracic and Critical Care Anesthesiology, Division of Cardiothoracic Anesthesia and Critical Care, University of Alabama, Birmingham, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neyra</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Nephrology, Division of Cardiothoracic Anesthesia and Critical Care, University of Alabama, Birmingham, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gosling</LastName><ForeName>Andre F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Division of Cardiothoracic Anesthesia and Critical Care, University of Alabama, Birmingham, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Ann Card Anaesth</MedlineTA><NlmUniqueID>9815987</NlmUniqueID><ISSNLinking>0971-9784</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>362O9ITL9D</RegistryNumber><NameOfSubstance UI="D000082">Acetaminophen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018712">Analgesics, Non-Narcotic</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000082" MajorTopicYN="Y">Acetaminophen</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018712" MajorTopicYN="Y">Analgesics, Non-Narcotic</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AKI</Keyword><Keyword MajorTopicYN="N">Acetaminophen</Keyword><Keyword MajorTopicYN="N">CABG</Keyword><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword></KeywordList><CoiStatement>There are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>1</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>9</Day><Hour>2</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40629778</ArticleId><ArticleId IdType="pmc">PMC12324758</ArticleId><ArticleId IdType="doi">10.4103/aca.aca_223_24</ArticleId><ArticleId IdType="pii">00660469-202507000-00005</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cheruku SR, Raphael J, Neyra JA, Fox AA. Acute kidney injury after cardiac surgery: Prediction, prevention, and management. Anesthesiology. 2023;139:880&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10841304</ArticleId><ArticleId IdType="pubmed">37812758</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Gao Y, Tian Y, Wang Y, Zhao W, Sessler DI, et al. Prediction of acute kidney injury after cardiac surgery from preoperative N-terminal pro-B-type natriuretic peptide. Br J Anaesth. 2021;127:862&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">34561052</ArticleId></ArticleIdList></Reference><Reference><Citation>Milne B, Gilbey T, Kunst G. Perioperative management of the patient at high-risk for cardiac surgery-associated acute kidney injury. J Cardiothorac Vasc Anesth. 2022;36:4460&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">36241503</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong C, Jia Y, Wu X, Zhao Y, Yuan S, Yan F, et al. Early postoperative acetaminophen administration and severe acute kidney injury after cardiac surgery. Am J Kidney Dis Off J Natl Kidney Found. 2023;81:675&#x2013;83.e1.</Citation><ArticleIdList><ArticleId IdType="pubmed">36586561</ArticleId></ArticleIdList></Reference><Reference><Citation>Desgrouas M, Boulain T. Paracetamol use and lowered risk of acute kidney injury in patients with rhabdomyolysis. J Nephrol. 2021;34:1725&#x2013;1735. doi:10.1007/s40620-020-00950-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">33400139</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Driest SL, Jooste EH, Shi Y, Choi L, Darghosian L, Hill KD, et al. Association between early postoperative acetaminophen exposure and acute kidney injury in pediatric patients undergoing cardiac surgery. JAMA Pediatr. 2018;172:655&#x2013;663. doi: 10.1001/jamapediatrics. 2018.0614.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6110290</ArticleId><ArticleId IdType="pubmed">29799947</ArticleId></ArticleIdList></Reference><Reference><Citation>Young AM, Strobel RJ, Rotar EP, Kleiman A, McNeil JS, Teman NR, et al. Perioperative acetaminophen is associated with reduced acute kidney injury after cardiac surgery. J Thorac Cardiovasc Surg. 2024;167:1372&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">36207161</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, Savovi&#x107; J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. doi: 10.1136/bmj.l4898.</Citation><ArticleIdList><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al.  The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.  [[Last accessed 2024 Apr 21]].  Available from: https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp .</Citation></Reference><Reference><Citation>Sterne JAC, Sutton AJ, Ioannidis JPA, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002. doi:10.1136/bmj.d4002.</Citation><ArticleIdList><ArticleId IdType="pubmed">21784880</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FT, Petracek MR, Roberts LJ, Pretorius M. Perioperative intravenous acetaminophen attenuates lipid peroxidation in adults undergoing cardiopulmonary bypass: A randomized clinical trial. PLoS One. 2015;10:e0117625.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4338200</ArticleId><ArticleId IdType="pubmed">25705899</ArticleId></ArticleIdList></Reference><Reference><Citation>Almoghrabi OA, Brungardt JG, Helmer SD, Reyes JM, Grizzell BE. Efficacy of intravenous acetaminophen as adjunct post-operative analgesic in cardiac surgery: A retrospective study. Kans J Med. 2020;13:143&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7324059</ArticleId><ArticleId IdType="pubmed">32612746</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahangiri Fard A, Babaee T, Alavi SM, Nasiri AA, Ghoreishi SM, Noori NM, et al. Intravenous patient-controlled remifentanil versus paracetamol in post-operative pain management in patients undergoing coronary artery bypass graft surgery. Anesthesiol Pain Med. 2014;4:e19862.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4333302</ArticleId><ArticleId IdType="pubmed">25729675</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramaniam B, Shankar P, Shaefi S, Mueller A, O&#x2019;Gara B, Banner-Goodspeed V, et al. Effect of intravenous acetaminophen vs placebo combined with propofol or dexmedetomidine on postoperative delirium among older patients following cardiac surgery: The DEXACET randomized clinical trial. JAMA. 2019;321:686&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6439609</ArticleId><ArticleId IdType="pubmed">30778597</ArticleId></ArticleIdList></Reference><Reference><Citation>Susheela AT, Packiasabapathy S, Gasangwa DV, Patxot M, O&#x2019;Neal J, Marcantonio E, et al. The use of dexmedetomidine and intravenous acetaminophen for the prevention of postoperative delirium in cardiac surgery patients over 60 years of age: A pilot study. F1000Res. 2017;6:1842.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5754745</ArticleId><ArticleId IdType="pubmed">29333240</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiam E, Bellomo R, Churilov L, Weinberg L. The hemodynamic effects of intravenous paracetamol (acetaminophen) vs normal saline in cardiac surgery patients: A single center placebo controlled randomized study. PLoS One. 2018;13:e0195931.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5901786</ArticleId><ArticleId IdType="pubmed">29659631</ArticleId></ArticleIdList></Reference><Reference><Citation>Jelacic S, Bollag L, Bowdle A, Rivat C, Cain KC, Richebe P. Intravenous acetaminophen as an adjunct analgesic in cardiac surgery reduces opioid consumption but not opioid-related adverse effects: A randomized controlled trial. J Cardiothorac Vasc Anesth. 2016;30:997&#x2013;1004.</Citation><ArticleIdList><ArticleId IdType="pubmed">27521969</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneko S, Ichinomiya T, Sato S, Sekino M, Murata H, Hara T. Effect of perioperative acetaminophen on body temperature after cardiovascular surgery with cardiopulmonary bypass: A single-center retrospective study. Ann Card Anaesth. 2021;24:155&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8253030</ArticleId><ArticleId IdType="pubmed">33884970</ArticleId></ArticleIdList></Reference><Reference><Citation>Altun D, &#xc7;&#x131;nar &#xd6;, &#xd6;zker E, T&#xfc;rk&#xf6;z A. The effect of tramadol plus paracetamol on consumption of morphine after coronary artery bypass grafting. J Clin Anesth. 2017;36:189&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">28183564</ArticleId></ArticleIdList></Reference><Reference><Citation>Arslan Y, Kudsioglu T, Yapici N, Aykac Z. Administration of paracetamol, diclofenac sodium, and tramadol in postoperative analgesia after coronary artery bypass surgery. J Cardio-Vasc-Thorac Anaesth Intensive Care Soc. 2018 doi: 10.5222/GKDAD.2018.023.</Citation></Reference><Reference><Citation>Mamoun NF, Lin P, Zimmerman NM, Mascha EJ, Mick SL, Insler SR, et al. Intravenous acetaminophen analgesia after cardiac surgery: A randomized, blinded, controlled superiority trial. J Thorac Cardiovasc Surg. 2016;152:881&#x2013;9.e1.</Citation><ArticleIdList><ArticleId IdType="pubmed">27236864</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastin AJ, Ostermann M, Slack AJ, Diller GP, Finney SJ, Evans TW. Acute kidney injury after cardiac surgery according to risk/injury/failure/loss/end-stage, acute kidney injury network, and kidney disease: Improving global outcomes classifications. J Crit Care. 2013;28:389&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">23743540</ArticleId></ArticleIdList></Reference><Reference><Citation>Englberger L, Suri RM, Li Z, Casey ET, Daly RC, Dearani JA, et al. Clinical accuracy of RIFLE and Acute Kidney Injury Network (AKIN) criteria for acute kidney injury in patients undergoing cardiac surgery. Crit Care. 2011;15:R16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3222049</ArticleId><ArticleId IdType="pubmed">21232094</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado MN, Nakazone MA, Maia LN. Prognostic value of acute kidney injury after cardiac surgery according to kidney disease: Improving Global Outcomes Definition and Staging (KDIGO) criteria. PLoS One. 2014;9:e98028.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4020924</ArticleId><ArticleId IdType="pubmed">24826910</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan S, Pannu N, Wilson T, Ball C, Tan Z, Tonelli M, et al. Prognostic implications of adding urine output to serum creatinine measurements for staging of acute kidney injury after major surgery: A cohort study. Nephrol Dial Transplant. 2016;31:2049&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">27941063</ArticleId></ArticleIdList></Reference><Reference><Citation>James MT, Dixon E, Roberts DJ, Barry R, Balint C, Bharwani A, et al. Improving prevention, early recognition and management of acute kidney injury after major surgery: Results of a planning meeting with multidisciplinary stakeholders. Can J Kidney Health Dis. 2014;1:20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4424428</ArticleId><ArticleId IdType="pubmed">25960886</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren J, Mehran R, Baber U, Xu K, Giacoppo D, Gersh BJ, et al. Incidence and impact of acute kidney injury in patients with acute coronary syndromes treated with coronary artery bypass grafting: Insights from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) and Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trials. Am Heart J. 2016;171:40&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">26699599</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Z, Besser M, Anderson S, Newey C, Iles R, Dunning J, et al. Pulsatile versus nonpulsatile flow during cardiopulmonary bypass: Extent of hemolysis and clinical significance. ASAIO J 1992. 2020;66:1025&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">32224786</ArticleId></ArticleIdList></Reference><Reference><Citation>Wozniak MJ, Sullo N, Qureshi S, Dott W, Cardigan R, Wiltshire M, et al. Randomized trial of red cell washing for the prevention of transfusion-associated organ injury in cardiac surgery. Br J Anaesth. 2017;118:689&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5430295</ArticleId><ArticleId IdType="pubmed">28475670</ArticleId></ArticleIdList></Reference><Reference><Citation>Goksedef D, Omeroglu SN, Balkanay OO, Denli Yalvac ES, Talas Z, Albayrak A, et al. Hemolysis at different vacuum levels during vacuum-assisted venous drainage: A prospective randomized clinical trial. Thorac Cardiovasc Surg. 2012;60:262&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">21789761</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Avondt K, Nur E, Zeerleder S. Mechanisms of haemolysis-induced kidney injury. Nat Rev Nephrol. 2019;15:671&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">31455889</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Michaca L, Farrugia G, Croatt AJ, Alam J, Nath KA. Heme: A determinant of life and death in renal tubular epithelial cells. Am J Physiol Renal Physiol. 2004;286:F370&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">14707007</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei C, Berra L, Rezoagli E, Yu B, Dong H, Yu S, et al. Nitric oxide decreases acute kidney injury and stage 3 chronic kidney disease after cardiac surgery. Am J Respir Crit Care Med. 2018;198:1279&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6290943</ArticleId><ArticleId IdType="pubmed">29932345</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamenshchikov NO, Anfinogenova YJ, Kozlov BN, Svirko YS, Pekarskiy SE, Evtushenko VV, et al. Nitric oxide delivery during cardiopulmonary bypass reduces acute kidney injury: A randomized trial. J Thorac Cardiovasc Surg. 2022;163:1393&#x2013;403.e9.</Citation><ArticleIdList><ArticleId IdType="pubmed">32718702</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutaud O, Moore KP, Reeder BJ, Harry D, Howie AJ, Wang S, et al. Acetaminophen inhibits hemoprotein-catalyzed lipid peroxidation and attenuates rhabdomyolysis-induced renal failure. Proc Natl Acad Sci U S A. 2010;107:2699&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2823910</ArticleId><ArticleId IdType="pubmed">20133658</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson SA, Zaccagni H, Bichell DP, Christian KG, Mettler BA, Donahue BS, et al. Acetaminophen attenuates lipid peroxidation in children undergoing cardiopulmonary bypass. Pediatr Crit Care Med. 2014;15:503&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4087071</ArticleId><ArticleId IdType="pubmed">24732290</ArticleId></ArticleIdList></Reference><Reference><Citation>Scurt FG, Bose K, Mertens PR, Chatzikyrkou C, Herzog C. Cardiac surgery&#x2013;associated acute kidney injury. Kidney360. 2024;5:909&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11219121</ArticleId><ArticleId IdType="pubmed">38689404</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan KM, Dean A, Soe MM. On academics&#x202f;: OpenEpi: A web-based epidemiologic and statistical calculator for public health. Public Health Reports&#xae;. 2009;124:471&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2663701</ArticleId><ArticleId IdType="pubmed">19445426</ArticleId></ArticleIdList></Reference><Reference><Citation>Khera T, Mathur PA, Banner-Goodspeed VM, Narayanan S, Mcgourty M, Kelly L, et al. Scheduled Prophylactic 6-Hourly IV AcetaminopheN to Prevent Postoperative Delirium in Older CaRdiac SurgicAl Patients (PANDORA): Protocol for a multicentre randomised controlled trial. BMJ Open. 2021;11:e044346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7949372</ArticleId><ArticleId IdType="pubmed">33692183</ArticleId></ArticleIdList></Reference><Reference><Citation>Green LV. How many hospital beds? Inq J Med Care Organ Provis Financ. 2002;39:400&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">12638714</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29550095</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>06</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2496</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>6</Issue><PubDate><Year>2018</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Urologic oncology</Title><ISOAbbreviation>Urol Oncol</ISOAbbreviation></Journal><ArticleTitle>Incidence and perioperative risk factors for early acute kidney injury after radical cystectomy and urinary diversion.</ArticleTitle><Pagination><StartPage>306.e17</StartPage><EndPage>306.e23</EndPage><MedlinePgn>306.e17-306.e23</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.urolonc.2018.02.011</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1078-1439(18)30067-X</ELocationID><Abstract><AbstractText Label="BACKGROUND">Early postoperative acute kidney injury (AKI) is associated with increased morbidity and mortality following major surgery. Only few reports exist on postoperative AKI and specifically its risk factors after radical cystectomy (RC) and urinary diversion (UD). We aimed to identify risk factors for AKI in patients undergoing RC and UD.</AbstractText><AbstractText Label="METHODS">In an observational single-center cohort study, 912 consecutive bladder cancer patients undergoing RC and UD from 2000 to 2016 were evaluated for risk factors for AKI. Multiple logistic regression analysis was performed to model the association between variables and AKI.</AbstractText><AbstractText Label="RESULTS">Early postoperative AKI occurred in 100/912 patients (11%). An increased risk was seen in patients with surgery lasting&gt;400minutes, male and obese patients (&gt;25kg/m&#xb2;). Independent predictors were duration of surgery (P = 0.020), intraoperative blood loss (P = 0.049), preoperative serum creatinine values (P = 0.004), intraoperative administration of crystalloids (P = 0.032), body mass index (P = 0.031), and fluid balance (P = 0.006). Patients with AKI had a longer hospitalization time (18d vs 17d, P = 0.040). Limitations include the potential bias due to the design as a case series with prospectively collected data with some missing values.</AbstractText><AbstractText Label="CONCLUSIONS">An increased risk for AKI was seen in patients with an operative time&gt;400 minutes. Hence, in this group of patients the role of postoperative fluid management for preserving renal function should be considered. Further independent predictors of postoperative AKI were male sex, obesity, intraoperative blood loss, and a low preoperative plasma creatinine. So specially in male and obese patients, optimized perioperative nephroprotective strategies are of importance.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Furrer</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Urology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Marc P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Urology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burkhard</LastName><ForeName>Fiona C</ForeName><Initials>FC</Initials><AffiliationInfo><Affiliation>Department of Urology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wuethrich</LastName><ForeName>Patrick Y</ForeName><Initials>PY</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Pain Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Electronic address: patrick.wuethrich@insel.ch.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Urol Oncol</MedlineTA><NlmUniqueID>9805460</NlmUniqueID><ISSNLinking>1078-1439</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Urol Oncol. 2018 Dec;36(12):533-534. doi: 10.1016/j.urolonc.2018.08.005.</RefSource><PMID Version="1">30279062</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015653" MajorTopicYN="N">Cystectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001749" MajorTopicYN="N">Urinary Bladder Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014547" MajorTopicYN="N">Urinary Diversion</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Body mass index</Keyword><Keyword MajorTopicYN="N">Cystectomy</Keyword><Keyword MajorTopicYN="N">Duration of surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29550095</ArticleId><ArticleId IdType="doi">10.1016/j.urolonc.2018.02.011</ArticleId><ArticleId IdType="pii">S1078-1439(18)30067-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34593867</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>30</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Adverse outcomes after noncardiac surgery in patients with aortic stenosis.</ArticleTitle><Pagination><StartPage>19517</StartPage><MedlinePgn>19517</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">19517</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-98507-6</ELocationID><Abstract><AbstractText>Whether aortic stenosis (AS) increases perioperative risk in noncardiac surgery remains controversial. Limited information is available regarding adequate anesthetic techniques for patients with AS. Using the reimbursement claims data of Taiwan's National Health Insurance, we performed propensity score matching analyses to evaluate the risk of adverse outcomes in patients with or without AS undergoing noncardiac surgery between 2008 and 2013. We also compared the perioperative risk of AS patients undergoing general anesthesia or neuraxial anesthesia. Multivariable logistic regressions were applied to calculate the adjusted odds ratios (aORs) with 95% confidence intervals (CIs) for postoperative mortality and major complications. The matching procedure generated 9741 matched pairs for analyses. AS was significantly associated with 30-day in-hospital mortality (aOR 1.31, 95% CI 1.03-1.67), acute renal failure (aOR 1.42, 95% CI 1.12-1.79), pneumonia (aOR 1.16, 95% CI 1.02-1.33), stroke (aOR 1.14, 95% CI 1.01-1.29), and intensive care unit stay (aOR 1.38, 95% CI 1.27-1.49). Compared with neuraxial anesthesia, general anesthesia was associated with increased risks of acute myocardial infarction (aOR 3.06, 95% CI 1.22-7.67), pneumonia (aOR 1.80, 95% CI 1.32-2.46), acute renal failure (aOR 1.82, 95% CI 1.11-2.98), and intensive care (aOR 4.05, 95% CI 3.23-5.09). The findings were generally consistent across subgroups. AS was an independent risk factor for adverse events after noncardiac surgery. In addition, general anesthesia was associated with greater postoperative complications in AS patients compared to neuraxial anesthesia. This real-world evidence suggests that neuraxial anesthesia should not be contraindicated in patients with AS.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tai</LastName><ForeName>Ying-Hsuan</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Chuen-Chau</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Taipei Medical University Hospital, 252 Wuxing St., Taipei, 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology and Health Policy Research Center, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeh</LastName><ForeName>Chun-Chieh</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Surgery, China Medical University Hospital, Taichung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University of Illinois, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cherng</LastName><ForeName>Yih-Giun</ForeName><Initials>YG</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ta-Liang</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology and Health Policy Research Center, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Chien-Chang</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan. jacky48863027@yahoo.com.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Taipei Medical University Hospital, 252 Wuxing St., Taipei, 110, Taiwan. jacky48863027@yahoo.com.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology and Health Policy Research Center, Taipei Medical University Hospital, Taipei, Taiwan. jacky48863027@yahoo.com.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center of Big Data and Meta-Analysis, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan. jacky48863027@yahoo.com.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan. jacky48863027@yahoo.com.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="N">Aortic Valve Stenosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062486" MajorTopicYN="N">Public Health Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N" Type="Geographic">Taiwan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34593867</ArticleId><ArticleId IdType="pmc">PMC8484466</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-98507-6</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-98507-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Peeters FECM, et al. Calcific aortic valve stenosis: hard disease in the heart: A biomolecular approach towards diagnosis and treatment. Eur. Heart. J. 2018;39(28):2618&#x2013;2624. doi: 10.1093/eurheartj/ehx653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehx653</ArticleId><ArticleId IdType="pmc">PMC6055545</ArticleId><ArticleId IdType="pubmed">29136138</ArticleId></ArticleIdList></Reference><Reference><Citation>Barreto-Filho JA, et al. Trends in aortic valve replacement for elderly patients in the United States, 1999&#x2013;2011. JAMA. 2013;310(19):2078&#x2013;2085. doi: 10.1001/jama.2013.282437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.282437</ArticleId><ArticleId IdType="pmc">PMC4089974</ArticleId><ArticleId IdType="pubmed">24240935</ArticleId></ArticleIdList></Reference><Reference><Citation>GBD 2017 Disease and Injury Incidence and Prevalence Collaborators Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990&#x2013;2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789&#x2013;1858. doi: 10.1016/S0140-6736(18)32279-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)32279-7</ArticleId><ArticleId IdType="pmc">PMC6227754</ArticleId><ArticleId IdType="pubmed">30496104</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleisher LA, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130(24):e278&#x2013;333.</Citation><ArticleIdList><ArticleId IdType="pubmed">25085961</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristensen SD, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: Cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA) Eur. Heart. J. 2014;35(35):2383&#x2013;2431. doi: 10.1093/eurheartj/ehu285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehu285</ArticleId><ArticleId IdType="pubmed">25086026</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldman L, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N. Engl. J. Med. 1977;297(16):845&#x2013;850. doi: 10.1056/NEJM197710202971601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM197710202971601</ArticleId><ArticleId IdType="pubmed">904659</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Keefe JH, et al. Risk of noncardiac surgical procedures in patients with aortic stenosis. Mayo Clin. Proc. 1989;64(4):400&#x2013;405. doi: 10.1016/S0025-6196(12)65728-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0025-6196(12)65728-0</ArticleId><ArticleId IdType="pubmed">2716354</ArticleId></ArticleIdList></Reference><Reference><Citation>Raymer K, Yang H. Patients with aortic stenosis: Cardiac complications in non-cardiac surgery. Can. J. Anaesth. 1998;45(9):855&#x2013;859. doi: 10.1007/BF03012219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03012219</ArticleId><ArticleId IdType="pubmed">9818108</ArticleId></ArticleIdList></Reference><Reference><Citation>Torsher LC, et al. Risk of patients with severe aortic stenosis undergoing noncardiac surgery. Am. J. Cardiol. 1998;81(4):448&#x2013;452. doi: 10.1016/S0002-9149(97)00926-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9149(97)00926-0</ArticleId><ArticleId IdType="pubmed">9485135</ArticleId></ArticleIdList></Reference><Reference><Citation>Kertai MD, et al. Aortic stenosis: An underestimated risk factor for perioperative complications in patients undergoing noncardiac surgery. Am. J. Med. 2004;116(1):8&#x2013;13. doi: 10.1016/j.amjmed.2003.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2003.07.012</ArticleId><ArticleId IdType="pubmed">14706659</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahid M, Sonel AF, Saba S, Good CB. Perioperative risk of noncardiac surgery associated with aortic stenosis. Am. J. Cardiol. 2005;96(3):436&#x2013;438. doi: 10.1016/j.amjcard.2005.03.095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2005.03.095</ArticleId><ArticleId IdType="pubmed">16054477</ArticleId></ArticleIdList></Reference><Reference><Citation>Adunsky A, Kaplan A, Arad M, Mizrahi E, Gottlieb S. Aortic stenosis in elderly hip fractured patients. Arch. Gerontol. Geriatr. 2008;46(3):401&#x2013;408. doi: 10.1016/j.archger.2007.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.archger.2007.05.013</ArticleId><ArticleId IdType="pubmed">17628722</ArticleId></ArticleIdList></Reference><Reference><Citation>Calleja AM, Dommaraju S, Gaddam R, Cha S, Khandheria BK, Chaliki HP. Cardiac risk in patients aged &gt;75 years with asymptomatic, severe aortic stenosis undergoing noncardiac surgery. Am. J. Cardiol. 2010;105(8):1159&#x2013;1163. doi: 10.1016/j.amjcard.2009.12.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2009.12.019</ArticleId><ArticleId IdType="pubmed">20381670</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal S, Rajamanickam A, Bajaj NS, Griffin BP, Catacutan T, Svensson LG. Impact of aortic stenosis on postoperative outcomes after noncardiac surgeries. Circ. Cardiovasc. Qual. Outcomes. 2013;6(2):193&#x2013;200. doi: 10.1161/CIRCOUTCOMES.111.000091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.111.000091</ArticleId><ArticleId IdType="pubmed">23481524</ArticleId></ArticleIdList></Reference><Reference><Citation>Tashiro T, et al. Perioperative risk of major non-cardiac surgery in patients with severe aortic stenosis: A reappraisal in contemporary practice. Eur. Heart J. 2014;35(35):2372&#x2013;2381. doi: 10.1093/eurheartj/ehu044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehu044</ArticleId><ArticleId IdType="pmc">PMC4176046</ArticleId><ArticleId IdType="pubmed">24553722</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson C, et al. Noncardiac surgery in patients with aortic stenosis: A contemporary study on outcomes in a matched sample from the Danish health care system. Clin. Cardiol. 2014;37(11):680&#x2013;686. doi: 10.1002/clc.22324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.22324</ArticleId><ArticleId IdType="pmc">PMC6649606</ArticleId><ArticleId IdType="pubmed">25224044</ArticleId></ArticleIdList></Reference><Reference><Citation>Taniguchi T, et al. Elective non-cardiac surgery in patients with severe aortic stenosis&#x2014;observations from the CURRENT AS Registry. Circ. J. 2020;84(7):1173&#x2013;1182. doi: 10.1253/circj.CJ-20-0026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-20-0026</ArticleId><ArticleId IdType="pubmed">32435000</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller R. Miller&#x2019;s Anesthesia. 8. Elsevier; 2014. p. 1692.</Citation></Reference><Reference><Citation>Johansson S, Lind MN. Central regional anaesthesia in patients with aortic stenosis&#x2014;a systematic review. Dan. Med. J. 2017;64(9):A5407.</Citation><ArticleIdList><ArticleId IdType="pubmed">28874243</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald SB. Is neuraxial blockade contraindicated in the patient with aortic stenosis? Reg. Anesth. Pain Med. 2004;29(5):496&#x2013;502. doi: 10.1097/00115550-200409000-00017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00115550-200409000-00017</ArticleId><ArticleId IdType="pubmed">15372397</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho MC, Beathe JC, Sharrock NE. Hypotensive epidural anesthesia in patients with aortic stenosis undergoing total hip replacement. Reg. Anesth. Pain Med. 2008;33(2):129&#x2013;133. doi: 10.1097/00115550-200803000-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00115550-200803000-00007</ArticleId><ArticleId IdType="pubmed">18299093</ArticleId></ArticleIdList></Reference><Reference><Citation>Leibowitz D, et al. Effect of severe aortic stenosis on the outcome in elderly patients undergoing repair of hip fracture. Gerontology. 2009;55(3):303&#x2013;306. doi: 10.1159/000209245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000209245</ArticleId><ArticleId IdType="pubmed">19287130</ArticleId></ArticleIdList></Reference><Reference><Citation>McBrien ME, et al. Previously undiagnosed aortic stenosis revealed by auscultation in the hip fracture population&#x2013;echocardiographic findings, management and outcome. Anaesthesia. 2009;64(8):863&#x2013;870. doi: 10.1111/j.1365-2044.2009.05960.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2009.05960.x</ArticleId><ArticleId IdType="pubmed">19604190</ArticleId></ArticleIdList></Reference><Reference><Citation>Samarendra P, Mangione MP. Aortic stenosis and perioperative risk with noncardiac surgery. J. Am. Coll. Cardiol. 2015;65(3):295&#x2013;302. doi: 10.1016/j.jacc.2014.10.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2014.10.051</ArticleId><ArticleId IdType="pubmed">25614427</ArticleId></ArticleIdList></Reference><Reference><Citation>Hausman MS, Jewell ES, Engoren M. Regional versus general anesthesia in surgical patients with chronic obstructive pulmonary disease: Does avoiding general anesthesia reduce the risk of postoperative complications? Anesth. Analg. 2015;120(6):1405&#x2013;1412. doi: 10.1213/ANE.0000000000000574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000000574</ArticleId><ArticleId IdType="pubmed">25526396</ArticleId></ArticleIdList></Reference><Reference><Citation>Guay J, Choi PT, Suresh S, Albert N, Kopp S, Pace NL. Neuraxial anesthesia for the prevention of postoperative mortality and major morbidity: An overview of Cochrane systematic reviews. Anesth. Analg. 2014;119(3):716&#x2013;725. doi: 10.1213/ANE.0000000000000339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000000339</ArticleId><ArticleId IdType="pubmed">24977635</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh CC, et al. Adverse outcomes after noncardiac surgery in patients with diabetes: A nationwide population-based retrospective cohort study. Diabetes Care. 2013;36(10):3216&#x2013;3221. doi: 10.2337/dc13-0770.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc13-0770</ArticleId><ArticleId IdType="pmc">PMC3781492</ArticleId><ArticleId IdType="pubmed">23990518</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao CC, Shen WW, Chang CC, Chang H, Chen TL. Surgical adverse outcomes in patients with schizophrenia: a population-based study. Ann. Surg. 2013;257(3):433&#x2013;438. doi: 10.1097/SLA.0b013e31827b9b25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e31827b9b25</ArticleId><ArticleId IdType="pubmed">23241870</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng CL, Lee CH, Chen PS, Li YH, Lin SJ, Yang YH. Validation of acute myocardial infarction cases in the national health insurance research database in Taiwan. J. Epidemiol. 2014;24(6):500&#x2013;507. doi: 10.2188/jea.JE20140076.</Citation><ArticleIdList><ArticleId IdType="doi">10.2188/jea.JE20140076</ArticleId><ArticleId IdType="pmc">PMC4213225</ArticleId><ArticleId IdType="pubmed">25174915</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilard M, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N. Engl. J. Med. 2012;366(18):1705&#x2013;1715. doi: 10.1056/NEJMoa1114705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1114705</ArticleId><ArticleId IdType="pubmed">22551129</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok M, et al. Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers, and functional status changes. JACC. Cardiovasc. Interv. 2013;6(10):1072&#x2013;1084. doi: 10.1016/j.jcin.2013.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2013.06.008</ArticleId><ArticleId IdType="pubmed">24156967</ArticleId></ArticleIdList></Reference><Reference><Citation>Smetana GW, Lawrence VA, Cornell JE. Preoperative pulmonary risk stratification for noncardiothoracic surgery: Systematic review for the American College of Physicians. Ann. Intern. Med. 2006;144(8):581&#x2013;595. doi: 10.7326/0003-4819-144-8-200604180-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-144-8-200604180-00009</ArticleId><ArticleId IdType="pubmed">16618956</ArticleId></ArticleIdList></Reference><Reference><Citation>van Lier F, et al. Epidural analgesia is associated with improved health outcomes of surgical patients with chronic obstructive pulmonary disease. Anesthesiology. 2011;115(2):315&#x2013;321. doi: 10.1097/ALN.0b013e318224cc5c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318224cc5c</ArticleId><ArticleId IdType="pubmed">21796055</ArticleId></ArticleIdList></Reference><Reference><Citation>Argalious MY, Mao G, Davison RK, Chow C, Bhavani S. Association of intraoperative tidal volumes and acute kidney injury after noncardiac surgery. Anesth. Analg. 2020;130(4):925&#x2013;932. doi: 10.1213/ANE.0000000000004254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000004254</ArticleId><ArticleId IdType="pubmed">31166234</ArticleId></ArticleIdList></Reference><Reference><Citation>Soni N, Williams P. Positive pressure ventilation: What is the real cost? Br. J. Anaesth. 2008;101(4):446&#x2013;457. doi: 10.1093/bja/aen240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aen240</ArticleId><ArticleId IdType="pubmed">18782885</ArticleId></ArticleIdList></Reference><Reference><Citation>Zorrilla-Vaca A, Grant MC, Mathur V, Li J, Wu CL. The impact of neuraxial versus general anesthesia on the incidence of postoperative surgical site infections following knee or hip arthroplasty: A meta-analysis. Reg. Anesth. Pain Med. 2016;41(5):555&#x2013;563. doi: 10.1097/AAP.0000000000000437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AAP.0000000000000437</ArticleId><ArticleId IdType="pubmed">27380106</ArticleId></ArticleIdList></Reference><Reference><Citation>Osnabrugge RL, et al. Aortic stenosis in the elderly: Disease prevalence and number of candidates for transcatheter aortic valve replacement: A meta-analysis and modeling study. J. Am. Coll. Cardiol. 2013;62(11):1002&#x2013;1012. doi: 10.1016/j.jacc.2013.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2013.05.015</ArticleId><ArticleId IdType="pubmed">23727214</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerman BJ, Popat RA, Assimes TL, Heidenreich PA, Wren SM. Association of left ventricular ejection fraction and symptoms with mortality after elective noncardiac surgery among patients with heart failure. JAMA. 2019;321(6):572&#x2013;579. doi: 10.1001/jama.2019.0156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.0156</ArticleId><ArticleId IdType="pmc">PMC6439591</ArticleId><ArticleId IdType="pubmed">30747965</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonekura H, Ide K, Onishi Y, Nahara I, Takeda C, Kawakami K. Preoperative echocardiography for patients with hip fractures undergoing surgery: a retrospective cohort study using a nationwide database. Anesth. Analg. 2019;128(2):213&#x2013;220. doi: 10.1213/ANE.0000000000003888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000003888</ArticleId><ArticleId IdType="pubmed">30379676</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32075682</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1478-6362</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Feb</Month><Day>19</Day></PubDate></JournalIssue><Title>Arthritis research &amp; therapy</Title><ISOAbbreviation>Arthritis Res Ther</ISOAbbreviation></Journal><ArticleTitle>Acute kidney injury after primary total hip arthroplasty: a risk multiplier for complication, mortality, and healthcare utilization.</ArticleTitle><Pagination><StartPage>31</StartPage><MedlinePgn>31</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">31</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13075-020-2116-3</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To assess whether acute kidney injury (AKI) is associated with more complications and higher healthcare utilization in people undergoing primary total hip arthroplasty (THA).</AbstractText><AbstractText Label="METHODS">Using a retrospective cohort study design, we performed multivariable-adjusted logistic regression of the&#xa0;1998-2014&#x2009;US National Inpatient Sample data to assess the association of AKI with complications (infection, transfusion, revision, and mortality) and healthcare utilization (total hospital charges, discharge to a rehabilitation facility, length of hospital stay) post-THA. We calculated the odds ratio (OR) and 95% confidence intervals (CI).</AbstractText><AbstractText Label="RESULTS">Adjusted for age, gender, race, income, underlying diagnosis, medical comorbidity, and the insurance payer, AKI in people who underwent primary THA was associated with significantly higher OR (95% CI) of (1) implant infection, 2.34 (95% CI, 1.87, 2.93); (2) transfusion, 2.46 (95% CI, 2.37, 2.56); (3) revision, 2.54 (95% CI, 2.16, 2.98); (4) death, 8.52 (95% CI, 7.47, 9.73); (5) total hospital charges above the median, 2.29 (95% CI, 1.99, 2.65); (6) discharge to a rehabilitation facility, 2.11 (95% CI, 2.02, 2.20); and (7) hospital stay &gt;&#x2009;3&#x2009;days, 4.34 (95% CI, 4.16, 4.53).</AbstractText><AbstractText Label="CONCLUSION">Quality improvement initiatives with optimization of the peri-operative care to reduce AKI and subsequently&#xa0;AKI-associated complications and healthcare utilization are needed. Mechanisms of AKI-associated post-THA complications need further examination.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Jasvinder A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0003-3485-0006</Identifier><AffiliationInfo><Affiliation>Birmingham Veterans Affairs (VA) Medical Center, Birmingham, 35233, AL, USA. Jasvinder.md@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine at the School of Medicine, University of Alabama at Birmingham, Faculty Office Tower 805B, 510 20th Street S, Birmingham, AL, 35294, USA. Jasvinder.md@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Epidemiology at the School of Public Health, University of Alabama at Birmingham, Faculty Office Tower 805B, 510 20th Street S, Birmingham, AL, 35294, USA. Jasvinder.md@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cleveland</LastName><ForeName>John D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Medicine at the School of Medicine, University of Alabama at Birmingham, Faculty Office Tower 805B, 510 20th Street S, Birmingham, AL, 35294, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Arthritis Res Ther</MedlineTA><NlmUniqueID>101154438</NlmUniqueID><ISSNLinking>1478-6354</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019644" MajorTopicYN="N">Arthroplasty, Replacement, Hip</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010342" MajorTopicYN="N">Patient Acceptance of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Complications</Keyword><Keyword MajorTopicYN="N">Healthcare utilization</Keyword><Keyword MajorTopicYN="N">Outcomes</Keyword><Keyword MajorTopicYN="N">THA</Keyword><Keyword MajorTopicYN="N">Total hip arthroplasty</Keyword></KeywordList><CoiStatement>There are no financial conflicts related directly to this study. JAS has received consultant fees from Crealta/Horizon, Medisys, Fidia, UBM LLC, Medscape, WebMD, Clinical Care options, Clearview healthcare partners, Putnam associates, Spherix, the National Institutes of Health, and the American College of Rheumatology. JAS owns stock options in Amarin pharmaceuticals and Viking therapeutics. JAS is a member of the executive of OMERACT, an organization that develops outcome measures in rheumatology and receives arms-length funding from 36 companies. JAS is a member of the Veterans Affairs Rheumatology Field Advisory Committee. JAS is the editor and the Director of the UAB Cochrane Musculoskeletal Group Satellite Center on Network Meta-analysis. JAS previously served as a member of the following committees: member, the American College of Rheumatology&#x2019;s (ACR) Annual Meeting Planning Committee (AMPC) and Quality of Care Committees; the Chair of the ACR Meet-the-Professor, Workshop and Study Group Subcommittee; and the co-chair of the ACR Criteria and Response Criteria subcommittee. The other author declares that there are no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>2</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32075682</ArticleId><ArticleId IdType="pmc">PMC7409675</ArticleId><ArticleId IdType="doi">10.1186/s13075-020-2116-3</ArticleId><ArticleId IdType="pii">10.1186/s13075-020-2116-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>1990 Census. We asked&#x2026;&#x2026;You told us. Race. http://www.census.gov//apsd/cqc/cqc4.pdf. In. Edited by Commerce USDo. Washington, D.C.: U.S. Census Bureau; 1992.</Citation></Reference><Reference><Citation>Hobson C, Ozrazgat-Baslanti T, Kuxhausen A, Thottakkara P, Efron PA, Moore FA, Moldawer LL, Segal MS, Bihorac A. Cost and mortality associated with postoperative acute kidney injury. Ann Surg. 2015;261(6):1207&#x2013;1214. doi: 10.1097/SLA.0000000000000732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000000732</ArticleId><ArticleId IdType="pmc">PMC4247993</ArticleId><ArticleId IdType="pubmed">24887982</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh JA, Vessely MB, Harmsen WS, Schleck CD, Melton LJ, 3rd, Kurland RL, Berry DJ. A population-based study of trends in the use of total hip and total knee arthroplasty, 1969-2008. Mayo Clin Proc. 2010;85(10):898&#x2013;904. doi: 10.4065/mcp.2010.0115.</Citation><ArticleIdList><ArticleId IdType="doi">10.4065/mcp.2010.0115</ArticleId><ArticleId IdType="pmc">PMC2947961</ArticleId><ArticleId IdType="pubmed">20823375</ArticleId></ArticleIdList></Reference><Reference><Citation>Gharaibeh KA, Hamadah AM, Sierra RJ, Leung N, Kremers WK, El-Zoghby ZM. The rate of acute kidney injury after total hip arthroplasty is low but increases significantly in patients with specific comorbidities. J Bone Joint Surg Am. 2017;99(21):1819&#x2013;1826. doi: 10.2106/JBJS.16.01027.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.16.01027</ArticleId><ArticleId IdType="pubmed">29088036</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson KB, Winter A, Russo L, Khan A, Hair M, MacGregor MS, Holt G. Acute kidney injury following primary hip and knee arthroplasty surgery. Ann R Coll Surg Engl. 2017;99(4):307&#x2013;312. doi: 10.1308/rcsann.2016.0324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1308/rcsann.2016.0324</ArticleId><ArticleId IdType="pmc">PMC5449674</ArticleId><ArticleId IdType="pubmed">27809577</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadkarni GN, Patel AA, Ahuja Y, Annapureddy N, Agarwal SK, Simoes PK, Konstantinidis I, Kamat S, Archdeacon M, Thakar CV. Incidence, risk factors, and outcome trends of acute kidney injury in elective total hip and knee arthroplasty. Am J Orthop (Belle Mead NJ) 2016;45(1):E12&#x2013;E19.</Citation><ArticleIdList><ArticleId IdType="pubmed">26761921</ArticleId></ArticleIdList></Reference><Reference><Citation>HCUP Databases. Healthcare Cost and Utilization Project (HCUP). Overview of the Nationwide Inpatient Sample (NIS). http://www.hcup-us.ahrq.gov/nisoverview.jsp. Last modified 8/13/18.</Citation></Reference><Reference><Citation>STROBE Statement. Strengthening the reporting of observational studies in epidemiology. Link: http://www.strobe-statement.org/fileadmin/Strobe/uploads/checklists/STROBE_checklist_v4_cohort.pdf Accessed 02/28/2017.</Citation></Reference><Reference><Citation>Katz JN, Losina E, Barrett J, Phillips CB, Mahomed NN, Lew RA, Guadagnoli E, Harris WH, Poss R, Baron JA. Association between hospital and surgeon procedure volume and outcomes of total hip replacement in the United States Medicare population. J Bone Joint Surg Am. 2001;83-A(11):1622&#x2013;1629. doi: 10.2106/00004623-200111000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/00004623-200111000-00002</ArticleId><ArticleId IdType="pubmed">11701783</ArticleId></ArticleIdList></Reference><Reference><Citation>Waikar SS, Wald R, Chertow GM, Curhan GC, Winkelmayer WC, Liangos O, Sosa MA, Jaber BL. Validity of international classification of diseases, ninth revision, clinical modification codes for acute renal failure. J Am Soc Nephrol. 2006;17(6):1688&#x2013;1694. doi: 10.1681/ASN.2006010073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2006010073</ArticleId><ArticleId IdType="pubmed">16641149</ArticleId></ArticleIdList></Reference><Reference><Citation>Santaguida PL, Hawker GA, Hudak PL, Glazier R, Mahomed NN, Kreder HJ, Coyte PC, Wright JG. Patient characteristics affecting the prognosis of total hip and knee joint arthroplasty: a systematic review. Can J Surg. 2008;51(6):428&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2592576</ArticleId><ArticleId IdType="pubmed">19057730</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006;1(1):19&#x2013;32. doi: 10.2215/CJN.00240605.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.00240605</ArticleId><ArticleId IdType="pubmed">17699187</ArticleId></ArticleIdList></Reference><Reference><Citation>Abelha FJ, Botelho M, Fernandes V, Barros H. Determinants of postoperative acute kidney injury. Crit Care. 2009;13(3):R79. doi: 10.1186/cc7894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc7894</ArticleId><ArticleId IdType="pmc">PMC2717442</ArticleId><ArticleId IdType="pubmed">19463152</ArticleId></ArticleIdList></Reference><Reference><Citation>Warth LC, Noiseux NO, Hogue MH, Klaassen AL, Liu SS, Callaghan JJ. Risk of acute kidney injury after primary and revision total hip arthroplasty and total knee arthroplasty using a multimodal approach to perioperative pain control including ketorolac and celecoxib. J Arthroplast. 2016;31(1):253&#x2013;255. doi: 10.1016/j.arth.2015.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2015.08.012</ArticleId><ArticleId IdType="pubmed">26377377</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqi A, White PB, Etcheson JI, George NE, Gwam CU, Mistry JB, Patel NG, Adam H, Delanois RE. Acute kidney injury after total knee arthroplasty: a clinical review. Surg Technol Int. 2017;31:243&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pubmed">29301167</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16(11):3365&#x2013;3370. doi: 10.1681/ASN.2004090740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2004090740</ArticleId><ArticleId IdType="pubmed">16177006</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26444030</PMID><DateCompleted><Year>2016</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2016</Year><Month>12</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1523-1755</ISSN><JournalIssue CitedMedium="Internet"><Volume>89</Volume><Issue>3</Issue><PubDate><Year>2016</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Kidney international</Title><ISOAbbreviation>Kidney Int</ISOAbbreviation></Journal><ArticleTitle>Perioperative dexmedetomidine reduces the incidence and severity of acute kidney injury following valvular heart surgery.</ArticleTitle><Pagination><StartPage>693</StartPage><EndPage>700</EndPage><MedlinePgn>693-700</MedlinePgn></Pagination><Abstract><AbstractText>Acute kidney injury (AKI) following cardiac surgery is closely interrelated with hemodynamic instability and sympathetic activity, and adversely influences prognosis. Here, we investigated in a randomized placebo-controlled trial whether dexmedetomidine, an &#x3b1;2 adrenoreceptor agonist, could prevent AKI after valvular heart surgery. Two hundred patients undergoing valvular heart surgery were randomly assigned to equal placebo or treatment groups. Dexmedetomidine was infused at a rate of 0.4 &#x3bc;g/kg/h starting immediately after anesthetic induction and continuing for 24 h after surgery. We then assessed the incidence of AKI during the first 48 postoperative hours, hemodynamic variables, and a composite of major morbidity end points. The incidence of AKI, based on Acute Kidney Injury Network criteria, was significantly lower in the treatment group compared with the control group (14 vs. 33%). The dexmedetomidine group exhibited a significantly lower incidence of a composite of major morbidity end points (21 vs. 38%) and a significantly shorter length of intensive care unit stay (3 [2, 3] days vs. 3 [2, 4] days) compared with the control group. Thus, perioperative infusion of dexmedetomidine effectively reduced both the incidence and severity of AKI, and improved outcome in patients undergoing valvular heart surgery without untoward hemodynamic side effects.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Jin Sun</ForeName><Initials>JS</Initials></Author><Author ValidYN="Y"><LastName>Shim</LastName><ForeName>Jae-Kwang</ForeName><Initials>JK</Initials></Author><Author ValidYN="Y"><LastName>Soh</LastName><ForeName>Sara</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Min Kyung</ForeName><Initials>MK</Initials></Author><Author ValidYN="Y"><LastName>Kwak</LastName><ForeName>Young-Lan</ForeName><Initials>YL</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Kidney Int</MedlineTA><NlmUniqueID>0323470</NlmUniqueID><ISSNLinking>0085-2538</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058647">Adrenergic alpha-2 Receptor Agonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>67VB76HONO</RegistryNumber><NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Kidney Int. 2016 May;89(5):1163-1164. doi: 10.1016/j.kint.2015.12.052.</RefSource><PMID Version="1">27083293</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Kidney Int. 2016 May;89(5):1164-1165. doi: 10.1016/j.kint.2016.02.013.</RefSource><PMID Version="1">27083294</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Kidney Int. 2016 May;89(5):1164. doi: 10.1016/j.kint.2015.12.053.</RefSource><PMID Version="1">27083295</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058647" MajorTopicYN="N">Adrenergic alpha-2 Receptor Agonists</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020927" MajorTopicYN="N">Dexmedetomidine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006349" MajorTopicYN="N">Heart Valve Diseases</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006351" MajorTopicYN="N">Heart Valves</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007263" MajorTopicYN="N">Infusions, Parenteral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N">Republic of Korea</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>10</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>10</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26444030</ArticleId><ArticleId IdType="doi">10.1038/ki.2015.306</ArticleId><ArticleId IdType="pii">S0085-2538(15)00034-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>